PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Koganezawa, S; Sano, H; Tani, H; Tagawa, N				Koganezawa, Shinji; Sano, Hirofumi; Tani, Hiroshi; Tagawa, Norio			Reduction in secondary-actuator displacement in dual-stage actuator system by imparting rotational stiffness in hard disk drives	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							HDD	For dual-stage actuator systems in hard disk drives, stroke-saturation of the secondary actuator must be avoided to prevent the servo system from becoming unstable. In this study, a reduction in the secondary-actuator displacement was investigated by imparting a rotational stiffness to a voice coil motor (VCM). It is shown that an increase in the first resonant frequency of the VCM is largely effective for decreasing the secondary-actuator displacement in the general dual-stage actuator system. Then, an actuator, which can impart a rotational stiffness to the VCM, was designed and facilitated. A new control system for dual-stage actuators employing the actuator was also considered. It was confirmed that the proposed servo system reduced the head-positioning errors due to air-flow-induced carriage vibration by more than 35 % compared with a conventional dual-stage actuator system. Furthermore the secondary-actuator displacement was reduced 52 % on average.	[Koganezawa, Shinji; Sano, Hirofumi; Tani, Hiroshi; Tagawa, Norio] Kansai Univ, Suita, Osaka, Japan	Koganezawa, S (reprint author), Kansai Univ, Suita, Osaka, Japan.	skoga@kansai-u.ac.jp					Koganezawa S, 2001, IEEE T MAGN, V37, P955, DOI 10.1109/20.917649; Koganezawa S, 1998, IEEE T MAGN, V34, P1910, DOI 10.1109/20.706740; Herrmann G, 2003, P AMER CONTR CONF, P743; Kuwajima H, 2002, IEEE T MAGN, V38, P2156, DOI 10.1109/TMAG.2002.802798; Nojima Y, 2011, J ADV MECH DES SYST, V5, P45, DOI [10.1299/jamdsm.4.45, 10.1299/jamdsm.5.45]; Hirano T, 2004, IEEE T MAGN, V40, P3171, DOI 10.1109/TMAG.2004.829840; Yamaguchi T, 2011, HIGH-SPEED PRECISION MOTION CONTROL, P1	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	OCT	2015	21	10					2187	2195		10.1007/s00542-014-2368-4		9	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Science & Technology - Other Topics; Materials Science; Physics	CV1KM	WOS:000364015000016		
J	Davis, KF; Yu, KL; Rulli, MC; Pichdara, L; D'Odorico, P				Davis, Kyle Frankel; Yu, Kailiang; Rulli, Maria Cristina; Pichdara, Lonn; D'Odorico, Paolo			Accelerated deforestation driven by large-scale land acquisitions in Cambodia	NATURE GEOSCIENCE			English	Article							GLOBALIZATION; INVESTMENTS	Investment in agricultural land in the developing world has rapidly increased in the past two decades(1-3). In Cambodia, there has been a surge in economic land concessions, in which long-term leases are provided to foreign and domestic investors for economic development. More than two million hectares(4) have been leased so far, sparking debate over the consequences for local communities and the environment(5). Here we combined official records of concession locations(4,6) with a high-resolution data set of changes in forest cover(7) to quantify the contribution of land concessions to deforestation between 2000 and 2012. We used covariate matching to control for variables other than classification as a concession that may influence forest loss. Nearly half of the area where concessions were granted between 2000 and 2012 was forested in 2000; this area then represented 12.4% of forest land cover in Cambodia. Within concessions, the annual rate of forest loss was between 29% and 105% higher than in comparable land areas outside concessions. Most of the deforestation within concessions occurred after the contract date, and whether an investor was domestic or foreign had no effect on deforestation rates. We conclude that land acquisitions can act as powerful drivers of deforestation.	[Davis, Kyle Frankel; Yu, Kailiang; D'Odorico, Paolo] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Rulli, Maria Cristina] Politecn Milan, Dept Civil & Environm Engn, I-20133 Milan, Italy; [Pichdara, Lonn] Kyushu Univ, Dept Agroenvironm Sci Bioresource & Bioenvironm S, Forest Management, Kyushu 8190395, Japan; [Pichdara, Lonn] Cambodia Dev Resource Inst, Phnom Penh 622, Cambodia; [D'Odorico, Paolo] Univ Maryland, Natl Social Environm Synth Ctr, Annapolis, MD 21401 USA	Davis, KF (reprint author), Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA.	kfd5zs@virginia.edu			NSF Graduate Research Fellowship Program [DGE-00809128]	Funding for this study was provided by the NSF Graduate Research Fellowship Program (Grant # DGE-00809128). We would also like to thank the staff at Open Development Cambodia for making georeferenced ELC data available.	Borras SM, 2012, J AGRAR CHANGE, V12, P34, DOI 10.1111/j.1471-0366.2011.00339.x; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Rulli MC, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064030; Messerli P, 2013, CURR OPIN ENV SUST, V5, P528, DOI 10.1016/j.cosust.2013.03.004; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2014, 2014 IMP REP; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; De Schutter O, 2011, J PEASANT STUD, V38, P249, DOI 10.1080/03066150.2011.559008; [Anonymous], 2015, LAND MATR DAT; [Anonymous], 2014, CENS 2008 VILL; [Anonymous], 2014, ELC GOV DAT; Neef A, 2013, J AGR ENVIRON ETHIC, V26, P1085, DOI 10.1007/s10806-013-9446-y; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; [Anonymous], 2014, EC LAND CONC; Arc2Earth software, 2015, GOOGL MAPS DAT ARCGI; Center for International Earth Science Information Network Centro Internacional de Agricultura Tropical, 2005, GRIDD POP WORLD VERS; Cleveland D. A., 2014, BALANCING PLANET FUT; Cotula L., 2009, LAND GRAB DEV OPPORT; Cotula L, 2012, J PEASANT STUD, V39, P649, DOI 10.1080/03066150.2012.674940; D'Odorico P., 2012, NATURE GEOSCI, V7, P324; Davis KF, 2014, POPUL ENVIRON, V36, P180, DOI 10.1007/s11111-014-0215-2; Deininger K., 2011, RISING GLOBAL INTERE; FAO, 2014, FAOSTAT DAT; Fritz S., 1980, GLOBAL CHANGE BIOL, V21, P1980; Golay C., 1630, THIRD WORLD Q, V34, P1630; IIASA/FAO, 2012, GLOB AGR ZON GAEZ V3; Kugelman M., 2012, GLOBAL FARMS RACE LA; Messerli P., 2014, APPL GEOGR, V53, P449; Montemayor R. Q., 2012, GLOBAL FARMS RACE LA, P135; Neef A., 2014, LAW DEV REV, V7, P187, DOI DOI 10.1515/LDR-2014-0020; Oldenburg C., 2014, LAW DEV REV, V7, P49, DOI DOI 10.1515/LDR-2014-0014; Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; United Nations Human Rights Council, 2012, HUM RIGHTS AN EC OTH; Zoomers A, 2010, J PEASANT STUD, V37, P429, DOI 10.1080/03066151003595325	37	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	OCT	2015	8	10					772	+		10.1038/NGEO2540		5	Geosciences, Multidisciplinary	Geology	CV0OW	WOS:000363951200015		
J	Barnard, PL; Short, AD; Harley, MD; Splinter, KD; Vitousek, S; Turner, IL; Allan, J; Banno, M; Bryan, KR; Doria, A; Hansen, JE; Kato, S; Kuriyama, Y; Randall-Goodwin, E; Ruggiero, P; Walker, IJ; Heathfield, DK				Barnard, Patrick L.; Short, Andrew D.; Harley, Mitchell D.; Splinter, Kristen D.; Vitousek, Sean; Turner, Ian L.; Allan, Jonathan; Banno, Masayuki; Bryan, Karin R.; Doria, Andre; Hansen, Jeff E.; Kato, Shigeru; Kuriyama, Yoshiaki; Randall-Goodwin, Evan; Ruggiero, Peter; Walker, Ian J.; Heathfield, Derek K.			Coastal vulnerability across the Pacific dominated by El Nino/Southern Oscillation	NATURE GEOSCIENCE			English	Article							SOUTHERN-OSCILLATION; WAVE CLIMATE; SEA-LEVEL; NORTHERN-HEMISPHERE; BEACH; VARIABILITY; NINO; FREQUENCY; EVENTS; HEIGHT	To predict future coastal hazards, it is important to quantify any links between climate drivers and spatial patterns of coastal change. However, most studies of future coastal vulnerability do not account for the dynamic components of coastal water levels during storms, notably wave-driven processes, storm surges and seasonal water level anomalies, although these components can add metres to water levels during extreme events. Here we synthesize multi-decadal, co-located data assimilated between 1979 and 2012 that describe wave climate, local water levels and coastal change for 48 beaches throughout the Pacific Ocean basin. We find that observed coastal erosion across the Pacific varies most closely with El Nino/Southern Oscillation, with a smaller influence from the Southern Annular Mode and the Pacific North American pattern. In the northern and southern Pacific Ocean, regional wave and water level anomalies are significantly correlated to a suite of climate indices, particularly during boreal winter; conditions in the northeast Pacific Ocean are often opposite to those in the western and southern Pacific. We conclude that, if projections for an increasing frequency of extreme El Nino and La Nina events over the twenty-first century are confirmed, then populated regions on opposite sides of the Pacific Ocean basin could be alternately exposed to extreme coastal erosion and flooding, independent of sea-level rise.	[Barnard, Patrick L.; Vitousek, Sean; Randall-Goodwin, Evan] US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA; [Short, Andrew D.] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia; [Harley, Mitchell D.] Univ Ferrara, Dept Phys & Earth Sci, I-44122 Ferrara, Italy; [Harley, Mitchell D.; Splinter, Kristen D.; Turner, Ian L.] UNSW Australia, Water Res Lab, Sch Civil & Environm Engn, Sydney, NSW 2093, Australia; [Allan, Jonathan] Oregon Dept Geol & Mineral Ind, Coastal Field Off, Newport, OR 97365 USA; [Banno, Masayuki; Kuriyama, Yoshiaki] Port & Airport Res Inst, Yokosuka, Kanagawa 2390826, Japan; [Bryan, Karin R.] Univ Waikato, Hamilton 3240, New Zealand; [Doria, Andre] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Hansen, Jeff E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Kato, Shigeru] Toyohashi Univ Technol, Aichi 4418580, Japan; [Randall-Goodwin, Evan] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95060 USA; [Ruggiero, Peter] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Walker, Ian J.; Heathfield, Derek K.] Univ Victoria, Coastal Eros & Dune Dynam CEDD Lab, Dept Geog, Victoria, BC V8P 5C2, Canada	Barnard, PL (reprint author), US Geol Survey, Pacific Coastal & Marine Sci Ctr, Santa Cruz, CA 95060 USA.	pbarnard@usgs.gov			Coastal and Marine Geology Program of the United States Geological Survey; California Department of Boating and Waterways; United States Army Corps of Engineers; Australian Research Council; Warringah Council	Funding for this project was provided by the Coastal and Marine Geology Program of the United States Geological Survey. California beach survey data collection was funded by the California Department of Boating and Waterways and the United States Army Corps of Engineers. Many thanks to C. Fletcher, A. Gibbs and B. Richmond for providing beach survey data from Hawaii. Waikato Regional Council and Hawkes Bay Regional Council provided the New Zealand data. Australian survey data collection in New South Wales was supported by the Australian Research Council and Warringah Council, with Queensland data provided by Gold Coast City Council. Wave and water level data for these sites was supplied by Manly Hydraulics Laboratory (New South Wales) and Gold Coast City Council (Queensland).	Abyswirigunawardena D. S., 2008, ATMOSPHERE, V46, P277; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI 10.1038/NCLIMATE2100; PHINN SR, 1992, J COASTAL RES, V8, P579; Arblaster JM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045384; Nicholls RJ, 2011, PHILOS T R SOC A, V369, P161, DOI [10.1098/rsta.2010.0291, 10.1098/rsta.2010.029]; Shimura T, 2013, J CLIMATE, V26, P8654, DOI 10.1175/JCLI-D-12-00397.1; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; L'Heureux ML, 2013, NAT CLIM CHANGE, V3, P571, DOI [10.1038/nclimate1840, 10.1038/NCLIMATE1840]; ROGERS JC, 1982, MON WEATHER REV, V110, P1375, DOI 10.1175/1520-0493(1982)110<1375:SVOSLP>2.0.CO;2; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Allan JC, 2006, J COASTAL RES, V22, P511, DOI 10.2112/03-0108.1; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Tokinaga H, 2011, J CLIMATE, V24, P267, DOI 10.1175/2010JCLI3789.1; CLARKE DJ, 1988, MAR GEOL, V79, P23, DOI 10.1016/0025-3227(88)90154-5; Ranasinghe R, 2004, MAR GEOL, V204, P273, DOI 10.1016/S0025-3227(04)00002-7; BRYANT E, 1983, NATURE, V305, P213, DOI 10.1038/305213a0; Hemer MA, 2010, INT J CLIMATOL, V30, P475, DOI 10.1002/joc.1900; Young IR, 2011, SCIENCE, V332, P451, DOI 10.1126/science.1197219; Stevenson SL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052759; Harley MD, 2010, INT J CLIMATOL, V30, P1322, DOI 10.1002/joc.1962; Sallenger AH, 2002, MAR GEOL, V187, P279, DOI 10.1016/S0025-3227(02)00316-X; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; Hemer MA, 2013, NAT CLIM CHANGE, V3, P471, DOI [10.1038/nclimate1791, 10.1038/NCLIMATE1791]; Storlazzi CD, 2000, GEOL SOC AM BULL, V112, P236, DOI 10.1130/0016-7606(2000)112<0236:IOENOS>2.3.CO;2; Barnard PL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047707; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI 10.1038/NCLIMATE2492; Dee D. P., 2010, Q J R METEOROL SOC, V137, P553; Dobrynin M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052843; Erikson L. H., 2015, OCEAN MODEL; Harley M. D., 2015, COAST SED 2015 P COA; Heathfield DK, 2013, EARTH SURF PROC LAND, V38, P751, DOI 10.1002/esp.3350; Kuriyama Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050704; Mori Nobuhito, 2010, Hydrological Research Letters, V4, DOI 10.3178/HRL.4.15; Previdi M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031243; Semedo A, 2013, J CLIMATE, V26, P8269, DOI 10.1175/JCLI-D-12-00658.1; Smith R. K., 2001, J COASTAL RES, V34, P573; Thom B. G., 1978, LANDFORM EVOLUTION A; WCRP Coupled Model Intercomparison Project Phase 5--CMIP5, 2011, CLIVAR EXCHANGES, P1; Wolter K., 1993, P 17 CLIM DIAGN WORK, P52; WOLTER K, 1987, J CLIM APPL METEOROL, V26, P540, DOI 10.1175/1520-0450(1987)026<0540:TSOISC>2.0.CO;2	40	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1752-0894	1752-0908		NAT GEOSCI	Nat. Geosci.	OCT	2015	8	10					801	+		10.1038/NGEO2539		8	Geosciences, Multidisciplinary	Geology	CV0OW	WOS:000363951200022		
J	Chapman, IT; Adamek, J; Akers, RJ; Allan, S; Appel, L; Asunta, O; Barnes, M; Ben Ayed, N; Bigelow, T; Boeglin, W; Bradley, J; Brunner, J; Cahyna, P; Carr, M; Caughman, J; Cecconello, M; Challis, C; Chapman, S; Chorley, J; Colyer, G; Conway, N; Cooper, WA; Cox, M; Crocker, N; Crowley, B; Cunningham, G; Danilov, A; Darrow, D; Dendy, R; Diallo, A; Dickinson, D; Diem, S; Dorland, W; Dudson, B; Dunai, D; Easy, L; Elmore, S; Field, A; Fishpool, G; Fox, M; Fredrickson, E; Freethy, S; Garzotti, L; Ghim, YC; Gibson, K; Graves, J; Gurl, C; Guttenfelder, W; Ham, C; Harrison, J; Harting, D; Havlickova, E; Hawke, J; Hawkes, N; Hender, T; Henderson, S; Highcock, E; Hillesheim, J; Hnat, B; Holgate, J; Horacek, J; Howard, J; Huang, B; Imada, K; Jones, O; Kaye, S; Keeling, D; Kirk, A; Klimek, I; Kocan, M; Leggate, H; Lilley, M; Lipschultz, B; Lisgo, S; Liu, YQ; Lloyd, B; Lomanowski, B; Lupelli, I; Maddison, G; Mailloux, J; Martin, R; McArdle, G; McClements, K; McMillan, B; Meakins, A; Meyer, H; Michael, C; Militello, F; Milnes, J; Morris, AW; Motojima, G; Muir, D; Nardon, E; Naulin, V; Naylor, G; Nielsen, A; O'Brien, M; O'Gorman, T; Ono, Y; Oliver, H; Pamela, S; Pangione, L; Parra, F; Patel, A; Peebles, W; Peng, M; Perez, R; Pinches, S; Piron, L; Podesta, M; Price, M; Reinke, M; Ren, Y; Roach, C; Robinson, J; Romanelli, M; Rozhansky, V; Saarelma, S; Sangaroon, S; Saveliev, A; Scannell, R; Schekochihin, A; Sharapov, S; Sharples, R; Shevchenko, V; Silburn, S; Simpson, J; Storrs, J; Takase, Y; Tanabe, H; Tanaka, H; Taylor, D; Taylor, G; Thomas, D; Thomas-Davies, N; Thornton, A; Turnyanskiy, M; Valovic, M; Vann, R; Walkden, N; Wilson, H; Wyk, LV; Yamada, T; Zoletnik, S				Chapman, I. T.; Adamek, J.; Akers, R. J.; Allan, S.; Appel, L.; Asunta, O.; Barnes, M.; Ben Ayed, N.; Bigelow, T.; Boeglin, W.; Bradley, J.; Bruenner, J.; Cahyna, P.; Carr, M.; Caughman, J.; Cecconello, M.; Challis, C.; Chapman, S.; Chorley, J.; Colyer, G.; Conway, N.; Cooper, W. A.; Cox, M.; Crocker, N.; Crowley, B.; Cunningham, G.; Danilov, A.; Darrow, D.; Dendy, R.; Diallo, A.; Dickinson, D.; Diem, S.; Dorland, W.; Dudson, B.; Dunai, D.; Easy, L.; Elmore, S.; Field, A.; Fishpool, G.; Fox, M.; Fredrickson, E.; Freethy, S.; Garzotti, L.; Ghim, Y. C.; Gibson, K.; Graves, J.; Gurl, C.; Guttenfelder, W.; Ham, C.; Harrison, J.; Harting, D.; Havlickova, E.; Hawke, J.; Hawkes, N.; Hender, T.; Henderson, S.; Highcock, E.; Hillesheim, J.; Hnat, B.; Holgate, J.; Horacek, J.; Howard, J.; Huang, B.; Imada, K.; Jones, O.; Kaye, S.; Keeling, D.; Kirk, A.; Klimek, I.; Kocan, M.; Leggate, H.; Lilley, M.; Lipschultz, B.; Lisgo, S.; Liu, Y. Q.; Lloyd, B.; Lomanowski, B.; Lupelli, I.; Maddison, G.; Mailloux, J.; Martin, R.; McArdle, G.; McClements, K.; McMillan, B.; Meakins, A.; Meyer, H.; Michael, C.; Militello, F.; Milnes, J.; Morris, A. W.; Motojima, G.; Muir, D.; Nardon, E.; Naulin, V.; Naylor, G.; Nielsen, A.; O'Brien, M.; O'Gorman, T.; Ono, Y.; Oliver, H.; Pamela, S.; Pangione, L.; Parra, F.; Patel, A.; Peebles, W.; Peng, M.; Perez, R.; Pinches, S.; Piron, L.; Podesta, M.; Price, M.; Reinke, M.; Ren, Y.; Roach, C.; Robinson, J.; Romanelli, M.; Rozhansky, V.; Saarelma, S.; Sangaroon, S.; Saveliev, A.; Scannell, R.; Schekochihin, A.; Sharapov, S.; Sharples, R.; Shevchenko, V.; Silburn, S.; Simpson, J.; Storrs, J.; Takase, Y.; Tanabe, H.; Tanaka, H.; Taylor, D.; Taylor, G.; Thomas, D.; Thomas-Davies, N.; Thornton, A.; Turnyanskiy, M.; Valovic, M.; Vann, R.; Walkden, N.; Wilson, H.; Wyk, L. V.; Yamada, T.; Zoletnik, S.		MAST Team; MAST Upgrade Team	Overview of MAST results	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	RMPs; MAST; numerical modelling; high confinement operation	SPHERICAL TOKAMAK; STABILITY; PHYSICS; PEDESTAL; FACILITY; TORUS; ELMS	The Mega Ampere Spherical Tokamak (MAST) programme is strongly focused on addressing key physics issues in preparation for operation of ITER as well as providing solutions for DEMO design choices. In this regard, MAST has provided key results in understanding and optimizing H-mode confinement, operating with smaller edge localized modes (ELMs), predicting and handling plasma exhaust and tailoring auxiliary current drive. In all cases, the high-resolution diagnostic capability on MAST is complemented by sophisticated numerical modelling to facilitate a deeper understanding. Mitigation of ELMs with resonant magnetic perturbations (RMPs) with toroidal mode number n(RMP) = 2, 3, 4, 6 has been demonstrated: at high and low collisionality; for the first ELM following the transition to high confinement operation; during the current ramp-up; and with rotating n(RMP) = 3 RMPs. n(RMP) = 4, 6 fields cause less rotation braking whilst the power to access H-mode is less with n(RMP) = 4 than n(RMP) = 3, 6. Refuelling with gas or pellets gives plasmas with mitigated ELMs and reduced peak heat flux at the same time as achieving good confinement. A synergy exists between pellet fuelling and RMPs, since mitigated ELMs remove fewer particles. Inter-ELM instabilities observed with Doppler backscattering are consistent with gyrokinetic simulations of micro-tearing modes in the pedestal. Meanwhile, ELM precursors have been strikingly observed with beam emission spectroscopy (BES) measurements. A scan in beta at the L-H transition shows that pedestal height scales strongly with core pressure. Gyro-Bohm normalized turbulent ion heat flux (as estimated from the BES data) is observed to decrease with increasing tilt of the turbulent eddies. Fast ion redistribution by energetic particle modes depends on density, and access to a quiescent domain with 'classical' fast ion transport is found above a critical density. Highly efficient electron Bernstein wave current drive (1 A W-1) has been achieved in solenoid-free start-up. A new proton detector has characterized escaping fusion products. Langmuir probes and a high-speed camera suggest filaments play a role in particle transport in the private flux region whilst coherence imaging has measured scrape-off layer (SOL) flows. BOUT++ simulations show that fluxes due to filaments are strongly dependent on resistivity and magnetic geometry of the SOL, with higher radial fluxes at higher resistivity. Finally, MAST Upgrade is due to begin operation in 2016 to support ITER preparation and importantly to operate with a Super-X divertor to test extended leg concepts for particle and power exhaust.	[Chapman, I. T.; Akers, R. J.; Allan, S.; Appel, L.; Ben Ayed, N.; Carr, M.; Challis, C.; Colyer, G.; Conway, N.; Cox, M.; Crowley, B.; Cunningham, G.; Elmore, S.; Field, A.; Fishpool, G.; Freethy, S.; Garzotti, L.; Gurl, C.; Ham, C.; Harrison, J.; Harting, D.; Havlickova, E.; Hawkes, N.; Hender, T.; Henderson, S.; Hillesheim, J.; Keeling, D.; Kirk, A.; Liu, Y. Q.; Lloyd, B.; Lupelli, I.; Maddison, G.; Mailloux, J.; Martin, R.; McArdle, G.; McClements, K.; Meakins, A.; Meyer, H.; Militello, F.; Milnes, J.; Morris, A. W.; Muir, D.; Naylor, G.; O'Brien, M.; O'Gorman, T.; Pamela, S.; Pangione, L.; Patel, A.; Piron, L.; Price, M.; Roach, C.; Romanelli, M.; Saarelma, S.; Scannell, R.; Sharapov, S.; Shevchenko, V.; Simpson, J.; Storrs, J.; Taylor, D.; Thomas-Davies, N.; Thornton, A.; Turnyanskiy, M.; Valovic, M.] Culham Sci Ctr, CCFE, Abingdon OX14 3DB, Oxon, England; [Adamek, J.; Cahyna, P.; Horacek, J.] AS CR, Inst Plasma Phys, Vvi, Prague, Czech Republic; [Asunta, O.] Aalto Univ, TEKES, Espoo, Finland; [Barnes, M.; Fox, M.; Highcock, E.; Parra, F.; Schekochihin, A.; Wyk, L. V.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford, England; [Bigelow, T.; Caughman, J.; Diem, S.; Peng, M.] Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA; [Boeglin, W.; Perez, R.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Bradley, J.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool L69 3BX, Merseyside, England; [Cecconello, M.; Klimek, I.; Sangaroon, S.] Uppsala Univ, VR, SE-75120 Uppsala, Sweden; [Cooper, W. A.; Graves, J.] Ecole Polytech Fed Lausanne, CRPP, CH-1015 Lausanne, Switzerland; [Crocker, N.; Peebles, W.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Danilov, A.] Inst Nucl Fus, Kurchatov Inst, Russian Res Ctr, Moscow, Russia; [Darrow, D.; Diallo, A.; Fredrickson, E.; Guttenfelder, W.; Kaye, S.; Podesta, M.; Ren, Y.; Taylor, G.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Dickinson, D.; Dudson, B.; Easy, L.; Gibson, K.; Imada, K.; Lipschultz, B.; Reinke, M.; Vann, R.; Walkden, N.; Wilson, H.] Univ York, Dept Phys, York Plasma Inst, York YO10 5DD, N Yorkshire, England; [Dunai, D.; Zoletnik, S.] KFKI RMKI, H-1525 Budapest, Hungary; [Ghim, Y. C.] Natl Fus Res Inst, Daejeon 169148, South Korea; [Hawke, J.] Dutch Inst Fundamental Energy Res, NL-3430 BE Nieuwegein, Netherlands; [Chapman, S.; Dendy, R.; Hnat, B.; McMillan, B.; Robinson, J.] Univ Warwick, Dept Phys, Ctr Fus Space & Astrophys, Coventry CV4 7AL, W Midlands, England; [Holgate, J.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Howard, J.; Michael, C.] Australian Natl Univ, Plasma Res Lab, Canberra, ACT 0200, Australia; [Bruenner, J.; Chorley, J.; Huang, B.; Jones, O.; Lomanowski, B.; Sharples, R.; Silburn, S.; Thomas, D.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Kocan, M.; Lisgo, S.; Pinches, S.] ITER Org, CS 90046, F-13067 St Paul Les Durance, France; [Leggate, H.] Dublin City Univ, Dublin 9, Ireland; [Lilley, M.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London SW7 2AZ, England; [Nardon, E.] CEN Cadarache, F-13108 St Paul Les Durance, France; [Naulin, V.; Nielsen, A.] Risoe, Natl Lab Sustainable Energy, Roskilde, Denmark; [Ono, Y.; Takase, Y.; Tanabe, H.; Yamada, T.] Univ Tokyo, Kashiwa, Chiba 2778561, Japan; [Oliver, H.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Rozhansky, V.] St Petersburg State Polytech Univ, Dept Plasma Phys, St Petersburg, Russia; [Saveliev, A.] Ioffe Inst, St Petersburg 194021, Russia; [Tanaka, H.] Kyoto Univ, Grad Sch Energy Sci, Kyoto 6068502, Japan; [Dorland, W.] Univ Maryland, College Pk, MD 20742 USA; [Motojima, G.] NIFS, Toki, Gifu, Japan; [Henderson, S.] Univ Strathclyde, Dept Phys SUPA, Glasgow G4 ONG, Lanark, Scotland	Chapman, IT (reprint author), Culham Sci Ctr, CCFE, Abingdon OX14 3DB, Oxon, England.	ian.chapman@ccfe.ac.uk	Parra, Felix I./C-1442-2012; Sharples, Ray/N-7309-2013; Dendy, Richard/A-4533-2009; Adamek, Jiri/G-7421-2014; Chapman, Sandra/C-2216-2008; Nielsen, Anders/A-3973-2012	Parra, Felix I./0000-0001-9621-7404; Sharples, Ray/0000-0003-3449-8583; Chapman, Sandra/0000-0003-0053-1584; 			Menard JE, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083015; Snyder PB, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085035; Walkden NR, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/10/105005; Shafer MW, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3691965; Fishpool G, 2013, J NUCL MATER, V438, pS356, DOI 10.1016/j.jnucmat.2013.01.067; Arter W, 2014, IEEE T PLASMA SCI, V42, P1932, DOI 10.1109/TPS.2014.2320904; Fedorczak N, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/103013; Valovic M, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073045; Angus JR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215002; Evans TE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177657; Scannell R, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/3/035013; Saarelma S, 2007, PLASMA PHYS CONTR F, V49, P31, DOI 10.1088/0741-3335/49/1/003; Kaye SM, 2007, NUCL FUSION, V47, P499, DOI 10.1088/0029-5515/47/7/001; Kirk A, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/1/015006; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; Stroth U, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104003; Highcock EG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.215003; Wilson HR, 2002, PHYS PLASMAS, V9, P1277, DOI 10.1063/1.1459058; Chapman IT, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083006; Cecconello M, 2015, PLASMA PHYS CONTR F, V57, DOI 10.1088/0741-3335/57/1/014006; Hender TC, 1999, FUSION ENG DES, V45, P265, DOI 10.1016/S0920-3796(99)00069-1; Garzotti L, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/3/035004; Snyder PB, 2004, NUCL FUSION, V44, P320, DOI 10.1088/0029-5515/44/2/014; Morris AW, 2012, IEEE T PLASMA SCI, V40, P682, DOI 10.1109/TPS.2011.2181540; Shimada M, 2007, NUCL FUSION, V47, pS1, DOI 10.1088/0029-5515/47/6/S01; Kaye SM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.175002; Kirk A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.255003; Valanju PM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3110984; Kwak JG, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104005; JOBES F, 1984, PHYS REV LETT, V52, P1005, DOI 10.1103/PhysRevLett.52.1005; Angioni C, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.215003; Thornton AJ, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/6/064011; Jeon YM, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.035004; Chapman IT, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801743; Michael CA, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095007; Kirk A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043007; Chapman IT, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075004; Easy L, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4904207; Chapman IT, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/10/105013; Bortolon A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.235003; Thornton AJ, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/5/055008; Kaye SM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063005; Chapman IT, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/12/123003; Rice JE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.265001; Turnyanskiy M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053016; Pfefferle D, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/6/064020; Shevchenko VF, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/022004; Ham CJ, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4895602; Kirk A, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124003; Liu YQ, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124013; Chapman IT, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/4/045007; Valovic M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075016; Snyder PB, 2007, NUCL FUSION, V47, P961, DOI 10.1088/0029-5515/47/8/030; Barnes M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055005; Angus JR, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4747619; Hill DN, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104001; Pamela SJP, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095001; Ryutov DD, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2738399; Keeling DL, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013021; Dorland W, 2000, PHYS REV LETT, V85, P5579, DOI 10.1103/PhysRevLett.85.5579; Jones OM, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/8/085009; Wan BN, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104006; Havlickova E, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075008; Ghim YC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.145002; Bird TM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013004; Chapman I.T., 2014, NUCL FUSION, V55; Colyer G., 2014, PHYS REV LETT UNPUB; Dudson B.D., 2014, COMPUT PHYS CO UNPUB; Dudson BD, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124012; Field A.R., 2014, NUCL FISION UNPUB; Ghim YC, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3479037; Ham C.J., 2014, PLASMA PHYS IN PRESS; Harrison J.R., 2014, NUCL FUSION UNPUB; Harrison JR, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/6/064015; Havlickova E., 2014, PLASMA PHYS CO UNPUB; Hillesheim J., 2015, NUCL FUSION UNPUB; Hillesheim J.C., 2014, NUCL FUSION UNPUB; Kirk A, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/4/043011; Liu Y.Q., 2014, NUCL FUSION IN PRESS; Martin R., 2014, 25 IAEA FUS EN C ST; Mercier C., 1979, PLASMA PHYS CONTROLL; Meyer H, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/1/015005; Militello F, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/2/025005; Morris A.W., 2014, IEEE T PLASMA UNPUB; Oliver HJC, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/12/125017; Peng YKM, 2005, PLASMA PHYS CONTR F, V47, pB263, DOI 10.1088/0741-3335/47/12B/S20; Perez RV, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4889736; Saarelma S., 2014, NUCL FUSION UNPUB; Scannell R., 2015, PLASMA PHYS CONTROL; Scannell R, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2971971; Shevchenko V., 2014, NUCL FUSION UNPUB; Silburn SA, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4891165; Thornton A.J., 2014, 21 PLASM SURF INT C; Valovic M, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/2/025009; Valovic M, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013011; Valovic M, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/7/075006; Wilson HR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.175006; Zohm H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073019	98	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104008	10.1088/0029-5515/55/10/104008		19	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900009		
J	Ida, K; Nagaoka, K; Inagaki, S; Kasahara, H; Evans, T; Yoshinuma, M; Kamiya, K; Ohdach, S; Osakabe, M; Kobayashi, M; Sudo, S; Itoh, K; Akiyama, T; Emoto, M; Dinklage, A; Du, X; Fujii, K; Goto, M; Goto, T; Hasuo, M; Hidalgo, C; Ichiguchi, K; Ishizawa, A; Jakubowski, M; Kawamura, G; Kato, D; Morita, S; Mukai, K; Murakami, I; Murakami, S; Narushima, Y; Nunami, M; Ohno, N; Pablant, N; Sakakibara, S; Seki, T; Shimozuma, T; Shoji, M; Tanaka, K; Tokuzawa, T; Todo, Y; Wang, H; Yokoyama, M; Yamada, H; Takeiri, Y; Mutoh, T; Imagawa, S; Mito, T; Nagayama, Y; Watanabe, KY; Ashikawa, N; Chikaraishi, H; Ejiri, A; Furukawa, M; Fujita, T; Hamaguchi, S; Igami, H; Isobe, M; Masuzaki, S; Morisaki, T; Motojima, G; Nagasaki, K; Nakano, H; Oya, Y; Suzuki, C; Suzuki, Y; Sakamoto, R; Sakamoto, M; Sanpei, A; Takahashi, H; Tsuchiya, H; Tokitani, M; Ueda, Y; Yoshimura, Y; Yamamoto, S; Nishimura, K; Sugama, H; Yamamoto, T; Idei, H; Isayama, A; Kitajima, S; Masamune, S; Shinohara, K; Bawankar, PS; Bernard, E; von Berkel, M; Funaba, H; Huang, XL; Ii, T; Ido, T; Ikeda, K; Kamio, S; Kumazawa, R; Kobayashi, T; Moon, C; Muto, S; Miyazawa, J; Ming, T; Nakamura, Y; Nishimura, S; Ogawa, K; Ozaki, T; Oishi, T; Ohno, M; Pandya, S; Shimizu, A; Seki, R; Sano, R; Saito, K; Sakaue, H; Takemura, Y; Tsumori, K; Tamura, N; Tanaka, H; Toi, K; Wieland, B; Yamada, I; Yasuhara, R; Zhang, H; Kaneko, O; Komori, A				Ida, K.; Nagaoka, K.; Inagaki, S.; Kasahara, H.; Evans, T.; Yoshinuma, M.; Kamiya, K.; Ohdach, S.; Osakabe, M.; Kobayashi, M.; Sudo, S.; Itoh, K.; Akiyama, T.; Emoto, M.; Dinklage, A.; Du, X.; Fujii, K.; Goto, M.; Goto, T.; Hasuo, M.; Hidalgo, C.; Ichiguchi, K.; Ishizawa, A.; Jakubowski, M.; Kawamura, G.; Kato, D.; Morita, S.; Mukai, K.; Murakami, I.; Murakami, S.; Narushima, Y.; Nunami, M.; Ohno, N.; Pablant, N.; Sakakibara, S.; Seki, T.; Shimozuma, T.; Shoji, M.; Tanaka, K.; Tokuzawa, T.; Todo, Y.; Wang, H.; Yokoyama, M.; Yamada, H.; Takeiri, Y.; Mutoh, T.; Imagawa, S.; Mito, T.; Nagayama, Y.; Watanabe, K. Y.; Ashikawa, N.; Chikaraishi, H.; Ejiri, A.; Furukawa, M.; Fujita, T.; Hamaguchi, S.; Igami, H.; Isobe, M.; Masuzaki, S.; Morisaki, T.; Motojima, G.; Nagasaki, K.; Nakano, H.; Oya, Y.; Suzuki, C.; Suzuki, Y.; Sakamoto, R.; Sakamoto, M.; Sanpei, A.; Takahashi, H.; Tsuchiya, H.; Tokitani, M.; Ueda, Y.; Yoshimura, Y.; Yamamoto, S.; Nishimura, K.; Sugama, H.; Yamamoto, T.; Idei, H.; Isayama, A.; Kitajima, S.; Masamune, S.; Shinohara, K.; Bawankar, P. S.; Bernard, E.; von Berkel, M.; Funaba, H.; Huang, X. L.; Ii, T.; Ido, T.; Ikeda, K.; Kamio, S.; Kumazawa, R.; Kobayashi, T.; Moon, C.; Muto, S.; Miyazawa, J.; Ming, T.; Nakamura, Y.; Nishimura, S.; Ogawa, K.; Ozaki, T.; Oishi, T.; Ohno, M.; Pandya, S.; Shimizu, A.; Seki, R.; Sano, R.; Saito, K.; Sakaue, H.; Takemura, Y.; Tsumori, K.; Tamura, N.; Tanaka, H.; Toi, K.; Wieland, B.; Yamada, I.; Yasuhara, R.; Zhang, H.; Kaneko, O.; Komori, A.		Collaborators	Overview of transport and MHD stability study: focusing on the impact of magnetic field topology in the Large Helical Device	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	helical; transport; topology	LHD	The progress in the understanding of the physics and the concurrent parameter extension in the large helical device since the last IAEA-FEC, in 2012 (Kaneko O et al 2013 Nucl. Fusion 53 095024), is reviewed. Plasma with high ion and electron temperatures (T-i(0) similar to T-e(0) similar to 6 keV) with simultaneous ion and electron internal transport barriers is obtained by controlling recycling and heating deposition. A sign flip of the nondiffusive term of impurity/momentum transport (residual stress and convection flow) is observed, which is associated with the formation of a transport barrier. The impact of the topology of three-dimensional magnetic fields (stochastic magnetic fields and magnetic islands) on heat momentum, particle/impurity transport and magnetohydrodynamic stability is also discussed. In the steady state operation, a 48 min discharge with a line-averaged electron density of 1 x 10(19) m(-3) and with high electron and ion temperatures (T-i(0) similar to T-e(0) similar to 2 keV), resulting in 3.36 GJ of input energy, is achieved.	[Ida, K.; Nagaoka, K.; Kasahara, H.; Yoshinuma, M.; Ohdach, S.; Osakabe, M.; Kobayashi, M.; Sudo, S.; Itoh, K.; Akiyama, T.; Emoto, M.; Goto, M.; Goto, T.; Ichiguchi, K.; Ishizawa, A.; Kawamura, G.; Kato, D.; Morita, S.; Mukai, K.; Murakami, I.; Narushima, Y.; Nunami, M.; Sakakibara, S.; Seki, T.; Shimozuma, T.; Shoji, M.; Tanaka, K.; Tokuzawa, T.; Todo, Y.; Wang, H.; Yokoyama, M.; Yamada, H.; Takeiri, Y.; Mutoh, T.; Imagawa, S.; Mito, T.; Nagayama, Y.; Watanabe, K. Y.; Ashikawa, N.; Chikaraishi, H.; Hamaguchi, S.; Igami, H.; Isobe, M.; Masuzaki, S.; Morisaki, T.; Motojima, G.; Nakano, H.; Suzuki, C.; Suzuki, Y.; Sakamoto, R.; Takahashi, H.; Tsuchiya, H.; Tokitani, M.; Yoshimura, Y.; Nishimura, K.; Sugama, H.; Yamamoto, T.; Bernard, E.; von Berkel, M.; Funaba, H.; Ii, T.; Ido, T.; Ikeda, K.; Kamio, S.; Kumazawa, R.; Kobayashi, T.; Moon, C.; Muto, S.; Miyazawa, J.; Ming, T.; Nakamura, Y.; Nishimura, S.; Ogawa, K.; Ozaki, T.; Oishi, T.; Shimizu, A.; Seki, R.; Saito, K.; Sakaue, H.; Takemura, Y.; Tsumori, K.; Tamura, N.; Tanaka, H.; Toi, K.; Wieland, B.; Yamada, I.; Yasuhara, R.; Kaneko, O.; Komori, A.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ida, K.; Nagaoka, K.; Yoshinuma, M.; Ohdach, S.; Kobayashi, M.; Sudo, S.; Du, X.; Goto, M.; Ishizawa, A.; Kato, D.; Morita, S.; Narushima, Y.; Nunami, M.; Sakakibara, S.; Todo, Y.; Yokoyama, M.; Yamada, H.; Takeiri, Y.; Mutoh, T.; Imagawa, S.; Mito, T.; Nagayama, Y.; Ashikawa, N.; Chikaraishi, H.; Isobe, M.; Suzuki, Y.; Sakamoto, R.; Bawankar, P. S.; Funaba, H.; Huang, X. L.; Muto, S.; Miyazawa, J.; Nakamura, Y.; Oishi, T.; Ohno, M.; Pandya, S.; Sano, R.; Tsumori, K.; Zhang, H.; Kaneko, O.; Komori, A.] Grad Univ Adv Studies, Toki, Gifu 5095292, Japan; [Inagaki, S.; Idei, H.] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Evans, T.] Gen Atom Co, San Diego, CA USA; [Kamiya, K.; Isayama, A.; Shinohara, K.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Dinklage, A.; Jakubowski, M.] Max Planck Inst Plasma Phys, D-17489 Greifswald, Germany; [Fujii, K.; Hasuo, M.] Kyoto Univ, Grad Sch Engn, Dept Mech Engn & Sci, Kyoto 6068501, Japan; [Hidalgo, C.] Asociac EURATOM CIEMAT, Lab Nacl Fus, Madrid 28040, Spain; [Murakami, S.] Kyoto Univ, Dept Nucl Engn, Kyoto 6068501, Japan; [Ohno, N.; Fujita, T.] Nagoya Univ, Dept Energy Engn & Sci, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Pablant, N.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Ejiri, A.] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Furukawa, M.] Tottori Univ, Fac Engn, Dept Appl Math & Phys, Tottori 6808552, Japan; [Nagasaki, K.; Yamamoto, S.] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Oya, Y.] Shizuoka Univ, Fac Sci, Radiosci Res Lab, Suruga Ku, Shizuoka 4228529, Japan; [Sakamoto, M.] Univ Tsukuba, Plasma Res Ctr, Tsukuba, Ibaraki 3058577, Japan; [Sanpei, A.; Masamune, S.] Kyoto Inst Technol, Sakyo Ku, Kyoto 6068585, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kitajima, S.] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan	Ida, K (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	ida@nifs.ac.jp	Kyushu, RIAM/F-4018-2015				Akiyama T., 2014, P IAEA FUS EN C; Ohyabu N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.055002; Mikkelsen DR, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4890973; Kobayashi M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3368681; Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; Inagaki S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.055002; Schauer F, 2013, FUSION ENG DES, V88, P1619, DOI 10.1016/j.fusengdes.2013.01.035; Takemura Y, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/10/102001; Ida K, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/6/064007; Osakabe M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/9/095011; Ida K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013061; Ida K, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3111097; Ida K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095024; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093032; Ida K, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/1/013022; Ida K, 2005, NUCL FUSION, V45, P391, DOI 10.1088/0029-5515/45/5/010; Ida K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.065001; Rice JE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.265001; Ida K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.055001; Sakakibara S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043010; Drapiko EA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073005; Takahashi H, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073034; Fujii K, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4789454; Kamiya K, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013003; Chowdhuri MB, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103784; Ida K, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/4/045001; Dinklage A., 2014, P 25 INT C FUS EN ST; Du X., 2014, P 25 INT C FUS EN ST; Emoto M., 2014, P 25 INT C FUS EN ST; Evans T., 2014, P IAEA FUS EN C; Fujii K., 2014, P 25 INT C FUS EN ST; Goto T., 2014, P 25 INT C FUS EN ST; Ichiguchi K., 2014, P 25 INT C FUS EN ST; Ida K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6816; Inagaki S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115001; Inagaki S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113006; Inagaki S., 2014, P 25 INT C FUS EN ST; Inagaki S., 2011, PLASMA FUSION RES, V9; Ishizawa A., 2014, P 25 INT C FUS EN ST; Jakubowski M., 2014, P 25 INT C FUS EN ST; Kaneko O, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104015; Kasahara H., 2014, P 25 INT C FUS EN ST; Kawamura G, 2014, P 25 INT C FUS EN ST; Kobayashi M., 2014, P 25 INT C FUS EN ST; Masuzaki S, 2013, J NUCL MATER, V438, pS133, DOI 10.1016/j.jnucmat.2013.01.021; Mukai K., 2014, P 25 INT C FUS EN ST; Murakami I., 2014, P 25 INT C FUS EN ST; Murakami S., 2014, P 25 INT C FUS EN ST; Mutoh T, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063017; Nagaoka K., 2014, P 25 INT C FUS EN ST; Narushima Y., 2014, P 25 INT C FUS EN ST; Nunami M, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4704568; Nunami Masanori, 2010, Plasma and Fusion Research, V5, DOI 10.1585/pfr.5.016; Nunami M., 2014, P 25 INT C FUS EN ST; Ohdachi S., 2014, P 25 INT C FUS EN ST; Ohno N., 2014, P 25 INT C FUS EN ST; Osakabe M., 2014, P 25 INT C FUS EN ST; Peterson B.J., 2013, PLASMA FUSION RES, V8; Sakakibara S., 2014, P 25 INT C FUS EN ST; Seki T., 2014, P 25 INT C FUS EN ST; Shimozuma T., 2014, P 25 INT C FUS EN ST; Shoji M., 2014, P 25 INT C FUS EN ST; Sudo S, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/9/095014; Sudo S., 2014, P 25 INT C FUS EN ST; Tanaka K., 2013, PLASMA FUSION RES, V8; Tokitani M, 2013, J NUCL MATER, V438, pS818, DOI 10.1016/j.jnucmat.2013.01.177; Wang H., 2014, P 25 INT C FUS EN ST; Yokoyama M., 2014, P 25 INT C FUS EN ST; Yokoyama M., 2013, PLASMA FUSION RES, V8; Yoshinuma M., 2014, P 25 INT C FUS EN ST	70	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104018	10.1088/0029-5515/55/10/104018		10	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900019		
J	Kamada, Y				Kamada, Yutaka			Special issue: overview and summary reports from the 25th Fusion Energy Conference (St Petersburg, Russian Federation, 13-18 October 2014)	NUCLEAR FUSION			English	Editorial Material									Japan Atom Energy Agcy, Tokyo, Japan	Kamada, Y (reprint author), Japan Atom Energy Agcy, Tokyo, Japan.	kamada.yutaka@jaea.go.jp						0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							100201	10.1088/0029-5515/55/10/100201		1	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900001		
J	Kaye, SM; Abrams, T; Ahn, JW; Allain, JP; Andre, R; Andruczyk, D; Barchfeld, R; Battaglia, D; Bhattacharjee, A; Bedoya, F; Bell, RE; Belova, E; Berkery, J; Berry, L; Bertelli, N; Beiersdorfer, P; Bialek, J; Bilato, R; Boedo, J; Bonoli, P; Boozer, A; Bortolon, A; Boyer, MD; Boyle, D; Brennan, D; Breslau, J; Brooks, J; Buttery, R; Capece, A; Canik, J; Chang, CS; Crocker, N; Darrow, D; Davis, W; Delgado-Aparicio, L; Diallo, A; D'Ippolito, D; Domier, C; Ebrahimi, F; Ethier, S; Evans, T; Ferraro, N; Ferron, J; Finkenthal, M; Fonck, R; Fredrickson, E; Fu, GY; Gates, D; Gerhardt, S; Glasser, A; Gorelenkov, N; Gorelenkova, M; Goumiri, I; Gray, T; Green, D; Guttenfelder, W; Harvey, R; Hassanein, A; Heidbrink, W; Hirooka, Y; Hooper, EB; Hosea, J; Humphreys, D; Jaeger, EF; Jarboe, T; Jardin, S; Jaworski, MA; Kaita, R; Kessel, C; Kim, K; Koel, B; Kolemen, E; Kramer, G; Ku, S; Kubota, S; LaHaye, RJ; Lao, L; LeBlanc, BP; Levinton, F; Liu, D; Lore, J; Lucia, M; Luhmann, N; Maingi, R; Majeski, R; Mansfield, D; Maqueda, R; McKee, G; Medley, S; Meier, E; Menard, J; Mueller, D; Munsat, T; Muscatello, C; Myra, J; Nelson, B; Nichols, J; Ono, M; Osborne, T; Park, JK; Peebles, W; Perkins, R; Phillips, C; Podesta, M; Poli, F; Raman, R; Ren, Y; Roszell, J; Rowley, C; Russell, D; Ruzic, D; Ryan, P; Sabbagh, SA; Schuster, E; Scotti, F; Sechrest, Y; Shaing, K; Sizyuk, T; Sizyuk, V; Skinner, C; Smith, D; Snyder, P; Solomon, W; Sovenic, C; Soukhanovskii, V; Startsev, E; Stotler, D; Stratton, B; Stutman, D; Taylor, C; Taylor, G; Tritz, K; Walker, M; Wang, W; Wang, Z; White, R; Wilson, JR; Wirth, B; Wright, J; Yuan, X; Yuh, H; Zakharov, L; Zweben, SJ				Kaye, S. M.; Abrams, T.; Ahn, J. -W; Allain, J. P.; Andre, R.; Andruczyk, D.; Barchfeld, R.; Battaglia, D.; Bhattacharjee, A.; Bedoya, F.; Bell, R. E.; Belova, E.; Berkery, J.; Berry, L.; Bertelli, N.; Beiersdorfer, P.; Bialek, J.; Bilato, R.; Boedo, J.; Bonoli, P.; Boozer, A.; Bortolon, A.; Boyer, M. D.; Boyle, D.; Brennan, D.; Breslau, J.; Brooks, J.; Buttery, R.; Capece, A.; Canik, J.; Chang, C. S.; Crocker, N.; Darrow, D.; Davis, W.; Delgado-Aparicio, L.; Diallo, A.; D'Ippolito, D.; Domier, C.; Ebrahimi, F.; Ethier, S.; Evans, T.; Ferraro, N.; Ferron, J.; Finkenthal, M.; Fonck, R.; Fredrickson, E.; Fu, G. Y.; Gates, D.; Gerhardt, S.; Glasser, A.; Gorelenkov, N.; Gorelenkova, M.; Goumiri, I.; Gray, T.; Green, D.; Guttenfelder, W.; Harvey, R.; Hassanein, A.; Heidbrink, W.; Hirooka, Y.; Hooper, E. B.; Hosea, J.; Humphreys, D.; Jaeger, E. F.; Jarboe, T.; Jardin, S.; Jaworski, M. A.; Kaita, R.; Kessel, C.; Kim, K.; Koel, B.; Kolemen, E.; Kramer, G.; Ku, S.; Kubota, S.; LaHaye, R. J.; Lao, L.; LeBlanc, B. P.; Levinton, F.; Liu, D.; Lore, J.; Lucia, M.; Luhmann, N., Jr.; Maingi, R.; Majeski, R.; Mansfield, D.; Maqueda, R.; McKee, G.; Medley, S.; Meier, E.; Menard, J.; Mueller, D.; Munsat, T.; Muscatello, C.; Myra, J.; Nelson, B.; Nichols, J.; Ono, M.; Osborne, T.; Park, J. -K.; Peebles, W.; Perkins, R.; Phillips, C.; Podesta, M.; Poli, F.; Raman, R.; Ren, Y.; Roszell, J.; Rowley, C.; Russell, D.; Ruzic, D.; Ryan, P.; Sabbagh, S. A.; Schuster, E.; Scotti, F.; Sechrest, Y.; Shaing, K.; Sizyuk, T.; Sizyuk, V.; Skinner, C.; Smith, D.; Snyder, P.; Solomon, W.; Sovenic, C.; Soukhanovskii, V.; Startsev, E.; Stotler, D.; Stratton, B.; Stutman, D.; Taylor, C.; Taylor, G.; Tritz, K.; Walker, M.; Wang, W.; Wang, Z.; White, R.; Wilson, J. R.; Wirth, B.; Wright, J.; Yuan, X.; Yuh, H.; Zakharov, L.; Zweben, S. J.			An overview of recent physics results from NSTX	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	NSTX; spherical torus; overview	TOROIDAL PLASMAS; TRANSPORT; SIMULATION; CODE; DISRUPTIONS; TURBULENCE; TOKAMAKS; GEOMETRY; MODELS	The National Spherical Torus Experiment (NSTX) is currently being upgraded to operate at twice the toroidal field and plasma current (up to 1 T and 2 MA), with a second, more tangentially aimed neutral beam (NB) for current and rotation control, allowing for pulse lengths up to 5 s. Recent NSTX physics analyses have addressed topics that will allow NSTX-Upgrade to achieve the research goals critical to a Fusion Nuclear Science Facility. These include producing stable, 100% non-inductive operation in high-performance plasmas, assessing plasma-material interface (PMI) solutions to handle the high heat loads expected in the next-step devices and exploring the unique spherical torus (ST) parameter regimes to advance predictive capability. Non-inductive operation and current profile control in NSTX-U will be facilitated by co-axial helicity injection (CHI) as well as radio frequency (RF) and NB heating. CHI studies using NIMROD indicate that the reconnection process is consistent with the 2D Sweet-Parker theory. Full-wave AORSA simulations show that RF power losses in the scrape-off layer (SOL) increase significantly for both NSTX and NSTX-U when the launched waves propagate in the SOL. Toroidal Alfven eigenmode avalanches and higher frequency Alfven eigenmodes can affect NB-driven current through energy loss and redistribution of fast ions. The inclusion of rotation and kinetic resonances, which depend on collisionality, is necessary for predicting experimental stability thresholds of fast growing ideal wall and resistive wall modes. Neutral beams and neoclassical toroidal viscosity generated from applied 3D fields can be used as actuators to produce rotation profiles optimized for global stability. DEGAS-2 has been used to study the dependence of gas penetration on SOL temperatures and densities for the MGI system being implemented on the Upgrade for disruption mitigation. PMI studies have focused on the effect of ELMs and 3D fields on plasma detachment and heat flux handling. Simulations indicate that snowflake and impurity seeded radiative divertors are candidates for heat flux mitigation in NSTX-U. Studies of lithium evaporation on graphite surfaces indicate that lithium increases oxygen surface concentrations on graphite, and deuterium-oxygen affinity, which increases deuterium pumping and reduces recycling. In situ and test-stand experiments of lithiated graphite and molybdenum indicate temperature-enhanced sputtering, although that test-stand studies also show the potential for heat flux reduction through lithium vapour shielding. Non-linear gyro kinetic simulations have indicated that ion transport can be enhanced by a shear-flow instability, and that non-local effects are necessary to explain the observed rapid changes in plasma turbulence. Predictive simulations have shown agreement between a microtearing-based reduced transport model and the measured electron temperatures in a microtearing unstable regime. Two Alfven eigenmode-driven fast ion transport models have been developed and successfully benchmarked against NSTX data. Upgrade construction is moving on schedule with initial physics research operation of NSTX-U planned for mid-2015.	[Kaye, S. M.; Abrams, T.; Andre, R.; Battaglia, D.; Bhattacharjee, A.; Bell, R. E.; Belova, E.; Bertelli, N.; Boyer, M. D.; Boyle, D.; Breslau, J.; Capece, A.; Chang, C. S.; Darrow, D.; Davis, W.; Delgado-Aparicio, L.; Diallo, A.; Ethier, S.; Fredrickson, E.; Fu, G. Y.; Gates, D.; Gerhardt, S.; Gorelenkov, N.; Gorelenkova, M.; Guttenfelder, W.; Hosea, J.; Jardin, S.; Jaworski, M. A.; Kaita, R.; Kessel, C.; Kim, K.; Kolemen, E.; Kramer, G.; Ku, S.; LeBlanc, B. P.; Maingi, R.; Majeski, R.; Mansfield, D.; Medley, S.; Menard, J.; Mueller, D.; Nichols, J.; Ono, M.; Park, J. -K.; Perkins, R.; Phillips, C.; Podesta, M.; Poli, F.; Ren, Y.; Skinner, C.; Solomon, W.; Startsev, E.; Stotler, D.; Stratton, B.; Taylor, G.; Wang, W.; Wang, Z.; White, R.; Wilson, J. R.; Yuan, X.; Zakharov, L.; Zweben, S. J.] Princeton Univ, Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Ahn, J. -W; Berry, L.; Canik, J.; Gray, T.; Green, D.; Ryan, P.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Allain, J. P.; Andruczyk, D.; Bedoya, F.; Lucia, M.; Ruzic, D.; Sizyuk, V.] Univ Illinois, Urbana, IL USA; [Barchfeld, R.; Domier, C.; Muscatello, C.] Univ Calif Davis, Davis, CA 95616 USA; [Berkery, J.; Bialek, J.; Boozer, A.; Sabbagh, S. A.] Columbia Univ, New York, NY USA; [Beiersdorfer, P.; Hooper, E. B.; Meier, E.; Scotti, F.; Soukhanovskii, V.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Bilato, R.] IPP, Garching, Germany; [Boedo, J.] Univ Calif San Diego, San Diego, CA 92103 USA; [Bonoli, P.; Wright, J.] MIT, Cambridge, MA 02139 USA; [Bortolon, A.; Wirth, B.] Univ Tennessee, Knoxville, TN USA; [Brennan, D.; Ebrahimi, F.; Goumiri, I.; Koel, B.; Lore, J.; Roszell, J.; Rowley, C.] Princeton Univ, Princeton, NJ 08544 USA; [Brooks, J.; Hassanein, A.; Sizyuk, T.; Taylor, C.] Purdue Univ, W Lafayette, IN 47907 USA; [Buttery, R.; Evans, T.; Ferraro, N.; Ferron, J.; Humphreys, D.; LaHaye, R. J.; Lao, L.; Osborne, T.; Snyder, P.; Walker, M.] Gen Atom Co, San Diego, CA USA; [Crocker, N.; Kubota, S.; Luhmann, N., Jr.; Peebles, W.] Univ Calif Los Angeles, Los Angeles, CA USA; [D'Ippolito, D.; Myra, J.; Russell, D.] Lodestar Res Corp, Boulder, CO USA; [Finkenthal, M.; Stutman, D.; Tritz, K.] Johns Hopkins Univ, Baltimore, MD USA; [Fonck, R.; McKee, G.; Shaing, K.; Smith, D.; Sovenic, C.] Univ Wisconsin, Madison, WI USA; [Glasser, A.; Jarboe, T.; Nelson, B.; Raman, R.] Univ Washington, Seattle, WA 98195 USA; [Harvey, R.] CompX, Del Mar, CA USA; [Heidbrink, W.; Liu, D.] Univ Calif Irvine, Irvine, CA USA; [Hirooka, Y.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Jaeger, E. F.] XCEL, Oak Ridge, TN USA; [Levinton, F.; Maqueda, R.; Yuh, H.] Nova Photon, Princeton, NJ USA; [Munsat, T.; Sechrest, Y.] Univ Colorado, Boulder, CO 80309 USA; [Schuster, E.] Lehigh Univ, Bethlehem, PA 18015 USA	Kaye, SM (reprint author), Princeton Univ, Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.	skaye@pppl.gov	Wirth, Brian/O-4878-2015; Stutman, Dan/P-4048-2015; Liu, Deyong/Q-2797-2015; 	Wirth, Brian/0000-0002-0395-0285; Liu, Deyong/0000-0001-9174-7078; Allain, Jean Paul/0000-0003-1348-262X			Abdou M.A., 1996, FUSION TECHNOL, V29; Menard JE, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083015; STOTLER D, 1994, CONTRIB PLASM PHYS, V34, P392, DOI 10.1002/ctpp.2150340246; Bortolon A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265008; Gerhardt SP, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083021; HIRSHMAN SP, 1983, PHYS FLUIDS, V26, P3553, DOI 10.1063/1.864116; Ghantous K, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4752011; Wang F, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4824739; Perkins RJ, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083025; Candy J, 2003, J COMPUT PHYS, V186, P545, DOI 10.1016/S0021-9991(03)00079-2; Scotti F, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083001; Kaye SM, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4893135; SHAING KC, 1983, PHYS FLUIDS, V26, P3315, DOI 10.1063/1.864108; Jenko F, 2000, PHYS PLASMAS, V7, P1904, DOI 10.1063/1.874014; Sabbagh SA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104007; Myra JR, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073013; Berkery JW, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4876610; Menard JE, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103014; Kugel HW, 2010, FUSION ENG DES, V85, P865, DOI 10.1016/j.fusengdes.2010.04.004; Zweben SJ, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/9/095010; Mansfield DK, 2009, J NUCL MATER, V390-91, P764, DOI 10.1016/j.jnucmat.2009.01.203; Heidbrink WW, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093006; Ahn JW, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/12/122004; Taylor G, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3371956; Hu B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.105002; Kaye SM, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045010; Kim K, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/7/073014; Podesta M, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/5/055003; Maingi R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135004; Park W, 1999, PHYS PLASMAS, V6, P1796, DOI 10.1063/1.873437; Pankin A, 2004, COMPUT PHYS COMMUN, V159, P157, DOI 10.1016/j.cpc.2003.11.002; Jaeger EF, 2001, PHYS PLASMAS, V8, P1573, DOI 10.1063/1.1359516; Spong DA, 2001, NUCL FUSION, V41, P711, DOI 10.1088/0029-5515/41/6/305; Stutman D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.115002; Bertelli N, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/8/083004; Redd AJ, 2009, J FUSION ENERG, V28, P203, DOI 10.1007/s10894-008-9183-9; Zweben SJ, 2004, NUCL FUSION, V44, P134, DOI 10.1088/0029-5515/44/1/016; Belova EV, 2003, PHYS PLASMAS, V10, P3240, DOI 10.1063/1.1592155; Wang WX, 2004, COMPUT PHYS COMMUN, V164, P178, DOI 10.1016/j.cpc.2004.06.027; Zhu W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.225002; Diallo A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093026; KAYE SM, 1988, NUCL FUSION, V28, P1963, DOI 10.1088/0029-5515/28/11/004; Jaworski MA, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124040; Berkery JW, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4873894; JARDIN SC, 1986, J COMPUT PHYS, V66, P481, DOI 10.1016/0021-9991(86)90077-X; Ebrahimi F, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821974; BONDESON A, 1994, PHYS REV LETT, V72, P2709, DOI 10.1103/PhysRevLett.72.2709; Raman R, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073017; Berkery JW, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3474925; Ferraro NM, 2009, J COMPUT PHYS, V228, P7742, DOI 10.1016/j.jcp.2009.07.015; Lin-Liu YR, 2003, PHYS PLASMAS, V10, P4064, DOI 10.1063/1.1610472; Wang WX, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3459096; Gerhardt SP, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043020; Gerhardt SP, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083020; Brambilla M, 1999, PLASMA PHYS CONTR F, V41, P1, DOI 10.1088/0741-3335/41/1/002; Ryutov DD, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2738399; Maingi R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.075001; CHENG CZ, 1987, J COMPUT PHYS, V71, P124, DOI 10.1016/0021-9991(87)90023-4; Rognlien TD, 2002, FUSION ENG DES, V60, P497, DOI 10.1016/S0920-3796(02)00005-4; REBUT PH, 1986, PLASMA PHYS CONTR F, V28, P113, DOI 10.1088/0741-3335/28/1A/010; Sun Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/5/053015; ROGNLIEN TD, 1992, J NUCL MATER, V196, P347, DOI 10.1016/S0022-3115(06)80058-9; Boyle DP, 2013, J NUCL MATER, V438, pS979, DOI 10.1016/j.jnucmat.2013.01.213; Boyle DP, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/10/105011; Canik JM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113016; Crocker NA, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043017; DeTEMMERMAN C.G., 2012, J VAC SCI TECHNOL A, V30; Devaux S, 2011, J NUCL MATER, V415, pS865, DOI 10.1016/j.jnucmat.2011.01.050; Eich T, 2011, J NUCL MATER, V415, pS856, DOI 10.1016/j.jnucmat.2010.11.079; Eich T, 2013, J NUCL MATER, V438, pS72, DOI 10.1016/j.jnucmat.2013.01.011; Fredrickson ED, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.145001; Fredrickson ED, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801663; Fredrickson ED, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013006; Gray T.K., 2014, NUCL FUSION, V54; Hawryluk R. J., 1980, PHYSICS PLASMAS CLOS, V1, P19; Hooper EB, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4821977; Kaita R., 2014, IEEE T PLASMA UNPUB; Kallman J, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3494381; Kramer G.J., 2013, PLASMA PHYS CONTROL, V55; Kritz A. H., 1982, P 3 INT S HEAT TOR P, V2, P707; Meier E.T., 2014, NUCL FUSION UNPUB; Morris A.W., 2014, IEEE T PLASMA SCI, V42, P402; Park J.-K., 2011, PHYS PLASMAS, V14; Perkins R.J., 2014, NUCL FUSION UNPUB; Podesta M.A., 2012, NUCL FUSION, V52; Raman R, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4885545; Raman R, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3628540; Rebut P.H., 1988, P 12 IAEA C PLASM PH; Scotti F., 2014, J NUCL MATER, V439, P1; Solomon W., 2009, PHYS REV LETT, V101; Sovenic C.R., 2004, J COMPUT PHYS, V195, P355; Wang F, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4816026	92	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104002	10.1088/0029-5515/55/10/104002		18	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900003		
J	Kobayashi, M; Xu, Y; Ida, K; Corre, Y; Feng, Y; Schmitz, O; Frerichs, H; Tabares, FL; Evans, TE; Coenen, JW; Liang, Y; Bader, A; Itoh, K; Yamada, H; Ghendrih, P; Ciraolo, G; Tafalla, D; Lopez-Fraguas, A; Guo, HY; Cui, ZY; Reiter, D; Asakura, N; Wenzel, U; Morita, S; Ohno, N; Peterson, BJ; Masuzaki, S				Kobayashi, M.; Xu, Y.; Ida, K.; Corre, Y.; Feng, Y.; Schmitz, O.; Frerichs, H.; Tabares, F. L.; Evans, T. E.; Coenen, J. W.; Liang, Y.; Bader, A.; Itoh, K.; Yamada, H.; Ghendrih, Ph.; Ciraolo, G.; Tafalla, D.; Lopez-Fraguas, A.; Guo, H. Y.; Cui, Z. Y.; Reiter, D.; Asakura, N.; Wenzel, U.; Morita, S.; Ohno, N.; Peterson, B. J.; Masuzaki, S.			3D effects of edge magnetic field configuration on divertor/scrape-off layer transport and optimization possibilities for a future reactor	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	3D effects; divertor transport; helical devices; tokamaks; magnetic perturbation	DYNAMIC ERGODIC DIVERTOR; ALCATOR C-MOD; LARGE HELICAL DEVICE; LONG-PULSE DISCHARGES; TORE-SUPRA; TOKAMAK PLASMAS; IMPURITY BEHAVIOR; ASDEX UPGRADE; TJ-II; NEOCLASSICAL TRANSPORT	This paper assesses the three-dimensional (3D) effects of the edge magnetic field structure on divertor/scrape-off layer transport, based on an inter-machine comparison of experimental data and on the recent progress of 3D edge transport simulation. The 3D effects are elucidated as a consequence of competition between transports parallel (parallel to) and perpendicular (perpendicular to) to the magnetic field, in open field lines cut by divertor plates, or in magnetic islands. The competition has strong impacts on divertor functions, such as determination of the divertor density regime, impurity screening and detachment control. The effects of magnetic perturbation on the edge electric field and turbulent transport are also discussed. Parameterization to measure the 3D effects on the edge transport is attempted for the individual divertor functions. Based on the suggested key parameters, an operation domain of the 3D divertor configuration is discussed for future devices.	[Kobayashi, M.; Ida, K.; Itoh, K.; Yamada, H.; Morita, S.; Peterson, B. J.; Masuzaki, S.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Xu, Y.; Cui, Z. Y.] Southwestern Inst Phys, Chengdu 610041, Peoples R China; [Corre, Y.; Ghendrih, Ph.; Ciraolo, G.] CEA Cadarache ST Paul Lez Durance, IRFM, St Paul Les Durance, France; [Feng, Y.; Wenzel, U.] Max Planck Inst Plasma Phys, D-17491 Greifswald, Germany; [Schmitz, O.; Frerichs, H.; Bader, A.] Univ Wisconsin, Madison, WI 53706 USA; [Tabares, F. L.; Tafalla, D.; Lopez-Fraguas, A.] CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain; [Evans, T. E.; Guo, H. Y.] Gen Atom, San Diego, CA 92186 USA; [Coenen, J. W.; Liang, Y.; Reiter, D.] Forschungszentrum Julich, Inst Energie & Klimaforsch Plasmaphys, D-52425 Julich, Germany; [Guo, H. Y.] Chinese Acad Sci, Inst Plasma Phys, Hefei, Peoples R China; [Asakura, N.] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Ohno, N.] Nagoya Univ, Nagoya, Aichi 4648603, Japan	Kobayashi, M (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	kobayashi.masahiro@lhd.nifs.ac.jp					Alejaldre C, 1999, PLASMA PHYS CONTR F, V41, pA539, DOI 10.1088/0741-3335/41/3A/047; Anderson DT, 2006, FUSION SCI TECHNOL, V50, P171; NEUHAUSER J, 1989, PLASMA PHYS CONTR F, V31, P1551, DOI 10.1088/0741-3335/31/10/006; LaBombard B, 1997, J NUCL MATER, V241, P149, DOI 10.1016/S0022-3115(97)80037-2; Strachan JD, 2004, NUCL FUSION, V44, P772, DOI 10.1088/0029-5515/44/7/009; Lehnen M, 2005, J NUCL MATER, V337, P171, DOI 10.1016/j.jnucmat.2004.10.100; Morisaki T, 2003, J NUCL MATER, V313, P548, DOI 10.1016/S0022-3115(02)01467-8; Tanaka H, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3496389; Xu Y, 2007, NUCL FUSION, V47, P1696, DOI 10.1088/0029-5515/47/12/008; Evans TE, 2006, NAT PHYS, V2, P419, DOI 10.1038/nphys312; SAMAIN A, 1984, J NUCL MATER, V128, P395, DOI 10.1016/0022-3115(84)90383-0; UO K, 1961, J PHYS SOC JPN, V16, P1380, DOI 10.1143/JPSJ.16.1380; Grigull P, 2003, J NUCL MATER, V313, P1287, DOI 10.1016/S0022-3115(02)01499-X; MAHDAVI MA, 1981, PHYS REV LETT, V47, P1602, DOI 10.1103/PhysRevLett.47.1602; Kobayashi M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3368681; Morita S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093017; Federici G, 2001, NUCL FUSION, V41, P1967, DOI 10.1088/0029-5515/41/12/218; Conway GD, 2015, PLASMA PHYS CONTR F, V57, DOI 10.1088/0741-3335/57/1/014035; STANGEBY PC, 1993, NUCL FUSION, V33, P1695, DOI 10.1088/0029-5515/33/11/I10; Kobayashi M, 2010, FUSION SCI TECHNOL, V58, P220; Evans TE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2177657; GROSMAN A, 1992, J NUCL MATER, V196, P59, DOI 10.1016/S0022-3115(06)80012-7; Feng Y, 2002, PLASMA PHYS CONTR F, V44, P611, DOI 10.1088/0741-3335/44/5/308; Colin C, 2015, J NUCL MATER, V463, P654, DOI 10.1016/j.jnucmat.2015.01.019; Xu Y, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/3/035005; Meslin B, 1999, J NUCL MATER, V266, P318, DOI 10.1016/S0022-3115(98)00875-7; Devynck P, 2002, NUCL FUSION, V42, P697, DOI 10.1088/0029-5515/42/6/308; Masuzaki S, 2003, J NUCL MATER, V313, P852, DOI 10.1016/S0022-3115(02)01461-7; Beyer P, 2002, PLASMA PHYS CONTR F, V44, P2167, DOI 10.1088/0741-3335/44/10/307; Evans TE, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024002; Stotler DP, 1999, J NUCL MATER, V266, P947, DOI 10.1016/S0022-3115(98)00555-8; Ahn JW, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/1/015005; Pitcher CS, 1997, PLASMA PHYS CONTR F, V39, P779, DOI 10.1088/0741-3335/39/6/001; Leonard AW, 1997, PHYS REV LETT, V78, P4769, DOI 10.1103/PhysRevLett.78.4769; EVANS TE, 1992, J NUCL MATER, V196, P421, DOI 10.1016/S0022-3115(06)80071-1; Strachan JD, 2003, NUCL FUSION, V43, P922, DOI 10.1088/0029-5515/43/9/317; Harrison JR, 2015, J NUCL MATER, V463, P757, DOI 10.1016/j.jnucmat.2014.11.125; HINTON FL, 1976, REV MOD PHYS, V48, P239, DOI 10.1103/RevModPhys.48.239; SHISHKIN AA, 1981, NUCL FUSION, V21, P603, DOI 10.1088/0029-5515/21/5/009; Tokar MZ, 1999, J NUCL MATER, V266, P958, DOI 10.1016/S0022-3115(98)00680-1; SHAING KC, 1986, PHYS FLUIDS, V29, P521, DOI 10.1063/1.865439; Hirsch M, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/5/053001; LIPPMANN S, 1991, NUCL FUSION, V31, P2131, DOI 10.1088/0029-5515/31/11/009; Frerichs H, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054008; Robinson JR, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/10/105007; Liang Y, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/2/025013; Li J, 2013, NAT PHYS, V9, P817, DOI [10.1038/nphys2795, 10.1038/NPHYS2795]; Wischmeier M, 2015, J NUCL MATER, V463, P22, DOI 10.1016/j.jnucmat.2014.12.078; Renner H, 2000, NUCL FUSION, V40, P1083, DOI 10.1088/0029-5515/40/6/306; GROSMAN A, 1990, PLASMA PHYS CONTR F, V32, P1011, DOI 10.1088/0741-3335/32/11/013; Telesca G, 2009, J NUCL MATER, V390-91, P227, DOI 10.1016/j.jnucmat.2009.01.061; Nakamura Y, 2003, NUCL FUSION, V43, P219, DOI 10.1088/0029-5515/43/4/301; HIRSHMAN SP, 1981, NUCL FUSION, V21, P1079, DOI 10.1088/0029-5515/21/9/003; Eich T, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093031; Leconte M, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/1/013004; OHYABU N, 1994, NUCL FUSION, V34, P387, DOI 10.1088/0029-5515/34/3/I07; Ida K, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013061; Finken KH, 1999, NUCL FUSION, V39, P637, DOI 10.1088/0029-5515/39/5/306; Feng Y, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/9/095002; Guo HY, 2000, NUCL FUSION, V40, P379, DOI 10.1088/0029-5515/40/3/308; Evans TE, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093029; Feng Y, 2014, CONTRIB PLASM PHYS, V54, P426, DOI 10.1002/ctpp.201410092; SHIMOMURA Y, 1983, NUCL FUSION, V23, P869, DOI 10.1088/0029-5515/23/7/002; Strachan JD, 2005, J NUCL MATER, V337, P25, DOI 10.1016/j.jnucmat.2004.09.069; ASAKURA N, 1995, NUCL FUSION, V35, P381, DOI 10.1088/0029-5515/35/4/I02; Xu Y, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063020; Feng Y, 2004, CONTRIB PLASM PHYS, V44, P57, DOI 10.1002/ctpp.20041009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/3/033011; Tokar MZ, 2004, PHYS PLASMAS, V11, P4610, DOI 10.1063/1.1791232; Yamada H, 2010, FUSION SCI TECHNOL, V58, P12; STANGEBY PC, 1990, NUCL FUSION, V30, P1225, DOI 10.1088/0029-5515/30/7/005; SPITZER L, 1958, PHYS FLUIDS, V1, P253, DOI 10.1063/1.1705883; Frerichs H, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/034004; Runov AM, 2001, PHYS PLASMAS, V8, P916, DOI 10.1063/1.1344921; Ida K, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3111097; Yoshinuma M, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/6/062002; Feng Y, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/2/024009; Kobayashi M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093032; Frerichs H, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4926524; Yanagi N, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/10/103017; Nakamura Y, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075014; Suttrop W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225004; Ghendrih P, 1996, PLASMA PHYS CONTR F, V38, P1653, DOI 10.1088/0741-3335/38/10/002; Loarte A, 1998, NUCL FUSION, V38, P331, DOI 10.1088/0029-5515/38/3/303; Nakamura Y, 2002, PLASMA PHYS CONTR F, V44, P2121, DOI 10.1088/0741-3335/44/10/304; Schmitz O, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/4/043005; Fischer R, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/11/115008; LOARTE A, 1992, CONTRIB PLASM PHYS, V32, P468, DOI 10.1002/ctpp.2150320344; Tokar MZ, 1997, PLASMA PHYS CONTR F, V39, P569, DOI 10.1088/0741-3335/39/4/005; TAKAMURA S, 1988, NUCL FUSION, V28, P183, DOI 10.1088/0029-5515/28/2/001; Feng Y, 2005, NUCL FUSION, V45, P89, DOI 10.1088/0029-5515/45/2/003; BRETON C, 1991, NUCL FUSION, V31, P1774, DOI 10.1088/0029-5515/31/9/017; Tamain P, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/7/075017; Liang Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.105003; Liang Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.235002; Zhou HY, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106103; Loarte A, 2007, NUCL FUSION, V47, pS203, DOI 10.1088/0029-5515/47/6/S04; Kallenbach A, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045007; Lasnier CJ, 1998, NUCL FUSION, V38, P1225, DOI 10.1088/0029-5515/38/8/209; Zagorski R, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024013; Liang Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073036; Schmitz O, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/12/124029; LIPSCHULTZ B, 1995, J NUCL MATER, V220, P50, DOI 10.1016/0022-3115(94)00446-3; Lunt T, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054013; WOOTTON AJ, 1990, J NUCL MATER, V176, P77, DOI 10.1016/0022-3115(90)90030-Q; Chatthong B, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/1/013007; Garcia-Cortes I, 2006, FUSION SCI TECHNOL, V50, P307; Tamain P, 2010, J COMPUT PHYS, V229, P361, DOI 10.1016/j.jcp.2009.09.031; Kobayashi M, 2015, J NUCL MATER, V463, P2, DOI 10.1016/j.jnucmat.2015.01.011; Bader A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113036; PAYAN J, 1995, NUCL FUSION, V35, P1357, DOI 10.1088/0029-5515/35/11/I03; LABOMBARD B, 1995, PHYS PLASMAS, V2, P2242, DOI 10.1063/1.871248; Corre Y, 2007, NUCL FUSION, V47, P119, DOI 10.1088/0029-5515/47/2/006; Schmitz O, 2009, J NUCL MATER, V390-91, P330, DOI 10.1016/j.jnucmat.2009.01.149; Garcia-Cortes I, 2005, J NUCL MATER, V337, P441, DOI 10.1016/j.jnucmat.2004.07.055; Drapiko EA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/7/073005; Ciraolo G, 2014, CONTRIB PLASM PHYS, V54, P432, DOI 10.1002/ctpp.201410018; MIZUUCHI T, 1990, J NUCL MATER, V176, P1070, DOI 10.1016/0022-3115(90)90194-R; Ida K, 1997, PHYS PLASMAS, V4, P310, DOI 10.1063/1.872091; Ishida S, 1999, NUCL FUSION, V39, P1211, DOI 10.1088/0029-5515/39/9Y/301; Evans TE, 2002, PHYS PLASMAS, V9, P4957, DOI 10.1063/1.1521125; Schmitz O, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024009; MCCOOL SC, 1989, NUCL FUSION, V29, P547, DOI 10.1088/0029-5515/29/4/001; Feng Y, 2006, NUCL FUSION, V46, P807, DOI 10.1088/0029-5515/46/8/006; NICOLAI A, 1985, PLASMA PHYS CONTR F, V27, P1479, DOI 10.1088/0741-3335/27/12B/002; Reiser D, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2771133; Loarte A, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/3/033007; Kukushkin AS, 2003, NUCL FUSION, V43, P716, DOI 10.1088/0029-5515/43/8/312; Coenen JW, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063030; Clever M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054005; Covele B, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/7/072006; Hill DN, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104001; Kocan M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073047; Ghendrih P, 2002, NUCL FUSION, V42, P1221, DOI 10.1088/0029-5515/42/10/308; Brezinsek S, 2015, J NUCL MATER, V463, P11, DOI 10.1016/j.jnucmat.2014.12.007; KASTELEWICZ H, 1995, PLASMA PHYS CONTR F, V37, P723, DOI 10.1088/0741-3335/37/7/003; Frerichs H, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/2/023001; Chowdhuri MB, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3103784; Gruber O, 1999, NUCL FUSION, V39, P1321, DOI 10.1088/0029-5515/39/9Y/309; Reiter D, 2005, FUSION SCI TECHNOL, V47, P172; Lehnen M, 2005, PLASMA PHYS CONTR F, V47, pB237, DOI 10.1088/0741-3335/47/12B/S18; Garcia OE, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2336422; Feng Y, 2003, J NUCL MATER, V313, P857, DOI 10.1016/S0022-3115(02)01463-0; SAMAIN A, 1982, J NUCL MATER, V111, P408, DOI 10.1016/0022-3115(82)90239-2; Loarte A, 1997, J NUCL MATER, V241, P118, DOI 10.1016/S0022-3115(96)00500-4; Asakura N., 2011, NUCL FUSION, V53; Boedo J.A., 2011, 38 EPS C PLASM PHYS; Burhenn R, 2004, FUSION SCI TECHNOL, V46, P115; Corre Y., 2001, THESIS U PARIS; Dei-cas R., 1975, PLASMA PHYS CONTROL, V1, P563; Evans T. E., 2005, Journal of Physics: Conference Series, V7, DOI 10.1088/1742-6596/7/1/015; Ezumi N., 2009, J PLASMA FUSION RES, V8, P429; Feng Y, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024012; Finken K.H., 2005, ENERGY TECHNOLOGY, V45; Frerichs H., 2015, COMMUNICATION; Frerichs H, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4864624; GHENDRIH P, 1992, PLASMA PHYS CONTR F, V34, P2007; Grigull P, 2001, PLASMA PHYS CONTR F, V43, pA175, DOI 10.1088/0741-3335/43/12A/313; Groth M, 2011, J NUCL MATER, V415, pS530, DOI 10.1016/j.jnucmat.2010.10.024; Horton C.W., 1984, HDB PLASMA PHYS, V2, P435; Hoshino K, 2011, J NUCL MATER, V415, pS549, DOI 10.1016/j.jnucmat.2011.01.003; Ida K., 2010, P 23 IAEA INT C FUS; Stambaugh R, 1999, NUCL FUSION, V39, P2391, DOI 10.1088/0029-5515/39/12/304; Itoh K., 1999, TRANSPORT STRUCTURAL, P36; Kadomtsev B.B., 1979, PLASMA PHYS CONTROLL, V1, P649; Kerst D.W., 1962, Journal of Nuclear Energy. C. Plasma Physics, Accelerators, Thermonuclear Research, V4, DOI 10.1088/0368-3281/4/4/303; Kobayashi M., 2013, JOINT 19 ISHW 16 IEA; Kobayashi M., 2009, J PLASMA FUSION RES, V85, P393; Koenig R., 2002, PLASMA PHYS CONTROL, V44, P2365; Leconte M, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3610547; Lipschultz B, 2007, FUSION SCI TECHNOL, V51, P369; Loarte A, 2001, PLASMA PHYS CONTR F, V43, pR183, DOI 10.1088/0741-3335/43/6/201; Lunt T, 2013, J NUCL MATER, V438, pS254, DOI 10.1016/j.jnucmat.2013.01.040; McLean A.G., 2015, J NUCL MATER, V463, P33; Muller HW, 2013, J NUCL MATER, V438, pS64, DOI 10.1016/j.jnucmat.2013.01.010; Nguyen F, 1997, NUCL FUSION, V37, P743, DOI 10.1088/0029-5515/37/6/I03; Peterson B.J., 2013, PLASMA FUSION RES, V8; Romanelli F, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104002; ROSENBLU.MN, 1966, NUCL FUSION, V6, P297, DOI 10.1088/0029-5515/6/4/008; Scarin P., 2010, P 23 IAEA C FUS EN D; Schmitz O, 2013, J NUCL MATER, V438, pS194, DOI 10.1016/j.jnucmat.2013.01.025; Schmitz O, 2011, J NUCL MATER, V415, pS886, DOI 10.1016/j.jnucmat.2011.01.136; Schmitz O., 2013, INT STELL HEL WORKSH; Spitzer Jr L., 1951, NYO993PMS1 US AT EN; Stangeby P., 2000, PLASMA BOUNDARY MAGN; Strumberger E, 1996, NUCL FUSION, V36, P891, DOI 10.1088/0029-5515/36/7/I06; Uo K., 1958, KAKU YUGO KENKYU, V1, P20	187	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104021	10.1088/0029-5515/55/10/104021		22	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900022		
J	Puiatti, ME; Dal Bello, S; Marrelli, L; Martin, P; Agostinetti, P; Agostini, M; Antoni, V; Auriemma, F; Barbisan, M; Barbui, T; Baruzzo, M; Battistella, M; Belli, F; Bettini, P; Bigi, M; Bilel, R; Boldrin, M; Bolzonella, T; Bonfiglio, D; Brombin, M; Buffa, A; Canton, A; Cappello, S; Carraro, L; Cavazzana, R; Cester, D; Chacon, L; Chapman, BE; Chitarin, G; Ciaccio, G; Cooper, WA; Dalla Palma, M; Deambrosis, S; Delogu, R; De Lorenzi, A; De Masi, G; Dong, JQ; Escande, DF; Esposito, B; Fassina, A; Fellin, F; Ferro, A; Finotti, C; Franz, P; Frassinetti, L; Palumbo, MF; Gaio, E; Ghezzi, F; Giudicotti, L; Gnesotto, F; Gobbin, M; Gonzales, WA; Grando, L; Guo, SC; Hanson, JD; Hirshman, SP; Innocente, P; Jackson, JL; Kiyama, S; Komm, M; Laguardia, L; Li, C; Liu, SF; Liu, YQ; Lorenzini, R; Luce, TC; Luchetta, A; Maistrello, A; Manduchi, G; Mansfield, DK; Marchiori, G; Marconato, N; Marocco, D; Marcuzzi, D; Martines, E; Martini, S; Matsunaga, G; Mazzitelli, G; Miorin, E; Momo, B; Moresco, M; Okabayashi, M; Olofsson, E; Paccagnella, R; Patel, N; Pavei, M; Peruzzo, S; Pilan, N; Pigatto, L; Piovan, R; Piovesan, P; Piron, C; Piron, L; Predebon, I; Rea, C; Recchia, M; Rigato, V; Rizzolo, A; Roquemore, AL; Rostagni, G; Ruset, C; Ruzzon, A; Sajo-Bohus, L; Sakakita, H; Sanchez, R; Sarff, JS; Sartori, E; Sattin, F; Scaggion, A; Scarin, P; Schmitz, O; Sonato, P; Spada, E; Spagnolo, S; Spolaore, M; Spong, DA; Spizzo, G; Stevanato, L; Takechi, M; Taliercio, C; Terranova, D; Trevisan, GL; Urso, G; Valente, M; Valisa, M; Veranda, M; Vianello, N; Viesti, G; Villone, F; Vincenzi, P; Visona', N; Wang, ZR; White, RB; Xanthopoulos, P; Xu, XY; Yanovskiy, V; Zamengo, A; Zanca, P; Zaniol, B; Zanotto, L; Zilli, E; Zuin, M				Puiatti, M. E.; Dal Bello, S.; Marrelli, L.; Martin, P.; Agostinetti, P.; Agostini, M.; Antoni, V.; Auriemma, F.; Barbisan, M.; Barbui, T.; Baruzzo, M.; Battistella, M.; Belli, F.; Bettini, P.; Bigi, M.; Bilel, R.; Boldrin, M.; Bolzonella, T.; Bonfiglio, D.; Brombin, M.; Buffa, A.; Canton, A.; Cappello, S.; Carraro, L.; Cavazzana, R.; Cester, D.; Chacon, L.; Chapman, B. E.; Chitarin, G.; Ciaccio, G.; Cooper, W. A.; Dalla Palma, M.; Deambrosis, S.; Delogu, R.; De Lorenzi, A.; De Masi, G.; Dong, J. Q.; Escande, D. F.; Esposito, B.; Fassina, A.; Fellin, F.; Ferro, A.; Finotti, C.; Franz, P.; Frassinetti, L.; Palumbo, M. Furno; Gaio, E.; Ghezzi, F.; Giudicotti, L.; Gnesotto, F.; Gobbin, M.; Gonzales, W. A.; Grando, L.; Guo, S. C.; Hanson, J. D.; Hirshman, S. P.; Innocente, P.; Jackson, J. L.; Kiyama, S.; Komm, M.; Laguardia, L.; Li, C.; Liu, S. F.; Liu, Y. Q.; Lorenzini, R.; Luce, T. C.; Luchetta, A.; Maistrello, A.; Manduchi, G.; Mansfield, D. K.; Marchiori, G.; Marconato, N.; Marocco, D.; Marcuzzi, D.; Martines, E.; Martini, S.; Matsunaga, G.; Mazzitelli, G.; Miorin, E.; Momo, B.; Moresco, M.; Okabayashi, M.; Olofsson, E.; Paccagnella, R.; Patel, N.; Pavei, M.; Peruzzo, S.; Pilan, N.; Pigatto, L.; Piovan, R.; Piovesan, P.; Piron, C.; Piron, L.; Predebon, I.; Rea, C.; Recchia, M.; Rigato, V.; Rizzolo, A.; Roquemore, A. L.; Rostagni, G.; Ruset, C.; Ruzzon, A.; Sajo-Bohus, L.; Sakakita, H.; Sanchez, R.; Sarff, J. S.; Sartori, E.; Sattin, F.; Scaggion, A.; Scarin, P.; Schmitz, O.; Sonato, P.; Spada, E.; Spagnolo, S.; Spolaore, M.; Spong, D. A.; Spizzo, G.; Stevanato, L.; Takechi, M.; Taliercio, C.; Terranova, D.; Trevisan, G. L.; Urso, G.; Valente, M.; Valisa, M.; Veranda, M.; Vianello, N.; Viesti, G.; Villone, F.; Vincenzi, P.; Visona', N.; Wang, Z. R.; White, R. B.; Xanthopoulos, P.; Xu, X. Y.; Yanovskiy, V.; Zamengo, A.; Zanca, P.; Zaniol, B.; Zanotto, L.; Zilli, E.; Zuin, M.			Overview of the RFX-mod contribution to the international Fusion Science Program	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	reversed field pinch; single helicity; tokamak; 3D boundary	REVERSED-FIELD PINCH; PLASMAS; MHD; BIFURCATION; TOKAMAK	The RFX-mod device is operated both as a reversed field pinch (RFP), where advanced regimes featuring helical shape develop, and as a tokamak. Due to its flexibility, RFX-mod is contributing to the solution of key issues in the roadmap to ITER and DEMO, including MHD instability control, internal transport barriers, edge transport and turbulence, isotopic effect, high density limit and three-dimensional (3D) non-linear MHD modelling. This paper reports recent advancements in the understanding of the self-organized helical states, featuring a strong electron transport barrier, in the RFP configuration; the physical mechanism driving the residual transport at the barrier has been investigated. Following the first experiments with deuterium as the filling gas, new results concerning the isotope effect in the RFP are discussed. Studies on the high density limit show that in the RFP it is related to a toroidal particle accumulation due to the onset of a convective cell. In the tokamak configuration, q(a) regimes down to q(a) = 1.2 have been pioneered, with (2,1) tearing mode (TM) mitigated and (2,1) resistive wall mode (RWM) stabilized: the control of such modes can be obtained both by poloidal and radial sensors. Progress has been made in the avoidance of disruptions due to the (2,1) TM by applying q(a) control, and on the general issue of error field control. The effect of externally applied 3D fields on plasma flow and edge turbulence, sawtooth control and runaway electron decorrelation has been analysed. The experimental program is supported by substantial theoretical activity: 3D non-linear visco-resistive MHD and non-local transport modelling have been advanced; RWMs have been studied by a toroidal MHD kinetic hybrid stability code.	[Puiatti, M. E.; Dal Bello, S.; Marrelli, L.; Martin, P.; Agostinetti, P.; Agostini, M.; Antoni, V.; Auriemma, F.; Barbisan, M.; Barbui, T.; Baruzzo, M.; Battistella, M.; Bettini, P.; Bigi, M.; Bilel, R.; Boldrin, M.; Bolzonella, T.; Bonfiglio, D.; Brombin, M.; Buffa, A.; Canton, A.; Cappello, S.; Carraro, L.; Cavazzana, R.; Chitarin, G.; Ciaccio, G.; Dalla Palma, M.; Delogu, R.; De Lorenzi, A.; De Masi, G.; Fassina, A.; Fellin, F.; Ferro, A.; Finotti, C.; Franz, P.; Palumbo, M. Furno; Gaio, E.; Giudicotti, L.; Gnesotto, F.; Gobbin, M.; Gonzales, W. A.; Grando, L.; Guo, S. C.; Innocente, P.; Lorenzini, R.; Luchetta, A.; Maistrello, A.; Manduchi, G.; Marchiori, G.; Marconato, N.; Marcuzzi, D.; Martines, E.; Martini, S.; Momo, B.; Moresco, M.; Paccagnella, R.; Patel, N.; Pavei, M.; Peruzzo, S.; Pilan, N.; Pigatto, L.; Piovan, R.; Piovesan, P.; Piron, C.; Piron, L.; Predebon, I.; Rea, C.; Recchia, M.; Rigato, V.; Rizzolo, A.; Rostagni, G.; Ruzzon, A.; Sartori, E.; Sattin, F.; Scaggion, A.; Scarin, P.; Sonato, P.; Spada, E.; Spagnolo, S.; Spolaore, M.; Spizzo, G.; Taliercio, C.; Terranova, D.; Trevisan, G. L.; Valente, M.; Valisa, M.; Veranda, M.; Vianello, N.; Vincenzi, P.; Visona', N.; Xu, X. Y.; Yanovskiy, V.; Zamengo, A.; Zanca, P.; Zaniol, B.; Zanotto, L.; Zilli, E.; Zuin, M.] Consorzio RFX, I-35137 Padua, Italy; [Belli, F.; Esposito, B.; Marocco, D.; Mazzitelli, G.] Ctr Ric Energia ENEA Frascati, Frascati, Italy; [Cester, D.; Rea, C.; Stevanato, L.; Viesti, G.] Univ Padua, Dipartimento Fis & Astron, Padua, Italy; [Chacon, L.; Hirshman, S. P.; Sanchez, R.; Spong, D. A.] ORNL Fus Energy Div, Oak Ridge, TN USA; [Chapman, B. E.; Miorin, E.; Sarff, J. S.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Cooper, W. A.] Ecole Polytech Fed Lausanne, Ctr Rech Phys Plasmas, CH-1015 Lausanne, Switzerland; [Deambrosis, S.] CNR IENI, I-35127 Padua, Italy; [Dong, J. Q.] Zhejiang Univ, Inst Fus Theory & Simulat, Hangzhou 310003, Zhejiang, Peoples R China; [Dong, J. Q.] Southwestern Inst Phys, Chengdu, Peoples R China; [Escande, D. F.] Aix Marseille Univ, CNRS, PIIM, UMR 7345, Marseille, France; [Frassinetti, L.; Olofsson, E.] Royal Inst Technol KTH, SE-10044 Stockholm, Sweden; [Ghezzi, F.; Laguardia, L.] CNR IFP, I-20125 Milan, Italy; [Hanson, J. D.] Auburn Univ, Dept Phys, Auburn, AL 36849 USA; [Jackson, J. L.; Luce, T. C.] Gen Atom Co, San Diego, CA 92186 USA; [Kiyama, S.; Sakakita, H.] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Plasma Frontier Grp, Tsukuba, Ibaraki 3058568, Japan; [Komm, M.] Acad Sci Czech Republic, Inst Plasma Phys, Prague, Czech Republic; [Liu, S. F.] Nankai Univ, Dept Phys, Tianjin 300071, Peoples R China; [Liu, Y. Q.] CCFE Fus Assoc, Culham Sci Ctr, Abingdon OX14 3DB, Oxon, England; [Mansfield, D. K.; Okabayashi, M.; Roquemore, A. L.; Wang, Z. R.; White, R. B.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Matsunaga, G.; Takechi, M.] Japan Atom Energy Agcy, Naka, Ibaraki 3110193, Japan; [Ruset, C.] Assoc Euratom MEdC, Natl Inst Laser Plasma & Radiat Phys, Bucharest, Romania; [Sajo-Bohus, L.] Univ Simon Bolivar, Nucl Phys Lab, Caracas, Venezuela; [Sanchez, R.] Univ Carlos III Madrid, Madrid, Spain; [Schmitz, O.] Univ Wisconsin, Dept Engn Phys, Madison, WI USA; [Urso, G.] CNR, Ist Applicaz Calcolo M Picone, Rome, Italy; [Villone, F.] Univ Cassino, DAEIMI, Consorzio CREATE, I-03043 Cassino, Italy; [Xanthopoulos, P.] Max Planck Inst Plasma Phys, Teilinst Greifswald, D-17491 Greifswald, Germany; [Li, C.] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China	Puiatti, ME (reprint author), Consorzio RFX, Corso Stati Uniti 4, I-35137 Padua, Italy.	mariaester.puiatti@igi.cnr.it	Spizzo, Gianluca/B-7075-2009; Komm, Michael/C-1602-2010; Martines, Emilio/B-1418-2009	Spizzo, Gianluca/0000-0001-8586-2168; Martines, Emilio/0000-0002-4181-2959			Alfier A, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/3/035013; Martin P, 2003, NUCL FUSION, V43, P1855, DOI 10.1088/0029-5515/43/12/028; Cappello S, 2000, PHYS REV LETT, V85, P3838, DOI 10.1103/PhysRevLett.85.3838; Terranova D, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/3/035006; Pusztai I, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3663844; Martin P, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/10/104018; Lorenzini R, 2009, NAT PHYS, V5, P570, DOI 10.1038/NPHYS1308; Gobbin M, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/10/105010; Albanese R, 2008, IEEE T MAGN, V44, P1654, DOI 10.1109/TMAG.2007.915303; WHITE RB, 1984, PHYS FLUIDS, V27, P2455, DOI 10.1063/1.864527; Liu YQ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3008045; Predebon I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.195001; Escande DF, 2000, PHYS REV LETT, V85, P3169, DOI 10.1103/PhysRevLett.85.3169; Cappello S, 2004, PLASMA PHYS CONTR F, V46, pB313, DOI 10.1088/0741-3335/46/12B/027; Veranda M, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/7/074015; Lorenzini R, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/4/043012; Spizzo G, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/5/054015; Puiatti ME, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124013; Piovesan P, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4806765; Franz P, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053011; Garofalo AM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.235001; Puiatti ME, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/4/045012; Piovesan P, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085036; Piron L, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113022; Terranova D, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113014; Hanson JD, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075031; Innocente P, 2015, J NUCL MATER, V463, P1138, DOI 10.1016/j.jnucmat.2014.11.088; Boozer AH, 2001, PHYS REV LETT, V86, P5059, DOI 10.1103/PhysRevLett.86.5059; Paccagnella R, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4868728; Puiatti ME, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073001; Bonfiglio D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.085002; Auriemma F., 2014, 41 EPS C PLASM PHYS; Bolzonella T., 2014, PLASMA FUSION RES, V9; Cappello S, 2012, P 24 IAEA FUS EN C S; Carraro L, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073048; Guo S., 2014, P 25 INT FUS EN C ST; Hirshman S.P., 1983, PHYS FLUIDS, V26, P3554; Horton W., 1996, CHAOS STRUCTURES NON; Howell DF, 2007, NUCL FUSION, V47, P1336, DOI 10.1088/0029-5515/47/9/034; Martin P., 2014, P 25 INT FUS EN C ST; Martines E, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/3/035015; Piovesan P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.045003; Spizzo G, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/4/043007; Spolaore M, 2014, P 25 INT FUS EN C ST; Vianello N., 2014, PLASMA PHYS CONTROL, V57; Wesson J., 2011, INT SERIES MONOGRAPH, V149; Wurden G.A., 1987, PHYSICS MIRRORS REVE, V1, P159; Zanca P, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/9/094004; Zanca P, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/1/015006; Zuin M, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/3/035012; Zuin M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.055002	51	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104012	10.1088/0029-5515/55/10/104012		13	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900013		
J	Sanchez, J; Alegre, D; Alonso, A; Alonso, J; Alvarez, P; Arevalo, J; Ascasibar, E; Baciero, A; Baiao, D; Barcala, JM; Blanco, E; Borchardt, M; Botija, J; Cabrera, S; de la Cal, E; Calvo, I; Cappa, A; Carrasco, R; Castejon, F; Castro, R; De Castro, A; Catalan, G; Chmyga, AA; Chamorro, M; Dinklage, A; Eliseev, L; Estrada, T; Fernandez-Marina, F; Fontdecaba, JM; Garcia, L; Garcia-Gomez, R; Garcia-Regana, JM; Guasp, J; Hatzky, R; Hernandez, J; Herranz, J; Hidalgo, C; Hollmann, E; Jimenez, JA; Jimenez-Denche, A; Kirpitchev, I; Kleiber, R; Komarov, AD; Kozachok, AS; Krupnik, L; Lapayese, F; Liniers, M; Liu, B; Lopez-Bruna, D; Lopez-Fraguas, A; Lopez-Razola, J; de Aguilera, AM; Martin-Diaz, F; Martin-Hernandez, F; Martin-Rojo, AB; Martinez-Fernandez, J; McCarthy, KJ; Medina, F; Medrano, M; Melon, L; Melnikov, AV; Mendez, P; van Milligen, B; Molinero, A; Monreal, P; Moreno, R; Navarro, M; Nedzelskiy, IS; Ochando, MA; Olivares, J; Oyarzabal, E; de Pablos, JL; Pacios, L; Pastor, I; Pedrosa, MA; de la Pena, A; Pereira, A; Petrov, A; Petrov, S; Portas, AB; Ratta, G; Rincon, E; Rios, L; Rodriguez, C; Rojo, B; Ros, A; Sanchez, M; Sanchez, E; Sanchez-Sarabia, E; Sarksian, K; Satake, S; Sebastian, JA; Silva, C; Solano, ER; Soleto, A; Sun, B; Tabares, FL; Tafalla, D; Tallents, S; Tolkachev, A; Vega, J; Velasco, G; Velasco, JL; Wolfers, G; Yokoyama, M; Zurro, B				Sanchez, J.; Alegre, D.; Alonso, A.; Alonso, J.; Alvarez, P.; Arevalo, J.; Ascasibar, E.; Baciero, A.; Baiao, D.; Barcala, J. M.; Blanco, E.; Borchardt, M.; Botija, J.; Cabrera, S.; de la Cal, E.; Calvo, I.; Cappa, A.; Carrasco, R.; Castejon, F.; Castro, R.; De Castro, A.; Catalan, G.; Chmyga, A. A.; Chamorro, M.; Dinklage, A.; Eliseev, L.; Estrada, T.; Fernandez-Marina, F.; Fontdecaba, J. M.; Garcia, L.; Garcia-Gomez, R.; Garcia-Regana, J. M.; Guasp, J.; Hatzky, R.; Hernandez, J.; Herranz, J.; Hidalgo, C.; Hollmann, E.; Jimenez, J. A.; Jimenez-Denche, A.; Kirpitchev, I.; Kleiber, R.; Komarov, A. D.; Kozachok, A. S.; Krupnik, L.; Lapayese, F.; Liniers, M.; Liu, B.; Lopez-Bruna, D.; Lopez-Fraguas, A.; Lopez-Razola, J.; Martin de Aguilera, A.; Martin-Diaz, F.; Martin-Hernandez, F.; Martin-Rojo, A. B.; Martinez-Fernandez, J.; McCarthy, K. J.; Medina, F.; Medrano, M.; Melon, L.; Melnikov, A. V.; Mendez, P.; van Milligen, B.; Molinero, A.; Monreal, P.; Moreno, R.; Navarro, M.; Nedzelskiy, I. S.; Ochando, M. A.; Olivares, J.; Oyarzabal, E.; de Pablos, J. L.; Pacios, L.; Pastor, I.; Pedrosa, M. A.; de la Pena, A.; Pereira, A.; Petrov, A.; Petrov, S.; Portas, A. B.; Ratta, G.; Rincon, E.; Rios, L.; Rodriguez, C.; Rojo, B.; Ros, A.; Sanchez, M.; Sanchez, E.; Sanchez-Sarabia, E.; Sarksian, K.; Satake, S.; Sebastian, J. A.; Silva, C.; Solano, E. R.; Soleto, A.; Sun, B.; Tabares, F. L.; Tafalla, D.; Tallents, S.; Tolkachev, A.; Vega, J.; Velasco, G.; Velasco, J. L.; Wolfers, G.; Yokoyama, M.; Zurro, B.			Transport, stability and plasma control studies in the TJ-II stellarator	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	transport; stability; control	CONFINEMENT; LITHIUM	The main TJ-II results since 2012 are presented in this overview. Impurity confinement is studied showing an isotopic dependence of impurity confinement time, asymmetries in parallel impurity flows in TJ-II ion-root plasmas and impurity density asymmetries within a flux surface. In addition, first observations of electrostatic potential variations within the same magnetic flux surface are presented. Evidence of the impact of three-dimensional magnetic structures on plasma confinement and L-H transitions is also presented. The leading role of the plasma turbulence is emphasized by the observed temporal ordering of the limit cycle oscillations at the L-I-H transition. Comparative studies between tokamaks and stellarators have provided direct experimental evidence for the importance of multi-scale physics to unravel the impact of the isotope effect on transport. Novel solutions for plasma facing components based on the recently installed Li-liquid limiters (LLLs) have been developed on TJ-II, showing the self-screening effect of evaporating liquid lithium, protecting plasma-facing components against heat loads, and tritium inventory control. Regarding plasma stability, magnetic well scan experiments show that traditional stability criteria, on which the optimization of stellarator configurations is based, may miss some stabilization mechanisms. Further effects of ECRH on Alfvenic instabilities are investigated, showing that moderate off-axis ECH power deposition modifies the continuous nature of the Alfven eigenmodes, and frequency chirping sets in. This result shows that ECH can be a tool for AE control that might be ITER and reactor-relevant.	[Sanchez, J.; Alegre, D.; Alonso, A.; Alonso, J.; Alvarez, P.; Arevalo, J.; Ascasibar, E.; Baciero, A.; Barcala, J. M.; Blanco, E.; Botija, J.; Cabrera, S.; de la Cal, E.; Calvo, I.; Cappa, A.; Carrasco, R.; Castejon, F.; Castro, R.; De Castro, A.; Catalan, G.; Chamorro, M.; Estrada, T.; Fernandez-Marina, F.; Fontdecaba, J. M.; Garcia-Gomez, R.; Guasp, J.; Hernandez, J.; Herranz, J.; Hidalgo, C.; Jimenez, J. A.; Jimenez-Denche, A.; Kirpitchev, I.; Lapayese, F.; Liniers, M.; Liu, B.; Lopez-Bruna, D.; Lopez-Fraguas, A.; Lopez-Razola, J.; Martin de Aguilera, A.; Martin-Hernandez, F.; Martin-Rojo, A. B.; Martinez-Fernandez, J.; McCarthy, K. J.; Medina, F.; Medrano, M.; Melon, L.; Mendez, P.; van Milligen, B.; Molinero, A.; Monreal, P.; Moreno, R.; Navarro, M.; Ochando, M. A.; Olivares, J.; Oyarzabal, E.; de Pablos, J. L.; Pacios, L.; Pastor, I.; Pedrosa, M. A.; de la Pena, A.; Pereira, A.; Portas, A. B.; Ratta, G.; Rincon, E.; Rios, L.; Rodriguez, C.; Rojo, B.; Ros, A.; Sanchez, M.; Sanchez, E.; Sanchez-Sarabia, E.; Sebastian, J. A.; Silva, C.; Solano, E. R.; Soleto, A.; Sun, B.; Tabares, F. L.; Tafalla, D.; Tolkachev, A.; Vega, J.; Velasco, G.; Velasco, J. L.; Wolfers, G.; Zurro, B.] CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain; [Baiao, D.; Nedzelskiy, I. S.] IST, Inst Plasmas & Fusao Nucl, Lisbon, Portugal; [Borchardt, M.; Dinklage, A.; Kleiber, R.] Max Planck Inst Plasma Phys, Greifswald, Germany; [Castejon, F.; Velasco, J. L.] Inst Biocomp & Fis Sistemas Complejos, Zaragoza, Spain; [Chmyga, A. A.; Komarov, A. D.; Kozachok, A. S.; Krupnik, L.; Petrov, A.] NSC KIPT, Inst Plasma Phys, UA-310108 Kharkov, Ukraine; [Eliseev, L.; Melnikov, A. V.] RNC Kurchatov Inst, Inst Nucl Fus, Moscow, Russia; [Garcia, L.] Univ Carlos III Madrid, Madrid, Spain; [Garcia-Regana, J. M.; Hatzky, R.] EURATOM, Max Planck Inst Plasmaphys, D-14476 Garching, Germany; [Garcia-Regana, J. M.] EUROfus PMU Garching, D-85748 Garching, Germany; [Hollmann, E.] Univ Calif San Diego, San Diego, CA 92103 USA; [Petrov, S.] AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; [Sarksian, K.] Russian Acad Sci, Inst Gen Phys, Moscow, Russia; [Satake, S.; Yokoyama, M.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Tallents, S.] Inst Tecnol Costa Rica, Cartago, Costa Rica	Sanchez, J (reprint author), CIEMAT, Lab Nacl Fus, E-28040 Madrid, Spain.	Joaquin.sanchez@ciemat.es	Garcia, Luis/A-5344-2015; Baiao, Diana/M-4434-2013; Ratta, Giuseppe A./I-5515-2012	Garcia, Luis/0000-0002-0492-7466; Baiao, Diana/0000-0002-5493-2175; Ratta, Giuseppe A./0000-0002-5676-9631			Alonso A., 2012, NUCL FUSION, V52; Reinke ML, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/4/045004; Estrada T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.245004; Linke J, 2006, FUSION SCI TECHNOL, V49, P455; Viezzer E, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/12/124037; Oyarzabal E, 2014, J NUCL MATER, V452, P37, DOI 10.1016/j.jnucmat.2014.04.046; Ichiguchi K, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/5/053021; Pedrosa MA, 2015, NUCL FUSION, V55, DOI 10.1088/0029-5515/55/5/052001; HIRSHMAN SP, 1986, PHYS FLUIDS, V29, P2951, DOI 10.1063/1.865495; Happel T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3160106; Garcia-Regana JM, 2013, PLASMA PHYS CONTR F, V55, DOI 10.1088/0741-3335/55/7/074008; Tallents S, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/7/075024; Apicella ML, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/3/035001; Estrada T, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/082002; WEYNANTS RR, 1993, PLASMA PHYS CONTR F, V35, pB177, DOI 10.1088/0741-3335/35/SB/014; Hidalgo C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.065001; Xu Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265005; Nagaoka K, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/072004; Vertkov AV, 2012, FUSION ENG DES, V87, P1755, DOI 10.1016/j.fusengdes.2011.10.004; Velasco JL, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.135003; Castellano J, 2002, PHYS PLASMAS, V9, P713, DOI 10.1063/1.1430435; van Milligen BP, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113034; Pedrosa MA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.215003; Sakakibara S, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/4/043010; Kim EJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.185006; SHAFRANOV VD, 1983, PHYS FLUIDS, V26, P357, DOI 10.1063/1.864172; Helander P, 1998, PHYS PLASMAS, V5, P3999, DOI 10.1063/1.873121; ITOH SI, 1988, PHYS REV LETT, V60, P2276, DOI 10.1103/PhysRevLett.60.2276; van Milligen BP, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023011; Hidalgo C, 2004, PLASMA PHYS CONTR F, V46, P287, DOI 10.1088/0741-3335/46/1/018; Arevalo J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/2/023003; Arevalo J, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/1/013008; Cheng J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265002; Dinklage A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063022; Doyle EJ, 2007, NUCL FUSION, V47, pS18, DOI 10.1088/0029-5515/47/6/S02; Estrada T, 2015, NUCL FUSION, V55, DOI [10.1088/0029-5515/55/6/063005, 10.1088/0020-5515/55/6/063005]; Liu B., 2014, 41 EPS C PLASM PHYS; Miki K, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4753931; Mohamed A., 2004, FUSION ENG DES, V72, P1; Pereverzev G.V., 2002, 598 IPP MAX PLANCK I; Satake S., 2006, PLASMA FUSION RES, V1, DOI 10.1585/pfr.1.002; Tabares F.L., 2014, J NUCL MATER, V463, P1142; Velasco J.L., 2014, 41 EPS C PLASM PHYS; Zurro B, 2014, PLASMA PHYS CONTR F, V56, DOI 10.1088/0741-3335/56/12/124007	44	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104014	10.1088/0029-5515/55/10/104014		9	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900015		
J	Terry, PW; Carmody, D; Doerk, H; Guttenfelder, W; Hatch, DR; Hegna, CC; Ishizawa, A; Jenko, F; Nevins, WM; Predebon, I; Pueschel, MJ; Sarff, JS; Whelan, GG				Terry, P. W.; Carmody, D.; Doerk, H.; Guttenfelder, W.; Hatch, D. R.; Hegna, C. C.; Ishizawa, A.; Jenko, F.; Nevins, W. M.; Predebon, I.; Pueschel, M. J.; Sarff, J. S.; Whelan, G. G.			Overview of gyrokinetic studies of finite-beta microturbulence	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	turbulence; electromagnetic; gyrokinetics	TEMPERATURE-GRADIENT TURBULENCE; TEARING INSTABILITIES; MAGNETIC RECONNECTION; ZONAL FLOWS; SIMULATIONS; TRANSPORT; TOKAMAK; DRIVEN; PLASMAS; MODES	Recent results on electromagnetic turbulence from gyrokinetic studies in different magnetic configurations are overviewed, detailing the physics of electromagnetic turbulence and transport, and the effect of equilibrium magnetic field scale lengths. Ion temperature gradient (ITG) turbulence is shown to produce magnetic stochasticity through nonlinear excitation of linearly stable tearing-parity modes. The excitation, which is catalyzed by the zonal flow, produces an electron heat flux proportional to beta(2) that deviates markedly from quasilinear theory. Above a critical beta known as the non-zonal transition (NZT), the magnetic fluctuations disable zonal flows by allowing electron streaming that shorts zonal potential between flux surfaces. This leads to a regime of very high transport levels. Kinetic ballooning mode (KBM) saturation is described. For tokamaks saturation involves twisted structures arising from magnetic shear; for helical plasmas oppositely inclined convection cells interact by mutual shearing. Microtearing modes are unstable in the magnetic geometry of tokamaks and the reversed field pinch (RFP). In NSTX instability requires finite collisionality, large beta, and is favored by increasing magnetic shear and decreasing safety factor. In the RFP, a new branch of microtearing with finite growth rate at vanishing collisionality is shown from analytic theory to require the electron grad-B/curvature drift resonance. However, gyrokinetic modeling of experimental MST RFP discharges at finite beta reveals turbulence that is electrostatic, has large zonal flows, and a large Dimits shift. Analysis shows that the shorter equilibrium magnetic field scale lengths increase the critical gradients associated with the instability of trapped electron modes, ITG and microtearing, while increasing beta thresholds for KBM instability and the NZT.	[Terry, P. W.; Carmody, D.; Hegna, C. C.; Pueschel, M. J.; Sarff, J. S.; Whelan, G. G.] Univ Wisconsin, Madison, WI 53706 USA; [Doerk, H.; Jenko, F.] Max Planck Inst Plasma Phys, D-85748 Garching, Germany; [Guttenfelder, W.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Hatch, D. R.] Univ Texas Austin, Austin, TX 78712 USA; [Ishizawa, A.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Jenko, F.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Nevins, W. M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Predebon, I.] Conzorzio RFX, I-35127 Padua, PD, Italy	Terry, PW (reprint author), Univ Wisconsin, Madison, WI 53706 USA.	pwterry@wisc.edu					Belli EA, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3495976; Naulin V, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1905603; Guttenfelder W, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/9/093022; Doerk H, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694663; Applegate DJ, 2007, PLASMA PHYS CONTR F, V49, P1113, DOI 10.1088/0741-3335/49/8/001; Predebon I, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4799980; Maeyama S, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4873379; Citrin J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.155001; Hatch DR, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4789448; Carmody D, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4803509; HAZELTINE RD, 1975, PHYS FLUIDS, V18, P1778, DOI 10.1063/1.861097; GLADD NT, 1980, PHYS FLUIDS, V23, P1182, DOI 10.1063/1.863119; Jenko F, 2001, PLASMA PHYS CONTR F, V43, pA141, DOI 10.1088/0741-3335/43/12A/310; Guttenfelder W, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694104; Predebon I, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.195001; Wang E, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574660; REWOLDT G, 1987, PHYS FLUIDS, V30, P807, DOI 10.1063/1.866332; RECHESTER AB, 1978, PHYS REV LETT, V40, P38, DOI 10.1103/PhysRevLett.40.38; Hatch DR, 2014, J PLASMA PHYS, V80, P531, DOI 10.1017/S0022377814000154; Zonca F, 1999, PHYS PLASMAS, V6, P1917, DOI 10.1063/1.873449; Rosenbluth MN, 1998, PHYS REV LETT, V80, P724, DOI 10.1103/PhysRevLett.80.724; Guttenfelder W, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.155004; Pueschel MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4823717; Chen Y, 2003, NUCL FUSION, V43, P1121, DOI 10.1088/0029-5515/43/10/013; CALLEN JD, 1977, PHYS REV LETT, V39, P1540, DOI 10.1103/PhysRevLett.39.1540; Holod I, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4798392; Tangri V, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3581072; Makwana KD, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3530186; Ishizawa A, 2015, J PLASMA PHYS, V81, DOI 10.1017/S0022377815000100; Daughton W, 2011, NAT PHYS, V7, P539, DOI [10.1038/nphys1965, 10.1038/NPHYS1965]; Pueschel MJ, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4872327; Pueschel MJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4825227; DRAKE JF, 1977, PHYS REV LETT, V39, P453, DOI 10.1103/PhysRevLett.39.453; Dickinson D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.135002; HASSAM AB, 1980, PHYS FLUIDS, V23, P2493, DOI 10.1063/1.862950; Falchetto GL, 2003, PHYS PLASMAS, V10, P1424, DOI 10.1063/1.1566028; Moradi S, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3688876; Carmody D, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4905709; Albergante M, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/5/054002; Terry PW, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4903207; Nevins WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.065003; Smith DR, 2011, PLASMA PHYS CONTR F, V53, DOI 10.1088/0741-3335/53/3/035013; Dorland W, 2000, PHYS REV LETT, V85, P5579, DOI 10.1103/PhysRevLett.85.5579; Parker SE, 2004, PHYS PLASMAS, V11, P2594, DOI 10.1063/1.1689668; CHEN L, 1977, PHYS REV LETT, V39, P460, DOI 10.1103/PhysRevLett.39.460; Swamy AK, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4893314; BEER MA, 1995, PHYS PLASMAS, V2, P2687, DOI 10.1063/1.871232; Candy J, 2005, PHYS PLASMAS, V12, DOI 10.1063/1.1954123; Canik JM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113016; Carraro L, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073048; Citrin J, 2015, PLASMA PHYS CONTR F, V57, DOI 10.1088/0741-3335/57/1/014032; Connor J.W., 1990, PLASMA PHYS CONTROL, V49, P1113; Diamond PH, 2005, PLASMA PHYS CONTR F, V47, pR35, DOI 10.1088/0741-3335/47/5/R01; Doerk H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.155003; Duff J., 2014, B AM PHYS SOC, V59, P253; Finn J.M., 1986, PHYS FLUIDS, V11, P3672; Hatch DR, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.175001; Hatch DR, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3563536; Hatch DR, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235002; Hatch DR, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.115003; Ishizawa A, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/5/053007; Ishizawa A, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4876960; Kim JH, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3496394; Makwana KD, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.095002; Nevins W.M., 2009, B AM PHYS SOC, V54, P35; Orszag S.A., 1973, FLUID DYNAMICS 1973, P237; Pueschel MJ, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3435280; Pueschel MJ, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.3005380; Pueschel MJ, 2014, ASTROPHYS J SUPPL S, V213, DOI 10.1088/0067-0049/213/2/30; Pueschel MJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.155005; Sarff JS, 2003, PLASMA PHYS CONTR F, V45, pA457, DOI 10.1088/0741-3335/45/12A/029; Scott BD, 2006, PLASMA PHYS CONTR F, V48, pB277, DOI 10.1088/0741-3335/48/12B/S27; Scott BD, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/092; Smolyakov A. I., 1989, Soviet Journal of Plasma Physics, V15; Synder P.B., 2001, PHYS PLASMAS, V8, P744; Tatsuno T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.015003; Terry PW, 2006, PHYS PLASMAS, V13, DOI 10.1063/1.2168453; Terry PW, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4828396; Waltz RE, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3449075; Whelan G.G., 2014, B AM PHYS SOC, V59, P318	80	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104011	10.1088/0029-5515/55/10/104011		12	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900012		
J	Xu, M; Duan, XR; Dong, JQ; Ding, XT; Yan, LW; Liu, Y; Song, XM; Huang, Y; Zou, XL; Yang, QW; Liu, DQ; Rao, J; Xuan, WM; Chen, LY; Mao, WC; Wang, QM; Li, Q; Cao, Z; Cao, JY; Lei, GJ; Zhang, JH; Li, XD; Xu, Y; Ji, XQ; Cheng, J; Chen, W; Yu, LM; Zhong, WL; Yu, DL; Zhang, YP; Shi, ZB; Chen, CY; Isobe, M; Morita, S; Cui, ZY; Dong, YB; Feng, BB; Cui, CH; Huang, M; Li, GS; Li, HJ; Li, Q; Peng, JF; Wang, YQ; Li, B; Yao, LH; Yao, LY; Yuan, BS; Zhou, J; Zhou, Y; Itoh, K; Liu, Y				Xu, M.; Duan, X. R.; Dong, J. Q.; Ding, X. T.; Yan, L. W.; Liu, Yi; Song, X. M.; Huang, Y.; Zou, X. L.; Yang, Q. W.; Liu, D. Q.; Rao, J.; Xuan, W. M.; Chen, L. Y.; Mao, W. C.; Wang, Q. M.; Li, Q.; Cao, Z.; Cao, J. Y.; Lei, G. J.; Zhang, J. H.; Li, X. D.; Xu, Y.; Ji, X. Q.; Cheng, J.; Chen, W.; Yu, L. M.; Zhong, W. L.; Yu, D. L.; Zhang, Y. P.; Shi, Z. B.; Chen, C. Y.; Isobe, M.; Morita, S.; Cui, Z. Y.; Dong, Y. B.; Feng, B. B.; Cui, C. H.; Huang, M.; Li, G. S.; Li, H. J.; Li, Qing; Peng, J. F.; Wang, Y. Q.; Li, B.; Yao, L. H.; Yao, L. Y.; Yuan, B. S.; Zhou, J.; Zhou, Y.; Itoh, K.; Liu, Yong		HL-2A Team	Overview of recent HL-2A experiments	NUCLEAR FUSION			English	Article; Proceedings Paper	25th Fusion Energy Conference (FEC)	OCT 13-18, 2014	Govt Russian Federat, St Petersburg, RUSSIA	State Atom Energy Corp Rosatom	Govt Russian Federat	fusion energy; tokamak; plasma physics; HL-2A	TOKAMAK PLASMAS	Since the last Fusion Energy Conference, the HL-2A experiment has made significant progress in the following areas: (i) physics on low-intermediate-high (L-I-H) transition and pedestal dynamics; (ii) magnetohydrodynamic (MHD) and energetic-particle (EP) physics; (iii) interaction between neoclassical tearing modes (NTMs) and non-local transport; (iv) and edge localized mode (ELM) mitigation by supersonic molecular beam injection (SMBI). Two types of limit-cycle-oscillations (LCOs) were observed in the intermediate phase (I-phase), which indicated a second type of predator-prey process between turbulence and pressure gradient in addition to the conventional predator-prey involving zonal flows and turbulence. It was found that a kink-type MHD mode often crashed prior to the I-H transition, which played a crucial role in triggering H-mode by increasing the edge pressure gradient and E x B flow shear and consequently suppressing turbulent transport. It was also found that impurity concentration played an important role in the multi-transitions between ELM-free H-mode and I-phase. Besides, a quasi-coherent mode around 50-100 kHz was found to be associated with pedestal density gradient saturation in ELM-free H-mode. For the first time, two types of magnetic activities with n = 0 were observed in the presence of strong tearing modes. Fourier bicoherence analysis suggested that these modes were generated by the nonlinear coupling between Alfven eigenmodes (AEs) and low-frequency MHD modes. Up-and down-sweeping reverse shear Alfven eigenmodes (RSAEs) were identified experimentally. The transitions between fishbone and long-lived mode (LLM) were also investigated. The results showed that fishbone could transit from/to LLM and even trigger tearing modes (TMs). For non-local transport, key characteristics of enhanced avalanches in the theory of self-organized criticality (SOC) were identified, including high Hurst exponents and large-scale radial propagation. Experimental results revealed a close correlation between NTMs and non-local transport. In addition, studies on ELM mitigation by SMBI have also progressed substantially.	[Xu, M.; Duan, X. R.; Dong, J. Q.; Ding, X. T.; Yan, L. W.; Liu, Yi; Song, X. M.; Huang, Y.; Yang, Q. W.; Liu, D. Q.; Rao, J.; Xuan, W. M.; Chen, L. Y.; Mao, W. C.; Wang, Q. M.; Li, Q.; Cao, Z.; Cao, J. Y.; Lei, G. J.; Zhang, J. H.; Li, X. D.; Xu, Y.; Ji, X. Q.; Cheng, J.; Chen, W.; Yu, L. M.; Zhong, W. L.; Yu, D. L.; Zhang, Y. P.; Shi, Z. B.; Chen, C. Y.; Cui, Z. Y.; Dong, Y. B.; Feng, B. B.; Cui, C. H.; Huang, M.; Li, G. S.; Li, H. J.; Li, Qing; Peng, J. F.; Wang, Y. Q.; Li, B.; Yao, L. H.; Yao, L. Y.; Yuan, B. S.; Zhou, J.; Zhou, Y.; Liu, Yong] Southwestern Inst Phys, Chengdu 610041, Peoples R China; [Zou, X. L.] CEA, IRFM, F-13108 St Paul Les Durance, France; [Isobe, M.; Morita, S.; Itoh, K.] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Xu, M (reprint author), Southwestern Inst Phys, POB 432, Chengdu 610041, Peoples R China.	minxu@swip.ac.cn					Mazurenko A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.225004; Schmitz L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155002; Zhang YP, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4872385; Chen W, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075022; Terry JL, 2005, NUCL FUSION, V45, P1321, DOI 10.1088/0029-5515/45/11/013; Chapman IT, 2010, NUCL FUSION, V50, DOI 10.1088/0029-5515/50/4/045007; Xu Y, 2015, PLASMA PHYS CONTR F, V57, DOI 10.1088/0741-3335/57/1/014028; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Gruber O, 1999, NUCL FUSION, V39, P1321, DOI 10.1088/0029-5515/39/9Y/309; Chen W, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/10/104002; Chen W, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/25001; Chen W., 2014, 25 IAEA C FUS EN SAI; Cheng J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.265002; Cheng J, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/11/114004; Deng W., 2014, NUCL FUSION, V54; Dong J.Q., 2014, 25 IAEA C FUS EN SAI; Estrada T, 2015, NUCL FUSION, V55, DOI [10.1088/0029-5515/55/6/063005, 10.1088/0020-5515/55/6/063005]; Hua MD, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/55001; Ji X.Q., 2014, 25 IAEA C FUS EN SAI; Menard J.E., NUCL FUSION, V45, P539; MONTGOMERY D, 1995, ASTROPHYS J, V447, P706, DOI 10.1086/175910; Xu Y., 2014, 41 EPS C PLASM PHYS, P107; Yu D.L., 2014, 25 IAEA C FUS EN SAI; Yu DL, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4886419; Yu L.M., 2014, 25 IAEA C FUS EN SAI; Zhang Y.P., 2014, 25 IAEA C FUS EN SAI; Zhong W.L., 2014, 41 EPS C PLASM PHYS; Zhong W.L., 2014, 25 IAEA C FUS EN SAI	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0029-5515	1741-4326		NUCL FUSION	Nucl. Fusion	OCT	2015	55	10							104022	10.1088/0029-5515/55/10/104022		10	Physics, Fluids & Plasmas; Physics, Nuclear	Physics	CU8AK	WOS:000363762900023		
J	Yamamoto, A; Kinoshita, K; Watanabe, T; Endo, T; Kodama, Y; Ohoka, Y; Ushio, T; Nagano, H				Yamamoto, Akio; Kinoshita, Kuniharu; Watanabe, Tomoaki; Endo, Tomohiro; Kodama, Yasuhiro; Ohoka, Yasunori; Ushio, Tadashi; Nagano, Hiroaki			Uncertainty Quantification of LWR Core Characteristics Using Random Sampling Method	NUCLEAR SCIENCE AND ENGINEERING			English	Article							NUCLEAR-DATA UNCERTAINTIES	Uncertainties of various neutronics characteristics in commercial boiling water reactor (BWR) and pressurized water reactor (PWR) cores due to cross-section covariance are evaluated by the Latin Hypercube Sampling (LHS) method, which is an efficient random sampling algorithm. Thermal-hydraulic feedback and burnup effects are fully and explicitly taken into account using a licensing-grade core simulator. Uncertainties for various core characteristics are evaluated by the statistical processing of core calculation results based on the LHS method. The calculation results indicate that uncertainty of critical eigenvalue (i.e., core reactivity) in the BWR core is comparable to that of a typical PWR core. On the other hand, uncertainties of assembly relative power distribution and maximum assembly burnup in the present BWR core are much smaller than those of the present PWR core. The strong thermal-hydraulic feedback effect in the BWR core significantly contributes to the difference of uncertainties in BWR and PWR cores.	[Yamamoto, Akio; Kinoshita, Kuniharu; Watanabe, Tomoaki; Endo, Tomohiro] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kodama, Yasuhiro; Ohoka, Yasunori; Ushio, Tadashi; Nagano, Hiroaki] Nucl Fuel Ind Ltd, Kumatori, Osaka, Japan	Yamamoto, A (reprint author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	a-yamamoto@nucl.nagoya-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [24561040]	This work was supported in part by Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Scientific Research (C) (24561040).	ABDEL-KHALIK H. S., 2004, THESIS N CAROLINA ST; [Anonymous], 2012, JENDL 4 0U; [Anonymous], 2009, SSP09447U; Klein M, 2011, KERNTECHNIK, V76, P174; [Anonymous], 2009, SSP09443U; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Pasichnyk I, 2013, NUCL TECHNOL, V183, P464; Williams ML, 2013, NUCL TECHNOL, V183, P515; Endo T, 2011, J NUCL SCI TECHNOL, V48, P1077, DOI 10.3327/jnst.48.1077; Cacuci D., 2003, SENSITIVITY UNCERTAI, V1; IVANOV K., 2007, NEANSCDOC200723; JESSEE M. A., 2008, THESIS N CAROLINA ST; KATO S., 2013, P ICAPP 2013 JEJ KOR; KINOSHITA K., 2014, P INT C PHYSOR 2014; KRZYKACZ B., 1994, P INT C PROB SAF ASS; LARSEN N. H., 1981, NP971 EL POW RES I; LARSEN N. H., 1978, NP563 EL POW RES I; Macfarlane R., 1994, LA12740M LOS AL NAT; McKAY M. D., 1995, NUREGCR6311 LOS AL N; SAKAI T., 2012, P FALL M AT EN SOC J; TAKATA T., 2009, P 13 INT TOPL M NUCL; Watanabe Tomoaki, 2013, Transactions of the American Nuclear Society, V109; WIESELQUIST W., 2012, P PHYSOR 2012 KNOXV; Yamamoto A, 2013, J NUCL SCI TECHNOL, V50, P966, DOI [10.1080/00223131.2013.820355, 10.1080/00223131.2013.820155]; ZWERMANN W., 2011, P INT C NUCL CRIT ED	25	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	OCT	2015	181	2					160	174		10.13182/NSE14-152		15	Nuclear Science & Technology	Nuclear Science & Technology	CT0ER	WOS:000362467200003		
J	Fuse, M; Nagase, M; Usui, N; Sato, Y; Aizawa, M; Ito, T; Hosokawa, H; Wada, Y; Ishida, K				Fuse, Motomasa; Nagase, Makoto; Usui, Naoshi; Sato, Yoshiteru; Aizawa, Motohiro; Ito, Tsuyoshi; Hosokawa, Hideyuki; Wada, Yoichi; Ishida, Kazushige			Cobalt Radioactivity Behaviors in a BWR Environment and Countermeasures for Dose Rate Reduction	NUCLEAR SCIENCE AND ENGINEERING			English	Article							HIGH-TEMPERATURE WATER; STRESS-CORROSION CRACKING; HYDROGEN-PEROXIDE; BOILING WATER; STAINLESS-STEEL; OXIDE-FILM; DEPOSITION; SURFACES; SYSTEM; SOLUBILITY	While under normal water chemistry without any specific metal ions in reactor coolant a high electrochemical corrosion potential caused by highly oxidizing species such as hydrogen peroxide promotes the formation of hematite film on piping surfaces with a densely packed film structure, the presence of a certain amount of nickel ions prevents the magnetite film from changing to hematite by forming a nickel ferrite. This formation of nickel ferrite instead of hematite accelerates cobalt buildup, and this is especially notable for carbon steel. The observed reduction of radioactivity concentration in reactor water by zinc injection or by nickel/iron ratio control can be explained by the role of zinc or nickel in preventing the film on the fuel rod surfaces from changing to hematite, thereby stabilizing the cobalt activity on this surface. A thermodynamic evaluation suggests that zinc ferrite is more stable than cobalt ferrite only when the ratio of cobalt to zinc divalent ions, [Co2+]/[Zn2+], is <0.011 in molar units. This ratio is consistent with the ratio of Co-60 activity to zinc concentration commonly used in industry to control reactor water zinc levels for a dose rate reduction under the hydrogen water chemistry condition. Based on the present understanding of radioactivity behaviors, the actual radiation dose reduction methods are classified into the several groups and summarized from the viewpoint of the interaction between the oxide and various metal ions.	[Fuse, Motomasa; Nagase, Makoto; Usui, Naoshi; Sato, Yoshiteru; Aizawa, Motohiro] Hitachi GE Nucl Energy Ltd, Hitachi Works, Hitachi, Ibaraki 3170073, Japan; [Ito, Tsuyoshi; Hosokawa, Hideyuki; Wada, Yoichi; Ishida, Kazushige] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191221, Japan	Fuse, M (reprint author), Res Inst Phys Sci & Technol, 2-11-13 Ushirono Cho, Hitachinaka, Ibaraki 3120014, Japan.	yoshiteru.sato.gh@hitachi.com					HONDA T, 1990, NUCL TECHNOL, V89, P365; ASAKURA Y, 1978, NUCL SCI ENG, V67, P1; UCHIDA S, 1987, J NUCL SCI TECHNOL, V24, P385, DOI 10.3327/jnst.24.385; Usui N, 2005, J NUCL SCI TECHNOL, V42, P75, DOI 10.3327/jnst.42.75; Hosokawa H, 2010, J NUCL SCI TECHNOL, V47, P531, DOI 10.3327/jnst.47.531; DINOV K, 1993, NUCL SCI ENG, V113, P207; Murayama Y, 2002, J NUCL SCI TECHNOL, V39, P1199, DOI 10.3327/jnst.39.1199; LISTER DH, 1976, NUCL SCI ENG, V59, P406; Hanzawa Y, 1997, NUCL SCI ENG, V127, P292; Kim YJ, 1999, CORROSION, V55, P81; Usui N, 2008, J NUCL SCI TECHNOL, V45, P72, DOI 10.3327/jnst.45.72; Wada Y, 2007, J NUCL SCI TECHNOL, V44, P1448, DOI 10.3327/jnst.44.1448; Aizawa M, 2002, J NUCL SCI TECHNOL, V39, P1051, DOI 10.3327/jnst.39.1051; ASAKURA Y., 1989, P WAT CHEM NUCL REAC; ASAKURA Y., 1998, P JAIF INT C WAT CHE; Beverskog B, 1999, CORROSION, V55, P1077; COWAN R. L., 2002, P INT C WAT CHEM NUC; COWAN R. L., 2012, P INT C WAT CHEM NUC; FUSE M., 2014, P INT C WAT CHEM NUC; GARCIA S. E., 2010, P INT C WAT CHEM NUC; GARCIA S. E., 1998, P JAIF INT C WAT CHE; HAGINUMA M., 1998, P JAIF INT C WAT CHE; HETTIARACHCHI S., 2010, P INT C WAT CHEM NUC; HETTIARACHCHI S., 2003, P 11 INT C ENV DEGR; HETTIARACHCHI S., 2005, P 12 INT C ENV DEGR; HISAMUNE K., 1991, P INT C WAT CHEM NUC; INAGAKI H., 2003, THESIS JAP ADV I SCI; ISHIDA K., 2013, J NUCL SCI TECHNOL, V50, P1071; ITO S., 2009, P S WAT CHEM CORR NU; KAJITANI H., 2009, P S WAT CHEM CORR NU; KIYOTOKI Y., 2006, P 9 NRC ASME S VALV; Kubaschewski O., 1962, OXIDATION METALS ALL; LIN C. C., 2009, P S WAT CHEM CORR NU; LIN C. C., 1994, P INT C WAT CHEM NUC; NAGASE M., 2012, P INT C WAT CHEM NUC; SAITO M., 2002, P INT C WAT CHEM NUC; SAITO T., 2012, P INT C WAT CHEM NUC; SAITO T., 2003, P S WAT CHEM CORR NU; SUZUKI N., 2002, P INT C WAT CHEM NUC; UCHIDA S., 2003, P 11 INT C ENV DEGR	40	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	0029-5639	1943-748X		NUCL SCI ENG	Nucl. Sci. Eng.	OCT	2015	181	2					175	190		10.13182/NSE14-101		16	Nuclear Science & Technology	Nuclear Science & Technology	CT0ER	WOS:000362467200004		
J	Mun, S; Park, MC; Yano, S				Mun, Sungchul; Park, Min-Chul; Yano, Sumio			Evaluation of viewing experiences induced by a curved three-dimensional display	OPTICAL ENGINEERING			English	Article						stereoscopic 3-D; curved display; realness; engagement; visual fatigue; event-related potential	STEREOSCOPIC 3D; VISUAL FATIGUE; IMAGING-SYSTEM; LENS ARRAY; SUSCEPTIBILITY; CORTEX; SSVEP; ERP	Despite an increased need for three-dimensional (3-D) functionality in curved displays, comparisons pertinent to human factors between curved and flat panel 3-D displays have rarely been tested. This study compared stereoscopic 3-D viewing experiences induced by a curved display with those of a flat panel display by evaluating subjective and objective measures. Twenty-four participants took part in the experiments and viewed 3-D content with two different displays (flat and curved 3-D display) within a counterbalanced and within-subject design. For the 30-min viewing condition, a paired t-test showed significantly reduced P300 amplitudes, which were caused by engagement rather than cognitive fatigue, in the curved 3-D viewing condition compared to the flat 3-D viewing condition at P-3 and P-4. No significant differences in P300 amplitudes were observed for 60-min viewing. Subjective ratings of realness and engagement were also significantly higher in the curved 3-D viewing condition than in the flat 3-D viewing condition for 30-min viewing. Our findings support that curved 3-D displays can be effective for enhancing engagement among viewers based on specific viewing times and environments. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Mun, Sungchul; Park, Min-Chul] Korea Inst Sci & Technol, Sensor Syst Res Ctr, Seoul 136791, South Korea; [Park, Min-Chul] Korea Univ Sci & Technol, Dept Human Comp Interact & Robot, Seoul 136791, South Korea; [Yano, Sumio] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Park, MC (reprint author), Korea Inst Sci & Technol, Sensor Syst Res Ctr, Hwarangno 14 Gil 5, Seoul 136791, South Korea.	minchul@kist.re.kr			'Cross-Ministry Giga KOREA Project' of the Ministry of Science, ICT and Future Planning, Republic of Korea (ROK) [Development of Interactive and Realistic Massive Giga-Content Technology] [GK15C0100]	This research was supported by the 'Cross-Ministry Giga KOREA Project' of the Ministry of Science, ICT and Future Planning, Republic of Korea (ROK) [Grant No. GK15C0100, Development of Interactive and Realistic Massive Giga-Content Technology].	Ahn S. H., 2014, J ERGONOMICS SOC KOR, V33, P191; Cholewiak RW, 2004, PERCEPT PSYCHOPHYS, V66, P970, DOI 10.3758/BF03194989; Mun S, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.12.123105; Lambooij M, 2011, IEEE T CIRC SYST VID, V21, P1913, DOI 10.1109/TCSVT.2011.2157193; Allison BZ, 2008, BIOL PSYCHOL, V77, P277, DOI 10.1016/j.biopsycho.2007.10.014; Mun S, 2013, INT J HUM-COMPUT INT, V29, P789, DOI 10.1080/10447318.2013.765289; Polonen M, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.1.011006; Hahn J, 2008, OPT EXPRESS, V16, P12372, DOI 10.1364/OE.16.012372; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Kim Y, 2004, OPT EXPRESS, V12, P421, DOI 10.1364/OPEX.12.000421; Miller MW, 2011, INT J PSYCHOPHYSIOL, V80, P75, DOI 10.1016/j.ijpsycho.2011.02.003; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; Mun S, 2012, NEUROSCI LETT, V525, P89, DOI 10.1016/j.neulet.2012.07.049; Yano S, 2002, P SOC PHOTO-OPT INS, V4864, P157, DOI 10.1117/12.454902; Park S, 2014, INT J PSYCHOPHYSIOL, V92, P42, DOI 10.1016/j.ijpsycho.2014.02.003; Lambooij M, 2013, DISPLAYS, V34, P8, DOI 10.1016/j.displa.2012.09.002; [Anonymous], 2012, J BROADCAST ENG; Kim Y, 2005, APPL OPTICS, V44, P546, DOI 10.1364/AO.44.000546; Cowan N., 1995, ATTENTION MEMORY INT; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Li Hyung-Chul, 2010, [JOURNAL OF BROADCAST ENGINEERING, 방송공학회 논문지], V15, P607; Mun S, 2014, INT J PSYCHOPHYSIOL, V94, P373, DOI 10.1016/j.ijpsycho.2014.08.1389; Park M., 2015, J DISP TECH IN PRESS; Reichelt S, 2010, PROC SPIE, V7690, DOI 10.1117/12.850094	24	0	0	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	OCT	2015	54	10							103104	10.1117/1.OE.54.10.103104		9	Optics	Optics	CV4EW	WOS:000364220200006		
J	Tu, QZ; Shen, XM; Zhou, JZ; He, XH; Yamamura, K				Tu, Qunzhang; Shen, Xinmin; Zhou, Jianzhao; He, Xiaohui; Yamamura, Kazuya			Efficient processing of reaction-sintered silicon carbide by anodically oxidation-assisted polishing	OPTICAL ENGINEERING			English	Article						reaction-sintered silicon carbide; anodically oxidation-assisted polishing; linear Deal-Grove model; oxidation rate; material removal rate; surface roughness	THERMAL-OXIDATION; REMOVAL	Reaction-sintered silicon carbide (RS-SiC) is a promising optical material for the space telescope systems. Anodically oxidation-assisted polishing is a method to machine RS-SiC. The electrolyte used in this study is a mixture of hydrogen peroxide (H2O2) and hydrochloric acid (HCl), and the oxidation potential has two modes: constant potential and high-frequency-square-wave potential. Oxide morphologies are compared by scanning electron microscope/energy dispersive x-ray spectroscopy and scanning white-light interferometer. The results indicate that anodic oxidation under constant potential can not only obtain a relatively smooth surface but also be propitious to obtain high material removal rate. The oxidation depth in anodic oxidation under constant potential is calculated by comparing surface morphologies before and after hydrofluoric acid etching. The theoretical oxidation rate is 5.3 nm/s based on the linear Deal-Grove model. Polishing of the oxidized RS-SiC is conducted to validate the machinability of the oxide layer. The obtained surface roughness root-mean-square is around 4.5 nm. Thus, anodically oxidation-assisted polishing can be considered as an efficient method, which can fill the performance gap between the rough figuring and fine finishing of RS-SiC. It can improve the machining quality of RS-SiC parts and promote the application of RS-SiC products. (C) 2015 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Tu, Qunzhang; Shen, Xinmin; Zhou, Jianzhao; He, Xiaohui] PLA Univ Sci & Technol, Coll Field Engn, Res Ctr Mech & Elect Engn, Nanjing 210007, Jiangsu, Peoples R China; [Yamamura, Kazuya] Osaka Univ, Grad Sch Engn, Res Ctr Ultraprecis Sci & Technol, Suita, Osaka 5650871, Japan	Shen, XM (reprint author), PLA Univ Sci & Technol, Coll Field Engn, Res Ctr Mech & Elect Engn, Haifu St, Nanjing 210007, Jiangsu, Peoples R China.	shenxmjfjlgdx2014@163.com			National Natural Science Foundation of China [51505498]; Natural Science Foundation of Jiangsu Province [BK20150714]	This work was supported by a grant from the National Natural Science Foundation of China (Grant No. 51505498) and a grant from the Natural Science Foundation of Jiangsu Province (Grant No. BK20150714). The authors also express their gratitude to the staffs and students of the Research Center for Ultra-precision Science and Technology of Osaka University.	Tam HY, 2007, J MATER PROCESS TECH, V192, P276, DOI 10.1016/j.jmatprotec.2007.04.091; Woon WS, 2009, THIN SOLID FILMS, V517, P2808, DOI 10.1016/j.tsf.2008.10.137; Suyama S, 2003, DIAM RELAT MATER, V12, P1201, DOI 10.1016/S0925-9635(03)00066-9; Ke Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3212541; Peng WQ, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.3.035104; Shen XM, 2015, OPT ENG, V54, DOI 10.1117/1.OE.54.5.055106; Chakrabarti OP, 2001, MATER CHEM PHYS, V67, P199, DOI 10.1016/S0254-0584(00)00439-9; Zhang ZY, 2011, INT J ADV MANUF TECH, V57, P117, DOI 10.1007/s00170-011-3289-3; Ding SQ, 2007, J EUR CERAM SOC, V27, P2095, DOI 10.1016/j.jeurceramsoc.2006.06.003; Shen XM, 2013, OPT EXPRESS, V21, P14780, DOI 10.1364/OE.21.014780; Yamamura K, 2012, PROC CIRP, V3, P335, DOI 10.1016/j.procir.2012.07.058; Yan JW, 2009, INT J MACH TOOL MANU, V49, P366, DOI 10.1016/j.ijmachtools.2008.12.007; Shen XM, 2013, OPT EXPRESS, V21, P26123, DOI 10.1364/OE.21.026123; DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945; Li C. H., 2007, J ELECT MAT, V5, P481; Zhu H, 2011, PROC SPIE, V8194, DOI 10.1117/12.900575	16	0	0	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	0091-3286	1560-2303		OPT ENG	Opt. Eng.	OCT	2015	54	10							105113	10.1117/1.OE.54.10.105113		10	Optics	Optics	CV4EW	WOS:000364220200041		
J	Neto, OA; Munakata, J				Avalone Neto, Olavo; Munakata, Jun			SEAT CHOICE AND DISTANCE JUDGMENT IN PUBLIC SPACES	PERCEPTUAL AND MOTOR SKILLS			English	Article							MITIGATES PERCEIVED THREAT; COMFORT	This research assessed whether public space users will adopt a least-effort approach and choose a less suitable seat nearby or seek the most suitable seat, even if it is farther away from them when the decision is made. How distance assessment affects seat choice was investigated through an observational survey, which allowed the identification of behavioral patterns. Those behavioral patterns were then tested in a paired comparison experiment with 40 participants. The results showed that the effect of distance on seat choice is related to the difference in distance between the options and that a sufficient difference can cause trade-offs between distance and seat properties. The necessary difference in distance is conditioned by the activity and the seat properties.	[Avalone Neto, Olavo; Munakata, Jun] Chiba Univ, Chiba, Chiba 2638522, Japan	Neto, OA (reprint author), Chiba Univ, Fac Engn, Div Architecture & Urban Planning, Dept Architecture, Bldg 10,3F,Room 303,Nishi Chiba Campus, Chiba, Chiba 2638522, Japan.	avalone@gmail.com					ABDULKARIM D., 2013, ENVIRON BEHAV, V20, P1; ABE M., 2009, SUMM ANN M ARCH I JA, P769; Lin TP, 2013, BUILD ENVIRON, V59, P599, DOI 10.1016/j.buildenv.2012.10.005; Stamps AE, 2011, PERCEPT MOTOR SKILL, V113, P751, DOI 10.2466/07.21.PMS.113.6.751-763; Golicnik B, 2010, LANDSCAPE URBAN PLAN, V94, P38, DOI 10.1016/j.landurbplan.2009.07.016; Stamps AE, 2012, PERCEPT MOTOR SKILL, V114, P709, DOI 10.2466/24.20.27.PMS.114.3.709-716; Crompton A, 2006, ENVIRON BEHAV, V38, P656, DOI 10.1177/0013916505281571; Montello DR, 1997, LECT NOTES COMPUT SC, V1329, P297; Jansen-Osmann P, 2002, ENVIRON BEHAV, V34, P178, DOI 10.1177/0013916502034002002; Nemeth J, 2009, URBAN STUD, V46, P2463, DOI 10.1177/0042098009342903; Walton D, 2007, BUILD ENVIRON, V42, P3166, DOI 10.1016/j.buildenv.2006.08.004; Banerjee T, 2001, J AM PLANN ASSOC, V67, P9, DOI 10.1080/01944360108976352; CHERULNIK P. D., 1993, APPL ENV BEHAV RES; Gehl J, 2010, CITIES PEOPLE; GEHL J., 2011, LIFE BUILDINGS USING; HAYASHI T., 1995, STUDY AFFORDANCE OUT, V851, P852; Kahneman D., 2011, THINKING FAST SLOW; LEFEBVRE H., 1991, O DIREITO A CIDADE; LI P-Y., 2009, J ASIAN ARCHIT BUILD, V8, P134; LYNCH K., 1984, SITE PLANNING; OHNO R., 2006, P 7 EUR ARCH END ASS, P151; THIEL P., 1997, PEOPLE PATHS PURPOSE; TSUKIDA K., 2011, ANAL PAIRED COMP DAT; Whyte W. H., 1980, SOCIAL LIFE SMALL UR; ZEISEL J., 1981, INQUIRY BY DESIGN	25	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	OCT	2015	121	2					548	567		10.2466/24.PMS.121c20x3		20	Psychology, Experimental	Psychology	CV2RM	WOS:000364104500017		
J	Kubota, H; Demura, S				Kubota, Hiroshi; Demura, Shinichi			ADJUSTMENT ERRORS IN ASCENDING AND DESCENDING PHASES OF TARGET LEVEL IN CONTROLLED FORCE EXERTION	PERCEPTUAL AND MOTOR SKILLS			English	Article							MOTOR UNIT RECRUITMENT; COORDINATED EXERTION; HAND DOMINANCE; CONTRACTIONS; PERFORMANCE; THRESHOLDS; REDUCTION; BEHAVIOR; ABILITY; WOMEN	Hand grip force adjustment errors to ascending and descending phases of a sinusoidal target force in a controlled force exertion (CFE) test were measured and the laterality of responses evaluated. 75 men (M age = 19.6 yr., SD = 1.6) performed the CFE test after one practice trial by matching handgrip force to target level (5-25% of maximal grip force). The CFE errors in ascending and descending phases of the target force were calculated as the absolute differences between actual force and target force in each phase. There were significantly smaller CFE errors in the ascending phase for both dominant and non-dominant hands, but CFE error for the dominant hand was significantly smaller in both phases. Therefore, error in force exertion in the ascending and descending phases of the target force differed, and laterality influenced error in both phases.	[Kubota, Hiroshi] Gifu Univ, Gifu, Gifu 5011193, Japan; [Demura, Shinichi] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan	Kubota, H (reprint author), Gifu Univ, Fac Educ, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.	hkubota@gifu-u.ac.jp					CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346; Demura S., 2009, Gazzetta Medica Italiana Archivio per le Scienze Mediche, V168, P169; ROMAIGUERE P, 1993, EXP BRAIN RES, V95, P517; Nagasawa Y, 2002, PERCEPT MOTOR SKILL, V94, P899, DOI 10.2466/PMS.94.3.899-913; Kubota H, 2012, ARCH GERONTOL GERIAT, V54, pE68, DOI 10.1016/j.archger.2011.06.027; Hayami T, 2010, JPN J PHYS FIT SPORT, V59, P207; Demura S, 2001, PERCEPT MOTOR SKILL, V93, P11, DOI 10.2466/PMS.93.4.11-23; Adam A, 1998, J NEUROPHYSIOL, V80, P1373; Nagasawa Y, 2000, PERCEPT MOTOR SKILL, V90, P995, DOI 10.2466/PMS.90.3.995-1007; Roy EA, 2003, BRAIN COGNITION, V53, P315, DOI 10.1016/S0278-2626(03)00133-7; Dolcos F, 2002, NEUROSCI BIOBEHAV R, V26, P819, DOI 10.1016/S0149-7634(02)00068-4; Gur RC, 1999, J NEUROSCI, V19, P4065; Gorassini M, 2002, J NEUROPHYSIOL, V87, P1859, DOI 10.1152/jn.00025.2001; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113; Kimura T, 2003, EXP BRAIN RES, V152, P123, DOI 10.1007/s00221-003-1518-1; Annett M, 2009, LANGUAGE LATERALIZATION AND PSYCHOSIS, P73, DOI 10.1017/CBO9780511576744.006; Nagasawa Y, 2004, PERCEPT MOTOR SKILL, V98, P551; AOKI H., 2008, SPORTS SCI HLTH, V3, P1, DOI 10.1007/s11332-008-0054-6; BROOKS V. B., 1986, NEURAL BASIS MOTOR C, P142; Cohen J., 1988, STAT POWER ANAL BEHA; CROSBY CA, 1994, J HAND SURG-AM, V19A, P665, DOI 10.1016/0363-5023(94)90280-1; GANDEVIA S. C., 1996, HDB PHYSIOL 12, P128; GESHWIND N., 1982, P NATL ACAD SCI USA, V79, P5097; KUBOTA H., 2011, HEALTH, V3, P684; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Schmidt R.A., 1991, MOTOR LEARNING PERFO	26	0	0	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	OCT	2015	121	2					613	620		10.2466/15.PMS.121c18x2		8	Psychology, Experimental	Psychology	CV2RM	WOS:000364104500020		
J	Sasakura, D; Nakayama, K; Chikuma, T				Sasakura, D.; Nakayama, K.; Chikuma, T.			Application of the quantitative detection of a change in concentration of magnesium stearate in a feeder tube of tableting manufacture by real-time near-infrared spectroscopy	PHARMAZIE			English	Article							PROCESS ANALYTICAL TECHNOLOGY; NIR SPECTROSCOPY; FLUIDIZED-BED; PAT TOOLS; GRANULATION	Process analytical technology is important for the analysis and control of manufacturing processes. Near-infrared spectroscopy is widely used in various process analytical technologies for the analysis of the chemical components of solid dosage forms. Lubrication is an important process carried out before a tablet is produced. In this process, the concentration of lubricant, such as magnesium stearate (StMg), might change for one of many reasons during powder transport, which would be a critical problem such as variation in tablet compressibility and dissolution failure of compressed tablets. Our group investigated the feasibility of the quantitative monitoring of a change in the concentration of StMg in the feeder tube of tableting equipment employing real-time near-infrared spectroscopy.	[Sasakura, D.; Chikuma, T.] Showa Pharmaceut Univ, Dept Analyt Chem Pharm, Machida, Tokyo 1948543, Japan; [Nakayama, K.] Towa Pharmaceut Co Ltd, Div Formulat Sci, Tokyo, Japan	Sasakura, D (reprint author), Showa Pharmaceut Univ, Dept Analyt Chem Med, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	saru_dai@hotmail.com					De Beer TRM, 2009, J PHARM SCI-US, V98, P3430, DOI 10.1002/jps.21633; Luypaert J, 2007, TALANTA, V72, P865, DOI 10.1016/j.talanta.2006.12.023; [Anonymous], 2008, INT C HARMONISATION; Lee MJ, 2010, J PHARM SCI-US, V99, P325, DOI 10.1002/jps.21795; Mehrotra A, 2007, INT J PHARM, V336, P284, DOI 10.1016/j.ijpharm.2006.12.013; Moes JJ, 2008, INT J PHARMACEUT, V357, P108, DOI 10.1016/j.ijpharm.2008.01.062; Sekulic SS, 1996, ANAL CHEM, V68, P509, DOI 10.1021/ac950964m; Nakagawa H, 2013, INT J PHARMACEUT, V441, P402, DOI 10.1016/j.ijpharm.2012.11.014; [Anonymous], 2005, INT C HARM TECHN REQ; [Anonymous], 2009, INT C HARMONISATION; Burggraeve A, 2013, EUR J PHARM BIOPHARM, V83, P2, DOI 10.1016/j.ejpb.2012.09.008; Tok A, 2008, AAPS PHARMSCITECH, V9, P1083, DOI 10.1208/s12249-008-9145-6; [Anonymous], 2012, INT C HARMONISATION; BOLHUIS GK, 1981, J PHARM SCI, V70, P1328, DOI 10.1002/jps.2600701210; Hagrasy ASH, 2006, PHARM DEV TECHNOL, V11, P303; Mollan MJ, 1996, INT J PHARM, V114, P1; Savitky A, 1964, ANAL CHEM, V36, P1627; U.S. Food and Drug Administration Guidance for Industry, 2004, PAT A FRAM INN PHARM	18	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	OCT	2015	70	10					636	639		10.1691/ph.2015.4219		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AU	WOS:000363909900002		
J	Tachi, T; Yasuda, M; Usui, K; Umeda, M; Nagaya, K; Osawa, T; Ichihashi, A; Noguchi, Y; Goto, H; Kasahara, S; Takahashi, T; Garo, C; Teramachi, H				Tachi, T.; Yasuda, M.; Usui, K.; Umeda, M.; Nagaya, K.; Osawa, T.; Ichihashi, A.; Noguchi, Y.; Goto, H.; Kasahara, S.; Takahashi, T.; Garo, C.; Teramachi, H.			Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma	PHARMAZIE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IDEC-C2B8	Rituximab (RTX), a monoclonal antibody against CD20, is known to cause fewer side effects than conventional anti-cancer drugs; however, infusion reaction (IR), which is specific to monoclonal antibody therapy, is frequently triggered by RTX. Therefore, we designed this study to identify risk factors based on clinical test values for developing IR after RTX administration. Eighty-nine patients with B-cell non-Hodgkin's lymphoma who had received RTX for the first time between February 2010 and March 2013, at the Gifu Municipal Hospital were enrolled as subjects. Analysis of data was conducted for 87 patients, after excluding patients whose data were missing. Univariate analysis showed significant differences in the number of patients exhibiting a soluble interleukin-2 receptor (sIL-2R) level > 2,000 U/L and hemoglobin (Hb) < lower standard limit (LSL) between the IR and non-IR groups. Multivariate analysis showed significant differences with respect to sIL-2R > 2,000 U/L [odds ratio (OR), 4.463; 95% confidence interval (Cl), 1.262-15.779; P=0.020], Hb < LSL [OR, 3.568; 95% Cl, 1.071-11.890; P=0.038], and steroid administration [OR, 0.284; 95% CI, 0.094-0.852; P= 0.025]. Our findings show that sIL-2R >2,000 U/L, Hb < LSL, and a lack of steroid premedication are risk factors for developing IR following RTX treatment.	[Tachi, T.; Usui, K.; Noguchi, Y.; Teramachi, H.] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Gifu 5011196, Japan; [Tachi, T.; Yasuda, M.; Umeda, M.; Nagaya, K.; Osawa, T.; Ichihashi, A.; Garo, C.] Gifu Municipal Hosp, Dept Pharm, Gifu, Japan; [Goto, H.; Kasahara, S.; Takahashi, T.] Gifu Municipal Hosp, Dept Hematol, Gifu, Japan	Teramachi, H (reprint author), Gifu Pharmaceut Univ, Lab Clin Pharm, 1-25-4 Daigaku Nishi, Gifu, Gifu 5011196, Japan.	teramachih@gifu-pu.ac.jp					Park JH, 2014, ANN HEMATOL, V93, P1755, DOI 10.1007/s00277-014-2115-z; Maloney DG, 1997, J CLIN ONCOL, V15, P3266; Lenz HJ, 2007, ONCOLOGIST, V12, P601, DOI 10.1634/theoncologist.12-5-601; Dillman RO, 1999, CANCER METAST REV, V18, P465, DOI 10.1023/A:1006341717398; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Hagberg H, 2000, MED ONCOL, V17, P218, DOI 10.1007/BF02780531; Winkler U, 1999, BLOOD, V94, P2217; Goto H, 2005, J CANCER RES CLIN, V131, P73, DOI 10.1007/s00432-004-0600-9; Plosker GL, 2003, DRUGS, V63, P803, DOI 10.2165/00003495-200363080-00005; RUBIN LA, 1990, ANN INTERN MED, V113, P619; Hong J, 2013, SUPPORT CARE CANCER, V21, P1145, DOI 10.1007/s00520-012-1639-9; Schwartzberg LS, 2008, SUPPORT CARE CANCER, V16, P393, DOI 10.1007/s00520-007-0329-5; Press O W, 2001, Hematology Am Soc Hematol Educ Program, P221, DOI 10.1182/asheducation-2001.1.221; Setoyama Y, 1994, Rinsho Byori, V42, P834; Yasuda Masahiro, 2014, Gan To Kagaku Ryoho, V41, P975	15	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	OCT	2015	70	10					674	677		10.1691/ph.2015.5620		4	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AU	WOS:000363909900009		
J	Harada, H; Toyoda, Y; Endo, T; Kobayashi, M				Harada, H.; Toyoda, Y.; Endo, T.; Kobayashi, M.			Cysteine amide adduct formation from carboxylic acid drugs via UGT-mediated bioactivation in human liver microsomes	PHARMAZIE			English	Article							GLUTATHIONE IN-VITRO; S-ACYL-GLUTATHIONE; CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY; NATIVE CHEMICAL LIGATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GAMMA-GLUTAMYL-TRANSPEPTIDASE; HUMAN SERUM-ALBUMIN; BILE-ACID; GLUCURONIDE METABOLITES; REACTIVE METABOLITES	Although chemical trapping has been widely used to evaluate cytochrome P450-mediated drug bioactivation, thus far, only a few in vitro-trapping studies have been performed on UDP-glucuronosyltransferase (UGT)-mediated drug bioactivation. In this study, we used cysteine (Cys) as trapping agent to gain new insights into the UGT-mediated bioactivation involving acyl glucuronides of carboxylic acid drugs. Diclofenac, ketoprofen and ibuprofen were incubated in human liver microsomes with UDPGA and Cys, followed by analysis using ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). The N-acyl-Cys amide adduct of diclofenac was characterized by mass analysis and was detectable even in photodiode array analysis. Our data indicated that the formation of such adducts reflects the reactivity of the corresponding acyl glucuronides. In addition, it was suggested that the adduct formation requires an N-terminal Cys moiety with both a free amine and a free thiol group, from the results using various cysteine derivatives. We propose that the S-acyl-Cys thioester adduct can form via transacylation of an acyl glucuronide and can then form to an N-acyl-Cys amide adduct through intramolecular S- to N-acyl rearrangement. This series of the reactions has important implications as a possible bioactivation mechanism for covalent binding of carboxylic acid drugs to macromolecules.	[Harada, H.; Toyoda, Y.; Endo, T.] Kissei Pharmaceut Co Ltd, Pharmacokinet Res Lab, Matsumoto, Nagano 3998710, Japan; [Kobayashi, M.] Kissei Pharmaceut Co Ltd, Cent Res Labs, Matsumoto, Nagano 3998710, Japan	Harada, H (reprint author), Kissei Pharmaceut Co Ltd, Pharmacokinet Res Lab, 19-48 Yoshino, Matsumoto, Nagano 3998710, Japan.	hiroshi_harada1@pharm.kissei.co.jp					Chiou Y, 1999, CHEM-BIOL INTERACT, V121, P141, DOI 10.1016/S0009-2797(99)00098-8; Boelsterli UA, 2003, TOXICOL APPL PHARM, V192, P307, DOI 10.1016/S0041-008X(03)0036805; Mano N, 2004, J BIOL CHEM, V279, P55034, DOI 10.1074/jbc.M409205200; Goto J, 2001, RAPID COMMUN MASS SP, V15, P104, DOI 10.1002/1097-0231(20010130)15:2<104::AID-RCM198>3.3.CO;2-E; Sallustio BC, 1997, TOXICOL APPL PHARM, V147, P459, DOI 10.1006/taap.1997.8322; Grillo MP, 2003, DRUG METAB DISPOS, V31, P1327, DOI 10.1124/dmd.31.11.1327; Bailey MJ, 2003, CHEM-BIOL INTERACT, V145, P117, DOI 10.1016/S0009-2797(03)00020-6; Olsen J, 2005, CHEM RES TOXICOL, V18, P1729, DOI 10.1021/tx0501785; Li C, 2002, CHEM RES TOXICOL, V15, P1309, DOI 10.1021/tx0200131; SMITH PC, 1992, BIOCHEM PHARMACOL, V44, P1661, DOI 10.1016/0006-2952(92)90484-Z; Grillo MP, 2003, CHEM RES TOXICOL, V16, P1410, DOI 10.1021/tx034038b; Regan SL, 2010, BIOPHARM DRUG DISPOS, V31, P367, DOI 10.1002/bdd.720; Liu JH, 1998, PHARMACEUT RES, V15, P343, DOI 10.1023/A:1011995408539; Georges H, 1999, LIFE SCI, V65, pPL151, DOI 10.1016/S0024-3205(99)00371-9; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; TATE SS, 1975, FEBS LETT, V54, P319, DOI 10.1016/0014-5793(75)80930-6; Grillo MP, 2002, DRUG METAB DISPOS, V30, P55, DOI 10.1124/dmd.30.1.55; Bolze S, 2002, DRUG METAB DISPOS, V30, P404, DOI 10.1124/dmd.30.4.404; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Skonberg C, 2008, EXPERT OPIN DRUG MET, V4, P425, DOI 10.1517/17425255.4.4.425 ; Ma SG, 2006, J MASS SPECTROM, V41, P1121, DOI 10.1002/jms.1098; Grillo MP, 2003, DRUG METAB DISPOS, V31, P1429, DOI 10.1124/dmd.31.11.1429; Sidenius U, 2004, CHEM RES TOXICOL, V17, P75, DOI 10.1021/tx034127o; Stachulski AV, 2006, J MED CHEM, V49, P6931, DOI 10.1021/jm060599z; KRETZROMMEL A, 1994, DRUG METAB DISPOS, V22, P956; SMITH PC, 1990, DRUG METAB DISPOS, V18, P639; Harada H, 2009, RAPID COMMUN MASS SP, V23, P564, DOI 10.1002/rcm.3912; Camarero JA, 2001, BIOORGAN MED CHEM, V9, P2479, DOI 10.1016/S0968-0896(01)00217-6; Castro-Perez J, 2005, RAPID COMMUN MASS SP, V19, P798, DOI 10.1002/rcm.1855; Grillo MP, 2001, CHEM RES TOXICOL, V14, P1033, DOI 10.1021/tx010039x; BOELSTERLI UA, 1995, CRIT REV TOXICOL, V25, P207, DOI 10.3109/10408449509089888; Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; FAED EM, 1984, DRUG METAB REV, V15, P1213, DOI 10.3109/03602538409033562; Sleno L, 2007, RAPID COMMUN MASS SP, V21, P2301, DOI 10.1002/rcm.3092; Joshi EM, 2004, CHEM RES TOXICOL, V17, P137, DOI 10.1021/tx0341409; Grillo MP, 2008, CHEM RES TOXICOL, V21, P1933, DOI 10.1021/tx800073p; Jenkins LMM, 2007, J AM CHEM SOC, V129, P11067, DOI 10.1021/ja071254o; Mitamura K, 2007, J CHROMATOGR B, V855, P88, DOI 10.1016/j.jchromb.2007.02.010; Yeo DSY, 2004, CHEM-EUR J, V10, P4664, DOI 10.1002/chem.200400414; Ebner T, 1999, DRUG METAB DISPOS, V27, P1143; Bolze S, 2002, CURR SEP, V20, P55; SPAHNLANGGUTH H, 1992, DRUG METAB REV, V24, P5	42	0	0	GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH	ESCHBORN	PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY	0031-7144			PHARMAZIE	Pharmazie	OCT	2015	70	10					678	683		10.1691/ph.2015.5636		6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CV0AU	WOS:000363909900010		
J	Adachi, K; Yang, Y; Ezashi, T; Alexenko, A; Sheridan, M; Schust, DJ; Schulz, LC; Amita, M; Roberts, RM; Kawana, K; Osuga, Y; Fujii, T				Adachi, Katsuyuki; Yang, Ying; Ezashi, Toshihiko; Alexenko, Andrei; Sheridan, Megan; Schust, D. J.; Schulz, L. C.; Amita, Mitsuyoshi; Roberts, R. M.; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki			SHORT TERM EXPOSURE OF BMP4 CREATED NOVEL TROPHOBLAST PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS	PLACENTA			English	Meeting Abstract									[Adachi, Katsuyuki; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Sch Med, Dept OB GYN, Tokyo 1138654, Japan; [Yang, Ying; Ezashi, Toshihiko; Alexenko, Andrei; Amita, Mitsuyoshi; Roberts, R. M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Schust, D. J.; Schulz, L. C.] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA; [Sheridan, Megan] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-15	A5	A5				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200033		
J	Aoki, A; Ikawa, M; Nakashima, A; Yoshimori, T; Saito, S				Aoki, Aiko; Ikawa, Masahito; Nakashima, Akitoshi; Yoshimori, Tamotsu; Saito, Shigeru			TROPHOBLAST SPECIFIC CONDITIONAL ATG7 KNOCKOUT PREGNANT MICE DEVELOP GESTATIONAL HYPERTENSION	PLACENTA			English	Meeting Abstract									[Aoki, Aiko; Nakashima, Akitoshi; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama, Japan; [Aoki, Aiko; Ikawa, Masahito] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Aoki, Aiko; Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Suita, Osaka 565, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-50	A13	A13				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200066		
J	Aoki, S; Higashimoto, K; Hidaka, H; Watanabe, H; Ohtsuka, Y; Mishima, H; Yoshiura, K; Yatsuki, H; Nishioka, K; Joh, K; Ohba, T; Katabuchi, H; Soejima, H				Aoki, Saori; Higashimoto, Ken; Hidaka, Hidenori; Watanabe, Hidetaka; Ohtsuka, Yasufumi; Mishima, Hiroyuki; Yoshiura, Koh-ichiro; Yatsuki, Hitomi; Nishioka, Kenichi; Joh, Kei-ichiro; Ohba, Takashi; Katabuchi, Hidetaka; Soejima, Hidenobu			MOLECULAR GENETIC INVESTIGATION OF PLACENTAL MESENCHYMAL DYSPLASIA	PLACENTA			English	Meeting Abstract									[Aoki, Saori; Higashimoto, Ken; Hidaka, Hidenori; Watanabe, Hidetaka; Ohtsuka, Yasufumi; Yatsuki, Hitomi; Nishioka, Kenichi; Joh, Kei-ichiro; Soejima, Hidenobu] Saga Univ, Div Mol Genet & Epigenet, Dept Biomol Sci, Fac Med, Saga, Japan; [Ohtsuka, Yasufumi; Mishima, Hiroyuki; Yoshiura, Koh-ichiro] Taiji Sch Biomed Sci, Fac Med, Dept Pediat, Nagasaki, Japan; [Aoki, Saori; Ohtsuka, Yasufumi; Ohba, Takashi; Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto 860, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-01	A2	A2				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200021		
J	Arizawa, M				Arizawa, Masayoshi			PLACENTAL DYSFUNCTION	PLACENTA			English	Meeting Abstract									[Arizawa, Masayoshi] Tokyo Metropolitan Otsuka Hosp, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-06	A3	A3				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200026		
J	Fukami, T; Yoneyama, K; Takeshita, T				Fukami, Takehiko; Yoneyama, Koichi; Takeshita, Toshiyuki			A CASE OF PLACENTA PERCRETA WITH MASSIVE HEMORRHAGE IN TERMINATION OF SECOND TRIMESTER PREGNANCY	PLACENTA			English	Meeting Abstract									[Fukami, Takehiko; Yoneyama, Koichi; Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstetor & Gynecol, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-33	A9	A9				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200049		
J	Furuta, N; Chizuko, Y; Hiroaki, I; Kazuhiro, S; Naohiro, K				Furuta, Naomi; Chizuko, Yaguchi; Hiroaki, Itoh; Kazuhiro, Sugihara; Naohiro, Kanayama			ANALYSIS OF 47 CASES OF VILLITIS OF UNKNOWN ETIOLOGY (VUE)	PLACENTA			English	Meeting Abstract									[Furuta, Naomi; Chizuko, Yaguchi; Hiroaki, Itoh; Kazuhiro, Sugihara; Naohiro, Kanayama] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-47	A12	A12				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200063		
J	Hamada, H; Okae, H; Arima, T; Yaegashi, N				Hamada, Hirotaka; Okae, Hiroaki; Arima, Takahiro; Yaegashi, Nobuo			SKEWED X CHROMOSOME INACTIVATION IN HUMAN PLACENTAL TISSUE	PLACENTA			English	Meeting Abstract									[Hamada, Hirotaka; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Hamada, Hirotaka; Okae, Hiroaki; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Dept Informat Genet, Sendai, Miyagi 980, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-03	A2	A2				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200023		
J	Hirohata, N; Aizawa-Komine, S; Watanabe, N; Hayakawa, S				Hirohata, Naoko; Aizawa-Komine, Shihoko; Watanabe, Noriko; Hayakawa, Satoshi			SUPERNATANT OF PORPHYROMONAS GINGIVALIS INHIBITS TROPHOBLAST INVASION VIA SUPPRESSION OF EPITHELIAL MESENCHYMAL TRANSITION (EMT)	PLACENTA			English	Meeting Abstract									[Hirohata, Naoko; Aizawa-Komine, Shihoko; Hayakawa, Satoshi] Nihon Univ, Div Microbiol, Dept Pathol & Microbiol, Sch Med, Tokyo 102, Japan; [Watanabe, Noriko] Nihon Univ, Div Pathol, Dept Pathol & Microbiol, Sch Med, Tokyo 102, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-37	A10	A10				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200053		
J	Inagaki, M; Nishimura, T; Nakanishi, T; Akanuma, S; Tachikawa, M; Tamai, I; Hosoya, K; Tomi, M; Nakashima, E				Inagaki, Mai; Nishimura, Tomohiro; Nakanishi, Takeo; Akanuma, Shin-ichi; Tachikawa, Masanori; Tamai, Ikumi; Hosoya, Ken-ichi; Tomi, Masatoshi; Nakashima, Emi			MOUSE PLACENTAL DISTRIBUTION OF ENZYMES AND TRANSPORTER MODULATING PGE2 LEVEL	PLACENTA			English	Meeting Abstract									[Inagaki, Mai; Nishimura, Tomohiro; Tomi, Masatoshi; Nakashima, Emi] Keio Univ, Fac Pharm, Tokyo 108, Japan; [Nakanishi, Takeo; Tamai, Ikumi] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan; [Akanuma, Shin-ichi; Hosoya, Ken-ichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Tachikawa, Masanori] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-24	A7	A7				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200041		
J	Ito, Y; Matsuoka, K; Tachimoto, R; Sugimoto, K; Sago, H; Hata, K; Okamoto, A				Ito, Yuki; Matsuoka, Kentaro; Tachimoto, Rie; Sugimoto, Kouhei; Sago, Haruhiko; Hata, Kenichiro; Okamoto, Aikou			INCREASED EXPRESSION OF PERFORIN, GRANZYME B, AND C5B-9 IN VILLITIS OF UNKNOWN ETIOLOGY	PLACENTA			English	Meeting Abstract									[Ito, Yuki; Tachimoto, Rie; Sugimoto, Kouhei; Okamoto, Aikou] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan; [Matsuoka, Kentaro] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Dept Maternal Fetal & Neonatal Med, Tokyo, Japan; [Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-48	A12	A13				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200064		
J	Iwahashi, N; Kobayashi, A; Tanizaki, Y; Shiro, M; Ota, N; Mabuchi, Y; Yagi, S; Minami, S; Ino, K				Iwahashi, Naoyuki; Kobayashi, Aya; Tanizaki, Yuko; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko			EXPRESSION OF ANGIOGENIC AND IMMUNOLOGICAL FACTORS IN PLACENTA WITH PREECLAMPSIA AND/OR FETAL GROWTH RESTRICTION	PLACENTA			English	Meeting Abstract									[Iwahashi, Naoyuki; Kobayashi, Aya; Tanizaki, Yuko; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Minami, Sawako; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-52	A14	A14				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200068		
J	Kawamura, H; Takeuchi, M; Sasahara, J; Ishii, K; Mitsuda, N				Kawamura, Hiroshi; Takeuchi, Makoto; Sasahara, Jun; Ishii, Keisuke; Mitsuda, Nobuaki			INFLAMMATORY RESPONSE IN ACUTE CHORIOAMNIONITIS AND OUTCOME OF VERY LOW BIRTH WEIGHT INFANTS	PLACENTA			English	Meeting Abstract									[Kawamura, Hiroshi; Sasahara, Jun; Ishii, Keisuke; Mitsuda, Nobuaki] Osaka Med Ctr, Dept Maternal Fetal Med, Osaka, Japan; [Kawamura, Hiroshi; Takeuchi, Makoto; Sasahara, Jun; Ishii, Keisuke; Mitsuda, Nobuaki] Res Inst Maternal & Child Hlth, Osaka, Japan; [Takeuchi, Makoto] Osaka Med Ctr, Dept Pathol, Osaka, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-40	A10	A11				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200056		
J	Kawasaki, K; Kondoh, E; Chigusa, Y; Sato, M; Takai, H; Kiyokawa, H; Ujita, M; Takeda, S; Konishi, I				Kawasaki, Kaoru; Kondoh, Eiji; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Kiyokawa, Hikaru; Ujita, Mari; Takeda, Satoru; Konishi, Ikuo			MGSO(4) POTENTIATES ANTI-OXIDANT AND ANTI-INFLAMMATORY ACTIVITIES IN TROPHOBLAST CELLS	PLACENTA			English	Meeting Abstract									[Kawasaki, Kaoru; Kondoh, Eiji; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Kiyokawa, Hikaru; Ujita, Mari; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Obstet & Gynecol, Kyoto 6068501, Japan; [Takeda, Satoru] Juntendo Univ, Dept Gynecol & Obstet, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-44	A11	A12				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200060		
J	Kobayashi, T; Usui, H; Shozu, M				Kobayashi, Tatsuya; Usui, Hirokazu; Shozu, Makio			THREE POINT MUTATIONS OF PROMOTER I.1 OF MARMOSET AROMATASE GIVES RISE OF HUMAN TYPE EXONI.1	PLACENTA			English	Meeting Abstract									[Kobayashi, Tatsuya; Usui, Hirokazu; Shozu, Makio] Chiba Univ, Postgrad Med Sch, Reprod Med, Chiba, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-04	A2	A3				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200024		
J	Kohata, A; Kasamatsu, A; Okada, H; Uemura, Y; Minamiguchi, S				Kohata, Akira; Kasamatsu, Atsushi; Okada, Hidetaka; Uemura, Yoshiko; Minamiguchi, Sachiko			A CASE OF ATYPICAL CELLULAR CHORANGIOMA	PLACENTA			English	Meeting Abstract									[Kohata, Akira; Kasamatsu, Atsushi; Okada, Hidetaka; Uemura, Yoshiko] Kansai Med Univ Hosp, Osaka, Japan; [Minamiguchi, Sachiko] Kyouto Med Univ Hosp, Kyoto, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-09	A4	A4				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200029		
J	Kojima, J; Akutsu, H; Nishi, H; Kuji, N; Isaka, K				Kojima, Junya; Akutsu, Hidenori; Nishi, Hirotaka; Kuji, Naoaki; Isaka, Keiichi			INDUCED PLURIPOTENT STEM CELLS (IPS CELL) DIFFERENTIATES TO TROPHOBLAST	PLACENTA			English	Meeting Abstract									[Kojima, Junya; Nishi, Hirotaka; Kuji, Naoaki; Isaka, Keiichi] Tokyo Med Univ, Dept Obstet & Gynecol, Tokyo 1608402, Japan; [Akutsu, Hidenori] Natl Ctr Child Hlth & Dev, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-16	A5	A5				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200034		
J	Masayoshi, A				Masayoshi, Arizawa			PLACENTAMEGALY: FREQUENCY, CAUSES, AND COMPLICATIONS	PLACENTA			English	Meeting Abstract									[Masayoshi, Arizawa] Tokyo Metropolitan Otsuka Hosp, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-17	A5	A5				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200035		
J	Minatoguchi, M; Tamaru, S; Miki, A; Kajihara, T; Okagaki, R; Kamei, Y; Ishihara, O; Soma, H; Murai, N; Oguro, T; Kuniba, H; Fujita, K; Mineo, S				Minatoguchi, Miki; Tamaru, Syunsuke; Miki, Akinori; Kajihara, Takeshi; Okagaki, Ryuugo; Kamei, Yoshimasa; Ishihara, Osamu; Soma, Hiroaki; Murai, Noriko; Oguro, Tatsuo; Kuniba, Hiroko; Fujita, Kouji; Mineo, Shyouichirou			PATHOLOGIC LESIONS OF THE FETUSES AND PLACENTAS INDUCED BY DECIDUAL VASCULOPATHY	PLACENTA			English	Meeting Abstract									[Minatoguchi, Miki; Tamaru, Syunsuke; Miki, Akinori; Kajihara, Takeshi; Okagaki, Ryuugo; Kamei, Yoshimasa; Ishihara, Osamu; Soma, Hiroaki] Saitama Med Univ, Obstet & Gynecol, Moroyama, Saitama, Japan; [Murai, Noriko] Saitama Med Univ, Electron Microscopy, Moroyama, Saitama, Japan; [Oguro, Tatsuo] Chiba Hokuso Hosp, Nippon Med Sch, Div Pathol, Chiba, Japan; [Kuniba, Hiroko; Fujita, Kouji; Mineo, Shyouichirou] Tokyo Med Univ, Electron Microscopy Mol Pathol, Tokyo 1608402, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-05	A3	A3				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200025		
J	Miwa, Y; Eiko, Y; Shizuka, S; Kenichi, N; Kimihiro, N; Kaoru, N; Tomomi, K; Fumitaka, K				Miwa, Yoko; Eiko, Yamamoto; Shizuka, Sato; Kenichi, Nakamura; Kimihiro, Nishino; Kaoru, Niimi; Tomomi, Kotani; Fumitaka, Kikkawa			EXPRESSION AND FUNCTION OF C-REL IN CHORIOCARCINOMA CELLS	PLACENTA			English	Meeting Abstract									[Miwa, Yoko; Eiko, Yamamoto; Shizuka, Sato; Kenichi, Nakamura; Kimihiro, Nishino; Kaoru, Niimi; Tomomi, Kotani; Fumitaka, Kikkawa] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4648601, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-36	A9	A10				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200052		
J	Miyoshi, T; Matsuyama, T; Daimon, A; Kuwazuru, C; Sawada, M; Sato, H; Horiuchi, C; Tsuritani, M; Iwanaga, N; Yoshimatsu, J; Ueda-Ishibashi, H				Miyoshi, Takekazu; Matsuyama, Taka-aki; Daimon, Atsushi; Kuwazuru, Chi-ichiro; Sawada, Masami; Sato, Hiroshi; Horiuchi, Chinami; Tsuritani, Mitsuhiro; Iwanaga, Naoko; Yoshimatsu, Jun; Ueda-Ishibashi, Hatsue			NOVEL PATHOLOGICAL FINDINGS OF PLACENTA WITH FETAL HEART FAILURE ASSOCIATED WITH CONGENITAL HEART DISEASE	PLACENTA			English	Meeting Abstract									[Miyoshi, Takekazu; Daimon, Atsushi; Kuwazuru, Chi-ichiro; Sawada, Masami; Sato, Hiroshi; Horiuchi, Chinami; Tsuritani, Mitsuhiro; Iwanaga, Naoko; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka, Japan; [Matsuyama, Taka-aki; Ueda-Ishibashi, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Suita, Osaka, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-29	A8	A8				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200045		
J	Naing, BT; Song, XH; Takizawa, T				Naing, Banyar Than; Song, Xiaohui; Takizawa, Toshihiro			DETECTION OF H19 EXPRESSION IN MOUSE PLACENTA BY REAL-TIME QUANTITATIVE PCR AND IN SITU HYBRIDIZATION	PLACENTA			English	Meeting Abstract									[Naing, Banyar Than; Song, Xiaohui; Takizawa, Toshihiro] Nippon Med Sch, Mol Med & Anat, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-23	A6	A7				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200040		
J	Nakashima, A; Shima, T; Ushijima, A; Aoki, A; Inacia, K; Shiozaki, A; Yoshino, O; Sharma, S; Saito, S				Nakashima, Akitoshi; Shima, Tomoko; Ushijima, Akemi; Aoki, Aiko; Inacia, Kumiko; Shiozaki, Arihiro; Yoshino, Osamu; Sharma, Surendra; Saito, Shigeru			PREECLAMPSIA SERUM DISRUPTS THE AUTOPHAGY PATHWAY COOPERATED WITH ENDOPLASMIC RETICULUM STRESS	PLACENTA			English	Meeting Abstract									[Nakashima, Akitoshi; Shima, Tomoko; Ushijima, Akemi; Aoki, Aiko; Inacia, Kumiko; Shiozaki, Arihiro; Yoshino, Osamu; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Fac Med, Toyama, Japan; [Nakashima, Akitoshi; Sharma, Surendra] Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Providence, RI 02912 USA								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-49	A13	A13				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200065		
J	Naruse, K; Shigemitsu, A; Akasaka, J; Yoshimoto, C; Tsunemi, T; Sado, T; Kobayashi, H				Naruse, Katsuhiko; Shigemitsu, Aiko; Akasaka, Juria; Yoshimoto, Chiharu; Tsunemi, Taihei; Sado, Toshiyuki; Kobayashi, Hiroshi			ABNORMAL ULTRASOUND FINDINGS RELATING PATHOPHYSIOLOGY AND OUTCOME OF THE LOW-LYING PLACENTA	PLACENTA			English	Meeting Abstract									[Naruse, Katsuhiko; Shigemitsu, Aiko; Akasaka, Juria; Yoshimoto, Chiharu; Tsunemi, Taihei; Sado, Toshiyuki; Kobayashi, Hiroshi] Nara Med Univ, Dept Obstet & Gynecol, Nara, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-19	A6	A6				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200037		
J	Negishi, Y; Shima, Y; Takahashi, H; Takeshita, T				Negishi, Yasuyuki; Shima, Yoshio; Takahashi, Hidemi; Takeshita, Toshiyuki			POSSIBLE ROLE OF DEC-205 POSITIVE DENDRITIC CELLS IN MODERATELY AND LATE PRETERM DELIVERY	PLACENTA			English	Meeting Abstract									[Negishi, Yasuyuki; Takahashi, Hidemi] Nippon Med Sch, Dept Microbiol & Immunol, Tokyo, Japan; [Negishi, Yasuyuki; Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo, Japan; [Shima, Yoshio] Nippon Med Sch, Musashikosugi Hosp, Dept Pediat, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-38	A10	A10				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200054		
J	Noguchi, T; Shiro, M; Ota, N; Mabuchi, Y; Yagi, S; Sawako, M; Ino, K				Noguchi, Tomoko; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Sawako, Minami; Ino, Kazuhiko			RISK FACOTOR OF RETAINED PRODUCTS OF CONCEPTION AFTER MID-TRIMESTER ABORTION	PLACENTA			English	Meeting Abstract									[Noguchi, Tomoko; Shiro, Michihisa; Ota, Nami; Mabuchi, Yasushi; Yagi, Shigetaka; Sawako, Minami; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-07	A3	A3				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200027		
J	Ohmaru, T; Asanoma, K; Rondo, Y; Hidaka, N; Fujita, Y; Kato, K				Ohmaru, Takako; Asanoma, Kazuo; Rondo, Yukiko; Hidaka, Nobuhiro; Fujita, Yasuyuki; Kato, Kiyoko			THE FIBROSIS RELATED FACTOR EXPRESSION AT VILLOUS STROMA OF PLACENTA COMPLICATED WITH PREGNANCY INDUCED HYPERTENSION	PLACENTA			English	Meeting Abstract									[Ohmaru, Takako; Asanoma, Kazuo; Rondo, Yukiko; Hidaka, Nobuhiro; Fujita, Yasuyuki; Kato, Kiyoko] Kyushu Univ, Dept Obstet & Gynecol, Grad Sch Med Sci, Fukuoka 812, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-41	A11	A11				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200057		
J	Oyama, R; Shino, T; Yuri, S; Kanasugi, T; Kikuchi, A; Sugiyama, T				Oyama, Rie; Shino, Tanaka; Yuri, Sasaki; Kanasugi, Tomonobu; Kikuchi, Akihiko; Sugiyama, Toru			A SURVIVED INFANT WITH PLACENTAL MESENCHYMAL DYSPLASIA	PLACENTA			English	Meeting Abstract									[Oyama, Rie; Shino, Tanaka; Yuri, Sasaki; Kanasugi, Tomonobu; Kikuchi, Akihiko; Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-02	A2	A2				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200022		
J	Sakuragi, T; Aoyama, Y; Aiko, Y; Tomonaga, C; Aramaki, S; Inagaki, H; Nakashima, K; Hachisuga, T; Shibata, E				Sakuragi, Toshihide; Aoyama, Yoko; Aiko, Yukiyo; Tomonaga, Chiharu; Aramaki, Satoshi; Inagaki, Hirohide; Nakashima, Kimi; Hachisuga, Toru; Shibata, Eiji			INVESTIGATION OF CALCIUM TRANSPORT AND REGULATION SYSTEM IN HUMAN PLACENTA	PLACENTA			English	Meeting Abstract									[Sakuragi, Toshihide; Aoyama, Yoko; Aiko, Yukiyo; Tomonaga, Chiharu; Aramaki, Satoshi; Inagaki, Hirohide; Nakashima, Kimi; Hachisuga, Toru; Shibata, Eiji] Univ Occupat & Environm Hlth, Dept Obstet & Gynecol, Kitakyushu, Fukuoka, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-26	A7	A7				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200042		
J	Sena, K; Shirasuna, K; Shimamura, N; Shiratsuki, S; Ohkuchi, A; Iwata, H; Kuwayama, T				Sena, Kotomi; Shirasuna, Koumei; Shimamura, Narumi; Shiratsuki, Shogo; Ohkuchi, Akihide; Iwata, Hisataka; Kuwayama, Takehito			AGE AND HMGB1 INDUCES INFLAMMATORY RESPONSE IN HUMAN TROPHOBLAST CELL LINE	PLACENTA			English	Meeting Abstract									[Sena, Kotomi; Shirasuna, Koumei; Shimamura, Narumi; Shiratsuki, Shogo; Iwata, Hisataka; Kuwayama, Takehito] Tokyo Univ Agr, Setagaya Ku, Tokyo 1568502, Japan; [Ohkuchi, Akihide] Jichi Med Univ, Shimotsuke, Tochigi, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-11	A4	A4				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200030		
J	Shiozaki, A; Imura, J; Yoneda, N; Ono, Y; Saitsu, Y; Tsuda, K; Aoki, A; Fukuta, M; Yoneda, S; Saito, S				Shiozaki, Arihiro; Imura, Johji; Yoneda, Noriko; Ono, Yousuke; Saitsu, Yoshiaki; Tsuda, Kei; Aoki, Aiko; Fukuta, Maori; Yoneda, Satoshi; Saito, Shigeru			A MEGA JET-FLOW OF SPIRAL ARTERY INTO INTERVILLOUS SPACE AND PARTIAL VILLOUS DEGENERATION: CASE REPORT	PLACENTA			English	Meeting Abstract									[Shiozaki, Arihiro; Yoneda, Noriko; Ono, Yousuke; Saitsu, Yoshiaki; Tsuda, Kei; Aoki, Aiko; Fukuta, Maori; Yoneda, Satoshi; Saito, Shigeru] Toyama Univ, Dept Obstet & Gynecol, Toyama, Japan; [Imura, Johji] Toyama Univ, Dept Diagnost Pathol, Toyama, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-22	A6	A6				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200039		
J	Sugimoto, J; Kinjo, T; Schust, D; Oda, T; Aoki, Y; Yoshihiro, J				Sugimoto, Jun; Kinjo, Tadatsugu; Schust, Danny; Oda, Takaya; Aoki, Yoichi; Yoshihiro, Jinno			EXPRESSION AND FUNCTIONAL ANALYSIS OF SUPPRESSYN IN PRIMARY TROPHOBLAST CELLS	PLACENTA			English	Meeting Abstract									[Sugimoto, Jun; Oda, Takaya; Yoshihiro, Jinno] Univ Ryukyus, Grad Sch Med Sci, Dept Human Mol Biol, Nishihara, Okinawa 90301, Japan; [Kinjo, Tadatsugu; Aoki, Yoichi] Univ Ryukyus, Grad Sch Med Sci, Dept Obstet & Gynecol, Nishihara, Okinawa 90301, Japan; [Schust, Danny] Univ Missouri, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-12	A4	A4				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200031		
J	Takai, H; Kondoh, E; Sato, M; Kawasaki, K; Kiyokawa, H; Ujita, M; Mogami, H; Takeda, S; Konishi, I				Takai, Hiroshi; Kondoh, Eiji; Sato, Mai; Kawasaki, Kaoru; Kiyokawa, Hikaru; Ujita, Mari; Mogami, Haruta; Takeda, Satoru; Konishi, Ikuo			SONIC HEDGEHOG PATHWAY IS DOWN-REGULATED IN PREECLAMPTIC PLACENTA	PLACENTA			English	Meeting Abstract									[Takai, Hiroshi; Kondoh, Eiji; Sato, Mai; Kawasaki, Kaoru; Kiyokawa, Hikaru; Ujita, Mari; Mogami, Haruta; Konishi, Ikuo] Kyoto Univ, Dept Gynecol & Obstet, Grad Sch Med, Kyoto 6068501, Japan; [Takeda, Satoru] Juntendo Univ Hosp, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-43	A11	A11				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200059		
J	Takamizu, A; Takeda, J; Makino, S; Itakura, A; Takeda, S				Takamizu, Ai; Takeda, Jun; Makino, Shintaro; Itakura, Atsuo; Takeda, Satoru			LEUKOCYTE MIGRATION ASSAY PREDICTS PRETERM BIRTH	PLACENTA			English	Meeting Abstract									[Takamizu, Ai; Takeda, Jun; Makino, Shintaro; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ Hosp, Tokyo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-39	A10	A10				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200055		
J	Tamada, S; Maki, J; Eguchi, T; Mitsui, T; Hirano, Y; Eto, E; Nobumoto, E; Hayata, K; Masuyama, H; Hiramatsu, Y				Tamada, Shoko; Maki, Jota; Eguchi, Takeshi; Mitsui, Takashi; Hirano, Yumika; Eto, Eriko; Nobumoto, Etsuko; Hayata, Kei; Masuyama, Hisashi; Hiramatsu, Yuji			TWO CASES OF CONGENITAL CYTOMEGALOVIRUS INFECTION	PLACENTA			English	Meeting Abstract									[Tamada, Shoko; Maki, Jota; Eguchi, Takeshi; Mitsui, Takashi; Hirano, Yumika; Eto, Eriko; Nobumoto, Etsuko; Hayata, Kei; Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Dept Obstet & Gynecol, Grad Sch Med Dent & Phamaceut Sci, Okayama 7008530, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-08	A3	A4				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200028		
J	Tanimura, K; Yamasaki, Y; Ueno, Y; Maeda, T; Ebina, Y; Deguchi, M; Morizane, M; Yamada, H				Tanimura, Kenji; Yamasaki, Yui; Ueno, Yoshiko; Maeda, Tetsuo; Ebina, Yasuhiko; Deguchi, Masashi; Morizane, Mayumi; Yamada, Hideto			PREDICTION OF ADHERENT PLACENTA IN PATIENTS WITH PLACENTA PREVIA USING ULTRASONOGRAPHY AND MAGNETIC RESONANCE IMAGING	PLACENTA			English	Meeting Abstract									[Tanimura, Kenji; Yamasaki, Yui; Ebina, Yasuhiko; Deguchi, Masashi; Morizane, Mayumi; Yamada, Hideto] Kobe Univ, Dept Obstet & Gynecol, Grad Sch Med, Kobe, Hyogo, Japan; [Ueno, Yoshiko; Maeda, Tetsuo] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-18	A5	A6				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200036		
J	Uchikura, Y; Matsubara, K; Matsubara, Y; Mori, M				Uchikura, Yuka; Matsubara, Keiichi; Matsubara, Yuko; Mori, Miki			ROLE OF HIGH-MOBILITY GROUP A1 PROTEIN IN HUMAN TROPHOBLAST INVASION	PLACENTA			English	Meeting Abstract									[Uchikura, Yuka; Matsubara, Keiichi; Matsubara, Yuko] Ehime Univ, Dept Obstet & Gynecol, Matsuyama, Ehime 790, Japan; [Mori, Miki] Ehime Prefectural Cent Hosp, Matsuyama, Ehime, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-34	A9	A9				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200050		
J	Ueda, M; Horie, A; Sato, Y; Suginami, K; Tani, H; Miyazaki, Y; Okumiya, A; Konishi, I				Ueda, Masashi; Horie, Akihito; Sato, Yukiyasu; Suginami, Koh; Tani, Hirohiko; Miyazaki, Yumiko; Okumiya, Asuka; Konishi, Ikuo			POSSIBLE ROLE OF CD59 IN SPIRAL ARTERY REMODELING	PLACENTA			English	Meeting Abstract									[Ueda, Masashi; Horie, Akihito; Suginami, Koh; Tani, Hirohiko; Miyazaki, Yumiko; Okumiya, Asuka; Konishi, Ikuo] Kyoto Univ, Grad Sch Med, Dept Gynecol & Obstet, Kyoto 6068501, Japan; [Sato, Yukiyasu] Otsu Red Cross Hosp, Dept Obstet & Gynecol, Otsu, Shiga, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-13	A4	A5				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200032		
J	Ujita, M; Kondoh, E; Kawasaki, K; Chigusa, Y; Sato, M; Takai, H; Kiyokawa, H; Nishimura, F; Fujita, K; Mogami, H; Konishi, I				Ujita, Mari; Kondoh, Eiji; Kawasaki, Kaoru; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Kiyokawa, Hikaru; Nishimura, Fumitomo; Fujita, Kohei; Mogami, Haruta; Konishi, Ikuo			WNT5A CAN BE INVOLVED IN THE PATHOGENESIS OF PREECLAMPSIA	PLACENTA			English	Meeting Abstract									[Ujita, Mari; Kondoh, Eiji; Kawasaki, Kaoru; Chigusa, Yoshitsugu; Sato, Mai; Takai, Hiroshi; Nishimura, Fumitomo; Fujita, Kohei; Mogami, Haruta; Konishi, Ikuo] Kyoto Univ, Dept Obstet & Gynecol, Kyoto 6068501, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-42	A11	A11				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200058		
J	Yaguchi, C; Furuta, N; Ueda, M; Itoh, H; Sugihara, K; Kanayama, N				Yaguchi, Chizuko; Furuta, Naomi; Ueda, Megumi; Itoh, Hiroaki; Sugihara, Kazuhiro; Kanayama, Naohiro			THE ASSOCIATION BETWEEN PLACENTAL PATHOLOGY AND NEONATAL/INFANTILE DEVELOPMENT	PLACENTA			English	Meeting Abstract									[Yaguchi, Chizuko; Furuta, Naomi; Ueda, Megumi; Itoh, Hiroaki; Sugihara, Kazuhiro; Kanayama, Naohiro] Hamamatsu Univ Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-46	A12	A12				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200062		
J	Yamaguchi, M; Honda, R; Honda, T; Ohba, T; Katabuchi, H				Yamaguchi, Munekage; Honda, Ritsuo; Honda, Tomoko; Ohba, Takashi; Katabuchi, Hidetaka			TRANSVAGINAL METHOTREXATE INJECTION IS EFFECTIVE FOR THE TREATMENT OF CESAREAN SCAR PREGNANCY DESPITE HCG LEVELS	PLACENTA			English	Meeting Abstract									[Yamaguchi, Munekage; Honda, Ritsuo; Honda, Tomoko; Ohba, Takashi; Katabuchi, Hidetaka] Kumamoto Univ, Dept Obstet & Gynecol, Fac Life Sci, Kumamoto 860, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-32	A8	A9				2	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200048		
J	Yokoyama, T; Tanaka, N; Miyoshi, H; Kudo, Y				Yokoyama, Takanori; Tanaka, Norifumi; Miyoshi, Hiroshi; Kudo, Yoshiki			A CASE OF A PREGNANT WOMAN WITH A MASSIVE SUBCHORIONIC HEMATOMA AND FETAL GROWTH RESTRICTION DETECTED IN THE SECOND TRIMESTER	PLACENTA			English	Meeting Abstract									[Yokoyama, Takanori; Tanaka, Norifumi; Miyoshi, Hiroshi; Kudo, Yoshiki] Hiroshima Univ, Dept Obstet & Gynecol, Grad Sch Biomed Sci, Hiroshima 730, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-27	A7	A7				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200043		
J	Yoshie, M; Tamura, K; Ohishi, K; Ishikawa, G; Nakai, A; Takeshita, T; Isaka, K; Kuwabara, N; Tachikawa, E				Yoshie, Mikihiro; Tamura, Kazuhiro; Ohishi, Kensuke; Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki; Isaka, Keiichi; Kuwabara, Naoko; Tachikawa, Eiichi			ROLES OF A SMALL G-PROTEIN RAP1 IN EGF RECEPTOR-MEDIATED EXTRAVILLOUS TROPHOBLAST CELL INVASION	PLACENTA			English	Meeting Abstract									[Yoshie, Mikihiro; Tamura, Kazuhiro; Ohishi, Kensuke; Kuwabara, Naoko; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Tokyo, Japan; [Ishikawa, Gen; Nakai, Akihito; Takeshita, Toshiyuki] Nippon Med Sch, Dept Obstet & Gynecol, Tokyo, Japan; [Isaka, Keiichi] Tokyo Med Univ, Dept Obstet & Gynecol, Tokyo 1608402, Japan								0	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	OCT	2015	36	10				JPA2015-35	A9	A9				1	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	CV4WM	WOS:000364267200051		
J	Maruyama, H; Tamauchi, H; Kawakami, F; Yoshinaga, K; Nakano, T				Maruyama, Hiroko; Tamauchi, Hidekazu; Kawakami, Fumitaka; Yoshinaga, Keiko; Nakano, Takahisa			Suppressive Effect of Dietary Fucoidan on Proinflammatory immune Response and MMP-1 Expression in UVB-Irradiated Mouse Skin	PLANTA MEDICA			English	Article						Undaria pinnatifida; Alariaceae; fucoidan; UVB; inflammatory cytokine; MMP-1	NF-KAPPA-B; UNDARIA-PINNATIFIDA; ANTITUMOR-ACTIVITY; MEKABU FUCOIDAN; IN-VITRO; FIBROBLASTS; PATHWAY; MICE; ACTIVATION; CELLS	It is well known that ultraviolet B irradiation leads to dermal inflammation. In this study, we found that Mekabu fucoidan suppressed edema, decreased the thickness of the prickle cell layer, and decreased matrix metalloprpteinase 1 in the skin of mice irradiated with ultraviolet B. Moreover, we found that the mean level of interferon gamma of Mekabu fucoidan-treated, ultraviolet B-irradiated mice (approximately 2.2 ng/mL) was not significantly different from that in normal mice (approximately 2.5 ng/mL). In contrast, a significant decrease in the mean level of interferon gamma (approximately 1.3 ng/mL) in ultraviolet B-irradiated control mice was observed compared with that in Mekabu fucoidan-treated, ultraviolet B-irradiated mice. The mean thickness of the prickle cell layer in the skin of Mekabu fucoidan-treated, ultraviolet B-irradiated mice was less than that in the ultraviolet B-irradiated control mice. Metalloproteinase 1 activity was significantly higher in the skin of ultraviolet B-irradiated mice than in the skin of untreated, nonirradiated normal mice. Metalloproteinase 1 in the skin of ultraviolet B-irradiated, Mekabu fucoidan- or L (+)-ascorbic acid (vitamin C)-treated mice was significantly lower than that in the ultraviolet B-irradiated control mice. Mitigation of the morphological changes in Mekabu fucoidan-treated mice was correlated with a decrease in metalloproteinase 1 levels. These data indicate that Mekabu fucoidan is an effective suppressor of inflammation in an ultraviolet B-irradiated mouse model.	[Maruyama, Hiroko] Kitasato Univ, Grad Sch Med Sci, Dept Cytopathol, Sagamihara, Kanagawa 2520373, Japan; [Tamauchi, Hidekazu] Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Sagamihara, Kanagawa 2520373, Japan; [Kawakami, Fumitaka] Kitasato Univ, Grad Sch Med Sci, Dept Immunol, Sagamihara, Kanagawa 2520373, Japan; [Yoshinaga, Keiko; Nakano, Takahisa] Riken Vitamin Co Ltd, Tokyo, Japan	Maruyama, H (reprint author), Kitasato Univ, Grad Sch Med Sci, Dept Cytopathol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	maruyama@ahs.kitasato-u.ac.jp			Kitasato University School of Allied Health Sciences	This work was supported by a grant from Kitasato University School of Allied Health Sciences.	YAMAMOTO I, 1986, CANCER LETT, V30, P125, DOI 10.1016/0304-3835(86)90080-7; Yoshimura M, 2005, BIOSCI BIOTECH BIOCH, V69, P2368, DOI 10.1271/bbb.69.2368; Ali F, 2012, MOL CELL BIOCHEM, V360, P133, DOI 10.1007/s11010-011-1051-7; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Maruyama H, 2005, INT ARCH ALLERGY IMM, V137, P289, DOI 10.1159/000086422; Rana S, 2008, AM J PATHOL, V172, P993, DOI 10.2353/ajpath.2008.070517; Maruyama H, 2008, BIOL PHARM BULL, V31, P714, DOI 10.1248/bpb.31.714; Shih MF, 2008, EUR J DERMATOL, V18, P303, DOI 10.1684/ejd.2008.0393; Paz ML, 2008, CYTOKINE, V44, P70, DOI 10.1016/j.cyto.2008.06.012; Wang XY, 2005, INT J MOL MED, V16, P1117; Dong KK, 2008, EXP DERMATOL, V17, P1037, DOI 10.1111/j.1600-0625.2008.00747.x; Lee JB, 2004, CHEM PHARM BULL, V52, P1091, DOI 10.1248/cpb.52.1091; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351; Van Loveren H, 2000, PHOTOCHEM PHOTOBIOL, V72, P253; Wilgus TA, 2000, PROSTAG OTH LIPID M, V62, P367, DOI 10.1016/S0090-6980(00)00089-7; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Maruyama H, 2003, IN VIVO, V17, P245; TEUNISSEN MBM, 1993, CLIN EXP IMMUNOL, V94, P208; Nishimura N, 1999, IMMUNOLOGY, V97, P77; Moon HJ, 2008, BIOL PHARM BULL, V31, P284, DOI 10.1248/bpb.31.284; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; GENSLER HL, 1989, CARCINOGENESIS, V10, P203, DOI 10.1093/carcin/10.1.203; Choi JI, 2010, CHEM-BIOL INTERACT, V183, P249, DOI 10.1016/j.cbi.2009.09.015; Panich U, 2011, ARCH PHARM RES, V34, P811, DOI 10.1007/s12272-011-0515-3; Sinha S, 2010, PHYTOCHEMISTRY, V71, P235, DOI 10.1016/j.phytochem.2009.10.014; Maruyama H, 2006, PLANTA MED, V72, P1415, DOI 10.1055/s-2006-951703	28	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	OCT	2015	81	15					1370	1374		10.1055/s-0035-1557821		5	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	CV2TG	WOS:000364109500007		
J	Hayashi, Y; Takada, N; Kanda, H; Goto, M				Hayashi, Yui; Takada, Noriharu; Kanda, Hideki; Goto, Motonobu			Effect of fine bubbles on electric discharge in water	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						pulsed electric discharge; fine bubble; water	HIGH-VOLTAGE DISCHARGE; HYDROGEN-PEROXIDE; ORGANIC-COMPOUNDS; MICROBUBBLES; GENERATION; PLASMA; TEMPERATURE; DEGRADATION; EROSION; OZONE	Ar or O-2 fine bubbles of diameter < 80 mu m were introduced in water and a pulsed discharge plasma was generated between cylinder electrodes in water. Fine bubbles in water affected discharge ignition and caused low inception voltage and suppression of rising temperature. The contamination from electrodes was suppressed in the case of fine bubbles addition because fine bubbles assisted plasma generation. In addition, discharge with fine bubbles enhanced plasma emission with high electron density compared to the no-bubbling case. Discharge with fine bubbles at low-pH conditions generated intense plasma emission compared to neutral and high-pH conditions owing to the electric charge of the fine bubbles.	[Hayashi, Yui; Kanda, Hideki; Goto, Motonobu] Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 464, Japan; [Takada, Noriharu] Nagoya Univ, Ctr Tech, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Hayashi, Y (reprint author), Nagoya Univ, Dept Chem Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 464, Japan.	mgoto@nuce.nagoya-u.ac.jp	Kanda, Hideki/K-5371-2012		Ministry of Education, Culture, Sports, Science and Technology, Japan [21110009]	This work was supported by the Grants-in-Aid for Scientific Research on 'Frontier Science of Interactions between Plasma and Nano Interfaces' (No. 21110009) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Saito N, 2009, THIN SOLID FILMS, V518, P912, DOI 10.1016/j.tsf.2009.07.156; Sato M, 1996, IEEE T IND APPL, V32, P106, DOI 10.1109/28.485820; Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Sunka P, 1999, PLASMA SOURCES SCI T, V8, P258, DOI 10.1088/0963-0252/8/2/006; Gao JZ, 2003, PLASMA SOURCES SCI T, V12, P533, DOI 10.1088/0963-0252/12/4/305; Takamatsu T, 2014, RSC ADV, V4, P39901, DOI 10.1039/c4ra05936k; Wahyudiono, 2012, CHEM ENG PROCESS, V61, P51, DOI 10.1016/j.cep.2012.06.011; Anpilov AM, 2001, J PHYS D APPL PHYS, V34, P993, DOI 10.1088/0022-3727/34/6/322; Chen Q, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/17/175212; Shih KY, 2010, PLASMA CHEM PLASMA P, V30, P1, DOI 10.1007/s11090-009-9207-x; Malik MA, 2001, PLASMA SOURCES SCI T, V10, P82, DOI 10.1088/0963-0252/10/1/311; Holzer F, 2008, PLASMA CHEM PLASMA P, V28, P1, DOI 10.1007/s11090-007-9107-x; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Tasaki T, 2009, J HAZARD MATER, V162, P1103, DOI 10.1016/j.jhazmat.2008.05.162; Bruggeman P, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/12/124005; Park S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866804; Bruggeman P, 2008, PLASMA SOURCES SCI T, V17, DOI 10.1088/0963-0252/17/4/045014; Ueda Y, 2014, ECS TRANSACTIONS, V58, P11, DOI 10.1149/05819.0011ecst; Baroch P, 2008, J ELECTROSTAT, V66, P294, DOI 10.1016/j.elstat.2008.01.010; Lindner JR, 2002, J AM SOC ECHOCARDIOG, V15, P396, DOI 10.1067/mje.2002.117290; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Ihara S, 1999, JPN J APPL PHYS 1, V38, P4601, DOI 10.1143/JJAP.38.4601; Tachibana K, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034005; Shih KY, 2009, PLASMA PROCESS POLYM, V6, P729, DOI 10.1002/ppap.200900044; Lavrov BP, 1999, PHYS REV E, V59, P3526, DOI 10.1103/PhysRevE.59.3526; Simek M, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/5055031; Sun B, 1999, J PHYS D APPL PHYS, V32, P1908, DOI 10.1088/0022-3727/32/15/319; Aoki H, 2008, PLASMA SOURCES SCI T, V17, DOI 10.1088/0963-0252/17/2/025006; Park S, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/3/034003; Ashkenazy J, 1991, AM PHYS SOC, V43, P10; Atkins P, 2012, ELEMENTS PHYS CHEM; Hayashi Y, 2014, JPN J APPL PHYS, V52; Korobeinikov S M, 2002, HIGH TEMP-USSR, V40, P706; Lukes P, 2006, CZECH J PHYS, V56, pB916, DOI 10.1007/s10582-006-0304-2; Namihira T, 2007, IEEE T PLASMA SCI, V35, P614, DOI 10.1109/TPS.2007.896965; Qian J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1921338; Ruma Lukes P, 2013, J PHYS D, V46, P125; SEHGAL C, 1980, J PHYS CHEM-US, V84, P388, DOI 10.1021/j100441a009; Shirafuji T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NE03	39	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055023	10.1088/0963-0252/24/5/055023		6	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600032		
J	Komuro, A; Takahashi, K; Ando, A				Komuro, Atsushi; Takahashi, Kazunori; Ando, Akira			Vibration-to-translation energy transfer in atmospheric-pressure streamer discharge in dry and humid air	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						streamer discharge; vibrational temperature; numerical simulation	RATE COEFFICIENTS; CROSS-SECTIONS; DISSOCIATIVE ATTACHMENT; ELECTRON COLLISIONS; NITROGEN MOLECULES; NONTHERMAL PLASMA; CORONA DISCHARGE; OZONE PRODUCTION; ATOMIC OXYGEN; RELAXATION	Vibration-to-translation (V-T) energy transfer in atmospheric-pressure streamer discharge is numerically simulated using a two-dimensional electro-hydrodynamic model. The model includes state-to-state vibrational kinetics in humid air and is coupled with the compressible flow equation of the gas fluid. The vibrational distribution of O-2(v) reaches equilibrium more quickly than that of N-2(v), whereas the energy released from O-2(v) does not increase the gas temperature. In humid air, the decay rate of the vibrational energy of N-2(v) is accelerated by the V-T energy transfer through water molecules and the energy heats the gas. However, the increase in gas temperature due to V-T energy transfer is not always seen because it competes with thermal diffusion.	[Komuro, Atsushi; Takahashi, Kazunori; Ando, Akira] Tohoku Univ, Dept Elect Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Komuro, A (reprint author), Tohoku Univ, Dept Elect Engn, Aoba Ku, 6-6-05 Aoba, Sendai, Miyagi 9808579, Japan.	komuro@ecei.tohoku.ac.jp			Mazda Foundation;  [26889004]	This work was partially supported by a Grant-in-Aid for Young Scientists (Start-up: 26889004) and a research grant from the Mazda Foundation.	Allan M, 1995, J PHYS B-AT MOL OPT, V28, P5163, DOI 10.1088/0953-4075/28/23/021; ALLAN M, 1985, J PHYS B-AT MOL OPT, V18, P4511, DOI 10.1088/0022-3700/18/22/018; Komuro A, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/5/055004; BILLING GD, 1994, CHEM PHYS, V179, P463, DOI 10.1016/0301-0104(94)87022-5; Komuro A, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175206; Komuro A, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/21/215203; BREEN JE, 1973, J CHEM PHYS, V59, P556, DOI 10.1063/1.1679846; Vereshchagin KA, 1997, TECH PHYS+, V42, P487, DOI 10.1134/1.1258658; HARTMANN G, 1975, J PHYS D APPL PHYS, V8, P670, DOI 10.1088/0022-3727/8/6/010; Mihajlov AA, 1999, J PHYS D APPL PHYS, V32, P2620, DOI 10.1088/0022-3727/32/20/307; Guerra V, 2004, EUR PHYS J-APPL PHYS, V28, P125, DOI 10.1051/epjap:2004188; BILLING GD, 1979, CHEM PHYS, V43, P395, DOI 10.1016/0301-0104(79)85207-6; CACCIATORE M, 1982, CHEM PHYS, V66, P141, DOI 10.1016/0301-0104(82)88013-0; Komuro A, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/265201; Miao L, 2004, J CRYST GROWTH, V260, P118, DOI 10.1016/j.jcrysgro.2003.08.010; Ono R, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/3/035006; GORDIETS BF, 1995, IEEE T PLASMA SCI, V23, P750, DOI 10.1109/27.467998; Lo A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/11/115201; Simek M, 2002, J PHYS D APPL PHYS, V35, P1171, DOI 10.1088/0022-3727/35/11/311; Esposito F, 2007, CHEM PHYS LETT, V443, P222, DOI 10.1016/j.cplett.2007.06.099; SCHRAM DC, 1994, PLASMA PHYS CONTR F, V36, pB65, DOI 10.1088/0741-3335/36/12B/005; OMALLEY TF, 1967, PHYS REV, V155, P59, DOI 10.1103/PhysRev.155.59; Huestis DL, 2006, J PHYS CHEM A, V110, P6638, DOI 10.1021/jp054889n; FINZI J, 1977, J CHEM PHYS, V67, P4053; Chen JH, 2002, PLASMA CHEM PLASMA P, V22, P495, DOI 10.1023/A:1021315412208; Filimonov S, 2007, J PHYS D APPL PHYS, V40, P2810, DOI 10.1088/0022-3727/40/9/022; Kalogerakis KS, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2110227; Teramoto Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4893474; WHITSON ME, 1977, J CHEM PHYS, V66, P2696, DOI 10.1063/1.434217; Esposito F, 2006, CHEM PHYS LETT, V418, P581, DOI 10.1016/j.cplett.2005.11.036; ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P1063, DOI 10.1109/27.125031; Baeva M, 2002, PLASMA SOURCES SCI T, V11, P1, DOI 10.1088/0963-0252/11/1/301; Hammer T, 2002, PLASMA SOURCES SCI T, V11, pA196, DOI 10.1088/0963-0252/11/3A/329; Ristic M, 2007, CHEM PHYS, V331, P410, DOI 10.1016/j.chemphys.2006.11.012; Eichwald O, 1997, J APPL PHYS, V82, P4781, DOI 10.1063/1.366336; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Chang JS, 2008, PLASMA SOURCES SCI T, V17, DOI 10.1088/0963-0252/17/4/045004; TREANOR CE, 1968, J CHEM PHYS, V48, P1798, DOI 10.1063/1.1668914; Meziane M, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801879; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; LOPEZPUERTAS M, 1995, J GEOPHYS RES-ATMOS, V100, P9131, DOI 10.1029/95JD00383; Luque A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435934; Ono R, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/1/015009; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Komuro A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/15/155202; Bourdon A, 2007, PLASMA SOURCES SCI T, V16, P656, DOI 10.1088/0963-0252/16/3/026; Esposito F, 2008, CHEM PHYS, V351, P91, DOI 10.1016/j.chemphys.2008.04.004; Komuro A, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/4/045002; Itikawa Y, 2006, J PHYS CHEM REF DATA, V35, P31, DOI [10.1063/1.1937426, 10.1063/1.937426]; Capitelli M., 2000, PLASMA KINETICS ATMO; Ferziger J. H., 1996, COMPUTATIONAL METHOD; HENDERSO.WR, 1969, PHYS REV, V183, P157, DOI 10.1103/PhysRev.183.157; Itikawa Y, 2009, J PHYS CHEM REF DATA, V38, P1, DOI 10.1063/1.3025886	53	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055020	10.1088/0963-0252/24/5/055020		10	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600029		
J	Shibata, H; Ohmichi, Y; Watanabe, Y; Suzuki, K				Shibata, Hisaichi; Ohmichi, Yuya; Watanabe, Yasumasa; Suzuki, Kojiro			Global stability analysis method to numerically predict precursor of breakdown voltage	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						linear stability analysis; drift-diffusion model; breakdown voltage	EQUATIONS; ELECTRONS; STATE	This study presents a new method for predicting a precursor of breakdown voltage. This method applies a global linear stability analysis to a drift-diffusion model coupled with the Poisson equation. The instability of the solution of these equations is evaluated with the proposed method and is considered to be the onset of a breakdown. The proposed method is validated in one dimension by using the Townsend theory as a reference. To extend the one-dimensional case and investigate the characteristics of multidimensional eigenmodes, we apply the method to two-dimensional plane-to-plane discharge tubes. To prove an adaptability against complex electrodes geometry, the discharge path and the corresponding breakdown voltage for the well-known corner-to-plane geometry are qualitatively evaluated.	[Shibata, Hisaichi; Watanabe, Yasumasa] Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan; [Ohmichi, Yuya] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Suzuki, Kojiro] Univ Tokyo, Dept Adv Energy, Kashiwa, Chiba 2778561, Japan	Shibata, H (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	shibata@daedalus.k.u-tokyo.ac.jp			Graduate School of Engineering; University of Tokyo Doctoral Student Special Incentives Program (SEUT-fellowship)	The first author gratefully acknowledges the financial support from the Graduate School of Engineering and the University of Tokyo Doctoral Student Special Incentives Program (SEUT-fellowship).	PHELPS AV, 1985, PHYS REV A, V31, P2932, DOI 10.1103/PhysRevA.31.2932; Theofilis V, 2011, ANNU REV FLUID MECH, V43, P319, DOI 10.1146/annurev-fluid-122109-160705; Schnyder R, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/28/285205; Ghaleb F, 2012, RADIAT EFF DEFECT S, V167, P377, DOI 10.1080/10420150.2012.660937; Lowke JJ, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/023002; Sijacic DD, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066402; Almeida PGC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/41/415203; LAWTON SA, 1978, J CHEM PHYS, V69, P1055, DOI 10.1063/1.436700; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; ERIKSSON LE, 1985, J COMPUT PHYS, V57, P90, DOI 10.1016/0021-9991(85)90054-3; Ding Y, 1998, INT J NUMER METH FL, V27, P139, DOI 10.1002/(SICI)1097-0363(199801)27:1/4<139::AID-FLD655>3.0.CO;2-D; Lehoucq R.B., 1997, ARPACK USERS GUIDE S; Meek J. M., 1953, ELECT BREAKDOWN GASE; Morrow R, 1997, J PHYS D APPL PHYS, V30, P614, DOI 10.1088/0022-3727/30/4/017; Paschen F., 1889, ANN PHYS CHEM, V273, P69, DOI DOI 10.1002/ANDP.18892730505; Raizer Yu. P., 1991, GAS DISCHARGE PHYS; Saad Y, 2011, CLASS APPL MATH, V66, P1, DOI 10.1137/1.9781611970739; Sanjay M, 2014, INT J NUMER METH FL, V75, P295; Warne L K, 2003, SAND20034078 SANDIA; Xingwen L, 2012, IEEE 58 HOLM C EL CO	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055014	10.1088/0963-0252/24/5/055014		12	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600023		
J	Suzuki, S; Itoh, H				Suzuki, S.; Itoh, H.			Gradual increase in secondary ionization coefficient gamma and charge accumulation on a dielectric electrode during DBD with repeated breakdown	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						dielectric barrier discharge; secondary ionization coefficient; dielectric electrode; accumulated charge	BARRIER DISCHARGES; MGO FILM; ARGON; SURFACE; NEON; MIXTURES	We have investigated the effect of the surface roughness of a dielectric electrode for dielectric barrier discharge (DBD). We prepared three alumina plates made from the same material with different surface roughnesses for use as electrodes. During the repeated breakdown from the first breakdown to the stationary state, we observed gradual increases in the secondary ionization coefficient and the charge accumulated on the alumina electrodes under the application of a sinusoidal voltage in argon up to a pressure of 105 Torr. A strong correlation was also observed between them, similarly to in a previous paper on CaO film electrodes. The results suggest that increasing the surface roughness of an alumina electrode results in a larger secondary ionization coefficient and greater charge accumulation on the electrode. Moreover, it is concluded that the charges that accumulate on the alumina can be liberated from the surface as initial electrons when it acts as a cathode, depending on the polarity of the alternating gap voltage. These electrons induce the formation of an atmospheric-pressure Townsend discharge. Finally, we discuss the effect of the secondary ionization coefficient in DBD.	[Suzuki, S.; Itoh, H.] Chiba Inst Technol, Dept Elect Elect & Comp Engn, Narashino, Chiba 2750016, Japan	Suzuki, S (reprint author), Chiba Inst Technol, Dept Elect Elect & Comp Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	susumu.suzuki@it-chiba.ac.jp					Stollenwerk L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.255001; Teranishi K, 2009, PLASMA SOURCES SCI T, V18, DOI [10.1088/0963-0252/18/4/045011, 10.1088/0963-0252/18/4/045012]; Bogaczyk M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/46/465202; NAKAMURA Y, 1988, J PHYS D APPL PHYS, V21, P718, DOI 10.1088/0022-3727/21/5/008; Golubovskii YB, 2006, J PHYS D APPL PHYS, V39, P1574, DOI 10.1088/0022-3727/39/8/016; Suzuki S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.106002; THEOBALD JK, 1953, J APPL PHYS, V24, P123, DOI 10.1063/1.1721223; Yamamoto K, 1999, J PHYS SOC JPN, V68, P1208, DOI 10.1143/JPSJ.68.1208; Stollenwerk L, 2011, CONTRIB PLASM PHYS, V51, P61, DOI 10.1002/ctpp.201000002; Penning FM, 1934, PHYSICA, V1, P1007, DOI 10.1016/S0031-8914(34)80297-2; Suzuki S, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/6/065030; Suzuki S, 2007, JPN J APPL PHYS 1, V46, P1129, DOI 10.1143/JJAP.46.1129; Kruithof AA, 1940, PHYSICA, V7, P519, DOI 10.1016/S0031-8914(40)90043-X; Almeida PGC, 2011, IEEE T PLASMA SCI, V39, P2190, DOI 10.1109/TPS.2011.2148129; Suzuki S, 2004, JPN J APPL PHYS 1, V43, P7234, DOI 10.1143/JJAP.43.7234; Kogelschatz U, 2010, J PHYS CONF SER, V257, DOI 10.1088/1742-6596/257/1/012015; Becker K H, 2005, NONEQUILIBRIUM AIR P; Bellan P.M., 2008, FUNDAMENTALS PLASMA; Benilov MS, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/5/050201; Callegari T, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/5/054003; DeGarmo E P, 2003, MAT PROCESSES MANUFA; Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075; Fukuda H, 2012, INT SYM DISCH ELECTR, P133, DOI 10.1109/DEIV.2012.6412469; GELLERT B, 1991, APPL PHYS B-PHOTO, V52, P14, DOI 10.1007/BF00405680; Itoh H, 1984, T IEE JPN A, V104, P17; Itoh H, 1991, T IEE JAPAN A, V111-A, P410; Kruithof AA, 1937, PHYSICA, V4, P0430, DOI 10.1016/S0031-8914(37)80075-0; Laroussi M, 2012, PLASMA MED APPL LOW; Massines F, 2009, EUR PHYS J-APPL PHYS, V47, DOI 10.1051/epjap/2009064; Raether H., 1964, ELECT AVALANCHES BRE; Raizer Y P, 1991, GAS DISCHARGE PHYS; Sokolova MV, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120412; Stollenwerk L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.255001; Suzuki S, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120442; Thomson J J, 1928, CONDUCTION ELECT GAS, V2, P466; Venkattraman A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/42/425205; Wild R, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/5/054004; Yagi S, 2012, BARRIER HOUDEN ASAKU; Yamamoto K, J PHYS SOC JAPAN, V63, P2157	39	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055016	10.1088/0963-0252/24/5/055016		12	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600025		
J	Takahashi, K; Komuro, A; Ando, A				Takahashi, Kazunori; Komuro, Atsushi; Ando, Akira			Effect of source diameter on helicon plasma thruster performance and its high power operation	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						helicon thruster; thrust measurement; electric propulsion	MAGNETIC NOZZLE	Thrust imparted by a helicon plasma thruster is experimentally measured for two different diameter source tubes. The measurements demonstrate that the thrust-over-power of the helicon thruster can be increased by enlarging the source diameter. This result is qualitatively understood with a simple analysis connecting a global model in the source and a one-dimensional magnetic nozzle model, where the model does not include the magnetic field effect in the source and the cross-field diffusion effect in the magnetic nozzle. A mass flow rate of propellant argon and a magnetic field strength are experimentally surveyed; then the thrust of similar to 18 mN is obtained for the rf power of 1 kW, the 95 mm diameter source, and the largest solenoid current being tested, while the maximum thrust for the 26 mm diameter source is only 5 mN. Furthermore the rf power is increased up to similar to 6 kW and a thrust close to 60 mN is obtained.	[Takahashi, Kazunori; Komuro, Atsushi; Ando, Akira] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan	Takahashi, K (reprint author), Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9808579, Japan.	kazunori@ecei.tohoku.ac.jp			Japan Society for the Promotion of Science [B 25287150, A 26247096]; Yazaki Memorial Foundation for Science and Technology	This work is partially supported by grant-in-aid for scientific research (Grants No. B 25287150 and A 26247096) from the Japan Society for the Promotion of Science and the Yazaki Memorial Foundation for Science and Technology.	Shabshelowitz A, 2013, J PROPUL POWER, V29, P919, DOI 10.2514/1.B34720; Boswell RW, 1997, IEEE T PLASMA SCI, V25, P1229, DOI 10.1109/27.650898; Charles C, 2012, PLASMA PHYS CONTR F, V54, DOI 10.1088/0741-3335/54/12/124021; Harle T, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015015; Chen FF, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4754580; Chabert P, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4737114; Goebel DM, 2008, IEEE T PLASMA SCI, V36, P2111, DOI 10.1109/TPS.2008.2004232; Lafleur T, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4871727; Takahashi K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.195003; Charles C, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/16/163001; Chen FF, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/1/014001; Takahashi K, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2803763; Shinohara S, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/3/034018; Ahedo E, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4798409; Charles C, 2007, PLASMA SOURCES SCI T, V16, pR1, DOI 10.1088/0963-0252/16/4/R01; Ahedo E, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3442736; Roberson BR, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3574753; Fruchtman A, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3691650; Fruchtman A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.065002; Boswell R W, 2015, FRONT PHYS, V3, P14; Cannat F, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4920966; Goebel D M, 2008, FUNDAMENTALS ELECT P; Lieberman L A, 2005, PRINCEPLES PLASMA DI; Little JM, 2015, IEEE T PLASMA SCI, V43, P277, DOI 10.1109/TPS.2014.2322522; Olsen CS, 2015, IEEE T PLASMA SCI, V43, P252, DOI 10.1109/TPS.2014.2321257; Takahashi K, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/4/044004	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055004	10.1088/0963-0252/24/5/055004		8	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600013		
J	Yang, XL; Sasaki, K; Nagatsu, M				Yang, Xiaoli; Sasaki, Koichi; Nagatsu, Masaaki			Self-absorption-calibrated vacuum ultraviolet absorption spectroscopy for absolute oxygen atomic density measurement	PLASMA SOURCES SCIENCE & TECHNOLOGY			English	Article						vacuum ultraviolet absorption spectroscopy; surface-wave plasma; oxygen atomic density	HOLLOW-CATHODE LAMP; FLUOROCARBON PLASMAS; REACTIVE PLASMAS; COUPLED PLASMA; SPECTRAL-LINES; ESCAPE FACTOR; SURFACE-WAVE; NM; ACTINOMETRY; FREQUENCY	Using a compact microwave plasma light source, a self-absorption-calibrated vacuum ultraviolet absorption spectroscopy (VUVAS) method was developed based on resonance escape factor theory and numerical analysis of the emission profile using Specair. After theoretical calibration of the self-absorption effect for two adjacent oxygen lines at 130.22 nm and 130.49 nm emitted from the light source, absolute oxygen atomic densities were measured for different N-2/O-2 gas mixture ratios in surface-wave plasmas. The oxygen atomic densities obtained for the two light probes were fairly close, supporting good reliability of the proposed self-absorption-calibrated VUVAS method. It is expected from the present results that the proposed method will extend the range of application of the VUVAS method in industrial plasma processing.	[Yang, Xiaoli; Nagatsu, Masaaki] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328561, Japan; [Sasaki, Koichi] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0600810, Japan	Yang, XL (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328561, Japan.	tmnagat@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science (JSPS) [21110010]	The author would like to thank Dr Chen Yue for help with the calculation of the theoretical absorption curve. This work was supported in part by a Grant-in-Aid for Scientific Research (Grant No. 21110010) from the Japan Society for the Promotion of Science (JSPS).	BOOTH JP, 1991, J APPL PHYS, V69, P618, DOI 10.1063/1.347395; Liao LM, 2014, OPTIK, V125, P1602, DOI 10.1016/j.ijleo.2013.09.027; Nagai H, 2003, REV SCI INSTRUM, V74, P3453, DOI 10.1063/1.1582386; Kruger P, 1999, SURF COAT TECH, V112, P240, DOI 10.1016/S0257-8972(98)00777-4; IRONS FE, 1979, J QUANT SPECTROSC RA, V22, P1, DOI 10.1016/0022-4073(79)90102-X; Milliron DJ, 2000, J APPL PHYS, V87, P572, DOI 10.1063/1.371901; Konjevic N, 1999, PHYS REP, V316, P339, DOI 10.1016/S0370-1573(98)00132-X; El-Gohary Z, 2003, J QUANT SPECTROSC RA, V78, P211, DOI 10.1016/S0022-4073(02)00211-X; Sasaki K, 1999, REV SCI INSTRUM, V70, P76, DOI 10.1063/1.1149543; Nagatsu M, 1999, JPN J APPL PHYS 2, V38, pL679, DOI 10.1143/JJAP.38.L679; Kuwahara A, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4770118; Takashima S, 1999, APPL PHYS LETT, V75, P3929, DOI 10.1063/1.125497; Gudimenko E, 2012, OPT EXPRESS, V20, P12699, DOI 10.1364/OE.20.012699; GRANIER A, 1994, J APPL PHYS, V75, P104, DOI 10.1063/1.355897; Hannachi R, 2008, SPECTROCHIM ACTA B, V63, P1054, DOI 10.1016/j.sab.2008.08.010; Tachibana K, 1999, APPL PHYS LETT, V74, P2390, DOI 10.1063/1.123861; Dobele HF, 2005, PLASMA SOURCES SCI T, V14, pS31, DOI 10.1088/0963-0252/14/2/S05; Hancock G, 2007, J PHYS D APPL PHYS, V40, P4515, DOI 10.1088/0022-3727/40/15/022; GOUSSET G, 1987, PLASMA CHEM PLASMA P, V7, P409, DOI 10.1007/BF01030487; Sasaki K, 1997, APPL PHYS LETT, V70, P1375, DOI 10.1063/1.118582; Kitajima T, 2004, J PHYS D APPL PHYS, V37, P2670, DOI 10.1088/0022-3727/37/19/010; BASSYOUNI AH, 1982, J QUANT SPECTROSC RA, V28, P161, DOI 10.1016/0022-4073(82)90089-9; Castanos-Martinez E, 2010, SPECTROCHIM ACTA B, V65, P199, DOI 10.1016/j.sab.2009.12.003; Drawin H. W., 1973, Beitraege aus der Plasma Physik, V13, DOI 10.1002/ctpp.19730130304; Mithell A C Q, 1961, RESONANCE RAD EXCITE, P92; Singh M K, 2009, NEW J PHYS, V11, P15; Wiese W L, 1996, J PHYS CHEM REF DATA, P340; Zhao Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF05; Zheng J, 2010, ATOMIC EMISSION SPEC, P36	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0963-0252	1361-6595		PLASMA SOURCES SCI T	Plasma Sources Sci. Technol.	OCT	2015	24	5							055019	10.1088/0963-0252/24/5/055019		8	Physics, Fluids & Plasmas	Physics	CV5UL	WOS:000364336600028		
J	Tsuji, K; Miyatake, T; Yamagishi, M; Shimada, M; Kuno, E				Tsuji, Kazuki; Miyatake, Takahisa; Yamagishi, Masaaki; Shimada, Masakazu; Kuno, Eiji			Yosiaki Ito 1930-2015	POPULATION ECOLOGY			English	Biographical-Item							EVOLUTION; ERADICATION; INSECT		[Tsuji, Kazuki] Univ Ryukyus, Fac Agr, Dept Agroenvironm Sci, Nishihara, Okinawa 9030213, Japan; [Miyatake, Takahisa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Yamagishi, Masaaki] Okinawa Prefectural Plant Protect Ctr, Okinawa 9020072, Japan; [Shimada, Masakazu] Univ Tokyo, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan	Tsuji, K (reprint author), Univ Ryukyus, Fac Agr, Dept Agroenvironm Sci, Nishihara, Okinawa 9030213, Japan.	tsujik@agr.u-ryukyu.ac.jp					KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90038-4; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Koyama J, 2004, ANNU REV ENTOMOL, V49, P331, DOI 10.1146/annurev.ento.49.061802.123224; ITO Y, PUBLICATION LIST; LACK D, 1954, NATURAL REGULATION A, P343; Leadbeater E, 2011, SCIENCE, V333, P874, DOI 10.1126/science.1205140; LIN N, 1972, Q REV BIOL, V47, P131, DOI 10.1086/407216; Mac Arthur RH, 1967, THEORY ISLAND BIOGEO; Pianka E. R., 1978, EVOLUTIONARY ECOLOGY; Pianka E.R., 1974, EVOLUTIONARY ECOLOGY; WEST-EBERHARD M J, 1978, Journal of the Kansas Entomological Society, V51, P832; Wilson E.O., 1975, SOCIOBIOLOGY NEW SYN	13	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1438-3896	1438-390X		POPUL ECOL	Popul. Ecol.	OCT	2015	57	4					545	550		10.1007/s10144-015-0514-1		6	Ecology	Environmental Sciences & Ecology	CV0QW	WOS:000363957300001		
J	Nishiguchi, M; Kikuyama, H; Kanazawa, T; Tsutsumi, A; Kaneko, T; Uenishi, H; Kawabata, Y; Kawashige, S; Koh, J; Yoneda, H				Nishiguchi, Masaki; Kikuyama, Hiroki; Kanazawa, Tetsufumi; Tsutsumi, Atsushi; Kaneko, Takao; Uenishi, Hiroyuki; Kawabata, Yasuo; Kawashige, Seiya; Koh, Jun; Yoneda, Hiroshi			Increases in iPS Transcription Factor (Oct4, Sox2, c-Myc, and Klf4) Gene Expression after Modified Electroconvulsive Therapy	PSYCHIATRY INVESTIGATION			English	Article						iPS cells; Electroconvulsive therapy; Schizophrenia; Depression; Oct4; Sox2	LONG-TERM POTENTIATION; PLURIPOTENT STEM-CELLS; STIMULATION; DEPRESSION; ECT; SCHIZOPHRENIA; HIPPOCAMPUS; MECHANISMS; PLASTICITY; CATENIN	Objective Electroconvulsive therapy (ECT) is a reasonable option for intractable depression or schizophrenia, but a mechanism of action has not been established. One credible hypothesis is related to neural plasticity. Three genes (Oct4, Sox2, c-Myc) involved in the induction of induced pluripotent stem (iPS) cells are Wnt-target genes, which constitute a key gene group involved in neural plasticity through the TOP family. Klf4 is the other gene among Yamanaka's four transcription factors, and increases in its expression are induced by stimulation of the canonical Wnt pathway. Methods We compared the peripheral blood gene expression of the four iPS genes (Oct4, Sox2, c-Myc, and Klf4) before and after modified ECT (specifically ECT with general anesthesia) of patients with intractable depression (n=6) or schizophrenia (n=6). Using Thymatron ten times the total bilateral electrical stimulation was evoked. Results Both assessments of the symptoms demonstrated significant improvement after mECT stimulation. Expression of all four genes was confirmed to increase after initial stimulation. The gene expression levels after treatment were significantly different from the initial gene expression in all twelve cases at the following treatment stages: at the 3rd mECT for Oct4; at the 6th and 10th mECT for Sox2; and at the 3rd, 6th and 10th mECT for c-Myc. Conclusion These significant differences were not present after correction for multiple testing; however, our data have the potential to explain the molecular mechanisms of mECT from a unique perspective. Further studie should be conducted to clarify the pathophysiological involvement of iPS-inducing genes in ECT.	[Nishiguchi, Masaki; Kikuyama, Hiroki; Kanazawa, Tetsufumi; Tsutsumi, Atsushi; Kaneko, Takao; Kawabata, Yasuo; Kawashige, Seiya; Koh, Jun; Yoneda, Hiroshi] Osaka Med Coll, Dept Neuropsychiat, Takatsuki, Osaka 5698686, Japan; [Uenishi, Hiroyuki] Kansai Univ, Psychol Serv, Suita, Osaka, Japan; [Uenishi, Hiroyuki] Kansai Univ, Ctr Counseling, Suita, Osaka, Japan	Kikuyama, H (reprint author), Osaka Med Coll, Dept Neuropsychiat, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	kikuyama@poh.osaka-med.ac.jp					American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Li W, 2012, J ECT, V28, P111, DOI 10.1097/YCT.0b013e31824a47ca; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Pompili M, 2013, SCHIZOPHR RES, V146, P1, DOI 10.1016/j.schres.2013.02.005; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Kellner CH, 2012, AM J PSYCHIAT, V169, P1238, DOI 10.1176/appi.ajp.2012.12050648; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Petrides G, 1996, CONVULSIVE THER, V12, P138; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Zervas IM, 2012, WORLD J BIOL PSYCHIA, V13, P96, DOI 10.3109/15622975.2011.564653; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Andersen P, 2003, PHILOS T ROY SOC B, V358, P613, DOI 10.1098/rstb.2002.1232; Naylor P, 1996, MOL BRAIN RES, V35, P349, DOI 10.1016/0169-328X(95)00264-S; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Andrade C, 2008, J PSYCHIATR RES, V42, P837, DOI 10.1016/j.jpsychires.2007.08.009; Yang SC, 2013, CANCER IMMUNOL IMMUN, V62, P727, DOI 10.1007/s00262-012-1378-2; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Kronfol Z, 2002, J AFFECT DISORDERS, V71, P211, DOI 10.1016/S0165-0327(01)00399-8; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; Bolwig TG, 2011, CAN J PSYCHIAT, V56, P13; Chaturvedi S, 2001, PSYCHIAT RES, V104, P265, DOI 10.1016/S0165-1781(01)00303-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Fochtmann U, 1998, J ECT, V14, P206; Hedlund JL, 1979, J OPER PSYCHIATR, V10, P149; Komiya Yuko, 2008, Organogenesis, V4, P68; Vleminckx K, 1999, MECH DEVELOP, V81, P65, DOI 10.1016/S0925-4773(98)00225-1	34	0	0	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	OCT	2015	12	4					532	537		10.4306/pi.2015.12.4.532		6	Psychiatry	Psychiatry	CV1BR	WOS:000363988700015		
J	Takahashi, S; Suzuki, M; Uchiyama, M				Takahashi, Sakae; Suzuki, Masahiro; Uchiyama, Makoto			One-Year Follow-Up of Serum Prolactin Level in Schizophrenia Patients Treated with Blonanserium A Case Series	PSYCHIATRY INVESTIGATION			English	Article						Blonanserin; Dose dependency; Hyperprolactinemia; Maintenance treatment; Schizophrenia.		In our previous study, a prolactin elevation was more frequently in risperidone than in blonanserin; however, it was more often in blonanserin than in olanzapine. Therefore, while a rate of PRL rising is low to moderate, hyperprolactinemia is a considerable adverse effect in the blonanserin treatment. In this study, to examine detailed characteristics of hyperprolactinemia of blonanserin, we analyzed the prolactin data in six schizophrenic patients who were switched to blonanserin from other antipsychotics and followed for one year. As a result, blonanserin dose was clearly associated with serum prolactin level. The average prolactin level was almost normal when the mean blonanserin dosage was 8.0 mg/day. Regardless of the dose decrease of blonanserin, there were no remarkable changes in symptoms and social functions. Based on our findings, we conclude that low dose blonanserin medication may be useful for schizophrenia maintenance treatment without hyperprolactinemia and a high rate of relapse.	[Takahashi, Sakae; Suzuki, Masahiro; Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Div Psychiat, Tokyo 1738610, Japan	Takahashi, S (reprint author), Nihon Univ, Sch Med, Dept Neuropsychiat, Itabashi Ku, 30-1 Oyaguchi,Kamicho, Tokyo 1738610, Japan.	takahashi.sakae@nihon-u.ac.jp					Haddad PM, 2007, CNS DRUGS, V21, P911; Takahashi S, 2013, ASIA-PAC PSYCHIAT, V5, P164, DOI 10.1111/j.1758-5872.2012.00232.x; Yang J, 2010, CLIN NEUROPHARMACOL, V33, P169, DOI 10.1097/WNF.0b013e3181dcda50; Henderson DC, 2008, J CLIN PSYCHIAT, V69, P32; Deeks ED, 2010, CNS DRUGS, V24, P65, DOI 10.2165/11202620-000000000-00000; Walters James, 2008, J Psychopharmacol, V22, P82, DOI 10.1177/0269881107086516	6	0	0	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	OCT	2015	12	4					566	568		10.4306/pi.2015.12.4.566		3	Psychiatry	Psychiatry	CV1BR	WOS:000363988700021		
J	Kawada, T				Kawada, Tomoyuki			Comment on "Atypical Epidemiologic Finding in Association between Depression and Alcohol Use or Smoldng in Korean Male: Korean Longitudinal Study of Aging"	PSYCHIATRY INVESTIGATION			English	Letter							SMOKING; SCALE; SDS		[Kawada, Tomoyuki] Nippon Med Sch, Dept Hyg & Publ Hlth, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atgersclerosis.2004.08.035; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508; Tjora T, 2014, ADDICTION, V109, P1022, DOI 10.1111/add.12522; Noh JW, 2014, PSYCHIAT INVEST, V11, P272, DOI 10.4306/pi.2014.11.3.272; JEGEDE RO, 1976, J PSYCHOL, V93, P27; ZUNG W W K, 1990, Journal of Clinical Psychiatry, V51, P77	7	0	0	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	OCT	2015	12	4					573	574		10.4306/pi.2015.12.4.573		3	Psychiatry	Psychiatry	CV1BR	WOS:000363988700023		
J	Fujii, Y; Cummings, J; Xue, Y; Schiller, A; Lee, T; Balmaseda, MA; Remy, E; Masuda, S; Brassington, G; Alves, O; Cornuelle, B; Martin, M; Oke, P; Smith, G; Yang, XS				Fujii, Yosuke; Cummings, James; Xue, Yan; Schiller, Andreas; Lee, Tong; Balmaseda, Magdalena Alonso; Remy, Elisabeth; Masuda, Shuhei; Brassington, Gary; Alves, Oscar; Cornuelle, Bruce; Martin, Matthew; Oke, Peter; Smith, Gregory; Yang, Xiaosong			Evaluation of the Tropical Pacific Observing System from the ocean data assimilation perspective	QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY			English	Review						TPOS2020; ocean data assimilation; TAO; TRITON array; observing system evaluation; observing system experiment	VARIATIONAL DATA ASSIMILATION; GENERAL-CIRCULATION MODEL; SEA-SURFACE TEMPERATURE; HEAT-CONTENT; EL-NINO; EQUATORIAL PACIFIC; CLIMATE PREDICTION; INSTABILITY WAVES; PART I; ENSEMBLE	The drastic reduction in the number of observation data from the Tropical Atmospheric Ocean (TAO)/Triangle Trans-Ocean Buoy Network (TRITON) array since 2012 has given rise to a need to assess the impact of those data in ocean data assimilation (DA) systems. This article provides a review of existing studies evaluating the impacts of data from the TAO/TRITON array and other components of the Tropical Pacific Observing System (TPOS) on current ocean DA systems used for a variety of operational and research applications. It can be considered as background information that can guide the evaluation exercise of TPOS. Temperature data from TAO/TRITON array are assimilated in most ocean DA systems which cover the tropical Pacific in order to constrain the ocean heat content, stratification, and circulation. It is shown that the impacts of observation data depend considerably on the system and application. The presence of model error often makes the results difficult to interpret. Nevertheless there is consensus that the data from TAO/TRITON generally have positive impacts complementary to Argo floats. In the equatorial Pacific, the impacts are generally around the same level or larger than those of Argo. We therefore conclude that, with the current configuration of TPOS, the loss of the TAO/TRITON data is having a significant detrimental impact on many applications based on ocean DA systems. This conclusion needs to be kept under review because the equatorial coverage by Argo is expected to improve in the future.	[Fujii, Yosuke] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki 30050052, Japan; [Cummings, James] Naval Res Lab, Monterey, CA USA; [Xue, Yan] NOAA NWS NCEP, Climate Predict Ctr, College Pk, MD USA; [Schiller, Andreas; Oke, Peter] CSIRO Oceans & Atmospher Flagship, Hobart, Tas, Australia; [Lee, Tong] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Balmaseda, Magdalena Alonso] European Ctr Medium Range Weather Forecasts, Reading RG2 9AX, Berks, England; [Remy, Elisabeth] Mercator Ocean, Toulouse, France; [Masuda, Shuhei] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa 2370061, Japan; [Brassington, Gary; Alves, Oscar] Bur Meteorol, Ctr Australian Weather & Climate Res, Melbourne, Vic, Australia; [Cornuelle, Bruce] UCSD, Scripps Inst Oceanog, La Jolla, CA USA; [Martin, Matthew] Met Off, Exeter, Devon, England; [Smith, Gregory] Environm Canada, Dorval, PQ, Canada; [Yang, Xiaosong] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ USA	Fujii, Y (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, 1-1 Nagamine, Tsukuba, Ibaraki 30050052, Japan.	yfujii@mri-jma.go.jp			JSPS KAKENHI [24740324]	We are very grateful to two reviewers for their constructive comments. We also thank Drs D. Anderson and T. Suga, and other members of science organizing committee of the TPOS2020 workshop, as well as their secretary, Dr K. Hill, for their fruitful advice and suggestions on the article. Parts of the data used were collected and made freely available by the International Argo Program and the national programs that contribute to it. (http://www.argo.ucsd.edu; accessed 24 May 2015, http://www.jcommops.org/argo; accessed 1 July 2015). The Argo Program is part of the Global Ocean Observing System. This work was partly supported by JSPS KAKENHI grant number 24740324.	Zhang S, 2007, MON WEATHER REV, V135, P3541, DOI 10.1175/MWR3466.1; Cummings JA, 2014, J ATMOS OCEAN TECH, V31, P1771, DOI 10.1175/JTECH-D-14-00011.1; Reul N, 2014, SURV GEOPHYS, V35, P681, DOI 10.1007/s10712-013-9244-0; de Boisseson E, 2014, GEOPHYS RES LETT, V41, P4398, DOI 10.1002/2014GL060257; Wen CH, 2012, J CLIMATE, V25, P6409, DOI 10.1175/JCLI-D-11-00477.1; Lee T, 2009, OCEANOGRAPHY, V22, P160; Kim SB, 2007, J CLIMATE, V20, P3822, DOI 10.1175/JCLI4206.1; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Masuda S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017604; Stammer D, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000888; Pohlmann H, 2013, CLIM DYNAM, V41, P775, DOI 10.1007/s00382-013-1663-6; Menkes CER, 2006, J PHYS OCEANOGR, V36, P847, DOI 10.1175/JPO2904.1; Masuda S, 2010, SCIENCE, V329, P319, DOI 10.1126/science.1188703; Maximenko N, 2009, J ATMOS OCEAN TECH, V26, P1910, DOI 10.1175/2009JTECHO672.1; Lee T, 2003, J CLIMATE, V16, P4022, DOI 10.1175/1520-0442(2003)016<4022:IVOTEI>2.0.CO;2; Blockley EW, 2014, GEOSCI MODEL DEV, V7, P2613, DOI 10.5194/gmd-7-2613-2014; Doblas-Reyes FJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015394; Tollefson J, 2014, NATURE, V508, P20, DOI 10.1038/508020a; Brasseur P, 2005, Q J ROY METEOR SOC, V131, P3561, DOI 10.1256/qj.05.142; [Anonymous], 2015, J OPER OCEANOGR, DOI DOI 10.1080/1755876X.2015.1014637; Dunstone NJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041609; Waters J, 2015, Q J ROY METEOR SOC, V141, P333, DOI 10.1002/qj.2388; Wunsch C, 2007, J CLIMATE, V20, P5889, DOI 10.1175/2007JCLI1840.1; Chang YS, 2013, CLIM DYNAM, V40, P775, DOI 10.1007/s00382-012-1412-2; Oke PR, 2009, OCEANOGRAPHY, V22, P144; Maes C, 2005, J CLIMATE, V18, P104, DOI 10.1175/JCLI-3214.1; Pohlmann H, 2013, GEOPHYS RES LETT, V40, P5798, DOI 10.1002/2013GL058051; Fujii Y, 2012, PURE APPL GEOPHYS, V169, P579, DOI 10.1007/s00024-011-0387-y; ROEMMICH D, 1994, J PHYS OCEANOGR, V24, P540, DOI 10.1175/1520-0485(1994)024<0540:FEJ>2.0.CO;2; Wijffels SE, 2008, J CLIMATE, V21, P5657, DOI 10.1175/2008JCLI2290.1; Yin YH, 2011, MON WEATHER REV, V139, P786, DOI 10.1175/2010MWR3419.1; Balmaseda M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035561; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Langland RH, 2004, TELLUS A, V56, P189, DOI 10.1111/j.1600-0870.2004.00056.x; Stammer D, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002082; Sugiura N, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004741; Oke PR, 2013, OCEAN MODEL, V67, P52, DOI 10.1016/j.ocemod.2013.03.008; Ueki I, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001611; MacLachlan C, 2015, Q J ROY METEOR SOC, V141, P1072, DOI 10.1002/qj.2396; Xue Y, 2012, J CLIMATE, V25, P6905, DOI 10.1175/JCLI-D-11-00542.1; Lee T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052232; Balmaseda M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030452; Hoteit I, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005437; Bleck R, 2002, OCEAN MODEL, V4, P55, DOI 10.1016/S1463-5003(01)00012-9; Brassington GB, 2013, GEOPHYS RES LETT, V40, P6191, DOI 10.1002/2013GL057752; ROSATI A, 1995, MON WEATHER REV, V123, P2206, DOI 10.1175/1520-0493(1995)123<2206:DAPFAO>2.0.CO;2; Fujii Y, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001745; Lellouche JM, 2013, OCEAN SCI, V9, P57, DOI 10.5194/os-9-57-2013; Mochizuki T, 2010, P NATL ACAD SCI USA, V107, P1833, DOI 10.1073/pnas.0906531107; JI M, 1995, MON WEATHER REV, V123, P460, DOI 10.1175/1520-0493(1995)123<0460:AOASFS>2.0.CO;2; Fukumori I, 2004, J PHYS OCEANOGR, V34, P582, DOI 10.1175/2515.1; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Carton JA, 2000, J PHYS OCEANOGR, V30, P294, DOI 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2; Torn RD, 2008, MON WEATHER REV, V136, P663, DOI 10.1175/2007MWR2132.1; Ando K, 2005, J ATMOS OCEAN TECH, V22, P282, DOI 10.1175/JTECH1704.1; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Balmaseda M. A., 2015, J OPER OCEANOGR, V8, P80, DOI [10.1080/1755876X.2015.1022329, DOI 10.1080/1755876X.2015.1022329]; Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Balmaseda MA, 2013, Q J ROY METEOR SOC, V139, P1132, DOI 10.1002/qj.2063; Balmaseda MA, 2014, TROP PAC OBS SYST 20, P64; Behringer D., 2004, 8 S INT OBS ASS SYST; Brassington GB, 2012, 052 CAWCR, P110; Brassington GB, 2015, GRL UNPUB; Cummings J.A., 2013, DATA ASSIMILATION FO, VII, P303; Davey M, 2006, CLIVAR EXCHANGES, V11, P22; Ferry N, 2012, MERCATOR Q NEWSLETTE, V44, P29; Fujii Y, 2011, CLIMATE VARIABILITY, P75, DOI [10.5772/30330, DOI 10.5772/30330]; Guemas V, 2013, NAT CLIM CHANGE, V3, P649, DOI [10.1038/nclimate1863, 10.1038/NCLIMATE1863]; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Kohl A, 2004, J PHYS OCEANOGR, V34, P529, DOI 10.1175/2513.1; Lea DJ, 2014, Q J ROY METEOR SOC, V140, P2037, DOI 10.1002/qj.2281; Magnusson L, 2013, CLIM DYNAM, V41, P2393, DOI 10.1007/s00382-012-1599-2; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; Oke PR, 2008, OCEAN MODEL, V21, P46, DOI 10.1016/j.ocemod.2007.11.002; Oke PR, 2015, J OPER OCEANOGR, V8, ps49, DOI [10.1080/1755876X.2015.1022067, DOI 10.1080/1755876X.2015.1022067]; Roemmich D, 2014, TROP PAC OBS SYST 20, P243; Rudnick DL, 2014, TROP PAC OBS SYST 20, P299; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Saha S, 2014, J CLIMATE, V27, P2185, DOI 10.1175/JCLI-D-12-00823.1; Smith DM, 2013, CLIM DYNAM, V41, P3325, DOI 10.1007/s00382-013-1683-2; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Smith GC, 2013, P ECMWF WWRP THORPEX; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Toyoda T, 2015, Q J ROY METEOR SOC, V141, P2750, DOI 10.1002/qj.2561; Xue Y, 2011, CLIM DYNAM, V37, P2511, DOI 10.1007/s00382-010-0954-4; Xue Y, 2015, CLIM DYN IN PRESS	86	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0035-9009	1477-870X		Q J ROY METEOR SOC	Q. J. R. Meteorol. Soc.	OCT	2015	141	692	A				2481	2496		10.1002/qj.2579		16	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CU9LJ	WOS:000363865700002		
J	Toyoda, T; Fujii, Y; Kuragano, T; Matthews, JP; Abe, H; Ebuchi, N; Usui, N; Ogawa, K; Kamachi, M				Toyoda, Takahiro; Fujii, Yosuke; Kuragano, Tsurane; Matthews, John P.; Abe, Hiroto; Ebuchi, Naoto; Usui, Norihisa; Ogawa, Koji; Kamachi, Masafumi			Improvements to a global ocean data assimilation system through the incorporation of Aquarius surface salinity data	QUARTERLY JOURNAL OF THE ROYAL METEOROLOGICAL SOCIETY			English	Article						sea surface salinity; Aquarius; data assimilation; 3DVAR; ocean estimation; mode water	SUBTROPICAL MODE WATER; WINTER MIXED-LAYER; AMAZON RIVER PLUME; NORTH PACIFIC; TEMPERATURE; SEA; VARIABILITY; ADVECTION; LATITUDE; FLOATS	The impact of using sea surface salinity (SSS) data derived from the Aquarius satellite within a global ocean data assimilation system is investigated. In the central-eastern North Pacific, the more realistic SSS structures introduced by the Aquarius data also influence the salinity, temperature and potential vorticity fields obtained in the subsurface layer via enhanced mode-water formation. Around the Indonesian maritime continent, the Aquarius data assimilation leads to salinity distributions which are closer to buoy observations, while in the region of the Amazon River plume, subsurface temperatures are improved following a better reproduction of the low-salinity plume in the surface layer. The SSS model biases are also reduced in the eastern equatorial Pacific and in the Arctic Ocean, although our data are limited in number and accuracy at high latitudes. These results indicate the importance of Aquarius data in deriving improved representations of the global ocean from dynamical models.	[Toyoda, Takahiro; Fujii, Yosuke; Kuragano, Tsurane; Usui, Norihisa; Kamachi, Masafumi] Japan Meteorol Agcy, Meteorol Res Inst, Oceanog & Geochem Res Dept, Tsukuba, Ibaraki 3050052, Japan; [Matthews, John P.] Kyoto Univ, Inst Liberal Arts & Sci, Kyoto 6068501, Japan; [Abe, Hiroto; Ebuchi, Naoto] Hokkaido Univ, Inst Low Temp Sci, Water & Mat Cycles Div, Sapporo, Hokkaido 060, Japan; [Ogawa, Koji] Japan Meteorol Agcy, Fukuoka Dist Meteorol Observ, Tsukuba, Ibaraki 3050052, Japan	Toyoda, T (reprint author), Japan Meteorol Agcy, Meteorol Res Inst, Oceanog & Geochem Res Dept, 1-1 Nagamine, Tsukuba, Ibaraki 3050052, Japan.	ttoyoda@mri-jma.go.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [10203655]; Japan Aerospace Exploration Agency (JAXA); Research Program on Climate Change Adaptation of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	We respectfully acknowledge the work of Dr. Gary Lagerloef in leading the Aquarius/SAC-D satellite mission. We thank three anonymous reviewers for their constructive comments. Argo and TRITON data and the MILA-GPV dataset (Hosoda et al., 2010) were provided by the Research Institute for Global Change, Japan Agency for Marine-Earth Science and Technology. Distribution of the a<INF>dg</INF>443 values derived from MODIS Aqua measurements were obtained from the OceanColor Home Page (http://oceancolor.gsfc.nasa.gov/). The TSG observational data were obtained from the home page of the GOSUD Project (http://www.gosud.org/). This work was partly supported by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number: 10203655), the Japan Aerospace Exploration Agency (JAXA) and the Research Program on Climate Change Adaptation of the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Benway HM, 2004, EARTH PLANET SC LETT, V224, P493, DOI 10.1016/j.epsl.2004.05.014; Bloom SC, 1996, MON WEATHER REV, V124, P1256, DOI 10.1175/1520-0493(1996)124<1256:DAUIAU>2.0.CO;2; Oka E, 2007, J OCEANOGR, V63, P293, DOI 10.1007/s10872-007-0029-2; Fujii Y, 2003, J OCEANOGR, V59, P173, DOI 10.1023/A:1025539104750; Alory G, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007802; Iwasaki S, 2014, REMOTE SENS ENVIRON, V140, P549, DOI 10.1016/j.rse.2013.09.026; Ffield A, 2007, J CLIMATE, V20, P316, DOI 10.1175/JCLI3985.1; Ishii M, 2005, INT J CLIMATOL, V25, P865, DOI 10.1002/joc.1169; Fujii Y, 2005, J OCEANOGR, V61, P655, DOI 10.1007/s10872-005-0073-8; Fujii Y, 2005, J OCEANOGR, V61, P167, DOI 10.1007/s10872-005-0029-z; Nikiema O, 2007, CONT SHELF RES, V27, P873, DOI 10.1016/j.csr.2006.12.004; Usui N, 2006, ADV SPACE RES, V37, P806, DOI 10.1016/j.asr.2005.09.022; Tsujino H, 2011, J OCEANOGR, V67, P449, DOI 10.1007/s10872-011-0050-3; Noh Y, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021289; Hosoda S, 2010, J OCEANOGR, V66, P773, DOI 10.1007/s10872-010-0063-3; Jochum M, 2006, J PHYS OCEANOGR, V36, P592, DOI 10.1175/JPO2870.1; Balmaseda MA, 2007, Q J ROY METEOR SOC, V133, P167, DOI 10.1002/qj.12; Kosaka Y, 2006, Q J ROY METEOR SOC, V132, P2009, DOI 10.1256/qj.05.204; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Lee T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052232; Gierach MM, 2013, GEOPHYS RES LETT, V40, P5188, DOI 10.1002/grl.50995; Suga T, 1997, J PHYS OCEANOGR, V27, P140, DOI 10.1175/1520-0485(1997)027<0140:TDITNP>2.0.CO;2; Del Vecchio R, 2004, J GEOPHYS RES-OCEANS, V109, DOI [10.1029/2004JC002503, 10.1029/2004jc002503]; Hu CM, 2004, DEEP-SEA RES PT II, V51, P1151, DOI 10.1016/j.dsr2.2004.04.001; Lagerloef G, 2008, OCEANOGRAPHY, V21, P68; Molleri GSF, 2010, CONT SHELF RES, V30, P342, DOI 10.1016/j.csr.2009.11.015; Moon JH, 2014, J GEOPHYS RES-OCEANS, V119, P6066, DOI 10.1002/2014JC009969; Antonov JI, 2010, NOAA ATLAS NESDIS 69, V2, P184; Balmaseda MA, 2015, J OPER OCEA IN PRESS; Boyer T.P., 2009, NOAA ATLAS NESDIS, P216; CLS, 2012, CLSDOSNT06034; Foti G, 2013, AQ010UG0008 CALTECH; Grodsky SA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053335; Hamilton D., 1994, EARTH SYST MONIT, V4, P4; Hasumi H, 2006, 25 CCSR U TOK; Ishii M, 2006, J OCEANOGR, V62, P155, DOI 10.1007/s10872-006-0041-y; Kuring N., 2014, AQUARIUS VERSION 2 0; Lagerloef G, 2013, AQUARIUS SALINITY VA; Lagerloef G., 2012, B AM METEOROL SOC, V93, pS70, DOI DOI 10.1175/2012BAMSSTATE0FTHECLIMATE.1; Lahoz W, 2010, CONSTITUENT ASSIMILA, P449; Large W., 2004, TN460STR NCAR; Murray RJ, 1996, J COMPUT PHYS, V126, P287; Piepmeier J, 2013, AQUARIUS RADIOMETER; PRATHER MJ, 1986, J GEOPHYS RES-ATMOS, V91, P6671, DOI 10.1029/JD091iD06p06671; Toyoda T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020677; Toyoda T, 2013, THEOR APPL MECH JPN, V61, P31, DOI 10.11345/nctam.61.31; Tsujino H, 2010, 59 MET RES I	47	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0035-9009	1477-870X		Q J ROY METEOR SOC	Q. J. R. Meteorol. Soc.	OCT	2015	141	692	A				2750	2759		10.1002/qj.2561		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CU9LJ	WOS:000363865700023		
J	Lawson, C; Shibayama, S				Lawson, Cornelia; Shibayama, Sotaro			International research visits and careers: An analysis of bioscience academics in Japan	SCIENCE AND PUBLIC POLICY			English	Article						international research visits; career paths; promotion; academic mobility	FACULTY-DEVELOPMENT; BRAIN-DRAIN; MOBILITY; KNOWLEDGE; PRODUCTIVITY; LABOR; SCIENTISTS; NETWORKS; MODEL	This paper investigates the effect of international research visits on promotion. Research visits may help to expand existing networks and promote knowledge transfer while at the same time ensuring career stability, identified as the main barrier to mobility in Europe and Japan. Using a dataset of 370 bioscience professors in Japan we find that international research visits have a positive effect on promotion and reduce the waiting time for promotion by one year. This provides evidence that these visits also benefit a researcher's career in the long-term. This positive research visit effect is weaker for academics who also change jobs, but stronger for inbred academics. Research visits may therefore be of specific importance for otherwise immobile academics. Further, we find that while research visits of tenured staff enhance the career by providing an early chair, postdoctoral fellowships have no lasting effect on career progression.	[Lawson, Cornelia] Coll Carlo Alberto, BRICK, I-10024 Moncalieri, Italy; [Lawson, Cornelia] Univ Nottingham, Sch Sociol & Social Policy, Nottingham NG7 2RD, England; [Shibayama, Sotaro] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Lawson, C (reprint author), Coll Carlo Alberto, BRICK, Via Real Coll 30, I-10024 Moncalieri, Italy.	cornelia.lawson@nottingham.ac.uk			European Commission [266588]; Collegio Carlo Alberto Project 'Researcher Mobility and Scientific Performance'; Konosuke Matsushita Memorial Foundation; Japan Society for the Promotion of Science [23810004]	The authors would like to thank Paula Stephan and three anonymous referees for valuable comments. Cornelia Lawson acknowledges financial support through the European Commission (FP7) Project 'An Observatorium for Science in Society based in Social Models - SISOB' (grant 266588) and the Collegio Carlo Alberto Project 'Researcher Mobility and Scientific Performance'. Sotaro Shibayama acknowledges financial support from the Konosuke Matsushita Memorial Foundation and Grant-in-Aid for Research Activity Start-up of the Japan Society for the Promotion of Science (grant 23810004).	Akabayashi H., 2004, EC SOC FAR E M 726 H; Glanzel W, 2008, SCIENTOMETRICS, V74, P71, DOI 10.1007/s11192-008-0104-5; Jonkers K, 2011, RES EVALUAT, V20, P411, DOI 10.3152/095820211X13176484436177; Robins JM, 1999, SYNTHESE, V121, P151, DOI 10.1023/A:1005285815569; JOVANOVIC B, 1979, J POLIT ECON, V87, P972, DOI 10.1086/260808; Canibano C, 2009, RES EVALUAT, V18, P86, DOI 10.3152/095820209X441754; Almeida P, 1999, MANAGE SCI, V45, P905, DOI 10.1287/mnsc.45.7.905; Canibano C, 2011, SCIENTOMETRICS, V89, P653, DOI 10.1007/s11192-011-0462-2; BECKER GS, 1962, J POLIT ECON, V70, P9, DOI 10.1086/258724; Canibano C, 2008, RES EVALUAT, V17, P17, DOI 10.3152/095820208X292797; Ackers L, 2008, MINERVA, V46, P411, DOI 10.1007/s11024-008-9110-2; Melin G, 2005, RES EVALUAT, V14, P229, DOI 10.3152/147154405781776102; Stephan P, 2005, AM ECON REV, V95, P71, DOI 10.1257/000282805774669619; HARGENS LL, 1973, AM J SOCIOL, V78, P1381, DOI 10.1086/225470; Enders J, 2005, HIGH EDUC, V49, P119, DOI 10.1007/s10734-004-2917-3; ALLISON PD, 1990, AM SOCIOL REV, V55, P469, DOI 10.2307/2095801; Hunter RS, 2009, ECON J, V119, pF231, DOI 10.1111/j.1468-0297.2009.02274.x; Su XH, 2011, J TECHNOL TRANSFER, V36, P275, DOI 10.1007/s10961-009-9133-3; Bozeman B, 2002, RES POLICY, V31, P769, DOI 10.1016/S0048-7333(01)00146-9; Camblin LD, 2000, HIGH EDUC, V39, P1, DOI 10.1023/A:1003827925543; Agrawal A, 2006, J ECON GEOGR, V6, P571, DOI 10.1093/jeg/lbl016; Musselin C, 2004, HIGH EDUC, V48, P55, DOI 10.1023/B:HIGH.0000033770.24848.41; Parent D, 1999, J LABOR ECON, V17, P298, DOI 10.1086/209922; Saxenian A, 2005, STUD COMP INT DEV, V40, P35, DOI 10.1007/BF02686293; Bozeman B, 2001, INT J TECHNOL MANAGE, V22, P716, DOI 10.1504/IJTM.2001.002988; Horta H, 2009, HIGH EDUC, V58, P689, DOI 10.1007/s10734-009-9221-1; LONG JS, 1993, AM SOCIOL REV, V58, P703, DOI 10.2307/2096282; Mahroum S, 2001, INT MIGR, V39, P27, DOI 10.1111/1468-2435.00170; Burris V, 2004, AM SOCIOL REV, V69, P239; Zubieta AF, 2009, RES EVALUAT, V18, P105, DOI 10.3152/095820209X443446; Ackers L, 2005, INT MIGR, V43, P99, DOI 10.1111/j.1468-2435.2005.00343.x; Pezzoni M, 2012, RES POLICY, V41, P704, DOI 10.1016/j.respol.2011.12.009; Colquitt JA, 2000, J APPL PSYCHOL, V85, P678, DOI 10.1037//0021-9010.85.5.678; Zellner C, 2003, RES POLICY, V32, P1881, DOI 10.1016/S0048-7333(03)00080-5; SHIMBORI M, 1981, HIGH EDUC, V10, P75, DOI 10.1007/BF00154894; Allen TD, 2004, J APPL PSYCHOL, V89, P127, DOI 10.1037/0021-9010,89.1.27; Horta H, 2010, MANAGE SCI, V56, P414, DOI 10.1287/mnsc.1090.1109; Arimoto A, 2011, CHANG ACAD, V2, P281, DOI 10.1007/978-94-007-1140-2_14; Azoulay Pierre, 2012, RATE DIRECTION INVEN, P107; BIS (Department for Business Innovation and Skills), 2013, PERF UK RES BAS INT; CENTRA JA, 1978, J HIGH EDUC, V49, P151, DOI 10.2307/1979280; CNUFM (Center for National University Finance and Management), 2009, RES TUIT EXP BAS ED; Cruz-Castro L, 2010, RES POLICY, V39, P27, DOI 10.1016/j.respol.2009.11.008; Enders J., 2004, HIGHER ED POLICY, V17, P135, DOI DOI 10.1057/PALGRAVE.HEP.8300047; European Commission, 2001, HIGH LEV EXP GROUP I; European Commission, 2010, EUR 2020 EUR STRAT S; Fernandez-Zubieta A., GLOBAL MOBI IN PRESS; Gaughan M., 2004, RES POLICY, V33, P109; Glaser J, 2001, INT J TECHNOL MANAGE, V22, P698, DOI 10.1504/IJTM.2001.002987; Heining J., 2007, REGENSBURGER DISKUSS; Horta H, 2011, ASIA PAC EDUC REV, V12, P35, DOI 10.1007/s12564-010-9126-9; Jons H., 2007, SOCIAL GEOGRAPHY, V2, P97; Jons H., 2000, GLOBAL NETW, V9, P315; MEXT, 1980, KYOIK HAK; MEXT, 2003, DEV RES GLOB COMP; MEXT, 2009, DEV HUM RES DRIV KNO; MEXT, 2012, STAT ABSTRACTS 2012; MEXT, 2013, CENTR COUNC ED U COM; MEXT, 1999, KYOIK HAK; Morichika N, 2015, RES EVALUAT, V24, P146, DOI 10.1093/reseval/rvv002; OECD, 2000, MOB HUM RES INN; Organization for Economic Cooperation and Development (OECD), 2008, GLOB COMP TAL MOB HI; RIHE, 2006, COE PUBL SER; Scellato G., 2012, 18577 NBER; Statistics Bureau Japan, 2012, JAP STAT YB; Stephan P., 2012, 18613 NBER; Stephan Paula E., 2012, EC SHAPES SCI; Takahashi S., 2009, 094 GSIR WP EAPO; Teichler U., 2013, CHANGING ACAD CHANGI; TOPEL RH, 1992, Q J ECON, V107, P439, DOI 10.2307/2118478; Trowler P., 2001, ACAD TRIBES TERRITOR; Tsuji N., 2010, TRANSITION OBJECTIVE; Yamanoi A., 2007, ACAD MARKETPLACE JAP; Zumeta W. M., 1985, EXTENDING ED LADDER	74	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0302-3427	1471-5430		SCI PUBL POLICY	Sci. Public Policy	OCT	2015	42	5					690	710		10.1093/scipol/scu084		21	Management; Planning & Development; Public Administration	Business & Economics; Public Administration	CV0YT	WOS:000363980600007		
J	Noh, SH; Tung, VC; Han, TH; Cruz-Silva, R				Noh, Sung Hyun; Tung, Vincent C.; Han, Tae Hee; Cruz-Silva, Rodolfo			Novel Hybridization Approaches for Graphene-Based Nanocomposites	SCIENCE OF ADVANCED MATERIALS			English	Review						Graphene Oxide; Composites; Molecular Interaction; Hybrids; Hybridization	WALLED CARBON NANOTUBES; PERFORMANCE LITHIUM STORAGE; GRAPHITE OXIDE; MECHANICAL-PROPERTIES; ELECTRICAL-PROPERTIES; SOLAR-CELLS; INTERFACIAL ENHANCEMENT; COAXIAL NANOTUBES; ION BATTERIES; NANORIBBONS	Graphene oxide is a novel class of carbon material that is being extensively studied in the field of nanocomposites. This unique sheet of mixed sp(2\) lattice clusters and oxygen functionalities is an optimal platform for various hybrid functionalization which imbues the original sheet with some novel characteristics. A variety of hybrid strategies allow graphene to be a promising candidate for nanocomposites fabrication. Our review analyzes the types of molecular interactions that are utilized during the formation of graphene-based composites through various examples. Also the review will highlight the recent advances in hybridization strategy of graphene with numerous counterpart materials and discuss their broad applications as well.	[Noh, Sung Hyun; Han, Tae Hee] Hanyang Univ, Dept Organ & Nano Engn, Seoul 133791, South Korea; [Tung, Vincent C.] Univ Calif, Sch Engn, Merced, CA 95343 USA; [Cruz-Silva, Rodolfo] Shinshu Univ, Res Ctr Exot Nanocarbons, Nagano 3808553, Japan	Tung, VC (reprint author), Univ Calif, Sch Engn, Merced, CA 95343 USA.	ctung@ucmerced.edu; than@hanyang.ac.kr; rcruzsilva.rcen@gmail.com	Han, Tae Hee/E-8590-2015	Han, Tae Hee/0000-0001-5950-7103	Exotic Nanocarbons Project, Japan Regional Innovation Strategy by the Excellence, JST; Basic Science Research Program by National Research Foundation of Korea [NRF 2014R1A1A1008196]; Office of Science, Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; ACS Petroleum Funds Doctoral New Investigator (PRF) [54717-DN110]	Authors acknowledge L. J. Cote, F. Kim, K. Sohn and J. Huang for providing additional experimental results discussed in this review. R. Cruz-Silva thanks the support from the Exotic Nanocarbons Project, Japan Regional Innovation Strategy by the Excellence, JST. T. H. Han acknowledges the Basic Science Research Program by National Research Foundation of Korea (NRF 2014R1A1A1008196). V. C. Tung acknowledges the support by the Office of Science, Basic Energy Sciences, of the U.S. Department of Energy (No. DE-AC02-05CH11231) and ACS Petroleum Funds Doctoral New Investigator (PRF# 54717-DN110).	Zhang LS, 2010, J MATER CHEM, V20, P5462, DOI 10.1039/c0jm00672f; Ouyang YJ, 2010, NANO RES, V3, P8, DOI 10.1007/s12274-010-1002-8; Wu DQ, 2012, CHEM SOC REV, V41, P6160, DOI 10.1039/c2cs35179j; Li M, 2014, CARBON, V67, P185, DOI 10.1016/j.carbon.2013.09.080; Zhang YL, 2010, NANO TODAY, V5, P15, DOI 10.1016/j.nantod.2009.12.009; Fan ZJ, 2014, CARBON, V66, P407, DOI 10.1016/j.carbon.2013.09.016; Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/nnano.2010.54, 10.1038/NNANO.2010.54]; Umeyama T, 2008, CHEM-EUR J, V14, P4875, DOI 10.1002/chem.200702053; Patra N, 2011, ACS NANO, V5, P1798, DOI 10.1021/nn102531h; Tung VC, 2009, NAT NANOTECHNOL, V4, P25, DOI [10.1038/nnano.2008.329, 10.1038/NNANO.2008.329]; Park S, 2010, NAT NANOTECHNOL, V5, P309, DOI 10.1038/nnano.2010.69; Umeyama T, 2010, ADV MATER, V22, P1767, DOI 10.1002/adma.200903056; Kosynkin DV, 2011, ACS NANO, V5, P968, DOI 10.1021/nn102326c; Chen L, 2012, ACS APPL MATER INTER, V4, P4398, DOI 10.1021/am3010576; Liu JB, 2010, J MATER CHEM, V20, P900, DOI 10.1039/b917752c; Luo YS, 2013, J MATER CHEM A, V1, P273, DOI 10.1039/c2ta00064d; Zheng XH, 2009, ACTA PHYS SIN-CH ED, V58, pS259; Yan J, 2010, CARBON, V48, P3825, DOI 10.1016/j.carbon.2010.06.047; Gao W, 2011, NAT NANOTECHNOL, V6, P496, DOI [10.1038/nnano.2011.110, 10.1038/NNANO.2011.110]; Cruz-Silva E, 2009, ACS NANO, V3, P1913, DOI 10.1021/nn900286h; Kim F, 2010, ADV FUNCT MATER, V20, P2867, DOI 10.1002/adfm.201000736; James DK, 2012, MACROMOL CHEM PHYS, V213, P1033, DOI 10.1002/macp.201200001; Shao QG, 2013, J MATER CHEM A, V1, P15423, DOI 10.1039/c3ta12789c; Liu K, 2012, J MATER RES, V27, P2360, DOI 10.1557/jmr.2012.232; Park H, 2013, B KOREAN CHEM SOC, V34, P3269, DOI 10.5012/bkcs.2013.34.11.3269; Zhang CG, 2012, ACS NANO, V6, P6023, DOI 10.1021/nn301039v; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680; Cote LJ, 2011, PURE APPL CHEM, V83, P95, DOI 10.1351/PAC-CON-10-10-25; Charlier JC, 2007, REV MOD PHYS, V79, P677, DOI 10.1103/RevModPhys.79.677; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Xu C, 2009, J SOLID STATE CHEM, V182, P2486, DOI 10.1016/j.jssc.2009.07.001; Arnold MS, 2005, NANO LETT, V5, P713, DOI 10.1021/nl050133o; Sun HT, 2014, J PHYS CHEM C, V118, P2263, DOI 10.1021/jp408021m; Bindl DJ, 2011, NANO RES, V4, P1174, DOI 10.1007/s12274-011-0167-0; Jiao LY, 2010, NANO RES, V3, P387, DOI 10.1007/s12274-010-1043-z; Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F; Xie LM, 2011, J AM CHEM SOC, V133, P10394, DOI 10.1021/ja203860a; Bets KV, 2009, NANO RES, V2, P161, DOI [10.1007/S12274-009-9015-X, 10.1007/s12274-009-9015-x]; Shi YM, 2011, J MATER CHEM, V21, P3277, DOI 10.1039/c0jm02953j; Sayyar S, 2013, CARBON, V52, P296, DOI 10.1016/j.carbon.2012.09.031; Cote LJ, 2009, J AM CHEM SOC, V131, P1043, DOI 10.1021/ja806262m; Qiu Y, 2014, CARBON, V72, P215, DOI 10.1016/j.carbon.2014.02.005; Yamamoto T, 2008, TOP APPL PHYS, V111, P165, DOI 10.1007/978-3-540-72865-8_5; Hugot N, 2012, J SOLID STATE CHEM, V194, P23, DOI 10.1016/j.jssc.2012.07.027; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Strong V, 2012, ACS NANO, V6, P1395, DOI 10.1021/nn204200w; Layek RK, 2013, MACROMOL MATER ENG, V298, P1166, DOI 10.1002/mame.201200233; Luo JY, 2013, ACCOUNTS CHEM RES, V46, P2225, DOI 10.1021/ar300180n; Zhu HW, 2009, SOL ENERG MAT SOL C, V93, P1461, DOI 10.1016/j.solmat.2009.04.006; Yadav M, 2013, CELLULOSE, V20, P687, DOI 10.1007/s10570-012-9855-5; Chang HX, 2013, ENERG ENVIRON SCI, V6, P3483, DOI 10.1039/c3ee42518e; Cote LJ, 2009, J AM CHEM SOC, V131, P11027, DOI 10.1021/ja902348k; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Nish A, 2007, NAT NANOTECHNOL, V2, P640, DOI 10.1038/nnano.2007.290; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Tao CG, 2011, NAT PHYS, V7, P616, DOI 10.1038/NPHYS1991; Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x; Guo L, 2012, CARBON, V50, P1667, DOI 10.1016/j.carbon.2011.12.011; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Singhbabu YN, 2013, J MATER CHEM C, V1, P958, DOI 10.1039/c2tc00304j; Li R, 2013, PROPELL EXPLOS PYROT, V38, P798, DOI 10.1002/prep.201200199; Jung I, 2008, NANO LETT, V8, P4283, DOI 10.1021/nl8019938; Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p; Shen JF, 2011, J COLLOID INTERF SCI, V356, P543, DOI 10.1016/j.jcis.2011.01.052; Shimizu T, 2011, NAT NANOTECHNOL, V6, P45, DOI [10.1038/nnano.2010.249, 10.1038/NNANO.2010.249]; Jain RM, 2012, ADV MATER, V24, P4436, DOI 10.1002/adma.201202088; Hu YJ, 2012, APPL CATAL B-ENVIRON, V111, P208, DOI 10.1016/j.apcatb.2011.10.001; Tsyboulski DA, 2007, NANO LETT, V7, P3080, DOI 10.1021/nl071561s; Rao SS, 2012, NANO LETT, V12, P1210, DOI 10.1021/nl203512c; Luo JY, 2010, J AM CHEM SOC, V132, P17667, DOI 10.1021/ja1078943; Liu Y, 2013, J MATER CHEM B, V1, P1826, DOI 10.1039/c3tb00531c; Brus L, 2010, NANO LETT, V10, P363, DOI 10.1021/nl904263b; Avouris P, 2010, MRS BULL, V35, P306, DOI 10.1557/mrs2010.553; Zhu Y, 2009, CHEM MATER, V21, P5284, DOI 10.1021/cm902939n; Liang JJ, 2010, ACS APPL MATER INTER, V2, P3310, DOI 10.1021/am1007326; Ando T, 2005, J PHYS SOC JPN, V74, P777, DOI 10.1143/JPSJ.74.777; Wang X, 2011, IND ENG CHEM RES, V50, P5376, DOI 10.1021/ie102566y; Jiao LY, 2012, NANO RES, V5, P292, DOI 10.1007/s12274-012-0209-2; Avouris P, 2008, NAT PHOTONICS, V2, P341, DOI 10.1038/nphoton.2008.94; Yamamoto Y, 2009, P NATL ACAD SCI USA, V106, P21051, DOI 10.1073/pnas.0905655106; Krishnan D, 2012, NANO TODAY, V7, P137, DOI 10.1016/j.nantod.2012.02.003; Liu JB, 2010, J AM CHEM SOC, V132, P7279, DOI 10.1021/ja100938r; Shen JF, 2010, COLLOID SURFACE B, V81, P434, DOI 10.1016/j.colsurfb.2010.07.035; Zhang XW, 2012, PHYSICA B, V407, P571, DOI 10.1016/j.physb.2011.10.024; Popov VN, 2004, MAT SCI ENG R, V43, P61, DOI 10.1016/j.mser.2003.10.001; Liu HY, 2012, J PHYS CHEM C, V116, P3334, DOI 10.1021/jp2102226; Kong J, 1999, APPL PHYS A-MATER, V69, P305, DOI 10.1007/s003390051005; Murariu M, 2010, POLYM DEGRAD STABIL, V95, P889, DOI 10.1016/j.polymdegradstab.2009.12.019; Fang M, 2009, J MATER CHEM, V19, P7098, DOI 10.1039/b908220d; Kim F, 2010, ADV MATER, V22, P1954, DOI 10.1002/adma.200903932; Zhang L, 2013, CARBON, V61, P105, DOI 10.1016/j.carbon.2013.04.074; Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995; Wang XR, 2011, NAT NANOTECHNOL, V6, P563, DOI [10.1038/nnano.2011.138, 10.1038/NNANO.2011.138]; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Hong WJ, 2010, J PHYS CHEM C, V114, P1822, DOI 10.1021/jp9101724; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Lee WJ, 2014, ENERG ENVIRON SCI, V7, P621, DOI 10.1039/c3ee43322f; Guo YQ, 2011, IND ENG CHEM RES, V50, P7772, DOI 10.1021/ie200152x; Gilje S, 2010, ADV MATER, V22, P419, DOI 10.1002/adma.200901902; Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Dimiev A, 2011, ACS APPL MATER INTER, V3, P4657, DOI 10.1021/am201071h; Tung VC, 2011, J AM CHEM SOC, V133, P4940, DOI 10.1021/ja1103734; Kim J, 2012, ACCOUNTS CHEM RES, V45, P1356, DOI 10.1021/ar300047s; Nasibulin AG, 2007, NAT NANOTECHNOL, V2, P156, DOI 10.1038/nnano.2007.37; Sinitskii A, 2010, ACS NANO, V4, P1949, DOI 10.1021/nn901899j; Han TH, 2010, ADV MATER, V22, P2060, DOI 10.1002/adma.200903221; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Zhou WW, 2011, ENERG ENVIRON SCI, V4, P4954, DOI 10.1039/c1ee02168k; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Tu FY, 2013, ELECTROCHIM ACTA, V106, P406, DOI 10.1016/j.electacta.2013.05.108; Mu B, 2013, ELECTROCHIM ACTA, V88, P177, DOI 10.1016/j.electacta.2012.10.025; Bindl DJ, 2010, ACS NANO, V4, P5657, DOI 10.1021/nn1012397; Liu XH, 2012, CARBON, V50, P3836, DOI 10.1016/j.carbon.2012.04.025; Sawangphruk M, 2013, FUEL CELLS, V13, P881, DOI 10.1002/fuce.201200159; Gizzatov A, 2012, CHEM COMMUN, V48, P5602, DOI 10.1039/c2cc31407j; Tang C, 2013, CARBON, V61, P458, DOI 10.1016/j.carbon.2013.04.103; Bao QL, 2010, ADV FUNCT MATER, V20, P782, DOI 10.1002/adfm.200901658; Jiang DE, 2008, J PHYS CHEM C, V112, P5348, DOI 10.1021/jp711660k; Poh HL, 2012, NANOSCALE, V4, P3515, DOI 10.1039/c2nr30490b; Bernardi M, 2012, ACS NANO, V6, P8896, DOI 10.1021/nn302893p; Yao HB, 2010, J MATER CHEM, V20, P5190, DOI 10.1039/c0jm00094a; Patra N, 2009, NANO LETT, V9, P3766, DOI 10.1021/nl9019616; Pendashteh A, 2013, ELECTROCHIM ACTA, V88, P347, DOI 10.1016/j.electacta.2012.10.088; Liang JJ, 2009, CARBON, V47, P922, DOI 10.1016/j.carbon.2008.12.038; Kim H, 2010, NANO RES, V3, P813, DOI 10.1007/s12274-010-0050-4; Wang F, 2005, SCIENCE, V308, P838, DOI 10.1126/science.1110265; Tung VC, 2012, ADV ENERGY MATER, V2, P299, DOI 10.1002/aenm.201100595; Bindl DJ, 2011, NANO LETT, V11, P455, DOI 10.1021/nl1031343; Bose S., 2014, NANOTECHNOLOGY, V25; Tans SJ, 1998, NATURE, V393, P49; Durkop T, 2004, NANO LETT, V4, P35, DOI 10.1021/nl034841q; Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640; Huang J. X., 2011, ABSTR PAP AM CHEM S, V242; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Kalita G., 2008, APPL PHYS LETT, V92; Liao A. D., 2011, PHYS REV LETT, V106; Lonita M, 2013, CARBOHYD POLYM, V94, P339; Luo F, 2012, J APPL POLYM SCI, V125, pE348, DOI 10.1002/app.36224; Poumirol J. M., 2010, PHYS REV B, V82; Qian K., 2013, SCI REP UK, V3; Rao S. S., 2011, APPL PHYS LETT, V98; Rao S. S., 2011, NEW J PHYS, V13; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Sinitskii A., 2012, APPL PHYS LETT, V100; Sinitskii A., 2009, APPL PHYS LETT, V95; Song PA, 2009, NANOSCALE, V1, P118, DOI 10.1039/b9nr00026g; Yamaguchi H., 2014, ADV ENERGY MAT, V4; Zhao J. H., 2012, J APPL PHYS, V111; Zheng X. H., 2009, APPL PHYS LETT, V95	153	1	1	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	1947-2935	1947-2943		SCI ADV MATER	Sci. Adv. Mater.	OCT	2015	7	10			SI		1962	1978		10.1166/sam.2015.2263		17	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	CV2SW	WOS:000364108500005		
J	Zimin, Y; Ueda, T				Zimin, Y.; Ueda, T.			Strain energy due to splitting forces as a basis for bonding criterion in wafer bonding	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Residual stress; Strain energy; Bonding criterion	BIMETAL THERMOSTATS; THIN-FILMS; STRESSES; MECHANICS; MODEL	Direct wafer bonding is an important technology in sensor manufacturing, but bonding strength between different materials is still in need of improvement due to thermally induced internal stresses. To estimate the negative influence of the internal stresses, a bonding criterion has been established that compares the surface energy, which dissipates as the bond is formed, to the specific strain energy, which is stored in bilayers structure due to internal stresses. In the literature, general practice assumes that the specific strain energy is the strain energy of pure bending. However, from the physical standpoint, the strain energy due to pure bending represents neither the total strain energy nor the strain energy due to the splitting forces. We have calculated the exact total strain energy of a curved bilayer and its two components: the strain energy due to the forces parallel and perpendicular to the interface. The strain energy of the forces perpendicular to the interface (splitting forces) has been proposed as the specific strain energy for the bonding criterion. The new specific strain energy strongly depends on the thickness ratio of the layers and can even equal zero at a certain thickness ratio called the point of equivalence. In turn, the point of equivalence does not depend on the total thickness of the bilayer structure. The point of equivalence, where internals stresses do not affect the bonding strength, was calculated for five structures: Si/Al2O3, Sit GaAs, Si/LiNbO3, Si/SiC, and Si/InP. The derived result has considerable importance for applications because it demonstrates how to avoid completely the negative influence of even strong internal stresses on the bonding strength. (C) 2015 Elsevier B.V. All rights reserved.	[Zimin, Y.; Ueda, T.] Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan	Zimin, Y (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Wakamatsu Ku, 2-7 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	ziminyury78@gmail.com					Turner KT, 2002, J APPL PHYS, V92, P7658, DOI 10.1063/1.1521792; SUHIR E, 1988, J APPL MECH-T ASME, V55, P143; HUNT RA, 1972, J PHYS D APPL PHYS, V5, P359, DOI 10.1088/0022-3727/5/2/318; Dobrynin AV, 1997, TECH PHYS LETT+, V23, P709, DOI 10.1134/1.1261664; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Gui C, 1999, J APPL PHYS, V85, P7448, DOI 10.1063/1.369377; Turner KT, 2012, ECS TRANSACTIONS, V50, P201, DOI 10.1149/05007.0201ecst; Turner KT, 2006, P ROY SOC A-MATH PHY, V462, P171, DOI 10.1098/rspa.2005.1571; Hong LN, 1998, JPN J APPL PHYS 1, V37, P5932, DOI 10.1143/JJAP.37.5932; THORNTON JA, 1989, THIN SOLID FILMS, V171, P5, DOI 10.1016/0040-6090(89)90030-8; Murray CE, 2002, PHILOS MAG A, V82, P3087, DOI 10.1080/01418610210154691; Yu HH, 1998, J MECH PHYS SOLIDS, V46, P829, DOI 10.1016/S0022-5096(97)00100-2; Suhir E, 1989, J APPL MECH-T ASME, V56, P595; Turner KT, 2004, J APPL PHYS, V95, P349, DOI 10.1063/1.1629776; Noyan IC, 2004, APPL PHYS LETT, V85, P724, DOI 10.1063/1.1776331; Bower R. W., 1995, Proceedings of the Third International Symposium on Semiconductor Wafer Bonding: Physics and Applications; Gosele U., 1993, P 2 INT S SEM WAF BO, p[93, 395]; Gui M., 1999, P 12 IEEE INT C MEMS, P290; Johnson K.L., 1976, THEORETICAL APPL MEC, P133; Lord Rayleigh A., 1936, P R SOC A, V156, P326; Obreimoff JW, 1930, P R SOC LOND A-CONTA, V127, P290, DOI 10.1098/rspa.1930.0058; Strengl R., 1989, P 1989 IEEE SOS SOI, P123; SUHIR E, 1986, J APPL MECH-T ASME, V53, P657; Suhir E., 1986, P 1986 INT S MICR OC, V2, P383; Suhir E., 1995, ASME, V12, P101; Timoshenko S., 1940, STRENGTH MAT; Tong Q.-Y., 1999, SEMICONDUCTOR WAFER, P187; Tong Q.-Y., 1995, P 3 INT S SEM WAF BO, V95, P155; Yu H.H., 1998, P MAT RES SOC S, V535, P127; Zhang Y., 2006, J APPL PHYS, V99, P513	30	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	OCT 1	2015	234						232	238		10.1016/j.sna.2015.09.002		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CU8XC	WOS:000363826400028		
J	Yamagishi, T; Akutsu, S; Cho, K; Inoue, Y; Li, Y; Matsumoto, Y				Yamagishi, Toshio; Akutsu, Satoshi; Cho, Kisuk; Inoue, Yumi; Li, Yang; Matsumoto, Yoshie			TWO-COMPONENT MODEL OF GENERAL TRUST: PREDICTING BEHAVIORAL TRUST FROM ATTITUDINAL TRUST	SOCIAL COGNITION			English	Article						general trust; attitudinal trust; trust game; behavioral trust; social-value orientation	SOCIAL VALUE ORIENTATION; INTERPERSONAL-TRUST; GAME-THEORY; RISK; TRUSTWORTHINESS; RECIPROCITY; MATTER; SIZE	General trust constitutes a critical aspect of social capital that facilitates democratic governance and economic prosperity of a society. Despite its theoretical importance, attitudinal measures of general trust often fail to predict actual trusting behavior in laboratory testing. We suspected that the failure of currently available measures of trust in predicting behavioral trust stems from the overly consequentialist approach to defining trust. We proposed that measures of attitudinal trust succeed in predicting behavioral trust when they tap both the responder's belief that his/her trust will be honored and his/her preference to be a trusting person. We constructed a new measure of general trust that includes both of these aspects. Using a non-student sample of trust game players (N = 470), we demonstrated that the newly constructed measure better predicts behavioral trust in a trust game and other related games, especially when the participant's social-value orientation is controlled.	[Yamagishi, Toshio; Akutsu, Satoshi; Inoue, Yumi] Hitotsubashi Univ, Tokyo 1018439, Japan; [Cho, Kisuk] Ewha Womans Univ, Seoul, South Korea; [Li, Yang; Matsumoto, Yoshie] Tamagawa Univ, Tokyo, Japan	Yamagishi, T (reprint author), Hitotsubashi Univ, Grad Sch Int Corp Strategy, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018439, Japan.	yamagishitoshio@gmail.com					Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Eckel CC, 2004, J ECON BEHAV ORGAN, V55, P447, DOI 10.1016/j.jebo.2003.11.003; Dunning D, 2014, J PERS SOC PSYCHOL, V107, P122, DOI 10.1037/a0036673; Houser D, 2010, J ECON BEHAV ORGAN, V74, P72, DOI 10.1016/j.jebo.2010.01.002; Kosugi M, 1998, JPN J PSYCHOL, V69, P349; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Johnson ND, 2012, ECON LETT, V116, P210, DOI 10.1016/j.econlet.2012.02.010; ROTTER JB, 1971, AM PSYCHOL, V26, P443, DOI 10.1037/h0031464; ROTTER JB, 1980, AM PSYCHOL, V35, P1; Ashraf N, 2006, EXP ECON, V9, P193, DOI 10.1007/s10683-006-9122-4; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P1330; Ermisch J, 2009, J R STAT SOC A STAT, V172, P749; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.6.1330; Mutz DC, 2005, PUBLIC OPIN QUART, V69, P393, DOI 10.1093/poq/nfi029; Parco JE, 2002, PSYCHOL SCI, V13, P292, DOI 10.1111/1467-9280.00454; Yamagishi T, 2013, ORGAN BEHAV HUM DEC, V120, P260, DOI 10.1016/j.obhdp.2012.06.002; Schechter L, 2007, J ECON BEHAV ORGAN, V62, P272, DOI 10.1016/j.jebo.2005.03.006; Evans AM, 2008, J RES PERS, V42, P1585, DOI 10.1016/j.jrp.2008.07.011; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Bohnet I, 2004, J ECON BEHAV ORGAN, V55, P467, DOI 10.1016/j.jebo.2003.11.004; Ben-Ner A, 2010, J ECON PSYCHOL, V31, P64, DOI 10.1016/j.joep.2009.10.001; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Capra C. M., 2007, WORKING PAPER; Fehr E., 2003, IZA DISCUSSION PAPER; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; HARDIN R, 1993, POLIT SOC, V21, P505, DOI 10.1177/0032329293021004006; Inglehart R, 1990, CULTURAL SHIFT ADV I; Johansson-Stenman O, 2005, ECON LETT, V88, P365, DOI 10.1016/j.econlet.2005.03.007; Kiyonari T., 1999, JAPANESE J SOCIAL PS, V15, P100; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; LaPorta R, 1997, J FINANC, V52, P1131, DOI 10.1111/j.1540-6261.1997.tb02727.x; Lazzarini S. G., 2004, 49 IBM; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; Mifune N., 2009, ANN M JAP ASS EV HUM; Putnam R. D, 2002, DEMOCRACIES FLUX EVO; Putnam R. D., 1993, MAKING DEMOCRACY WOR; Putnam Robert D., 2000, BOWLING ALONE COLLAP; RABIN M, 1993, AM ECON REV, V83, P1281; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Yamagishi T., 2001, TRUST SOC; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397; Yamagishi T., 1998, SHINRAI NO KOZO KOKO; Yamagishi T, 2014, PSYCHOL SCI, V25, P1699, DOI 10.1177/0956797614538065; Yamagishi T., 1999, ASIAN J SOC PSYCHOL, V2, P145, DOI [10.1111/1467-839X.00030, DOI 10.1111/1467-839X.00030]; Yamagishi T, 2011, SCI MIND, P1, DOI 10.1007/978-4-431-53936-0	48	0	0	GUILFORD PUBLICATIONS INC	NEW YORK	370 SEVENTH AVE, SUITE 1200, NEW YORK, NY 10001-1020 USA	0278-016X			SOC COGNITION	Soc. Cogn.	OCT	2015	33	5					436	458				23	Psychology, Social	Psychology	CV4TD	WOS:000364258500005		
J	Matsumoto, T; Chung, S				Matsumoto, Takenori; Chung, Seungjin			Japanese Colonizers in the Honam Plain of Colonial Korea	SUNGKYUN JOURNAL OF EAST ASIAN STUDIES			English	Article						Japanese colonialism; colonial settlers; migration; development; local elite; public sphere; assimilation		Japan, as a latecomer to imperial expansion, began to seek a food supply for its empire in its neighbor Korea's southern rice basket-the Honam Plain. With the outbreak of the Russo-Japanese War (1904-1905), a massive wave of Japanese immigration brought many settlers to the Honam Plain, where they initiated their own development (takushoku ) and production (shokusan ) activities centered around their farms, ahead of officials and merchants. Emerging in time as local "elites or notables" (K. yuji, J. yashi these settler farm owners extended their activities to the arena of public and community projects by organizing and supporting a host of public and semi-official organizations. Economically based on agricultural farms tilled by Korean tenants, they succeeded in turning themselves into colonial masters in their localities by dominating the colonial public sphere that was largely closed to Koreans and local politics. During the period of the well-known Campaign to Increase Rice Production (1920-1933), they served as symbiotic local partners of the Government-General of Korea in implementing assimilation (Mut Mt) through local development. Their activities also allowed the authorities to present their rule in a positive light, in spite of worsening conditions for the Korean rural population.	[Matsumoto, Takenori] Univ Tokyo, Tokyo 1138654, Japan; [Chung, Seungjin] Sungkyunkwan Univ, Seoul, South Korea	Matsumoto, T (reprint author), Univ Tokyo, Tokyo 1138654, Japan.	amat@mail.ecc.u-tokyo.ac.jp; june0504@skku.edu					[Anonymous], MIYAZAKI YOSHITAROO; [Anonymous], CHOSEN SOTOKUFU KANH; Matsumoto T, 2009, KOREA J, V49, P121; [Anonymous], TAEHAN MAEIL SINBO; [Anonymous], MAEIL SINBO; [Anonymous], TONGA ILBO; Asada Kyoji, 1968, NIPPON TEIHOHUSHUGI; Caprio Mark, 2009, JAPANESE ASSIMILATIO; Chae Sudo, 2011, ILBON CHEGUKCHUUI UI; Chi Sugol, 2010, YOKSA PIPYONG, V90, P156; Chonbuk nongji kaeryang chohap, 1978, CHONB NONGJ 70NYONSA; Chosen sotokufu Noshokobu, 1910, KANKOKU SUISANSHI, V3; Chung Seungjin, 2004, HANGUK KYONGJE YONGU, V12, P139; Chung Seungjin, 2005, YEOKSA BIPYEONG, V73, P241; Chung Seungjin, 2015, TAEDONG MUNHWA YONGU, V90, P329; Chung Seungjin, 2013, TAEDONG MUNHWA YONGU, V84, P495; Chung Seungjin, 2013, REV KOREAN STUDIES, V16, P127; Chung Seungjin, 2013, HIGASHI AJIA KINDAIS, V16, P114; Elkins Caroline, 2005, SETTLER COLONIALISM; Fujii Kantaro, 1911, CHOSEN TOCHI DAN; Gunsan-fu, 1935, GUNSAN FU SHI; Haedong Yun, 2010, SINGMINJI HONGGONGSO; Ho Suyol, 2011, ILCHE CHOGI CHOSON U; Hodaka Masaki, 1925, GUNSAN KAIKOSHI; Hong Songch'an, 2006, ILCHEHA MANGYONG KAN; Hong Sun'gwon, 2009, ILCHE KANGJOMHA PUSA; Hyongsik Yi, 2013, CHEGUK KWA SINGMINJI; Ikeda Hiroshi, 2007, DAITOA KYOEIKEN NO B, P293; Ishii Kanji, 2012, TEIKOKUSHUGI NIPPON; Ishikawa Hisao, 1996, CHUKYO HOGAKU, V30-4, P237; Kamata Hakudo, 1936, CHOSEN NO JINBUTSU T, V1; Kang Ch'angil, 2002, KUNDAE ILBON UI CHOS; Kang Sangjung, 1996, ORITALIJUM UL NOMOSO; Kawai Kazuo, 1999, KOKUSAKU KAISHA TOTA; Kihara Hitoshi, 1928, EKISAN GUN JIJO; Kim Yongjong, 2006, KUNDAE HANGGU TOSI K; Kimura Kenji, 1989, ZAICHO NIPPONJIN NO; Kwon T'aeok, 2014, ILCHE UI HANGUK SING; Kyusu Yi, 2007, SINGMINJI CHOSON KWA; Matsuda Toshihiko, 2013, CHIIKI SHAHI KARA MI; Matsumoto Takenori, 1998, SHOKUMINCHI KENRYOKU; Matsumoto Takenori, 2005, CHOSEN NOSON NO SHOK; Miil O, 2005, YOKSA WA KYONGGYE, V57, P121; Miwa Tadashi, 1907, TOMI NO GUNSAN; Namgung Pong, 1990, THESIS SEOUL NATL U; Oguma Eiji, 1998, NIPPONJIN NO KYOKAI; Research Institute of Korean Rural Economy, 1985, NONGJI KAEHYOKSI PIB; Ryu Chehon, 1994, HANGUK KUNDAE WA YOK; Said E., 1993, CULTURE IMPERIALISM; Scupin Raymond, 2006, PEOPLES CULTURES ASI; Shin Gi-Wook, 1999, COMP STUDIES SOC HIS, V4, P784; Shin Gi-Wook, 1999, COLONIAL MODERNITY K, P70; So Kiyong, 1932, IKSAN KUNJI; Son Chongmok, 1992, HANGUK CHIBANG CHEDO; Sunyol So, 1994, THESIS KYOTO U; Takasaki Soji, 2002, SHOKUMINCHI CHOSEN N; Tanaka Stefan, 1993, JAPANS ORIENT RENDER; Tongjin nongji kaeryang chohap, 1975, TONGJ NONGJ HAERY CH; Uchida Jun, 2011, BROKERS EMPIRE JAPAN; Utsuki Hatsusabura, 1929, CHOSEN NO SANGYO; Utsuki Hatsusaburo, 1928, CHOSEN NO HOKO ZENRA; Utsuki Hatsusaburo, 1934, KONAN NO HOKO KINTEI; Yamashita Eiji, 1927, KONAN HOKO IN ANNAI; Yamashita Eiji, 1915, KONAN HOKO IRI ANNAI; Yun Haedong, 2003, SINGMINJI UI HOESAEH; Zenrahokudo, 1928, ZENRAHOKUDO YORAN; Zenshu-fu, 2009, ZENSHUFU SHI	67	0	0	ACAD EAST ASIAN STUD, SUNGKYUNKWAN UNIVERSITY	JONGNO-GU	53 MYEONGNYUN-DONG 3-GA, JONGNO-GU, SEOUL 110-745, SOUTH KOREA	1598-2661			SUNGKYUN J EAST ASIA	Sungkyun J. East Asian Stud.	OCT	2015	15	2					263	289				27	Asian Studies	Asian Studies	CU5UV	WOS:000363598400006		
J	Radtke, KW				Radtke, Kurt W.			The China Problem in Postwar Japan: Japanese National Identity and Sino-Japanese Relations.	SUNGKYUN JOURNAL OF EAST ASIAN STUDIES			English	Book Review									[Radtke, Kurt W.] Waseda Univ, Japanese & Chinese Studies, Tokyo, Japan; [Radtke, Kurt W.] Leiden Univ, NL-2300 RA Leiden, Netherlands	Radtke, KW (reprint author), Leiden Univ, NL-2300 RA Leiden, Netherlands.	kurtradtke@online.nl					Alagappa M., 1988, ASIAN SECURITY ISSUE; HOPPENS R, 2015, CHINA PROBLEM POSTWA; Masao Maruyama, 1998, CHUSEI TO HANGYAKU; Radtke K. W., 2000, COMPREHENSIVE SECURI; Radtke K W., 2006, NEOHEGEMONIA AM MULT, P101	5	0	0	ACAD EAST ASIAN STUD, SUNGKYUNKWAN UNIVERSITY	JONGNO-GU	53 MYEONGNYUN-DONG 3-GA, JONGNO-GU, SEOUL 110-745, SOUTH KOREA	1598-2661			SUNGKYUN J EAST ASIA	Sungkyun J. East Asian Stud.	OCT	2015	15	2					291	294				4	Asian Studies	Asian Studies	CU5UV	WOS:000363598400007		
J	Hanaki, R				Hanaki, Ryo			On scannable properties of the original knot from a knot shadow	TOPOLOGY AND ITS APPLICATIONS			English	Article						Knot shadow; Pseudo diagram; Trivializing number; Unknotting number; Genus; Positive knot	LINKS; NUMBER; GENUS	A knot shadow is a diagram with all crossing information missing. We cannot determine the original knot from a knot shadow in general. In this paper, we investigate properties (unknotting number, genus, braid index, etc.) of the original knot from a knot shadow. (C) 2015 Elsevier B.V. All rights reserved.	Nara Univ Educ, Dept Math Educ, Nara 6308528, Japan	Hanaki, R (reprint author), Nara Univ Educ, Dept Math Educ, Nara 6308528, Japan.	hanaki@nara-edu.ac.jp			KAKENHI [26800039]	The author would like to thank Professors Kouki Taniyama and Makoto Ozawa for their encouragement and advices. The author would like to thank Professor Kazuhiro Ichihara for information on [6]. The author would like to thank Professor Tetsuya Abe for his advice on [14]. This work was supported by KAKENHI Grant-in-Aid for Young Scientists (B) 26800039.	CROMWELL PR, 1989, J LOND MATH SOC, V39, P535; Henrich A, 2011, J KNOT THEOR RAMIF, V20, P625, DOI 10.1142/S0218216511009388; Stoimenow A, 2001, P AM MATH SOC, V129, P2141, DOI 10.1090/S0002-9939-01-05823-3; Rasmussen J, 2010, INVENT MATH, V182, P419, DOI 10.1007/s00222-010-0275-6; KAUFFMAN LH, 1987, TOPOLOGY, V26, P395; Przytycki JH, 2010, J KNOT THEOR RAMIF, V19, P187, DOI 10.1142/S0218216510007838; THISTLETHWAITE MB, 1987, TOPOLOGY, V26, P297, DOI 10.1016/0040-9383(87)90003-6; YAMADA S, 1987, INVENT MATH, V89, P347, DOI 10.1007/BF01389082; Nakamura T, 2000, OSAKA J MATH, V37, P441; Hanaki R, 2010, OSAKA J MATH, V47, P863; MENASCO W, 1993, ANN MATH, V138, P113, DOI 10.2307/2946636; Cromwell P. R., 2004, KNOTS LINKS; Hanaki R., 2014, J MATH SOC JPN, V20, P435; Iwata N., 1999, THESIS TSUDA COLL; MURASUGI K, 1987, TOPOLOGY, V26, P187, DOI 10.1016/0040-9383(87)90058-9; Przytycki JH, 1989, B POLISH ACAD SCI MA, V37, P559; Taniyama K., 1989, TOKYO J MATH, V12, P205	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	OCT	2015	194						296	305		10.1016/j.topol.2015.08.012		10	Mathematics, Applied; Mathematics	Mathematics	CV4NY	WOS:000364245000020		
J	Chayama, K; Hayes, CN				Chayama, Kazuaki; Hayes, C. Nelson			HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy	VIRUSES-BASEL			English	Review						hepatitis C; direct-acting antivirals; protease inhibitor; NS5A inhibitor; sustained viral response; resistance	HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN 5A; DACLATASVIR PLUS ASUNAPREVIR; TREATMENT-NAIVE PATIENTS; GENOTYPE 1B INFECTION; POLYMERASE INHIBITORS; INTERGENOTYPIC RECOMBINANT; TREATMENT OPTIONS; SERINE-PROTEASE; NS5A INHIBITOR	Sustained virological response (SVR) rates have increased dramatically following the approval of direct acting antiviral (DAA) therapies. While individual DAAs have a low barrier to resistance, most patients can be successfully treated using DAA combination therapy. However, DAAs are vulnerable to drug resistance, and resistance-associated variants (RAVs) may occur naturally prior to DAA therapy or may emerge following drug exposure. While most RAVs are quickly lost in the absence of DAAs, compensatory mutations may reinforce fitness. However, the presence of RAVs does not necessarily preclude successful treatment. Although developments in hepatitis C virus (HCV) therapy in Asia have largely paralleled those in the United States, Japan's July 2014 approval of asunaprevir plus daclatasvir combination therapy as the first all-oral interferon-free therapy was not repeated in the United States. Instead, two different combination therapies were approved: sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir/dasabuvir. This divergence in treatment approaches may lead to differences in resistance challenges faced by Japan and the US. However, the recent approval of sofosbuvir plus ledipasvir in Japan and the recent submissions of petitions for approval of paritaprevir/ritonavir plus ombitasvir suggest a trend towards a new consensus on emerging DAA regimens.	[Chayama, Kazuaki; Hayes, C. Nelson] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Metab,Minami Ku, Hiroshima 7348551, Japan; [Chayama, Kazuaki] RIKEN, Inst Phys & Chem Res, Ctr Genom Med, Lab Digest Dis, Hiroshima 7348551, Japan; [Chayama, Kazuaki; Hayes, C. Nelson] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan	Chayama, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Metab,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp; nelsonhayes@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education Culture Sports Science and Technology, Government of Japan	This work was supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and Ministry of Education Culture Sports Science and Technology, Government of Japan.	Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Tanwar S, 2012, EXPERT OPIN INV DRUG, V21, P1193, DOI 10.1517/13543784.2012.690392; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Ozeki I, 2011, J GASTROENTEROL, V46, P929, DOI 10.1007/s00535-011-0411-0; Yoshimi S, 2015, J MED VIROL, V87, P1913, DOI 10.1002/jmv.24255; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Chayama K, 2011, J GASTROENTEROL, V46, P545, DOI 10.1007/s00535-010-0358-6; St Laurent DR, 2012, BIOORG MED CHEM LETT, V22, P6063, DOI 10.1016/j.bmcl.2012.08.049; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Paolucci S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-355; Chayama K, 2015, HEPATOLOGY, V61, P1523, DOI 10.1002/hep.27705; Gerber L, 2013, LIVER INT, V33, P85, DOI 10.1111/liv.12068; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Yoshimi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130022; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Lu LJ, 2007, ANTIMICROB AGENTS CH, V51, P1889, DOI 10.1128/AAC.01004-06; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Akamatsu S, 2015, J HEPATOL, V63, P554, DOI 10.1016/j.jhep.2015.03.033; Bell TW, 2010, CHEMMEDCHEM, V5, P1663, DOI 10.1002/cmdc.201000334; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Nyanguile O, 2010, J VIROL, V84, P2923, DOI 10.1128/JVI.01980-09; Chayama K, 2010, HEPATOL RES, V40, P1155, DOI 10.1111/j.1872-034X.2010.00726.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Gentile I, 2014, CURR MED CHEM, V21, P3261; Uchida Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112647; [Anonymous], 2014, J HEPATOL, V60, P392, DOI DOI 10.1016/J.JHEP.2013.11.003; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Fung A, 2014, ANTIMICROB AGENTS CH, V58, P3636, DOI 10.1128/AAC.02666-14; Noell BC, 2015, DRUG DES DEV THER, V9, P2367, DOI 10.2147/DDDT.S65255; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Nettles RE, 2011, HEPATOLOGY, V54, P1956, DOI 10.1002/hep.24609; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Soriano V, 2013, NAT REV GASTRO HEPAT, V10, P568, DOI 10.1038/nrgastro.2013.165; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Gentile Ivan, 2014, Rev Recent Clin Trials, V9, P115; Hedskog C, 2015, HEPATOLOGY, V61, P471, DOI 10.1002/hep.27361; Itakura J., 2015, HEPATOL RES, DOI [10.1111/hepr.1247425564756, DOI 10.1111/HEPR.1247425564756]; Izquierdo Laure, 2014, Pharmgenomics Pers Med, V7, P241, DOI 10.2147/PGPM.S52715; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Panel AIHG, 2015, HEPATOLOGY, V62, P932; Poole RM, 2014, DRUGS, V74, P1559, DOI 10.1007/s40265-014-0279-4; Talwani R, 2013, DRUG TODAY, V49, P769, DOI 10.1358/dot.2013.49.12.2067249; Wendt Astrid, 2014, Clin Pharmacol, V6, P1, DOI 10.2147/CPAA.S30338; Wyles David L, 2012, Top Antivir Med, V20, P139	59	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	OCT	2015	7	10					5328	5342		10.3390/v7102876		15	Virology	Virology	CV4MW	WOS:000364242200011		
J	Okunaga, S; Takasu, A; Meshii, N; Imai, T; Hamada, M; Iwai, S; Yura, Y				Okunaga, Shusuke; Takasu, Ayako; Meshii, Noritoshi; Imai, Tomoaki; Hamada, Masakagu; Iwai, Soichi; Yura, Yoshiaki			Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound	VIRUSES-BASEL			English	Article						oncolytic HSV-1; squamous cell carcinoma; ultrasound; microbubble	TARGETED-MICROBUBBLE-DESTRUCTION; DRUG-DELIVERY; IN-VIVO; THERAPY; CANCER; SONOPORATION; TRANSFECTION; CISPLATIN; ENHANCE; TUMORS	Low-intensity ultrasound is a useful method to introduce materials into cells due to the transient formation of micropores, called sonoporations, on the cell membrane. Whether oncolytic herpes simplex virus type 1 (HSV-1) can be introduced into oral squamous cell carcinoma (SCC) cells through membrane pores remains undetermined. Human SCC cell line SAS and oncolytic HSV-1 RH2, which was deficient in the (1)34.5 gene and fusogenic, were used. Cells were exposed to ultrasound in the presence or absence of microbubbles. The increase of virus entry was estimated by plaque numbers. Viral infection was hardly established without the adsorption step, but plaque number was increased by the exposure of HSV-1-inoculated cells to ultrasound. Plaque number was also increased even if SAS cells were exposed to ultrasound and inoculated with RH2 without the adsorption step. This effect was abolished when the interval from ultrasound exposure to virus inoculation was prolonged. Scanning electron microscopy revealed depressed spots on the cell surface after exposure to ultrasound. These results suggest that oncolytic HSV-1 RH2 can be introduced into SAS cells through ultrasound-mediated pores of the cell membrane that are resealed after an interval.	[Okunaga, Shusuke; Takasu, Ayako; Imai, Tomoaki; Hamada, Masakagu; Iwai, Soichi; Yura, Yoshiaki] Osaka Univ, Dept Oral & Maxillofacial Surg, Grad Sch Dent, Suita, Osaka 5650871, Japan; [Meshii, Noritoshi] Izumisano Municipal Hosp, Dent & Oral Surg, Izumisano, Osaka 5988577, Japan	Yura, Y (reprint author), Osaka Univ, Dept Oral & Maxillofacial Surg, Grad Sch Dent, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	migakedentan@mail.goo.ne.jp; a-takasu@dent.osaka-u.ac.jp; ich_liebe_dich_auch@msn.com; tomoaki@dent.osaka-u.ac.jp; hmdmskz@dent.osaka-u.ac.jp; s-iwai@dent.osaka-u.ac.jp; yura@dent.osaka-u.ac.jp			Ministry of Education, Science and Culture of Japan [24390453]	This study was supported in part by a Grant-in-Aid (No. 24390453) for Scientific Research from the Ministry of Education, Science and Culture of Japan.	Nozaki T, 2003, J GENE MED, V5, P1046, DOI 10.1002/jgm.445; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Zhou Y, 2009, ULTRASOUND MED BIOL, V35, P1756, DOI 10.1016/j.ultrasmedbio.2009.05.012; Dollery SJ, 2010, J VIROL, V84, P3759, DOI 10.1128/JVI.02573-09; Shintani M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-446; Li HL, 2009, GENE THER, V16, P1146, DOI 10.1038/gt.2009.84; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; Kodama T, 2006, ULTRASOUND MED BIOL, V32, P905, DOI 10.1016/j.ultrasmedbio.2006.03.004; Kowalczuk L, 2011, ULTRASOUND MED BIOL, V37, P1814, DOI 10.1016/j.ultrasmedbio.2011.07.010; Takaoka H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-294; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Harrington KJ, 2010, CLIN CANCER RES, V16, P4005, DOI 10.1158/1078-0432.CCR-10-0196; BOUCHER Y, 1990, CANCER RES, V50, P4478; Geers B, 2011, MOL PHARMACEUT, V8, P2244, DOI 10.1021/mp200112y; Frenkel V, 2008, ADV DRUG DELIVER REV, V60, P1193, DOI 10.1016/j.addr.2008.03.007; Zheng XZ, 2009, MOL MED REP, V2, P937, DOI 10.3892/mmr_00000195; Mehier-Humbert S, 2005, J CONTROL RELEASE, V104, P213, DOI 10.1016/j.jconrel.2005.01.007; Maeda H, 2009, J ORAL PATHOL MED, V38, P572, DOI 10.1111/j.1600-0714.2009.00759.x; Takahashi G, 2013, J GEN VIROL, V94, P726, DOI 10.1099/vir.0.044834-0; Okunaga S, 2015, CANCER GENE THER, V22, P163, DOI 10.1038/cgt.2015.3	23	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1999-4915			VIRUSES-BASEL	Viruses-Basel	OCT	2015	7	10					5610	5618		10.3390/v7102890		9	Virology	Virology	CV4MW	WOS:000364242200029		
J	Kubojima, Y; Kobayashi, I; Suzuki, Y; Tonosaki, M				Kubojima, Yoshitaka; Kobayashi, Isao; Suzuki, Youki; Tonosaki, Mario			EFFECT OF HIGH TEMPERATURE AND HIGH HUMIDITY TREATMENT ON BENDING PROPERTIES OF WOOD	WOOD AND FIBER SCIENCE			English	Article						Cedar; high humidity; high temperature; impact bending; static bending; strength	GREEN WOOD; VIBRATIONAL PROPERTIES; MOISTURE-CONTENT; HEAT-TREATMENT; WATER-VAPOR; STRENGTH; NITROGEN; STEAM	Japanese cedar (Cryptomeria Japonica D. Don) 110 x 110 x 1000-mm green boxed-heart timbers were dried under high temperature (110-140 degrees C) and high humidity (0.01-0.24 MPa gauge pressure) conditions until the weight remained unchanged. Then strength properties were examined. Wood became brittle because of the high temperature and high humidity treatment. We hypothesize that the wood was seriously damaged by hydrolysis because of the long treatment time used in this study and that the large cross-sectional area and high set gauge pressure lengthened the time of water loss from the wood. We considered viscosity and plasticity, rather than elasticity, to be the main factors that contributed to the decrease of work for rupture.	[Kubojima, Yoshitaka; Kobayashi, Isao; Suzuki, Youki] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Tonosaki, Mario] Forestry & Forest Prod Res Inst, Shikoku Res Ctr, Kochi 7808077, Japan	Kubojima, Y (reprint author), Forestry & Forest Prod Res Inst, 1 Matsunosato, Tsukuba, Ibaraki 3058687, Japan.	kubojima@ffpri.affrc.go.jp; kobayas@ffpri.affrc.go.jp; youki@ffpri.affrc.go.jp; tonosaki@ffpri.affrc.go.jp			Forestry and Forest Products Research Institute [200005]	This study was financially supported by the Research grant no. 200005 of the Forestry and Forest Products Research Institute.	Boonstra MJ, 2007, ANN FOREST SCI, V64, P679, DOI 10.1051/forest:2007048; Poncsak S, 2006, WOOD SCI TECHNOL, V40, P647, DOI 10.1007/s00226-006-0082-9; Esteves BM, 2009, BIORESOURCES, V4, P370; Tjeerdsma BF, 1998, HOLZ ROH WERKST, V56, P149, DOI 10.1007/s001070050287; STAMM AJ, 1946, IND ENG CHEM, V38, P630, DOI 10.1021/ie50438a027; Arnold M, 2010, J MATER SCI, V45, P669, DOI 10.1007/s10853-009-3984-8; Kubojima Y, 2005, HOLZFORSCHUNG, V59, P446, DOI 10.1515/HF.2005.073; Shi JL, 2007, HOLZ ROH WERKST, V65, P255, DOI 10.1007/s00107-007-0173-9; Kubojima Y, 1998, J WOOD SCI, V44, P73, DOI 10.1007/BF00521878; Kubojima Y, 2009, MOKUZAI GAKKAISHI, V55, P279; Kubojima Y, 2003, HOLZFORSCHUNG, V57, P634, DOI 10.1515/HF.2003.095; Kubojima Y, 2000, J WOOD SCI, V46, P8, DOI 10.1007/BF00779547; Kim GH, 1998, MATER ORGANISMEN, V32, P101; Kubojima Y, 2002, WOOD FIBER SCI, V34, P643; Kubojima Y, 2013, EUR J WOOD WOOD PROD, V71, P689, DOI 10.1007/s00107-013-0732-1; Volkmer T, 2014, EUR J WOOD WOOD PROD, V72, P249, DOI 10.1007/s00107-014-0777-9; Xie YJ, 2013, EUR J WOOD WOOD PROD, V71, P401, DOI 10.1007/s00107-013-0693-4; MITCHELL PH, 1988, WOOD FIBER SCI, V20, P320; Korkut S, 2008, BIORESOURCE TECHNOL, V99, P1861, DOI 10.1016/j.biortech.2007.03.038; INOUE M, 1993, WOOD FIBER SCI, V25, P224; EBIHARA T, 1985, MOKUZAI GAKKAISHI, V31, P1040; Esteves B, 2007, WOOD SCI TECHNOL, V41, P193, DOI 10.1007/s00226-006-0099-0; Hisada T, 1998, WOODWORKING MACHINER, V181, P5; Ikeda K, 2009, WOOD IND, V64, P308; Japanese Industrial Standards Committee, 2009, JAP IND STAND Z 2101; Kobayashi I, 1995, 45 ANN M JAP WOOD RE, V151; Kobayashi I, 1997, 47 ANN M JAP WOOD RE; Kobayashi I, 1996, 46 ANN M JAP WOOD RE; Kubojima Y, 2001, WOOD IND, V56, P64; Kubojima Y, 1998, WOOD IND, V53, P115; Kubojima Y, 2004, B FOR FOR PROD RES I, V3, P335; Kuch W, 1943, HOLZ ROH WERKST, V6, P157, DOI 10.1007/BF02617664; Matsumoto T, 1962, B KYUSHU U FOREST, V36, P1; Mitchell R. L., 1953, Journal of the Forest Products Research Society, V3, P38; Miyajima H., 1979, Research Bulletins, College Experiment Forests, Hokkaido University, V36, P421; Saito S, 1995, 45 ANN M JAP WOOD RE, V150; Sandberg Dick, 2013, Wood Material Science & Engineering, V8, DOI 10.1080/17480272.2012.751935; Sumi H, 1986, WOOD IND, V42, P55; Urakami H, 1985, J SOC MAT SCI JPN, V34, P949	39	0	0	SOC WOOD SCI TECHNOL	MADISON	ONE GIFFORD PINCHOT DR, MADISON, WI 53705 USA	0735-6161			WOOD FIBER SCI	Wood Fiber Sci.	OCT	2015	47	4					319	326				8	Forestry; Materials Science, Paper & Wood; Materials Science, Textiles	Forestry; Materials Science	CV1CX	WOS:000363992000001		
J	Liu, HH; Yang, L; Xu, W; Wu, ZH; Hayashi, K; Huang, QT				Liu, Honghai; Yang, Lin; Xu, Wei; Wu, Zhihui; Hayashi, Kazuo; Huang, Qiongtao			EQUILIBRIUM MOISTURE CONTENT UNDER VACUUM CONDITIONS	WOOD AND FIBER SCIENCE			English	Article						Database building; desorption isotherm; equilibrium moisture content (EMC); vacuum condition	WOOD; PRESSURE	The equilibrium moisture content (EMC) of three species was measured under vacuum conditions. Temperature, RH, and ambient pressure in a chamber were controlled during the experiments to obtain accurate EMC measurement under vacuum. Based on the experimental results and on the Hailwood Honobin model for EMC, the desorption isotherms of wood under vacuum were analyzed. EMC charts and a database under vacuum conditions were also built. Results showed that the desorption isotherms of wood under vacuum conditions also presented a typical sigmoid shape similar to the one at atmospheric conditions. The effect of ambient pressure on EMC was small at high RH ranges and became obvious with decreasing RH. Also, the EMC of ambient pressure from 53.3 to 101.3 kPa was not obvious because the difference in EMC was only 0.1-0.4%. Conversely, the effect of pressure became greater from 53.3 to 13.3 kPa and the difference in EMC was 1.2-1.9%. EMC corresponding to temperature, RH, and ambient pressure at vacuum conditions was built with the chart and equations based on experimental results from the real-time MC measurement for vacuum drying and serves as an aid in wood research and drying control under vacuum conditions.	[Liu, Honghai; Yang, Lin; Xu, Wei; Wu, Zhihui] Nanjing Forestry Univ, Coll Furniture & Ind Design, Nanjing, Jiangsu, Peoples R China; [Hayashi, Kazuo] Ehime Univ, Fac Agr, Dept Forest Resources, Matsuyama, Ehime 790, Japan; [Huang, Qiongtao] Guangdong Yihua Timber Co Ltd, Dept Res, Shantou, Japan; [Huang, Qiongtao] Guangdong Yihua Timber Co Ltd, Dev Ctr, Shantou, Japan	Liu, HH (reprint author), Nanjing Forestry Univ, Coll Furniture & Ind Design, Nanjing, Jiangsu, Peoples R China.	seaman-liu@163.com; forest-yang@163.com; xuwei@njfu.edu.cn; wzh550@sina.com; hayashi@agr.ehime-u.ac.jp; huangqt@yihua.com			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Startup Foundation of Scientific Research, Nanjing Forestry University [GXL026]; Science and Technology Innovation Project of Guangdong Yihua Timber Co., Ltd [YH-NL-2014002A]	Special acknowledgement is extended to the Yasujima Company and Francois-Xavier Maquart for their assistance. This study was financially supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Startup Foundation of Scientific Research, Nanjing Forestry University (GXL026), and the Science and Technology Innovation Project of Guangdong Yihua Timber Co., Ltd (Grant No.YH-NL-2014002A).	Lopatin VV, 2014, EUR J WOOD WOOD PROD, V72, P779, DOI 10.1007/s00107-014-0835-3; SIMPSON WT, 1987, FOREST PROD J, V37, P35; Cai YC, 2007, J WOOD SCI, V53, P1, DOI 10.1007/s10086-006-0813-4; Chen ZJ, 2009, WOOD FIBER SCI, V41, P325; Chen ZJ, 2002, WOOD FIBER SCI, V34, P553; Liu HH, 2010, J WOOD SCI, V56, P95, DOI 10.1007/s10086-009-1079-4; Xiao Hui, 2009, Journal of Forestry Research (Harbin), V20, P165, DOI 10.1007/s11676-009-0029-8; Yi SL, 2008, WOOD FIBER SCI, V40, P321; Liu HH, 2010, WOOD FIBER SCI, V42, P346; AVRAMIDIS S, 1989, WOOD SCI TECHNOL, V23, P251; FPL, 1999, WOOD HDB WOOD ENG MA; Hailwood AJ, 1946, T FARADAY SOC B, V42B, P94; Hailwood A.J., 1946, Transactions of the Faraday Society, V42B; Kollmann FFP, 1968, PRINCIPLES WOOD SCI, P189; Myojin M. Y., 2006, MOKUZAI KOGYO, V61, P105; Sasaki K., 1987, B KYUSHU U FORESTS, V57, P245; Siau JF, 1995, WOOD INFLUENCE MOIST, P22; Simpson WT, 1979, P S WOOD MOISTURE CO, P36; Simpson W. T., 1971, Forest Products Journal, V21, P48; Skaar C, 1988, WOOD WATER RELATIONS, P22; Stamm A. J., 1964, WOOD CELLULOSE SCI; Voigt H, 1940, HOLZ, V3, P364, DOI 10.1007/BF02718033; Yang L, 2014, DRY TECHNOL, V32, P1675, DOI 10.1080/07373937.2014.917426; Zhou QF, 2013, J AGR, V3, P53	24	0	0	SOC WOOD SCI TECHNOL	MADISON	ONE GIFFORD PINCHOT DR, MADISON, WI 53705 USA	0735-6161			WOOD FIBER SCI	Wood Fiber Sci.	OCT	2015	47	4					345	354				10	Forestry; Materials Science, Paper & Wood; Materials Science, Textiles	Forestry; Materials Science	CV1CX	WOS:000363992000004		
J	Ogawa, K; Sasaki, Y; Yamasaki, M; Fukuta, S				Ogawa, Keita; Sasaki, Yasutoshi; Yamasaki, Mariko; Fukuta, Satoshi			THEORETICAL ESTIMATION OF MECHANICAL PROPERTIES OF PLYWOOD-SHEATHED SHEAR WALL WITH COMBINED USE OF ADHESIVE TAPE AND WOOD DOWELS	WOOD AND FIBER SCIENCE			English	Article						Mechanical properties; theoretical estimation; shear wall; adhesive tape; wood dowel	STRENGTH; OPENINGS; RESISTANCE; BEHAVIOR	Shear walls often function as elements that provide resistance to horizontal external forces exerted on wooden frames. Many shear walls with superior strength performance have been developed for this purpose. Amidst this backdrop, we have attempted to develop a shear wall that, in addition to strength performance, decreases the time and labor required for disposal. More specifically, the authors proposed a novel "metalless" shear wall: a shear wall in which industrial double-sided adhesive tape is used to attach plywood to the framework. Also, wood dowels are used as supplementary connectors with the aim of enhancing strength performance. Unlike conventional shear walls that use nails and metal fixtures, separation at the time of disposal is unnecessary, and therefore, disposal time and labor of the wall are anticipated to be significantly decreased. Thus, this study involved demonstrating and verifying a method of theoretical analysis for the mechanical performance of these kinds of shear walls toward in-plane shear force. Specifically, this study derived a method to estimate the mechanical behavior (load-deformation angle relationship) of plywood-sheathed shear walls based on shear performance obtained from double shear tests of joint specimens with the combined use of adhesive tape and wood dowels. Also, the validity of the method was experimentally verified. The results showed that the method proposed in this study was able to estimate the mechanical behavior and mechanical properties of the newly proposed shear wall, and the validity of the method was confirmed.	[Ogawa, Keita] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan; [Sasaki, Yasutoshi; Yamasaki, Mariko] Nagoya Univ, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan; [Fukuta, Satoshi] Aichi Ctr Ind & Sci Technol, Ctr Ind Res, Kariya, Aichi, Japan	Sasaki, Y (reprint author), Nagoya Univ, Dept Biosphere Resources Sci, Nagoya, Aichi 4648601, Japan.	ogawa.keita@e.mbox.nagoya-u.ac.jp; ysasaki@nagoya-u.jp; marikoy@agr.nagoya-u.ac.jp; fukuta@aichi-inst.jp					SUGIYAMA H, 1994, MOKUZAI GAKKAISHI, V40, P280; Kallsner B, 2009, MATER STRUCT, V42, P301, DOI 10.1617/s11527-008-9463-x; EASLEY JT, 1982, J STRUCT DIV-ASCE, V108, P2460; SUGIYAMA H, 1993, MOKUZAI GAKKAISHI, V39, P75; MCCUTCHEON WJ, 1985, J STRUCT ENG-ASCE, V111, P257; SCHMIDT RJ, 1989, J STRUCT ENG-ASCE, V115, P201; SUGIYAMA H, 1993, MOKUZAI GAKKAISHI, V39, P924; TUOMI RL, 1978, J STRUCT DIV-ASCE, V104, P1131; Fukuta S, 2015, EUR J WOOD WOO UNPUB; Fukuta S, 2013, WOOD IND, V68, P55; GUPTA AK, 1985, J STRUCT ENG-ASCE, V111, P1722; Hirashima Y, 1981, MOKUZAI GAKKAISHI, V27, P141; Japan Housing and Wood Technology Center, 2008, ALL STRESS DES WOOD, P571; Kamiya F, 1981, T ARCH I JAPAN, V56, P86; Murakami M, 1999, J STRUCT CONSTR ENG, V519, P87	15	0	0	SOC WOOD SCI TECHNOL	MADISON	ONE GIFFORD PINCHOT DR, MADISON, WI 53705 USA	0735-6161			WOOD FIBER SCI	Wood Fiber Sci.	OCT	2015	47	4					421	430				10	Forestry; Materials Science, Paper & Wood; Materials Science, Textiles	Forestry; Materials Science	CV1CX	WOS:000363992000012		
J	Nakano, N; Miyauchi, M; Nakanishi, K; Saigoh, K; Mitsui, Y; Kato, A				Nakano, Naoki; Miyauchi, Masaharu; Nakanishi, Kinya; Saigoh, Kazumasa; Mitsui, Yoshiyuki; Kato, Amami			Successful Combination of Pallidal and Thalamic Stimulation for Intractable Involuntary Movements in Patients with Neuroacanthocytosis	WORLD NEUROSURGERY			English	Article						Combination; Deep brain stimulation; Globus pallidum interna; Involuntary movement; Neuroacanthocytosis; Ventralis oralis complex	DEEP BRAIN-STIMULATION; CHOREA-ACANTHOCYTOSIS; MOTOR THALAMUS; DYSTONIA; DISORDERS	OBJECTIVE: Neuroacanthocytosis (NA) is a rare neurodegenerative disease that involves severe involuntary movements including chorea, dystonia, and trunk spasms. Current treatments are not effective for these involuntary movements. Although there are a few reports on the use of deep brain stimulation to treat patients with NA, the optimal stimulation target is not yet definitive. Some authors have reported successful improvement of NA symptoms with stimulation of the globus pallidum interna, and others have reported a reduction in trunk spasm with stimulation of the ventralis oralis complex of the thalamus. We investigated whether the optimal target is well defined for NA. METHODS: We describe the effect of combination stimulation of the globus pallidum interna and the ventralis oralis complex of the thalamus in 2 patients with NA who presented with severe intractable involuntary movements. RESULTS: Gpi stimulation alone was an insufficient effect for trunk spasm and/or chorea. Vo complex stimulation given without Gpi stimulation resulted in improvement of trunk spasm after 2 weeks and might also have had an incomplete effect on involuntary movement including a chorea. The combination of Gpi and Vo complex stimulation reduced the trunk spasms and chorea. This improvement was maintained at 3 months after surgery. The Unified Huntington's Disease Rating Scale score at 1 year after surgery was lower than that before surgery. CONCLUSIONS: Gpi stimulation appears to be insufficient to control violent involuntary movements; therefore, combined GPi and Vo complex stimulation provided some moderate advantage over Gpi stimulation alone.	[Nakano, Naoki; Miyauchi, Masaharu; Nakanishi, Kinya; Kato, Amami] Kinki Univ, Sch Med, Dept Neurosurg, Osaka 589, Japan; [Saigoh, Kazumasa; Mitsui, Yoshiyuki] Kinki Univ, Sch Med, Dept Neurol, Osaka 589, Japan	Nakano, N (reprint author), Kinki Univ, Sch Med, Dept Neurosurg, Osaka 589, Japan.	nnakano@med.kindai.ac.jp					Nakano N, 2005, J NEUROSURG, V102, P1137, DOI 10.3171/jns.2005.102.6.1137; Wihl G, 2001, MOVEMENT DISORD, V16, P572, DOI 10.1002/mds.1109; Shin H, 2012, STEREOT FUNCT NEUROS, V90, P273, DOI 10.1159/000338216; Ruiz PJG, 2009, MOVEMENT DISORD, V24, P1546, DOI 10.1002/mds.22592; Thompson TP, 2000, J NEUROSURG, V92, P718, DOI 10.3171/jns.2000.92.4.0718; Guehl D, 2007, NEUROLOGY, V68, P160, DOI 10.1212/01.wnl.0000250536.81426.1a; Zittel S, 2009, J NEUROL NEUROSUR PS, V80, P811, DOI 10.1136/jnnp.2008.153262; Burbaud P, 2002, MOVEMENT DISORD, V17, P204, DOI 10.1002/mds.1260; Li P, 2012, NEUROL SCI, V33, P269, DOI 10.1007/s10072-011-0741-y; Burbaud P, 2002, NEUROLOGY, V59, P1982; Oropilla JQL, 2010, J NEUROSURG, V112, P1267, DOI 10.3171/2009.10.JNS091062; Trottenberg T, 2001, J NEUROL NEUROSUR PS, V70, P557, DOI 10.1136/jnnp.70.4.557; Edwards TC, 2012, MOVEMENT DISORD, V27, P357, DOI 10.1002/mds.23967; Foote KD, 2006, NEUROSURGERY, V58, P280, DOI 10.1227/01.NEU.0000192692.95455.FD	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2015	84	4							UNSP 1177.e1	10.1016/j.wneu.2015.06.052		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV0EI	WOS:000363920900053		
J	Shimano, H; Kondo, A; Yasuda, S; Inoue, H; Park, YT; Murao, K				Shimano, Hiroshi; Kondo, Akinori; Yasuda, Soichiro; Inoue, Hiroto; Park, Yan Tee; Murao, Kenichi			Microvascular Decompression for Hemifacial Spasm Associated with Bilateral Vertebral Artery Compression	WORLD NEUROSURGERY			English	Article						Hemifacial spasm; Microvascular decompression; Root exit zone; Vertebral artery	TRIGEMINAL NEURALGIA	BACKGROUND: Microvascular decompression (MVD) has been established as an effective treatment for hemifacial spasm (HFS). However, replacement of bilateral vertebral arteries (VAs) from the root exit zone (REZ) is difficult and requires special techniques. Reports of HFS cases associated with bilateral VA compression are quite rare. This study investigated the characteristics of these arteries and methods for safe and definite decompression. METHODS: Among 131 patients who underwent MVD for HFS, 33 patients (25.2%) had associated VA compression; 4 patients (3.1%) had bilateral VA compression. Sufficient dissection of the arachnoid membrane allowed good visualization around the REZ, and the dolichoectatic VAs were successfully transposed and fixed to the nearby dura mater in 3 cases. RESULTS: The offending arteries were bilateral VAs plus the posterior inferior cerebellar artery in 2 cases, bilateral VAs plus the anterior inferior cerebellar arteryeposterior inferior cerebellar artery in 1 case, and bilateral VAs in 1 case. The contralateral VA of the symptomatic side was more ectatic, dolichoectatic, and tougher than the ipsilateral VA in 3 patients and was difficult to remove. In 3 patients treated with the transposition method, complete resolution of spasm was experienced immediately after surgery. Minimal residual spasm occurred in 1 patient treated with the interposition method. Transient facial palsy developed in 1 case, and moderate hearing loss developed in another case. CONCLUSIONS: HFS caused by bilateral VA compression is rare; however, replacement of VAs from the REZ is not easy because such VAs are invariably dolichoectatic and tough. Treatment of such cases requires special techniques.	[Shimano, Hiroshi; Kondo, Akinori; Yasuda, Soichiro; Inoue, Hiroto; Park, Yan Tee; Murao, Kenichi] Shiroyama Hosp, Brain & Spine Surg Ctr, Dept Neurosurg, Osaka, Japan	Shimano, H (reprint author), Shiroyama Hosp, Brain & Spine Surg Ctr, Dept Neurosurg, Osaka, Japan.	shimano@shiroyama-hsp.or.jp			Shiroyama Hospital	This research was funded solely by Shiroyama Hospital.	Kondo A, 1997, NEUROSURGERY, V40, P46, DOI 10.1097/00006123-199701000-00009; Ichikawa T, 2011, NEUROSURGERY, V68, P377, DOI 10.1227/NEU.0b013e318217141c; LINSKEY ME, 1994, J NEUROSURG, V81, P1, DOI 10.3171/jns.1994.81.1.0001; Kurokawa Y, 2004, SURG NEUROL, V61, P398, DOI 10.1016/S0090-3019(03)00425-7; GARDNER WJ, 1962, J NEUROSURG, V19, P947, DOI 10.3171/jns.1962.19.11.0947; Yuan Y, 2005, CHINESE MED J-PEKING, V118, P833; Kyoshima K, 1999, NEUROSURGERY, V45, P1487, DOI 10.1097/00006123-199912000-00048; BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; Ferreira J, 2011, J NEUROSURG, V114, P1800; Hyuk JC, 2013, TURKISH NEUROSURG, V23, P241; JANNETTA PJ, 1980, ANN SURG, V192, P518, DOI 10.1097/00000658-198010000-00010; JANNETTA PJ, 1985, ARCH NEUROL-CHICAGO, V42, P800; Joo PK, 2008, J KOREAN NEUROSURG S, V44, P131; NIWA J, 1988, Neurological Surgery, V16, P621; Qinghua L, 2012, ACTA NEUROCHIR, V154, P1621; Sang SC, 2001, STEREOT FUNCT NEUROS, V77, P190; SUZUKI S, 1990, Neurologia Medico-Chirurgica, V30, P1020, DOI 10.2176/nmc.30.1020; YAMAMOTO Y, 1987, Neurological Surgery, V15, P243	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2015	84	4							UNSP 1178.E5	10.1016/j.wneu.2015.06.026		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV0EI	WOS:000363920900057		
J	Harada, K; Morita, A; Minakawa, Y; Baek, YM; Sora, S; Sugita, N; Kimura, T; Tanikawa, R; Ishikawa, T; Mitsuishi, M				Harada, Kanako; Morita, Akio; Minakawa, Yoshiaki; Baek, Young Min; Sora, Shigeo; Sugita, Naohiko; Kimura, Toshikazu; Tanikawa, Rokuya; Ishikawa, Tatsuya; Mitsuishi, Mamoru			Assessing Microneurosurgical Skill with Medico-Engineering Technology	WORLD NEUROSURGERY			English	Article						Anastomosis; Medical engineering; Microsurgery; Neurosurgery; Surgical skill assessment; Training	MICROSURGICAL SKILL	OBJECTIVES: Most methods currently used to assess surgical skill are rather subjective or not adequate for microneurosurgery. Objective and quantitative microneurosurgical skill assessment systems that are capable of accurate measurements are necessary for the further development of microneurosurgery. METHODS: Infrared optical motion tracking markers, an inertial measurement unit, and strain gauges were mounted on tweezers to measure many parameters related to instrument manipulation. We then recorded the activity of 23 neurosurgeons. The task completion time, tool path, and needle-gripping force were evaluated for three stitches made in an anastomosis of 0.7-mmartificial blood vessels. Videos of the activity were evaluated by three blinded expert surgeons. RESULTS: Surgeons who had recently done many bypass procedures demonstrated better skills. These skilled surgeons performed the anastomosis with in a shorter time, with a shorter tool path, and with a lesser force when extracting the needle. CONCLUSIONS: These results show the potential contribution of the system to microsurgical skill assessment. Quantitative and detailed analysis of surgical tasks helps surgeons better understand the key features of the required skills.	[Harada, Kanako; Minakawa, Yoshiaki; Baek, Young Min; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Dept Mech Engn, Tokyo, Japan; [Morita, Akio] Nippon Med Sch, Dept Neurol Surg, Tokyo 113, Japan; [Sora, Shigeo] Tokyo Metropolitan Police Hosp, Dept Neurosurg, Tokyo, Japan; [Kimura, Toshikazu] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo, Japan; [Tanikawa, Rokuya] Teishinkai Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Ishikawa, Tatsuya] Res Inst Brain & Blood Vessels, Dept Neurol Surg, Akita, Japan	Morita, A (reprint author), Nippon Med Sch, Dept Neurol Surg, 1-1-5 Sendagi, Tokyo 113, Japan.	amor-tky@umin.ac.jp			 [23226006];  [24592177]	This study was partially supported by the Japanese Grant-in-Aid for Scientific Research(S) 23226006 and Japanese Grant-in-Aid for Scientific Research(C) 24592177.	Kirkman MA, 2014, J NEUROSURG, V121, P228, DOI 10.3171/2014.5.JNS131766; Reiley CE, 2011, SURG ENDOSC, V25, P356, DOI 10.1007/s00464-010-1190-z; Harada K, 2011, IEEE ENG MED BIO, P6700, DOI 10.1109/IEMBS.2011.6091652; Kalu PU, 2005, MICROSURG, V25, P25, DOI 10.1002/micr.20078; Grober ED, 2010, AM J SURG, V199, P81, DOI 10.1016/j.amjsurg.2009.07.033; Horeman T, 2010, SURG ENDOSC, V24, P3102, DOI 10.1007/s00464-010-1096-9; Mason JD, 2013, SURG ENDOSC, V27, P1468, DOI 10.1007/s00464-012-2631-7; Delorme S, 2012, NEUROSURGERY, V71, P32, DOI 10.1227/NEU.0b013e318249c744; van Hove PD, 2010, BRIT J SURG, V97, P972, DOI 10.1002/bjs.7115; Trejos AL, 2014, SURG ENDOSC, V28, P2106, DOI 10.1007/s00464-014-3442-9; Lin Z, 2009, IEEE ENG MED BIO, P2320, DOI 10.1109/IEMBS.2009.5335116; McBeth Paul B, 2005, Comput Aided Surg, V10, P173, DOI 10.3109/10929080500229694	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2015	84	4					964	971		10.1016/j.wneu.2015.05.033		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV0EI	WOS:000363920900021		
J	Kitahara, I; Fukuda, A; Imamura, Y; Ikawa, M; Yokochi, T				Kitahara, Isao; Fukuda, Ataru; Imamura, Yoshiki; Ikawa, Masako; Yokochi, Tomoki			Pathogenesis, Surgical Treatment, and Cure for SUNCT Syndrome	WORLD NEUROSURGERY			English	Article						Microvascular decompression; SUNA; SUNCT; Typical trigeminal neuralgia	UNILATERAL NEURALGIFORM HEADACHE; DEEP BRAIN-STIMULATION; MICROVASCULAR DECOMPRESSION; CONJUNCTIVAL INJECTION; TRIGEMINAL NEURALGIA; TEARING SUNCT; COMPRESSION; FEATURES; NERVE	BACKGROUND: Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) are characterized by attacks of moderate to severe stabbing pain, strictly unilateral, with periorbital or temporal distribution, associated with cranial autonomic symptoms, such as lacrimation and redness of the ipsilateral eye. METHODS: To obtain mechanistic insights into the pathogenesis of SUNCT syndrome, more than 800 cases treated in our institution during the last 7 years were retrospectively reviewed. Two patients showed typical autonomic symptoms of SUNCT. RESULTS: Magnetic resonance imaging suggested potential compression of the trigeminal nerve by the intracranial artery in these cases and complete remission was achieved by microvascular decompression. CONCLUSIONS: Microvascular decompression provides an appropriate therapeutic choice if vascular compression of the trigeminal nerve is identified. From our 2 cases, we propose that, in some cases of SUNCT diagnosed previously, characteristic symptoms were induced by compression of the side surface of the first branch of the trigeminal nerve at the root exit zone by the intracranial artery.	[Kitahara, Isao; Fukuda, Ataru] Chiba Tokushukai Hosp, Dept Neurosurg, Funabashi, Chiba, Japan; [Imamura, Yoshiki] Nihon Univ, Sch Dent, Dept Oral Diagnost Sci, Tokyo 101, Japan; [Ikawa, Masako] Shizuoka Shimizu Municipal Hosp, Dept Oral Surg, Shimizu, Shizuoka, Japan; [Yokochi, Tomoki] Chiba Tokushukai Hosp, Dept Clin Res, Funabashi, Chiba, Japan	Kitahara, I (reprint author), Chiba Tokushukai Hosp, Dept Neurosurg, Funabashi, Chiba, Japan.	isao.k@tokushukai.jp					Lambru G, 2013, NEUROL SCI, V34, pS75, DOI 10.1007/s10072-013-1366-0; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; Irimia P, 2010, CEPHALALGIA, V30, P626, DOI 10.1111/j.1468-2982.2009.01943.x; Cohen AS, 2006, BRAIN, V129, P2746, DOI 10.1093/brain/aw1202; Lyons MK, 2009, J NEUROSURG, V110, P279, DOI 10.3171/2008.4.17493; Black DF, 2002, CEPHALALGIA, V22, P201, DOI 10.1046/j.1468-2982.2002.00348.x; Gardella L, 2001, CEPHALALGIA, V21, P996, DOI 10.1046/j.1468-2982.2001.00252.x; JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159; Leone M, 2005, ANN NEUROL, V57, P924, DOI 10.1002/ana.20507; Bartsch T, 2011, CEPHALALGIA, V31, P1405, DOI 10.1177/0333102411409070; Favoni V, 2013, CEPHALALGIA, V33, P1337, DOI 10.1177/0333102413494273; Williams MH, 2008, J CLIN NEUROSCI, V15, P526, DOI 10.1016/j.jocn.2006.09.006; Williams M, 2010, J NEUROL NEUROSUR PS, V81, P992, DOI 10.1136/jnnp.2009.182824; Headache Classification Committee of the International Headache Society (IHS), 2013, CEPHALALGIA, V33, P629, DOI DOI 10.1177/0333102413485658; Sebastian S, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0332-0	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2015	84	4					1080	1083		10.1016/j.wneu.2015.05.024		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CV0EI	WOS:000363920900036		
J	Sato, M; Yuyama, K; Li, XC; Ashikawa, N; Sagara, A; Yoshida, N; Chikada, T; Oya, Y				Sato, Misaki; Yuyama, Kenta; Li, Xiao-Chun; Ashikawa, Naoko; Sagara, Akio; Yoshida, Naoaki; Chikada, Takumi; Oya, Yasuhisa			EFFECT OF HEATING TEMPERATURE ON DEUTERIUM RETENTION BEHAVIOR FOR HELIUM/CARBON IMPLANTED TUNGSTEN	FUSION SCIENCE AND TECHNOLOGY			English	Article							IRRADIATION	The effect of heating temperature on deuterium (D) retention behavior for helium (He+) / carbon (C+) implanted tungsten (W) was studied. It was found that D retention behavior for He+ implanted W was not limited by the size of the He bubbles. The microstructure observation showed that the large helium bubbles were formed near the surface for He+ implanted W at 1173 K, suggesting that the D retention was reduced by the growth of the helium bubbles. In addition, to evaluate the effect of implantation ion species at high temperature, D retention behavior for He+ implanted W at 1173 K was compared with that for C+ implanted W at 673 K It is concluded that the D retention depends on ion species, which makes different kinds of damages like He bubbles for He+ implantation and vacancy-ion complex (voids) for C+ implantation.	[Sato, Misaki; Yuyama, Kenta; Li, Xiao-Chun; Chikada, Takumi; Oya, Yasuhisa] Shizuoka Univ, Grad Sch Sci, Suruga Ku, Shizuoka 4228529, Japan; [Ashikawa, Naoko; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Yoshida, Naoaki] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Sato, M (reprint author), Shizuoka Univ, Grad Sch Sci, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	oya.yasuhisa@shizuoka.ac.jp	Kyushu, RIAM/F-4018-2015		NIFS collaboration program [NIFS14KEMF059]; Instrumental Research Support Office, Research Institute of Green Science and Technology at Shizuoka University	This study was supported by NIFS collaboration program, NIFS14KEMF059. The TEM observation was performed under the collaboration program at the Institute of Applied Mechanics, Kyushu University. This study was also supported by Instrumental Research Support Office, Research Institute of Green Science and Technology at Shizuoka University.	Kim IS, 2000, J NUCL MATER, V280, P264, DOI 10.1016/S0022-3115(00)00066-0; Baldwin MJ, 2009, J NUCL MATER, V390-91, P886, DOI 10.1016/j.jnucmat.2009.01.247; Ueda Y, 2009, J NUCL MATER, V390-91, P44, DOI 10.1016/j.jnucmat.2009.01.042; Oya Y, 2011, J NUCL MATER, V415, pS701, DOI 10.1016/j.jnucmat.2010.09.058; Sharma SK, 2012, FUSION ENG DES, V87, P77, DOI 10.1016/j.fusengdes.2011.10.001; Miura R, 2013, FUSION ENG DES, V88, P1827, DOI 10.1016/j.fusengdes.2013.04.051; Ogorodnikova OV, 2003, J NUCL MATER, V313, P469, DOI 10.1016/S0022-3115(02)01375-2; Luo GN, 2006, FUSION ENG DES, V81, P957, DOI 10.1016/j.fusengdes.2005.09.023; ELEVELD H, 1992, J NUCL MATER, V191, P433; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					531	534		10.13182/FST14-971		4	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400013		
J	Nogami, S; Yamamoto, K; Fukuda, M; Hasegawa, A				Nogami, S.; Yamamoto, K.; Fukuda, M.; Hasegawa, A.			FATIGUE CRACK INITIATION OF F82H REDUCED ACTIVATION FERRITIC/MARTENSITIC STEEL	FUSION SCIENCE AND TECHNOLOGY			English	Article							LOW-CYCLE FATIGUE; MECHANICAL-PROPERTIES; HELIUM IMPLANTATION; ALPHA-IRON; 573 K; MICROSTRUCTURE; IRRADIATION; BEHAVIOR; HFIR; DEFORMATION	To improve the fatigue life assessment of the relatively thin wall structure of the fusion reactor blanket, the fatigue micro-crack initiation behavior of the F82H steel at room temperature was investigated. The micro-crack initiation life was approximately 20-30 % of the fatigue life. The crack initiation was observed at the prior austenitic grain boundary, the packet boundary, the block boundary, and the inside of the block structure. The majority was the transgranular crack initiation, which exceeded 90 % of the all. The effect of the irradiation damage (irradiation hardening) was only a shortening of the micro-crack initiation life. No change of the micro-crack initiation sites and their ratio were observed.	[Nogami, S.; Yamamoto, K.; Fukuda, M.; Hasegawa, A.] Tohoku Univ, Sendai, Miyagi 9808579, Japan	Nogami, S (reprint author), Tohoku Univ, Sendai, Miyagi 9808579, Japan.	shuhei.nogami@qse.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23760803]	The authors are grateful to Dr. K. Kobayashi of Tohoku University for his help with the EBSD work and also grateful to Dr. S. Matsuyama and Mr. Fujisawa of Tohoku University for their help with the irradiation test. This study was supported by the Grant-in-aid for young scientists (B) 23760803 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Sacksteder I, 2011, J NUCL MATER, V417, P127, DOI 10.1016/j.jnucmat.2011.02.012; Materna-Morris E, 2011, FUSION ENG DES, V86, P2607, DOI 10.1016/j.fusengdes.2011.03.060; Tanigawa H, 2003, FUSION SCI TECHNOL, V44, P206; LANKFORD J, 1984, METALL TRANS A, V15, P1579, DOI 10.1007/BF02657797; Sommer C, 1998, ACTA MATER, V46, P1537, DOI 10.1016/S1359-6454(97)00363-7; Hirose T, 2013, J NUCL MATER, V442, pS557, DOI 10.1016/j.jnucmat.2013.05.063; Nogami S, 2013, J NUCL MATER, V441, P125, DOI 10.1016/j.jnucmat.2013.05.051; Hashimoto N, 2003, FUSION SCI TECHNOL, V44, P490; Murase Y, 2011, J NUCL MATER, V417, P120, DOI 10.1016/j.jnucmat.2010.12.049; Kim SW, 2009, J NUCL MATER, V386-88, P529, DOI 10.1016/j.jnucmat.2008.12.168; Peng L, 2011, J NUCL MATER, V417, P996, DOI 10.1016/j.jnucmat.2010.12.208; Gaganidze E, 2011, J NUCL MATER, V417, P93, DOI 10.1016/j.jnucmat.2010.12.047; Ando M, 2009, J NUCL MATER, V386-88, P315, DOI 10.1016/j.jnucmat.2008.12.123; MUGHRABI H, 1981, INT J FRACTURE, V17, P193, DOI 10.1007/BF00053520; EDWARDS L, 1994, ACTA METALL MATER, V42, P1423, DOI 10.1016/0956-7151(94)90161-9; Nogami S, 2011, J NUCL SCI TECHNOL, V48, P60, DOI 10.3327/jnst.48.60; Hirose T, 2011, J NUCL MATER, V417, P108, DOI 10.1016/j.jnucmat.2010.12.044; Enoeda M, 2003, NUCL FUSION, V43, P1837, DOI 10.1088/0029-5515/43/12/026; Nishio S, 2006, FUSION ENG DES, V81, P1271, DOI 10.1016/j.fusengdes.2005.08.100; Hasegawa A, 2009, J NUCL MATER, V386-88, P241, DOI 10.1016/j.jnucmat.2008.12.102; Jitsukawa S, 2007, J NUCL MATER, V367, P539, DOI 10.1016/j.jnucmat.2007.03.202; Akiba M, 2009, FUSION ENG DES, V84, P329, DOI 10.1016/j.fusengdes.2009.01.057; Tanigawa H, 2004, J NUCL MATER, V329, P283, DOI 10.1016/j.jnucmat.2004.04.053; Jia XJ, 2004, J NUCL MATER, V329, P309, DOI 10.1016/j.jnucmat.2004.04.048; Bertsch J, 2000, J NUCL MATER, V283, P832, DOI 10.1016/S0022-3115(00)00313-5; Gaganidze E, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/8/083012; Hirose T, 2002, J NUCL MATER, V307, P304, DOI 10.1016/S0022-3115(02)01199-6; Miwa Y, 2004, J NUCL MATER, V329, P1098, DOI 10.1016/j.jnucmat.2004.04.029; Schaeublin R, 2002, J NUCL MATER, V307, P197, DOI 10.1016/S0022-3115(02)01034-6; SHIBA K., 2002, INT TOWN ADV FERRITI; Stolarz J, 1997, MAT SCI ENG A-STRUCT, V234, P861, DOI 10.1016/S0921-5093(97)00408-5; Tanigawa H, 2002, J NUCL MATER, V307, P293, DOI 10.1016/S0022-3115(02)01002-4	32	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					601	606		10.13182/FST14-927		6	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400024		
J	Nogami, S; Guan, W; Fukuda, M; Tanigawa, H; Hasegawa, A				Nogami, S.; Guan, W.; Fukuda, M.; Tanigawa, H.; Hasegawa, A.			EFFECT OF NON-UNIFORM DEFORMATION ON LOW CYCLE FATIGUE PROPERTIES OF ELECTRON BEAM WELD JOINT OF F82H STEEL	FUSION SCIENCE AND TECHNOLOGY			English	Article								To improve the fatigue properties evaluation of the joint region of the fusion reactor blanket, the effect of the non-uniform distribution of the microstructure and strength on the fatigue properties of the electron beam weld joint of the F82H steel was investigated by the fatigue test and the numerical simulation of the deformation under the test. The fatigue life of the joint was approximately 10-20 % of that of the base metal. The fracture under the fatigue test occurred around the over-tempered heat affected zone (the region with the lowest hardness). One of the reasons of the shorter fatigue life of the joint could be the higher crack growth rate induced by the peak strain around the over-tempered heat affected zone due to the non-uniform deformation.	[Nogami, S.; Guan, W.; Fukuda, M.; Hasegawa, A.] Tohoku Univ, Sendai, Miyagi 9808579, Japan; [Tanigawa, H.] Japan Atom Energy Agcy, Rokkasho 0393212, Japan	Nogami, S (reprint author), Tohoku Univ, Sendai, Miyagi 9808579, Japan.	shuhei.nogami@qse.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23760803]	This study was supported by the Grant-in-aid for young scientists (B) 23760803 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Enoeda M, 2006, FUSION ENG DES, V81, P415, DOI 10.1016/j.fusengdes.2005.08.097; Nogami S, 2013, J NUCL MATER, V441, P125, DOI 10.1016/j.jnucmat.2013.05.051; Tanigawa H, 2008, FUSION ENG DES, V83, P1471, DOI 10.1016/j.fusengdes.2008.07.024; Sawai T, 2000, J NUCL MATER, V283, P657, DOI 10.1016/S0022-3115(00)00089-1; [Anonymous], 1986, ANN BOOK ASTM, P227; Nakata T, 2012, FUSION ENG DES, V87, P589, DOI 10.1016/j.fusengdes.2012.01.048; NOGAMI S., 2010, J PLASMA FUSION RES, V9, P232	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					607	611		10.13182/FST14-929		5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400025		
J	Satake, S; Sawamura, H; Kimura, M; Kunugi, T				Satake, S.; Sawamura, H.; Kimura, M.; Kunugi, T.			DNS OF TURBULENT HEAT TRANSFER IN PIPE FLOW VIA THE HELIOS SUPERCOMPUTER SYSTEM AT IFERC-CSC	FUSION SCIENCE AND TECHNOLOGY			English	Article							TRANSVERSE MAGNETIC-FIELD	In this work, a simulation is presented that plays an important part in estimating the characteristics of cooling in a blanket used for high-temperature plasma in a fusion reactor. The objective of this study is to perform a large-scale direct numerical simulation (DNS) on the heat transfer of turbulent flow of the coolant materials assumed gas flow. The coolant flow conditions in a fusion reactor are assumed to be defined by a Reynolds number of a higher order. To investigate the effect of Reynolds number on the scalar structures, the Reynolds number based on a friction velocity and a pipe radius was set to be Re tau = 1050. The numbers of the computational grid points used for Re tau= 1050 were 2048 x 512 x 768 in the z(-), r(-), and phi-directions, respectively. In this work, details on the turbulent quantities such as the mean flow, turbulent stresses, turbulent kinetic energy budget, and the turbulent statistics were obtained.	[Satake, S.; Sawamura, H.; Kimura, M.] Tokyo Univ Sci, Katsushika Ku, Tokyo 1258585, Japan; [Kunugi, T.] Kyoto Univ, Nishikyo Ku, Kyoto, Japan	Satake, S (reprint author), Tokyo Univ Sci, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	satake@te.noda.tus.ac.jp					Satake S, 2000, LECT NOTES COMPUT SC, V1940, P514; Smolentsev S, 2002, INT J ENG SCI, V40, P693, DOI 10.1016/S0020-7225(01)00088-X; REED CB, 1978, J FLUID MECH, V89, P147, DOI 10.1017/S0022112078002517; Wu XH, 2008, J FLUID MECH, V608, P81, DOI 10.1017/S0022112008002085; GARDNER RA, 1971, J FLUID MECH, V47, P737, DOI 10.1017/S0022112071001344; Wong CPC, 2004, FUSION ENG DES, V72, P245, DOI 10.1016/j.fusengdes.2004.07.011	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					640	643		10.13182/FST14-956		4	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400031		
J	Ando, M; Nozawa, T; Hirose, T; Tanigawa, H; Wakai, E; Stoller, RE; Myers, J				Ando, M.; Nozawa, T.; Hirose, T.; Tanigawa, H.; Wakai, E.; Stoller, R. E.; Myers, J.			EFFECT OF HELIUM ON IRRADIATION CREEP BEHAVIOR OF B-DOPED F82H IRRADIATED IN HFIR	FUSION SCIENCE AND TECHNOLOGY			English	Article							ACTIVATION FERRITIC STEELS; RESEARCH-AND-DEVELOPMENT; FERRITIC/MARTENSITIC STEELS; BORON	The diameter of pressurized tubes of F82H and B-doped F82H irradiated up to similar to 6 dpa have been measured by a non-contacting laser profilometer. The irradiation creep strains of F82H irradiated at 573 and 673K were almost linearly dependent on the effective stress level for stresses below 260 MPa and 170 MPa, respectively. The creep strain of (BN)-B-10-F82H was similar to that of F82H IEA at each effective stress level except 294 MPa at 573K irradiation. For 673K irradiation, the creep strain of some (BN)-B-10-F82H tubes was larger than that of F82H tubes. However, the generation of similar to 300 appm He did not cause a large difference in the irradiation creep behavior at 6 dpa.	[Ando, M.; Nozawa, T.; Hirose, T.; Tanigawa, H.; Wakai, E.] Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan; [Stoller, R. E.; Myers, J.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	Ando, M (reprint author), Japan Atom Energy Agcy, Rokkasho, Aomori 0393212, Japan.	ando.masami@jaea.go.jp			Office of Fusion Energy Sciences, U.S. Department of Energy and Japan Atomic Energy Agency [DE-AC05-00OR22725]; UT-Battelle, LLC	This research was sponsored by the Office of Fusion Energy Sciences, U.S. Department of Energy and Japan Atomic Energy Agency, under contract DE-AC05-00OR22725 with UT-Battelle, LLC. The authors would like to thank the assistance of Mr. Patrick S. Bishop and hot cell operators of the ORNL Building 3025 hot cell facility to the experimental work.	Ando M, 2007, J NUCL MATER, V367, P122, DOI 10.1016/j.jnucmat.2007.03.157; Wakai E, 2003, J NUCL MATER, V318, P267, DOI 10.1016/S0022-3115(03)00122-3; Tanigawa H, 2011, J NUCL MATER, V417, P9, DOI 10.1016/j.jnucmat.2011.05.023; Enoeda M, 2014, FUSION ENG DES, V89, P1131, DOI 10.1016/j.fusengdes.2014.01.035; Wakai E, 2000, J NUCL MATER, V283, P799, DOI 10.1016/S0022-3115(00)00268-3; Wakai E, 2010, J NUCL MATER, V398, P64, DOI 10.1016/j.jnucmat.2009.10.011; Kimura A, 2007, J NUCL MATER, V367, P60, DOI 10.1016/j.jnucmat.2007.03.013; GILBERT ER, 1977, J ENG MATER-T ASME, V99, P168; Hashimoto N, 2002, J NUCL MATER, V307, P222, DOI 10.1016/S0022-3115(02)01183-2; Kimura A, 2002, J NUCL MATER, V307, P521, DOI 10.1016/S0022-3115(02)01211-4; KOHYAMA A, 1994, J NUCL MATER, V212, P751, DOI 10.1016/0022-3115(94)90157-0; McDuffee J.L., 2010, SEMI ANN PROGR REPOR, V49, P110; Okubo N, 2007, J NUCL MATER, V367, P107, DOI 10.1016/j.jnucmat.2007.03.159; PUIGH R. J., 1986, ASTM, P19; Shiba K, 2000, J NUCL MATER, V283, P474, DOI 10.1016/S0022-3115(00)00369-X; Wakai E, 2002, J NUCL MATER, V307, P203, DOI 10.1016/S0022-3115(02)01261-8; Wakai E., 2015, J PLASMA FUSION RES, V11, P104; Yamamoto N, 2002, J NUCL MATER, V307, P217, DOI 10.1016/S0022-3115(02)01182-0	18	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					648	651		10.13182/FST14-963		4	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400033		
J	Yokomine, T; Yoshida, T; Kunugi, T; Wakai, E				Yokomine, Takehiko; Yoshida, Takahide; Kunugi, Tomoaki; Wakai, Eiichi			NEUTRONIC ANALYSIS OF IFMIF HIGH FLUX TEST MODULE FOR HIGH TEMPERATURE IRRADIATION	FUSION SCIENCE AND TECHNOLOGY			English	Article								The Japanese design of HFTM, so-called HFTM-H, aims to be used for high temperature irradiation test up to 1000 degrees C for SiC/SiCf composite and refractory materials. During irradiation test periods in the IFMIF, irradiated materials must be maintained at constant temperatures. It is confirmed that the conceptual design of HFTM-H can satisfy) the requirement for displacement per atom (dpa). The gas production rate to dpa ratio, which is important requirement for the design of HFTM-H as well as dpa is calculated. Nuclear heating distribution in HFTM-H is also predicted, which is served to temperature control design and structural analysis.	[Yokomine, Takehiko; Yoshida, Takahide; Kunugi, Tomoaki] Kyoto Univ, Nishikyo Ku, Kyoto 6158540, Japan; [Wakai, Eiichi] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Yokomine, T (reprint author), Kyoto Univ, Nishikyo Ku, Kyoto 6158540, Japan.	yokomine@nucleng.kyoto-u.ac.jp					Kondo K, 2012, FUSION ENG DES, V87, P983, DOI 10.1016/j.fusengdes.2012.02.060; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Simakov SP, 2012, FUSION SCI TECHNOL, V62, P233; Yamamoto M, 2013, FUSION ENG DES, V88, P746, DOI 10.1016/j.fusengdes.2013.03.062; IFMIF International Team, 2004, IFMIF COMPR DES REP	5	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					657	661		10.13182/FST14-967		5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400035		
J	Katayama, K; Ushida, H; Matsuura, H; Fukada, S; Goto, M; Nakagawa, S				Katayama, Kazunari; Ushida, Hiroki; Matsuura, Hideaki; Fukada, Satoshi; Goto, Minoru; Nakagawa, Shigeaki			EVALUATION OF TRITIUM CONFINEMENT PERFORMANCE OF ALUMINA AND ZIRCONIUM FOR TRITIUM PRODUCTION IN A HIGH-TEMPERATURE GAS-COOLED REACTOR FOR FUSION REACTORS	FUSION SCIENCE AND TECHNOLOGY			English	Article							HYDROGEN DIFFUSION; PERMEATION; SOLUBILITY; DEUTERIUM; GTHTR300; OXIDE	Tritium production utilizing nuclear reactions by neutron and lithium in a high-temperature gas-cooled reactor is attractive for development of a fusion reactor. From viewpoints of tritium safety and recovery efficiency, tritium confinement is an important issue. It is known that alumina has high resistance for gas permeation. In this study, hydrogen permeation experiments in commercial alumina tubes were conducted and hydrogen permeability, diffusivity and solubility were evaluated By using obtained data, tritium permeation behavior from an Al2O3-coated Li-compound particle was simulated Additionally, by using literature data for hydrogen behavior in zirconium, an effect of Zr incorporation into an Al2O3 coating on tritium permeation was discussed It was indicated that the majority of produced tritium was released through the Al2O3 coating above 500 degrees C. However, it is expected that total tritium leak is suppressed to below 0.67 % of total tritium produced at 500 degrees C by incorporating Zr fine particles into the inside of Al2O3 coating, assuming tritium pressure inside particle is kept at the plateau pressure of the Zr hydride generation reaction.	[Katayama, Kazunari; Ushida, Hiroki; Fukada, Satoshi] Kyushu Univ, Dept Adv Energy Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Matsuura, Hideaki] Kyushu Univ, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 8190395, Japan; [Goto, Minoru; Nakagawa, Shigeaki] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan	Katayama, K (reprint author), Kyushu Univ, Dept Adv Energy Engn Sci, 6-1 Kasugakouen, Kasuga, Fukuoka 8168580, Japan.	kadzu@nucl.kyushu-u.ac.jp			JSPS KAKENHI [25630421, 15H04230]	This work was supported by JSPS KAKENHI Grant-in-Aid for Challenging Exploratory Research 25630421 and JSPS KAKENHI Grant-in-Aid for Scientific Research (B) 15H04230.	CAUSEY RA, 1979, CARBON, V17, P323, DOI 10.1016/0008-6223(79)90003-4; Matsuura H, 2013, FUSION ENG DES, V88, P2219, DOI 10.1016/j.fusengdes.2013.05.022; Serra E, 2005, J AM CERAM SOC, V88, P15, DOI 10.1111/j.1551-2916.2004.00003.x; Yan X, 2003, NUCL ENG DES, V222, P247, DOI 10.1016/S0029-5493(03)00030-X; ROBERTS RM, 1979, J AM CERAM SOC, V62, P495, DOI 10.1111/j.1151-2916.1979.tb19114.x; NISHIKAWA M, 1995, FUSION TECHNOL, V28, P1233; Kunitomi K, 2004, NUCL ENG DES, V233, P309, DOI 10.1016/j.nucengdes.2004.08.026; Chikada T, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/6/063023; Matsuura H, 2012, NUCL ENG DES, V243, P95, DOI 10.1016/j.nucengdes.2011.12.008; Yao ZY, 2000, J NUCL MATER, V283, P1287, DOI 10.1016/S0022-3115(00)00349-4; Shiraishi T, 1998, J NUCL MATER, V254, P205, DOI 10.1016/S0022-3115(97)00362-0; ROY SK, 1967, J AM CERAM SOC, V50, P435, DOI 10.1111/j.1151-2916.1967.tb15152.x; FOWLER JD, 1977, J AM CERAM SOC, V60, P155, DOI 10.1111/j.1151-2916.1977.tb15493.x; MAZZOLAI FM, 1976, J LESS-COMMON MET, V49, P323, DOI 10.1016/0022-5088(76)90044-8; MAJER G, 1994, J PHYS-CONDENS MAT, V6, P2935, DOI 10.1088/0953-8984/6/15/015; Nishikawa M, 2012, FUSION ENG DES, V87, P466, DOI 10.1016/j.fusengdes.2011.12.022; YAMANAKA S, 1989, J NUCL MATER, V167, P231, DOI 10.1016/0022-3115(89)90446-7; Yamashita K, 1998, J ATOM ENERG SOC JPN, V40, P65; BUXBAUM RE, 1992, J NUCL MATER, V189, P183, DOI 10.1016/0022-3115(92)90531-O; Levchuk D, 2004, J NUCL MATER, V328, P103, DOI 10.1016/j.jnucmat.2004.03.008; GOODE Jr W.D., 1959, BMI1373 USAEC; SOMENO M., 1960, J JPN I MET, V24, P249; Zuzek E., 1990, B ALLOY PHASE DIAGRA, V11, P385, DOI 10.1007/BF02843318	23	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					662	668		10.13182/FST14-968		7	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400036		
J	Shishido, H; Yusa, N; Hashizume, H; Ishii, Y; Ohtori, N				Shishido, Hiroki; Yusa, Noritaka; Hashizume, Hidetoshi; Ishii, Yoshiki; Ohtori, Norikazu			EVALUATION OF PHYSICAL PROPERTIES OF THE MOLTEN SALT MIXTURES FLINABE FOR A FUSION BLANKET SYSTEM USING MOLECULAR DYNAMICS SIMULATION	FUSION SCIENCE AND TECHNOLOGY			English	Article							1ST-PRINCIPLES DESCRIPTION; LIQUID BEF2; LIF	This study evaluates the physical properties of the molten salt Flinabe, using molecular dynamics simulations to discuss its applicability to a fusion blanket system. More specifically, the simulations calculate the density and viscosity of Flinabe to facilitate further discussion of the applicability from the viewpoint of the heat removal of the first wall. The results of the simulations are compared with data reported in earlier publications, which support the validity of the simulations. This study reveals that Flinabe tends to have lower viscosity than Flibe even when they contain almost the same BeF2. Analyzing the results of the simulations confirms that the degree of polymerization in Flinabe correlates with its viscosity, as that in Flibe does. The analyses also revealed, however, that the correlation in the case of Flibe is not directly applicable to the case of Flinabe.	[Shishido, Hiroki; Yusa, Noritaka; Hashizume, Hidetoshi] Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ishii, Yoshiki] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Ohtori, Norikazu] Niigata Univ, Fac Sci, Dept Chem, Nishi Ku, Niigata 9502181, Japan	Shishido, H (reprint author), Tohoku Univ, Grad Sch Engn, Dept Quantum Sci & Energy Engn, Aoba Ku, 6-6-01-2 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	hshishi@karma.qse.tohoku.ac.jp					MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Sagara A, 2014, FUSION ENG DES, V89, P2114, DOI 10.1016/j.fusengdes.2014.02.076; Heaton RJ, 2006, J PHYS CHEM B, V110, P11454, DOI 10.1021/jp061000+; Salanne M, 2011, MOL PHYS, V109, P2299, DOI 10.1080/00268976.2011.617523; Yeh IC, 2004, J PHYS CHEM B, V108, P15873, DOI 10.1021/jp0477147; Aguado A, 2003, J CHEM PHYS, V119, P7471, DOI 10.1063/1.1605941; Sagara A, 2005, FUSION SCI TECHNOL, V47, P524; McDonald JM, 2005, FUSION SCI TECHNOL, V47, P554; Madden PA, 1996, CHEM SOC REV, V25, P339, DOI 10.1039/cs9962500339; Salanne M, 2006, J PHYS CHEM B, V110, P11461, DOI 10.1021/jp061002u; BENES O., 2013, MOLTEN SALTS CHEM LA, P63; CANTOR S., 1973, ORNLTM4308; CANTOR S., 1968, ORNLTM2316, DOI [http://dx.doi.org/10.2172/4492893, DOI 10.2172/4492893]; Hansen J.-P., 2006, THEORY SIMPLE LIQUID; Powers W.D., 1963, NUCL SCI ENG, V71, P200, DOI DOI 10.13182/NSE63-5; Salanne M, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1143-9; Tildesley D. J., 1987, COMPUTER SIMULATIONS; TOENNIES J. P., 1984, J CHEM PHYS, V80, P3726, DOI [http://dx.doi.org/10.1063/L447150, DOI 10.1063/1.447150]; WILLIAMS D. F., 2006, ORNLTN200612, DOI [http://dx.doi.org/10.2172/885975, DOI 10.2172/885975]	19	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					669	673		10.13182/FST14-975		5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400037		
J	Fukuda, M; Nogami, S; Yabuuchi, K; Hasegawa, A; Muroga, T				Fukuda, Makoto; Nogami, Shuhei; Yabuuchi, Kiyohiro; Hasegawa, Akira; Muroga, Takeo			ANISOTROPY IN THE MECHANICAL PROPERTIES OF POTASSIUM AND RHENIUM DOPED TUNGSTEN ALLOY PLATES FOR FUSION REACTOR APPLICATIONS	FUSION SCIENCE AND TECHNOLOGY			English	Article								The effects of K-bubble dispersion and 3 wt.% Re addition on the tensile properties and their anisotropy in W were investigated in this work. K-doped W and K-doped W-3%Re showed similar to 45 and similar to 65% higher tensile strengths than pure W, respectively. The ultimate tensile strength and its temperature dependence in pure W, K-doped W, and K-doped W-3%Re showed anisotropy. However, the effects of K-bubble dispersion and 3% Re addition on the anisotropic tensile strength were not clearly observed. K-doped W and K-doped W-3%Re showed better deformation abilities than pure W K-doped W-3%Re showed better tensile properties than pure W under non-irradiation conditions used in this work. Since irradiation hardening is suppressed by adding 3% Re, K-doped W-3%Re is expected to be more advantageous as a plasma facing material in a fusion reactor than pure W and K-doped W	[Fukuda, Makoto; Nogami, Shuhei; Yabuuchi, Kiyohiro; Hasegawa, Akira] Tohoku Univ, Sendai, Miyagi 9808579, Japan; [Muroga, Takeo] Natl Inst Fus Sci, Gifu 5095292, Japan	Fukuda, M (reprint author), Tohoku Univ, 6-6-01-2 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	fukuda@jupiter.qse.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24246151]; Grant-in-Aid for JSPS Fellows [26-3841]; NIFS LHD collaboration research program [NIFS11KOBF019]	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 24246151, Grant-in-Aid for JSPS Fellows (26-3841), and NIFS LHD collaboration research program (NIFS11KOBF019). The tensile tests were carried out at the International Research Center for Nuclear Materials Science of the Institute for Materials Research (IMR), Tohoku University, Japan. The authors thank Dr. H. Kurishita, Dr. S. Matsuo, and the IMR staff for their assistance.	KLOPP WD, 1975, J LESS-COMMON MET, V42, P261, DOI 10.1016/0022-5088(75)90046-6; Fukuda M, 2014, FUSION ENG DES, V89, P1033, DOI 10.1016/j.fusengdes.2014.02.062; Toschi R, 2001, FUSION ENG DES, V56-57, P163, DOI 10.1016/S0920-3796(01)00577-4; SNOW DB, 1979, METALL TRANS A, V10, P815, DOI 10.1007/BF02658299; ESCOURBIAC F., 2012, 24 IAEA FUS EN C SAN; HASEGAWA A., 2014, 25 IAEA FUS EN C SAI; Romaner L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195503	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					690	693		10.13182/FST14-998		4	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400041		
J	Tanaka, T; Muta, H; Hishinuma, Y; Tamura, H; Muroga, T; Sagara, A				Tanaka, Teruya; Muta, Hiroaki; Hishinuma, Yoshimitsu; Tamura, Hitoshi; Muroga, Takeo; Sagara, Akio			APPLICABILITY OF HYDRIDE MATERIALS FOR RADIATION SHIELDING IN HELICAL REACTOR FFHR-D1	FUSION SCIENCE AND TECHNOLOGY			English	Article							DESIGN; BLANKET; BOROHYDRIDE	Performance and applicability of hydride shielding materials are investigated in the helical reactor FFHR-d1 design. Performance of ZrH2 and TiH2 in fast neutron shielding are close to that of WC, which is most effective among candidate materials, for both in-vessel and out-vessel use. The investigation confirms that neutron shielding performance of a two-layered terrific steel (FS)/ZrH2 or TiH2 shield is similar to that of a one-layered ZrH2 or TiH2 shield with the same total thickness. This shielding property is an important feature to maintain consistency with the structure design of FFHRd1. In attenuation of direct neutrons from the core plasma in a bending duct, the hydride duct walls show superior performance compared with FS + B4C and WC duct walls. While controls for temperature (at <300 degrees C) and hydrogen concentration in the coolant gas would be required particularly for in-vessel use, the lower weight densities and quick decay of contact dose rates compared with other candidate materials would be reasons to select these hydride shielding materials.	[Tanaka, Teruya; Hishinuma, Yoshimitsu; Tamura, Hitoshi; Muroga, Takeo; Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Muta, Hiroaki] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Tanaka, T (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshicho, Toki, Gifu 5095292, Japan.	teru@nifs.ac.jp			JSPS KAKENHI [25289344, NIFS11UFFF0251]	The present study has been conducted under supports of JSPS KAKENHI Grant-in-Aid for Scientific Research (B) 25289344 and NIFS11UFFF0251.	AKIYAMA T., 2014, 25 IAEA FUS EN C SAI; Catalan JP, 2012, FUSION SCI TECHNOL, V62, P190; Hayashi T, 2006, FUSION ENG DES, V81, P1285, DOI 10.1016/j.fusengdes.2005.09.060; Sagara A, 2000, FUSION ENG DES, V49-50, P661, DOI 10.1016/S0920-3796(00)00360-4; Sagara A, 2012, FUSION ENG DES, V87, P594, DOI 10.1016/j.fusengdes.2012.01.030; Tanaka T, 2012, FUSION ENG DES, V87, P584, DOI 10.1016/j.fusengdes.2012.01.049; VETRANO JB, 1970, NUCL ENG DES, V14, P390; Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; Hayashi T, 2009, J NUCL MATER, V386-88, P119, DOI 10.1016/j.jnucmat.2008.12.073; BRIESMESTER J.F., 2000, LA12625M LOS AL NAT; CHEN Y., 2003, 6763 FZKA; ELGUEBALY LA, 1989, FUSION ENG DES, V10, P181, DOI 10.1016/0920-3796(89)90051-3; MUTA H., 2015, PLASMA FUSION RES, V10, P021, DOI [http://dx.doi.org/10.1585/pfr.10.3405021, DOI 10.1585/PFI-.10.3405021]; SANDROCK G., 1997, N0001497M0001 OFF NA; TANAKA T., 2012, 24 IAEA FUS EN C SAN; WILFING G., 2005, ULLMANNS ENCY IND CH	16	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					705	710		10.13182/FST15-110		6	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400044		
J	Yuki, K; Kawamoto, M; Hattori, M; Suzuki, K; Sunamoto, K; Sagara, A				Yuki, Kazuhisa; Kawamoto, Makoto; Hattori, Munehito; Suzuki, Koichi; Sunamoto, Ken-ichi; Sagara, Akio			GAS-COOLED DIVERTOR CONCEPT WITH HIGH THERMAL CONDUCTIVITY POROUS MEDIA	FUSION SCIENCE AND TECHNOLOGY			English	Article							DESIGN	In this study, in order to enhance heat transfer performance of helium gas flow for divertor cooling, high thermal conductivity porous media that are copper-particles-sintered ones are introduced as the referential porous media. In order to predict the heat transfer performance of He gas impinging jet flow with the porous medium, nitrogen gas is used as the simulant of helium gas in the pressure range of 0.1 MPa to 0.8 MPa. With the porous medium, the particle introduced is highly size-adjusted one of 1000 gm in diameter and the porosity is almost 30 %. The maximum heat transfer performance is evaluated by numerically simulating temperature field in a heat transfer block based on the measured temperature data. The experiments prove that the heat transfer coefficient of N-2 gas impinging jet flow with the porous medium is much higher than that of common impinging jet flow without the porous medium from the view point of not only flow velocity but also pumping power.	[Yuki, Kazuhisa; Kawamoto, Makoto; Suzuki, Koichi] Tokyo Univ Sci, Yamaguchi, Sanyo Onoda 7590884, Japan; [Hattori, Munehito] Tohoku Univ, Sendai, Miyagi 9808579, Japan; AKANE Co Ltd, Aki, Hiroshima 7360082, Japan; [Sagara, Akio] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Yuki, K (reprint author), Tokyo Univ Sci, Daigaku Dori 1-1-1, Yamaguchi, Sanyo Onoda 7590884, Japan.	kyuki@rs.tus.ac.jp			NIPS Collaborative Research Program NIFS [NIFS13KERF015]	This work was performed with the support and under the auspices of the NIPS Collaborative Research Program NIFS (NIFS13KERF015). Furthermore, this work was also strongly supported by Mr. K. Sunamoto at Akane Co., Ltd. We wish to acknowledge their support and assistance to our work.	Sharafat S, 2007, FUSION SCI TECHNOL, V52, P559; Sharafat S, 2011, FUSION SCI TECHNOL, V60, P203; Ihli T, 2007, FUSION ENG DES, V82, P249, DOI 10.1016/j.fusengdes.2006.11.004; Li Chen, 2005, P 2005 ASME SUMM HEA; Patankar SV, 1980, NUMERICAL HEAT TRANS; Akiba M, 1998, FUSION ENG DES, V39-40, P219, DOI 10.1016/S0920-3796(98)00107-0; Yuki K., 2008, ASME, V130, DOI [http://dx.doi.org/10.1115/1.2780175, DOI 10.1115/1.2780175]	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	OCT	2015	68	3					715	719		10.13182/FST15-115		5	Nuclear Science & Technology	Nuclear Science & Technology	CT6OX	WOS:000362933400046		
J	Sasahara, T				Sasahara, Toru			Tangentially biharmonic Lagrangian H-umbilical submanifolds in complex space forms	ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG			English	Article						Tangentially biharmonic submanifolds; Lagrangian H-umbilical submanifolds	SURFACES	The notion of Lagrangian H-umbilical submanifolds was introduced by Chen (Isr J Math 99:69-108, 1997), and these submanifolds have appeared in several important problems in the study of Lagrangian submanifolds from the Riemannian geometric point of view. Recently, the author introduced the notion of tangentially biharmonic submanifolds, which are defined as submanifolds such that the bitension field of the inclusion map has vanishing tangential component. The normal bundle of a round hypersphere in can be immersed as a tangentially biharmonic Lagrangian H-umbilical submanifold in . Motivated by this fact, we classify tangentially biharmonic Lagrangian H-umbilical submanifolds in complex space forms.	Hachinohe Inst Technol, Ctr Liberal Arts & Sci, Hachinohe, Aomori 0318501, Japan	Sasahara, T (reprint author), Hachinohe Inst Technol, Ctr Liberal Arts & Sci, Hachinohe, Aomori 0318501, Japan.	sasahara@hi-tech.ac.jp					Liang T, 2013, RESULTS MATH, V64, P91, DOI 10.1007/s00025-012-0299-x; Chen BY, 1997, ISRAEL J MATH, V99, P69, DOI 10.1007/BF02760677; Loubeau E, 2008, P EDINBURGH MATH SOC, V51, P421, DOI 10.1017/S00130915060000394; HASANIS T, 1995, MATH NACHR, V172, P145, DOI 10.1002/mana.19951720112; Li HZ, 2009, RESULTS MATH, V56, P387, DOI 10.1007/s00025-009-0422-9; Balmus A, 2013, ARK MAT, V51, P197, DOI 10.1007/s11512-012-0169-5; Chen BY, 1997, TOHOKU MATH J, V49, P277, DOI 10.2748/tmj/1178225151; Sasahara T, 2012, ARCH MATH, V99, P281, DOI 10.1007/s00013-012-0410-2; Sasahara T, 2012, GEOMETRIAE DEDICATA, V160, P185, DOI 10.1007/s10711-011-9675-z; Chen BY, 2006, P JPN ACAD A-MATH, V82, P173; EELLS J, 1964, AM J MATH, V86, P109, DOI 10.2307/2373037; HARVEY R, 1982, ACTA MATH-DJURSHOLM, V148, P47, DOI 10.1007/BF02392726; Chen BY, 2013, PUBL MATH-DEBRECEN, V82, P193, DOI 10.5486/PMD.2013.5405; Fetcu D, 2012, TOHOKU MATH J, V64, P195; Fetcu D, 2010, MATH Z, V266, P505, DOI 10.1007/s00209-009-0582-z; CASTRO I, 1995, ANN GLOB ANAL GEOM, V13, P59, DOI 10.1007/BF00774568; Chen BY, 2013, DIFFER GEOM APPL, V31, P808, DOI 10.1016/j.difgeo.2013.09.006; Caddeo R, 2014, ANN MAT PUR APPL, V193, P529, DOI 10.1007/s10231-012-0289-3; Chen B.-Y., 1974, MICH MATH J, V21, P225; Jiang G. Y., 1986, CHINESE ANN MATH A, V7, p[389, 209]; O'Neill B., 1965, CAN J MATH, V17, P905; Vrancken L., 1992, PUBLICATIONS I MATH, V51, P94	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5858	1865-8784		ABH MATH SEM HAMBURG	Abh. Math. Semin. Univ. Hamburg	OCT	2015	85	2					107	123		10.1007/s12188-015-0110-5		17	Mathematics	Mathematics	CU7MP	WOS:000363724300002		
J	Hamahata, Y				Hamahata, Yoshinori			Mean values of Goss L-functions and Dedekind sums	ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG			English	Article						Goss L-functions; Dedekind sums; Drinfeld modules; Function fields	RADEMACHER SUMS; FUNCTION-FIELDS	Using Dedekind sums in function fields,we give a formula for the mean values of the product of Goss L-functions.	Okayama Univ Sci, Dept Appl Math, Okayama 7000005, Japan	Hamahata, Y (reprint author), Okayama Univ Sci, Dept Appl Math, Ridai Cho 1-1, Okayama 7000005, Japan.	hamahata@xmath.ous.ac.jp			Japan Society for the Promotion of Science [15K04801]	The author would like to thank the referee for valuable comments. The author is supported by a Grant-in-Aid for Scientific Research (No. 15K04801), Japan Society for the Promotion of Science.	Bayad A, 2014, INT J NUMBER THEORY, V10, P1291, DOI 10.1142/S1793042114500274; Bayad A, 2012, J NUMBER THEORY, V132, P332, DOI 10.1016/j.jint.2011.05.020; Bayad A, 2012, J NUMBER THEORY, V132, P1645, DOI 10.1016/j.jnt.2012.01.014; Bayad A, 2012, ACTA ARITH, V152, P71, DOI 10.4064/aa152-1-6; GOSS D, 1980, B AM MATH SOC, V2, P391, DOI 10.1090/S0273-0979-1980-14751-5; Damamme G., 1999, J THEOR NOMBR BORDX, V11, P369; Goss D., 1998, BASIC STRUCTURES FUN; Louboutin S., 2001, C MATH, V90, P69, DOI 10.4064/cm90-1-6; LOUBOUTIN S, 1993, CAN MATH BULL, V36, P190, DOI 10.4153/CMB-1993-028-8; Louboutin S, 1999, P JPN ACAD A-MATH, V75, P143; Rademacher H., 1972, DEDEKIND SUMS; Rosen M., 2002, NUMBER THEORY FUNCTI; WALUM H, 1982, ILLINOIS J MATH, V26, P1; Zhang W., 1996, J THEORIE NOMBRES, V8, P429	14	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5858	1865-8784		ABH MATH SEM HAMBURG	Abh. Math. Semin. Univ. Hamburg	OCT	2015	85	2					187	196		10.1007/s12188-015-0111-4		10	Mathematics	Mathematics	CU7MP	WOS:000363724300005		
J	Graillat, S; Lauter, C; Tang, PTP; Yamanaka, N; Oishi, S				Graillat, Stef; Lauter, Christoph; Tang, Ping Tak Peter; Yamanaka, Naoya; Oishi, Shin'ichi			Efficient Calculations of Faithfully Rounded l(2)-Norms of n-Vectors	ACM TRANSACTIONS ON MATHEMATICAL SOFTWARE			English	Article						Floating-point arithmetic; error-free transformations; faithful rounding; 2-norm; underflow; overflow	FLOATING-POINT SUMMATION; PRECISION	In this article, we present an efficient algorithm to compute the faithful rounding of the l(2)-norm of a floating-point vector. This means that the result is accurate to within 1 bit of the underlying floating-point type. This algorithm does not generate overflows or underflows spuriously, but does so when the final result calls for such a numerical exception to be raised. Moreover, the algorithm is well suited for parallel implementation and vectorization. The implementation runs up to 3 times faster than the netlib version on current processors.	[Graillat, Stef; Lauter, Christoph] Univ Paris 06, Univ Paris 04, UMR 7606, LIP6, F-75005 Paris, France; [Tang, Ping Tak Peter] Intel Corp, Santa Clara, CA 95054 USA; [Yamanaka, Naoya] Teikyo Heisei Univ, Fac Modern Life, Nakano Ku, Tokyo 1648530, Japan; [Yamanaka, Naoya] JST, CREST, Tokyo, Japan; [Oishi, Shin'ichi] Waseda Univ, Fac Sci & Engn, Tokyo 1698555, Japan	Graillat, S (reprint author), Univ Paris 06, Univ Paris 04, UMR 7606, LIP6, F-75005 Paris, France.	stef.graillat@lip6.fr; christoph.lauter@lip6.fr; peter.tang@intel.com; n.yamanaka@thu.ac.jp; oishi@waseda.jp			CNRS/JSPS	Part of this work was done while Professor Shin'ichi Oishi was holding a position of Visiting Professor at UMPC and while Ping Tak Peter Tang was visiting UPMC. Stef Graillat was supported by a CNRS/JSPS Exchange Scientist grant.	Anderson E., 1999, LAPACK USERS GUIDE; Rump SM, 2009, SIAM J SCI COMPUT, V31, P3466, DOI 10.1137/080738490; Rump SM, 2008, SIAM J SCI COMPUT, V31, P189, DOI 10.1137/050645671; Ogita T, 2005, SIAM J SCI COMPUT, V26, P1955, DOI 10.1137/030601818; DEKKER TJ, 1971, NUMER MATH, V18, P224, DOI 10.1007/BF01397083; Rump SM, 2008, SIAM J SCI COMPUT, V31, P1269, DOI 10.1137/07068816X; Blue J. L., 1978, ACM Transactions on Mathematical Software, V4, DOI 10.1145/355769.355771; Higham N. J., 2002, SOC IND APPL MATH; Knuth D.E., 1998, ART COMPUTER PROGRAM, V2; Li XYS, 2002, ACM T MATH SOFTWARE, V28, P152, DOI 10.1145/567806.567808; Muller JM, 2010, HANDBOOK OF FLOATING-POINT ARITHMETIC, P1, DOI 10.1007/978-0-8176-4705-6; Zhu YK, 2009, SIAM J SCI COMPUT, V31, P2981, DOI 10.1137/070710020; Zhu Y.-K., 2010, ACM T MATH SOFTWARE, V37, P3	13	0	0	ASSOC COMPUTING MACHINERY	NEW YORK	2 PENN PLAZA, STE 701, NEW YORK, NY 10121-0701 USA	0098-3500	1557-7295		ACM T MATH SOFTWARE	ACM Trans. Math. Softw.	OCT	2015	41	4							24	10.1145/2699469		20	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CU7PE	WOS:000363733000002		
J	Tsuruoka, T; Valov, I; Tappertzhofen, S; van den Hurk, J; Hasegawa, T; Waser, R; Aono, M				Tsuruoka, Tohru; Valov, Ilia; Tappertzhofen, Stefan; van den Hurk, Jan; Hasegawa, Tsuyoshi; Waser, Rainer; Aono, Masakazu			Redox Reactions at Cu,Ag/Ta2O5 Interfaces and the Effects of Ta2O5 Film Density on the Forming Process in Atomic Switch Structures	ADVANCED FUNCTIONAL MATERIALS			English	Article						electrochemical metallization cells; film density; gapless-type atomic switch; oxides; redox reaction	SOLID-ELECTROLYTE; MEMORIES; SCALE	Cu and Ag redox reactions at the interfaces with Ta2O5 and the impact of Ta2O5 film density on the forming process of Cu,Ag/Ta2O5/Pt atomic switch structures are investigated. Cyclic voltammetry measurements revealed that under positive bias to the Cu (Ag) electrode, Cu is preferentially oxidized to Cu2+, while Ag is oxidized to Ag+ ions. Subsequent negative bias causes a reduction of oxidized Cu (Ag) ions at the interfaces. The diffusion coefficient of the Cu and Ag ions in the Ta2O5 film is estimated from the results from different bias voltage sweep rates. It is also found that the redox current is enhanced and the forming voltage of the Cu/Ta2O5/Pt cell is reduced when the density of the Ta2O5 film is decreased. This result indicates the importance of the structural properties of the matrix oxide film in understanding and controlling resistive switching behavior.	[Tsuruoka, Tohru; Hasegawa, Tsuyoshi; Aono, Masakazu] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Tsuruoka, Tohru; Hasegawa, Tsuyoshi] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Valov, Ilia; Waser, Rainer] Forschungszentrum Julich, Peter Gruenberg Inst Elect Mat, D-52425 Julich, Germany; [Valov, Ilia; Tappertzhofen, Stefan; van den Hurk, Jan; Waser, Rainer] Rhein Westfal TH Aachen, Inst Werkstoffe Elektroteckn 2, D-52074 Aachen, Germany	Tsuruoka, T (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	Tsuruoka.Tohru@nims.go.jp		van den Hurk, Jan/0000-0001-7710-8325	JSPS KAKENHI [24350278]; BMBF [03x0140]	This work was supported in part by JSPS KAKENHI Grant No. 24350278 and by BMBF Project No. 03x0140. The authors would like to thank A. Besmehn and P. Grewe for the XPS and XRR measurements of Ta<INF>2</INF>O<INF>5</INF> films, respectively.	Hasegawa T, 2009, MRS BULL, V34, P929, DOI 10.1557/mrs2009.215; Valov I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254003; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Tappertzhofen S, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662013; Tsuruoka T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/42/425205; Tappertzhofen S, 2012, NANOSCALE, V4, P3040, DOI 10.1039/c2nr30413a; Chu AK, 1999, J ELECTRON MATER, V28, P1457, DOI 10.1007/s11664-999-0141-8; Tsuruoka T, 2013, AIP ADV, V3, DOI 10.1063/1.4795140; Tappertzhofen S, 2013, ACS NANO, V7, P6396, DOI 10.1021/nn4026614; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201; Valov I, 2012, NAT MATER, V11, P530, DOI [10.1038/nmat3307, 10.1038/NMAT3307]; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/nmat3054, 10.1038/NMAT3054]; Tsuruoka T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254013; Banno N, 2008, IEEE T ELECTRON DEV, V55, P3283, DOI 10.1109/TED.2008.2004246; Tsuruoka T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/43/435705; Dimitrova T, 1998, VACUUM, V51, P151, DOI 10.1016/S0042-207X(98)00148-1; Valov I, 2014, CHEMELECTROCHEM, V1, P26, DOI 10.1002/celc.201300165; Ngaruiya JM, 2003, PHYS STATUS SOLIDI A, V198, P99, DOI 10.1002/pssa.200306444; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Tsuruoka T, 2012, ADV FUNCT MATER, V22, P70, DOI 10.1002/adfm.201101846; Tappertzhofen S, 2014, CHEMELECTROCHEM, V1, P1287, DOI 10.1002/celc.201402106; Bard A, 1985, STANDARD POTENTIALS; Bard A.J., 2001, ELECTROCHEMICAL METH; Chandrasekaran N., 2013, IEDM, P344; Kund M., 2005, IEDM, P754, DOI 10.1109/IEDM.2005.1609463; Mannequin C., UNPUB	26	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	OCT	2015	25	40			SI		6374	6381		10.1002/adfm.201500853		8	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CU7AC	WOS:000363685900008		
J	Fujita, T				Fujita, Tetsuji			An Unexpected Inverse Association between Colon Adenomas and Colitis	AMERICAN JOURNAL OF GASTROENTEROLOGY			English	Letter							MICROSCOPIC COLITIS; COLORECTAL-CANCER; COLONOSCOPY; POLYPS		Jikei Univ, Sch Med, Dept Surg, Minato Ku, Tokyo 1058461, Japan	Fujita, T (reprint author), Jikei Univ, Sch Med, Dept Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	tetsu@jg8.so-net.ne.jp					Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Anderson JC, 2013, CLIN GASTROENTEROL H, V11, P1308, DOI 10.1016/j.cgh.2013.04.042; Yen EF, 2012, DIGEST DIS SCI, V57, P161, DOI 10.1007/s10620-011-1852-2; Cooper K, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI [10.3310/hta14320, 10.3310/hta.14320]; Datta I, 2009, CAN J SURG, V52, pE167; Tontini GE, 2014, INFLAMM BOWEL DIS, V20, P882, DOI 10.1097/MIB.0000000000000030; Sonnenberg A, 2015, AM J GASTROENTEROL, V110, P1056, DOI 10.1038/ajg.2015.130; Lee KK, 2015, GASTROINTEST ENDOSC, V81, P728, DOI 10.1016/j.gie.2014.11.036; Fujita T, 2013, HEPATOLOGY, V58, P1862, DOI 10.1002/hep.26448; Sonnenberg A, 2013, DIGEST DIS SCI, V58, P2970, DOI 10.1007/s10620-013-2718-6; HAYDEN GF, 1982, JAMA-J AM MED ASSOC, V247, P326, DOI 10.1001/jama.247.3.326	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0002-9270	1572-0241		AM J GASTROENTEROL	Am. J. Gastroenterol.	OCT	2015	110	10					1508	1509		10.1038/ajg.2015.292		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CU7KP	WOS:000363716200024		
J	Kim, SB; Miller, S; Suzuki, N; Senda, T; Nishihara, R; Suzuki, K				Kim, Sung Bae; Miller, Simon; Suzuki, Nobuhiro; Senda, Toshiya; Nishihara, Ryo; Suzuki, Koji			Cation-driven Optical Properties of Artificial Luciferases	ANALYTICAL SCIENCES			English	Article						Bioluminescence; metal cation; artificial luciferase; supersecondary structure code	METAL-ION-BINDING; REPORTER-GENE; BIOLUMINESCENCE; SPECIFICITY; MECHANISM; BIOASSAYS; LIGHT; SITE	The present study demonstrates cation-driven optical properties of artificial luciferases (ALucs) from copepod luciferases, as an optical readout for bioanalysis. An assignment of the supersecondary structure code (SSC) of ALucs revealed that ALucs carry a helix-loop-helix structure, which appears at the same sites of the EF-hands of typical Ca2+-binding proteins. A mutagenesis study shows that the EF-hand-like structure is a pivotal site for enzymatic activity. The effects of 20 kinds of mono- and multivalent cations on ALuc activities were estimated with column-purified ALuc16. High pH values boost the ALuc activities with both the native coelenterazine and an analog called 6-pi-OH-CTZ. Multivalent cations, Can, Mg(II), and Cr(VI), elevate and prolong the ALuc activities, whereas Co(II), Cu(II) and Pb(II) greatly hamper the ALuc activities. Ca(II) greatly prolongs the optical intensities, suggesting a contribution to the structural robustness of ALucs. The inhibitory effect of multivalent cations on the ALuc activities was utilized for creating dose-response curves. The intrinsic cation-driven selectivity and optical intensity of ALucs enable researchers to constitute de novo biosensors for multivalent cations.	[Kim, Sung Bae] Natl Inst Adv Ind Sci & Technol, AIST Tsukuba West, Tsukuba, Ibaraki 3058569, Japan; [Miller, Simon; Suzuki, Nobuhiro; Senda, Toshiya] High Energy Accelerator Res Org KEK, Struct Biol Res Ctr, Photon Factory, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Senda, Toshiya] Grad Univ Adv Studies Soken Dai, Dept Mat Struct Sci, Sch High Energy Accelerator Sci, Tsukuba, Ibaraki 3050801, Japan; [Nishihara, Ryo; Suzuki, Koji] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Kim, SB (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba West, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	kimu-sb@aist.go.jp			JSPS KAKENHI [26288088, 24225001]	This work was partly supported by JSPS KAKENHI Grants: Nos. 26288088 and 24225001.	Kim SB, 2013, BIOCONJUGATE CHEM, V24, P2067, DOI 10.1021/bc400411h; Ozawa T, 1999, BBA-PROTEIN STRUCT M, V1434, P211, DOI 10.1016/S0167-4838(99)00185-5; Ozawa T, 2013, ANAL CHEM, V85, P590, DOI 10.1021/ac3031724; Takenaka Y, 2012, MOL BIOL EVOL, V29, P1669, DOI 10.1093/molbev/mss009; Wang Y, 2011, PHOTOCHEM PHOTOBIOL, V87, P846, DOI 10.1111/j.1751-1097.2011.00931.x; Ruecker O, 2008, MOL GENET GENOMICS, V280, P153, DOI 10.1007/s00438-008-0352-3; Takenaka Y, 2008, GENE, V425, P28, DOI 10.1016/j.gene.2008.07.041; SNYDER EE, 1990, BIOCHEMISTRY-US, V29, P3937, DOI 10.1021/bi00468a021; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Izumi H, 2013, J CHEM INF MODEL, V53, P584, DOI 10.1021/ci300420d; Ohmiya Y, 1996, CHEM BIOL, V3, P337, DOI 10.1016/S1074-5521(96)90116-7; Rodionova NS, 2006, J PHOTOCH PHOTOBIO B, V83, P123, DOI 10.1016/j.jphotobiol.2005.12.014; Inouye S, 2007, PROTEIN EXPRES PURIF, V56, P261, DOI 10.1016/j.pep.2007.08.002; Inouye S, 2008, BIOCHEM BIOPH RES CO, V365, P96, DOI 10.1016/j.bbrc.2007.10.152; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Loening AM, 2010, NAT METHODS, V7, P5, DOI 10.1038/nmeth0110-05; FALKE JJ, 1991, BIOCHEMISTRY-US, V30, P8690, DOI 10.1021/bi00099a029; Kim SB, 2014, BIOCHEM BIOPH RES CO, V448, P418, DOI 10.1016/j.bbrc.2014.04.128; Nishihara R., 2014, CHEM COMMUN, V51, P391; Rowe L., 2007, GENETICALLY ENG OPTI, V6449, pT4490; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1	22	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					955	960				6	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900001		
J	Ohno, M; Toyota, T; Nomoto, T; Fujinami, M				Ohno, Masashi; Toyota, Taro; Nomoto, Tomonori; Fujinami, Masanori			Changes in Interfacial Tension of a Lipid Membrane Formed at the Water/Chloroform Interface upon DNA Complex Formation	ANALYTICAL SCIENCES			English	Article						Quasi-elastic laser scattering (QELS) method; DNA complexation; lipid membrane; water/chloroform interface	INVERTED HEXAGONAL PHASE; AIR-WATER-INTERFACE; CATIONIC LIPOSOMES; GENE DELIVERY; ADSORPTION; MONOLAYERS; PHOSPHATIDYLETHANOLAMINE; SCATTERING; SURFACES; BINDING	Changes in the interfacial tension of a lipid monolayer membrane formed at the water/chloroform interface upon DNA addition were measured using the quasi-elastic laser scattering (QELS) method. A cationic lipid, N-[1-(2,3-dioleoyloxy)-propyl]-N,N,N-trimethylammonium chloride(DOTAP), as well as zwitterionic lipids, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), were used to form lipid monolayer membranes at different calcium ion concentrations. A rapid decrease of the interfacial tension resulting from electrostatic interactions between DOTAP and DNA was observed within 10 s. However, such rapid decreases were not observed for DOPE or DOPC. A decrease in the interfacial tension was exhibited by DOPE after 1000 s from the addition of DNA, which may be due to an overall structural change in the DOPE membrane. A DOTAP/DOPE complex system showed behaviors attributable to both DOTAP and DOPE, whereas the behavior of the DOTAP/DOPC system resembled that of DOPC alone. The current results provide a model for the so-called lipoplex carriers used in gene therapy.	[Ohno, Masashi; Nomoto, Tomonori; Fujinami, Masanori] Chiba Univ, Dept Appl Chem & Biotechnol, Inage, Chiba 2638522, Japan; [Toyota, Taro] Univ Tokyo, Dept Basic Sci, Meguro, Tokyo 1538902, Japan; [Toyota, Taro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Fujinami, M (reprint author), Chiba Univ, Dept Appl Chem & Biotechnol, 1-33 Yayoi, Inage, Chiba 2638522, Japan.	fujinami@faculty.chiba-u.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [24655056]	This work was partially supported by JSPS (Japan Society for the Promotion of Science) KAKENHI grant No. 24655056.	Ohno M, 2015, COLLOID SURFACE A, V480, P85, DOI 10.1016/j.colsurfa.2014.12.054; Francescangeli O, 2004, EUROPHYS LETT, V67, P669, DOI 10.1209/epl/i2004-10091-y; FROMMER MA, 1968, J PHYS CHEM-US, V72, P2862, DOI 10.1021/j100854a029; Cardenas M, 2005, J COLLOID INTERF SCI, V286, P166, DOI 10.1016/j.jcis.2005.01.008; SAKAI K, 1991, REV SCI INSTRUM, V62, P1192, DOI 10.1063/1.1141999; Beaman DK, 2012, P NATL ACAD SCI USA, V109, P3226, DOI 10.1073/pnas.1200244109; McLoughlin D, 2005, LANGMUIR, V21, P1900, DOI 10.1021/la047700s; Wu JC, 2006, PHYSICA B, V385-86, P838, DOI 10.1016/j.physb.2006.05.120; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7; Madeira C, 2011, BBA-BIOMEMBRANES, V1808, P2694, DOI 10.1016/j.bbamem.2011.07.020; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Oberle V, 2000, BIOPHYS J, V79, P1447; Langner M, 1999, CHEM PHYS LIPIDS, V101, P3, DOI 10.1016/S0009-3084(99)00052-3; TSUI FC, 1986, BIOPHYS J, V49, P459; Hansda C, 2013, SURF SCI, V617, P124, DOI 10.1016/j.susc.2013.07.013; Benatti CR, 2009, BBA-BIOMEMBRANES, V1788, P1304, DOI 10.1016/j.bbamem.2009.02.003; Chattoraj DK, 2009, CURR SCI INDIA, V97, P1430; Lobo BA, 2003, BIOPHYS CHEM, V104, P67, DOI 10.1016/S0301-4622(02)00339-3; Stuart MCA, 2007, BBA-BIOMEMBRANES, V1768, P2681, DOI 10.1016/j.bbamem.2007.06.024; OHKI S, 1976, J THEOR BIOL, V62, P389, DOI 10.1016/0022-5193(76)90126-0; Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796; Nomoto T, 2014, ANAL SCI, V30, P707; BUDKER VG, 1978, FEBS LETT, V95, P143, DOI 10.1016/0014-5793(78)80070-2; Cantor C.R., 1980, BIOPHYSICAL CHEM; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; Feigner J. H., 1994, J BIOL CHEM, V269, P2550; Feigner P. L., 1987, P NATL ACAD SCI USA, V84, P7413; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Lamb H, 1932, HYDRODYNAMICS; WROBEL I, 1995, BBA-BIOMEMBRANES, V1235, P296, DOI 10.1016/0005-2736(95)80017-A	32	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					979	986				8	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900004		
J	Yang, HY; Imanishi, Y; Harata, A				Yang, Haiya; Imanishi, Yasushi; Harata, Akira			Estimating pH at the Air/Water Interface with a Confocal Fluorescence Microscope	ANALYTICAL SCIENCES			English	Article						pH; the air/water interface; confocal fluorescence microscope; rhodamine B; zwitterionic	LIQUID WATER-SURFACE; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTIONS; HYDROGEN; MODELS; BASE; ACID	One way to determine the pH at the air/water interface with a confocal fluorescence microscope has been proposed. The relation between the pH at the air/water interface and that in a bulk solution has been formulated in connection with the adsorption equilibrium and the dissociation equilibrium of the dye adsorbed. Rhodamine B (RhB) is used as a surface-active fluorescent pH probe. The corrected fluorescence spectrum of RhB molecules at the air/water interface with the surface density of 1.0 nmol m(-2) level shows pH-dependent shifts representing an acid-base equilibrium. Two ways to determine the unknown acid-base equilibrium constant of RhB molecules at the air/water interface have been discussed. With surface-tension measurements, the adsorption properties, maximum surface density, and adsorption equilibrium constants were estimated for both cationic and zwitterionic forms of RhB molecules at the air/water interface.	[Yang, Haiya; Imanishi, Yasushi; Harata, Akira] Kyushu Univ, Dept Mol & Mat Sci, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Harata, A (reprint author), Kyushu Univ, Dept Mol & Mat Sci, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	harata@mm.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23655067]	This work is financially supported by a Grant-in-Aid for challenging Exploratory Research (No. 23655067) from the Ministry of Education, Culture, Sports, Science and Technology. The authors greatly thank Dr. Kenji Furuya, Dr. Toshio Ishioka, and Mrs. Miki Isoda for their kind help and discussions.	Yamaguchi S, 2011, J PHYS CHEM C, V115, P4168, DOI 10.1021/jp1113174; Prosser AJ, 2001, COLLOID SURFACE A, V178, P1, DOI 10.1016/S0927-7757(00)00706-8; Dang LX, 1997, J CHEM PHYS, V106, P8149, DOI 10.1063/1.473820; Tian CS, 2008, J AM CHEM SOC, V130, P13033, DOI 10.1021/ja8021297; Petersen PB, 2008, CHEM PHYS LETT, V458, P255, DOI 10.1016/j.cplett.2008.04.010; Najafi AS, 2007, J COLLOID INTERF SCI, V308, P344, DOI 10.1016/j.jcis.2007.01.014; Raymond EA, 2003, J PHYS CHEM B, V107, P546, DOI 10.1021/jp021366w; Li YQ, 1999, LANGMUIR, V15, P3035, DOI 10.1021/la980896+; ARBELOA IL, 1986, CHEM PHYS LETT, V128, P474, DOI 10.1016/0009-2614(86)80656-X; Buch V, 2007, P NATL ACAD SCI USA, V104, P7342, DOI 10.1073/pnas.0611285104; Takahashi M, 2005, J PHYS CHEM B, V109, P21858, DOI 10.1021/jp0445270; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Tabe Y, 2014, J PHYS CHEM C, V118, P977, DOI 10.1021/jp4078882; Enami S, 2010, J PHYS CHEM LETT, V1, P1599, DOI 10.1021/jz100322w; Tarbuck TL, 2006, J AM CHEM SOC, V128, P14519, DOI 10.1021/ja063184b; Zheng XY, 2001, SPECTROCHIM ACTA A, V57, P315, DOI 10.1016/S1386-1425(00)00389-9; Mucha M, 2005, J PHYS CHEM B, V109, P7617, DOI 10.1021/jp0445730; Yamaguchi S, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4758805; Petersen PB, 2005, J PHYS CHEM B, V109, P7976, DOI 10.1021/jp044479j; ZHAO XL, 1993, CHEM PHYS LETT, V214, P203, DOI 10.1016/0009-2614(93)90082-C; Sato M, 2004, J PHYS CHEM B, V108, P12111, DOI 10.1021/jp0491616; Kazoe Y, 2011, ANAL CHEM, V83, P8152, DOI 10.1021/ac201654r; Li YQ, 1999, INSTRUM SCI TECHNOL, V27, P159, DOI 10.1080/10739149908085846; Butt H.-J., 2006, PHYS CHEM INTERFACES; Harata A., 2010, CHARGED PARTICLE PHO, P445, DOI 10.1201/b10389-18	25	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					1005	1010				6	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900007		
J	Miyabe, K; Takahashi, R; Shimazaki, Y				Miyabe, Kanji; Takahashi, Ryohei; Shimazaki, Youki			Kinetic Study of Interaction between Solute Molecule and Surfactant Micelle	ANALYTICAL SCIENCES			English	Article						Intermolecular interaction; affinity kinetics; moment theory; capillary electrophoresis; chromatographic capillary electrophoresis; association rate constant; dissociation rate constant; sodium dodecylsulfate; micelle; MEKC	SODIUM DODECYL-SULFATE; AFFINITY CAPILLARY-ELECTROPHORESIS; DIFFERENT STRUCTURAL CHARACTERISTICS; MOMENT EQUATIONS; BINDING CONSTANTS; STATIONARY PHASES; CHROMATOGRAPHY; EQUILIBRIUM; CE; SOLUBILIZATION	We developed moment analysis of affinity kinetics by chromatographic capillary electrophoresis (MKCCE) method for the kinetic study of intermolecular interactions. Association and dissociation rate constants of the interaction in a micellar electrokinetic chromatography (MEKC) system between thymol and sodium dodecylsulfate micelle were determined by the MKCCE method. It is a method based on the moment theory for the kinetic study of intermolecular interactions under the conditions that neither immobilization nor chemical modification of molecules is required. In CCE mode, experimental conditions are controlled so that the migration of solute-micelle complex is stopped and only solute molecules migrate in a capillary. Mass transfer behavior of solute molecules in the CCE system is analogous to that in a chromatographic system. However, because it was difficult in practice to really perform CE experiments under the CCE conditions, CE data were measured with changing experimental conditions, i.e., applied pressure, under the conditions that the migration velocity of solute-micelle complex was around zero. The rate constants could be analytically determined from the CE data. In the MKCCE method, it is not necessary to fit elution curves numerically calculated to those experimentally measured for the determination of the rate constants. Regarding the interaction between thymol and SDS association equilibrium constant and association and dissociation rate constants were determined as 6.35 x 10(3) dm(3) mol(-1), 5.6 x 10(4) dm(3) mol(-1) s(-1), and 8.7 s(-1), respectively. It was demonstrated that the MKCCE method was effective for the kinetic study of intermolecular interactions.	[Miyabe, Kanji; Takahashi, Ryohei; Shimazaki, Youki] Rikkyo Univ, Dept Chem, Fac Sci, Tokyo 1718501, Japan	Miyabe, K (reprint author), Rikkyo Univ, Dept Chem, Fac Sci, 3-34-1 Nishi Ikebukuro, Tokyo 1718501, Japan.	kmiyabe@rikkyo.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Rikkyo University Special Fund	This study was, in part, supported by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities and by the Rikkyo University Special Fund for Research 2015.	Petrov A, 2005, J AM CHEM SOC, V127, P17104, DOI 10.1021/ja0562321; Colton IJ, 1998, ELECTROPHORESIS, V19, P367, DOI 10.1002/elps.1150190303; Miyabe K, 2011, ANAL SCI, V27, P1007; OGINO K, 1976, B CHEM SOC JPN, V49, P3679, DOI 10.1246/bcsj.49.3679; Jiang CX, 2010, ELECTROPHORESIS, V31, P17, DOI 10.1002/elps.200900528; GEHLEN MH, 1993, J PHYS CHEM-US, V97, P11242, DOI 10.1021/j100145a021; QUINA FH, 1995, J PHYS CHEM-US, V99, P17028, DOI 10.1021/j100046a031; Cherney LT, 2011, ANAL CHEM, V83, P1381, DOI 10.1021/ac102768r; Mullerova L, 2013, ELECTROPHORESIS, V34, P768, DOI 10.1002/elps.201200490; Mironov GG, 2011, ANAL CHEM, V83, P2364, DOI 10.1021/ac200010u; AVILA LZ, 1993, J MED CHEM, V36, P126, DOI 10.1021/jm00053a016; Galievsky VA, 2015, ANAL CHEM, V87, P157, DOI 10.1021/ac504219r; BERR SS, 1988, LANGMUIR, V4, P1247, DOI 10.1021/la00084a005; BIRDI KS, 1974, COLLOID POLYM SCI, V252, P551, DOI 10.1007/BF01558150; Daneshbod Y, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051922; DOUGHTY DA, 1979, J PHYS CHEM-US, V83, P2621, DOI 10.1021/j100483a014; Chen Z, 2008, TRAC-TREND ANAL CHEM, V27, P738, DOI 10.1016/j.trac.2008.06.008; Okhonin V, 2010, J AM CHEM SOC, V132, P7062, DOI 10.1021/ja100104m; LIANOS P, 1980, J PHYS CHEM-US, V84, P3339, DOI 10.1021/j100462a003; Miyabe K, 2014, J CHROMATOGR A, V1356, P171, DOI 10.1016/j.chroma.2014.06.052; Miyabe K, 2008, J CHROMATOGR A, V1183, P49, DOI 10.1016/j.chroma.2007.12.064; Krylov SN, 2007, ELECTROPHORESIS, V28, P69, DOI 10.1002/elps.200600577; Newman CID, 2008, ELECTROPHORESIS, V29, P44, DOI 10.1002/elps.200700086; Bales BL, 1998, J PHYS CHEM B, V102, P10347, DOI 10.1021/jp983364a; Okhonin V, 2004, ANAL CHEM, V76, P1507, DOI 10.1021/ac035259p; ABE M, 1984, J COLLOID INTERF SCI, V99, P226, DOI 10.1016/0021-9797(84)90104-8; Miyabe K, 2002, J PHYS CHEM B, V106, P8898, DOI 10.1021/jp020555b; Miyabe K, 2007, ANAL CHEM, V79, P7457, DOI 10.1021/ac070825s; Bromberg A, 2003, ANAL CHEM, V75, P1188, DOI 10.1021/ac020599g; LOVE LJC, 1984, ANAL CHEM, V56, P1132; Hellqvist A, 2013, ELECTROPHORESIS, V34, P3252, DOI 10.1002/elps.201300305; Kiessig S., 2012, SUPRAMOLECULAR CHEM; Landers J. P., 2008, HDB CAPILLARY MICROC; Poling B. E., 2001, PROPERTIES GASES LIQ; Ruttinger H.-H., 2003, AFFINITY CAPILLARY E; Shamsi SA, 2001, ANAL CHEM, V73, p140A, DOI 10.1021/ac012412b; Svec F., 2001, CAPILLARY ELECTROCHR; Swarbrick J., 1972, J COLLOID INTERF SCI, V41, P609, DOI 10.1016/0021-9797(72)90385-2; TOKIWA F, 1968, J PHYS CHEM-US, V72, P1214, DOI 10.1021/j100850a024; Treybal R.E., 1980, MASS TRANSFER OPERAT	40	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					1019	1025				7	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900009		
J	Pino, F; Ivandini, TA; Naikata, K; Fujishima, A; Merkoci, A; Einaga, Y				Pino, Flavio; Ivandini, Tribidasari A.; Naikata, Kazuya; Fujishima, Akira; Merkoci, Arben; Einaga, Yasuaki			Magnetic Enzymatic Platform for Organophosphate Pesticide Detection Using Boron-doped Diamond Electrodes	ANALYTICAL SCIENCES			English	Article						Magnetic pre-concentration platform; boron-doped diamond electrode; organophosphate; inhibition based detection system	DIRECT ELECTROCHEMICAL OXIDATION; AMPEROMETRIC BIOSENSORS; SERUM-CHOLINESTERASE; SENSITIVE DETECTION; CARBON ELECTRODE; NERVE AGENTS; ACETYLCHOLINESTERASE; THIOCHOLINE; SENSOR; INSECTICIDES	A simple and reliable enzymatic system for organophosporus pesticide detection was successfully developed, by exploiting the synergy between the magnetic beads collection capacity and the outstanding electrochemistry property of boron-doped diamond electrodes. The determination of an organophosphate pesticide, chlorpyrifos (CPF), was performed based on the inhibition system of the enzyme acetylcholinesterase bonded to magnetic beads through a biotin-streptavidin complex system. A better sensitivity was found for a system with magnetic beads in the concentration range of 10(-9) to 10(-5) M. The estimated limits of detection based on IC10 (10% acetylcholinesterase (AChE) inhibition) have been detected and optimized to be 5.7 x 10(-10) M CPF. Spiked samples of water of Yokohama (Japan) have been measured to validate the efficiency of the enzymatic system. The results suggested that the use of magnetic beads to immobilize biomolecules or biosensing agents is suitable to maintain the superiority of BDD electrodes.	[Pino, Flavio; Merkoci, Arben] UAB, CSIC, Nanobioelect & Biosensors Grp, ICN2,CERCA, Barcelona 08193, Spain; [Ivandini, Tribidasari A.] Univ Indonesia, Dept Chem, Fac Math & Sci, Jakarta 16424, Indonesia; [Naikata, Kazuya; Fujishima, Akira] Tokyo Univ Sci, Res Inst Sci & Technol, Photocatalysis Int Res Ctr, Noda, Chiba 2788510, Japan; [Merkoci, Arben] ICREA, Barcelona 08010, Spain; [Einaga, Yasuaki] Keio Univ, Dept Chem, Yokohama, Kanagawa 2238522, Japan; [Einaga, Yasuaki] JST CREST ACCEL, Yokohama, Kanagawa 2238522, Japan	Einaga, Y (reprint author), Keio Univ, Dept Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	einaga@chem.keio.ac.jp	Nakata, Kazuya/D-7633-2011	Nakata, Kazuya/0000-0002-6648-8534	Japan Science and Technology Agency (JST)-Strategic International Research Cooperative Program (SICP); MICINN (Spain) [PIB2010JP-00278]; Hibah Penguatan Kolaborasi UI [1835/H2.R12/HKP05.00.Perjanjian/2014]	This work is supported by Japan Science and Technology Agency (JST)-Strategic International Research Cooperative Program (SICP). Furthermore, MICINN (Spain) for PIB2010JP-00278 projects and Hibah Penguatan Kolaborasi UI 2014, Grant No. 1835/H2.R12/HKP05.00.Perjanjian/2014 are acknowledged.	Istamboulie G, 2010, TALANTA, V82, P957, DOI 10.1016/j.talanta.2010.05.070; Chauhan N, 2011, BIOSENS BIOELECTRON, V29, P82, DOI 10.1016/j.bios.2011.07.070; Pundir CS, 2012, ANAL BIOCHEM, V429, P19, DOI 10.1016/j.ab.2012.06.025; Ivandini TA, 2012, ANAL CHEM, V84, P9825, DOI 10.1021/ac302090y; NENNER M, 1973, ARCH TOXIKOL, V30, P87, DOI 10.1007/BF02425925; Liu T, 2011, MICROCHIM ACTA, V175, P129, DOI 10.1007/s00604-011-0665-5; Ishii Y, 2013, ANAL CHEM, V85, P4284, DOI 10.1021/ac400043b; Racchi M, 2004, PHARMACOL RES, V50, P441, DOI 10.1016/j.phrs.2003.12.027; Kim K, 2011, CHEM REV, V111, P5345, DOI 10.1021/cr100193y; Wei M, 2014, MICROCHIM ACTA, V181, P121, DOI 10.1007/s00604-013-1078-4; Ye J, 2010, ENVIRON POLLUT, V158, P2371, DOI 10.1016/j.envpol.2010.03.014; Zhai C, 2013, BIOSENS BIOELECTRON, V42, P124, DOI 10.1016/j.bios.2012.10.058; Aragay G, 2012, CHEM REV, V112, P5317, DOI 10.1021/cr300020c; Terashima C, 2003, ANAL CHEM, V75, P1564, DOI 10.1021/ac020583q; Chailapakul O, 2002, ANALYST, V127, P1164, DOI 10.1039/b205822g; Llopis X, 2009, LAB CHIP, V9, P213, DOI 10.1039/b816643a; Wang J, 2005, ELECTROCHEM COMMUN, V7, P652, DOI 10.1016/j.elecom.2005.04.013; Chiku M, 2008, J ELECTROANAL CHEM, V612, P201, DOI 10.1016/j.jelechem.2007.09.027; PARVARI R, 1983, ANAL BIOCHEM, V133, P450, DOI 10.1016/0003-2697(83)90107-0; Wahyuni WT, 2015, ELECTROCHEMISTRY, V83, P357, DOI 10.5796/electrochemistry.83.357; HART JP, 1994, ANALYST, V119, P259, DOI 10.1039/an9941900259; Du D, 2012, ANAL CHEM, V84, P1380, DOI 10.1021/ac202391w; Chauhan N, 2011, ANAL CHIM ACTA, V701, P66, DOI 10.1016/j.aca.2011.06.014; Booth LH, 2001, B ENVIRON CONTAM TOX, V67, P633, DOI 10.1007/s00128-001-0171-2; Liu GD, 2005, ELECTROCHEM COMMUN, V7, P1163, DOI 10.1016/j.elecom.2005.08.025; Wang J, 2002, ANAL CHEM, V74, P1187, DOI 10.1021/ac0111356; Yamada M, 2001, CLIN CHEM, V47, P1962; DIETZ AA, 1973, CLIN CHEM, V19, P1309; Sun X, 2013, IEEE SENS J, V13, P172, DOI 10.1109/JSEN.2012.2208455; Bucur MP, 2013, SENSORS-BASEL, V13, P1603, DOI 10.3390/s130201603; Dirtu AC, 2012, ANAL BIOANAL CHEM, V404, P2555, DOI 10.1007/s00216-012-6053-0; Ricci F, 2004, J ELECTROANAL CHEM, V563, P229, DOI 10.1016/j.jelechem.2003.09.016; Rotariu L, 2012, ANAL CHIM ACTA, V748, P81, DOI 10.1016/j.aca.2012.08.045; Wang J, 2001, ANAL CHEM, V73, P1804, DOI 10.1021/ac001421e; Gao Y, 2009, ANAL LETT, V42, P2711, DOI 10.1080/00032710903243661; Periasamy AP, 2009, SENSORS-BASEL, V9, P4034, DOI 10.3390/s90604034; Martorell D, 1997, ANAL CHIM ACTA, V337, P305, DOI 10.1016/S0003-2670(96)00384-4; Fierro S., 2013, TALANTA, V1003, P33; Fujishima A., 2005, DIAMOND ELECTROCHEMI; Gruss R., 1989, ANAL LETT, V222, P1159; Istarnboulie G, 2007, BIOSENS BIOELECTRON, V23, P506, DOI 10.1016/j.bios.2007.06.022; Oujji N. B., 2012, Sensors, V12, P7893, DOI 10.3390/s120607893; Viswanathan R., 2009, BIOSENS BIOELECTRON, V24, P2772	43	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					1061	1068				8	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900015		
J	Shibuya, Y; Itoh, T; Matsuura, S; Yamaguchi, A				Shibuya, Yuuta; Itoh, Tetsuji; Matsuura, Shun-ichi; Yamaguchi, Akira			Structural Stability of Light-harvesting Protein LH2 Adsorbed on Mesoporous Silica Supports	ANALYTICAL SCIENCES			English	Article						Mesoporous silica; membrane protein; LH2	MEMBRANE-PROTEIN; COMPLEX LH2; PHOTOSYNTHETIC BACTERIA; ACIDOPHILA; SURFACTANT; B800-850	In the present study, we examined the reversible thermal deformation of the membrane protein light-harvesting complex LH2 adsorbed on mesoporous silica (MPS) supports. The LH2 complex from Thermochromatium tepidum cells was conjugated to MPS supports with a series of pore diameter (2.4 to 10.6 nm), and absorption spectra of the resulting LH2/MPS conjugates were observed over a temperature range of 273 - 313 K in order to examine the structure of the LH2 adsorbed on the MPS support. The experimental results confirmed that a slight ellipsoidal deformation of LH2 was induced by adsorption on the MPS supports. On the other hand, the structural stability of LH2 was not perturbed by the adsorption. Since the pore diameter of MPS support did not influence the structural stability of LH2, it could be considered that the spatial confinement of LH2 in size-matches pore did not improve the structural stability of LH2.	[Shibuya, Yuuta; Yamaguchi, Akira] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Itoh, Tetsuji; Matsuura, Shun-ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Chem Proc Technol, Sendai, Miyagi 9838551, Japan	Yamaguchi, A (reprint author), Ibaraki Univ, Coll Sci, 2-1-1 Bunkyo, Mito, Ibaraki 3108512, Japan.	akira.yamaguchi.sci@vc.ibaraki.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [24350034]	We acknowledge Professor Z.-Y. Wang-Otomo for providing the LH2 samples and for discussion. We also acknowledge Mr. Hiroaki Ishikawa of Industrial Technology Institute of Ibaraki Prefecture for the XRD measurements. This work was supported in part by Grants-in-Aid for Scientific Research (No. 24350034) and Grant-in-Aid for Scientific Research on Innovative Areas "Artificial Photosynthesis (AnApple)" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Sloan CDK, 2013, ANAL CHEM, V85, P2970, DOI 10.1021/ac3037359; Suemori Y, 2006, PHOTOSYNTH RES, V90, P17, DOI 10.1007/s11120-006-9101-9; Hong XG, 2004, BIOPHYS J, V86, P1082; Mizoguchi K, 2002, J MEMBRANE SCI, V208, P285, DOI 10.1016/S0376-7388(02)00304-6; Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a; Trinkunas G, 2012, J PHYS CHEM B, V116, P5192, DOI 10.1021/jp302042w; Oda I, 2006, J PHYS CHEM B, V110, P1114, DOI 10.1021/jp0540860; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Miyachi M, 2010, CHEM COMMUN, V46, P2557, DOI 10.1039/b926841c; Ikemoto H, 2013, J PHYS CHEM C, V117, P2868, DOI 10.1021/jp311239y; Fraser NJ, 1999, BIOCHEMISTRY-US, V38, P9684, DOI 10.1021/bi990796i; Gall A, 2003, BIOCHEMISTRY-US, V42, P13019, DOI 10.1021/bi0350351; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Sekine F, 2012, PHOTOSYNTH RES, V111, P9, DOI 10.1007/s11120-011-9658-9; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Kumar D, 2001, COLLOID SURFACE A, V187, P109, DOI 10.1016/S0927-7757(01)00638-0; Matsuura S, 2010, MICROPOR MESOPOR MAT, V127, P61, DOI 10.1016/j.micromeso.2009.06.029; Bopp MA, 1999, P NATL ACAD SCI USA, V96, P11271, DOI 10.1073/pnas.96.20.11271; Tang CS, 2006, ANAL CHEM, V78, P711, DOI 10.1021/ac051244a; Timpmann K, 2001, J PHYS CHEM B, V105, P8436, DOI 10.1021/jp003496f; Zerlauskiene O, 2008, J PHYS CHEM B, V112, P15883, DOI 10.1021/jp803439w; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Prince SM, 1997, J MOL BIOL, V268, P412, DOI 10.1006/jmbi.1997.0966; Shubert A., 2004, BIOPHYS J, V86, P2363	24	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					1069	1074				6	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900016		
J	Quezada, AA; Murakami, H; Teshima, N; Sakai, T; Motomizu, S				Quezada, Alejandro Ayala; Murakami, Hiroya; Teshima, Norio; Sakai, Tadao; Motomizu, Shoji			Advanced Stopped-in-Loop Flow Analysis with a Reagents-Merging Zones Technique for a Catalytic Successive Determination of Vanadium and Iron	ANALYTICAL SCIENCES			English	Article						Reagents-merging zones; stopped-in-loop flow analysis; spectrophotometry; vanadium; iron; catalytic reaction; drinking water	INJECTION SPECTROPHOTOMETRIC DETERMINATION; WATER SAMPLES; TRACE VANADIUM; NATURAL-WATERS; OXIDATION; IRON(III); OPTIMIZATION; BROMATE; SYSTEM; COPPER	An advanced stopped-in-loop flow analysis (SELFA) is proposed for the catalytic determinations of vanadium and iron. The chemistry relies on a vanadium- or iron-catalyzed oxidative reaction of p-anisidine by bromate or hydrogen peroxide in the presence of an activator (Tiron or 1,10-phenanthlorine) to form a red dye (510 nm). Reagents for the vanadium- or iron-catalyzed reaction are well mixed by a reagents-merging zones technique. A sample solution is loaded together with well-mixed reagents into a loop in the SILFA configuration, followed by spectrophotometric detection. The advanced SILFA system provides a selective method for the trace determination of vanadium and iron.	[Quezada, Alejandro Ayala; Murakami, Hiroya; Teshima, Norio; Sakai, Tadao; Motomizu, Shoji] Aichi Inst Technol, Dept Appl Chem, Toyota 4700392, Japan	Teshima, N (reprint author), Aichi Inst Technol, Dept Appl Chem, 1247 Yachigusa,Yakusa Cho, Toyota 4700392, Japan.	teshima@aitech.ac.jp			JSPS KAKENHI [26288072, 25860024]; Ministry of Education, Culture, Sports, Science and Technology in Japan	This work was partly supported by JSPS KAKENHI Grant Nos. 26288072 (Grant-in-Aid for Scientific Research (B) for N. T.) and 25860024 (Grant-in-Aid for Young Scientists (B) for H. M.). A. A.-Q. acknowledges to the Ministry of Education, Culture, Sports, Science and Technology in Japan for the scholarship given to support this work.	Ferreira SLC, 2007, ANAL CHIM ACTA, V597, P179, DOI 10.1016/j.aca.2007.07.011; Asan A, 2008, CHEM PAP, V62, P345, DOI 10.2478/s11696-008-0048-5; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Teshima N, 2010, ANAL SCI, V26, P143; Fortes PR, 2010, TALANTA, V81, P1409, DOI 10.1016/j.talanta.2010.02.044; Yamane T, 1998, TALANTA, V45, P583, DOI 10.1016/S0039-9140(97)00188-4; Ohno S, 2004, ANAL SCI, V20, P171, DOI 10.2116/analsci.20.171; Lunvongsa S, 2006, TALANTA, V68, P969, DOI 10.1016/j.talanta.2005.06.067; Ponhong K, 2015, TALANTA, V133, P71, DOI 10.1016/j.talanta.2014.05.065; Kawakubo S, 1996, ANAL SCI, V12, P237, DOI 10.2116/analsci.12.237; Lunvongsa S, 2006, ANAL SCI, V22, P169, DOI 10.2116/analsci.22.169; Shiobara T, 1999, TALANTA, V49, P1083, DOI 10.1016/S0039-9140(99)00020-X; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Kawakubo S, 2003, ANAL SCI, V19, P373, DOI 10.2116/analsci.19.373; Nakano S, 2003, TALANTA, V61, P203, DOI 10.1016/S0039-9140(03)00241-8; Teshima N, 2007, ANAL SCI, V23, P1, DOI 10.2116/analsci.23.1; Asan A, 2013, ENVIRON MONIT ASSESS, V185, P2115, DOI 10.1007/s10661-012-2693-y; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; Wei J, 2008, ANAL SCI, V24, P371, DOI 10.2116/analsci.24.371; Shiller AM, 1998, LIMNOL OCEANOGR, V43, P526; Asan A, 2003, ANAL SCI, V19, P1033, DOI 10.2116/analsci.19.1033; Huang YM, 2012, TALANTA, V93, P86, DOI 10.1016/j.talanta.2012.01.050; Elsuccary SAA, 2015, TALANTA, V131, P108, DOI 10.1016/j.talanta.2014.07.068; Ayala Quezada A., TALANTA UNPUB; Kitta T., 2003, PHARMACOMETRICS, V64, P77; NAKANO S, 1989, ANAL SCI, V5, P69, DOI 10.2116/analsci.5.69; Ratanawimarnwong N., 2014, J FLOW INJECTION ANA, V31, P15; Teshima N, 1996, TALANTA, V43, P1755, DOI 10.1016/0039-9140(96)01966-2; Teshima N, 2009, TALANTA, V79, P517, DOI 10.1016/j.talanta.2009.04.018; Tsuji A, 2000, TALANTA, V52, P161, DOI 10.1016/S0039-9140(99)00340-9	30	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	OCT	2015	31	10					1099	1103				5	Chemistry, Analytical	Chemistry	CU8ZP	WOS:000363832900020		
J	Hasegawa, K; Fujiwara, R; Sato, K; Shin, J; Kim, SJ; Kim, M; Kang, HY				Hasegawa, Kiyotaka; Fujiwara, Rumiko; Sato, Kiyoshi; Shin, Jaeyoung; Kim, Sang Jin; Kim, Misun; Kang, Hee Young			Possible Involvement of Keratinocyte Growth Factor in the Persistence of Hyperpigmentation in both Human Facial Solar Lentigines and Melasma	ANNALS OF DERMATOLOGY			English	Letter							MELANOCYTES		[Hasegawa, Kiyotaka; Fujiwara, Rumiko; Sato, Kiyoshi] Shiseido Res Ctr, Yokohama, Kanagawa, Japan; [Shin, Jaeyoung; Kim, Sang Jin; Kim, Misun; Kang, Hee Young] Ajou Univ, Grad Sch, Dept Dermatol, Suwon 16499, South Korea; [Kim, Misun; Kang, Hee Young] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 16499, South Korea; [Kim, Misun; Kang, Hee Young] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 16499, South Korea	Kang, HY (reprint author), Ajou Univ, Sch Med, Dept Dermatol, 164 WorldCup Ro, Suwon 16499, South Korea.	hykang@ajou.ac.kr					Chen NN, 2010, EXP DERMATOL, V19, P865, DOI 10.1111/j.1600-0625.2009.00957.x; Torres-Alvarez B, 2011, AM J DERMATOPATH, V33, P291, DOI 10.1097/DAD.0b013e3181ef2d45; Iriyama S, 2011, J DERMATOL SCI, V64, P223, DOI 10.1016/j.jdermsci.2011.09.007; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Hirobe T, 2013, J DERMATOL SCI, V71, P45, DOI 10.1016/j.jdermsci.2013.03.012; Lee DJ, 2012, BRIT J DERMATOL, V166, P684, DOI 10.1111/j.1365-2133.2011.10648.x; Lin CB, 2010, J DERMATOL SCI, V59, P91, DOI 10.1016/j.jdermsci.2010.06.006; HODGSON C, 1963, ARCH DERMATOL, V87, P197; Kang HY, 2010, ANN DERMATOL, V22, P373, DOI 10.5021/ad.2010.22.4.373; Gilchrest Barbara A, 2011, J Invest Dermatol, V131, pE14, DOI 10.1038/skinbio.2011.6	10	0	0	KOREAN DERMATOLOGICAL ASSOC	SEOUL	305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL, 137-858, SOUTH KOREA	1013-9087			ANN DERMATOL	Ann. Dermatol.	OCT	2015	27	5					626	629		10.5021/ad.2015.27.5.626		4	Dermatology	Dermatology	CU8ZO	WOS:000363832800025		
J	Yamaoka, T; Inoue, T; Kitaba, S; Yokomi, A; Azukizawa, H; Terao, M; Murota, H; Higashiyama, M; Katayama, I				Yamaoka, Toshifumi; Inoue, Tomoko; Kitaba, Shun; Yokomi, Akinori; Azukizawa, Hiroaki; Terao, Mika; Murota, Hiroyuki; Higashiyama, Mari; Katayama, Ichiro			Psoriatic Arthritis Complicating Systemic Sclerosis: Possible Involvement of M2 Macrophages	ANNALS OF DERMATOLOGY			English	Letter									[Yamaoka, Toshifumi; Inoue, Tomoko; Kitaba, Shun; Yokomi, Akinori; Azukizawa, Hiroaki; Terao, Mika; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Higashiyama, Mari] Nissay Hosp, Dept Dermatol, Osaka, Japan	Yamaoka, T (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamaoka@derma.med.osaka-u.ac.jp					Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Vandooren B, 2009, ARTHRITIS RHEUM, V60, P966, DOI 10.1002/art.24406; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066	5	0	0	KOREAN DERMATOLOGICAL ASSOC	SEOUL	305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL, 137-858, SOUTH KOREA	1013-9087			ANN DERMATOL	Ann. Dermatol.	OCT	2015	27	5					631	632		10.5021/ad.2015.27.5.631		2	Dermatology	Dermatology	CU8ZO	WOS:000363832800027		
J	Davidge, TJ; Andersen, DR; Lardiere, O; Bradley, C; Blain, C; Oya, S; Akiyama, M; Ono, YH				Davidge, T. J.; Andersen, D. R.; Lardiere, O.; Bradley, C.; Blain, C.; Oya, S.; Akiyama, M.; Ono, Y. H.			RAVEN AND THE CENTER OF MAFFEI 1: MULTI-OBJECT ADAPTIVE OPTICS OBSERVATIONS OF THE CENTER OF A NEARBY ELLIPTICAL GALAXY AND THE DETECTION OF AN INTERMEDIATE AGE POPULATION	ASTROPHYSICAL JOURNAL			English	Article						galaxies: elliptical and lenticular, cD; galaxies: evolution; galaxies: individual (Maffei 1)	ASYMPTOTIC GIANT BRANCH; STELLAR EVOLUTION DATABASE; K-BAND OBSERVATIONS; INFRARED COLORS; SPACE-TELESCOPE; MASS FUNCTION; STARS; MODELS; DISTANCE; METALLICITY	Near-infrared (NIR) spectra that have an angular resolution of similar to 0.15 arcsec are used to examine the stellar content of the central regions of the nearby elliptical galaxy Maffei 1. The spectra were recorded at the Subaru Telescope, with wavefront distortions corrected by the RAVEN Multi-object Adaptive Optics science demonstrator. The Ballick-Ramsey C-2 absorption bandhead near 1.76 mu m is detected, and models in which similar to 10%-20% of the light near 1.8 mu m originates from stars of spectral type C5 reproduce the depth of this feature. Archival NIR and mid-infrared images are also used to probe the structural and photometric properties of the galaxy. Comparisons with models suggest that an intermediate age population dominates the spectral energy distribution between 1 and 5 mu m near the galaxy center. This is consistent not only with the presence of C stars, but also with the large H beta index that has been measured previously for Maffei 1. The J - K color is more or less constant within 15 arcsec of the galaxy center, suggesting that the brightest red stars are well-mixed in this area.	[Davidge, T. J.; Andersen, D. R.] Natl Res Council Canada, Dominion Astrophys Observ, Victoria, BC V9E 2E7, Canada; [Lardiere, O.; Bradley, C.; Blain, C.] Univ Victoria, Dept Mech Engn, Victoria, BC V8W 3P2, Canada; [Oya, S.] Natl Opt Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Akiyama, M.; Ono, Y. H.] Tohoku Univ, Astron Inst, Aoba Ku, Sedai 9808578, Japan	Davidge, TJ (reprint author), Natl Res Council Canada, Dominion Astrophys Observ, 5071 West Saanich Rd, Victoria, BC V9E 2E7, Canada.	tim.davidge@nrc.ca; david.andersen@nrc.ca; lardiere@uvic.ca; cbr@uvic.ca; celia.blain@gmail.com; oya@subaru.naoj.org; akiyama@astr.tohoku.ac.jp; yo-2007@astr.tohoku.ac.jp					Alksnis A., 2001, BALT ASTRON, V10, P1; Andersen D. R., 2012, P SOC PHOTO-OPT INS, V8447, p3F; LUPPINO GA, 1993, ASTROPHYS J, V410, P81, DOI 10.1086/172726; Buta R, 2003, ASTRON J, V125, P1150, DOI 10.1086/367789; Fingerhut RL, 2003, ASTROPHYS J, V587, P672, DOI 10.1086/368339; Fingerhut RL, 2007, ASTROPHYS J, V655, P814, DOI 10.1086/509862; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Tamura N, 2000, ASTRON J, V119, P2134, DOI 10.1086/301333; BERTELLI G, 1994, ASTRON ASTROPHYS SUP, V106, P275; Mouhcine M, 2003, MON NOT R ASTRON SOC, V338, P572, DOI 10.1046/j.1365-8711.2003.06026.x; Jarrett TH, 2003, ASTRON J, V125, P525, DOI 10.1086/345794; Reach WT, 2005, PUBL ASTRON SOC PAC, V117, P978, DOI 10.1086/432670; Harris GLH, 2010, PUBL ASTRON SOC AUST, V27, P457, DOI 10.1071/AS09061; Percival SM, 2009, ASTROPHYS J, V690, P427, DOI 10.1088/0004-637X/690/1/427; Buta RJ, 1999, ASTROPHYS J SUPPL S, V124, P33, DOI 10.1086/313255; Trager SC, 1998, ASTROPHYS J SUPPL S, V116, P1, DOI 10.1086/313099; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; Marigo P, 2007, ASTRON ASTROPHYS, V469, P239, DOI 10.1051/0004-6361:20066772; IBEN I, 1978, ASTROPHYS J, V220, P980, DOI 10.1086/155986; Mortlock A, 2013, MON NOT R ASTRON SOC, V433, P1185, DOI 10.1093/mnras/stt793; Naab T, 1999, ASTROPHYS J, V523, pL133, DOI 10.1086/312275; Tokunaga AT, 1998, P SOC PHOTO-OPT INS, V3354, P512, DOI 10.1117/12.317277; Battinelli P, 2005, ASTRON ASTROPHYS, V434, P657, DOI 10.1051/0004-6361:20042278; Brewer JP, 1996, ASTRON J, V112, P491, DOI 10.1086/118030; Khochfar S, 2005, MON NOT R ASTRON SOC, V359, P1379, DOI 10.1111/j.1365-2966.2005.08988.x; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; Bureau M, 2006, MON NOT R ASTRON SOC, V370, P753, DOI 10.1111/j.1365-2966.2006.10471.x; Rayner JT, 2009, ASTROPHYS J SUPPL S, V185, P289, DOI 10.1088/0067-0049/185/2/289; Richichi A, 1999, ASTRON ASTROPHYS, V344, P511; RENZINI A, 1981, ASTRON ASTROPHYS, V94, P175; BARNES JE, 1992, ASTROPHYS J, V393, P484, DOI 10.1086/171522; Boyer ML, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/83; CARTER D, 1978, MON NOT R ASTRON SOC, V182, P797; Chabrier G, 2001, ASTROPHYS J, V554, P1274, DOI 10.1086/321401; Cordier D, 2007, ASTRON J, V133, P468, DOI 10.1086/509870; Davidge TJ, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/66; Davidge TJ, 2005, PUBL ASTRON SOC PAC, V117, P589, DOI 10.1086/430367; Davidge TJ, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/1/97; Davidge TJ, 2002, ASTRON J, V124, P2012, DOI 10.1086/342535; Davidge TJ, 2001, ASTROPHYS J, V553, pL133, DOI 10.1086/320692; Fitzpatrick EL, 1999, PUBL ASTRON SOC PAC, V111, P63, DOI 10.1086/316293; Girardi L, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/142; Groenewegen MAT, 2006, ASTRON ASTROPHYS, V448, P181, DOI 10.1051/0004-6361:20054163; Isizuki S., 1990, NATUR, V344, P224; JEDRZEJEWSKI RI, 1987, MON NOT R ASTRON SOC, V226, P747; Karakas AI, 2014, MON NOT R ASTRON SOC, V445, P347, DOI 10.1093/mnras/stu1727; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Lardiere O., 2014, P SOC PHOTO-OPT INS, V9148, p1GL; Maraston C, 2005, MON NOT R ASTRON SOC, V362, P799, DOI 10.1111/j.1365-2966.2005.09270.x; Maraston C, 1998, MON NOT R ASTRON SOC, V300, P872, DOI 10.1046/j.1365-8711.1998.01947.x; McCall ML, 2004, ASTRON J, V128, P2144, DOI 10.1086/424933; McCall ML, 2014, MON NOT R ASTRON SOC, V440, P405, DOI 10.1093/mnras/stu199; Miner J, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/1/L15; Monachesi A, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/97; Pecaut MJ, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/9; Humphreys EML, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/13; Rosenfield P, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/22; Salaris M, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201423542; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; WORTHEY G, 1994, ASTROPHYS J SUPPL S, V95, P107, DOI 10.1086/192096; Wu P.-O., 2014, AJ, V148, pA7	61	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							133	10.1088/0004-637X/811/2/133		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800061		
J	Folatelli, G; Bersten, MC; Kuncarayakti, H; Benvenuto, OG; Maeda, K; Nomoto, K				Folatelli, Gaston; Bersten, Melina C.; Kuncarayakti, Hanindyo; Benvenuto, Omar G.; Maeda, Keiichi; Nomoto, Ken'ichi			THE PROGENITOR OF THE TYPE IIb SN 2008ax REVISITED	ASTROPHYSICAL JOURNAL			English	Article						supernovae: general; supernovae: individual (SN 2008ax)	CORE-COLLAPSE SUPERNOVAE; SUPERGIANT PROGENITOR; MASSIVE STARS; LIGHT CURVES; BINARY PROGENITOR; VELOCITY-FIELD; 1993J; EVOLUTION; 2011DH; EXTINCTION	Hubble Space Telescope observations of the site of the supernova (SN) SN 2008ax obtained in 2011 and 2013 reveal that the possible progenitor object detected in pre-explosion images was in fact multiple. Four point sources are resolved in the new, higher-resolution images. We identify one of the sources with the fading SN. The other three objects are consistent with single supergiant stars. We conclude that their light contaminated the previously identified progenitor candidate. After subtraction of these stars, the progenitor appears to be significantly fainter and bluer than previously measured. Post-explosion photometry at the SN location indicates that the progenitor object has disappeared. If single, the progenitor is compatible with a supergiant star of B to mid-A spectral type, while a Wolf-Rayet (W-R) star would be too luminous in the ultraviolet to account for the observations. Moreover, our hydrodynamical modeling shows that the pre-explosion mass was 4-5 M-circle dot and the radius was 30-50 R-circle dot, which is incompatible with a W-R progenitor. We present a possible interacting binary progenitor computed with our evolutionary models that reproduces all the observational evidence. A companion star as luminous as an O9-B0 main-sequence star may have remained after the explosion.	[Folatelli, Gaston; Bersten, Melina C.; Benvenuto, Omar G.] Inst Astrofis La Plata, La Plata, Buenos Aires, Argentina; [Folatelli, Gaston; Bersten, Melina C.; Benvenuto, Omar G.] Univ Nacl La Plata, Fac Ciencias Astron & Geofis, RA-1900 La Plata, Buenos Aires, Argentina; [Folatelli, Gaston; Bersten, Melina C.; Maeda, Keiichi; Nomoto, Ken'ichi] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Kuncarayakti, Hanindyo] Millennium Inst Astrophys MAS, Santiago, Chile; [Kuncarayakti, Hanindyo] Univ Chile, Dept Astron, Santiago, Chile; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan	Folatelli, G (reprint author), Inst Astrofis La Plata, La Plata, Buenos Aires, Argentina.	gaston@fcaglp.unlp.edu.ar			World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; JSPS; Ministry of Economy, Development, and Tourism's Millennium Science Initiative [IC120009]; CONICYT through FONDECYT [3140563];  [3224004];  [26400222];  [26800100]	We would like to thank the Hubble Legacy Archive Hotseat Office, in particular Rick White, for valuable help with handling the WFPC2/F606W images. This research has been supported by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan, and by Grants-in-Aid for Scientific Research (3224004, 26400222, and 26800100) and by JSPS Open Partnership Bilateral Joint Research Projects. Support for H.K. is provided by the Ministry of Economy, Development, and Tourism's Millennium Science Initiative through grant IC120009, awarded to The Millennium Institute of Astrophysics, MAS. H.K. acknowledges support by CONICYT through FONDECYT grant 3140563. The present work is based on observations made with the NASA/ESA Hubble Space Telescope. and obtained from the Hubble Legacy Archive, which is a collaboration between the Space Telescope Science Institute (STScI/NASA), the Space Telescope European Coordinating Facility (ST-ECF/ESA), and the Canadian Astronomy Data Centre (CADC/NRC/CSA). Gemini data were provided by the Canadian Astronomy Data Centre operated by the National Research Council of Canada with the support of the Canadian Space Agency. We have made use of the NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with the National Aeronautics and Space Administration.	Gal-Yam A, 2014, NATURE, V509, P471, DOI 10.1038/nature13304; Chevalier RA, 2010, ASTROPHYS J LETT, V711, pL40, DOI 10.1088/2041-8205/711/1/L40; Smartt SJ, 2009, MON NOT R ASTRON SOC, V395, P1409, DOI 10.1111/j.1365-2966.2009.14506.x; Pastorello A, 2008, MON NOT R ASTRON SOC, V389, P955, DOI 10.1111/j.1365-2966.2008.13618.x; Bufano F, 2014, MON NOT R ASTRON SOC, V439, P1807, DOI 10.1093/mnras/stu065; NOMOTO K, 1988, PHYS REP, V163, P13, DOI 10.1016/0370-1573(88)90032-4; Hamuy M, 2006, PUBL ASTRON SOC PAC, V118, P2, DOI 10.1086/500228; Matheson T, 2000, ASTRON J, V120, P1487, DOI 10.1086/301518; Eldridge JJ, 2013, MON NOT R ASTRON SOC, V436, P774, DOI 10.1093/mnras/stt1612; WOOSLEY SE, 1994, ASTROPHYS J, V429, P300, DOI 10.1086/174319; Benvenuto OG, 2003, MON NOT R ASTRON SOC, V342, P50, DOI 10.1046/j.1365-8711.2003.06458.x; Theureau G, 2007, ASTRON ASTROPHYS, V465, P71, DOI 10.1051/0004-6361:20066187; Matheson T, 2000, ASTRON J, V120, P1499, DOI 10.1086/301519; ALDERING G, 1994, ASTRON J, V107, P662, DOI 10.1086/116886; Lyman JD, 2014, MON NOT R ASTRON SOC, V437, P3848, DOI 10.1093/mnras/stt2187; Maurer I, 2010, MON NOT R ASTRON SOC, V409, P1441, DOI 10.1111/j.1365-2966.2010.17186.x; Van Dyk SD, 2002, PUBL ASTRON SOC PAC, V114, P1322, DOI 10.1086/344382; Munari U, 1997, ASTRON ASTROPHYS, V318, P269; Terry JN, 2002, ASTRON ASTROPHYS, V393, P57, DOI 10.1051/0004-6361:20021018; Roming PWA, 2009, ASTROPHYS J LETT, V704, pL118, DOI 10.1088/0004-637X/704/2/L118; HOLTZMAN J, 1995, PUBL ASTRON SOC PAC, V107, P156, DOI 10.1086/133533; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Maund JR, 2004, NATURE, V427, P129, DOI 10.1038/nature02161; Crockett RM, 2008, MON NOT R ASTRON SOC, V391, pL5, DOI 10.1111/j.1745-3933.2008.00540.x; Benvenuto OG, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/74; Bersten MC, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/61; Bersten MC, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/31; Bersten MC, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/4/68; Biretta J., 2010, HST WFPC2 DATA HDB V; Chornock R, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/41; Dolphin AE, 2000, PUBL ASTRON SOC PAC, V112, P1383, DOI 10.1086/316630; Drout MR, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/97; Folatelli G, 2014, ASTROPHYS J LETT, V793, DOI 10.1088/2041-8205/793/2/L22; Fox OD, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/17; Georgy C, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118340; Groh JH, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321906; Groh JH, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220741; HARRIS WE, 1990, PUBL ASTRON SOC PAC, V102, P949, DOI 10.1086/132720; Jerkstrand A, 2015, ASTRON ASTROPHYS, V573, DOI 10.1051/0004-6361/201423983; Karachentsev ID, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/4/101; Kurucz R, 1993, ATLAS9 STELLAR ATMOS, P13; Li W., 2008, CBET, V1306, P1; Maeda K., 2015, ARXIV150406668; Maund JR, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L37; Phillips MM, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/1/38; Pritchard TA, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/157; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Taubenberger S, 2011, MON NOT R ASTRON SOC, V413, P2140, DOI 10.1111/j.1365-2966.2011.18287.x; Tsvetkov D. Y., 2009, PEREM ZVEZDY, V29, P2; Tully R. B., 1988, NEARBY GALAXY CATALO; Turatto M., 2003, P ESO MPA MPE WORKSH, V200; Van Dyk SD, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/2/L28; Van Dyk SD, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/2/37	53	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							147	10.1088/0004-637X/811/2/147		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800075		
J	Matsuoka, Y; Strauss, MA; Shen, Y; Brandt, WN; Greene, JE; Ho, LC; Schneider, DP; Sun, MY; Trump, JR				Matsuoka, Yoshiki; Strauss, Michael A.; Shen, Yue; Brandt, William N.; Greene, Jenny E.; Ho, Luis C.; Schneider, Donald P.; Sun, Mouyuan; Trump, Jonathan R.			THE SLOAN DIGITAL SKY SURVEY REVERBERATION MAPPING PROJECT: POST-STARBURST SIGNATURES IN QUASAR HOST GALAXIES AT z < 1	ASTROPHYSICAL JOURNAL			English	Article						galaxies: active; galaxies: evolution; galaxies: nuclei; galaxies: stellar content; quasars: general; quasars: supermassive black holes	ACTIVE GALACTIC NUCLEI; SUPERMASSIVE BLACK-HOLES; STAR-FORMATION RATES; RADIO-QUIET QUASARS; INITIAL MASS FUNCTION; OSCILLATION SPECTROSCOPIC SURVEY; NEAR-INFRARED SPECTROSCOPY; IONIZED-GAS NEBULAE; X-RAY; LUMINOSITY FUNCTION	Quasar host galaxies are key for understanding the relation between galaxies and the supermassive black holes (SMBHs) at their centers. We present a study of 191 broad-line quasars and their host galaxies at z < 1, using high signal-to-noise ratio (S/N) spectra produced by the Sloan Digital Sky Survey Reverberation Mapping project. Clear detection of stellar absorption lines allows a reliable decomposition of the observed spectra into nuclear and host components, using spectral models of quasar and stellar radiations as well as emission lines from the interstellar medium. We estimate age, mass M-*, and velocity dispersion sigma(*) of the host stars, the star formation rate (SFR), quasar luminosity, and SMBH mass M-center dot, for each object. The quasars are preferentially hosted by massive galaxies with M-* similar to 10(11) M-circle dot characterized by stellar ages around 1 billion yr, which coincides with the transition phase of normal galaxies from the blue cloud to the red sequence. The host galaxies have relatively low SFRs and fall below the main sequence of star-forming galaxies at similar redshifts. These facts suggest that the hosts have experienced an episode of major star formation sometime in the past 1 billion yr, which was subsequently quenched or suppressed. The derived M-center dot-sigma(*) and M-center dot-M-* relations agree with our past measurements and are consistent with no evolution from the local universe. The present analysis demonstrates that reliable measurements of stellar properties of quasar host galaxies are possible with high-S/N fiber spectra, which will be acquired in large numbers with future powerful instruments such as the Subaru Prime Focus Spectrograph.	[Matsuoka, Yoshiki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Matsuoka, Yoshiki; Strauss, Michael A.; Greene, Jenny E.] Princeton Univ Observ, Princeton, NJ 08544 USA; [Shen, Yue; Ho, Luis C.] Peking Univ, Kavli Inst Astron & Astrophys, Beijing 100871, Peoples R China; [Shen, Yue] Carnegie Observ, Pasadena, CA 91101 USA; [Brandt, William N.; Schneider, Donald P.; Sun, Mouyuan; Trump, Jonathan R.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Brandt, William N.; Schneider, Donald P.; Sun, Mouyuan; Trump, Jonathan R.] Penn State Univ, Inst Gravitat & Cosmos, University Pk, PA 16802 USA; [Brandt, William N.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Ho, Luis C.] Peking Univ, Sch Phys, Dept Astron, Beijing 100871, Peoples R China; [Sun, Mouyuan] Xiamen Univ, Dept Astron, Xiamen 361005, Fujian, Peoples R China; [Sun, Mouyuan] Xiamen Univ, Inst Theoret Phys & Astrophys, Xiamen 361005, Fujian, Peoples R China	Matsuoka, Y (reprint author), Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan.	yk.matsuoka@nao.ac.jp			NSF [AST-1108604]; Chinese Academy of Science (Emergence of Cosmological Structures) from the Strategic Priority Research Program [XDB09030102]; National Natural Science Foundation of China [11473002]; NASA by the Space Telescope Science Institute for NASA [HST-HF-51314, NAS 5-26555]; China Scholarship Council [[2013]3009]; Alfred P. Sloan Foundation; National Science Foundation; U.S. Department of Energy Office of Science; University of Arizona; Brazilian Participation Group; Brookhaven National Laboratory; University of Cambridge; Carnegie Mellon University; University of Florida; French Participation Group; German Participation Group; Harvard University; Instituto de Astrofisica de Canarias; Michigan State/Notre Dame/JINA Participation Group; Johns Hopkins University; Lawrence Berkeley National Laboratory; Max Planck Institute for Astrophysics; Max Planck Institute for Extraterrestrial Physics; New Mexico State University; New York University; Ohio State University; Pennsylvania State University; University of Portsmouth; Princeton University; Spanish Participation Group; University of Tokyo; University of Utah; Vanderbilt University; University of Virginia; University of Washington; Yale University	We are grateful to the referee for useful comments and suggestions. Y.M. thanks Nobunari Kashikawa for fruitful discussions. W.N.B. thanks NSF grant AST-1108604 for support. L.C.H. acknowledges support by the Chinese Academy of Science through grant No. XDB09030102 (Emergence of Cosmological Structures) from the Strategic Priority Research Program and by the National Natural Science Foundation of China through grant No. 11473002. Support for the work of Y.S. was provided by NASA through Hubble Fellowship grant number HST-HF-51314, awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. M.Y.S. acknowledges support from the China Scholarship Council (No. [2013]3009).; Funding for SDSS-III has been provided by the Alfred P. Sloan Foundation, the Participating Institutions, the National Science Foundation, and the U.S. Department of Energy Office of Science. The SDSS-III Web site is http://www.sdss3.org/.; SDSS-III is managed by the Astrophysical Research Consortium for the Participating Institutions of the SDSS-III Collaboration including the University of Arizona, the Brazilian Participation Group, Brookhaven National Laboratory, University of Cambridge, Carnegie Mellon University, University of Florida, the French Participation Group, the German Participation Group, Harvard University, the Instituto de Astrofisica de Canarias, the Michigan State/Notre Dame/JINA Participation Group, Johns Hopkins University, Lawrence Berkeley National Laboratory, Max Planck Institute for Astrophysics, Max Planck Institute for Extraterrestrial Physics, New Mexico State University, New York University, Ohio State University, Pennsylvania State University, University of Portsmouth, Princeton University, the Spanish Participation Group, University of Tokyo, University of Utah, Vanderbilt University, University of Virginia, University of Washington, and Yale University.	Aird J, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/90; Alam Sh., 2015, ARXIV150100963; Annis J, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/120; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; DRESSLER A, 1983, ASTROPHYS J, V270, P7, DOI 10.1086/161093; Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Cardamone CN, 2010, ASTROPHYS J LETT, V721, pL38, DOI 10.1088/2041-8205/721/1/L38; OSTERBROCK DE, 1985, ASTROPHYS J, V297, P166, DOI 10.1086/163513; Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Hao L, 2005, ASTRON J, V129, P1795, DOI 10.1086/428486; Marconi A, 2004, MON NOT R ASTRON SOC, V351, P169, DOI 10.1111/j.1365-2966.2004.07765.x; Liu GL, 2013, MON NOT R ASTRON SOC, V430, P2327, DOI 10.1093/mnras/stt051; Springel V, 2005, ASTROPHYS J, V620, pL79, DOI 10.1086/428772; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Abazajian K, 2004, ASTRON J, V128, P502, DOI 10.1086/421365; Choi JH, 2011, MON NOT R ASTRON SOC, V410, P2579, DOI 10.1111/j.1365-2966.2010.17632.x; Schawinski K, 2010, ASTROPHYS J, V711, P284, DOI 10.1088/0004-637X/711/1/284; BOROSON TA, 1982, NATURE, V296, P397, DOI 10.1038/296397a0; Wu XB, 2015, NATURE, V518, P512, DOI 10.1038/nature14241; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; CALZETTI D, 1994, ASTROPHYS J, V429, P582, DOI 10.1086/174346; Ronnback J, 1996, MON NOT R ASTRON SOC, V283, P282; Brotherton MS, 2002, PUBL ASTRON SOC PAC, V114, P593, DOI 10.1086/341690; Elbaz D, 2007, ASTRON ASTROPHYS, V468, P33, DOI 10.1051/0004-6361:20077525; KOTILAINEN JK, 1994, MON NOT R ASTRON SOC, V266, P953; Dave R, 2011, MON NOT R ASTRON SOC, V415, P11, DOI 10.1111/j.1365-2966.2011.18680.x; Bell EF, 2003, ASTROPHYS J SUPPL S, V149, P289, DOI 10.1086/378847; Kim M, 2006, ASTROPHYS J, V642, P702, DOI 10.1086/501422; RICHSTONE DO, 1980, ASTROPHYS J, V235, P361, DOI 10.1086/157640; DiPompeo MA, 2014, MON NOT R ASTRON SOC, V442, P3443, DOI 10.1093/mnras/stu1115; KORMENDY J, 1982, ASTROPHYS J, V256, P460, DOI 10.1086/159923; Salvato M, 2009, ASTROPHYS J, V690, P1250, DOI 10.1088/0004-637X/690/2/1250; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; Liu GL, 2013, MON NOT R ASTRON SOC, V436, P2576, DOI 10.1093/mnras/stt1755; SCHMIDT M, 1983, ASTROPHYS J, V269, P352, DOI 10.1086/161048; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Silverman JD, 2008, ASTROPHYS J, V675, P1025, DOI 10.1086/527283; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; McLure RJ, 2002, MON NOT R ASTRON SOC, V331, P795, DOI 10.1046/j.1365-8711.2002.05236.x; Jiang LH, 2009, ASTRON J, V138, P305, DOI 10.1088/0004-6256/138/1/305; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Nesvadba NPH, 2006, ASTROPHYS J, V650, P693, DOI 10.1086/507266; Silverman JD, 2009, ASTROPHYS J, V696, P396, DOI 10.1088/0004-637X/696/1/396; Ganguly R, 2007, ASTROPHYS J, V665, P990, DOI 10.1086/519759; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Quintero AD, 2004, ASTROPHYS J, V602, P190, DOI 10.1086/380601; Shi Y, 2009, ASTROPHYS J, V703, P1107, DOI 10.1088/0004-637X/703/1/1107; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Di Matteo T, 2005, NATURE, V433, P604, DOI 10.1038/nature03335; Urrutia T, 2008, ASTROPHYS J, V674, P80, DOI 10.1086/523959; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Pounds KA, 2003, MON NOT R ASTRON SOC, V345, P705, DOI 10.1046/j.1365-8711.2003.07006.x; Le Borgne JF, 2003, ASTRON ASTROPHYS, V402, P433, DOI 10.1051/0004-6361:20030243; Kirhakos S, 1999, ASTROPHYS J, V520, P67, DOI 10.1086/307430; Hopkins PF, 2007, ASTROPHYS J, V654, P731, DOI 10.1086/509629; Bower RG, 2006, MON NOT R ASTRON SOC, V370, P645, DOI 10.1111/j.1365-2966.2006.10519.x; Greene JE, 2006, ASTROPHYS J, V641, P117, DOI 10.1086/500353; Bahcall JN, 1997, ASTROPHYS J, V479, P642, DOI 10.1086/303926; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Merritt D, 2001, MON NOT R ASTRON SOC, V320, pL30, DOI 10.1046/j.1365-8711.2001.04165.x; Ferrara A, 2014, MON NOT R ASTRON SOC, V443, P2410, DOI 10.1093/mnras/stu1280; PREVOT ML, 1984, ASTRON ASTROPHYS, V132, P389; Gofford J, 2013, MON NOT R ASTRON SOC, V430, P60, DOI 10.1093/mnras/sts481; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; Keel WC, 2012, MON NOT R ASTRON SOC, V420, P878, DOI 10.1111/j.1365-2966.2011.20101.x; Jahnke K, 2009, ASTROPHYS J LETT, V706, pL215, DOI 10.1088/0004-637X/706/2/L215; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Reeves JN, 2009, ASTROPHYS J, V701, P493, DOI 10.1088/0004-637X/701/1/493; Wang R, 2010, ASTROPHYS J, V714, P699, DOI 10.1088/0004-637X/714/1/699; Pentericci L, 2003, ASTRON ASTROPHYS, V410, P75, DOI 10.1051/0004-6361:20031201; Hopkins AM, 2003, ASTROPHYS J, V599, P971, DOI 10.1086/379608; Fu H, 2009, ASTROPHYS J, V690, P953, DOI 10.1088/0004-637X/690/1/953; Jiang LH, 2007, ASTRON J, V134, P1150, DOI 10.1086/520811; Hickox RC, 2009, ASTROPHYS J, V696, P891, DOI 10.1088/0004-637X/696/1/891; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; McLure RJ, 1999, MON NOT R ASTRON SOC, V308, P377, DOI 10.1046/j.1365-8711.1999.02676.x; Shimizu TT, 2015, MON NOT R ASTRON SOC, V452, P1841, DOI 10.1093/mnras/stv1407; Jahnke K, 2007, MON NOT R ASTRON SOC, V378, P23, DOI 10.1111/j.1356-2966.2007.11623.x; Richards GT, 2006, ASTRON J, V131, P2766, DOI 10.1086/503559; Jahnke K, 2004, ASTROPHYS J, V614, P568, DOI 10.1086/423233; Hopkins PF, 2004, ASTRON J, V128, P1112, DOI 10.1086/423291; Gunn JE, 2006, ASTRON J, V131, P2332, DOI 10.1086/500975; Charlot S, 2000, ASTROPHYS J, V539, P718, DOI 10.1086/309250; Georgakakis A, 2008, MON NOT R ASTRON SOC, V385, P2049, DOI 10.1111/j.1365-2966.2008.12962.x; BARNES JE, 1991, ASTROPHYS J, V370, pL65, DOI 10.1086/185978; DiPompeo MA, 2015, MON NOT R ASTRON SOC, V446, P3492, DOI 10.1093/mnras/stu2341; Banados E, 2014, ASTRON J, V148, DOI 10.1088/0004-6256/148/1/14; Bernardi M, 2003, ASTRON J, V125, P1817, DOI 10.1086/367776; Bolton AS, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/144; Brandt WN, 2015, ASTRON ASTROPHYS REV, V23, DOI 10.1007/s00159-014-0081-z; Brotherton MS, 1999, ASTROPHYS J, V520, pL87, DOI 10.1086/312152; Canalizo G, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/132; Cano-Diaz M, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201118358; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Comastri A, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201425496; Croom SM, 2009, MON NOT R ASTRON SOC, V399, P1755, DOI 10.1111/j.1365-2966.2009.15398.x; Daddi E, 2007, ASTROPHYS J, V670, P156, DOI 10.1086/521818; Dawson KS, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/1/10; Dressler A., 1989, P IAUS, P217; Dunlop JS, 2003, MON NOT R ASTRON SOC, V340, P1095, DOI 10.1046/j.1365-8711.2003.06333.x; Eisenstein DJ, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/72; Elbaz D, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117239; Elitzur M, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L33; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Feruglio C, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201015164; Francis PJ, 1996, PUBL ASTRON SOC AUST, V13, P212; Glikman E, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/51; Goto T, 2005, MON NOT R ASTRON SOC, V357, P937, DOI 10.1111/j.1365-2966.2005.08701.x; Greene JE, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/9; Hainline KN, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/74; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Ho LC, 2005, ASTROPHYS J, V629, P680, DOI 10.1086/431643; Husemann B, 2010, ASTRON ASTROPHYS, V519, DOI 10.1051/0004-6361/201014559; Ivezic Z, 2002, ASTRON J, V124, P2364, DOI 10.1086/344069; Kaiser N, 2010, PROC SPIE, V7733, DOI 10.1117/12.859188; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kormendy J., 1993, P M NEAR ACT GAL M N, P197; Krawczyk C. M., 2014, ARXIV14127039; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Lacy M, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/24; Madau P., 2014, ASTROPHYS J LETT, V784, pLL38; Maraston C, 2011, MON NOT R ASTRON SOC, V418, P2785, DOI 10.1111/j.1365-2966.2011.19738.x; Markwardt CB, 2009, ASTR SOC P, V411, P251; Matsuoka Y, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/54; Matsuoka Y, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/91; Matsuoka Y, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/2/162; Matute I., 2012, ASTRON ASTROPHYS, V542, pAA20; Mullaney J. R., 2015, ARXIV150605459; Mullaney JR, 2012, MON NOT R ASTRON SOC, V419, P95, DOI 10.1111/j.1365-2966.2011.19675.x; Muzzin A, 2013, ASTROPHYS J SUPPL S, V206, DOI 10.1088/0067-0049/206/1/8; Nandra K, 2007, ASTROPHYS J, V660, pL11, DOI 10.1086/517918; Netzer H., 2015, ARXIV150500811; Newman JA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/5; Noeske KG, 2007, ASTROPHYS J, V660, pL43, DOI 10.1086/517926; Pattarakijwanich P., 2014, ARXIV14107394; PEI YCC, 1992, ASTROPHYS J, V395, P130, DOI 10.1086/171637; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Reyes R, 2008, ASTRON J, V136, P2373, DOI 10.1088/0004-6256/136/6/2373; Richards GT, 2003, ASTRON J, V126, P1131, DOI 10.1086/377014; Rosario DJ, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/59; Salim S, 2007, ASTROPHYS J SUPPL S, V173, P267, DOI 10.1086/519218; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Santini P, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201118266; Schulze A, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117564; Shen Y., 2015, ARXIV150201034; Shen Y, 2013, B ASTRON SOC INDIA, V41, P61; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Shen Y, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/125; Shen Y, 2015, ASTROPHYS J SUPPL S, V216, DOI 10.1088/0067-0049/216/1/4; Smee SA, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/32; SOLTAN A, 1982, MON NOT R ASTRON SOC, V200, P115; Steinhardt CL, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L25; Sun M, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/1/14; Takada M, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst019; Tombesi F, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200913440; Trump J. R., 2015, ARXIV150102801; Trump JR, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/133; Trump JR, 2006, ASTROPHYS J SUPPL S, V165, P1, DOI 10.1086/503834; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Vanden Berk D. E., 2006, Astronomical Journal, V131, DOI 10.1086/497973; Xue YQ, 2010, ASTROPHYS J, V720, P368, DOI 10.1088/0004-637X/720/1/368; Yesuf HM, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/2/84; Yu QJ, 2002, MON NOT R ASTRON SOC, V335, P965, DOI 10.1046/j.1365-8711.2002.05532.x; Zakamska NL, 2003, ASTRON J, V126, P2125, DOI 10.1086/378610	169	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							91	10.1088/0004-637X/811/2/91		20	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800019		
J	Ruud, TM; Fuskeland, U; Wehus, IK; Vidal, M; Araujo, D; Bischoff, C; Buder, I; Chinone, Y; Cleary, K; Dumoulin, RN; Kusaka, A; Monsalve, R; Naess, SK; Newburgh, LB; Reeves, RA; Zwart, JTL; Bronfman, L; Davies, RD; Davis, R; Dickinson, C; Eriksen, HK; Gaier, T; Gundersen, JO; Hasegawa, M; Hazumi, M; Huffenberger, KM; Jones, ME; Lawrence, CR; Leitch, EM; Limon, M; Miller, AD; Pearson, TJ; Piccirillo, L; Radford, SJE; Readhead, ACS; Samtleben, D; Seiffert, M; Shepherd, MC; Staggs, ST; Tajima, O; Thompson, KL				Ruud, T. M.; Fuskeland, U.; Wehus, I. K.; Vidal, M.; Araujo, D.; Bischoff, C.; Buder, I.; Chinone, Y.; Cleary, K.; Dumoulin, R. N.; Kusaka, A.; Monsalve, R.; Naess, S. K.; Newburgh, L. B.; Reeves, R. A.; Zwart, J. T. L.; Bronfman, L.; Davies, R. D.; Davis, R.; Dickinson, C.; Eriksen, H. K.; Gaier, T.; Gundersen, J. O.; Hasegawa, M.; Hazumi, M.; Huffenberger, K. M.; Jones, M. E.; Lawrence, C. R.; Leitch, E. M.; Limon, M.; Miller, A. D.; Pearson, T. J.; Piccirillo, L.; Radford, S. J. E.; Readhead, A. C. S.; Samtleben, D.; Seiffert, M.; Shepherd, M. C.; Staggs, S. T.; Tajima, O.; Thompson, K. L.		QUIET Collaboration	THE Q/U IMAGING EXPERIMENT: POLARIZATION MEASUREMENTS OF THE GALACTIC PLANE AT 43 AND 95 GHz	ASTROPHYSICAL JOURNAL			English	Article						cosmic background radiation; cosmology: observations; Galaxy: center; Galaxy: general; polarization	PROBE WMAP OBSERVATIONS; MICROWAVE BACKGROUND DATA; POWER SPECTRUM; DUST EMISSION; RADIO-SOURCES; COMPLEX; MAPS; SYNCHROTRON; REGION; IMAGER	We present polarization observations of two Galactic plane fields centered on Galactic coordinates (l, b) = (0 degrees, 0 degrees) and (329 degrees, 0 degrees) at both Q (43 GHz) and W bands (95 GHz), covering between 301 and 539 square degrees depending on frequency and field. These measurements were made with the QUIET instrument between 2008 October and 2010 December, and include a total of 1263 hr of observations. The resulting maps represent the deepest large-area Galactic polarization observations published to date at the relevant frequencies with instrumental rms noise varying between 1.8 and 2.8 mu K deg, 2.3-6 times deeper than corresponding WMAP and Planck maps. The angular resolution is 27'.3 and 12 8 FWHM at Q and W bands, respectively. We find excellent agreement between the QUIET and WMAP maps over the entire fields, and no compelling evidence for significant residual instrumental systematic errors in either experiment, whereas the Planck 44 GHz map deviates from these in a manner consistent with reported systematic uncertainties for this channel. We combine QUIET and WMAP data to compute inverse-variance-weighted average maps, effectively retaining small angular scales from QUIET and large angular scales from WMAP. From these combined maps, we derive constraints on several important astrophysical quantities, including a robust detection of polarized synchrotron spectral index steepening of approximate to 0.2 off the plane, as well as the Faraday rotation measure toward the Galactic center (RM = -4000 +/- 200 radm(-2)), all of which are consistent with previously published results. Both the raw QUIET and the co-added QUIET+WMAP maps are made publicly available together with all necessary ancillary information.	[Ruud, T. M.; Fuskeland, U.; Naess, S. K.; Eriksen, H. K.] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [Wehus, I. K.; Gaier, T.; Lawrence, C. R.; Leitch, E. M.; Seiffert, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Vidal, M.; Davies, R. D.; Davis, R.; Dickinson, C.; Piccirillo, L.] Univ Manchester, Sch Phys & Astron, Jodrell Bank Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Araujo, D.; Dumoulin, R. N.; Zwart, J. T. L.; Limon, M.; Miller, A. D.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Araujo, D.; Dumoulin, R. N.; Zwart, J. T. L.; Limon, M.; Miller, A. D.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Bischoff, C.; Buder, I.; Tajima, O.] Univ Chicago, Kavli Inst Cosmol Phys, Enrico Fermi Inst, Dept Phys, Chicago, IL 60637 USA; [Bischoff, C.; Buder, I.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Chinone, Y.; Hasegawa, M.; Hazumi, M.; Tajima, O.] High Energy Accelerator Res Org KEK, Oho, Ibaraki 3050801, Japan; [Chinone, Y.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Cleary, K.; Pearson, T. J.; Radford, S. J. E.; Readhead, A. C. S.; Shepherd, M. C.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA; [Kusaka, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Phys, Berkeley, CA 94720 USA; [Kusaka, A.; Staggs, S. T.] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Monsalve, R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Naess, S. K.; Jones, M. E.] Univ Oxford, Dept Astrophys, Oxford OX1 3RH, England; [Newburgh, L. B.] Univ Toronto, Dunlap Inst, Toronto, ON M5S 3H4, Canada; [Reeves, R. A.] Univ Concepcion, Dept Astron, CePIA, Concepcion, Chile; [Zwart, J. T. L.] Univ Western Cape, Dept Phys, ZA-7535 Bellville, South Africa; [Zwart, J. T. L.] Univ Cape Town, Dept Astron, Astrophys Cosmol & Grav Ctr, ZA-7701 Rondebosch, South Africa; [Bronfman, L.] Univ Chile, Dept Astron, Santiago, Chile; [Gundersen, J. O.] Univ Miami, Dept Phys, Coral Gables, FL 33146 USA; [Huffenberger, K. M.] Florida State Univ, Phys, Tallahassee, FL 32306 USA; [Samtleben, D.] Leiden Univ, Huygens Kamerlingh Onnes Lab, NL-2300 RA Leiden, Netherlands; [Samtleben, D.] NIKHEF H, NL-1009 DB Amsterdam, Netherlands; [Thompson, K. L.] Stanford Univ, Stanford, CA 94305 USA; [Thompson, K. L.] Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA	Ruud, TM (reprint author), Univ Oslo, Inst Theoret Astrophys, POB 1029 Blindern, N-0315 Oslo, Norway.	t.m.ruud@astro.uio.no	Pearson, Timothy/N-2376-2015	Pearson, Timothy/0000-0001-5213-6231	NSF [PHY-0355328, AST-0448909, AST-1010016, PHY-0551142]; KAKENHI [20244041, 20740158, 21111002]; PRODEX [C90284]; KIPAC Enterprise grant; Strategic Alliance for the Implementation of New Technologies (SAINT); JPL R TD program; ERC Starting Grant under FP7; ERC [307209]; STFC (U.K.); South Africa National Research Foundation; CONICYT [PFB-06]	Support for the QUIET instrument and operation comes through the NSF cooperative agreement AST-0506648. Support was also provided by NSF awards PHY-0355328, AST-0448909, AST-1010016, and PHY-0551142; KAKENHI 20244041, 20740158, and 21111002; PRODEX C90284; a KIPAC Enterprise grant; and by the Strategic Alliance for the Implementation of New Technologies (SAINT). This work was performed on the Abel cluster, owned and maintained by the University of Oslo and NOTUR (the Norwegian High Performance Computing Consortium). Portions of this work were performed at the Jet Propulsion Laboratory (JPL) and California Institute of Technology, operating under a contract with the National Aeronautics and Space Administration. The Q-band polarimeter modules were developed using funding from the JPL R & TD program. H.K.E. acknowledges an ERC Starting Grant under FP7. C.D. and M.V. acknowledge support from an ERC Starting Grant (no. 307209). C.D. also acknowledges support from the STFC (U.K.). J.Z. gratefully acknowledges a South Africa National Research Foundation Square Kilometre Array Research Fellowship. L.B. acknowledges support from CONICYT Grant PFB-06. A.D.M. acknowledges a Sloan Fellowship.	Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321591; Ade PAR, 2014, ASTRON ASTROPHYS, V571, DOI 10.1051/0004-6361/201321573; Chiang HC, 2010, ASTROPHYS J, V711, P1123, DOI 10.1088/0004-637X/711/2/1123; Law CJ, 2008, ASTROPHYS J SUPPL S, V177, P255, DOI 10.1086/533587; Tsuboi M, 1995, PUBL ASTRON SOC JPN, V47, P829; Hivon E, 2002, ASTROPHYS J, V567, P2, DOI 10.1086/338126; Kogut A, 2007, ASTROPHYS J, V665, P355, DOI 10.1086/519754; Dickel JR, 2000, ASTROPHYS J, V543, P840, DOI 10.1086/317160; Gorski KM, 2005, ASTROPHYS J, V622, P759, DOI 10.1086/427976; HAYNES RF, 1992, ASTRON ASTROPHYS, V264, P500; Page L, 2007, ASTROPHYS J SUPPL S, V170, P335, DOI 10.1086/513699; de Oliveira-Costa A, 2008, MON NOT R ASTRON SOC, V388, P247, DOI 10.1111/j.1365-2966.2008.13376.x; Jaffe TR, 2013, MON NOT R ASTRON SOC, V431, P683, DOI 10.1093/mnras/stt200; PEDLAR A, 1989, ASTROPHYS J, V342, P769, DOI 10.1086/167635; MacTavish CJ, 2006, ASTROPHYS J, V647, P799, DOI 10.1086/505558; Roy S, 2005, MON NOT R ASTRON SOC, V360, P1305, DOI 10.1111/j.1365-2966.2005.09107.x; Bond JR, 1998, PHYS REV D, V57, P2117, DOI 10.1103/PhysRevD.57.2117; Ade PAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.241101; Sievers JL, 2007, ASTROPHYS J, V660, P976, DOI 10.1086/510504; WARDLE JFC, 1974, ASTROPHYS J, V194, P249, DOI 10.1086/153240; YUSEFZADEH F, 1984, NATURE, V310, P557, DOI 10.1038/310557a0; Ade PAR, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.101301; Finkbeiner DP, 1999, ASTROPHYS J, V524, P867, DOI 10.1086/307852; Readhead ACS, 2004, SCIENCE, V306, P836, DOI 10.1126/science.1105598; Page L, 2003, ASTROPHYS J SUPPL S, V148, P39, DOI 10.1086/377223; WEILER KW, 1988, ANNU REV ASTRON ASTR, V26, P295; King OG, 2014, MON NOT R ASTRON SOC, V438, P2426, DOI 10.1093/mnras/stt2359; Araujo D., 2012, APJ, V760, P145; Bennett CL, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/2/20; BICEP2/Keck Array and Planck Collaborations, 2015, ARXIV150200612; Bierman EM, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/81; Bischoff C., 2012, ARXIV12075562; Bischoff C, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/111; BURN BJ, 1966, MON NOT R ASTRON SOC, V133, P67; Cabral B., 1993, ACM SIGGRAPH SPECIAL, V1993, P263; Carretti E., 2009, S BAND POLARIZATION; Fuskeland U, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/104; Garcia P, 2014, ASTROPHYS J SUPPL S, V212, DOI 10.1088/0067-0049/212/1/2; Green DA, 2009, B ASTRON SOC INDIA, V37, P45; Huffenberger K. M., 2014, ARXIV14121111; Ichiki K., 2014, PTEP; Keskitalo R, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/200912606; King O. G., 2010, P SOC PHOTO-OPT INS, V7741, P1; Liddle A.R., 2000, COSMOLOGICAL INFLATI; Montier L, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424451; Petrolini A, 2014, AM J PHYS, V82, P1178, DOI 10.1119/1.4893679; Planck Collaboration I, 2015, A A UNPUB; Planck Collaboration I, 2014, ASTRON ASTROPHYS, V571, pA1; Planck Collaboration II, 2015, A A UNPUB; *PLANCK COLL, 2011, ASTROPHYSICS, V0536; Planck Collaboration VIII, 2015, A A UNPUB; Planck Collaboration X, 2015, A A UNPUB; Planck Collaboration XI, 2015, A A UNPUB; Planck Collaboration XIII, 2015, A A UNPUB; Rubino-Martin J. A., 2012, ADAST, V2012, P40; Tegmark M, 1997, ASTROPHYS J, V480, pL87, DOI 10.1086/310631; Vidal M., 2014, MNRAS IN PRESS; Vidal M., 2014, MNRAS UNPUB; Woodbury M. A., 1950, 42 PRINC U STAT RES, V4	59	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							89	10.1088/0004-637X/811/2/89		21	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800017		
J	Sano, K; Kawara, K; Matsuura, S; Kataza, H; Arai, T; Matsuoka, Y				Sano, K.; Kawara, K.; Matsuura, S.; Kataza, H.; Arai, T.; Matsuoka, Y.			DERIVATION OF A LARGE ISOTOPIC DIFFUSE SKY EMISSION COMPONENT AT 1.25 AND 2.2 mu m FROM THE COBE/DIRBE DATA	ASTROPHYSICAL JOURNAL			English	Article						cosmic background radiation; dust, extinction; infrared: ISM; infrared: stars; scattering; zodiacal dust	EXTRAGALACTIC BACKGROUND LIGHT; LOW-RESOLUTION SPECTRUM; SOURCE INFRARED SKY; DEEP GALAXY COUNTS; ENERGY GAMMA-RAYS; DIRBE MINUS 2MASS; 100 MICRON CIRRUS; GALACTIC LIGHT; EXPERIMENT SEARCH; COSMOLOGICAL IMPLICATIONS	Using all-sky maps obtained with COBE/DIRBE, we reanalyzed the diffuse sky brightness at 1.25 and 2.2 mu m, which consists of zodiacal light, diffuse Galactic light (DGL), integrated starlight (ISL), and isotropic emission including the extragalactic background light. Our new analysis including an improved estimate of the DGL and the ISL with the 2MASS data showed that deviations of the isotropic emission from isotropy were less than 10% in the entire sky at high Galactic latitude (vertical bar b vertical bar > 35 degrees). We derived the DGL to 100 mu m brightness ratios of similar to 4.79 and similar to 1.49 n W m(-2) MJy(-1) at 1.25 and 2.2 mu m, respectively. The result of our analysis revealed a significantly large isotropic component at 1.25 and 2.2 mu m with intensities of 60.15 +/- 16.14 and 27.68 +/- 6.21 n W m(-2) sr(-1), respectively. This intensity is larger than the integrated galaxy light, upper limits from gamma-ray observation, and potential contribution from exotic sources (i.e., Population III stars, intrahalo light, direct collapse black holes, and dark stars). We therefore conclude that the excess light may originate from the local universe: the Milky Way and/or the solar system.	[Sano, K.; Kataza, H.] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Sano, K.; Kataza, H.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Kawara, K.] Univ Tokyo, Inst Astron, Mitaka, Tokyo 1810015, Japan; [Matsuura, S.] Kwansei Gakuin Univ, Sch Sci & Engn, Dept Phys, Sanda, Hyogo 6691337, Japan; [Arai, T.] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Matsuoka, Y.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Sano, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sano@ir.isas.jaxa.jp			NASA; National Science Foundation	This publication uses the COBE data sets developed by the NASA Goddard Space Flight Center under the guidance of the COBE Science Working Group. This publication also makes use of data products from the 2MASS, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by NASA and the National Science Foundation.	Fazio GG, 2004, ASTROPHYS J SUPPL S, V154, P39, DOI 10.1086/422585; Cambresy L, 2001, ASTROPHYS J, V555, P563, DOI 10.1086/321470; Dwek E, 1998, ASTROPHYS J, V508, pL9, DOI 10.1086/311714; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Levenson LR, 2008, ASTROPHYS J, V683, P585, DOI 10.1086/589808; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351; Fernandez ER, 2013, MON NOT R ASTRON SOC, V433, P2047, DOI 10.1093/mnras/stt874; PALEY ES, 1991, ASTROPHYS J, V376, P335, DOI 10.1086/170283; Thompson RI, 2007, ASTROPHYS J, V666, P658, DOI 10.1086/520634; Zagury F, 1999, ASTRON ASTROPHYS, V352, P645; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Meyer M, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118284; GUHATHAKURTA P, 1989, ASTROPHYS J, V346, P773, DOI 10.1086/168058; Dwek E, 2005, ASTROPHYS J, V634, P155, DOI 10.1086/462400; Zemcov M, 2014, SCIENCE, V346, P732, DOI 10.1126/science.1258168; Dwek E, 2005, ASTROPHYS J, V635, P784, DOI 10.1086/497569; Wright EL, 2000, ASTROPHYS J, V545, P43, DOI 10.1086/317776; Madau P, 2000, MON NOT R ASTRON SOC, V312, pL9, DOI 10.1046/j.1365-8711.2000.03268.x; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Albert J, 2008, SCIENCE, V320, P1752, DOI 10.1126/science.1157087; WAINSCOAT RJ, 1992, ASTROPHYS J SUPPL S, V83, P111, DOI 10.1086/191733; Matsumoto T, 2005, ASTROPHYS J, V626, P31, DOI 10.1086/429383; Salvaterra R, 2003, MON NOT R ASTRON SOC, V339, P973, DOI 10.1046/j.1365-8711.2003.06244.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; MATHIS JS, 1983, ASTRON ASTROPHYS, V128, P212; Franceschini A, 2008, ASTRON ASTROPHYS, V487, P837, DOI 10.1051/0004-6361:200809691; Dwek E, 2013, ASTROPART PHYS, V43, P112, DOI 10.1016/j.astropartphys.2012.09.003; Totani T, 2001, ASTROPHYS J, V550, pL137, DOI 10.1086/319646; Leinert C, 1998, ASTRON ASTROPHYS SUP, V127, P1, DOI 10.1051/aas:1998105; Elvey CT, 1937, ASTROPHYS J, V85, P213, DOI 10.1086/143815; Cooray A, 2012, NATURE, V490, P514, DOI 10.1038/nature11474; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Dwek E, 2005, ASTROPHYS J, V618, P657, DOI 10.1086/426010; Levenson LR, 2007, ASTROPHYS J, V666, P34, DOI 10.1086/520112; Mazin D, 2007, ASTRON ASTROPHYS, V471, P439, DOI 10.1051/0004-6361:20077158; Yue B, 2013, MON NOT R ASTRON SOC, V433, P1556, DOI 10.1093/mnras/stt826; Arendt RG, 1998, ASTROPHYS J, V508, P74, DOI 10.1086/306381; Gorjian V, 2000, ASTROPHYS J, V536, P550, DOI 10.1086/308974; Kelsall T, 1998, ASTROPHYS J, V508, P44, DOI 10.1086/306380; Stecker FW, 2006, ASTROPHYS J, V648, P774, DOI 10.1086/506188; Dwek E, 1998, ASTROPHYS J, V508, P106, DOI 10.1086/306382; Lagache G, 2000, ASTRON ASTROPHYS, V354, P247; LAUREIJS RJ, 1987, ASTRON ASTROPHYS, V184, P269; Kashlinsky A, 2005, NATURE, V438, P45, DOI 10.1038/nature04143; Matsuoka Y, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/119; Aharonian F, 2006, NATURE, V440, P1018, DOI 10.1038/nature04680; Guy J, 2000, ASTRON ASTROPHYS, V359, P419; Finke JD, 2010, ASTROPHYS J, V712, P238, DOI 10.1088/0004-637X/712/1/238; Cooray A, 2007, ASTROPHYS J, V659, pL91, DOI 10.1086/517969; Arai T, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/69; Bernstein RA, 2007, ASTROPHYS J, V666, P663, DOI 10.1086/519824; Brandt TD, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/129; COHEN M, 1993, ASTRON J, V105, P1860, DOI 10.1086/116560; COHEN M, 1994, ASTRON J, V107, P582, DOI 10.1086/116878; COHEN M, 1995, ASTROPHYS J, V444, P874, DOI 10.1086/175659; Cooray A, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/92; Cutri R. M., 2003, IRSA 2MASS ALL SKY P; Dominguez A, 2011, MON NOT R ASTRON SOC, V410, P2556, DOI 10.1111/j.1365-2966.2010.17631.x; Draine BT, 2011, PR S ASTROP, P1; Hauser M. G., 1998, APJ, V508, P106; Hauser M. G., 1998, COBE DIFFUSE INFRA S; Hauser MG, 2001, ANNU REV ASTRON ASTR, V39, P249, DOI 10.1146/annurev.astro.39.1.249; Ienaka N, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/80; Inoue Y, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/197; Kashlinsky A, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/63; MAGNER TJ, 1987, OPT ENG, V26, P264, DOI 10.1117/12.7974060; Matsumoto T, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/124; MATTILA K, 1979, ASTRON ASTROPHYS, V78, P253; Maurer A, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/166; Orr MR, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/77; Schroedter M, 2005, ASTROPHYS J, V628, P617, DOI 10.1086/431173; Tsumura K, 2013, PUBL ASTRON SOC JPN, V65; Tsumura K, 2013, PUBL ASTRON SOC JPN, V65; VANDEHUL.HC, 1969, PHYSICA, V41, P151, DOI 10.1016/0031-8914(69)90249-3; Wright EL, 2001, ASTROPHYS J, V553, P538, DOI 10.1086/320942; Wright EL, 1998, ASTROPHYS J, V496, P1, DOI 10.1086/305345	76	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							77	10.1088/0004-637X/811/2/77		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800005		
J	Toriumi, S; Cheung, MCM; Katsukawa, Y				Toriumi, Shin; Cheung, Mark C. M.; Katsukawa, Yukio			LIGHT BRIDGE IN A DEVELOPING ACTIVE REGION. II. NUMERICAL SIMULATION OF FLUX EMERGENCE AND LIGHT BRIDGE FORMATION	ASTROPHYSICAL JOURNAL			English	Article						sunspots; Sun: interior; Sun: magnetic fields; Sun: photosphere	SOLAR MAGNETIC FEATURES; SUNSPOT UMBRA; PLASMA EJECTIONS; MHD SIMULATIONS; FINE-STRUCTURE; HINODE; DYNAMICS; FIELDS; PHOTOSPHERE; DOTS	Light bridges, the bright structure dividing umbrae in sunspot regions, show various activity events. In Paper I, we reported on an analysis of multi-wavelength observations of a light bridge in a developing active region (AR) and concluded that the activity events are caused by magnetic reconnection driven by magnetconvective evolution. The aim of this second paper is to investigate the detailed magnetic and velocity structures and the formation mechanism of light bridges. For this purpose, we analyze numerical simulation data from a radiative magnetohydrodynamics model of an emerging AR. We find that a weakly magnetized plasma upflow in the near-surface layers of the convection zone is entrained between the emerging magnetic bundles that appear as pores at the solar surface. This convective upflow continuously transports horizontal fields to the surface layer and creates a light bridge structure. Due to the magnetic shear between the horizontal fields of the bridge and the vertical fields of the ambient pores, an elongated cusp-shaped current layer is formed above the bridge, which may be favorable for magnetic reconnection. The striking correspondence between the observational results of Paper I and the numerical results of this paper provides a consistent physical picture of light bridges. The dynamic activity phenomena occur as a natural result of the bridge formation and its convective nature, which has much in common with those of umbral dots and penumbral filaments.	[Toriumi, Shin; Katsukawa, Yukio] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Cheung, Mark C. M.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA	Toriumi, S (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	shin.toriumi@nao.ac.jp			JSPS KAKENHI [26887046, 25220703]; NASA [NNX14AI14G]	The authors thank the anonymous referee for improving the manuscript. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in co-operation with ESA and NSC (Norway). This work was supported by JSPS KAKENHI Grant Number 26887046 (PI: S. Toriumi) and 25220703 (PI: S. Tsuneta). M. C. M. C. acknowledges support by NASA grant NNX14AI14G (Heliophysics Grand Challenges Research).	Shimizu T, 2009, ASTROPHYS J LETT, V696, pL66, DOI 10.1088/0004-637X/696/1/L66; THOMAS JH, 1992, NATO ADV SCI I C-MAT, V375, P3; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Clyne J, 2005, PROC SPIE, V5669, P284, DOI 10.1117/12.586032; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Cheung MCM, 2008, ASTROPHYS J, V687, P1373, DOI 10.1086/591245; Katsukawa Y, 2007, SCIENCE, V318, P1594, DOI 10.1126/science.1146046; ROY JR, 1973, SOL PHYS, V28, P95, DOI 10.1007/BF00152915; Louis RE, 2008, SOL PHYS, V252, P43, DOI 10.1007/s11207-008-9247-z; Rempel M, 2009, SCIENCE, V325, P171, DOI 10.1126/science.1173798; LITES BW, 1991, ASTROPHYS J, V373, P683, DOI 10.1086/170089; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Lites BW, 2013, SOL PHYS, V283, P579, DOI 10.1007/s11207-012-0206-3; Asai A, 2001, ASTROPHYS J, V555, pL65, DOI 10.1086/321738; BISKAMP D, 1995, PHYS REV LETT, V75, P3850, DOI 10.1103/PhysRevLett.75.3850; Strous LH, 1999, ASTROPHYS J, V527, P435, DOI 10.1086/308071; SOLANKI SK, 1993, ASTRON ASTROPHYS, V275, P283; Cheung MCM, 2010, ASTROPHYS J, V720, P233, DOI 10.1088/0004-637X/720/1/233; RUEDI I, 1995, ASTRON ASTROPHYS, V302, P543; BECKERS JM, 1969, SOL PHYS, V10, P384, DOI 10.1007/BF00145526; Berger TE, 2003, ASTROPHYS J, V589, pL117, DOI 10.1086/376494; Cheung MCM, 2007, ASTRON ASTROPHYS, V467, P703, DOI 10.1051/0004-6361:20077048; Hood AW, 2009, ASTRON ASTROPHYS, V503, P999, DOI 10.1051/0004-6361/200912189; Vogler A, 2005, ASTRON ASTROPHYS, V429, P335, DOI 10.1051/0004-6361:20041507; Borrero JM, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201424584; Borrero JM, 2011, LIVING REV SOL PHYS, V8; Cheung MCM, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/6; CHOUDHURI AR, 1986, ASTROPHYS J, V302, P809, DOI 10.1086/164042; Clyne J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/301; Evershed J., 1909, Monthly Notices of the Royal Astronomical Society, V69; Fan Y., 2003, ASTROPHYS J LETT, V589L, P105, DOI DOI 10.1086/375834; Jurcak J, 2006, ASTRON ASTROPHYS, V453, P1079, DOI 10.1051/0004-6361:20054471; Katsukawa Y., 2007, PASJ, V59, P577; Lagg A, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424071; Leake JE, 2014, SPACE SCI REV, V184, P107, DOI 10.1007/s11214-014-0103-1; Leka KD, 1997, ASTROPHYS J, V484, P900, DOI 10.1086/304363; Nishizuka N, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/152; PARKER EN, 1979, ASTROPHYS J, V234, P333, DOI 10.1086/157501; Rempel M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/5; Rempel M, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/62; Rempel M, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/90; Rimmele T, 2008, ASTROPHYS J, V672, P684, DOI 10.1086/523702; Scharmer GB, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220899; Toriumi S, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/137; Schussler M, 2006, ASTROPHYS J, V641, pL73, DOI 10.1086/503772; Zakharov V., 2008, ASTRON ASTROPHYS, V488L, P17; ZWAAN C, 1985, SOL PHYS, V100, P397, DOI 10.1007/BF00158438	48	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							138	10.1088/0004-637X/811/2/138		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800066		
J	Toriumi, S; Katsukawa, Y; Cheung, MCM				Toriumi, Shin; Katsukawa, Yukio; Cheung, Mark C. M.			LIGHT BRIDGE IN A DEVELOPING ACTIVE REGION. I. OBSERVATION OF LIGHT BRIDGE AND ITS DYNAMIC ACTIVITY PHENOMENA	ASTROPHYSICAL JOURNAL			English	Article						Sun: chromosphere; Sun: corona; Sun: interior; Sun: magnetic fields; Sun: photosphere; sunspots Supporting material: animation	SOLAR MAGNETIC FEATURES; X-RAY JETS; HIGH-RESOLUTION; FINE-STRUCTURE; PLASMA EJECTIONS; SUNSPOT UMBRA; HINODE; RECONNECTION; FIELDS; SIMULATION	Light bridges, the bright structures that divide the umbra of sunspots and pores into smaller pieces, are known to produce a wide variety of activity events in solar active regions (ARs). It is also known that the light bridges appear in the assembling process of nascent sunspots. The ultimate goal of this series of papers is to reveal the nature of light bridges in developing ARs and the occurrence of activity events associated with the light bridge structures from both observational and numerical approaches. In this first paper, exploiting the observational data obtained by Hinode, the. Interface Region Imaging Spectrograph, and the. Solar Dynamics Observatory, we investigate the detailed structure of the light bridge in NOAA AR 11974 and its dynamic activity phenomena. As a result, we find that the light bridge has a weak, horizontal magnetic field, which is transported from the interior by a large-scale convective upflow and is surrounded by strong, vertical fields of adjacent pores. In the chromosphere above the bridge, a transient brightening occurs repeatedly and intermittently, followed by a recurrent dark surge ejection into higher altitudes. Our analysis indicates that the brightening is the plasma heating due to magnetic reconnection at lower altitudes, while the dark surge is the cool, dense plasma ejected from the reconnection region. From the observational results, we conclude that the dynamic activity observed in a light bridge structure such as chromospheric brightenings and dark surge ejections are driven by magnetoconvective evolution within the light bridge and its interaction with the surrounding magnetic fields.	[Toriumi, Shin; Katsukawa, Yukio] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Cheung, Mark C. M.] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA	Toriumi, S (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	shin.toriumi@nao.ac.jp			ESA; JSPS KAKENHI [26887046, 25220703]; NASA [NNG09FA40C, NNG04EA00C, NNM07AA01C, NNX14AI14G]; Norwegian Space Centre	The authors thank the anonymous referee for improving the manuscript. Data are courtesy of the science teams of Hinode, SDO and IRIS. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway). HMI and AIA are instruments on board SDO, a mission for NASA's Living With a Star program. IRIS is a NASA small explorer mission developed and operated by LMSAL with mission operations executed at NASA Ames Research center and major contributions to downlink communications funded by ESA and the Norwegian Space Centre. This work was carried out on the Solar Data Analysis System operated by the Astronomy Data Center in cooperation with the Hinode Science Center of NAOJ. This work was supported by JSPS KAKENHI Grant Number 26887046 (PI: S. Toriumi) and 25220703 (PI: S. Tsuneta). MCMC acknowledges support by NASA contracts NNG09FA40C (IRIS), NNG04EA00C (SDO/AIA) and NNM07AA01C (Hinode/SOT), and grant NNX14AI14G (Heliophysics Grand Challenges Research).	Shimizu T, 2009, ASTROPHYS J LETT, V696, pL66, DOI 10.1088/0004-637X/696/1/L66; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; Shibata K, 2007, SCIENCE, V318, P1591, DOI 10.1126/science.1146708; Bharti L, 2007, MON NOT R ASTRON SOC, V376, P1291, DOI 10.1111/j.1365-2966.2007.11525.x; Lemen James R., 2012, Solar Physics, V275, DOI 10.1007/s11207-011-9776-8; YOKOYAMA T, 1995, NATURE, V375, P42, DOI 10.1038/375042a0; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Hurlburt NE, 1996, ASTROPHYS J, V457, P933, DOI 10.1086/176786; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Yokoyama T, 1996, PUBL ASTRON SOC JPN, V48, P353; ROY JR, 1973, SOL PHYS, V28, P95, DOI 10.1007/BF00152915; Scherrer PH, 2012, SOL PHYS, V275, P207, DOI 10.1007/s11207-011-9834-2; NOVEMBER LJ, 1988, ASTROPHYS J, V333, P427, DOI 10.1086/166758; Louis RE, 2008, SOL PHYS, V252, P43, DOI 10.1007/s11207-008-9247-z; Hirzberger J, 2002, ASTRON ASTROPHYS, V383, P275, DOI 10.1051/0004-6361:20011685; LITES BW, 1991, ASTROPHYS J, V373, P683, DOI 10.1086/170089; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Lites BW, 2013, SOL PHYS, V283, P579, DOI 10.1007/s11207-012-0206-3; Asai A, 2001, ASTROPHYS J, V555, pL65, DOI 10.1086/321738; Freeland SL, 1998, SOL PHYS, V182, P497, DOI 10.1023/A:1005038224881; Pesnell WD, 2012, SOL PHYS, V275, P3, DOI 10.1007/s11207-011-9841-3; Louis RE, 2009, ASTROPHYS J LETT, V704, pL29, DOI 10.1088/0004-637X/704/1/L29; LITES BW, 1995, ASTROPHYS J, V446, P877, DOI 10.1086/175845; Cheung MCM, 2010, ASTROPHYS J, V720, P233, DOI 10.1088/0004-637X/720/1/233; SOBOTKA M, 1994, ASTROPHYS J, V426, P404, DOI 10.1086/174076; RUEDI I, 1995, ASTRON ASTROPHYS, V302, P543; BECKERS JM, 1969, SOL PHYS, V10, P384, DOI 10.1007/BF00145526; Ellerman F, 1917, ASTROPHYS J, V46, P298, DOI 10.1086/142366; Berger TE, 2003, ASTROPHYS J, V589, pL117, DOI 10.1086/376494; Schou J, 2012, SOL PHYS, V275, P229, DOI 10.1007/s11207-011-9842-2; Bray R. J., 1964, INT ASTROPHYSICS SER; Cheung MCM, 2014, LIVING REV SOL PHYS, V11, P5, DOI 10.12942/lrsp-2014-3; CHOUDHURI AR, 1986, ASTROPHYS J, V302, P809, DOI 10.1086/164042; Garcia de La Rosa J. I., 1987, SOPH, V112, P49; Jurcak J, 2006, ASTRON ASTROPHYS, V453, P1079, DOI 10.1051/0004-6361:20054471; Katsukawa Y., 2007, PASJ, V59, P577; Lagg A, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201424071; Leka KD, 1997, ASTROPHYS J, V484, P900, DOI 10.1086/304363; Lites B., 2007, MEM SOC ASTRON ITAL, V78, P148; PARKER EN, 1979, ASTROPHYS J, V234, P333, DOI 10.1086/157501; Peter H, 2014, SCI, V346, P315; Rempel M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/5; Shibata K, 2011, LIVING REV SOL PHYS, V8; Takasao S, 2013, PUBL ASTRON SOC JPN, V65; Toriumi S, 2014, ASTROPHYS J, V794, DOI [10.1088/0004-637X/794/1/19, 10.1088/0004637X/794/1/19]; Toriumi S, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/138; Vissers G. J. M., 2015, APJ IN PRESS	48	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							137	10.1088/0004-637X/811/2/137		13	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800065		
J	Yokozawa, T; Asano, M; Kayano, T; Suwa, Y; Kanda, N; Koshio, Y; Vagins, MR				Yokozawa, Takaaki; Asano, Mitsuhiro; Kayano, Tsubasa; Suwa, Yudai; Kanda, Nobuyuki; Koshio, Yusuke; Vagins, Mark R.			PROBING THE ROTATION OF CORE-COLLAPSE SUPERNOVA WITH A CONCURRENT ANALYSIS OF GRAVITATIONAL WAVES AND NEUTRINOS	ASTROPHYSICAL JOURNAL			English	Article						gravitational waves; neutrinos; stars: rotation; supernovae: general	CIRCLE-DOT STAR; DRIVEN SUPERNOVA; NEUTRON-STARS; HYDRODYNAMICS SIMULATIONS; EXPLOSION MODELS; MASSIVE STARS; SASI ACTIVITY; TRANSPORT; RADIATION; INSTABILITY	The next time a core-collapse supernova (SN) explodes in our galaxy, various detectors will be ready and waiting to detect its emissions of gravitational waves (GWs) and neutrinos. Current numerical simulations have successfully introduced multi-dimensional effects to produce exploding SN models, but thus far the explosion mechanism is not well understood. In this paper, we focus on an investigation of progenitor core rotation via comparison of the start time of GW emission and that of the neutronization burst. The GW and neutrino detectors are assumed to be, respectively, the KAGRA detector and a co-located gadolinium-loaded water Cherenkov detector, either EGADS or GADZOOKS!. Our detection simulation studies show that for a nearby SN (0.2 kpc) we can confirm the lack of core rotation close to 100% of the time, and the presence of core rotation about 90% of the time. Using this approach there is also the potential to confirm rotation for considerably more distant Milky Way SN explosions.	[Yokozawa, Takaaki; Asano, Mitsuhiro; Kanda, Nobuyuki] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Kayano, Tsubasa; Koshio, Yusuke] Okayama Univ, Dept Phys, Okayama, Okayama 7008530, Japan; [Suwa, Yudai] Kyoto Univ, Yukawa Inst Theoret Phys, Sakyo Ku, Kyoto 6068502, Japan; [Suwa, Yudai] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Vagins, Mark R.] Univ Tokyo, Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Vagins, Mark R.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	Yokozawa, T (reprint author), Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan.				MEXT [24103004, 24103005, 24103006, 25103511]; JSPS postdoctoral fellowships for research abroad; MEXT SPIRE; JICFuS	This work was supported by the MEXT Grant-in-Aid for Scientific Research on Innovative Areas "New Developments in Astrophysics Through Multi-messenger Observations of Gravitational Wave Sources" (Nos. 24103004, 24103005, 24103006, 25103511), JSPS postdoctoral fellowships for research abroad, MEXT SPIRE, and JICFuS. Numerical computations in this study were in part carried on XC30 at CfCA in NAOJ and SR16000 at YITP in Kyoto University.	Abdikamalov E., 2013, ARXIV13113678; Abe K., 2011, ARXIV11093262; Adams SM, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/164; Anderson WG, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.042003; BIONTA RM, 1987, PHYS REV LETT, V58, P1494, DOI 10.1103/PhysRevLett.58.1494; HIRATA K, 1987, PHYS REV LETT, V58, P1490, DOI 10.1103/PhysRevLett.58.1490; Ott CD, 2008, ASTROPHYS J, V685, P1069, DOI 10.1086/591440; Dimmelmeier H, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.064056; Burrows A, 1996, PHYS REV LETT, V76, P352, DOI 10.1103/PhysRevLett.76.352; Kotake K, 2012, ADV ASTRON, DOI 10.1155/2012/428757; Dighe AS, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.033007; Buras R, 2006, ASTRON ASTROPHYS, V457, P281, DOI 10.1051/0004-6361:20054654; Beacom JF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.171101; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; Summerscales TZ, 2008, ASTROPHYS J, V678, P1142, DOI 10.1086/528362; Pagliaroli G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.031102; Ott CD, 2006, ASTROPHYS J SUPPL S, V164, P130, DOI 10.1086/500832; MONCHMEYER R, 1991, ASTRON ASTROPHYS, V246, P417; Heger A, 2005, ASTROPHYS J, V626, P350, DOI 10.1086/429868; Aso Y, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043007; Grover K, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.042004; ALEKSEEV EN, 1987, JETP LETT+, V45, P589; Lindblom L, 1998, PHYS REV LETT, V80, P4843, DOI 10.1103/PhysRevLett.80.4843; Abbott BP, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/7/076901; Beck PG, 2012, NATURE, V481, P55, DOI 10.1038/nature10612; LATTIMER JM, 1991, NUCL PHYS A, V535, P331, DOI 10.1016/0375-9474(91)90452-C; WAINSCOAT RJ, 1992, ASTROPHYS J SUPPL S, V83, P111, DOI 10.1086/191733; TOTANI T, 1995, ASTROPART PHYS, V3, P367, DOI 10.1016/0927-6505(95)00015-9; Halzen F, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.087301; Accadia T, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/11/114002; Abdikamalov E, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.044001; Engels WJ, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.124026; Burrows A, 2006, ASTROPHYS J, V640, P878, DOI 10.1086/500174; Kuroda T, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.044011; COLGATE SA, 1966, ASTROPHYS J, V143, P626, DOI 10.1086/148549; Ikeda M, 2007, ASTROPHYS J, V669, P519, DOI 10.1086/521547; BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; Kachelriess M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.063003; Ando S, 2002, PROG THEOR PHYS, V107, P957, DOI 10.1143/PTP.107.957; Watanabe H, 2009, ASTROPART PHYS, V31, P320, DOI 10.1016/j.astropartphys.2009.03.002; Obergaulinger M, 2006, ASTRON ASTROPHYS, V450, P1107, DOI 10.1051/0004-6361:20054306; Burrows A, 2013, REV MOD PHYS, V85, P245, DOI 10.1103/RevModPhys.85.245; Hayama K, 2008, CLASSICAL QUANT GRAV, V25, DOI 10.1088/0264-9381/25/18/184022; Rover C, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.102004; BAHCALL JN, 1995, PHYS REV D, V51, P6146, DOI 10.1103/PhysRevD.51.6146; Logue J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.044023; BETHE HA, 1990, REV MOD PHYS, V62, P801, DOI 10.1103/RevModPhys.62.801; Tomas R, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.093013; Marek A, 2009, ASTROPHYS J, V694, P664, DOI 10.1088/0004-637X/694/1/664; Dimmelmeier H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.251101; Jaranowski P, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.063001; Suwa Y, 2010, PUBL ASTRON SOC JPN, V62, pL49; Ott CD, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.024026; Nishino H, 2009, NUCL INSTRUM METH A, V610, P710, DOI 10.1016/j.nima.2009.09.026; Bruenn SW, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/1/L6; BRUENN SW, 1985, ASTROPHYS J SUPPL S, V58, P771, DOI 10.1086/191056; Couch SM, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/123; Dolence JC, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/10; Edwards MC, 2014, INVERSE PROBL, V30, DOI 10.1088/0266-5611/30/11/114008; EPSTEIN R, 1978, ASTROPHYS J, V223, P1037, DOI 10.1086/156337; ERIGUCHI Y, 1985, ASTRON ASTROPHYS, V146, P260; Gando A, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.021601; Handy T, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/125; Hanke F, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/66; Hanke F, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/138; Janka HT, 2012, ANNU REV NUCL PART S, V62, P407, DOI 10.1146/annurev-nucl-102711-094901; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Kuroda K, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084004; Lentz EJ, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/73; Lentz E. J., 2015, ARXIV150505110; Liebendorfer M, 2009, ASTROPHYS J, V698, P1174, DOI 10.1088/0004-637X/698/2/1174; Melson T, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L24; Mohanty SD, 2002, CLASSICAL QUANT GRAV, V19, P1513, DOI 10.1088/0264-9381/19/7/338; Mori T., 2013, JPCS, V408, P1; Mueller E., 1997, ASTRON ASTROPHYS, V317, P140; Muller B., 2015, ARXIV150605139; Muller B, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/1/84; Muller B, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/1/43; Ott CD, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/6/063001; Pan K.-C., 2015, ARXIV150502513; Sawai H, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L19; Scheidegger S, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913220; Sekiguchi Y, 2010, PROG THEOR PHYS, V124, P331; Suwa Y., 2014, ARXIV14066414; Suwa Y, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/165; Suwa Y, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/1/99; Suwa Y, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/pst030; Takiwaki T, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/30; Takiwaki T, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/83; Takiwaki T, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/98; Yokozawa T., 2011, ICRC, V4, P90; Zwerger T, 1997, ASTRON ASTROPHYS, V320, P209	92	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2015	811	2							86	10.1088/0004-637X/811/2/86		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CU4QE	WOS:000363513800014		
J	Ellegood, J; Nakai, N; Nakatani, J; Henkelman, M; Takumi, T; Lerch, J				Ellegood, Jacob; Nakai, Nobuhiro; Nakatani, Jin; Henkelman, Mark; Takumi, Toru; Lerch, Jason			Neuroanatomical Phenotypes Are Consistent With Autism-Like Behavioral Phenotypes in the 15q11-13 Duplication Mouse Model	AUTISM RESEARCH			English	Article						animal models; structural MRI; neuroanatomy; copy number variation; molecular genetics; 15q11-13 duplication	FRAGILE-X-SYNDROME; COPY NUMBER VARIATION; IMAGE REGISTRATION; SPECTRUM DISORDER; 15Q DUPLICATION; PROXIMAL 15Q; MUTANT MOUSE; BRAIN; MRI; MICE	Paternally and maternally inherited deletions and duplications of human chromosome 15q11-13 are relatively common in the human population. Furthermore, duplications in the 15q region are often associated with autism. Both maternal and paternal interstitial 15q11-13 duplication mouse models have been previously created, where several behavioral differences were found in the paternal duplication (patDp/+) mouse but not in the maternal duplication (matDp/+). These included decreased sociability, behavioral inflexibility, abnormal ultrasonic vocalizations, decreased spontaneous activity, and increased anxiety. Similarly, in the current study, we found several anatomical differences in the patDp/+ mice that were not seen in the matDp/+ mice. Regional differences that are evident only in the paternal duplication are a smaller dentate gyrus and smaller medial striatum. These differences may be responsible for the behavioral inflexibility. Furthermore, a smaller dorsal raphe nucleus could be responsible for the reported serotonin defects. This study highlights consistency that can be found between behavioral and anatomical phenotyping. Autism Res2015, 8: 545-555. (c) 2015 International Society for Autism Research, Wiley Periodicals, Inc.	[Ellegood, Jacob; Henkelman, Mark; Lerch, Jason] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5T 3H7, Canada; [Nakai, Nobuhiro; Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Nakatani, Jin] Shiga Univ Med Sci, Otsu, Shiga, Japan; [Nakatani, Jin; Henkelman, Mark] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	Ellegood, J (reprint author), Hosp Sick Children, Mouse Imaging Ctr, 25 Orde St, Toronto, ON M5T 3H7, Canada.	jacob@mouseimaging.ca			Ministry of Education, Culture, Sports, Science and Technology in Japan; CREST from the Japanese Science and Technology Agency; Canadian Institute for Health Research (CIHR); Ontario Brain Institute (OBI)	This work was supported by Ministry of Education, Culture, Sports, Science and Technology in Japan Grants-in-Aid for Scientific Research (T.T.), CREST from the Japanese Science and Technology Agency (T.T.), the Canadian Institute for Health Research (CIHR), and the Ontario Brain Institute (OBI).	Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; Lerch JR, 2011, METHODS MOL BIOL, V711, P349, DOI 10.1007/978-1-61737-992-5_17; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Dai JX, 2008, P NATL ACAD SCI USA, V105, P11981, DOI 10.1073/pnas.0801329105; Ellegood J, 2014, MOL PSYCHIATR, V19, P99, DOI 10.1038/mp.2013.112; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Harper KM, 2012, HUM MOL GENET, V21, P3489, DOI 10.1093/hmg/dds180; BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Ellegood J, 2011, AUTISM RES, V4, P368, DOI 10.1002/aur.215; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Zhang JY, 2010, NEUROIMAGE, V49, P2340, DOI 10.1016/j.neuroimage.2009.10.027; Pacey LKK, 2013, HUM MOL GENET, V22, P3920, DOI 10.1093/hmg/ddt246; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Mercer RE, 2009, AM J MED GENET B, V150B, P1085, DOI 10.1002/ajmg.b.30934; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Nomura J, 2012, NEURAL PLAST, DOI 10.1155/2012/589524; Mao R, 2000, GENET MED, V2, P131, DOI 10.1097/00125817-200003000-00003; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Bolton PF, 2001, AM J MED GENET, V105, P675, DOI 10.1002/ajmg.1551; Bock NA, 2005, MAGNET RESON MED, V54, P1311, DOI 10.1002/mrm.20683; Takumi T, 2011, J NEURODEV DISORD, V3, P270, DOI 10.1007/s11689-011-9088-1; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Portmann T, 2014, CELL REP, V7, P1077, DOI 10.1016/j.celrep.2014.03.036; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Cook EH, 1997, AM J HUM GENET, V60, P928; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Vousden DA, 2015, BRAIN STRUCT FUNCT, V220, P2043, DOI 10.1007/s00429-014-0774-0; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Ward BC, 2008, NEUROBIOL DIS, V31, P110, DOI 10.1016/j.nbd.2008.03.009; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.00123.x; Veltman MWM, 2005, J AUTISM DEV DISORD, V35, P117, DOI 10.1007/s10803-004-1039-1; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; Havekes R, 2006, LEARN MEMORY, V13, P753, DOI 10.1101/lm.323606; Wegiel J, 2012, J NEUROPATH EXP NEUR, V71, P382, DOI 10.1097/NEN.0b013e318251f537; Kooy RF, 1999, EUR J HUM GENET, V7, P526, DOI 10.1038/sj.ejhg.5200348; Battaglia A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-30; Boronat S, 2015, J CHILD NEUROL, V30, P333, DOI 10.1177/0883073814538669; Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators Centers for Disease Control and Prevention (CDC), 2010, MMWR SURVEILL SUMM, V63, P1; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Ellegood J, 2014, MOL PSYCHIATR, V20, P118; Ellegood Jacob, 2012, Front Psychiatry, V3, P37, DOI 10.3389/fpsyt.2012.00037; Farook MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043030; Liu XX, 2014, BIOCHEM BIOPH RES CO, V452, P244, DOI 10.1016/j.bbrc.2014.08.108; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV; Saywell Véronique, 2006, Biochem Biophys Res Commun, V340, P776, DOI 10.1016/j.bbrc.2005.12.080; Tamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015126	61	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-3792	1939-3806		AUTISM RES	Autism Res.	OCT	2015	8	5					545	555		10.1002/aur.1469		11	Behavioral Sciences; Psychology, Developmental	Behavioral Sciences; Psychology	CU9OT	WOS:000363874700008		
J	Iwamoto, S; Boonvisut, S; Makishima, S; Ishizuka, Y; Watanabe, K; Nakayama, K				Iwamoto, Sadahiko; Boonvisut, Supichaya; Makishima, Saho; Ishizuka, Yuumi; Watanabe, Kazuhisa; Nakayama, Kazuhiro			The role of TRIB1 in lipid metabolism; from genetics to pathways	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article						lipid transfer protein; molecular interaction; single nucleotide polymorphism (SNP) association studies; triglyceride; very low-density lipoprotein (VLDL)	DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; PROTEIN-BETA DELETION; BINDING-PROTEIN; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; HEPATIC STEATOSIS; BLOOD-LIPIDS; LOCI	The plasma concentration of lipids is a heritable risk factor for the development of atherosclerosis and related coronary artery diseases (CAD). Mammalian tribbles homologue 1 (TRIB1) is a human locus, the downstream linkage disequilibrium (LD) block of which affects plasma low-density lipoprotein (LDL)-associated cholesterol, triglyceride (TG) levels and CAD across multiple ethnic groups. In addition, association of TRIB1 with non-alcoholic fatty liver disease (NAFLD) has also been shown. A regulatory sequence that enhances TRIB1 promoter activity was identified in the LD block and the minor allele of a single nt polymorphism (SNP, rs6982502) in this regulatory sequence reduces the activity of the TRIB1 promoter. The minor allele of rs6982502 is a risk allele for increasing plasma lipid levels and NAFLD. Trib1 deficiency increases plasma cholesterol and TGs in mice and overexpression of TRIB1 in mouse liver reduces these factors. Expression of rate-limiting lipogenic enzymes is increased in Trib1-knockout mouse liver and decreased with overexpression. Recently, carbohydrate-responsive element-binding protein (ChREBP) emerged as a novel binding partner of TRIB1. Furthermore, novel binding partner, Sin3A (Swi-independent 3A)-associated protein, 18 kDa, was identified, which activates microsomal TG transfer protein (MTTP) expression by binding with MTTP regulatory elements in co-ordination with mSin3A and TRIB1. Very recently, a small molecular compound that up-regulates TRIB1 expression in HepG2 cells has been discovered. Further exploration of the binding partners of TRIB1 and their involvement in lipid metabolism may aid discovery of novel pharmacological targets for the management of dyslipidaemia and steatosis.	[Iwamoto, Sadahiko; Boonvisut, Supichaya; Makishima, Saho; Ishizuka, Yuumi; Watanabe, Kazuhisa; Nakayama, Kazuhiro] Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan	Iwamoto, S (reprint author), Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan.	siwamoto@jichi.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [25461377]; Takeda Science Foundation [3-2313-004]	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology [grant number 25461377]; and the Takeda Science Foundation [grant number 3-2313-004].	Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Garcia-Rios A, 2011, NUTR METAB CARDIOVAS, V21, P957, DOI 10.1016/j.numecd.2010.04.002; Sung HY, 2006, IMMUNOL LETT, V104, P171, DOI 10.1016/j.imlet.2005.11.010; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Nakayama K, 2009, J MED GENET, V46, P370, DOI 10.1136/jmg.2008.064063; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI [10.1172/JCI44213, 10.1172/JC144213]; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Schunkert H, 2011, NAT GENET, V43, P333, DOI 10.1038/ng.784; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Lewington S, 2007, LANCET, V370, P1829; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Lee YH, 1997, MOL CELL BIOL, V17, P6014; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Matsusue K, 2004, MOL ENDOCRINOL, V18, P2751, DOI 10.1210/me.2004-0213; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Tai ES, 2009, J LIPID RES, V50, P514, DOI 10.1194/jlr.M800456-JLR200; Kitamoto A, 2014, ENDOCR J, V61, P683, DOI 10.1507/endocrj.EJ14-0052; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Varbo A, 2011, ARTERIOSCL THROM VAS, V31, P451, DOI 10.1161/ATVBAHA.110.216333; Qiao LP, 2006, ENDOCRINOLOGY, V147, P3060, DOI 10.1210/en.2005-1507; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Douvris A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000884; Ishizuka Y., 2014, J MOL ENDOCRINOL, V24, P145; Nagiec MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120295; Schroeder-Gloeckler JM, 2007, J BIOL CHEM, V282, P15717, DOI 10.1074/jbc.M701329200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Zhang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027305	36	0	0	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	OCT	2015	43		5				1063	1068		10.1042/BST20150094		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU7ZF	WOS:000363759700044		
J	Nakamura, T				Nakamura, Takuro			The role of Trib1 in myeloid leukaemogenesis and differentiation	BIOCHEMICAL SOCIETY TRANSACTIONS			English	Article						acute myeloid leukaemia (AML); CCAAT/enhancer binding protein (C/EBP); haematopoiesis; mitogen-activated protein kinase (MAPK); tribbles homolog 1 (Trib1)	ACUTE MYELOGENOUS LEUKEMIA; C/EBP-ALPHA MUTATIONS; INITIATING CELLS; DOUBLE MINUTES; AMPLIFICATION; DEGRADATION; EXPRESSION; MIGRATION; MEIS1; HOXA9	Tribbles homolog 1 (Trib1) was identified as a common integration site of the Homeobox a9 (Hoxa9)/murine ecotropic virus integration site 1 (Meis1) retrovirus in acute myeloid leukaemia (AML). Trib1 is by itself a transforming gene for myeloid cells but also significantly accelerates progression of Hoxa9/Meis1-induced AML. The strong transforming activity of Trib1 depends on its bi-directional function in CCAAT/enhancer-binding protein (C/EBP alpha) degradation and MAPK/ERK kinase (MEK)/extracellular-signal-regulated kinase (ERK) activation. TRIB1 is also involved in a certain type of human AML and a TRIB1 somatic point mutation R107L was identified in a case of Down syndrome (DS)-related acute megakaryocytic leukaemia. Although Trib1 knockout (KO) did not suppress haematopoiesis in mouse bone marrow significantly, increase in mature granulocytes was observed and promotion of myeloid differentiation was associated with the increased C/EBP alpha protein. Trib1 thus plays an important role in myeloid cell development and transformation.	Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Tokyo 1358550, Japan	Nakamura, T (reprint author), Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Tokyo 1358550, Japan.	takuro-ind@umin.net			Japan Society for the Promotion of Science [26640085]	This work was supported by the Japan Society for the Promotion of Science [grant number 26640085].	Yokoyama T, 2012, BLOOD, V119, P2608, DOI 10.1182/blood-2010-12-324806; Yoshida A, 2013, BLOOD, V122, P1750, DOI 10.1182/blood-2012-12-476101; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Rothlisberger B, 2007, CANCER GENET CYTOGEN, V176, P58, DOI 10.1016/j.cancergencyto.2007.03.003; Rorth P, 2000, MOL CELL, V6, P23; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Kato N, 2011, BLOOD, V117, P221, DOI 10.1182/blood-2010-02-270181; Quere R, 2011, BLOOD, V117, P5918, DOI 10.1182/blood-2010-08-301879; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Sugawara W, 2011, GENE CHROMOSOME CANC, V50, P535, DOI 10.1002/gcc.20878; Storlazzi CT, 2006, HUM MOL GENET, V15, P933, DOI 10.1093/hmg/ddl010; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Nakamura T, 2005, CANCER SCI, V96, P7, DOI 10.1111/j.1349-7006.2005.00011.x; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Bruckert P, 2000, CANCER GENET CYTOGEN, V120, P73, DOI 10.1016/S0165-4608(99)00235-6; Kanezaki R, 2010, BLOOD, V116, P4631, DOI 10.1182/blood-2010-05-282426; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Naiki T, 2007, J BIOL CHEM, V282, P24075, DOI 10.1074/jbc.M701409200; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Bailey FP, 2015, BIOCHEM J, V465, P195, DOI 10.1042/BJ20141060; Das R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109530; Kiss-Toth E., 2004, J BIOL CHEM, V279, P41703; Silvernnoinen O., 2015, BLOOD IN PRESS; Sung H.Y., 2007, J BIOL CHEM, V282, P13879	36	0	0	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0300-5127	1470-8752		BIOCHEM SOC T	Biochem. Soc. Trans.	OCT	2015	43		5				1104	1107		10.1042/BST20150110		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU7ZF	WOS:000363759700051		
J	Fu, KCD; Libera, FD; Ishiguro, H				Fu, Kin Chung Denny; Libera, Fabio Dalla; Ishiguro, Hiroshi			Extracting motor synergies from random movements for low-dimensional task-space control of musculoskeletal robots	BIOINSPIRATION & BIOMIMETICS			English	Article						motor synergies; dimensionality reduction; task-space control; Kernel-based learning; musculoskeletal robots	MUSCLE SYNERGIES; OPERATIONAL SPACE; BEHAVIOR	In the field of human motor control, the motor synergy hypothesis explains how humans simplify body control dimensionality by coordinating groups of muscles, called motor synergies, instead of controlling muscles independently. In most applications of motor synergies to low-dimensional control in robotics, motor synergies are extracted from given optimal control signals. In this paper, we address the problems of how to extract motor synergies without optimal data given, and how to apply motor synergies to achieve low-dimensional task-space tracking control of a human-like robotic arm actuated by redundant muscles, without prior knowledge of the robot. We propose to extract motor synergies from a subset of randomly generated reaching-like movement data. The essence is to first approximate the corresponding optimal control signals, using estimations of the robot's forward dynamics, and to extract the motor synergies subsequently. In order to avoid modeling difficulties, a learning-based control approach is adopted such that control is accomplished via estimations of the robot's inverse dynamics. We present a kernel-based regression formulation to estimate the forward and the inverse dynamics, and a sliding controller in order to cope with estimation error. Numerical evaluations show that the proposed method enables extraction of motor synergies for low-dimensional task-space control.	[Fu, Kin Chung Denny; Libera, Fabio Dalla; Ishiguro, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Suita, Osaka 565, Japan	Fu, KCD (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Suita, Osaka 565, Japan.	denny.fu@irl.sys.es.osaka-u.ac.jp; fabiodl@gmail.com; ishiguro@is.sys.es.osaka-u.ac.jp					Alessandro C, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00191; Alessandro C, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00043; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Schaal S, 2005, CURR OPIN NEUROBIOL, V15, P675, DOI 10.1016/j.conb.2005.10.009; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Malhotra M, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P5117, DOI 10.1109/ICRA.2012.6224651; Nakanishi J, 2008, INT J ROBOT RES, V27, P737, DOI 10.1177/0278364908091463; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Artemiadis PK, 2010, IEEE T ROBOT, V26, P393, DOI 10.1109/TRO.2009.2039378; Chhabra M, 2006, NEURAL COMPUT, V18, P2320, DOI 10.1162/neco.2006.18.10.2320; Luck KS, 2014, IEEE INT C INT ROBOT, P1434, DOI 10.1109/IROS.2014.6942745; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Diamond A, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/1/016015; Berniker M, 2009, P NATL ACAD SCI USA, V106, P7601, DOI 10.1073/pnas.0901512106; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Latash ML, 2010, HUM MOVEMENT SCI, V29, P642, DOI 10.1016/j.humov.2009.11.002; Nguyen-Tuong D, 2012, IEEE T NEUR NET LEAR, V23, P1417, DOI 10.1109/TNNLS.2012.2201261; Romero J, 2013, IEEE T ROBOT, V29, P1342, DOI 10.1109/TRO.2013.2272249; Peters J, 2008, INT J ROBOT RES, V27, P197, DOI 10.1177/0278364907087548; Bernstein N.A., 1967, COORDINATION REGULAT; Bishop C. M., 2009, PATTERN RECOGNITION; Bitzer S, 2009, IEEE RAS INT C HUM R, P574; Caligiore D., 2008, INT C COGN SYST, pE1; Fu Kin Chung Denny, 2013, International Journal of Automation and Computing, V10, DOI 10.1007/s11633-013-0749-2; Michael E, 2003, P 9 INT WORKSH ART I, P3; Millard M, 2013, ASME J BIOMECH ENG, V135; Rolf M, 2010, IEEE T AUTON MENT DE, V3, P216; Salaun C, 2009, P 2009 IEEE INT C IN; Sankaranarayanan V, 2009, T ROBOT, V25, P459; Schmidt R. A., 1999, MOTOR CONTROL LEARNI; Scholkopf B, 2001, LEARNING KERNELS SUP; Slotine JJE, 1991, APPL NONLINEAR CONTR; Winters J, 1990, MULTIPLE MUSCLE SYST, P69; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-3182	1748-3190		BIOINSPIR BIOMIM	Bioinspir. Biomim.	OCT	2015	10	5							056016	10.1088/1748-3190/10/5/056016		17	Engineering, Multidisciplinary; Materials Science, Biomaterials; Robotics	Engineering; Materials Science; Robotics	CU5AM	WOS:000363543700025		
J	Shi, Q; Ishii, H; Tanaka, K; Sugahara, Y; Takanishi, A; Okabayashi, S; Huang, Q; Fukuda, T				Shi, Qing; Ishii, Hiroyuki; Tanaka, Katsuaki; Sugahara, Yusuke; Takanishi, Atsuo; Okabayashi, Satoshi; Huang, Qiang; Fukuda, Toshio			Behavior modulation of rats to a robotic rat in multi-rat interaction	BIOINSPIRATION & BIOMIMETICS			English	Article						robotics; multi-rat interaction; motion control	SOCIAL-INTERACTION; OPEN-FIELD; PERSONALITY; CONTEXT	In this paper, we study the behavioral response of rats to a robotic rat during multi-rat interaction. Experiments are conducted in an open-field where a robotic rat called WR-5 is put together with three laboratory rats. WR-5 is following one rat (target), while avoiding the other two rats (outside observers) during interaction. The behavioral characteristics of each target rat is evaluated by scoring its locomotor activity and frequencies of performing rearing, body grooming and mounting actions. Additionally, the frequency of being mounted by other rats is also measured. Experimental results show that the target becomes more active after interaction. The rat species, with more active behavioral characteristics, is more susceptible to being adjusted by the robot. The increased time spent by the outside observers in the vicinity of the robot indicates that a biomimetic robot has the promise for modulating rat behavior even without direct interaction. Thus, this study provide a novel approach to shaping the sociality of animals living in groups.	[Shi, Qing; Huang, Qiang; Fukuda, Toshio] Beijing Inst Technol, Sch Mechatron Engn, Intelligent Robot Inst, Beijing 100081, Peoples R China; [Shi, Qing; Ishii, Hiroyuki; Tanaka, Katsuaki; Takanishi, Atsuo; Okabayashi, Satoshi] Waseda Univ, TWInS, Ctr Adv Biomed Sci, Tokyo 1628480, Japan; [Sugahara, Yusuke] Tokyo Inst Technol, Dept Mech Sci & Engn, Tokyo 1528552, Japan	Shi, Q (reprint author), Beijing Inst Technol, Sch Mechatron Engn, Intelligent Robot Inst, Beijing 100081, Peoples R China.	shiqing@bit.edu.cn			National Natural Science Foundation of China (NSFC) [61403032]; Beijing Natural Science Foundation [4144082]; SolidWorks Corp.; STMicroelectronics	This work was supported in part by the National Natural Science Foundation of China (NSFC) under grant no. 61403032, the Beijing Natural Science Foundation under grant no. 4144082, SolidWorks Corp., and STMicroelectronics.	Ananthanarayanan A, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046005; PELLIS SM, 1992, BEHAV BRAIN RES, V50, P135, DOI 10.1016/S0166-4328(05)80295-5; Henley CL, 2011, FRONT NEUROENDOCRIN, V32, P146, DOI 10.1016/j.yfrne.2011.02.010; Shi Q, 2011, ADV ROBOTICS, V25, P2255, DOI 10.1163/016918611X603819; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Werfel J, 2014, SCIENCE, V343, P754, DOI 10.1126/science.1245842; Dally JM, 2008, BEHAVIOUR, V145, P1101, DOI 10.1163/156853908784474470; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; FILE SE, 1978, BRIT J PHARMACOL, V62, P19; LORENZINI CA, 1987, ARCH ITAL BIOL, V125, P155; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Shi Q, 2015, IEEE-ASME T MECH, V20, P1832, DOI 10.1109/TMECH.2014.2356595; MEANEY MJ, 1979, ANIM LEARN BEHAV, V7, P397, DOI 10.3758/BF03209692; Mazzolai B, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/2/025005; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Libby T, 2012, NATURE, V481, P181, DOI 10.1038/nature10710; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Shi Q, 2012, P IEEE RAS-EMBS INT, P967; Shi Q, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/046002; Fuller SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0281; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Ward AJW, 2012, BEHAV ECOL SOCIOBIOL, V66, P223, DOI 10.1007/s00265-011-1270-7; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Barrow P, 1996, LAB ANIM, V30, P22, DOI 10.1258/002367796780744901; BECK CHM, 1984, PHYSIOL BEHAV, V32, P941, DOI 10.1016/0031-9384(84)90282-8; Cristianini N, 2000, INTRO SUPPORT VECTOR; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; Jonason G D W P K, 2008, EVOLUTIONARY PSYCHOL, V6, P637; Krause A W J, 2011, TRENDS ECOL EVOL, V26, P369; Lawlor M M, 2002, COMFORTABLE QUATERS; Marvi H, 2014, SCIENCE, V346, P224, DOI 10.1126/science.1255718; Michmizos K, 2015, NEURAL SYSTEMS REHAB, P1; Phamduy P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036021; Remington G, 2009, MENT HEALTH PHYS ACT, V2, P10; Tramacere F, 2013, J R SOC INTERFACE, V11; Weiss O, 2015, ANIM COGN, V18, P39, DOI 10.1007/s10071-014-0775-7; Whishaw I Q, 2004, HDB TESTS CH BEHAV L	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-3182	1748-3190		BIOINSPIR BIOMIM	Bioinspir. Biomim.	OCT	2015	10	5							056011	10.1088/1748-3190/10/5/056011		9	Engineering, Multidisciplinary; Materials Science, Biomaterials; Robotics	Engineering; Materials Science; Robotics	CU5AM	WOS:000363543700020		
J	Nakamachi, T; Ishida, H; Hirohashi, N				Nakamachi, Takeru; Ishida, Hideki; Hirohashi, Noritaka			Sound Production in the Aquatic Isopod Cymodoce japonica (Crustacea: Peracarida)	BIOLOGICAL BULLETIN			English	Article							COMMUNICATION; COURTSHIP; BEHAVIOR; STRIDULATION; SHRIMP	A vast variety of acoustic behaviors and mechanisms occur in arthropods. Sound production, in particular, in insects and decapod crustaceans has been well documented. However, except for a brief, anecdotal statement, there has been no report on the acoustic behavior of aquatic isopods. We present the first empirical evidence in aquatic Isopoda that males of Cymodoce japonica produce sound by stridulation, or the rubbing together of body parts. Sound production was associated with tail-lifting behavior, suggesting that stridulation occurs on thoracic and/or abdominal somites. Acoustic analysis revealed that syllable length was similar throughout the stridulation, at a mode of 2500-3000 Hz. With a scanning electron microscope, we identified file-like structures on the inner surface of the dorsal exoskeleton. Each file consisted of 188 +/- 11.1 ridges at about 0.5 mu m intervals; the theoretical frequency (number of ridges per syllable length) was estimated to be 2208-3646 Hz. This finding suggests that the stridulation sounds arose from these structures. Laboratory observations show that stridulation may play a role in the threatening of other males in the context of territorial and/or reproductive competitions.	[Nakamachi, Takeru; Hirohashi, Noritaka] Shimane Univ, Oki Marine Biol Stn, Oki, Shimane 6850024, Japan; [Nakamachi, Takeru; Ishida, Hideki] Shimane Univ, Dept Biol Sci, Matsue, Shimane 6908504, Japan	Nakamachi, T (reprint author), Kyoto Univ, Seto Marine Biol Lab, 459 Shirahama, Wakayama 6492211, Japan.	nakamachi.takeru.83c@st.kyoto-u.ac.jp			Shimane University	We thank Drs. Kohzoh Ohtsu, Akira Asakura, Keiichi Kakui, Noboru Nunomura, Ryuzo Yanagimachi, and Eiji Fujiwara for their technical support. This study was supported by Shimane University, which has provided research funds to two authors (IH and HN).	ABELE L G, 1973, Crustaceana (Leiden), V25, P147, DOI 10.1163/156854073X00795; ALEXANDE.RD, 1967, ANNU REV ENTOMOL, V12, P495, DOI 10.1146/annurev.en.12.010167.002431; Zimmer M, 2001, ANIM BEHAV, V62, P815, DOI 10.1006/anbe.2001.1845; HAZLETT BA, 1966, ECOLOGY, V47, P316, DOI 10.2307/1933783; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; GLYNN PW, 1968, B MAR SCI, V18, P572; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; Thiel M, 1999, MAR BIOL, V135, P321, DOI 10.1007/s002270050630; Carisio L, 2004, POPUL ECOL, V46, P27, DOI 10.1007/s10144-004-0170-3; Jonsson T, 2011, FLY, V5, P29, DOI 10.4161/fly.5.1.13713; STRATTON GE, 1983, ANIM BEHAV, V31, P164, DOI 10.1016/S0003-3472(83)80185-7; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; SHUSTER SM, 1990, ANIM BEHAV, V40, P390, DOI 10.1016/S0003-3472(05)80935-2; Briffa M, 2003, BEHAV ECOL, V14, P74, DOI 10.1093/beheco/14.1.74; Bouwma PE, 2009, NEW ZEAL J MAR FRESH, V43, P3; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; MEYERROCHOW VB, 1976, J EXP MAR BIOL ECOL, V23, P191, DOI 10.1016/0022-0981(76)90141-6; FRASER J, 1982, ANIM BEHAV, V30, P627, DOI 10.1016/S0003-3472(82)80077-8; Herman LM, 2013, BEHAV ECOL SOCIOBIOL, V67, P1653, DOI 10.1007/s00265-013-1576-8; [Anonymous], 1878, NATURE, V18, P53; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; NAKAZATO M, 1987, NIPPON SUISAN GAKK, V53, P967; Caruso D., 1976, ANIMALIA, V3, P17; Dumortier B., 1963, ACOUSTIC BEHAV ANIMA, P277; HORCH K, 1975, Crustaceana (Leiden), V29, P193; Richardson H., 1906, P US NATL MUS, V31, P1; Ryabov V., 2011, SCI RES, V1, P41; Sandeman D. C., 1982, J EXP BIOL, V99, P462; Shen C. J., 1929, Bulletin of the Fan Memorial Institute of Biology Peiping, V1, P65; WALKER T J, 1975, International Journal of Insect Morphology and Embryology, V4, P151, DOI 10.1016/0020-7322(75)90013-6	30	0	0	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185	1939-8697		BIOL BULL-US	Biol. Bull.	OCT 1	2015	229	2					167	172				6	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	CU8OF	WOS:000363801800005		
J	Sato-Okoshi, W; Okoshi, K; Fujiwara, Y				Sato-Okoshi, Waka; Okoshi, Kenji; Fujiwara, Yoshihiro			A New Species of Protodrilus (Annelida, Protodrilidae), Covering Bone Surfaces Bright Red, in Whale-Fall Ecosystems in the Northwest Pacific	BIOLOGICAL BULLETIN			English	Article							POLYCHAETA; OSEDAX; JAPAN; ULTRASTRUCTURE; RECONSTRUCTION; SYSTEMATICS; SEQUENCES; ECOLOGY; GENUS; 18S	There are unique ecosystems in the ocean that are driven by chemosynthesis. Whale-fall communities are one of these reducing habitats, and many unknowns are left to be resolved to understand their uniqueness. A new species of the genus Protodrilus was discovered on the exposed bones of sperm whale carcasses found in the waters off Cape Nomamisaki in the northwest Pacific. Protodrilus puniceus sp. nov. was the most abundant annelid to be found on the 2.5-y-old carcasses; the exposed bone surfaces appeared bright red due to the coloration of the innumerable worms covering them. Closer inspection revealed that this species was found in the small pores of both the internal and external surfaces of the bones. P. puniceus shows simple morphology; it has paired palps and pygidial lobes, but no eyespots, nuchal organs, statocysts, or ciliary rings dorsoanteriorly-an exceptional finding in this group. A ventral ciliary band was conspicuous, extending over each segment of the animal. The male of the species possessed paired, separated lateral organs on segments 6-11; salivary glands were inconspicuous. From morphological, biological, and ecological characteristics, P. puniceus showed differences from the already known Protodrilus group of shallow interstitial inhabitants. P. puniceus is thought to be a unique deposit feeder, acquiring nutrients by adhering to organic substances from whale carcasses. This is the first description of this group to be found in the organically enriched whale-fall environments of the deep sea below 200 m and from Japanese waters. Information on a nuclear, 18S ribosomal RNA gene sequence is included.	[Sato-Okoshi, Waka] Tohoku Univ, Grad Sch Agr Sci, Lab Biol Oceanog, Sendai, Miyagi 9818555, Japan; [Okoshi, Kenji] Toho Univ, Dept Environm Sci, Fac Sci, Chiba 2748510, Japan; [Fujiwara, Yoshihiro] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan	Sato-Okoshi, W (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Biol Oceanog, Sendai, Miyagi 9818555, Japan.	wsokoshi@bios.tohoku.ac.jp					Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Fauchald K, 1997, ZOOL SCR, V26, P71, DOI 10.1111/j.1463-6409.1997.tb00411.x; Struck TH, 2011, J ZOOL SYST EVOL RES, V49, P340, DOI 10.1111/j.1439-0469.2011.00640.x; PURSCHKE G, 1993, ZOOMORPHOLOGY, V113, P1, DOI 10.1007/BF00430973; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Daly M, 2007, J NAT HIST, V41, P1, DOI 10.1080/00222930601121775; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; Di Domenico M, 2013, HELGOLAND MAR RES, V67, P733, DOI 10.1007/s10152-013-0358-z; VONNORDHEIM H, 1983, ZOOL SCR, V12, P171; Nishikawa T, 2004, ZOOL SCI, V21, P1131, DOI 10.2108/zsj.21.1131; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; PURSCHKE G, 1988, J ZOOL, V215, P405; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Martinez A, 2013, MAR BIOL RES, V9, P676, DOI 10.1080/17451000.2013.765574; PURSCHKE G, 1990, ZOOMORPHOLOGY, V110, P91, DOI 10.1007/BF01632815; VONNORDHEIM H, 1989, ZOOL SCR, V18, P245; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Gascuel O, 1997, MOL BIOL EVOL, V14, P685; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Kinoshita G, 2010, CAH BIOL MAR, V51, P423; Fujioka K., 1993, J GEOGR, V102, P507; Glover G. A., 2005, P BIOL SCI, V272, P2587; Hatschek B., 1878, STUDIEN ENTWICKLUNGS; Hatschek B., 1888, LEHRBUCH ZOOLOGIE MO, V1-3; Hatschek B., 1893, LOTOS, V13, P123; Langerhans P., 1880, Z WISS ZOOL, V34, P87; Naganuma Takeshi, 1996, Journal of Oceanography, V52, P1, DOI 10.1007/BF02236529; Okutani T., 2003, VENUS, V63, P61; Reiser N. W., 1997, P BIOL SOC WASH, V110, P552; REMANE A., 1926, ZOOL ANZ, V67, P119; Remane A., 1932, TIERWELT NORD OSTSEE, V6, P1; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Wada H., 1993, SHIZUOKA CHIGAKU, V67, P1; Westheide W., 1985, ORIGIN RELATIONSHIPS, P310; Westheide W., 2008, POLYCHAETES INTERSTI; WIESER WOLFGANG, 1957, TRANS AMER MLCROSC SOC, V76, P275, DOI 10.2307/3223891	42	0	0	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185	1939-8697		BIOL BULL-US	Biol. Bull.	OCT 1	2015	229	2					209	219				11	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	CU8OF	WOS:000363801800009		
J	Hara, K; Watanabe, A; Matsumoto, S; Matsuda, Y; Kuwata, T; Kan, H; Yamada, T; Koizumi, M; Shinji, S; Yamagishi, A; Ishiwata, T; Naito, Z; Shimada, T; Uchida, E				Hara, Keisuke; Watanabe, Atsushi; Matsumoto, Satoshi; Matsuda, Yoko; Kuwata, Takeshi; Kan, Hayato; Yamada, Takeshi; Koizumi, Michihiro; Shinji, Seiichi; Yamagishi, Aya; Ishiwata, Toshiyuki; Naito, Zenya; Shimada, Takashi; Uchida, Eiji			Surgical Specimens of Colorectal Cancer Fixed with PAXgene Tissue System Preserve High-Quality RNA	BIOPRESERVATION AND BIOBANKING			English	Article							PARAFFIN-EMBEDDED TISSUE; COLON-CANCER; MOLECULAR ANALYSES; INTEGRITY NUMBER; GENE-EXPRESSION; NUCLEIC-ACIDS; FORMALIN; PROFILES; IMPACT; ISSUES	Background: RNA analysis of surgical specimens is one of the most useful methods for exploring biomarkers of advanced cancer. The most readily available source for RNA is formalin-fixed, paraffin-embedded (FFPE) specimens, but RNA isolated from FFPE tissue is of limited use. The PAXgene Tissue (PAX) system is a formalin-free system designed to improve the quality of molecular analysis without diminishing the quality of histopathological analysis. In this human colorectal cancer tissue study, we aimed to evaluate whether surgical specimens fixed with PAX can preserve high-quality RNA in comparison with FFPE and fresh-frozen tissue specimens. Methods: Ten consecutive advanced colorectal cancer patients undergoing colectomy were examined. Each specimen was processed in three ways: as frozen tissue, as PAX-fixed tissue, and as formalin-fixed tissue. RNA integrity numbers (RINs) were assessed using an Agilent Bioanalyzer. RNA transcript levels and stability were investigated by quantitative real-time PCR. We also evaluated the immunohistochemical intensity of Ki-67, CEA, and EGFR in the PAX samples. Results: The average RINs of RNA extracted from frozen and PAX samples were significantly higher than those from FFPE samples (p<0.001). The cycle threshold (Ct) values were similar in PAX and frozen samples, but significantly increased in FFPE samples (p<0.001). Most of the Ct values in the PAX samples did not differ significantly from those in the matched frozen samples. On the other hand, most of the Ct values in the FFPE samples differed significantly from those in the matched frozen samples. The immunohistochemical intensity in the PAX samples was well preserved. Conclusions: The quality of RNA extracted from PAX samples may be slightly inferior to that from frozen samples, but is greatly superior to that from FFPE samples.	[Hara, Keisuke; Matsumoto, Satoshi; Kan, Hayato; Yamada, Takeshi; Koizumi, Michihiro; Shinji, Seiichi; Yamagishi, Aya; Uchida, Eiji] Nippon Med Sch, Dept Gastrointestinal & Hepato Biliary Pancreat S, Tokyo 113, Japan; [Watanabe, Atsushi; Shimada, Takashi] Nippon Med Sch, Dept Biochem & Mol Biol, Tokyo 113, Japan; [Matsuda, Yoko; Ishiwata, Toshiyuki; Naito, Zenya] Nippon Med Sch, Dept Pathol & Integrat Oncol Pathol, Tokyo 113, Japan; [Kuwata, Takeshi] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan	Watanabe, A (reprint author), Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	aw3703@nms.ac.jp					Mahalingam D, 2010, BRIT J CANCER, V102, P754, DOI 10.1038/sj.bjc.6605545; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Bao WG, 2013, ANN SURG ONCOL, V20, P1737, DOI 10.1245/s10434-012-2440-1; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Kim J, 2014, CANCER LETT, V349, P35, DOI 10.1016/j.canlet.2014.03.025; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Belloni B, 2013, J CLIN PATHOL, V66, P124, DOI 10.1136/jclinpath-2012-200983; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Viertler C, 2012, J MOL DIAGN, V14, P458, DOI 10.1016/j.jmoldx.2012.05.002; Kap M, 2014, BIOPRESERV BIOBANK, V12, P81, DOI 10.1089/bio.2013.0051; Hamatani K, 2006, J HISTOCHEM CYTOCHEM, V54, P773, DOI 10.1369/jhc.5A6859.2006; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Mc Sherry EA, 2007, CLIN GENET, V72, P441, DOI 10.1111/j.1399-0004.2007.00882.x; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Yamagishi A, 2014, ONCOL REP, V31, P1531, DOI 10.3892/or.2014.3053; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Clark-Langone KM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-691; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Kap M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027704; Viljoen KS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-14; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1947-5535	1947-5543		BIOPRESERV BIOBANK	Biopreserv. Biobank.	OCT 1	2015	13	5					325	334		10.1089/bio.2014.0101		10	Cell Biology; Chemistry, Applied; Medical Laboratory Technology	Cell Biology; Chemistry; Medical Laboratory Technology	CU9SX	WOS:000363886600005		
J	Papp, K; Thaci, D; Reich, K; Riedl, E; Langley, RG; Krueger, JG; Gottlieb, AB; Nakagawa, H; Bowman, EP; Mehta, A; Li, Q; Zhou, Y; Shames, R				Papp, K.; Thaci, D.; Reich, K.; Riedl, E.; Langley, R. G.; Krueger, J. G.; Gottlieb, A. B.; Nakagawa, H.; Bowman, E. P.; Mehta, A.; Li, Q.; Zhou, Y.; Shames, R.			Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial	BRITISH JOURNAL OF DERMATOLOGY			English	Article							TO-SEVERE PSORIASIS; DOUBLE-BLIND; IL-23; IL-12; IMMUNITY; PHOTOCARCINOGENESIS; INTERLEUKIN-23; USTEKINUMAB; INFECTION; EFFICACY	Background Tildrakizumab is a high-affinity, humanized, IgG1/kappa, anti-interleukin (IL)-23p19 monoclonal antibody that does not bind human IL-12 or p40 is being developed for the treatment of chronic plaque psoriasis. Objectives To evaluate the safety and efficacy of subcutaneous tildrakizumab in patients with moderate-to-severe chronic plaque psoriasis. Methods A three-part, randomized, double-blind, phase IIb trial was conducted in 355 adults with chronic plaque psoriasis. Participants were randomized to receive subcutaneous tildrakizumab (5, 25, 100, 200 mg) or placebo at weeks 0 and 4 (part I) and every 12 weeks thereafter until week 52 (part II). Study drug was discontinued at week 52 and participants were followed through week 72 (part III). Primary efficacy end point was Psoriasis Area and Severity Index (PASI) 75 response at week 16. Adverse events (AEs) and vital signs were monitored throughout the study. Results At week 16, PASI 75 responses were 33.3% (n = 14), 64.4% (n = 58), 66.3% (n = 59), 74.4% (n = 64) and 4.4% (n = 2) in the 5-, 25-, 100- and 200-mg tildrakizumab and placebo groups, respectively (P <= 0.001 for each tildrakizumab dose vs. placebo). PASI 75 response was generally maintained through week 52; only eight of 222 participants who achieved PASI 75 response at week 52 and continued to part III relapsed following discontinuation up to week 72. Possible drug-related serious AEs included bacterial arthritis and lymphoedema (part I), and melanoma, stroke, epiglottitis and knee infection (part II). Conclusions Tildrakizumab had treatment effects that were superior to placebo, maintained for 52 weeks of treatment, and persisted for 20 weeks after cessation. Tildrakizumab was generally safe and well tolerated. These results suggest that IL-23p19 is a key target for suppressing psoriasis.	[Papp, K.] Prob Med Res, Waterloo, ON N2J 1C4, Canada; [Thaci, D.] Univ Lubeck, Univ Med Sch Schleswig Holstein, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Reich, K.] SCIderm Res Inst & Dermatologikum Hamburg, Hamburg, Germany; [Riedl, E.] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria; [Langley, R. G.] Dalhousie Univ, Halifax, NS, Canada; [Krueger, J. G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Gottlieb, A. B.] Tufts Med Ctr, Dept Dermatol, Boston, MA USA; [Nakagawa, H.] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Bowman, E. P.; Mehta, A.; Li, Q.; Zhou, Y.; Shames, R.] Merck & Co Inc, Kenilworth, NJ USA	Papp, K (reprint author), Prob Med Res, 135 Union St East, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com			Merck & Co., Inc., Kenilworth, NJ, U.S.A.	This study was funded by Merck & Co., Inc., Kenilworth, NJ, U.S.A.	Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Maeda A, 2006, CANCER RES, V66, P2962, DOI 10.1158/0008-5472.CAN-05-3614; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Chackerian AA, 2006, INFECT IMMUN, V74, P6092, DOI 10.1128/IAI.00621-06; Jantschitsch C, 2012, J INVEST DERMATOL, V132, P1479, DOI 10.1038/jid.2011.469; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Krueger G, 2001, ARCH DERMATOL, V137, P280; Gordon KB, 2012, J INVEST DERMATOL, V132, P304, DOI 10.1038/jid.2011.304; Teng MWL, 2012, CANCER RES, V72, P3987, DOI 10.1158/0008-5472.CAN-12-1337; Schulz SM, 2008, J IMMUNOL, V181, P7891; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Bansback N, 2009, DERMATOLOGY, V219, P209, DOI 10.1159/000233234; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Papp KA, 2013, J EUR ACAD DERMATOL, V28, P790; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x	25	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					930	939		10.1111/bjd.13932		10	Dermatology	Dermatology	CU9WG	WOS:000363896800016		
J	Papp, KA; Menter, MA; Abe, M; Elewski, B; Feldman, SR; Gottlieb, AB; Langley, R; Luger, T; Thaci, D; Buonanno, M; Gupta, P; Proulx, J; Lan, S; Wolk, R				Papp, K. A.; Menter, M. A.; Abe, M.; Elewski, B.; Feldman, S. R.; Gottlieb, A. B.; Langley, R.; Luger, T.; Thaci, D.; Buonanno, M.; Gupta, P.; Proulx, J.; Lan, S.; Wolk, R.		Opt Pivotal 1 Investigator; Opt Pivotal 2 Investigator	Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials	BRITISH JOURNAL OF DERMATOLOGY			English	Article							TO-SEVERE PSORIASIS; NAIL PSORIASIS; HERPES-ZOSTER; ARTHRITIS; EFFICACY; MODERATE; SAFETY; THERAPY; METAANALYSIS; DISEASE	Background Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. Objectives To determine the 16-week efficacy and safety of two oral tofacitinib doses vs. placebo in patients with moderate-to-severe chronic plaque psoriasis. Methods Patients in two similarly designed phase III studies (OPT Pivotal 1, NCT01276639, n = 901; OPT Pivotal 2, NCT01309737, n = 960) were initially randomized 2 : 2 : 1 to tofacitinib 10 or 5 mg or placebo, twice daily. Coprimary efficacy end points (week 16) included the proportion of patients achieving Physician's Global Assessment (PGA) of 'clear' or 'almost clear' (PGA response) and the proportion achieving >= 75% reduction in Psoriasis Area and Severity Index (PASI 75). Results Across OPT Pivotal 1 and OPT Pivotal 2, 745 patients received tofacitinib 5 mg, 741 received tofacitinib 10 mg and 373 received placebo. At week 16, a greater proportion of patients achieved PGA responses with tofacitinib 5 and 10 mg twice daily vs. placebo (OPT Pivotal 1, 41.9% and 59.2% vs. 9.0%; OPT Pivotal 2, 46.0% and 59.1% vs. 10.9%; all P < 0.001). Higher PASI 75 rates were observed with tofacitinib vs. placebo (OPT Pivotal 1, 39.9%, 59.2% and 6.2%, respectively, for tofacitinib 5 and 10 mg twice daily and placebo; OPT Pivotal 2, 46.0%, 59.6% and 11.4%; all P < 0.001 vs. placebo). Adverse event (AE) rates appeared generally similar across groups; rates of serious AEs, infections, malignancies and discontinuations due to AEs were low. Twelve patients reported herpes zoster across the tofacitinib treatment groups in both studies vs. none in the respective placebo groups. The most common AE across groups was nasopharyngitis. Conclusions Oral tofacitinib demonstrated significant efficacy vs. placebo during the initial 16 weeks of treatment in patients with moderate-to-severe psoriasis. Safety findings were consistent with prior studies.	[Papp, K. A.] Prob Med Res & K Papp Clin Res Inc, Waterloo, ON N2J 1C4, Canada; [Menter, M. A.] Baylor Res Inst, Dallas, TX USA; [Abe, M.] Gunma Univ Hosp, Maebashi, Gumma, Japan; [Elewski, B.] Univ Alabama, Tuscaloosa, AL USA; [Feldman, S. R.] Wake Forest Baptist Hlth, Winston Salem, NC USA; [Gottlieb, A. B.] Tufts Med Ctr, Boston, MA USA; [Langley, R.] Dalhousie Univ, Halifax, NS, Canada; [Luger, T.] Univ Munster, D-48149 Munster, Germany; [Thaci, D.] Univ Hosp Schleswig Holstein, Lubeck, Germany; [Buonanno, M.; Gupta, P.; Proulx, J.; Lan, S.; Wolk, R.] Pfizer Inc, Groton, CT 06340 USA	Papp, KA (reprint author), Prob Med Res & K Papp Clin Res Inc, 135 Union St East, Waterloo, ON N2J 1C4, Canada.	kapapp@kpappclinical.com			Pfizer Inc.	Pfizer Inc.	Alexander Walter, 2013, P T, V38, P288; Bissonnette R, 2015, BRIT J DERMATOL, V172, P1395, DOI 10.1111/bjd.13551; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; Adelzadeh L, 2014, J EUR ACAD DERMATOL, V28, P846, DOI 10.1111/jdv.12307; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Lebwohl MG, 2014, J AM ACAD DERMATOL, V70, P871, DOI 10.1016/j.jaad.2013.12.018; McInnes IB, 2014, ANN RHEUM DIS, V73, P124, DOI 10.1136/annrheumdis-2012-202442; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Radtke MA, 2013, J DTSCH DERMATOL GES, V11, P203, DOI 10.1111/ddg.12054; Schmitt J, 2014, BRIT J DERMATOL, V170, P274, DOI 10.1111/bjd.12663; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Dreiher J, 2012, J EUR ACAD DERMATOL, V26, P1127, DOI 10.1111/j.1468-3083.2011.04230.x; Augustin M, 2010, BRIT J DERMATOL, V163, P580, DOI 10.1111/j.1365-2133.2010.09831.x; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Smith CH, 2009, BRIT J DERMATOL, V161, P987, DOI 10.1111/j.1365-2133.2009.09505.x; Signorovitch JE, 2015, BRIT J DERMATOL, V172, P504, DOI 10.1111/bjd.13437; Weger W, 2010, BRIT J PHARMACOL, V160, P810, DOI 10.1111/j.1476-5381.2010.00702.x; Armesto S, 2011, Actas Dermosifiliogr, V102, P365, DOI 10.1016/j.ad.2011.02.007; Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Ghoreschi K, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12265; Kimball AB, 2015, J AM ACAD DERMATOL, V72, P115, DOI 10.1016/j.jaad.2014.08.050; Klaassen KMG, 2014, J EUR ACAD DERMATOL, V28, P1690, DOI 10.1111/jdv.12368; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; OShea JJ, 2004, ANN RHEUM DIS S, V63, P67; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Umezawa Y, 2014, J DERMATOL, V41, P168, DOI 10.1111/1346-8138.12370; Winthrop KL, 2014, ARTHRITIS RHEUMATOL, V66, P2675, DOI 10.1002/art.38745	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					949	961		10.1111/bjd.14018		13	Dermatology	Dermatology	CU9WG	WOS:000363896800018		
J	Lallas, A; Kyrgidis, A; Koga, H; Moscarella, E; Tschandl, P; Apalla, Z; Di Stefani, A; Ioannides, D; Kittler, H; Kobayashi, K; Lazaridou, E; Longo, C; Phan, A; Saida, T; Tanaka, M; Thomas, L; Zalaudek, I; Argenziano, G				Lallas, A.; Kyrgidis, A.; Koga, H.; Moscarella, E.; Tschandl, P.; Apalla, Z.; Di Stefani, A.; Ioannides, D.; Kittler, H.; Kobayashi, K.; Lazaridou, E.; Longo, C.; Phan, A.; Saida, T.; Tanaka, M.; Thomas, L.; Zalaudek, I.; Argenziano, G.			The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma	BRITISH JOURNAL OF DERMATOLOGY			English	Article							MALIGNANT-MELANOMA; MELANOCYTIC NEVI; MICROSCOPIC FEATURES; LENTIGINOUS MELANOMA; AFRICAN-AMERICANS; WHITE-POPULATION; SKIN-LESIONS; VOLAR SKIN; ABCD RULE; PATTERNS	Background The parallel ridge pattern (PRP) is considered the dermoscopic hallmark of acral melanoma (AM). However, it was recently shown that approximately one-third of AMs do not display a PRP dermoscopically, rendering their detection more troublesome. Objectives To investigate the diagnostic accuracy of dermoscopic criteria for the diagnosis of AM. Methods Dermoscopic images of consecutive cases of histopathologically diagnosed AMs and acral naevi with histopathological diagnosis or with at least 1 year of follow-up were evaluated by three independent investigators for the presence of predefined criteria. Crude and adjusted odds ratios and their corresponding 95% confidence intervals were calculated by univariate and multivariate logistic regression, respectively. Receiver operating characteristic curves were used to choose among competing classification schemes. Results In total 603 lesions (472 naevi and 131 AMs) were included in the study. A scoring system (named BRAAFF) composed of six variables was associated with optimal area under the curve and sensitivity for the diagnosis of AM. This method includes four positive (irregular blotches, ridge pattern, asymmetry of structures and asymmetry of colours) and two negative predictors (furrow pattern and fibrillar pattern). Conclusions The BRAAFF checklist significantly improves the diagnostic accuracy of dermoscopy for the diagnosis of AM.	[Lallas, A.; Kyrgidis, A.; Moscarella, E.; Longo, C.] Arcispedale Santa Maria Nuova IRCCS, Skin Canc Unit, I-42100 Reggio Emilia, Italy; [Koga, H.; Ioannides, D.; Lazaridou, E.] Shinshu Univ, Sch Med, Dept Dermatol, Matsumoto, Nagano 390, Japan; [Tschandl, P.; Saida, T.] Med Univ, Dept Dermatol, Div Gen Dermatol, Vienna, Austria; [Apalla, Z.; Kittler, H.] Aristotle Univ Thessaloniki, Sch Med, Dept Dermatol 1, GR-54006 Thessaloniki, Greece; [Di Stefani, A.] Complesso Integrato Columbus, Div Dermatol, Rome, Italy; [Kobayashi, K.; Tanaka, M.] Tokyo Womens Med Univ, Med Ctr East, Dept Dermatol, Tokyo, Japan; [Kobayashi, K.] Kobayashi Clin, Tokyo, Japan; [Phan, A.; Thomas, L.] Univ Lyon 1, Ctr Hosp Lyon Sud, Dept Dermatol, Pierre Benite, France; [Zalaudek, I.] Med Univ, Dept Dermatol & Venereol, Graz, Austria; [Argenziano, G.] Univ Naples 2, Dermatol Unit, Naples, Italy	Lallas, A (reprint author), Arcispedale Santa Maria Nuova IRCCS, Skin Canc Unit, Viale Risorgimento 80, I-42100 Reggio Emilia, Italy.	emlallas@gmail.com		Tschandl, Philipp/0000-0003-0391-7810	Italian Ministry of Health [RF-2010-2316524]	This study was supported in part by the Italian Ministry of Health (RF-2010-2316524).	Bellows CF, 2001, J SURG ONCOL, V78, P10, DOI 10.1002/jso.1116; Altamura D, 2006, ARCH DERMATOL, V142, P1123, DOI 10.1001/archderm.142.9.1123; Phan A, 2006, BRIT J DERMATOL, V155, P561, DOI 10.1111/j.1365-2133.2006.07368.x; SAIDA T, 1995, ARCH DERMATOL, V131, P298, DOI 10.1001/archderm.131.3.298; Oguchi S, 1998, ARCH DERMATOL, V134, P563, DOI 10.1001/archderm.134.5.563; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; Lallas A, 2014, MELANOMA RES, V24, P83, DOI 10.1097/CMR.0000000000000037; Ishihara Y, 2006, AM J DERMATOPATH, V28, P21, DOI 10.1097/01.dad.0000187931.05030.a0; Saida T, 2011, J DERMATOL, V38, P25, DOI 10.1111/j.1346-8138.2010.01174.x; Akasu R, 1996, AM J DERMATOPATH, V18, P10, DOI 10.1097/00000372-199602000-00002; Argenziano G, 2009, SEMIN CUTAN MED SURG, V28, P142, DOI 10.1016/j.sder.2009.06.001; STEVENS NG, 1990, INT J CANCER, V45, P691, DOI 10.1002/ijc.2910450421; Steyerberg EW, 2001, STAT NEERL, V55, P76, DOI 10.1111/1467-9574.00157; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Byrd KM, 2004, J AM ACAD DERMATOL, V50, P21, DOI 10.1016/S0192-9622(03)02091-7; Conti EMS, 2001, EUR J CANCER, V37, P780, DOI 10.1016/S0959-8049(01)00006-5; Pappo AS, 2003, EUR J CANCER, V39, P2651, DOI 10.1016/j.ejca.2003.06.001; Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; Green A, 1999, CANCER CAUSE CONTROL, V10, P21, DOI 10.1023/A:1008872014889; REINTGEN DS, 1982, JAMA-J AM MED ASSOC, V248, P1856, DOI 10.1001/jama.248.15.1856; Ishihara K, 2008, INT J CLIN ONCOL, V13, P33, DOI 10.1007/s10147-007-0751-1; Braun RP, 2013, DERMATOLOGY, V227, P373, DOI 10.1159/000356178; Saida T, 2007, ARCH DERMATOL, V143, P1423, DOI 10.1001/archderm.143.11.1423; Bradford PT, 2009, ARCH DERMATOL, V145, P427, DOI 10.1001/archdermatol.2008.609; Saida T, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.13.s8.24.x; Saida T, 2008, ARCH DERMATOL, V144, P1232, DOI 10.1001/archderm.144.9.1232; Saida T, 2002, CLIN DERMATOL, V20, P279, DOI 10.1016/S0738-081X(02)00219-5; Koga H, 2011, ARCH DERMATOL, V147, P741, DOI 10.1001/archdermatol.2011.136; Ozdemir F, 2007, ARCH DERMATOL, V143, P1378, DOI 10.1001/archderm.143.11.1378; Saida T, 2004, ARCH DERMATOL, V140, P1233, DOI 10.1001/archderm.140.10.1233; Phan A, 2010, BRIT J DERMATOL, V162, P765, DOI 10.1111/j.1365-2133.2009.09594.x; Menzies SW, 1996, ARCH DERMATOL, V132, P1178, DOI 10.1001/archderm.132.10.1178; Puig S, 2004, ARCH DERMATOL, V140, P338; Saida T, DERMOSCOPY PIGMENTED; Saida T., 2007, EXPERT REV DERMATOL, V2, P125, DOI 10.1586/17469872.2.2.125; Saida Toshiaki, 2005, Int J Clin Oncol, V10, P371, DOI 10.1007/s10147-005-0539-0; Seiji M, 1983, J INVEST DERMATOL, V80, p56s; STOLZ W, 1994, EUR J DERMATOL, V4, P521	38	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					1041	1049		10.1111/bjd.14045		9	Dermatology	Dermatology	CU9WG	WOS:000363896800029		
J	Okada, K; Endo, Y; Miyachi, Y; Koike, Y; Kuwatsuka, Y; Utani, A				Okada, K.; Endo, Y.; Miyachi, Y.; Koike, Y.; Kuwatsuka, Y.; Utani, A.			Glycosaminoglycan and versican deposits in taxane-induced sclerosis	BRITISH JOURNAL OF DERMATOLOGY			English	Article							SYSTEMIC-SCLEROSIS; DOCETAXEL TAXOTERE; BREAST-CANCER; SCLERODERMA; ASSOCIATION; PACLITAXEL	Docetaxel and paclitaxel are widely used in the treatment of various malignant neoplasms. Taxane-induced sclerosis is dose-dependent and usually not generalized. Little information on the pathogenesis of scleroderma is currently available. Here, we report a case of generalized scleroderma and a case of early-stage oedematous sclerosis, both of which presented with intense versican deposits after administration of taxane for angiosarcoma.	[Okada, K.; Endo, Y.; Miyachi, Y.] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Koike, Y.; Kuwatsuka, Y.; Utani, A.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 8528501, Japan	Utani, A (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	utani@nagasaki-u.ac.jp					Cleveland MG, 2000, CANCER, V88, P1078, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1078::AID-CNCR19>3.0.CO;2-T; De Angelis R, 2003, CLIN RHEUMATOL, V22, P49, DOI 10.1007/s10067-002-0635-8; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Farrant PBJ, 2004, CLIN EXP DERMATOL, V29, P360, DOI 10.1111/j.1365-2230.2004.01519.x; Hesselstrand R, 2002, CLIN EXP RHEUMATOL, V20, P301; Ikeda M, 2009, BIOCHEM BIOPH RES CO, V390, P1221, DOI 10.1016/j.bbrc.2009.10.125; Yagi Y, 2013, J INVEST DERMATOL, V133, P386, DOI 10.1038/jid.2012.314; BATTAFARANO DF, 1995, CANCER, V76, P110, DOI 10.1002/1097-0142(19950701)76:1<110::AID-CNCR2820760117>3.0.CO;2-9; AKIMOTO S, 1992, BRIT J DERMATOL, V126, P29, DOI 10.1111/j.1365-2133.1992.tb08399.x; Zhang ZW, 2012, INT J MOL SCI, V13, P6873, DOI 10.3390/ijms13066873; Hassett G, 2001, CLIN EXP RHEUMATOL, V19, P197; Vignes S, 2007, J EUR ACAD DERMATOL, V21, P1131, DOI 10.1111/j.1468-3083.2006.02119.x; Kupfer I, 2003, J AM ACAD DERMATOL, V48, P279, DOI 10.1067/mjd.2003.30; Itoh M, 2007, BRIT J DERMATOL, V156, P363, DOI 10.1111/j.1365-2133.2006.07597.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					1054	1058		10.1111/bjd.13899		5	Dermatology	Dermatology	CU9WG	WOS:000363896800031		
J	Ugajin, T; Takahashi, M; Miyagishi, C; Takayama, K; Yokozeki, H				Ugajin, T.; Takahashi, M.; Miyagishi, C.; Takayama, K.; Yokozeki, H.			A case of bullous pemphigoid associated with infiltration and activation of basophils	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							RESPONSES; CELLS		[Ugajin, T.; Takahashi, M.; Miyagishi, C.; Takayama, K.; Yokozeki, H.] Tokyo Med & Dent Univ, Grad Sch, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan	Ugajin, T (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Dermatol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ugajin.derm@tmd.ac.jp					Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Agis H, 2006, AM J CLIN PATHOL, V125, P273, DOI 10.1309/M9FQMQGF66167N2X; Rico MJ, 1999, BRIT J DERMATOL, V140, P1079; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Schroeder JT, 2001, ADV IMMUNOL, V77, P93, DOI 10.1016/S0065-2776(01)77015-0; ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P243; Kasperkiewicz M, 2007, CLIN REV ALLERG IMMU, V33, P67, DOI 10.1007/s12016-007-0030-y	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					1095	1098		10.1111/bjd.13875		4	Dermatology	Dermatology	CU9WG	WOS:000363896800043		
J	Watanabe, M; Ujiie, H; Nishimura, K; Kamiyama, T; Abe, R; Shimizu, H				Watanabe, M.; Ujiie, H.; Nishimura, K.; Kamiyama, T.; Abe, R.; Shimizu, H.			Mycosis fungoides associated with splenic infarction and muscle involvement	BRITISH JOURNAL OF DERMATOLOGY			English	Letter							CUTANEOUS-LYMPHOMAS; CLASSIFICATION; RUPTURE; EORTC		[Watanabe, M.; Ujiie, H.; Nishimura, K.; Abe, R.; Shimizu, H.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kamiyama, T.] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 1, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Ujiie, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	h-ujiie@med.hokudai.ac.jp					BENNETT SR, 1984, AM J CLIN PATHOL, V82, P104; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Nores M, 1998, AM SURGEON, V64, P182; EPSTEIN EH, 1972, MEDICINE, V51, P61, DOI 10.1097/00005792-197201000-00004; Schiodt I, 2000, ANN HEMATOL, V79, P158, DOI 10.1007/s002770050572; Olsen E, 2007, BLOOD, V110, P1713, DOI 10.1182/blood-2007-03-055749; RAPPAPOR.H, 1974, CANCER, V34, P1198, DOI 10.1002/1097-0142(197410)34:4<1198::AID-CNCR2820340431>3.0.CO;2-E; Weishaupt Carsten, 2011, J Am Acad Dermatol, V64, pe118, DOI 10.1016/j.jaad.2010.09.726	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-0963	1365-2133		BRIT J DERMATOL	Br. J. Dermatol.	OCT	2015	173	4					1100	1102		10.1111/bjd.13916		3	Dermatology	Dermatology	CU9WG	WOS:000363896800045		
J	Hagiwara, Y; Matsuoka, S; Hobara, S; Mori, AS; Hirose, D; Osono, T				Hagiwara, Yusuke; Matsuoka, Shunsuke; Hobara, Satoru; Mori, Akira S.; Hirose, Dai; Osono, Takashi			Bleaching of leaf litter and associated microfungi in subboreal and subalpine forests	CANADIAN JOURNAL OF MICROBIOLOGY			English	Article						decomposition; elevational gradient; fungal diversity; leaves; lignin; ligninolytic fungi	PHANEROCHAETE-CHRYSOSPORIUM; XYLARIACEOUS ENDOPHYTES; LIGNIN DECOMPOSITION; FUNGAL SUCCESSION; NEEDLE LITTER; TEMPERATE; DIVERSITY; COLONIZATION; MACROFUNGI; LEAVES	Fungal decomposition of lignin leads to the whitening, or bleaching, of leaf litter, especially in temperate and tropical forests, but less is known about such bleaching in forests of cooler regions, such as boreal and subalpine forests. The purposes of the present study were to examine the extent of bleached area on the surface of leaf litter and its variation with environmental conditions in subboreal and subalpine forests in Japan and to examine the microfungi associated with the bleaching of leaf litter by isolating fungi from the bleached portions of the litter. Bleached area accounted for 21.7%-32.7% and 2.0%-10.0% of total leaf area of Quercus crispula and Betula ermanii, respectively, in subboreal forests, and for 6.3% and 18.6% of total leaf area of B. ermanii and Picea jezoensis var. hondoensis, respectively, in a subalpine forest. In subboreal forests, elevation, C/N ratio and pH of the FH layer, and slope aspect were selected as predictor variables for the bleached leaf area. Leaf mass per area and lignin content were consistently lower in the bleached area than in the nonbleached area of the same leaves, indicating that the selective decomposition of acid unhydrolyzable residue (recalcitrant compounds such as lignin, tannins, and cutins) enhanced the mass loss of leaf tissues in the bleached portions. Isolates of a total of 11 fungal species (6 species of Ascomycota and 5 of Basidiomycota) exhibited leaf-litter-bleaching activity under pure culture conditions. Two fungal species (Coccomyces sp. and Mycena sp.) occurred in both subboreal and subalpine forests, which were separated from each other by approximately 1100 km.	[Hagiwara, Yusuke; Matsuoka, Shunsuke; Osono, Takashi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Hobara, Satoru] Rakuno Gakuen Univ, Dept Environm Symbiot Sci, Ebetsu, Hokkaido 0698501, Japan; [Mori, Akira S.] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2048501, Japan; [Hirose, Dai] Nihon Univ, Coll Pharm, Funabashi, Chiba 2748555, Japan	Osono, T (reprint author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan.	tosono@ecology.kyoto-u.ac.jp	Osono, Takashi/N-9580-2014	Osono, Takashi/0000-0001-8552-7490	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19780114, 15K07480]; Sumitomo Foundation; Japan Securities Scholarship Foundation	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) (Nos. 19780114 and 15K07480), the Sumitomo Foundation, and the Japan Securities Scholarship Foundation. The Shiretoko Foundation provided logistical support for the fieldwork. We thank H. Kondo, K. Koizumi, Y. Miyake, W. Azuma, H. Kamauchi, and N. Mori for their assistance.	Osono T, 2006, PROCEEDINGS OF THE 8TH INTERNATIONAL MYCOLOGICAL CONGRESS, P111; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Tian XJ, 2000, EUR J SOIL BIOL, V36, P81, DOI 10.1016/S1164-5563(00)01049-9; van der Wal A, 2013, FEMS MICROBIOL REV, V37, P477, DOI 10.1111/1574-6976.12001; Osono T, 2007, CAN J MICROBIOL, V53, P1, DOI 10.1139/W06-092; Osono T, 2009, MYCOSCIENCE, V50, P52, DOI 10.1007/s10267-008-0442-4; Osono T, 2009, FUNGAL DIVERS, V36, P101; Osono T, 2015, J FOREST RES-JPN, V20, P272, DOI 10.1007/s10310-014-0475-9; KEYSER P, 1978, J BACTERIOL, V135, P790; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Hirose Dai, 2006, Mycoscience, V47, P242, DOI 10.1007/s10267-006-0299-3; Osono T, 2011, FOREST PATHOL, V41, P156, DOI 10.1111/j.1439-0329.2010.00648.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ikeda A, 2014, POPUL ECOL, V56, P289, DOI 10.1007/s10144-013-0412-3; Osono T, 2013, MYCOSCIENCE, V54, P54, DOI 10.1016/j.myc.2012.08.003; Gourbiere F, 2001, MYCOL RES, V105, P1101, DOI 10.1016/S0953-7562(08)61973-5; Mori AS, 2015, J BIOGEOGR, V42, P1383, DOI 10.1111/jbi.12514; Osono T, 2011, FUNGAL ECOL, V4, P210, DOI 10.1016/j.funeco.2010.11.003; FENN P, 1981, ARCH MICROBIOL, V130, P66, DOI 10.1007/BF00527074; Hagiwara Y, 2012, J FOREST RES-JPN, V17, P51, DOI 10.1007/s10310-011-0265-6; Osono T, 2008, ECOL RES, V23, P909, DOI 10.1007/s11284-007-0455-z; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Osono T, 2008, CAN J MICROBIOL, V54, P427, DOI 10.1139/W08-023; Osono T, 2002, SOIL BIOL BIOCHEM, V34, P1537, DOI 10.1016/S0038-0717(02)00123-2; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Osono T, 2009, CAN J MICROBIOL, V55, P783, DOI [10.1139/w09-030, 10.1139/W09-030]; van Maanen A, 2000, MYCOL RES, V104, P1133, DOI 10.1017/S0953756299002282; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koide K, 2005, ECOL RES, V20, P599, DOI 10.1007/s11284-005-0077-2; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Eriksson K., 1990, MICROBIAL ENZYMATIC; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hintikka V., 1970, COMMUNICATIONES I FO, V69, P1; Hirose D, 2013, POLAR BIOL, V36, P919, DOI 10.1007/s00300-013-1320-x; Koide Kanade, 2005, Mycoscience, V46, P280, DOI 10.1007/s10267-005-0247-7; Matsuda Y., 1999, J FOR RES, V4, P145, DOI DOI 10.1007/BF02762239; Miura K., 1970, T MYCOLOGICAL SOC JA, V11, P116; Miyamoto Toshizumi, 2000, Mycoscience, V41, P105, DOI 10.1007/BF02464317; Miyamoto Toshizumi, 1998, Mycoscience, V39, P337, DOI 10.1007/BF02464018; Osono T, 1999, APPL FOR SCI KANSAI, V8, P103; Osono T, 2015, J FOREST RES-JPN, V20, P60, DOI 10.1007/s10310-014-0459-9; Osono T, 2015, J FOREST RES-JPN, V20, P69, DOI 10.1007/s10310-014-0461-2; Osono T, 2015, J FOREST RES-JPN, V20, P77, DOI 10.1007/s10310-014-0462-1; Boddy L, 2008, BR MYCOL SY, V28, P1; VILGALYS R, 1990, J BACTERIOL, V172, P4238	47	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4166	1480-3275		CAN J MICROBIOL	Can. J. Microbiol.	OCT	2015	61	10					735	743		10.1139/cjm-2015-0111		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Immunology; Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Immunology; Microbiology	CU9ZP	WOS:000363906100003		
J	Semi, K; Yamada, Y				Semi, Katsunori; Yamada, Yasuhiro			Induced pluripotent stem cell technology for dissecting the cancer epigenome	CANCER SCIENCE			English	Review						Cancer epigenetics; cancer model; DNA methylation; iPS cell; reprogramming	GLOBAL DNA HYPOMETHYLATION; GROWTH-FACTOR RECEPTOR; IN-VIVO; WILMS-TUMOR; IPS CELLS; EPIGENETIC REGULATION; INTESTINAL NEOPLASIA; ACTIVATING MUTATIONS; HELICOBACTER-PYLORI; EMBRYONIC STEM	Cancer arises through the accumulation of both genetic and epigenetic alterations. Although the causal role of genetic mutations on cancer development has been established in vivo, similar evidence for epigenetic alterations is limited. Moreover, mutual interactions between genetic mutations and epigenetic alterations remain unclear. Cellular reprogramming technology can be used to actively modify the epigenome without affecting the underlying genomic sequences. Here we introduce recent studies that have utilized this property for cancer research. We propose that just as it has potential for regenerative medicine and disease modeling, cell reprogramming could also be a powerful tool for dissecting the role of the cancer epigenome in the development and maintenance of cancer cells.	[Semi, Katsunori; Yamada, Yasuhiro] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Lab Stem Cell Oncol, Kyoto 6068507, Japan; [Semi, Katsunori; Yamada, Yasuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan	Yamada, Y (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	y-yamada@cira.kyoto-u.ac.jp			P-DIRECT from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; SICORP; Takeda Science Foundation; Naito Foundation	The authors were supported in part by P-DIRECT, a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Ministry of Health, Labor, and Welfare of Japan, by the SICORP, by the Takeda Science Foundation, by the Naito Foundation.	Tomita H, 2010, CARCINOGENESIS, V31, P1627, DOI 10.1093/carcin/bgq129; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Esteller M, 2000, J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Baba S, 2009, CANCER SCI, V100, P1186, DOI 10.1111/j.1349-7006.2009.01171.x; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Ohnishi K, 2014, BIOCHEM BIOPH RES CO, V455, P10, DOI 10.1016/j.bbrc.2014.07.020; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; COLOMER R, 1994, BRIT J CANCER, V70, P819, DOI 10.1038/bjc.1994.405; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; SCHMID M, 1984, HUM GENET, V67, P257, DOI 10.1007/BF00291352; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Taron M, 2005, CLIN CANCER RES, V11, P5878, DOI 10.1158/1078-0432.CCR-04-2618; Natsume A, 2013, CANCER RES, V73, P4559, DOI 10.1158/0008-5472.CAN-13-0109; Chan AOO, 2003, GUT, V52, P502, DOI 10.1136/gut.52.4.502; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Kim J, 2013, CELL REP, V3, P2088, DOI 10.1016/j.celrep.2013.05.036; Hattori N, 2014, BIOCHEM BIOPH RES CO, V455, P3, DOI 10.1016/j.bbrc.2014.08.140; Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/nmeth.1409, 10.1038/NMETH.1409]; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Buganim Y, 2014, CELL STEM CELL, V15, P295, DOI 10.1016/j.stem.2014.07.003; Kondo Y, 2014, CANCER SCI, V105, P363, DOI 10.1111/cas.12379; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Chen RZ, 1998, NATURE, V395, P89; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Esteller M, 2000, ONCOGENE, V19, P164, DOI 10.1038/sj.onc.1203227; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Feil Robert, 2011, Nat Rev Genet, V13, P97, DOI 10.1038/nrg3142; Hatano Y, 2015, CARCINOGENESIS, V36; Schwartzentruber J, 2012, NATURE, V482, P226, DOI 10.1038/nature10833; Yamada Y, 2014, STEM CELL TRANSL MED, V3, P1182, DOI 10.5966/sctm.2014-0090	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1251	1256		10.1111/cas.12758		6	Oncology	Oncology	CU7ON	WOS:000363731300001		
J	Sakamoto, S; Matsueda, S; Takamori, S; Toh, U; Noguchi, M; Yutani, S; Yamada, A; Shichijo, S; Yamada, T; Suekane, S; Kawano, K; Sasada, T; Hattori, N; Kohno, N; Itoh, K				Sakamoto, Shinjiro; Matsueda, Satoko; Takamori, Shinzo; Toh, Uhi; Noguchi, Masanori; Yutani, Shigeru; Yamada, Akira; Shichijo, Shigeki; Yamada, Teppei; Suekane, Shigetaka; Kawano, Kouichiro; Sasada, Tetsuro; Hattori, Noboru; Kohno, Nobuoki; Itoh, Kyogo			Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele	CANCER SCIENCE			English	Article						Cancer vaccines; cytotoxic T-Lymphocytes; HLA-A26; IgG; peptide vaccines	CELL LUNG-CANCER; PHASE-II; HLA-A; FEASIBILITY; RESPONSES; SURVIVAL	To develop a peptide vaccine for cancer patients with the HLA-A26 allele, which is a minor population worldwide, we investigated the immunological responses of HLA-A26(+)/A26(+) cancer patients to four different CTL epitope peptides under personalized peptide vaccine regimens. In personalized peptide vaccine regimens, two to four peptides showing positive peptide-specific IgG responses in pre-vaccination plasma were selected from the four peptide candidates applicable for HLA-A26(+)/A26(+) cancer patients and administered s.c. Peptide-specific CTL and IgG responses along with cytokine levels were measured before and after vaccination. Cell surface markers in PBMCs and plasma cytokine levels were also measured. In this study, 21 advanced cancer patients, including seven lung, three breast, two pancreas, and two colon cancer patients, were enrolled. Their HLA-A26 genotypes were HLA-A26:01 (n=24), HLA-A26:03 (n=10), and HLA-A26:02 (n=8). One, 14, and 6 patients received two, three, and four peptides, respectively. Grade 1 or 2 skin reactions at the injection sites were observed in the majority of patients, but no severe adverse events related to the vaccination were observed. Peptide-specific CTL responses were augmented in 39% or 22% of patients after one or two cycles of vaccination, respectively. Notably, peptide-specific IgG were augmented in 63% or 100% of patients after one or two cycles of vaccination, respectively. Personalized peptide vaccines with these four CTL epitope peptides could be feasible for HLA-A26(+) advanced cancer patients because of their safety and higher rates of immunological responses. Personalized peptide vaccine with 4 CTL epitope peptides could be feasible for HLA-A26+ advanced cancer patients because of the safety and higher rates of immunological responses.	[Sakamoto, Shinjiro; Noguchi, Masanori; Yamada, Akira] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Sakamoto, Shinjiro; Matsueda, Satoko; Yutani, Shigeru; Shichijo, Shigeki; Sasada, Tetsuro; Itoh, Kyogo] Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 8300011, Japan; [Sakamoto, Shinjiro; Hattori, Noboru; Kohno, Nobuoki] Hiroshima Univ, Sch Med, Dept Mol & Internal Med, Hiroshima, Japan; [Takamori, Shinzo; Toh, Uhi] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 8300011, Japan; [Yamada, Teppei] Fukuoka Univ, Sch Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan; [Suekane, Shigetaka] Kurume Univ, Sch Med, Dept Urol, Kurume, Fukuoka 8300011, Japan; [Kawano, Kouichiro] Kurume Univ, Sch Med, Dept Gynecol, Kurume, Fukuoka 8300011, Japan; [Sasada, Tetsuro] Kanagawa Canc Ctr Res Inst, Yokohama, Kanagawa, Japan	Sakamoto, S (reprint author), Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	sakamoto_shinjiro@kurume-u.ac.jp			Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan; Sendai Kousei Hospital	Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan; Sendai Kousei Hospital.	Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Mine T, 2004, CLIN CANCER RES, V10, P929, DOI 10.1158/1078-0432.CCR-1117-3; Noguchi M, 2007, PROSTATE, V67, P933, DOI 10.1002/pros.20572; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Ikeda N, 2015, TISSUE ANTIGENS, V85, P252, DOI 10.1111/tan.12536; Yanagimoto H, 2010, ONCOL REP, V24, P795, DOI 10.3892/or_00000923; Terasaki M, 2011, J CLIN ONCOL, V29, P337, DOI 10.1200/JCO.2010.29.7499; Takahashi R, 2013, CANCER SCI, V104, P1285, DOI 10.1111/cas.12226; Tung NM, 2015, J CLIN ONCOL, V33, P969, DOI 10.1200/JCO.2014.59.6031; Noguchi M, 2013, CANCER IMMUNOL IMMUN, V62, P919, DOI 10.1007/s00262-012-1379-1; Niu YM, 2009, CANCER SCI, V100, P2167, DOI 10.1111/j.1349-7006.2009.01298.x; Noguchi M, 2010, CANCER BIOL THER, V10, P1266, DOI 10.4161/cbt.10.12.13448; Kawano K, 2014, IMMUNOPHARM IMMUNOT, V36, P224, DOI 10.3109/08923973.2014.913617; Komatsu N, 2004, SCAND J CLIN LAB INV, V64, P535, DOI 10.1080/00365510410007008; Yoshida K, 2011, ONCOL REP, V25, P57, DOI 10.3892/or_00001041; Matsumoto K, 2011, BJU INT, V108, P831, DOI 10.1111/j.1464-410X.2010.09933.x; Matsueda S, 2013, DEV COMP IMMUNOL, V41, P68, DOI 10.1016/j.dci.2013.04.004; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Terazaki Y, 2012, CANCER SCI, V103, P638, DOI 10.1111/j.1349-7006.2012.02202.x; Sasada T, 2014, CURR MED CHEM, V21, P2332; Hattori T, 2009, CANCER IMMUNOL IMMUN, V58, P1845, DOI 10.1007/s00262-009-0695-6; Waki K, 2014, CANCER SCI, V105, P1229, DOI 10.1111/cas.12502; Yamada T, 2015, INT J ONCOL, V46, P55, DOI 10.3892/ijo.2014.2699	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1257	1263		10.1111/cas.12757		7	Oncology	Oncology	CU7ON	WOS:000363731300002		
J	Minami, D; Takigawa, N; Kato, Y; Kudo, K; Isozaki, H; Hashida, S; Harada, D; Ochi, N; Fujii, M; Kubo, T; Ohashi, K; Sato, A; Tanaka, T; Hotta, K; Tabata, M; Toyooka, S; Tanimoto, M; Kiura, K				Minami, Daisuke; Takigawa, Nagio; Kato, Yuka; Kudo, Kenichiro; Isozaki, Hideko; Hashida, Shinsuke; Harada, Daijiro; Ochi, Nobuaki; Fujii, Masanori; Kubo, Toshio; Ohashi, Kadoaki; Sato, Akiko; Tanaka, Takehiro; Hotta, Katsuyuki; Tabata, Masahiro; Toyooka, Shinichi; Tanimoto, Mitsune; Kiura, Katsuyuki			Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model	CANCER SCIENCE			English	Article						Asbestos; carcinogenesis; iron; malignant mesothelioma; TBXAS1	THROMBOXANE SYNTHASE; INDUCED CARCINOGENESIS; RAT MESOTHELIOMA; BREAST-CANCER; CARCINOMA; PATHOGENESIS; INDUCTION; OVERLOAD; DISEASE; GROWTH	Malignant mesothelioma is an aggressive and therapy-resistant neoplasm arising from mesothelial cells. Evidence suggests that the major pathology associated with asbestos-induced mesothelioma is local iron overload. In the present study, we induced iron-induced mesothelioma in rats based on previous reports. Ten Wistar rats were given ferric saccharate and nitrilotriacetate i.p. for 5 days a week. Five of the ten rats exhibited widespread mesotheliomas in the peritoneum and tunica vaginalis. The tumor cells showed positive immunostaining for calretinin, wilms tumor-1, podoplanin and the oxidative DNA marker 8-hydroxy-2-deoxyguanosine. In three of the five rats with mesothelioma, array-based comparative genomic hybridization analysis identified a common chromosomal deletion mapped to the chromosomal 4q31 locus, which encompasses the TBXAS1 gene. Downregulation of the TBXAS1 gene was confirmed using quantitative PCR. TBXAS1 gene expression was also reduced in three of four human malignant pleural mesothelioma cell lines compared with normal bronchial epithelial cells. Immunohistochemistry revealed that TBXAS1 expression was weakly positive and positive in five and three out of eight human malignant mesothelioma samples, respectively. In conclusion, TBXAS1 gene expression was downregulated in rats with iron-induced mesothelioma. The relationship between iron overload and TBXAS1 downregulation should be pursued further.	[Minami, Daisuke; Harada, Daijiro; Fujii, Masanori; Kubo, Toshio; Ohashi, Kadoaki; Sato, Akiko; Hotta, Katsuyuki; Tabata, Masahiro; Kiura, Katsuyuki] Okayama Univ Hosp, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan; [Takigawa, Nagio; Ochi, Nobuaki] Kawasaki Med Univ, Dept Gen Internal Med, Okayama, Japan; [Kato, Yuka; Kudo, Kenichiro; Isozaki, Hideko; Tanimoto, Mitsune] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol Oncol & Resp Med, Okayama, Japan; [Hashida, Shinsuke; Toyooka, Shinichi] Okayama Univ Hosp, Thorac Breast & Endocrinol Surg, Okayama 7008558, Japan; [Hashida, Shinsuke; Toyooka, Shinichi] Okayama Univ Hosp, Clin Genom Med, Okayama 7008558, Japan; [Tanaka, Takehiro] Okayama Univ Hosp, Pathol, Okayama 7008558, Japan	Minami, D (reprint author), Okayama Univ Hosp, Dept Hematol Oncol & Resp Med, Okayama 7008558, Japan.	d-minami@bj8.so-net.ne.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23659432]; Okayama University Center of Excellence Strategic Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology, Japan (23659432). Okayama University Center of Excellence Strategic Research Foundation Grant-aided Project for Private Universities Ministry of Education, Culture, Sport, Science, and Technology, Japan Grant-in-Aid from Novartis Pharma K.K, Japan	Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403; Amthor M, 1998, PATHOLOGE, V9, P55; Hu Q, 2010, LAB INVEST, V90, P360, DOI 10.1038/labinvest.2009.140; Moussa O, 2005, CANCER RES, V65, P11581, DOI 10.1158/0008-5472.CAN-05-1622; Okazaki Y, 2013, CANCER SCI, V104, P989, DOI 10.1111/cas.12185; CABRAL JRP, 1983, TUMORI, V69, P195; Jiang L, 2012, J PATHOL, V228, P366, DOI 10.1002/path.4075; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1159/000025327; GHOSAL SP, 1988, J PEDIATR-US, V113, P49, DOI 10.1016/S0022-3476(88)80527-4; Zacharski LR, 2008, J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Tanaka KI, 2012, CHEST, V142, P1011, DOI 10.1378/chest.11-2879; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Nie DT, 2004, AM J PATHOL, V164, P429, DOI 10.1016/S0002-9440(10)63133-1; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Abraham JE, 2009, CLIN CANCER RES, V15, P2181, DOI 10.1158/1078-0432.CCR-08-0716; OKADA S, 1989, BRIT J CANCER, V60, P708, DOI 10.1038/bjc.1989.344; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; Kato J, 2007, J GASTROENTEROL, V42, P830, DOI 10.1007/s00535-007-2095-z; KE Y, 1989, AM J PATHOL, V134, P979; Genevieve D, 2008, NAT GENET, V40, P284, DOI 10.1038/ng.2007.66; Nagai H, 2013, CANCER PREV RES, V6, P1222, DOI 10.1158/1940-6207.CAPR-13-0244; Toyokuni S, 2014, REDOX REP, V19, P1, DOI 10.1179/1351000213Y.0000000075; Toyokuni S, 2006, J CLIN BIOCHEM NUTR, V39, P3, DOI 10.3164/jcbn.39.3; Nie DT, 2000, BIOCHEM BIOPH RES CO, V267, P245, DOI 10.1006/bbrc.1999.1840; Kajita S, 2005, MODERN PATHOL, V18, P221, DOI 10.1038/modpathol.3800285; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Marques O, 2014, CANCER LETT, V347, P1, DOI 10.1016/j.canlet.2014.01.029; Cathcart MC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-25; des Assis LV, 2014, BIOCHIM BIOPHYS ACTA, V1845, P232; desSmith A., 2007, HUM MOL GENET, V16, P2783; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; RICHMOND HG, 1959, BRIT MED J, V1, P947; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6; Watkins Gareth, 2005, Int Semin Surg Oncol, V2, P23, DOI 10.1186/1477-7800-2-23	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1296	1302		10.1111/cas.12752		7	Oncology	Oncology	CU7ON	WOS:000363731300006		
J	Islam, SMR; Suenaga, Y; Takatori, A; Ueda, Y; Kaneko, Y; Kawana, H; Itami, M; Ohira, M; Yokoi, S; Nakagawara, A				Islam, S. M. Rafiqul; Suenaga, Yusuke; Takatori, Atsushi; Ueda, Yasuji; Kaneko, Yoshiki; Kawana, Hidetada; Itami, Makiko; Ohira, Miki; Yokoi, Sana; Nakagawara, Akira			Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells	CANCER SCIENCE			English	Article						Induced pluripotent stem cells; neuroblastoma; plasticity; reprogramming; Sendai virus	PLURIPOTENT STEM-CELLS; ISLAND METHYLATOR PHENOTYPE; CANCER-CELLS; GENERATION; DIFFERENTIATION; OCT4; MYCN; NCYM	Neuroblastoma (NB) is the most common extracranial solid tumor that originates from multipotent neural crest cells. NB cell populations that express embryonic stem cell-associated genes have been identified and shown to retain a multipotent phenotype. However, whether somatic reprogramming of NB cells can produce similar stem-cell like populations is unknown. Here, we sought to reprogram NB cell lines using an integration-free Sendai virus vector system. Of four NB cell lines examined, only SH-IN cells formed induced pluripotent stem cell-like colonies (SH-IN 4F colonies) at approximately 6weeks following transduction. These SH-IN 4F colonies were alkaline phosphatase-positive. Array comparative genomic hybridization analysis indicated identical genomic aberrations in the SH-IN 4F cells as in the parental cells. SH-IN 4F cells had the ability to differentiate into the three embryonic germ layers invitro, but rather formed NBs invivo. Furthermore, SH-IN 4F cells exhibited resistance to cisplatin treatment and differentiated into endothelial-like cells expressing CD31 in the presence of vascular endothelial growth factor. These results suggest that SH-IN 4F cells are partially reprogrammed NB cells, and could be a suitable model for investigating the plasticity of aggressive tumors.	[Islam, S. M. Rafiqul; Suenaga, Yusuke; Takatori, Atsushi; Kaneko, Yoshiki; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan; [Islam, S. M. Rafiqul; Suenaga, Yusuke; Takatori, Atsushi; Kaneko, Yoshiki; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Childrens Canc Res Ctr, Chiba 2608717, Japan; [Suenaga, Yusuke; Yokoi, Sana] Chiba Canc Ctr Res Inst, Canc Genome Ctr, Chiba 2608717, Japan; [Ueda, Yasuji] DNAVEC Corp, Div Business & Technol Dev, Tokyo, Japan; [Kawana, Hidetada; Itami, Makiko] Chiba Canc Ctr, Div Surg Pathol, Chiba 2608717, Japan; [Ohira, Miki] Chiba Canc Ctr Res Inst, Lab Canc Genom, Chiba 2608717, Japan	Suenaga, Y (reprint author), Chiba Canc Ctr Res Inst, Canc Genome Ctr, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	ysuenaga@chiba-cc.jp; nakagawara-a@koseikan.jp			Japan Agency for Medical Research and Development, AMED; Ministry of Health, Labor, and Welfare for the Third Term Comprehensive Control Research for Cancer, Japan; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Japan Society for the Promotion of Science [JSPS] KAKENHI [17015046, 24249061, 22890241, 24700957]; Fund for Health and Labor Sciences Research [26271201]	This work was supported in part by: the Japan Agency for Medical Research and Development, AMED (AN, MO, and YN); a Grant-in-Aid from the Ministry of Health, Labor, and Welfare for the Third Term Comprehensive Control Research for Cancer, Japan (AN); a Grant-in-Aid from the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (AN); a Grant-in-Aid from the Takeda Science Foundation (AN); a Grant-in-Aid for Scien-tific Research on Priority Areas (Japan Society for the Promotion of Science [JSPS] KAKENHI Grant Number 17015046, AN); a Grant-in-Aid for Scientific Research (A; JSPS KAKENHI Grant Number 24249061, AN); a Grant-in-Aid for Research Activity start-up (JSPS KAKENHI Grant Number 22890241, YS); a Grant-in-Aid for Young Scientists (B; JSPS KAKENHI Grant Number 24700957, YS); and a Fund for Health and Labor Sciences Research (Grant Number 26271201, AN).	Hu Kejin, 2011, Blood, V117, pe109, DOI 10.1182/blood-2010-07-298331; Liu Y, 2014, LEUKEMIA, V28, P1071, DOI 10.1038/leu.2013.304; Kobayashi K, 2006, CANCER RES, V66, P8331, DOI 10.1158/0008-5472.CAN-06-0756; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; CICCARONE V, 1989, CANCER RES, V49, P219; Yin J, 2013, J CANCER RES CLIN, V139, P1591, DOI 10.1007/s00432-013-1431-3; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Ikegaki N, 2013, P NATL ACAD SCI USA, V110, P6097, DOI 10.1073/pnas.1118262110; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Kobayashi K, 2013, ONCOGENE, V32, P2640, DOI 10.1038/onc.2012.285; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237; Shoji W, 2015, BIOCHEM BIOPH RES CO, V461, P501, DOI 10.1016/j.bbrc.2015.04.050; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Cioce M, 2014, ONCOTARGET, V5, P4129; Kaneko Y, 2015, CANCER SCI, V106, P840, DOI 10.1111/cas.12677; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Pezzolo A, 2011, CELL RES, V21, P1470, DOI 10.1038/cr.2011.38; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Walton JD, 2004, NEOPLASIA, V6, P838, DOI 10.1593/neo.04310; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Asada K, 2013, JPN J CLIN ONCOL, V43, P641, DOI 10.1093/jjco/hyt058; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Abe M, 2005, CANCER RES, V65, P828; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Mahalingam D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00592; Suenaga Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003996	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1351	1361		10.1111/cas.12746		11	Oncology	Oncology	CU7ON	WOS:000363731300012		
J	Kaida, A; Miura, M				Kaida, Atsushi; Miura, Masahiko			Unusual prolongation of radiation-induced G2 arrest in tumor xenografts derived from HeLa cells	CANCER SCIENCE			English	Article						Fluorescent ubiquitination-based cell cycle indicator (Fucci); G2 arrest; ionizing radiation; live imaging; tumor microenvironments	DOUBLE-STRAND BREAKS; FLUORESCENCE KINETICS; IONIZING-RADIATION; CYCLE INDICATOR; DNA-DAMAGE; REPAIR; HYPOXIA; CANCER; EXPRESSION; FUCCI	The effect of ionizing radiation on cell cycle kinetics in solid tumors remains largely unknown because of technical limitations and these tumors' complicated structures. In this study, we analyzed intratumoral cell cycle kinetics after X-irradiation of tumor xenografts derived from HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci), a novel system to visualize cell cycle kinetics invivo. Cell cycle kinetics after X-irradiation was examined by using tumor sections and invivo real-time imaging system in tumor xenografts derived from HeLa cells expressing Fucci. We found that G2 arrest was remarkably prolonged, up to 5days after 10-Gy irradiation, in contrast to monolayer cultures where G2 arrest returned within 24h. Cells isolated from tumors 5days after irradiation exhibited a higher surviving fraction than those isolated immediately or one day after irradiation. In this study, we clearly demonstrated unusual post-irradiation cell cycle kinetics in tumor xenografts derived from HeLa-Fucci cells. Our findings imply that prolonged G2 arrest occurring in tumor microenvironments following irradiation may function as a radioresistance mechanism.	[Kaida, Atsushi; Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Sect Oral Radiat Oncol, Tokyo 1138549, Japan	Miura, M (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth Sci, Sect Oral Radiat Oncol,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	masa.mdth@tmd.ac.jp			MEXT [26861569, 26293399, 25670796]	Scientific Research from MEXT (26861569, 26293399, and 25670796).	Okada S, 2001, INT J RADIAT ONCOL, V49, P1149, DOI 10.1016/S0360-3016(00)01429-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Kaida A, 2012, EXP CELL RES, V318, P288, DOI 10.1016/j.yexcr.2011.10.016; Kaida A, 2013, BIOCHEM BIOPH RES CO, V439, P453, DOI 10.1016/j.bbrc.2013.08.093; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Theron T, 1998, CELL PROLIFERAT, V31, P49, DOI 10.1046/j.1365-2184.1998.00107.x; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Pellegata NS, 1996, P NATL ACAD SCI USA, V93, P15209, DOI 10.1073/pnas.93.26.15209; He FQ, 2008, CANCER RES, V68, P8597, DOI 10.1158/0008-5472.CAN-08-0677; Yano S, 2013, CLIN CANCER RES, V19, P6495, DOI 10.1158/1078-0432.CCR-13-0742; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kaida A, 2011, CELL BIOL INT, V35, P359, DOI 10.1042/CBI20100643; Wang C, 2013, INT J RADIAT ONCOL, V86, P440, DOI 10.1016/j.ijrobp.2013.01.011; Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Park HJ, 2003, RADIAT RES, V159, P86, DOI 10.1667/0033-7587(2003)159[0086:IOEPOG]2.0.CO;2; LITTLE JB, 1973, RADIOLOGY, V106, P689; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P67; Harada H, 2012, NAT COMMUN, V3, P783, DOI DOI 10.1038/NC0MMS3314.-; Maeda J, 2014, RADIAT RES, V182, P448, DOI 10.1667/RR13744.1; Ponnala S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026191	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1370	1376		10.1111/cas.12748		7	Oncology	Oncology	CU7ON	WOS:000363731300014		
J	Hashida, S; Yamamoto, H; Shien, K; Miyoshi, Y; Ohtsuka, T; Suzawa, K; Watanabe, M; Maki, Y; Soh, J; Asano, H; Tsukuda, K; Miyoshi, S; Toyooka, S				Hashida, Shinsuke; Yamamoto, Hiromasa; Shien, Kazuhiko; Miyoshi, Yuichiro; Ohtsuka, Tomoaki; Suzawa, Ken; Watanabe, Mototsugu; Maki, Yuho; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi			Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib	CANCER SCIENCE			English	Article						Afatinib; cancer stem cells; drug resistance; EGFR-TKI; non-small cell lung cancer	TYROSINE KINASE INHIBITOR; GEFITINIB RESISTANCE; ACTIVATING MUTATIONS; MET AMPLIFICATION; EGFR INHIBITORS; ERLOTINIB; ADENOCARCINOMA; BIOCONDUCTOR; T790M; TRIAL	Afatinib is an irreversible epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) that is known to be effective against the EGFR T790M variant, which accounts for half of the mechanisms of acquired resistance to reversible EGFR-TKIs. However, acquired resistance to afatinib was also observed in clinical use. Thus, elucidating and overcoming the mechanisms of resistance are important issues in the treatment of non-small cell lung cancer. In this study, we established various afatinib-resistant cell lines and investigated the resistance mechanisms. EGFR T790M mutations were not detected using direct sequencing in established resistant cells. Several afatinib-resistant cell lines displayed MET amplification, and these cells were sensitive to the combination of afatinib plus crizotinib. As a further investigation, a cell line that acquired resistance to afatinib plus crizotinib, HCC827-ACR, was established from one of the MET amplified-cell lines. Several afatinib-resistant cell lines including HCC827-ACR displayed epithelial-to-mesenchymal transition (EMT) features and epigenetic silencing of miR-200c, which is a suppresser of EMT. In addition, these cell lines also exhibited overexpression of ALDH1A1 and ABCB1, which are putative stem cell markers, and resistance to docetaxel. In conclusion, we established afatinib-resistant cells and found that MET amplification, EMT, and stem cell-like features are observed in cells with acquired resistance to EGFR-TKIs. This finding may provide clues to overcoming resistance to EGFR-TKIs.	[Hashida, Shinsuke; Yamamoto, Hiromasa; Shien, Kazuhiko; Miyoshi, Yuichiro; Ohtsuka, Tomoaki; Suzawa, Ken; Watanabe, Mototsugu; Maki, Yuho; Soh, Junichi; Asano, Hiroaki; Tsukuda, Kazunori; Miyoshi, Shinichiro; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Breast & Endocrinol Surg, Okayama 7008558, Japan; [Hashida, Shinsuke; Shien, Kazuhiko; Toyooka, Shinichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Okayama 7008558, Japan	Toyooka, S (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Clin Genom Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toyooka@md.okayama-u.ac.jp	Shien, Kazuhiko/B-8560-2012	Shien, Kazuhiko/0000-0002-4959-4220	Japan Society for the Promotion of Science (JSPS KAKENHI) [25293302]	This study was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number: 25293302 to ST).	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Zumwalde NA, 2013, J IMMUNOL, V191, P3681, DOI 10.4049/jimmunol.1201954; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Murakami H, 2012, CANCER CHEMOTH PHARM, V69, P891, DOI 10.1007/s00280-011-1738-1; Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Girard L, 2000, CANCER RES, V60, P4894; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Shien K, 2012, LUNG CANCER, V77, P162, DOI 10.1016/j.lungcan.2012.02.006; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Craveiro V, 2013, CANCER MED-US, V2, P751, DOI 10.1002/cam4.115; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Katakami N, 2013, J CLIN ONCOL, V31, P3335, DOI 10.1200/JCO.2012.45.0981; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hata A, 2013, CANCER-AM CANCER SOC, V119, P4325, DOI 10.1002/cncr.28364; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; R Core Team, 2015, R LANG ENV STAT COMP; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1377	1384		10.1111/cas.12749		8	Oncology	Oncology	CU7ON	WOS:000363731300015		
J	Yagishita, S; Horinouchi, H; Sunami, KS; Kanda, S; Fujiwara, Y; Nokihara, H; Yamamoto, N; Sumi, M; Shiraishi, K; Kohno, T; Furuta, K; Tsuta, K; Tamura, T; Ohe, Y				Yagishita, Shigehiro; Horinouchi, Hidehito; Sunami, Kuniko S.; Kanda, Shintaro; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Sumi, Minako; Shiraishi, Kouya; Kohno, Takashi; Furuta, Koh; Tsuta, Koji; Tamura, Tomohide; Ohe, Yuichiro			Impact of KRAS mutation on response and outcome of patients with stageIII non-squamous non-small cell lung cancer	CANCER SCIENCE			English	Article						Biomarkers; chemoradiotherapy; KRAS; non-small cell lung cancer; relapse	CONCURRENT THORACIC RADIOTHERAPY; GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; ADJUVANT CHEMOTHERAPY; PHASE-III; CHEMORADIOTHERAPY; CISPLATIN; THERAPY; TRIAL; ADENOCARCINOMA	The frequency and clinical profile of patients with stageIII non-small cell lung cancer harboring KRAS mutations have not yet been well documented. Here, we analyzed hotspot KRAS mutations using high-resolution melting analyses in tumor specimens from patients who received chemoradiotherapy between January 2001 and December 2010 at the National Cancer Center Hospital. The associations between the presence of KRAS mutations and the response rate, relapse-free survival, first relapse sites, survival post-progression and overall survival were investigated. A total of 274 non-squamous non-small cell lung cancer patients received chemoradiotherapy at our hospital. After excluding 121 patients for whom tumor specimens were not available and 34 patients with EGFR mutations, the remaining 119 patients were included in the analysis. KRAS mutations were found at a frequency of 13%. Patients with KRAS mutations had a shorter median relapse-free survival (6.1 vs 10.9months) and a lower response rate (63% vs 81%). As for the first relapse site, patients with KRAS mutations had fewer local relapses (8% vs 23%) and more brain metastases (46% vs 12%). After disease progression, patients with KRAS mutations had a significantly shorter median survival post-progression (2.5 vs 7.3months, P=0.028) and median overall survival (15.1 vs 29.1months, P=0.022). Our results suggested that KRAS mutation could be associated with a reduced efficacy of chemoradiotherapy and a shortened survival time.	[Yagishita, Shigehiro; Horinouchi, Hidehito; Sunami, Kuniko S.; Kanda, Shintaro; Fujiwara, Yutaka; Nokihara, Hiroshi; Yamamoto, Noboru; Tamura, Tomohide; Ohe, Yuichiro] Natl Canc Ctr, Dept Thorac Oncol, Tokyo 1040045, Japan; [Yagishita, Shigehiro] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan; [Horinouchi, Hidehito; Sunami, Kuniko S.; Ohe, Yuichiro] Juntendo Univ, Grad Sch Med, Adv Clin Res Canc, Tokyo, Japan; [Sumi, Minako] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan; [Sunami, Kuniko S.; Shiraishi, Kouya; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Tokyo, Japan; [Furuta, Koh] Natl Canc Ctr, Dept Clin Labs, Tokyo, Japan; [Tsuta, Koji] Natl Canc Ctr, Dept Pathol, Tokyo, Japan	Horinouchi, H (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	hhorinou@ncc.go.jp			National Cancer Center Research and Development Fund [23-A-30, 24-A-1]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22131006]; Foundation for Promotion of Cancer Research (Japan)	This work was supported in part by the National Cancer Center Research and Development Fund (23-A-30, 24-A-1), by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas (22131006), and by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control of Japan including Awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan).	Sekine I, 2012, INT J RADIAT ONCOL, V82, P953, DOI 10.1016/j.ijrobp.2011.01.008; Ready N, 2010, J THORAC ONCOL, V5, P1382, DOI 10.1097/JTO.0b013e3181eba657; Sekine I, 2006, J THORAC ONCOL, V1, P810, DOI 10.1097/01243894-200610000-00009; Govindan R, 2008, J THORAC ONCOL, V3, P917, DOI 10.1097/JTO.0b013e318180270b; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Horinouchi H, 2013, CANCER SCI, V104, P93, DOI 10.1111/cas.12028; Blackstock AW, 2007, J CLIN ONCOL, V25, P4146, DOI 10.1200/JCO.2007.12.6581; Yamamoto N, 2010, J CLIN ONCOL, V28, P3739, DOI 10.1200/JCO.2009.24.5050; Tsao MS, 2007, J CLIN ONCOL, V25, P5240, DOI 10.1200/JCO.2007.12.6953; Akiyoshi K, 2013, ANTICANCER RES, V33, P2129; Broglio KR, 2009, JNCI-J NATL CANCER I, V101, P1642, DOI 10.1093/jnci/djp369; Schiller JH, 2001, J CLIN ONCOL, V19, P448; Broermann P, 2002, CANCER, V94, P2055, DOI 10.1002/cncr.10387; Shepherd FA, 2013, J CLIN ONCOL, V31, P2173, DOI 10.1200/JCO.2012.48.1390; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Segawa Y, 2010, J CLIN ONCOL, V28, P3299, DOI 10.1200/JCO.2009.24.7577; Johung KL, 2013, CLIN CANCER RES, V19, P5523, DOI 10.1158/1078-0432.CCR-13-0836; Niho S, 2012, ANN ONCOL, V23, P2253, DOI 10.1093/annonc/mds012; GLOBOCAN WHO, 2012, CANC FACT SHEETS LUN; Hallqvist A, 2012, LUNG CANC INT, V2012, P1; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; NCCN, 2014, NCCN CLIN PRACT GUID; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Yagishita S, 2015, INT J RADIAT ONCOL, V91, P140, DOI 10.1016/j.ijrobp.2014.08.344	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1402	1407		10.1111/cas.12740		6	Oncology	Oncology	CU7ON	WOS:000363731300018		
J	Tahara, M; Fuse, N; Mizusawa, J; Sato, A; Nihei, K; Kanato, K; Kato, K; Yamazaki, K; Muro, K; Takaishi, H; Boku, N; Ohtsu, A				Tahara, Makoto; Fuse, Nozomu; Mizusawa, Junki; Sato, Akihiro; Nihei, Keiji; Kanato, Keisuke; Kato, Ken; Yamazaki, Kentaro; Muro, Kei; Takaishi, Hiromasa; Boku, Narikazu; Ohtsu, Atsushi			Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)	CANCER SCIENCE			English	Article						Chemoradiotherapy; cisplatin; esophageal carcinoma; S-1; stage II/III	SQUAMOUS-CELL CARCINOMA; DEFINITIVE CHEMORADIOTHERAPY; ANTITUMOR-ACTIVITY; PLUS CISPLATIN; LOCAL FAILURE; III TRIAL; CANCER; THERAPY; IRRADIATION; RADIATION	We carried out a phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin to determine the maximum tolerated dose and recommended dose and to evaluate the efficacy and safety of this treatment in patients with esophageal carcinoma. Thoracic esophageal cancer patients with clinical stage II/III disease, excluding T4, were eligible. Chemotherapy consisted of S-1 at a dose of 60-80 mg/m(2)/day on days 1-14, and cisplatin at 75 mg/m(2) on day 1, repeated twice every 4 weeks. Single daily radiation of 50.4 Gy was given in 28 fractions concurrently starting on day 1. Patients achieving an objective response after chemoradiotherapy underwent two additional cycles of chemotherapy. Patient accrual was terminated early due to slow enrolment after 44 patients were accrued. In the phase I part, two of six patients experienced dose-limiting toxicities at each level of S-1 (S-1 60 or 80 mg/m(2)/day). Considering treatment compliance, the recommended dose was determined to be S-1 60 mg/m(2)/day. The complete response rate, the primary endpoint of phase II, was 59.5% (22/37; 90% confidence interval, 44.6-73.1%; weighted threshold, 57.2%; P = 0.46 by the exact binomial test) on central review. In the phase II part, 3-year progression-free survival was 48.4%, with a 3-year overall survival of 61.9%. Grade 3 or 4 toxicity in phase II included leukopenia (57.9%), neutropenia (50%), hyponatremia (28.9%), anorexia (21.1%), anemia (18.4%), thrombocytopenia (18.4%), and febrile neutropenia (2.6%). No treatment-related deaths were observed. Although this combination showed acceptable toxicity and favorable 3-year survival, the study did not meet its primary endpoint. This trial was registered at the UMIN Clinical Trials Registry as UMIN000000710.	[Tahara, Makoto] Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, Kashiwa, Chiba 2778577, Japan; [Tahara, Makoto; Fuse, Nozomu; Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Gastrointestinal Oncol, Kashiwa, Chiba 2778577, Japan; [Mizusawa, Junki] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Tokyo 104, Japan; [Sato, Akihiro; Ohtsu, Atsushi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Nihei, Keiji] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Radiol, Tokyo, Japan; [Kanato, Keisuke] Natl Canc Ctr, Japan Clin Oncol Grp Operat Off, Tokyo 104, Japan; [Kato, Ken; Boku, Narikazu] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan; [Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan; [Takaishi, Hiromasa] Keio Univ Hosp, Keio Canc Ctr, Tokyo, Japan	Tahara, M (reprint author), Natl Canc Ctr Hosp East, Dept Head & Neck Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	matahara@east.ncc.go.jp			Ministry of Health, Labor and Welfare; Ministry of Health, Labor and Welfare for the Third Term Comprehensive Strategy for Cancer Control; National Cancer Center Research and Development Fund [23-A-16, 23-A-19, 26-A-4];  [17S-3];  [17S-5];  [20S-3];  [20S-6]	Japan Medical Association subsidized by the Ministry of Health, Labor and Welfare, a Grant from the Ministry of Health, Labor and Welfare for the Third Term Comprehensive Strategy for Cancer Control, a Grant-in-Aid for Cancer Research (17S-3, 17S-5, 20S-3, and 20S-6), and the National Cancer Center Research and Development Fund (23-A-16, 23-A-19, and 26-A-4).	Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Tahara M, 2011, CANCER SCI, V102, P419, DOI 10.1111/j.1349-7006.2010.01799.x; Ajani JA, 2005, J CLIN ONCOL, V23, P6957, DOI 10.1200/JCO.2005.01.917; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; GREEN SJ, 1992, STAT MED, V11, P853, DOI 10.1002/sim.4780110703; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P752, DOI 10.1093/jjco/hyt061; Tahara M, 2005, JPN J CLIN ONCOL, V35, P316, DOI 10.1093/jjco/hyi095; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Gardner-Thorpe J, 2007, BRIT J SURG, V94, P1059, DOI 10.1002/bjs.5865; Fukushima M, 2010, ONCOL REP, V24, P1307, DOI 10.3892/or_00000987; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Kato K, 2013, JPN J CLIN ONCOL, V43, P608, DOI 10.1093/jjco/hyt048; Kato K, 2011, INT J RADIAT ONCOL, V81, P684, DOI 10.1016/j.ijrobp.2010.06.033; Daigo S, 2002, PHARMACOGENETICS, V12, P299, DOI 10.1097/00008571-200206000-00005; Fukushima M, 2005, EJC SUPPL, V3, P343; Yano T, 2008, ENDOSCOPY, V40, P717, DOI 10.1055/s-2008-1077480; Shirasaka T, 1996, CANCER RES, V56, P2602; Cohen EEW, 2012, ASCO M S15, V30, P5500; Japanese Society for Esophageal Diseases, 2004, ESOPHAGUS, V1, P107; Satake H, 2013, J CLIN ONCOL S, V31; van der Weide J, 1999, ANN CLIN BIOCHEM, V36, P722	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1414	1420		10.1111/cas.12764		7	Oncology	Oncology	CU7ON	WOS:000363731300020		
J	Tjhay, F; Motohara, T; Tayama, S; Narantuya, D; Fujimoto, K; Guo, JY; Sakaguchi, I; Honda, R; Tashiro, H; Katabuchi, H				Tjhay, Francisca; Motohara, Takeshi; Tayama, Shingo; Narantuya, Dashdemberel; Fujimoto, Koichi; Guo, Jianying; Sakaguchi, Isao; Honda, Ritsuo; Tashiro, Hironori; Katabuchi, Hidetaka			CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer	CANCER SCIENCE			English	Article						Cancer stem cell; CD44; ovarian cancer; peritoneal metastasis; prognosis	STEM-CELLS; INITIATING CELLS; CARCINOMA-CELLS; TUMOR-CELLS; METASTASIS; EXPRESSION; P53; MOLECULE; NICHE	Cancer stem cells (CSCs) drive tumor initiation and metastasis in several types of human cancer. However, the contribution of ovarian CSCs to peritoneal metastasis remains unresolved. The cell adhesion molecule CD44 has been identified as a major marker for CSCs in solid tumors, including epithelial ovarian cancer. CD44 exists as a standard form (CD44s) and also as numerous variant isoforms (CD44v) generated by alternative mRNA splicing. Here we show that disseminated ovarian tumors in the pelvic peritoneum contain highly enriched CD44v6-positive cancer cells, which drive tumor metastasis and are responsible for tumor resistance to chemotherapy. Clinically, an increased number of CD44v6-positive cancer cells in primary tumors was associated with a shortened overall survival in stage III-IV ovarian cancer patients. Furthermore, a subpopulation of CD44v6-positive cancer cells manifested the ability to initiate tumor metastasis in the pelvic peritoneum in an in vivo mouse model, suggesting that CD44v6-positive cells show the potential to serve as metastasis-initiating cells. Thus, the peritoneal disseminated metastasis of epithelial ovarian cancer is initiated by the CD44v6-positive subpopulation, and CD44v6 expression is a biomarker for the clinical outcome of advanced ovarian cancer patients. Given that a distinct subpopulation of CD44v6-positive cancer cells plays a critical role in peritoneal metastasis, definitive treatment should target this subpopulation of CD44v6-positive cells in epithelial ovarian cancer.	[Tjhay, Francisca; Motohara, Takeshi; Tayama, Shingo; Narantuya, Dashdemberel; Fujimoto, Koichi; Guo, Jianying; Sakaguchi, Isao; Honda, Ritsuo; Katabuchi, Hidetaka] Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Kumamoto, Kumamoto 8608556, Japan; [Tashiro, Hironori] Kumamoto Univ, Dept Maternal Newborn Nursing, Kumamoto, Kumamoto 8608556, Japan	Motohara, T (reprint author), Kumamoto Univ, Fac Life Sci, Dept Obstet & Gynecol, Chuo Ku, Honjo 1-1-1, Kumamoto, Kumamoto 8608556, Japan.	kan@kumamoto-u.ac.jp			Japan Society for the promotion of Science [15K20151, 25293344]	This work was supported by grants from the Japan Society for the promotion of Science (grant numbers 15K20151 and 25293344).	TANABE KK, 1994, CRIT REV ONCOGENESIS, V5, P201; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Afify AM, 2011, INT J BIOL MARKER, V26, P50, DOI 10.5301/JBM.2011.6291; Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391; Hong SC, 2006, J OBSTET GYNAECOL RE, V32, P379, DOI 10.1111/j.1447-0756.2006.00422.x; Motohara T, 2010, CANCER SCI, V101, P1550, DOI 10.1111/j.1349-7006.2010.01556.x; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Mitsui H, 2012, GYNECOL ONCOL, V124, P303, DOI 10.1016/j.ygyno.2011.10.006; SLIUTZ G, 1995, BRIT J CANCER, V72, P1494, DOI 10.1038/bjc.1995.535; Heintz APM, 2003, INT J GYNECOL OBSTET, V83, P135, DOI 10.1016/S0020-7292(03)90118-4; Motohara T, 2011, CARCINOGENESIS, V32, P1597, DOI 10.1093/carcin/bgr183; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; TANABE KK, 1993, MOL CARCINOGEN, V7, P212, DOI 10.1002/mc.2940070403; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Kamura T, 1999, ONCOL REP, V6, P97; Sakai K, 1999, GYNECOL ONCOL, V72, P360, DOI 10.1006/gyno.1998.5266; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Yang YM, 2008, CANCER INVEST, V26, P725, DOI 10.1080/07357900801941845; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Lengyel Ernst, 2010, Am J Pathol, V177, P1053, DOI 10.2353/ajpath.2010.100105; Shi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-182; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tavassoli FA, 2003, PATHOLOGY GENETICS T; Unternaehrer JJ, 2008, CELL, V133, P704; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1421	1428		10.1111/cas.12765		8	Oncology	Oncology	CU7ON	WOS:000363731300021		
J	Matsumoto, K; Maeda, H; Oki, A; Takatsuka, N; Yasugi, T; Furuta, R; Hirata, R; Mitsuhashi, A; Kawana, K; Fujii, T; Iwata, T; Hirai, Y; Yokoyama, M; Yaegashi, N; Watanabe, Y; Nagai, Y; Yoshikawa, H				Matsumoto, Koji; Maeda, Hiroo; Oki, Akinori; Takatsuka, Naoyoshi; Yasugi, Toshiharu; Furuta, Reiko; Hirata, Ranko; Mitsuhashi, Akira; Kawana, Kei; Fujii, Takuma; Iwata, Takashi; Hirai, Yasuo; Yokoyama, Masatoshi; Yaegashi, Nobuo; Watanabe, Yoh; Nagai, Yutaka; Yoshikawa, Hiroyuki		JHACC Study Grp	Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?	CANCER SCIENCE			English	Article						cervical cancer; cervical intraepithelial neoplasia; human leukocyte antigen; human papillomavirus; low-grade squamous intraepithelial lesion	HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; RISK; POLYMORPHISMS; WOMEN; SPECIFICITY; PROGRESSION; REGRESSION; CARCINOMA; HLA-DRB1	We investigated the role of human leukocyte antigen (HLA) class II alleles in multistage cervical carcinogenesis. Cross-sectional analysis for HLA association with cervical cancer included 1253 Japanese women: normal cytology (NL, n=341), cervical intraepithelial neoplasia grade 1 (CIN1, n=505), CIN grade 2 or 3 (CIN2/3, n=96), or invasive cervical cancer (ICC, n=311). The HLA class II allele frequencies were compared by Fisher's exact test or the (2)-test. The Bonferroni adjustment corrected for multiple comparisons. Among the study subjects, 454 women with low-grade squamous intraepithelial lesion cytology were prospectively monitored by cytology and colposcopy every 3-4months to analyze cumulative risk of CIN3 within the next 10years in relation to HLA class II alleles. HLA class II DRB1*1302 allele frequency was similar between women with NL (11.7%) and CIN1 (11.9%), but significantly decreased to 5.2% for CIN2/3 and 5.8% for ICC (P=0.0003). Correction for multiple testing did not change this finding. In women with low-grade squamous intraepithelial lesion cytology, the cumulative risk of CIN3 diagnosed within 10years was significantly reduced among DRB1*1302-positive women (3.2% vs. 23.7%, P=0.03). In conclusion, the two different types of analysis in this single study showed the protective effect of the DRB1*1302 allele against progression from CIN1 to CIN2/3.	[Matsumoto, Koji; Oki, Akinori; Yoshikawa, Hiroyuki] Univ Tsukuba, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan; [Maeda, Hiroo; Hirata, Ranko] Saitama Med Univ, Saitama Med Ctr, Dept Transfus Med & Cell Therapy, Saitama, Japan; [Takatsuka, Naoyoshi] Gifu Univ, Grad Sch Med, Dept Hlth Econ, Gifu, Japan; [Yasugi, Toshiharu; Kawana, Kei] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan; [Furuta, Reiko] Japanese Fdn Canc Res, Inst Canc, Dept Pathol, Tokyo 170, Japan; [Mitsuhashi, Akira] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan; [Fujii, Takuma; Iwata, Takashi] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Hirai, Yasuo] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gynecol, Tokyo, Japan; [Hirai, Yasuo] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Cytopathol, Tokyo, Japan; [Yokoyama, Masatoshi] Saga Univ, Fac Med, Dept Obstet & Gynecol, Saga 840, Japan; [Yaegashi, Nobuo] Tohoku Univ, Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Watanabe, Yoh] Kinki Univ, Sch Med, Dept Obstet & Gynecol, Osaka 589, Japan; [Nagai, Yutaka] Univ Ryukyus, Fac Med, Dept Obstet & Gynecol, Okinawa, Japan	Matsumoto, K (reprint author), Univ Tsukuba, Fac Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan.	matsumok@mui.biglobe.ne.jp			Ministry of Education, Science, Sports and Culture of Japan [12218102, 25462585]	This work was supported by Ministry of Education, Science, Sports and Culture of Japan (grant nos. 12218102 and 25462585).	Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Coquillard G, 2011, GYNECOL ONCOL, V120, P89, DOI 10.1016/j.ygyno.2010.09.013; Breitburd F, 1996, SEMIN CANCER BIOL, V7, P359, DOI 10.1006/scbi.1996.0045; Matsumoto K, 2003, INT J CANCER, V106, P919, DOI 10.1002/ijc.11332; HAN R, 1992, NATURE, V356, P66; Nakagawa S, 2000, J MED VIROL, V62, P251, DOI 10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V; APPLE RJ, 1994, NAT GENET, V6, P157, DOI 10.1038/ng0294-157; Darragh TM, 2012, ARCH PATHOL LAB MED, V136, P1266; Konno Y, 1999, INVEST OPHTH VIS SCI, V40, P1838; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.ob013e31805152ab; Maciag PC, 2000, CANCER EPIDEM BIOMAR, V9, P1183; Cuzick J, 2000, BRIT J CANCER, V82, P1348; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Scarinci IC, 2010, CANCER-AM CANCER SOC, V116, P2531, DOI 10.1002/cncr.25065; Bouvard V, 2009, LANCET ONCOL, V10, P321; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; Maciag PC, 2002, J INFECT DIS, V186, P164, DOI 10.1086/341080; Sastre-Garau X, 2004, OBSTET GYNECOL, V104, P751, DOI 10.1097/01.AOG.0000139834.84628.61; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Matsumoto K, 2012, INT J GYNECOL CANCER, V22, P471, DOI 10.1097/IGC.0b013e3182439500; Beskow AH, 2001, INT J CANCER, V93, P817, DOI 10.1002/ijc.1412; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0; Wang SS, 2001, J INFECT DIS, V184, P1310, DOI 10.1086/324209; Yang YC, 2006, HUM IMMUNOL, V67, P331, DOI 10.1016/j.humimm.2006.03.017; Castellsague X, 2003, J NATL CANC I MONOGR, V31, P20; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI DOI 10.1002/IJC.25516; Nagano H, 1996, J Obstet Gynaecol Res, V22, P1	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1448	1454		10.1111/cas.12760		7	Oncology	Oncology	CU7ON	WOS:000363731300024		
J	Yoshida, N; Tsuzuki, S; Karube, K; Takahara, T; Suguro, M; Miyoshi, H; Nishikori, M; Shimoyama, M; Tsukasaki, K; Ohshima, K; Seto, M				Yoshida, Noriaki; Tsuzuki, Shinobu; Karube, Kennosuke; Takahara, Taishi; Suguro, Miyuki; Miyoshi, Hiroaki; Nishikori, Momoko; Shimoyama, Masanori; Tsukasaki, Kunihiro; Ohshima, Koichi; Seto, Masao			STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas	CANCER SCIENCE			English	Article						Functional analyses; genomic loss of 6q24; peripheral T-cell lymphomas; STX11; tumor suppressor gene	FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FOLLICULAR LYMPHOMA; MUTATIONS; LEUKEMIA/LYMPHOMA; IDENTIFICATION; MALIGNANCIES; SYNTAXIN-11; ABERRATIONS; REVEALS	Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin lymphomas with poor prognosis. Their molecular pathogenesis has not been entirely elucidated. We previously showed that 6q24 is one of the most frequently deleted regions in primary thyroid T-cell lymphoma. In this study, we extended the analysis to other subtypes of PTCL and performed functional assays to identify the causative genes of PTCL that are located on 6q24. Genomic loss of 6q24 was observed in 14 of 232 (6%) PTCL cases. The genomic loss regions identified at 6q24 always involved only two known genes, STX11 and UTRN. The expression of STX11, but not UTRN, was substantially lower in PTCL than in normal T-cells. STX11 sequence analysis revealed mutations in two cases (one clinical sample and one T-cell line). We further analyzed the function of STX11 in 14 cell lines belonging to different lineages. STX11 expression only suppressed the proliferation of T-cell lines bearing genomic alterations at the STX11 locus. Interestingly, expression of a novel STX11 mutant (p.Arg78Cys) did not exert suppressive effects on the induced cell lines, suggesting that this mutant is a loss-of-function mutation. In addition, STX11-altered PTCL not otherwise specified cases were characterized by the presence of hemophagocytic syndrome (67% vs 8%, P=0.04). They also tended to have a poor prognosis compared with those without STX11 alteration. These results suggest that STX11 plays an important role in the pathogenesis of PTCL and they may contribute to the future development of new drugs for the treatment of PTCL.	[Yoshida, Noriaki; Tsuzuki, Shinobu; Karube, Kennosuke; Takahara, Taishi; Suguro, Miyuki; Seto, Masao] Aichi Canc Ctr Res Inst, Div Mol Med, Nagoya, Aichi, Japan; [Yoshida, Noriaki; Seto, Masao] Nagoya Univ, Grad Sch Med, Aichi Canc Ctr Res Inst, Dept Canc Genet, Nagoya, Aichi 4648601, Japan; [Yoshida, Noriaki; Miyoshi, Hiroaki; Ohshima, Koichi; Seto, Masao] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Takahara, Taishi] Nagoya Univ, Grad Sch Med, Dept Pathol & Lab Med, Nagoya, Aichi 4648601, Japan; [Nishikori, Momoko] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Shimoyama, Masanori] Natl Canc Ctr, Multi Inst Clin Trial Support Ctr, Tokyo 104, Japan; [Tsukasaki, Kunihiro] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba, Japan	Seto, M (reprint author), Kurume Univ, Sch Med, Dept Pathol, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	seto_masao@kurume-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation	Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Japan Society for the Promotion of Science; and Takeda Science Foundation.	Boi M, 2013, BLOOD, V122, P2683, DOI 10.1182/blood-2013-04-497933; Chihara D, 2014, BRIT J HAEMATOL, V164, P536, DOI 10.1111/bjh.12659; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Zhang XH, 2004, CANCER SCI, V95, P809, DOI 10.1111/j.1349-7006.2004.tb02186.x; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; Kucuk C, 2011, P NATL ACAD SCI USA, V108, P20119, DOI 10.1073/pnas.1115128108; Nakagawa M, 2009, CLIN CANCER RES, V15, P30, DOI 10.1158/1078-0432.CCR-08-1808; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Umino A, 2011, BLOOD, V117, P5473, DOI 10.1182/blood-2010-12-327791; Pileri SA, 2012, J CLIN INVEST, V122, P3448, DOI 10.1172/JCI61205; Karube K, 2012, EXP HEMATOL, V40, P1005, DOI 10.1016/j.exphem.2012.08.005; Sutton RB, 1998, NATURE, V395, P347; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Yoo HY, 2014, NAT GENET, V46, P371, DOI 10.1038/ng.2916; Kogl T, 2013, BLOOD, V121, P604, DOI 10.1182/blood-2012-07-441139; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Liu F, 2013, EUR J HAEMATOL, V90, P51, DOI 10.1111/ejh.12030; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Rudd E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.035253; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Yamamoto K, 2005, J HUM GENET, V50, P600, DOI 10.1007/s10038-005-0293-1; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Sepulveda FE, 2013, BLOOD, V121, P595, DOI 10.1182/blood-2012-07-440339; Karube K, 2011, BLOOD, V118, P3195, DOI 10.1182/blood-2011-04-346890; Odqvist L, 2013, CLIN CANCER RES, V19, P2319, DOI 10.1158/1078-0432.CCR-12-3151; Thorns C, 2007, GENE CHROMOSOME CANC, V46, P37, DOI 10.1002/gcc.20386; Arita K, 2013, EXP HEMATOL, V41, P731, DOI 10.1016/j.exphem.2013.04.001; Yoshida N, 2013, BRIT J HAEMATOL, V161, P214, DOI 10.1111/bjh.12255; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Fukuhara N, 2007, GENE CHROMOSOME CANC, V46, P784, DOI 10.1002/gcc.20464; Tagawa H, 2007, LEUKEMIA, V21, P2549, DOI 10.1038/sj.leu.240481; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101; Li Y, 2007, ONCOGENE, V26, P6220, DOI 10.1038/sj.onc.1210432; Salaverria I, 2008, BRIT J HAEMATOL, V140, P516, DOI 10.1111/j.1365-2141.2007.06924.x; Bryceson YT, 2007, BLOOD, V110, P1906, DOI 10.1182/blood-2007-02-074468; Odejide O, 2014, BLOOD, V123, P1293, DOI 10.1182/blood-2013-10-531509; Piccaluga PP, 2014, INT J HEMATOL, V99, P219, DOI 10.1007/s12185-014-1522-1; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Yoshida N, 2014, CANCER RES, V74, P6129, DOI 10.1158/0008-5472.CAN-14-0643	45	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1455	1462		10.1111/cas.12742		8	Oncology	Oncology	CU7ON	WOS:000363731300025		
J	Hiramatsu, K; Serada, S; Kobiyama, K; Nakagawa, S; Morimoto, A; Matsuzaki, S; Ueda, Y; Fujimoto, M; Yoshino, K; Ishii, KJ; Enomoto, T; Kimura, T; Naka, T				Hiramatsu, Kosuke; Serada, Satoshi; Kobiyama, Kouji; Nakagawa, Satoshi; Morimoto, Akiko; Matsuzaki, Shinya; Ueda, Yutaka; Fujimoto, Minoru; Yoshino, Kiyoshi; Ishii, Ken J.; Enomoto, Takayuki; Kimura, Tadashi; Naka, Tetsuji			CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody	CANCER SCIENCE			English	Article						Antitumor antibody; bone marrow stromal antigen 2; CpG oligodeoxynucleotides; macrophage; natural killer cell	NATURAL-KILLER-CELLS; CANCER; CARCINOMA; EFFICACY	Numerous monoclonal antibodies (mAb) targeting tumor antigens have recently been developed. Antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) via effector cells such as tumor-infiltrating natural killer (NK) cells and macrophages are often involved in mediating the antitumor activity of mAb. CpG oligodeoxynucleotides (ODN) have a potent antitumor activity and are considered to increase tumor infiltration of NK cells and macrophages. Our group previously reported significant antitumor activity of anti-bone marrow stromal antigen 2 (BST2) mAb against BST2-positive endometrial cancer cells through ADCC. In this study, we evaluated the synergistic antitumor activity of combination therapy with anti-BST-2 mAb and CpG ODN using SCID mice and elucidated the mechanisms underlying this activity. Anti-BST2 mAb and CpG ODN monotherapy had a significant dose-dependent antitumor activity (P=0.0135 and P=0.0196, respectively). Combination therapy with anti-BST2 mAb and CpG ODN had a significant antitumor activity in SCID mice (P<0.01), but not in NOG mice. FACS analysis revealed significantly increased numbers of NK cells and macrophages in tumors treated with a combination of anti-BST2 mAb and CpG ODN and with CpG ODN alone in SCID mice (P<0.05 and P<0.01, respectively). These results suggested that the combination therapy with anti-BST2 mAb and CpG ODN has a significant antitumor activity and induces tumor infiltration of NK cells and macrophages. Combination therapy with CpG ODN and anti-BST2 mAb or other antitumor mAb depending on ADCC may represent a new treatment option for cancer.	[Hiramatsu, Kosuke; Nakagawa, Satoshi; Morimoto, Akiko; Matsuzaki, Shinya; Ueda, Yutaka; Yoshino, Kiyoshi; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Hiramatsu, Kosuke; Serada, Satoshi; Nakagawa, Satoshi; Fujimoto, Minoru; Naka, Tetsuji] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Ibaraki, Osaka 5670085, Japan; [Kobiyama, Kouji; Ishii, Ken J.] Natl Inst Biomed Innovat Hlth & Nutr, Lab Adjuvant Innovat, Ibaraki, Osaka 5670085, Japan; [Enomoto, Takayuki] Niigata Univ, Sch Med, Dept Obstet & Gynecol, Niigata, Japan	Naka, T (reprint author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, 7-6-8 Saitoasagi, Ibaraki, Osaka 5670085, Japan.	tnaka@nibiohn.go.jp			Ministry of Health, Labour and Welfare of Japan	This study was supported by a Grant-in-Aid from the Ministry of Health, Labour and Welfare of Japan.	Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Halama N, 2011, CLIN CANCER RES, V17, P678, DOI 10.1158/1078-0432.CCR-10-2173; Ishii KJ, 2003, CLIN CANCER RES, V9, P6516; Li ZJ, 2013, J IMMUNOL METHODS, V389, P45, DOI 10.1016/j.jim.2012.12.009; Yokoyama T, 2013, INT J CANCER, V132, P472, DOI 10.1002/ijc.27679; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639; Terme M, 2012, CANCER RES, V72, P2757, DOI 10.1158/0008-5472.CAN-11-3379; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Harada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083905; Sommariva M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-25	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1474	1478		10.1111/cas.12738		5	Oncology	Oncology	CU7ON	WOS:000363731300027		
J	Tokudome, S				Tokudome, Shinkan			Re: Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy-user bias	CANCER SCIENCE			English	Letter							MORTALITY; TRIAL		Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo 162, Japan	Tokudome, S (reprint author), Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo 162, Japan.	tokudome2013@gmail.com					Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Hamashima C, 2009, JPN J CLIN ONCOL, V39, P339, DOI 10.1093/jjco/hyp025; Pinsky PF, 2010, CLIN TRIALS, V7, P303, DOI 10.1177/1740774510374091; [Anonymous], 2010, INT J UROL, V17, P830; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Hoffman RM, UPTODATE; Ministry of Health, PRACT CANC SCREEN MU; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schroder FH, 2014, SCREENING PROSTATE C; TABUCHI, 2015, CANCER SCI, V106, P108; Tabuchi T, 2015, CANCER SCI, V106, P14; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	OCT	2015	106	10					1479	1480		10.1111/cas.12753		2	Oncology	Oncology	CU7ON	WOS:000363731300028		
J	Hayashi, K; Konno, T; Tada, H; Tani, S; Liu, L; Fujino, N; Nohara, A; Hodatsu, A; Tsuda, T; Tanaka, Y; Kawashiri, MA; Ino, H; Makita, N; Yamagishi, M				Hayashi, Kenshi; Konno, Tetsuo; Tada, Hayato; Tani, Satoyuki; Liu, Li; Fujino, Noboru; Nohara, Atsushi; Hodatsu, Akihiko; Tsuda, Toyonobu; Tanaka, Yoshihiro; Kawashiri, Masa-Aki; Ino, Hidekazu; Makita, Naomasa; Yamagishi, Masakazu			Functional Characterization of Rare Variants Implicated in Susceptibility to Lone Atrial Fibrillation	CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY			English	Article						analysis of variance; atrial fibrillation; genetic association studies; genetic variation; ion channels	QT SYNDROME; GENETIC-VARIANTS; MUTATIONS; IMPACT; RISK; PATHOGENICITY; MECHANISMS	Background Few rare variants in atrial fibrillation (AF)-associated genes have been functionally characterized to identify a causal relationship between these variants and development of AF. We here sought to determine the clinical effect of rare variants in AF-associated genes in patients with lone AF and characterized these variants electrophysiologically and bioinformatically. Methods and Results We screened all coding regions in 12 AF-associated genes in 90 patients with lone AF, with an onset of 4711 years (66 men; mean age, 56 +/- 13 years) by high-resolution melting curve analysis and DNA sequencing. The potassium and sodium currents were analyzed using whole-cell patch clamping. In addition to using 4 individual in silico prediction tools, we extended those predictions to an integrated tool (Combined Annotation Dependent Depletion). We identified 7 rare variants in KCNA5, KCNQ1, KCNH2, SCN5A, and SCN1B genes in 8 patients: 2 of 8 probands had a family history of AF. Electrophysiological studies revealed that 2 variants showed a loss-of-function, and 4 variants showed a gain-of-function. Five of 6 variants with electrophysiological abnormalities were predicted as pathogenic by Combined Annotation Dependent Depletion scores. Conclusions In our cohort of patients with lone AF, 7 rare variants in cardiac ion channels were identified in 8 probands. A combination of electrophysiological studies and in silico predictions showed that these variants could contribute to the development of lone AF, although further in vivo study is necessary to confirm these results. More than half of AF-associated rare variants showed gain-of-function behavior, which may be targeted using genotype-specific pharmacological therapy.	Kanazawa Univ Grad Sch Med, Div Cardiovascular Med, Kanazawa, Ishikawa, Japan; [Hayashi, Kenshi; Konno, Tetsuo; Tada, Hayato; Tani, Satoyuki; Fujino, Noboru; Nohara, Atsushi; Hodatsu, Akihiko; Tsuda, Toyonobu; Tanaka, Yoshihiro; Kawashiri, Masa-Aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med Sci, Div Cardiovasc Med, Kanazawa, Ishikawa 9208640, Japan; [Ino, Hidekazu] Komatsu Municipal Hosp, Dept Cardiol, Komatsu, Japan; [Makita, Naomasa] Nagasaki Univ, Dept Mol Physiol, Grad Sch Biomed Sci, Nagasaki 852, Japan	Hayashi, K (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	kenshi@med.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [19790520]; Ministry of Health, Labor, and Welfare of Japan [H26-040, H24-033]; Takeda Science Foundation	This study was supported by grants from Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science (19790520 to K.Hayashi), the Ministry of Health, Labor, and Welfare of Japan for Clinical Research on Intractable Diseases (H26-040 and H24-033 to K. Hayashi), and Takeda Science Foundation (K. Hayashi).	Mann SA, 2012, J AM COLL CARDIOL, V59, P1017, DOI 10.1016/j.jacc.2011.11.039; Olesen MS, 2014, EUR J HUM GENET, V22, P297, DOI 10.1038/ejhg.2013.139; Otagiri T, 2008, PEDIATR RES, V64, P482, DOI 10.1203/PDR.0b013e3181841eca; Giudicessi JR, 2012, CIRC-CARDIOVASC GENE, V5, P519, DOI 10.1161/CIRCGENETICS.112.963785; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; Priori SG, 1999, CIRCULATION, V99, P529; Everett BM, 2013, EUR HEART J, V34, P2243, DOI 10.1093/eurheartj/eht033; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Tucker NR, 2014, CIRC RES, V114, P1469, DOI 10.1161/CIRCRESAHA.114.302225; Darbar D, 2013, NAT REV CARDIOL, V10, P317, DOI 10.1038/nrcardio.2013.53; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Campbell CM, 2013, CIRC-ARRHYTHMIA ELEC, V6, P960, DOI 10.1161/CIRCEP.113.000439; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; Hayashi K, 2009, CLIN SCI, V117, P415, DOI 10.1042/CS20080528; Yang YQ, 2009, J HUM GENET, V54, P277, DOI 10.1038/jhg.2009.26; Oyen N, 2012, J AM COLL CARDIOL, V60, P917, DOI 10.1016/j.jacc.2012.03.046; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Olesen MS, 2014, HEART RHYTHM, V11, P246, DOI 10.1016/j.hrthm.2013.10.034; Sudandiradoss C, 2008, Genomic Med, V2, P55, DOI 10.1007/s11568-009-9027-3; Tada H, 2014, STROKE, V45, P2856, DOI 10.1161/STROKEAHA.114.006072; Yang RQ, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-74	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	OCT	2015	8	5					1095	1104		10.1161/CIRCEP.114.002519		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CU2SP	WOS:000363374100017		
J	Montambault, JR; Wongbusarakum, S; Leberer, T; Joseph, E; Andrew, W; Castro, F; Nevitt, B; Golbuu, Y; Oldiais, NW; Groves, CR; Kostka, W; Houk, P				Montambault, Jensen Reitz; Wongbusarakum, Supin; Leberer, Trina; Joseph, Eugene; Andrew, Wayne; Castro, Fran; Nevitt, Brooke; Golbuu, Yimnang; Oldiais, Noelle W.; Groves, Craig R.; Kostka, Willy; Houk, Peter			Use of monitoring data to support conservation management and policy decisions in Micronesia	CONSERVATION BIOLOGY			English	Article						adaptive management; communications; community-based conservation; ecosystem management; Oceania	NORTHERN MARIANA ISLANDS; CORAL-REEF FISHERY; ADAPTIVE MANAGEMENT; RESOURCE-MANAGEMENT; POHNPEI; SCIENCE; KNOWLEDGE; IMPLEMENTATION; COMMONWEALTH; OCEANIA	Adaptive management implies a continuous knowledge-based decision-making process in conservation. Yet, the coupling of scientific monitoring and management frameworks remains rare in practice because formal and informal communication pathways are lacking. We examined 4 cases in Micronesia where conservation practitioners are using new knowledge in the form of monitoring data to advance marine conservation. These cases were drawn from projects in Micronesia Challenge jurisdictions that received funding for coupled monitoring-to-management frameworks and encompassed all segments of adaptive management. Monitoring in Helen Reef, Republic of Palau, was catalyzed by coral bleaching and revealed evidence of overfishing that led to increased enforcement and outreach. In Nimpal Channel, Yap, Federated States of Micronesia (FSM), monitoring the recovery of marine food resources after customary restrictions were put in place led to new, more effective enforcement approaches. Monitoring in Laolao Bay, Saipan, Commonwealth of the Northern Mariana Islands, was catalyzed by observable sediment loads from poor land-use practices and resulted in actions that reduced land-based threats, particularly littering and illegal burning, and revealed additional threats from overfishing. Pohnpei (FSM) began monitoring after observed declines in grouper spawning aggregations. This data led to adjusting marine conservation area boundaries and implementing market-based size class restrictions. Two themes emerged from these cases. First, in each case monitoring was conducted in a manner relevant to the social and ecological systems and integrated into the decision-making process. Second, conservation practitioners and scientists in these cases integrated culturally appropriate stakeholder engagement throughout all phases of the adaptive management cycle. More broadly, our study suggests, when describing adaptive management, providing more details on how monitoring and management activities are linked at similar spatial scales and across similar time frames can enhance the application of knowledge.	[Montambault, Jensen Reitz] Nature Conservancy, Charlottesville, VA 22903 USA; [Wongbusarakum, Supin] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Wongbusarakum, Supin] Natl Ocean & Atmospher Adm, Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Div, Honolulu, HI 96818 USA; [Leberer, Trina] Nature Conservancy, Hagatna, GU 96932 USA; [Joseph, Eugene] Conservat Soc Pohnpei, Kolonia, PA 96941 USA; [Andrew, Wayne] OneReef, Koror 96940, PW, Palau; [Castro, Fran] Off Governor, Div Environm Qual, Saipan, CM 96950 USA; [Nevitt, Brooke] Pacific Marine Resources Inst, Saipan, PA 96950 USA; [Golbuu, Yimnang; Oldiais, Noelle W.] Palau Int Coral Reef Ctr, Koror 96940, PW, Palau; [Oldiais, Noelle W.] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Groves, Craig R.] Nature Conservancy, Bozeman, MT 59715 USA; [Kostka, Willy] Micronesia Conservat Trust, Pohnpei, CA 96941 USA; [Houk, Peter] Univ Guam, Marine Lab, Mangilao, GU 96923 USA	Montambault, JR (reprint author), Nature Conservancy, 490 Westfield Rd, Charlottesville, VA 22903 USA.	jmontambault@tnc.org					Andrew W., 2011, J MICRONESIA FISHING, V3, P8; Victor S, 2006, ESTUAR COAST SHELF S, V66, P409, DOI 10.1016/j.ecss.2005.07.025; Houk P, 2012, CORAL REEFS, V31, P13, DOI 10.1007/s00338-011-0826-3; Nie MA, 2012, CONSERV BIOL, V26, P1137, DOI 10.1111/j.1523-1739.2012.01915.x; McDonald-Madden E, 2010, TRENDS ECOL EVOL, V25, P547, DOI 10.1016/j.tree.2010.07.002; Sarewitz D, 2007, ENVIRON SCI POLICY, V10, P5, DOI 10.1016/j.envsci.2006.10.001; Rhodes KL, 2008, CORAL REEFS, V27, P443, DOI 10.1007/s00338-007-0331-x; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolysis.33.010802.150524; Clarke P, 2010, ENVIRON CONSERV, V37, P98, DOI 10.1017/S0376892910000354; Geupel GR, 2011, TRENDS ECOL EVOL, V26, P107, DOI 10.1016/j.tree.2010.11.007; HESTER FJ, 1974, MAR FISH REV, V36, P17; Brosi BJ, 2007, CONSERV BIOL, V21, P875, DOI 10.1111/j.1523-1739.2007.00654.x; Larson AJ, 2013, J FOREST, V111, P348, DOI 10.5849/jof.13-021; Keppel G, 2012, CONSERV LETT, V5, P256, DOI 10.1111/j.1755-263X.2012.00243.x; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Bejarano S, 2013, MAR ECOL PROG SER, V482, P197, DOI 10.3354/meps10270; Rhodes KL, 2002, B MAR SCI, V70, P851; Maragos JE, 1995, CORAL REEFS, V14, P237; Houk P, 2006, PAC SCI, V60, P177, DOI 10.1353/psc.2006.0005; Houk P, 2013, MAR POLLUT BULL, V71, P209, DOI 10.1016/j.marpolbul.2013.03.012; Leslie HM, 2013, CONSERV BIOL, V27, P1126, DOI 10.1111/cobi.12080; Rhodes KL, 2013, J FISH BIOL, V82, P1333, DOI 10.1111/jfb.12076; Aswani S, 2005, REV FISH BIOL FISHER, V15, P285, DOI 10.1007/s11160-005-4868-x; Houk P, 2013, BIOSCIENCE, V63, P297, DOI 10.1525/bio.2013.63.4.10; Wintle BA, 2010, ECOL LETT, V13, P1325, DOI 10.1111/j.1461-0248.2010.01514.x; Cook CN, 2013, CONSERV BIOL, V27, P669, DOI 10.1111/cobi.12050; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Hutto RL, 2013, FOREST ECOL MANAG, V289, P183, DOI 10.1016/j.foreco.2012.10.005; Walters CJ, 2007, AMBIO, V36, P304, DOI 10.1579/0044-7447(2007)36[304:IAMHTS]2.0.CO;2; Castro F, 2014, ANAL ISSUES AFFECTIN; Chieng CL, 2011, NIMPAL MARINE CONSER; Cuetos-Bueno J, 2015, REV FISH BIOL FISHER, V25, P179, DOI 10.1007/s11160-014-9358-6; Englberger Lois, 2011, Hawaii Med J, V70, P31; Golbuu Y, 2013, RECOVERY CORAL POPUL; Gorong B, 2009, J MICRONESIA FIS FAL, P8; Herrmann K, 2009, LAOLAO BAY CONSERVAT; Houk P, 2007, RAPID ECOLOGICAL ASS; Houk P, 1991, LAOLAO BAY ROAD COAS; Houk P, 2009, ASSESSMENT ECOLOGICA; Koshiba S, 2011, BIOL SURVEYS 3 MPAS; Layzer JA, 2012, SUSTAINABILITY SCI E, P177; Lee KN, 1999, CONSERV ECOL, V3, P3, DOI DOI 10.1201/9781420042597.SEC1; Montambault Jensen R., 2012, P133; Muir M., 2010, ARE WE MEASURING CON; NRC (National Research Council), 2004, AD MAN WAT RES PROJ; Oldiais N, 2009, HELEN REEF HATOHOBEI; Olsudong D, 2012, BIOL SURVEYS NIMPAL; Petersen B, 2014, ENVIRON MANAGE, V54, P782, DOI 10.1007/s00267-014-0337-4; Remengesau TE, 2006, DECLARATION COMMITME; Republic of Palau, 2012, PROT MON MAR PROT AR; Rhodes KL, 2007, CORAL REEFS, V27, P443; Sadovy De Mitcheson Yvonne, 2008, Conserv Biol, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; SeaWeb, 2014, NA10NOS4190074 SEAWE; Starmer J, 2007, QUANTITATIVE ASSESSM; Trianni MS., 2002, BECHE DE MER INFO B, V16, P5; Wongbusarakum S, 2008, SEM PASIFIKA SOCIOEC	60	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0888-8892	1523-1739		CONSERV BIOL	Conserv. Biol.	OCT	2015	29	5					1279	1289		10.1111/cobi.12542		11	Biodiversity Conservation; Ecology; Environmental Sciences	Biodiversity & Conservation; Environmental Sciences & Ecology	CU7NW	WOS:000363729100004		
J	Ikuta, Y; Kamei, N; Ishikawa, M; Adachi, N; Ochi, M				Ikuta, Yasunari; Kamei, Naosuke; Ishikawa, Masakazu; Adachi, Nobuo; Ochi, Mitsuo			In Vivo Kinetics of Mesenchymal Stem Cells Transplanted into the Knee Joint in a Rat Model Using a Novel Magnetic Method of Localization	CTS-CLINICAL AND TRANSLATIONAL SCIENCE			English	Article						stem cell transplantation; marrow; stem cell transplantation; surgery	LONG-TERM ENGRAFTMENT; BONE-MARROW; STROMAL CELLS; ARTICULAR-CARTILAGE; MYOCARDIAL-INFARCTION; DELIVERY-SYSTEM; REPAIR; DEFECTS; REGENERATION; ENHANCEMENT	We have developed a magnetic system for targeting cells in minimally invasive cell transplantation. Magnetically labeled MSCs (m-MSCs) with nanoscale iron particles can be guided into the desired region by magnetic force from an extracorporeal device. We reported that magnetic targeting of m-MSCs enhances cartilage repair in a mini-pig model. However, the detailed kinetics of these magnetically targeted m-MSCs remain unknown. For clinical use, this aspect should be clarified from a safety standpoint. We therefore investigated the spatial and temporal distribution of the fluorescently-labeled m-MSCs transplanted into the knee joint using in vivo fluorescence combined with three-dimensional computed tomographic imaging in a rat model. Although the intraarticularly injected m-MSCs were spread throughout the joint cavity in the absence of magnetic force, the magnetic force caused the injected m-MSCs to accumulate around the chondral lesion. Further examinations including ex vivo imaging, histological assessments and reverse transcription polymerase chain reaction revealed that transplanted MSCs were not present in any major organs after intraarticular administration, regardless of magnetic targeting. Our data suggest that m-MSCs can be accumulated efficiently into a chondral lesion using our magnetic targeting system, while none of the intraarticularly transplanted MSCs migrate to other major organs.	[Ikuta, Yasunari; Kamei, Naosuke; Ishikawa, Masakazu; Adachi, Nobuo; Ochi, Mitsuo] Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Ikuta, Y (reprint author), Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	yas.1091@gmail.com					Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Kamei G, 2013, AM J SPORT MED, V41, P1255, DOI 10.1177/0363546513483270; Bentzon JF, 2005, BIOCHEM BIOPH RES CO, V330, P633, DOI 10.1016/j.bbrc.2005.03.072; Sherman LS, 2011, CTS-CLIN TRANSL SCI, V4, P380, DOI 10.1111/j.1752-8062.2011.00283.x; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Matsumoto T, 2006, AM J PATHOL, V169, P1440, DOI 10.2353/ajpath.2006.060064; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Oshima S, 2010, J BONE JOINT SURG BR, V92B, P1606, DOI 10.1302/0301-620X.92B11.23491; Hyun JS, 2013, BIOTECHNOL ADV, V31, P736, DOI 10.1016/j.biotechadv.2012.11.003; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Lin P, 2014, MOL THER, V22, P160, DOI 10.1038/mt.2013.221; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Nishimori M, 2006, J BONE JOINT SURG BR, V88B, P1236, DOI 10.1302/0301-620X.88B9.17810; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Kodama A, 2012, J BONE JOINT SURG BR, V94B, P998, DOI 10.1302/0301-620X.94B7.28521; Behfar A, 2008, CTS-CLIN TRANSL SCI, V1, P34, DOI 10.1111/j.1752-8062.2008.00024.x; Bekkers JEJ, 2013, AM J SPORT MED, V41, P2158, DOI 10.1177/0363546513494181; Kobayashi T, 2008, ARTHROSCOPY, V24, P69, DOI 10.1016/j.arthro.2007.08.017; Assis ACM, 2010, CELL TRANSPLANT, V19, P219, DOI 10.3727/096368909X479677; Nakabayashi A, 2013, J ORTHOP RES, V31, P754, DOI 10.1002/jor.22282; Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895; Kobayashi T, 2009, ARTHROSCOPY, V25, P1435, DOI 10.1016/j.arthro.2009.06.009; Candela ME, 2014, MATRIX BIOL, V39, P44, DOI 10.1016/j.matbio.2014.08.015; Cucchiarini M, 2014, Eur Cell Mater, V27, P12; Nishida K, 2006, NEUROREPORT, V17, P1269, DOI 10.1097/01.wnr.0000227993.07799.a2; Semont A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070170; Taghavi S, 2015, CLIN TRANSL SCI	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-8054	1752-8062		CTS-CLIN TRANSL SCI	CTS-Clin. Transl. Sci.	OCT	2015	8	5					467	474		10.1111/cts.12284		8	Medicine, Research & Experimental	Research & Experimental Medicine	CU6ON	WOS:000363652100010		
J	Imai, C; Armstrong, B; Chalabi, Z; Mangtani, P; Hashizume, M				Imai, Chisato; Armstrong, Ben; Chalabi, Zaid; Mangtani, Punam; Hashizume, Masahiro			Time series regression model for infectious disease and weather	ENVIRONMENTAL RESEARCH			English	Article						Time series; Method; Infectious disease; Weather; Climate	COUNT DATA; SURVEILLANCE DATA; CHOLERA DYNAMICS; NONLINEAR MODELS; CLIMATE-CHANGE; EPIDEMIOLOGY; RAINFALL; MALARIA; ASSOCIATION; ADMISSIONS	Time series regression has been developed and long used to evaluate the short-term associations of air pollution and weather with mortality or morbidity of non-infectious diseases. The application of the regression approaches from this tradition to infectious diseases, however, is less well explored and raises some new issues. We discuss and present potential solutions for five issues often arising in such analyses: changes in immune population, strong autocorrelations, a wide range of plausible lag structures and association patterns, seasonality adjustments, and large overdispersion. The potential approaches are illustrated with datasets of cholera cases and rainfall from Bangladesh and influenza and temperature in Tokyo. Though this article focuses on the application of the traditional time series regression to infectious diseases and weather factors, we also briefly introduce alternative approaches, including mathematical modeling, wavelet analysis, and autoregressive integrated moving average (ARIMA) models. Modifications proposed to standard time series regression practice include using sums of past cases as proxies for the immune population, and using the logarithm of lagged disease counts to control autocorrelation due to true contagion, both of which are motivated from "susceptible-infectious-recovered" (SIR) models. The complexity of lag structures and association patterns can often be informed by biological mechanisms and explored by using distributed lag non-linear models. For overdispersed models, alternative distribution models such as quasi-Poisson and negative binomial should be considered. Time series regression can be used to investigate dependence of infectious diseases on weather, but may need modifying to allow for features specific to this context. (C) 2015 The Authors. Published by Elsevier Inc.	[Imai, Chisato; Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 8528523, Japan; [Armstrong, Ben; Chalabi, Zaid] London Sch Hyg & Trop Med, Dept Social & Environm Hlth, London WC1H 9SH, England; [Mangtani, Punam] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England	Imai, C (reprint author), Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	chisato.imai@gmail.com; ben.armstrong@lshtm.ac.uk; Zaid.Chalabi@lshtm.ac.uk; punam.mangtani@lshtm.ac.uk; hashizum@nagasaki-u.ac.jp			JSPS fellowship; School of Tropical Medicine and Global Health, Nagasaki University	We thank Yoonhee Kim for her support with demonstration analysis, ASG Faruque for sharing cholera data with us, and Katia Koelle for explaining her research to us that provided important insights to our study. Chisato Imai is also supported by JSPS fellowship. This study was supported by the School of Tropical Medicine and Global Health, Nagasaki University.	Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Gasparrini A, 2011, J STAT SOFTW, V43, P1; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; COX DR, 1983, BIOMETRIKA, V70, P269, DOI 10.1093/biomet/70.1.269; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; Eisenberg MC, 2013, EPIDEMICS-NETH, V5, P197, DOI 10.1016/j.epidem.2013.09.004; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Kim YM, 2012, ENVIRON HEALTH PERSP, V120, P1314, DOI 10.1289/ehp.1104577; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Cazelles B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0585; Jusot JF, 2011, T ROY SOC TROP MED H, V105, P637, DOI 10.1016/j.trstmh.2011.07.011; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Subak S, 2003, AM J EPIDEMIOL, V157, P531, DOI 10.1093/aje/kwg014; Zeileis A, 2008, J STAT SOFTW, V27, P1; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Lee JH, 2012, EPIDEMIOL INFECT, V140, P1087, DOI 10.1017/S095026881100166X; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Mangtani P, 2006, CLIN INFECT DIS, V42, P640, DOI 10.1086/499810; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; Hussain S, 2005, J APPL STAT, V32, P191, DOI 10.1080/02664760500054384; Cameron A.C., 2013, REGRESSION ANAL COUN; Campbell M.J., 2005, ENCY BIOSTATISTICS; Grassly NC, 2006, P R SOC B, V273, P2541, DOI 10.1098/rspb.2006.3604; Heymann DL, 2008, CONTROL COMMUNICABLE; Imai Chisato, 2015, Trop Med Health, V43, P1, DOI 10.2149/tmh.2014-21; Lambert D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Lopman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006671; Luque Fernandez MA, 2009, T R SOC TROP MED HYG, V103, P137; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Schwartz J., 1996, J EPIDEMIOL COMMU S1, V50, pS3; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Ver Hoef J. M., 2007, ECOLOGY, V88, P2766; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-57	40	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	OCT	2015	142						319	327		10.1016/j.envres.2015.06.040		9	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CU5WN	WOS:000363602800038		
J	Meyer-Rochow, VB; Gross, JV; Steffany, F; Zeuss, D; Erren, TC				Meyer-Rochow, V. Benno; Gross, J. Valerie; Steffany, Frank; Zeuss, Dominique; Erren, Thomas C.			Commentary: Plastic ocean and the cancer connection: 7 questions and answers	ENVIRONMENTAL RESEARCH			English	Editorial Material							URINARY BISPHENOL-A; ENDOCRINE DISRUPTING COMPOUNDS; MARINE-ENVIRONMENT; WILDLIFE CANCER; HUMAN EXPOSURE; BREAST-CANCER; MAMMARY-GLAND; CORD BLOOD; FOOD-CHAIN; CHEMICALS	A plethora of recent scientific reports testifies to challenges the world is facing from an ever-increasing marine plastic pollution. Toxicological concerns have been put forward, but possible links between the now ubiquitous synthetic polymers and human as well as wildlife cancers remain to be investigated. Hence, this commentary which addresses seven questions. Given numerous uncertainties on the factual impacts of plastics, we should embark on empirical studies into the validity of biologically plausible links between plastic residues and cancers and concomitantly consider ways to reduce plastics in the world within and around us. (C) 2015 Elsevier Inc. All rights reserved.	[Meyer-Rochow, V. Benno] Res Inst Luminous Organisms, Tokyo, Japan; [Gross, J. Valerie; Zeuss, Dominique; Erren, Thomas C.] Univ Cologne, UNIKLIN KOLN, Inst & Policlin Occupat Med Environm Med & Preven, D-50931 Cologne, Germany; [Steffany, Frank] Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany	Meyer-Rochow, VB (reprint author), Res Inst Luminous Organisms, Tokyo, Japan.	meyrow@gmail.com					Andrady A. L, 2003, PLASTICS ENV; Kale G, 2007, MACROMOL BIOSCI, V7, P255, DOI 10.1002/mabi.200600168; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; Zincke T, 1905, LIEBIGS ANN CHEM, V343, P75; Gatidou G, 2010, MAR POLLUT BULL, V60, P2111, DOI 10.1016/j.marpolbul.2010.07.003; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Hammer J, 2012, REV ENVIRON CONTAM T, V220, P1, DOI 10.1007/978-1-4614-3414-6_1; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; LaKind JS, 2015, ENVIRON RES, V142, P84, DOI 10.1016/j.envres.2015.06.013; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Tanaka K, 2013, MAR POLLUT BULL, V69, P219, DOI 10.1016/j.marpolbul.2012.12.010; Michael HA, 2005, NATURE, V436, P1145, DOI 10.1038/nature03935; Koelmans AA, 2013, ENVIRON SCI TECHNOL, V47, P7812, DOI 10.1021/es401169n; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Muncke Jane, 2009, Sci Total Environ, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006; van Franeker JA, 2015, ENVIRON POLLUT, V203, P89, DOI 10.1016/j.envpol.2015.02.034; Glausiusz J, 2014, NATURE, V508, P306, DOI 10.1038/508306a; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; Weinhouse C, 2014, ENVIRON HEALTH PERSP, V122, P485, DOI 10.1289/ehp.1307449; Ashley-Martin J, 2015, ENVIRON RES, V140, P360, DOI 10.1016/j.envres.2015.04.010; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; OPPENHEIMER BS, 1953, SCIENCE, V118, P305, DOI 10.1126/science.118.3063.305; vom Saal FS, 2008, JAMA-J AM MED ASSOC, V300, P1353, DOI 10.1001/jama.300.11.1353; Acevedo N, 2013, ENVIRON HEALTH PERSP, V121, P1040, DOI 10.1289/ehp.1306734; Kwon BG, 2014, ENVIRON POLLUT, V188, P45, DOI 10.1016/j.envpol.2014.01.019; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9; Koelmans AA, 2014, ENVIRON POLLUT, V187, P49, DOI 10.1016/j.envpol.2013.12.013; Prins GS, 2007, REPROD TOXICOL, V23, P374, DOI 10.1016/j.reprotox.2006.10.001; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Endo S, 2013, MAR POLLUT BULL, V74, P125, DOI 10.1016/j.marpolbul.2013.07.018; Lusher AL, 2015, ENVIRON POLLUT, V199, P185, DOI 10.1016/j.envpol.2015.01.023; SOTO AM, 1991, ENVIRON HEALTH PERSP, V92, P167, DOI 10.2307/3431154; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; Seltenrich N, 2015, ENVIRON HEALTH PERSP, V123, pA34, DOI 10.1289/ehp.123-A34; McAloose D, 2009, NAT REV CANCER, V9, P517, DOI 10.1038/nrc2665; Romano ME, 2015, ENVIRON RES, V138, P453, DOI 10.1016/j.envres.2015.03.003; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Bergmann M, 2015, MARINE ANTHROPOGENIC; Brophy JT, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-87; Chou WC, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-94; Covaci A., 2014, ENV RES; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Eisner P., 2004, POLYM ENG TECHNOLOGI; Erren T., 2013, EXPLORING THEMES AQU, P51; Erren T, 2009, NAT REV CANCER, V9, DOI 10.1038/nrc2665-c1; Erren TC, 2014, REPROD TOXICOL, V50, P180, DOI 10.1016/j.reprotox.2014.07.079; Erren T.C., 2015, ENV POLLUT; IARC, 2002, SOM TRAD HERB MED SO, V82; IARC, 2012, CHEM AG REL OCC F, V100F; Kim JH, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-33; Letasiova S, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S11; McGuinn LA, 2015, ENVIRON RES, V136, P381, DOI 10.1016/j.envres.2014.10.037; Moore C.P.C., 2011, PLASTIC OCEAN; Nahar MS, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-20; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Tarapore P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090332; Tibbetts JH, 2015, ENVIRON HEALTH PERSP, V123, pA90, DOI 10.1289/ehp.123-A90; Zoeller RT, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0029-4	64	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	OCT	2015	142						575	578		10.1016/j.envres.2015.08.015		4	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CU5WN	WOS:000363602800066		
J	Michikawa, T; Morokuma, S; Fukushima, K; Ueda, K; Takeuchi, A; Kato, K; Nitta, H				Michikawa, Takehiro; Morokuma, Seiichi; Fukushima, Kotaro; Ueda, Kayo; Takeuchi, Ayano; Kato, Kiyoko; Nitta, Hiroshi			A register-based study of the association between air pollutants and hypertensive disorders in pregnancy among the Japanese population	ENVIRONMENTAL RESEARCH			English	Article						Ozone; Hypertensive disorders in pregnancy; First trimester; Register-based; Japan	CARDIOVASCULAR-DISEASE; OBSTETRICAL COMPLICATIONS; POLLUTION; PREECLAMPSIA; EXPOSURE; RISK; METAANALYSIS; COHORT	Background: Ambient air pollution is hypothesized to be a risk factor for hypertensive disorders in pregnancy, one of the major pregnancy complications. Past studies have reported the supporting evidence, however this mainly referred to the Western population, and results from trimester-specific analysis have been varied. In this study, we focused on exposure during the first trimester of pregnancy (placental development stage), and tested the hypothesis among the Japanese population. Methods: We drew on data from the Japan Perinatal Registry Network database, and studied 36,620 singleton pregnant women without medical complications, in western Japan (Kyushu and Okinawa districts) between 2005 and 2010. In addition, data on ozone, suspended particulate matter (SPM), nitrogen dioxide (NO2), and sulfur dioxide (SO2) concentrations were obtained. The nearest monitoring station to the respective birthing hospital was used as a reference point for assigning average concentrations of each pollutant during the first trimester of pregnancy for each woman. The logistic regression model was applied to assess the association between quintiles of each pollutant and hypertensive disorders in pregnancy. Results: Mean concentrations during the first trimester were 41.3 ppb for ozone, 27.4 mu g/m(3) for SPM, 11.8 ppb for NO2, and 3.2 ppb for SO2. High exposure to ozone was associated with an increased risk of hypertensive disorders in pregnancy (for highest quintile vs. lowest: odds ratio= 1.20, 95% confidence interval=1.01-1.42). With regard to SPM, NO2 and SO2, we did not obtain the results with constant directionality. Conclusions: Ozone exposure during early pregnancy may be a risk factor for hypertensive disorders in pregnancy. (C) 2015 Elsevier Inc. All rights reserved.	[Michikawa, Takehiro; Ueda, Kayo; Takeuchi, Ayano; Nitta, Hiroshi] Natl Inst Environm Studies, Environm Epidemiol Sect, Ctr Environm Hlth Sci, Tsukuba, Ibaraki 3058506, Japan; [Morokuma, Seiichi; Kato, Kiyoko] Kyushu Univ, Kyushu Univ Hosp, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 8128582, Japan; [Fukushima, Kotaro] Fukuoka Childrens Hosp, Dept Obstet, Higashi Ku, Fukuoka 8130017, Japan; [Ueda, Kayo] Kyoto Univ, Grad Sch Engn, Sakura Ku, Kyoto 6158530, Japan; [Takeuchi, Ayano] Keio Univ, Prevent Med & Publ Hlth, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan	Michikawa, T (reprint author), Natl Inst Environm Studies, Environm Epidemiol Sect, Ctr Environm Hlth Sci, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan.	tmichikawa@nies.go.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [25241015]	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (25241015). The funding source had no role in the design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the article for publication.	Malmqvist E, 2013, ENVIRON HEALTH PERSP, V121, P488, DOI 10.1289/ehp.1205736; Mobasher Z, 2013, ENVIRON RES, V123, P9, DOI 10.1016/j.envres.2013.01.006; Dadvand P, 2014, OCCUP ENVIRON MED, V71, P570, DOI 10.1136/oemed-2013-101693; van den Hooven EH, 2011, HYPERTENSION, V57, P406, DOI 10.1161/HYPERTENSIONAHA.110.164087; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Lo JO, 2013, CURR OPIN OBSTET GYN, V25, P124, DOI 10.1097/GCO.0b013e32835e0ef5; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Lee PC, 2013, MATERN CHILD HLTH J, V17, P545, DOI 10.1007/s10995-012-1028-5; Srebot V, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-30; Pereira G, 2013, J EPIDEMIOL COMMUN H, V67, P147, DOI 10.1136/jech-2011-200805; Xu XH, 2014, J EPIDEMIOL COMMUN H, V68, P13, DOI 10.1136/jech-2013-202902; Matsuda Y, 2011, J OBSTET GYNAECOL RE, V37, P538, DOI 10.1111/j.1447-0756.2010.01408.x; Wu J, 2011, ENVIRON RES, V111, P685, DOI 10.1016/j.envres.2011.03.008; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P1365, DOI 10.1289/ehp.1206430; Yorifuji T, 2015, SCI TOTAL ENVIRON, V508, P188, DOI 10.1016/j.scitotenv.2014.11.077; Pedersen M, 2014, HYPERTENSION, V64, P494, DOI 10.1161/HYPERTENSIONAHA.114.03545; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Sarnat SE, 2010, J EXPO SCI ENV EPID, V20, P135, DOI 10.1038/jes.2009.10; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Matsuda Y, 2011, J OBSTET GYNAECOL RE, V37, P1409, DOI 10.1111/j.1447-0756.2011.01552.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Jedrychowski WA, 2012, CARDIOVASC TOXICOL, V12, P216, DOI 10.1007/s12012-012-9157-z; Bellamy L, 2007, BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.85301.BE; Bigagli E., 2011, J TOXICOL, V2011, P87074; Brown M.A., 2001, HYPERTENS PREGNANCY, V20, pIx; Engel SM, 2013, EPIDEMIOLOGY, V24, P379, DOI 10.1097/EDE.0b013e3182873a73; Hu H, 2014, ATMOS ENVIRON, V97, P336, DOI 10.1016/j.atmosenv.2014.08.027; Ibrahimou B, 2014, J OCCUP ENVIRON MED, V56, P1228, DOI 10.1097/JOM.0000000000000317; Itano Y., 2013, J JPN SOC ATMOS ENV, V48, P154; Japan Ministory of the Environment, 2009, AIR QUALITY; Miinzel T., 2014, EUR HEART J, V35, P829; Naruse K, 2013, HYPERTENS RES PREGNA, V1, P5; Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458; Olsson D., 2013, BMJ OPEN, V5, P2; Watanabe K, 2013, HYPERTENS RES PREGNA, V1, P3; Wu CS, 2009, AM J OBSTET GYNECOL, V201, P269	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	OCT	2015	142						644	650		10.1016/j.envres.2015.08.024		7	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CU5WN	WOS:000363602800076		
J	Ionas, AC; Gomez, AB; Uchida, N; Suzuki, G; Kajiwara, N; Takata, K; Takigami, H; Leonards, PEG; Covaci, A				Ionas, Alin C.; Gomez, Ana Ballesteros; Uchida, Natsuyo; Suzuki, Go; Kajiwara, Natsuko; Takata, Kyoko; Takigami, Hidetaka; Leonards, Pim E. G.; Covaci, Adrian			Comprehensive characterisation of flame retardants in textile furnishings by ambient high resolution mass spectrometry, gas chromatography-mass spectrometry and environmental forensic microscopy	ENVIRONMENTAL RESEARCH			English	Article						Flame retardants; PBDEs; PFRs; Textiles; Home furnishings; Mass spectrometry	POLYBROMINATED DIPHENYL ETHERS; CONSUMER PRODUCTS; INDOOR DUST; PLASTICIZERS; TOXICITY; ORGANOPHOSPHATE	The presence and levels of flame retardants (FRs), such as polybrominated diphenyl ethers (PBDEs) and organophosphate flame retardants (PFRs), was determined in textile home furnishings, such as carpets and curtains from stores in Belgium. A comprehensive characterisation of FRs in textile was done by ambient high resolution mass spectrometry (qualitative screening), gas chromatography-mass spectrometry (GC-MS) (quantitation), and environmental forensic microscopy (surface distribution). Ambient ionisation coupled to a time-of-flight (TOF) high resolution mass spectrometer (direct probe-TOF-MS) was investigated for the rapid screening of FRs. Direct probe-TOF-MS proved to be useful for a first screening step of textiles to detect FRs below the levels required to impart flame retardancy and to reduce, in this way, the number of samples for further quantitative analysis. Samples were analysed by GC-MS to confirm the results obtained by ambient mass spectrometry and to obtain quantitative information. The levels of PBDEs and PFRs were typically too low to impart flame retardancy. Only high levels of BDE-209 (11-18% by weight) were discovered and investigated in localised hotspots by employing forensic microscopy techniques. Most of the samples were made of polymeric materials known to be inherently flame retarded to some extent, so it is likely that other alternative and halogen-free FR treatments/solutions are preferred for the textiles on the Belgian market. (C) 2015 Elsevier Inc. All rights reserved.	[Ionas, Alin C.; Covaci, Adrian] Univ Antwerp, Toxicol Ctr, B-2610 Antwerp, Belgium; [Ionas, Alin C.; Gomez, Ana Ballesteros; Leonards, Pim E. G.] Vrije Univ Amsterdam, Inst Environm Studies, NL-1081 HV Amsterdam, Netherlands; [Uchida, Natsuyo; Suzuki, Go; Kajiwara, Natsuko; Takata, Kyoko; Takigami, Hidetaka] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki 3058506, Japan	Ionas, AC (reprint author), Univ Antwerp, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium.		Ballesteros-Gomez, Ana /K-9526-2013	Ballesteros-Gomez, Ana /0000-0003-1583-1459	European Union Seventh Framework Program (FP7) [264600, 295138]; Research Council of the University of Antwerp [BOF DOCPRO1]; Netherlands Organization for Scientific Research (NWO) [VENI2014-722.014.003]	ACI acknowledges the funding of a PhD scholarship and research stay from the European Union Seventh Framework Program (FP7/2007-2013) under Grant agreements no 264600 (INFLAME project) and 295138 (INTERFLAME project), respectively, and a BOF DOCPRO1 grant from the Research Council of the University of Antwerp. ABG also acknowledges funding by the Netherlands Organization for Scientific Research (NWO) (VENI2014-722.014.003). Dr. Sicco H. Brandsma is gratefully acknowledged for valuable discussions.	van der Veen I, 2012, CHEMOSPHERE, V88, P1119, DOI 10.1016/j.chemosphere.2012.03.067; Kajiwara N, 2013, ENVIRON SCI-PROC IMP, V15, P653, DOI 10.1039/c3em30887a; Kajiwara N, 2009, CHEMOSPHERE, V74, P1485, DOI 10.1016/j.chemosphere.2008.11.046; Wei GL, 2015, ENVIRON POLLUT, V196, P29, DOI 10.1016/j.envpol.2014.09.012; Ionas AC, 2014, ENVIRON INT, V65, P54, DOI 10.1016/j.envint.2013.12.019; Shin JH, 2012, TEXT RES J, V82, P1307, DOI 10.1177/0040517512439943; Hornsby PR, 2007, SPRINGER SER MATER S, V97, P3; Suzuki G, 2009, ENVIRON SCI TECHNOL, V43, P1437, DOI 10.1021/es802599d; Kajiwara N, 2013, ENVIRON SCI-PROC IMP, V15, P1957, DOI 10.1039/c3em00359k; Betts KS, 2008, ENVIRON HEALTH PERSP, V116, pA210; Kemmlein S, 2003, ATMOS ENVIRON, V37, P5485, DOI 10.1016/j.atmosenv.2003.09.025; Sato Y, 2010, ANAL METHODS-UK, V2, P701, DOI 10.1039/b9ay00161a; Vonderheide AP, 2008, SCI TOTAL ENVIRON, V400, P425, DOI 10.1016/j.scitotenv.2008.05.003; Rauert C, 2014, SCI TOTAL ENVIRON, V493, P639, DOI 10.1016/j.scitotenv.2014.06.029; Kajiwara N, 2011, J HAZARD MATER, V192, P1250, DOI 10.1016/j.jhazmat.2011.06.043; Ballesteros-Gomez A, 2014, ANAL BIOANAL CHEM, V406, P2503, DOI 10.1007/s00216-014-7636-8; Ballesteros-Gomez A, 2013, ANAL CHEM, V85, P9572, DOI 10.1021/ac4017314; European Commission, 2003, EUR UN RISK ASS REP; Horrocks AR, 2007, J FIRE SCI, V25, P523, DOI 10.1177/0734904107083553; Kajiwara N., 2009, BEHAV ADDITIVE BROMI; Levchik S.V., 2009, FLAME RETARDANTS PLA, DOI [http://dx.doi.org/10.3139/9783446430655, DOI 10.3139/9783446430655]; Lyche JL, 2015, ENVIRON INT, V74, P170, DOI 10.1016/j.envint.2014.09.006; Rauert C., 2014, INDOOR AIR	23	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	OCT	2015	142						712	719		10.1016/j.envres.2015.09.012		8	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CU5WN	WOS:000363602800084		
J	Kimura, Y; Tanigawa, M; Kawawaki, J; Takagi, K; Mizushima, T; Maeda, T; Tanaka, K				Kimura, Yoko; Tanigawa, Mirai; Kawawaki, Junko; Takagi, Kenji; Mizushima, Tsunehiro; Maeda, Tatsuya; Tanaka, Keiji			Conserved Mode of Interaction between Yeast Bro1 Family V Domains and YP(X)nL Motif-Containing Target Proteins	EUKARYOTIC CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RIM101 PATHWAY; UBIQUITIN HOMEOSTASIS; PLASMA-MEMBRANE; DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; ESCRT PATHWAY; ALIX; PH; BINDING	Yeast Bro1 and Rim20 belong to a family of proteins which possess a common architecture of Bro1 and V domains. Alix and His domain protein tyrosine phosphatase (HD-PTP), mammalian Bro1 family proteins, bind YP(X)nL (n = 1 to 3) motifs in their target proteins through their V domains. In Alix, the Phe residue, which is located in the hydrophobic groove of the V domain, is critical for binding to the YP(X)nL motif. Although the overall sequences are not highly conserved between mammalian and yeast V domains, we show that the conserved Phe residue in the yeast Bro1 V domain is important for binding to its YP(X)nL-containing target protein, Rfu1. Furthermore, we show that Rim20 binds to its target protein Rim101 through the interaction between the V domain of Rim20 and the YPIKL motif of Rim101. The mutation of either the critical Phe residue in the Rim20 V domain or the YPIKL motif of Rim101 affected the Rim20-mediated processing of Rim101. These results suggest that the interactions between V domains and YP(X)nL motif-containing proteins are conserved from yeast to mammalian cells. Moreover, the specificities of each V domain to their target protein suggest that unidentified elements determine the binding specificity.	[Kimura, Yoko] Shizuoka Univ, Dept Agr, Grad Sch Integrated Sci & Technol, Shizuoka, Japan; [Kimura, Yoko; Kawawaki, Junko; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Tokyo 113, Japan; [Tanigawa, Mirai; Maeda, Tatsuya] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; [Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Picobiol Inst, Dept Life Sci, Grad Sch Life Sci, Kobe, Hyogo 6500044, Japan	Kimura, Y (reprint author), Shizuoka Univ, Dept Agr, Grad Sch Integrated Sci & Technol, Shizuoka, Japan.	kimura.yoko@shizuoka.ac.jp			JSPS [26440070, 25291042]	This work was supported by JSPS KAKENHI grants 26440070 (to Y. Kimura) and 25291042 (to T. Maeda).	Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Xu WJ, 2001, J BACTERIOL, V183, P6917, DOI 10.1128/JB.183.23.6917-6923.2001; Han ZY, 2015, J INFECT DIS, V212, pS138, DOI 10.1093/infdis/jiu838; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jch.200403139; Wemmer M, 2011, J CELL BIOL, V192, P295, DOI 10.1083/jcb.201007018; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kimura Y, 2014, J BIOL CHEM, V289, P21760, DOI 10.1074/jbc.M114.550871; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Maeda T, 2012, FEBS J, V279, P1407, DOI 10.1111/j.1742-4658.2012.08548.x; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/E-C.00024-07; Zhai QT, 2011, J VIROL, V85, P9222, DOI 10.1128/JVI.02653-10; Vincent O, 2003, MOL CELL BIOL, V23, P1647, DOI 10.1128/MCB.23.5.1647-1655.2003; Zhou X, 2010, BIOCHEM J, V432, P525, DOI 10.1042/BJ20100862; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Galindo A, 2012, J CELL SCI, V125, P1784, DOI 10.1242/jcs.098897; Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Boysen JH, 2006, MOL BIOL CELL, V17, P1344; Lee S, 2007, NAT STRUCT MOL BIOL, V14, P194, DOI 10.1038/nsmb1203; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Lamb TM, 2001, J BIOL CHEM, V276, P1850; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Li WS, 1997, GENETICS, V145, P63; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Penalva MA, 2014, CURR OPIN MICROBIOL, V22, P49, DOI 10.1016/j.mib.2014.09.005	41	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1535-9778	1535-9786		EUKARYOT CELL	Eukaryot. Cell	OCT	2015	14	10					976	982		10.1128/EC.00091-15		7	Microbiology; Mycology	Microbiology; Mycology	CU8SP	WOS:000363813800001		
J	Lee, JH; Heuser, JE; Roth, R; Goodenough, U				Lee, Jae-Hyeok; Heuser, John E.; Roth, Robyn; Goodenough, Ursula			Eisosome Ultrastructure and Evolution in Fungi, Microalgae, and Lichens	EUKARYOTIC CELL			English	Article							PLASMA-MEMBRANE DOMAINS; SACCHAROMYCES-CEREVISIAE; CELL-WALL; ELECTRON-MICROSCOPY; FINE-STRUCTURE; BAR DOMAINS; SCHIZOSACCHAROMYCES-POMBE; CYANIDIOSCHYZON-MEROLAE; SPHINGOLIPID METABOLISM; MEDIATED ENDOCYTOSIS	Eisosomes are among the few remaining eukaryotic cellular differentations that lack a defined function(s). These trough-shaped invaginations of the plasma membrane have largely been studied in Saccharomyces cerevisiae, in which their associated proteins, including two BAR domain proteins, have been identified, and homologues have been found throughout the fungal radiation. Using quick-freeze deep-etch electron microscopy to generate high-resolution replicas of membrane fracture faces without the use of chemical fixation, we report that eisosomes are also present in a subset of red and green microalgae as well as in the cysts of the ciliate Euplotes. Eisosome assembly is closely correlated with both the presence and the nature of cell walls. Microalgal eisosomes vary extensively in topology and internal organization. Unlike fungi, their convex fracture faces can carry lineage-specific arrays of intramembranous particles, and their concave fracture faces usually display fine striations, also seen in fungi, that are pitched at lineage-specific angles and, in some cases, adopt a broad-banded patterning. The conserved genes that encode fungal eisosome-associated proteins are not found in sequenced algal genomes, but we identified genes encoding two algal lineage-specific families of predicted BAR domain proteins, called Green-BAR and Red-BAR, that are candidate eisosome organizers. We propose a model for eisosome formation wherein (i) positively charged recognition patches first establish contact with target membrane regions and (ii) a (partial) unwinding of the coiled-coil conformation of the BAR domains then allows interactions between the hydrophobic faces of their amphipathic helices and the lipid phase of the inner membrane leaflet, generating the striated patterns.	[Lee, Jae-Hyeok] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Heuser, John E.] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Roth, Robyn] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Goodenough, Ursula] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Goodenough, U (reprint author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	goodenough@wustl.edu			National Alliance for Advanced Biofuels and Bioproducts (NAABB) from the U.S. Department of Energy (DOE) [DE-EE0003046]; DOE Office of Science [DE-SC0006873]; Korea CCS RD Center (KCRC) [2013M1A8A1056300]; Korean Ministry of Science; Natural Sciences and Engineering Research Council (NSERC) of Canada [418471-12, 9599-12]; NSF [EAR031193, EAR0311930D]; Kenneth Ingham Consulting; NIH [P20RR18754, R01GM098616, 2R15GM071374]; National Institutes of Health (NIH) [R01 AI071007, AI07879]; DOE [DE-EE0006316]; National Science Foundation [IIA-1301346]; NAABB	Support for this work was provided as follows. The Goodenough lab was supported by contract DE-EE0003046 via the National Alliance for Advanced Biofuels and Bioproducts (NAABB) from the U.S. Department of Energy (DOE) and by grant DE-SC0006873 from the DOE Office of Science (BER). The J.-H. Lee lab was supported by grant 2013M1A8A1056300 from the Korea CCS R&D Center (KCRC), Korean Ministry of Science, and by Discovery Grant 418471-12 from the Natural Sciences and Engineering Research Council (NSERC) of Canada. The Northrup lab was supported by NSF grants EAR031193 and EAR0311930D and Kenneth Ingham Consulting, with technical support from the University of New Mexico's Molecular Biology Facility supported by NIH grant P20RR18754. The Doering lab was supported by National Institutes of Health (NIH) grants R01 AI071007 and AI07879. The Kovar lab was supported by an NIH postdoctoral fellowship in Tom Pollard's lab at Yale University. The Lammers lab was supported by DOE contract DE-EE0006316 for the Realization of Algae Potential and by National Science Foundation award IIA-1301346 Energize New Mexico (EPSCoR). The R. W. Lee lab was supported by discovery grant 9599-12 from the Natural Sciences and Engineering Research Council (NSERC) of Canada. The Lipke lab was supported by NIH grant R01GM098616. The Polle lab was supported by the NAABB. The Sayre lab was supported by the NAABB. The VanWinkle-Swift lab was supported by NIH grant 2R15GM071374.	Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; NEEDHAM D, 1990, BIOPHYS J, V58, P997; Drolle E, 2013, BBA-BIOMEMBRANES, V1828, P2247, DOI 10.1016/j.bbamem.2013.05.015; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080; Armaleo D, 2009, SYMBIOSIS, V49, P43, DOI 10.1007/s13199-009-0012-3; Stark MR, 2015, P NATL ACAD SCI USA, V112, pE1191, DOI 10.1073/pnas.1416879112; GOODENOUGH UW, 1985, J CELL BIOL, V101, P1550, DOI 10.1083/jcb.101.4.1550; Konomi M, 2003, YEAST, V20, P427, DOI 10.1002/yea.974; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Sadowska-Des AD, 2014, MOL PHYLOGENET EVOL, V76, P202, DOI 10.1016/j.ympev.2014.03.020; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Frohlich F, 2009, J CELL BIOL, V185, P1227, DOI 10.1083/jcb.200811081; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Malinsky J, 2013, ANNU REV PLANT BIOL, V64, P501, DOI 10.1146/annurev-arplant-050312-120103; BUDEL B, 1987, PROTOPLASMA, V139, P145, DOI 10.1007/BF01282285; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; BARUG D, 1985, ANTIMICROB AGENTS CH, V28, P643; Moreira KE, 2012, J CELL BIOL, V198, P405, DOI 10.1083/jcb.201202097; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Alvarez FJ, 2008, MOL BIOL CELL, V19, P5214, DOI 10.1091/mbc.E08-05-0479; BRAY DF, 1974, J ULTRA MOL STRUCT R, V47, P125, DOI 10.1016/S0022-5320(74)80065-1; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Smith DR, 2014, PLANT PHYSIOL, V164, P1812, DOI 10.1104/pp.113.233718; GROSS H, 1978, J CELL BIOL, V79, P646, DOI 10.1083/jcb.79.3.646; Selvaratnam T, 2014, BIORESOURCE TECHNOL, V156, P395, DOI 10.1016/j.biortech.2014.01.075; Loibl M, 2010, EUKARYOT CELL, V9, P1184, DOI 10.1128/EC.00006-10; Verni F, 2011, ITAL J ZOOL, V78, P134, DOI 10.1080/11250003.2011.560579; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Buchheim MA, 2013, EUR J PHYCOL, V48, P318, DOI 10.1080/09670262.2013.830344; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; BRANTON D, 1966, P NATL ACAD SCI USA, V55, P1048, DOI 10.1073/pnas.55.5.1048; Young ME, 2002, MOL CELL BIOL, V22, P927; Murphy ER, 2011, EUR J CELL BIOL, V90, P825, DOI 10.1016/j.ejcb.2011.06.006; Takei K, 1999, NAT CELL BIOL, V1, P33; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223; Demchenko E, 2012, EUR J PHYCOL, V47, P264, DOI 10.1080/09670262.2012.678388; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; MIRAGALL F, 1986, J GEN MICROBIOL, V132, P2845; Vangelatos I, 2010, EUKARYOT CELL, V9, P1441, DOI 10.1128/EC.00087-10; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; MOOR H, 1963, J CELL BIOL, V17, P609, DOI 10.1083/jcb.17.3.609; CLARKE KJ, 1985, PROTOPLASMA, V129, P120, DOI 10.1007/BF01279909; TAKEO K, 1973, J BACTERIOL, V113, P1442; STEELE SD, 1974, CAN J MICROBIOL, V20, P929; [Anonymous], 1998, MICRON, DOI DOI 10.1016/S0968-4328(97)00072-3; Goodenough U, 2014, EUKARYOT CELL, V13, P591, DOI 10.1128/EC.00013-14; den Hertog AL, 2005, BIOCHEM J, V388, P689; Parchert KJ, 2012, GEOMICROBIOL J, V29, P752, DOI 10.1080/01490451.2011.619636; Athanasopoulos A, 2013, FUNGAL GENET BIOL, V53, P84, DOI 10.1016/j.fgb.2013.01.002; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; GOODENOUGH UW, 1988, J CELL SCI, V90, P735; Aguilar PS, 2010, NAT STRUCT MOL BIOL, V17, P901, DOI 10.1038/nsmb.1829; Olivera-Couto A, 2015, BIOPHYS J, V108, P1633, DOI 10.1016/j.bpj.2015.02.011; Heuser JE, 2011, J ELECTRON MICROSC, V60, pS3, DOI 10.1093/jmicro/dfr044; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Darienko T, 2015, J PHYCOL, V51, P394, DOI 10.1111/jpy.12279; Buchheim MA, 1997, J PHYCOL, V33, P286, DOI 10.1111/j.0022-3646.1997.00286.x; Misumi O, 2005, PLANT PHYSIOL, V137, P567, DOI 10.1104/pp.104.053991; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002; Kabeche R, 2011, MOL BIOL CELL, V22, P4059, DOI 10.1091/mbc.E11-07-0605; BROWN DL, 1976, PROTOPLASMA, V90, P139, DOI 10.1007/BF01276484; OPEKAROVA M, 1993, EUR J BIOCHEM, V211, P683, DOI 10.1111/j.1432-1033.1993.tb17596.x; Toplin JA, 2008, APPL ENVIRON MICROB, V74, P2822, DOI 10.1128/AEM.02741-07; Seger S, 2011, J CELL SCI, V124, P1629, DOI 10.1242/jcs.082487; NECAS O, 1969, EXP CELL RES, V58, P411; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Mallet MA, 2006, J EUKARYOT MICROBIOL, V53, P79, DOI 10.1111/j.1550-7408.2005.00079.x; VANWINKLESWIFT KP, 1983, NATURE, V303, P167, DOI 10.1038/303167a0; VANDERREST ME, 1995, MICROBIOL REV, V59, P304; Peksa O, 2011, MOL ECOL, V20, P3936, DOI 10.1111/j.1365-294X.2011.05168.x; Hagen C, 2002, EUR J PHYCOL, V37, P217, DOI 10.1017/S0967026202003669; Beck A, 1998, NEW PHYTOL, V139, P709, DOI 10.1046/j.1469-8137.1998.00231.x; TAKEO K, 1984, FEMS MICROBIOL LETT, V22, P97, DOI 10.1111/j.1574-6968.1984.tb00704.x; Moreira KE, 2009, MOL BIOL CELL, V20, P809, DOI 10.1091/mbc.E08-03-0313; Wang HX, 2011, EUKARYOT CELL, V10, P72, DOI 10.1128/EC.00167-10; Brach T, 2011, J CELL SCI, V124, P328, DOI 10.1242/jcs.078519; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Arakawa-Kobayashi S, 2004, J STRUCT BIOL, V146, P401, DOI 10.1016/j.jsb.2004.01.016; BROWN RM, 1976, P NATL ACAD SCI USA, V73, P143, DOI 10.1073/pnas.73.1.143; Frohlich F, 2014, MOL BIOL CELL, V25, P2797, DOI 10.1091/mbc.E13-11-0639; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Harris E., 2009, CHLAMYDOMONAS SOURCE; Kabeche R, 2014, J CELL SCI, V127, P1318, DOI 10.1242/jcs.143545; Kobayashi Y, 2010, J ENDOCYTOBIOSIS CEL, V20, P53; LEVIN KR, 1980, CIRC RES, V46, P244; LITTLEFI.LJ, 1972, PROTOPLASMA, V74, P271, DOI 10.1007/BF01282533; PATTERSO.GW, 1971, LIPIDS, V6, P120, DOI 10.1007/BF02531327; Roberts K, 1982, ELECTRON MICROS, V3, P1; Scazzocchio Claudio, 2011, Commun Integr Biol, V4, P64, DOI 10.4161/cib.4.1.13764; Scholz MJ, 2014, EUKARYOT CELL, V13, P1450, DOI 10.1128/EC.00183-14; Yu H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002892; Takeo K., 1998, JPN J MED MYCOL, V39, P129; Triemer RE, 1976, BR PHYCOL J, V12, P23; Vaskovicova K, 2015, EUR J CELL BIOL, V94, P1, DOI 10.1016/j.ejcb.2014.10.003	101	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	1535-9778	1535-9786		EUKARYOT CELL	Eukaryot. Cell	OCT	2015	14	10					1017	1042		10.1128/EC.00106-15		26	Microbiology; Mycology	Microbiology; Mycology	CU8SP	WOS:000363813800005		
J	Madadi, A; Itazaki, M; Gable, RW; Moubaraki, B; Murray, KS; Boskovic, C				Madadi, Azadeh; Itazaki, Masumi; Gable, Robert W.; Moubaraki, Boujemaa; Murray, Keith S.; Boskovic, Colette			Electronic Lability in a Dinuclear Cobalt-Bis(dioxolene) Complex	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Spin crossover; Valence tautomerism; Mixed-valent compounds; Redox-active ligands; Magnetic properties	VALENCE TAUTOMERISM; SPIN-CROSSOVER; MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURES; REDOX POTENTIALS; COBALT COMPLEXES; ORGANIC-LIGANDS; METAL-COMPLEXES; TRANSITION	Remarkable electronic lability is evident from a preliminary study of a dinuclear cobalt complex with a bis(dioxolene) bridging ligand and tetraazamacrocylic ancillary ligands. Structural, magnetic, spectroscopic, and electrochemical data indicate coinciding metal- and ligand-based mixed-valence involving cobalt(II)/cobalt(III) and catecholate/semiquinonate couples. A thermally stimulated spin-crossover or valence-tautomeric transition is also observed above 200 K.	[Madadi, Azadeh; Itazaki, Masumi; Gable, Robert W.; Boskovic, Colette] Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia; [Itazaki, Masumi] Osaka City Univ, Grad Sch Sci, Dept Chem, Sumiyoshi Ku, Osaka 5588585, Japan; [Moubaraki, Boujemaa; Murray, Keith S.] Monash Univ, Sch Chem, Clayton, Vic 3800, Australia	Boskovic, C (reprint author), Univ Melbourne, Sch Chem, Parkville, Vic 3010, Australia.	c.boskovic@unimelb.edu.au	Boskovic, Colette/D-8468-2014	Boskovic, Colette/0000-0002-1882-2139	Australian Research Council	We thank Kerwyn Alley for assistance with electrochemistry and the Australian Research Council for funding to C. B. and K. S. M.	Gass IA, 2014, INORG CHEM, V53, P5055, DOI 10.1021/ic5001057; Tezgerevska T, 2014, COORDIN CHEM REV, V268, P23, DOI 10.1016/j.ccr.2014.01.014; Alley KG, 2012, INORG CHEM, V51, P3944, DOI 10.1021/ic3002527; Krivokapic I, 2007, COORDIN CHEM REV, V251, P364, DOI 10.1016/j.ccr.2006.05.006; Narayanan J, 2008, INORG CHIM ACTA, V361, P2747, DOI 10.1016/j.ica.2008.01.049; Araujo CM, 2012, DALTON T, V41, P3562, DOI 10.1039/c2dt12195f; Sato O, 2007, ACCOUNTS CHEM RES, V40, P361, DOI 10.1021/ar600014m; Caneschi A, 2002, INORG CHEM, V41, P3508, DOI 10.1021/ic020243n; Kang SK, 2006, B KOR CHEM SOC, V27, P1877; Kilner CA, 2010, DALTON T, V39, P9008, DOI 10.1039/c0dt00295j; Alley KG, 2013, J AM CHEM SOC, V135, P8304, DOI 10.1021/ja4021155; BUCHANAN RM, 1980, J AM CHEM SOC, V102, P4951, DOI 10.1021/ja00535a021; Hayami S, 2011, COORDIN CHEM REV, V255, P1981, DOI 10.1016/j.ccr.2011.05.016; Dei A, 2010, APPL MAGN RESON, V38, P139, DOI 10.1007/s00723-010-0121-4; CHE CM, 1994, POLYHEDRON, V13, P771, DOI 10.1016/S0277-5387(00)81683-6; Brown SN, 2012, INORG CHEM, V51, P1251, DOI 10.1021/ic202764j; Beni A, 2008, CHEM-EUR J, V14, P1804, DOI 10.1002/chem.200701163; Goodwin HA, 2004, TOP CURR CHEM, V234, P23, DOI 10.1007/b95411; Smolko L, 2015, MONATSH CHEM, V146, P243, DOI 10.1007/s00706-014-1332-4; Graf M, 2010, ANGEW CHEM INT EDIT, V49, P950, DOI 10.1002/anie.200903789; Brooker S, 2015, CHEM SOC REV, V44, P2880, DOI 10.1039/c4cs00376d; Decaroli C, 2015, ACTA CRYSTALLOGR B, V71, P20, DOI 10.1107/S2052520614024809; Graf M., 2010, ANGEW CHEM, V122, P962; Kruger HJ, 2009, COORDIN CHEM REV, V253, P2450, DOI 10.1016/j.ccr.2009.06.004; Evangelio E, 2005, EUR J INORG CHEM, P2957, DOI 10.1002/ejic.200500323	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	OCT	2015		30					4991	4995		10.1002/ejic.201500980		5	Chemistry, Inorganic & Nuclear	Chemistry	CU9QN	WOS:000363879700002		
J	Quinn, MN; Jukna, V; Ebisuzaki, T; Dicaire, I; Soulard, R; Summerer, L; Couairon, A; Mourou, G				Quinn, M. N.; Jukna, V.; Ebisuzaki, T.; Dicaire, I.; Soulard, R.; Summerer, L.; Couairon, A.; Mourou, G.			Space-based application of the CAN laser to LIDAR and orbital debris remediation	EUROPEAN PHYSICAL JOURNAL-SPECIAL TOPICS			English	Article							WHITE-LIGHT FILAMENTS; FEMTOSECOND PULSES; SYSTEM; ACCELERATORS; REMOVAL; FUTURE; ICAN	Development of pulsed lasers for space-based science missions entail many additional challenges compared to terrestrial experiments. For systems requiring short pulses a parts per thousand(a)1 ns with energies > 100 mJ and fast repetition rates > 10 kHz there are currently few if no laser architectures capable of operating with high electrical efficiency > 20% and have good system stability. The emergence of a mulit-channel fiber-based Coherent-Amplifying-Network or CAN laser potentially enables such capability for space based missions. Here in this article we present an analysis of two such missions scaling up in pulse energy from a parts per thousand 100 mJ for a supercontinuum LIDAR application utilising atmospheric filamentation to the higher energy demands needed for space debris remediation requiring a parts per thousand 10 J pulses. This scalability of the CAN laser provides pathways for development of the core science and technology where many new novel space applications can be made possible.	[Quinn, M. N.; Soulard, R.; Mourou, G.] Ecole Polytech, IZEST, F-91128 Palaiseau, France; [Jukna, V.; Couairon, A.] Univ Paris Saclay, CNRS, Ecole Polytech, Ctr Phys Theor, F-91128 Palaiseau, France; [Ebisuzaki, T.] RIKEN, Wako, Saitama 3510198, Japan; [Dicaire, I.] European Space Agcy, Adv Concepts Team, NL-2200 AG Noordwijk, Netherlands	Quinn, MN (reprint author), Ecole Polytech, IZEST, F-91128 Palaiseau, France.	mark.quinn@polytechnique.edu			CEA; Ecole Polytechnique and Thales in France; JSPS KAKENHI [23340081, 24244042]; RIKEN Strategic Research Programs for RD in Japan	This work was supported by the CEA, Ecole Polytechnique and Thales in France together with JSPS KAKENHI Nos. 23340081, 24244042, and RIKEN Strategic Research Programs for R&D in Japan.	Prawiharjo J, 2008, OPT EXPRESS, V16, P15074, DOI 10.1364/OE.16.015074; Weeden B, 2011, SPACE POLICY, V27, P38, DOI 10.1016/j.spacepol.2010.12.019; Danzmann K, 2015, NAT PHYS, V11, P613; KESSLER DJ, 1978, J GEOPHYS RES-SPACE, V83, P2637, DOI 10.1029/JA083iA06p02637; Ebisuzaki T, 2015, ACTA ASTRONAUT, V112, P102, DOI 10.1016/j.actaastro.2015.03.004; Wagner T, 2008, J OPT A-PURE APPL OP, V10, DOI 10.1088/1464-4258/10/10/104019; Kasparian J, 2003, SCIENCE, V301, P61, DOI 10.1126/science.1085020; Klenke A, 2013, OPT LETT, V38, P2283, DOI 10.1364/OL.38.002283; Bellanger C, 2010, OPT LETT, V35, P3931, DOI 10.1364/OL.35.003931; Phipps C, 2010, J PROPUL POWER, V26, P609, DOI 10.2514/1.43733; Soulard R, 2015, APPL OPTICS, V54, P4640, DOI 10.1364/AO.54.004640; Mourou G, 2013, NAT PHOTONICS, V7, P258; Liou JC, 2011, ADV SPACE RES, V47, P1865, DOI 10.1016/j.asr.2011.02.003; Brocklesby WS, 2014, EUR PHYS J-SPEC TOP, V223, P1189, DOI 10.1140/epjst/e2014-02172-4; BRAUN A, 1995, OPT LETT, V20, P73; Phipps C, 2006, APPL SURF SCI, V252, P4838, DOI 10.1016/j.apsusc.2005.07.079; Bourayou R, 2005, J OPT SOC AM B, V22, P369, DOI 10.1364/JOSAB.22.000369; Berger M, 2012, REMOTE SENS ENVIRON, V120, P84, DOI 10.1016/j.rse.2011.07.023; Bourderionnet J., 2011, OPT EXPR, V19; Daniault L, 2015, EUR PHYS J-SPEC TOP, V224, P2609, DOI 10.1140/epjst/e2015-02571-y; DeYoung R. J., 1983, N83 NASA STI REC, V83, P27200; Fujii T., 2005, LASER REMOTESENSING; Jukna V., 2015, 139291 ESA AR; Kessler D, 1991, ADV SPACE RES, V11, P63, DOI DOI 10.1016/0273-I; Liou J.-C., 2013, P 64 INT ASTR C BEIJ; Mourou G, 2014, NUCL INSTRUM METH A, V740, P17, DOI 10.1016/j.nima.2013.10.041; Novo-Gradac A., 2004, GEOSC REM SENS S 200, V1; Phipps C., 1994, AIP C P, P318; Phipps CR, 2014, ACTA ASTRONAUT, V104, P243, DOI 10.1016/j.actaastro.2014.08.007; Schall WO, 1998, P SOC PHOTO-OPT INS, V3574, P426, DOI 10.1117/12.334466; Soulard R, 2014, ACTA ASTRONAUT, V105, P192, DOI 10.1016/j.actaastro.2014.09.004; Takahashi Y., 2008, NEW J PHYS, V11; Wormnes Kjetil, 2013, P 6 IAASS C 22 25 AP; Yu A. W., 2012, FIBER LASERS AMPLIFI	34	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1951-6355	1951-6401		EUR PHYS J-SPEC TOP	Eur. Phys. J.-Spec. Top.	OCT	2015	224	13					2645	2655		10.1140/epjst/e2015-02577-5		11	Physics, Multidisciplinary	Physics	CU6QL	WOS:000363657300017		
J	Lau, EMT; Tamura, Y; McGoon, MD; Sitbon, O				Lau, Edmund M. T.; Tamura, Yuichi; McGoon, Michael D.; Sitbon, Olivier			The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress	EUROPEAN RESPIRATORY JOURNAL			English	Editorial Material							ARTERIAL-HYPERTENSION; THERAPY; INTERVENTIONS; MANAGEMENT; RIOCIGUAT; GAP		[Lau, Edmund M. T.] Univ Sydney, Dept Resp Med, Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia; [Tamura, Yuichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Tamura, Yuichi; Sitbon, Olivier] Univ Paris 11, Le Kremlin Bicetre, France; [Tamura, Yuichi; Sitbon, Olivier] Hop Bicetre, AP HP, Serv Pneumol, DHU Thorax Innovat, Le Kremlin Bicetre, France; [Tamura, Yuichi; Sitbon, Olivier] INSERM, UMR S999, LabEx LERMIT, Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [McGoon, Michael D.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA	Lau, EMT (reprint author), Univ Sydney, Dept Resp Med, Royal Prince Alfred Hosp, Missenden Rd, Camperdown, NSW 2050, Australia.	edmund.lau@sydney.edu.au					Gunther S, 2012, ARTHRITIS RHEUM-US, V64, P2995, DOI 10.1002/art.34501; Mehta S, 2010, CAN RESPIR J, V17, P301; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; RUBIN LJ, 1993, CHEST, V104, P236, DOI 10.1378/chest.104.1.236; Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655; McLaughlin V, 2015, EUR RESPIR J, V46, P405, DOI 10.1183/13993003.02044-2014; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Pulido T, 2014, NEW ENGL J MED, V370, P82, DOI 10.1056/NEJMc1313112; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Bero LA, 1998, BRIT MED J, V317, P465; Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793; Humbert M, 2014, CIRCULATION, V130, P2189, DOI 10.1161/CIRCULATIONAHA.114.006974; [Anonymous], 2009, J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2009.01.004; McLaughlin VV, 2013, CHEST, V143, P324, DOI 10.1378/chest.11-3060; Galie N, 2014, EUR RESP J S58, V44, pA2916; Galie N, 2009, EUR RESPIR J, V34, P1219; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Institute of Medicine, CONS REP CLIN PRACT; Lau EMT, 2015, NAT REV CARDIOL, V12, P143, DOI 10.1038/nrcardio.2014.191; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; McLaughlin VV, 2015, J AM COLL CARDIO SA, V65, pA380; Perros F, 2015, CIRCULATION IN PRESS, DOI [10.1161/CIRCULATIONAHA.115.014207, DOI 10.1161/CIRCULATI0NAHA.115.014207]]; Ranchoux B, 2015, AM J PATHOL, V185, P356, DOI 10.1016/j.ajpath.2014.10.021; Rubin LJ, 2004, CHEST, V126, p7S, DOI 10.1378/chest.126.1_suppl.7S; Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI 10.1016/j.jacc.2013.10.029; Strasser T, 1975, PRIM PULM HYP REP WH	28	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	OCT	2015	46	4					879	882		10.1183/13993003.01177-2015		4	Respiratory System	Respiratory System	CU5WM	WOS:000363602700001		
J	Gupta, N; Meraj, R; Tanase, D; James, LE; Seyama, K; Lynch, DA; Akira, M; Meyer, CA; Ruoss, SJ; Burgers, CD; Young, LR; Almoosa, KF; Veeraraghavan, S; Barker, AF; Lee, AS; Dilling, DF; Inoue, Y; Cudzilo, CJ; Zafar, MA; McCormack, FX				Gupta, Nishant; Meraj, Riffat; Tanase, Daniel; James, Laura E.; Seyama, Kuniaki; Lynch, David A.; Akira, Masanori; Meyer, Cristopher A.; Ruoss, Stephen J.; Burgers, Charles D.; Young, Lisa R.; Almoosa, Khalid F.; Veeraraghavan, Srihari; Barker, Alan F.; Lee, Augustine S.; Dilling, Daniel F.; Inoue, Yoshikazu; Cudzilo, Corey J.; Zafar, Muhammad A.; McCormack, Francis X.			Accuracy of chest high-resolution computed tomography in diagnosing diffuse cystic lung diseases	EUROPEAN RESPIRATORY JOURNAL			English	Letter							LYMPHANGIOLEIOMYOMATOSIS; MANAGEMENT; SIROLIMUS; EFFICACY; SOCIETY; CT		[Gupta, Nishant; Meraj, Riffat; Tanase, Daniel; Cudzilo, Corey J.; Zafar, Muhammad A.; McCormack, Francis X.] Univ Cincinnati, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA; [James, Laura E.] Shriners Hosp Children Cincinnati, Res Dept, Cincinnati, OH USA; [Seyama, Kuniaki] Juntendo Univ, Dept Resp Med, Tokyo, Japan; [Lynch, David A.] Natl Jewish Hlth, Dept Radiol, Denver, CO USA; [Akira, Masanori] Natl Kinki Chuo Chest Med Ctr, Dept Radiol, Osaka, Japan; [Meyer, Cristopher A.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Ruoss, Stephen J.] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Burgers, Charles D.; Lee, Augustine S.] Mayo Clin, Div Pulm & Crit Care Med, Jacksonville, FL 32224 USA; [Young, Lisa R.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Almoosa, Khalid F.] Univ Texas Hlth Sci Ctr Houston, Div Crit Care Med, Houston, TX 77030 USA; [Veeraraghavan, Srihari] Emory Univ, Sch Med, Div Pulm Allergy & Crit Care, Atlanta, GA USA; [Barker, Alan F.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care, Portland, OR 97201 USA; [Dilling, Daniel F.] Loyola Univ, Dept Med, Chicago, IL 60611 USA; [Inoue, Yoshikazu] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Dept Diffuse Lung Dis & Resp Failure, Osaka, Japan	Gupta, N (reprint author), 231 Albert Sabin Way,ML 0564,MSB Room 6053, Cincinnati, OH 45267 USA.	guptans@ucmail.uc.edu		Gupta, Nishant/0000-0001-9112-1315; McCormack, Francis/0000-0001-7168-9464			Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Koyama M, 2003, AM J ROENTGENOL, V180, P827; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573; Bonelli FS, 1998, AM J ROENTGENOL, V170, P1507; Cordier JF, 2011, EUR RESPIR MONOGR, P46, DOI 10.1183/1025448x.10007510; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Young LR, 2013, LANCET RESP MED, V1, P445, DOI 10.1016/S2213-2600(13)70090-0	10	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	OCT	2015	46	4					1196	1199		10.1183/13993003.00570-2015		4	Respiratory System	Respiratory System	CU5WM	WOS:000363602700029		
J	Eitel, F; Pareja, J; Geyer, D; Johchi, A; Michel, F; Elsaesser, W; Dreizler, A				Eitel, Felix; Pareja, Jhon; Geyer, Dirk; Johchi, Ayane; Michel, Florian; Elsaesser, Wolfgang; Dreizler, Andreas			A novel plasma heater for auto-ignition studies of turbulent non-premixed flows	EXPERIMENTS IN FLUIDS			English	Article							LAMINAR LIFTED FLAMES; VITIATED COFLOW; AIR; AUTOIGNITION; TEMPERATURE; SIMULATIONS; MIXTURES; TORCH; JETS; OH	In this paper, the development and characterization of a novel test rig for auto-ignition (AI) studies of a fuel jet propagating into a hot turbulent co-flow is reported. The test rig, based on microwave plasma heating, is capable of achieving co-flow temperatures up to 1300 K and velocities up to 40 ms(-1). Important boundary conditions at nozzle exit such as temperature, species, and velocity field were determined to prove the capabilities and limitations of the test rig. Liftoff height (LOH) measurements of CH4, C2H4, and CH4/H-2 jets, propagating into a turbulent heated air co-flow, were taken using chemiluminescence imaging. Effects of the temperature and Reynolds number (Re) of co-flow and jet were also studied. Results showed that the flame stabilization mechanism is supported substantially by AI rather than pure flame propagation. While the co-flow temperature dominates the AI process, the Re and temperature of the jet just have a small impact on the LOH.	[Eitel, Felix; Pareja, Jhon; Dreizler, Andreas] Tech Univ Darmstadt, Reakt Stromungen & Messtech, D-64287 Darmstadt, Germany; [Pareja, Jhon; Dreizler, Andreas] Tech Univ Darmstadt, Darmstadt Grad Sch Excellence Energy Sci & Engn, D-64287 Darmstadt, Germany; [Geyer, Dirk] Hsch Darmstadt, Thermodynam & Alternat Antriebe, D-64285 Darmstadt, Germany; [Johchi, Ayane] Tokyo Inst Technol, Dept Mech & Aerosp Engn, Meguro Ku, Tokyo 1528550, Japan; [Michel, Florian; Elsaesser, Wolfgang] Tech Univ Darmstadt, Inst Angew Phys, D-64289 Darmstadt, Germany	Pareja, J (reprint author), Tech Univ Darmstadt, Reakt Stromungen & Messtech, Jovanka Bontschits Str 2, D-64287 Darmstadt, Germany.	pareja@rsm.tu-darmstadt.de; dreizler@csi.tu-darmstadt.de			DFG [DR 374/8-1]; Excellence Initiative, Darmstadt Graduate School of Excellence Energy Science and Engineering [GSC 1070]; Gottfried Wilhelm Leibniz program of DFG	We gratefully acknowledge financial support by DFG (DR 374/8-1) and the Excellence Initiative, Darmstadt Graduate School of Excellence Energy Science and Engineering (GSC 1070). Fruitful discussions with E. Mastorakos, C. Markides, and Martina Leins are appreciated. We are thankful to R.S. Barlow for providing us data of Fig. 14 in Cabra et al. (2005). We are thankful for an intense cooperation with Mugge GmbH, Germany, during design of the MWPH. Andreas Dreizler is grateful for the generous support by the Gottfried Wilhelm Leibniz program of DFG.	Markides CN, 2007, EXP THERM FLUID SCI, V31, P393, DOI 10.1016/j.expthermflusci.2006.04.008; Kim KN, 2007, P COMBUST INST, V31, P947, DOI 10.1016/j.proci.2006.08.012; Oldenhof E, 2010, COMBUST FLAME, V157, P1167, DOI 10.1016/j.combustflame.2010.01.002; Hu EJ, 2015, FUEL, V158, P1, DOI 10.1016/j.fuel.2015.05.010; Mastorakos E, 2009, PROG ENERG COMBUST, V35, P57, DOI 10.1016/j.pecs.2008.07.002; Cabra R, 2005, COMBUST FLAME, V143, P491, DOI 10.1016/j.combustflame.2005.08.019; Gordon RL, 2008, COMBUST FLAME, V155, P181, DOI 10.1016/j.combustflame.2008.07.001; Brubach J, 2009, OPT LASER ENG, V47, P75, DOI 10.1016/j.optlaseng.2008.07.015; Fuhrmann N, 2014, APPL PHYS B-LASERS O, V116, P359, DOI 10.1007/s00340-013-5700-2; Tendero C, 2006, SPECTROCHIM ACTA B, V61, P2, DOI 10.1016/j.sab.2005.10.003; Takita K, 2007, P COMBUST INST, V31, P2489, DOI 10.1016/j.proci.2006.07.108; Dunn MJ, 2007, COMBUST FLAME, V151, P46, DOI 10.1016/j.combustflame.2007.05.010; Mastorakos E, 1997, COMBUST FLAME, V109, P198, DOI 10.1016/S0010-2180(96)00149-6; Choi BC, 2012, COMBUST FLAME, V159, P1481, DOI 10.1016/j.combustflame.2011.11.016; Tan Y, 1999, COMBUST FLAME, V119, P346, DOI 10.1016/S0010-2180(99)00064-4; Egolfopoulos FN, 2000, COMBUST SCI TECHNOL, V156, P173, DOI 10.1080/00102200008947302; Gordon RL, 2009, COMBUST THEOR MODEL, V13, P645, DOI 10.1080/13647830902957200; Brubach J, 2013, PROG ENERG COMBUST, V39, P37, DOI 10.1016/j.pecs.2012.06.001; Du CM, 2007, PLASMA SOURCES SCI T, V16, P791, DOI 10.1088/0963-0252/16/4/014; Goodwin DG, 2014, CANTERA OBJECT ORIEN; JIN QH, 1991, SPECTROCHIM ACTA B, V46, P417, DOI 10.1016/0584-8547(91)80039-6; Kee RJ, 1989, SAND899009; Kulkarni R, 2012, J COMBUSTION, V2012, P1; Leins M., 2009, PLASMA PROCESS POLYM, V6, P227; Milovanovic N, 2001, 2001011890 SAE; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P450; Smith GP, 1997, GRI MECH VERSION 3 0; Somers B, 1994, THESIS TU EINDHOVEN	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	OCT	2015	56	10							186	10.1007/s00348-015-2059-7		13	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CU4GV	WOS:000363486500007		
J	Yoshioka, T; Yamamoto, Y; Yokomori, T; Ohmura, R; Ueda, T				Yoshioka, Tomoki; Yamamoto, Yuji; Yokomori, Takeshi; Ohmura, Ryo; Ueda, Toshihisa			Experimental study on combustion of a methane hydrate sphere	EXPERIMENTS IN FLUIDS			English	Article							LAMINAR BOUNDARY-LAYER; NATURAL-GAS; TRANSPORTATION; DISSOCIATION; DROPLETS	The combustion behavior of a methane hydrate sphere under normal gravity is experimentally investigated. The initial diameter of the sphere is 20 mm. Variation in temperature at the center of the sphere (T-c) is measured with a K-type thermocouple at ignition temperatures (T-c,T-i) from 193 to 253 K at 20 K intervals. Variation in the near-surface temperature of the sphere (T-s) is measured at ignition temperatures (T-s,T-i) from 233 to 263 K at 10 K intervals. Two combustion phases are observed. When the hydrate is ignited, a stable flame envelope is formed around the sphere (phase 1). In phase 1, the surface of the sphere is dry. After a few seconds, water formed by dissociation of the methane hydrate appears on the surface and methane bubbles are formed by methane ejected from inside the sphere (phase 2), thus destabilizing the flame and causing local extinction. Methane bubbles move down along the surface and merge into a large methane bubble at the bottom of the sphere. This bubble bursts, releasing methane to form a temporary flame, and the water drops from the hydrate sphere. Water on the surface is cooled by the hydrate inside, and an ice shell confines the methane gas that dissociated inside the sphere. Because the dissociation occurs continuously inside the hydrate, the inner pressure gradually increases and at some instant, the ice cracks and methane gas is ejected from the cracks, which results in a micro-explosion with a flame. In phase 1, the surface temperature is below the freezing point of water, and so the surface remains dry and a stable flame envelope is formed; in phase 2, the surface temperature is above the freezing point, and so water appears on the surface. When the temperature at the center of the sphere is lower (193, 213, or 233 K), some methane hydrate remains even after flame extinction because heat transfer from the flame decreases in phase 2 as a result of local extinction. The diameter of the sphere decreases during combustion in accordance with the d-square law, which indicates that the heat of dissociation is supplied by the flame and methane is supplied by the dissociation of methane hydrate in the sphere, as in single-droplet combustion.	[Yoshioka, Tomoki; Yamamoto, Yuji; Yokomori, Takeshi; Ohmura, Ryo; Ueda, Toshihisa] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Ueda, T (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ueda@mech.keio.ac.jp					Nakoryakov VE, 2013, CHEM ENG SCI, V104, P1, DOI 10.1016/j.ces.2013.08.049; WILLIAMS A, 1973, COMBUST FLAME, V21, P1, DOI 10.1016/0010-2180(73)90002-3; Maruyama Y, 2013, P COMBUST INST, V34, P2131, DOI 10.1016/j.proci.2012.06.179; Nakoryakov VE, 2013, J ENG THERMOPHYS-RUS, V22, P169, DOI 10.1134/S1810232813030016; Kim NJ, 2004, KSME INT J, V18, P699; TAKAHASHI F, 1989, COMBUST SCI TECHNOL, V65, P151, DOI 10.1080/00102208908924046; Misyura SY, 2013, ENERG FUEL, V27, P7089, DOI 10.1021/ef401211t; Stern LA, 2001, J PHYS CHEM B, V105, P1756, DOI 10.1021/jp003061s; Klauda JB, 2005, ENERG FUEL, V19, P459, DOI 10.1021/ef049798o; Javanmardi J, 2005, APPL THERM ENG, V25, P1708, DOI 10.1016/j.applthermaleng.2004.10.009; Nakamura Y, 2009, ENERG FUEL, V23, P1445, DOI 10.1021/ef800814f; Misyura SY, 2013, CHEM PHYS LETT, V583, P34, DOI 10.1016/j.cplett.2013.08.010; Chen XR, 2015, ENERGIES, V8, P1242, DOI 10.3390/en8021242; Godsave GA, 1953, P COMBUST INST, V4, P818; Gudmundsson JS, 1996, P 2 INT C NAT GAS HY, P415; Iwata M, 2002, P 4 INT C GAS HYDR, P1059; Kaneko H, 1997, P 35 S JAP COMB, P462; Kitamura Y, 2002, P 4 INT C GAS HYDR, V4, P1055; Kumagai S, 1956, P COMBUST INST, V6, P726; Kuo K. K., 1986, PRINCIPLES COMBUSTIO; LAW CK, 1982, PROG ENERG COMBUST, V8, P171, DOI 10.1016/0360-1285(82)90011-9; Matsuo K, 2005, MITSUI ZOSEN TECHNIC, V184, P38; Mori Y. H., 2003, J CHEM IND ENG S, V54, P1; Spalding DB, 1953, P COMBUST INST, V4, P847; Takahashi F, 1998, P COMBUST INST, V21, P1983; Williams F. A., 1985, COMBUSTION THEORY; Yoshioka T, 2015, MECH ENG LETT, V1, P15	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0723-4864	1432-1114		EXP FLUIDS	Exp. Fluids	OCT	2015	56	10							192	10.1007/s00348-015-2041-4		9	Engineering, Mechanical; Mechanics	Engineering; Mechanics	CU4GV	WOS:000363486500015		
J	Yokokawa, H				Yokokawa, H.			Towards Comprehensive Description of Stack Durability/Reliability Behavior	FUEL CELLS			English	Article						Anomalous Diffusion; Conductivity Decrease; Degradation; Deterioration; Durability; Impurity; Life Prediction; Poisoning; Reliability; Simulation; Solid Oxide Fuel Cell	OXIDE FUEL-CELLS; YTTRIA-STABILIZED ZIRCONIA; DOPED ZRO2 ELECTROLYTE; MICROSTRUCTURAL CHANGE; NATIONAL PROJECT; SOFC DEVELOPMENT; CERMET ANODE; NEDO PROJECT; PART II; CATHODE	A new five-year NEDO project on durability, on the basis of past two projects on SOFC durability/reliability, places an emphasis on simulation technologies to be utilized in comparison with measured long term stack behaviors and in prediction for 90,000 h durability. To extract true degradation issues, use is made of stack materials tested for a long term operation or for thermal cycles; to further confirm the mechanisms, use is made of single cells or button cells for specified issues. This makes it possible to correlate degradation behaviors of cell components with operational conditions such as temperature and oxygen potential with an aid of predetermination of microstructures of electrodes by FIB-SEM or of the impurity levels inside major components at the beginning of cell operation. There are two major streams in such a comprehensive treatment of degradation; one is to predict the stack performance, the other being the prediction of mechanical instability. These will be described in details with special emphases on impurity effects and anomalous diffusion properties associated with respective extracted degradation issues.	Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Yokokawa, H (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	yokokawa@iis.u-tokyo.ac.jp					Wang FF, 2014, J POWER SOURCES, V258, P281, DOI 10.1016/j.jpowsour.2014.02.046; Wang FF, 2012, SOLID STATE IONICS, V225, P157, DOI 10.1016/j.ssi.2012.05.026; Ma L, 2005, J FUEL CELL SCI TECH, V2, P246, DOI 10.1115/1.2039958; Yokokawa H, 2011, J POWER SOURCES, V196, P7070, DOI 10.1016/j.jpowsour.2010.07.093; Ogasawara K, 2007, J ELECTROCHEM SOC, V154, pB657, DOI 10.1149/1.2735919; Shimazu M, 2012, SOLID STATE IONICS, V224, P6, DOI 10.1016/j.ssi.2012.06.025; Kishimoto H, 2011, ECS TRANSACTIONS, V35, P1171, DOI 10.1149/1.3570100; Jud E, 2005, J ELECTROCERAM, V14, P247, DOI 10.1007/s10832-005-0964-5; Yokokawa H, 2011, ECS TRANSACTIONS, V35, P207, DOI 10.1149/1.3569995; Shimonosono T, 2012, SOLID STATE IONICS, V225, P61, DOI 10.1016/j.ssi.2012.03.046; Yashima M, 1996, SOLID STATE IONICS, V86-8, P1131, DOI 10.1016/0167-2738(96)00386-4; Yokokawa H, 2008, J POWER SOURCES, V182, P400, DOI 10.1016/j.jpowsour.2008.02.016; MORI M, 1990, DENKI KAGAKU, V58, P528; Yoon KJ, 2013, ECS TRANSACTIONS, V57, P3099, DOI 10.1149/05701.3099ecst; Matsuzaki Y, 2013, ECS TRANSACTIONS, V57, P325, DOI 10.1149/05701.0325ecst; Hattori M, 2004, J POWER SOURCES, V126, P23, DOI 10.1016/j.jpowsour.2003.08.018; Abbaspour A, 2006, J POWER SOURCES, V161, P965, DOI 10.1016/j.jpowsour.2006.05.021; Yokokawa H, 2009, ECS TRANSACTIONS, V25, P401, DOI 10.1149/1.3205549; Nakajo A, 2012, J POWER SOURCES, V216, P434, DOI 10.1016/j.jpowsour.2012.05.077; Wang FF, 2014, SOLID STATE IONICS, V262, P454, DOI 10.1016/j.ssi.2014.04.002; Suzuki M, 2013, ECS TRANSACTIONS, V57, P309, DOI 10.1149/05701.0309ecst; Xiong YP, 2009, J ELECTROCHEM SOC, V156, pB588, DOI 10.1149/1.3090169; Matsui T, 2010, J ELECTROCHEM SOC, V157, pB1790, DOI 10.1149/1.3499357; Shimazu M, 2011, SOLID STATE IONICS, V204, P120, DOI 10.1016/j.ssi.2011.09.024; Matsui T, 2012, SOLID STATE IONICS, V225, P50, DOI 10.1016/j.ssi.2012.03.035; Eguchi K, 2012, FUEL CELLS, V12, P537, DOI 10.1002/fuce.201100204; Shimazu M, 2011, SOLID STATE IONICS, V182, P120, DOI 10.1016/j.ssi.2010.08.030; Hosoi K, 2011, ECS TRANSACTIONS, V35, P11, DOI 10.1149/1.3569974; Yokokawa H, 2007, ECS TRANSACTIONS, V7, P133, DOI 10.1149/1.2729082; Hosoi K, 2009, ECS TRANSACTIONS, V25, P11, DOI 10.1149/1.3205503; Yokokawa H, 2011, ECS TRANSACTIONS, V35, P2191, DOI 10.1149/1.3570212; Horiuchi K, 2013, ECS TRANSACTIONS, V57, P3, DOI 10.1149/05701.0003ecst; Kishimoto H, 2010, J ELECTROCHEM SOC, V157, pB802, DOI 10.1149/1.3362896; Yamamoto T, 2009, ECS TRANSACTIONS, V25, P499, DOI 10.1149/1.3205560; Horita T, 2009, J POWER SOURCES, V193, P194, DOI 10.1016/j.jpowsour.2008.10.127; Wilson JR, 2006, NAT MATER, V5, P541, DOI 10.1038/nmat1668; Hauch A, 2013, ECS TRANSACTIONS, V57, P615, DOI 10.1149/05701.0615ecst; Smith JR, 2009, SOLID STATE IONICS, V180, P90, DOI 10.1016/j.ssi.2008.10.017; MIZUSAKI J, 1994, J ELECTROCHEM SOC, V141, P2129, DOI 10.1149/1.2055073; Xiong YP, 2009, ELECTROCHEM SOLID ST, V12, pB31, DOI 10.1149/1.3058997; MIZUSAKI J, 1987, SOLID STATE IONICS, V22, P323, DOI 10.1016/0167-2738(87)90150-0; Yokokawa H, 2009, ECS TRANSACTIONS, V25, P2131, DOI 10.1149/1.3205761; Nakajo A, 2009, J POWER SOURCES, V193, P203, DOI 10.1016/j.jpowsour.2008.12.050; Linderoth S, 2001, J AM CERAM SOC, V84, P2652; Yokokawa H, 2013, FUEL CELLS, V13, P526, DOI 10.1002/fuce.201200164; Coors WG, 2009, SOLID STATE IONICS, V180, P246, DOI 10.1016/j.ssi.2008.12.004; Wang FF, 2011, J ELECTROCHEM SOC, V158, pB1391, DOI 10.1149/2.059111jes; Yamaji K, 2013, SOLID STATE IONICS, V247, P102, DOI 10.1016/j.ssi.2013.05.019; Terada K, 2011, ECS TRANSACTIONS, V35, P923, DOI 10.1149/1.3570073; Kawada T, 2009, ECS TRANSACTIONS, V25, P467, DOI 10.1149/1.3205556; Kobayashi Y, 2014, J ELECTROCHEM SOC, V161, pF214, DOI 10.1149/2.027403jes; Yokokawa H, 2003, ANNU REV MATER RES, V33, P581, DOI 10.1146/annurev.matsci.33.022802.093856; VANROOSMALEN JAM, 1992, SOLID STATE IONICS, V52, P303, DOI 10.1016/0167-2738(92)90177-Q; Colpan O., 2008, INT J ENERG RES, V32, P336; Gerdes K, 2013, ECS TRANSACTIONS, V57, P289, DOI 10.1149/05701.0289ecst; Horita T., 2012, SOLID STATE IONICS, V255, P141; Horita T., 2012, ELECTROCHEM SOLID ST, V13, pB135; Horiuchi K., 2014, P 11 EUR SOFC SOE FO, pA104; Kawada T, 1997, KEY ENG MATER, V125-1, P187; Nakayama S., 2010, ECS T, V25, P2573; NEDO, 2013, FIN REP EV SOLID OX; Shimonosono T., 2012, SOLID STATE IONICS, V255, P69; Singhal S. C., 1995, SOLID OXIDE FUEL CEL, VIV, P195; Tianshu Z., 2001, J MATER PROCESS TECH, V113, P463, DOI 10.1016/S0924-0136(01)00600-8; Yokokawa Harumi, 2012, [Journal of The Korean Ceramic Society, 한국세라믹학회지], V49, P11; Yokokawa H., 2014, STAT OF THE ART FUEL, P31; Yokokawa H., 2013, ENCY SUSTAINABILITY, P9934; Yokokawa H., 2009, HDB FUEL CELLS FUNDA, V6, P923; Yokokawa H, 2013, ECS TRANSACTIONS, V57, P299, DOI 10.1149/05701.0299ecst; Yokokawa Harumi, 2010, [Journal of The Korean Ceramic Society, 한국세라믹학회지], V47, P26	70	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	OCT	2015	15	5			SI		652	668		10.1002/fuce.201400182		17	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CT0TG	WOS:000362509300002		
J	Kawasaki, A				Kawasaki, Akira			Fujitsu's Approach to Smart Mobility	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								The various problems related to urban transportation depend on several factors such as the country, region, and stage of economic development, so one solution is insufficient. However, there is an approach that can not only solve transportation problems but also provide the optimum solution in line with urban growth: use of a platform to aggregate and visualize massive amounts of information about movement including automobiles, public transportation systems, and people's demand for movement. A combination of analysis and prediction programs can be applied to such information, and improvement criteria can be quantified in accordance with the respective country, region, and stage of economic development. Fujitsu is leveraging its technology for developing telematics services that it has built up over the years and technology for using probe data collected from running vehicles to build a mobility platform that visualizes urban transportation.	Fujitsu Ltd, Ishikawa, Japan	Kawasaki, A (reprint author), Fujitsu Ltd, Ishikawa, Japan.						[Department of Economic and Social Affairs United Nations Population Division], 2012, WORLD URB PROSP 2011; FUJITSU RESEARCH INSTUTUTE, OPP ISS CHIN AUT IND; Japan Productivity Center, 2012, ACH SMART MOB SOC; Nakajima Kaori, 2008, Fujitsu, V59; [Trade and Industry (METI) Ministry of Economy], 2010, SMART COMM FOR SECR	5	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					3	7				5	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200002		
J	Ninomiya, J; Murayama, K; Yamaoka, T; Sakai, K				Ninomiya, Junichi; Murayama, Kazunori; Yamaoka, Tetsuya; Sakai, Katsushi			Next-generation Ubiquitous Device for New Mobility Society: Next-generation Cane	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Fujitsu develops products under a "human-centric" philosophy that seeks to leverage the power of information and communications technology (ICT). Its Human Centric Engine (HCE) incorporated in smartphones is a typical example of a technology that can provide easy-to-use products along with safety and security. Applying mobile sensing technologies developed and enhanced over many years, HCE has become a core component of user support functions. Fujitsu has studied the application of HCE to other products with the aim of supporting people in their everyday lives and has developed an advanced type of walking stick called the "Nextgeneration Cane." This paper describes the technical aspects of developing this novel product from studies of basic specifications to actual prototype development. It also discusses reactions to the Next-generation Cane at exhibitions and demonstrations and touches upon future developments.	[Ninomiya, Junichi; Murayama, Kazunori] Fujitsu Ltd, Ishikawa, Japan; [Yamaoka, Tetsuya] Fujitsu Design Ltd, Ishikawa, Japan; [Sakai, Katsushi] Fujitsu Labs Ltd, Ishikawa, Japan	Ninomiya, J (reprint author), Fujitsu Ltd, Ishikawa, Japan.						Chujo K, 2013, FUJITSU SCI TECH J, V49, P153; [Government of Japan Cabinet Office], FY2009 ATT SURV EV L	2	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					8	13				6	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200003		
J	Hida, K; Sawada, K; Hirokawa, Y; Yaginuma, Y				Hida, Kazuo; Sawada, Kensuke; Hirokawa, Yukio; Yaginuma, Yoshinori			Method for Introducing Wi-Fi-based Area Detection System	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								The demand for mobility services that are available anywhere is increasing as work styles become increasingly diversified. Location-based services (LBSs) that leverage the user's present location to provide optimal services are attracting attention as a special class of mobility services, and to achieve indoor LBSs, a variety of techniques for detecting the area in which a user is present have been proposed. Area detection by wireless LAN (Wi-Fi) is particularly attractive since its use eliminates the need for installing a new infrastructure for positioning purposes. However, specialized knowledge has so far been required to judge the detection performance of a system using wireless technology. To eliminate this requirement, we have developed a method for visualizing inter-area detection performance so that non-specialists can judge detection performance of a Wi-Fi-based area detection system. This paper describes the method and shows the results of an evaluation test.	[Hida, Kazuo; Sawada, Kensuke; Yaginuma, Yoshinori] Fujitsu Labs Ltd, Ishikawa, Japan; [Hirokawa, Yukio] Fujitsu Ltd, Ishikawa, Japan	Hida, K (reprint author), Fujitsu Labs Ltd, Ishikawa, Japan.						Cisco, 2014, CISC VIS NETW IND GL, P2013; Dempster A., 2009, QZSSS INDOOR MESSAGI; Hida K., 2014, MULT DISTR COOP MOB, p8G; Hightower J., 2001, IEEE COMPUT, P57; ITU-R, 2012, ITU R PROPAGATION DA, P1238; Malm Andre, 2013, BERG INSIGHT; Salt S., 2011, SOCIAL LOCATION MARK	7	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					14	20				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200004		
J	Ikeda, T; Fujita, T; Ben-Akiva, ME				Ikeda, Takuro; Fujita, Takushi; Ben-Akiva, Moshe E.			Mobility on Demand for Improving Business Profits and User Satisfaction	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								For a sustainable society, we need to design a mobility management system that does not excessively depend on private vehicles. To achieve this goal, an innovative transportation system is required that provides high user satisfaction in terms of both convenience and fares and is viable as a profit-making business. Recently on-demand transportation, which makes use of information and communications technology (ICT), has been growing and may be a viable solution to the challenges mentioned above. We are developing an innovative on-demand transportation system that has flexibility in terms of vehicle allocation and provides a menu of travel options to users. The system dynamically allocates a fleet of vehicles owned by a business to different transportation services such as taxi, shared taxi, and minibus. It offers convenient and reasonably priced transportation services through an optimization framework where services are assigned on the basis of a choice model in order to maximize profit. The system is expected to improve both user satisfaction and business profits as compared to conventional means of transportation. This paper presents the concept of the system and provides experimental results as a proof of concept using a simulation framework.	[Ikeda, Takuro; Fujita, Takushi] Fujitsu Labs Ltd, Ishikawa, Japan; [Ben-Akiva, Moshe E.] MIT, Cambridge, MA 02139 USA	Ikeda, T (reprint author), Fujitsu Labs Ltd, Ishikawa, Japan.						Basak K., 2013, ITS WORLD C TOK JAP; Ben-Akiva M., 1985, DISCRETE CHOICE ANAL; Ikeda T., 2014, WORKING PAPER; Ikeda T., 2014, 49 C COMM INFR PLANN	4	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					21	26				6	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200005		
J	Tanizawa, T; Suzumiya, T; Ikeda, K				Tanizawa, Tetsu; Suzumiya, Takayuki; Ikeda, Kazuto			Cloud-connected Battery Management System Supporting e-Mobility	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Electric vehicles have evolved along with a reduction in the size and weight of batteries. This has led to the development of bicycles, motorcycles, and small vehicles suitable for short distances that are driven by batteries small enough to be replaced by the user. Once batteries become readily replaceable even when away from the home or office, problems such as lengthy charging times and limited running distances will be overcome, and the practicality of electric vehicles will further increase. Since it would be difficult for users to carry replacement batteries with them or to store them at convenient locations, a battery-sharing system is essential. Fujitsu aims to establish a mechanism for grasping the status of shared batteries that will enable users to replace batteries with peace of mind and with no perceived degradation in battery quality. This cloud-connected battery management system will maximize the value of the shared batteries by using a location data cloud to continuously connect to the batteries, manage the state of their charge, and monitor changes in their characteristics. This paper presents the technology to be used to achieve this system and discusses how it will create new value.	[Tanizawa, Tetsu; Suzumiya, Takayuki; Ikeda, Kazuto] Fujitsu Ltd, Ishikawa, Japan	Tanizawa, T (reprint author), Fujitsu Ltd, Ishikawa, Japan.						[Fujitsu RESC Ltd], 2013, FUJ RESC BEG COLL BU; Japan Automobile Manufacturers Association Inc. (JAMA), 2011, FISC 2011 SURV PASS; Kobayashi T., 2011, ILLUSTRATED INTRO SE	3	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					27	35				9	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200006		
J	Hashiguchi, N; Tohno, M				Hashiguchi, Norio; Tohno, Masatoshi			Realization of Safe Driving Environment	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								In the field of transportation and traffic, big data are beginning to be used for improving transport efficiency and assisting in safe driving. Fujitsu has commercialized FUJITSU Intelligent Society Solution SPATIOWL, a cloud service that uses location data, to build a system that accumulates in the cloud various types of information associated with location data of mobile objects including vehicles. We have also developed sensing technologies for use in vehicles or on road infrastructure that promote road traffic safety. Data acquired by sensing technologies related to road traffic systems have so far only been used in limited applications such as individual vehicle systems and safety systems for specific road sections. But systems are now in place that make it easier to connect with data in the cloud, and this facilitates data aggregation and accumulation. Adequate analysis of the massive amounts of accumulated data makes it possible to identify information about points requiring attention in driving, and to do this requires analysis technology that can accurately identify significant pieces of information that suit the purpose of analysis, out of massive amounts of data. This paper presents a technique of efficiently analyzing massive amounts of data from drive recorders and detecting truly necessary information. Then we introduce a system that utilizes SPATIOWL to implement that technique as a functional component for assisting in safe driving.	[Hashiguchi, Norio; Tohno, Masatoshi] Fujitsu Ltd, Ishikawa, Japan	Hashiguchi, N (reprint author), Fujitsu Ltd, Ishikawa, Japan.						Anagnostopoulos CNE, 2006, IEEE T INTELL TRANSP, V7, P377, DOI 10.1109/TITS.2006.880641; Ghoting A, 2011, PROC INT CONF DATA, P231, DOI 10.1109/ICDE.2011.5767930; Bishop C. M., PATTERN RECOGNITION, V1; Fujitsu, EN SMART MOB SPATIOW; Ghoting A., 2011, P 17 ACM SIGKDD INT, P334, DOI DOI 10.1145/2020408.2020464; Institute forTraffic Accident Research and Data Analysis, TRAFF ACC DUE MISC C; Ministry of Land Infrastructure Transport and Tourism, 2011, FIN REP 3 PART INV T, P9; Nakano Y., 2008, FUJITSU, V59, P416; [National Police Agency Traffic Bureau], CHAR FAT TRAFF ACC S; [National Police Agency Traffic Bureau], STAT FAT TRAFF ACC V; Research committee on effective traffic safety education utilizing drive recorders, 2009, TRAFF ED UT IM REC D, P10	11	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					36	42				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200007		
J	Matsu, N; Hayakawa, S; Harada, S				Matsu, Naoshi; Hayakawa, Shoji; Harada, Shouji			Technology to Detect Levels of Stress Based on Voice Information	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article							EXCISED CANINE LARYNGES	As a monitoring service technology, Fujitsu has developed a way to process voice signals in order to detect the level of a person's stress based on their conversation, and also developed prototypes of a terminal center linking system using smartphones, which are increasingly becoming widespread, to evaluate the system's operation. This technology is intended to be used to detect problems between customers and employees at an early stage so as to improve customer satisfaction and to monitor elderly people living alone and people driving vehicles in order to ensure safety, security, etc. This technology to detect the level of stress analyzes changes in the tone of a person's voice, that is, in the pitch and level of their voice, compared with a normal situation. Such changes occur when a person is under stress and has a dry throat. As a result of examining the detection accuracy in an evaluation experiment with simulated conversations in which the subjects were put under stress, it was found that this system can detect the level of stress with an accuracy of 90% or higher. This paper describes the technology to detect the level of stress based on the pitch and intensity of a voice and the configurations of the two prototype systems developed.	[Matsu, Naoshi; Hayakawa, Shoji; Harada, Shouji] Fujitsu Ltd, Ishikawa, Japan	Matsu, N (reprint author), Fujitsu Ltd, Ishikawa, Japan.				Core Research for Evolutional Science and Technology (CREST) - Japan Science and Technology Agency (JST)	This project was partly sponsored by the Core Research for Evolutional Science and Technology (CREST) funding by the Japan Science and Technology Agency (JST).	Animo Limited and Fujitsu Laboratories Limited, JAP 1 KEYW TYP VOIC; Zhou GJ, 2001, IEEE T SPEECH AUDI P, V9, P201, DOI 10.1109/89.905995; Nakagawa H, 1998, FOLIA PHONIATR LOGO, V50, P183, DOI 10.1159/000021460; Witt RE, 2011, OTOLARYNG HEAD NECK, V144, P108, DOI 10.1177/0194599810390893; Cabinet Office of Japan, POP FOR LON SEN; Kitamura T., 2009, 23 GEN M PHON UNPUB, P45; National Consumer Affairs Center of Japan, INF MON PROT SEN CHI; National Police Agency, FRAUD PHON CRIM INC; Seed Planning Inc., MARK SIZ MON SERV	9	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					48	54				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200009		
J	Kishida, M; Ohguchi, K; Shono, M				Kishida, Masayuki; Ohguchi, Katsuyuki; Shono, Masayoshi			79 GHz-Band High-Resolution Millimeter-Wave Radar	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								High-resolution millimeter-wave radar that operates in the 79 GHz band is expected to achieve a significant increase in the distance resolution of radar systems because of the availability of a wide frequency bandwidth of 4 GHz as compared with 0.5 GHz of the existing 77 GHz-band millimeter-wave radar. For this reason, it has the potential to distinguish between a vehicle and a human, which was conventionally difficult, and recognize their movements. Therefore it raises expectations for use as a surrounding monitoring radar in driving safety support and automatic driving. As one of FUJITSU TEN's efforts regarding sensing technologies for driving safety support and automatic driving, it has been developing 79 GHz-band high-resolution millimeter-wave radar. This paper presents specifications of radar for application to systems that assist in safe driving and automatic driving and the results of testing a prototype for a wider bandwidth that is required to accomplish the technology's purpose. This radar increases the ability to detect a pedestrian in the surroundings of a vehicle, which was difficult to do with the existing 77 GHz-band radar. Furthermore, this paper also describes how the newly developed radar offers the possibility of improving the performance of a sensor for automatic driving and systems to assist in safe driving.	[Kishida, Masayuki; Ohguchi, Katsuyuki; Shono, Masayoshi] Fujitsu Ten Ltd, Ishikawa, Japan	Kishida, M (reprint author), Fujitsu Ten Ltd, Ishikawa, Japan.						Asanuma H., 2009, TECHN SESS ITS WORLD; Honda K., 2008, FUJITSU 10 TECHNICAL, P60; Kobashi S., 2012, SESS ITS WORLD C 201; Shima N., 2010, MED INT SESS ITS WOR	4	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					55	59				5	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200010		
J	Sawada, T				Sawada, Teru			Car Navigation System with Enhanced Connecting Function	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								In November 2013, FUJITSU TEN released three models of Z Series as new products of ECLIPSE car navigation systems, and they were the first commercially available models with Wi-Fi communication. They offer the following services: a voice interactive destination search service, push-type agent application software through which information on the surrounding facilities is given to the driver in speech form, and a new service that allows the driver to remotely operate a car navigation system from an electronic user manual application on a smartphone. In conjunction with the My Cloud service provided by Fujitsu, these products also come with application software that lets users retrieve and enjoy pictures and music saved on their home PC via the Internet. In November 2014, three further models were released as the SZ Series, and they came with a feature to automatically update the map data and facility information installed on the system. This paper gives an overview of these services and their features, and describes the future challenges in their development.	Fujitsu Ten Ltd, Ishikawa, Japan	Sawada, T (reprint author), Fujitsu Ten Ltd, Ishikawa, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					60	66				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200011		
J	Takee, A; Ota, M; Shigematsu, S				Takee, Akira; Ota, Mitsuru; Shigematsu, Satoshi			Approach to M2M in Mobility Field	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Machine-to-machine communication (M2M), which has evolved as one solution to social issues such as energy saving and reduction of environmental impact, now makes it possible to have advanced analysis and prediction by making use of big data and is being applied to an increasingly wider range of fields. Application of M2M is expanding also in the field of mobility, which can contribute to a next-generation car-oriented society, such as in emergency call and theft tracking systems that will be made mandatory and in promotion of car sharing by ultra-small vehicles. FUJITSU TEN is also moving ahead with the development of in-vehicle communication units and working to realize telematics services based on having drive recorders connected with a cloud service. This paper describes FUJITSU TEN's approach to mobility M2M. It also presents technology for installing VolP radio transceivers in vehicles and for automobile control systems related to smartphones that can be used to solve issues related to communication stability and information security that need to be overcome when connecting vehicles to a network.	[Takee, Akira; Ota, Mitsuru; Shigematsu, Satoshi] Fujitsu Ten Ltd, Ishikawa, Japan	Takee, A (reprint author), Fujitsu Ten Ltd, Ishikawa, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					67	73				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200012		
J	Harashina, N				Harashina, Naoki			Global Rollout of Telematics Service	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Along with the advent of the age of big data utilization, services and areas covered by telematics services are increasing globally. The forms of services are undergoing a shift from those provided by service providers to those offered by automotive original equipment manufacturers (OEMs), which have their own service centers and launch services independently. As an example of big data utilization, Fujitsu has planned the rollout of a traffic information provision service, which is one type of telematics service, for automotive OEMs in Europe. For the rollout of this service, we have adopted the traffic message channel (TMC) data format based on our understanding that adopting a standard traffic information data format for service data input and output will be key to the service's success. This paper describes the global rollout of Fujitsu's traffic information provision service.	Fujitsu Ltd, Ishikawa, Japan	Harashina, N (reprint author), Fujitsu Ltd, Ishikawa, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					74	78				5	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200013		
J	Kurose, Y				Kurose, Yoshitoshi			M2M Network for Smart Mobility	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								In smart mobility, information is gathered from vehicles and in-vehicle devices and is analyzed as big data. The analyzed data is then provided to drivers and vehicle manufacturers as a service. To provide information to and gather it from a vehicle and an in-vehicle device, a wireless network is used as a machine-to-machine (M2M) network. However, when the number of vehicles providing data increases from tens of thousands to millions, communication traffic increases and quality degrades. Additional issues facing smart mobility include increased communications cost and the need to ensure security on the network while providing various services. Fujitsu ENhanced Information and Communication Services (FENICS) II Business Network, which is a set of network services offered by Fujitsu for enterprises, offers FUJITSU Managed Infrastructure Service FENICS II M2M service that can solve these issues related to M2M and Internet of Things (IoT). This paper describes our M2M network which can support smart mobility and explains FENICS II M2M service in detail, including application examples.	Fujitsu Ltd, Ishikawa, Japan	Kurose, Y (reprint author), Fujitsu Ltd, Ishikawa, Japan.						Fujitsu, 2010, AMADA EMPLOYS FUJITS; Fujitsu, WELCOME FUJITSU CLOU; [Fujitsu KDDI], VERFIFICATION ENHANC; Fujitsu, BIG DATA USE APPL CO; Fujitsu, 2007, FUJITSU UNVEILS NETW; Fujitsu, 2013, FUJITSU PROVIDES WOR; Fujitsu, 2015, FUJITSU RELEASES FUJ; FUJITSU TEN, IP WIRELESS TAXI DIS; FUJITSU TEN, INTRO REMOTE ENGINE; GSMA, CONNECTED CAR FORECA; GSMA, GSMA CONN CAR FOR 20; ITS Japan, VEH OP ACC TRAFF RES	12	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	OCT	2015	51	4					79	85				7	Engineering, Electrical & Electronic	Engineering	CU5WH	WOS:000363602200014		
J	Imashuku, S; Arceci, RJ				Imashuku, Shinsaku; Arceci, Robert J.			Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis The Problem of Neurodegenerative Syndrome	HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA			English	Article						Langerhans cell histiocytosis; Central nervous system; Diabetes insipidus; Neurodegenerative disease; Neuroinflammatory disease	NECROSIS-FACTOR-ALPHA; CENTRAL DIABETES-INSIPIDUS; MILD-COGNITIVE-IMPAIRMENT; DECOY RECEPTOR-3 DCR3; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; T-CELLS; MICROGLIAL ACTIVATION; NEUROMYELITIS-OPTICA; DISEASE-ACTIVITY	Diseases of the central nervous system (CNS) are common in patients with Langerhans cell histiocytosis (LCH). Besides active LCH lesions, neurodegenerative (ND) lesions of the cerebellum and/or basal ganglia may occur as late sequelae of LCH. While the etiology of this ND disease remains unclear, biomarkers in cerebrospinal fluid (CSF) may reflect the activity of CNS disease in these patients. However, no well-planned CSF studies have yet been performed in patients at high risk for ND-CNS-LCH. Potential parallels with other neuroinflammatory/neurodegenerative diseases suggest the utility of examining these other disorders in establishing strategies for the prevention and/or treatment of ND-CNS-LCH.	[Imashuku, Shinsaku] Takasago Seibu Hosp, Div Hematol, Takasago, Hyogo 6760812, Japan; [Arceci, Robert J.] Univ Arizona, Coll Med, Childrens Ctr Canc & Blood Disorders, Dept Child Hlth,Phoenix Childrens Hosp, Phoenix, AZ 85004 USA	Imashuku, S (reprint author), Takasago Seibu Hosp, Div Hematol, 1-10-41 Nakasuji, Takasago, Hyogo 6760812, Japan.	shinim95@mbox.kyoto-inet.or.jp					Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Baumann M, 2012, HEMATOL ONCOL, V30, P101, DOI 10.1002/hon.1005; Ottaviano F, 2003, J PEDIAT HEMATOL ONC, V25, P575, DOI 10.1097/00043426-200307000-00017; Prosch H, 2003, MED PEDIATR ONCOL, V41, P474, DOI 10.1002/mpo.10380; Chen SJ, 2009, MOL IMMUNOL, V47, P567, DOI 10.1016/j.molimm.2009.09.017; Dotevall L, 1999, EUR J NEUROL, V6, P169, DOI 10.1111/j.1468-1331.1999.tb00010.x; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Mellergard J, 2010, MULT SCLER, V16, P208, DOI 10.1177/1352458509355068; Shioda Y, 2011, INT J HEMATOL, V94, P545, DOI 10.1007/s12185-011-0965-x; Ishii R, 2006, PEDIATR BLOOD CANCER, V47, P194, DOI 10.1002/pbc.20595; Colucci S, 2009, LEUKEMIA, V23, P2139, DOI 10.1038/leu.2009.136; Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; Mitosek-Szewczyk K, 2010, ACTA NEUROL SCAND, V122, P409, DOI 10.1111/j.1600-0404.2010.01330.x; Hirohata S, 1997, CLIN IMMUNOL IMMUNOP, V82, P12, DOI 10.1006/clin.1996.4268; Imashuku S, 2009, INT J HEMATOL, V90, P506, DOI 10.1007/s12185-009-0420-4; Grois NG, 1998, HEMATOL ONCOL CLIN N, V12, P287, DOI 10.1016/S0889-8588(05)70511-6; Kimura A, 2008, INTERNAL MED, V47, P135, DOI 10.2169/internalmedicine.47.0370; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Grois N, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P208; Gonzalez H, 2004, J NEUROIMMUNOL, V150, P139, DOI 10.1016/j.jneuroim.2004.01.010; Gonzalez H, 2009, J PROTEOMICS, V71, P670, DOI 10.1016/j.jprot.2008.11.014; Janke AD, 2006, NEUROL RES, V28, P270, DOI 10.1179/016164106X98143; Rosso DA, 2003, J PEDIAT HEMATOL ONC, V25, P480, DOI 10.1097/00043426-200306000-00010; Allen CE, 2010, PEDIATR BLOOD CANCER, V54, P416, DOI 10.1002/pbc.22326; Nelson DS, 2015, GENE CHROMOSOME CANC, V54, P361, DOI 10.1002/gcc.22247; Gavhed D, 2011, ACTA PAEDIATR, V100, pe36, DOI 10.1111/j.1651-2227.2010.02125.x; John CC, 2008, CYTOKINE, V41, P204, DOI 10.1016/j.cyto.2007.12.008; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Burdo TH, 2008, J INFECT DIS, V198, P715, DOI 10.1086/590504; Nelson DS, 2014, BLOOD, V123, P3152, DOI 10.1182/blood-2013-06-511139; Malter MP, 2013, SEIZURE-EUR J EPILEP, V22, P136, DOI 10.1016/j.seizure.2012.12.013; Christensen JE, 2006, J IMMUNOL, V176, P4235; Dheen ST, 2007, CURR MED CHEM, V14, P1189; John CC, 2008, AM J TROP MED HYG, V78, P198; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; GROIS N, 1993, AM J PEDIAT HEMATOL, V15, P245; van Immerzeel TD, 2010, EUR J PEDIATR, V169, P1151, DOI 10.1007/s00431-010-1172-0; Hartung HP, 2010, J NEUROL, V257, P163, DOI 10.1007/s00415-009-5359-0; Moravan M, 2009, NEUROLOGY, V72, P337, DOI 10.1212/01.wnl.0000341278.26993.22; Grois N, 2006, PEDIATR BLOOD CANCER, V46, P228, DOI 10.1002/pbc.20425; Sulik A, 2008, SCAND J IMMUNOL, V68, P323, DOI 10.1111/j.1365-3083.2008.02137.x; Gavhed D, 2009, PEDIATR BLOOD CANCER, V53, P1264, DOI 10.1002/pbc.22238; Chan A, 2003, J NEUROIMMUNOL, V135, P161, DOI 10.1016/S0165-5728(02)00433-2; Kuhle J, 2009, EUR J NEUROL, V16, P771, DOI 10.1111/j.1468-1331.2009.02560.x; Dhall G, 2008, PEDIATR BLOOD CANCER, V50, P72, DOI 10.1002/pbc.21225; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Huda R, 2014, REV NEUROSCIENCE, V25, P575, DOI 10.1515/revneuro-2014-0021; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; Grois N, 2005, BRAIN, V128, P829, DOI 10.1093/brain/awh403; Prasse A, 2009, AM J PATHOL, V174, P1683, DOI 10.2353/ajpath.2009.080689; Wang H, 2014, SCAND J IMMUNOL, V79, P127, DOI 10.1111/sji.12132; Mueller AM, 2009, J NEUROIMMUNOL, V209, P57, DOI 10.1016/j.jneuroim.2009.01.024; Matarin MM, 2006, NEUROSCI LETT, V407, P162, DOI 10.1016/j.neulet.2006.08.030; Bartosik-Psujek H, 2005, EUR J NEUROL, V12, P49, DOI 10.1111/j.1468-1331.2004.00951.x; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; Lee KY, 2004, J NEUROL SCI, V220, P73, DOI 10.1016/j.jns.2004.02.008; Savardekar A, 2013, J NEUROSURG-PEDIATR, V12, P258, DOI 10.3171/2013.6.PEDS13132; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Osterlundh G, 2008, PEDIATR BLOOD CANCER, V50, P793, DOI 10.1002/pbc.21378; Buchler T, 2005, PEDIATR BLOOD CANCER, V44, P286, DOI 10.1002/pbc.20175; Ghosal N, 2001, DIAGN CYTOPATHOL, V24, P123, DOI 10.1002/1097-0339(200102)24:2<123::AID-DC1023>3.0.CO;2-U; Imashuku S, 2015, INT J HEMATOL, V101, P191, DOI 10.1007/s12185-014-1717-5; Okonkwo OC, 2010, ARCH NEUROL-CHICAGO, V67, P688, DOI 10.1001/archneurol.2010.118; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; Gregory A, 2008, NEUROLOGY, V71, P1402, DOI 10.1212/01.wnl.0000327094.67726.28; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; Giunta B, 2009, DRUG FUTURE, V34, P333, DOI 10.1358/dof.2009.34.4.1358595; Badalian-Very G, 2013, ANNU REV PATHOL-MECH, V8, P1, DOI 10.1146/annurev-pathol-020712-163959; Press R, 2003, J CLIN IMMUNOL, V23, P259, DOI 10.1023/A:1024532715775; Imashuku S, 2009, CNS NEUROL DISORD-DR, V8, P380; Weitzman S, 2005, HISTIOCYTIC DISORDERS OF CHILDREN AND ADULTS, P1, DOI 10.1017/CBO9780511545252.002; Yang CR, 2004, CELL DEATH DIFFER, V11, pS97, DOI 10.1038/sj.cdd.4401403; Chowdhury SA, 2008, ARCH NEUROL-CHICAGO, V65, P232, DOI 10.1001/archneurol.2007.33; Rupprecht TA, 2005, J NEUROL, V252, P820, DOI 10.1007/s00415-005-0752-9; Chan KH, 2001, ANN NEUROL, V50, P301, DOI 10.1002/ana.1127; MATSUZONO Y, 1995, ACTA PAEDIATR, V84, P879, DOI 10.1111/j.1651-2227.1995.tb13784.x; Annels NE, 2003, J EXP MED, V197, P1385, DOI 10.1084/jem.20030137; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; DEGRAAF JH, 1994, AM J PATHOL, V144, P466; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Idbaih A, 2004, PEDIATR BLOOD CANCER, V43, P55, DOI 10.1002/pbc.20040; Martino D, 2004, CURR OPIN NEUROL, V17, P425, DOI 10.1097/01.wco.0000137532.76491.19; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Maghnie M, 2006, CLIN ENDOCRINOL, V65, P470, DOI 10.1111/j.1365-2265.2006.02616.x; Toth C, 2007, ACTA NEUROL SCAND, V116, P259, DOI 10.1111/j.1600-0404.2007.00870.x; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; Finehout EJ, 2005, DIS MARKERS, V21, P93; Kuroda H, 2013, J NEUROIMMUNOL, V254, P178, DOI 10.1016/j.jneuroim.2012.09.002; Fainardi E, 2006, MULT SCLER, V12, P294, DOI 10.1191/135248506ms1274oa; Church AJ, 2004, ARCH DIS CHILD, V89, P611, DOI 10.1136/adc.2003.031880; Pivonello R, 2003, J CLIN ENDOCR METAB, V88, P1629, DOI 10.1210/jc.2002-020791; Lepej SZ, 2007, ACTA NEUROL SCAND, V115, P109, DOI 10.1111/j.1600-0404.2006.00726.x; Peters TL, 2011, MOL THER, V19, P1433, DOI 10.1038/mt.2011.106; Egeler RM, 1999, BLOOD, V94, P4195; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Ichiyama T, 1998, NEUROLOGY, V50, P407; Fischer L, 2009, CLIN CANCER RES, V15, P5968, DOI 10.1158/1078-0432.CCR-09-0108; Pul R, 2009, J NEUROIMMUNOL, V217, P46, DOI 10.1016/j.jneuroim.2009.09.016; SHARIEF MK, 1991, NEW ENGL J MED, V325, P749, DOI 10.1056/NEJM199109123251101; Hsieh CC, 2009, CHILD NERV SYST, V25, P461, DOI 10.1007/s00381-008-0715-4; Mahad DJ, 2002, J NEUROL NEUROSUR PS, V72, P498; Murase S, 2000, NEUROL RES, V22, P434; Faull Matthew, 2014, Am J Neurodegener Dis, V3, P143; Hamzaoui K, 2009, CLIN EXP RHEUMATOL, V27, pS52; Imashuku S, 2008, HAEMATOL-HEMATOL J, V93, P615, DOI 10.3324/haematol.11827; Jimenez-Jimenez FJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00369; Kang JH, 2014, KOREAN J PHYSIOL PHA, V18, P447, DOI 10.4196/kjpp.2014.18.6.447; Lleo A, 2015, NAT REV NEUROL, V11, P41, DOI 10.1038/nrneurol.2014.232; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Miyajima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074453; Rommer PS, 2014, TOHOKU J EXP MED, V234, P313, DOI 10.1620/tjem.234.313; Rossi S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-32; Saruhan-Direskeneli G, 2005, CYTOKINE, V32, P104, DOI 10.1016/j.cyto.2005.08.004; Sugiyama Nobuyoshi, 2010, Tokai J Exp Clin Med, V35, P25; Toledo JB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt266; Tsai M L, 1996, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V37, P16	122	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8588	1558-1977		HEMATOL ONCOL CLIN N	Hematol. Oncol. Clin. North Am.	OCT	2015	29	5					875	+		10.1016/j.hoc.2015.06.006		20	Oncology; Hematology	Oncology; Hematology	CU8WC	WOS:000363823800007		
J	Nakade, S; Sakuma, T; Sakane, Y; Hara, Y; Kurabayashi, A; Kashiwagi, K; Kashiwagi, A; Yamamoto, T; Obara, M				Nakade, Shota; Sakuma, Tetsushi; Sakane, Yuto; Hara, Yoshihiro; Kurabayashi, Atsushi; Kashiwagi, Keiko; Kashiwagi, Akihiko; Yamamoto, Takashi; Obara, Masanobu			Homeolog-specific targeted mutagenesis in Xenopus laevis using TALENs	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						Homeolog; TALEN; Targeted mutagenesis; Xenopus laevis	MULTIPLE; DNA; CYTOGLOBIN; NUCLEASES; SEQUENCES; ALIGNMENT; MODELS; GENES; CELLS	Transcription activator-like effector nucleases (TALENs) have previously been used for targeted genome editing in various organisms including Xenopus laevis. However, because of genomic polyploidization, X. laevis usually possess homeologous genes (homeologs) with quite similar sequences that make the analysis of gene function difficult. In the present study, we show methodological examples of targeted gene modification of X. laevis homeologs. The X. laevis cytoglobin gene (cygb) consists of two homeologs (xlcygba and xlcygbb), and molecular phylogenetic analysis suggested that they have potentially different functions. Thus, there is a need to establish a method of homeolog-specific gene disruption to clarify gene functions in detail. Here, we show successful examples of homeolog-specific and simultaneous gene disruption for xlcygba and xlcygbb. We found that selective digestion can be performed with at least three mismatches in TALEN target sites in both homeologs. This report paves the way for the functional analyses of X. laevis homeologs, even those containing nearly identical sequences.	[Nakade, Shota; Sakuma, Tetsushi; Sakane, Yuto; Hara, Yoshihiro; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Kurabayashi, Atsushi; Kashiwagi, Keiko; Kashiwagi, Akihiko] Hiroshima Univ, Grad Sch Sci, Inst Amphibian Biol, Higashihiroshima, Hiroshima 7398526, Japan; [Obara, Masanobu] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 7398526, Japan	Yamamoto, T (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	tybig@hiroshima-u.ac.jp; msobara@hiroshima-u.ac.jp					Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Uno Y, 2013, HEREDITY, V111, P430, DOI 10.1038/hdy.2013.65; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Fuchs C, 2005, BIOCHEM BIOPH RES CO, V337, P216, DOI 10.1016/j.bbrc.2005.08.271; Sakane Y, 2014, DEV GROWTH DIFFER, V56, P108, DOI 10.1111/dgd.12105; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Sakuma T, 2014, DEV GROWTH DIFFER, V56, P2, DOI 10.1111/dgd.12111; Xi Y, 2007, GENE, V398, P94, DOI 10.1016/j.gene.2007.01.040; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ochiai H, 2010, GENES CELLS, V15, P875, DOI 10.1111/j.1365-2443.2010.01425.x; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	OCT	2015	51	9					879	884		10.1007/s11626-015-9912-0		6	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU7LP	WOS:000363720500001		
J	Furui, S; Takano, T				Furui, Sadataka; Takano, Tomoyuki			On the Amplitude of External Perturbation and Chaos via Devil's Staircase - Stability of Attractors	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Devil's staircase; chaos; octonions; Chua's circuit; memristor	STRANGE NONCHAOTIC ATTRACTORS; CIRCUIT; BIFURCATIONS; SYSTEMS; CONTINUATION; ODES; MAPS	We designed a chaotic memristive circuit proposed by Chua and Muthuswamy, and analyzed the behavior of the voltage of the capacitor, electric current in the inductor and the voltage of the memristor by adding an external sinusoidal oscillation of a type gamma omega cos omega t to (y) over dot(t) similar or equal to (i) over dot(L)(t), when (x) over dot(t) similar or equal to (v) over dot(C)(t) is expressed by y(t)/C, and studied Devil's staircase route to chaos. We compared the frequency of the driving oscillation f(s) and the frequency of the response f(d) in the window and assigned W = f(s)/f(d) to each window. When capacitor C = 1.0, we observe stable attractors of Farey sequences W = {1/2, 2/3, 3/4, 4/5, ..., 14/15, 1/1}, which can be interpreted as hidden attractors, while when C = 1.2, we observe disturbed attractors. Frequency dependent stability of chaotic circuits due to octonions is discussed.	[Furui, Sadataka] Teikyo Univ, Grad Sch Sci & Engn, Utsunomiya, Tochigi 3200003, Japan; [Takano, Tomoyuki] IIX Inc, Shinagawa Ku, Tokyo 1410031, Japan	Furui, S (reprint author), Teikyo Univ, Grad Sch Sci & Engn, 2-17-12 Toyosatodai, Utsunomiya, Tochigi 3200003, Japan.	furui@umb.teikyo-u.ac.jp; takano_t@iix.co.jp					HEAGY JF, 1994, PHYSICA D, V70, P140, DOI 10.1016/0167-2789(94)90061-2; Zhu ZW, 1997, INT J BIFURCAT CHAOS, V7, P227, DOI 10.1142/S0218127497000169; Thamilmaran K, 2002, INT J BIFURCAT CHAOS, V12, P783, DOI 10.1142/S0218127402004681; Furui S, 2012, FEW-BODY SYST, V52, P171, DOI 10.1007/s00601-011-0274-1; Furui S, 2013, AIP CONF PROC, V1558, P2233, DOI 10.1063/1.4825983; KHIBNIK AI, 1993, PHYSICA D, V62, P360, DOI 10.1016/0167-2789(93)90294-B; Dos Santos S, 2000, IEEE T ULTRASON FERR, V47, P1147, DOI 10.1109/58.869055; DING MZ, 1989, PHYS LETT A, V137, P167, DOI 10.1016/0375-9601(89)90204-1; Glendinning P, 2002, DYNAM SYST, V17, P287, DOI 10.1080/14689360210160878; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Doedel EJ, 2003, SIAM J NUMER ANAL, V41, P401, DOI 10.1137/S0036142902400779; Baptista MS, 1998, NONLINEAR DYNAM, V17, P119, DOI 10.1023/A:1008284804398; GREBOGI C, 1984, PHYSICA D, V13, P261, DOI 10.1016/0167-2789(84)90282-3; Pikovsky A, 1997, PHYS REV E, V56, P7320, DOI 10.1103/PhysRevE.56.7320; Furui S, 2007, CHAOS SOLITON FRACT, V34, P966, DOI 10.1016/j.chaos.2006.04.034; Keller G, 1996, FUND MATH, V151, P139; CHUA LO, 1986, IEEE T CIRCUITS SYST, V33, P1072, DOI 10.1109/TCS.1986.1085869; Fan YZ, 2008, MON NOT R ASTRON SOC, V384, P1483, DOI 10.1111/j.1365-2966.2007.12765.x; CHUA LO, 1986, INT J CIRC THEOR APP, V14, P315, DOI 10.1002/cta.4490140405; Leonov GA, 2010, DOKL MATH, V82, P663, DOI 10.1134/S1064562410040411; Furui S, 2013, AIP CONF PROC, V1558, P521, DOI 10.1063/1.4825542; Alseda L, 2008, J DIFFER EQU APPL, V14, P1175, DOI 10.1080/10236190802332274; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Ginoux JM, 2010, INT J BIFURCAT CHAOS, V20, P3819, DOI 10.1142/S0218127410027878; Muthuswamy B, 2010, INT J BIFURCAT CHAOS, V20, P1567, DOI 10.1142/S0218127410027076; Govaerts W, 2005, SIAM J SCI COMPUT, V27, P231, DOI 10.1137/030600746; ATLAS Collaboration, 2013, EUR PHYS J C, V73, P2304; Cartan E., 1966, THEORY SPINORS; Chua L, 2011, APPL PHYS A-MATER, V102, P765, DOI 10.1007/s00339-011-6264-9; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; CHUA LO, 1976, P IEEE, V64, P209, DOI 10.1109/PROC.1976.10092; DEBOOR C, 1973, SIAM J NUMER ANAL, V10, P582, DOI 10.1137/0710052; Dhooge A., 2007, MATH COMP MODEL DYN, V14, P147; Dos Santos S., 1998, THESIS U FRANCHE COM; Furui S, 2014, FEW-BODY SYST, V55, P1083, DOI 10.1007/s00601-014-0897-0; Furui S, 2014, ARXIV140903761HEPPH; Furui S., 2015, ARXIV150403795HEPPH; Gilmore R., 2010, J PHYS A, V43; Ginoux J.-M., 2009, J PHYS A, V42; Groger M., 2013, ARXIV11116574V2MATHD; Hayes S., 1993, REV MOD PHYS, V70, P2031; Hestenes D., 1986, CLIFFORD ALGEBRAS TH, P321; Launesto P., 2001, CLIFFORD ALGEBRAS SP; Leonov GA, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413300024; Manimehan I., 2005, NAT C NONL SYST DYN, P1; Penrose R., 1986, SPINORS SPACE TIME, V2; Pivka L., 1994, INT J BIFURCAT CHAOS, V20, P1743; Saito T., 2003, AIP Conference Proceedings	48	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	OCT	2015	25	11							1550145	10.1142/S021812741550145X		17	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	CU7PL	WOS:000363733700009		
J	Harada, E; Kato, M; Fujikoshi, S; Wohlreich, MM; Berggren, L; Tokuoka, H				Harada, E.; Kato, M.; Fujikoshi, S.; Wohlreich, M. M.; Berggren, L.; Tokuoka, H.			Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							MAJOR DEPRESSION; DISORDER; SYMPTOMS; PAROXETINE; SEROTONIN; ESCITALOPRAM; FLUOXETINE; INHIBITOR; REMISSION; EFFICACY	Aims: The aim of this study was to assess how quickly and effectively duloxetine improves energy compared with placebo in patients with major depressive disorder (MDD). Methods: Data from 10 randomised, double-blind, placebo-controlled clinical trials examining duloxetine (40-60 mg/day) vs. placebo in patients diagnosed with MDD were analysed. Change from baseline at Week 1 through Week 8 in Hamilton Depression Rating Scale (HAM-D) retardation subscale score (Item 1 - depressed mood, Item 7 - work and activities, Item 8 - retardation and Item 14 - genital symptoms) was assessed with mixed model repeated measures analysis. Positive predictive values and negative predictive values were calculated for predictor analysis. Results: Patients treated with duloxetine (N = 1522) experienced statistically significantly (p <= 0.05) greater reductions in HAM-D retardation subscale scores vs. placebo (N = 1180) starting at Week 1 throughout Week 8 of treatment. Of the patients with early energy improvement (>= 20% reduction in HAM-D retardation subscale scores) at Week 1, 48% achieved remission (HAM-D total score = 7) at Week 8; 48% and 46% of patients who experienced early energy improvement at Weeks 2 and 4, respectively, achieved remission at Week 8. Discussion: We demonstrated that treatment with duloxetine, quickly and with increasing magnitude over treatment time, improves low energy symptoms. As early as 1 week after starting treatment with duloxetine, improvement of low energy may serve as a predictor of remission at end-point. Conclusions: Treatment with duloxetine improves energy in patients with MDD and early response in retardation may serve as a modest predictor of remission at end-point.	[Harada, E.; Tokuoka, H.] Eli Lilly Japan KK, Med Sci, Kobe, Hyogo 6510086, Japan; [Kato, M.] Kansai Med Univ, Dept Neuropsychiat, Osaka, Japan; [Fujikoshi, S.] Eli Lilly Japan KK, Stat Sci, Kobe, Hyogo 6510086, Japan; [Wohlreich, M. M.] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA; [Berggren, L.] Eli Lilly & Co, Global Stat Sci, Bad Homburg, Germany	Tokuoka, H (reprint author), Eli Lilly Japan KK, Lilly Res Labs Japan, Kobe, Hyogo 6510086, Japan.	tokuoka_hirofumi@lilly.com			Eli Lilly Japan K.K.	This manuscript was sponsored by Eli Lilly Japan K.K. The authors thank Dr Ralf Jaeger, full-time employee of Accovion, for statistical analysis support. In addition, the authors thank Ms. Aki Yoshikawa, full-time employee of Eli Lilly Japan K.K., for writing and logistical support and Dr Alexandra Heinloth and Ms. Angela Lorio, both full-time employees of inVentiv Health Clinical, LLC, for writing and editorial support. Eli Lilly Japan K.K. contracted Accovion for statistical support and inVentiv Health Clinical for writing and editorial support.	Singh AB, 2013, INT CLIN PSYCHOPHARM, V28, P121, DOI 10.1097/YIC.0b013e32835f1b9f; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Robinson M, 2014, AM J GERIAT PSYCHIAT, V22, P34, DOI 10.1016/j.jagp.2013.01.019; Judge R, 2000, J CLIN PSYCHOPHARM, V20, P666, DOI 10.1097/00004714-200012000-00013; Oakes TMM, 2012, HUM PSYCHOPHARM CLIN, V27, P47, DOI 10.1002/hup.1262; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; Detke MJ, 2002, J CLIN PSYCHIAT, V63, P308; Shelton RC, 2007, INT J CLIN PRACT, V61, P1337, DOI 10.1111/j.1742-1241.2007.01444.x; Maurice-Tison S, 1998, BRIT J GEN PRACT, V48, P1245; Papakostas GI, 2006, BIOL PSYCHIAT, V60, P1350, DOI 10.1016/j.biopsych.2006.06.015; Cowen PJ, 2005, CURR MED RES OPIN, V21, P345, DOI 10.1185/030079905X30680; Joliat MJ, 2004, J CLIN PSYCHOPHARM, V24, P464, DOI 10.1097/01.jcp.0000132345.35713.16; Brannan SK, 2005, J PSYCHIATR RES, V39, P43, DOI 10.1016/j.jpsychires.2004.04.011; Wong David T, 2002, Prog Drug Res, V58, P169; Bymaster FP, 2003, BIOORG MED CHEM LETT, V13, P4477, DOI 10.1016/j.bmcl.2003.08.079; Pigott TA, 2007, CURR MED RES OPIN, V23, P1303, DOI 10.1185/030079907X188107; Detke MJ, 2002, J PSYCHIATR RES, V36, P383, DOI 10.1016/S0022-3956(02)00060-2; Perahia DGS, 2006, EUR PSYCHIAT, V21, P367, DOI 10.1016/j.eurpsy.2006.03.004; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; McClintock SM, 2011, J CLIN PSYCHOPHARM, V31, P180, DOI 10.1097/JCP.0b013e31820ebd2c; Goldstein DJ, 2002, J CLIN PSYCHIAT, V63, P225; BIALIK RJ, 1995, J PSYCHIATR NEUROSCI, V20, P265; Stassen H H, 1993, Eur Neuropsychopharmacol, V3, P127, DOI 10.1016/0924-977X(93)90264-M; Conradi HJ, 2011, PSYCHOL MED, V41, P1165, DOI 10.1017/S0033291710001911; Goldstein DJ, 2004, J CLIN PSYCHOPHARM, V24, P389, DOI 10.1097/01.jcp.0000132448.65972.d9; Tylee A, 1999, INT CLIN PSYCHOPHARM, V14, P139, DOI 10.1097/00004850-199905030-00001; Karpa KD, 2002, CNS DRUG REV, V8, P361; Nierenberg AA, 2007, CURR MED RES OPIN, V23, P401, DOI 10.1185/030079906X167453; Katz MM, 2009, PSYCHOPHARMACOL BULL, V42, P94; Ball SG, 2013, DRUGS CONTEXT, V3, P212; Cleary M, 1975, DRUGS EXP CLIN RES, V1, P115; Kennedy Sidney H, 2008, Dialogues Clin Neurosci, V10, P271; Nemeroff Charles B, 2002, Psychopharmacol Bull, V36, P106	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	OCT	2015	69	10					1139	1148		10.1111/ijcp.12658		10	Medicine, General & Internal; Pharmacology & Pharmacy	General & Internal Medicine; Pharmacology & Pharmacy	CU7NZ	WOS:000363729400009		
J	Yoshida, T; Mori, T; Yamazaki, K; Sonobe, N; Shimizu, H; Matsumoto, T; Kikuchi, K; Miyagawa, M; Mochizuki, T; Ueno, SI				Yoshida, Taku; Mori, Takaaki; Yamazaki, Kiyohiro; Sonobe, Naomi; Shimizu, Hideaki; Matsumoto, Teruhisa; Kikuchi, Keiichi; Miyagawa, Masao; Mochizuki, Teruhito; Ueno, Shu-ichi			Relationship between regional cerebral blood flow and neuropsychiatric symptoms in dementia with Lewy bodies	INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						dementia with Lewy bodies; neuropsychiatric symptoms; SPECT; agitation; disinhibition; irritability	VISUAL HALLUCINATIONS; PSYCHOTIC SYMPTOMS; ALZHEIMERS-DISEASE; FACE AREA; DLB; CONSORTIUM; CORTEX; DYSFUNCTION; METABOLISM; PERCEPTION	Objective: This aim of this study was to examine the mechanisms underlying the neuropsychiatric symptoms in dementia with Lewy bodies by investigating regional cerebral blood flow. Methods: Participants were 27 patients who fulfilled the diagnostic criteria for probable dementia with Lewy bodies. All subjects underwent single-photon emission computed tomography scans using technetium-99m hexamethylpropyleneamine oxime. Neuropsychiatric symptoms were evaluated by neuropsychiatric inventory. Multiple regression analyses using neuropsychiatric inventory and voxel-based analyses of covariance of the regional cerebral blood flow images between subjects with or without each neuropsychiatric symptom were performed. Additionally, similar voxel-based analyses of covariance between subjects with each neuropsychiatric symptom and normal subjects were performed. Results: There were no significant correlations in any psychiatric symptoms in multiple regression analyses. All subjects had hallucination but none had euphoria. We analyzed eight neuropsychiatric symptom scores with the exception of hallucination and euphoria using voxel-based analyses of covariance. Significant differences of regional cerebral blood flow were shown in groups with agitation, disinhibition, and irritability. Subjects with agitation showed hypoperfusion in the parietal lobule, the precuneus, and the angular gyrus, and hyperperfusion in the fusiform gyrus, the lingual gyrus, and the thalamus. Subjects with disinhibition showed hypoperfusion in the left frontal gyrus. Subjects with irritability showed hyperperfusion in the right frontal gyrus. There were no significant differences in regional cerebral blood flow between subjects with any neuropsychiatric symptoms and normal subjects. Conclusion: This study reveals that dysfunction of specific brain regions is associated with various neuropsychiatric symptoms in dementia with Lewy bodies. Copyright (C) 2015 John Wiley & Sons, Ltd.	[Yoshida, Taku; Mori, Takaaki; Yamazaki, Kiyohiro; Sonobe, Naomi; Shimizu, Hideaki; Matsumoto, Teruhisa; Ueno, Shu-ichi] Ehime Univ, Grad Sch Med, Dept Neuropsychiat, Toon, Ehime, Japan; [Kikuchi, Keiichi; Miyagawa, Masao; Mochizuki, Teruhito] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime, Japan	Ueno, SI (reprint author), Ehime Univ, Grad Sch Med, Dept Neuropsychiat, Toon, Ehime, Japan.	ueno@m.ehime-u.ac.jp					McKeith IG, 1996, NEUROLOGY, V47, P1113; Yamamoto R, 2006, J NEUROL SCI, V246, P95, DOI 10.1016/j.jns.2006.02.016; Claus ED, 2013, J STUD ALCOHOL DRUGS, V74, P141; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Galati G, 2001, EUR J NEUROSCI, V14, P737, DOI 10.1046/j.0953-816x.2001.01674.x; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; Borroni B, 2008, ARCH GERONTOL GERIAT, V46, P101, DOI 10.1016/j.archger.2007.03.003; Lee TMC, 2009, J CLIN PSYCHIAT, V70, P36; Nagahama Y, 2007, AM J GERIAT PSYCHIAT, V15, P961, DOI 10.1097/JGP.0b013e3180cc1fdf; Ishii K, 1998, NEUROLOGY, V51, P125; Perneczky R, 2008, DEMENT GERIATR COGN, V25, P531, DOI 10.1159/000132084; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Fujishiro H, 2008, J NEUROPATH EXP NEUR, V67, P649, DOI 10.1097/NEN.0b013e31817d7a1d; Middelkoop HAM, 2001, NEUROLOGY, V57, P2117; Fujimi K, 2008, BRAIN PATHOL, V18, P317, DOI 10.1111/j.1750-3639.2008.00169.x; Kumari V, 2006, SCHIZOPHR RES, V84, P144, DOI 10.1016/j.schres.2006.02.017; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Krueger CE, 2011, NEUROPSYCHOLOGY, V25, P249, DOI 10.1037/a0021681; Hickok G, 2012, J COMMUN DISORD, V45, P393, DOI 10.1016/j.jcomdis.2012.06.004; Salavert J, 2011, J AFFECT DISORDERS, V131, P260, DOI 10.1016/j.jad.2011.01.001; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Imamura T, 1999, NEUROREPORT, V10, P1903, DOI 10.1097/00001756-199906230-00020; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Nagahama Y, 2010, BRAIN, V133, P557, DOI 10.1093/brain/awp295; Samuels SC, 2004, MT SINAI J MED, V71, P55; Baskys A, 2004, J CLIN PSYCHIAT, V65, P16; Hall DA, 2003, AUDIOL NEURO-OTOL, V8, P1, DOI 10.1159/000067894; Hashimoto M, 1998, NEUROLOGY, V51, P357; Mori T, 2006, NEUROLOGY, V66, P935, DOI 10.1212/01.wnl.0000203114.03976.b0; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Barton JJS, 2002, NEUROLOGY, V58, P71; Marui W, 2002, J NEUROL SCI, V195, P153, DOI 10.1016/S0022-510X(02)00006-0; Bar M, 2008, CEREB CORTEX, V18, P1233, DOI 10.1093/cercor/bhm170; KOSAKA K, 1990, J NEUROL, V237, P197, DOI 10.1007/BF00314594	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-6230	1099-1166		INT J GERIATR PSYCH	Int. J. Geriatr. Psychiatr.	OCT	2015	30	10					1068	1075		10.1002/gps.4263		8	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CU7OB	WOS:000363729700009		
J	Heeley, E; Anderson, CS; Woodward, M; Arima, H; Robinson, T; Stapf, C; Parsons, M; Lavados, PM; Huang, YN; Wang, YX; Crozier, S; Parry-Jones, A; Wang, J; Chalmers, J				Heeley, Emma; Anderson, Craig S.; Woodward, Mark; Arima, Hisatomi; Robinson, Thompson; Stapf, Christian; Parsons, Mark; Lavados, Pablo M.; Huang, Yining; Wang, Yanxia; Crozier, Sophie; Parry-Jones, Adrian; Wang, Jiguang; Chalmers, John		Interact2 Investigators	Poor utility of grading scales in acute intracerebral hemorrhage: results from the INTERACT2 trial	INTERNATIONAL JOURNAL OF STROKE			English	Article						BP lowering treatment; ICH scales; INTERACT2; intracerebral hemorrhage; prognosis	RECOVERY PATTERNS; STROKE; SCORE; PREDICTION; MORTALITY; MODELS; CARE	Background Several simple clinical grading scores have been developed for intracerebral hemorrhage, primarily to predict 30-day mortality. Aims We aimed to determine the accuracy of three popular scores (original intracerebral hemorrhage, modified intracere-bral hemorrhage, and intracerebral hemorrhage grading scale) on 30-day mortality and 90-day death or major disability, and whether the magnitude of benefit varies according to prognosis graded by the three predictive scores. Methods Data from the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial which included 2839 intracerebral hemorrhage patients (<6 hours) and elevated systolic blood pressure (150-220 mmHg), randomized to intensive (target systolic blood pressure <140 mmHg) or guideline-based (<180 mmHg) blood pressure management. Discrimination of scales for predicting death and poor outcome (modified Rankin scale 3-6) was evaluated in area under receiver operator characteristic curves. Results Among 2556 (90%) participants with available data, the modified intracerebral hemorrhage had the highest discrimination (receiver operator characteristic 0.75) for 90-day poor outcome compared with the original intracerebral hemorrhage (receiver operator characteristic 0.68) and intracerebral hemorrhage grading scale (receiver operator characteristic 0.69). All scores had good positive predictive value (approximately 80-90%) for poor outcome but poor sensitivity and positive predictive value for death. The scores do not clearly discriminate a patient group most likely to benefit from blood pressure lowering. Conclusions Intracerebral hemorrhage prognostic scores are not useful in defining patients at high probability of early death, but they are reliable for predicting poor outcome, defined by death or major disability. Potential benefits of early intensive blood pressure lowering are broadly applicable across grades of severity defined by such scores.	[Heeley, Emma; Anderson, Craig S.; Woodward, Mark; Arima, Hisatomi; Chalmers, John] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Anderson, Craig S.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Oxford, England; [Arima, Hisatomi] Seta Univ Med Sci, Otsu, Shiga, Japan; [Robinson, Thompson] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Robinson, Thompson] Univ Leicester, NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Stapf, Christian] Univ Paris Diderot, Sorbonne Paris Cite, Dept Neurol, APHP Hop Lariboisiere, Paris, France; [Stapf, Christian] Univ Paris Diderot, Sorbonne Paris Cite, DHU NeuroVasc Paris Sorbonne, Paris, France; [Parsons, Mark] Univ Newcastle, Dept Neurol, John Hunter Hosp, Newcastle, NSW 2300, Australia; [Lavados, Pablo M.] Univ Desarrollo, Serv Neurol, Dept Med, Clin Alemana,Ctr Neurociencias, Santiago, Chile; [Lavados, Pablo M.] Univ Chile, Dept Ciencias Neurol, Santiago, Chile; [Huang, Yining] Peking Univ, Dept Neurol, Hosp 1, Beijing 100871, Peoples R China; [Wang, Yanxia] Hejian City Peoples Hosp, Hejian City, Hebei, Peoples R China; [Crozier, Sophie] Hop La Pitie Salpetriere, AP HP, Stroke Unit, Paris, France; [Parry-Jones, Adrian] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Wang, Jiguang] Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Rui Jin Hosp, Shanghai 200030, Peoples R China	Anderson, CS (reprint author), Univ Sydney, George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	canderson@georgeinstitute.org.au	Woodward, Mark/D-8492-2015; 	Lavados, Pablo/0000-0002-9118-9093; Robinson, Thompson/0000-0003-2144-2468	National Health and Medical Research Council (NHMRC) of Australia; NHMRC	The INTERACT2 study was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia. Professor Anderson holds an NHMRC senior principal research fellowship.	YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; TEASDALE G, 1974, LANCET, V2, P81; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI [10.1016/S2214-109X(13)70089-5, 10.1016/S0140-6736(13)61953-4]; Hemphill JC, 2001, STROKE, V32, P891; BROTT T, 1989, STROKE, V20, P864; Godoy DA, 2006, STROKE, V37, P1038, DOI 10.1161/01.STR.0000206441.79646.49; Toschke AM, 2010, EUR J NEUROL, V17, P219, DOI 10.1111/j.1468-1331.2009.02774.x; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Hwang BY, 2010, NEUROCRIT CARE, V13, P141, DOI 10.1007/s12028-010-9382-x; Weimar C, 2006, J NEUROL, V253, P788, DOI 10.1007/s00415-006-0119-x; Ariesen MJ, 2005, J NEUROL NEUROSUR PS, V76, P839, DOI 10.1136/jnnp.2004.048223; Parry-Jones AR, 2013, STROKE, V44, P1840, DOI 10.1161/STROKEAHA.113.001009; Wei JW, 2010, STROKE, V41, P1877, DOI 10.1161/STROKEAHA.110.586909; Becker KJ, 2001, NEUROLOGY, V56, P766; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Woo D, 1999, STROKE, V30, P2355; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9; RANKIN J, 1957, Scott Med J, V2, P200	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-4930	1747-4949		INT J STROKE	Int. J. Stroke	OCT	2015	10	7					1101	1107		10.1111/ijs.12518		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CU7OL	WOS:000363731100029		
J	Sano, H; Ichioka, S				Sano, Hitomi; Ichioka, Shigeru			Which cleansing care is better, foot bath or shower? Analysis of 236 limb ulcers	INTERNATIONAL WOUND JOURNAL			English	Article						Chronic ulcer; Infection; Irrigation; Limb prognosis; Limb salvage	THERMAL THERAPY	Foot baths and showering are two widely used methods to cleanse limb ulcers. However, some clinicians warn that foot baths may contribute to the spread of infection at the ulcer site. This study aimed to retrospectively investigate the relationship between cleansing methods and the limb prognoses of 236 patients with chronic limb ulcers. These patients were divided into two groups according to the method used to cleanse their ulcers, foot bath and showering. Limb prognosis, including loss of all toes and major amputation, was retrospectively analysed. The rates of loss of all toes and major amputation were 53.0% and 30% in the foot bath group, and 35.3% and 18.4% in the showering group, respectively. The rates of loss of all toes (adjusted odds ratios = 2.07; P = 0.0066; 95% confidence intervals, 1.22-3.50) and major amputation (adjusted odds ratio = 1.90; P = 0.037; 95% confidence intervals, 1.03-3.50) were significantly higher in the foot bath group than those in the showering group. Our results demonstrate that showering is preferable to foot baths for the cleansing of chronic limb ulcers. Clinicians should be cautious that inappropriate cleansing may cause ulcer infections to spread.	[Sano, Hitomi] Univ Tokyo, Grad Sch Med, Dept Surg Sci, Tokyo 1138603, Japan; [Ichioka, Shigeru] Saitama Med Univ Hosp, Dept Plast & Reconstruct Surg, Saitama, Japan	Sano, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg Sci, Bunkyo Ku, Sendagi 1-1-5, Tokyo 1138603, Japan.	sasasa116sasasa@hotmail.com					Imamura M, 2001, J AM COLL CARDIOL, V38, P1083, DOI 10.1016/S0735-1097(01)01467-X; Biro S, 2003, EXP BIOL MED, V228, P1245; Atiyeh BS, 2009, INT WOUND J, V6, P420, DOI 10.1111/j.1742-481X.2009.00639.x; NEETENS A, 1977, DOC OPHTHALMOL, V42, P375, DOI 10.1007/BF02742251; Vuorisalo S, 2009, J CARDIOVASC SURG, V50, P275; Ng ABY, 2009, FOOT ANKLE INT, V30, P860, DOI 10.3113/FAI.2009.0860; Steed DL, 2006, WOUND REPAIR REGEN, V14, P680, DOI 10.1111/j.1524-475X.2006.00176.x; Seto Natsuko, 2008, Journal of the Japan Diabetes Society, V51, P347; IWAI T, 1989, J CARDIOVASC SURG, V30, P490; TEI C, 1995, CIRCULATION, V91, P2582; Ledermann HP, 2002, AM J ROENTGENOL, V179; Aragon-Sanchez J, 2012, DIABET FOOT ANKLE, V3, DOI [10.3402/dfa.v3i0.18693, DOI 10.3402/DFA.V3I0.18693]; Batchelor G. K., 1967, INTRO FLUID DYNAMICS; Bergstrom N, 1994, AHCPR PUB; Doughty D, 1994, J Wound Ostomy Continence Nurs, V21, P224; Ichioka S, 2001, JPN J PU, V3, P27; Meade J W, 1968, Med Times, V96, P154; Schultz Gregory S., 2003, Wound Repair and Regeneration, V11, P1; Terashi H, 2006, KEISEIGEKA, V49, P181; Toriyama T., 2002, International Angiology, V21, P367; Uebaba Kazuo, 2004, Journal of Japanese Association of Physical Medicine Balneology and Climatology, V67, P119; WILSON RM, 1986, DIABETIC MED, V3, P509	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	OCT	2015	12	5					577	580		10.1111/iwj.12167		4	Dermatology; Surgery	Dermatology; Surgery	CU8RL	WOS:000363810700015		
J	Nakagami, G; Kimura, N; Takehara, K; Nakamura, T; Kawashima, M; Tsunemi, Y; Sanada, H				Nakagami, Gojiro; Kimura, Nao; Takehara, Kimie; Nakamura, Tetsuro; Kawashima, Makoto; Tsunemi, Yuichiro; Sanada, Hiromi			Relationship between activity of daily living and asteatosis in the lower legs among elderly residents in long-term care institutions: a cross-sectional study	INTERNATIONAL WOUND JOURNAL			English	Article						Activity of daily living; Asteatosis; Dry skin; Long-term care facility; Senile xerosis	ECZEMA; SKIN; PREVALENCE	This cross-sectional observational study investigated the relationship between the level of activities of daily living (ADL) and asteatosis in the lower legs among elderly residents. We enrolled 173 residents from a long-term care health facility and two special nursing homes for elderly persons in the Tokyo metropolitan area and Oshima Island, Japan. The level of ADL was measured by the Barthel Index. The relationship between the Barthel Index total score and the presence of asteatosis in the lower legs diagnosed by a dermatologist was analysed by multivariate logistic regression analysis. Among the residents, 79.2% had asteatosis in their lower legs. An increase of 1 point in the Barthel Index total score was significantly associated with a decreased probability of lower leg asteatosis after adjusting for age, sex and the type of institution (adjusted odds ratio = 0.982; 95% confidence interval: 0.966-0.998). A higher level of ADL is associated with a lower probability of having asteatosis in the lower legs among residents in long-term care institutions. Nurses should pay specific attention to residents with limited ADL for initiating preventive care for asteatosis.	[Nakagami, Gojiro; Kimura, Nao; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo 1130033, Japan; [Takehara, Kimie] Univ Tokyo, Grad Sch Med, Dept Nursing Adm, Tokyo 1130033, Japan; [Nakamura, Tetsuro] Abe Clin, Tokyo, Japan; [Kawashima, Makoto; Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan	Sanada, H (reprint author), Univ Tokyo, Fac Med, Dept Gerontol Nursing Wound Care Management,Grad, Bunkyo Ku, Bldg 306,7-3-1 Hongo, Tokyo 1130033, Japan.	hsanada-tky@umin.ac.jp			Non-Profit Organisation Health Institute Research of Skin; Daiwa Securities Health Foundation; Chiyoda Mutual Life Foundation; St. Luke's Life Science Institute; Japan Foundation for Aging and Health	The authors acknowledge all participants and staff of the three facilities covered by long-term care insurance for their kind cooperation and support. The authors have no conflict of interests to declare regarding this article. This study was partly supported by grants from the Non-Profit Organisation Health Institute Research of Skin, Daiwa Securities Health Foundation, Chiyoda Mutual Life Foundation, St. Luke's Life Science Institute and Japan Foundation for Aging and Health.	Aisen E, 1997, ACTA DERM-VENEREOL, V77, P142; ALLMAN RM, 1995, JAMA-J AM MED ASSOC, V273, P865, DOI 10.1001/jama.273.11.865; WEITZMAN I, 1995, CLIN MICROBIOL REV, V8, P240; Kilic A, 2008, ARCH GERONTOL GERIAT, V47, P93, DOI 10.1016/j.archger.2007.07.007; Holm EA, 2006, BRIT J DERMATOL, V154, P719, DOI 10.1111/j.1365-2133.2005.07050.x; Li LF, 2008, BRIT J DERMATOL, V159, P243, DOI 10.1111/j.1365-2133.2008.08598.x; Smith DR, 2002, INT J DERMATOL, V41, P754, DOI 10.1046/j.1365-4362.2002.01425.x; White-Chu EF, 2011, CLIN DERMATOL, V29, P37, DOI 10.1016/j.clindermatol.2010.07.005; GURALNIK JM, 1988, J AM GERIATR SOC, V36, P807; Paul C, 2011, DERMATOLOGY, V223, P260, DOI 10.1159/000334631; Kimura N, 2013, J DERMATOL, V40, P770, DOI 10.1111/1346-8138.12217; Della Pietra GL, 2011, STROKE, V42, P2077; MAHONEY F I, 1965, Md State Med J, V14, P61; Norman Robert A, 2003, Dermatol Ther, V16, P254, DOI 10.1046/j.1529-8019.2003.01635.x; Sunwoo Yujin, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P7, DOI 10.2114/jpa2.25.7	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	OCT	2015	12	5					586	589		10.1111/iwj.12169		4	Dermatology; Surgery	Dermatology; Surgery	CU8RL	WOS:000363810700017		
J	Hirai, I; Sakiyama, T; Konohana, A; Takae, Y; Matsuura, S				Hirai, Ikuko; Sakiyama, Tomo; Konohana, Akira; Takae, Yujiro; Matsuura, Shiro			A case of neutrophilic dermatosis of the dorsal hand in acute leukemia - a distributional variant of Sweet's syndrome	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			English	Letter							PUSTULAR VASCULITIS		[Hirai, Ikuko; Sakiyama, Tomo; Konohana, Akira; Takae, Yujiro] Saiseikai Yokohama City Nanbu Hosp, Div Dermatol, Yokohama, Kanagawa 2348503, Japan; [Matsuura, Shiro] Saiseikai Yokohama City Nanbu Hosp, Div Hematol, Yokohama, Kanagawa 2348503, Japan	Hirai, I (reprint author), Saiseikai Yokohama City Nanbu Hosp, Div Dermatol, Konan Ku, 3-2-10 Konandai, Yokohama, Kanagawa 2348503, Japan.	ih831221@yahoo.co.jp					STRUTTON G, 1995, J AM ACAD DERMATOL, V32, P192, DOI 10.1016/0190-9622(95)90125-6; Weenig RH, 2004, INT J DERMATOL, V43, P95, DOI 10.1111/j.1365-4632.2004.01845.x; HEERSONDERHOFF AH, 1995, ANN HEMATOL, V71, P257, DOI 10.1007/s002770050115; Walling HW, 2006, ARCH DERMATOL, V142, P57, DOI 10.1001/archderm.142.1.57; Galaria NA, 2000, J AM ACAD DERMATOL, V43, P870, DOI 10.1067/mjd.2000.109286; Ozcelik T, 2006, LEUKEMIA RES, V30, P1466, DOI 10.1016/j.leukres.2006.01.019; Cohen PR, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-34; von den Driesch P., 1994, J AM ACAD DERMATOL, V31, P535	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	OCT	2015	13	10					1033	1034		10.1111/ddg.12644		2	Dermatology	Dermatology	CU9UJ	WOS:000363890900011		
J	Nishio, M; Satoh, M				Nishio, M.; Satoh, M.			Genomic best linear unbiased prediction method reflecting the degree of linkage disequilibrium	JOURNAL OF ANIMAL BREEDING AND GENETICS			English	Article						Genomic relationship matrix; genomic selection; linkage disequilibrium; predictive ability; simulation	SELECTION; WIDE; SNPS; HERITABILITY; COMPONENTS; SHRINKAGE; MODELS; MAPS	The degree of linkage disequilibrium (LD) between markers differs depending on the location of the genome; this difference biases genetic evaluation by genomic best linear unbiased prediction (GBLUP). To correct this bias, we used three GBLUP methods reflecting the degree of LD (GBLUP-LD). In the three GBLUP-LD methods, genomic relationship matrices were conducted from single nucleotide polymorphism markers weighted according to local LD levels. The predictive abilities of GBLUP-LD were investigated by estimating variance components and assessing the accuracies of estimated breeding values using simulation data. When quantitative trait loci (QTL) were located at weak LD regions, the predictive abilities of the three GBLUP-LD methods were superior to those of GBLUP and Bayesian lasso except when the number of QTL was small. In particular, the superiority of GBLUP-LD increased with decreasing trait heritability. The rates of QTL at weak LD regions would increase when selection by GBLUP continues; this consequently decreases the predictive ability of GBLUP. Thus, the GBLUP-LD could be applicable for populations selected by GBLUP for a long time. However, if QTL were located at strong LD regions, the accuracies of three GBLUP-LD methods were lower than GBLUP and Bayesian lasso.	[Nishio, M.; Satoh, M.] NARO Inst Livestock & Grassland Sci, Tsukuba, Ibaraki 3050901, Japan	Nishio, M (reprint author), NARO Inst Livestock & Grassland Sci, 2 Ikenodai, Tsukuba, Ibaraki 3050901, Japan.	mtnishio@affrc.go.jp					HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; JOHNSON DL, 1995, J DAIRY SCI, V78, P449; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Habier D, 2013, GENETICS, V194, P597, DOI 10.1534/genetics.113.152207; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706; Legarra A, 2011, GENET RES, V93, P77, DOI 10.1017/S0016672310000534; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Meuwissen THE, 2001, GENETICS, V157, P1819; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Falconer DS, 1996, INTRO QUANTITATIVE G; Liu HM, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-8; Mc Hugh N., 2011, J DAIRY SCI, V8, P4109; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Nishio M, 2014, ANIM SCI J, V85, P879, DOI 10.1111/asj.12224; Wang L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-115	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0931-2668	1439-0388		J ANIM BREED GENET	J. Anim. Breed. Genet.	OCT	2015	132	5					357	365		10.1111/jbg.12162		9	Agriculture, Dairy & Animal Science	Agriculture	CU7OW	WOS:000363732200004		
J	Kobayashi, K; Tsukasaki, N; Uchida, R; Yamaguchi, Y; Tomoda, H				Kobayashi, Keisuke; Tsukasaki, Nobuaki; Uchida, Ryuji; Yamaguchi, Yuichi; Tomoda, Hiroshi			Clonoamide, a new inhibitor of sterol O-acyltransferase, produced by Clonostachys sp BF-0131	JOURNAL OF ANTIBIOTICS			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; E-DEFICIENT MICE; ACYL-COA; ACAT INHIBITOR; COENZYME; CELLS; ATHEROSCLEROSIS; IDENTIFICATION; ACCUMULATION; EXPRESSION	A new compound designated as clonoamide was isolated from a culture broth of the fungus Clonostachys sp. BF-0131 by solvent extraction, Diaion HP20 column chromatography, octadecylsilyl column chromatography and preparative HPLC as an inhibitor of sterol O-acyltransferase (SOAT). The structure of clonoamide was elucidated as 2-oxo-9E, 11E-tridecandienyl acetamide by various spectral analyses including NMR. The compound inhibited SOAT1 and SOAT2 isozymes with IC50 values of 39 and 110 mu M, respectively, in a cell-based assay using SOAT1-and SOAT2-expressing Chinese hamster ovary cells.	[Kobayashi, Keisuke; Uchida, Ryuji; Yamaguchi, Yuichi; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Tsukasaki, Nobuaki; Uchida, Ryuji; Tomoda, Hiroshi] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Yamaguchi, Yuichi] Chugai Pharmaceut Co Ltd, Tokyo, Japan	Tomoda, H (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tomodah@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26253009]	We wish to thank Ms Noriko Sato and Dr Kenichiro Nagai (School of Pharmaceutical Sciences, Kitasato University) for measurements of NMR spectra and MS data. This work was supported by a Grant-in-aid for Scientific Research (A) 26253009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to HT).	Ohshiro T, 2007, J ANTIBIOT, V60, P43; Terasaka N, 2007, ATHEROSCLEROSIS, V190, P239, DOI 10.1016/j.atherosclerosis.2006.03.007; GOULD FE, 1960, J ORG CHEM, V25, P1658, DOI 10.1021/jo01079a600; Buhman KK, 2000, NAT MED, V6, P1341; Junquero D, 2001, BIOCHEM PHARMACOL, V61, P97, DOI 10.1016/S0006-2952(00)00523-2; Namatame I, 1999, J BIOCHEM-TOKYO, V125, P319; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; FIELD FJ, 1982, GASTROENTEROLOGY, V83, P873; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Lada AT, 2004, J LIPID RES, V45, P378, DOI 10.1194/jlr.D300037-JLR200; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Namatame I, 2004, P NATL ACAD SCI USA, V101, P737, DOI 10.1073/pnas.0307757100; Lee HT, 1996, J MED CHEM, V39, P5031, DOI 10.1021/jm960674d; Tomoda H, 2007, PHARMACOL THERAPEUT, V115, P375, DOI 10.1016/j.pharmthera.2007.05.008; Ohshiro T, 2011, FUTURE MED CHEM, V3, P2039, DOI [10.4155/fmc.11.158, 10.4155/FMC.11.158]; Ohte S, 2011, J ANTIBIOT, V64, P489, DOI 10.1038/ja.2011.32; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; MURAKAMI S, 1995, LIFE SCI, V56, P509, DOI 10.1016/0024-3205(94)00480-G; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; OBrien PM, 1996, J MED CHEM, V39, P2354, DOI 10.1021/jm960170f; Ohshiro T., 2014, EXPERT OPIN THER PAT, V25, P145; Shrecker A. W., 1958, J AM CHEM SOC, V80, P6077	26	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					615	619		10.1038/ja.2015.37		5	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800004		
J	Fukuda, T; Shinkai, M; Sasaki, E; Nagai, K; Kurihara, Y; Kanamoto, A; Tomoda, H				Fukuda, Takashi; Shinkai, Minori; Sasaki, Eri; Nagai, Kenichiro; Kurihara, Yuko; Kanamoto, Akihiko; Tomoda, Hiroshi			Graphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp OPMF00224	JOURNAL OF ANTIBIOTICS			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; EPICOCCUM-NIGRUM; BIOLOGICAL EVALUATION; A-D; STAPHYLOXANTHIN; VIRULENCE; BIOSYNTHESIS; DERIVATIVES; INHIBITORS; METABOLITES	Eight new thiodiketopiperazines, designated as graphiumins A to H (1-8), were isolated along with bisdethiobis(methylthio)-deacetylaranotin (9) and bisdethiobis(methylthio)-deacetylapoaranotin (10) from the culture broth of the marine-derived fungus Graphium sp. OPMF00224. The structures of the graphiumins were elucidated based on spectroscopic analyses (1D and 2D NMR data, ROESY correlations and CD data) and chemical methods. The absolute configuration of the common (3S)-3-hydroxyoctanoyl acid residue in 1, 3 and 4 was determined by hydrolysis, benzoyl derivatization and HPLC analysis using a chiral column. Five graphiumins moderately inhibited yellow pigment production by methicillin-resistant Staphylococcus aureus.	[Fukuda, Takashi; Shinkai, Minori; Sasaki, Eri; Nagai, Kenichiro; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Kurihara, Yuko; Kanamoto, Akihiko] OP BIO FACTORY Co Ltd, Okinawa, Japan	Tomoda, H (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tomodah@pharm.kitasato-u.ac.jp			Takeda Science Foundation; JSPS [25870704]	We wish to thank Ms Noriko Sato (School of Pharmaceutical Sciences, Kitasato University) for measuring the NMR spectra. This work was supported by Takeda Science Foundation (TF) and JSPS KAKENHI Grant Number 25870704 (TF).	Fukuda T, 2012, J ANTIBIOT, V65, P565, DOI 10.1038/ja.2012.70; Fukuda T, 2012, J NAT PROD, V75, P2228, DOI 10.1021/np300428r; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Lee JH, 2012, CURR MICROBIOL, V65, P726, DOI 10.1007/s00284-012-0229-x; Chinworrungsee M, 2006, J NAT PROD, V69, P1404, DOI 10.1021/np0601197; Hegde VR, 1997, TETRAHEDRON LETT, V38, P911, DOI 10.1016/S0040-4039(96)02457-4; Gross U, 2010, CHEM-EUR J, V16, P11624, DOI 10.1002/chem.201001169; Kurihara Y, 2008, MYCOSCIENCE, V49, P241, DOI 10.1007/s10267-008-0414-8; MARSHALL JH, 1981, J BACTERIOL, V147, P900; Nagai K, 2006, J COMB CHEM, V8, P103, DOI 10.1021/cc050084d; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; MARSHALL JH, 1981, J BACTERIOL, V147, P914; Meng LH, 2014, J NAT PROD, V77, P1921, DOI 10.1021/np500382k; Tan RX, 2004, J NAT PROD, V67, P1374, DOI 10.1021/np049920b; Wang JM, 2010, J NAT PROD, V73, P1240, DOI 10.1021/np1000895; Wang JM, 2013, TETRAHEDRON, V69, P1195, DOI 10.1016/j.tet.2012.11.047; Chai CLL, 2004, BIOORGAN MED CHEM, V12, P5991, DOI 10.1016/j.bmc.2004.08.015; DEFFIEUX G, 1978, J ANTIBIOT, V31, P1102; Kong FD, 2014, J NAT PROD, V77, P132, DOI 10.1021/np400802d; Guo CJ, 2013, J AM CHEM SOC, V135, P7205, DOI 10.1021/ja3123653; Liu CI, 2012, J BIOL CHEM, V287, P18750, DOI 10.1074/jbc.M112.351254; Zhang YG, 2007, J NAT PROD, V70, P1522, DOI 10.1021/np070239u; Sakai K, 2012, BIOL PHARM BULL, V35, P48; Suzuki Y, 2000, J ANTIBIOT, V53, P45; Hagimori K, 2007, BIOL PHARM BULL, V30, P1379, DOI 10.1248/bpb.30.1379; Lee JH, 2013, APPL MICROBIOL BIOT, V97, P4543, DOI 10.1007/s00253-012-4674-z; Fukuda T, 2014, J ANTIBIOT, V67, P445, DOI 10.1038/ja.2014.14; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Iwatsuki M, 2007, J ANTIBIOT, V60, P357; Song YC, 2009, J MED CHEM, V52, P3869, DOI 10.1021/jm9001764; Ohshiro T, 2011, FUTURE MED CHEM, V3, P2039, DOI [10.4155/fmc.11.158, 10.4155/FMC.11.158]; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; BRIAN PW, 1945, ANN APPL BIOL, V32, P214, DOI 10.1111/j.1744-7348.1945.tb06238.x; Centers for Disease Control and Prevention (CDC), 1997, MMWR-MORBID MORTAL W, V46, P765; Kawashima A., 1990, Jpn. Kokai Tokkyo Koho Patent, Patent No. [JP2062880 (19900302), 2062880]; Kobayashi K, 2015, J ANTIBIOT, V68, P126, DOI 10.1038/ja.2014.100; Neuss N, 1968, Antimicrob Agents Chemother (Bethesda), V8, P213; Trown P W, 1968, Antimicrob Agents Chemother (Bethesda), V8, P225	38	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					620	627		10.1038/ja.2015.41		8	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800005		
J	Yamazaki, H; Saito, R; Takahashi, O; Kirikoshi, R; Toraiwa, K; Iwasaki, K; Izumikawa, Y; Nakayama, W; Namikoshi, M				Yamazaki, Hiroyuki; Saito, Ryo; Takahashi, Ohgi; Kirikoshi, Ryota; Toraiwa, Kengo; Iwasaki, Kohei; Izumikawa, Yuta; Nakayama, Wataru; Namikoshi, Michio			Trichoketides A and B, two new protein tyrosine phosphatase 1B inhibitors from the marine-derived fungus Trichoderma sp.	JOURNAL OF ANTIBIOTICS			English	Article							SPONGE EURYSPONGIA SP; NATURAL-PRODUCTS; A-D; TARGET; PTP1B	Two new octaketides, trichoketides A (1) and B (2), were isolated from a culture broth of the seawater-derived fungus Trichoderma sp. TPU1237 together with two known analogs, trichodermaketones C (3) and D (4), by ODS column chromatography followed by preparative ODS and chiral HPLC. The structures of 1 and 2 were elucidated on the basis of their spectroscopic data, and absolute configurations were assigned by comparing their experimental electronic circular dichroism (ECD) spectra with the calculated ECD spectra. Compounds 1 and 2 were epimers at the C-8 position (a-position of dihydrofuran ring). The IC50 values of compounds 1-4 against protein tyrosine phosphatase 1B were 53.1, 65.1, 68.0 and 55.9 mu M, respectively.	[Yamazaki, Hiroyuki; Saito, Ryo; Takahashi, Ohgi; Kirikoshi, Ryota; Toraiwa, Kengo; Iwasaki, Kohei; Izumikawa, Yuta; Nakayama, Wataru; Namikoshi, Michio] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Sendai, Miyagi 9818558, Japan	Yamazaki, H (reprint author), Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	yamazaki@tohoku-pharm.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25870660]; Foundation for Japanese Chemical Research	This work was supported in part by a Grant-in-Aid for Scientific Research (25870660) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to HY and by the Foundation for Japanese Chemical Research to HY. We express our thanks to T Matsuki and S Sato of Tohoku Pharmaceutical University for measuring mass and NMR spectra, and K Endo, T Ogasawara, Y Watanabe and M Takahashi of Tohoku Pharmaceutical University for their technical assistance.	Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Yamazaki H, 2013, J NAT MED-TOKYO, V67, P730, DOI 10.1007/s11418-012-0735-y; Lee S, 2007, MED RES REV, V27, P553, DOI 10.1002/med.20079; Abdjul DB, 2015, BIOORG MED CHEM LETT, V25, P904, DOI 10.1016/j.bmcl.2014.12.058; Jiang CS, 2012, ACTA PHARMACOL SIN, V33, P1217, DOI 10.1038/aps.2012.90; Cui L, 2006, BIOORG MED CHEM LETT, V16, P1426, DOI 10.1016/j.bmcl.2005.11.071; Nugroho AE, 2014, J NAT MED-TOKYO, V68, P1, DOI 10.1007/s11418-013-0768-x; Barr AJ, 2010, FUTURE MED CHEM, V2, P1563, DOI [10.4155/fmc.10.241, 10.4155/FMC.10.241]; Yamazaki H, 2013, BIOORG MED CHEM LETT, V23, P2151, DOI 10.1016/j.bmcl.2013.01.102; Song FH, 2010, J NAT PROD, V73, P806, DOI 10.1021/np900642p; Sun Y, 2008, ORG LETT, V10, P393, DOI 10.1021/ol702674f; Dennington R., 2009, GAUSSVIEW VERSION 5; FRISCH MJ, 2004, GAUSSIAN 03 REVISION; Yamazaki H, 2015, BIOORGAN MED CHEM, V23, P797, DOI 10.1016/j.bmc.2014.12.049	16	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					628	632		10.1038/ja.2015.44		5	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800006		
J	Ishii, T; Nonaka, K; Sugawara, A; Iwatsuki, M; Masuma, R; Hirose, T; Sunazuka, T; Omura, S; Shiomi, K				Ishii, Takahiro; Nonaka, Kenichi; Sugawara, Akihiro; Iwatsuki, Masato; Masuma, Rokuro; Hirose, Tomoyasu; Sunazuka, Toshiaki; Omura, Satoshi; Shiomi, Kazuro			Cinatrins D and E, and virgaricin B, three novel compounds produced by a fungus, Virgaria boninensis FKI-4958	JOURNAL OF ANTIBIOTICS			English	Article								Two new hydroxycitric acid lactone derivatives named cinatrins D (1) and E (2), and a new gamma-lactam, virgaricin B (3), along with a known similar compound, virgaricin (4), were isolated from a fermentation broth of the fungus Virgaria boninensis FKI-4958. The absolute stereo structures of the new compounds were established by a combination of spectroscopic methods and chemical modifications. All three newly discovered compounds possessed weak antibacterial activity.	[Ishii, Takahiro; Nonaka, Kenichi; Sugawara, Akihiro; Iwatsuki, Masato; Masuma, Rokuro; Hirose, Tomoyasu; Sunazuka, Toshiaki; Omura, Satoshi; Shiomi, Kazuro] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo 1088641, Japan; [Ishii, Takahiro; Nonaka, Kenichi; Sugawara, Akihiro; Iwatsuki, Masato; Masuma, Rokuro; Hirose, Tomoyasu; Sunazuka, Toshiaki; Shiomi, Kazuro] Kitasato Univ, Grad Sch Infect Control Sci, Minato Ku, Tokyo 1088641, Japan	Shiomi, K (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	omuras@insti.kitasato-u.ac.jp; shiomi@lisci.kitasato-u.ac.jp					ANDO T, 1988, J ANTIBIOT, V41, P25; Nonaka K, 2013, MYCOSCIENCE, V54, P394, DOI 10.1016/j.myc.2013.01.004; Ishii T, 2012, J ANTIBIOT, V65, P139, DOI 10.1038/ja.2011.123; Rogers JD, 2002, CAN J BOT, V80, P478, DOI [10.1139/B02-033, 10.1139/b02-033]; Weber D, 2005, Z NATURFORSCH C, V60, P467; KAMEOKA H, 1975, PHYTOCHEMISTRY, V14, P1676, DOI 10.1016/0031-9422(75)85395-7; Iwatsuki M, 2008, J ANTIBIOT, V61, P222, DOI 10.1038/ja.2008.32; Yabuuchi T, 2000, J ORG CHEM, V65, P397, DOI 10.1021/jo991218a; HAMADA Y, 1991, TETRAHEDRON, V47, P8635, DOI 10.1016/S0040-4020(01)82406-6; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; GROVE JF, 1971, J CHEM SOC C, P2261, DOI 10.1039/j39710002261; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; WHITE TJ, 1990, AMPLIFICATION DIRECT, P315, DOI DOI 10.1002/MRD.1080280418	13	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					633	637		10.1038/ja.2015.45		5	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800007		
J	Kobayashi, K; Fukuda, T; Terahara, T; Harunari, E; Imada, C; Tomoda, H				Kobayashi, Keisuke; Fukuda, Takashi; Terahara, Takeshi; Harunari, Enjuro; Imada, Chiaki; Tomoda, Hiroshi			Diketopiperazines, inhibitors of sterol O-acyltransferase, produced by a marine-derived Nocardiopsis sp KM2-16	JOURNAL OF ANTIBIOTICS			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; ACYL-COA; MICE; ATHEROSCLEROSIS; IDENTIFICATION; XANTHOMATOSIS; EXPRESSION; AMAUROMINE; ALKALOIDS; COENZYME		[Kobayashi, Keisuke; Fukuda, Takashi; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Terahara, Takeshi; Harunari, Enjuro; Imada, Chiaki] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo, Japan	Tomoda, H (reprint author), Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	tomodah@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26253009]	We thank Ms Noriko Sato and Dr Kenichiro Nagai (School of Pharmaceutical Sciences, Kitasato University) for measurements of NMR spectra and MS data. This work was supported by a Grant-in-aid for Scientific Research (A) 26253009 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to HT).	Ohshiro T, 2007, J ANTIBIOT, V60, P43; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; TAKASE S, 1985, TETRAHEDRON, V41, P3037, DOI 10.1016/S0040-4020(01)96656-6; Buhman KK, 2000, NAT MED, V6, P1341; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; ARAI K, 1989, CHEM PHARM BULL, V37, P2937; SCOTT PM, 1976, J AGR FOOD CHEM, V24, P865, DOI 10.1021/jf60206a028; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; TAKASE S, 1984, J ANTIBIOT, V37, P1320; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; Yin WB, 2010, ORG BIOMOL CHEM, V8, P1133, DOI 10.1039/b922440h; Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Ohte S, 2011, J ANTIBIOT, V64, P489, DOI 10.1038/ja.2011.32; Willner EL, 2003, P NATL ACAD SCI USA, V100, P1262, DOI 10.1073/pnas.0336398100; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; DEGUZMAN FS, 1992, J NAT PROD, V55, P931, DOI 10.1021/np50085a013; SHINOHARA C, 1994, J ANTIBIOT, V47, P163	19	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					638	641		10.1038/ja.2015.38		4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800008		
J	Su, J; Iehara, M; Yasukawa, J; Matsumoto, Y; Hamamoto, H; Sekimizu, K				Su, Jie; Iehara, Maki; Yasukawa, Jyunichiro; Matsumoto, Yasuhiko; Hamamoto, Hiroshi; Sekimizu, Kazuhisa			A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin	JOURNAL OF ANTIBIOTICS			English	Article							CELL-WALL; RESISTANCE; MEMBRANE; PROGRESS; TARGETS		[Su, Jie; Iehara, Maki; Yasukawa, Jyunichiro; Matsumoto, Yasuhiko; Hamamoto, Hiroshi; Sekimizu, Kazuhisa] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan	Sekimizu, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Tokyo, Japan.	sekimizu@mol.f.u-tokyo.ac.jp			MEXT [24102510, 26102714]; JSPS [24689008]	This study was supported by Genome Pharmaceuticals Institute, Grant-in-Aid for Scientific Research on Innovative Areas 'Chemical Biology of Natural Products' (24102510) for KS and (26102714) for HH from MEXT, and in partly by Grant-in-Aid for Young Scientists (A) (24689008) for HH from JSPS. We thank Ms Kiyomi Kyogoku (University of Tokyo), Dr Keiko Kataoka (University of Tokyo) and Mr Yoshihiro Nakatani (Genome Pharmaceuticals Insititute) for technical assistance.	Hamamoto H, 2015, NAT CHEM BIOL, V11, P127, DOI [10.1038/nchembio.1710, 10.1038/NCHEMBIO.1710]; Garcia-Lara J, 2005, DRUG DISCOV TODAY, V10, P643, DOI 10.1016/S1359-6446(05)03432-X; Baltz RH, 2009, CURR OPIN CHEM BIOL, V13, P144, DOI 10.1016/j.cbpa.2009.02.031; Mehta S, 2012, ANTIMICROB AGENTS CH, V56, P92, DOI 10.1128/AAC.00432-10; Boyle-Vavra S, 2013, ANTIMICROB AGENTS CH, V57, P83, DOI 10.1128/AAC.01651-12; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Berscheid A, 2014, J ANTIMICROB CHEMOTH, V69, P3190, DOI 10.1093/jac/dku297; Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2009, M07A8 CLSI, V29; Kaito C, 2007, Drug Discov Ther, V1, P89; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; National Committee for Clinical Laboratory Standards Methods for determining bactericidal activity of antimicrobial agents, 1999, M26A NCCLS, V19; [Anonymous], 1991, METHOD ENZYMOL	16	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					646	648		10.1038/ja.2015.42		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800010		
J	Suga, T; Asami, Y; Hashimoto, S; Nonaka, K; Iwatsuki, M; Nakashima, T; Sugahara, R; Shiotsuki, T; Yamamoto, T; Shinohara, Y; Ichimaru, N; Murai, M; Miyoshi, H; Omura, S; Shiomi, K				Suga, Takuya; Asami, Yukihiro; Hashimoto, Shohei; Nonaka, Kenichi; Iwatsuki, Masato; Nakashima, Takuji; Sugahara, Ryohei; Shiotsuki, Takahiro; Yamamoto, Takenori; Shinohara, Yasuo; Ichimaru, Naoya; Murai, Masatoshi; Miyoshi, Hideto; Omura, Satoshi; Shiomi, Kazuro			Ascosteroside C, a new mitochondrial respiration inhibitor discovered by pesticidal screening using recombinant Saccharomyces cerevisiae	JOURNAL OF ANTIBIOTICS			English	Article							TETRANYCHUS-URTICAE; CROSS-RESISTANCE; ACARI; MITE; CYFLUMETOFEN; EFFICACY; MODE; ACID		[Suga, Takuya; Asami, Yukihiro; Nonaka, Kenichi; Iwatsuki, Masato; Shiomi, Kazuro] Kitasato Univ, Dept Drug Discovery Sci, Grad Sch Infect Control Sci, Tokyo 1088641, Japan; [Asami, Yukihiro; Nonaka, Kenichi; Iwatsuki, Masato; Omura, Satoshi; Shiomi, Kazuro] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Hashimoto, Shohei] Kitasato Univ, Dept Chem, Sch Sci, Tokyo, Kanagawa, Japan; [Nakashima, Takuji] Kitasato Univ, Res Org Infect Control Sci, Tokyo 1088641, Japan; [Sugahara, Ryohei; Shiotsuki, Takahiro] Natl Inst Agrobiol Sci, Insect Growth Regulat Res Unit, Tsukuba, Ibaraki, Japan; [Yamamoto, Takenori; Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 770, Japan; [Ichimaru, Naoya; Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	Shiomi, K (reprint author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	omuras@insti.kitasato-u.ac.jp; shiomi@lisci.kitasato-u.ac.jp			Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution, Japan	The study was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Technology Research Advancement Institution, Japan. We are grateful to Dr Kenichiro Nagai and Ms Noriko Sato, School of Pharmacy, Kitasato University, for help in obtaining NMR and MS data and are grateful to Dr Rokuro Masuma, Dr Mihoko Mori and Dr Hidetaka Yuge, Kitasato University, for suggestions concerning the experiments.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Khalighi M, 2014, PEST MANAG SCI, V70, P365, DOI 10.1002/ps.3641; Hashimoto M, 1999, BBA-BIOENERGETICS, V1409, P113, DOI 10.1016/S0005-2728(98)00155-8; Kim YJ, 2004, PEST MANAG SCI, V60, P1001, DOI 10.1002/ps.909; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Asami Y, 2003, J NAT PROD, V66, P729, DOI 10.1021/np030041j; KLINGENBERG M, 1976, EUR J BIOCHEM, V65, P601, DOI 10.1111/j.1432-1033.1976.tb10377.x; Asami Y, 2004, TETRAHEDRON, V60, P7085, DOI 10.1016/j.tet.2003.09.104; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; Herron GA, 2003, EXP APPL ACAROL, V31, P131, DOI 10.1023/B:APPA.0000005112.65573.be; Weber RWS, 2007, PHYTOCHEMISTRY, V68, P886, DOI 10.1016/j.phytochem.2006.12.017; Herron G, 1996, EXP APPL ACAROL, V20, P495, DOI 10.1007/BF00048282; Hayashi N, 2013, PEST MANAG SCI, V69, P1080, DOI 10.1002/ps.3470; MIZOGUCHI J, 1977, J ANTIBIOT, V30, P308; Leet JE, 1996, J ANTIBIOT, V49, P553; Kaufman PE, 2001, VET PARASITOL, V97, P123, DOI 10.1016/S0304-4017(00)00439-8; Jagow V. G., 1975, BIOCHIM BIOPHYS ACTA, V387, P409; Van Nieuwenhuyse P, 2009, PEST MANAG SCI, V65, P404, DOI 10.1002/ps.1705; Wakasa F, 1999, AGROCHEM JPN, V75, P17	19	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2015	68	10					649	652		10.1038/ja.2015.43		4	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CU9QO	WOS:000363879800011		
J	Takashima, Y; Fujita, K; Ardin, AC; Nagayama, K; Nomura, R; Nakano, K; Matsumoto-Nakano, M				Takashima, Y.; Fujita, K.; Ardin, A. C.; Nagayama, K.; Nomura, R.; Nakano, K.; Matsumoto-Nakano, M.			Characterization of the dextran-binding domain in the glucan-binding protein C of Streptococcus mutans	JOURNAL OF APPLIED MICROBIOLOGY			English	Article						biofilm; bioinformatics; dextran-binding domain; glucan-binding protein C; Streptococcus mutans	ESCHERICHIA-COLI; DENTAL-CARIES; GENE; CLONING; EXPRESSION; DATABASE	Aims: Streptococcus mutans produces multiple glucan-binding proteins (Gbps), among which GbpC encoded by the gbpC gene is known to be a cell-surface-associated protein involved in dextran-induced aggregation. The purpose of the present study was to characterize the dextran-binding domain of GbpC using bioinformatics analysis and molecular techniques. Methods and Results: Bioinformatics analysis specified five possible regions containing molecular binding sites termed GB1 through GB5. Next, truncated recombinant GbpC (rGbpC) encoding each region was produced using a protein expression vector and five deletion mutant strains were generated, termed CDGB1 through CDGB5 respectively. The dextran-binding rates of truncated rGbpC that included the GB1, GB3, GB4 and GB5 regions in the upstream sequences were higher than that of the construct containing GB2 in the downstream region. In addition, the rates of dextran-binding for strains CDGB4 and CD1, which was entire gbpC deletion mutant, were significantly lower than for the other strains, while those of all other deletion mutants were quite similar to that of the parental strain MT8148. Biofilm structures formed by CDGB4 and CD1 were not as pronounced as that of MT8148, while those formed by other strains had greater density as compared to that of CD1. Conclusion: Our results suggest that the dextran-binding domain may be located in the GB4 region in the interior of the gbpC gene. Significance and Impact of the Study: Bioinformatics analysis is useful for determination of functional domains in many bacterial species.	[Takashima, Y.; Fujita, K.; Matsumoto-Nakano, M.] Okayama Univ, Dept Pediat Dent, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Ardin, A. C.; Nagayama, K.; Nomura, R.; Nakano, K.] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Suita, Osaka, Japan	Matsumoto-Nakano, M (reprint author), Okayama Univ, Dept Pediat Dent, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	mnakano@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [25862013]	This study was supported by a Grant-in Aid for Young Scientist (B) 25862013 from the Japan Society for the Promotion of Science.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Matsumoto-Nakano M, 2008, ORAL MICROBIOL IMMUN, V23, P265, DOI 10.1111/j.1399-302X.2007.00421.x; Matsumoto M, 2003, FEMS MICROBIOL LETT, V228, P73, DOI 10.1016/S0378-1097(03)00723-7; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; SMITH DJ, 1994, INFECT IMMUN, V62, P2545; AOKI H, 1986, INFECT IMMUN, V53, P587; Zhu M, 2009, APPL ENVIRON MICROB, V75, P7037, DOI 10.1128/AEM.01015-09; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Banas JA, 2001, METHOD ENZYMOL, V337, P425; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; TOBIAN JA, 1982, J BACTERIOL, V152, P215; Matsumoto M, 2006, ORAL MICROBIOL IMMUN, V21, P42; Sato Y, 1997, INFECT IMMUN, V65, P668; OOSHIMA T, 1983, JPN J MED SCI BIOL, V36, P219; LIS M, 1995, APPL ENVIRON MICROB, V61, P2040; Matsumoto-Nakano M, 2007, ORAL MICROBIOL IMMUN, V22, P30; Lin YC, 2011, J AM CHEM SOC, V133, P16617, DOI 10.1021/ja206692g; RUSSELL RRB, 1985, J GEN MICROBIOL, V131, P295; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HAMADA S, 1984, J DENT RES, V63, P407, DOI 10.1177/00220345840630031001; BOUVET A, 1981, J BACTERIOL, V146, P1075; Niu GQ, 2008, J BACTERIOL, V190, P7268, DOI 10.1128/JB.00967-08; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Punta M, 2011, NUCLEIC ACIDS RES, V40, pD290, DOI DOI 10.1093/NAR/GKR1065	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1364-5072	1365-2672		J APPL MICROBIOL	J. Appl. Microbiol.	OCT	2015	119	4					1148	1157		10.1111/jam.12895		10	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CU3SE	WOS:000363444600014		
J	Tsujimoto, H; Tanzawa, A; Miyamoto, H; Horii, T; Tsuji, M; Kawasumi, A; Tamura, A; Wang, Z; Abe, R; Tanaka, S; Yamanaka, K; Matoba, M; Torii, H; Ozamoto, Y; Takamori, H; Suzuki, S; Morita, S; Ikada, Y; Hagiwaral, A				Tsujimoto, Hiroyuki; Tanzawa, Ayumi; Miyamoto, Hiroe; Horii, Tsunehito; Tsuji, Misaki; Kawasumi, Akari; Tamura, Atsushi; Wang, Zhen; Abe, Rie; Tanaka, Shota; Yamanaka, Kouki; Matoba, Mari; Torii, Hiroko; Ozamoto, Yuki; Takamori, Hideki; Suzuki, Shuko; Morita, Shinichiro; Ikada, Yoshito; Hagiwara, Akeo			Biological properties of a thermally crosslinked gelatin film as a novel anti-adhesive material: Relationship between the biological properties and the extent of thermal crosslinking	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS			English	Article						gelatin film; thermal crosslinking; anti-adhesive effect; biodegradability	ABDOMINAL ADHESIONS; MULTICENTER; MEMBRANE; PREVENTION; REDUCTION; COLLAGEN; SURGERY; BARRIER	In order to prevent postoperative adhesion and the related complications, a thermally crosslinked gelatin (TCG) film was developed and the basic biological properties were examined, paying special attention to the relationship between these properties and the extent of crosslinking of the film. The gelatin films crosslinked thermally for five different time periods (0, 1, 3, 8, and 14 hours) were developed and the following tests were performed. Regarding the material characterization of the films, the water content, the water solubility, and the enzymatic degradation for collagenase were found to be closely related to the duration of thermal crosslinking. In an in vitro study conducted to examine the cell growth of fibroblasts cultured on the films, the degree of cell growth, except no crosslinked film, was less than that observed in the control group, thus suggesting that such effects of the films on fibroblast cell growth may be related with their anti-adhesive effects. In in vivo tests, the films crosslinked for longer time periods (3, 8, and 14 hours) were retained for longer after being implanted into the abdominal cavity in rats and showed a significant anti-adhesive effect in the rat cecum adhesion models, indicating that the biodegradability and anti-adhesive effects of the TCG films depend on the duration of thermal crosslinking. In order to develop useful and effective anti-adhesive gelatin film, it is very important to optimize duration of the thermal crosslinking. t7-.) (C) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 1038: 1511-1518,2015.	[Tsujimoto, Hiroyuki; Tanzawa, Ayumi; Miyamoto, Hiroe; Horii, Tsunehito; Tsuji, Misaki; Kawasumi, Akari; Tamura, Atsushi; Wang, Zhen; Abe, Rie; Tanaka, Shota; Yamanaka, Kouki; Matoba, Mari; Torii, Hiroko; Ozamoto, Yuki; Takamori, Hideki; Hagiwara, Akeo] Doshisha Univ, Dept Life & Med Sci, Div Med Life Syst, Kyotanabe, Kyoto 6100394, Japan; [Takamori, Hideki; Suzuki, Shuko; Morita, Shinichiro] Gunze Ltd, Dept Res & Dev, Ayabe, Kyoto 6238511, Japan; [Suzuki, Shuko; Ikada, Yoshito] Nara Med Univ, Dept Med, Kashihara, Nara 6348521, Japan	Tsujimoto, H (reprint author), Doshisha Univ, Dept Life & Med Sci, Div Med Life Syst, Kyotanabe, Kyoto 6100394, Japan.	sk108621@mail.doshisha.ac.jp					Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4; [Anonymous], Japan patent, Patent No. [2005:A289841, 2005289841]; Diamond MP, 1996, FERTIL STERIL, V66, P904; Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006; Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002; FUJII T, 1969, H-S Z PHYSIOL CHEM, V350, P1257, DOI 10.1515/bchm2.1969.350.2.1257; Tsujimoto H, 2013, J BIOMED MATER RES B, V101B, P99, DOI 10.1002/jbm.b.32821; Forest P, 2007, BIO-MED MATER ENG, V17, P199; Parker MC, 2004, HOSP MED, V65, P330; CASPI E, 1979, FERTIL STERIL, V31, P296; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Becker JM, 1996, J AM COLL SURGEONS, V183, P297; Burns JW, 1997, EUR J SURG S, V57, P40; Daniell IF., 1989, J GYNECOL SURG, V5, P61; Di Zerega G. S., 1997, EUR J SURG S, V577, P10; Diamond MP, 1984, INFERTILITY, V7, P39; EEC regulatory document, 1992, BIOMATERIALS, V20, P155; Ellis H, 1997, EUR J SURG S, V577, P5; Jeekel H., 1997, EUR J SURG S, V579, P43; Shlaff WD, 1990, FERTIL STERIL, V54, P984; Tomihata K, 2001, RRD BIOTECH BIOENGN, V4, P35	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-4973	1552-4981		J BIOMED MATER RES B	J. Biomed. Mater. Res. Part B	OCT	2015	103	7					1511	1518		10.1002/jbm.b.33340		8	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CU7CO	WOS:000363693600018		
J	Tsuji, M; Shudo, K; Kagechika, H				Tsuji, Motonori; Shudo, Koichi; Kagechika, Hiroyuki			Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors	JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN			English	Article						Retinoid X receptors; Retinoic acid receptors; All-trans retinoic acid; 9-cis retinoic acid; 13-cis retinoic acid; Docking simulation	UNION-OF-PHARMACOLOGY; DIAZEPINYLBENZOIC ACIDS; NUCLEAR RECEPTORS; CRYSTAL-STRUCTURE; LIGAND; DOMAIN; SYNERGISTS; ACTIVATION; AGONISTS; CELLS	Retinoid X receptors (RXRs) are ligand-controlled transcription factors which heterodimerize with other nuclear receptors to regulate gene transcriptions associated with crucial biological events. 9-cis retinoic acid (9cRA), which transactivates RXRs, is believed to be an endogenous RXR ligand. All-trans retinoic acid (ATRA) is a natural ligand for retinoic acid receptors (RARs), which heterodimerize with RXRs. Although the concentration of 9cRA in tissues is very low, ATRA is relatively abundant and some reports show that ATRA activates RXRs. We computationally studied the possibility of ATRA binding to RXRs using two different docking methods with our developed programs to assess the binding affinities of naturally occurring retinoids. The simulations showed good correlations to the reported binding affinities of these molecules for RXRs and RARs.	[Tsuji, Motonori] Inst Mol Funct, Misato Shi, Saitama 3410037, Japan; [Shudo, Koichi] Japan Pharmaceut Informat Ctr, Shibuya Ku, Tokyo 1500002, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan	Tsuji, M (reprint author), Inst Mol Funct, 2-105-14 Takasu, Misato Shi, Saitama 3410037, Japan.	motonori@molfunction.com					Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Amano Y, 2014, CHEM PHARM BULL, V62, P254; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Fukunishi Y, 2005, J MOL GRAPH MODEL, V24, P34, DOI 10.1016/j.jmgm.2005.04.004; Tsuji M, 2014, J STRUCT BIOL, V185, P355, DOI 10.1016/j.jsb.2013.12.007; Kawamura K, 2013, DEV BIOL, V384, P343, DOI 10.1016/j.ydbio.2013.10.004; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Mizuguchi Y, 2006, BIOL PHARM BULL, V29, P1803, DOI 10.1248/bpb.29.1803; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Camacho M, 2008, J LIPID RES, V49, P1707, DOI 10.1194/jlr.M700559-JLR200; le Maire A, 2012, CURR TOP MED CHEM, V12, P505; Ebisawa M, 1999, CHEM PHARM BULL, V47, P1778; Iijima T, 1999, CHEM PHARM BULL, V47, P398; Tashima T, 1997, CHEM PHARM BULL, V45, P1805; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Liu Y, 2008, J NEUROCHEM, V106, P1104, DOI 10.1111/j.1471-4159.2008.05445.x; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Amano Y, 2013, BIOORGAN MED CHEM, V21, P4342, DOI 10.1016/j.bmc.2013.04.053; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Idres N, 2002, J BIOL CHEM, V277, P31491, DOI 10.1074/jbc.M205016200; Ruhl R, 2001, TOXICOL SCI, V63, P82, DOI 10.1093/toxsci/63.1.82; Ohta K, 1998, BIOL PHARM BULL, V21, P544; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; ALLEGRETTO EA, 1993, J BIOL CHEM, V268, P26625; Gaddipati R, 2014, INT J BIOSCI BIOCH B, V4, P100; Huang R, 2014, CHEM REV, V114, P233; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Mic DA, 2003, PNAS, V100, P7135; Osz J., 2012, P NATL ACAD SCI USA, V109, P588; Radominska-Pandya A, 2002, BIOCHEMISTRY-US, V41, P4883, DOI 10.1021/bi0121151; Sato Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015119; Svenssonstberg T, 2003, EMBO J, V22, P4625; Tsuji M, 2015, DOCKING STUDY HYPERC; Tsuji M, 2015, HOMOLOGY MODELING PR; Tsuji M, 2006, Seitaikoubunnsi Niokeru Sougosayoubui No Yosokuhouhou, Patent No. [2007-299125, 2007299125]; Tsuji M, 2007, MOL SCI, V1, pNP004; Vina A., 2010, J COMPUT CHEM, V31, P455	40	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-654X	1573-4951		J COMPUT AID MOL DES	J. Comput.-Aided Mol. Des.	OCT	2015	29	10					975	988		10.1007/s10822-015-9869-9		14	Biochemistry & Molecular Biology; Biophysics; Computer Science, Interdisciplinary Applications	Biochemistry & Molecular Biology; Biophysics; Computer Science	CU5EV	WOS:000363555600005		
J	Murakami, D; Griffith, DA				Murakami, Daisuke; Griffith, Daniel A.			Random effects specifications in eigenvector spatial filtering: a simulation study	JOURNAL OF GEOGRAPHICAL SYSTEMS			English	Article						Eigenvector spatial filtering; Mixed effects model; Geostatistics; Spatial econometrics; Spatial confounding	MODELING NETWORK AUTOCORRELATION; LINEAR-REGRESSION MODELS; ECONOMETRIC-MODELS; NEIGHBOR MATRICES; ECOLOGICAL DATA; DEPENDENCE; FLOWS; SCALE	Eigenvector spatial filtering (ESF) is becoming a popular way to address spatial dependence. Recently, a random effects specification of ESF (RE-ESF) is receiving considerable attention because of its usefulness for spatial dependence analysis considering spatial confounding. The objective of this study was to analyze theoretical properties of RE-ESF and extend it to overcome some of its disadvantages. We first compare the properties of RE-ESF and ESF with geostatistical and spatial econometric models. There, we suggest two major disadvantages of RE-ESF: it is specific to its selected spatial connectivity structure, and while the current form of RE-ESF eliminates the spatial dependence component confounding with explanatory variables to stabilize the parameter estimation, the elimination can yield biased estimates. RE-ESF is extended to cope with these two problems. A computationally efficient residual maximum likelihood estimation is developed for the extended model. Effectiveness of the extended RE-ESF is examined by a comparative Monte Carlo simulation. The main findings of this simulation are as follows: Our extension successfully reduces errors in parameter estimates; in many cases, parameter estimates of our RE-ESF are more accurate than other ESF models; the elimination of the spatial component confounding with explanatory variables results in biased parameter estimates; efficiency of an accuracy maximization-based conventional ESF is comparable to RE-ESF in many cases.	[Murakami, Daisuke] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Griffith, Daniel A.] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX 75083 USA	Murakami, D (reprint author), Natl Inst Environm Studies, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	murakami.daisuke@nies.go.jp; dagriffith@utdallas.edu			Japan Society for the Promotion of Science; Global Climate Risk Management Strategies project [S10]	We received helpful comments from Professor Arthur Getis at the 59th Annual North American Meetings of the Regional Science Association International. Also, we received generous support from Professor Morito Tsutsumi, University of Tsukuba, and Professor Yoshiki Yamagata, National Institute for Environmental Studies. We would particularly like to thank them. In addition, we are grateful to anonymous referees for their many suggestive comments. This work was supported by a grant-in-aid from the Japan Society for the Promotion of Science Fellows. In addition, this is an achievement of the Global Climate Risk Management Strategies (S10) project.	HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Griffith DA, 2006, J GEOGR SYST, V8, P335, DOI 10.1007/s10109-006-0034-9; Moniruzzaman M, 2012, HEALTH PLACE, V18, P1323, DOI 10.1016/j.healthplace.2012.09.013; Griffith DA, 2004, ENVIRON PLANN A, V36, P1791, DOI 10.1068/a36247; Chun YW, 2014, GEOGR ANAL, V46, P165, DOI 10.1111/gean.12034; Griffith DA, 2009, J GEOGR SYST, V11, P117, DOI 10.1007/s10109-009-0082-z; Griffith DA, 2008, ENVIRON PLANN A, V40, P2751, DOI 10.1068/a38218; Drineas P, 2005, J MACH LEARN RES, V6, P2153; Chun Y, 2011, ANN ASSOC AM GEOGR, V101, P523, DOI 10.1080/00045608.2011.561070; Getis A, 2002, GEOGR ANAL, V34, P130, DOI 10.1111/j.1538-4632.2002.tb01080.x; Pace RK, 2013, SPAT ECON ANAL, V8, P352, DOI 10.1080/17421772.2013.807355; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Griffith DA, 2000, LINEAR ALGEBRA APPL, V321, P95, DOI 10.1016/S0024-3795(00)00031-8; Wang YY, 2013, J TRANSP GEOGR, V31, P123, DOI 10.1016/j.jtrangeo.2013.06.001; Patuelli R, 2011, INT REGIONAL SCI REV, V34, P253, DOI 10.1177/0160017610386482; Griffith DA, 2013, J GEOGR SYST, V15, P291, DOI 10.1007/s10109-013-0182-7; Pace RK, 2010, ADV SPAT SCI, P17, DOI 10.1007/978-3-642-03326-1_2; Thayn JB, 2013, ANN ASSOC AM GEOGR, V103, P47, DOI 10.1080/00045608.2012.685048; Seya H, 2014, GEOGR ANAL, V46, P126, DOI 10.1111/gean.12032; ANSELIN L, 1991, GEOGR ANAL, V23, P112; Elhorst JP, 2010, SPAT ECON ANAL, V5, P9, DOI 10.1080/17421770903541772; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Haskard KA, 2009, GEODERMA, V153, P18, DOI 10.1016/j.geoderma.2009.07.006; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Hodges JS, 2010, AM STAT, V64, P325, DOI 10.1198/tast.2010.10052; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Scherngell T, 2013, PAP REG SCI, V92, P555, DOI 10.1111/j.1435-5957.2012.00419.x; Chun YW, 2008, J GEOGR SYST, V10, P317, DOI 10.1007/s10109-008-0068-2; Griffith DA, 2011, COMPUT ENVIRON URBAN, V35, P140, DOI 10.1016/j.compenvurbsys.2010.08.003; Paciorek CJ, 2010, STAT SCI, V25, P107, DOI 10.1214/10-STS326; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Arbia G, 2008, PAP REG SCI, V87, P311, DOI 10.1111/j.1435-5957.2008.00208.x; LeSage JP, 2007, GEOGR ANAL, V39, P241, DOI 10.1111/j.1538-4632.2007.00703.x; GETIS A, 1990, PAP REG SCI ASSOC, P69; Fischer MM, 2008, J REGIONAL SCI, V48, P969, DOI 10.1111/j.1467-9787.2008.00572.x; Hughes J, 2013, J R STAT SOC B, V75, P139, DOI 10.1111/j.1467-9868.2012.01041.x; Bates D.M., 2010, LME4 MIXED EFFECTS M; Chun Y, 2013, SPATIAL STAT GEOSTAT; Chun YW, 2014, SPAT STAT-NETH, V10, P1, DOI 10.1016/j.spasta.2014.04.001; Cressie N, 2011, STAT SPATIO TEMPORAL; Cressie N.A.C., 1993, STAT SPATIAL DATA; Cuaresma CJ, 2013, J APPL EC, V28, P720; Franzese RJ, 2014, NEW FRONTIERS STUDY; GETIS A, 1992, GEOGR ANAL, V24, P189; Griffith DA, 1996, CAN GEOGR-GEOGR CAN, V40, P351, DOI 10.1111/j.1541-0064.1996.tb00462.x; Griffith D. A., 1993, PAPERS REGIONAL SCI, V72, P283, DOI 10.1007/BF01434277; Griffith D. A., 2003, SPATIAL AUTOCORRELAT; Griffith DA, 2011, ADV GEOGR INFORM SCI, P1, DOI 10.1007/978-3-642-16043-1; Griffith DA, 2013, HDB REGIONAL SCI, P1477; Griffith DA, 1997, P SECT STAT ENV AM S, P91; Griffith DA, 2004, J GEOGR SYST, V6, P263, DOI 10.1007/s10109-004-0134-3; Griffith DA, 2002, STAT PROBABIL LETT, V58, P245, DOI 10.1016/S0167-7152(02)00099-8; Griffith DA, 2010, HDB APPL SPATIAL ANA, P301, DOI 10.1007/978-3-642-03647-7_16; Grimpe C, 2009, ANN REGIONAL SCI, V46, P519; Helbich M, 2014, CARTOGR GEOGR INF SC, V42, P134; Hodges JS, 2013, RICHLY PARAMETERIZED; Jacob GB, 2008, INT J HEALTH GEOGR, V7, P11; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; LeSage J, 2009, STAT TEXTB MONOGR, P1; LeSage JP, 2014, ECONOM, V2, P217; Pintore A, 2004, NONSTATIONARY COVARI; Seya H, 2015, GEOGR ANAL, V47, P284, DOI 10.1111/gean.12054; Tiefelsdorf M, 2007, ENVIRON PLANN A, V39, P1193, DOI 10.1068/a37378	64	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1435-5930	1435-5949		J GEOGR SYST	J. Geogr. Syst.	OCT	2015	17	4					311	331		10.1007/s10109-015-0213-7		21	Geography	Geography	CU5FI	WOS:000363556900002		
J	Shahid, F; Alam, MK; Khamis, MF; Komori, A; Kubo, K; Maeda, H				Shahid, Fazal; Alam, Mohammad Khursheed; Khamis, Mohd Fadhli; Komori, Atsuo; Kubo, Katsutoshi; Maeda, Hatsuhiko			A New Method to Measure and Assess Tooth Size and Tooth Size Discrepancy Via Circumferential Measurements using Stereomicroscope	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Circumferential tooth size; Tooth size discrepancy; Digital dental models	DIFFERENT MALOCCLUSION GROUPS; ORTHODONTIC PATIENTS; DENTAL MEASUREMENTS; PLASTER MODELS; POPULATION; REPRODUCIBILITY; RELIABILITY; MAXILLARY; ACCURACY; VALIDITY	An accurate evaluation of tooth size and tooth size discrepancy is critically important in orthodontic diagnosis and treatment planning. The purpose of this study was to establish a new method to measure and assess tooth size and tooth size discrepancy with accuracy and reproducibility, named as circumferential tooth size (CFT), circumferential anterior tooth size ratio (CAR), circumferential overall tooth size ratio (COR) respectively. Total 128 dental models were scanned via Hirox digital stereomicroscope for the fabrication of the digital models. Dental models were selected on the basis of inclusion criteria. All the measurements were obtained with the accuracy of 0.1 x10(-6)mm; the mean and the SD for the CFT, CAR and COR were calculated. The developed norms for the CFT, demonstrated significantly greater values for males in relation to females. More precisely, there were statistically significant differences observed in different variables (*p <= 0.05 to ***p <= 0.001). CAR and COR ratio show slight greater value for males without any statistically significant differences. The findings provide valuable information that CFT cover the tooth size in all dimensional aspects. For the prediction of ideal occlusion to be achieved at the finishing stage, orthodontist needs to evaluate CAR and COR ratios via proposed method.	[Shahid, Fazal; Alam, Mohammad Khursheed] Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia; [Khamis, Mohd Fadhli] Univ Sains Malaysia, Forens Dent Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia; [Komori, Atsuo; Kubo, Katsutoshi; Maeda, Hatsuhiko] Aichi Gakuin Univ, Sch Dent, Dept Oral Pathol, Nagoya, Aichi 464, Japan	Alam, MK (reprint author), Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia.	dralam@gmail.com			Universiti Sains Malaysia [304/PPSG/61313104]	The authors would like to acknowledge the support from the Universiti Sains Malaysia 304/PPSG/61313104 short-term grant.	Alam MK, 2013, INT MED J, V20, P229; Alam MK, 2013, INT MED J, V20, P462; Bailey E, 2013, AM J ORTHOD DENTOFAC, V143, P574, DOI 10.1016/j.ajodo.2012.09.022; [Anonymous], 2014, INT MED J; Mullen SR, 2007, AM J ORTHOD DENTOFAC, V132, P346, DOI 10.1016/j.ajodo.2005.08.044; Freeman JE, 1996, AM J ORTHOD DENTOFAC, V110, P24, DOI 10.1016/S0889-5406(96)70083-5; Ta TA, 2001, AM J ORTHOD DENTOFAC, V120, P556, DOI 10.1067/mod.2001.118998; Paredes V, 2006, AM J ORTHOD DENTOFAC, V129, P428, DOI 10.1016/j.ajodo.2005.03.020; Santoro M, 2003, AM J ORTHOD DENTOFAC, V124, P101, DOI 10.1016/S0889-5406(03)00152-5; Shahid F, 2015, J HARD TISSUE BIOL, V24, P155; Tarazona B, 2013, EUR J ORTHODONT, V35, P1, DOI 10.1093/ejo/cjr005; Alam MK, 2013, ACTA ODONTOL SCAND, V71, P1520, DOI 10.3109/00016357.2013.775336; Smith SS, 2000, AM J ORTHOD DENTOFAC, V117, P169, DOI 10.1016/S0889-5406(00)70228-9; Araujo E, 2003, ANGLE ORTHOD, V73, P307; Karaman F, 2006, J FORENSIC SCI, V51, P630, DOI 10.1111/j.1556-4029.2006.00133.x; Mihailidis S, 2013, AM J PHYS ANTHROPOL, V152, P19, DOI 10.1002/ajpa.22323; Alam MK, 2014, ACTA ODONTOL SCAND, V72, P1047, DOI 10.3109/00016357.2014.946967; CROSBY DR, 1989, AM J ORTHOD DENTOFAC, V95, P457, DOI 10.1016/0889-5406(89)90408-3; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Stevens DR, 2006, AM J ORTHOD DENTOFAC, V129, P794, DOI 10.1016/j.ajodo.2004.08.023; Sonbol HN, 2011, SAUDI MED J, V32, P895; Uysal T, 2005, ANGLE ORTHOD, V75, P208; [Anonymous], 2001, WORLD J ORTHOD; O'Mahony G, 2011, ANGLE ORTHOD, V81, P130, DOI 10.2319/050610-246.1; Endo T, 2008, ANGLE ORTHOD, V78, P994, DOI 10.2319/101007-486.1; Bennett JC, 1993, ORTHODONTIC TREATMEN; Bolton WA, 1958, ANGLE ORTHOD, V28, P113; BOLTON WA, 1962, AM J ORTHOD DENTOFAC, V48, P504, DOI 10.1016/0002-9416(62)90129-X; Garino F, 2002, WORLD J ORTHOD, V3, P250; Graber LW, 2011, ORTHODONTICS CURRENT; Grunheid T, 2014, AM J ORTHOD DENTOFAC, V145, P157, DOI 10.1016/j.ajodo.2013.10.012; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kansal A, 2012, IND J DENT, V3, P139; Khamis MF, 2014, FORENSIC SCI INT, V234; LAVELLE CLB, 1972, AMER J ORTHODONTICS, V61, P29, DOI 10.1016/0002-9416(72)90173-X; Proffit WR, 2006, CONT ORTHODONTICS; Shahid F, 2014, J HARD TISSUE BIOL, V23, P439; Vandenbroucke JP, 2007, ANN INTERN MED, V47, P163	38	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					305	310				6	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700001		
J	Tsukinowa, T; Onodera, S; Yoshizawa, Y; Saito, A; Muramatsu, T; Furusawa, M; Azuma, T				Tsukinowa, Takashi; Onodera, Shoko; Yoshizawa, Yuusei; Saito, Akiko; Muramatsu, Takashi; Furusawa, Masahiro; Azuma, Toshifumi			Synergistic and Mutual Antagonistic Regulations of Wnt Inhibitors Play an Important Role in Osteoblast Differentiation of Human Periodontal Ligament Cells	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Wnt Signaling Pathway; Bone Morphogenetic Protein; SOST; Periodontal Ligament; Osteogenesis	ALKALINE-PHOSPHATASE EXPRESSION; BONE MORPHOGENETIC PROTEIN-2; OSTEOGENESIS; REGENERATION; SCLEROSTIN; DICKKOPF-1; TGF-BETA-1; INCREASE; PATHWAY; DISEASE	Recent studies have suggested that a balance between Wnt and bone morphogenetic protein (BMP) output may be a key factor for regulatory networks involved in bone regeneration. Here we report that Wnt inhibitors coordinately regulate osteoblastic differentiation induced by BMPs of human periodontal ligament cell. Human periodontal ligament (HPDL) cells were stimulated with BMP2/7, Dexamethasone (Dex), or a combination of these reagents. After treatment, we analyzed the phosphorylated Smad1/5 and osteoblast differentiation markers. Specific antagonists such as Dickkopfs Dkk1, Dkk2), secreted Frizzled-related proteins (SFRP1,SFRP2), and sclerostin(SOST) which are believed to play important roles in osteoblast differentiations were also examined by quantitative RT-PCR. BMP2/7 treatment increased ALP activity modestly, and the combination of BMP2/7 with Dex greatly enhanced ALP activity. SOST expression increased sharply following BMP2/7 treatment; however, adding BMP2/7 and Dex drastically reversed this increase in SOST. BMP2/7 and Dex treatment synergistically decreased DKK2 and sFRP2 expression. In contrast, BMP2/7 and Dex had a significant inductive effect on DKK1 and sFRP1 expression. BMP2/7 treatment resulted in Smad1/5 phosphorylation, but adding Dex did not induce p-Smad1/5. However, BMP2/7-induced Smad1/5 phosphorylation was inhibited in the combined treatment group. These opposite trends support the previous reports showing mutual antagonism between DKK1 and DKK2 or sFRP1 and sFRP2. In conclusion, well-balanced Wnt inhibitors may be crucial for bone tissue homeostasis.	[Tsukinowa, Takashi; Yoshizawa, Yuusei; Muramatsu, Takashi; Furusawa, Masahiro] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo 1010061, Japan; [Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo 1010061, Japan	Azuma, T (reprint author), Tokyo Dent Coll, Dept Biochem, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	tazuma@tdc.ac.jp			JSPS KAKENHI [25462900, 25861761, 26861686, 26861560]	This work was supported by JSPS KAKENHI (C) Grant Number 25462900, and by JSPS KAKENHI for young scientist (B) Grant Numbers 25861761, 26861686 and 26861560.	Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Ito S, 2007, BONE, V40, P84, DOI 10.1016/j.bone.2006.07.012; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Cho SW, 2008, BIOCHEM BIOPH RES CO, V367, P399, DOI 10.1016/j.bbrc.2007.12.128; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Aida N, 2012, J HARD TISSUE BIOL, V21, P359; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Yamashita H, 2014, J HARD TISSUE BIOL, V23, P9; Voronkov A, 2013, CURR PHARM DESIGN, V19, P634; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Tomokiyo A, 2008, DIFFERENTIATION, V76, P337, DOI 10.1111/j.1432-0436.2007.00233.x; Sun P, 2012, DENT MATER J, V31, P239, DOI 10.4012/dmj.2011-191; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Zhao M, 2005, J CELL BIOCHEM, V95, P1, DOI 10.1002/jcb.20411; Mikami Y, 2010, J CELL PHYSIOL, V223, P123, DOI 10.1002/jcp.22017; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Chan BY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3837; Ochiai-Shino H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099534; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2015, DOI 10.1016/j.biomaterials.2009.11.071	33	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					311	318				8	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700002		
J	Lee, HJ; Arikawa, K				Lee, Hye-Jin; Arikawa, Kazumune			Influence of Low Level Sodium Fluoride on Expression of IGF-1 and IGF-2 Protein in Experimental Type 2 Diabetes with Periodontitis Model	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						NaF; IGF-1; IGF-2; P. gingivalis; Diabetes	FACTOR-I RECEPTOR; GROWTH-FACTOR-II; HUMAN BONE-CELLS; GINGIVAL FIBROBLASTS; TRANSGENIC MICE; SMOOTH-MUSCLE; PHENYTOIN; PHOSPHATASE; RATS; CLASSIFICATION	Dysregulation of growth and inflammatory mediators might contribute to defective tissue homeostasis and healing, as commonly observed in sedentary lifestyles and in conditions such as diabetes mellitus and periodontitis. Periodontitis is an inflammatory disease characterized by extensive bone resorption. Sodium fluoride (NaF) causes proliferation and differentiation, and modulates the activity of growth factors. In this study, we investigated the effects of NaF on insulin-like growth factor (IGF) 1 and 2 in Goto-Kakizaki (GK) rats, a spontaneous model of type 2 diabetes induced by Porphyromonas gingivalis, an important colonizer of the oral cavity that has been implicated in periodontitis. NaF strongly inhibited the P. gingivalis-induced alveolar bone loss. That effect was accompanied by decreased levels of TNF-alpha, IL-1 beta, and RM4, which were upregulated in P gingivalis-induced diabetes model. Consistent with the anti-inflammatory effect, NaF inhibited osteoclast markers, the receptor activator of nuclear factor kappa B ligand (RANKL) and Cathepsin K protein expression. IGF-1, -2 was strongly expressed by periodontal ligament, fibroblasts, particularly those in areas close to cementum and bone surfaces in NaF-treated groups. In the periodontal ligament, strong staining was noted in the fiber bundles inserting into alveolar bone and cementum. Our findings suggest the mechanism of IGF signaling by which NaF alters periodontal tissue repair in type 2 diabetes.	[Lee, Hye-Jin] Howon Univ, Dept Dent Hyg, Gunsan, South Korea; [Arikawa, Kazumune] Nihon Univ, Sch Dent Matsudo, Dept Prevent & Publ Oral Hlth, Matsudo, Chiba 2718587, Japan	Arikawa, K (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Prevent & Publ Oral Hlth, 2-870-1 Sakae Cho Nishi, Matsudo, Chiba 2718587, Japan.	arikawa.kazumune@nihon-u.ac.jp			Howon University	We would like to thank Dr. Toyama and Dr. Sato for P. gingivalis infection and the staff of animal facility for care of the 1 rats. We thank Prof. Ramada and Prof. Arakawa for fruitful discussions; Dr. Bhawal for histological and microscopy analysis; Dr. Fujita for technical assistance. This work was supported by Howon University in 2015.	KHOKHER MA, 1990, METABOLISM, V39, P1118, DOI 10.1016/0026-0495(90)90081-M; Koyama H, 2000, ARCH ORAL BIOL, V45, P647, DOI 10.1016/S0003-9969(00)00036-4; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hill DJ, 1998, DIABETES CARE, V21, pB60; Kornman KS, 2008, J PERIODONTOL, V79, P1560, DOI 10.1902/jop.2008.080213; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Andersen CCP, 2006, J PERIODONTOL, V77, P350, DOI 10.1902/jop.2006.050184; Petrik J, 1999, ENDOCRINOLOGY, V140, P2353, DOI 10.1210/en.140.5.2353; Pak CYC, 1995, TRENDS ENDOCRIN MET, V6, P229, DOI 10.1016/1043-2760(95)00111-T; Nakade O, 1996, J BONE MINER RES, V11, P1880; Goto Y, 1988, Adv Exp Med Biol, V246, P29; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Taylor JJ, 2013, J CLIN PERIODONTOL, V40, pS113, DOI [10.1111/jcpe.12059, 10.1902/jop.2013.134005]; Guan ZZ, 2000, ARCH TOXICOL, V74, P602, DOI 10.1007/s002040000177; Delafontaine P, 1996, J CLIN INVEST, V97, P139, DOI 10.1172/JCI118381; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Martin MA, 2005, ENDOCRINOLOGY, V146, P1364, DOI 10.1210/en.2004-0665; FARLEY JR, 1983, SCIENCE, V222, P330; HARRISON JE, 1981, J CLIN ENDOCR METAB, V52, P751; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; Lee HJ, 2015, KAOHSIUNG J MED SCI, V31, P303, DOI 10.1016/j.kjms.2015.03.005; Ammann P, 1998, BONE, V22, P39, DOI 10.1016/S8756-3282(97)00206-8; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Hill DJ, 1999, J ENDOCRINOL, V160, P305, DOI 10.1677/joe.0.1600305; Sima C, 2013, CURR DIABETES REP, V13, P445, DOI 10.1007/s11892-013-0367-y; CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318; Hill DJ, 2000, ENDOCRINOLOGY, V141, P1151, DOI 10.1210/en.141.3.1151; DILL RE, 1993, J PERIODONTOL, V64, P169; BURGENER D, 1995, J BONE MINER RES, V10, P164; MODEER T, 1990, J ORAL PATHOL MED, V19, P188, DOI 10.1111/j.1600-0714.1990.tb00822.x; LAU KHW, 1989, METABOLISM, V38, P858; Hanes Philip J, 2010, EPMA J, V1, P101, DOI 10.1007/s13167-010-0016-3; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3	35	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					319	324				6	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700003		
J	Hirayama, Y; Watanabe, T; Yokoyama, M; Fujiseki, M; Yamazaki, T; Sohn, WJ; Kim, JY; Yamamoto, H				Hirayama, Yuzo; Watanabe, Tae; Yokoyama, Megumi; Fujiseki, Motoya; Yamazaki, Takaki; Sohn, Wern-Joo; Kim, Jae-Young; Yamamoto, Hitoshi			Histological Observation of the Jaws and Teeth of the Green Spotted Pufferfish (Tetraodon Nigroviridis)	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Tetraodon nigroviridis; Tooth; Jaw; Histology	MEDAKA ORYZIAS-LATIPES; VERTEBRATE DENTITION; PHARYNGEAL TEETH; FISH; EXPRESSION; EVOLUTION; ENAMEL; ZEBRAFISH; PATTERNS; MODEL	The green spotted pufferfish (Tetraodon nigroviridis) is a brackish tropical fish whose draft genomic sequence has been published. Its genome is the smallest among vertebrates, and genes account for a high rate of the genome. In addition, many genes have a specific function. Because of these characteristics, the green spotted pufferfish is used as a model animal for genetics. Therefore, this species is likely to be used for basic and clinical studies, similarly to zebrafish and medaka, but no study on its jaw bone and tooth structures has been reported. In this study, we observed the jaw and tooth structures of green spotted pufferfish with an about 3-cm body length using electron and light microscopes. In its jaws, the bilateral bones were joined through finger-like processes at the middle on both upper and lower sides. Several tooth germs in different developmental stages were vertically arranged in the jaw bone, which may have a rod-like morphology in the mesio-distal direction. Soft tissue was present between the tooth germs. A protrusion containing tooth germs was present on the bilateral lingual sides in the upper and lower jaw bones, but the position of this protrusion was lower than the jaw bone apex. Based on these findings, the green spotted pufferfish may be used as an experimental animal useful for studies on tooth morphogenesis.	[Hirayama, Yuzo; Watanabe, Tae; Fujiseki, Motoya; Yamazaki, Takaki; Yamamoto, Hitoshi] Tokyo Dent Coll, Dept Histol & Dev Biol, Tokyo 1010061, Japan; [Yokoyama, Megumi] Nihon Univ, Sch Dent Matsudo, Dept Physiol, Matsudo, Chiba, Japan; [Sohn, Wern-Joo] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu, South Korea; [Kim, Jae-Young] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Daegu, South Korea	Yamamoto, H (reprint author), Tokyo Dent Coll, Dept Histol & Dev Biol, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	hyamamoto@tdc.ac.jp					Patton EE, 2010, J INVEST DERMATOL, V130, P14, DOI 10.1038/jid.2009.293; Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; HEROLD RCB, 1975, ARCH ORAL BIOL, V20, P635, DOI 10.1016/0003-9969(75)90130-2; Davit-Beal T, 2006, J MORPHOL, V267, P1048, DOI 10.1002/jmor.10455; Domon T, 2004, ANAT EMBRYOL, V209, P119, DOI 10.1007/s00429-004-0437-7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Johanson Z, 2003, J MORPHOL, V257, P289, DOI 10.1002/jmor.10124; Smith MM, 1998, EUR J ORAL SCI, V106, P482; KEMP NE, 1974, ARCH ORAL BIOL, V19, P633, DOI 10.1016/0003-9969(74)90131-9; MOSS ML, 1964, SCIENCE, V145, P940, DOI 10.1126/science.145.3635.940; Singh BN, 2015, GENES-BASEL, V6, P417, DOI 10.3390/genes6020417; Fraser GJ, 2012, P NATL ACAD SCI USA, V109, P8179, DOI 10.1073/pnas.1119635109; Atukorala ADS, 2010, ARCH HISTOL CYTOL, V73, P139; Sasagawa I, 2012, CELL TISSUE RES, V347, P369, DOI 10.1007/s00441-011-1305-4; Enax J, 2014, ACTA BIOMATER, V10, P3959, DOI 10.1016/j.actbio.2014.04.028; KEREBEL LM, 1980, CELL TISSUE RES, V206, P211; Abduweli D, 2014, MICROSCOPY-JPN, V63, P141, DOI 10.1093/jmicro/dft085; Vaccari E, 2010, DEV BIOL, V343, P94, DOI 10.1016/j.ydbio.2010.04.016; MOLVEN A, 1990, DEVELOPMENT, V109, P279; Hertwig O., 1874, JENA Z NATURW, V8, P33; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Qu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071890; Shaya L, 2014, COMP BIOCHEM PHYS C, V166, P115, DOI 10.1016/j.cbpc.2014.06.008	24	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					325	329				5	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700004		
J	Yoshizawa, Y; Ochiai-Shino, H; Tsukinowa, T; Onodera, S; Muramatsu, T; Furusawa, M; Azuma, T				Yoshizawa, Yuusei; Ochiai-Shino, Hiromi; Tsukinowa, Takashi; Onodera, Shoko; Muramatsu, Takashi; Furusawa, Masahiro; Azuma, Toshifumi			The Comparison between Single vs Repeated Administration of Wnt3A of HPDL Cells	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Transforming Growth Factors; Periodontal Ligament; Osteogenesis; Wnt Proteins	HUMAN PERIODONTAL-LIGAMENT; OSTEOBLAST DIFFERENTIATION; BETA-CATENIN; BONE MASS; DISEASE; RUNX2; EXPRESSION; OSTEOGENESIS; PROTEINS; PATHWAY	Developmental studies indicate the Wnt/beta-catenin pathway biphasically regulates tissue differentiation. Bone morphogenetic protein (BMP) and Wnt signaling reported function in osteoblast differentiation, but few studies have investigated these complex mechanisms. We hypothesized that Wnt/beta-catenin signaling acts, either promoting or inhibiting osteogenesis of human periodontal ligament (HPDL) cells depending on times of treatment of Wnt3A. HPDL cells were treated with single or repeated administration (12- or 24-h intervals) of 10 ng/ml of Wnt3A and cultured for 3 days. Single Wnt3A administration increased alkaline phosphatase (ALP) activity. Conversely, repeated Wnt3A administration significantly decreased the expression of osteoblast marker genes. Single Wnt3A administration resulted in Smad1/5 and Akt phosphorylation; however, repeated Wnt3A administration inhibited it. BMP2/7 or IGF-1 treatment was sufficient to reverse the inhibitory effects of repeated Wnt3A treatment. Single administration of a glycogen synthase kinase 3 inhibitors, CHIR99021, increased ALP expression, but repeated CHIR99021 administration significantly decreased ALP expression and ALP activity compared with single administration. These findings suggest that repeated activation of Wnt signaling inhibits osteoblast differentiation by suppressing the BMP2/7 Smad1/5 and phosphatidylinositide 3-kinase (PI3K) /Akt pathways in HPDL cells. This indicated that crosstalk between the Wnt, Smad1/5, and PI3K/Akt pathways is important for osteoblastic differentiation of HPDL cells.	[Yoshizawa, Yuusei; Tsukinowa, Takashi; Muramatsu, Takashi; Furusawa, Masahiro] Tokyo Dent Coll, Dept Endodont & Clin Cariol, Tokyo 1010061, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo 1010061, Japan	Azuma, T (reprint author), Tokyo Dent Coll, Dept Biochem, Chiyoda Ku, 2-9-18 Misaki Cho, Tokyo 1010061, Japan.	tazuma@tdc.ac.jp			JSPS KAKENHI [25462900, 25861761, 26861686, 26861560]	This work was supported by JSPS KAKENHI (C) Grant Number 25462900, and by JSPS KAKENHI for young scientist (B) Grant Numbers 25861761, 26861686 and 26861560. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Li XD, 2009, J BONE MINER RES, V24, P578, DOI [10.1359/jbmr.081206, 10.1359/JBMR.081206]; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Rosen CJ, 2004, BONE, V35, P1046, DOI 10.1016/j.bone.2004.07.008; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502165200; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Tomokiyo A, 2008, DIFFERENTIATION, V76, P337, DOI 10.1111/j.1432-0436.2007.00233.x; Ikeya M, 2001, MECH DEVELOP, V103, P27, DOI 10.1016/S0925-4773(01)00338-0; Ling L, 2010, J BIOL CHEM, V285, P26233, DOI 10.1074/jbc.M110.122069; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Ochiai H, 2010, J HARD TISSUE BIOL, V19, P187, DOI 10.2485/jhtb.19.187; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234	35	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					331	340				10	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700005		
J	Hirota, M; Shimpo, H; Ohkubo, C; Umegaki, T; Toyama, T; Hayakawa, T				Hirota, Masatsugu; Shimpo, Hidemasa; Ohkubo, Chikahiro; Umegaki, Tetsushi; Toyama, Takeshi; Hayakawa, Tohru			Bone Adaptation of Fibronectin-Immobilized Titanium Implants Using a Tresyl Chloride-Activated Method	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Titanium implant; Fibronectin; Tresyl chloride; Osteoblast; Bone-to-implant contact	CELL ATTACHMENT; GENE-EXPRESSION; IN-VITRO; SURFACE; ADHESION	The aim of the present study was to evaluate the bone adaptation of fibronectin-immobilized titanium implants in vivo using a tresyl chloride-activated method in implantation experiments with rabbit tibiae. Cylindrical pure titanium (3.5 mm in diameter and 7 mm in height) was treated with tresyl chloride (2,2,2-trifluoroethanesulfonyl chloride, CF3CH2SO2Cl) and then coupled with fibronectin to give fibronectin-immobilized cylindrical titanium (Fn/Ti) implants. Non-treated cylindrical titanium (Ti) implants were used as a control. Ti and Fn/Ti implants were implanted into bone defects in the tibiae of rabbits. The implants were excised 12 weeks later and non-decalcified thin sections were prepared. After staining each section with methylene blue and basic fuchsin, the implant-bone interface was histologically evaluated and the bone-to-implant contact ratio (BIC) and bone mass (BM) were histomorphometrically calculated using an image analysis system. A larger amount of new bone formation was recognized for Fn/Ti implants and histomorphometrical evaluations showed that BIC and BM were significantly higher for Fn/Ti implants than for Ti implants. Fn/Ti implants also showed better bone adaptation. These results demonstrated that the immobilization of fibronectin onto cylindrical titanium implants effectively enhanced bone regeneration around implants.	[Hirota, Masatsugu; Hayakawa, Tohru] Tsurumi Univ, Sch Dent Med, Dept Dent Engn, Yokohama, Kanagawa, Japan; [Shimpo, Hidemasa; Ohkubo, Chikahiro] Tsurumi Univ, Sch Dent Med, Dept Removable Prosthodont, Yokohama, Kanagawa, Japan; [Umegaki, Tetsushi; Toyama, Takeshi] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo 101, Japan	Hirota, M (reprint author), 2-1-3 Tsurumi,Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan.	hirota-masatsugu@tsurumi-u.ac.jp			Society for Tsurumi University School of Dental Medicine [23014]; Japan Society for the Promotion of Science [15K20492]	This work was supported by a Grant-in-Aid from the Society for Tsurumi University School of Dental Medicine (Grant number. 23014), and in part by Grants-in-Aid for Scientific Research (B) (15K20492) from the Japan Society for the Promotion of Science.	Albrektsson T, 2005, INT IMPLANTS RES, V16, P657; Hirota M, 2014, J BIOMED MATER RES B, V102, P1277, DOI 10.1002/jbm.b.33112; Yamamichi N, 2008, DENT MATER J, V27, P744; Ma CF, 2012, ACTA BIOMATER, V8, P860, DOI 10.1016/j.actbio.2011.09.021; Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B; Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus; Suzuki T, 2014, DENT MATER J, V33, P233, DOI 10.4012/dmj.2014-006; El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R; Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833; Culp LA, 1998, J BIOMAT SCI-POLYM E, V9, P1161, DOI 10.1163/156856298X00703; Pugdee K, 2007, DENT MATER J, V26, P647; Hayakawa T, 2005, J BIOMED MATER RES B, V73B, P271, DOI 10.1002/jbm.b.30207; Nagai M, 2002, DENT MATER J, V21, P250; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; NILSSON K, 1987, METHOD ENZYMOL, V135, P65; Hayakawa T, 2003, J BIOMED MATER RES A, V67A, P684, DOI 10.1002/jbm.a.10143; Yoshida E, 2012, J BIOMED MATER RES A, V100A, P1556, DOI 10.1002/jbm.a.34084; Ferraris S, 2011, J MATER SCI-MATER M, V22, P1835, DOI 10.1007/s10856-011-4365-9; Amemiya T, 2014, J HARD TISSUE BIOL, V23, P137; Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721; DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x; Hayakawa T, 2004, INT J ORAL MED SCI, V3, P20; Hayakawa T, 2005, J ORAL TISSUE ENG, V2, P14; Honda Ryo, 2012, International Journal of Modern Physics: Conference Series, V6, DOI 10.1142/S2010194512003972; Schupbach P, 2005, CLIN IMPLANT DENT R, V7, pS36, DOI 10.1111/j.1708-8208.2005.tb00073.x	25	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					341	345				5	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700006		
J	Nakamura, H; Matsuno, T; Hashimoto, Y; Nakamura, T; Mataga, I				Nakamura, Hiroki; Matsuno, Tomonori; Hashimoto, Yoshiya; Nakamura, Tatsuo; Mataga, Izumi			Comparison of a Hydroxyapatite-Coated and an Anodic Oxidized Titanium Implant for Experimentally Induced Peri-Implantitis: Macroscopic and Novel Radiographic Evaluations in a Canine Model	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Peri-implantitis; Hydroxyapatite-coated; Anodic oxidized; Dental radiography; Multislice computed tomography	BEAGLE DOG; BONE LOSS; OCCLUSAL OVERLOAD; MULTICENTER; RESOLUTION; BREAKDOWN; SURFACES; SURVIVAL; DEFECTS; HEALTHY	This study aimed to compare the response of pen-implant tissue surrounding hydroxyapatite-coated titanium (HA) implants and anodic oxidized titanium (MO) implants, as well as associated ligature-induced peri-implantitis. The third and fourth premolars (P3, P4) of the mandible were extracted in five beagle dogs. After 2 months, 10 dental implants with different surfaces (HA/AnO) were inserted into the mandible in five beagle dogs. A plaque control program was maintained until the second-stage surgery. Three months after implantation, a healing-cap connection was performed, and silk ligatures were placed in the submarginal position around the neck of the implants to induce peri-implantitis. Macroscopic evaluations including modified plaque index (mPI), modified gingival index (mGI), and probing depth (PD), and radiographic evaluations including dental radiography and multislice computed tomography (MSCT) were conducted for 24 weeks following ligature placement. Bone loss around the implant was evaluated according to the radiolucent area on dental radiographic images and the hyperpermeability area on MSCT images. All macroscopic parameters except PD exhibited a consistent increase for all implants. Over the course of the study, bone loss associated with the HA implant was greater than losses with the AnO implant. Following evaluation of dental radiographs at 20 and 24 weeks after ligature placement, a significant difference was detected between the HA and AnO implants (P < 0.05). The results suggested that the resistance of the HA implant to peri-implantitis was inferior to that of the AnO implant.	[Nakamura, Hiroki; Matsuno, Tomonori; Mataga, Izumi] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral & Maxillofacial Surg, Tokyo 1028159, Japan; [Hashimoto, Yoshiya] Osaka Dent Univ, Dept Biomat, Osaka, Japan; [Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan	Nakamura, H (reprint author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral & Maxillofacial Surg, Chiyoda Ku, 1-9-20 Fujimi, Tokyo 1028159, Japan.	tombow0114@gmail.com					Renvert S, 2011, J CLIN PERIODONTOL, V38, P214, DOI 10.1111/j.1600-051X.2010.01661.x; Naert I, 2012, CLIN ORAL IMPLAN RES, V23, P95, DOI 10.1111/j.1600-0501.2012.02550.x; Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P161, DOI 10.1111/j.1600-0501.2006.01320.x; Chambrone L, 2010, J PERIODONTOL, V81, P1367, DOI 10.1902/jop.2010.100176; de Waal YCM, 2013, J CLIN PERIODONTOL, V40, P266, DOI 10.1111/jcpe.12013; Schou S, 2002, CLIN ORAL IMPLAN RES, V13, P113, DOI 10.1034/j.1600-0501.2002.130201.x; Abrahamsson I, 2006, CLIN ORAL IMPLAN RES, V17, P601, DOI 10.1111/j.1600-0501.2006.01235.x; Serino G, 2013, CLIN ORAL IMPLAN RES, V24, P91, DOI 10.1111/j.1600-0501.2012.02470.x; Zechner W, 2004, CLIN ORAL IMPLAN RES, V15, P23, DOI 10.1111/j.1600-0501.2004.00984.x; Wennstrom JL, 2004, J CLIN PERIODONTOL, V31, P713, DOI 10.1111/j.1600-051X.2004.00568.x; Zetterqvist L, 2010, J PERIODONTOL, V81, P493, DOI 10.1902/jop.2009.090492; Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Hultin M, 2002, CLIN ORAL IMPLAN RES, V13, P349, DOI 10.1034/j.1600-0501.2002.130402.x; Naitoh M, 2004, CLIN ORAL IMPLAN RES, V15, P570, DOI 10.1111/j.1600-0501.2004.01034.x; Schliephake H, 2003, CLIN ORAL IMPLAN RES, V14, P193, DOI 10.1034/j.1600-0501.2003.140209.x; Fransson C, 2008, CLIN ORAL IMPLAN RES, V19, P142, DOI 10.1111/j.1600-0501.2007.01448.x; Tillmanns HWS, 1998, INT J ORAL MAX IMPL, V13, P59; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x; Rosenberg ES, 2004, INT J ORAL MAX IMPL, V19, P873; Persson LG, 1999, CLIN ORAL IMPLAN RES, V10, P195, DOI 10.1034/j.1600-0501.1999.100302.x; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Shibli JA, 2003, INT J ORAL MAX IMPL, V18, P383; MARINELLO CP, 1995, J CLIN PERIODONTOL, V22, P475, DOI 10.1111/j.1600-051X.1995.tb00180.x; Martins MC, 2005, J PERIODONTOL, V76, P1367, DOI 10.1902/jop.2005.76.8.1367; Astrand Per, 2004, Clin Implant Dent Relat Res, V6, P130, DOI 10.1111/j.1708-8208.2004.tb00213.x; Dalal T, 2005, RADIOLOGY, V236, P671, DOI 10.1148/radiol.2362041565; Martins MC, 2004, INT J ORAL MAX IMPL, V19, P839; McGlumphy EA, 2003, INT J ORAL MAX IMPL, V18, P82; Misch C E, 1990, Int J Oral Implantol, V6, P23; Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x; Naitoh Munetaka, 2005, J Oral Implantol, V31, P234, DOI 10.1563/1548-1336(2005)31[234:AOTXIR]2.0.CO;2; Schwartz-Arad D, 2005, INT J ORAL MAX IMPL, V20, P238; Snauwaert K, 2000, Clin Oral Investig, V4, P13, DOI 10.1007/s007840050107; Tillmanns H, 1996, INT J ORAL MAXILLOF, V12, P611	35	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					347	355				9	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700007		
J	Nakamura, T; Sakagami, R; Ozaki, M; Taniguchi, K				Nakamura, Tetsuya; Sakagami, Ryuji; Ozaki, Masao; Taniguchi, Kunihisa			The Effect of Insulin Administration and Antibacterial Irrigation with Chlorhexidine Gluconate on the Disturbance of Periodontal Tissue Caused by Food Impaction in Streptozotocin-Induced Diabetic Rats	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Streptozotocin-induced diabetic rat; Gingival col; Mechanical compression; CPeriodontal tissue; Insulin administration; Chlorhexidine gluconate	ALVEOLAR BONE LOSS; DIABETOGENIC ACTION; GLYCEMIC CONTROL; MELLITUS; DISEASE; NIDDM	This histopathological study used streptozotocin (STZ)-induced diabetic rats to investigate insulin administration in conjunction with an antibacterial irrigation of chlorhexidine gluconate solution and its effect on the disturbance of periodontal tissue and destruction of alveolar bone induced by mechanical compression at the col due to food impaction. The experimental animals were divided into normal rats (Group N) and STZ-induced diabetes mellitus (DM) rats. Mechanical compression was done by insertion of a gutta-percha point (GP). The diabetic rats were further divided into Group (DM+Ins), in which insulin was administered, and into Group (DM+Chlo), in which 0.2% chlorhexidine gluconate solution was used for bactericidal irrigation. Histological comparisons of the destructive process and reparative changes of the periodontal tissue were performed at 1, 3, 7 and 14 days after the col compression. The antibacterial irrigation effects caused by chlorhexidine gluconate solution were considered to be low during the early stages. However, since there was no sequestrum formation at the alveolar crest at 7 days after the col compression, reparative changes of periodontal tissue were able to progress. These results suggest that there was a constant antibacterial effect after the chlorhexidine gluconate solution irrigation. Even so, the use of only chlorhexidine gluconate solution in cases with very destructive changes or in cases with persistent mechanical compression, made it difficult to perform a successful treatment of the disturbance of the periodontal tissue. Results for Group (DM+Ins) were better than those for Group (DM+Chlo) with regard to the inhibition of bacterial contaminant at the food impaction area, alleviation, and improvement of the healing process after disturbance in the periodontal tissue. The persistent use of 0.2 % chlorhexidine gluconate solution did appear to lead to a constant effect on the bacteria. Therefore, when treating a disturbance of the periodontal tissue due to food impaction in the diabetic state, the first step should include the administration of insulin in order to improve the diabetic state.	[Nakamura, Tetsuya; Ozaki, Masao] Fukuoka Dent Coll, Dept Growth & Dev, Div Pediat Dent, Fukuoka, Japan; [Sakagami, Ryuji] Fukuoka Dent Coll, Dept Odontol, Div Periodontol, Fukuoka, Japan; [Taniguchi, Kunihisa] Fukuoka Dent Coll, Fukuoka, Japan	Ozaki, M (reprint author), Dept Oral Growth & Dev, Div Pediat Dent, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	mozaki@college.fdcnet.ac.jp					ABIKO Y, 1989, Shikwa Gakuho, V89, P1819; Al-Shammari Khalaf F, 2006, J Int Acad Periodontol, V8, P109; LASSILA V, 1989, SCAND J DENT RES, V97, P216; NELSON RG, 1990, DIABETES CARE, V13, P836, DOI 10.2337/diacare.13.8.836; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; CERDA J, 1994, J PERIODONTOL, V65, P991; JUNOD A, 1967, P SOC EXP BIOL MED, V126, P201; PRAKASH A, 1973, INDIAN J MED RES, V61, P1200; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Taylor GW, 1998, J PERIODONTOL, V69, P76; SEPPALA B, 1993, J CLIN PERIODONTOL, V20, P161, DOI 10.1111/j.1600-051X.1993.tb00338.x; KOBAYASHI H, 1989, INFECT CONT HOSP EP, V10, P562; ABBEY LM, 1972, ORAL SURG ORAL MED O, V33, P672, DOI 10.1016/0030-4220(72)90379-9; Tervonen T, 1997, J CLIN PERIODONTOL, V24, P505, DOI 10.1111/j.1600-051X.1997.tb00219.x; GROSSMAN E, 1986, J PERIODONTAL RES, V21, P33, DOI 10.1111/j.1600-0765.1986.tb01513.x; Tervonen T, 2000, J CLIN PERIODONTOL, V27, P567, DOI 10.1034/j.1600-051x.2000.027008567.x; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; PRAKASH A, 1974, INT SURG, V59, P25; de Molon RS, 2013, CLIN ORAL IMPLAN RES, V24, P831, DOI 10.1111/j.1600-0501.2012.02467.x; ROSEN RG, 1961, SURGERY, V50, P525; Mishima N, 2002, ARCH ORAL BIOL, V47, P843, DOI 10.1016/S0003-9969(02)00152-8; GOODSON WH, 1977, J SURG RES, V22, P221, DOI 10.1016/0022-4804(77)90137-8; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Block SS, 2001, DISINFECTION STERILI; BONESVOL.P, 1974, ARCH ORAL BIOL, V19, P209, DOI 10.1016/0003-9969(74)90263-5; CARRANZA F A JR, 1971, Journal of Periodontal Research, V6, P65, DOI 10.1111/j.1600-0765.1971.tb00589.x; Fermin A, 1984, GLICKMANS CLIN PERIO; Firatli E, 1997, J PERIODONTOL, V68, P136; Fujimoto Y., 1988, J JPN SOC PERIODONTO, V30, P802; Giglio M J, 2000, Implant Dent, V9, P143, DOI 10.1097/00008505-200009020-00006; Herai T, 1980, J JPN SOC PERIODONTO, V22, P476; Hobo R., 1984, J JPN SOC PERIODONTO, V26, P201; Inoue M, 1982, J JPN PROTHODONT SOC, V26, P849; Irokawa T., 1981, J JPN SOC PERIODONTO, V23, P233; Irokawa T, 1977, J JPN SOC PERIODONTO, V19, P333; Kaneko H, 1990, Showa Shigakkai Zasshi, V10, P216; Kato K, 1996, J JPN SOC PERIODONTO, V38, P400; Kato K, 1996, J JPN SOC PERIODONTO, V38, P415; Kinoshita S, 1985, COLOR ATLAS PERIODON, P105; Kobayashi T, 1990, JPN J ORAL BIOL, V32, P600; LOE H, 1970, Journal of Periodontal Research, V5, P79, DOI 10.1111/j.1600-0765.1970.tb00696.x; Matsuura T, 1988, KYUSHU SHIKA GAKKAI, V42, P733; Meenawat Ajita, 2013, J Indian Soc Periodontol, V17, P597, DOI 10.4103/0972-124X.119286; Miyajima F., 1979, J OSAKA ODONT SOC, V42, P589; Morooka M, 1998, J FUKUOKA DENT COLL, V25, P283; Murai S., 2001, J JPN SOC PERIODONTO, V43, P197; Nishikata S, 1989, J STOMATOL SOC, V38, P550; Nishimura F, 2000, J Int Acad Periodontol, V2, P49; Oda M, 1993, JPN J ORAL BIOL, V35, P157; Osaki H, 1992, J FUKUOKA DENT COLL, V19, P147; Ramfjord SP, 1979, PERIODONTOLOGY PERIO; RERUP C C, 1970, Pharmacological Reviews, V22, P485; ROLLA G, 1975, J DENT RES, V54, pB57, DOI 10.1177/00220345750540022601; Sasaki S, 1988, J ASS PERIODONT, V30, P399; Sasaki S, 1988, J JPN SOC PERIODONTO, V30, P414; Sawakuma B, 2004, J FUKUOKA DENT COLL, V31, P71; SEGRETO VA, 1986, J PERIODONTAL RES, V21, P23, DOI 10.1111/j.1600-0765.1986.tb01512.x; Van Strydonck Daniëlle A C, 2012, J Clin Periodontol, V39, P1042, DOI 10.1111/j.1600-051X.2012.01883.x; Stahl SS, 1960, ORAL SURG ORAL MED O, V13, P616; Tanaka K., 1988, J JPN ASS PERIODONT, V30, P383; Taylor G W, 1998, Ann Periodontol, V3, P30, DOI 10.1902/annals.1998.3.1.30; Tokunaga T, 2014, J HARD TISSUE BIOL, V23, P189; Wada H, 1980, J JPN SOC PERIODONTO, V22, P319; Yamada S, 1978, J JPN SOC PERIODONTO, V20, P234; Yokota M, 1975, J JPN SOC PERIODONTO, V17, P12	65	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					357	373				17	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700008		
J	Takahashi, M; Yamaguchi, M; Tanimoto, Y; Yao-Umezawa, E; Kasai, K				Takahashi, Momoko; Yamaguchi, Masaru; Tanimoto, Yasuhiro; Yao-Umezawa, Eriko; Kasai, Kazutaka			Biological Evaluation of a Prototype Material made of Polyglycolic Acid and Hydroxyapatite	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						PGA; Hydroxyapatite; Osteoblast; Alkaline phosphatase; Collagen type I; Osteocalcin; Anchor screw	ORTHODONTIC ANCHORAGE; MINI-IMPLANTS; MANDIBULAR FRACTURES; ALKALINE-PHOSPHATASE; PLACEMENT; COLLAGEN; SCREWS; HYDROXYLAPATITE; EXPRESSION; FIXATION	Orthodontic anchor screws, which made from titanium are widely used as anchorage units in orthodontic treatment. However, there are some problems, including dropout during treatment and the invasive nature of screw removal. An orthodontic anchor screw, in which the main component is a bioabsorbable material is therefore sought. We investigated the biological evaluation of a prototype material composed of polyglycolic acid (PGA) and hydroxyapatite (HAp). Five types of PGA/HAp composites were examined. The HAp compound ratios by weight were 0, 5, 10,30 and 50 %. We examined the effects of the PGA/HAp components on the gene and protein expression of collagen type 1 (COL-1), alkaline phosphatase (ALP) and osteocalcin (OCN) from mouse osteoblasts (MC3T3-E1) in vitro by real-time a PCR and an ELISA. Furthermore, we evaluated the osteoinductive potential in vivo, in a rat calvarial defect model after subjecting samples to a mu-CT image analysis. COL-1 and ALP production peaked on day 7, and increased dependent on the concentration of HAp. OCN production also increased in a dose- and time dependent manner up to day 10 in vitro. In the in vivo study, mu-CT image analyses showed that newly formed bone areas in defects for PGA/HAp disk were significantly higher at two and three months after surgery than in controls that underwent sham operations. The results suggest that the biological properties of the PGA-based trial prototype were increased with the addition of HAp. An orthodontic anchor screw constructed of PGA may be useful for orthodontists.	[Takahashi, Momoko; Yamaguchi, Masaru; Yao-Umezawa, Eriko; Kasai, Kazutaka] Nihon Univ, Sch Dent Matsudo, Dept Orthodont, Matsudo, Chiba 2718587, Japan; [Tanimoto, Yasuhiro] Nihon Univ, Sch Dent Matsudo, Dent Biomat, Matsudo, Chiba 2718587, Japan	Yamaguchi, M (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Orthodont, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	yamaguchi.masaru@nihon-u.ac.jp			Japan Society for the Promotion of Science [25463200]; Nihon University Multidisciplinary Research Grant [13-020, 14-018]	This research was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C) (25463200) and Nihon University Multidisciplinary Research Grant for (13-020, 14-018).	Cheng SJ, 2004, INT J ORAL MAX IMPL, V19, P100; Shinozaki Y, 2013, J HARD TISSUE BIOL, V22, P401; Kim TW, 2006, AM J ORTHOD DENTOFAC, V130, P676, DOI 10.1016/j.ajodo.2005.07.013; GETTER L, 1972, J ORAL SURG, V30, P344; Cho UH, 2010, ANGLE ORTHOD, V80, P130, DOI 10.2319/011509-535.1; Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247; WEINREB M, 1990, J BONE MINER RES, V5, P831; GARCIA R, 1992, J MATER SCI-MATER M, V3, P154, DOI 10.1007/BF00705285; Kim SH, 2010, AM J ORTHOD DENTOFAC, V138, P264, DOI 10.1016/j.ajodo.2008.07.026; BEERTSEN W, 1991, J DENT RES, V70, P176, DOI 10.1177/00220345910700030401; Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3; Aoki T, 2005, DENT MATER J, V24, P628; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1; BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666; Herman RJ, 2006, AM J ORTHOD DENTOFAC, V130, P228, DOI 10.1016/j.ajodo.2006.02.029; Tseng YC, 2006, INT J ORAL MAX SURG, V35, P704, DOI 10.1016/j.ijom.2006.02.018; Bord S, 2005, BONE, V36, P812, DOI 10.1016/j.bone.2004.12.006; Hench LL, 1998, AM CERAM SOC BULL, V77, P67; BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9; Freudenthaler JW, 2001, CLIN ORAL IMPLAN RES, V12, P358, DOI 10.1034/j.1600-0501.2001.012004358.x; Kadioglu O, 2008, AM J ORTHOD DENTOFAC, V134, P353, DOI 10.1016/j.ajodo.2006.09.069; CHEGINI N, 1988, J BIOMED MATER RES, V22, P71, DOI 10.1002/jbm.820220108; Bae Seong-Min, 2002, J Clin Orthod, V36, P298; Bergsmaju E, 1995, BIOMATERIALS, V16, P25; Bosh C, 1998, J CRANIOFAC SURG, V9, P310; Buschang Peter H, 2008, J Clin Orthod, V42, P513; Costa A, 1998, Int J Adult Orthodon Orthognath Surg, V13, P201; Eppley B L, 1996, J Craniomaxillofac Trauma, V2, P56; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Golub E. E, 2007, CURR OPIN ORTHOP, V18, P444, DOI DOI 10.1097/BCO.0B013E3282630851; HARADA Y, 1989, Shikwa Gakuho, V89, P263; Kanomi R, 1997, J Clin Orthod, V31, P763; Kravitz ND, 2007, AM J ORTHOD DENTOFAC, V131, P43; Markic Goran, 2014, Prog Orthod, V15, P29, DOI 10.1186/s40510-014-0029-x; Massora MR, 2008, J PERIODONTAL RES, V43, P723; Park Hyo-Sang, 2002, J Clin Orthod, V36, P592; Park J, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.015; Patti A, 2013, INT J ENDOCRINOL, DOI 10.1155/2013/846480	39	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					375	383				9	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700009		
J	Kitagawa, Y; Ueno, T; Ito, Y; Takahashi, Y; Kimura, Y; Nakajima, Y; Kasuya, S; Kanou, M; Fukui, N; Moy, PK; Yamamoto, K; Suwa, Y; Tano, T; Sunano, A; Hashiguchi, N; Terai, H				Kitagawa, Yusuke; Ueno, Takaaki; Ito, Yuichi; Takahashi, Yasuko; Kimura, Yoshihiro; Nakajima, Yoichiro; Kasuya, Shin; Kanou, Miwa; Fukui, Nozomu; Moy, Peter K.; Yamamoto, Kayoko; Suwa, Yoshifumi; Tano, Tomoyuki; Sunano, Akihiro; Hashiguchi, Norihiro; Terai, Haruhiko			Preliminary Study of the Efficacy of Conservative Treatment Using a Bite Plate for Condylar Neck Fracture of the Mandible	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Bite plate; Condylar neck fracture; Conservative therapy	FIXATION	Fracture of the mandibular condyle accounts for 20-30 % of mandibular fracture cases overall. We will hereby report on four cases of fracture of the mandibular condyle for which good outcomes were achieved by means of fixation and aggressive mouth-opening exercises using a bite plate as a type of conservative treatment. Patients between the ages of 6 and 53 years with the mean age of 37.25 years were investigated. The male to female ratio was 3:1. Of the four patients with fracture of the mandibular condyle, three exhibited midline fracture of the mandible. Bite plates were fabricated and intermaxillary fixation was conducted for 1-3 weeks with these bite plates for patients who presented at hospital from 1-10 days after injury and were refused surgery. After completion of intermaxillary fixation, aggressive mouth-opening exercises were implemented. Once sufficient mouth opening was possible, the healing progress was confirmed on computed tomography (CT) images. Treatment methods for fracture of the mandibular condyle include invasive and non-invasive ones. Favorable treatment outcomes were achieved with intermaxillary fixation using a bite plate and mouth-opening exercises in this study. Therefore, we conducted a preliminary study on the efficacy of this treatment and will hereby report on the results.	[Kitagawa, Yusuke; Ueno, Takaaki; Ito, Yuichi; Takahashi, Yasuko; Kimura, Yoshihiro; Nakajima, Yoichiro; Kasuya, Shin; Kanou, Miwa; Fukui, Nozomu; Moy, Peter K.; Yamamoto, Kayoko; Suwa, Yoshifumi; Tano, Tomoyuki; Sunano, Akihiro; Hashiguchi, Norihiro; Terai, Haruhiko] Osaka Med Coll, Div Med Funct & Morphol Sensor Organ Dent & Oral, Osaka, Japan; [Fukui, Nozomu; Moy, Peter K.] Univ Calif Los Angeles, Surg Implant Dent, Los Angeles, CA USA	Kitagawa, Y (reprint author), Osaka Med Collage, Div Med Funct & Morphol Sensor Organ Dent & Oral, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ora066@poh.osaka-med.ac.jp					Schiel S, 2013, J ORAL MAXIL SURG, V71, P1220, DOI 10.1016/j.joms.2013.03.023; HAYWARD JR, 1993, J ORAL MAXIL SURG, V51, P57; Rinna C, 2007, ANN PLAS SURG, V58, P57, DOI 10.1097/01.sap.0000250753.17709.5b; SLEEPER EL, 1952, ORAL SURG ORAL MED O, V5, P4, DOI 10.1016/0030-4220(52)90067-4; Ohba S, 2013, J HARD TISSUE BIOL, V22, P147; MACLENNAN WD, 1952, BRIT J PLAST SURG, V5, P122; Arita K, 2005, J HARD TISSUE BIOL, V14, P51, DOI 10.2485/jhtb.14.51; Blevins C, 1961, J ORAL SURG, V19, P392; Kommers SC, 2013, J CRANIOMAXILLOFAC S, V41, P221; Kubo S, 1983, JPN J ORAL MAXOLLOFA, V29, P1794; Morinaga H, 1990, JPN J ORAL MAXILLOFA, V36, P2055; Nukata J, 1993, JPN J ORAL MAXILLOFA, V39, P1069; Sasaki I, 1991, JPN J ORAL MAXILLOFA, V37, P447; THOMA K H, 1955, Oral Surg Oral Med Oral Pathol, V8, P774, DOI 10.1016/0030-4220(55)90042-6; Thoma KH, 1954, J ORAL SURG, V12	15	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					385	389				5	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700010		
J	Kim, YK; Um, IW; Cho, WJ; Murata, M; Jun, SH; Lee, JK				Kim, Young-Kyun; Um, In-Woong; Cho, Woo-Jin; Murata, Masaru; Jun, Sang-Ho; Lee, Jeong-Keun			Applications of Moldable Autogenous Tooth Bone Graft (M-AutoBT) Mixed with Hydroxypropylmethyl Cellulose for Sinus Lifting	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Bone; Dentin; Graft Material; Moldable AutoBT (M-AutoBT); hydroxypropylmethyl cellulose (HPMC); Demineralized dentin matrix (DDM)	DEMINERALIZED DENTIN MATRIX; REGENERATION; INDUCTION; CARRIER; TEETH	The purpose of this study is to evaluate an ability of a moldable autogenous tooth bone graft material (M-AutoBT), which is made of demineralized dentin matrix (DDM) and hydroxypropylmethyl cellulose (HPMC) to repair sinus-related defects in the implant dentistry. Sinus-related alveolar defects were classified into three types depending on the remnant of socket wall as follows; Class I: Only alveolar bone repair is required even if sinus cavity is involved (remained socket wall >5mm). Class II: Both alveolar bone and sinus repair are required (3mm < remained socket wall < 5mm). Class III: Only sinus repair is required without any alveolar bone (remained socket wall < 3mm). Sinus cavity should always be involved during the implant placement regardless of defect types. The histological examination of three case reports, which represented class I, II and III defect respectively, showed osteoconductive and osteoinductive functions of M-AutoBT that is similar to the effect of the conventional AutoBT. Therefore, HPMC might be the suitable base material for AutoBT.	[Kim, Young-Kyun] Seoul Natl Univ, Bundang Hosp, Sect Dent, Dept Oral & Maxillofacial Surg, Songnam, South Korea; [Um, In-Woong; Cho, Woo-Jin] Korea Tooth Bank, R&D Inst, Seoul, South Korea; [Murata, Masaru] Hlth Sci Univ Hokkaido, Sch Dent, Div Oral & Maxillofacial Surg, Sapporo, Hokkaido, Japan; [Jun, Sang-Ho] Korea Univ, Anam Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Seoul, South Korea; [Lee, Jeong-Keun] Ajou Univ, Med Ctr, Dept Oral & Maxillofacial Surg, Suwon 441749, South Korea	Um, IW (reprint author), Korea Tooth Bank, R&D Inst, 3F,229-4 Pyeongchang Dong, Seoul, South Korea.	h-bmp@daum.net					Murata M, 2012, J BIOMED MATER RES A, V100A, P571, DOI 10.1002/jbm.a.33236; HUGGINS CB, 1970, SCIENCE, V167, P896, DOI 10.1126/science.167.3919.896; Yagihashi K, 2009, CALCIFIED TISSUE INT, V84, P210, DOI 10.1007/s00223-008-9205-7; YEOMANS JD, 1967, ARCH ORAL BIOL, V12, P999, DOI 10.1016/0003-9969(67)90095-7; Kim YK, 2014, OR SURG OR MED OR PA, V117, pE39, DOI 10.1016/j.oooo.2012.04.018; Kim YK, 2010, ORAL SURG ORAL MED O, V109, P496, DOI 10.1016/j.tripleo.2009.10.017; Miyata Y, 2011, INT J ORAL MAX IMPL, V26, P1210; Cavalho VA, 2004, INT J ORAL MAXILLIOF, V19, P679; Gomes MF, 2001, INT J ORAL MAX IMPL, V16, P563; Jun SH, 2014, J ADV PROSTHODONT, V6, P528, DOI 10.4047/jap.2014.6.6.528; Kim YK, 2013, J KOREAN ASS MAXILLO, V35, P310; Kim YK, 2014, J PERIODONTAL IMPLAN, V44, P216, DOI 10.5051/jpis.2014.44.5.216; Kim YK, 2014, J HARD TISSUE BIOL, V23, P415; Kim YK, 2011, J KOREAN ASS MAXILLO, V33, P264; Kim YK, 2013, ADV BIOMATERIALS SCI, P405; Ku JK, 2015, J KOREAN ASS ORAL MA, V41, P357; Lee Du Han, 2013, [Journal of the Korean Association of Oral and Maxillofacial Surgeons, 대한구강악안면외과학회지], V39, P120; Lee EG, 2013, DENTISTRY, V3, P174; Lee JY, 2013, J KOREA DENT ASS, V51, P459; Murata M, 2005, J HARD TISSUE BIOL, V14, P80, DOI 10.2485/jhtb.14.80; Pierre W, 2005, KEY ENG MATER, V284-286, P1053	21	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					391	396				6	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700011		
J	Matsuda, S; Yokoi, Y; Moriyama, K; Shoumura, M; Osuga, N; Nakano, K; Kawakami, T				Matsuda, Saeka; Yokoi, Yukiko; Moriyama, Keita; Shoumura, Masahito; Osuga, Naoto; Nakano, Keisuke; Kawakami, Toshiyuki			Pathological Examination of Experimentally Induced Periodontal Polyp in Mice	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Periodontal polyp; Micro-CT; Histopathology; Experimental model	LIGAMENT; TISSUES; BONE	The mechanism in the formation of periodontal polyp has been established in several histological studies but details on cell differentiation and/or proliferation have not been elucidated. In the present study, we established a convenient and possible experimental system using ddY mice. Briefly, pentobarbital sodium (Somnopentyl) was injected into the abdominal cavity of the mouse followed by access cavity preparation on maxillary first molar using low speed 1/2 round bur (Merufa Inc), exposing the pulp and then allowed to perforate the floor of the pulp chamber. Observation was done over time until 6 months using micro CT (m_CT) image photography. Results with transmission image using m_CT showed the expansion in the width of the periodontal ligament in the furcation area. The lesion was excised as one mass and examined histopathologically. The granulation tissue was covered with stratified squamous epithelium. The present experimental technique has been confirmed to be effective in analyzing the formation of periodontal polyp induced by mechanical perforation.	[Matsuda, Saeka; Kawakami, Toshiyuki] Matsumoto Dent Univ, Grad Sch Oral Med, Hard Tissue Pathol Unit, Shiojiri 3990781, Japan; [Matsuda, Saeka; Yokoi, Yukiko; Moriyama, Keita; Shoumura, Masahito; Osuga, Naoto] Matsumoto Dent Univ, Sch Dent, Dept Pediat Dent, Shiojiri 3990781, Japan; [Shoumura, Masahito; Osuga, Naoto] Matsumoto Dent Univ, Grad Sch Oral Med, Oral Hlth Anal Unit, Shiojiri 3990781, Japan; [Nakano, Keisuke] Okayama Univ, Grad Sch Med Dent & Phamaceut Sci, Dept Oral Pathol & Med, Okayama, Japan	Kawakami, T (reprint author), Matsumoto Dent Univ, Grad Sch Oral Med, Hard Tissue Pathol Unit, 1780 Hirooka Gobara, Shiojiri 3990781, Japan.	kawakami@po.mdu.ac.jp			Japan Society for the Promotion of Science [25463204, 26463104, 26463031]	This study was supported in part by Grant-in-Aid for Scientific Research (C) #25463204, (C) # 26463104 and (C) #26463031 from the Japan Society for the Promotion of Science.	Kaneko K, 2015, INT J MED SCI, V12, P689, DOI 10.7150/ijms.12883; [Anonymous], 2001, PRACTICAL MODEL 3DX; Tsujigiwa H, 2011, J HARD TISSUE BIOL, V20, P147; Park JC, 2011, J CLIN PERIODONTOL, V38, P721, DOI 10.1111/j.1600-051X.2011.01716.x; Muraoka R, 2011, J HARD TISSUE BIOL, V20, P301; Osuga N, 2013, J HARD TISSUE BIOL, V22, P517; Arai Y, 2005, ORAL RADIOL, V21, P14, DOI 10.1007/s11282-005-0024-5; Imaizumi Ichiro, 1996, Aichi-Gakuin Journal of Dental Science, V34, P717; Ishida T, 1985, JPN J CONSERV DENT, V28, P1372; Kudoh J, 1989, JPN J CONSERV DENT, V32, P201; Li CH, 2014, CELLS TISSUES ORGANS, V199, P256, DOI 10.1159/000367986; Nakajima R, 2014, J DENT RES, V93, P1133, DOI 10.1177/0022034514549377; Nakamura C, 1979, J MATSUMOTO DENT U S, V5, P89; Oka Y, 1991, JPN J CONSERV DENT, V34, P1574	14	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					397	400				4	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700012		
J	Hatanaka, S; Mihara, H; Kohno, S; Fujimoto, E; Tanaka, M; Takehara, M; Yamasaki, T; Nakanishi, T				Hatanaka, Shiho; Mihara, Hiroki; Kohno, Sayuki; Fujimoto, Erika; Tanaka, Miyuki; Takehara, Motoharu; Yamasaki, Tsutomu; Nakanishi, Tohru			Establishment of Sandwich Enzyme-Linked ImmunoSorbent Assay (ELISA) System for Quantitation of CD81	JOURNAL OF HARD TISSUE BIOLOGY			English	Article						Rheumatoid arthritis; CD81; Monoclonal antibody; Sandwich enzyme-linked immunosorbent assay (ELISA)	ANTIPROLIFERATIVE ANTIBODY; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; TAPA-1; PROLIFERATION; DEGRADATION; TARGET; CELLS	CD81 belongs to a family of cell-surface proteins (tetraspanins) that have four transmembrane domains and two outer-membrane loops. CD81 has been shown to be up-regulated in rheumatoid arthritis (RA) synoviocytes and is involved in the progression of RA through the promotion of synoviolin expression. Recently, we showed that small interfering RNA targeting CD81 (CD81 siRNA) ameliorates paw swelling in collagen-induced arthritic (CIA) rats. CD81 siRNA also decreases the expression of TNF-alpha in SW982 cells. Previoitsly, we established hybridoma cell lines producing monoclonal antibodies (MAbs) against CD81, which decrease the proliferation of rat C6 glioma cells. Here, we established a sandwich enzyme-linked immunosorbent assay (ELISA) system for the quantitation of CD81 using these MAbs.	[Hatanaka, Shiho; Mihara, Hiroki; Kohno, Sayuki; Tanaka, Miyuki; Takehara, Motoharu; Yamasaki, Tsutomu] Shujitsu Univ, Sch Pharm, Okayama 7038516, Japan; [Fujimoto, Erika] Kyokuto Hosp, Okayama, Japan; [Nakanishi, Tohru] Shujitsu Univ, Grad Sch Pharm, Mol Biol & Clin Diag, Okayama 7038516, Japan	Nakanishi, T (reprint author), Shujitsu Univ, Grad Sch Pharm, 1-6-1 Nishigawara, Okayama 7038516, Japan.	torhoshi@shujitsu.ac.jp			Ministry of Education, Science, Sports, and Culture	We thank Dr. Yuji Arai for valuable suggestions. We also thank Ms. Yukiko Iwamoto for and Ms. Kumiko Itami for technical assistance. This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture to T.N.	Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Hanada T, 2013, J HARD TISSUE BIOL, V22, P195; Nakagawa S, 2009, BIOCHEM BIOPH RES CO, V388, P467, DOI 10.1016/j.bbrc.2009.06.150; Mori H, 2008, YAKUGAKU ZASSHI, V128, P263, DOI 10.1248/yakushi.128.263; Cao J, 2007, J MICROBIOL METH, V68, P601, DOI 10.1016/j.mimet.2006.11.009; OREN R, 1990, MOL CELL BIOL, V10, P4007; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Fujimoto E, 2014, J HARD TISSUE BIOL, V23, P131; TAKAHASHI S, 1990, J IMMUNOL, V145, P2207; Yamasaki S, 2005, ARTHRITIS RES THER, V7, P181, DOI 10.1186/ar1808; Ma JF, 2010, J HUAZHONG U SCI-MED, V30, P201, DOI 10.1007/s11596-010-0214-1; Nakanishi T, 2011, ARTHR RES THERAP, V14, P52	14	0	0	JOURNAL HARD TISSUE BIOLOGY	MINATO KU	NIHON GAKUKUTSU KYORYOKU ZAIDAN, 3- 24- 20, NISHIAZABU, MINATO KU, TOKYO 106-0031, JAPAN	1341-7649			J HARD TISSUE BIOL	J. Hard Tissue Biol.	OCT	2015	24	4					401	404				4	Engineering, Biomedical	Engineering	CU8ZN	WOS:000363832700013		
J	Jinam, TA; Kanzawa-Kiriyama, H; Inoue, I; Tokunaga, K; Omoto, K; Saitou, N				Jinam, Timothy A.; Kanzawa-Kiriyama, Hideaki; Inoue, Ituro; Tokunaga, Katsushi; Omoto, Keiichi; Saitou, Naruya			Unique characteristics of the Ainu population in Northern Japan	JOURNAL OF HUMAN GENETICS			English	Article							WIDE SNP DATA; GENOME; INDIVIDUALS; GENOTYPES; HISTORY; MODEL; ASSOCIATION; ARCHIPELAGO; PERSPECTIVE; INFERENCE	Various genetic data (classic markers, mitochondrial DNAs, Y chromosomes and genome-wide single-nucleotide polymorphisms (SNPs)) have confirmed the coexistence of three major human populations on the Japanese Archipelago: Ainu in Hokkaido, Ryukyuans in the Southern Islands and Mainland Japanese. We compared genome-wide SNP data of the Ainu, Ryukyuans and Mainland Japanese, and found the following results: (1) the Ainu are genetically different from Mainland Japanese living in Tohoku, the northern part of Honshu Island; (2) using Ainu as descendants of the Jomon people and continental Asians (Han Chinese, Koreans) as descendants of Yayoi people, the proportion of Jomon genetic component in Mainland Japanese was similar to 18% and similar to 28% in Ryukyuans; (3) the time since admixture for Mainland Japanese ranged from 55 to 58 generations ago, and 43 to 44 generations ago for the Ryukyuans, depending on the number of Ainu individuals with varying rates of recent admixture with Mainland Japanese; (4) estimated haplotypes of some Ainu individuals suggested relatively long-term admixture with Mainland Japanese; and (5) highly differentiated genomic regions between Ainu and Mainland Japanese included EDAR and COL7A1 gene regions, which were shown to influence macroscopic phenotypes. These results clearly demonstrate the unique status of the Ainu and Ryukyuan people within East Asia.	[Jinam, Timothy A.; Saitou, Naruya] Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka 4110831, Japan; [Jinam, Timothy A.; Kanzawa-Kiriyama, Hideaki; Inoue, Ituro; Saitou, Naruya] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan; [Jinam, Timothy A.; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 411, Japan; [Kanzawa-Kiriyama, Hideaki] Natl Museum Nat & Sci, Dept Anthropol, Tsukuba, Ibaraki, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Omoto, Keiichi] Univ Tokyo, Fac Sci, Dept Anthropol, Tokyo 113, Japan; [Saitou, Naruya] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	Saitou, N (reprint author), Natl Inst Genet, Div Populat Genet, 1111 Yata, Mishima, Shizuoka 4110831, Japan.	saitounr@nig.ac.jp			SOKENDAI Grant	We thank Japanese Archipelago Human Population Genetics Consortium and Asian DNA Repository Consortium for permission of access to SNP data. This study was supported by a SOKENDAI Grant on modern human dispersal. Finally, we appreciate people on the Japanese Archipelago (Ainu, Ryukyuan and Mainland Japanese) who kindly donated their DNA to this and past anthropological studies.	Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; [Anonymous], 1987, BIOL EVOL; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Ossenberg NS, 2006, ANTHROPOL SCI, V114, P99, DOI 10.1537/ase.00090; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bannai M, 2000, TISSUE ANTIGENS, V55, P128, DOI 10.1034/j.1399-0039.2000.550204.x; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Kumasaka N, 2010, J HUM GENET, V55, P525, DOI 10.1038/jhg.2010.63; Jinam T, 2012, J HUM GENET, V57, P787, DOI 10.1038/jhg.2012.114; Nakagome S, 2015, MOL BIOL EVOL, V32, P1533, DOI 10.1093/molbev/msv045; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Rasteiro R, 2009, J HUM GENET, V54, P349, DOI 10.1038/jhg.2009.39; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Bae JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019091; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Hanihara K, 1991, JAPAN REV, V2, P1; He YB, 2012, SCI REP, V2, P1; Imamura K., 1996, PREHISTORIC JAPAN NE; Kudo M., 2001, ANCIENT HIST EMISHI; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Nakaoka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060793; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Saitou N., 2008, MCDONALD I MONOGRAPH, P89; Sato T, 2014, MOL BIOL EVOL, V31, P2929, DOI 10.1093/molbev/msu230; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Tomiyama K., 2003, WORLD RYUKYU OKINAWA; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641	33	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					565	571		10.1038/jhg.2015.79		7	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200002		
J	Saka, S; Hirawa, N; Oka, A; Yatsu, K; Hirukawa, T; Yamamoto, R; Matsusaka, T; Imai, E; Narita, I; Endoh, M; Ichikawa, I; Umemura, S; Inoko, H				Saka, Sanae; Hirawa, Nobuhito; Oka, Akira; Yatsu, Keisuke; Hirukawa, Takeshi; Yamamoto, Ryohei; Matsusaka, Taiji; Imai, Enyu; Narita, Ichiei; Endoh, Masayuki; Ichikawa, Iekuni; Umemura, Satoshi; Inoko, Hidetoshi			Genome-wide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population	JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE-NUCLEOTIDE POLYMORPHISMS; IMMUNOGLOBULIN-A NEPHROPATHY; DISEASE; REGION; HLA; 6Q22-23; LOCI; GENE	Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis in many parts of the world. Although previous genome-wide association studies (GWAS) identified the major susceptibility loci for IgAN, the causal genes currently remain unknown. We performed a GWAS using 23 465 microsatellite (MS) markers to identify genes related to IgAN in a Japanese population. A pooled sample analysis was conducted in three-stage screenings of three independent case-control populations, and after the final step of individual typing, 11 markers survived. Of these, we focused on two regions on 6p21 and 12q21 because they (i) showed the strongest relationship with IgAN, and (ii) appeared to be highly relevant to IgAN in view of several previous studies. These regions contained the HLA, TSPAN8 and PTPRR genes. This study on GWAS, using >20 000 MS markers, provides a new approach regarding susceptible genes for IgAN for investigators seeking new tools for the prevention and treatment of IgAN.	[Saka, Sanae; Yatsu, Keisuke; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2320024, Japan; [Saka, Sanae; Hirawa, Nobuhito] Yokohama City Univ, Med Ctr, Dept Hypertens & Nephrol, Yokohama, Kanagawa 2320024, Japan; [Oka, Akira; Inoko, Hidetoshi] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Hirukawa, Takeshi; Matsusaka, Taiji; Endoh, Masayuki] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 25911, Japan; [Yamamoto, Ryohei] Osaka Univ, Grad Sch Med, Dept Nephrol, Osaka, Japan; [Imai, Enyu] Nakayamadera Imai Clin, Takarazuka, Hyogo, Japan; [Imai, Enyu] Fujita Hlth Univ, Dept Nephrol, Toyoake, Aichi, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata, Japan; [Ichikawa, Iekuni] Shinshu Univ, Dept Eth, Nagano, Japan; [Ichikawa, Iekuni] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Ichikawa, Iekuni] Vanderbilt Univ, Dept Med, Nashville, TN USA	Hirawa, N (reprint author), Yokohama City Univ, Med Ctr, Dept Hypertens & Nephrol, Minami Ku, 4-57 Urafune Cho, Yokohama, Kanagawa 2320024, Japan.	hirawa@yokohama-cu.ac.jp			Research from Yokohama City University, Japan; study group on IgA nephropathy in Japan	We are grateful to the patients and relatives for their cooperation in this study, as well as all of the control subjects who donated blood samples. We thank all members of the laboratory for technical support and discussion. We also thank all staff and doctors who contributed to blood sample collection from the subjects. Our work was supported in part by a grant for Research from Yokohama City University, Japan and a grant from the study group on IgA nephropathy in Japan.	Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Gesierich S, 2006, CANCER RES, V66, P7083, DOI 10.1158/0008-5472.CAN-06-0391; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; RAGUENES O, 1995, TISSUE ANTIGENS, V45, P246, DOI 10.1111/j.1399-0039.1995.tb02447.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Schena FP, 2002, J AM SOC NEPHROL, V13, P453; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Maxwell PH, 2006, NEPHRON EXP NEPHROL, V102, pE76, DOI 10.1159/000089685; Collins HE, 2000, HUM GENET, V106, P218, DOI 10.1007/s004390051031; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Champy MF, 2011, INT J OBESITY, V35, P605, DOI 10.1038/ijo.2010.165; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543; Takei T, 2002, AM J HUM GENET, V70, P781, DOI 10.1086/339077; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Gharavi AG, 2000, NAT GENET, V26, P354; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Oka A, 2003, TISSUE ANTIGENS, V61, P203, DOI 10.1034/j.1399-0039.2003.00007.x; Goertsches R, 2003, J NEUROIMMUNOL, V143, P124, DOI 10.1016/j.jneuroim.2003.08.026; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; JULIAN BA, 1985, NEW ENGL J MED, V312, P202, DOI 10.1056/NEJM198501243120403; Kawashima M, 2006, AM J HUM GENET, V79, P252, DOI 10.1086/505539; Beerman I, 2007, NAT CLIN PRACT NEPHR, V3, P325, DOI 10.1038/ncpneph0492; Akiyama F, 2002, J HUM GENET, V47, P532, DOI 10.1007/s100380200080; TOLKOFFRUBIN NE, 1978, TRANSPLANTATION, V26, P430, DOI 10.1097/00007890-197812000-00014; Gödde René, 2005, J Negat Results Biomed, V4, P7, DOI 10.1186/1477-5751-4-7; Gulcher Jeffrey, 2012, Cold Spring Harb Protoc, V2012, P425, DOI 10.1101/pdb.top068510; Hirukawa Takashi, 2014, Nephron Extra, V4, P70, DOI 10.1159/000362451; Yu XQ, 2012, NAT GENET, V44, P178, DOI 10.1038/ng.1047	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					573	580		10.1038/jhg.2015.88		8	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200003		
J	Kawai, Y; Mimori, T; Kojima, K; Nariai, N; Danjoh, I; Saito, R; Yasuda, J; Yamamoto, M; Nagasaki, M				Kawai, Yosuke; Mimori, Takahiro; Kojima, Kaname; Nariai, Naoki; Danjoh, Inaho; Saito, Rumiko; Yasuda, Jun; Yamamoto, Masayuki; Nagasaki, Masao			Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals	JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; LOW-FREQUENCY; VARIANTS; DISEASE; RISK	The Tohoku Medical Megabank Organization constructed the reference panel (referred to as the 1KJPN panel), which contains 420 million single nucleotide polymorphisms (SNPs), from whole-genome sequence data from 1070 Japanese individuals. The 1KJPN panel contains the largest number of haplotypes of Japanese ancestry to date. Here, from the 1KJPN panel, we designed a novel custom-made SNP array, named the Japonica array, which is suitable for whole-genome imputation of Japanese individuals. The array contains 659 253 SNPs, including tag SNPs for imputation, SNPs of Y chromosome and mitochondria, and SNPs related to previously reported genome-wide association studies and pharmacogenomics. The Japonica array provides better imputation performance for Japanese individuals than the existing commercially available SNP arrays with both the 1KJPN panel and the International 1000 genomes project panel. For common SNPs (minor allele frequency (MAF) > 5%), the genomic coverage of the Japonica array (r(2)>0.8) was 96.9%, that is, almost all common SNPs were covered by this array. Nonetheless, the coverage of low-frequency SNPs (0.5% < MAF <= 5%) of the Japonica array reached 67.2%, which is higher than those of the existing arrays. In addition, we confirmed the high quality genotyping performance of the Japonica array using the 288 samples in 1KJPN; the average call rate 99.7% and the average concordance rate 99.7% to the genotypes obtained from high-throughput sequencer. As demonstrated in this study, the creation of custom-made SNP arrays based on a populationspecific reference panel is a practical way to facilitate further association studies through genome-wide genotype imputations.	[Kawai, Yosuke; Mimori, Takahiro; Kojima, Kaname; Nariai, Naoki; Danjoh, Inaho; Saito, Rumiko; Yasuda, Jun; Yamamoto, Masayuki; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi 9808573, Japan; [Kawai, Yosuke; Kojima, Kaname; Nariai, Naoki; Yasuda, Jun; Yamamoto, Masayuki; Nagasaki, Masao] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kojima, Kaname; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Cohort Genome Informat Anal, Sendai, Miyagi 980, Japan; [Nagasaki, Masao] Tohoku Univ, Grad Sch Informat Sci, Sendai, Miyagi 980, Japan	Nagasaki, M (reprint author), Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808573, Japan.	nagasaki@megabank.tohoku.ac.jp			Tohoku Medical Megabank Project; Japan Science and Technology Agency, JST	This work was supported (in part) by the Tohoku Medical Megabank Project (Special Account for reconstruction from the Great East Japan Earthquake). This work was supported by The Center of Innovation Program from Japan Science and Technology Agency, JST. All computational resources were provided by the ToMMo supercomputer system. We are grateful to Takanori Hasegawa for helpful discussion. We are indebted to all volunteers who participated in this ToMMo project. We also thank all other members of ToMMo Japanese Reference Panel Project.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Kojima K, 2014, LECT N BIOINFORMAT, V8542, P107, DOI 10.1007/978-3-319-07953-0_9; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Genome of the Netherlands C, 2014, NAT GENET, V46, P818; Gurdasani D, 2015, NATURE, V517, P327, DOI 10.1038/nature13997; Howie B. N., 2009, PLOS GENET, V5; Katsuoka F, 2014, ANAL BIOCHEM, V466, P27, DOI 10.1016/j.ab.2014.08.015; Nagasaki M., NAT COMMUN IN PRESS; Sato Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-664; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882	23	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					581	587		10.1038/jhg.2015.68		7	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200004		
J	Tomoshige, K; Matsumoto, K; Tsuchiya, T; Oikawa, M; Miyazaki, T; Yamasaki, N; Mishima, H; Kinoshita, A; Kubo, T; Fukushima, K; Yoshiura, K; Nagayasu, T				Tomoshige, Koichi; Matsumoto, Keitaro; Tsuchiya, Tomoshi; Oikawa, Masahiro; Miyazaki, Takuro; Yamasaki, Naoya; Mishima, Hiroyuki; Kinoshita, Akira; Kubo, Toru; Fukushima, Kiyoyasu; Yoshiura, Koh-ichiro; Nagayasu, Takeshi			Germline mutations causing familial lung cancer	JOURNAL OF HUMAN GENETICS			English	Article							DNA-SEQUENCING DATA; SUSCEPTIBILITY LOCUS; CHROMOSOME 6Q23-25; GROWTH-FACTOR; C-MET; GENE; VARIANTS; RISK; IDENTIFICATION; FRAMEWORK	Genetic factors are important in lung cancer, but as most lung cancers are sporadic, little is known about inherited genetic factors. We identified a three-generation family with suspected autosomal dominant inherited lung cancer susceptibility. Sixteen individuals in the family had lung cancer. To identify the gene(s) that cause lung cancer in this pedigree, we extracted DNA from the peripheral blood of three individuals and from the blood of one cancer-free control family member and performed whole-exome sequencing. We identified 41 alterations in 40 genes in all affected family members but not in the unaffected member. These were considered candidate mutations for familial lung cancer. Next, to identify somatic mutations and/or inherited alterations in these 40 genes among sporadic lung cancers, we performed exon target enrichment sequencing using 192 samples from sporadic lung cancer patients. We detected somatic 'candidate' mutations in multiple sporadic lung cancer samples; MAST1, CENPE, CACNB2 and LCT were the most promising candidate genes. In addition, the MAST1 gene was located in a putative cancer-linked locus in the pedigree. Our data suggest that several genes act as oncogenic drivers in this family, and that MAST1 is most likely to cause lung cancer.	[Tomoshige, Koichi; Matsumoto, Keitaro; Tsuchiya, Tomoshi; Oikawa, Masahiro; Miyazaki, Takuro; Yamasaki, Naoya; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Translat Med Sci, Div Surg Oncol, Nagasaki 8528523, Japan; [Tomoshige, Koichi; Mishima, Hiroyuki; Kinoshita, Akira; Yoshiura, Koh-ichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki 8528523, Japan; [Kubo, Toru; Fukushima, Kiyoyasu] Japanese Red Cross Nagasaki Genbaku Isahaya Hosp, Dept Internal Med, Nagasaki, Japan	Yoshiura, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	kyoshi@nagasaki-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Japan Society for the Promotion of Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan [25293084, 25550033, 25462180]	This work was supported by the Ministry of Health, Labor and Welfare of Japan (KY); the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (B) grant number 25293084 (KY), Challenging Exploratory Research grant number 25550033 (KY), Grant-in-Aid for Scientific Research (C) grant number 25462180 (TM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Mirzaa GM, 2014, HUM GENET, V133, P1023, DOI 10.1007/s00439-014-1443-3; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Nagy R, 2004, ONCOGENE, V23, P6445, DOI 10.1038/sj.onc.1207714; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Amos CI, 2010, CANCER RES, V70, P2359, DOI 10.1158/0008-5472.CAN-09-3096; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fang SY, 2010, CANCER EPIDEM BIOMAR, V19, P3157, DOI 10.1158/1055-9965.EPI-10-0792; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Davis IJ, 2010, CANCER RES, V70, P639, DOI 10.1158/0008-5472.CAN-09-1121; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Liu Y, 2009, CANCER RES, V69, P7844, DOI 10.1158/0008-5472.CAN-09-1833; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Bacsi K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-317; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Tsai MF, 2007, NUCLEIC ACIDS RES, V35, pW63, DOI 10.1093/nar/gkm383; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van der Auwera G. A., 2013, CURR PROTOC BIOINFOR, V11, P1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yamamoto H, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt338	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					597	603		10.1038/jhg.2015.75		7	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200006		
J	Taniguchi, M; Matsuo, H; Shimizu, S; Nakayama, A; Suzuki, K; Hamajima, N; Shinomiya, N; Nishio, S; Kosugi, S; Usami, S; Ito, J; Kitajiri, S				Taniguchi, Mirei; Matsuo, Hirotaka; Shimizu, Seiko; Nakayama, Akiyoshi; Suzuki, Koji; Hamajima, Nobuyuki; Shinomiya, Nariyoshi; Nishio, Shinya; Kosugi, Shinji; Usami, Shin-ichi; Ito, Juichi; Kitajiri, Shin-ichiro			Carrier frequency of the GJB2 mutations that cause hereditary hearing loss in the Japanese population	JOURNAL OF HUMAN GENETICS			English	Article							CONNEXIN 26 GENE; SENSORINEURAL DEAFNESS; RECESSIVE DEAFNESS; HIGH PREVALENCE; DISEASE	Hearing impairment is one of the most common sensory disorders that affect similar to 1 in 1000 children, and half of them are considered to be hereditary. Information about the carrier frequencies of mutations that underlie autosomal recessive disorders is indispensable for accurate genetic counseling to predict the probability of patients' children's disease. However, there have been few reports specific to the Japanese population. GJB2 mutations are reported to be the most frequent cause of hereditary hearing loss, and the mutation spectrum and frequency of GJB2 mutations were reported to vary among different ethnic groups. In this study, we investigated the carrier frequency of GJB2 mutations and the mutation spectrum in 509 individuals randomly selected from the general Japanese population. We show that the carrier frequencies of the two most common pathogenic mutations are 1.57% (8/509) for c.235delC and 1.77% (9/509) for p.Val37lle. In addition to these mutations, we found two pathogenic variants (p.[Gly45Glu; Tyr136*] and p.Arg143Trp), and the total carrier frequency was estimated to be around 3.73% (19/509). We also detected six unclassified variants, including two novel variants (p.Cys60Tyr and p.Phe106Leu), with the former predicted to be pathogenic. These findings will provide indispensable information for genetic counseling in the Japanese population.	[Taniguchi, Mirei; Ito, Juichi; Kitajiri, Shin-ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068507, Japan; [Matsuo, Hirotaka; Shimizu, Seiko; Nakayama, Akiyoshi; Shinomiya, Nariyoshi] Natl Def Med Coll, Dept Integrat Physiol & Bionano Med, Tokorozawa, Saitama 359, Japan; [Suzuki, Koji] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi 47011, Japan; [Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Healthcare Adm, Nagoya, Aichi 4648601, Japan; [Nishio, Shinya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; [Kosugi, Shinji] Kyoto Univ, Sch Publ Hlth, Dept Med Eth Med Genet, Kyoto, Japan	Kitajiri, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kawaharacho 54, Kyoto 6068507, Japan.	kitajiri@ent.kuhp.kyoto-u.ac.jp			Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan	This study was supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan to JI. We would like to thank Dr Hiroki Inoue for collection of samples and also for technical assistance.	Kenna MA, 2001, ARCH OTOLARYNGOL, V127, P1037; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Song MJ, 2012, J HUM GENET, V57, P139, DOI 10.1038/jhg.2011.144; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Lucotte G, 2001, GENET TEST, V5, P149, DOI 10.1089/109065701753145646; Kato R, 2004, AM J MED GENET A, V127A, P54, DOI 10.1002/ajmg.a.20669; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Ohtsuka A, 2003, HUM GENET, V112, P329, DOI 10.1007/s00439-002-0889-x; Abe S, 2007, GENET TEST, V11, P333, DOI 10.1089/gte.2007.0002; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Kusuda Y, 2000, J HUM GENET, V45, P86, DOI 10.1007/s100380050017; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Brobby GW, 1998, NEW ENGL J MED, V338, P548, DOI 10.1056/NEJM199802193380813; Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Fuse Y, 1999, NEUROREPORT, V10, P1853, DOI 10.1097/00001756-199906230-00010; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Shimizu N, 1999, PEDIATR INT, V41, P409, DOI 10.1046/j.1442-200x.1999.01092.x; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Roux Anne-Françoise, 2004, BMC Med Genet, V5, P5, DOI 10.1186/1471-2350-5-5; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x	31	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					613	617		10.1038/jhg.2015.82		5	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200008		
J	Tsurusaki, Y; Tanaka, R; Shimada, S; Shimojima, K; Shiina, M; Nakashima, M; Saitsu, H; Miyake, N; Ogata, K; Yamamoto, T; Matsumoto, N				Tsurusaki, Yoshinori; Tanaka, Ryuta; Shimada, Shino; Shimojima, Keiko; Shiina, Masaaki; Nakashima, Mitsuko; Saitsu, Hirotomo; Miyake, Noriko; Ogata, Kazuhiro; Yamamoto, Toshiyuki; Matsumoto, Naomichi			Novel compound heterozygous LIAS mutations cause glycine encephalopathy	JOURNAL OF HUMAN GENETICS			English	Article							NONKETOTIC HYPERGLYCINEMIA; LIPOIC ACID; GLDC-GENE; PROTEIN; DECARBOXYLASE; PREDICTION	Glycine encephalopathy (GCE) is a rare autosomal recessive disorder caused by defects in the glycine cleavage complex. Here we report a patient with GCE and elevated level of glycine in both the serum and the cerebrospinal fluid. Trio-based whole-exome sequencing identified novel compound heterozygous mutations (c.738-2A>G and c.929T>C (p.Met310Thr)) in LIAS. To date, three homozygous mutations have been reported in LIAS. All previously reported GCE patients also show elevated level of serum glycine. Our data further supports LIAS mutations as a genetic cause for GCE.	[Tsurusaki, Yoshinori; Nakashima, Mitsuko; Saitsu, Hirotomo; Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Tanaka, Ryuta] Univ Tsukuba, Inst Clin Med, Dept Child Hlth, Tsukuba, Ibaraki 305, Japan; [Shimada, Shino; Shimojima, Keiko; Yamamoto, Toshiyuki] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan; [Shiina, Masaaki; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Yokohama, Kanagawa 232, Japan	Matsumoto, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Japan Science and Technology Agency (the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems); Ministry of Education, Culture, Sports, Science and Technology of Japan (the Strategic Research Program for Brain Sciences)	We thank the patients and their families for their participation in this study. We also thank Nobuko Watanabe for her excellent technical assistance. This work was supported by the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science (Grants-in-Aid for Scientific Research (A) (B) (C)); the Takeda Science Foundation; the Japan Science and Technology Agency (the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems); the Ministry of Education, Culture, Sports, Science and Technology of Japan (the Strategic Research Program for Brain Sciences); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle).	Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; KURE S, 1991, BIOCHEM BIOPH RES CO, V174, P1176, DOI 10.1016/0006-291X(91)91545-N; NANAO K, 1994, HUM GENET, V93, P655; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328; KOYATA H, 1991, AM J HUM GENET, V48, P351; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Hennermann JB, 2012, J INHERIT METAB DIS, V35, P253, DOI 10.1007/s10545-011-9398-1; Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011; Kanekar S, 2013, METAB BRAIN DIS, V28, P717, DOI 10.1007/s11011-013-9415-1; Brenton JN, 2014, PEDIATR NEUROL, V50, P536, DOI [10.1016/j.pediatrneurol.2014.01.018, 10.1016/j.pediatrneuro1.2014.01.018]; Harmer JE, 2014, BIOCHEM J, V464, P123, DOI 10.1042/BJ20140895; Tsurusaki Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5011	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					631	635		10.1038/jhg.2015.72		5	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200011		
J	Kadota, C; Arimura, T; Hayashi, T; Naruse, TK; Kawai, S; Kimura, A				Kadota, Chika; Arimura, Takuro; Hayashi, Takeharu; Naruse, Taeko K.; Kawai, Sachio; Kimura, Akinori			Screening of sarcomere gene mutations in young athletes with abnormal findings in electrocardiography: identification of a MYH7 mutation and MYBPC3 mutations	JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MYOSIN HEAVY-CHAIN; JAPANESE PATIENTS; SUDDEN-DEATH; HEART; PREVALENCE; RISK	There is an overlap between the physiological cardiac remodeling associated with training in athletes, the so-called athlete's heart, and mild forms of hypertrophic cardiomyopathy (HCM), the most common hereditary cardiac disease. HCM is often accompanied by unfavorable outcomes including a sudden cardiac death in the adolescents. Because one of the initial signs of HCM is abnormality in electrocardiogram (ECG), athletes may need to monitor for ECG findings to prevent any unfavorable outcomes. HCM is caused by mutations in genes for sarcomere proteins, but there is no report on the systematic screening of gene mutations in athletes. One hundred and two genetically unrelated young Japanese athletes with abnormal ECG findings were the subjects for the analysis of four sarcomere genes, MYH7, MYBPC3, TNNT2 and TNNI3. We found that 5 out of 102 (4.9%) athletes carried mutations: a heterozygous MYH7 Glu935Lys mutation, a heterozygous MYBPC3 Arg160Trp mutation and another heterozygous MYBPC3 Thr1046Met mutation, all of which had been reported as HCM-associated mutations, in 1, 2 and 2 subjects, respectively. This is the first study of systematic screening of sarcomere gene mutations in a cohort of athletes with abnormal ECG, demonstrating the presence of sarcomere gene mutations in the athlete's heart.	[Kadota, Chika; Arimura, Takuro; Hayashi, Takeharu; Naruse, Taeko K.; Kimura, Akinori] TMDU, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1138510, Japan; [Kawai, Sachio] Juntendo Univ, Grad Sch Hlth & Sports Sci, Dept Sports Med, Inzai 2701695, Japan	Kawai, S (reprint author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Dept Sports Med, 1-1 Hiragagakuendai, Inzai 2701695, Japan.	chyabo@sakura.juntendo.ac.jp; akitis@mri.tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25293181, 25670172, 26460407]; research grant for Idiopathic Cardiomyopathy from the Ministry of Health, Labor and Welfare, Japan; research grant from Association Francaise contre les Myopathies; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Tokyo Medical and Dental University	We thank Ms Yukiko Ueda and Nana Ohkubo for their technical assistance and clinicians for their contribution in blood sampling and clinical examination of HCM patients and family relatives. This work was supported in part by Grant-in-Aids from the Ministry of Education, Culture, Sports, Science and Technology, Japan (25293181, 25670172 and 26460407); a research grant for Idiopathic Cardiomyopathy from the Ministry of Health, Labor and Welfare, Japan; and a research grant from Association Francaise contre les Myopathies. The study was also supported by Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University and a support for women researchers from the Tokyo Medical and Dental University.	Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Lauschke J, 2009, CLIN RES CARDIOL, V98, P80, DOI 10.1007/s00392-008-0721-2; Otsuka H, 2012, CIRC J, V76, P453, DOI 10.1253/circj.CJ-11-0876; Anan R, 2007, AM J CARDIOL, V99, P1750, DOI 10.1016/j.amjcard.2007.01.066; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Maron BJ, 2010, CIRC J, V74, P2271, DOI 10.1253/circj.CJ-10-0921; Erdmann J, 2003, CLIN GENET, V64, P339, DOI 10.1034/j.1399-0004.2003.00151.x; MARON BJ, 1995, CIRCULATION, V91, P1596; Fuller CM, 1997, MED SCI SPORT EXER, V29, P1131, DOI 10.1097/00005768-199709000-00003; Richard P, 1999, J MED GENET, V36, P542; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; Olivetti G, 2000, CARDIOVASC RES, V45, P68, DOI 10.1016/S0008-6363(99)00298-9; Pelliccia A, 2000, CIRCULATION, V102, P278; Kimura A, 2010, J HUM GENET, V55, P81, DOI 10.1038/jhg.2009.138; Pelliccia A, 2012, PROG CARDIOVASC DIS, V54, P387, DOI 10.1016/j.pcad.2012.01.003; NISHI H, 1994, BIOCHEM BIOPH RES CO, V200, P549, DOI 10.1006/bbrc.1994.1483	17	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					641	645		10.1038/jhg.2015.81		5	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200013		
J	Emi, M; Yoshikawa, Y; Sato, C; Sato, A; Sato, H; Kato, T; Tsujimura, T; Hasegawa, S; Nakano, T; Hashimoto-Tamaoki, T				Emi, Mitsuru; Yoshikawa, Yoshie; Sato, Chika; Sato, Ayuko; Sato, Hidenori; Kato, Takeo; Tsujimura, Tohru; Hasegawa, Seiki; Nakano, Takashi; Hashimoto-Tamaoki, Tomoko			Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level	JOURNAL OF HUMAN GENETICS			English	Article							PLEURAL MESOTHELIOMA; SOMATIC MUTATIONS; GERMLINE	Malignant mesothelioma (MM) is an asbestos-related malignancy arising from surface serosal cells of pleural and peritoneal cavities. Somatic mutations of BRCA1 associated protein-1 (BAP1) gene were recently found in MM as well as in uveal melanoma and kidney cancer among the Caucasian and Japanese people. However, frequency of mutations varies among the reported studies, which might be due to presence of undetected gross rearrangements of BAP1 gene that might escape detection by sequencing strategy. We investigated the presence and frequency of gross genomic rearrangements in the BAP1 gene by multiplex ligation-dependent probe amplification (MLPA) in 17 Japanese cases of MM tumors. We found five tumors with partial deletion of BAP1 gene; each tumors displayed partial deletion of exons 1-4 (MM39), exons 1-5 (MM48), exons 11-17 (MM57), exons 1-15 (MM19) and exons 1-16 (MM21). Two tumors (MM34, MM14) had biallelic deletion and four tumors (MM29, MM35, MM45 and MM56) had monoallelic deletion of entire BAP1 gene. Therefore, MLPA analysis revealed large gene rearrangements of BAP1 gene in 65% of MM (11/17). Unusually high frequency of large deletions indicates that the 3p21 chromosomal region surrounding BAP1 gene is structurally unstable. MLPA was useful in characterizing both monoallelic and biallelic deletion of BAP1 gene precisely at exon level.	[Emi, Mitsuru; Yoshikawa, Yoshie; Hashimoto-Tamaoki, Tomoko] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan; [Emi, Mitsuru] Univ Hawaii, Ctr Canc, Thorac Oncol Program, Honolulu, HI 96822 USA; [Sato, Chika] Hyogo Coll Med, Dept Clin Genet, Nishinomiya, Hyogo 6638501, Japan; [Sato, Ayuko; Kato, Takeo] Hyogo Coll Med, Dept Mol Pathol, Nishinomiya, Hyogo 6638501, Japan; [Sato, Hidenori; Kato, Takeo] Yamagata Univ, Sch Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 99023, Japan; [Hasegawa, Seiki] Hyogo Coll Med, Dept Gen Thorac Surg, Nishinomiya, Hyogo 6638501, Japan; [Nakano, Takashi] Hyogo Coll Med, Dept Internal Med, Div Resp Med, Nishinomiya, Hyogo 6638501, Japan	Emi, M (reprint author), Hyogo Coll Med, Dept Genet, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	mitsuruemi@me.com			KAKENHI [24590715, 25460710]	This work was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI, 24590715 to TT, 25460710 to ME) and a Grants-in-Aid for involved researchers.	Guo GW, 2015, CANCER RES, V75, P264, DOI 10.1158/0008-5472.CAN-14-1008; Yamada H, 2011, CANCER SCI, V102, P1782, DOI 10.1111/j.1349-7006.2011.02038.x; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Yoshikawa Y, 2012, CANCER SCI, V103, P868, DOI 10.1111/j.1349-7006.2012.02223.x; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Zauderer MG, 2013, J THORAC ONCOL, V8, P1430, DOI 10.1097/JTO.0b013e31829e7ef9; Cerutti R, 2010, FAM CANCER, V9, P275, DOI 10.1007/s10689-009-9315-z; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Homig-Holzel C, 2012, DIAGN MOL PATHOL, V21, P189, DOI 10.1097/PDM.0b013e3182595516; Baumann F., 2013, LANCET ONCOL, V4, P576; Nasu M., J THORAC ONCOL, V10, P565; Yoshikawa Y, 2015, INT J CANCER, V136, P560, DOI 10.1002/ijc.29015	13	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	OCT	2015	60	10					647	649		10.1038/jhg.2015.91		3	Genetics & Heredity	Genetics & Heredity	CU8MN	WOS:000363797200014		
J	Horner-Johnson, W; Keys, CB; Henry, D; Yamaki, K; Watanabe, K; Oi, F; Fujimura, I; Graham, BC; Shimada, H				Horner-Johnson, W.; Keys, C. B.; Henry, D.; Yamaki, K.; Watanabe, K.; Oi, F.; Fujimura, I.; Graham, B. C.; Shimada, H.			Staff attitudes towards people with intellectual disabilities in Japan and the United States	JOURNAL OF INTELLECTUAL DISABILITY RESEARCH			English	Article						attitudes; community inclusion; cross-cultural comparison; intellectual disability; staff	MENTAL-RETARDATION; PARTICIPATION; MEMBERS; IMPACT	Background Staff attitudes may affect choices available to persons with intellectual disabilities (ID). This study examined attitudes towards people with ID among staff working with people with ID in Japan and the United States. Method Attitudes of staff working with people with ID in Japan and the United States were compared using the Community Living Attitudes Scale, Intellectual Disabilities Form. Responses were examined via multivariate analysis of variance. Results In unadjusted analyses, Japanese staff exhibited a greater tendency towards Sheltering and Exclusion of people with ID and lower endorsement of Empowerment and Similarity of people with ID. After controlling for covariates, the country effect was no longer significant for Sheltering and Exclusion. Age and education were significantly associated with attitudes in the adjusted model. Conclusions While attitudes in Japan appeared less supportive of community inclusion of people with ID, some of the differences between countries were attributable to other staff characteristics such as age and education. Findings provide new information about how attitudes of staff in each country compare with each other.	[Horner-Johnson, W.] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Portland, OR 97239 USA; [Keys, C. B.] Depaul Univ, Coll Sci & Hlth, Chicago, IL 60604 USA; [Henry, D.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA; [Yamaki, K.] Univ Illinois, Dept Disabil & Human Dev, Chicago, IL USA; [Watanabe, K.] Higashi Nippon Int Univ, Dept Social Welf, Iwaki, Fukushima, Japan; [Oi, F.] Hokuriku Gakuin Univ, Kanazawa, Ishikawa, Japan; [Fujimura, I.] SUN Total Partners Inc, Nagano, Nagano, Japan; [Graham, B. C.] Depaul Univ, Dept Psychol, Chicago, IL 60604 USA; [Shimada, H.] Meisei Univ, Dept Educ, Tokyo, Japan	Horner-Johnson, W (reprint author), Oregon Hlth & Sci Univ, Inst Dev & Disabil, 707 SW Gaines St, Portland, OR 97239 USA.	hornerjo@ohsu.edu		Horner-Johnson, Willi/0000-0003-3568-1400	Office of Social Science Research; Psychology Department of the University of Illinois at Chicago; University Research Council of DePaul University	We appreciate the support of the Office of Social Science Research and the Psychology Department of the University of Illinois at Chicago, the generosity of Gershon Berkson, and the funding provided by the University Research Council of DePaul University.	Tachibana T, 2004, EDUC TRAIN DEV DISAB, V39, P227; Verdonschot MML, 2009, J INTELL DISABIL RES, V53, P54, DOI 10.1111/j.1365-2788.2008.01128.x; Horner-Johnson W, 2002, J INTELL DISABIL RES, V46, P365, DOI 10.1046/j.1365-2788.2002.00406.x; Henry D, 1996, MENT RETARD, V34, P149; Ouellette-Kuntz H, 2003, CAN J PSYCHIAT, V48, P538; Henry D, 1996, MENT RETARD, V34, P367; BECKWITH JB, 1995, J INTELL DISABIL RES, V39, P255; Henry DB, 2004, MENT RETARD, V42, P26, DOI 10.1352/0047-6765(2004)42<26:AOAAIS>2.0.CO;2; Mansell J, 2010, J INTELL DISABIL RES, V54, P104, DOI 10.1111/j.1365-2788.2009.01239.x; Patka M, 2013, AJIDD-AM J INTELLECT, V118, P32, DOI 10.1352/1944-7558-118.1.32; Jones J, 2008, J POLICY PRACT INTEL, V5, P219, DOI 10.1111/j.1741-1130.2008.00183.x; Perry J, 2013, J INTELL DISABIL RES, V57, P139, DOI 10.1111/j.1365-2788.2012.01558.x; McDonald KE, 2008, AM J COMMUN PSYCHOL, V42, P79, DOI 10.1007/s10464-008-9192-x; Braddock D., 2013, STATE STATES DEV DIS; HAHN H, 1993, POLICY STUD J, V21, P740, DOI 10.1111/j.1541-0072.1993.tb02171.x; Keys C., 2001, J REHABILITATION ADM, V25, P1; Parmenter T. R., 2004, J DISABIL POLICY STU, V15, P97, DOI DOI 10.1177/10442073040150020401; Siperstein G. N., 2003, MULTINATIONAL STUDY	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0964-2633	1365-2788		J INTELL DISABIL RES	J. Intell. Disabil. Res.	OCT	2015	59	10					942	947		10.1111/jir.12179		6	Education, Special; Genetics & Heredity; Clinical Neurology; Psychiatry; Rehabilitation	Education & Educational Research; Genetics & Heredity; Neurosciences & Neurology; Psychiatry; Rehabilitation	CU9RG	WOS:000363881900006		
J	Barroga, E; Vardaman, M				Barroga, Edward; Vardaman, Maya			Essential Components of Educational Programs on Biomedical Writing, Editing, and Publishing	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Academic Program; Education; Editing; Publishing; Writing	SCIENTIFIC PUBLICATIONS; PEER REVIEWERS; AUTHORS; EDITORS	The primary objective of educational programs on biomedical writing, editing, and publishing is to nurture ethical skills among local and international researchers and editors from diverse professional backgrounds. The mechanics, essential components, and target outcomes of these programs are described in this article. The mechanics covers the objectives, design, benefits, duration, participants and qualifications, program formats, administrative issues, and mentorship. The essential components consist of three core schedules: Schedule I Basic aspects of biomedical writing, editing, and communications; Schedule II Essential skills in biomedical writing, editing, and publishing; and Schedule III Interactive lectures on relevant topics. The target outcomes of the programs comprise knowledge acquisition, skills development, paper write-up, and journal publication. These programs add to the prestige and academic standing of the host institutions.	[Barroga, Edward; Vardaman, Maya] Tokyo Med Univ, Dept Int Med Commun, Tokyo 1600023, Japan	Barroga, E (reprint author), Tokyo Med Univ, Dept Int Med Commun, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	eb@dimc-tmu.jp					Gasparyan AY, 2013, J KOREAN MED SCI, V28, P1117, DOI 10.3346/jkms.2013.28.8.1117; Rohrig B, 2009, DTSCH ARZTEBL INT, V106, P262, DOI 10.3238/arztebl.2009.0262; Gasparyan AY, 2013, J KOREAN MED SCI, V28, P1270, DOI 10.3346/jkms.2013.28.9.1270; Miller JE, 2007, HEALTH SERV RES, V42, P311, DOI 10.1111/j.1475-6773.2006.00588.x; Cals JWL, 2013, J CLIN EPIDEMIOL, V66, P585, DOI 10.1016/j.jclinepi.2013.01.005; Snyder PJ, 2002, BRAIN COGNITION, V50, P335, DOI 10.1016/S0278-2626(02)00506-7; [Anonymous], 2014, ACTA INFORM MED, V22, P210; Gasparyan AY, 2011, RHEUMATOL INT, V31, P1409, DOI 10.1007/s00296-011-1999-3; Groves T, 2010, ORAL DIS, V16, P313, DOI 10.1111/j.1601-0825.2010.01663.x; Gasparyan AY, 2011, CROAT MED J, V52, P735, DOI 10.3325/cmj.2011.52.735; Baron TH, 2012, KOREAN J RADIOL, V13, pS1, DOI 10.3348/kjr.2012.13.S1.S1; Foote M, 2007, CHEST, V132, P344, DOI 10.1378/chest.07-0320; Barroga EF, 2014, J KOREAN MED SCI, V29, P1587, DOI 10.3346/jkms.2014.29.12.1587; Barroga EF, 2012, EUR SCI ED, V38, P32; Coghill AM, 2006, ACS STYLE GUIDE EFFE, P59; Durbin Charles G Jr, 2004, Respir Care, V49, P1233; Forlini G, 2004, GRAMMAR COMPOSITION, p[73, 185]; Galipeau James, 2013, Syst Rev, V2, P41, DOI 10.1186/2046-4053-2-41; Gasparyan AY, 2013, CROAT MED J, V54, P600, DOI 10.3325/cmj.2013.54.600; Hong ST, 2014, J KOREAN MED SCI, V29, P1035, DOI 10.3346/jkms.2014.29.8.1035; John Hopkins University, SCI WRIT HOPK; Longo Anne, 2012, J Nurses Staff Dev, V28, P16, DOI 10.1097/NND.0b013e318240a699; Rabinowitz H, 2009, MANUAL SCI STYLE ELE, P137; Sengupta S, 2014, INDIAN J OPHTHALMOL, V62, P1089, DOI 10.4103/0301-4738.146760; Setiati Siti, 2007, Acta Med Indones, V39, P50; Stolerman I, PREPARING MANUSCRIPT; The University of Chicago Graham School, MED WRIT ED; Thiese MS, 2015, BIOCHEM MEDICA, V25, P5, DOI 10.11613/BM.2015.001; University of Innsbruck, MAST SCI MED WRIT; University of the Sciences, BIOM WRIT PROGR MED; Welch Stephen J, 2006, Chest, V129, P822, DOI 10.1378/chest.129.3.822	31	0	0	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	OCT	2015	30	10					1381	1387		10.3346/jkms.2015.30.10.1381		7	Medicine, General & Internal	General & Internal Medicine	CV4BE	WOS:000364209600002		
J	Barroga, E				Barroga, Edward			Predatory Publishing Practices Corrode the Credibility of Science	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Editorial Material									[Barroga, Edward] Tokyo Med Univ, Dept Int Med Commun, Tokyo 1600023, Japan	Barroga, E (reprint author), Tokyo Med Univ, Dept Int Med Commun, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	eb@dimc-tmu.jp					Caplan AL, 2015, MAYO CLIN PROC, V90, P565, DOI 10.1016/j.mayocp.2015.02.017; Barroga EF, 2013, MED WRIT, V22, P4; Barroga EF, 2014, J KOREAN MED SCI, V29, P1450, DOI 10.3346/jkms.2014.29.11.1450; Gasparyan AY, 2015, J KOREAN MED SCI, V30, P1010, DOI 10.3346/jkms.2015.30.8.1010; Sorrell J, 2015, OJIN, V20, DOI [10.3912/OJIN.Vol20No03EthCol01, DOI 10.3912/OJIN.VOL20NO03ETHCOL01]	5	0	0	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	OCT	2015	30	10					1535	1536		10.3346/jkms.2015.30.10.1535		2	Medicine, General & Internal	General & Internal Medicine	CV4BE	WOS:000364209600024		
J	Esposito, C; Miyano, G; Caione, P; Escolino, M; Chiarenza, F; Riccipetitoni, G; Yamataka, A; Cerulo, M; Savanelli, A; Settimi, A; Valla, JS				Esposito, Ciro; Miyano, Go; Caione, Paolo; Escolino, Maria; Chiarenza, Fabio; Riccipetitoni, Giovanna; Yamataka, Atsuyuki; Cerulo, Mariapina; Savanelli, Antonio; Settimi, Alessandro; Valla, Jean-Stephane			Retroperitoneoscopic Heminephrectomy in Duplex Kidney in Infants and Children: Results of a Multicentric Survey	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							LAPAROSCOPIC PARTIAL NEPHRECTOMY; PARTIAL NEPHROURETERECTOMY; SURGERY; HEMINEPHROURETERECTOMY; TRANSPERITONEAL; COHORT; SERIES	Purpose: Retroperitoneoscopic partial nephrectomy (RPN) in children is considered a complex technique with limited diffusion among pediatric surgeons and urologists. We aimed to report the outcome of this technique in infants and children with duplex kidney in a 5-year retrospective multicentric international survey. Materials and Methods: Data on 50 children who underwent RPN (41 upper-pole nephrectomies and 9 lower-pole nephrectomies) were retrospectively collected in this six-institution survey. Median age at surgery was 3.3 years. There were 35 girls and 15 boys. The left side was affected in 28 patients, versus the right side in 22 patients. We assessed intraoperative and postoperative morbidity. Follow-up (median, 2.5 years; range, 12 months-5 years) was based on clinical controls and echo color Doppler renal ultrasound scans. Results: Median duration of surgery was 255 minutes. Surgery was always performed with the patient in a lateral position. Special hemostatic devices were used for dissection and parenchymal section in all centers. Three patients from two centers (6%) required conversion to open surgery. We recorded seven complications (six peritoneal perforations, one opening of the remaining calyxes) in the 50 cases. Re-operation rate was 0%. Average length of hospital stay was 4.1 days. Conclusions: Our survey shows that RPN remains a challenging procedure with a long learning curve, performed only in pediatric centers with huge experience in this field. In our survey operative time was longer than 4 hours. The complication rate remains high (7/50, or 14%), with complications classified as Grade II according to the Clavien-Dindo classification. They did not require further surgery, but they were associated with a prolonged hospital stay.	[Esposito, Ciro; Escolino, Maria; Cerulo, Mariapina; Savanelli, Antonio; Settimi, Alessandro] Univ Naples Federico II, Dept Translat Med Sci, I-80131 Naples, Italy; [Miyano, Go; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Tokyo 113, Japan; [Caione, Paolo] Bambino Gesu Pediat Hosp, Dept Pediat Urol, Rome, Italy; [Chiarenza, Fabio] San Bortolo Hosp, Dept Pediat Surg, Vicenza, Italy; [Riccipetitoni, Giovanna] Buzzi Hosp, Dept Pediat Surg, Milan, Italy; [Valla, Jean-Stephane] CHU Lenval, Dept Pediat Surg, Nice, France	Esposito, C (reprint author), Univ Naples Federico II, Dept Translat Med Sci, Via Pansini 5, I-80131 Naples, Italy.	ciroespo@unina.it					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Yao D, 2000, J UROLOGY, V163, P1531, DOI 10.1016/S0022-5347(05)67672-0; Miyano G, 2013, J LAPAROENDOSC ADV S, V23, P723, DOI 10.1089/lap.2013.0135; Kawauchi A, 2004, INT J UROL, V11, P7, DOI 10.1111/j.1442-2042.2004.00736.x; Valla JS, 2003, EUR UROL, V43, P426, DOI 10.1016/S0302-2838(03)00043-5; El-Ghoneimi A, 2003, BJU INT, V91, P532, DOI 10.1046/j.1464-410X.2003.04126.x; Borzi PA, 2001, BJU INT, V87, P517, DOI 10.1046/j.1464-410X.2001.00130.x; Marszalek M, 2011, UROLOGY, V77, P109, DOI 10.1016/j.urology.2010.02.057; Singh RR, 2010, J PEDIATR UROL, V6, P66, DOI 10.1016/j.jpurol.2009.04.005; Leclair MD, 2009, EUR UROL, V56, P385, DOI 10.1016/j.eururo.2008.07.015; Elashry OM, 1997, J ENDOUROL, V11, P15, DOI 10.1089/end.1997.11.15; Goyal A, 2010, J PEDIATR UROL, V6, P153, DOI 10.1016/j.jpurol.2009.07.013; JORDAN GH, 1993, J UROLOGY, V150, P940; Lee RS, 2005, J UROLOGY, V174, P708, DOI 10.1097/01.ju.0000164748.00339.4c; El-Ghoneimi A, 1998, J UROLOGY, V160, P1138, DOI 10.1016/S0022-5347(01)62719-8; Wallis MC, 2006, J UROLOGY, V175, P2277, DOI 10.1016/S0022-5347(06)00338-7; Jackman SV, 1998, J ENDOUROL, V12, P441, DOI 10.1089/end.1998.12.441; Castellan M, 2006, J UROLOGY, V176, P2636, DOI 10.1016/j.juro.2006.08.053; Esposito C, 2014, MINERVA UROL NEFROL, V66, P101; Hayakawa K, 1999, J UROLOGY, V161, P1559, DOI 10.1016/S0022-5347(05)68954-9; Borzi PA, 2000, BRIT J UROL S4, V85, P20; Fernandez Cordoba MS, 2011, CIR PEDIAT, V24, P232; Ku JH, 2004, UROLOGY, V63, P570; Ku JH, 2004, UROLOGY, V63, P566, DOI 10.1016/j.urology.2003.11.040; Valla Jean-Stephane, 2007, Semin Pediatr Surg, V16, P270, DOI 10.1053/j.sempedsurg.2007.06.010	25	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	OCT 1	2015	25	10					864	869		10.1089/lap.2014.0654		6	Surgery	Surgery	CU9TM	WOS:000363888200015		
J	McCairn, KW; Iriki, A; Isoda, M				McCairn, Kevin W.; Iriki, Atsushi; Isoda, Masaki			Common therapeutic mechanisms of pallidal deep brain stimulation for hypo- and hyperkinetic movement disorders	JOURNAL OF NEUROPHYSIOLOGY			English	Review						deep brain stimulation; nonhuman primate; Parkinson's disease; Tourette syndrome; globus pallidus	HIGH-FREQUENCY STIMULATION; EXTERNAL GLOBUS-PALLIDUS; PRIMARY MOTOR CORTEX; SUBTHALAMIC NUCLEUS STIMULATION; BASAL GANGLIA CIRCUITRY; NIGRA PARS RETICULATA; LA-TOURETTE-SYNDROME; MPTP-TREATED MONKEY; PARKINSONS-DISEASE; NEURONAL-ACTIVITY	Abnormalities in cortico-basal ganglia (CBG) networks can cause a variety of movement disorders ranging from hypokinetic disorders, such as Parkinson's disease (PD), to hyperkinetic conditions, such as Tourette syndrome (TS). Each condition is characterized by distinct patterns of abnormal neural discharge (dysrhythmia) at both the local single-neuron level and the global network level. Despite divergent etiologies, behavioral phenotypes, and neurophysiological profiles, high-frequency deep brain stimulation (HF-DBS) in the basal ganglia has been shown to be effective for both hypo- and hyperkinetic disorders. The aim of this review is to compare and contrast the electro-physiological hallmarks of PD and TS phenotypes in nonhuman primates and discuss why the same treatment (HF-DBS targeted to the globus pallidus internus, GPi-DBS) is capable of ameliorating both symptom profiles. Recent studies have shown that therapeutic GPi-DBS entrains the spiking of neurons located in the vicinity of the stimulating electrode, resulting in strong stimulus-locked modulations in firing probability with minimal changes in the population-scale firing rate. This stimulus effect normalizes/suppresses the pathological firing patterns and dysrhythmia that underlie specific phenotypes in both the PD and TS models. We propose that the elimination of pathological states via stimulus-driven entrainment and suppression, while maintaining thalamocortical network excitability within a normal physiological range, provides a common therapeutic mechanism through which HF-DBS permits information transfer for purposive motor behavior through the CBG while ameliorating conditions with widely different symptom profiles.	[McCairn, Kevin W.] Korea Brain Res Inst, Syst Neurosci & Movement Disorders Lab, Daegu 701300, South Korea; [Iriki, Atsushi] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Isoda, Masaki] Kansai Med Univ, Sch Med, Dept Physiol, Hirakata, Osaka, Japan	McCairn, KW (reprint author), Korea Brain Res Inst, Syst Neurosci & Movement Disorders Lab, Daegu 701-300as, Daegu 701300, South Korea.	kevin.mccairn@yahoo.com			Tourette Syndrome Association-USA - Ministry of Science, ICT and Future Planning [2231-415]; Korea Brain Research Institute basic research program - Ministry of Science, ICT and Future Planning [2231-415]	This research was supported by the Tourette Syndrome Association-USA and the Korea Brain Research Institute basic research program funded by the Ministry of Science, ICT and Future Planning (no. 2231-415) to K. W. McCairn. The monkeys used in this research were in part provided by the National BioResource Project "Japanese Monkeys" of the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Ackermans L, 2013, WORLD NEUROSURG, V80; Agnesi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074462; Alam M, 2015, J NEURAL TRANSM, V122, P687, DOI 10.1007/s00702-014-1277-0; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Hashimoto T, 2003, J NEUROSCI, V23, P1916; McCairn KW, 2012, NEUROREPORT, V23, P206, DOI 10.1097/WNR.0b013e32834fab9d; Guridi J, 1997, NEUROSURGERY, V41, P1169, DOI 10.1097/00006123-199711000-00029; Johnson MD, 2008, J NEUROPHYSIOL, V100, P2549, DOI 10.1152/jn.90372.2008; Raz A, 2000, J NEUROSCI, V20, P8559; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; Kuncel AM, 2006, MOVEMENT DISORD, V21, P1920, DOI 10.1002/mds.21087; Leblois A, 2010, NEUROBIOL DIS, V38, P288, DOI 10.1016/j.nbd.2010.01.020; Mink JW, 2003, ARCH NEUROL-CHICAGO, V60, P1365, DOI 10.1001/archneur.60.10.1365; Rubin JE, 2012, EUR J NEUROSCI, V36, P2213, DOI 10.1111/j.1460-9568.2012.08108.x; McCairn KW, 2013, J NEUROSCI, V33, P697, DOI 10.1523/JNEUROSCI.4018-12.2013; Sato F, 2000, J COMP NEUROL, V424, P142, DOI 10.1002/1096-9861(20000814)424:1<142::AID-CNE10>3.0.CO;2-8; LAITINEN LV, 1992, STEREOT FUNCT NEUROS, V58, P14, DOI 10.1159/000098965; Stefani A, 2005, ANN NEUROL, V57, P448, DOI 10.1002/ana.20402; Parent A, 2000, TRENDS NEUROSCI, V23, pS20, DOI 10.1016/S1471-1931(00)00022-7; McCairn KW, 2009, BRAIN, V132, P2125, DOI 10.1093/brain/awp142; Chiken S, 2013, J NEUROSCI, V33, P2268, DOI 10.1523/JNEUROSCI.4144-11.2013; Moran A, 2012, NEUROBIOL DIS, V45, P583, DOI 10.1016/j.nbd.2011.09.016; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.366-04.2004; SMITH Y, 1994, J COMP NEUROL, V343, P297, DOI 10.1002/cne.903430209; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; McCairn KW, 2015, J NEUROPHYSIOL, V113, P2537, DOI 10.1152/jn.00701.2014; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; GARDINER TW, 1992, EXP BRAIN RES, V88, P517; Baup N, 2008, J NEUROSCI, V28, P8785, DOI 10.1523/JNEUROSCI.2384-08.2008; Soares J, 2004, J NEUROSCI, V24, P6417, DOI 10.1523/JNEUROSCI.0836-04.2004; LOZANO AM, 1995, LANCET, V346, P1383, DOI 10.1016/S0140-6736(95)92404-3; Abdi A, 2015, J NEUROSCI, V35, P6667, DOI 10.1523/JNEUROSCI.4662-14.2015; Baron MS, 2001, J COMP NEUROL, V429, P490; HAZRATI LN, 1990, BRAIN RES, V533, P171, DOI 10.1016/0006-8993(90)91813-V; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Bronfeld M, 2011, J NEUROSCI, V31, P8713, DOI 10.1523/JNEUROSCI.0195-11.2011; COOPER IS, 1980, APPL NEUROPHYSIOL, V43, P244; Dehning S, 2008, MOVEMENT DISORD, V23, P1300, DOI 10.1002/mds.21930; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Nambu A, 1997, J COMP NEUROL, V377, P85; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Boertien T, 2011, MOVEMENT DISORD, V26, P1835, DOI 10.1002/mds.23788; HOLLERMAN JR, 1992, NEUROSCIENCE, V47, P589, DOI 10.1016/0306-4522(92)90168-2; Rizzone M, 2001, J NEUROL NEUROSUR PS, V71, P215, DOI 10.1136/jnnp.71.2.215; Stein E, 2013, EXP NEUROL, V245, P52, DOI 10.1016/j.expneurol.2012.07.023; PARENT A, 1995, BRAIN RES, V698, P280, DOI 10.1016/0006-8993(95)01017-P; BECKSTEAD RM, 1983, BRAIN RES BULL, V11, P629, DOI 10.1016/0361-9230(83)90003-5; Isoda M, 2008, J NEUROSCI, V28, P7209, DOI 10.1523/JNEUROSCI.0487-08.2008; HEDREEN JC, 1991, J COMP NEUROL, V304, P569, DOI 10.1002/cne.903040406; Hershey T, 2003, NEUROLOGY, V61, P816; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Nambu A, 1997, NEUROSCI LETT, V239, P13, DOI 10.1016/S0304-3940(97)00877-X; Agid Y, 1999, BRAIN RES BULL, V50, P475, DOI 10.1016/S0361-9230(99)00141-0; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Zauber SE, 2014, CLIN NEUROPHYSIOL, V125, P1923, DOI 10.1016/j.clinph.2014.01.003; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Nambu A, 2000, J NEUROPHYSIOL, V84, P289; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Posch DK, 2012, BEHAV BRAIN RES, V232, P130, DOI 10.1016/j.bbr.2012.02.046; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; BENAZZOUZ A, 1995, NEUROSCI LETT, V189, P77, DOI 10.1016/0304-3940(95)11455-6; Wu YR, 2001, MOVEMENT DISORD, V16, P208, DOI 10.1002/mds.1046; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Bar-Gad I, 2003, J NEUROSCI, V23, P4012; Worbe Y, 2009, CEREB CORTEX, V19, P1844, DOI 10.1093/cercor/bhn214; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; SCARNATI E, 1988, ARCH ITAL BIOL, V126, P145; FILION M, 1991, BRAIN RES, V547, P142; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Marsden JF, 2001, BRAIN, V124, P378, DOI 10.1093/brain/124.2.378; BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344; Magill PJ, 2000, J NEUROSCI, V20, P820; Parent M, 2004, PARKINSONISM RELAT D, V10, P203, DOI 10.1016/j.parkreldis.2004.02.007; Krauss JK, 1999, LANCET, V354, P837; DELONG MR, 1972, BRAIN RES, V40, P127, DOI 10.1016/0006-8993(72)90118-7; NINI A, 1995, J NEUROPHYSIOL, V74, P1800; Beiser DG, 1998, J NEUROPHYSIOL, V79, P3168; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Sidibe M, 1997, J COMP NEUROL, V382, P323; Shahed J, 2007, NEUROLOGY, V68, P159, DOI 10.1212/01.wnl.0000250354.81556.90; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Birdno MJ, 2008, NEUROTHERAPEUTICS, V5, P14, DOI 10.1016/j.nurt.2007.10.067; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/01.wnr.0000125783.35268.9f; Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Dorval AD, 2008, J NEUROPHYSIOL, V100, P2807, DOI 10.1152/jn.90763.2008; Sato F, 2000, J COMP NEUROL, V417, P17; Arimura N, 2013, J NEUROSCI, V33, P13639, DOI 10.1523/JNEUROSCI.1620-13.2013; Liu LD, 2012, J NEUROPHYSIOL, V108, P5, DOI 10.1152/jn.00527.2011; Eusebio A, 2008, EXP NEUROL, V209, P125, DOI 10.1016/j.expneurol.2007.09.007; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Martinez-Torres I, 2009, NEUROLOGY, V72, P1787, DOI 10.1212/WNL.0b013e3181a60a0c; Francois C, 2004, BRAIN, V127, P2055, DOI 10.1093/brain/awh239; Goldberg JA, 2002, J NEUROSCI, V22, P4639; Parent A, 2001, PARKINSONISM RELAT D, V7, P193, DOI 10.1016/S1353-8020(00)00058-4; Israelashvili M, 2015, J NEUROPHYSIOL, V114, P6, DOI 10.1152/jn.00277.2015; Johnson MD, 2012, J NEUROPHYSIOL, V108, P567, DOI 10.1152/jn.00039.2012; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Pasquereau B, 2011, CEREB CORTEX, V21, P1362, DOI 10.1093/cercor/bhq217; Mastro KJ, 2014, J NEUROSCI, V34, P2087, DOI 10.1523/JNEUROSCI.4646-13.2014; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127; Garcia L, 2005, J NEUROPHYSIOL, V94, P3662, DOI 10.1152/jn.00496.2005; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x; Marsden J, 2001, NEUROREPORT, V12, P1113, DOI 10.1097/00001756-200105080-00013; Turner RS, 2005, J NEUROSCI, V25, P2965, DOI 10.1523/JNEUROSCI.4036-04.2005; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; HAZRATI LN, 1991, BRAIN RES, V550, P142, DOI 10.1016/0006-8993(91)90418-U; Angelov SD, 2014, BRAIN STIMUL, V7, P595, DOI 10.1016/j.brs.2014.03.013; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Grados MA, 2008, BIOL PSYCHIAT, V64, P219, DOI 10.1016/j.biopsych.2008.01.019; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; GONYAMAGEE T, 1983, EXP BRAIN RES, V49, P269; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Birdno MJ, 2012, J NEUROPHYSIOL, V107, P364, DOI 10.1152/jn.00906.2010; Draper A, 2014, CURR BIOL, V24, P2343, DOI 10.1016/j.cub.2014.08.038; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Montgomery EB, 2006, CLIN NEUROPHYSIOL, V117, P2691, DOI 10.1016/j.clinph.2006.08.011; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Azoulay-Zyss J, 2011, ARCH NEUROL-CHICAGO, V68, P94, DOI 10.1001/archneurol.2010.338; Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Rosenbaum R, 2014, NEUROBIOL DIS, V62, P86, DOI [10.1016/j.nbd.2013.09.006, 10.1016/j.nbd2013.09.006]; McCairn KW, 2011, NEUROSCI RES, V71, pE143, DOI 10.1016/j.neures.2011.07.616; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; McCairn KW, 2013, J NEUROSCI, V33, P6581, DOI 10.1523/JNEUROSCI.4874-12.2013; Welter ML, 2010, CURR OPIN NEUROL, V23, P420, DOI 10.1097/WCO.0b013e32833b7798; Cleary DR, 2013, J NEUROPHYSIOL, V109, P978, DOI 10.1152/jn.00420.2012; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Timmermann L, 2004, MOVEMENT DISORD, V19, P1328, DOI 10.1002/mds.20198; Smith Y, 1998, NEUROSURG CLIN N AM, V9, P203; HUTCHISON WD, 1994, NEUROREPORT, V5, P1533, DOI 10.1097/00001756-199407000-00031; Dueck A, 2009, NEUROPEDIATRICS, V40, P239, DOI 10.1055/s-0030-1247519; Zhuang P, 2009, J NEUROL NEUROSUR PS, V80, P1075, DOI 10.1136/jnnp.2008.161869; Kita H, 1999, NEUROREPORT, V10, P1467, DOI 10.1097/00001756-199905140-00014; Starr PA, 1998, NEUROSURGERY, V43, P989, DOI 10.1097/00006123-199811000-00001; Chen CC, 2007, EXP NEUROL, V205, P214, DOI 10.1016/j.expneurol.2007.01.027; Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Marceglia S, 2010, MOVEMENT DISORD, V25, P300, DOI 10.1002/mds.22982; Dodson PD, 2015, NEURON, V86, P501, DOI 10.1016/j.neuron.2015.03.007; McCairn KW, 2013, INT REV NEUROBIOL, V112, P179, DOI 10.1016/B978-0-12-411546-0.00007-X; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Baron MS, 1996, ANN NEUROL, V40, P355, DOI 10.1002/ana.410400305; Bar-Gad I, 2004, J NEUROSCI, V24, P9410; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chiken S, 2015, NEUROSCIENTIST, V22, P222; Chu HY, 2015, NEURON, V85, P364, DOI 10.1016/j.neuron.2014.12.022; Gerfen CR, 1996, HAND CHEM N, V12, P371; Gilles de la Tourette G, 1885, ARCH NEUROL-CHICAGO, V9, P158; Hoshi E, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00158; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; Kaminer J, 2014, EUR J NEUROSCI, V40, P3237, DOI 10.1111/ejn.12697; Lerner A, 2012, BRAIN, V22, P222; Martinez-Fernandez R, 2011, MOVEMENT DISORD, V26, P1922, DOI 10.1002/mds.23734; Mastro KJ, 2015, NEURON, V85, P233, DOI 10.1016/j.neuron.2014.12.062; McCairn KW, 2013, TOURETTE SYNDROME, P329; MEYERS R, 1951, Acta Psychiatr Neurol Suppl, V67, P1; Moran Anan, 2011, Front Syst Neurosci, V5, P21, DOI 10.3389/fnsys.2011.00021; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Peterson B S, 2001, Adv Neurol, V85, P179; Piedimonte F, 2012, NEUROMODULATION, V22, P222; Schrock LE, 2015, MOVEMENT DISORD, V30, P448, DOI 10.1002/mds.26094; Starr Philip A, 2004, Neurosurg Focus, V17, pE4; The Tourette Syndrome Classification Study Group, 1993, ARCH NEUROL-CHICAGO, V10, P1013; van der Linden C, 2002, MOVEMENT DISORD, V17, pS341; Xu M, 2015, P NATL ACAD SCI USA, V22, P222; Yu DM, 2015, AM J PSYCHIAT, V172, P82, DOI 10.1176/appi.ajp.2014.13101306; Zimnik AJ, 2015, J NEUROSCI, V35, P3978, DOI 10.1523/JNEUROSCI.4899-14.2015	182	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT 1	2015	114	4					2090	2104		10.1152/jn.00223.2015		15	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CU5CC	WOS:000363548300005		
J	Kasuga, S; Telgen, S; Ushiba, J; Nozaki, D; Diedrichsen, J				Kasuga, Shoko; Telgen, Sebastian; Ushiba, Junichi; Nozaki, Daichi; Diedrichsen, Joern			Learning feedback and feedforward control in a mirror-reversed visual environment	JOURNAL OF NEUROPHYSIOLOGY			English	Article						arm-reaching; visuomotor transformation; online correction; feedback control; feedforward control	REACHING MOVEMENTS; MOTOR ADAPTATION; INTERNAL-MODELS; HUNTINGTONS-DISEASE; TASK; CORTEX; INTEGRATION; MULTIJOINT; ROTATION	When we learn a novel task, the motor system needs to acquire both feedforward and feedback control. Currently, little is known about how the learning of these two mechanisms relate to each other. In the present study, we tested whether feedforward and feedback control need to be learned separately, or whether they are learned as common mechanism when a new control policy is acquired. Participants were trained to reach to two lateral and one central target in an environment with mirror (left-right)-reversed visual feedback. One group was allowed to make online movement corrections, whereas the other group only received visual information after the end of the movement. Learning of feedforward control was assessed by measuring the accuracy of the initial movement direction to lateral targets. Feedback control was measured in the responses to sudden visual perturbations of the cursor when reaching to the central target. Although feedforward control improved in both groups, it was significantly better when online corrections were not allowed. In contrast, feedback control only adaptively changed in participants who received online feedback and remained unchanged in the group without online corrections. Our findings suggest that when a new control policy is acquired, feedforward and feedback control are learned separately, and that there may be a trade-off in learning between feedback and feedforward controllers.	[Kasuga, Shoko; Ushiba, Junichi] Keio Univ, Fac Sci & Technol, Tokyo, Kanagawa 108, Japan; [Telgen, Sebastian; Diedrichsen, Joern] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Ushiba, Junichi] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan	Diedrichsen, J (reprint author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	j.diedrichsen@ucl.ac.uk			Ministry of Education, Culture, Sports, Science, and Technology [25750267]	This work was supported by Grant-in-Aid for Young Scientists (B) and the Ministry of Education, Culture, Sports, Science, and Technology (no. 25750267) to S. Kasuga.	HORE J, 1988, J NEUROPHYSIOL, V60, P1285; Ahmadi-Pajouh MA, 2012, J NEUROSCI, V32, P9537, DOI 10.1523/JNEUROSCI.4275-11.2012; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Pruszynski JA, 2011, NATURE, V478, P387, DOI 10.1038/nature10436; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Sing GC, 2009, NEURON, V64, P575, DOI 10.1016/j.neuron.2009.10.001; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Lillicrap TP, 2013, EXP BRAIN RES, V228, P327, DOI 10.1007/s00221-013-3565-6; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Gritsenko V, 2010, J NEUROPHYSIOL, V104, P3084, DOI 10.1152/jn.00909.2009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Desmurget M, 1999, NAT NEUROSCI, V2, P563; Schaefer SY, 2012, J NEUROPHYSIOL, V107, P1247, DOI 10.1152/jn.00273.2011; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; White O, 2010, CURR BIOL, V20, P1290, DOI 10.1016/j.cub.2010.05.069; Cluff T, 2013, J NEUROSCI, V33, P15903, DOI 10.1523/JNEUROSCI.0263-13.2013; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Yousif N, 2012, J NEUROPHYSIOL, V108, P2373, DOI 10.1152/jn.00315.2012; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853; Braun DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008973; Diedrichsen J, 2014, COGNITIVE NEUROSCIEN; Saijo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009399; Wagner MJ, 2008, J NEUROSCI, V28, P10663, DOI 10.1523/JNEUROSCI.5479-07.2008; Telgen S, 2014, J NEUROSCI, V34, P13768, DOI 10.1523/JNEUROSCI.5306-13.2014	35	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT 1	2015	114	4					2187	2193		10.1152/jn.00096.2015		7	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CU5CC	WOS:000363548300012		
J	Takahashi, I; Yoshino, M				Takahashi, Izumi; Yoshino, Masami			Functional coupling between sodium-activated potassium channels and voltage-dependent persistent sodium currents in cricket Kenyon cells	JOURNAL OF NEUROPHYSIOLOGY			English	Article						functional coupling; Kenyon cells; mushroom body; Na-activated; K current; Na current	K+ CHANNELS; MUSHROOM BODY; CA2+ CHANNELS; SENSORY NEURONS; IONIC CURRENTS; BRAIN-STEM; SLACK; SIGNALS; SLICK; INACTIVATION	In this study, we examined the functional coupling between Na+-activated potassium (K-Na) channels and Na+ influx through voltage-dependent Na+ channels in Kenyon cells isolated from the mushroom body of the cricket Gryllus bimaculatus. Single-channel activity of K-Na channels was recorded with the cell-attached patch configuration. The open probability (P-o) of K-Na channels increased with increasing Na+ concentration in a bath solution, whereas it decreased by the substitution of Na+ with an equimolar concentration of Li+. The P-o of K-Na channels was also found to be reduced by bath application of a high concentration of TTX (1 mu M) and riluzole (100 mu M), which inhibits both fast (I-Naf) and persistent (I-NaP) Na+ currents, whereas it was unaffected by a low concentration of TTX (10 nM), which selectively blocks I-Naf. Bath application of Cd2+ at a low concentration (50 mu M), as an inhibitor of I-NaP, also decreased the P-o of K-Na channels. Conversely, bath application of the inorganic Ca2+-channel blockers Co2+ and Ni2+ at high concentrations (500 mu M) had little effect on the P-o of K-Na channels, although Cd2+ (500 mu M) reduced the P-o of K-Na channels. Perforated whole cell clamp analysis further indicated the presence of sustained outward currents for which amplitude was dependent on the amount of Na+ influx. Taken together, these results indicate that K-Na channels could be activated by Na+ influx passing through voltage-dependent persistent Na+ channels. The functional significance of this coupling mechanism was discussed in relation to the membrane excitability of Kenyon cells and its possible role in the formation of long-term memory.	[Takahashi, Izumi; Yoshino, Masami] Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan	Yoshino, M (reprint author), Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan.	myoshi@u-gakugei.ac.jp			Japan Society for the Promotion of Science [24570083]	This work was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) 24570083.	SAITO M, 1991, J NEUROSCI, V11, P2135; Zakharov SI, 1999, J PHYSIOL-LONDON, V514, P71, DOI 10.1111/j.1469-7793.1999.071af.x; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233; Mistry DK, 1996, EXP PHYSIOL, V81, P899; GROLLEAU F, 1994, NEUROSCI LETT, V167, P46, DOI 10.1016/0304-3940(94)91024-3; Unoki S, 2006, EUR J NEUROSCI, V24, P2031, DOI 10.1111/j.1460-9568.2006.05099.x; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; Santi CM, 2006, J NEUROSCI, V26, P5059, DOI 10.1523/JNEUROSCI.3372-05.2006; DRYER SE, 1991, J PHYSIOL-LONDON, V435, P513; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; Nakamura A, 2013, J NEUROPHYSIOL, V109, P1735, DOI 10.1152/jn.00915.2012; Standker L, 2006, TOXICON, V48, P211, DOI 10.1016/j.toxicon.2006.05.001; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Carbone E, 1997, J PHYSIOL-LONDON, V504, P1, DOI 10.1111/j.1469-7793.1997.001bf.x; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; SCHAFER S, 1994, J NEUROSCI, V14, P4600; Matsumoto Y, 2006, LEARN MEMORY, V13, P35, DOI 10.1101/lm.130506; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Hage TA, 2012, J NEUROSCI, V32, P2714, DOI 10.1523/JNEUROSCI.5088-11.2012; Salceda E, 2002, J PHARMACOL EXP THER, V303, P1067, DOI 10.1124/jpet.102.038570; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; Bosmans F, 2002, FEBS LETT, V532, P131, DOI 10.1016/S0014-5793(02)03653-0; DRYER SE, 1989, J PHYSIOL-LONDON, V410, P283; Aoki K, 2008, J NEUROPHYSIOL, V100, P1211, DOI 10.1152/jn.90459.2008; EGAN TM, 1992, J NEUROSCI, V12, P1964; KAMEYAMA M, 1984, NATURE, V309, P354, DOI 10.1038/309354a0; Chen HJ, 2009, J NEUROSCI, V29, P5654, DOI 10.1523/JNEUROSCI.5978-08.2009; Inoue S, 2014, J INSECT PHYSIOL, V68, P44, DOI 10.1016/j.jinsphys.2014.06.013; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; BADER CR, 1985, NATURE, V317, P540, DOI 10.1038/317540a0; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; HAIMANN C, 1992, PFLUG ARCH EUR J PHY, V422, P287, DOI 10.1007/BF00376215; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Budelli G, 2009, NAT NEUROSCI, V12, P745, DOI 10.1038/nn.2313; Yang B, 2007, J NEUROSCI, V27, P2617, DOI 10.1523/JNEUROSCI5308-06.2007; DALE N, 1993, J PHYSIOL-LONDON, V462, P349; Billen B, 2010, FRONT PHARMACOL, V1, P1; Bischoff U, 1998, J PHYSL, V510, P734; Hille B., 2001, IONIC CHANNELS EXCIT, P457; Kim GE, 2014, CELL REP, V9, P1661, DOI 10.1016/j.celrep.2014.11.015; Safronov BV, 1996, J PHYSIOL-LONDON, V497, P727; Sakmann B, 1983, SINGLE CHANNEL RECOR, P42; Schwaerzel M, 2003, J NEUROSCI, V23, P10495	44	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT 1	2015	114	4					2450	2459		10.1152/jn.00087.2015		10	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CU5CC	WOS:000363548300036		
J	Hanajima, R; Shadmehr, R; Ohminami, S; Tsutsumi, R; Shirota, Y; Shimizu, T; Tanaka, N; Terao, Y; Tsuji, S; Ugawa, Y; Uchimura, M; Inoue, M; Kitazawa, S				Hanajima, Ritsuko; Shadmehr, Reza; Ohminami, Shinya; Tsutsumi, Ryosuke; Shirota, Yuichiro; Shimizu, Takahiro; Tanaka, Nobuyuki; Terao, Yasuo; Tsuji, Shoji; Ugawa, Yoshikazu; Uchimura, Motoaki; Inoue, Masato; Kitazawa, Shigeru			Modulation of error-sensitivity during a prism adaptation task in people with cerebellar degeneration	JOURNAL OF NEUROPHYSIOLOGY			English	Article						cerebellum; degenerative ataxia; cerebellar cortex	REACH ADAPTATION; COMPLEX SPIKES; MOTOR CORTEX; ADAPTIVE-CONTROL; ARM MOVEMENTS; 6 SCA6; LESIONS; MEMORY; MONKEYS; PERTURBATION	Cerebellar damage can profoundly impair human motor adaptation. For example, if reaching movements are perturbed abruptly, cerebellar damage impairs the ability to learn from the perturbation-induced errors. Interestingly, if the perturbation is imposed gradually over many trials, people with cerebellar damage may exhibit improved adaptation. However, this result is controversial, since the differential effects of gradual vs. abrupt protocols have not been observed in all studies. To examine this question, we recruited patients with pure cerebellar ataxia due to cerebellar cortical atrophy (n = 13) and asked them to reach to a target while viewing the scene through wedge prisms. The prisms were computer controlled, making it possible to impose the full perturbation abruptly in one trial, or build up the perturbation gradually over many trials. To control visual feedback, we employed shutter glasses that removed visual feedback during the reach, allowing us to measure trial-by-trial learning from error (termed error-sensitivity), and trial-by-trial decay of motor memory (termed forgetting). We found that the patients benefited significantly from the gradual protocol, improving their performance with respect to the abrupt protocol by exhibiting smaller errors during the exposure block, and producing larger aftereffects during the postexposure block. Trial-by-trial analysis suggested that this improvement was due to increased error-sensitivity in the gradual protocol. Therefore, cerebellar patients exhibited an improved ability to learn from error if they experienced those errors gradually. This improvement coincided with increased error-sensitivity and was present in both groups of subjects, suggesting that control of error-sensitivity may be spared despite cerebellar damage.	[Hanajima, Ritsuko; Terao, Yasuo; Tsuji, Shoji] Tokyo Univ Hosp, Dept Neurol, Tokyo 113, Japan; [Ohminami, Shinya; Tsutsumi, Ryosuke; Shirota, Yuichiro; Shimizu, Takahiro; Tanaka, Nobuyuki; Terao, Yasuo; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Div Neurosci, Tokyo, Japan; [Hanajima, Ritsuko; Tsutsumi, Ryosuke] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 2520380, Japan; [Uchimura, Motoaki; Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Suita, Osaka, Japan; [Uchimura, Motoaki; Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Suita, Osaka, Japan; [Inoue, Masato; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Shadmehr, Reza] Johns Hopkins Sch Med, Dept Biomed Engn, Lab Computat Motor Control, Baltimore, MD USA; [Ugawa, Yoshikazu] Fukushima Med Univ, Dept Neurol, Fukushima, Japan	Hanajima, R (reprint author), Kitasato Univ, Sch Med, Dept Neurol, Minami Ku, 2-1-1 Asamizodai, Sagamihara, Kanagawa 2520380, Japan.	hanajima-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23591270, 22390181, 22590954, 25119002]; Catecholamine; Magnetic Health Science Foundation; Kato Memorial Trust for Nambyo Research, Japan; Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan; Uehara Memorial Foundation; Human Frontiers Science Program; National Institute of Neurological Disorders and Stroke Grant [NS-078311]; Novartis Foundation (Japan) for the Promotion of Science; Neurological Disorders Symposium	This work was supported in part by grants from Research Project Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology Nos. 23591270 (R. Hanajima), 22390181 (Y. Ugawa), 22590954 (Y. Terao), and 25119002 (S. Kitazawa); a research grant from the Catecholamine and the Neurological Disorders Symposium (R. Hanajima); research funds from the Magnetic Health Science Foundation (R. Hanajima, Y. Terao) and the Kato Memorial Trust for Nambyo Research, Japan (Y. Terao); the Research Committee on Degenerative Ataxia from the Ministry of Health and Welfare of Japan; the Magnetic Health Science Foundation; the Uehara Memorial Foundation and The Novartis Foundation (Japan) for the Promotion of Science (Y. Ugawa); the Human Frontiers Science Program (R. Shadmehr and S. Kitazawa), and National Institute of Neurological Disorders and Stroke Grant NS-078311 (R. Shadmehr).	Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x; MILDER DG, 1983, ARCH NEUROL-CHICAGO, V40, P339; Herzfeld DJ, 2014, NEUROIMAGE, V98, P147, DOI 10.1016/j.neuroimage.2014.04.076; Niimi Y, 2013, NEUROPATHOLOGY, V33, P600, DOI 10.1111/neup.12032; Takahashi H, 1998, ACTA NEUROPATHOL, V95, P333; Ahmadi-Pajouh MA, 2012, J NEUROSCI, V32, P9537, DOI 10.1523/JNEUROSCI.4275-11.2012; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Barash S, 1999, J NEUROSCI, V19, P10931; Uchimura M, 2013, J NEUROSCI, V33, P7595, DOI 10.1523/JNEUROSCI.5702-12.2013; Wang XJ, 2010, NEUROPATHOLOGY, V30, P501, DOI 10.1111/j.1440-1789.2009.01094.x; Xu-Wilson M, 2009, J NEUROSCI, V29, P12930, DOI 10.1523/JNEUROSCI.3115-09.2009; Schlerf JE, 2012, J NEUROSCI, V32, P11610, DOI 10.1523/JNEUROSCI.1609-12.2012; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Sasaki H, 1998, ACTA NEUROPATHOL, V95, P199; Uchimura M, 2011, NEUROSCI RES, V71, pE253, DOI 10.1016/j.neures.2011.07.1104; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Kimura T, 2006, J NEUROSCI, V26, P9272, DOI 10.1523/JNEUROSCI.3886-05.2006; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Maschke M, 2004, J NEUROPHYSIOL, V91, P230, DOI 10.1152/jn.00557.2003; Yang Y, 2014, NATURE, V510, P529, DOI 10.1038/nature13282; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Kitazawa S, 2002, EXP BRAIN RES, V144, P258, DOI 10.1007/s00221-002-1089-6; Werner S, 2010, EXP BRAIN RES, V201, P429, DOI 10.1007/s00221-009-2052-6; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Wong J, 2009, J NEUROPHYSIOL, V101, P246, DOI 10.1152/jn.90371.2008; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Norris SA, 2011, J NEUROPHYSIOL, V105, P2248, DOI 10.1152/jn.01009.2010; de Xivry JJO, 2013, J NEUROPHYSIOL, V109, P124, DOI 10.1152/jn.00785.2012; Gibo TL, 2013, J NEUROPHYSIOL, V110, P322, DOI 10.1152/jn.00745.2012; Herzfeld DJ, 2014, SCIENCE, V345, P1349, DOI 10.1126/science.1253138; Ethier V, 2008, J NEUROPHYSIOL, V99, P2577, DOI 10.1152/jn.00015.2008; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Soetedjo R, 2009, J NEUROSCI, V29, P15213, DOI 10.1523/JNEUROSCI.4296-09.2009; KITAZAWA S, 1995, J NEUROSCI, V15, P7644; Ito M, 2001, PHYSIOL REV, V81, P1143; Kimura T, 2009, J NEUROPHYSIOL, V102, P2220, DOI 10.1152/jn.90907.2008; WEINER MJ, 1983, NEUROLOGY, V33, P766; Criscimagna-Hemminger SE, 2010, J NEUROPHYSIOL, V103, P2275, DOI 10.1152/jn.00822.2009; Criscimagna-Hemminger SE, 2008, J NEUROSCI, V28, P9610, DOI 10.1523/JNEUROSCI.3071-08.2008; Hadipour-Niktarash A, 2007, J NEUROSCI, V27, P13413, DOI 10.1523/JNEUROSCI.2570-07.2007; de Xivry JJO, 2011, CEREB CORTEX, V21, P1475, DOI 10.1093/cercor/bhq192; Shadmehr R, 2012, COMPUT NEUROSCI-MIT, P1; Thoroughman KA, 2000, NATURE, V407, P742; Trent MC, 2013, FRONT COMPUT NEUROSC, V7, P1; Welch RB, 1978, PERCEPTUAL MODIFICAT	53	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT 1	2015	114	4					2460	2471		10.1152/jn.00145.2015		12	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	CU5CC	WOS:000363548300037		
J	Sugiyama, M; Yokoi, T; Kawakami, N; Kikkawa, M; Tokunaga, Y; Chayama, K				Sugiyama, Masanaka; Yokoi, Takehito; Kawakami, Nobuhiro; Kikkawa, Makiko; Tokunaga, Yasuyuki; Chayama, Kosuke			Chin Numbness and Pain in a Patient with Burkitt Acute Lymphoblastic Leukemia	JOURNAL OF PEDIATRICS			English	Editorial Material							MENTAL NERVE NEUROPATHY		[Sugiyama, Masanaka; Yokoi, Takehito; Kawakami, Nobuhiro; Kikkawa, Makiko; Tokunaga, Yasuyuki; Chayama, Kosuke] Toyonaka City Hosp, Dept Pediat, Osaka, Japan	Sugiyama, M (reprint author), Toyonaka City Hosp, Dept Pediat, Osaka, Japan.						BERNSTEIN ML, 1986, AM J PEDIAT HEMATOL, V8, P240; Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]; Laurencet FM, 2000, CRIT REV ONCOL HEMAT, V34, P71, DOI 10.1016/S1040-8428(00)00050-0; SEELER RA, 1982, AM J PEDIAT HEMATOL, V4, P212; Hiraki A, 1997, ORAL SURG ORAL MED O, V83, P555, DOI 10.1016/S1079-2104(97)90120-7; Hamdoun E, 2012, J CHILD NEUROL, V27, P1038, DOI 10.1177/0883073811431498; Pansy J, 2011, INDIAN PEDIATR, V48, P481; Seixas DV, 2006, EUR J PAEDIATR NEURO, V10, P145, DOI 10.1016/j.ejpn.2006.02.009; Antunes NL, 2000, J PEDIAT HEMATOL ONC, V22, P521, DOI 10.1097/00043426-200011000-00010; Kraigher-Krainer E, 2008, PEDIATR BLOOD CANCER, V51, P426, DOI 10.1002/pbc.21627; RUBINSTE.MK, 1969, ANN INTERN MED, V70, P49	11	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	OCT	2015	167	4					938	U219		10.1016/j.jpeds.2015.06.070		2	Pediatrics	Pediatrics	CU5BE	WOS:000363545800033		
J	Kondo, T; Hayashi, N; Ohde, S; Suzuki, K; Yoshida, A; Yagata, H; Niikura, N; Iwamoto, T; Kida, K; Murai, M; Takahashi, Y; Tsunoda, H; Nakamura, S; Yamauchi, H				Kondo, Takafumi; Hayashi, Naoki; Ohde, Sachiko; Suzuki, Koyu; Yoshida, Atsushi; Yagata, Hiroshi; Niikura, Naoki; Iwamoto, Takayuki; Kida, Kumiko; Murai, Michiko; Takahashi, Yuko; Tsunoda, Hiroko; Nakamura, Seigo; Yamauchi, Hideko			A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed With Ductal Carcinoma In Situ of the Breast	JOURNAL OF SURGICAL ONCOLOGY			English	Article						breast cancer; ductal carcinoma in situ; sclerosing adenosis; nomogram	LYMPH-NODE BIOPSY; STANDARD AXILLARY TREATMENT; CORE-NEEDLE BIOPSY; AMERICAN-SOCIETY; CANCER; DCIS; UNDERESTIMATION; DIFFERENTIATION; METAANALYSIS; RECURRENCE	Background: The aims of this study were to determine clinicopathological factors associated with postoperative upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS) and to develop a model to predict the risk of upstaging. Methods: Pre- and post-operative pathological diagnoses and radiological findings were assessed for 1,187 consecutive patients. Results: Of the patients, 306 (25.8%) were upstaged on the surgical specimen. In multivariate analysis, the following four factors were significantly associated with upstaging: 1) the presence of sclerosing adenosis on the preoperative biopsy specimen (odds ratio [OR] 0.46, P = 0.013); 2) pleomorphic calcifications on the mammogram (OR 1.68, P = 0.009); 3) a mass suspicious for invasive carcinoma on ultrasonography and/or MRI (OR 2.13, P<0.001); 4) tumor size >= 2 cm on ultrasonography (OR 1.80, P = 0.032). HER2-positive (OR 1.54, P = 0.062) and comedo necrosis (OR 1.42, P = 0.056) demonstrated a trend towards significance. A prediction model incorporating these variables demonstrated that the risk of upstaging was 5.1% with score 0-2 and was 58.1% with score 10. Conclusions: The prediction model incorporating clinicopathological features may be used to guide the selection of patients with DCIS for sentinel lymph node biopsy. (C) 2015 Wiley Periodicals, Inc.	[Kondo, Takafumi; Hayashi, Naoki; Yoshida, Atsushi; Yagata, Hiroshi; Kida, Kumiko; Murai, Michiko; Takahashi, Yuko; Yamauchi, Hideko] St Lukes Int Hosp, Dept Breast Surg Oncol, Tokyo 1048560, Japan; [Ohde, Sachiko] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Suzuki, Koyu] St Lukes Int Hosp, Dept Pathol, Tokyo 1048560, Japan; [Niikura, Naoki] Tokai Univ, Sch Med, Dept Breast, Hiratsuka, Kanagawa 2591100, Japan; [Niikura, Naoki] Tokai Univ, Sch Med, Dept Endocrine Surg, Hiratsuka, Kanagawa 2591100, Japan; [Iwamoto, Takayuki] Okayama Univ, Dept Gastroenterol Surg & Surg Oncol, Okayama, Japan; [Tsunoda, Hiroko] St Lukes Int Hosp, Dept Radiol, Tokyo 1048560, Japan; [Nakamura, Seigo] Showa Univ, Sch Med, Dept Surg, Div Breast Surg Oncol, Tokyo 142, Japan	Niikura, N (reprint author), St Lukes Int Hosp, Dept Breast Surg Oncol, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	naokiha@luke.ac.jp			Japan Breast Cancer Society	Takafumi Kondo received an international travel grant award from the Japan Breast Cancer Society to present this study at the 2014 ASCO Annual meeting.	Chen SC, 2003, BRIT J RADIOL, V76, P600, DOI 10.1259/bjr/55630504; Tan JCC, 2007, ANN SURG ONCOL, V14, P638, DOI 10.1245/s10434-006-9211-9; Goldberg JI, 2010, ANN SURG ONCOL, V17, P3278, DOI 10.1245/s10434-010-1155-4; Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158; Houssami N, 2011, ANN SURG ONCOL, V18, P1364, DOI 10.1245/s10434-010-1438-9; Osako T, 2013, CANCER SCI, V104, P453, DOI 10.1111/cas.12095; Yoshida A, 2012, CLIN BREAST CANCER, V12, P398, DOI 10.1016/j.clbc.2012.08.002; Houssami N, 2007, CANCER, V109, P487, DOI 10.1002/cncr.22435; Siziopikou KP, 2013, BREAST CANCER RES TR, V142, P415, DOI 10.1007/s10549-013-2755-z; Goyal A, 2006, BREAST CANCER RES TR, V98, P311, DOI 10.1007/s10549-006-9167-2; Lee JW, 2008, J SURG ONCOL, V98, P15, DOI 10.1002/jso.21077; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012; Skaane P, 1998, AM J ROENTGENOL, V170, P109; Ansari B, 2008, BRIT J SURG, V95, P547, DOI 10.1002/bjs.6162; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Curigliano G, 2015, ANN ONCOL, V26, P682, DOI 10.1093/annonc/mdv013; Claus EB, 2001, EXP MOL PATHOL, V70, P303, DOI 10.1006/exmp.2001.2366; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Bijker N, 2001, BRIT J CANCER, V84, P539, DOI 10.1054/bjoc.2000.1618; Barthelmes L, 2010, EJSO-EUR J SURG ONC, V36, P399, DOI 10.1016/j.ejso.2009.10.007; Cserni G, 2007, PATHOL ONCOL RES, V13, P5; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Chin-Lenn L, 2014, ANN SURG ONCOL, V21, P66, DOI 10.1245/s10434-013-3239-4; Chan MYP, 2010, ASIAN J SURG, V33, P76, DOI 10.1016/S1015-9584(10)60013-9; Lee SK, 2013, BRIT J SURG, V100, P1756, DOI 10.1002/bjs.9337; Millet I, 2014, RADIOLOGY, V270, P57, DOI 10.1148/radiol.13122758; National comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; The World Health Organization, 1983, NEOPLASMA, V30, P113	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	OCT	2015	112	5					476	480		10.1002/jso.24037		5	Oncology; Surgery	Oncology; Surgery	CU5SB	WOS:000363591200005		
J	Kawaguchi, Y; Nagai, M; Nomura, Y; Kokudo, N; Tanaka, N				Kawaguchi, Yoshikuni; Nagai, Motoki; Nomura, Yukihiro; Kokudo, Norihiro; Tanaka, Nobutaka			Usefulness of Indocyanine Green-Fluorescence Imaging During Laparoscopic Hepatectomy to Visualize Subcapsular Hard-To-Identify Hepatic Malignancy	JOURNAL OF SURGICAL ONCOLOGY			English	Editorial Material							VENOOCCLUSIVE REGIONS; LIVER CANCERS; IDENTIFICATION; SURGERY		[Kawaguchi, Yoshikuni; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div, Tokyo 1138655, Japan; [Kawaguchi, Yoshikuni; Nagai, Motoki; Nomura, Yukihiro; Tanaka, Nobutaka] Asahi Gen Hosp, Dept Surg, Chiba, Japan	Kawaguchi, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yokawaguchi-tky@umin.ac.jp; nbtanaka@hospital.asahi.chiba.jp					CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Kudo H, 2014, SURG ENDOSC, V28, P2504, DOI 10.1007/s00464-014-3468-z; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; Kubota K, 2006, J HEPATO-BILIARY-PAN, V13, P100, DOI 10.1007/s00534-005-1014-z; Kawaguchi Y, 2013, J HEPATOL, V58, P247, DOI 10.1016/j.jhep.2012.09.028; Kawaguchi Y, 2011, J AM COLL SURGEONS, V212, pE33, DOI 10.1016/j.jamcollsurg.2011.03.006; Ishizawa Takeaki, 2009, J Am Coll Surg, V208, pe1, DOI 10.1016/j.jamcollsurg.2008.09.024; Kawaguchi Y, 2013, DIG DIS SCI; Kawaguchi Y, 2013, LIVER TRANSPLANT, V19, P778, DOI 10.1002/lt.23657	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4790	1096-9098		J SURG ONCOL	J. Surg. Oncol.	OCT	2015	112	5					514	516		10.1002/jso.24021		3	Oncology; Surgery	Oncology; Surgery	CU5SB	WOS:000363591200012		
J	Koyama, T; Maeda, K; Anzai, H; Koganei, Y; Shamoto, H; Wakabayashi, H				Koyama, Tamami; Maeda, Keisuke; Anzai, Hideaki; Koganei, Yutaka; Shamoto, Hiroshi; Wakabayashi, Hidetaka			Early Commencement of Oral Intake and Physical Function are Associated with Early Hospital Discharge with Oral Intake in Hospitalized Elderly Individuals with Pneumonia	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							COMMUNITY-ACQUIRED PNEUMONIA; SARCOPENIC DYSPHAGIA; ADULTS		[Koyama, Tamami] Tomei Atsugi Hosp, Dept Dysphagia Rehabil, Atsugi, Kanagawa, Japan; [Maeda, Keisuke] Tamana Reg Hlth Med Ctr, Dept Internal Med, Kumamoto, Japan; [Anzai, Hideaki] Tomei Atsugi Hosp, Dept Internal Med, Atsugi, Kanagawa, Japan; [Koganei, Yutaka] Tomei Atsugi Hosp, Dept Rehabil, Atsugi, Kanagawa, Japan; [Shamoto, Hiroshi] Minamisoma Municipal Gen Hosp, Dept Neurosurg, Fukushima, Japan; [Wakabayashi, Hidetaka] Yokohama City Univ, Dept Rehabil Med, Med Ctr, Yokohama, Kanagawa, Japan	Koyama, T (reprint author), Tomei Atsugi Hosp, Dept Dysphagia Rehabil, Atsugi, Kanagawa, Japan.			Maeda, Keisuke/0000-0001-7132-7818			Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Miyashita N, 2006, INTERNAL MED, V45, P419, DOI 10.2169/internalmedicine.45.1691; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Almirall J, 2013, EUR RESPIR J, V41, P923, DOI 10.1183/09031936.00019012; Kohno Shigeru, 2013, Respir Investig, V51, P103, DOI 10.1016/j.resinv.2012.11.001; Maeda K, 2015, DYSPHAGIA, V30, P80, DOI 10.1007/s00455-014-9577-y; Wakabayashi H., 2014, J FRAILTY AGING, V3, P97	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2183	2185		10.1111/jgs.13679		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800032		
J	Shiina, S; Sakakibara, R; Doi, H; Tateno, F; Sato, M; Masaka, T; Kishi, M; Tsuyusaki, Y; Ogata, T; Aiba, Y; Tateno, H				Shiina, Shunsuke; Sakakibara, Ryuji; Doi, Hirokazu; Tateno, Fuyuki; Sato, Mitsutoshi; Masaka, Tohru; Kishi, Masahiko; Tsuyusaki, Yohei; Ogata, Tsuyoshi; Aiba, Yosuke; Tateno, Hiromi			Levodopa Does Not Worsen Gastric Emptying in Parkinson's Disease	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							MOTILITY		[Shiina, Shunsuke; Doi, Hirokazu; Masaka, Tohru] Toho Univ, Sakura Med Ctr, Dept Internal Med, Pharmaceut Unit, Sakura, Japan; [Sakakibara, Ryuji; Tateno, Fuyuki; Kishi, Masahiko; Tsuyusaki, Yohei; Ogata, Tsuyoshi; Aiba, Yosuke; Tateno, Hiromi] Toho Univ, Sakura Med Ctr, Dept Internal Med, Div Neurol, Sakura, Japan; [Sato, Mitsutoshi] Toho Univ, Sch Pharmaceut Sci, Dept Chem Pharmacol, Narashino, Chiba, Japan	Shiina, S (reprint author), Toho Univ, Sakura Med Ctr, Dept Internal Med, Pharmaceut Unit, Sakura, Japan.						HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Doi H, 2014, MOVEMENT DISORD, V29, P562, DOI 10.1002/mds.25777; Doi H, 2012, J NEUROL SCI, V319, P86, DOI 10.1016/j.jns.2012.05.010; Tateno F, 2011, PARKINSONISM RELAT D, V17, P662, DOI 10.1016/j.parkreldis.2011.06.002; Dive A, 2000, INTENS CARE MED, V26, P901, DOI 10.1007/s001340051279; Marrinan S, 2014, MOVEMENT DISORD, V29, P23, DOI 10.1002/mds.25708; Hardoff R, 2001, MOVEMENT DISORD, V16, P1041, DOI 10.1002/mds.1203; Tanaka Y, 2011, J NEUROL, V258, P421, DOI 10.1007/s00415-010-5769-z; ROBERTSON DRC, 1992, EUR J CLIN PHARMACOL, V42, P409; Sakakibara R, 2011, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011/924605	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2185	2186		10.1111/jgs.13675		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800033		
J	Tateno, F; Sakakibara, R; Nagao, T; Tuyusaki, Y; Aiba, Y; Tateno, H; Kishi, M; Ogata, T				Tateno, Fuyuki; Sakakibara, Ryuji; Nagao, Takeki; Tuyusaki, Yohei; Aiba, Yosuke; Tateno, Hiromi; Kishi, Masahiko; Ogata, Tsuyoshi			Deep Brain Stimulation Ameliorates Postural Hypotension in Parkinson's Disease	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							ORTHOSTATIC HYPOTENSION; SUBTHALAMIC NUCLEUS; LEVODOPA; SYSTEM		[Tateno, Fuyuki; Sakakibara, Ryuji; Tuyusaki, Yohei; Aiba, Yosuke; Tateno, Hiromi; Kishi, Masahiko; Ogata, Tsuyoshi] Toho Univ, Sakura Med Ctr, Dept Neurol, Dept Internal Med, Sakura, Japan; [Nagao, Takeki] Toho Univ, Sakura Med Ctr, Dept Neurosurg, Sakura, Japan	Tateno, F (reprint author), Toho Univ, Sakura Med Ctr, Dept Neurol, Dept Internal Med, Sakura, Japan.						Stemper B, 2006, NEUROLOGY, V67, P1781, DOI 10.1212/01.wnl.0000244416.30605.f1; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Pursiainen V, 2012, ACTA NEUROL SCAND, V126, pe20, DOI 10.1111/j.1600-0404.2012.01648.x; Okun MS, 2012, NEW ENGL J MED, V367, P1529, DOI 10.1056/NEJMct1208070; Ludwig J, 2007, J NEUROL NEUROSUR PS, V78, P742, DOI 10.1136/jnnp.2006.103739; Sakakibara R, 2000, J NEUROL NEUROSUR PS, V68, P65, DOI 10.1136/jnnp.68.1.65; Goldstein DS, 2005, HYPERTENSION, V46, P1333, DOI 10.1161/01.HYP.0000188052.69549.e4; Senard JM, 2001, DRUG AGING, V18, P495, DOI 10.2165/00002512-200118070-00003; Zibetti M, 2007, EUR NEUROL, V58, P218, DOI 10.1159/000107943	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2186	2189		10.1111/jgs.13674		4	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800034		
J	Fukuda, S; Kuriyama, N; Egawa, M				Fukuda, Shimpei; Kuriyama, Nagato; Egawa, Masato			Acupuncture for Gait Disturbance in Parkinson's Disease: Immediate Effects of Acupuncture Treatment	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter									[Fukuda, Shimpei; Egawa, Masato] Meiji Univ Integrat Med, Dept Hlth Promoting & Geriatr Acupuncture & Moxib, Kyoto, Japan; [Kuriyama, Nagato] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto, Japan	Fukuda, S (reprint author), Meiji Univ Integrat Med, Dept Hlth Promoting & Geriatr Acupuncture & Moxib, Kyoto, Japan.						Kang JM, 2007, BRAIN RES, V1131, P211, DOI 10.1016/j.brainres.2006.10.089; Chae Y, 2009, MOVEMENT DISORD, V24, P1794, DOI 10.1002/mds.22673; Yang JL, 2011, BRAIN BEHAV IMMUN, V25, P1452, DOI 10.1016/j.bbi.2011.05.012; Cristian A, 2005, MOVEMENT DISORD, V20, P1185, DOI 10.1002/mds.20503; MURRAY MP, 1978, AM J PHYS MED REHAB, V57, P278; Mitoma H, 2010, INTERNAL MED, V49, P2401, DOI 10.2169/internalmedicine.49.3511; Tomlinson C.L., 2012, COCHRANE DB SYST REV, V8	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2189	2190		10.1111/jgs.13690		2	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800035		
J	Hirose, D; Hanyu, H; Fukusawa, R; Hatanaka, H; Namioka, N; Okita, M				Hirose, Daisuke; Hanyu, Haruo; Fukusawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Okita, Misa			Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus-Related Dementia	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Letter							ALZHEIMERS-DISEASE		[Hirose, Daisuke; Hanyu, Haruo; Fukusawa, Raita; Hatanaka, Hirokuni; Namioka, Nayuta; Okita, Misa] Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan	Hirose, D (reprint author), Tokyo Med Univ, Dept Geriatr Med, Tokyo 1608402, Japan.						Shuvaev VV, 2001, NEUROBIOL AGING, V22, P397, DOI 10.1016/S0197-4580(00)00253-0; Valente T, 2010, NEUROBIOL DIS, V37, P67, DOI 10.1016/j.nbd.2009.09.008; Hanyu H, 2015, J AM GERIATR SOC, V63, P1721, DOI 10.1111/jgs.13581; Fukasawa R, 2014, GERIATR GERONTOL INT, V14, P229, DOI 10.1111/ggi.12140; Girones X, 2004, FREE RADICAL BIO MED, V36, P1241, DOI 10.1016/j.freeradbiomed.2004.02.006; Bar KJ, 2003, NEUROBIOL AGING, V24, P333, DOI 10.1016/S0197-4580(02)00086-6; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Fukasawa R, 2015, J NEUROL SCI, V349, P45, DOI 10.1016/j.jns.2014.12.023; Fukazawa R, 2013, DEMENT GERIATR COGN, V35, P280, DOI 10.1159/000348407; Meli M., 2002, Journal of Alzheimer's Disease, V4, P93	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2015	63	10					2196	2198		10.1111/jgs.13683		3	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CU8PQ	WOS:000363805800039		
J	Okumura, A; Rasmussen, AL; Halfmann, P; Feldmann, F; Yoshimura, A; Feldmann, H; Kawaoka, Y; Harty, RN; Katze, MG				Okumura, Atsushi; Rasmussen, Angela L.; Halfmann, Peter; Feldmann, Friederike; Yoshimura, Akihiko; Feldmann, Heinz; Kawaoka, Yoshihiro; Harty, Ronald N.; Katze, Michael G.			Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection	JOURNAL OF VIROLOGY			English	Article							VESICULAR STOMATITIS-VIRUS; INNATE ANTIVIRAL RESPONSE; DENDRITIC CELLS; MATRIX PROTEIN; RECEPTOR 4; SOCS-BOX; VP40 PROTEIN; GLYCOPROTEIN; INTERACTS; MOTIF	Ebola virus (EBOV) initially targets monocytes and macrophages, which can lead to the release of proinflammatory cytokines and chemokines. These inflammatory cytokines are thought to contribute to the development of circulatory shock seen in fatal EBOV infections. The VP40 matrix protein is a key viral structural protein that is critical for virion egress. Physical and functional interactions between VP40 and host proteins such as Tsg101 and Nedd4 facilitate efficient release of VP40-driven viruslike particles (VLPs) and infectious virus. Here, we show that host suppressor of cytokine signaling 3 (SOCS3) can also bind to EBOV VP40, leading to enhanced ubiquitinylation and egress of VP40. Indeed, titers of infectious EBOV derived from SOCS3 knockout mouse embryonic fibroblasts (MEFs) were significantly reduced compared to those from wild-type (WT) MEFs at 24 and 48 h postinfection. Importantly, this reduced virus yield could be rescued back to WT levels by exogenously expressing SOCS3. Lastly, we show that SOCS3 expression is induced by EBOV glycoprotein (GP) expression and that VLPs containing EBOV VP40 and GP induced production of proinflammatory cytokines, which induced SOCS3 for negative-feedback regulation. These data indicate that host innate immune protein SOCS3 may play an important role in budding and pathogenesis of EBOV. IMPORTANCE The VP40 matrix protein is a key structural protein critical for Ebola virus budding. Physical and functional interactions between VP40 and host proteins such as Tsg101 and Nedd4 facilitate efficient release of VLPs and infectious virus. We reported that host TLR4 is a sensor for Ebola GP on VLPs and that the resultant TLR4 signaling pathways lead to the production of proinflammatory cytokines. Host SOCS3 regulates the innate immune response by controlling and limiting the proinflammatory response through negative-feedback inhibition of cytokine receptors. We present evidence that Ebola virus VLPs stimulate induction of SOCS3 as well as proinflammatory cytokines, and that expression of human SOCS3 enhances budding of Ebola VLPs and infectious virus via a mechanism linked to the host ubiquitinylation machinery.	[Okumura, Atsushi; Rasmussen, Angela L.; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA; [Halfmann, Peter; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Okumura, Atsushi; Feldmann, Friederike; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens, Tokyo, Japan; [Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Katze, MG (reprint author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	honey@uw.edu			National Institute of Allergy and Infectious Diseases [R21 AI077014, R21 AI090284, U54 AI081680, U19 AI109761]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health	This study was supported in part by National Institute of Allergy and Infectious Diseases grants R21 AI077014 and R21 AI090284 to R.N.H., U54 AI081680 to Y.K., and U54 AI081680 and U19 AI109761 to M.G.K. and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Zimmermann S, 2006, J IMMUNOL, V176, P1840; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143; Takada A, 2000, VIROLOGY, V278, P20, DOI 10.1006/viro.2000.0601; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Craven RC, 1999, J VIROL, V73, P3359; Bourette RP, 2001, J BIOL CHEM, V276, P22133, DOI 10.1074/jbc.M101878200; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Martinez O, 2007, VIROLOGY, V364, P342, DOI 10.1016/j.virol.2007.03.020; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Qureshi ST, 1999, TRENDS GENET, V15, P291, DOI 10.1016/S0168-9525(99)01782-5; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Zhao DC, 2007, J INFECTION, V54, P393, DOI 10.1016/j.jinf.2006.06.005; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Feldmann H, 1996, J VIROL, V70, P2208; Harty RN, 1999, J VIROL, V73, P2921; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Hill-Batorski L, 2013, J VIROL, V87, P13795, DOI 10.1128/JVI.02422-13; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Hoshino K, 1999, J IMMUNOL, V162, P3749; Miyoshi H, 2005, J HEPATOL, V43, P757, DOI 10.1016/j.jhep.2005.03.028; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Bosio CM, 2004, VIROLOGY, V326, P280, DOI 10.1016/j.virol.2004.05.025; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Wahl-Jensen V, 2005, J VIROL, V79, P2413, DOI 10.1128/JVI79.4.2413-2419.2005; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Mahller YY, 2008, CANCER GENE THER, V15, P733, DOI 10.1038/cgt.2008.40; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Wool-Lewis RJ, 1998, VIROLOGY, V72, P3155	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2015	89	20					10399	10406		10.1128/JVI.01736-15		8	Virology	Virology	CU3ZG	WOS:000363464700021		
J	Koga, R; Sugita, Y; Noda, T; Yanagi, Y; Ohno, S				Koga, Ritsuko; Sugita, Yukihiko; Noda, Takeshi; Yanagi, Yusuke; Ohno, Shinji			Actin-Modulating Protein Cofilin Is Involved in the Formation of Measles Virus Ribonucleoprotein Complex at the Perinuclear Region	JOURNAL OF VIROLOGY			English	Article							V-PROTEIN; C-PROTEIN; INTERFERON INDUCTION; LIM-KINASE; CELLULAR RECEPTOR; CELLS; PHOSPHORYLATION; REPLICATION; EXPRESSION; REORGANIZATION	In measles virus (MV)-infected cells, the ribonucleoprotein (RNP) complex, comprised of the viral genome and the nucleocapsid (N) protein, phosphoprotein (P protein), and large protein, assembles at the perinuclear region and synthesizes viral RNAs. The cellular proteins involved in the formation of the RNP complex are largely unknown. In this report, we show that cofilin, an actin-modulating host protein, interacts with the MV N protein and aids in the formation of the RNP complex. Knockdown of cofilin using the short hairpin RNA reduces the formation of the RNP complex after MV infection and that of the RNP complex-like structure after plasmid-mediated expression of MV N and P proteins. A lower level of formation of the RNP complex results in the reduction of viral RNA synthesis. Cofilin phosphorylation on the serine residue at position 3, an enzymatically inactive form, is increased after MV infection and the phosphorylated form of cofilin is preferentially included in the complex. These results indicate that cofilin plays an important role in MV replication by increasing formation of the RNP complex and viral RNA synthesis. IMPORTANCE Many RNA viruses induce within infected cells the structure called the ribonucleoprotein (RNP) complex in which viral RNA synthesis occurs. It is comprised of the viral genome and proteins that include the viral RNA polymerase. The cellular proteins involved in the formation of the RNP complex are largely unknown. In this report, we show that cofilin, an actin-modulating host protein, binds to the measles virus (MV) nucleocapsid protein and plays an important role in the formation of the MV RNP complex and MV RNA synthesis. The level of the phosphorylated form of cofilin, enzymatically inactive, is increased after MV infection, and the phosphorylated form is preferentially associated with the RNP complex. Our findings determined with cofilin will help us better understand the mechanism by which the RNP complex is formed in virus-infected cells and develop new antiviral drugs targeting the RNP complex.	[Koga, Ritsuko; Yanagi, Yusuke; Ohno, Shinji] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan; [Sugita, Yukihiko; Noda, Takeshi] Univ Tokyo, Inst Med Sci, Div Virol, Tokyo, Japan	Yanagi, Y (reprint author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 812, Japan.	yyanagi@virology.med.kyushu-u.ac.jp; soono@virology.med.kyushu-u.ac.jp			JSPS KAKENHI [24115005]; Ministry of Health, Labor and Welfare of Japan (the Research Committee of Prion Disease and Slow Virus Infection)	This study was supported by JSPS KAKENHI grant number 24115005 and by a grant from the Ministry of Health, Labor and Welfare of Japan (the Research Committee of Prion Disease and Slow Virus Infection).	Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Yokota S, 2003, VIROLOGY, V306, P135, DOI 10.1016/S0042-6822(02)00026-0; NIWA H, 1991, GENE, V108, P193; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; BELLINI WJ, 1985, J VIROL, V53, P908; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Pfaller CK, 2008, J VIROL, V82, P12365, DOI 10.1128/JVI.01321-08; Xiang YF, 2012, J VIROL, V86, P8440, DOI 10.1128/JVI.00609-12; Komune N, 2011, J VIROL, V85, P13019, DOI 10.1128/JVI.05942-11; Fontana JM, 2008, VIROLOGY, V374, P71, DOI 10.1016/j.virol.2007.12.031; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Takeda M, 2008, J VIROL, V82, P11979, DOI 10.1128/JVI.00867-08; Shaffer JA, 2003, VIROLOGY, V315, P389, DOI 10.1016/S0042-6822(03)00537-3; Lahaye X, 2009, J VIROL, V83, P7948, DOI 10.1128/JVI.00554-09; Kousaka K, 2008, GENESIS, V46, P246, DOI 10.1002/dvg.20389; Arber S, 1998, NATURE, V393, P805; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Wakimoto H, 2013, J VIROL, V87, P1974, DOI 10.1128/JVI.02371-12; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; Nakatsu Y, 2013, J VIROL, V87, P4683, DOI 10.1128/JVI.02189-12; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Palosaari H, 2003, J VIROL, V77, P7635, DOI 10.1128/JVI.77.13.7635-7644.2003; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Tober C, 1998, J VIROL, V72, P8124; Hoenen T, 2012, J VIROL, V86, P11779, DOI 10.1128/JVI.01525-12; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Ikegame S, 2010, J VIROL, V84, P372, DOI 10.1128/JVI.01690-09; Iwasaki M, 2011, P NATL ACAD SCI USA, V108, P15384, DOI 10.1073/pnas.1107382108; Toshima J, 2001, MOL BIOL CELL, V12, P1131; Wen XY, 2014, J VIROL, V88, P6906, DOI 10.1128/JVI.00023-14; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Bravo-Cordero JJ, 2013, NAT REV MOL CELL BIO, V14, P405, DOI 10.1038/nrm3609; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Davis ME, 2014, CELL HOST MICROBE, V16, P19, DOI 10.1016/j.chom.2014.06.007; Tatsuo H, 2000, NATURE, V406, P893; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Yang N, 1998, NATURE, V393, P809; Dietzel E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-249; Griffin DE, 2013, FIELDS VIROLOGY, P1042; Heinrich BS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000958; Katoh H, 2015, J VIROL, V89, P3188, DOI 10.1128/JVI.03343-14; Komarova AV, 2011, MOL CELL PROTEOMICS, V10; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ramachandran Aparna, 2008, J Virol, V82, P8330, DOI 10.1128/JVI.00831-08	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	OCT	2015	89	20					10524	10531		10.1128/JVI.01819-15		8	Virology	Virology	CU3ZG	WOS:000363464700032		
J	Sato, K; Sueyoshi, H; Yamada, K				Sato, Kaoru; Sueyoshi, Hitoshi; Yamada, Katsumi			Characterization of complex phase steel using backscattered electron images with controlled collection angles	MICROSCOPY			English	Article						scanning electron microscope; backscattered electron image; Z contrast; channeling contrast; complex phase steel; martensite; crystallographic defects; multiple scattering	CHANNELING CONTRAST; MICROSCOPY	For optimizing the microstructure of complex phase (CP) steels, characterization using scanning electron microscopy (SEM) is powerful because it allows observations from very low to high magnification. SEM specimens of steels are often etched in order to distinguish between the different phases by producing topographic information. This is however an 'indirect' method of characterization, which does not give precise structural information. We have developed a new technique for the selective imaging of the martensite (M) phase in a ferritic (F)-M complex phase steel. Backscattered electron (BSE) images at 15-20 kV were recorded by systematically changing the collection angle theta, where theta is measured from the specimen surface. When theta was 30-45A degrees, strong channeling contrast was observed. For lower values of theta, it is the low energy loss electrons that mainly contribute to the contrast. As theta increases, the M phase exhibits brighter contrast. When theta exceeds 60A degrees, a selective imaging of the M phase is achieved. This is not because martensite has a larger mean atomic number than ferrite, but is due to the fact that martensite has a high crystallographic defect density. Anomalously bright M contrast is due to multiple scattering of BSE due to the high density of planar defects and dislocations. Low angle BSE allows high resolution characterization of complex microstructures, while high angle BSE gives quantitative assessment of the distribution and the volume fraction of the martensite phase.	[Sato, Kaoru] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba, Chiba 2600835, Japan; [Sueyoshi, Hitoshi] JFE Steel Corp, Intellectual Property Div, Chiyoda Ku, Tokyo 1000011, Japan; [Yamada, Katsumi] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan	Sato, K (reprint author), JFE Steel Corp, Steel Res Lab, Chuo Ku, 1 Kawasaki Cho, Chiba, Chiba 2600835, Japan.	ka-sato@jfe-steel.co.jp					Kaneko Y, 2002, J JPN I MET, V66, P1297; Aoyama T, 2011, ISIJ INT, V51, P1487, DOI 10.2355/isijinternational.51.1487; Mikmekova S, 2013, MICROSCOPY-JPN, V62, P589, DOI 10.1093/jmicro/dft036; Wilkinson AJ, 1997, MICRON, V28, P279, DOI 10.1016/S0968-4328(97)00032-2; Sato K, 2001, INST PHYS CONF SER, P77; Aoyama T, 2014, SURF INTERFACE ANAL, V46, P1291, DOI 10.1002/sia.5564; Gutierrez-Urrutia I, 2012, SCRIPTA MATER, V66, P343, DOI 10.1016/j.scriptamat.2011.11.027; Hoffmann K E, 1982, ELECTRON BEAM INTERA, P209; Jaksch H, 2008, MICROSCOPY MICROA S2, V14, P1226; Kanda K, MONTE CARLO SIMULATI; MATSUMURA O, 1987, T IRON STEEL I JPN, V27, P570; Ng BC, 1997, MAT SCI ENG A-STRUCT, V240, P150, DOI 10.1016/S0921-5093(97)00574-1; Reimer L., 1998, SCANNING ELECT MICRO; Speich G R, 1981, FUNDAMENTALS DUAL PH, P3	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					297	304		10.1093/jmicro/dfv022		8	Microscopy	Microscopy	CT5EU	WOS:000362831900001		
J	Takagi, Y; Kono, M; Yamamoto, S; Wada, A; Morikawa, T				Takagi, Yuri; Kono, Mari; Yamamoto, Shiori; Wada, Atsushi; Morikawa, Takashi			Comparison of optical data from flow cytometry and microscopy of leukocytes after exposure to specific reagents	MICROSCOPY			English	Article						flow cytometry; electron microscopy; fluorescent microscopy; leukocytes; scatter light intensity; fluorescent intensity	TRITON X-100; RESISTANCE	Flow cytometry and microscopy are equally important in cell analysis. However, few reports have compared the optical data (cell size, internal complexity and fluorescent signal) from flow cytometry and microscopy. In this study, we compared the scattergram from XN-series, a flow cytometry based hematology analyzer with microscopic images of similarly treated leukocytes, and investigated the correlation between the appearance in the scattergram and cell size, internal complexity and fluorescence intensity. Healthy human peripheral blood was analyzed using the XN analyzer. For microscopic comparison, five types of leukocytes (monocytes, lymphocytes, basophils, neutrophils and eosinophils) were isolated from the peripheral blood by centrifugation and magnetic cell sorting, treated with a specific reagent and analyzed using electron microscopy, laser microscopy and confocal laser microscopy. Cell size, residual internal structures and fluorescence intensity correlated with intensity of forward-scattering, side scattering and fluorescent light. In this study, optical data from a clinically used hematology analyzer was clarified using microscopic images.	[Takagi, Yuri; Kono, Mari; Yamamoto, Shiori; Wada, Atsushi; Morikawa, Takashi] Sysmex Corp, Sci Res, Sci Affairs, Nishi Ku, Kobe, Hyogo 6512241, Japan	Takagi, Y (reprint author), Sysmex Corp, Sci Res, Sci Affairs, Nishi Ku, 1-3-2 Murotani, Kobe, Hyogo 6512241, Japan.	kono.mari@sysmex.co.jp					Alberts B., 2002, MOL BIOL CELL; Spyropoulos B, 2011, CLIN LAB, V57, P131; ERENPREISA J, 1983, ACTA MORPHOL HUNG, V31, P387; El Kirat K, 2007, BBA-BIOMEMBRANES, V1768, P2300, DOI 10.1016/j.bbamem.2007.05.006; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Kono M, 2013, CYTOM PART A, V83A, P396, DOI 10.1002/cyto.a.22262; Holowka David, 2009, Biochem J, V424, pe5, DOI 10.1042/BJ20091623; Mizutani T, 1999, Patent no. US, Patent No. 6004816; Ochi Y, 2011, SYSMEX J S2, V34, P31; YANG S-C, 1989, Taiwan yixuehui zazhi, V88, P1128	11	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					305	310		10.1093/jmicro/dfv023		6	Microscopy	Microscopy	CT5EU	WOS:000362831900002		
J	Aoyama, T; Nagoshi, M; Sato, K				Aoyama, Tomohiro; Nagoshi, Masayasu; Sato, Kaoru			Quantitative analysis of angle-selective backscattering electron image of iron oxide and steel	MICROSCOPY			English	Article						scanning electron microscopy; backscattered electron; contrast; primary electron energy; take-off angle	ENERGY; CONTRAST	The contrasts in backscattered electron ( BSE) images, such as topographic, channeling and mean atomic number ( Z) contrasts, were investigated quantitatively fromthe cross section of a heat- treated steel sheet using a scanning electron microscope ( SEM). High primary electron energy ( EP) enhances Z contrast, whereas low EP improves channeling contrast. A high take- off angle (theta; measured from the specimen surface) also enhances Z contrast, whereas low. improves channeling contrast. When theta becomes very low, topographic information is enhanced and superimposed on channeling contrast due to the tilt effect of BSE. The relationship of the behaviors of the Z contrast and the channeling contrast can be understood by the detection ratio of low- loss electrons ( LLEs) to the inelastic BSE components emitted from the sample surface; LLEs contribute to channeling contrast, and their ratio increaseswith decreasing EP and theta. The systematic results obtained in this study are useful for controlling SEM conditions in order to enhance the target information in BSE images for practicalmaterials of interest.	[Aoyama, Tomohiro] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218510, Japan; [Nagoshi, Masayasu] JFE Steel Corp, Steel Res Lab, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Sato, Kaoru] JFE Steel Corp, Steel Res Lab, Chuo Ku, Chiba, Chiba 2600835, Japan	Aoyama, T (reprint author), JFE Steel Corp, Steel Res Lab, 1 Kokan Cho, Fukuyama, Hiroshima 7218510, Japan.	to-aoyama@jfe-steel.co.jp					Liu Z, 2013, MICROSCOPY-JPN, V62, P109, DOI 10.1093/jmicro/dfs098; Aoyama T, 2011, ISIJ INT, V51, P1487, DOI 10.2355/isijinternational.51.1487; Mikmekova S, 2013, MICROSCOPY-JPN, V62, P589, DOI 10.1093/jmicro/dft036; AUTRATA R, 1989, SCANNING MICROSCOPY, V3, P739; Nagoshi M, 2013, ULTRAMICROSCOPY, V124, P20, DOI 10.1016/j.ultramic.2012.08.011; NIEDRIG H, 1982, J APPL PHYS, V53, pR15, DOI 10.1063/1.331005; Aoyama T, 2014, SURF INTERFACE ANAL, V46, P1291, DOI 10.1002/sia.5564; Berger D, 2002, SCANNING, V24, P70; Hoffmann K E, 1982, ELECTRON BEAM INTERA, P209; Kawano T, 2006, JFE TECH REP, V13, P5; Nagoshi M, 2006, P AS STEEL 06 FUK JA, P836; Nagoshi M, 2003, J SURF FINISH SOC JP, V54, P31; Newbury D E, 1986, ADV SCANNING ELECT M; Niedrig H, 1982, ELECTRON BEAM INTERA, P51; Reimer L, 1993, IMAGE FORMATION LOW; Reimer L., 1998, SCANNING ELECT MICRO; Sato K., 2004, Oyo Buturi, V73; Sato K, 2010, P 17 INT MICR C IMC1, pI3; Umbaugh S E, 2010, DIGITAL IMAGE PROCES	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					319	325		10.1093/jmicro/dfv026		7	Microscopy	Microscopy	CT5EU	WOS:000362831900004		
J	Hayatsu, M; Suzuki, S				Hayatsu, Manabu; Suzuki, Suechika			Electron probe X-ray microanalysis studies on the distribution change of intra- and extracellular calcium in the elongation zone of horizontally reoriented soybean roots	MICROSCOPY			English	Article						calcium; cryosection; electron probe X-ray microanalysis; gravitropic response; horizontally reorientated root; soybean root	ZEA-MAYS; MAIZE COLEOPTILES; AVENA COLEOPTILE; COLUMELLA CELLS; GRAVITY; AUXIN; GRAVITROPISM; TRANSPORT; MOVEMENT	To clarify the contribution of Ca to the gravitropic response, quantitative X-ray microanalyses were performed on cryosections of roots of soybean seedlings reoriented horizontally from their original vertical orientation. After reorientation, the roots bent gradually toward the ground at the elongation zone. The concentrations of Ca in the cell walls, cytoplasmic matrices and central vacuoles of cortical cells were measured in the upper and lower halves of the elongation zone at 0, 30, 60 and 120 min after reorientation. The Ca concentration did not significantly change in the cytoplasmic matrices or vacuoles. Additionally, the Ca concentration did not change significantly in cell walls at 30 min after reorientation; however, beyond 30 min, this concentration significantly increased gradually in the lower half of the elongation zone and decreased in the upper half of the elongation zone, indicating a typical asymmetrical distribution of Ca. These results suggest that Ca moves apoplastically in soybean roots to produce an asymmetrical Ca distribution in the elongation zone, which contributes to root curvature. The possible role of Ca in accelerating or repressing the effect of auxin is also discussed in this study.	[Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan; [Hayatsu, Manabu; Suzuki, Suechika] Kanagawa Univ, Res Inst Integrated Sci, Hiratsuka, Kanagawa 2591293, Japan	Hayatsu, M (reprint author), Kanagawa Univ, Fac Sci, Dept Biol Sci, Hiratsuka, Kanagawa 2591293, Japan.	hayatsu-bio@kanagawa-u.ac.jp					Saito C, 2005, PLANT CELL, V17, P548, DOI 10.1105/tpc.104.026138; HASENSTEIN KH, 1988, PLANT PHYSIOL, V86, P890, DOI 10.1104/pp.86.3.890; Hayatsu M, 2014, J PLANT PHYSIOL, V171, P1385, DOI 10.1016/j.jplph.2014.06.008; SIEVERS A, 1984, Z PFLANZENPHYSIOL, V114, P195; TORIYAMA H, 1972, PLANT PHYSIOL, V49, P72, DOI 10.1104/pp.49.1.72; GEHRING CA, 1990, NATURE, V345, P528, DOI 10.1038/345528a0; MOORE R, 1986, AM J BOT, V73, P574, DOI 10.2307/2444263; BJORKMAN T, 1991, PLANTA, V185, P379, DOI 10.1007/BF00201060; LEE JS, 1983, PLANT PHYSIOL, V73, P874, DOI 10.1104/pp.73.4.874; COOIL BJ, 1957, PLANTA, V48, P696, DOI 10.1007/BF01911596; Hayatsu M, 2012, J ELECTRON MICROSC, V61, P57, DOI 10.1093/jmicro/dfr095; YOUNG LM, 1990, PLANT PHYSIOL, V92, P792, DOI 10.1104/pp.92.3.792; Chen RJ, 1999, PLANT PHYSIOL, V120, P343, DOI 10.1104/pp.120.2.343; JARVIS MC, 1984, PLANT CELL ENVIRON, V7, P153, DOI 10.1111/1365-3040.ep11614586; TAGAWA T, 1957, PLANT PHYSIOL, V32, P207, DOI 10.1104/pp.32.3.207; SACK FD, 1985, PLANTA, V164, P56, DOI 10.1007/BF00391025; Band LR, 2012, P NATL ACAD SCI USA, V109, P4668, DOI 10.1073/pnas.1201498109; MOORE R, 1987, ANN BOT-LONDON, V59, P667; Bennet-Clark T A, 1956, CHEM MODE ACTION PLA, P284; Colodny N, 1927, BIOL ZENTRALBL, V47, P604; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; MOORE R, 1985, ANN BOT-LONDON, V56, P173; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1	23	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					327	334		10.1093/jmicro/dfv031		8	Microscopy	Microscopy	CT5EU	WOS:000362831900005		
J	Adhika, DR; Tanaka, M; Daio, T; Higashida, K				Adhika, Damar Rastri; Tanaka, Masaki; Daio, Takeshi; Higashida, Kenji			Crack tip shielding observed with high-resolution transmission electron microscopy	MICROSCOPY			English	Article						HRTEM; brittle-to-ductile transition; dislocation shielding effect; fracture toughness; geometric phase analysis	BRITTLE DUCTILE TRANSITION; SILICON SINGLE-CRYSTALS; FRACTURE-TOUGHNESS; DISLOCATIONS; MULTIPLICATION; TOMOGRAPHY; MODEL	The dislocation shielding field at a crack tip was experimentally proven at the atomic scale by measuring the local strain in front of the crack tip using high-resolution transmission electron microscopy (HRTEM) and geometric phase analysis (GPA). Single crystalline (110) silicon wafers were employed. Cracks were introduced using a Vickers indenter at room temperature. The crack tip region was observed using HRTEM followed by strain measurements using GPA. The measured strain field at the crack tip was compressive owing to dislocation shielding, which is in good agreement with the strain field calculated from elastic theory.	[Adhika, Damar Rastri; Tanaka, Masaki; Higashida, Kenji] Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan; [Daio, Takeshi] Kyushu Univ, Dept Hydrogen Energy Syst, Nishi Ku, Fukuoka 8190395, Japan	Tanaka, M (reprint author), Kyushu Univ, Dept Mat Sci & Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	masaki@zaiko.kyushu-u.ac.jp			JSPS KAKENHI [24686079, 15H04147]; Kazato Research Foundation	The authors thank JSPS KAKENHI (#24686079, #15H04147) and Kazato Research Foundation for partly supporting this research. Funding to pay the Open Access publication charges for the article was provided by JSPS KAKENHI.	NIIHARA K, 1983, J MATER SCI LETT, V2, P221, DOI 10.1007/BF00725625; BREDE M, 1988, ACTA METALL MATER, V36, P2003, DOI 10.1016/0001-6160(88)90302-1; Tanaka M, 2005, MAT SCI ENG A-STRUCT, V400, P426, DOI 10.1016/j.msea.2005.02.084; RICE JR, 1974, PHILOS MAG, V29, P73, DOI 10.1080/14786437408213555; SAMUELS J, 1989, P ROY SOC LOND A MAT, V421, P1, DOI 10.1098/rspa.1989.0001; Tanaka M, 2011, J MATER RES, V26, P508, DOI 10.1557/jmr.2010.99; Higashida K, 2008, MAT SCI ENG A-STRUCT, V483-84, P13, DOI 10.1016/j.msea.2006.12.174; Tanaka M, 2006, INT J FRACTURE, V139, P383, DOI 10.1007/s10704-006-0021-7; Higashida K, 1997, MAT SCI ENG A-STRUCT, V237, P72, DOI 10.1016/S0921-5093(97)00118-4; MALIS T, 1988, J ELECTRON MICR TECH, V8, P193, DOI 10.1002/jemt.1060080206; HIRSCH PB, 1989, P ROY SOC LOND A MAT, V421, P25, DOI 10.1098/rspa.1989.0002; Tanaka M, 2011, MATER TRANS, V52, P352, DOI 10.2320/matertrans.MB201024; STJOHN C, 1975, PHILOS MAG, V32, P1193; NARITA N, 1989, MATER T JIM, V30, P895; Michot G, 1999, MAT SCI ENG A-STRUCT, V272, P83, DOI 10.1016/S0921-5093(99)00473-6; Hirth J P, 1982, THEORY DISLOCATIONS; Hytch M.J., 1997, SCANNING MICROSCOPY, V11, P53; Thomson R, 1986, SOLID STATE PHYS ADV	18	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					335	340		10.1093/jmicro/dfv032		6	Microscopy	Microscopy	CT5EU	WOS:000362831900006		
J	Seki, T; Abe, E				Seki, Takehito; Abe, Eiji			Local cluster symmetry of a highly ordered quasicrystalline Al58Cu26Ir16 extracted through multivariate analysis of STEM images	MICROSCOPY			English	Article						STEM; quasicrystals; atomic-resolution imaging; structure analysis; image analysis	TRANSMISSION ELECTRON-MICROSCOPY; NONNEGATIVE MATRIX FACTORIZATION; UNIT-CELL MODEL; TRANSLATIONAL SYMMETRY; CO; QUASICRYSTAL; ATOMS	The structure of a highly ordered Al58Cu26Ir16 decagonal quasicrystal (d-QC), which is constructed by a periodic stack of quasiperiodic atomic planes, was investigated using aberration-corrected scanning transmission electron microscopy. The entire quasiperiodic structure can be well described based on the pentagonal Penrose lattice decorated with a decagonal columnar cluster 2 nm across, and the individual clusters apparently showed up with localized atomic disorder to various degree that blurs the underlying cluster symmetry. Multivariate analysis of the cluster images with principal component analysis has successfully extracted two fundamental clusters, which are with definite mirror and 10-fold-rotation symmetries; this is the first solid example of the d-QC composed of multiple fundamental clusters with different symmetry. Consequently, it is found that all the observed variations can be reasonably interpreted by a linear combination between these two fundamental clusters of mirror and 10-fold symmetries, indicating that the possible atomic disorder is strongly restricted by these particular symmetries. Characteristic distributions of the mirror/10-fold clusters on the pentagonal Penrose lattice are also described.	[Seki, Takehito; Abe, Eiji] Univ Tokyo, Dept Mat Sci & Engn, Tokyo 1138656, Japan	Abe, E (reprint author), Univ Tokyo, Dept Mat Sci & Engn, Tokyo 1138656, Japan.	abe@material.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [26630290];  [25-10561]	Part of this study is supported by grants-in-aid for scientific research (Houga, No. 26630290) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. T.S. acknowledges the support by grants-in-aid for JSPS Fellows (No. 25-10561).	Abe E, 2011, SCANNING TRANSMISSIO, P583; Pennycook SJ, 2011, J ELECTRON MICROSC, V60, pS213, DOI 10.1093/jmicro/dfr030; Yamamoto A, 1996, ACTA CRYSTALLOGR A, V52, P509, DOI 10.1107/S0108767396000967; Abe E, 2012, CHEM SOC REV, V41, P6787, DOI 10.1039/c2cs35303b; Abe E, 2004, NAT MATER, V3, P759, DOI 10.1038/nmat1244; Coddens G, 1999, PHYS REV B, V60, P270, DOI 10.1103/PhysRevB.60.270; Kuczera P, 2012, ACTA CRYSTALLOGR B, V68, P578, DOI 10.1107/S0108768112041134; Borisevich A, 2010, ACS NANO, V4, P6071, DOI 10.1021/nn1011539; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Lee DD, 1999, NATURE, V401, P788; Yamamoto Y, 2014, MICROSCOPY-JPN, V63, P209, DOI 10.1093/jmicro/dfu001; Yamamoto A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144202; Taniguchi S, 2008, PHILOS MAG, V88, P1949, DOI 10.1080/14786430802035683; BENDERSKY L, 1985, PHYS REV LETT, V55, P1461, DOI 10.1103/PhysRevLett.55.1461; Dellby N, 2001, J ELECTRON MICROSC, V50, P177, DOI 10.1093/jmicro/50.3.177; LUBENSKY TC, 1986, PHYS REV LETT, V57, P1440, DOI 10.1103/PhysRevLett.57.1440; Abe E, 2001, J ELECTRON MICROSC, V50, P187, DOI 10.1093/jmicro/50.3.187; Yan Y, 1998, PHYS REV LETT, V81, P5145, DOI 10.1103/PhysRevLett.81.5145; Steurer W, 2004, Z KRISTALLOGR, V219, P391, DOI 10.1524/zkri.219.7.391.35643; Nicoletti O, 2013, NATURE, V502, P80, DOI 10.1038/nature12469; Francoual S, 2006, PHILOS MAG, V86, P1029, DOI 10.1080/14786430500Z63496; Steinhardt PJ, 1998, NATURE, V396, P55, DOI 10.1038/23902; ELSER V, 1985, PHYS REV LETT, V55, P2883, DOI 10.1103/PhysRevLett.55.2883; Abe E, 2000, PHYS REV LETT, V84, P4609, DOI 10.1103/PhysRevLett.84.4609; Abe E, 2003, NATURE, V421, P347, DOI 10.1038/nature01337; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Tsuda K, 1996, PHILOS MAG A, V74, P697; PENNYCOOK SJ, 1991, ULTRAMICROSCOPY, V37, P14, DOI 10.1016/0304-3991(91)90004-P; BEELI C, 1994, PHILOS MAG B, V70, P215, DOI 10.1080/01418639408241802; Hiraga K, 1997, ADV IMAG ELECT PHYS, V101, P37, DOI 10.1016/S1076-5670(08)70260-X; Saitoh K, 1997, JPN J APPL PHYS 2, V36, pL1400; Seki T, 2014, MICROSCOPY, V63, pi17; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Tsai A P, 1999, PHYS PROPERTIES QUAS, P5	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					341	349		10.1093/jmicro/dfv035		9	Microscopy	Microscopy	CT5EU	WOS:000362831900007		
J	Kaku, H; Inoue, K; Muranaka, Y; Park, P; Ikeda, K				Kaku, Hiroki; Inoue, Kanako; Muranaka, Yoshinori; Park, Pyoyun; Ikeda, Kenichi			Rapid contrast evaluation method based on affinity beads and backscattered electron imaging for the screening of electron stains	MICROSCOPY			English	Article						non-isotope; uranyl acetate; contrast; samarium chloride; backscattered electron image; scanning electron microscope	URANYL ACETATE; MICROSCOPY; SUBSTITUTE; SECTIONS	Uranyl salts are toxic and radioactive; therefore, several studies have been conducted to screen for substitutes of electron stains. In this regard, the contrast evaluation process is time consuming and the results obtained are inconsistent. In this study, we developed a novel contrast evaluation method using affinity beads and a backscattered electron image (BSEI), obtained using scanning electron microscopy. The contrast ratios of BSEI in each electron stain treatment were correlated with those of transmission electron microscopic images. The affinity beads bound to cell components independently. Protein and DNA samples were enhanced by image contrast treated with electron stains; however, this was not observed for sugars. Protein-conjugated beads showed an additive effect of image contrast when double-stained with lead. However, additive effect of double staining was not observed in DNA-conjugated beads. The varying chemical properties of oligopeptides showed differences in image contrast when treated with each electron stain. This BSEI-based evaluation method not only enables screening for alternate electron stains, but also helps analyze the underlying mechanisms of electron staining of cellular structures.	[Kaku, Hiroki; Inoue, Kanako; Park, Pyoyun; Ikeda, Kenichi] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Inoue, Kanako; Muranaka, Yoshinori] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka 5670047, Japan	Ikeda, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.	ikeken@phoenix.kobe-u.ac.jp			program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science [22580048, 25450059]; Science and Technology Research Promotion for Agriculture, Forestry, Fisheries and Food Industry	This study was supported by the program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN), Science and Technology Research Promotion for Agriculture, Forestry, Fisheries and Food Industry and by a Grant-in-Aid for Scientific Research C (No. 22580048 and 25450059) from the Japan Society for the Promotion of Science.	Ikeda K, 2011, MICROSC RES TECHNIQ, V74, P825, DOI 10.1002/jemt.20964; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; STEMPAK JG, 1964, J CELL BIOL, V22, P697, DOI 10.1083/jcb.22.3.697; Sarsfield MJ, 2004, J AM CHEM SOC, V126, P1036, DOI 10.1021/ja039101y; KELLENBERGER E, 1958, J BIOPHYS BIOCHEM CY, V4, P671, DOI 10.1083/jcb.4.6.671; Inaga S, 2007, ARCH HISTOL CYTOL, V70, P43, DOI 10.1679/aohc.70.43; Yamaguchi K, 2010, J ELECTRON MICROSC, V59, P113, DOI 10.1093/jmicro/dfp045; Nakakoshi M, 2011, J ELECTRON MICROSC, V60, P401, DOI 10.1093/jmicro/dfr084; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P242; Horiuchi Y, 2007, J ELECT MICROSC TECH, V21, P21; Ministry of Education Culture Sports Science and Technology, 2009, GBT47892 MIN PUBL HL, P1; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					361	368		10.1093/jmicro/dfv041		8	Microscopy	Microscopy	CT5EU	WOS:000362831900009		
J	Sato, K; Miyazaki, H; Gondo, T; Miyazaki, S; Murayama, M; Hata, S				Sato, K.; Miyazaki, H.; Gondo, T.; Miyazaki, S.; Murayama, M.; Hata, S.			Development of a novel straining holder for transmission electron microscopy compatible with single tilt-axis electron tomography	MICROSCOPY			English	Article						in situ transmission electron microscopy; in situ deformation; electron tomography; dynamic 3D observation	ALUMINUM; DISLOCATIONS; DEFORMATION; CONTRAST; IRON	We have developed a newly designed straining specimen holder for in situ transmission electron microscopy (TEM) compatible with high-angle single tilt-axis electron tomography. The holder can deform a TEM specimen under tensile stress with the strain rate between 1.5 x 10(-6) and 5.2 x 10(-3) s(-1). We have also confirmed that the maximum tilt angle of the specimen holder reaches +/- 60 degrees with a rectangular shape aluminum specimen. The new specimen holder, termed as 'straining and tomography holder', will have wide range potential applications in materials science.	[Sato, K.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyazaki, H.; Gondo, T.] Mel Build Corp, Nishi Ku, Fukuoka 8190052, Japan; [Miyazaki, S.] FEI Co Japan Ltd, Minato Ku, Tokyo 1080075, Japan; [Murayama, M.] Virginia Tech, Dept Mat Sci & Engn, Blacksburg, VA 24061 USA; [Hata, S.] Kyushu Univ, Dept Engn Sci Elect & Mat, Kasuga, Fukuoka 8168580, Japan	Sato, K (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	ksato@imr.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [25102703]; Japan Science Technology Agency (JST) 'Development of systems and technology for advanced measurement and analysis' program	This study was supported by the Grant-in-Aid for Scientific Research on Innovative Area, 'Bulk Nanostructured Metals' (No. 25102703) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). K.S. and S.H. acknowledge the financial support from the Japan Science Technology Agency (JST) 'Development of systems and technology for advanced measurement and analysis' program.	Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; FUJITA H, 1969, J PHYS SOC JPN, V26, P1437, DOI 10.1143/JPSJ.26.1437; Huang XX, 2006, SCIENCE, V312, P249, DOI 10.1126/science.1124268; POCZA JF, 1969, J VAC SCI TECHNOL, V6, P472; Liu GS, 2011, J MATER RES, V26, P514, DOI 10.1557/jmr.2010.83; SAKA H, 1972, J PHYS SOC JPN, V32, P702, DOI 10.1143/JPSJ.32.702; Kacher J, 2012, ACTA MATER, V60, P6657, DOI 10.1016/j.actamat.2012.08.036; Miyajima Y, 2010, MAT SCI ENG A-STRUCT, V528, P776, DOI 10.1016/j.msea.2010.09.058; Hata S, 2011, ULTRAMICROSCOPY, V111, P1168, DOI 10.1016/j.ultramic.2011.03.021; FUJITA H, 1967, J PHYS SOC JPN, V23, P1349, DOI 10.1143/JPSJ.23.1349; Kimura K, 2005, J ELECTRON MICROSC, V54, P373, DOI 10.1093/jmicro/dfi060; Kubel C, 2005, MICROSC MICROANAL, V11, P378, DOI 10.1017/S1431927605050361; Kacher J, 2012, MICRON, V43, P1099, DOI 10.1016/j.micron.2012.01.017; Dehm G, 2012, IN SITU ELECT MICROS; Tsuji N, 2002, SCRIPTA MATER, V47, P893, DOI 10.1016/S1359-6462(02)00282-8	15	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	OCT	2015	64	5					369	375		10.1093/jmicro/dfv021		7	Microscopy	Microscopy	CT5EU	WOS:000362831900010		
J	Nagao, Y; Kimura, K; Wang, SJ; Fujiwara, T; Mizoguchi, A				Nagao, Yasuaki; Kimura, Kazushi; Wang, Shujie; Fujiwara, Takeshi; Mizoguchi, Akira			Real-Time Histological Imaging of Kidneys Stained With Food Dyes Using Multiphoton Microscopy	MICROSCOPY RESEARCH AND TECHNIQUE			English	Article						glomerulus; renal tubule; filtration	MODULATING FLUORESCENCE PROPERTIES; TERM TOXICITY; DDY MICE; ERYTHROSINE; VIVO; STRAIN	We have developed a real-time imaging technique for diagnosis of kidney diseases which is composed of two steps, staining renal cells safely with food dyes and optical sectioning of living renal tissue to obtain histological images by multiphoton microscopy (MPM). Here, we demonstrated that the MPM imaging with food dyes, including erythrosine and indigo carmine, could be used as fluorescent agents to visualize renal functions and structures such as glomerular bloodstreams, glomerular filtration, and morphology of glomeruli and renal tubules. We also showed that the kidneys of IgA nephropathy model-mice stained with the food dyes presented histopathological characteristics different from those observed in normal kidneys. The use of the food dyes enhances the quality of tissue images obtained by MPM and offers the potential to contribute to a clinical real-time diagnosis of kidney diseases. Microsc. Res. Tech. 78: 847-858, 2015. (C) 2015 Wiley Periodicals, Inc.	[Nagao, Yasuaki; Kimura, Kazushi; Wang, Shujie; Fujiwara, Takeshi; Mizoguchi, Akira] Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, Tsu, Mie 5148507, Japan; [Kimura, Kazushi] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Phys Therapy, Eniwa, Japan	Mizoguchi, A (reprint author), Mie Univ, Grad Sch Med, Dept Neural Regenerat & Cell Commun, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	k-kimura@do-bunkyodai.ac.jp; amizomie@doc.medic.mie-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300284]	Contract grant sponsor: Grants-in-Aid for Fundamental Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Contract grant number: 23300284.	Tanaka T, 2001, FOOD CHEM TOXICOL, V39, P447, DOI 10.1016/S0278-6915(00)00163-0; BUTTERWORTH KR, 1976, FOOD COSMET TOXICOL, V14, P525, DOI 10.1016/S0015-6264(76)80001-6; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Konig K, 1996, OPT LETT, V21, P1090, DOI 10.1364/OL.21.001090; Ueno T, 2004, J AM CHEM SOC, V126, P14079, DOI 10.1021/ja048241k; Muso E, 1996, KIDNEY INT, V50, P1946, DOI 10.1038/ki.1996.517; Yu WM, 2005, AM J PHYSIOL-CELL PH, V289, pC1197, DOI 10.1152/ajpcell.00197.2005; Dela Cruz JM, 2010, BIOMED OPT EXPRESS, V1, P1320, DOI 10.1364/BOE.1.001320; Hall AM, 2011, J AM SOC NEPHROL, V22, P1297, DOI 10.1681/ASN.2010101054; Koike Y, 2011, J THROMB THROMBOLYS, V32, P138, DOI 10.1007/s11239-011-0600-y; Chequer FMD, 2012, FOOD CHEM TOXICOL, V50, P3447, DOI 10.1016/j.fct.2012.07.042; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Miyawaki S, 1997, NEPHRON, V76, P201; Satoh M, 2010, MICROCIRCULATION, V17, P103, DOI 10.1111/j.1549-8719.2009.00010.x; Tanaka K, 2012, ONCOL REP, V28, P1822, DOI 10.3892/or.2012.1983; Miura T, 2003, J AM CHEM SOC, V125, P8666, DOI 10.1021/ja035282s; Rogart JN, 2008, CLIN GASTROENTEROL H, V6, P95, DOI 10.1016/j.cgh.2007.10.008; Mpountoukas P, 2010, FOOD CHEM TOXICOL, V48, P2934, DOI 10.1016/j.fct.2010.07.030; Blackburn SC, 2014, SEMIN PEDIATR SURG, V23, P326, DOI 10.1053/j.sempedsurg.2014.06.002; Boekel J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-123; HOOSON J, 1975, FOOD COSMET TOXICOL, V13, P167, DOI 10.1016/S0015-6264(75)80001-0; Garg AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034475; GAUNT I. F., 1967, FOOD COSMET TOXICOL, V5, P187, DOI 10.1016/S0015-6264(67)82966-3; Japanese Society of Nephrology, 2009, EV BAS PRACT GUID 20, P7; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, P495; Liu SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041331; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; Schiessl IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052499	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1059-910X	1097-0029		MICROSC RES TECHNIQ	Microsc. Res. Tech.	OCT	2015	78	10					847	858		10.1002/jemt.22535		12	Anatomy & Morphology; Biology; Microscopy	Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics; Microscopy	CU7NH	WOS:000363726700001		
J	Murphy, KE; Gysbers, AM; Abbott, SK; Spiro, AS; Furuta, A; Cooper, A; Garner, B; Kabuta, T; Halliday, GM				Murphy, Karen E.; Gysbers, Amanda M.; Abbott, Sarah K.; Spiro, Adena S.; Furuta, Akiko; Cooper, Antony; Garner, Brett; Kabuta, Tomohiro; Halliday, Glenda M.			Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease	MOVEMENT DISORDERS			English	Article						-synuclein; chaperone-mediated autophagy (CMA); LAMP2; nucleic acid autophagy; Parkinson's disease	CHAPERONE-MEDIATED AUTOPHAGY; LEWY BODY DISEASE; ALPHA-SYNUCLEIN; LAMP-2 GENE; SELECTIVE PATHWAY; IN-VITRO; DEGRADATION; EXPRESSION; RECEPTOR; LIPIDS	Lysosomes are the primary catabolic compartment for the degradation of intracellular proteins through autophagy. The presence of abnormal intracellular -synuclein-positive aggregates in Parkinson's disease (PD) indicates that the degradative capacity of lysosomes is impaired in PD. Specific dysfunction of chaperone-mediated autophagy (CMA) in PD is suggested by reductions in the CMA membrane receptor, lysosomal-associated membrane protein (LAMP) 2A, although whether LAMP2A is the only LAMP2 isoform affected by PD is unknown. Messenger RNA (mRNA) and protein expression of all three LAMP2 isoforms was assessed in brain extracts from regions with and without PD-related increases in -synuclein in autopsy samples from subjects in the early pathological stage of PD (n=9), compared to age- and postmortem delay-matched controls (n=10). In the early stages of PD, mRNA expression of all LAMP2 isoforms was not different from controls, with LAMP2B and LAMP2C protein levels also unchanged in PD. The selective loss of LAMP2A protein directly correlated with the increased levels of -synuclein and decreased levels of the CMA chaperone heat shock cognate protein 70 in the same PD samples, as well as with the accumulation of cytosolic CMA substrate proteins. Our data show that LAMP2 protein isoforms are differentially affected in the early stages of PD, with LAMP2A selectively reduced in association with increased -synuclein, and suggests that dysregulation of CMA-mediated protein degradation occurs before substantial -synuclein aggregation in PD. (c) 2015 International Parkinson and Movement Disorder Society.	[Murphy, Karen E.; Gysbers, Amanda M.; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Murphy, Karen E.; Halliday, Glenda M.] Univ New S Wales, Fac Med, Sch Med Sci, Sydney, NSW, Australia; [Abbott, Sarah K.; Spiro, Adena S.; Garner, Brett] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Abbott, Sarah K.; Spiro, Adena S.; Garner, Brett] Univ Wollongong, Fac Sci Med & Hlth, Sch Biol Sci, Wollongong, NSW, Australia; [Furuta, Akiko; Kabuta, Tomohiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo, Japan; [Cooper, Antony] Garvan Inst Med Res, Sydney, NSW, Australia; [Cooper, Antony] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Cooper, Antony] Univ New S Wales, Fac Sci, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Halliday, GM (reprint author), Neurosci Res Australia, Barker St, Randwick, NSW 2031, Australia.	g.halliday@neura.edu.au	Halliday, Glenda/E-8555-2011	Halliday, Glenda/0000-0003-0422-8398	National Health and Medical Research Council of Australia (NHMRC) [1008307, 1010839]; Ministry of Health, Education, Culture, Sports, Science and Technology, Japan [23590244]; Japan Society for the Promotion of Science [24680038]; University of New South Wales; Rebecca Cooper grant	This work was supported by project grants from the National Health and Medical Research Council of Australia (NHMRC; # 1008307 [to G.M.H. and B.G.] and # 1010839 [to A.A.C.]) and, in part, by a Grant-in-Aid for Scientific Research (C) from the Ministry of Health, Education, Culture, Sports, Science and Technology, Japan (# 23590244; to A.F.), a Grant-in-Aid for Young Scientists (A) from the Japan Society for the Promotion of Science (# 24680038; to T.K.) and a University of New South Wales grant and a Rebecca Cooper grant (to G.M.H.).	Alvarez-Erviti L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.73; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Zhou JX, 2011, ACTA NEUROPATHOL, V121, P695, DOI 10.1007/s00401-011-0815-1; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; HATEM CL, 1995, J CELL SCI, V108, P2093; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Wu GH, 2011, BRAIN RES, V1394, P105, DOI 10.1016/j.brainres.2011.04.013; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; Lue LF, 2012, BRAIN PATHOL, V22, P745, DOI 10.1111/j.1750-3639.2012.00585.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; Huang J, 2012, CLIN BIOCHEM, V45, P1229, DOI 10.1016/j.clinbiochem.2012.06.016; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Kaushik S, 2007, AUTOPHAGY, V3, P387; Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073; Chu YP, 2009, NEUROBIOL DIS, V35, P385, DOI 10.1016/j.nbd.2009.05.023; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI [10.1001/archneurol.2010.198, 10.1001/archneuro1.2010.198]; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Pang SC, 2012, NEUROSCI LETT, V526, P63, DOI 10.1016/j.neulet.2012.07.044; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Fantini J, 2011, BBA-BIOMEMBRANES, V1808, P2343, DOI 10.1016/j.bbamem.2011.06.017; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Abbott SK, 2013, LIPIDS, V48, P307, DOI 10.1007/s11745-013-3760-z; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; Morris JC, 1997, INT PSYCHOGERIATR S, V9, P177; Murphy Karen E, 2013, Acta Neuropathol Commun, V1, P11, DOI 10.1186/2051-5960-1-11; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Sala G, 2014, BRAIN RES, V1546, P46, DOI 10.1016/j.brainres.2013.12.017; The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease, 1997, NEUROBIOL AGING S, V18, pS1	54	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	OCT	2015	30	12					1639	1647		10.1002/mds.26141		9	Clinical Neurology	Neurosciences & Neurology	CU2GU	WOS:000363342800010		
J	Thanabalasingam, D; Kumar, NS; Jayasinghe, L; Fujimoto, Y				Thanabalasingam, Dharushana; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori			Endophytic Fungus Nigrospora oryzae from a Medicinal plant Coccinia grandis, a High Yielding New Source of Phenazine-1-carboxamide	NATURAL PRODUCT COMMUNICATIONS			English	Article						Coccinia grandis; Endophytic fungi; Nigrospora oryzae; Phenazine-l-carboxylic acid; Phenazine-l-carboxamide		Nigrospora oryzae was isolated as an endophytic fungus from the leaves of Coccinia grandis, a popular medicinal plant used to control diabetes. Fermentation of the fungus in potato dextrose broth and chromatographic purification of the ethyl acetate extracts of the broth and mycelium yielded two phenazine secondary metabolites, which were identified as phenazine-l-carboxylic acid (1) and phenazine-l-carboxamide (2) by comparing their spectral data with those reported in the literature. Compound 2, isolated in high yield (1 g/4 L medium), showed strong antifungal activity against the plant pathogen Cladosporium cladosporioides. This is the first report of the isolation of N. oryzae as an endophytic fungus of C. grandis. These phenazines have never been isolated from any fungal source. Antifungal activity of 2 against C. cladosporioides is reported for the first time.	[Thanabalasingam, Dharushana; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori] Inst Fundamental Studies, Kandy, Sri Lanka; [Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Jayasinghe, L (reprint author), Inst Fundamental Studies, Hantana Rd, Kandy, Sri Lanka.	ulbj2003@yahoo.com					MEYER BN, 1982, PLANTA MED, V45, P31, DOI 10.1055/s-2007-971236; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; MAZZOLA M, 1992, APPL ENVIRON MICROB, V58, P2616; Kumar RS, 2005, J APPL MICROBIOL, V98, P145, DOI 10.1111/j.1365-2672.2004.02435.x; Tepe B, 2007, FOOD CHEM, V100, P985, DOI 10.1016/j.foodchem.2005.10.062; D'Abrosca B, 2005, PHYTOCHEMISTRY, V66, P2681, DOI 10.1016/j.phytochem.2005.09.011; HOMANS AL, 1970, J CHROMATOGR, V51, P327, DOI 10.1016/S0021-9673(01)96877-3; Strobel GA, 2003, MICROBES INFECT, V5, P535, DOI 10.1016/S1286-4579(03)00073-X; Raio A, 2011, BIOL CONTROL, V58, P133, DOI 10.1016/j.biocontrol.2011.04.012; Bhardwaj A, 2014, WORLD J PHARM PHARM, V3, P228; Jayaweera DMA, 1980, MED PLANTS USED CE 2; Li DL, 2014, REC NAT PROD, V8, P330; Mazumder P. M., 2008, Natural Product Radiance, V7, P15; Rane MR, 2001, J SCI IND RES INDIA, V66, P627; Rathod DP, 2014, AUSTIN J BIOTECHNOLO, V1, P5; Sachin N, 2013, SCI CORRESPONDENCE, V104, P178; Zhao J, 2010, CURRENT RES TECHNOLO, V1, P567	18	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	OCT	2015	10	10					1659	1660				2	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CU7JZ	WOS:000363713800008		
J	Bandara, HMSKH; Kumar, NS; Jayasinghe, L; Masubuti, H; Fujimoto, Y				Bandara, H. M. S. K. H.; Kumar, N. Savitri; Jayasinghe, Lalith; Masubuti, Hironori; Fujimoto, Yoshinori			A 3-Vinyl Cephem Derivative, a Useful Intermediate in the Synthesis of Cepham Antibiotics, from Aspergillus awamori Associated with Banana Fruit	NATURAL PRODUCT COMMUNICATIONS			English	Article						3-Vinyl cephem; Aspergillus awamori; Musa acuminata; Fungal metabolites; Cepham antibiotics	METABOLITES; NIGER; NIGRAGILLIN; INHIBITORS	Aspergillus awamori was isolated from a diseased banana fruit, Musa acuminata cv. Ambul. The fungus was fermented in potato dextrose broth and on potato dextrose agar media and the fungal media were extracted with EtOAc. Chromatographic separation of the EtOAc extracts furnished 4-methoxybenzyl 7-phenylacetamido-3-vinyl-3-cephem-4-carboxylate (1), along with three naphtho-gamma-pyrones, flavasperone (2), foncesinone A (3) and aurasperone A (4), and three alkaloids, aspernigrin A (5), pestalamide C (6) and nigragillin (7). Compound 1, a known key intermediate in the chemical synthesis of cepham antibiotics, was isolated from a natural source for the first time. Compound 1 is the first 3-vinyl cephem derivative of microbial origin.	[Bandara, H. M. S. K. H.; Kumar, N. Savitri; Jayasinghe, Lalith; Fujimoto, Yoshinori] Inst Fundamental Studies, Kandy, Sri Lanka; [Masubuti, Hironori; Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Jayasinghe, L (reprint author), Inst Fundamental Studies, Hantana Rd, Kandy, Sri Lanka.	ulbj2003@yahoo.com					Aly HA, 2011, FUNGAL DIVERS, V50, P3; Nickavar B, 2008, IRAN J PHARM RES, V7, P297; Siriwardane AMDA, 2015, NAT PROD RES, V29, P1384, DOI 10.1080/14786419.2015.1025230; Chao MY, 2009, ORG PROCESS RES DEV, V13, P924, DOI 10.1021/op900053j; Sakurai M, 2002, J ANTIBIOT, V55, P685; ISOGAI A, 1975, AGR BIOL CHEM TOKYO, V39, P739; Ding G, 2008, J NAT PROD, V71, P1861, DOI 10.1021/np800357g; GHOSAL S, 1979, J AGR FOOD CHEM, V27, P1347, DOI 10.1021/jf60226a018; Lin S, 2014, J FUNCT FOODS, V7, P278, DOI 10.1016/j.jff.2014.02.001; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Campos FR, 2005, MAGN RESON CHEM, V43, P962, DOI 10.1002/mrc.1654; Ye YH, 2005, J NAT PROD, V68, P1106, DOI 10.1021/np050059p; Souza SA, 2013, GENET MOL BIOL, V36, P252, DOI 10.1590/S1415-47572013000200016; TAKAO T, 1994, BIOSCI BIOTECH BIOCH, V58, P1780; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Photita W, 2004, FUNGAL DIVERS, V16, P131; HOMANS AL, 1970, J CHROMATOGR, V51, P327, DOI 10.1016/S0021-9673(01)96877-3; HUANG SP, 1992, J ANTIBIOT, V45, P1939; Song YC, 2004, FEMS MICROBIOL LETT, V241, P67, DOI 10.1016/j.femsle.2004.10.005; Herr A, 2014, METAB ENG, V25, P131, DOI 10.1016/j.ymben.2014.07.002; Núñez-Trujillo G., 2013, Journal of Horticulture, Forestry and Biotechnology, V17, P22; Gaurave K., 2012, INT J PHARM PHARM SC, V4, P659; KOYAMA K, 1988, J PHARMACOBIO-DYNAM, V11, P630; Krishnaraju AV, 2005, INT J APPL SCI ENG, V2, P125; Kumar VJ, 2010, PHARM CHEM, V2, P230; Shaaban Mohamed, 2012, Org Med Chem Lett, V2, P6, DOI 10.1186/2191-2858-2-6; TDeG Baratelli, 2011, BIOCHEM SYST ECOL, V41, P119	27	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	OCT	2015	10	10					1663	1666				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CU7JZ	WOS:000363713800010		
J	Onoda, K; Yamaguchi, S				Onoda, Keiichi; Yamaguchi, Shuhei			Dissociative contributions of the anterior cingulate cortex to apathy and depression: Topological evidence from resting-state functional MRI	NEUROPSYCHOLOGIA			English	Article						Apathy; Depression; Graph theory; Resting state functional MRI; Anterior cingulate cortex; Salience network	CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; BASAL GANGLIA; PARKINSONS-DISEASE; POSTSTROKE APATHY; FRONTOTEMPORAL DEMENTIA; NETWORK CONNECTIVITY; HEALTHY-INDIVIDUALS; PREFRONTAL CORTEX; BRAIN PERFUSION	Apathy is defined as a mental state characterized by a lack of goal-directed behavior. However, the underlying mechanisms of apathy remain to be fully understood. Apathy shares certain symptoms with depression and both these affective disorders are known to be associated with dysfunctions of the frontal cortex-basal ganglia circuits. It is expected that clarifying differences in neural mechanisms between the two conditions would lead to an improved understanding of apathy. The present study was designed to investigate whether apathy and depression depend on different network properties of the frontal cortex-basal ganglia circuits, by using resting state fMRI. Resting-state fMRI measurement and neuropsychological testing were conducted on middle-aged and older adults (N=392). Based on graph theory, we estimated nodal efficiency (functional integration), local efficiency (functional segregation), and betweenness centrality. We conducted multiple regression analyses for the network parameters using age, sex, apathy, and depression as predictors. Interestingly, results indicated that the anterior cingulate cortex showed lower nodal efficiency, local efficiency, and betweenness centrality in apathy, whereas in depression, it showed higher nodal efficiency and betweenness centrality. The anterior cingulate cortex constitutes the so-called "salience network", which detects salient experiences. Our results indicate that apathy is characterized by decreased salience-related processing in the anterior cingulate cortex, whereas depression is characterized by increased salience-related processing. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Onoda, Keiichi; Yamaguchi, Shuhei] Shimane Univ, Dept Neurol, Izumo, Shimane 6938501, Japan	Onoda, K (reprint author), Shimane Univ, Dept Neurol, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	onodak1@med.shimane-u.ac.jp			Japan Society for the Promotion of Science [26870375]	This study was supported by Grants-in-Aid for Scientific Research of Japan Society for the Promotion of Science (Grant number: 26870375). None of the authors have any conflict of interest regarding the findings presented in this manuscript.	Hama S, 2007, INT J GERIATR PSYCH, V22, P1046, DOI 10.1002/gps.1866; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Ott BR, 1996, J NEUROPSYCH CLIN N, V8, P41; Farb NAS, 2013, CORTEX, V49, P1856, DOI 10.1016/j.cortex.2012.09.008; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Stanton BR, 2013, J NEUROL, V260, P2481, DOI 10.1007/s00415-013-6989-9; Benoit M, 2002, PSYCHIAT RES-NEUROIM, V114, P103, DOI 10.1016/S0925-4927(02)00003-3; Bora E, 2012, PSYCHOL MED, V42, P671, DOI 10.1017/S0033291711001668; Spalletta G, 2013, HUM BRAIN MAPP, V34, P3193, DOI 10.1002/hbm.22137; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Kim JW, 2011, AM J GERIAT PSYCHIAT, V19, P644, DOI 10.1097/JGP.0b013e31820dcc73; Kang JY, 2012, ALZ DIS ASSOC DIS, V26, P217, DOI 10.1097/WAD.0b013e318231e5fc; Benoit M, 2004, INT J GERIATR PSYCH, V19, P864, DOI 10.1002/gps.1163; Harris AL, 2014, TRANSL STROKE RES, V5, P292, DOI 10.1007/s12975-013-0293-y; Hama S, 2011, PSYCHOGERIATRICS, V11, P68, DOI 10.1111/j.1479-8301.2011.00358.x; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5; Massimo L, 2009, DEMENT GERIATR COGN, V27, P96, DOI 10.1159/000194658; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Tunnard C, 2011, INT J GERIATR PSYCH, V26, P741, DOI 10.1002/gps.2603; Grool AM, 2014, NEUROLOGY, V82, P1628, DOI 10.1212/WNL.0000000000000378; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Dubois B, 2000, NEUROLOGY, V55, P1621; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lanctot KL, 2007, DEMENT GERIATR COGN, V24, P65, DOI 10.1159/000103633; Wigg CMD, 1999, ARQ NEURO-PSIQUIAT, V57, P547, DOI 10.1590/S0004-282X1999000400002; Ota M, 2012, INT J GERIATR PSYCH, V27, P722, DOI 10.1002/gps.2779; Peters F, 2006, DEMENT GERIATR COGN, V21, P373, DOI 10.1159/000091898; Marshall GA, 2007, ARCH NEUROL-CHICAGO, V64, P1015, DOI 10.1001/archneur.64.7.1015; Starkstein SE, 2006, J NEUROL NEUROSUR PS, V77, P8, DOI 10.1136/jnnp.2005.069575; Ohtani T, 2014, SCHIZOPHR RES, V157, P190, DOI 10.1016/j.schres.2014.05.016; Holthoff VA, 2005, BIOL PSYCHIAT, V57, P412, DOI 10.1016/j.biopsych.2004.11.035; Kostic VS, 2011, J NEUROL SCI, V310, P61, DOI [10.1016/j.jns.2011.05.036, 10.1016/j.jns.2011.08.036]; Caeiro L, 2013, CEREBROVASC DIS, V35, P23, DOI 10.1159/000346076; Delmaire C, 2013, HUM BRAIN MAPP, V34, P2141, DOI 10.1002/hbm.22055; Okada K, 1997, STROKE, V28, P2437; Onoda K, 2011, CEREBROVASC DIS, V31, P6, DOI 10.1159/000319771; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Alexopoulos GS, 2013, J AFFECT DISORDERS, V149, P398, DOI 10.1016/j.jad.2012.11.023; de Marco G, 2006, NEUROIMAGE, V30, P1030, DOI 10.1016/j.neuroimage.2005.10.001; PORRINO LJ, 1981, J COMP NEUROL, V198, P121, DOI 10.1002/cne.901980111; Skidmore FM, 2013, NEUROIMAGE, V81, P484, DOI 10.1016/j.neuroimage.2011.07.012; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Paz R, 2013, CURR OPIN NEUROBIOL, V23, P381, DOI [10.1016/j.conb.2013.01.008, 10.1016/j.conb.2013.1.008]; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Adams KB, 2001, GERONTOLOGIST, V41, P768; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Apostolova LG, 2007, DEMENT GERIATR COGN, V24, P91, DOI 10.1159/000103914; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335; Tagariello P, 2009, ARCH GERONTOL GERIAT, V49, P246, DOI 10.1016/j.archger.2008.09.002; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Kenny ER, 2010, AM J GERIAT PSYCHIAT, V18, P643, DOI 10.1097/JGP.0b013e3181cabd0e; Baggio HC, 2015, MOVEMENT DISORD, V30, P671, DOI 10.1002/mds.26137; BECHTOLDT HP, 1962, PSYCHOL REC, V12, P147; Bohr Iwo Jerzy, 2012, Front Psychiatry, V3, P116, DOI 10.3389/fpsyt.2012.00116; Buckner Randy L, 2013, Dialogues Clin Neurosci, V15, P351; Dutta A, 2014, PSYCHIAT RES-NEUROIM, V224, P139, DOI 10.1016/j.pscychresns.2014.10.003; [Anonymous], 1975, J PSYCHIATR RES, DOI DOI 10.1016/0022-3956(75)90026-6; Horn D. I., 2010, FRONT SYST NEUROSCI, V4, P33, DOI DOI 10.3389/FNSYS.2010.00033; Kamat R, 2014, J CLIN EXP NEUROPSYC, V36, P854, DOI 10.1080/13803395.2014.950636; Kobayashi S, 1987, JPN J NEUROPSYCHOL, V3, P67; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Marin R.S., 1991, J NEUROPSYCHIATRY CL, V3, P243; Murakami T., 2012, AM J GERIAT PSYCHIAT, V21, P1; Okada K, 1998, JPN J STROKE, V20, P318; Pennuto M., 2013, PSYCHOL MED, P1; Siegel JS, 2014, NEUROIMAGE-CLIN, V6, P320, DOI 10.1016/j.nicl.2014.09.012; Yang S., 2014, EUR J NEUROL, V22, P341; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63	76	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	OCT	2015	77						10	18		10.1016/j.neuropsychologia.2015.07.030		9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Behavioral Sciences; Neurosciences & Neurology; Psychology	CU8SX	WOS:000363815500002		
J	Miyatani, F; Kuriyama, N; Watanabe, I; Nomura, R; Nakano, K; Matsui, D; Ozaki, E; Koyama, T; Nishigaki, M; Yamamoto, T; Mizuno, T; Tamura, A; Akazawa, K; Takada, A; Takeda, K; Yamada, K; Nakagawa, M; Ihara, M; Kanamura, N; Friedland, RP; Watanabe, Y				Miyatani, F.; Kuriyama, N.; Watanabe, I.; Nomura, R.; Nakano, K.; Matsui, D.; Ozaki, E.; Koyama, T.; Nishigaki, M.; Yamamoto, T.; Mizuno, T.; Tamura, A.; Akazawa, K.; Takada, A.; Takeda, K.; Yamada, K.; Nakagawa, M.; Ihara, M.; Kanamura, N.; Friedland, R. P.; Watanabe, Y.			Relationship between Cnm-positive Streptococcus mutans and cerebral microbleeds in humans	ORAL DISEASES			English	Article						Cnm-positive Streptococcus Mutans; microbleeds; collagen-binding protein; Magnetic Resonance Imaging; stroke intracranial hemorrhage	RISK-FACTORS; HEMORRHAGIC STROKE; ISCHEMIC-STROKE; ROTTERDAM SCAN; ECHO MRI; ASSOCIATION; PREVALENCE; LEUKOARAIOSIS; INFLAMMATION; DYSFUNCTION	OBJECTIVE: Cerebral hemorrhage has been shown to occur in animals experimentally infected with Streptococcus mutans carrying the collagen-binding Cnm gene. However, the relationship between cerebral microbleeds and oral hygiene, with a focus on Cnm gene-positive S. mutans infection, remains unclear. MATERIAL AND METHODS: One hundred and thirty-nine subjects participated. The presence or absence of Cnm-positive S. mutans and its collagen-binding activity were investigated using saliva samples, and relationship with cerebral microbleeds detected on MRI investigated, including clinical information and oral parameters. RESULTS: Fifty-one subjects were identified as Cnm-positive S. mutans carriers (36.7%), with cerebral microbleeds being detected in 43 (30.9%). A significantly larger number of subjects carried Cnm-positive S. mutans in the cerebral microbleeds (+) group. S. mutans with Cnm collagen-binding ability was detected in 39 (28.1%) of all subjects, and the adjusted odds ratio for cerebral microbleeds in the Cnm-positive group was 14.4. Regarding the presence of cerebral microbleeds, no significant differences were noted in the number of remaining teeth, dental caries, or in classic arteriosclerosis risk factors. CONCLUSIONS: The occurrence of cerebral microbleeds was higher in subjects carrying Cnm-positive S. mutans, indicating that the presence of Cnm-positive S. mutans increases cerebral microbleeds, and is an independent risk for the development of cerebrovascular disorders.	[Miyatani, F.; Watanabe, I.; Matsui, D.; Nishigaki, M.; Yamamoto, T.; Kanamura, N.] Kyoto Prefectural Univ Med, Dept Dent Med, Kyoto 6028566, Japan; [Miyatani, F.; Kuriyama, N.; Watanabe, I.; Matsui, D.; Ozaki, E.; Koyama, T.; Watanabe, Y.] Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kyoto 6028566, Japan; [Nomura, R.; Nakano, K.] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Osaka, Japan; [Kuriyama, N.; Mizuno, T.; Tamura, A.; Nakagawa, M.] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Akazawa, K.; Takeda, K.] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan; [Takada, A.; Takeda, K.] Kyoto Ind Hlth Assoc, Kyoto 6048472, Japan; [Ihara, M.] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan; [Friedland, R. P.] Univ Louisville, Dept Neurol, Louisville, KY 40292 USA	Kuriyama, N (reprint author), Kyoto Prefectural Univ Med, Dept Epidemiol Community Hlth & Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	nkuriyam@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0001, 14448834];  [17015018];  [23390176]	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas of Cancer (17015018) and on Innovative Areas (221S0001) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, a Grant-in-Aid for Scientific Research (B) (23390176), and Grant-in-Aid for Young Scientists (B) (14448834) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4289; Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Jeerakathil T, 2004, STROKE, V35, P1831, DOI 10.1161/01.STR.0000131809.35202.1b; Ohshima Y, 2013, J NUTR HEALTH AGING, V17, P456, DOI 10.1007/s12603-012-0419-z; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Kim CK, 2012, J NEUROL, V259, P2599, DOI 10.1007/s00415-012-6546-y; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Gregoire SM, 2012, CEREBROVASC DIS, V33, P430, DOI 10.1159/000336237; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/aw1387; Poels MMF, 2012, NEUROLOGY, V78, P326, DOI 10.1212/WNL.0b013e3182452928; Tanaka A, 1999, STROKE, V30, P1637; Kuriyama N, 2013, ARCH GERONTOL GERIAT, V56, P55, DOI 10.1016/j.archger.2011.11.009; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; TANAKA H, 1982, STROKE, V13, P62; Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789; Naka H, 2004, AM J NEURORADIOL, V25, P714; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; SHINTON R, 1989, BRIT MED J, V298, P789; Shoamanesh A, 2015, NEUROLOGY, V84, P825, DOI 10.1212/WNL.0000000000001279; Yamashiro Kazuo, 2014, Cerebrovasc Dis Extra, V4, P212, DOI 10.1159/000369294; Yates Paul A, 2014, Front Neurol, V4, P205, DOI 10.3389/fneur.2013.00205	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	OCT	2015	21	7					886	893		10.1111/odi.12360		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CU7SO	WOS:000363742000009		
J	Tomizawa, D				Tomizawa, Daisuke			Recent progress in the treatment of infant acute lymphoblastic leukemia	PEDIATRICS INTERNATIONAL			English	Review						acute lymphoblastic leukemia; epigenetics; hematopoietic stem cell transplantation; infant; mixed lineage leukemia	STEM-CELL TRANSPLANTATION; CHILDRENS ONCOLOGY GROUP; MLL GENE REARRANGEMENTS; MINIMAL RESIDUAL DISEASE; HEMATOPOIETIC-CELL; PROGNOSTIC-SIGNIFICANCE; FUSION LEUKEMIA; FLT3 EXPRESSION; JAPAN; RISK	Treatment of infants with acute lymphoblastic leukemia (ALL), especially those with mixed lineage leukemia (MLL) rearrangement (MLL-r), which account for approximately 80% of cases, is still a major challenge for pediatric hematologists and oncologists worldwide. Continuing efforts by collaborative clinical study groups in Europe, North America, and Japan have rescued approximately half of the MLL-r ALL patients with intensive chemotherapy with or without allogeneic hematopoietic stem cell transplantation. Recent progress has clarified the unique mechanism of MLL-r ALL: the aberrant methylation and histone modifications via DOT1L and other related molecules by MLL fusion proteins lead to leukemogenetic gene expression, thus to overt leukemia. In order to overcome this dismal subtype of ALL, novel targeted therapy based on leukemia biology is urgently needed. Due to the extreme rarity of the disease, collaboration between the study groups in Europe (Interfant), North America (Children's Oncology Group), and Japan (Japanese Pediatric Leukemia/Lymphoma Study Group) is under way.	[Tomizawa, Daisuke] Natl Ctr Child Hlth & Dev, Div Leukemia & Lymphoma, Childrens Canc Ctr, Tokyo 1578535, Japan	Tomizawa, D (reprint author), Natl Ctr Child Hlth & Dev, Div Leukemia & Lymphoma, Childrens Canc Ctr, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	tomizawa-d@ncchd.go.jp			Cancer Research from Ministry of Health, Labour, and Welfare of Japan; Clinical Cancer Research	The author acknowledges all the individuals who were involved in infant ALL studies in Japan, especially Drs Eiichi Ishii (Department of Pediatrics, Ehime University Graduate School of Medicine) and Katsuyoshi Koh (Department of Hematology/Oncology, Saitama Children's Medical Center) for their strong leadership. Infant ALL studies in Japan are supported by Grants for Clinical Cancer Research and Grants-in-Aid for Cancer Research from the Ministry of Health, Labour, and Welfare of Japan. The author also acknowledges Dr Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for critical comments and assistance with the manuscript. The author declares that he has no conflicts of interest.	Hilden JM, 2006, BLOOD, V108, P441, DOI 10.1182/blood-2005-07-3011; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Van der Velden VHJ, 2009, LEUKEMIA, V23, P1073, DOI 10.1038/leu.2009.17; Dordelmann M, 1999, BLOOD, V94, P1209; Kawashima N, 2013, INT J HEMATOL, V97, P147, DOI 10.1007/s12185-012-1246-z; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; Kato M, 2015, BRIT J HAEMATOL, V168, P564, DOI 10.1111/bjh.13174; Stam RW, 2005, BLOOD, V106, P2484, DOI 10.1182/blood-2004-09-3667; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Sanders JE, 2005, BLOOD, V105, P3749, DOI 10.1182/blood-2004-08-3312; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Stam RW, 2007, BLOOD, V110, P2774, DOI 10.1182/blood-2007-05-091934; Brown P, 2005, BLOOD, V105, P812, DOI 10.1182/blood-2004-06-2498; ISHII E, 1991, MED PEDIATR ONCOL, V19, P28, DOI 10.1002/mpo.2950190106; Taki T, 1996, LEUKEMIA, V10, P1303; Tomizawa D, 2009, PEDIATR BLOOD CANCER, V52, P808, DOI 10.1002/pbc.21975; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Dreyer ZE, 2011, J CLIN ONCOL, V29, P214, DOI 10.1200/JCO.2009.26.8938; Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Kikuchi A, 2009, INT J HEMATOL, V90, P492, DOI 10.1007/s12185-009-0402-6; Stumpel DJPM, 2012, LEUKEMIA, V26, P682, DOI 10.1038/leu.2011.278; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Nagayama J, 2006, BLOOD, V107, P4663, DOI 10.1182/blood-2005-11-4728; Lonnerholm G, 2009, PEDIATR BLOOD CANCER, V52, P596, DOI 10.1002/pbc.21925; Spector LG, 2005, CANCER EPIDEM BIOMAR, V14, P651, DOI 10.1158/1055-9965.EPI-04-0602; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Nishimura S, 1999, INT J HEMATOL, V69, P244; Salzer WL, 2012, PEDIATR BLOOD CANCER, V59, P834, DOI 10.1002/pbc.24132; Tomizawa D, 2007, LEUKEMIA, V21, P2258, DOI 10.1038/sj.leu.2404903; Corker E, 2012, BRIT J HAEMATOL, V159, P104, DOI 10.1111/j.1365-2141.2012.09228.x; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; Horibe K, 2013, INT J HEMATOL, V98, P74, DOI 10.1007/s12185-013-1364-2; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Greaves MF, 2003, BLOOD, V102, P2321, DOI 10.1182/blood-2002-12-3817; Sakaki H, 2009, INT J HEMATOL, V90, P653, DOI 10.1007/s12185-009-0446-7; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Meyer C, 2013, LEUKEMIA, V27, P2165, DOI 10.1038/leu.2013.135; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Isoyama K, 2002, BRIT J HAEMATOL, V118, P999, DOI 10.1046/j.1365-2141.2002.03754.x; Pieters R, 1998, LEUKEMIA, V12, P1344, DOI 10.1038/sj.leu.2401129; Vora A, 2013, LANCET ONCOL, V14, P199, DOI 10.1016/S1470-2045(12)70600-9; Koh K, 2015, LEUKEMIA, V29, P290, DOI 10.1038/leu.2014.172; Kosaka Y, 2004, BLOOD, V104, P3527, DOI 10.1182/blood-2004-04-1390; Pieters R, 2007, LANCET, V370, P240, DOI 10.1016/S0140-6736(07)61126-X; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Stumpel DJPM, 2013, EUR J CANCER, V49, P175, DOI 10.1016/j.ejca.2012.07.013; Aoki Y, 2014, BLOOD, V125, P967; Dreyer ZE, 2015, PEDIATR BLOOD CANCER, V62, P419, DOI 10.1002/pbc.25322; Hoffman Lindsey M, 2014, Front Oncol, V4, P63, DOI 10.3389/fonc.2014.00063; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; De Lorenzo P, 2014, LEUKEMIA, V28, P428, DOI 10.1038/leu.2013.280; Mori M, 2014, PEDIATR INFECT DIS J, V33, P1183, DOI 10.1097/INF.0000000000000392; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; VansDongen JJ, 1998, LANCET, V352, P1731	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					811	819		10.1111/ped.12758		9	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600001		
J	Yokoyama, U				Yokoyama, Utako			Prostaglandin E-mediated molecular mechanisms driving remodeling of the ductus arteriosus	PEDIATRICS INTERNATIONAL			English	Review						arterial intima; ductus arteriosus; prostaglandin E; prostanoid receptor EP4; vascular remodeling	SMOOTH-MUSCLE-CELLS; GESTATIONAL-AGE; EP4 RECEPTOR; IN-VIVO; PROSTANOID RECEPTORS; EXTRACELLULAR-MATRIX; NEOINTIMAL FORMATION; VASCULAR-TONE; FETAL RABBIT; EXPRESSION	The ductus arteriosus (DA), a fetal arterial connection between the pulmonary arteries and aorta, normally closes after birth. Persistent DA patency usually has life-threatening consequences. In certain DA-dependent congenital heart diseases, however, patient survival depends on maintaining DA patency. Complete closure of the DA involves both functional closure, induced by muscle contraction, and anatomical closure, achieved through morphological and molecular remodeling. Anatomical closure of the DA is associated with the formation of intimal thickening, which is characterized by deposition of extracellular matrix in the subendothelial region, sparse elastic fiber formation, and migration of medial smooth muscle cells into the subendothelial space. In addition, fetal molecular remodeling that is suitable for postnatal muscle contraction has been observed in the DA. After the second trimester, high concentration of prostaglandin E-2 (PGE(2)) causes the DA to dilate through the remainder of the fetal period. Emerging evidence from studies using pharmacological approaches and genetically modified mice suggests that, in addition to its vasodilatory effect, this chronic exposure to PGE(2) promotes DA-specific anatomical and molecular remodeling through EP4, one of four receptor subtypes for PGE(2). Signals that are downstream of PGE(2)-EP4, such as cyclic AMP (cAMP)-protein kinase A (PKA), exchange protein activated by cAMP (Epac), phospholipase C, and Wnt/-catenin, may be involved in the regulation of intimal thickening, elastogenesis, and contraction-related genes. Understanding the physiological role of PGE(2) in DA remodeling could enable more effective regulation of PDA, both in isolation and in the context of congenital cardiac anomalies.	[Yokoyama, Utako] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan	Yokoyama, U (reprint author), Yokohama City Univ, Cardiovasc Res Inst, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	utako@yokohama-cu.ac.jp			Ministry of Health, Labor and Welfare of Japan; Yokohama Foundation for Advanced Medical Science; Kanae Foundation for the Promotion for Medical Science; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Vehicle Racing Commemorative Foundation	The author is grateful to Yoshihiro Ishikawa and Susumu Minamisawa for instruction and support. This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Health, Labor and Welfare of Japan and by grants from Yokohama Foundation for Advanced Medical Science, Kanae Foundation for the Promotion for Medical Science, Miyata Cardiology Research Promotion Funds, Takeda Science Foundation, and Vehicle Racing Commemorative Foundation. The author declares no conflicts of interest.	COCEANI F, 1978, PROSTAGLANDINS, V15, P551, DOI 10.1016/0090-6980(78)90051-5; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JCI33304, 10.1172/JC133304]; Kurzrok R, 1930, P SOC EXP BIOL MED, V28, P268; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; FRIEDMAN WF, 1976, NEW ENGL J MED, V295, P526, DOI 10.1056/NEJM197609022951003; Jager BV, 1942, AM J PATHOL, V18, P595; BUTCHER RW, 1968, J BIOL CHEM, V243, P1713; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; CLYMAN RI, 1978, PROSTAGLANDINS, V16, P259, DOI 10.1016/0090-6980(78)90028-X; CLYMAN RI, 1980, J PEDIATR-US, V97, P455, DOI 10.1016/S0022-3476(80)80205-8; SILVER MM, 1981, HUM PATHOL, V12, P1123; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Leonhardt A, 2003, BRIT J PHARMACOL, V138, P655, DOI 10.1038/sj.bjp.0705092; TODA T, 1980, J ANAT, V131, P25; NAKANISHI T, 1993, CIRC RES, V72, P1218; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; HONDA A, 1993, J BIOL CHEM, V268, P7759; Smith GCS, 1998, PHARMACOL REV, V50, P35; WALSH RS, 1987, SURGERY, V102, P313; TADA T, 1990, ACTA ANAT, V139, P326; Momma K, 2005, PEDIATR RES, V58, P971, DOI 10.1203/01.pdr.0000182182.49476.24; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Momma K, 2009, NEONATOLOGY, V96, P69, DOI 10.1159/000203336; COCEANI F, 1986, CAN J PHYSIOL PHARM, V64, P737; Reeve HL, 2001, J PHYSIOL-LONDON, V533, P253, DOI 10.1111/j.1469-7793.2001.0253b.x; Michelakis E, 2000, LANCET, V356, P134, DOI 10.1016/S0140-6736(00)02452-1; COCEANI F, 1973, CAN J PHYSIOL PHARM, V51, P220; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Kajino H, 2004, PEDIATR RES, V56, P586, DOI 10.1203/01.PDR.0000139409.25014.35; Reese J, 2009, PEDIATR RES, V66, P155, DOI 10.1203/PDR.0b013e3181aa07eb; Goldbarg S, 2003, PEDIATR RES, V54, P204, DOI 10.1203/01.PDR.0000072519.61060.E5; TristaniFirouzi M, 1996, J CLIN INVEST, V98, P1959, DOI 10.1172/JCI118999; Bokenkamp R, 2006, PEDIATR RES, V60, P407, DOI 10.1203/01.pdr.0000238243.37116.a6; Yokoyama U, 2008, J BIOL CHEM, V283, P28702, DOI 10.1074/jbc.M804223200; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Ichikawa Y, 2012, CIRC J, V76, P2456, DOI 10.1253/circj.CJ-12-0215; Yokoyama U, 2014, CIRCULATION, V129, P487, DOI 10.1161/CIRCULATIONAHA.113.004726; Clyman RI, 2001, CIRCULATION, V103, P1806; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003; SMITH GCS, 1994, J PHARMACOL EXP THER, V271, P390; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Bouayad A, 2001, SEMIN PERINATOL, V25, P70, DOI 10.1053/sper.2001.23186; DEREEDER EG, 1988, AM J PATHOL, V132, P574; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Banu SK, 2009, MOL ENDOCRINOL, V23, P1291, DOI 10.1210/me.2009-0017; TADA T, 1985, ACTA PATHOL JAPON, V35, P23; BERGSTROM S, 1957, ACTA CHEM SCAND, V11, P1086, DOI 10.3891/acta.chem.scand.11-1086; KIM HS, 1993, CIRCULATION, V88, P1804; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Yokoyama U, 2008, AM J PHYSIOL-HEART C, V295, pH1547, DOI 10.1152/ajpheart.01317.2007; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Yokoyama U, 2010, CIRC RES, V106, P1882, DOI 10.1161/CIRCRESAHA.109.214924; Momma K, 2005, PROSTAG OTH LIPID M, V78, P117, DOI 10.1016/j.prostaglandins.2005.04.006; Nguyen MT, 1997, NATURE, V390, P78; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Smith GCS, 2001, J CARDIOVASC PHARM, V37, P697, DOI 10.1097/00005344-200106000-00007; Loftin CD, 2001, P NATL ACAD SCI USA, V98, P1059, DOI 10.1073/pnas.031573498; Gruzdev A, 2012, PROSTAG OTH LIPID M, V97, P109, DOI 10.1016/j.prostaglandins.2012.02.001; Rheinlaender C, 2006, PEDIATR RES, V60, P270, DOI 10.1203/01.pdr.0000233066.28496.7c; ELLIOTT RB, 1975, LANCET, V1, P140; Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Hammerman C, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.5.e56; Bhattacharya M, 1999, CIRCULATION, V100, P1751; Chen JX, 2012, PEDIATR RES, V72, P122, DOI 10.1038/pr.2012.58; desReeder EG, 1990, ANAT EMBRYOL BERL, V182, P473; desRooij J, 1998, NATURE, V396, P474; GITTENBERGERDEGROOT AC, 1985, J AM COLL CARDIOL, V6, P394; GITTENBERGERDEGROOT AC, 1980, CIRCULATION, V62, P183; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; GITTENBERGERDEGROOT AC, 1978, BRIT HEART J, V40, P215; GITTENBERGERDEGROOT AC, 1977, BRIT HEART J, V39, P610; Hermes- DeSantis ER, 2006, J PERINATOL S1, V26, pS22; Hermes-DeSantis ER, 2006, J PERINATOL, V26, pS14, DOI 10.1038/sj.jp.7211465; Klapholz-Brown Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000945; VAN DORPD, 1964, Biochim Biophys Acta, V90, P204	82	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					820	827		10.1111/ped.12769		8	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600002		
J	Oue, T; Fukuzawa, M; Koshinaga, T; Okita, H; Nozaki, M; Chin, M; Kaneko, Y; Tanaka, Y; Haruta, M; Tsuchiya, K; Kuwajima, S; Takimoto, T				Oue, Takaharu; Fukuzawa, Masahiro; Koshinaga, Tsugumichi; Okita, Hajime; Nozaki, Miwako; Chin, Motoki; Kaneko, Yasuhiko; Tanaka, Yukichi; Haruta, Masayuki; Tsuchiya, Kunihiko; Kuwajima, Shigeko; Takimoto, Tetsuya			Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group	PEDIATRICS INTERNATIONAL			English	Review						prognostic factor; rhabdoid tumor of the kidney; risk classification; treatment; Wilms tumor	HISTOLOGY	The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter cooperative study was initiated thereafter. JWiTS-1 (1996-2005) was analyzed, and JWiTS-2 (2005-2014) is now under analysis; the following problems have been identified and used to decide future study protocol: (i) there has been a decline in survival rate for patients with rhabdoid tumor of the kidney (RTK) and new treatment strategies are required; (ii) the survival rate for bilateral Wilms tumors (BWT) has improved, but results for renal preservation are unsatisfactory; (iii) the prognosis of stage IV favorable nephroblastoma is very good, suggesting that the current protocols provide overtreatment, particularly for patients with lung metastasis; and (iv) no effective biological risk factors exist for predicting the outcome of Wilms tumor, and a study of the genetic changes of these tumors is necessary to determine biological markers for use in risk classification. To solve these issues, the development of a new risk classification of pediatric renal tumors is required. In addition, different study protocols should be developed according to the risk-based classification of the patients. Further, a new study protocol for BWT began in 2015, and new study protocols are being prepared for RTK, and for Wilms tumor with lung metastasis. In addition, an analysis of biological markers with regard to risk classification is to be performed. Furthermore, to create new protocols for patients with rare renal tumors, international collaboration with Children's Oncology Group and International Society of Pediatric Oncology is necessary.	[Oue, Takaharu; Fukuzawa, Masahiro; Koshinaga, Tsugumichi; Okita, Hajime; Nozaki, Miwako; Chin, Motoki; Kaneko, Yasuhiko; Tanaka, Yukichi; Haruta, Masayuki; Tsuchiya, Kunihiko; Kuwajima, Shigeko; Takimoto, Tetsuya] Japan Wilms Tumor Study Grp JWiTS, Tokyo, Japan	Oue, T (reprint author), Hyogo Coll Med, Dept Pediat Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ta-oue@hyo-med.ac.jp			Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED	This research is partially supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development, AMED. The authors declare no conflicts of interest.	Yamamoto M, 2006, J PEDIAT HEMATOL ONC, V28, P286, DOI 10.1097/01.mph.0000212901.84146.5a; Shamberger RC, 1999, ANN SURG, V229, P292, DOI 10.1097/00000658-199902000-00019; Watanabe K, 2013, INT J CLIN ONCOL, V18, P955, DOI 10.1007/s10147-013-0616-8; Kinoshita Y, 2012, J PEDIATR SURG, V47, P2205, DOI 10.1016/j.jpedsurg.2012.09.009; Oue T, 2009, PEDIATR SURG INT, V25, P923, DOI 10.1007/s00383-009-2449-0; Ohshima J, 2012, PEDIATR BLOOD CANCER, V59, P499, DOI 10.1002/pbc.24093; Grundy PE, 2012, PEDIATR BLOOD CANCER, V59, P631, DOI 10.1002/pbc.24123; DANGIO GJ, 1976, CANCER, V38, P633, DOI 10.1002/1097-0142(197608)38:2<633::AID-CNCR2820380203>3.0.CO;2-S; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; D'Angio GJ, 2007, LIFETIME DATA ANAL, V13, P463, DOI 10.1007/s10985-007-9062-0; Oue T, 2014, PEDIATR BLOOD CANCER, V61, P1184, DOI [10.1002/pbc.24979, 10.1002/pbc.24971]; Dome Jeffrey S, 2014, Am Soc Clin Oncol Educ Book, P215, DOI 10.14694/EdBook_AM.2014.34.215; Grundy Paul, 2005, Curr Probl Cancer, V29, P221; Malempati S, 2012, PEDIAT BLOOD CANC, V15, P5; van den Heuvel-Eibrink MM, 2011, PEDIATR BLOOD CANCER, V56, P733, DOI 10.1002/pbc.22922	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					828	831		10.1111/ped.12787		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600003		
J	Tanoue, K; Matsui, K				Tanoue, Koji; Matsui, Kiyoshi			Differences between abusive head trauma and physical abuse in Japan	PEDIATRICS INTERNATIONAL			English	Article						abusive head trauma; child abuse; physical abuse; risk factor	SHAKEN-BABY-SYNDROME; AGE-RELATED INCIDENCE; YOUNG-CHILDREN; CHANGE KNOWLEDGE; CONTROLLED-TRIAL; UNITED-STATES; POPULATION; CHILDHOOD; SHAKING; PARENTS	Background We examined differences in characteristics between abusive head trauma (AHT) and physical abuse (PA). Methods We examined 45 AHT patients and 119 PA patients during the period 1 April 2000-31 March 2014, at Kanagawa Children's Medical Center (Kanagawa, Japan). We compared patient age, young maternal or parental age, being the first child, child factors (chronic illness, developmental disabilities and preterm birth), parental factors (substance abuse/alcohol abuse and depression or other mental illness), environmental factors (single-parent home, non-biologically related man living in the home and family or intimate partner violence). Logistic regression was used to examine predictors of differences between AHT and PA for children <1year of age. Results There were differences in characteristics between AHT and PA in those <1year old in child factors (OR, 3.47; 95%CI: 1.01-11.9) and environmental factors (OR, 14.2; 95%CI: 1.45-139). Conclusions The risk factors for AHT differ from those of PA. We speculate that AHT is not merely physical abuse of young infants; the characteristics of AHT differ significantly from those of PA. These observations are important for understanding and thereby preventing child abuse.	[Tanoue, Koji; Matsui, Kiyoshi] Kanagawa Childrens Med Ctr, Dept Gen Med, Mutsukawa, Kanagawa, Japan	Tanoue, K (reprint author), Kanagawa Childrens Med Ctr, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	ktanoue@kcmc.jp			Kanagawa Prefectural Hospitals Child Health Care and Research Fund	This study was supported by Kanagawa Prefectural Hospitals Child Health Care and Research Fund. The authors declare no conflicts of interest.	KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Flaherty EG, 2010, PEDIATRICS, V126, P833, DOI 10.1542/peds.2010-2087; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Barr RG, 2005, J DEV BEHAV PEDIATR, V26, P14; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; St James-Roberts I, 2006, PEDIATRICS, V117, pE1146, DOI 10.1542/peds.2005-2387; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; SCHMITT BD, 1987, CHILD ABUSE NEGLECT, V11, P421, DOI 10.1016/0145-2134(87)90015-9; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; CICCHETTI D, 1995, J AM ACAD CHILD PSY, V34, P541, DOI 10.1097/00004583-199505000-00008; Dias Mark S, 2005, Pediatrics, V115, pe470, DOI 10.1542/peds.2004-1896; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Krugman RD, 1985, PEDIATRICIAN, V12, P68; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					845	848		10.1111/ped.12632		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600006		
J	Liu, JF; Sekine, M; Tatsuse, T; Fujimura, Y; Hamanishi, S; Zheng, XY				Liu, Jufen; Sekine, Michikazu; Tatsuse, Takashi; Fujimura, Yuko; Hamanishi, Shimako; Zheng, Xiaoying			Association among number, order and type of siblings and adolescent mental health at age 12	PEDIATRICS INTERNATIONAL			English	Article						birth cohort; mental health; quality of life; sibling	TOYAMA BIRTH COHORT; QUALITY-OF-LIFE; HIGH-SCHOOL STUDENTS; GENDER-DIFFERENCES; CHILDREN; CHILDHOOD; DEPRESSION; JAPAN; VICTIMIZATION; OVERWEIGHT	Background Although the sibling relationship is a unique one, the effects of the number and type of siblings on mental health among adolescents have not been reported. Methods Japanese children (total, 9276; boys, 4654; girls, 4622), all 12years old, and from the Japanese Toyama Birth Cohort Study, were followed up until 2002. Subject self-reported mental health was obtained from the Japanese version of the Dartmouth Primary Care Co-operative Project (COOP) charts. The associations between number and type of siblings and self-reported mental health were examined. Results There was a significant difference in mental health between different sibling pairs, with brother pairs and brother/sister pairs having a positive effect on adolescent mental health, compared with those in sister pairs. Girls with brothers had better self-reported mental health than those without. The adjusted OR of good mental health was 1.44 (95%CI:1.00-2.08) for those with an older brother and 1.67 (95%CI: 1.17-2.38) for those with a younger brother compared with those without. Boys with a younger sister had a higher OR of good self-reported health than those without (OR,1.62; 95%CI: 1.08-2.43). Conclusions Children with siblings had better mental health status than those without, which has practical implications for Asian countries and worldwide considering the declining fertility.	[Liu, Jufen] Peking Univ, Inst Reprod & Child Hlth, Minist Hlth, Key Lab Reprod Hlth,Dept Epidemiol & Biostat,Sch, Beijing 100871, Peoples R China; [Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; [Liu, Jufen; Sekine, Michikazu; Tatsuse, Takashi; Fujimura, Yuko; Hamanishi, Shimako] Toyama Univ, Dept Epidemiol & Hlth Policy, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan	Sekine, M (reprint author), Toyama Univ, Dept Epidemiol & Hlth Policy, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	sekine@med.u-toyama.ac.jp			Nishiyama Takahito Fund of University of Toyama; National Natural Science Foundation of China [81202265]; Ministry of Health and Welfare [H10-Child-020]; Ministry of Health, Labour and Welfare [H13-Health-022]; Toyama Medical Association; Japan Heart Foundation	We thank all the children and their parents who participated in this study. We are indebted to the principals and school nurses in Toyama Prefecture for their help and cooperation in the study. We also acknowledge the contribution of Ms Yasuko Yamazaki for data collection and general management of this study. This work was supported in part by Nishiyama Takahito Fund of University of Toyama and the National Natural Science Foundation of China (grant no. 81202265). The Toyama birth cohort study has been supported by grants from the Ministry of Health and Welfare (H10-Child-020), the Ministry of Health, Labour and Welfare (H13-Health-022), Toyama Medical Association, and the Japan Heart Foundation. We authors declare no conflicts of interest.	Tucker CJ, 2001, J FAM PSYCHOL, V15, P254, DOI 10.1037//0893-3200.15.2.254; Lindhout IE, 2003, J ANXIETY DISORD, V17, P593, DOI 10.1016/S0887-6185(02)00230-X; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Chen X, 2005, CHILD CARE HLTH DEV, V31, P433, DOI 10.1111/j.1365-2214.2005.00529.x; Buist KL, 2013, CLIN PSYCHOL REV, V33, P97, DOI 10.1016/j.cpr.2012.10.007; McGuinness TM, 2012, J PSYCHOSOC NURS MEN, V50, P17, DOI 10.3928/02793695-20120508-05; Bearman SK, 2008, J ABNORM CHILD PSYCH, V36, P1251, DOI 10.1007/s10802-008-9248-2; Noller P, 2005, PERS RELATIONSHIP, V12, P1, DOI 10.1111/j.1350-4126.2005.00099.x; Chen XL, 2003, J EPIDEMIOL, V13, P278; Chen XL, 2005, PREV MED, V40, P668, DOI 10.1016/j.ypmed.2004.09.034; Fagan AA, 2003, J ADOLESCENCE, V26, P547, DOI 10.1016/S0140-1971(03)00055-1; Karmaus W, 2002, J EPIDEMIOL COMMUN H, V56, P209, DOI 10.1136/jech.56.3.209; Wang HB, 2008, QUAL LIFE RES, V17, P257, DOI 10.1007/s11136-007-9301-6; Afifi M., 2007, SMJ Singapore Medical Journal, V48, P385; Tucker CJ, 2014, CHILD ABUSE NEGLECT, V38, P1599, DOI 10.1016/j.chiabu.2014.05.007; Silberg J, 1999, ARCH GEN PSYCHIAT, V56, P225, DOI 10.1001/archpsyc.56.3.225; Hankin BL, 1999, ANN MED, V31, P372, DOI 10.3109/07853899908998794; Wang HB, 2007, PREV MED, V44, P45, DOI 10.1016/j.ypmed.2006.07.015; Imaizumi Y, 2011, TWIN RES HUM GENET, V14, P179, DOI 10.1375/twin.14.2.179; MEREDITH WH, 1992, J PSYCHOL, V126, P411; Gass K, 2007, J CHILD PSYCHOL PSYC, V48, P167, DOI 10.1111/j.1469-7610.2006.01699.x; Feinberg ME, 2012, CLIN CHILD FAM PSYCH, V15, P43, DOI 10.1007/s10567-011-0104-5; BUHRMESTER D, 1990, CHILD DEV, V61, P1387, DOI 10.1111/j.1467-8624.1990.tb02869.x; [Anonymous], 2009, SURV POP SOC SEC; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Bogolyubova O, 2015, J INTERPERS VIOLENCE, V30, P1153, DOI 10.1177/0886260514539849; Lim Jae Woo, 2011, Korean J Pediatr, V54, P429, DOI 10.3345/kjp.2011.54.11.429; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Sekine Michikazu, 2002, J Epidemiol, V12, P33; Yi Siyan, 2012, Asian J Psychiatr, V5, P132, DOI 10.1016/j.ajp.2012.04.002	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					849	855		10.1111/ped.12629		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600007		
J	Naito, M; Aoki, S; Kamide, A; Miyamura, K; Honda, M; Nagai, A; Mezawa, H; Hashimoto, K				Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Nagai, Akira; Mezawa, Hidetoshi; Hashimoto, Keiji			Gait analysis in Down syndrome pediatric patients using a sheet-type gait analyzer: Pilot study	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; flat feet; gait analysis; gait development	CHILDREN	Background Children with Down syndrome (DS), who are likely to suffer from a large number of muscloskeletal problems, tend to have a unique pattern of walking in clinical settings. Despite such apparent uniqueness, few studies have empirically investigated gait development pattern in DS children, especially at an earlier age. We therefore conducted gait analysis in young DS children who are prescribed insoles, to explore how their gait patterns develop, using the gait parameters identified by Sutherland et al. as determinants of gait maturity of typical children. Methods Participants consisted of 63 DS children (31 boys) aged 1-6 years (mean, 4years 1month) with a diagnosis of flat feet who were prescribed orthotic insoles. A 2.4m sheet-type gait analyzer was used to analyze gait pattern. We measured the following variables: walking velocity (cm/min), cadence (steps/min), step length (cm), and single-limb stance phase ratio (%), and examined their relationship with age on regression analysis. Results Walking velocity and step length were significantly and positively related to age. Cadence was also significantly, but negatively associated with age. In contrast, SLS phase ratio did not have a statistically significant relationship with age. Conclusion Down syndrome children have unique gait development patterns. Although walking velocity, cadence, and step length were found to develop with age, as in typical children, SLS phase ratio did not change with age in DS children. Further studies with a larger sample are necessary to replicate these findings.	[Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Mezawa, Hidetoshi; Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Div Rehabil Med, Tokyo 1578535, Japan; [Naito, Makiko; Aoki, Sayaka; Kamide, Anri; Miyamura, Kohei; Honda, Manami; Mezawa, Hidetoshi; Hashimoto, Keiji] Natl Ctr Child Hlth & Dev, Dev Evaluat Ctr, Tokyo 1578535, Japan; [Naito, Makiko; Nagai, Akira] Natl Ctr Child Hlth & Dev, Div Gen Pediat & Interdisciplinary Med, Tokyo 1578535, Japan; [Aoki, Sayaka; Mezawa, Hidetoshi] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo 1578535, Japan; [Honda, Manami] Nico Childrens Clin, Tokyo, Japan	Naito, M (reprint author), Natl Ctr Child Hlth & Dev, Div Gen Pediat & Interdisciplinary Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	m.aiba0520@gmail.com					Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040; BECK RJ, 1981, J BONE JOINT SURG AM, V63, P1452; Presson AP, 2013, J PEDIATR-US, V163, P1163, DOI 10.1016/j.jpeds.2013.06.013; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336; Merrick J, 2000, J PEDIATR ORTHOP B, V9, P185; [Anonymous], 1996, GAIT POSTURE, DOI 10.1016/0966-6362(95)01057-2; Diamond L., 1992, SYNDROME ADV MED CAR, P111; Kanbayashi H, 1988, B SPEC ED, V13, P9; Tawada S., 2011, J CLIN REHABIL, V20, P529; Yamamoto T, 2006, J JPN PEDIAT ORTHOP, V15, P252	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					860	863		10.1111/ped.12691		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600009		
J	Isojima, T; Kushima, R; Goishi, K; Tsuchida, S; Watanabe, T; Takahashi, N; Kitanaka, S				Isojima, Tsuyoshi; Kushima, Reiko; Goishi, Keiji; Tsuchida, Shinya; Watanabe, Toyoko; Takahashi, Naoto; Kitanaka, Sachiko			Mineral status of premature infants in early life and linear growth at age 3	PEDIATRICS INTERNATIONAL			English	Article						metabolic bone disease of prematurity; mineral supplementation; short stature; very low-birthweight infant	METABOLIC BONE-DISEASE; BIRTH-WEIGHT INFANTS; PRETERM INFANTS; ALKALINE-PHOSPHATASE; INORGANIC-PHOSPHATE; CATCH-UP; CHILDHOOD; RICKETS; FAILURE; HEALTH	Background Preterm infants are at significant risk of reduced bone mineral content and subsequent bone disease (metabolic bone disease of prematurity, MBDP). MBDP is frequently found in very low-birthweight (VLBW) infants, but long-term height prognosis is not well known. Methods VLBW infants from two major neonatal intensive care units were studied. Medical records were reviewed. A total of 143 subjects were analyzed after excluding subjects who died, or who had severe complications that could affect linear growth, Silver-Russell syndrome, severe cholestasis, and/or chromosomal abnormality. The relationship between MBDP and height at age 3 was investigated. Results Height standard deviation score (SDS) at age 3 negatively correlated with peak serum alkaline phosphatase (ALP) activity in early life (r=-0.30, P=0.0003) and positively correlated with serum phosphorus (P) at peak ALP (r=0.33, P=0.0002). In addition, serum P independently affected height SDS at 3 years of age (=0.19, P=0.018), and was significantly different between infants with and without catch-up growth in height (difference: 0.23mmol/L, 95%CI: 0.09-0.36, P=0.0010). Conclusions MBDP, particularly hypophosphatemia in the early period of life, is associated with linear growth until 3 years of age in VLBW infants.	[Isojima, Tsuyoshi; Goishi, Keiji; Tsuchida, Shinya; Takahashi, Naoto; Kitanaka, Sachiko] Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; [Kushima, Reiko; Tsuchida, Shinya; Watanabe, Toyoko] Tokyo Metropolitan Bokutoh Hosp, Dept Neonatol, Sumida Ku, Tokyo, Japan	Kitanaka, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sachi-tky@umin.ac.jp					Backstrom MC, 2000, ACTA PAEDIATR, V89, P867, DOI 10.1080/080352500750043792; Cooke RWI, 2004, ARCH DIS CHILD, V89, P201, DOI 10.1136/adc.2003.030197; MCINTOSH N, 1986, LANCET, V2, P981; Rigo J, 2000, CLIN PERINATOL, V27, P147, DOI 10.1016/S0095-5108(05)70011-7; Ericson A, 1998, ARCH DIS CHILD, V78, pF171; KOO WWK, 1989, J PEDIATR ORTHOPED, V9, P326; BISHOP N, 1989, ARCH DIS CHILD, V64, P1403; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Fewtrell MS, 2009, BONE, V45, P142, DOI 10.1016/j.bone.2009.03.657; Senterre T, 2012, ACTA PAEDIATR, V101, pE64, DOI 10.1111/j.1651-2227.2011.02443.x; LUCAS A, 1989, ARCH DIS CHILD, V64, P902; Visser F, 2012, ACTA PAEDIATR, V101, P562, DOI 10.1111/j.1651-2227.2012.02626.x; Monset-Couchard M, 2000, BIOL NEONATE, V78, P161, DOI 10.1159/000014265; Masumoto K, 2008, PEDIATR RES, V63, P686, DOI 10.1203/PDR.0b013e31816c8fcc; Huysman WA, 2003, ARCH DIS CHILD, V88, P46; Fewtrell MS, 2000, J PEDIATR-US, V137, P668, DOI 10.1067/mpd.2000.108953; Viswanathan S, 2014, JPEN-PARENTER ENTER, V38, P982, DOI 10.1177/0148607113499590; Dusick AM, 2003, SEMIN PERINATOL, V27, P302, DOI 10.1016/S0146-0005(03)00044-2; Rigo J, 2007, ACTA PAEDIATR, V96, P969, DOI 10.1111/j.1651-2227.2007.00336.x; Harrison CM, 2008, ACTA PAEDIATR, V97, P407, DOI 10.1111/j.1651-2227.2007.00721.x; Chan GM, 2008, J PERINATOL, V28, P619, DOI 10.1038/jp.2008.59; SPARKS JW, 1984, SEMIN PERINATOL, V8, P74; Bonsante F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072880; Fewtrell MS, 2011, AM J CLIN NUTR, V94, p1870S, DOI 10.3945/ajcn.110.000844; Forsen T, 1999, BRIT MED J, V319, P1403; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Itabashi K, 2010, JPN J PEDIAT, V117, P1771; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Paneth N., 2012, AVERYS DIS NEWBORN, P1; Tanaka T, 2011, J JPN ASS HUM AUXOL, V17, P84; Yamadate S., 2005, RINSHOKAGAKU, V34, P6	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					864	869		10.1111/ped.12657		6	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600010		
J	Sakazume, S; Kido, Y; Murakami, N; Matsubara, T; Numabe, H				Sakazume, Satoru; Kido, Yasuhiro; Murakami, Nobuyuki; Matsubara, Tomoyo; Numabe, Hironao			Additional patients with 4q deletion: Severe growth delay and polycystic kidney disease associated with 4q21q22 loss	PEDIATRICS INTERNATIONAL			English	Article						4q21q22 deletion; developmental delay; growth delay; polycystic kidney disease	LONG ARM; MICRODELETION; CHROMOSOME-4; RETARDATION	BackgroundTo the best of our knowledge, this is the third report concerning 4q21q22 deletions. In this report, we describe the cases of two girls with 4q deletion and polycystic kidney disease. G-banding confirmed the deletion in one patient but not in the other. MethodsWe describe the cases of two girls with 4q deletion and polycystic kidney disease. Chromosomal deletions were mapped to 4q21-22. One patient had a simple 4q contiguous gene deletion, whereas the other patient had a complicated chromosomal rearrangement. In patient 1, a smaller part of the 4q deletion was translocated to the 3p region. ResultsFifty-four genes and 72 genes were deleted in patients 1 and 2, respectively. In both patients, 52 genes were consistently deleted. ConclusionThe present two patients had a similar phenotype, including severe growth and developmental retardation, and a characteristic facial appearance. The loss of RPKG2 and RASGEF1B causes severe growth defect. PKD2 loss causes kidney cysts.	[Sakazume, Satoru; Kido, Yasuhiro; Murakami, Nobuyuki; Matsubara, Tomoyo] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Numabe, Hironao] Ochanomizu Univ, Grad Sch Human Genet & Sci, Dept Genet Counseling, Tokyo 112, Japan	Sakazume, S (reprint author), Haramachi Red Cross Hosp, Dept Pediat, 698 Higasi Agatsuma, Agatsuma Dist, Gunma 3770822, Japan.	saka377@gmail.com			Dokkyo Medical University, Investigator-Initiated Research Grant, Japan [2012-01-6]; JSPS KAKENHI [24 591 524]; Japan Foundation for Pediatric Research	This research was partially supported by a Dokkyo Medical University, Investigator-Initiated Research Grant (No.2012-01-6), Japan. This research was supported by JSPS KAKENHI 24 591 524, Grant-in-Aid for Scientific Research (C), and the Japan Foundation for Pediatric Research. The authors declare no conflicts of interest.	Harada N, 2002, CLIN GENET, V61, P226, DOI 10.1034/j.1399-0004.2002.610311.x; Bhoj E, 2013, AM J MED GENET A, V161, P2327, DOI 10.1002/ajmg.a.36061; MCDERMOTT A, 1980, HUM GENET, V53, P305; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; Bonnet C, 2010, J MED GENET, V47, P377, DOI 10.1136/jmg.2009.071902	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					880	883		10.1111/ped.12742		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600013		
J	Kakuya, F; Kinebuchi, T; Fujiyasu, H; Tanaka, R; Okubo, H; Kano, H				Kakuya, Fujio; Kinebuchi, Takahiro; Fujiyasu, Hiroaki; Tanaka, Ryosuke; Okubo, Hitoshi; Kano, Hiroki			Clinical findings in 10 children with H275Y influenza A(H1N1)pdm09 virus infection	PEDIATRICS INTERNATIONAL			English	Article						antiviral resistance; clinical effectiveness; H275Y substitution; influenza A(H1N1)pdm09; neuraminidase inhibitor	OSELTAMIVIR-RESISTANT; NEURAMINIDASE MUTATION; COMMUNITY CLUSTER; JAPAN; PERAMIVIR; FITNESS	BackgroundLittle is known about the clinical effectiveness of neuraminidase inhibitors against H275Y influenza A(H1N1)pdm09 virus. A cluster of H275Y influenza A(H1N1)pdm09 virus with cross-resistance to oseltamivir and peramivir was detected among untreated community patients in Hokkaido, Japan, during the 2013-2014 influenza season. MethodsThis was a retrospective observational study. Specimens from nasopharyngeal swabs underwent rapid testing and single-nucleotide polymorphism identification on real-time polymerase chain reaction. We collected clinical data from the H275Y group and a 275H wild-type comparison group. All children were given one of four neuraminidase inhibitors. ResultsTwenty-eight children infected with influenza A(H1N1)pdm09 virus were analyzed. Ten viruses had the H275Y substitution, while the other 18 had wild-type 275H. Mean fever duration after treatment and after onset was 25.3h (95%CI: 14.1-36.5) and 48.9h (95%CI: 34.4-63.3) in the H275Y group, respectively, and 26.1h (95%CI: 18.7-33.6) and 46.3h (95%CI: 35.7-56.8) in the 275H group, respectively. In the H275Y group, three patients were treated with oseltamivir, one with peramivir, five with zanamivir, and one with laninamivir. All of them had mild symptoms and received only outpatient care. Fever duration was 7.5-21.0h and 18.0-66.0h after treatment and after onset, respectively, in the patients treated with oseltamivir and peramivir, and 20.5-42.0h and 42.0-88.0h, respectively, in those treated with zanamivir and laninamivir. ConclusionFever in the H275Y children treated with oseltamivir and peramivir resolved rapidly during the 2013-2014 influenza season.	[Kakuya, Fujio; Fujiyasu, Hiroaki; Tanaka, Ryosuke; Okubo, Hitoshi] Furano Kyokai Hosp, Dept Pediat, Furano, Hokkaido 0768765, Japan; [Kinebuchi, Takahiro; Kano, Hiroki] Furano Kyokai Hosp, Clin Lab, Furano, Hokkaido 0768765, Japan	Kakuya, F (reprint author), Furano Kyokai Hosp, Dept Pediat, 1-30 Sumiyoshi Cho, Furano, Hokkaido 0768765, Japan.	f768fk@furano.ne.jp					Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Kawai N, 2009, CLIN INFECT DIS, V49, P1828, DOI 10.1086/648424; Nakauchi M, 2011, J MED VIROL, V83, P1121, DOI 10.1002/jmv.22101; Boivin G, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/irv.12176; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Takashita E, 2013, INFLUENZA OTHER RESP, V7, P1390, DOI 10.1111/irv.12132; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Sugaya N, 2010, ANTIMICROB AGENTS CH, V54, P2575, DOI 10.1128/AAC.01755-09; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Saito R, 2010, PEDIATR INFECT DIS J, V29, P898, DOI 10.1097/INF.0b013e3181de9d24; Abed Y, 2012, ANTIMICROB AGENTS CH, V56, P4375, DOI 10.1128/AAC.00753-12; Chugai Pharmaceutical, 2013, TAM OS PHOSPH PACK I; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Hurt AC, 2011, EUROSURVEILLANCE, V16, P24; National Institute of Infectious Diseases Japan, ANT AG RES INFL VIR; National Institute of Infectious Diseases Japan, INFECT AGENTS SURVEI; Shionogi, 2013, RAP PER HYDR PACK IN; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					888	892		10.1111/ped.12658		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600015		
J	Tsuchiya, S; Ohashi, K				Tsuchiya, Sayaka; Ohashi, Kazutomo			Childbirth expense support and small-for-gestational-age infants in Japan	PEDIATRICS INTERNATIONAL			English	Article						birthweight; low birthweight; poverty; small for gestational age; socioeconomic factor	BIRTH-WEIGHT; SOCIOECONOMIC-STATUS; FETAL-GROWTH; HEALTH; METAANALYSIS; PREGNANCY; OUTCOMES; RISK; INEQUALITIES; TRENDS	BackgroundPoor nutritional status during the fetal period could cause perinatal and lifelong health disadvantages in neonates. The aim of this study was to investigate the background of pregnant women receiving childbirth expense support (CES), pregnancy outcome, and neonatal anthropometric data. MethodsA retrospective cohort study was conducted using 823 antenatal and delivery records in a perinatal center located in one of the poorest areas in Japan. Neonates who were small for gestational age (SGA) were compared between the CES and the non-CES groups. ResultsThe incidences of low birthweight (LBW) and SGA were significantly higher in the group receiving CES (14.6% and 14.6%, respectively). The adjusted OR of CES was 2.78 (95%CI: 1.32-5.87) and the adjusted OR of maternal smoking was 5.03 (95%CI: 2.74-9.21), indicating that CES and maternal smoking were directly associated with SGA. ConclusionsCES recipients had a higher prevalence of SGA infants. CES was independently associated with SGA. Previous studies have shown that smoking is a major risk factor for SGA. Further studies are needed to identify risk factors of SGA specific to CES recipients.	[Tsuchiya, Sayaka; Ohashi, Kazutomo] Osaka Univ, Grad Sch Med, Div Hlth Sci, Suita, Osaka 5650871, Japan	Ohashi, K (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	ohashi@sahs.med.osaka-u.ac.jp			Fumiko Yamaji Trust for Academic Nursing Education and Research, Tokyo, Japan	We thank all the subjects and staff at the center. We also thank Dr Haruyasu Fujita for his support with the statistical analysis. This study was supported by Fumiko Yamaji Trust for Academic Nursing Education and Research, Tokyo, Japan.	Lee BJ, 2010, CHILD YOUTH SERV REV, V32, P1670, DOI 10.1016/j.childyouth.2010.07.009; Dashe JS, 2000, OBSTET GYNECOL, V96, P321, DOI 10.1016/S0029-7844(00)00943-1; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Teramoto S, 2006, PEDIATR INT, V48, P274, DOI 10.1111/j.1442-200X.2006.02203.x; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Tsukamoto H, 2007, PEDIATR INT, V49, P985, DOI 10.1111/j.1442-200X.2007.02494.x; Moser K, 2003, J EPIDEMIOL COMMUN H, V57, P687, DOI 10.1136/jech.57.9.687; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Berg G, 2012, PLOS ONE, V7; Japan Society of Obstetrics and Gynecology and Japan Association of Obstetricians and Gynecologists, 2014, GUID OBST PRACT JAP; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kawachi I, 2002, HLTH NATIONS WHY INE; Kohara M, 2010, JPN J LABOUR STUD, V595, P15; Kurazawa K, 2010, J JPN SOC PERINAT NE, V46, P1091; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)71146-6; Ministry of Health Labour and Welfare Japan, 2010, VIT STAT; Ministry of Health Labour and Welfare Japan, FRAUD PUBL ASS JAP; Ministry of Health Labour and Welfare Japan, IMP RES TAX; Ministry of Health Labour and Welfare Japan, 2014, NAT HLTH NUTR SURV; OECD, 2013, CRIS SQUEEZ INC PUTS; Ogawa Y, 1998, ACTA NEONAT JPN, V34, P624; Raisanen S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-28; Statistics Bureau Ministry of Internal Affairs and Communications Japan, 2012, STAT BUR ANN REP LAB; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Wilkinson R.G., 1996, UNHEALTHY SOC AFFLIC; Wilkinson RG, 2003, SOCIAL DETERMINANTS	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					897	901		10.1111/ped.12633		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600017		
J	Shirasu, A; Ashida, A; Matsumura, H; Nakakura, H; Tamai, H				Shirasu, Akihiko; Ashida, Akira; Matsumura, Hideki; Nakakura, Hyogo; Tamai, Hiroshi			Clinical characteristics of rotavirus gastroenteritis with urinary crystals	PEDIATRICS INTERNATIONAL			English	Article						ammonium acid urate stone; rotavirus gastroenteritis; uric acid crystal	RENAL-FAILURE; CHILDREN; ACIDOSIS; INFANTS	BackgroundRotavirus gastroenteritis is severe and often results in dehydration and pre-renal azotemia. In addition, some patients with acute obstructive uropathy due to ammonium acid urate stones, developing approximately 6-7 days after the onset of rotavirus gastroenteritis, have been reported, mainly in Japan. The pathophysiological mechanism responsible for stone formation has not been clarified. In the present study, we investigated the clinical characteristics of these patients, and analyzed the pathophysiology underlying the formation of urinary stones. MethodsA total of 164 patients were enrolled. All had acute gastroenteritis due to rotavirus infection and were treated at Osaka Medical College Hospital and affiliated hospitals between January 2009 and May 2011. All were younger than 15 years of age, and their laboratory data, including urinalysis, were available. ResultsAmong the enrolled patients, 30 (20 boys and 10 girls aged 0.2-10 years; median, 1.5 years; interquartile range, 1-3 years) had crystals in their urine. Most of the patients were admitted approximately 2 days after onset of gastroenteritis and had hyperuricemia and aciduria. The crystals consisted mainly of uric acid, and rarely of ammonium acid urate. ConclusionIn order for ammonium acid urate stones to form in patients with acute obstructive uropathy associated with rotavirus gastroenteritis, prolonged continuous acidosis with hyperuricemia, might be necessary. Therefore, normalization of metabolic acidosis is important in order to prevent the onset of obstructive uropathy associated with rotavirus gastroenteritis.	[Shirasu, Akihiko; Ashida, Akira; Matsumura, Hideki; Nakakura, Hyogo; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan	Ashida, A (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ped006@poh.osaka-med.ac.jp					Ashida A, 2012, CLIN NEPHROL, V77, P49, DOI 10.5414/CN107098; Fujinaga S, 2005, PEDIATR NEPHROL, V20, P239, DOI 10.1007/s00467-004-1675-x; DICK WH, 1990, J UROLOGY, V143, P244; Kaneko K, 2010, PEDIATR NEPHROL, V25, P2187, DOI 10.1007/s00467-010-1490-5; Uemura O, 2011, CLIN EXP NEPHROL, V15, P694, DOI 10.1007/s10157-011-0452-y; Hoppe B, 1997, J UROLOGY, V158, P557, DOI 10.1016/S0022-5347(01)64550-6; Bernstein DI, 2009, PEDIATR INFECT DIS J, V28, pS50, DOI 10.1097/INF.0b013e3181967bee; Morita T, 2010, CLIN NEPHROL, V73, P398; Fujita T, 2009, PEDIATR NEPHROL, V24, P2467, DOI 10.1007/s00467-009-1222-x; TIZIANELLO A, 1982, J CLIN INVEST, V69, P240, DOI 10.1172/JCI110436; TALLETT S, 1977, PEDIATRICS, V60, P217; SIMPSON DP, 1971, MEDICINE, V50, P503, DOI 10.1097/00005792-197111000-00002; Barrett KE, 2012, GANONGS REV MED PHYS, P711	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					917	921		10.1111/ped.12626		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600020		
J	Iwasaki, H; Fujita, Y; Hara, M				Iwasaki, Hiroki; Fujita, Yukihiko; Hara, Mitsuhiko			Susceptibility-weighted imaging in acute-stage pediatric convulsive disorders	PEDIATRICS INTERNATIONAL			English	Article						child; laterality; regional; seizure; susceptibility-weighted imaging	STATUS EPILEPTICUS; SWI	Background: The aim of this preliminary study was to investigate the clinical use of acute-stage susceptibility-weighted imaging (SWI) in children with prolonged convulsive disorder. Methods: Ten children with prolonged convulsive disorder who underwent SWI within 2 h after termination of seizure (acute-stage SWI group) and 15 control children who underwent SWI >2 h after their seizures terminated or for other purposes were enrolled. The cerebral venous vasculature was compared between the groups. The acute-stage SWI group was further divided into three subgroups: normal group, those with regional low signals in the cerebral veins (regional group) and those with diffuse low signals in the cerebral veins (generalized group). Inter-ictal electroencephalography (EEG) and venous blood gas findings during seizure activity were compared between these subgroups. Results: All patients in the acute-stage SWI group had low cerebral vein signal. Four patients were assigned to the regional group and six patients to the generalized group. Decrease of venous pH and the increase of venous pCO(2) during seizure activity was more prominent in the regional group than in the generalized group. In the regional group, low-signal areas in the cerebral veins were consistent with abnormal areas on EEG; these low-signal areas resolved completely in all patients on follow-up SWI. Ten patients in the control group had normal SWI, and five had a generalized low signal. Conclusions: Acute-stage SWI may be a useful alternative for identifying lateralization of seizures in children with prolonged convulsive disorder.	[Iwasaki, Hiroki] Tama Hokubu Med Ctr, Dept Pediat, Tokyo 1898511, Japan; [Fujita, Yukihiko] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Hara, Mitsuhiko] Tokyo Metropolitan Hiroo Gen Hosp, Dept Pediat, Tokyo, Japan	Iwasaki, H (reprint author), Tama Hokubu Med Ctr, Dept Pediat, 1-7-1 Aoba Cho, Tokyo 1898511, Japan.	ilsayakkum@ae.auone-net.jp					Aellen J, 2014, EUR RADIOL, V24, P2980, DOI 10.1007/s00330-014-3284-9; Sedlacik J, 2010, AM J NEURORADIOL, V31, P901, DOI 10.3174/ajnr.A1960; Iwasaki H, 2014, PEDIATR NEUROL, V50, P171, DOI 10.1016/j.pediatrneurol.2013.09.004; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Lee YJ, 2014, CLIN NEURORADIOL, V24, P69, DOI 10.1007/s00062-013-0204-3; Verschuuren S, 2012, AM J ROENTGENOL, V198, pW440, DOI 10.2214/AJR.11.8049; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Haacke EM, 2004, MAGNET RESON MED, V52, P612, DOI 10.1002/mrm.20198; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Ida M., 2011, SUSCEPTIBILITY WEIGH	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					922	929		10.1111/ped.12678		8	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600021		
J	Hartini, S; Hapsara, S; Herini, SE; Takada, S				Hartini, Sri; Hapsara, Sunartini; Herini, Siti E.; Takada, Satoshi			Verifying the Indonesian version of the Child Behavior Checklist	PEDIATRICS INTERNATIONAL			English	Article						assessment; Child Behavior Checklist; emotional and behavioral problems; Indonesia; validity	UNITED-STATES; CRITERION VALIDITY; CBCL; RELIABILITY; TRF	Background: The Child Behavior Checklist for Ages 6-18 (CBCL/6-18) is widely used to assess emotional and behavioral problems in children in the USA and Europe. Given that Indonesia has a more traditional culture that is different from the USA and Europe, it is possible that the CBCL is not effective in assessing the emotional and behavioral problems of Indonesian children, due to a difference in culture. Moreover, the validity and reliability of the Indonesian version of the CBCL/6-18 have not been tested. The purpose of this study was therefore to test the validity and reliability of the Indonesian version of the CBCL/6-18. Methods: Three hundred and eight mothers of children attending public primary schools participated in this study by completing the self-administered questionnaire. Results: All items of the CBCL were positively correlated with total score (0.15-0.59), and total problems score had high internal consistency (r=0.94). The correlations between questionnaire items and the eight subscales of the CBCL ranged from 0.10 to 0.74 and from 0.12 to 0.64 for the internalizing and externalizing scales, respectively (P<0.01). The eight subscales of the CBCL had good internal consistency (0.61-0.87). Conclusions: The CBCL/6-18 is a valid and reliable instrument to measure emotional and behavioral problems in Indonesian children aged 6-12 years.	[Hartini, Sri; Takada, Satoshi] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Hartini, Sri] Gadjah Mada Univ, Sch Nursing, Yogyakarta, Indonesia; [Hapsara, Sunartini; Herini, Siti E.] Gadjah Mada Univ, Fac Med, Yogyakarta, Indonesia	Takada, S (reprint author), Kobe Univ, Grad Sch Hlth Sci, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	satoshi@kobe-u.ac.jp					Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Agency of Statistics Indonesia, 2010, POP IND RES POP CENS; Roessner V, 2007, EUR ARCH PSY CLIN N, V257, P352, DOI 10.1007/s00406-007-0738-y; French DC, 2005, INT J BEHAV DEV, V29, P304, DOI 10.1080/01650250544000080; French DC, 2002, CHILD DEV, V73, P1143, DOI 10.1111/1467-8624.00463; French DC, 2005, SOC DEV, V14, P458, DOI 10.1111/j.1467-9507.2005.00311.x; Ang RP, 2012, CHILD PSYCHIAT HUM D, V43, P70, DOI 10.1007/s10578-011-0253-2; Senaratna B. C. V., 2008, Ceylon Medical Journal, V53, P40; Leung PWL, 2006, J CHILD PSYCHOL PSYC, V47, P970, DOI 10.1111/j.1469-7610.2005.01570.x; Brown S, 2013, CHILD WELFARE, V3, P119; Doost MT, 2011, IRAN J PEDIATR, V3, P331; Heubeck BG, 2000, J ABNORM CHILD PSYCH, V28, P439, DOI 10.1023/A:1005131605891; Itani T, 2001, SHOUNI NO SEISHIN TO, V41, P243; Jastrowski M, 2009, J CHILD FAM STUD, V5, P606; Rahman FN, 2013, PEDIATR INT, V55, P422; Rescorla L, 2007, J EMOT BEHAV DISORD, V15, P130, DOI 10.1177/10634266070150030101; Souza DC, 2007, J TRAUMA STRESS, V20, P263	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					936	941		10.1111/ped.12669		6	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600023		
J	Murata, S; Aomatsu, T; Yoden, A; Tamai, H				Murata, Shinya; Aomatsu, Tomoki; Yoden, Atsushi; Tamai, Hiroshi			Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis	PEDIATRICS INTERNATIONAL			English	Article						bed rest; biliary pseudolithiasis; ceftriaxone; cholelithiasis; fasting	BILIARY PSEUDOLITHIASIS; GALLBLADDER; CHILDREN; PRECIPITATIONS; THERAPY; SLUDGE	Background: Cholelithiasis is one of the side-effects of ceftriaxone (CTRX). Reportedly, the cholelithiasis resolves relatively soon after cessation of CTRX, hence, it is called pseudolithiasis. Previous reports have suggested that biliary pseudolithiasis can cause not only gallstone attacks, but also severe adverse events, such as cholecystitis and pancreatitis. The purpose of this study was to prospectively elucidate the risk factors and clinical features of CTRX-associated pseudolithiasis in pediatric patients. Methods: We prospectively examined the incidence and clinical outcome of CTRX-associated biliary pseudolithiasis. Subjects included infants and children who were admitted to hospital with acute disease. Ultrasonography was used to confirm the absence of stones and sludge in the gallbladder before CTRX therapy, and in assessment of pseudolithiasis on days 3, 5, 7 and 10 after initiation of CTRX in all subjects. The pseudolithiasis group was then compared with the non-pseudolithiasis group in terms of age, sex, CTRX dose, CTRX duration, duration of fever, fasting period, period of bed rest, and blood test results. Results: Sixty patients were enrolled in the study. Eleven of them had biliary pseudolithiasis on ultrasonography (18.3%). Formation of biliary pseudolithiasis was prevalent in the fasting and bed rest groups, appearing relatively early in these groups. Conclusions: Special attention should be paid to the degree of oral intake and patient activity when CTRX is prescribed. We recommend regular ultrasonographic follow up of patients receiving CTRX, to evaluate the formation of biliary pseudolithiasis.	[Murata, Shinya] Hirakata City Hosp, Dept Pediat, Hirakata, Osaka 5731013, Japan; [Aomatsu, Tomoki; Yoden, Atsushi; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 569, Japan	Murata, S (reprint author), Hirakata City Hosp, Dept Pediat, 2-14-1 Kinya Honmachi, Hirakata, Osaka 5731013, Japan.	wildwind1980@live.jp					SHIFFMAN ML, 1990, GASTROENTEROLOGY, V99, P1772; Acun C, 2004, ANN TROP PAEDIATR, V24, P25, DOI 10.1179/027249304225013349; RICHARDS DM, 1984, DRUGS, V27, P469, DOI 10.2165/00003495-198427060-00001; Ruggiero S, 2010, J CHEMOTHERAPY, V22, P63; Palanduz A, 2000, J CLIN ULTRASOUND, V28, P166, DOI 10.1002/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G; SCHAAD UB, 1988, LANCET, V2, P1411; Biner B, 2006, J CLIN ULTRASOUND, V34, P217, DOI 10.1002/jcu.20228; SCHAAD UB, 1986, PEDIATR INFECT DIS J, V5, P708, DOI 10.1097/00006454-198611000-00026; Kim S, 2006, PEDIATR SURG INT, V22, P562, DOI 10.1007/s00383-006-1656-1; Papadopoulou F, 1999, ACTA PAEDIATR, V88, P1352, DOI 10.1080/080352599750030077; PARK HZ, 1991, GASTROENTEROLOGY, V100, P1665; RICCABONA M, 1993, KLIN PADIATR, V205, P421, DOI 10.1055/s-2007-1025261; Fishman DS, 2011, PEDIAT GASTROINTESTI, P866, DOI 10.1016/B978-1-4377-0774-8.10079-X; Frederick JS, 2011, NELSON TEXT PEDIAT, P1707; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6; Kawasaki T., 1967, JAP J ALLERG, V16, P178; Kimura M, 2006, J JPN PEDIAT SOC, V110, P773; Lee SP, 2003, TXB GASTROENTEROLOGY, P2177	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					942	946		10.1111/ped.12625		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600024		
J	Tamura, A; Minami, K; Tsuda, Y; Yoshikawa, N				Tamura, Akira; Minami, Koichi; Tsuda, Yuuko; Yoshikawa, Norishige			Total parenteral nutrition treatment efficacy in adolescent eating disorders	PEDIATRICS INTERNATIONAL			English	Article						adolescent females; alkaline phosphatase; eating disorders; gonadotropins; total parenteral nutrition	ANOREXIA-NERVOSA PATIENTS; HOSPITALIZED ADOLESCENTS; WEIGHT-GAIN; RECOVERY; CHILDREN; INDICATORS; EVOLUTION; BULIMIA; STAY; DSM	Background: Management of adolescent patients with severe eating disorders who refuse treatment for weight loss is complicated. Nutritional rehabilitation is most important during the growth period; thus, strong support in the form of total parenteral nutrition (TPN) as soon as possible is necessary in severe cases. No studies involving detailed, long-term follow up have evaluated biochemical markers and gonadotropin in patients undergoing TPN treatment. Methods: Twenty-five adolescent female patients admitted to hospital received TPN immediately, and biochemical marker and gonadotropin levels were measured and analyzed. If subsequent weight gain was observed, TPN treatment was gradually reduced and stopped. Results: No patients dropped out of the study. A significant increase in weight was observed during hospitalization (average, 8.0kg). Under this treatment, serum total bilirubin was significantly decreased at 3 months, total cholesterol was significantly decreased at 2 months, and alkaline phosphatase (ALP) was significantly increased at 3 and 6 months. Follicle-stimulating hormone response significantly preceded both luteinizing hormone response and appetite recovery. After this treatment, nine of the 25 patients were readmitted for recurrence of appetite loss. Two patients required additional TPN treatment, but seven immediately recovered their appetite after hospitalization without TPN treatment. Bodyweight gain per day was significantly lower and ALP on admission was significantly higher in patients with than without recurrence. Conclusions: Most patients had a remarkable recovery of appetite without refusal behaviors and without evidence of malnutrition after admission. Nutrition maintenance with TPN support is particularly important during the growth period.	[Tamura, Akira; Minami, Koichi; Tsuda, Yuuko; Yoshikawa, Norishige] Wakayama Med Univ, Dept Pediat, Wakayama 6410012, Japan	Tamura, A (reprint author), Wakayama Med Univ, Dept Pediat, 811-1 Kimiidera, Wakayama 6410012, Japan.	tamy@wakayama-med.ac.jp					Agostino H, 2013, J ADOLESCENT HEALTH, V53, P590, DOI 10.1016/j.jadohealth.2013.06.005; American Pyschiatric Association, 1994, DIAGN STAT MAN MENT; Golden NH, 2013, J ADOLESCENT HEALTH, V53, P573, DOI 10.1016/j.jadohealth.2013.05.014; Nova E, 2004, CLIN NUTR, V23, P1353, DOI 10.1016/j.clnu.2004.05.004; ISAACS AJ, 1980, ACTA ENDOCRINOL-COP, V94, P145; ARDEN MR, 1990, J ADOLESCENT HEALTH, V11, P199, DOI 10.1016/0197-0070(90)90348-6; Nova E, 2001, EUR J CLIN NUTR, V55, P547, DOI 10.1038/sj.ejcn.1601181; Mehler PS, 2007, INT J EAT DISORDER, V40, P285, DOI 10.1002/eat.20371; Nogal P, 2009, NEUROENDOCRINOL LETT, V30, P32; Peebles R, 2006, J ADOLESCENT HEALTH, V39, P800, DOI 10.1016/j.jadohealth.2006.05.013; Nicholls D, 2000, INT J EAT DISORDER, V28, P317, DOI 10.1002/1098-108X(200011)28:3<317::AID-EAT9>3.0.CO;2-#; Whitelaw M, 2010, J ADOLESCENT HEALTH, V46, P577, DOI 10.1016/j.jadohealth.2009.11.207; Nova E, 2008, J HUM NUTR DIET, V21, P23, DOI 10.1111/j.1365-277X.2007.00833.x; GARNER DM, 1979, PSYCHOL MED, V9, P273; Pike KM, 1998, CLIN PSYCHOL REV, V18, P447, DOI 10.1016/S0272-7358(98)00014-2; Garber AK, 2013, J ADOLESCENT HEALTH, V53, P579, DOI 10.1016/j.jadohealth.2013.07.014; MORDASINI R, 1978, METABOLISM, V27, P71, DOI 10.1016/0026-0495(78)90125-7; Le Grange D, 2012, INT J EAT DISORDER, V45, P711, DOI 10.1002/eat.22006; Campbell K, 2014, PEDIATRICS, V134, P582, DOI 10.1542/peds.2014-0194; Couturier J, 2006, INT J EAT DISORDER, V39, P550, DOI 10.1002/eat.20309; MIRA M, 1987, ANN CLIN BIOCHEM, V24, P29; Thomas JJ, 2009, PSYCHOL BULL, V135, P407, DOI 10.1037/a0015326; MORGAN HG, 1988, BRIT J PSYCHIAT, V152, P367, DOI 10.1192/bjp.152.3.367; WELTZIN TE, 1991, AM J PSYCHIAT, V148, P1675; Meguerditchian C, 2009, J AM COLL NUTR, V28, P397; Rosen David S, 2003, Adolesc Med, V14, P49; Tachikawa H, 2004, Eat Weight Disord, V9, P107	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					947	953		10.1111/ped.12717		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600025		
J	Ino, T; Kurosawa, K				Ino, Toshihiro; Kurosawa, Kazuo			Screening for secondhand smoke in schoolchildren in Japan	PEDIATRICS INTERNATIONAL			English	Article						biomarker; carcinogen; cotinine; screening; secondhand smoke	MATERNAL SMOKING; TOBACCO; EXPOSURE; BIOMARKERS; PREGNANCY; CHILDREN; METABOLITES	BackgroundThere is no systematic screening for secondhand smoke exposure in children. MethodsIn 2002, we began a secondhand smoke screening (SSS) program for grade 4 elementary schoolchildren with the cooperation of public administration. The SSS program consisted of urinary cotinine measurement in children and a questionnaire survey of their parents. ResultsMore than 1200 schoolchildren were enrolled in this program annually. The level of urinary cotinine in 30% of the children was >5ng/mL, whereas in half of them it was undetectable. The major risk factor affecting cotinine level was mother's smoking. Average cotinine was significantly high in children who had a history of short stature, decayed tooth and/or periodontal disease, and frequent stridor. In addition, the highest level of cotinine was detected in children whose father and/or mother smoked in the living room and the lowest level of cotinine was detected in children whose father and/or mother smoked on the veranda or outside the door. These levels, however, were two-fivefold higher than in children whose parents did not smoke. On follow-up questionnaire survey 4years after initial SSS, significant elevated motivation for smoking cessation was noted. ConclusionsThe SSS program is a very simple mass screen that can be done using only a urine test and is very effective for motivating parents to stop smoking with regard to cost benefit.	[Ino, Toshihiro; Kurosawa, Kazuo] Gunma Paz Coll, Fac Hlth Sci, Takasaki, Gumma, Japan; [Ino, Toshihiro] Ino Clin, Kumagaya, Saitama 3600014, Japan	Ino, T (reprint author), Ino Clin, 1-12-24 Hakoda, Kumagaya, Saitama 3600014, Japan.	ino-t@sk9.so-net.ne.jp			Ministry of Health, Labor, and Welfare [H21-third-regular-005]; Japan Society for the Promotion of Science [23591514]	We would like to express our gratitude to the pediatric doctors of the Kumagaya Medical Association and the members of the Board of Education in Kumagaya-RC City. This study was supported by grants from the Ministry of Health, Labor, and Welfare (H21-third-regular-005) and from the Japan Society for the Promotion of Science (23591514). The authors declare no conflicts of interest.	Benowitz NL, 1996, EPIDEMIOL REV, V18, P188; Hecht SS, 2001, CANCER EPIDEM BIOMAR, V10, P1109; Hecht SS, 2014, CANCER PREV RES, V7, P639, DOI 10.1158/1940-6207.CAPR-14-0095; Ino T, 2011, PEDIATR INT, V53, P851, DOI 10.1111/j.1442-200X.2011.03383.x; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Saffer H, 2000, J HEALTH ECON, V19, P1117, DOI 10.1016/S0167-6296(00)00054-0; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Llaquet H, 2010, ANAL BIOANAL CHEM, V396, P379, DOI 10.1007/s00216-009-2831-8; Ino T, 2006, PREV MED, V42, P427, DOI 10.1016/j.ypmed.2006.01.012; Matsumoto Akiko, 2010, Environmental Health and Preventive Medicine, V15, P211, DOI 10.1007/s12199-009-0129-2; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; Lovasi GS, 2010, AM J EPIDEMIOL, V171, P54, DOI 10.1093/aje/kwp358; Lodovici M, 2009, INT J ENV RES PUB HE, V6, P874, DOI 10.3390/ijerph6030874; Ino T, 2011, J CLIN LAB ANAL, V25, P354, DOI 10.1002/jcla.20485; Ino T, 2012, INT J OBESITY, V36, P554, DOI 10.1038/ijo.2011.255; Ino T, 2006, NIHONSHOUNIKAGAKKAIZ, V110, P1105; Ino T, 2008, JUDOUKITSUEN KAITAIS; Ino T, 2008, HEART, V40, P124; Ministry of Health Labor and Welfare, TOB OR HLTH; OECD, EC ENV SOC STAT; Ohta M, 2007, JPN J MED PHARM SCI, V58, P589; Yamato Hiroshi, 2004, Nihon Kokyuki Gakkai Zasshi, V42, P616	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					961	967		10.1111/ped.12630		7	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600027		
J	Makino, S; Kunishima, S; Ikumi, A; Awaguni, H; Shinozuka, J; Tanaka, S; Maruyama, R; Imashuku, S				Makino, Shigeru; Kunishima, Shinji; Ikumi, Aki; Awaguni, Hitoshi; Shinozuka, Jun; Tanaka, Shin-ichiro; Maruyama, Rikken; Imashuku, Shinsaku			Sporadic Epstein syndrome with macrothrombocytopenia, sensorineural hearing loss and renal failure	PEDIATRICS INTERNATIONAL			English	Article						de novo mutation; Epstein syndrome; macrothrombocytopenia; MYH9 disorder; sporadic case	MYH9 R702 MUTATIONS; FECHTNER SYNDROMES; DISORDERS; DISEASE	We report here a sporadic case of Epstein syndrome, one of the MYH9 disorders. A Japanese boy was first noted to have thrombocytopenia at 3years of age. Blood smear showed giant platelets but no Dohle-like bodies in the neutrophils. He had no family history of thrombocytopenia, hearing loss, and/or renal failure. Thrombocytopenia took a chronic course and platelet count fluctuated in the range 18 000-46 000/L, not responding to i.v. immunoglobulin or prednisolone treatment. The patient had episodes of gross nasal bleeding at 7 and 18years of age. Mild hearing loss was suspected at 6, and proteinuria was first noted at 14years of age. At the development of renal failure at 24years of age, he was identified to have de novo R702H MYH9 mutation. This case illustrates the importance of suspecting MYH9 disorder even in cases of chronic macrothrombocytopenia without family history.	[Makino, Shigeru; Ikumi, Aki; Awaguni, Hitoshi; Shinozuka, Jun; Tanaka, Shin-ichiro; Maruyama, Rikken] Uji Tokushukai Med Ctr, Dept Pediat, Uji, Kyoto 6110042, Japan; [Imashuku, Shinsaku] Uji Tokushukai Med Ctr, Div Lab Med, Uji, Kyoto 6110042, Japan; [Kunishima, Shinji] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan	Imashuku, S (reprint author), Uji Tokushukai Med Ctr, Div Lab Med, Uji, Kyoto 6110042, Japan.	shinim95@mbox.kyoto-inet.or.jp					Arrondel C, 2002, J AM SOC NEPHROL, V13, P65; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4; Pecci A, 2010, BLOOD, V116, P5832, DOI 10.1182/blood-2010-08-304725; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Kunishima S, 2007, EUR J HAEMATOL, V78, P220, DOI 10.1111/j.1600-0609.2006.00806.x; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Pecci A, 2008, NEPHROL DIAL TRANSPL, V23, P2690, DOI 10.1093/ndt/gfn277; Pecci A, 2014, HUM MUTAT, V35, P236, DOI 10.1002/humu.22476	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					977	981		10.1111/ped.12736		5	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600031		
J	Asano, T; Narazaki, H; Kaizu, K; Matsukawa, S; Takema-Tochikubo, Y; Fujii, S; Saitoh, N; Mashiko, K; Fujino, O				Asano, Takeshi; Narazaki, Hidehiko; Kaizu, Kiyohiko; Matsukawa, Shouhei; Takema-Tochikubo, Yuki; Fujii, Shuichi; Saitoh, Nobuyuki; Mashiko, Kunihiko; Fujino, Osamu			Neglect-induced pseudo-thrombotic thrombocytopenic purpura due to vitamin B12 deficiency	PEDIATRICS INTERNATIONAL			English	Article						neglect; pseudo-thrombotic thrombocytopenic purpura; vitamin B12 deficiency	CHILD	Although thrombotic thrombocytopenic purpura (TTP) is rare, early diagnosis and treatment are important for decreasing the mortality rate. Acquired vitamin B12 deficiency is frequently overlooked because of its rarity in developed countries, particularly in children and adolescents. The hematological changes in vitamin B12 deficiency present as megaloblastic anemia, increased lactate dehydrogenase, vasoconstriction, increased platelet aggregation, and abnormal activation of the coagulation followed by microangiopathy as well as neutropenia and thrombocytopenia. We report herein the case of a 15-year-old girl who had been neglected, which might have caused pseudo-TTP through malnutrition, particularly vitamin B12 deficiency. When we encounter cases of TTP in children, clinicians must be aware of the possibility of malnutrition, particularly with vitamin B12 deficiency, even in developed countries, and investigate the cause of malnutrition including neglect.	[Asano, Takeshi; Narazaki, Hidehiko; Kaizu, Kiyohiko; Matsukawa, Shouhei; Takema-Tochikubo, Yuki; Fujii, Shuichi; Fujino, Osamu] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Pediat, Inzai City, Chiba 2701694, Japan; [Saitoh, Nobuyuki; Mashiko, Kunihiko] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Emergency & Crit Care Med, Inzai City, Chiba 2701694, Japan	Asano, T (reprint author), Chiba Hokusoh Hosp, Nippon Med Sch, Dept Pediat, 1715 Kamagari, Inzai City, Chiba 2701694, Japan.	VFF13540@nifty.ne.jp					Green R, 2012, HEMATOL-AM SOC HEMAT, P492, DOI 10.1182/asheducation-2012.1.492; Nappo F, 1999, JAMA-J AM MED ASSOC, V281, P2113, DOI 10.1001/jama.281.22.2113; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Simsek OP, 2004, J PEDIAT HEMATOL ONC, V26, P834; Motto D, 2012, SEMIN NEPHROL, V32, P208, DOI 10.1016/j.semnephrol.2012.02.007; Dimond A, 2009, PEDIATR BLOOD CANCER, V52, P420, DOI 10.1002/pbc.21788; Johnson CF, 2004, NELSON TXB PEDIAT, P129	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					988	990		10.1111/ped.12718		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600034		
J	Taniguchi, K; Ono, H; Sato, A; Kinomoto, S; Tagawa, N; Umehara, N; Kato, H; Sago, H				Taniguchi, Kosuke; Ono, Hiroshi; Sato, Anna; Kinomoto, Satoko; Tagawa, Naomi; Umehara, Nagayoshi; Kato, Hitoshi; Sago, Haruhiko			Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease	PEDIATRICS INTERNATIONAL			English	Article						coronary aneurysm; Kawasaki disease; low-dose aspirin; pregnancy; unfractionated heparin	AMERICAN-HEART-ASSOCIATION; PROFESSIONALS; GUIDELINES; STATEMENT; DIAGNOSIS; THERAPY	Coronary artery aneurysms (CAA) may occur in Kawasaki disease (KD). Patients with giant CAA (diameter >8mm), in particular, have higher risk of myocardial infarction. Previous reports have demonstrated the necessity of anticoagulation therapy in such cases. The management of patients with KD complicated by giant CAA later in life, however, remains controversial. Here, we describe the strict management in the case of a 28-year-old pregnant Japanese woman with KD with giant CAA (diameter, 11mm). Instead of warfarin, the patient was given low-dose aspirin and i.v. unfractionated heparin during pregnancy to prevent thrombosis in the giant CAA. At 38weeks of gestation, she had spontaneous delivery of a healthy baby. No thrombotic or bleeding complications were observed. The strict anticoagulation therapy resulted in successful pregnancy and delivery without any adverse events.	[Taniguchi, Kosuke; Sato, Anna; Kinomoto, Satoko; Tagawa, Naomi; Umehara, Nagayoshi; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reproduct Med, Setagaya Ku, Tokyo 1578535, Japan; [Ono, Hiroshi; Kato, Hitoshi] Natl Ctr Child Hlth & Dev, Div Cardiol, Setagaya Ku, Tokyo 1578535, Japan	Sago, H (reprint author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reproduct Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	sagou-h@ncchd.go.jp					Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Tsuda E, 2006, CARDIOL YOUNG, V16, P173, DOI 10.1017/S1047951106000126; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Nishimura RA, 2014, CIRCULATION, V129, pE521, DOI 10.1161/CIR.0000000000000031; Onouchi Z, 2005, CIRC J, V69, P265, DOI 10.1253/circj.69.265; Suda K, 2009, CIRC J, V73, P1319; Hirsh J, 2001, CIRCULATION, V103, P2994; Ogawa S, 2010, CIRC J, V74, P1989, DOI 10.1253/circj.CJ-10-74-0903	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					990	992		10.1111/ped.12679		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600035		
J	Yamaga, K; Kobayashi, E; Kubota, D; Setsu, N; Tanaka, Y; Minami, Y; Tanzawa, Y; Nakatani, F; Kawai, A; Chuman, H				Yamaga, Kensaku; Kobayashi, Eisuke; Kubota, Daisuke; Setsu, Nokitaka; Tanaka, Yuya; Minami, Yusuke; Tanzawa, Yoshikazu; Nakatani, Fumihiko; Kawai, Akira; Chuman, Hirokazu			Pediatric myositis ossificans mimicking osteosarcoma	PEDIATRICS INTERNATIONAL			English	Article						child; humerus; myositis ossificans; osteosarcoma; periosteal reaction		Myositis ossificans (MO) is a rare benign cause of heterotopic bone formation in soft tissue that most commonly affects young adults, typically following trauma. We report the case of an 11-year-old girl who developed MO mimicking osteosarcoma in her right shoulder. Plain radiography and computed tomography showed poorly defined flocculated densities in the soft tissue and a periosteal reaction along the proximal humerus. On magnetic resonance imaging, the mass displayed an ill-defined margin and inhomogeneous signal change. Histologically, the mass had a pseudosarcomatous appearance. Based on these findings, the patient was initially misdiagnosed with osteosarcoma at another hospital. The diagnosis was difficult because the patient was 11years old and had no trauma history, with atypical radiographic changes and a predilection for the site of origin for osteosarcomas. We finally made the correct diagnosis of MO by carefully reviewing and reflecting on the pathological differences between stages.	[Yamaga, Kensaku; Kobayashi, Eisuke; Kubota, Daisuke; Setsu, Nokitaka; Tanaka, Yuya; Minami, Yusuke; Tanzawa, Yoshikazu; Nakatani, Fumihiko; Kawai, Akira; Chuman, Hirokazu] Natl Canc Ctr, Div Musculoskeletal Oncol, Tokyo 1040045, Japan	Yamaga, K (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	y10142527@gmail.com					Yoshida A, 2010, MODERN PATHOL, V23, P1279, DOI 10.1038/modpathol.2010.124; Koob M, 2010, PEDIATR RADIOL, V40, P34, DOI 10.1007/s00247-010-1769-5; OGILVIEHARRIS DJ, 1980, J BONE JOINT SURG AM, V62, P1274; Gindele A, 2000, PEDIATR RADIOL, V30, P451, DOI 10.1007/s002479900168; DESMET AA, 1992, SKELETAL RADIOL, V21, P503; NORMAN A, 1970, RADIOLOGY, V96, P301; NUOVO MA, 1992, SKELETAL RADIOL, V21, P87; Goldblum JR, 2013, ENZINGER WEISSS SOFT, P926; Rosenberg AE, 2013, WHO CLASSIFICATION T, P50	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					996	999		10.1111/ped.12672		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600037		
J	Tanaka, Y; Miyamoto, T; Yoshitake, S; Naito, Y; Kobayashi, T				Tanaka, Yuki; Miyamoto, Takashi; Yoshitake, Shuichi; Naito, Yuji; Kobayashi, Tomio			Rare combination of congenital heart disease and pulmonary alveolar proteinosis	PEDIATRICS INTERNATIONAL			English	Article						congenital heart disease; lung disease; neonate; pulmonary alveolar proteinosis; total anomalous pulmonary venous return		Here, we describe a case of total anomalous pulmonary venous return with coarctation of the aorta that was diagnosed as pulmonary alveolar proteinosis at autopsy in a male infant. Surgical repair was performed at 1day of age, but the infant died on postoperative day 51 due to respiratory insufficiency without any evidence of pulmonary venous obstruction. He had been unexpectedly diagnosed with pulmonary alveolar proteinosis and pulmonary hypoplasia on autopsy. Congenital pulmonary alveolar proteinosis is a serious condition with a high mortality rate, which should be considered in the differential diagnosis in patients with a clinical picture of pulmonary venous obstruction, because most patients are unable to survive without proper treatment. In this report, we address specific issues that should be discussed in such cases based on our recent experience.	[Tanaka, Yuki; Miyamoto, Takashi; Yoshitake, Shuichi; Naito, Yuji] Gunma Childrens Med Ctr, Dept Pediat Cardiovasc Surg, Shibukawa, Gunma 3778577, Japan; [Kobayashi, Tomio] Gunma Childrens Med Ctr, Pediat Cardiol, Shibukawa, Gunma 3778577, Japan	Tanaka, Y (reprint author), Gunma Childrens Med Ctr, Dept Pediat Cardiovasc Surg, 779 Shimohakoda, Shibukawa, Gunma 3778577, Japan.	tfjgp484@yahoo.co.jp					deMello DE, 2001, PEDIATR PATHOL MOL M, V20, P413; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Dirksen U, 1997, J CLIN INVEST, V100, P2211, DOI 10.1172/JCI119758; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Ben-Dov I, 1999, ISRAEL MED ASSOC J, V1, P75; Hamvas A, 2007, NEONATOLOGY, V91, P311, DOI 10.1159/000101347	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					999	1001		10.1111/ped.12695		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600038		
J	Sakai, T; Sawai, T; Shimizu, Y; Morimune, T; Okuda, Y; Maruo, Y; Iyoda, S; Takeuchi, Y				Sakai, Tomoyuki; Sawai, Toshihiro; Shimizu, Yasuyo; Morimune, Takao; Okuda, Yusuke; Maruo, Yoshihiro; Iyoda, Sunao; Takeuchi, Yoshihiro			Escherichia coli O121:H19 infection identified on microagglutination assay and PCR	PEDIATRICS INTERNATIONAL			English	Article						atypical hemolytic uremic syndrome; Escherichia coli O121; microagglutination assay; non-O157 STEC strain	HEMOLYTIC-UREMIC SYNDROME; NON-O157 SHIGA TOXIN; ECULIZUMAB; O157; O111; FOOD	Non-O157 Shiga toxin-producing Escherichia coli (STEC) strains are increasingly recognized as foodborne pathogens that trigger hemolytic uremic syndrome (HUS). The detection and isolation of these strains is important, but distinguishing their bacteriological profiles is difficult. A 2-year-old girl developed HUS with mild renal involvement 22days after consuming barbecued meat. Clinical and laboratory findings gradually improved without specific treatment. Because neither enterohemorrhagic E. coli (EHEC) nor Shiga toxins were detected in stool cultures in a clinical laboratory and the patient tested negative for circulating antibodies to O157 lipopolysaccharide, the case was initially diagnosed as probable atypical HUS. Subsequent serodiagnostic microagglutination assay and polymerase chain reaction-based molecular testing, however, indicated the presence of the EHEC O121:H19 strain with stx2. Thus, to correctly diagnose and treat HUS, a system for detecting non-O157 STEC in a clinical setting is urgently needed.	[Sakai, Tomoyuki; Sawai, Toshihiro; Morimune, Takao; Okuda, Yusuke; Maruo, Yoshihiro; Takeuchi, Yoshihiro] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan; [Shimizu, Yasuyo] Nagahama Red Cross Hosp, Dept Pediat, Shiga, Japan; [Iyoda, Sunao] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan	Sakai, T (reprint author), Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 5202192, Japan.	sakai-tomoyuki@umin.ac.jp					Wang F, 2013, FOODBORNE PATHOG DIS, V10, P665, DOI 10.1089/fpd.2012.1448; Operario DJ, 2014, J CLIN MICROBIOL, V52, P1003, DOI 10.1128/JCM.02855-13; Sawai T, 2014, PEDIATR INT, V56, P1, DOI 10.1111/ped.12274; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Mellmann A, 2005, CLIN INFECT DIS, V41, P785, DOI 10.1086/432722; Ardissino G, 2014, AM J KIDNEY DIS, V64, P633, DOI 10.1053/j.ajkd.2014.01.434; Isobe J, 2014, J CLIN MICROBIOL, V52, P1112, DOI 10.1128/JCM.03469-13; Niaudet P., UPTODATE OVERVIEW HE; Saini A, 2015, CLIN PEDIATR, V54, P387, DOI 10.1177/0009922814534520; Salvadori Maurizio, 2013, World J Nephrol, V2, P56, DOI 10.5527/wjn.v2.i3.56	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1001	1003		10.1111/ped.12699		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600039		
J	Kunitsu, T; Koshida, S; Tanaka, K; Nakahara, S; Yanagi, T; Maruo, Y; Takeuchi, Y; Kubota, Y				Kunitsu, Tomoaki; Koshida, Shigeki; Tanaka, Katsunori; Nakahara, Sayuri; Yanagi, Takahide; Maruo, Yoshihiro; Takeuchi, Yoshihiro; Kubota, Yoshihiro			Neonatal Meckel diverticulum: Obstruction due to a short mesodiverticular band	PEDIATRICS INTERNATIONAL			English	Article						bowel obstruction; intestinal obstruction; Meckel diverticulum; mesodiverticular band; neonate	INTESTINAL-OBSTRUCTION	This is the first report of symptomatic Meckel diverticulum in a newborn, in which direct compression by a short mesodiverticular band (MDB) caused intestinal obstruction. A short MDB can cause intestinal obstruction due to direct compression. There are two mechanisms by which Meckel diverticulum with MDB can cause intestinal obstruction: internal hernia and direct compression. Onset of intestinal obstruction due to direct compression by a short MDB might be earlier than that for internal hernia with long MDB.	[Kunitsu, Tomoaki; Koshida, Shigeki; Tanaka, Katsunori; Nakahara, Sayuri; Yanagi, Takahide; Maruo, Yoshihiro; Takeuchi, Yoshihiro] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan; [Kubota, Yoshihiro] Shiga Univ Med Sci, Dept Breast & Gen Surg, Otsu, Shiga, Japan	Kunitsu, T (reprint author), Saiseikai Shiga Hosp, 2-4-1 Ohashi, Rittoshi, Shiga 5203046, Japan.	tkunitsu@gmail.com					PFALZGRAF RR, 1988, ARCH PATHOL LAB MED, V112, P182; SINGH RB, 1995, PEDIATR SURG INT, V10, P269; DSOUZA CR, 1993, SURGERY, V114, P984; Park JJ, 2005, ANN SURG, V241, P529, DOI 10.1097/01.sla.0000154270.14308.5f; SEAGRAM CGF, 1968, CAN J SURG, V11, P369; Sun C, 2012, J ULTRAS MED, V31, P2035; Vork JC, 2003, FORENSIC SCI INT, V138, P114, DOI 10.1016/j.forsciint.2003.08.013; Prasad T R Sai, 2006, JSLS, V10, P310; RUTHERFO.RB, 1966, SURGERY, V59, P618; WILLIAMS RS, 1981, BRIT J SURG, V68, P477, DOI 10.1002/bjs.1800680712	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1007	1009		10.1111/ped.12694		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600041		
J	Watanabe, H; Ayusawa, M; Kato, M; Chou, A; Komori, A; Abe, Y; Matsumura, M; Kamiyama, H; Izumi, H; Takahashi, S				Watanabe, Hirofumi; Ayusawa, Mamoru; Kato, Masataka; Chou, Ami; Komori, Akiko; Abe, Yuriko; Matsumura, Masaharu; Kamiyama, Hiroshi; Izumi, Hiroyuki; Takahashi, Shori			Idiopathic pulmonary hemosiderosis complicated by Down syndrome	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; hemolytic anemia; hemoptysis; idiopathic pulmonary hemosiderosis; prednisolone		We report the case of a 9-year-old girl with Down syndrome (DS) diagnosed with idiopathic pulmonary hemosiderosis (IPH). Although acute pneumonia complicated by hemolytic anemia was suspected, IPH was finally diagnosed on bronchoscopy. Treatment with prednisolone achieved good clinical response. An association between IPH and DS was not able to be identified, but immunological issues in DS may contribute to the onset of IPH. Recurrent and intractable respiratory symptoms with marked infiltrative shadows in the bilateral lungs and complicated by severe anemia in patients with DS should suggest IPH.	[Watanabe, Hirofumi; Ayusawa, Mamoru; Kato, Masataka; Chou, Ami; Komori, Akiko; Abe, Yuriko; Matsumura, Masaharu; Kamiyama, Hiroshi; Izumi, Hiroyuki; Takahashi, Shori] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo 1738610, Japan; [Izumi, Hiroyuki] Itabashi Med Assoc Hosp, Itabashi Ku, Tokyo, Japan	Watanabe, H (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, 30-1 Ooyaguchikamichou, Tokyo 1738610, Japan.	mehi11016@g.nihon-u.ac.jp					Aceti A, 2012, SARCOIDOSIS VASC DIF, V29, P58; Akio N, 1992, NIHON KYOBU SHIKKAN, V30, P1749; Sethi GR, 2011, PEDIATR PULM, V46, P302, DOI 10.1002/ppul.21357; Saeed MM, 1999, CHEST, V116, P721, DOI 10.1378/chest.116.3.721; Nuesslein TG, 2006, PAEDIATR RESPIR REV, V7, P45, DOI 10.1016/j.prrv.2005.11.003; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; NOVO E, 1993, AM J MED GENET, V46, P384, DOI 10.1002/ajmg.1320460408; Gencer M, 2007, CAN RESPIR J, V14, P490; Mourato Felipe Alves, 2014, Rev Paul Pediatr, V32, P159, DOI 10.1590/0103-0582201432218913; Sato Y, CASE REPORT IDIOPATH; Taruhisa K, 1995, IRYO, V49, P580; Taytard J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-161	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1009	1012		10.1111/ped.12690		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600042		
J	Okada, S; Hasegawa, S; Suzuki, Y; Ichimura, T; Kaneyasu, H; Shimomura, M; Wakabayashi-Takahara, M; Nakamura, K; Kobayashi, M; Ohga, S				Okada, Seigo; Hasegawa, Shunji; Suzuki, Yasuo; Ichimura, Takuya; Kaneyasu, Hidenobu; Shimomura, Maiko; Wakabayashi-Takahara, Midori; Nakamura, Kazuhiro; Kobayashi, Masao; Ohga, Shouichi			Remission of autoimmune neutropenia after development of Kawasaki disease	PEDIATRICS INTERNATIONAL			English	Article						autoimmune neutropenia; granulocyte colony-stimulating factor; Kawasaki disease; transforming growth factor-beta 1	CHILDREN; NEUTROPHILS; ACTIVATION	We report the second case of the association of Kawasaki disease (KD) and autoimmune neutropenia (AIN). A 21-month-old female diagnosed as having AIN of infancy developed a complete KD when severe neutropenia continued. The patient suffered from no coronary artery leions, and well responded to a single high-dose gamma-globulin therapy. The cytokine profile of the neutropenic infant was representative of the typical KD. Neutrophil counts notably increased during the convalescent phase of KD, and were then normalized forthwith. The prompt resolutions of KD and AIN paralleled the increase of circulating transforming growth factor (TGF)-beta 1 levels. The clinical course of the patient was contrasted to that of the first reported case of a patient who developed severe and refractory KD after the high dose granulocyte-colony stimulating factor (G-CSF) therapy.	[Okada, Seigo; Hasegawa, Shunji; Suzuki, Yasuo; Ichimura, Takuya; Kaneyasu, Hidenobu; Shimomura, Maiko; Wakabayashi-Takahara, Midori; Ohga, Shouichi] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Ube, Yamaguchi 7558505, Japan; [Nakamura, Kazuhiro; Kobayashi, Masao] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Minami Ku, Hiroshima, Japan	Okada, S (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Pediat, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	p002um@yamaguchi-u.ac.jp			Ministry of Health, Labour and Welfare of Japan	This work was supported in part by a grant from the Ministry of Health, Labour and Welfare of Japan. The authors declare no conflicts of interest.	Yoshimura K, 2009, EUR J PEDIATR, V168, P1037, DOI 10.1007/s00431-008-0872-1; Matsubara T, 1997, SCAND J RHEUMATOL, V26, P314; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; Nakamura K, 2009, BRIT J HAEMATOL, V145, P642, DOI 10.1111/j.1365-2141.2009.07662.x; FURUKAWA S, 1992, EUR J PEDIATR, V151, P44, DOI 10.1007/BF02073890; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Ueno K, 2011, PEDIATR INT, V53, P388, DOI 10.1111/j.1442-200X.2011.03376.x; Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; KAVERI SV, 1991, CLIN EXP IMMUNOL, V86, P192; Kobayashi M, 2002, BLOOD, V99, P3468, DOI 10.1182/blood.V99.9.3468; Fujimaru T, 2014, CYTOKINE, V70, P156, DOI 10.1016/j.cyto.2014.07.003; Ni FF, 2014, CLIN EXP IMMUNOL, V178, P384, DOI 10.1111/cei.12418	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1012	1014		10.1111/ped.12701		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600043		
J	Keino, D; Tsuzuki, Y; Mori, T; Kakuage, S; Nakano, M; Asoh, K; Mori, T; Kinoshita, A; Yamamoto, H				Keino, Dai; Tsuzuki, Yoshimitsu; Mori, Takashi; Kakuage, Shiori; Nakano, Marie; Asoh, Kentaro; Mori, Tetsuya; Kinoshita, Akitoshi; Yamamoto, Hitoshi			Infective endocarditis associated with acute leukemia: Report of two cases	PEDIATRICS INTERNATIONAL			English	Article						acute leukemia; daptomycin; infective endocarditis; Staphylococcus aureus	STAPHYLOCOCCUS-AUREUS BACTEREMIA; AGRANULOCYTOSIS	There have been few reports regarding infective endocarditis (IE) in patients with leukemia. In the first case, a 15-year-old girl with Down syndrome was diagnosed with acute lymphoblastic leukemia. On admission, methicillin-sensitive Staphylococcus aureus (MSSA) was detected on blood culture. Echocardiography was performed because MSSA was detected repeatedly even after treatment. Vegetation in all of the atria and ventricles met the Duke criteria defining IE. She died of multiple organ failure 21days after diagnosis. In the second case, an 11-year-old boy with acute myeloid leukemia underwent peripheral blood stem cell transplantation (PBSCT). He had fever 68 days after PBSCT, and methicillin-resistant S. aureus (MRSA) was detected on blood culture. Echocardiography showed vegetation in the right atrium and ventricle. Daptomycin was administered for 7weeks, and recurrence was not observed. IE should be considered when S. aureus bacteremia is documented even in patients with leukemia.	[Keino, Dai; Tsuzuki, Yoshimitsu; Mori, Takashi; Kakuage, Shiori; Nakano, Marie; Asoh, Kentaro; Mori, Tetsuya; Kinoshita, Akitoshi; Yamamoto, Hitoshi] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa 2168511, Japan	Keino, D (reprint author), St Marianna Univ, Sch Med, Dept Pediat, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	d2keino@marianna-u.ac.jp					Kuruvilla J, 2007, BIOL BLOOD MARROW TR, V13, P925, DOI 10.1016/j.bbmt.2007.04.006; Skov R, 1995, SCAND J INFECT DIS, V27, P563, DOI 10.3109/00365549509047068; ESPERSEN F, 1987, ACTA MED SCAND, V222, P465; Mondejar PL, 1997, REV CLIN ESP, V197, P814; SOTMAN SB, 1980, AM J MED, V69, P814, DOI 10.1016/S0002-9343(80)80005-2; BELIK J, 1980, ACTA PAEDIATR SCAND, V69, P731, DOI 10.1111/j.1651-2227.1980.tb07141.x; LIEPMAN MK, 1984, CANCER, V54, P804, DOI 10.1002/1097-0142(19840901)54:5<804::AID-CNCR2820540506>3.0.CO;2-C; Tomizawa D, 2013, LEUKEMIA, V27, P2413, DOI 10.1038/leu.2013.153; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Antachopoulos C, 2012, INFECTION, V40, P367, DOI 10.1007/s15010-011-0240-3; DWYER DE, 1994, MED J AUSTRALIA, V160, P709; Dwyer DE, 1994, MED J AUSTRALIA, V160, P716	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1017	1020		10.1111/ped.12700		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600045		
J	Sato, N; Sugiura, T; Nagasaki, R; Suzuki, K; Ito, K; Kato, T; Inukai, S; Saitoh, S				Sato, Nikiko; Sugiura, Tokio; Nagasaki, Rika; Suzuki, Kazutaka; Ito, Koichi; Kato, Takenori; Inukai, Sachiko; Saitoh, Shinji			Effects of tolvaptan on congestive heart failure complicated with chylothorax in a neonate	PEDIATRICS INTERNATIONAL			English	Article						chylothorax; congestive heart failure; neonate; surgery for congenital heart disease; tolvaptan	HYPONATREMIA; ANTAGONIST; TRIAL	Tolvaptan is an oral vasopressin type 2 receptor antagonist that can be used for heart failure patients with hyponatremia or symptomatic congestion. Although the effects of tolvaptan in adults have been well documented, only limited information is available in children. The case of a neonate with congestive heart failure complicated with chylothorax after palliative surgery for transposition of the great arteries treated with tolvaptan is reported. Slow up-titration to 0.1mg/kg successfully increased urine output and improved refractory congestive heart failure without hypernatremia. Subsequently, bodyweight and chylothorax decreased gradually. Moreover, the use of tolvaptan reduced the dosage of furosemide. Tolvaptan could be an alternative drug for neonates with congestive heart failure. Further large studies are needed to confirm the efficacy and identify the appropriate dose of tolvaptan in neonates.	[Sato, Nikiko; Sugiura, Tokio; Nagasaki, Rika; Suzuki, Kazutaka; Ito, Koichi; Kato, Takenori; Inukai, Sachiko; Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi 4678601, Japan	Sugiura, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	tokio@med.nagoya-cu.ac.jp					Horibata Y, 2014, CARDIOL YOUNG, V24, P155, DOI 10.1017/S1047951112002272; Chan EH, 2005, ANN THORAC SURG, V80, P1864, DOI 10.1016/j.athoracsur.2005.04.048; Udelson JE, 2008, J AM COLL CARDIOL, V52, P1540, DOI 10.1016/j.jacc.2008.08.013; Sharkey AJ, 2012, TEX HEART I J, V39, P428; O'Connell JB, 2012, POSTGRAD MED, V124, P29, DOI 10.3810/pgm.2012.03.2534; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Regen RB, 2013, PEDIATR CARDIOL, V34, P1463, DOI 10.1007/s00246-013-0671-y; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Yi Joo-Hark, 2011, Electrolyte Blood Press, V9, P50, DOI 10.5049/EBP.2011.9.2.50	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1020	1022		10.1111/ped.12697		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600046		
J	Sakakibara, K; Okayama, Y; Fukushima, K; Kaji, S; Muraoka, M; Arao, Y; Shimada, A				Sakakibara, Kanae; Okayama, Yoshiki; Fukushima, Kenji; Kaji, Shunsaku; Muraoka, Michiko; Arao, Yujiro; Shimada, Akira			Japanese family with congenital factor VII deficiency	PEDIATRICS INTERNATIONAL			English	Article						factor VII deficiency; hepaplastin test; mutation; vitamin K	MUTATIONS; GENE	Congenital factor VII (FVII) deficiency is a rare bleeding disorder with autosomal recessive inheritance. The present female patient was diagnosed with congenital FVII deficiency because of low hepaplastin test (HPT), although vitamin K was given. Heterozygous p.A191T mutation was detected in the peripheral blood, and the same mutation was also found in the mother and sister. To the best of our knowledge, this is the fourth reported case of p.A191T mutation of FVII in the literature and the first to be reported in Japan. FVII coagulation activity (FVII:C) in asymptomatic heterozygous carriers is mildly reduced. Therefore, some patients may not be accurately diagnosed with congenital FVII deficiency. In infants with low HPT without vitamin K deficiency, congenital FVII deficiency should be considered.	[Sakakibara, Kanae] Okayama Univ Hosp, Div Med Support, Tsuyama, Okayama, Japan; [Muraoka, Michiko; Shimada, Akira] Okayama Univ Hosp, Dept Pediat, Tsuyama, Okayama, Japan; [Sakakibara, Kanae; Arao, Yujiro] Okayama Univ, Grad Sch Hlth Sci, Field Med Technol, Tsuyama, Okayama, Japan; [Okayama, Yoshiki; Fukushima, Kenji; Kaji, Shunsaku] Tsuyama Cent Hosp, Dept Pediat, Tsuyama, Okayama, Japan	Shimada, A (reprint author), Okayama Univ Hosp, Dept Pediat, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	pajj236e@okayama-u.ac.jp					Herrmann FH, 2009, HAEMOPHILIA, V15, P267, DOI 10.1111/j.1365-2516.2008.01910.x; McVey JH, 2001, HUM MUTAT, V17, P3, DOI 10.1002/1098-1004(2001)17:1<3::AID-HUMU2>3.0.CO;2-V; Borensztajn K, 2005, THROMB RES, V116, P115, DOI 10.1016/j.thromres.2004.11.005; TUDDENHAM EGD, 1995, THROMB HAEMOSTASIS, V74, P313; OHARA PJ, 1987, P NATL ACAD SCI USA, V84, P5158, DOI 10.1073/pnas.84.15.5158; Landau D, 2009, HAEMOPHILIA, V15, P774, DOI 10.1111/j.1365-2516.2009.02004.x; Erduran E, 1998, HAEMOSTASIS, V28, P14; Giansily-Blaizot M, 2001, EUR J HUM GENET, V9, P105, DOI 10.1038/sj.ejhg.5200593; Mariani G, 2009, SEMIN THROMB HEMOST, V35, P400, DOI 10.1055/s-0029-1225762	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1023	1024		10.1111/ped.12696		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600047		
J	Kobayashi, R; Suzuki, D; Hori, D; Kishimoto, K; Sano, H; Nakazawa, A; Yasuda, K; Kobayashi, K				Kobayashi, Ryoji; Suzuki, Daisuke; Hori, Daiki; Kishimoto, Kenji; Sano, Hirozumi; Nakazawa, Atsuko; Yasuda, Kazue; Kobayashi, Kunihiko			Spontaneous improvement in a pediatric patient with peripheral T-cell lymphoma	PEDIATRICS INTERNATIONAL			English	Article						child; hemophagocytic syndrome; peripheral T-cell lymphoma	HEMOPHAGOCYTIC SYNDROME; CHILDHOOD	Peripheral T-cell lymphoma (PTCL) is rare in children, and it has a poor prognosis compared with other types of lymphoma. We report the case of a 7-year-old boy with spontaneous improvement of PTCL complicated by hemophagocytic syndrome as the initial symptom. He complained of pain and swelling of the right neck and presented with high fever. Pancytopenia, liver dysfunction, elevated ferritin and soluble interleukin 2 receptor were noted on laboratory tests. Peripheral blood plasma and white blood cells were positive for Epstein-Barr virus (EBV) genome but, after several days, the fever abated and laboratory data improved. On histopathology of lymph node biopsy, he was diagnosed as having PTCL not otherwise specified (PTCL-NOS) with EBV infection. He received no chemotherapy and was disease free at the last follow up, 6years 8months after onset. This is probably the first case of spontaneous improvement in PTCL-NOS. Careful treatment planning is therefore necessary in PTCL-NOS, given the possibility of spontaneous improvement of symptoms.	[Kobayashi, Ryoji; Suzuki, Daisuke; Hori, Daiki; Kishimoto, Kenji; Sano, Hirozumi; Yasuda, Kazue; Kobayashi, Kunihiko] Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Sapporo, Hokkaido 0030006, Japan; [Nakazawa, Atsuko] Natl Ctr Child Hlth & Dev, Dept Pathol, Setagaya Ku, Tokyo, Japan	Kobayashi, R (reprint author), Sapporo Hokuyu Hosp, Dept Pediat, Shiroishi Ku, Higashi Sapporo 6-6, Sapporo, Hokkaido 0030006, Japan.	r-koba@jacls.jp					Windsor R, 2008, PEDIATR BLOOD CANCER, V50, P784, DOI 10.1002/pbc.21293; Kobayashi R, 2010, PEDIATR BLOOD CANCER, V54, P212, DOI 10.1002/pbc.22329; Medhi K, 2008, J PEDIAT HEMATOL ONC, V30, P558, DOI 10.1097/MPH.0b013e31817588e8; Brodkin DE, 2008, J PEDIAT HEMATOL ONC, V30, P938, DOI 10.1097/MPH.0b013e31817e4b25; Imashuku S, 1997, INT J HEMATOL, V66, P135; Lim GY, 2009, PEDIATR RADIOL, V39, P57, DOI 10.1007/s00247-008-1002-y; Hutchison RE, 2008, PEDIATR BLOOD CANCER, V51, P29, DOI 10.1002/pbc.21543; Tong HY, 2008, LEUKEMIA LYMPHOMA, V49, P81, DOI 10.1080/10428190701713630; International T cell lymphomas Project, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1035	1037		10.1111/ped.12784		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600051		
J	Higashigawa, M; Maeyama, T; Yoshino, A; Matsuda, K; Ito, M; Maji, T; Ichimi, R				Higashigawa, Masamune; Maeyama, Takatoshi; Yoshino, Ayako; Matsuda, Kazuyuki; Ito, Mitsue; Maji, Tomoaki; Ichimi, Ryouji			Incidence of childhood primary immune thrombocytopenic purpura	PEDIATRICS INTERNATIONAL			English	Article						child; immune thrombocytopenic purpura; incidence		There is a discrepancy in the reported incidence of childhood immune thrombocytopenic purpura (ITP) between Europe (2.9-5.3 per 100 000 persons) and Japan (1.91). Ise district is a suitable area in which to conduct epidemiological study because there is little fluctuation in the sociodemographic factors. We performed a retrospective population-based study to clarify the incidence of primary childhood ITP. We calculated person-years for children aged <15 years based on the Ise district demographics between 2002 and 2012. The calculated person-years were 298 533. The number of hospitalized patients in Ise district was 25 (M/F, 14/11) during the study period. The calculated incidence was therefore 8.4 per 100 000 person-years. It is possible that the difference in incidence between the present calculation and that of the European studies is due to variation in accuracy and/or registration criteria between the studies.	[Higashigawa, Masamune; Maeyama, Takatoshi; Yoshino, Ayako; Matsuda, Kazuyuki; Ito, Mitsue; Maji, Tomoaki; Ichimi, Ryouji] Ise Red Cross Hosp, Dept Pediat, Ise, Mie 5168512, Japan	Higashigawa, M (reprint author), Ise Red Cross Hosp, Dept Pediat, 1-471-2 Funae, Ise, Mie 5168512, Japan.	higashigawa@hotmail.com					LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251; Watts RG, 2004, CLIN PEDIATR, V43, P691, DOI 10.1177/000992280404300802; Zeller B, 2000, PEDIATR HEMAT ONCOL, V17, P551; COHN J, 1976, SCAND J HAEMATOL, V16, P226; BoltonMaggs PHB, 1997, LANCET, V350, P620, DOI 10.1016/S0140-6736(97)04143-3; Kurata Y, 2011, INT J HEMATOL, V93, P329, DOI 10.1007/s12185-011-0791-1; Shirahata A, 2006, INT J HEMATOL, V83, P29, DOI 10.1532/IJH97.05123	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1041	1043		10.1111/ped.12788		3	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600053		
J	Yamamoto-Hanada, K; Futamura, M; Kitazawa, H; Ohya, Y; Kobayashi, F; Kusuda, T; Sanefuji, M; Oda, M; Mitsubuchi, H; Shibata, E; Tsuji, M; Kayama, F; Nakano, Y; Suda, E; Michikawa, T; Katoh, T; Saito, H				Yamamoto-Hanada, Kiwako; Futamura, Masaki; Kitazawa, Hiroshi; Ohya, Yukihiro; Kobayashi, Fumio; Kusuda, Takeshi; Sanefuji, Masafumi; Oda, Masako; Mitsubuchi, Hiroshi; Shibata, Eiji; Tsuji, Mayumi; Kayama, Fujio; Nakano, Yuko; Suda, Eiko; Michikawa, Takehiro; Katoh, Takahiko; Saito, Hirohisa			Relieving pain and distress during venipuncture: Pilot study of the Japan Environment and Children's Study (JECS)	PEDIATRICS INTERNATIONAL			English	Article						distress; lidocaine/prilocaine cream; pain; psychological intervention in venipuncture		Pain management for needle-related procedures is poor in Japan. In many countries the use of lidocaine/prilocaine cream for the relief of pain associated with venipuncture has been approved. In children, a psychological approach has also been shown to be effective in reducing pain with venipuncture. We developed a multidisciplinary procedure that combines a cream (2.5% lidocaine and 2.5% prilocaine) and pharmacological approaches such as preparation, education, positioning and distraction. We evaluated the feasibility and acceptability of the procedure for young children. Among 132 pediatric participants, 58.3% did not cry during venipuncture. According to caregiver questionnaire, 71.9% felt that the multidisciplinary procedure eliminated the fear of needle-related procedures in the children; 90.9% were satisfied with it and 75.8% thought it should be applied to all children undergoing venipuncture. The present results suggest that the multidisciplinary procedure is feasible, acceptable and suitable for use in children undergoing venipuncture.	[Yamamoto-Hanada, Kiwako; Futamura, Masaki; Kitazawa, Hiroshi; Ohya, Yukihiro; Saito, Hirohisa] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo 1578535, Japan; [Yamamoto-Hanada, Kiwako; Kobayashi, Fumio] Aichi Med Univ, Sch Med, Dept Hlth & Psychosocial Med, Nagoya, Aichi, Japan; [Kusuda, Takeshi] Kyushu Univ Hosp, Dept Pediat, Fukuoka 812, Japan; [Sanefuji, Masafumi] Kyushu Univ, Res Ctr Environm & Dev Sci, Fukuoka 812, Japan; [Shibata, Eiji] Univ Occupat & Environm Hlth, Sch Med, Dept Obstet & Gynecol, Fukuoka, Japan; [Tsuji, Mayumi] Univ Occupat & Environm Hlth, Sch Med, Dept Environm Hlth, Fukuoka, Japan; [Oda, Masako; Mitsubuchi, Hiroshi; Katoh, Takahiko] Kumamoto Univ, Japan Environm & Childrens Study, South Kyushu & Okinawa Reg Ctr, Kumamoto, Japan; [Kayama, Fujio] Jichi Med Univ, Sch Med, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Nakano, Yuko] Jichi Med Univ, Sch Med, Dept Pediat, Shimotsuke, Tochigi, Japan; [Suda, Eiko; Michikawa, Takehiro] Natl Inst Environm Studies, Natl Ctr Japan Environm & Childrens Study, Ibaraki, Japan; [Kitazawa, Hiroshi] Miyagi Childrens Hosp, Dept Gen Pediat, Sendai, Miyagi, Japan	Yamamoto-Hanada, K (reprint author), Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	yamamoto-k@ncchd.go.jp		Yamamoto-Hanada, Kiwako/0000-0003-1288-9620	Ministry of the Environment, Japan	We are extremely grateful to all study participants and members of the pilot study for the JECS. We thank Ms Megumi Aiyoshi, a child life specialist, for advice. We thank Dr Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development, for assistance with the manuscript. This study was supported by a grant for Japan Environment and Children's Pilot Study from the Ministry of the Environment, Japan. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the aforementioned government. The authors declare no conflicts of interest.	Inal S, 2012, INT J NURS PRACT, V18, P210, DOI 10.1111/j.1440-172X.2012.02016.x; Taddio A, 2010, CAN MED ASSOC J, V182, P1989, DOI 10.1503/cmaj.092048; HARRISON A, 1991, PAIN, V45, P299, DOI 10.1016/0304-3959(91)90054-2; Eden L, 2014, PEDIAT HLTH MED THER, V5, P127; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; McLure H A, 2005, Minerva Anestesiol, V71, P59; Rogers Tanya L, 2004, J Pediatr Nurs, V19, P33, DOI 10.1016/j.pedn.2003.09.005; Uman LS, 2013, COCHRANE DB SYST REV, V10	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1044	1047		10.1111/ped.12818		4	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600054		
J	Tagawa, M; Wakabayashi, H				Tagawa, Manabu; Wakabayashi, Hiroto			Ingested large fish hook in the stomach of a 2-year-old boy	PEDIATRICS INTERNATIONAL			English	Editorial Material									[Tagawa, Manabu; Wakabayashi, Hiroto] Takeda Gen Hosp, Dept Gastroenterol, Fukushima, Japan; [Tagawa, Manabu] Univ Tsukuba, Univ Tsukuba Hosp, Dept Pediat, Tsukuba, Ibaraki 3058576, Japan	Tagawa, M (reprint author), Univ Tsukuba, Univ Tsukuba Hosp, Dept Pediat, 2-1-1 Amakubo, Tsukuba, Ibaraki 3058576, Japan.	manabutagawa@jeans.ocn.ne.jp					Iwamuro M, 2009, GASTROINTEST ENDOSC, V70, P550, DOI 10.1016/j.gie.2009.04.023; Pan Cheng-Ching, 2010, J Emerg Med, V38, pe45, DOI 10.1016/j.jemermed.2007.08.062	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1048	1048		10.1111/ped.12729		1	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600055		
J	Onoda, T; Meguro, T; Kanno, M; Ohta, H; Nakamura, M; Ohtake, H; Mitsui, T				Onoda, Tadashi; Meguro, Toru; Kanno, Miyako; Ohta, Hiroshi; Nakamura, Megumi; Ohtake, Hiroya; Mitsui, Tetsuo			Giant thymolipoma in a young child initially diagnosed as cardiomegaly	PEDIATRICS INTERNATIONAL			English	Editorial Material									[Onoda, Tadashi; Meguro, Toru; Kanno, Miyako; Mitsui, Tetsuo] Yamagata Univ, Dept Pediat, Fac Med, Yamagata, Yamagata 9909585, Japan; [Ohta, Hiroshi; Nakamura, Megumi] Yamagata Univ, Dept Surg 2, Fac Med, Yamagata, Yamagata 9909585, Japan; [Ohtake, Hiroya] Yamagata Univ, Dept Pathol, Fac Med, Yamagata, Yamagata 9909585, Japan; [Onoda, Tadashi] Yamagata Prefectural Cent Hosp, Dept Pediat, Yamagata, Japan	Onoda, T (reprint author), Yamagata Univ, Dept Pediat, Fac Med, 2-2-2 Iida Nishi, Yamagata, Yamagata 9909585, Japan.	onoda-t@med.id.yamagata-u.ac.jp					Halnon NJ, 2005, PEDIATR RES, V57, P42, DOI 10.1203/01.PDR.0000147735.19342.DE; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Hudacko R, 2009, ANN DIAGN PATHOL, V13, P185, DOI 10.1016/j.anndiagpath.2008.02.006; MORAN CA, 1995, MODERN PATHOL, V8, P741; Parakh A, 2014, PAEDIATR INT CHILD H, V34, P230, DOI 10.1179/2046905513Y.0000000108	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1051	1052		10.1111/ped.12786		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600057		
J	Morioka, I; Yamana, K; Kurokawa, D; Nishida, K; Nagasaka, M; Fujita, K; Fukushima, S; Tokuda, O; Iwatani, S; Koda, T				Morioka, Ichiro; Yamana, Keiji; Kurokawa, Daisuke; Nishida, Kosuke; Nagasaka, Miwako; Fujita, Kaori; Fukushima, Sachiyo; Tokuda, Oshi; Iwatani, Sota; Koda, Tsubasa			How long is transient tachypnea of the newborn dependent on oxygen supplementation?	PEDIATRICS INTERNATIONAL			English	Letter									[Morioka, Ichiro; Yamana, Keiji; Kurokawa, Daisuke; Nishida, Kosuke; Nagasaka, Miwako; Fujita, Kaori; Fukushima, Sachiyo; Tokuda, Oshi; Iwatani, Sota; Koda, Tsubasa] Kobe Univ, Grad Sch Med, Dept Pediat, Kobe, Hyogo 6500017, Japan	Morioka, I (reprint author), Kobe Univ, Grad Sch Med, Dept Pediat, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ichim@med.kobe-u.ac.jp					Ochi F, 2015, PEDIATR INT, V57, P263, DOI 10.1111/ped.12505; Welty S, 2005, AVERYS DIS NEWBORN, P697	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1054	1055		10.1111/ped.12768		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600059		
J	Takakura, M; Shimizu, M; Inoue, N; Tasaki, Y; Ishikawa, S; Ohta, K; Yachie, A				Takakura, Maiko; Shimizu, Masaki; Inoue, Natsumi; Tasaki, Yuko; Ishikawa, Sayaka; Ohta, Kazuhide; Yachie, Akihiro			Iodine-induced non-autoimmune hypothyroidism in a patient with steroid-resistant nephrotic syndrome	PEDIATRICS INTERNATIONAL			English	Letter							CHILDREN		[Takakura, Maiko; Shimizu, Masaki; Inoue, Natsumi; Tasaki, Yuko; Ishikawa, Sayaka; Yachie, Akihiro] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, Kanazawa, Ishikawa 9208641, Japan; [Ohta, Kazuhide] Kanazawa Med Ctr, Dept Pediat, Kanazawa, Ishikawa, Japan	Shimizu, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Sch Med, Dept Pediat, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	shimizum@staff.kanazawa-u.ac.jp					Kapoor K, 2014, CLIN EXP NEPHROL, V18, P113, DOI 10.1007/s10157-013-0800-1; Dagan A, 2012, NEPHROL DIAL TRANSPL, V27, P2171, DOI 10.1093/ndt/gfr665; Padovani RP, 2012, THYROID, V22, P926, DOI 10.1089/thy.2012.0099; FONSECA V, 1991, LANCET, V338, P475, DOI 10.1016/0140-6736(91)90546-2; CORRADI A, 1990, ARZNEIMITTEL-FORSCH, V40-2, P830; Bando Y, 2002, EXP CLIN ENDOCR DIAB, V110, P408, DOI 10.1055/s-2002-36427; Ho JD, 2014, J THYROID RES, V2014	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	OCT	2015	57	5					1055	1056		10.1111/ped.12759		2	Pediatrics	Pediatrics	CU8AQ	WOS:000363763600060		
J	Yana, E; Mayama, S				Yana, Ekkachai; Mayama, Shigeki			Two new taxa of Achnanthidium and Encyonema (Bacillariophyceae) from the Yom River, Thailand, with special reference to the areolae occlusions implying ontogenetic relationship	PHYCOLOGICAL RESEARCH			English	Article						Achnanthidium pseudoconspicuum var; yomensis; Encyonema yuwadeeanum; hymen; new species; new variety; South-East Asia; valve ontogeny	BENTHIC DIATOMS; NITZSCHIA; MORPHOLOGY; MODEL	We discovered two new taxa of Achnanthidium and Encyonema occurring with high abundance in the upstream of the Yom River, which is one of four major rivers in Northern Thailand. Achnanthidium pseudoconspicuum var. yomensis var. nov. closely resembles Achnanthidium pseudoconspicuum var. pseudoconspicuum in scanning electron microscopy (SEM), but has clearly different valve morphometry under the light microscopy (LM). Achnanthidium pseudoconspicuum var. yomensis is also similar to A.japonicum in valve morphology under LM, but differs to this species based on SEM observation. Encyonema yuwadeeanum sp. nov. shows similarities to Encyonema leei and Encyonema subkukenanum, but differs in valve shape and/or polar fissure shape. We discuss the possible valve ontogenetic relationship between Achnanthidium and Cymbellales based on the detailed areolae structures of these two new taxa.	[Yana, Ekkachai] Chiang Mai Univ, Fac Sci, Environm Sci Program, Chiang Mai 50000, Thailand; [Yana, Ekkachai] Lampang Rajabhat Univ, Environm Sci Program, Fac Sci, Lampang, Thailand; [Mayama, Shigeki] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo 184, Japan	Yana, E (reprint author), Chiang Mai Univ, Fac Sci, Environm Sci Program, Chiang Mai 50000, Thailand.	ekkachai_y@hotmail.co.th			Center of Excellence on Environmental Health, Toxicology and Management of Chemicals and Graduate School, Chiang Mai University, Thailand	We thank Nina Lundholm for sending type material and slides from the Foged's Collection, Copenhagen. This study was partly supported by a grant from the Center of Excellence on Environmental Health, Toxicology and Management of Chemicals and Graduate School, Chiang Mai University, Thailand.	Willis L, 2010, PLANT ECOL EVOL, V143, P297, DOI 10.5091/plecevo.2010.415; Mayama S, 2004, PHYCOL RES, V52, P129; Suphan S, 2010, CHIANG MAI J SCI, V37, P326; REICHARDT E, 1988, NOVA HEDWIGIA, V47, P81; [Anonymous], 1975, NOVA HEDWIGIA S, V53, P323; Kermarrec L, 2011, DIATOM RES, V26, P305, DOI 10.1080/0269249X.2011.633255; Sumper M, 2002, SCIENCE, V295, P2430, DOI 10.1126/science.1070026; KOBAYASI H, 1985, HYDROBIOLOGIA, V127, P97, DOI 10.1007/BF00004189; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Bukhtiyarova LN, 2006, NOVA HEDWIGIA, P85; Tremarin PI, 2011, NOVA HEDWIGIA, V92, P107, DOI 10.1127/0029-5035/2011/0092-0107; MartinezGoss MR, 1997, P ACAD NAT SCI PHILA, V147, P119; Juttner I, 2011, DIATOM RES, V26, P21, DOI 10.1080/0269249X.2011.573707; Kobayasi H, 1997, NOVA HEDWIGIA, V65, P147; Rimet F, 2011, DIATOM RES, V26, P273, DOI 10.1080/0269249X.2011.597988; Cox EJ, 2012, J PHYCOL, V48, P1, DOI 10.1111/j.1529-8817.2011.01081.x; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Cox E.J., 2004, DIATOM, V20, P33; Cox E.J., 1981, P 6 S REC FOSS DIAT, P267; Eaton AE, 2005, STANDARD METHOD EXAM; Foged N., 1971, NOVA HEDWIGIA, V22, P267; Fujita Y., 2005, DIATOM, V21, P71; Helmcke J. G., 1962, DIATOMEENSCHALEN E 2; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P638; Hustedt F., 1937, ARCH HYDROBIOL S, V16, p[1937, 274]; Hustedt Friedrich, 1942, INTERNAT REV GES HYDROBIOL U HYDROGR, V42, P1, DOI 10.1002/iroh.19420420102; HUSTEDT F., 1937, ARCH HYDROBIOL S, V15, p[131, 638, 9]; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P187; Hustedt F., 1937, ARCH HYDROBIOL S, V15, P393; HUSTEDT F., 1937, ARCH HYDROBIOL S, V16, P1; Kobayashi H., 1986, Proceedings IECON '86. 1986 International Conference on Industrial Electronics, Control and Instrumentation. Industrial Applications of Mini, Micro and Personal Computers (Cat. No.86CH2334-1); Kobayasi H., 1986, DIATOM, V2, P83; Kobayasi H., 2006, H KOBAYASIS ATLAS JA; Krammer K., 1997, CYMBELLOIDEN DIATO 1, V36; Krammer K., 1997, CYMBELLOIDEN DIATO 2, V37; Krammer K., 1982, MICROMORPHOLOGY DIAT, V11; Kulikovskiy M. S., 2012, LAKE BAIKAL HOTSPOT, V23; Lee J. H., 1994, DIATOM, V9, P17; Lee J. H., 1992, DIATOM, V7, P45; Leelahakriengkrai P., 2010, ASIA, V3, P82; Leelahakriengkrai P, 2011, INT J AGRIC BIOL, V13, P309; Mann D. G., 1981, P 6 S REC FOSS DIAT, P279; Martinez-Goss M. R., 2010, PHILIPP J SCI, V139, P207; Martinez-Goss M. R., 2001, SCI DILIMAN, V13, P1; Martinez-Goss M. R., 2011, PHILIPP J SCI, V140, P7; MAYAMA S, 1991, Japanese Journal of Phycology, V39, P131; Metzeltin D., 2003, DIATOMAS URUGUAYAS; Ohtsuka T., 2009, DIATOM, V25, P134; Ohtsuka T., 2004, DIATOM, V20, P145; Okuno H., 1974, DIATOMEENSCHALEN ELE, P825; Pekthong T., 2001, CHIANG MAI J SCI, V28, P97; Podzorski A. C., 1987, FRESHWATER MARINE DI, V13; Potapova G. M., 2004, DIATOM RES, V19, P33; Potapova G. M., 2014, PHYTOTAXA, V184, P115; Potapova G. M., 2012, DIATOM RES, V27, P29; Ross R., 1979, NOVA HEDWIGIA BEIH, V64, P513; Round F.E., 1990, DIATOMS BIOL MORPHOL; Salleh A., 1995, DIATOM, V10, P49; Salleh A., 1994, DIATOM, V9, P73; Suzawa T., 2011, DIATOM, V27, P58; Suzuki H, 2014, PHYTOTAXA, V161, P219; Suzuki H., 2012, PHYTOTAXA, V68, P35; Watanabe T., 1987, DIATOM, V3, P33; Whitton B. A., 1996, USE ALGAE MONITORING; Yamakawa S., 1997, DIATOM, V13, P233; Yana E., 2013, INT J APPL ENV SCI, V8, P1935	66	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					239	252		10.1111/pre.12109		14	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000001		
J	Miyamura, S; Nagumo, T; Maegawa, M; Hori, T				Miyamura, Shinichi; Nagumo, Tamotsu; Maegawa, Miyuki; Hori, Terumitsu			Rearrangement of the flagellar apparatuses and eyespots of isogametes during the fertilization of the marine green alga, Monostroma nitidum (Ulvophyceae, Chlorophyta)	PHYCOLOGICAL RESEARCH			English	Article						basal body; cell fusion; eyespot; flagellar apparatus; gamete; mating structure; microtubular root; Monostroma	FINE-STRUCTURAL ASPECTS; ULVA-LACTUCA ULVALES; ULOTHRIX-FLACCA VAR; CELL-FUSION SITE; CHLAMYDOMONAS-REINHARDTII; MATING STRUCTURE; SPATIAL ARRANGEMENT; BASAL BODY; ULTRASTRUCTURE; ZYGOTES	Behaviors of the flagellar apparatuses (flagella, basal bodies, microtubular roots, etc.), mating structures and eyespots of gametes during the fertilization of Monostroma nitidum were studied using field emission scanning electron microscopy and transmission electron microscopy. The biflagellate isogamete (mt(+) and mt(-)) mating structure has a position that is converse between mt(+) and mt(-) gametes relative to the flagellar beat plane and the eyespot. After the adhesion of mt(+) and mt(-) gametes, gamete fusion occurred between the two mating structures. The cell fusion plane expanded to the cell surface as circumscribed by 1s-2d roots in mt(+) gamete and 1d-2s roots in the mt(-) gamete. Two sets of flagellar apparatuses lay side by side in the planozygote and soon become mutually close. The no.1 basal body of mt(+) gamete and the no.2 basal body of mt(-) gamete rotated in a counterclockwise direction, as viewed from the cell anterior. Then, the no. 2 basal body of mt(+) gamete and the no. 1 basal body of mt(-) gamete slid into a face to face position. Finally, four flagella and basal bodies exhibited a cruciate arrangement. The basal bodies of the opposing pair (no. 1 and no. 2) were offset in a counterclockwise orientation by the basal body diameter. The 1s and 2d roots of the mt(+) gamete lay nearly parallel to the 1d and 2s roots of the mt(-) gamete, respectively, at the cell fusion plane. Because of the asymmetric localization of the mating structure, association, and subsequent rearrangement of basal bodies and microtubular roots, two eyespots lay on the same side of the planozygote. After the settlement of the planozygote, the flagellar apparatus started to disintegrate in the zygote cytoplasm.	[Miyamura, Shinichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Hori, Terumitsu] Lab Ginkgo Sci, Tsukuba, Ibaraki, Japan; [Nagumo, Tamotsu] Nippon Dent Univ Tokyo, Dept Biol, Tokyo, Japan; [Maegawa, Miyuki] Mie Univ, Fac Bioresources, Lab Phycol, Tsu, Mie 514, Japan	Miyamura, S (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	shinichi.miyamura.fw@u.tsukuba.ac.jp			KAKENHI [22570084, 20370025, 22370024, 25291070]	This work was partly supported by a KAKENHI Grant-in-Aid for Scientific Research (C) (No. 22570084) and (b) (No. 20370025, 22370024, 25291070).	Mogi Y, 2008, J PHYCOL, V44, P1290, DOI 10.1111/j.1529-8817.2008.00573.x; O'kelly CJ, 2004, J PHYCOL, V40, P209, DOI 10.1046/j.1529-8817.2004.03104.x; ANDERSEN RA, 1991, PROTOPLASMA, V164, P1, DOI 10.1007/BF01320809; Calado AJ, 2006, J PHYCOL, V42, P434, DOI 10.1111/j.1529-8817.2006.00195.x; Miyamura S, 2010, PHYCOL RES, V58, P258, DOI 10.1111/j.1440-1835.2010.00585.x; OKELLY CJ, 1984, PLANT SYST EVOL, V144, P179, DOI 10.1007/BF00984132; BERGERPERROT Y, 1986, PROTOPLASMA, V134, P17, DOI 10.1007/BF01276372; WEISS RL, 1984, J CELL SCI, V67, P133; FOREST CL, 1983, EXP CELL RES, V148, P143, DOI 10.1016/0014-4827(83)90194-5; JONSSON S, 1974, CR ACAD SCI D NAT, V278, P1557; Callow ME, 1997, J PHYCOL, V33, P938, DOI 10.1111/j.0022-3646.1997.00938.x; ROBENEK H, 1981, J CELL SCI, V50, P149; HEIMANN K, 1989, PROTOPLASMA, V148, P106, DOI 10.1007/BF02079329; KORNMANN P, 1977, HELGOLAND WISS MEER, V29, P1, DOI 10.1007/BF01611137; Miyamura S, 2009, CYTOLOGIA, V74, P409; Nagasato C, 2005, J PLANT RES, V118, P361, DOI 10.1007/s10265-005-0244-0; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; MELKONIAN M, 1980, J CELL SCI, V46, P149; GOODENOUGH UW, 1975, J CELL BIOL, V67, P623, DOI 10.1083/jcb.67.3.623; HOFFMAN LR, 1973, J PHYCOL, V9, P62, DOI 10.1111/j.0022-3646.1973.00062.x; Kreimer G, 2009, CURR GENET, V55, P19, DOI 10.1007/s00294-008-0224-8; MOESTRUP O, 1989, PROTOPLASMA, V148, P41, DOI 10.1007/BF01403990; MELKONIAN M, 1989, PLANT SYST EVOL, V164, P93, DOI 10.1007/BF00940432; BERGERPERROT Y, 1993, PHYCOLOGIA, V32, P356, DOI 10.2216/i0031-8884-32-5-356.1; FOSTER KW, 1980, MICROBIOL REV, V44, P572; Miyamura S, 2007, PHYCOL RES, V55, P47, DOI 10.1111/j.1440-1835.2006.00444.x; Miyamura S, 2005, J PHYCOL, V41, P114, DOI 10.1111/j.1529-8817.2005.04124.x; HOLMES JA, 1989, J CELL SCI, V94, P273; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; JONSSON S, 1984, B SOC BOT FR-LETT, V131, P247; CAVALIER.T, 1974, J CELL SCI, V16, P529; CLAYTON MN, 1992, BRIT PHYCOL J, V27, P219; FLETCHER RL, 1992, BRIT PHYCOL J, V27, P303; FRIEDMAN.I, 1968, J CELL SCI, V3, P115; Gaffal K. P., 1991, ENDOCYT CELL RES, V8, P151; Graham L. E., 2009, ALGAE; HORIGUCHI T, 1991, Journal of Phycology, V27, P32; HORI T, 1988, Japanese Journal of Phycology, V36, P113; Kida W., 1967, J FAC FISH PREF U MI, V7, P81; Margulis L., 1989, HDB PROTOCTISTA; Melkonian M., 1984, Progress phycol. Res., V3, P193; Miyamura Shinichi, 2003, Phycological Research, V51, P143, DOI 10.1111/j.1440-1835.2003.tb00180.x; Miyamura Shinichi, 2005, Cytologia (Tokyo), V70, P93, DOI 10.1508/cytologia.70.93; Moestrup O., 2000, FLAGELLATES UNITY DI, P69; Nakayama Takeshi, 2000, Phycological Research, V48, P63, DOI 10.1046/j.1440-1835.2000.00186.x; TATEWAKI M, 1969, Scientific Papers of the Institute of Algological Research Faculty of Science Hokkaido University, V6, P1	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					284	299		10.1111/pre.12108		16	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000005		
J	Nishihara, GN; Yamada, C; Kimura, R; Terada, R				Nishihara, Gregory N.; Yamada, Chizuru; Kimura, Ryutaro; Terada, Ryuta			Under slow flow conditions, daily rates of canopy photosynthesis of marine macrophytes were insensitive to model choice and flow-rate	PHYCOLOGICAL RESEARCH			English	Article						canopy respiration; gross photosynthesis; hydrodynamics; mass transport; net photosynthesis; state-space model	KELP MACROCYSTIS-PYRIFERA; ECOSYSTEM METABOLISM; BOUNDARY-LAYERS; WATER-FLOW; THALASSIA-TESTUDINUM; AQUATIC MACROPHYTES; NITRATE UPTAKE; OXYGEN; MACROALGAE; COMMUNITY	Water motion drives the flux of suspended and dissolved material (e.g., nutrients, gametes, and dissolved oxygen) to and from macrophyte canopies, and is one of the most important mechanisms that can regulate the growth, survival, and persistence of marine macrophytes populations. At small spatial scales (e.g., lamina or leaves and individuals), increasing flow-rates have been demonstrated to enhance physiological processes, especially photosynthesis rates, and we expected a similar response at the canopy scale. We conducted seven experiments over 25 days using a pair of open-air flow-chambers under natural light, temperature, and seawater conditions. In the four marine macrophyte (Sargassum piluliferum, S.siliquastrum, S.thunbergii, and Zostera marina) canopies examined, an increase in flow-rate did not enhance photosynthesis rates. The odds that daily gross photosynthesis rates increase with a decrease in flow-rates was 1.77 to 1. We also examined if two non-linear equations and one linear equation, often used to describe the relationship between photosynthesis to photosynthetic photon flux density (PPFD), biased estimates of the daily rates of photosynthesis and respiration. It was revealed that the functional form of the equation strongly influenced photosynthesis and respiration rate estimates at short time scales (i.e., minutes), however, daily rates were insensitive to the type of equation used to model the relationship between photosynthesis and PPFD. We suggest that the predominance of photosynthesis rates occurring in under-saturating PPFD conditions (> 40 % of daylight hours) may be one of the reasons for this insensitivity.	[Nishihara, Gregory N.] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan; [Yamada, Chizuru] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Kimura, Ryutaro] Pacific Consultants Co Ltd, Tokyo, Japan; [Terada, Ryuta] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Nishihara, GN (reprint author), Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan.	greg@nagasaki-u.ac.jp	Terada, Ryuta/O-2813-2013	Terada, Ryuta/0000-0003-3193-6592	Japanese Ministry of Education, Culture, Sport and Technology [22510033, 25450260]; Ministry of Education, Culture, Sports, Science and Technology, Japan (Sustainable Aquatic Food and Environment Project in the East China Sea)	This research was sponsored in part by a Grant-in-Aid for Scientific Research (#22510033 and #25450260) from the Japanese Ministry of Education, Culture, Sport and Technology (RT and GNN) and in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Sustainable Aquatic Food and Environment Project in the East China Sea) to GNN.	Raven JA, 2012, PHOTOSYNTH RES, V113, P105, DOI 10.1007/s11120-012-9768-z; Enriquez S, 2006, MAR ECOL PROG SER, V323, P119, DOI 10.3354/meps323119; Cornwall CE, 2013, LIMNOL OCEANOGR, V58, P121, DOI 10.4319/lo.2013.58.1.0121; Nishihara GN, 2010, PHYCOL RES, V58, P29, DOI 10.1111/j.1440-1835.2009.00555.x; KOCH EW, 1994, MAR BIOL, V118, P767, DOI 10.1007/BF00347527; EHLERINGER J, 1977, PLANT PHYSIOL, V59, P86, DOI 10.1104/pp.59.1.86; Holtgrieve GW, 2010, LIMNOL OCEANOGR, V55, P1047, DOI 10.4319/lo.2010.55.3.1047; Nishihara GN, 2011, ECOL RES, V26, P1051, DOI 10.1007/s11284-011-0854-z; Cornelisen CD, 2004, J MARINE SYST, V49, P177, DOI 10.1016/j.jmarsys.2003.05.008; Nishihara GN, 2006, LIMNOL OCEANOGR, V51, P2734; Chen ZB, 2013, WATER RESOUR RES, V49, P5537, DOI 10.1002/wrcr.20403; Duarte CM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003793; Champenois W, 2012, LIMNOL OCEANOGR, V57, P347, DOI 10.4319/lo.2012.57.1.0347; Rominger JT, 2011, J FLUID MECH, V680, P636, DOI 10.1017/jfm.2011.199; Stevens CL, 1997, HYDROBIOLOGIA, V346, P119, DOI 10.1023/A:1002914015683; Hurd CL, 1996, MAR BIOL, V126, P205, DOI 10.1007/BF00347445; Cornelisen CD, 2006, MAR ECOL PROG SER, V312, P1, DOI 10.3354/meps312001; Staehr PA, 2010, LIMNOL OCEANOGR, V55, P817, DOI 10.4319/lo.2009.55.2.0817; Staehr PA, 2012, LIMNOL OCEANOGR, V57, P1317, DOI 10.4319/lo.2012.57.5.1317; Pedersen MF, 2012, MAR ECOL PROG SER, V451, P45, DOI 10.3354/meps09594; Hume AC, 2011, LIMNOL OCEANOGR, V56, P86, DOI 10.4319/lo.2011.56.1.0086; Hepburn CD, 2007, MAR ECOL PROG SER, V339, P99, DOI 10.3354/meps339099; Gaylord B, 2012, J EXP BIOL, V215, P997, DOI 10.1242/jeb.059824; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Stewart HL, 2003, ECOLOGY, V84, P2999, DOI 10.1890/02-0092; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205; Hanson PC, 2008, LIMNOL OCEANOGR-METH, V6, P454; Batt RD, 2012, LIMNOL OCEANOGR-METH, V10, P20, DOI 10.4319/lom.2012.10.20; Tanino Y, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3119862; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722; WHEELER WN, 1980, MAR BIOL, V56, P103, DOI 10.1007/BF00397128; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Gelman A, 2013, BAYESIAN DATA ANAL; Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; Staehr PA, 2011, AQUAT SCI, V74, P155; Stan Development Team, 2014, STAN A C LIB PROB SA; Stephens TA, 2014, MAR ECOL PROG SER, V515, P97, DOI 10.3354/meps10974; Gacia E, 2003, ESTUAR COAST SHELF S, V56, P909, DOI 10.1016/S0272-7714(02)00286-X	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	OCT	2015	63	4					307	317		10.1111/pre.12098		11	Marine & Freshwater Biology	Marine & Freshwater Biology	CU6SF	WOS:000363663000007		
J	Nasruddin; Nakajima, Y; Mukai, K; Komatsu, E; Rahayu, HSE; Nur, M; Ishijima, T; Enomoto, H; Uesugi, Y; Sugama, J; Nakatani, T				Nasruddin; Nakajima, Yukari; Mukai, Kanae; Komatsu, Emi; Rahayu, Heni Setyowati Esti; Nur, Muhammad; Ishijima, Tatsuo; Enomoto, Hiroshi; Uesugi, Yoshihiko; Sugama, Junko; Nakatani, Toshio			A Simple Technique to Improve Contractile Effect of Cold Plasma Jet on Acute Mouse Wound by Dropping Water	PLASMA PROCESSES AND POLYMERS			English	Article						cold plasma; plasma jet; wound healing; in vivo; myofibroblast	DRY CONDITIONS; DERMAL REPAIR; NITRIC-OXIDE; MEDICINE; MOIST	A simple technique is tested to improve the contractile effect of a cold plasma jet on acute wounds of mice. Distilled water on the order of microliters is dropped onto wounds before treatment. To assess the fate of the water, an infrared thermal imager is applied. To evaluate the healing effect, macroscopic and immunohistological studies are conducted. Regarding the wound contractile effect, we show that combination treatment of plasma with dropped water seemed to have a greater effect than plasma treatment alone. Plasma may modify the wound surface through such water, chemically and physically. The histological stiffness of the wound surface during maturation and remodeling, however, may also influence the fate of the water during treatment.	[Nasruddin; Nakajima, Yukari; Mukai, Kanae; Komatsu, Emi] Kanazawa Univ, Grad Sch Med Pharmaceut & Hlth Sci, Grad Course Nursing Sci, Kanazawa, Ishikawa 9200942, Japan; [Nasruddin; Rahayu, Heni Setyowati Esti] Muhammadiyah Univ Magelang, Fac Hlth Sci, Magelang 56172, Central Java, Indonesia; [Nur, Muhammad] Diponegoro Univ, Dept Phys, Semarang, Indonesia; [Ishijima, Tatsuo; Enomoto, Hiroshi; Uesugi, Yoshihiko] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9200942, Japan; [Enomoto, Hiroshi] Kanazawa Univ, Inst Sci & Engn, Fac Mech Engn, Kanazawa, Ishikawa 9200942, Japan; [Uesugi, Yoshihiko] Kanazawa Univ, Inst Sci & Engn, Fac Elect & Comp Engn, Kanazawa, Ishikawa 9200942, Japan; [Sugama, Junko; Nakatani, Toshio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Div Nursing, Fac Hlth Sci, Kanazawa, Ishikawa 9200942, Japan	Nakatani, T (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Div Nursing, Fac Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 9200942, Japan.	nakatosi@staff.kanazawa-u.ac.jp			Directorate General of Higher Education (DIKTI), Indonesia through the Joint Scholarship Program DIKTI-Kanazawa University, Japan; JSPS [25293430, 25390107]	Nasruddin would like to acknowledge the help of the Directorate General of Higher Education (DIKTI), Indonesia, which supported him financially during his PhD study through the Joint Scholarship Program DIKTI-Kanazawa University, Japan. Part of this study was supported by JSPS KAKEN Grant Number 25293430 and 25390107.	Jones V, 2006, BRIT MED J, V332, P777, DOI 10.1136/bmj.332.7544.777; Teschke M, 2005, IEEE T PLASMA SCI, V33, P310, DOI 10.1109/TPS.2005.845377; Heinlin J, 2013, WOUND REPAIR REGEN, V21, P800, DOI 10.1111/wrr.12078; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Xia ZD, 2000, WOUND REPAIR REGEN, V8, P138, DOI 10.1046/j.1524-475x.2000.00138.x; Kong MG, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174018; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Volotskova O, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053019; DYSON M, 1988, J INVEST DERMATOL, V91, P434, DOI 10.1111/1523-1747.ep12476467; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Yonemori S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/12/125401; Ninomiya K, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/42/425401; DYSON M, 1992, J INVEST DERMATOL, V99, P729, DOI 10.1111/1523-1747.ep12614460; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Laroussi M, 2009, IEEE T PLASMA SCI, V37, P714, DOI 10.1109/TPS.2009.2017267; ARMSTRONG WA, 1963, CAN J CHEM, V41, P1575, DOI 10.1139/v63-215; Roy S, 2003, CIRC RES, V92, P264, DOI 10.1161/01.RES.0000056770.30922.E6; Baronski S., 2012, WOUND CARE ESSENTIAL; BRANEMAR.PI, 1967, J BONE JOINT SURG AM, VA 49, P48; Fernandez R., 2012, COCHRANE DB SYST REV, P2; Flur J. W., 2011, EXP DERMATOL, V21, P130; Metelmann H.-R., 2014, CONTRIB PLASM PHYS, V54, P104; Nasruddin Y, 2014, CLIN PLASMA MED, V2, P28; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Soneja A, 2005, PHARMACOL REP, V57, P108; Stoffels E, 2007, CONTRIB PLASM PHYS, V47, P40, DOI 10.1002/cttp.200710007; Tanaka A., 2004, EURO WOUND MANAGE AS, V4, P13; Weltmann KD, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100452	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	OCT	2015	12	10					1128	1138		10.1002/ppap.201400236		11	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CU7OR	WOS:000363731700010		
J	Cools, P; Sainz-Garcia, E; De Geyter, N; Nikiforov, A; Blajan, M; Shimizu, K; Alba-Elias, F; Leys, C; Morent, R				Cools, Pieter; Sainz-Garcia, Elisa; De Geyter, Nathalie; Nikiforov, Anton; Blajan, Marius; Shimizu, Kazuo; Alba-Elias, Fernando; Leys, Christophe; Morent, Rino			Influence of DBD Inlet Geometry on the Homogeneity of Plasma-Polymerized Acrylic Acid Films: The Use of a Microplasma-Electrode Inlet Configuration	PLASMA PROCESSES AND POLYMERS			English	Article						acrylic acid; deposition homogeneity; microplasma-electrode; optical reflectance spectroscopy; plasma polymerization; XPS	DIELECTRIC BARRIER DISCHARGE; SURFACE MODIFICATION; MEDIUM PRESSURE; CELLS; DEPOSITION; POLY(L-LACTIDE); BIOMATERIALS; PERFORMANCE; IMPROVEMENT; ADHESION	Multiple vapor inlet systems have been developed to enhance the homogeneity of deposited polyacrylic acid films via medium and atmospheric pressure plasma technology. Different inlet systems were experimentally tested and optical reflectance spectrometry (OPS) was used to measure the differences in thickness of the films along the exposed surface. Standard deviations of more than 65% were reduced to less than 10%. COMSOL models point to the gas flow as the main contributor to the film homogeneity. OPS analysis of the best set-up shows a linear relationship between thickness and exposure time (100-200 nm/min). XPS C1s deconvolution indicates a preservation of +50% of the -COOH groups and a significant incorporation of other oxygen containing groups.	[Cools, Pieter; De Geyter, Nathalie; Nikiforov, Anton; Leys, Christophe; Morent, Rino] Univ Ghent, Fac Engn & Architecture, Dept Appl Phys, RUPT, B-9000 Ghent, Belgium; [Sainz-Garcia, Elisa; Alba-Elias, Fernando] Univ La Rioja, Dept Mech Engn, Logrono 26004, La Rioja, Spain; [Blajan, Marius; Shimizu, Kazuo] Shizuoka Univ, Grad Sch Engn, Hamamatsu, Shizuoka 4328561, Japan; [Shimizu, Kazuo] Shizuoka Univ, Org Innovat & Social Collaborat, Hamamatsu, Shizuoka 4328561, Japan	Cools, P (reprint author), Univ Ghent, Fac Engn & Architecture, Dept Appl Phys, RUPT, St Pietersnieuwstr 41 B4, B-9000 Ghent, Belgium.	Pieter.cools@ugent.be	Alba-Elias, Fernando/M-2037-2014	Alba-Elias, Fernando/0000-0002-3918-0155	European Research Council under the European Union [279022]	This research has received funding from the European Research Council under the European Union's Seventh Framework Program (FP/2007-2013)/ERC Grant Agreement n. 279022 (PLASMAPOR). The author E. Sainz-Garcia would like to thank the program of predoctoral contracts for the information of research staff funded by the autonomous community of La Rioja.	Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102; Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5; Zhao Y, 2013, APPL SURF SCI, V283, P181, DOI 10.1016/j.apsusc.2013.06.078; Jacobs T, 2013, J MATER SCI-MATER M, V24, P469, DOI 10.1007/s10856-012-4807-z; Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521; Jafari R, 2006, REACT FUNCT POLYM, V66, P1757, DOI 10.1016/j.reactfunctpolym.2006.08.006; De Geyter N, 2010, SURF COAT TECH, V204, P3272, DOI 10.1016/j.surfcoat.2010.03.037; Teraoka F, 2006, DENT MATER J, V25, P560; Morent R, 2010, APPL SURF SCI, V257, P372, DOI 10.1016/j.apsusc.2010.06.080; Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI [10.1002/adfm.200400562, 10.1005/adfm.200400562]; Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8; Ward LJ, 2003, CHEM MATER, V15, P1466, DOI 10.1021/cm020289e; Morent R, 2010, PLASMA CHEM PLASMA P, V30, P525, DOI 10.1007/s11090-010-9233-8; Morent R, 2011, PROG ORG COAT, V70, P336, DOI 10.1016/j.porgcoat.2010.09.031; Hegemann D, 2009, PLASMA PROCESS POLYM, V6, P246, DOI 10.1002/ppap.200800089; Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257; Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027; Morent R, 2009, PLASMA CHEM PLASMA P, V29, P103, DOI 10.1007/s11090-009-9167-1; Alexander MR, 1998, SURF INTERFACE ANAL, V26, P961, DOI 10.1002/(SICI)1096-9918(199812)26:13<961::AID-SIA432>3.0.CO;2-7; Wagner HE, 2003, VACUUM, V71, P417, DOI 10.1016/S0042-207X(02)00765-0; Gancarz I, 1999, ACTA POLYM, V50, P317, DOI 10.1002/(SICI)1521-4044(19990901)50:9<317::AID-APOL317>3.0.CO;2-Q; De Geyter N, 2009, PROG ORG COAT, V64, P230, DOI 10.1016/j.porgcoat.2008.07.029; Blajan M, 2012, IEEE T PLASMA SCI, V40, P1730, DOI 10.1109/TPS.2012.2190994; De Geyter N, 2007, SURF COAT TECH, V201, P7066, DOI 10.1016/j.surfcoat.2007.01.008; Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X; Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648; Carton O, 2012, PLASMA PROCESS POLYM, V9, P984, DOI 10.1002/ppap.201200044; Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038; Blajan M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749825; Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s; Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011; Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8; Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013; OToole L, 1996, MACROMOLECULES, V29, P5172, DOI 10.1021/ma9518417; Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356; Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153; Colombo V, 2014, PLASMA PROCESS POLYM, V11, P247, DOI 10.1002/ppap.201300141; Da Ponte G, 2011, EUR PHYS J-APPL PHYS, V56, P7; Mattioli-Belmonte M, 2005, J BIOACT COMPAT POL, V20, P343, DOI 10.1177/0883911505055159; Palumbo F., 1999, PLASMAS POLYM, V4, P133, DOI 10.1023/A:1021896808872; Shimizu K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PJ01; Shimizu K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.08HB05	42	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1612-8850	1612-8869		PLASMA PROCESS POLYM	Plasma Process. Polym.	OCT	2015	12	10					1153	1163		10.1002/ppap.201500007		11	Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter; Polymer Science	Physics; Polymer Science	CU7OR	WOS:000363731700012		
J	Shoji, M; Ujiie, Y; Harada, R; Kayanuma, M; Shigeta, Y; Murakawa, T; Hayashi, H				Shoji, Mitsuo; Ujiie, Yuzuru; Harada, Ryuhei; Kayanuma, Megumi; Shigeta, Yasuteru; Murakawa, Takeshi; Hayashi, Hideyuki			Molecular dynamics study on the key catalytic intermediates of threonine synthase	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Shoji, Mitsuo; Ujiie, Yuzuru; Harada, Ryuhei; Kayanuma, Megumi; Shigeta, Yasuteru] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Murakawa, Takeshi; Hayashi, Hideyuki] Osaka Med Coll, Takatsuki, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PB-027	18	18				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100032		
J	Kubo, T; Naimuddin, M; Ono, S				Kubo, Tai; Naimuddin, Mohammed; Ono, Seigo			In vitro evolution from pluripotent peptide libraries with natural neurotoxin scaffolds to target receptors, proteases and trophic factors	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kubo, Tai; Naimuddin, Mohammed; Ono, Seigo] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PB-088	55	56				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100092		
J	Saito, K; Konogami, T; Yang, YW; Yamashita, Y; Iga, M; Hoshikawa, T; Kataoka, H				Saito, Kazuki; Konogami, Tadafumi; Yang, Yiwen; Yamashita, Yusuke; Iga, Masatoshi; Hoshikawa, Tamari; Kataoka, Hiroshi			Preparation of insect prothoracicotropic hormone with complicated disulfide-bond structure, by the heterologous expression in Brevibacillus choshinensis	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Saito, Kazuki; Konogami, Tadafumi; Yang, Yiwen; Yamashita, Yusuke; Iga, Masatoshi; Hoshikawa, Tamari; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-004	58	58				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100097		
J	Konogami, T; Yang, YW; Ogihara, MH; Hikiba, J; Kataoka, H; Saito, K				Konogami, Tadafumi; Yang, Yiwen; Ogihara, Mari H.; Hikiba, Juri; Kataoka, Hiroshi; Saito, Kazuki			Role of the disulfide bridges in the transmembrane region of the insect prothoracicotropic-hormone receptor, Torso	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Konogami, Tadafumi; Yang, Yiwen; Ogihara, Mari H.; Hikiba, Juri; Kataoka, Hiroshi; Saito, Kazuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-005	59	59				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100098		
J	Matsumiya, M; Kakizaki, H; Ikeda, M				Matsumiya, Masahiro; Kakizaki, Hiromi; Ikeda, Mana			Glycoside hydrolase family18 chitinase from the stomach of fish: characteristics of isozymes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			PENNAHIA-ARGENTATUS; SILVER CROAKER; PURIFICATION		[Matsumiya, Masahiro; Kakizaki, Hiromi; Ikeda, Mana] Nihon Univ, Coll Bioresource Sci, Tokyo 102, Japan							Ikeda M, 2009, PROTEIN EXPRES PURIF, V65, P214, DOI 10.1016/j.pep.2009.01.015; Ikeda M, 2013, PROCESS BIOCHEM, V48, P1324, DOI 10.1016/j.procbio.2013.06.016; Ikeda M, 2012, BIOSCI BIOTECH BIOCH, V76, P971, DOI 10.1271/bbb.110989; Matsumiya M, 2006, BIOSCI BIOTECH BIOCH, V70, P971, DOI 10.1271/bbb.70.971; Ikeda M., 2014, J CHITIN CHITOSAN SC, V2, P106	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-009	61	61				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100102		
J	Kim, J; Kinoshita, M; Ikegami, T; Kurisu, G; Goto, Y; Hase, T; Lee, YH				Kim, Juyaen; Kinoshita, Misaki; Ikegami, Takahisa; Kurisu, Genji; Goto, Yuji; Hase, Toshiharu; Lee, Young-Ho			Delicate Balance of Noncovalent Forces Control the Electron Transfer Complex between Ferredoxin and Sulfite Reductase to Optimize Enzymatic Activity	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kim, Juyaen; Kinoshita, Misaki; Ikegami, Takahisa; Kurisu, Genji; Goto, Yuji; Hase, Toshiharu; Lee, Young-Ho] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Ikegami, Takahisa] Yokohama City Univ, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PC-015	64	65				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100108		
J	Ikenoue, T; Young-Ho, L; Uenoyama, T; Otzen, D; Goto, Y				Ikenoue, Tatsuya; Young-Ho, Lee; Uenoyama, Tetsuhei; Otzen, Daniel; Goto, Yuji			Establishment of thermodynamics of protein aggregation using isothermal titration calorimetry	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ikenoue, Tatsuya; Young-Ho, Lee; Uenoyama, Tetsuhei; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Otzen, Daniel] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-010	77	77				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100128		
J	Sato, D; Ohtomo, H; Kurobe, A; Takebe, S; Yamada, Y; Fujiwara, K; Ikeguchi, M				Sato, Daisuke; Ohtomo, Hideaki; Kurobe, Atsushi; Takebe, Satsuki; Yamada, Yoshiteru; Fujiwara, Kazuo; Ikeguchi, Masamichi			Repulsion between net charges of subunits during ferritin assembly	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sato, Daisuke; Ohtomo, Hideaki; Kurobe, Atsushi; Takebe, Satsuki; Fujiwara, Kazuo; Ikeguchi, Masamichi] Soka Univ, Grad Sch Engn, Dept Bioinformat, Aliso Viejo, CA USA; [Yamada, Yoshiteru] JASRI SPring 8, Sayo Dist, Hyogo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-029	87	88				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100147		
J	Kakimoto, T; Nakano, H; Nakai, Y; Shiozaki, K; Akioka, K; Otomaru, K; Matsumoto, M; Nagano, M; Sugimoto, Y; Kanouchi, H				Kakimoto, Toshiaki; Nakano, Hideya; Nakai, Yuji; Shiozaki, Kazuhiro; Akioka, Kohei; Otomaru, Konosuke; Matsumoto, Mitsuharu; Nagano, Masanobu; Sugimoto, Yasushi; Kanouchi, Hiroaki			Kurozu Increases HSPA1A Expression and Ameliorates Cognitive Dysfunction in Aged SAM P8 Mice	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kakimoto, Toshiaki; Nakano, Hideya; Kanouchi, Hiroaki] Kagoshima Univ, Dept Vet Pathobiol, Kagoshima 890, Japan; [Nakai, Yuji] Hirosaki Univ, Inst Food Sci, Hirosaki, Aomori, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan; [Akioka, Kohei] Kagoshima Univ, Dept Vet Histopathol, Kagoshima 890, Japan; [Otomaru, Konosuke] Kagoshima Univ, Vet Clin Training Ctr, Kagoshima 890, Japan; [Matsumoto, Mitsuharu] Kagoshima Univ, Dept Vet Anat, Kagoshima 890, Japan; [Sugimoto, Yasushi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-034	90	90				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100152		
J	Lee, YH; Ikenoue, T; Kawata, Y; Goto, Y				Lee, Young-Ho; Ikenoue, Tatsuya; Kawata, Yasushi; Goto, Yuji			Cold Denaturation of Alpha-Synuclein Amyloid Fibrils	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Lee, Young-Ho; Ikenoue, Tatsuya; Goto, Yuji] Osaka Univ, Inst Prot Res, Lab Prot Folding, Suita, Osaka 565, Japan; [Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Tottori, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PD-035	91	91				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100153		
J	Park, S; Hwang, IW; Kato, T; Park, E; Terzic, A				Park, Sungjo; Hwang, In-Wook; Kato, Tatsuya; Park, Enoch; Terzic, Andre			High-fidelity recombinant protein production in a silkworm bioreactor	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Park, Sungjo; Hwang, In-Wook; Terzic, Andre] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA; [Kato, Tatsuya; Park, Enoch] Shizuoka Univ, Lab Biotechnol, Shizuoka 4228529, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PE-019	112	112				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100192		
J	Sugimoto, Y; Kamada, Y; Nawata, Y; Kusakabe, T				Sugimoto, Yasushi; Kamada, Yoshiki; Nawata, Yusuke; Kusakabe, Takahiro			Amyloidogenic lysozyme accumulates in the endoplasmic reticulum tangling with GRP78/BiP and evokes ER stress	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sugimoto, Yasushi; Kamada, Yoshiki; Nawata, Yusuke] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 890, Japan; [Kusakabe, Takahiro] Kyushu Univ, Grad Sch Agr Sci, Fukuoka 812, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PF-029	135	136				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100230		
J	Fujitani, H				Fujitani, Hideaki			Dynamical structure changes in binding of pharmaceutical target proteins	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Fujitani, Hideaki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-007	148	148				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100247		
J	Kamiya, N; Bekker, GJ; Shiraki, T; Nakamura, H				Kamiya, Narutoshi; Bekker, Gert-Jan; Shiraki, Takuma; Nakamura, Haruki			In-vitro and in-silico studies of ligand binding to the nuclear receptor PPARgamma using FRET and MD	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			MOLECULAR-DYNAMICS SIMULATIONS		[Kamiya, Narutoshi; Bekker, Gert-Jan; Nakamura, Haruki] Osaka Univ, IPR, Suita, Osaka 565, Japan; [Shiraki, Takuma] Kinki Univ, Higashiosaka, Osaka 577, Japan							Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; Kamiya N, 2013, CHEM PHYS LETT, V568, P26, DOI 10.1016/j.cplett.2013.03.014; Mashimo T, 2013, J CHEM THEORY COMPUT, V9, P5599, DOI 10.1021/ct400342e; Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Fukuda I, 2014, J CHEM PHYS, V140; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-012	151	151				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100252		
J	Matsushita, Y; Sekiguchi, H; Ohta, N; Ikezaki, K; Goto, Y; Sasaki, Y				Matsushita, Yufuku; Sekiguchi, Hiroshi; Ohta, Noboru; Ikezaki, Keigo; Goto, Yuji; Sasaki, Yuji			Time-resolved X-ray Observations of Nano-scale Protein Assembly Networks	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Matsushita, Yufuku; Ikezaki, Keigo; Sasaki, Yuji] Univ Tokyo, Grad Sch Frontier Sci, Adv Mat Sci, Tokyo 1138654, Japan; [Sekiguchi, Hiroshi; Ohta, Noboru] SPring 8, Sayo, Kyoto, Japan; [Goto, Yuji; Sasaki, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-018	154	155				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100258		
J	Seo, D; Sakurai, H; Setif, P; Sakurai, T				Seo, Daisuke; Sakurai, Hidehiro; Setif, Pierre; Sakurai, Takeshi			Differences in redox reactions with NADP plus /H between ferredoxin-NADP plus oxidoreductases from Bacillus subtilis and Rhodopseudomonas palustris	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Seo, Daisuke; Sakurai, Takeshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Sakurai, Hidehiro] Kanagawa Univ, Res Inst Photobiol Hydrogen Prod, Kanagawa, Japan; [Setif, Pierre] CEA, iBiTecS, New Delhi, India								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-024	158	158				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100264		
J	Sljoka, A; Bezginov, A				Sljoka, Adnan; Bezginov, Alexandr			Transmission of rigidity at a distance - new insights into allosteric signalling in G-Protein Coupled Receptors	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sljoka, Adnan] Kyoto Univ, Kyoto 6068501, Japan; [Bezginov, Alexandr] Univ Toronto, Toronto, ON M5S 1A1, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-027	159	160				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100267		
J	Yonetani, T; Kanaori, K				Yonetani, Takashi; Kanaori, Kenji			Oxygen-Affinity and Cooperativity of Hemoglobin (Hb) are Regulated by 4D Structural Changes (Protein Dynamics), rather than 3D Structural Changes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc			LOW-TEMPERATURE PHOTODISSOCIATION; HEMOPROTEINS; MYOGLOBIN		[Yonetani, Takashi] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Kanaori, Kenji] Kyoto Inst Technol, Dept Biomol Engn, Kyoto, Japan							Laberge M, 2008, BIOPHYS J, V94, P2737, DOI 10.1529/biophysj.107.114942; YAMAMOTO H, 1977, BIOINORG CHEM, V7, P189, DOI 10.1016/S0006-3061(00)80093-9; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; IIZUKA T, 1974, BIOCHIM BIOPHYS ACTA, V351, P182, DOI 10.1016/0005-2795(74)90180-9; IIZUKA T, 1974, BIOCHIM BIOPHYS ACTA, V371, P126, DOI 10.1016/0005-2795(74)90161-5; Yonetani T, 2013, BBA-PROTEINS PROTEOM, V1834, P1873, DOI 10.1016/j.bbapap.2013.04.026; Yonetani T, 2008, BBA-PROTEINS PROTEOM, V1784, P1146, DOI 10.1016/j.bbapap.2008.04.025; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200; YONETANI T, 1974, J BIOL CHEM, V249, P2168	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-029	160	161				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100269		
J	Sato, Y; Tanaka, Y; Sekiguchi, H; Inaba, S; Maruno, T; Sasaki, YC; Kobayashi, Y; Azuma, T; Oda, M				Sato, Yusui; Tanaka, Yusuke; Sekiguchi, Hiroshi; Inaba, Satomi; Maruno, Takahiro; Sasaki, Yuji C.; Kobayashi, Yuji; Azuma, Takachika; Oda, Masayuki			Generation of single-chain Fv antibody against (4-hydroxy-3-nitrophenyl)acetyl and analysis of its structural dynamics	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sato, Yusui; Tanaka, Yusuke; Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Sekiguchi, Hiroshi] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo, Japan; [Maruno, Takahiro; Kobayashi, Yuji] Osaka Univ, Grad Sch Engn, Suita, Osaka 565, Japan; [Sasaki, Yuji C.] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Azuma, Takachika] Tokyo Univ Sci, Res Inst Biol Sci, Tokyo 162, Japan							Furukawa, 1999, IMMUNITY, V11, P329; Murakami, 2010, MOL IMMUNOL, V48, P48; Sagawa, 2003, MOL IMMUNOL, V39, P801; Sekiguchi, 2014, SCI REP, V4, P6384	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-033	163	164				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100273		
J	Sekiguchi, H; Matsushita, Y; Nishino, Y; Ikezaki, K; Miyazawa, A; Kubo, T; Huron, C; Changeux, JP; Corringer, PJ; Sasaki, Y				Sekiguchi, Hiroshi; Matsushita, Yufuku; Nishino, Yuri; Ikezaki, Keigo; Miyazawa, Atsuo; Kubo, Tai; Huron, Christele; Changeux, Jean-Pierre; Corringer, Pierre-Jean; Sasaki, Yuji			Single Molecule Motion Map of Pentameric Ligand Gated Ion Channel by Diffracted X-ray Tracking	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Sekiguchi, Hiroshi] JASRI SPring 8, Res & Utilizat Div, Sayo, Japan; [Matsushita, Yufuku; Ikezaki, Keigo; Sasaki, Yuji] Univ Tokyo, Grad Sch Frontier Sci, Tokyo 1138654, Japan; [Nishino, Yuri; Miyazawa, Atsuo] Univ Hyogo, Grad Sch Sci, Kobe, Hyogo 6500044, Japan; [Kubo, Tai] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Huron, Christele; Changeux, Jean-Pierre; Corringer, Pierre-Jean] Inst Pasteur, Paris, France							Sasaki YC, 2000, PHYS REV E, V62, P3843, DOI 10.1103/PhysRevE.62.3843; Sekiguchi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06384; Sekiguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064176	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-039	167	167				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100279		
J	Oda, T; Fuchita, N; Motoshima, H; Watanabe, K				Oda, Tokuro; Fuchita, Naoki; Motoshima, Hiroyuki; Watanabe, Keiichi			X-ray crystallographic analysis of cold-adapted and thermostable glucokinase	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Oda, Tokuro; Fuchita, Naoki; Motoshima, Hiroyuki; Watanabe, Keiichi] Saga Univ, Dept Appl Biochem & Food Sci, Saga, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PH-048	174	174				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100288		
J	Ojima-Kato, T; Fukui, K; Kojima, T; Nakano, H				Ojima-Kato, Teruyo; Fukui, Kansuke; Kojima, Takaaki; Nakano, Hideo			Leucine Zipper fused Fab; Enhancement of active Fab formation in E. coli in vitro and in vivo expression systems	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ojima-Kato, Teruyo] Aichi Sci & Technol Fdn, Nagoya, Aichi, Japan; [Ojima-Kato, Teruyo; Fukui, Kansuke; Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-031	194	194				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100318		
J	Nakatsuji, M; Inoue, H; Kohno, M; Saito, M; Tsuge, S; Shimizu, S; Ishibashi, O; Inui, T				Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishibashi, Osamu; Inui, Takashi			A novel drug delivery system for poorly water-soluble anti-tumor drug SN-38 utilizing intravital transporter protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Nakatsuji, Masatoshi; Inoue, Haruka; Kohno, Masaki; Saito, Mayu; Tsuge, Syogo; Shimizu, Shota; Ishibashi, Osamu; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan			Inui, Takashi/G-1069-2011				Fukuhara A., 2012, J CONTROL RELEASE, V158, P143	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-045	201	202				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100332		
J	Akanuma, S				Akanuma, Satoshi			Essential and non-essential amino acid species for an ancestral protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Akanuma, Satoshi] Waseda Univ, Fac Human Sci, Tokyo, Japan							Akanuma, 2013, P NATL ACAD SCI USA, V110, P11067	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-047	202	203				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100334		
J	Yagi, S; Akanuma, S; Yamagishi, A				Yagi, Sota; Akanuma, Satoshi; Yamagishi, Akihiko			De novo design of protein-protein interaction using hydrophobic and electrostatic interactions	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Yagi, Sota; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Dept Appl Life Scien, Tokyo, Japan; [Akanuma, Satoshi] Waseda Univ, Fac Human Sci, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-048	203	204				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100335		
J	Kaji, A; Niiro, H; Akanuma, S; Uchida, T; Yamagishi, A				Kaji, Asumi; Niiro, Hiroya; Akanuma, Satoshi; Uchida, Tetsuya; Yamagishi, Akihiko			Designing of a novel platinum-binding amino acid sequence on a protein surface	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kaji, Asumi; Niiro, Hiroya; Uchida, Tetsuya; Yamagishi, Akihiko] Tokyo Univ Pharm & Life Sci, Tokyo, Japan; [Akanuma, Satoshi] Waseda Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-050	204	204				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100337		
J	Nemoto, N; Okawa, R; Yoshikawa, Y; Miyajima, T; Kobayashi, S				Nemoto, Naoto; Okawa, Ryoya; Yoshikawa, Yuki; Miyajima, Toshiki; Kobayashi, Shota			In vitro selection of liposome anchoring peptide by cDNA display	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Nemoto, Naoto; Okawa, Ryoya; Yoshikawa, Yuki; Miyajima, Toshiki; Kobayashi, Shota] Saitama Univ, Grad Sch Sci & Engn, Saitama, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-049	204	204				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100336		
J	Nakane, S; Matsuda, Z				Nakane, Shuhei; Matsuda, Zene			Generation of fluorescent protein-tagged gp120 mutants to analyze the intracellular distribution of HIV-1 envelope protein	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo 1138654, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-054	207	207				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100341		
J	Zhang, K; Voet, A; Noguchi, H; Addy, C; Tame, J				Zhang, Kam; Voet, Arnout; Noguchi, Hiroki; Addy, Christine; Tame, Jeremy			RE3volutionary computational design of symmetric proteins that biomineralize nano-crystals	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Noguchi, Hiroki; Addy, Christine; Tame, Jeremy] Yokohama City Univ, GSMLS, Drug Design Lab, Yokohama, Kanagawa, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-057	208	208				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100344		
J	Shimizu, S; Nakatsuji, M; Yamaguchi, K; Sano, Y; Miyamoto, Y; Inui, T				Shimizu, Shota; Nakatsuji, Masatoshi; Yamaguchi, Keisuke; Sano, Yuya; Miyamoto, Yuya; Inui, Takashi			Construction of protein capsule possessing drugs controlled release ability	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Shimizu, Shota; Nakatsuji, Masatoshi; Yamaguchi, Keisuke; Sano, Yuya; Miyamoto, Yuya; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-063	211	212				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100350		
J	Miyamoto, T; Kuribayashi, M; Nagao, S; Shomura, Y; Higuchi, Y; Hirota, S				Miyamoto, Takaaki; Kuribayashi, Mai; Nagao, Satoshi; Shomura, Yasuhito; Higuchi, Yoshiki; Hirota, Shun			Formation of Cytochrome cb562 Oligomers by Domain Swapping	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Miyamoto, Takaaki; Kuribayashi, Mai; Nagao, Satoshi; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara, Japan; [Shomura, Yasuhito] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki, Japan; [Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kobe, Hyogo 6500044, Japan							Nagao S, 2012, DALTON T, V41, P11378, DOI 10.1039/c2dt30893b; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; Parui P. P., 2012, BIOCHEMISTRY-US, V52, P8732	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-064	212	213				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100351		
J	Ito, Y; Enomoto, Y; Umemura, S; Fujiyama, A; Mieno, R; Kato, Y; Kato, D				Ito, Yuji; Enomoto, Yurie; Umemura, Shuhei; Fujiyama, Aiko; Mieno, Ryoko; Kato, Yukiko; Kato, Dai-ichiro			Identification of disease-related antigen-specific human antibodies by a method that combines biopanning and high throughput sequencing from patient-derived scFv antibody library	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Ito, Yuji; Enomoto, Yurie; Umemura, Shuhei; Fujiyama, Aiko; Mieno, Ryoko; Kato, Yukiko; Kato, Dai-ichiro] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 890, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PI-069	215	215				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100356		
J	Kameshita, I; Sueyoshi, N; Sugiyama, Y				Kameshita, Isamu; Sueyoshi, Noriyuki; Sugiyama, Yasunori			Multi-PTK antibody: a powerful tool to detect a wide variety of protein tyrosine kinases (PTKs)	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kameshita, Isamu; Sueyoshi, Noriyuki; Sugiyama, Yasunori] Kagawa Univ, Takamatsu, Kagawa 760, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PJ-028	251	251				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100418		
J	Uchikoga, N; Ohue, M; Matsuzaki, Y; Akiyama, Y				Uchikoga, Nobuyuki; Ohue, Masahito; Matsuzaki, Yuri; Akiyama, Yutaka			Post-docking analysis by physicochemical properties of protein-protein interactions generated from rigid-body docking processes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Uchikoga, Nobuyuki] Chuo Univ, Dept Phys, Concepcion, Chile; [Ohue, Masahito] Tokyo Tech, Grad Sch Inform Sci & Engn, Tokyo, Japan; [Matsuzaki, Yuri; Akiyama, Yutaka] Tokyo Tech, ACLS, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PJ-033	253	253				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100422		
J	Inaba, S; Numoto, N; Morii, H; Ikura, T; Abe, R; Ito, N; Oda, M				Inaba, Satomi; Numoto, Nobutaka; Morii, Hisayuki; Ikura, Teikichi; Abe, Ryo; Ito, Nobutoshi; Oda, Masayuki			Structural and thermodynamic analysis of co-stimulation receptor CD28 phosphopeptide interactions with Grb2, Gads, and PI3-kinese SH2 domains	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Inaba, Satomi; Oda, Masayuki] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Numoto, Nobutaka; Ikura, Teikichi; Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Morii, Hisayuki] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Tokyo 162, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-040	287	287				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100481		
J	Kusakabe, T; Mon, H; Lee, J				Kusakabe, Takahiro; Mon, Hiroaki; Lee, JaeMan			Novel kinetochore protein complex from silkworm holocentric chromosomes	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Kusakabe, Takahiro; Mon, Hiroaki; Lee, JaeMan] Kyushu Univ, Grad Sch, Fukuoka 812, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-041	288	288				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100482		
J	Fukuda, I; Kamiya, N; Wang, H; Kasahara, K; Nakamura, H				Fukuda, Ikuo; Kamiya, Narutoshi; Wang, Han; Kasahara, Kota; Nakamura, Haruki			Development and application of novel non-Ewald methods for calculating electrostatic interactions in molecular simulations	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Fukuda, Ikuo; Kamiya, Narutoshi; Kasahara, Kota; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Wang, Han] Free Univ Berlin, Berlin, Germany							Fukuda I, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3582791; [Anonymous], 2014, J CHEM PHYS; Arakawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076606; Fukuda Ikuo, 2012, Biophysical Reviews, V4, DOI 10.1007/s12551-012-0089-4; Fukuda I., 2013, J CHEM PHYS, V139; Fukuda I, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739789; Kamiya N., 2013, J CHEM THEORY COMPUT, V26, P568; Kasahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112419; Nishikawa Y, 2014, J MOL BIOL, V426, P3232, DOI 10.1016/j.jmb.2014.06.023	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-047	290	290				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100486		
J	Minami, S; Chikenji, G; Ota, M				Minami, Shintaro; Chikenji, George; Ota, Motonori			Non-sequential protein structure alignment program MICAN and its applications	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Minami, Shintaro; Ota, Motonori] Nagoya Univ, Dept Info Sci, Nagoya, Aichi 4648601, Japan; [Chikenji, George] Nagoya Univ, Dept Comp Schi & Engn, Nagoya, Aichi 4648601, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-058	296	296				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100497		
J	Kuwahara, J; Uwatoko, C; Hibino, E; Matsuzaki, K; Hoshino, M				Kuwahara, Jun; Uwatoko, Chisana; Hibino, Emi; Matsuzaki, Katsumi; Hoshino, Masaru			Glutamine-rich activation domain of transcription factor Sp1-biochemical activity and structure	PROTEIN SCIENCE			English	Meeting Abstract	29th Annual Symposium of the Protein-Society	JUL 22-25, 2015	Barcelona, SPAIN	Prot Soc					[Hibino, Emi; Matsuzaki, Katsumi; Hoshino, Masaru] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0961-8368	1469-896X		PROTEIN SCI	Protein Sci.	OCT	2015	24			1	SI	PL-085	312	312				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CU6QS	WOS:000363658100524		
J	Chaplin, WJ; Lund, MN; Handberg, R; Basu, S; Buchhave, LA; Campante, TL; Davies, GR; Huber, D; Latham, DW; Latham, CA; Serenelli, A; Antia, HM; Appourchaux, T; Ball, WH; Benomar, O; Casagrande, L; Christensen-Dalsgaard, J; Coelho, HR; Creevey, OL; Elsworth, Y; Garcia, RA; Gaulme, P; Hekker, S; Kallinger, T; Karoff, C; Kawaler, SD; Kjeldsen, H; Lundkvist, MS; Marcadon, F; Mathur, S; Miglio, A; Mosser, B; Regulo, C; Roxburgh, IW; Aguirre, VS; Stello, D; Verma, K; White, TR; Bedding, TR; Barclay, T; Buzasi, DL; Dehuevels, S; Gizon, L; Houdek, G; Howell, SB; Salabert, D; Soderblom, DR				Chaplin, W. J.; Lund, M. N.; Handberg, R.; Basu, S.; Buchhave, L. A.; Campante, T. L.; Davies, G. R.; Huber, D.; Latham, D. W.; Latham, C. A.; Serenelli, A.; Antia, H. M.; Appourchaux, T.; Ball, W. H.; Benomar, O.; Casagrande, L.; Christensen-Dalsgaard, J.; Coelho, H. R.; Creevey, O. L.; Elsworth, Y.; Garcia, R. A.; Gaulme, P.; Hekker, S.; Kallinger, T.; Karoff, C.; Kawaler, S. D.; Kjeldsen, H.; Lundkvist, M. S.; Marcadon, F.; Mathur, S.; Miglio, A.; Mosser, B.; Regulo, C.; Roxburgh, I. W.; Aguirre, V. Silva; Stello, D.; Verma, K.; White, T. R.; Bedding, T. R.; Barclay, T.; Buzasi, D. L.; Dehuevels, S.; Gizon, L.; Houdek, G.; Howell, S. B.; Salabert, D.; Soderblom, D. R.			Asteroseismology of Solar-Type Stars with K2: Detection of Oscillations in C1 Data	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC			English	Article							CANDIDATE HOST STARS; MAIN-SEQUENCE STARS; RED-GIANT STARS; BOLOMETRIC CORRECTIONS; FUNDAMENTAL PROPERTIES; KEPLER; PARAMETERS; MISSION; DETECTABILITY; AMPLITUDES	We present the first detections by the NASA K2 mission of oscillations in solar-type stars, using short-cadence data collected during K2 Campaign 1 (C1). We understand the asteroseismic detection thresholds for Cl-like levels of photometric performance, and we can detect oscillations in subgiants having dominant oscillation frequencies around 1000 mu Hz. Changes to the operation of the fine-guidance sensors are expected to give significant improvements in the high-frequency performance from C3 onwards. A reduction in the excess high-frequency noise by a factor of 2.5 in amplitude would bring main-sequence stars with dominant oscillation frequencies as high as similar or equal to 2500 mu Hz into play as potential asteroseismic targets for K2.	[Chaplin, W. J.; Lund, M. N.; Handberg, R.; Campante, T. L.; Davies, G. R.; Coelho, H. R.; Elsworth, Y.; Miglio, A.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Chaplin, W. J.; Lund, M. N.; Handberg, R.; Campante, T. L.; Davies, G. R.; Huber, D.; Christensen-Dalsgaard, J.; Coelho, H. R.; Elsworth, Y.; Hekker, S.; Karoff, C.; Kjeldsen, H.; Lundkvist, M. S.; Miglio, A.; Aguirre, V. Silva; Stello, D.; Bedding, T. R.; Houdek, G.] Aarhus Univ, Dept Phys & Astron, SAC, DK-8000 Aarhus C, Denmark; [Basu, S.] Yale Univ, Dept & Astron, New Haven, CT 06520 USA; [Buchhave, L. A.; Latham, D. W.; Latham, C. A.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Buchhave, L. A.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Huber, D.; Stello, D.; Bedding, T. R.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Huber, D.] SETI Inst, Mountain View, CA 94043 USA; [Serenelli, A.] Inst Ciencias Espacio ICE CSIC IEEC, Cerdanyola Del Valles 08193, Spain; [Antia, H. M.; Verma, K.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Appourchaux, T.; Marcadon, F.] Univ Paris 11, CNRS, Inst Astrophys Spatiale, UMR8617, F-91405 Orsay, France; [Ball, W. H.; White, T. R.; Gizon, L.] Univ Gottingen, Inst Astrophys, D-37077 Gottingen, Germany; [Benomar, O.] Univ Tokyo, Tokyo 1130033, Japan; [Casagrande, L.] Australian Natl Univ, Mt Stromlo Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Creevey, O. L.] Univ Nice Sophia Antipolis, Lab Lagrange, UMR 7293, CNRS, Nice, France; [Creevey, O. L.] Observ Cote Azur, F-06003 Nice, France; [Garcia, R. A.; Salabert, D.] Univ Paris Diderot, Ctr Saclay, Lab AIM Paris Saclay, IRFU SAp,Ctr Saclay, F-91191 Gif Sur Yvette, France; [Gaulme, P.] New Mexico State Univ, Dept Astron, Las Cruces, NM 88003 USA; [Gaulme, P.] Apache Point Observ, Sunspot, NM 88349 USA; [Hekker, S.; Gizon, L.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Kallinger, T.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Kawaler, S. D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Mathur, S.] Space Sci Inst, Boulder, CO 80301 USA; [Mosser, B.] PSL Res Univ, Observ Paris, LESIA, CNRS, F-92195 Meudon, France; [Mosser, B.] Univ Paris 06, Univ Denis Diderot, F-92195 Meudon, France; [Regulo, C.] Inst Astrofis Canarias, Tenerife 38205, Spain; [Regulo, C.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Roxburgh, I. W.] Queen Mary Univ London, Astron Unit, London E1 4NS, England; [Barclay, T.; Howell, S. B.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Barclay, T.] Bay Area Environm Res Inst, Sonoma, CA 95476 USA; [Buzasi, D. L.] Florida Gulf Coast Univ, Dept Chem & Phys, South Ft Myers, FL 33965 USA; [Dehuevels, S.] Univ Toulouse, IRAP, UPS OMP, F-31028 Toulouse, France; [Gizon, L.] New York Univ, Ctr Space Sci, Abu Dhabi, U Arab Emirates; [Soderblom, D. R.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Soderblom, D. R.] Johns Hopkins Univ, Dept Phys & Astron, Ctr Astrophys Sci, Baltimore, MD 21218 USA	Chaplin, WJ (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.				NASA's Science Mission Directorate	Funding for this Discovery mission is provided by NASA's Science Mission Directorate. The authors wish to thank the entire Kepler team, without whom these results would not be possible. We also thank all funding councils and agencies that have supported the activities of KASC Working Group 1.	Handberg R, 2014, MON NOT R ASTRON SOC, V445, P2698, DOI 10.1093/mnras/stu1823; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Miglio A, 2013, MON NOT R ASTRON SOC, V429, P423, DOI 10.1093/mnras/sts345; Verner GA, 2011, MON NOT R ASTRON SOC, V415, P3539, DOI 10.1111/j.1365-2966.2011.18968.x; Mosser B, 2009, ASTRON ASTROPHYS, V508, P877, DOI 10.1051/0004-6361/200912944; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Creevey OL, 2013, MON NOT R ASTRON SOC, V431, P2419, DOI 10.1093/mnras/stt336; Carney BW, 2001, ASTRON J, V122, P3419, DOI 10.1086/324233; Hekker S, 2010, MON NOT R ASTRON SOC, V402, P2049, DOI 10.1111/j.1365-2966.2009.16030.x; Quirion PO, 2010, ASTROPHYS J, V725, P2176, DOI 10.1088/0004-637X/725/2/2176; Arentoft T, 2008, ASTROPHYS J, V687, P1180, DOI 10.1086/592040; Garcia RA, 2010, SCIENCE, V329, P1032, DOI 10.1126/science.1191064; Houdek G, 1999, ASTRON ASTROPHYS, V351, P582; Chaplin WJ, 2013, ANNU REV ASTRON ASTR, V51, P353, DOI 10.1146/annurev-astro-082812-140938; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Basu S, 2010, ASTROPHYS J, V710, P1596, DOI 10.1088/0004-637X/710/2/1596; Rodrigues TS, 2014, MON NOT R ASTRON SOC, V445, P2758, DOI 10.1093/mnras/stu1907; Bazot M, 2012, MON NOT R ASTRON SOC, V427, P1847, DOI 10.1111/j.1365-2966.2012.21818.x; BROWN TM, 1991, ASTROPHYS J, V368, P599, DOI 10.1086/169725; Serenelli AM, 2013, MON NOT R ASTRON SOC, V429, P3645, DOI 10.1093/mnras/sts648; Chaplin WJ, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/54; Benomar O, 2012, MON NOT R ASTRON SOC, V420, P2178, DOI 10.1111/j.1365-2966.2011.20184.x; Campante TL, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/123; Campante T. L., 2012, THESIS U PORTO; Casagrande L, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913204; Chaplin WJ, 2011, ASTROPHYS J LETT, V732, DOI 10.1088/2041-8205/732/1/L5; Chaplin WJ, 2014, ASTROPHYS J SUPPL S, V210, DOI 10.1088/0067-0049/210/1/1; Christensen-Dalsgaard J, 2008, J PHYS CONF SER, V118, DOI 10.1088/1742-6596/118/1/012039; Drimmel R, 2003, ASTRON ASTROPHYS, V409, P205, DOI 10.1051/0004-6361:20031070; Pinsonneault MH, 2014, ASTROPHYS J SUPPL S, V215, DOI 10.1088/0067-0049/215/2/19; Fiiresz G., 2008, THESIS U SZEGED; Flower PJ, 1996, ASTROPHYS J, V469, P355, DOI 10.1086/177785; Gai N, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/63; Gilliland RL, 2010, PUBL ASTRON SOC PAC, V122, P131; Gilliland RL, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/2; Gilliland RL, 2010, ASTROPHYS J LETT, V713, pL160, DOI 10.1088/2041-8205/713/2/L160; Hecker S., 2013, ASTRON ASTROPHYS, V556, P59; Hekker S., 2014, ASTRON ASTROPHYS, V564, P105; Howell SB, 2014, PUBL ASTRON SOC PAC, V126, P398; Huber D, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/127; Huber D., 2009, COMMUN ASTEROSEISMOL, V160, P74; Kallinger T., 2010, ASTRON ASTROPHYS, V522, P1; Lund MN, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/30; Lundkvist M., 2014, ASTRON ASTROPHYS, V566, P82; Mathur S., 2010, ASTRON ASTROPHYS, V511, P46; Roxburgh IW, 2009, ASTRON ASTROPHYS, V506, P435, DOI 10.1051/0004-6361/200911906; Samadi R., 2010, ASTRON ASTROPHYS, V509, P15; Aguirre VS, 2015, MON NOT R ASTRON SOC, V452, P2127, DOI 10.1093/mnras/stv1388; Steno D., 2009, APJ, V700, P1589; Torres G, 2010, ASTRON J, V140, P1158, DOI 10.1088/0004-6256/140/5/1158; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357	51	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0004-6280	1538-3873		PUBL ASTRON SOC PAC	Publ. Astron. Soc. Pac.	OCT	2015	127	956					1038	1044				7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU5VM	WOS:000363600100007		
J	Oseki, S; Oyabu, S; Ishihara, D; Enya, K; Haze, K; Kotani, T; Kaneda, H; Nishiyama, M; Abe, L; Yamamuro, T				Oseki, S.; Oyabu, S.; Ishihara, D.; Enya, K.; Haze, K.; Kotani, T.; Kaneda, H.; Nishiyama, M.; Abe, L.; Yamamuro, T.			Coronagraphic Demonstration Experiment Using Aluminum Mirrors for Space Infrared Astronomical Observations	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF THE PACIFIC			English	Article							CHECKERBOARD PUPIL MASK; CONTRAST	For future space infrared astronomical coronagraphy, we perform experimental studies on the application of aluminum mirrors to a coronagraph. Cooled reflective optics is required for broadband mid-infrared observations in space, while high-precision optics are required for coronagraphy. For the coronagraph instrument originally proposed for the next-generation infrared astronomical satellite project SPICA (SCI: SPICA Coronagraph Instrument), we fabricated and evaluated the optics consisting of high-precision aluminum off-axis mirrors with diamond-turned surfaces, and conducted a coronagraphic demonstration experiment using the optics with a coronagraph mask. We first measured the wave front errors (WFEs) of the aluminum mirrors with a He Ne Fizeau interferometer to confiati that the power spectral densities of the WFEs satisfy the SCI requirements. Then we integrated the minors into an optical system and evaluated the overall performance of the system. As a result, we estimate the total WFE of the optics to be 33 nm (rms), each mirror contributing 10-20 mu (rms) for the central 14 mm area of the optics, and obtain a contrast of 10(-5.4) as a coronagraph in the visible light. At a wavelength of 5 Am, the coronagraphic system is expected to achieve a contrast of similar to 10(-7) based on our model calculation with the measured optical performance. Thus our experiment demonstrates that aluminum mirror optics is applicable to a highly WFE-sensitive instrument such as a coronagraph in space.	[Oseki, S.; Oyabu, S.; Ishihara, D.; Kaneda, H.; Nishiyama, M.] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Enya, K.; Haze, K.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Kotani, T.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Abe, L.] Lab Univ Astrophysque Nice, UMR 6525, F-06108 Nice, France; [Yamamuro, T.] Optcraft, Sagamihara, Kanagawa 2291101, Japan	Oseki, S (reprint author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	oseki@u.phys.nagoya-u.ac.jp					Vanderbei RJ, 2003, ASTROPHYS J, V599, P686, DOI 10.1086/379238; Vanderbei RJ, 2004, ASTROPHYS J, V615, P555, DOI 10.1086/423947; Belikov R, 2007, P SOC PHOTO-OPT INS, V6693, pY6930, DOI 10.1117/12.734976; Haze K, 2011, PUBL ASTRON SOC JPN, V63, P873; Kasdin NJ, 2005, APPL OPTICS, V44, P1117, DOI 10.1364/AO.44.001117; Haze K, 2009, ADV SPACE RES, V43, P181, DOI 10.1016/j.asr.2008.10.007; Enya K, 2007, ASTRON ASTROPHYS, V461, P783, DOI 10.1051/0004-6361:20066351; Enya K, 2011, ADV SPACE RES, V48, P323, DOI 10.1016/j.asr.2011.03.010; Enya K, 2008, ASTRON ASTROPHYS, V480, P899, DOI 10.1051/0004-6361:20078627; Borde PJ, 2006, ASTROPHYS J, V638, P488, DOI 10.1086/498669; Carlotti A., 2011, ARXIV11084050; Enya K, 2010, PUBL ASTRON SOC JPN, V62, P1407; Enya K, 2012, PROC SPIE, V8442, DOI 10.1117/12.925524; Enya K, 2011, PROC SPIE, V8146, DOI 10.1117/12.893508; Haze K., 2012, THESIS GRADUATE U AD; Kasdin N. J., 2005, P SOC PHOTO-OPT INS, V5905, P128; Spergel D. N., 2001, ARXIVASTROPH0101142; Vanderbei RJ, 2003, ASTROPHYS J, V590, P593, DOI 10.1086/374971	18	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0004-6280	1538-3873		PUBL ASTRON SOC PAC	Publ. Astron. Soc. Pac.	OCT	2015	127	956					1077	1083				7	Astronomy & Astrophysics	Astronomy & Astrophysics	CU5VM	WOS:000363600100010		
J	Nakanishi, J; Morimoto, Y; Ogura, I; Kobayashi, N; Naya, M; Ema, M; Endoh, S; Shimada, M; Ogami, A; Myojyo, T; Oyabu, T; Gamo, M; Kishimoto, A; Igarashi, T; Hanai, S				Nakanishi, Junko; Morimoto, Yasuo; Ogura, Isamu; Kobayashi, Norihiro; Naya, Masato; Ema, Makoto; Endoh, Shigehisa; Shimada, Manabu; Ogami, Akira; Myojyo, Toshihiko; Oyabu, Takako; Gamo, Masashi; Kishimoto, Atsuo; Igarashi, Takuya; Hanai, Sosuke			Risk Assessment of the Carbon Nanotube Group	RISK ANALYSIS			English	Article						CNT; CNT toxicity; OEL; risk assessment	IN-VIVO GENOTOXICITY; INTRATRACHEAL INSTILLATION; INHALATION EXPOSURE; TITANIUM-DIOXIDE; PULMONARY TOXICITY; LUNG-CANCER; COMET ASSAY; PART B; SINGLE; RATS	This study assessed the health risks via inhalation and derived the occupational exposure limit (OEL) for the carbon nanotube (CNT) group rather than individual CNT material. We devised two methods: the integration of the intratracheal instillation (IT) data with the inhalation (IH) data, and the biaxial approach. A four-week IH test and IT test were performed in rats exposed to representative materials to obtain the no observed adverse effect level, based on which the OEL was derived. We used the biaxial approach to conduct a relative toxicity assessment of six types of CNTs. An OEL of 0.03 mg/m(3) was selected as the criterion for the CNT group. We proposed that the OEL be limited to 15 years. We adopted adaptive management, in which the values are reviewed whenever new data are obtained. The toxicity level was found to be correlated with the Brunauer-Emmett-Teller (BET)-specific surface area (BET-SSA) of CNT, suggesting the BET-SSA to have potential for use in toxicity estimation. We used the published exposure data and measurement results of dustiness tests to compute the risk in relation to particle size at the workplace and showed that controlling micron-sized respirable particles was of utmost importance. Our genotoxicity studies indicated that CNT did not directly interact with genetic materials. They supported the concept that, even if CNT is genotoxic, it is secondary genotoxicity mediated via a pathway of genotoxic damage resulting from oxidative DNA attack by free radicals generated during CNT-elicited inflammation. Secondary genotoxicity appears to involve a threshold.	[Nakanishi, Junko; Ogura, Isamu; Ema, Makoto; Gamo, Masashi; Igarashi, Takuya; Hanai, Sosuke] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Morimoto, Yasuo; Ogami, Akira; Myojyo, Toshihiko; Oyabu, Takako] Univ Occupat & Environm Hlth, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Kobayashi, Norihiro] Natl Inst Hlth Sci, Div Environm Chem, Tokyo, Japan; [Naya, Masato] Publ Interest Inc Fdn, BSRC, Iwata, Japan; [Endoh, Shigehisa] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Shimada, Manabu] Hiroshima Univ, Fac Engn, Dept Chem Engn, Higashihiroshima 724, Japan; [Kishimoto, Atsuo] Univ Tokyo, Grad Sch Publ Policy, Policy Alternat Res Inst, Tokyo, Japan	Nakanishi, J (reprint author), AIST, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	j-nakanishi@aist.go.jp			New Energy and Industrial Technology Development Organization of Japan (NEDO) grant "Evaluating risks associated with manufactured nanomaterials" [P06041]	This study was supported by the New Energy and Industrial Technology Development Organization of Japan (NEDO) grant "Evaluating risks associated with manufactured nanomaterials" (P06041).	Allion KL, 2009, ADV DRUG DELIV, V61, P457; Magdolenova Z, 2014, NANOTOXICOLOGY, V8, P233, DOI 10.3109/17435390.2013.773464; Sargent LM, 2012, MUTAT RES-GEN TOX EN, V745, P28, DOI 10.1016/j.mrgentox.2011.11.017; Methner M, 2010, J OCCUP ENVIRON HYG, V7, P163, DOI 10.1080/15459620903508066; Aschberger K, 2010, CRIT REV TOXICOL, V40, P759, DOI 10.3109/10408444.2010.506638; Di Giorgio ML, 2011, MUTAT RES-GEN TOX EN, V722, P20, DOI 10.1016/j.mrgentox.2011.02.008; Kuempel ED, 2012, ANN OCCUP HYG, V56, P491, DOI 10.1093/annhyg/mes040; Nagai H, 2011, P NATL ACAD SCI USA, V108, pE1330, DOI 10.1073/pnas.1110013108; Driscoll KE, 2000, TOXICOL SCI, V55, P24, DOI 10.1093/toxsci/55.1.24; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P587, DOI 10.3109/17435390.2011.594912; Ogura I, 2011, J NANOPART RES, V13, P1265, DOI 10.1007/s11051-010-0119-8; Sakamoto Y, 2009, J TOXICOL SCI, V34, P65; Hext PM, 2005, ANN OCCUP HYG, V49, P461, DOI 10.1093/annhyg/mei012; Morimoto Y, 2012, NANOTOXICOLOGY, V6, P766, DOI 10.3109/17435390.2011.620719; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688; Wirkes A, 2010, J APPL PHYSIOL, V109, P1662, DOI 10.1152/japplphysiol.00674.2010; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Castranova V, 2013, ACCOUNTS CHEM RES, V46, P642, DOI 10.1021/ar300004a; Schins RPF, 2007, INHAL TOXICOL, V19, P189, DOI 10.1080/08958370701496202; Nel AE, 2013, ACS NANO, V7, P6422, DOI 10.1021/nn4037927; Ema M, 2012, REGUL TOXICOL PHARM, V63, P188, DOI 10.1016/j.yrtph.2012.03.014; Bolt HM, 2004, TOXICOL LETT, V151, P29, DOI 10.1016/j.toxlet.2004.04.004; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Maruya KA, 2014, INTEGR ENVIRON ASSES, V10, P69, DOI 10.1002/ieam.1483; Ema M, 2011, REGUL TOXICOL PHARM, V61, P276, DOI 10.1016/j.yrtph.2011.08.007; Schulte PA, 2010, J NANOPART RES, V12, P1971, DOI 10.1007/s11051-010-0008-1; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI 10.1080/08958370801942238 ; Shimada M, 2009, ENVIRON SCI TECHNOL, V43, P5529, DOI 10.1021/es9008773; Ema M, 2013, J APPL TOXICOL, V33, P1053, DOI 10.1002/jat.2810; Kobayashi N, 2011, INHAL TOXICOL, V23, P814, DOI 10.3109/08958378.2011.614968; Ema M, 2013, J APPL TOXICOL, V33, P933, DOI 10.1002/jat.2772; Warheit DB, 2003, EXP LUNG RES, V29, P593, DOI 10.1080/01902140390240104; Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529; Moller P, 2010, FREE RADICAL RES, V44, P1, DOI 10.3109/10715760903300691; Baan RA, 2007, INHAL TOXICOL, V19, P213, DOI 10.1080/08958370701497903; Kobayashi N, 2010, TOXICOLOGY, V276, P143, DOI 10.1016/j.tox.2010.07.021; Hubbard R, 2000, AM J RESP CRIT CARE, V161, P5; Seto T, 2010, AEROSOL SCI TECH, V44, P734, DOI 10.1080/02786826.2010.487881; Naya M, 2012, REGUL TOXICOL PHARM, V64, P124, DOI 10.1016/j.yrtph.2012.05.020; Toyokuni S, 2013, ADV DRUG DELIVER REV, V65, P2098, DOI 10.1016/j.addr.2013.05.011; Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X; Johnson DR, 2010, ENVIRON HEALTH PERSP, V118, P49, DOI 10.1289/ehp.0901076; Naya M, 2011, REGUL TOXICOL PHARM, V61, P192, DOI 10.1016/j.yrtph.2011.07.008; Lanone S, 2006, CURR MOL MED, V6, P651, DOI 10.2174/156652406778195026; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Greim H, 2007, INHAL TOXICOL, V19, P199, DOI 10.1080/08958370701497689; Borm PJA, 2004, INT J CANCER, V110, P3, DOI 10.1002/ijc.20064; Shvedova AA, 2013, SMALL, V9, P1691, DOI 10.1002/smll.201201470; Okamoto S, 1998, INT ARCH OCC ENV HEA, V71, P111, DOI 10.1007/s004200050257; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Lai DY, 2012, WIRES NANOMED NANOBI, V4, P1, DOI 10.1002/wnan.162; Johnston H, 2013, CRIT REV TOXICOL, V43, P1, DOI 10.3109/10408444.2012.738187; Miller FJ, 2000, INHAL TOXICOL, V12, P19, DOI 10.1080/089583700196536; Applied Research Associates Inc. (ARA), MULT PATH PART DOS M; Asakura M, 2010, J OCCUP HEALTH, V52, P155; ECHA, 2011, GUID INF REQ CHEM SA; Ema M, 2011, JAP J ENV TOXICOL, V14, P81; Endoh Shigehisa, 2010, Journal of the Society of Powder Technology, Japan, V47, DOI 10.4164/sptj.47.600; Fujita K, 2014, NANOTOXICOLOGY, V9, P1; Hinds WC, 1999, AEROSOL TECHNOLOGY P, P182; Borm PYA, 2000, INHAL TOXICOL, V12, P1; ISO, 2014, 18637 ISO PDTR; Luizi F, 2009, EUR RESP CAR C PRAG; Ma-Hock L, 2009, TOXICOL SCI, V12, P468; Methner Mark M, 2008, J Occup Environ Hyg, V5, pD63, DOI 10.1080/15459620802059393; Nakanishi J, 2011, P06041 NEDO; National Research Council, 2013, RES PROGR ENV HLTH S; Ogura I, 2012, P06041 NEDO; Sargent LM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-3; Shevedova AA, 2014, AM J PHYSIOL-LUNG C, V306, pL170; Shvedova AA, 2012, TOXICOLOGY APPL PHAR, V261, P21; Shvedova AA, 2009, PHARMACOL THERAPEUT, V12, P192; Siegrist KJ, 2014, PARTICLE FIBRE TOXIC, V11, DOI 1i86/1743-8977-11-6; Takaya M, 2010, J OCCUP HLTH LOND, V52, P182; U. S. NIOSH, 2013, DHHS NIOSH PUBLICATI, V65; U.S. NIOSH, 2009, DHHS NIOSH PUBLICATI, V2009-125	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0272-4332	1539-6924		RISK ANAL	Risk Anal.	OCT	2015	35	10					1940	1956		10.1111/risa.12394		17	Public, Environmental & Occupational Health; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods	Public, Environmental & Occupational Health; Mathematics; Mathematical Methods In Social Sciences	CU4BE	WOS:000363470200012		
J	Seki, K; Nagy, A; Jackman, CM; Crary, F; Fontaine, D; Zarka, P; Wurz, P; Milillo, A; Slavin, JA; Delcourt, DC; Wiltberger, M; Ilie, R; Jia, X; Ledvina, SA; Liemohn, MW; Schunk, RW				Seki, K.; Nagy, A.; Jackman, C. M.; Crary, F.; Fontaine, D.; Zarka, P.; Wurz, P.; Milillo, A.; Slavin, J. A.; Delcourt, D. C.; Wiltberger, M.; Ilie, R.; Jia, X.; Ledvina, S. A.; Liemohn, M. W.; Schunk, R. W.			A Review of General Physical and Chemical Processes Related to Plasma Sources and Losses for Solar System Magnetospheres	SPACE SCIENCE REVIEWS			English	Review						Planetary magnetosphere; Plasma sources; General processes	INTERPLANETARY MAGNETIC-FIELD; PHOTON-STIMULATED DESORPTION; AURORAL KILOMETRIC RADIATION; KELVIN-HELMHOLTZ VORTICES; MAGNETOPAUSE RECONNECTION RATE; ELECTRON-CYCLOTRON MASER; RING CURRENT COMPOSITION; ENERGETIC NEUTRAL ATOMS; SINGLE-PARTICLE ORBITS; MONTE-CARLO-SIMULATION	The aim of this paper is to provide a review of general processes related to plasma sources, their transport, energization, and losses in the planetary magnetospheres. We provide background information as well as the most up-to-date knowledge of the comparative studies of planetary magnetospheres, with a focus on the plasma supply to each region of the magnetospheres. This review also includes the basic equations and modeling methods commonly used to simulate the plasma sources of the planetary magnetospheres. In this paper, we will describe basic and common processes related to plasma supply to each region of the planetary magnetospheres in our solar system. First, we will describe source processes in Sect. 1. Then the transport and energization processes to supply those source plasmas to various regions of the magnetosphere are described in Sect. 2. Loss processes are also important to understand the plasma population in the magnetosphere and Sect. 3 is dedicated to the explanation of the loss processes. In Sect. 4, we also briefly summarize the basic equations and modeling methods with a focus on plasma supply processes for planetary magnetospheres.	[Seki, K.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan; [Nagy, A.; Slavin, J. A.; Ilie, R.; Jia, X.; Liemohn, M. W.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [Jackman, C. M.] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Crary, F.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Fontaine, D.; Delcourt, D. C.] Ecole Polytech, CNRS EP UPMC UPSud, Lab Phys Plasmas, F-91128 Palaiseau, France; [Zarka, P.] Univ Paris Diderot, CNRS, Observ Paris, LESIA, F-92195 Meudon, France; [Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Milillo, A.] INAF, Inst Space Astrophys & Planetol, Rome, Italy; [Wiltberger, M.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80212 USA; [Ledvina, S. A.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Schunk, R. W.] Utah State Univ, Ctr Atmospher & Space Sci, Logan, UT 84322 USA	Seki, K (reprint author), Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan.	seki@stelab.nagoya-u.ac.jp	Wiltberger, Michael/B-8781-2008; 	Wiltberger, Michael/0000-0002-4844-3148; Milillo, Anna/0000-0002-0266-2556	JSPS and MEXT of Japan [24340118]; GEMSIS project at STEL, Nagoya University; Royal Astronomical Society Fellowship; Science and Technology Facilities Council Ernest Rutherford Fellowship; JPL [1467206]; NASA [NNH12AU10I, NNH11AR82I, NNX12AK34G, NNX12AM74G]; National Science Foundation; NSF [AGS 1203232]	This work was partially supported by Grant-In-Aid for Scientific Research (B) 24340118 from JSPS and MEXT of Japan. KS also thanks for supports from the GEMSIS project at STEL, Nagoya University. CMJ's work at Southampton was supported by a Royal Astronomical Society Fellowship and a Science and Technology Facilities Council Ernest Rutherford Fellowship. FC is funded by JPL contract 1467206. MW is supported by NASA grants NNH12AU10I and NNH11AR82I. The National Center for Atmospheric Research is sponsored by the National Science Foundation. XJ is supported by NASA grants NNX12AK34G and NNX12AM74G, and by NSF grant AGS 1203232.	Andersen H., 1981, SPUTTERING PARTICLE; Wiltberger M, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015579; Marconi ML, 2007, ICARUS, V190, P155, DOI 10.1016/j.icarus.2007.02.016; SISCOE G, 1975, GEOPHYS RES LETT, V2, P158, DOI 10.1029/GL002i004p00158; Pontius DH, 1997, GEOPHYS RES LETT, V24, P2961, DOI 10.1029/97GL53157; DiBraccio GA, 2013, J GEOPHYS RES-SPACE, V118, P997, DOI 10.1002/jgra.50123; Zoennchen JH, 2011, ANN GEOPHYS-GERMANY, V29, P2211, DOI 10.5194/angeo-29-2211-2011; MEYERVERNET N, 1995, ICARUS, V116, P202, DOI 10.1006/icar.1995.1121; Nykyri K, 2006, ANN GEOPHYS-GERMANY, V24, P2619; HUANG TS, 1992, J GEOPHYS RES, V97, P1511, DOI 10.1029/91JA02611; Vogt MF, 2014, J GEOPHYS RES-SPACE, V119, P821, DOI 10.1002/2013JA019393; GOSLING JT, 1990, GEOPHYS RES LETT, V17, P1833, DOI 10.1029/GL017i011p01833; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Ilie R, 2013, J ATMOS SOL-TERR PHY, V99, P92, DOI 10.1016/j.jastp.2012.03.010; Zoennchen JH, 2010, ANN GEOPHYS-GERMANY, V28, P1221, DOI 10.5194/angeo-28-1221-2010; SMITH PH, 1978, SPACE SCI REV, V22, P301; Muller M, 2002, PLANET SPACE SCI, V50, P1101, DOI 10.1016/S0032-0633(02)00048-X; Yakshinskiy BV, 1999, NATURE, V400, P642; BRICE NM, 1970, ICARUS, V13, P173, DOI 10.1016/0019-1035(70)90048-5; Lai HR, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017263; Toth G, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011126; Winglee RM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000214; HILL TW, 1976, J GEOPHYS RES-SPACE, V81, P4561, DOI 10.1029/JA081i025p04561; SPJELDVIK WN, 1977, J GEOPHYS RES-SPACE, V82, P2801, DOI 10.1029/JA082i019p02801; CONNERNEY JEP, 1984, NATURE, V312, P136, DOI 10.1038/312136a0; DEVRIES AE, 1984, J PHYS CHEM-US, V88, P4510, DOI 10.1021/j150664a014; Hess S, 2009, PLANET SPACE SCI, V57, P23, DOI 10.1016/j.pss.2008.10.006; CAAN MN, 1973, J GEOPHYS RES, V78, P8087, DOI 10.1029/JA078i034p08087; Bhardwaj A, 2000, REV GEOPHYS, V38, P295, DOI 10.1029/1998RG000046; Thomsen MF, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015267; Cowley SWH, 2004, ANN GEOPHYS-GERMANY, V22, P1379; CHIU YT, 1978, J GEOPHYS RES-SPACE, V83, P629, DOI 10.1029/JA083iA02p00629; Ledvina SA, 2008, SPACE SCI REV, V139, P143, DOI 10.1007/s11214-008-9384-6; Keika K, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011789; Wurz P, 2007, ICARUS, V191, P486, DOI 10.1016/j.icarus.2007.04.034; HAREL M, 1981, J GEOPHYS RES-SPACE, V86, P2217, DOI 10.1029/JA086iA04p02217; HARING RA, 1984, NUCL INSTRUM METH B, V5, P483, DOI 10.1016/0168-583X(84)90005-3; Bolton SJ, 2004, CAMB PLANET, P671; Toth G, 2012, J COMPUT PHYS, V231, P870, DOI 10.1016/j.jcp.2011.02.006; Yau AW, 1997, SPACE SCI REV, V80, P1, DOI 10.1023/A:1004947203046; BURTON RK, 1975, J GEOPHYS RES-SPACE, V80, P4204, DOI 10.1029/JA080i031p04204; De Keyser J, 2010, ANN GEOPHYS-GERMANY, V28, P2027, DOI 10.5194/angeo-28-2027-2010; Newell PT, 1998, J GEOPHYS RES-SPACE, V103, P4739, DOI 10.1029/97JA03622; Frederick-Frost KM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011942; Matsumoto Y, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2004JA010988; Nichols JD, 2006, ANN GEOPHYS-GERMANY, V24, P393; REIMANN CT, 1984, SURF SCI, V147, P227, DOI 10.1016/0039-6028(84)90177-8; FAHR HJ, 1974, SPACE SCI REV, V15, P483; FONTAINE D, 1985, J GEOPHYS RES-SPACE, V90, P8343, DOI 10.1029/JA090iA09p08343; Yakshinskiy BV, 2001, J GEOPHYS RES-PLANET, V106, P33303, DOI 10.1029/2000JE001345; Wing S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013950; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Johnson RE, 2002, ICARUS, V156, P136, DOI 10.1006/icar.2001.6763; Wu XY, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2000JA000190; Krupp N, 2004, CAMB PLANET, P617; Treumann RA, 2006, ASTRON ASTROPHYS REV, V13, P229, DOI 10.1007/s00159-006-0001-y; Oieroset M, 1999, J GEOPHYS RES-SPACE, V104, P6987, DOI 10.1029/1998JA900177; Fox JL, 2001, J GEOPHYS RES-SPACE, V106, P21305, DOI 10.1029/2001JA000069; Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208; ZWAN BJ, 1976, J GEOPHYS RES-SPACE, V81, P1636, DOI 10.1029/JA081i010p01636; PERREAULT P, 1978, GEOPHYS J ROY ASTR S, V54, P547, DOI 10.1111/j.1365-246X.1978.tb05494.x; Feldstein YI, 2001, ANN GEOPHYS-GERMANY, V19, P495; PRANGE R, 1992, ADV SPACE RES-SERIES, V12, P379, DOI 10.1016/0273-1177(92)90413-R; Fukazawa K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031784; Mauk BH, 2003, NATURE, V421, P920, DOI 10.1038/nature01431; Tam SWY, 2007, J ATMOS SOL-TERR PHY, V69, P1984, DOI 10.1016/j.jastp.2007.08.006; Paschmann G, 2013, SPACE SCI REV, V178, P385, DOI 10.1007/s11214-012-9957-2; Jackman CM, 2014, J GEOPHYS RES-SPACE, V119, P5465, DOI 10.1002/2013JA019388; Kivelson MG, 1998, J GEOPHYS RES-PLANET, V103, P19963, DOI 10.1029/98JE00227; Fok MC, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011839; ROOSENDAAL HE, 1982, NUCL INSTRUM METHODS, V194, P579, DOI 10.1016/0029-554X(82)90584-5; Ergun RE, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011253; LYSAK RL, 1990, SPACE SCI REV, V52, P33, DOI 10.1007/BF00704239; FARRUGIA CJ, 1995, J GEOPHYS RES-SPACE, V100, P19245, DOI 10.1029/95JA01080; Slavin JA, 1998, GEOPH MONOG SERIES, V105, P225; BURTON RK, 1975, SCIENCE, V189, P717, DOI 10.1126/science.189.4204.717; Mozer FS, 2001, J GEOPHYS RES-SPACE, V106, P5763, DOI 10.1029/2000JA900117; BAGENAL F, 1981, J GEOPHYS RES-SPACE, V86, P8447, DOI 10.1029/JA086iA10p08447; Pryor WR, 2011, NATURE, V472, P331, DOI 10.1038/nature09928; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017926; COWLEY SWH, 1982, REV GEOPHYS, V20, P531, DOI 10.1029/RG020i003p00531; SONNERUP BU, 1971, J GEOPHYS RES, V76, P8211, DOI 10.1029/JA076i034p08211; Terada N, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013937; MOZER FS, 1980, SPACE SCI REV, V27, P155; Nose M, 2000, J GEOPHYS RES-SPACE, V105, P7669, DOI 10.1029/1999JA000318; Jackman CM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016682; Garcia KS, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015730; McAndrews HJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012581; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017367; Ganguli SB, 1996, REV GEOPHYS, V34, P311, DOI 10.1029/96RG00497; SCHUNK RW, 1980, REV GEOPHYS, V18, P813, DOI 10.1029/RG018i004p00813; POTTER AE, 1995, GEOPHYS RES LETT, V22, P3289, DOI 10.1029/95GL03181; SCURRY L, 1991, J GEOPHYS RES, V96, P9541, DOI 10.1029/91JA00569; HEIKKILA WJ, 1977, J GEOPHYS RES-SPACE, V82, P1610, DOI 10.1029/JA082i010p01610; Delamere PA, 2013, J GEOPHYS RES-SPACE, V118, P393, DOI 10.1029/2012JA018197; Thorne RM, 1997, GEOPHYS RES LETT, V24, P2131, DOI 10.1029/97GL01788; Mura A, 2009, ICARUS, V200, P1, DOI 10.1016/j.icarus.2008.11.014; Fama M, 2008, SURF SCI, V602, P156, DOI 10.1016/j.susc.2007.10.002; Hansen KC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022835; Szego K, 2000, SPACE SCI REV, V94, P429, DOI 10.1023/A:1026568530975; Jia XZ, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014375; Masters A, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015351; Cassidy T, 2010, SPACE SCI REV, V153, P299, DOI 10.1007/s11214-009-9625-3; Terasawa T, 1997, GEOPHYS RES LETT, V24, P935, DOI 10.1029/96GL04018; Mangano V, 2007, PLANET SPACE SCI, V55, P1541, DOI 10.1016/j.pss.2006.10.008; Cassidy TA, 2005, ICARUS, V176, P499, DOI 10.1016/j.icarus.2005.02.013; Khurana KK, 2007, ICARUS, V191, P193, DOI 10.1016/j.icarus.2007.04.022; IPAVICH FM, 1984, GEOPHYS RES LETT, V11, P504, DOI 10.1029/GL011i005p00504; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; WESTLEY MS, 1995, NATURE, V373, P405, DOI 10.1038/373405a0; MCELROY MB, 1973, SPACE SCI REV, V14, P460, DOI 10.1007/BF00214756; Paschmann G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035297; Ogawa Y, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012791; Burlaga LF, 2001, PLANET SPACE SCI, V49, P1619, DOI 10.1016/S0032-0633(01)00098-8; MICHEL FC, 1974, PLANET SPACE SCI, V22, P1501, DOI 10.1016/0032-0633(74)90015-4; BROWN WL, 1986, NUCL INSTRUM METH B, V13, P295, DOI 10.1016/0168-583X(86)90516-1; PRITCHETT PL, 1986, PHYS FLUIDS, V29, P2919, DOI 10.1063/1.865492; FRANK LA, 1967, J GEOPHYS RES, V72, P3753, DOI 10.1029/JZ072i015p03753; Wurz P, 2003, ICARUS, V164, P1, DOI 10.1016/S0019-1035(03)00123-4; LYONS LR, 1980, J GEOPHYS RES-SPACE, V85, P17, DOI 10.1029/JA085iA01p00017; Powell KG, 1999, J COMPUT PHYS, V154, P284, DOI 10.1006/jcph.1999.6299; Waite JH, 2001, NATURE, V410, P787, DOI 10.1038/35071018; Brambles OJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015469; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017575; Wanliss JA, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011034; Hasegawa H, 2004, NATURE, V430, P755, DOI 10.1038/nature02799; Shi M, 1995, J GEOPHYS RES-PLANET, V100, P26387, DOI 10.1029/95JE03099; BROWN WL, 1984, NUCL INSTRUM METH B, V1, P307, DOI 10.1016/0168-583X(84)90085-5; Yakshinskiy BV, 2005, SURF SCI, V593, P202, DOI 10.1016/j.susc.2005.062; Wilson RJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040225; Borovsky JE, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012645; Forsyth RJ, 1996, J GEOPHYS RES, V101, P395, DOI 10.1029/95JA02977; Jackman CM, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010614; SERGEEV VA, 1993, J GEOPHYS RES, V98, P7609, DOI 10.1029/92JA02587; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003; CLADIS JB, 1986, GEOPHYS RES LETT, V13, P893, DOI 10.1029/GL013i009p00893; Fuselier SA, 2011, SPACE SCI REV, V160, P95, DOI 10.1007/s11214-011-9820-x; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; EICHHORN G, 1978, PLANET SPACE SCI, V26, P469, DOI 10.1016/0032-0633(78)90068-5; FITE WL, 1958, PHYS REV, V112, P1161, DOI 10.1103/PhysRev.112.1161; Carlson CW, 1998, GEOPHYS RES LETT, V25, P2013, DOI 10.1029/98GL01592; Ono Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013918; Majeed T, 1996, J GEOPHYS RES-PLANET, V101, P7589, DOI 10.1029/96JE00115; Ostgaard N, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009749; Fukazawa K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028373; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Yu YQ, 2013, J GEOPHYS RES-SPACE, V118, P1711, DOI 10.1029/2012JA018411; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Clarke JT, 2012, GEOPHYS MONOGR SER, V197, P113, DOI 10.1029/2011GM001199; SERGEEV VA, 1983, PLANET SPACE SCI, V31, P1147, DOI 10.1016/0032-0633(83)90103-4; Andre M, 1997, SPACE SCI REV, V80, P27, DOI 10.1023/A:1004921619885; McFadden JP, 1999, J GEOPHYS RES-SPACE, V104, P14453, DOI 10.1029/1998JA900167; ROSENBAUER H, 1975, J GEOPHYS RES-SPACE, V80, P2723, DOI 10.1029/JA080i019p02723; Marklund GT, 2009, SPACE SCI REV, V142, P1, DOI 10.1007/s11214-008-9373-9; ASHOURABDALLA M, 1992, GEOPHYS RES LETT, V19, P1739, DOI 10.1029/92GL01810; MITCHELL DG, 1990, GEOPHYS RES LETT, V17, P583, DOI 10.1029/GL017i005p00583; Raeder J, 2008, SPACE SCI REV, V141, P535, DOI 10.1007/s11214-008-9421-5; BANKS PM, 1969, J GEOPHYS RES, V74, P6317, DOI 10.1029/JA074i026p06317; Phan TD, 2013, GEOPHYS RES LETT, V40, P11, DOI 10.1029/2012GL054528; Masters A, 2009, PLANET SPACE SCI, V57, P1769, DOI 10.1016/j.pss.2009.02.010; Cassidy TA, 2013, PLANET SPACE SCI, V77, P64, DOI 10.1016/j.pss.2012.07.008; Krimigis SM, 2005, SCIENCE, V307, P1270, DOI 10.1126/science.1105978; CHAMBERLAIN JW, 1963, PLANET SPACE SCI, V11, P901, DOI 10.1016/0032-0633(63)90122-3; Grocott A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014330; SPJELDVIK WN, 1978, J GEOPHYS RES-SPACE, V83, P1583, DOI 10.1029/JA083iA04p01583; Russell CT, 1998, SCIENCE, V280, P1061, DOI 10.1126/science.280.5366.1061; Kivelson MG, 2004, ADV SPACE RES, V33, P2061, DOI 10.1016/j.asr.2003.08.042; Cooper JF, 2001, ICARUS, V149, P133, DOI 10.1006/icar.2000.6498; Chane E, 2013, J GEOPHYS RES-SPACE, V118, P2157, DOI 10.1002/jgra.50258; Killen RM, 1999, REV GEOPHYS, V37, P361, DOI 10.1029/1999RG900001; MOZER FS, 1977, PHYS REV LETT, V38, P292, DOI 10.1103/PhysRevLett.38.292; Winske D, 2003, LECT NOTES PHYS, V615, P136, DOI 10.1007/3-540-36530-3_8; Ray LC, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013969; WILLIAMS DJ, 1981, PLANET SPACE SCI, V29, P1195, DOI 10.1016/0032-0633(81)90124-0; Shematovich VI, 2005, ICARUS, V173, P480, DOI 10.1016/j.icarus.2004.08.013; Galopeau PHM, 1995, J GEOPHYS RES-PLANET, V100, P26397, DOI 10.1029/95JE02132; AXFORD WI, 1964, PLANET SPACE SCI, V12, P45, DOI 10.1016/0032-0633(64)90067-4; Kitamura N, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017459; DELCOURT DC, 1994, GEOPHYS RES LETT, V21, P1543, DOI 10.1029/94GL01291; Plainaki C, 2010, ICARUS, V210, P385, DOI 10.1016/j.icarus.2010.06.041; SONNERUP BU, 1974, J GEOPHYS RES, V79, P1546, DOI 10.1029/JA079i010p01546; PILIPP WG, 1978, J GEOPHYS RES-SPACE, V83, P5670, DOI 10.1029/JA083iA12p05670; Cassidy TA, 2007, ICARUS, V191, P755, DOI 10.1016/j.icarus.2007.04.033; Jackman CM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013083; Jackman CM, 2014, SPACE SCI REV, V182, P85, DOI 10.1007/s11214-014-0060-8; Bailey J, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016531; Lyon JG, 2004, J ATMOS SOL-TERR PHY, V66, P1333, DOI 10.1016/j.jastp.2004.03.020; Paranicas C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014127; Smyth WH, 2006, ICARUS, V181, P510, DOI 10.1016/j.icarus.2005.10.019; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016900; ANICICH VG, 1993, J PHYS CHEM REF DATA, V22, P1469; Sundberg T, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017268; WU CS, 1979, ASTROPHYS J, V230, P621, DOI 10.1086/157120; Gosling JT, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL022406, 10.1029/2005GL023357]; Kozyra JU, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000023; Kidder A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013100; STUART GW, 1959, PHYS REV LETT, V2, P417, DOI 10.1103/PhysRevLett.2.417; Vogt MF, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015098; Slavin JA, 2014, J GEOPHYS RES-SPACE, V119, P8087, DOI 10.1002/2014JA020319; Orsini S, 1999, NUOVO CIMENTO C, V22, P633; EICHHORN G, 1978, PLANET SPACE SCI, V26, P463, DOI 10.1016/0032-0633(78)90067-3; Lavraud B, 2013, J GEOPHYS RES-SPACE, V118, P1089, DOI 10.1002/jgra.50145; Mitchell DG, 2003, SPACE SCI REV, V109, P63, DOI 10.1023/B:SPAC.0000007513.55076.00; KNIGHT S, 1973, PLANET SPACE SCI, V21, P741, DOI 10.1016/0032-0633(73)90093-7; Prange R, 1996, NATURE, V379, P323, DOI 10.1038/379323a0; Pallier L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018041; PELLINEN RJ, 1978, J GEOPHYS RES-SPACE, V83, P1544, DOI 10.1029/JA083iA04p01544; Hess S, 2007, PLANET SPACE SCI, V55, P89, DOI 10.1016/j.pss.2006.05.016; Kronberg EA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012880; Bonfond B, 2012, GEOPHYS MONOGR SER, V197, P133, DOI 10.1029/2011GM001169; CHEN J, 1986, J GEOPHYS RES, V91, P1499, DOI 10.1029/JA091iA02p01499; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; Kivelson MG, 1997, GEOPHYS RES LETT, V24, P2127, DOI 10.1029/97GL02202; JOHNSON RE, 1983, ASTRON ASTROPHYS, V123, P343; Bruno M, 2007, PLANET SPACE SCI, V55, P1494, DOI 10.1016/j.pss.2006.10.006; BRECHT SH, 1988, COMPUT PHYS COMMUN, V48, P135, DOI 10.1016/0010-4655(88)90031-8; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA018183; Gershman DJ, 2013, J GEOPHYS RES-SPACE, V118, P7181, DOI 10.1002/2013JA019244; Bagenal F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016294; Grocott A, 2003, ANN GEOPHYS-GERMANY, V21, P509; MCNUTT RL, 1979, NATURE, V280, P803, DOI 10.1038/280803a0; Plainaki C, 2012, ICARUS, V218, P956, DOI 10.1016/j.icarus.2012.01.023; SOLOMON SC, 1993, GEOPHYS RES LETT, V20, P185, DOI 10.1029/93GL00081; Delcourt DC, 2002, J ATMOS SOL-TERR PHY, V64, P551, DOI 10.1016/S1364-6826(02)00012-3; EVANS DS, 1974, J GEOPHYS RES, V79, P2853, DOI 10.1029/JA079i019p02853; Phan TD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023355; Abe T, 1996, J GEOMAGN GEOELECTR, V48, P319; THOMAS BT, 1980, J GEOPHYS RES-SPACE, V85, P6861, DOI 10.1029/JA085iA12p06861; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Glocer A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014053; Yau AW, 2007, J ATMOS SOL-TERR PHY, V69, P1936, DOI 10.1016/j.jastp.2007.08.010; Kim YH, 2014, J GEOPHYS RES-SPACE, V119, P384, DOI 10.1002/2013JA019022; HARRIS EG, 1962, NUOVO CIMENTO, V23, P115, DOI 10.1007/BF02733547; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; Luhmann JG, 2006, ICARUS, V181, P465, DOI 10.1016/j.icarus.2005.11.022; Nykyri K, 2001, GEOPHYS RES LETT, V28, P3565, DOI 10.1029/2001GL013239; ASHOURABDALLA M, 1994, J GEOPHYS RES, V99, P14891, DOI 10.1029/94JA00141; AXFORD WI, 1961, CAN J PHYS, V39, P1433; Badman S.V., 2007, ANN GEOPHYS, V25, P94; Bagenal F, 2007, J ATMOS SOL-TERR PHY, V69, P387, DOI 10.1016/j.jastp.2006.08.012; Baragiola RA, 2003, NUCL INSTRUM METH B, V209, P294, DOI 10.1016/S0168-583X(02)02052-9; BARGATZE LF, 1985, J GEOPHYS RES-SPACE, V90, P6387, DOI 10.1029/JA090iA07p06387; Behrisch R., 2007, SPUTTERING PARTICLE; BIERSACK JP, 1984, APPL PHYS A-MATER, V34, P73, DOI 10.1007/BF00614759; Bird GA, 1994, MOL GAS DYNAMICS DIR; Birkeland K, 1910, CR HEBD ACAD SCI, V150, P246; Bishop J, 1996, J GEOPHYS RES, V101, P17325, DOI 10.1029/95JA03468; BORING JW, 1984, NUCL INSTRUM METH B, V1, P321, DOI 10.1016/0168-583X(84)90087-9; Borovsky JE, 1998, J GEOPHYS RES-SPACE, V103, P17617, DOI 10.1029/97JA02986; BROWN DG, 1995, J GEOPHYS RES, V100, P17499, DOI 10.1029/95JA00592; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Burch JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022611; Cecconi B, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013830; Chappell C.R., 2015, SPACE SCI R IN PRESS; Chen F. F., 1984, INTRO PLASMA PHYS CO; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Cravens T.E., 1997, PHYS SOLAR SYSTEM PL, DOI [10.1017/CBO9780511529467, DOI 10.1017/CBO9780511529467]; Delamere PA, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015347; Delcourt DC, 1996, J GEOPHYS RES, V101, P17409, DOI 10.1029/96JA01006; DELCOURT DC, 1990, J GEOPHYS RES, V95, P20853, DOI 10.1029/JA095iA12p20853; Delcourt DC, 1999, J GEOPHYS RES-SPACE, V104, P22635, DOI 10.1029/1999JA900251; Dessler J., 1959, J GEOPHYS RES, V64, P2239, DOI [10.1029/JZ064i012p02239, DOI 10.1029/JZ064I012P02239]; Eckstein W., 2007, SPUTTERING PARTICLE, P21; Fuselier SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044140; Gombosi T.I., 1998, PHYS SPACE ENV; Hasegawa H, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014042; Hill TW, 1974, GEOPHYS RES LETT, V1, DOI 10.1029/GL001i001p00003; Hill TW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022620; HODGES RR, 1994, J GEOPHYS RES, V99, P23229, DOI 10.1029/94JA02183; Hofer W.O., 1991, SPUTTERING PARTICLE, P15; HONES EW, 1977, J GEOPHYS RES-SPACE, V82, P5633, DOI 10.1029/JA082i035p05633; Hones Jr E. W., 1976, PHYSICS SOLAR PLANET, P559; Huba J.D., 2005, P ISSS MARCH, V7, P26; HUFF RL, 1988, J GEOPHYS RES, V93, P11445, DOI 10.1029/JA093iA10p11445; Imber S.M., 2014, J GEOPHYS RES UNPUB; Jackman CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029764; Johnson R.E., 1990, ENERGETIC CHARGED PA, VX, P19; Johnson R.E., 2009, EUROPA, P507; Johnson R.E, 2001, ADV SERIES PHYS CHEM, V11, P390; Jorgensen M., 1931, J GEOPHYS RES, V106, P1931, DOI [10.1029/2000JA000124, DOI 10.1029/2000JA000124]; Keika K., 2003, AGU FALL M, pA565; Keiling A., 2004, GEOPHYS RES LETT, V31; Krall N., 1986, PRINCIPLES PLASMA PH; Krupp N, 2001, J GEOPHYS RES-SPACE, V106, P26017, DOI 10.1029/2000JA900138; Lagg A., 2003, GEOPHYS RES LETT, V30; Liemohn M.W., 2005, INNER MAGNETOSPHERE, V155, P211; Lipatov A., 2002, HYBRID MULTISCALE SI; LOUARN P, 1990, J GEOPHYS RES, V95, P5983, DOI 10.1029/JA095iA05p05983; Masters A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051372; Matsumoto Y, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014637; MAUK BH, 1986, J GEOPHYS RES, V91, P3423, DOI 10.1029/JA091iA12p13423; Meinel B., 1951, ASTROPHYS J, V113, P50, DOI [10.1086/145375, DOI 10.1086/145375]; Moore TE, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000194; Mottez F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016367; Nagy A.F., 1980, J GEOPHYS RES, V85, P7795, DOI 10.1029/JA085iA13p07795; Nakamura TKM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012803; NEISHTADT AI, 1987, PMM-J APPL MATH MEC+, V51, P586; Norqvist P, 1996, J GEOPHYS RES, V101, P13179, DOI 10.1029/95JA03596; Northrop T. G., 1963, ADIABATIC MOTION CHA; NORTHROP TG, 1982, J GEOPHYS RES-SPACE, V87, P6045, DOI 10.1029/JA087iA08p06045; Ogino T.R., 1998, J GEOPHYS RES, V84, P47; Paschmann G., 2003, AURORAL PLASMA PHYS; PEYMIRAT C, 1994, J GEOPHYS RES, V99, P11155, DOI 10.1029/93JA02546; Plainaki C, 2015, ICARUS, V245, P306, DOI 10.1016/j.icarus.2014.09.018; Plainaki C, 2013, PLANET SPACE SCI, V88, P42, DOI 10.1016/j.pss.2013.08.011; RAIRDEN RL, 1986, J GEOPHYS RES, V91, P3613, DOI 10.1029/JA091iA12p13613; ROUX A, 1993, J GEOPHYS RES, V98, P11657, DOI 10.1029/92JA02309; Sandholt PE, 1998, J GEOPHYS RES-SPACE, V103, P20279, DOI 10.1029/98JA01541; Schunk R., 2009, IONOSPHERES; Schunk RW, 1997, J GEOPHYS RES-SPACE, V102, P11625, DOI 10.1029/97JA00292; SHABANSK.VP, 1971, SPACE SCI REV, V12, P299, DOI 10.1007/BF00165511; Sigmund P., 1969, THEORY SPUTTERING; SISCOE GL, 1977, J GEOPHYS RES-SPACE, V82, P1641, DOI 10.1029/JA082i010p01641; SLAVIN JA, 1984, J GEOPHYS RES-SPACE, V89, P2708, DOI 10.1029/JA089iA05p02708; Strangeway RJ, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010829; Sugiura M., 1964, HOURLY VALUES EQUATO, V35, P9; Teolis BD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245422; Thomas N., 2004, JUPITER PLANET SATEL, P560; Vasyliunas V., 1970, PARTICLES FIELDS MAG; Vasyliunas V. M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI DOI 10.1017/CBO9780511564574.013; Wolf R.A., 1979, SPACE SCI REV, V17, P535; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Ziegler J. F., 1984, STOPPING RANGES IONS, V1	325	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	OCT	2015	192	1-4					27	89		10.1007/s11214-015-0170-y		63	Astronomy & Astrophysics	Astronomy & Astrophysics	CU7MF	WOS:000363723000003		
J	Raines, JM; DiBraccio, GA; Cassidy, TA; Delcourt, DC; Fujimoto, M; Jia, X; Mangano, V; Milillo, A; Sarantos, M; Slavin, JA; Wurz, P				Raines, J. M.; DiBraccio, G. A.; Cassidy, T. A.; Delcourt, D. C.; Fujimoto, M.; Jia, X.; Mangano, V.; Milillo, A.; Sarantos, M.; Slavin, J. A.; Wurz, P.			Plasma Sources in Planetary Magnetospheres: Mercury	SPACE SCIENCE REVIEWS			English	Review							BIDIRECTIONAL REFLECTANCE SPECTROSCOPY; PHOTON-STIMULATED DESORPTION; MESSENGER ORBITAL OBSERVATIONS; SOLAR-WIND INTERACTION; ION MASS-SPECTROMETRY; NEUTRAL SODIUM ATOMS; FLUX-TRANSFER EVENTS; MAGNETIC-FIELD; POTASSIUM ATMOSPHERES; SPATIAL-DISTRIBUTION		[Raines, J. M.; DiBraccio, G. A.; Jia, X.; Slavin, J. A.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [DiBraccio, G. A.] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Cassidy, T. A.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80303 USA; [Delcourt, D. C.] Univ Paris 06, CNRS, Ecole Polytech, LPP, F-75252 Paris, France; [Fujimoto, M.] JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Mangano, V.; Milillo, A.] INAF, Inst Space Astrophys & Planetol, Rome, Italy; [Sarantos, M.] NASA, Goddard Space Flight Ctr, Heliophys Sci Div, Greenbelt, MD 20771 USA; [Wurz, P.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Raines, JM (reprint author), Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA.	jraines@umich.edu		Milillo, Anna/0000-0002-0266-2556	NASA Planetary Atmospheres program [NNX14AJ46G]; Solar System Workings program [NNX15AH28G]; Heliophysics Supporting Research program [NNX15AJ68G]; Discovery Data Analysis program [NNX15AK88G, NNX15AL01G]; NASA Discovery Program [NASW-00002, NAS5-97271]	This work was supported by the NASA Planetary Atmospheres program through grant NNX14AJ46G. Additional support was provided through the Solar System Workings program through grant NNX15AH28G, the Heliophysics Supporting Research program through grant NNX15AJ68G and the Discovery Data Analysis program through grants NNX15AK88G and NNX15AL01G. The MESSENGER project is supported by the NASA Discovery Program under contracts NASW-00002 to the Carnegie Institution of Washington and NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory.	Anderson BJ, 2014, GEOPHYS RES LETT, V41, P7444, DOI 10.1002/2014GL061677; ANGELOPOULOS V, 1994, J GEOPHYS RES, V99, P21257, DOI 10.1029/94JA01263; Leblanc F, 2007, PLANET SPACE SCI, V55, P1069, DOI 10.1016/j.pss.2006.11.008; Winglee RM, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013750; DiBraccio GA, 2013, J GEOPHYS RES-SPACE, V118, P997, DOI 10.1002/jgra.50123; BAKER DN, 1986, J GEOPHYS RES, V91, P8742, DOI 10.1029/JA091iA08p08742; Killen RM, 2004, ICARUS, V171, P1, DOI 10.1016/j.icarus.2004.04.007; BAUMJOHANN W, 1989, GEOPHYS RES LETT, V16, P295, DOI 10.1029/GL016i004p00295; Sundberg T, 2011, PLANET SPACE SCI, V59, P2051, DOI 10.1016/j.pss.2011.05.008; Lepping RP, 1996, J GEOMAGN GEOELECTR, V48, P589; HAPKE B, 1984, ICARUS, V59, P41, DOI 10.1016/0019-1035(84)90054-X; Baker DN, 2013, J GEOPHYS RES-SPACE, V118, P45, DOI 10.1029/2012JA018064; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; Cremonese G, 2005, ICARUS, V177, P122, DOI 10.1016/j.icarus.2005.03.022; Muller M, 2002, PLANET SPACE SCI, V50, P1101, DOI 10.1016/S0032-0633(02)00048-X; Yakshinskiy BV, 1999, NATURE, V400, P642; SISCOE GL, 1975, J GEOPHYS RES-SPACE, V80, P4359, DOI 10.1029/JA080i031p04359; Yakshinskiy BV, 2004, ICARUS, V168, P53, DOI 10.1016/j.icarus.2003.12.007; Yau AW, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017803; CAAN MN, 1973, J GEOPHYS RES, V78, P8087, DOI 10.1029/JA078i034p08087; Slavin JA, 2010, SCIENCE, V329, P665, DOI 10.1126/science.1188067; McClintock WE, 2009, SCIENCE, V324, P610, DOI 10.1126/science.1172525; Wurz P, 2001, PLANET SPACE SCI, V49, P1643, DOI 10.1016/S0032-0633(01)00102-7; Delcourt DC, 2011, ANN GEOPHYS-GERMANY, V29, P987, DOI 10.5194/angeo-29-987-2011; HONES EW, 1984, GEOPHYS RES LETT, V11, P1046, DOI 10.1029/GL011i010p01046; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Boardsen SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043606; Wurz P, 2007, ICARUS, V191, P486, DOI 10.1016/j.icarus.2007.04.034; Wang YC, 2010, ICARUS, V209, P46, DOI 10.1016/j.icarus.2010.05.020; Imber SM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016026; Potter AE, 2006, ICARUS, V181, P1, DOI 10.1016/j.icarus.2005.10.026; Seki K, 2013, J GEOPHYS RES-SPACE, V118, P3233, DOI 10.1002/jgra.50181; Zurbuchen TH, 2011, SCIENCE, V333, P1862, DOI 10.1126/science.1211302; Winslow RM, 2014, GEOPHYS RES LETT, V41, P4463, DOI 10.1002/2014GL060258; Gershman DJ, 2014, GEOPHYS RES LETT, V41, P5740, DOI 10.1002/2014GL060468; Alexeev II, 2010, ICARUS, V209, P23, DOI 10.1016/j.icarus.2010.01.024; Lavraud B, 2005, SURV GEOPHYS, V26, P135, DOI 10.1007/s10712-005-1875-3; Glassmeier KH, 2007, SPACE SCI REV, V132, P511, DOI 10.1007/s11214-007-9244-9; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Huang CS, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014232; Orsini S, 2014, ICARUS, V239, P281, DOI 10.1016/j.icarus.2014.05.031; SPEISER TW, 1965, J GEOPHYS RES, V70, P4219, DOI 10.1029/JZ070i017p04219; Zurbuchen TH, 2008, SCIENCE, V321, P90, DOI 10.1126/science.1159314; SLAVIN JA, 1992, GEOPHYS RES LETT, V19, P825, DOI 10.1029/92GL00394; Masters A, 2013, J GEOPHYS RES-SPACE, V118, P4381, DOI 10.1002/jgra.50428; ZWAN BJ, 1976, J GEOPHYS RES-SPACE, V81, P1636, DOI 10.1029/JA081i010p01636; Schmidt CA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017217; Cassidy TA, 2015, ICARUS, V248, P547, DOI 10.1016/j.icarus.2014.10.037; Anderson BJ, 2011, SCIENCE, V333, P1859, DOI 10.1126/science.1211001; Killen RM, 2015, ICARUS, V250, P230, DOI 10.1016/j.icarus.2014.11.035; Kidder A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013038; Milillo A, 2010, PLANET SPACE SCI, V58, P40, DOI 10.1016/j.pss.2008.06.005; BENNINGHOVEN A, 1975, SURF SCI, V53, P596, DOI 10.1016/0039-6028(75)90158-2; Liljeblad E, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020614; Domingue DL, 1997, ICARUS, V128, P75, DOI 10.1006/icar.1997.5725; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017926; RUSSELL CT, 1989, GEOPHYS RES LETT, V16, P1253, DOI 10.1029/GL016i011p01253; SLAVIN JA, 1979, J GEOPHYS RES-SPACE, V84, P2076, DOI 10.1029/JA084iA05p02076; Vervack RJ, 2010, SCIENCE, V329, P672, DOI 10.1126/science.1188572; LEPPING RP, 1995, GEOPHYS RES LETT, V22, P1193; Sarantos M, 2011, PLANET SPACE SCI, V59, P1992, DOI 10.1016/j.pss.2011.05.002; Massetti S, 2003, ICARUS, V166, P229, DOI 10.1016/j.icarus.2003.08.005; Pfleger M, 2015, PLANET SPACE SCI, V115, P90, DOI 10.1016/j.pss.2015.04.016; Benna M, 2010, ICARUS, V209, P3, DOI 10.1016/j.icarus.2009.11.036; McLain JL, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003714; Raeder J, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015876; ELPHIC RC, 1991, GEOPHYS RES LETT, V18, P2165, DOI 10.1029/91GL02669; OGILVIE KW, 1977, J GEOPHYS RES-SPACE, V82, P1807, DOI 10.1029/JA082i013p01807; Mura A, 2009, ICARUS, V200, P1, DOI 10.1016/j.icarus.2008.11.014; Leblanc F, 2003, ICARUS, V164, P261, DOI 10.1016/S0019-1035(03)00147-7; MCGRATH MA, 1986, NATURE, V323, P694, DOI 10.1038/323694a0; Hidalgo MA, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA900100; HORWITZ JL, 1984, GEOPHYS RES LETT, V11, P1111, DOI 10.1029/GL011i011p01111; Kivelson MG, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012302; Lammer H, 2003, ICARUS, V166, P238, DOI 10.1016/j.icarus.2003.08.012; Milan SE, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010350; Killen RM, 2001, J GEOPHYS RES-PLANET, V106, P20509, DOI 10.1029/2000JE001401; Paral J, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044413; Mangano V, 2007, PLANET SPACE SCI, V55, P1541, DOI 10.1016/j.pss.2006.10.008; Richer E, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017898; Boardsen SA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017822; Korth H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049451; NESS NF, 1974, SCIENCE, V185, P151, DOI 10.1126/science.185.4146.151; Burlaga LF, 2001, PLANET SPACE SCI, V49, P1619, DOI 10.1016/S0032-0633(01)00098-8; HOOD LL, 1979, J GEOPHYS RES-SPACE, V84, P2641, DOI 10.1029/JA084iA06p02641; Yakshinskiy BV, 2000, SURF REV LETT, V7, P75, DOI 10.1016/S0218-625X(00)00011-7; Anderson BJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004159; Sundberg T, 2010, PLANET SPACE SCI, V58, P1434, DOI 10.1016/j.pss.2010.06.008; SUESS ST, 1979, J GEOPHYS RES-SPACE, V84, P3306, DOI 10.1029/JA084iA07p03306; Wurz P, 2003, ICARUS, V164, P1, DOI 10.1016/S0019-1035(03)00123-4; Imber SM, 2014, J GEOPHYS RES-SPACE, V119, P5613, DOI 10.1002/2014JA019884; Winslow RM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051472; Yakshinskiy BV, 2005, SURF SCI, V593, P202, DOI 10.1016/j.susc.2005.062; SERGEEV VA, 1993, J GEOPHYS RES, V98, P7609, DOI 10.1029/92JA02587; Tanaka KG, 2011, PLANET SPACE SCI, V59, P510, DOI 10.1016/j.pss.2010.04.014; Wurz P, 2010, PLANET SPACE SCI, V58, P1599, DOI 10.1016/j.pss.2010.08.003; BROADFOOT AL, 1976, GEOPHYS RES LETT, V3, P577, DOI 10.1029/GL003i010p00577; Potter AE, 2002, METEORIT PLANET SCI, V37, P1165; CLADIS JB, 1986, GEOPHYS RES LETT, V13, P893, DOI 10.1029/GL013i009p00893; Yagi M, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015226; Boardsen SA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036034; Raines JM, 2011, PLANET SPACE SCI, V59, P2004, DOI 10.1016/j.pss.2011.02.004; OGILVIE KW, 1974, SCIENCE, V185, P145, DOI 10.1126/science.185.4146.145; Doressoundiram A, 2009, ASTRON J, V137, P3859, DOI 10.1088/0004-6256/137/4/3859; Raines JM, 2013, J GEOPHYS RES-SPACE, V118, P1604, DOI 10.1029/2012JA018073; Bida TA, 2000, NATURE, V404, P159, DOI 10.1038/35004521; SHIOKAWA K, 1994, J GEOMAGN GEOELECTR, V46, P231; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Killen R, 2007, SPACE SCI REV, V132, P433, DOI 10.1007/s11214-007-9232-0; Domingue DL, 2007, SPACE SCI REV, V131, P161, DOI 10.1007/s11214-007-9260-9; Sarantos M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052001; SIMPSON JA, 1974, SCIENCE, V185, P160, DOI 10.1126/science.185.4146.160; Raines JM, 2014, J GEOPHYS RES-SPACE, V119, DOI 10.1002/2014JA020120; Potter AE, 1999, PLANET SPACE SCI, V47, P1441, DOI 10.1016/S0032-0633(99)00070-7; ASHOURABDALLA M, 1992, GEOPHYS RES LETT, V19, P1739, DOI 10.1029/92GL01810; WANG YX, 1984, J VAC SCI TECHNOL A, V2, P732, DOI 10.1116/1.572560; Kallio E, 2003, ANN GEOPHYS-GERMANY, V21, P2133; MITCHELL DG, 1990, GEOPHYS RES LETT, V17, P583, DOI 10.1029/GL017i005p00583; Leblanc F, 2010, ICARUS, V209, P280, DOI 10.1016/j.icarus.2010.04.020; HAPKE B, 1986, ICARUS, V67, P264, DOI 10.1016/0019-1035(86)90108-9; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; Schmidt CA, 2013, J GEOPHYS RES-SPACE, V118, P4564, DOI 10.1002/jgra.50396; Mouawad N, 2011, ICARUS, V211, P21, DOI 10.1016/j.icarus.2010.10.019; Killen RM, 1999, REV GEOPHYS, V37, P361, DOI 10.1029/1999RG900001; Kameda S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039036; Winslow RM, 2013, J GEOPHYS RES-SPACE, V118, P2213, DOI 10.1002/jgra.50237; Ho GC, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017983; Killen R, 2009, ASTROPHYS J SUPPL S, V181, P351, DOI 10.1088/0067-0049/181/2/351; Benkhoff J, 2010, PLANET SPACE SCI, V58, P2, DOI 10.1016/j.pss.2009.09.020; Burger MH, 2010, ICARUS, V209, P63, DOI 10.1016/j.icarus.2010.05.007; Anderson BJ, 2007, SPACE SCI REV, V131, P417, DOI 10.1007/s11214-007-9246-7; Cladis JB, 2000, GEOPHYS RES LETT, V27, P915, DOI 10.1029/1999GL010737; Sarantos M, 2001, PLANET SPACE SCI, V49, P1629, DOI 10.1016/S0032-0633(01)00100-3; Burger MH, 2014, ICARUS, V238, P51, DOI 10.1016/j.icarus.2014.04.049; Orsini S, 2010, PLANET SPACE SCI, V58, P166, DOI 10.1016/j.pss.2008.09.012; Mura A, 2007, PLANET SPACE SCI, V55, P1569, DOI 10.1016/j.pss.2006.11.028; Stern SA, 1999, REV GEOPHYS, V37, P453, DOI 10.1029/1999RG900005; Poppe AR, 2013, J GEOPHYS RES-PLANET, V118, P1934, DOI 10.1002/jgre.20148; Leblanc F, 2011, ICARUS, V216, P551, DOI 10.1016/j.icarus.2011.09.028; Slavin JA, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA016900; Slavin JA, 2008, SCIENCE, V321, P85, DOI 10.1126/science.1159040; Farrell WM, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004070; Sundberg T, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017268; SHELLEY EG, 1972, J GEOPHYS RES, V77, P6104, DOI 10.1029/JA077i031p06104; Delcourt DC, 2003, ANN GEOPHYS-GERMANY, V21, P1723; Potter AE, 2007, ICARUS, V186, P571, DOI 10.1016/j.icarus.2006.09.025; Smith MF, 1996, REV GEOPHYS, V34, P233, DOI 10.1029/96RG00893; Korth H, 2014, J GEOPHYS RES-SPACE, V119, P2917, DOI 10.1002/2013JA019567; Slavin JA, 2014, J GEOPHYS RES-SPACE, V119, P8087, DOI 10.1002/2014JA020319; Slavin JA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010878; McClintock WE, 2007, SPACE SCI REV, V131, P481, DOI 10.1007/s11214-007-9264-5; Mall U, 1998, GEOPHYS RES LETT, V25, P3799, DOI 10.1029/1998GL900003; Mangano V, 2013, PLANET SPACE SCI, V82-83, P1, DOI 10.1016/j.pss.2013.03.002; Ashour-Abdalla M, 2011, NAT PHYS, V7, P360, DOI [10.1038/nphys1903, 10.1038/NPHYS1903]; HILL TW, 1976, GEOPHYS RES LETT, V3, P429, DOI 10.1029/GL003i008p00429; Potter AE, 1997, PLANET SPACE SCI, V45, P95, DOI 10.1016/S0032-0633(96)00100-6; SMYTH WH, 1995, ASTROPHYS J, V441, P839, DOI 10.1086/175407; Slavin JA, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009557; Sarantos M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036207; Leblanc F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035322; Bruno M, 2007, PLANET SPACE SCI, V55, P1494, DOI 10.1016/j.pss.2006.10.006; Ip WH, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA009171; Wang YC, 2011, ICARUS, V216, P387, DOI 10.1016/j.icarus.2011.09.023; Delcourt DC, 2013, ANN GEOPHYS-GERMANY, V31, P1673, DOI 10.5194/angeo-31-1673-2013; Gershman DJ, 2013, J GEOPHYS RES-SPACE, V118, P7181, DOI 10.1002/2013JA019244; Gershman DJ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017829; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; Delcourt DC, 2002, J ATMOS SOL-TERR PHY, V64, P551, DOI 10.1016/S1364-6826(02)00012-3; Kabin K, 2000, ICARUS, V143, P397, DOI 10.1006/icar.1999.6252; Kuznetsova MM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012316; Jia XZ, 2015, J GEOPHYS RES-SPACE, V120, P4763, DOI 10.1002/2015JA021143; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; JOHNSON RE, 1991, GEOPHYS RES LETT, V18, P2169, DOI 10.1029/91GL02095; DiBraccio GA, 2015, PLANET SPACE SCI, V115, P77, DOI 10.1016/j.pss.2014.12.016; ARMSTRONG TP, 1975, J GEOPHYS RES-SPACE, V80, P4015, DOI 10.1029/JA080i028p04015; Ieda A, 1998, J GEOPHYS RES-SPACE, V103, P4453, DOI 10.1029/97JA03240; Andrews GB, 2007, SPACE SCI REV, V131, P523, DOI 10.1007/s11214-007-9272-5; LEPPING RP, 1990, J GEOPHYS RES, V95, P11957, DOI 10.1029/JA095iA08p11957; SHEMANSKY DE, 1977, REV GEOPHYS, V15, P491, DOI 10.1029/RG015i004p00491; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Behrisch R., 2007, SPUTTERING PARTICLE, P110; Borin P, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/201014312; BROADFOO.AL, 1974, SCIENCE, V185, P166, DOI 10.1126/science.185.4146.166; Broadfoot A. L., 1977, Space Science Instrumentation, V3; BUCHNER J, 1989, J GEOPHYS RES, V94, P11821, DOI 10.1029/JA094iA09p11821; Burger MH, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004158; Christon S. P, 1987, MAGNETOTAIL PHYS, P393; CINTALA MJ, 1992, J GEOPHYS RES-PLANET, V97, P947; Cowley S. W. H., 1984, AGU MONOGRAPH MAGNET, V30, P228; Cowley S. W. H., 1982, J GEOPHYS RES, V20, P531; Delcourt D. C., 2002, Geophysical Research Letters, V29, DOI 10.1029/2001GL013829; Delcourt DC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL054085; Delcourt DC, 1996, J GEOPHYS RES, V101, P17409, DOI 10.1029/96JA01006; DiBraccio G. A., 2015, GEOPHYS RES IN PRESS; ERAKER JH, 1986, J GEOPHYS RES, V91, P9973, DOI 10.1029/JA091iA09p09973; FAIRFIEL.DH, 1971, J GEOPHYS RES, V76, P6700, DOI 10.1029/JA076i028p06700; Fjelbo G., 1976, ICARUS, V29, P407, DOI 10.1016/0019-1035(76)90063-4; Gershman D. J., 2015, J GEOPHYS R IN PRESS; HAPKE B, 1981, J GEOPHYS RES, V86, P3039, DOI 10.1029/JB086iB04p03039; Hesse M., 1998, NEW PERSPECTIVES EAR, DOI [10.1029/GM105p0139, DOI 10.1029/GM105P0139]; Hidalgo MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013875; Hunten D. M., 1988, MERCURY, P562; Leblanc F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038089; MCPHERRO.RL, 1973, J GEOPHYS RES, V78, P3131, DOI 10.1029/JA078i016p03131; MOLDWIN MB, 1992, J GEOPHYS RES, V97, P19259, DOI 10.1029/92JA01598; Muller Joachim, 2012, Icarus, V218, DOI 10.1016/j.icarus.2011.12.028; Paral J., 2009, ADV GEOSCI, V15, P1; Paral J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2676; Runov A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016316; Russell C. T., 1988, MERCURY, P514; RUSSELL CT, 1985, J GEOPHYS RES-SPACE, V90, P1067, DOI 10.1029/JA090iA11p11067; SCHINDLE.K, 1974, J GEOPHYS RES, V79, P2803, DOI 10.1029/JA079i019p02803; SLAVIN JA, 1993, J GEOPHYS RES, V98, P15425, DOI 10.1029/93JA01467; Slavin JA, 2007, SPACE SCI REV, V131, P133, DOI 10.1007/s11214-007-9154-x; Solomon C. S., 2007, SPACE SCI REV, V131, P3; Strangeway R. J., 2010, AGU FALL M, P1893; Travnicek P., 2010, ICARUS, V209, P11, DOI [10.1016/j.icarus.2010.01.008, DOI 10.1016/J.ICARUS.2010.01.008]; Travnicek P., 2007, GEOPHYS RES LETT, V34, P5104, DOI [10.1029/2006GL028518, DOI 10.1029/2006GL028518]; Vervack R. J., 2011, AGU FALL M ABSTR A2, VA2; Vilas F., 1988, MERCURY	220	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	OCT	2015	192	1-4					91	144		10.1007/s11214-015-0193-4		54	Astronomy & Astrophysics	Astronomy & Astrophysics	CU7MF	WOS:000363723000004		
J	Maeda, A; Eguchi, H; Nakahata, K; Lo, PC; Yamanaka, K; Kawamura, T; Matsuura, R; Sakai, R; Asada, M; Okuyama, H; Miyagawa, S				Maeda, Akira; Eguchi, Hiroshi; Nakahata, Kengo; Lo, Pei-Chi; Yamanaka, Kazuaki; Kawamura, Takuji; Matsuura, Rei; Sakai, Rieko; Asada, Mayumi; Okuyama, Hiroomi; Miyagawa, Shuji			Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity	TRANSPLANT IMMUNOLOGY			English	Article						Myeloid-derived suppressor cells (MDSCs); Xenotransplantation; Indoleamine 2,3-dioxygenase (IDO); Macrophage-mediated cytotoxicity	NATURAL-KILLER-CELL; SUPPRESSOR-CELLS; XENOGRAFT REJECTION; LOCAL EXPRESSION; RESPONSES; ALLOGRAFT; SURVIVAL; SUBSETS; MICE	Background: Xenotransplantation is considered to be one of the most attractive strategies for overcoming the worldwide shortage of organs. However, many obstructions need to be overcome before it will achieve clinical use in patients. One such obstacle is the development of an effective immunosuppressive strategy. We previously reported that myeloid-derived suppressor cells (MDSCs), a heterogeneous population of progenitor and immature myeloid cells, suppress xenogenic CTL-mediated cytotoxicity. Because of their heterogeneous nature, MDSC can function via several suppressive mechanisms that disrupt both innate and adaptive immunity. Since macrophages play a pivotal role in the rejection of a xenograft, in this study, we evaluated the suppressive effects of MDSC against macrophage-mediated xenogenic rejection. Materials and methods: To evaluate the effect of monocyte-derived MDSCs on xenogenic immune reactions, a CFSE(carboxyfluorescein diacetate, succinimidyl ester)assay was employed to assess cytotoxicity. Results: While, in the absence of activation, primed MDSCs had no detectable effect on macrophage-induced cytotoxicity against SEC cells, LPS-activated MDSCs were found to significantly suppress xenogenic cytotoxicity. A CFSE cytotoxicity assay revealed that MDSCs significantly suppressed macrophage-induced cytotoxicity. Furthermore, an indoleamine 2,3 dioxygenase (IDO) inhibitor, 1-methyl tryptophan (1-MT), abolished the MDSC-induced suppression of macrophage-mediated xeno-rejection, indicating that MDSCs may suppress macrophage-mediated cytotoxicity in an IDO-dependent manner. Conclusion: These findings indicate that MDSCs have great potential for immunosuppressing macrophagemediated xeno-rejection. (C) 2015 Elsevier B.V. All rights reserved.	[Maeda, Akira; Eguchi, Hiroshi; Nakahata, Kengo; Lo, Pei-Chi; Yamanaka, Kazuaki; Kawamura, Takuji; Matsuura, Rei; Sakai, Rieko; Asada, Mayumi; Okuyama, Hiroomi; Miyagawa, Shuji] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan	Maeda, A (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Div Organ Transplantat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ZUL06720@nifty.com			 [T264619440]	The authors wish to thank Dr. Milton. S. Feather for his editing of the manuscript. This work was supported by Grants-in Aid for Scientific Research (#T264619440), Japan.	Lin Y, 1997, J IMMUNOL, V158, P5658; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Chiarugi A, 2003, J LEUKOCYTE BIOL, V73, P172, DOI 10.1189/jlb.0502220; Fox A, 2001, J IMMUNOL, V166, P2133; FAST DJ, 1991, INFECT IMMUN, V59, P2987; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Wennberg L, 1997, XENOTRANSPLANTATION, V4, P228, DOI 10.1111/j.1399-3089.1997.tb00187.x; Jalili RB, 2010, DIABETES, V59, P2219, DOI 10.2337/db09-1560; Miki T, 2001, TRANSPLANT P, V33, P129, DOI 10.1016/S0041-1345(00)02792-5; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Youn JI, 2008, J IMMUNOL, V181, P5791; Li YY, 2006, J INVEST DERMATOL, V126, P128, DOI 10.1038/sj.jid.5700022; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Dorling A, 1996, EUR J IMMUNOL, V26, P1378, DOI 10.1002/eji.1830260630; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Vollbrecht T, 2012, AIDS, V26, pF31, DOI 10.1097/QAD.0b013e328354b43f; Fox A, 1998, TRANSPLANTATION, V66, P1407, DOI 10.1097/00007890-199812150-00002; Maeda A, 2014, XENOTRANSPLANTATION, V21, P46, DOI 10.1111/xen.12067; Yi SN, 2003, J IMMUNOL, V170, P2750; Sekkai D, 1997, ARCH BIOCHEM BIOPHYS, V340, P117, DOI 10.1006/abbi.1997.9913; Cadili A, 2008, TRANSPL P, V40, P3289, DOI 10.1016/j.transproceed.2008.08.125; Maeda A, 2014, TRANSPL P, V46, P1254, DOI 10.1016/j.transproceed.2013.11.025; Melillo G., 1994, J BIOL CHEM, V269, P190; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Morris SM, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3135pe27; Morris SM, 2007, J NUTR, V137, p1602S; Poormasjedi-Meibod MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071044; Puga Yung Gisella, 2009, Curr Opin Organ Transplant, V14, P154, DOI 10.1097/MOT.0b013e328329250d; Schuurman HJ, 2003, XENOTRANSPLANTATION, V10, P293, DOI 10.1034/j.1399-3089.2003.02092.x; Youn J. I., 2013, NAT IMMUNOL, V3, P211	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0966-3274	2210-3384		TRANSPL IMMUNOL	Transpl. Immunol.	OCT	2015	33	2					140	145		10.1016/j.trim.2015.07.002		6	Immunology; Transplantation	Immunology; Transplantation	CU8TY	WOS:000363818200013		
J	Tanaka, S; Hayashi, T; Sugaya, S; Osabe, M; Ueno, Y; Tani, Y; Hirayama, F				Tanaka, S.; Hayashi, T.; Sugaya, S.; Osabe, M.; Ueno, Y.; Tani, Y.; Hirayama, F.			A hollow-fibre column system to effectively prepare washed platelets	VOX SANGUINIS			English	Article						hollow fibre; platelet; transfusion reactions; washed platelets	ANAPHYLACTIC TRANSFUSION REACTIONS; SOLUTION M-SOL; HLA CLASS-I; ALLERGIC REACTIONS; WASHING PLATELETS; ADVERSE-REACTIONS; BACTERIAL-GROWTH; PLASMA; FEBRILE; STORAGE	Background and Objectives We developed a hollow-fibre column system specifically adapted to prepare washed platelet concentrates (WPCs). This study was performed to evaluate the efficacy of the hollow-fibre column system for preparing WPCs. Materials and Methods First, the percentages of platelet (PLT) recovery and remaining plasma proteins were calculated by determining the PLT count, volume and plasma protein levels in both the prewash and postwash. Secondly, washed PLTs and unwashed control PLTs were stored for 5 days, and the changes during this 5-day storage of in vitro PLT characteristics were determined. Results The hollow-fibre column system effectively removed >98% of plasma in platelet concentrates (PCs), and the PLT recovery was 97% on an average. The CD62P-expression level on washed PLTs immediately after washing was approximately twofold higher than that on prewashed PLTs as well as on PLTs washed via manual methods or cell washing devices. Until day 5 during storage, PLT aggregability, hypotonic shock response and swirling scores of washed PLTs were not significantly different from those of the control PCs. Conclusion Our novel hollow-fibre column system proved valuable in preparing washed PLTs with <2% of residual plasma proteins and high recovery of PLTs.	[Tanaka, S.; Hayashi, T.; Tani, Y.; Hirayama, F.] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Osaka 5670085, Japan; [Sugaya, S.; Osabe, M.; Ueno, Y.] Toray Industries Ltd, Otsu, Shiga, Japan	Tanaka, S (reprint author), Japanese Red Cross Kinki Block Blood Ctr, Dept Preparat Dev, 7-5-17 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	tanakas1113@leto.eonet.ne.jp					HEDDLE NM, 1993, TRANSFUSION, V33, P794, DOI 10.1046/j.1537-2995.1993.331094054613.x; Tobian AAR, 2011, TRANSFUSION, V51, P1676, DOI 10.1111/j.1537-2995.2010.03008.x; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Hirayama J, 2007, TRANSFUSION, V47, P960, DOI 10.1111/j.1537-2995.2007.01229.x; Oikawa S, 2012, VOX SANG, V102, P110, DOI 10.1111/j.1423-0410.2011.01520.x; Hirayama J, 2011, TRANSFUSION, V51, P1592, DOI 10.1111/j.1537-2995.2011.03102.x; Kluter H, 1999, TRANSFUSION, V39, P1179, DOI 10.1046/j.1537-2995.1999.39111179.x; Ghio M, 1999, BLOOD, V93, P1770; Holme S, 1998, TRANSFUSION, V38, P31, DOI 10.1046/j.1537-2995.1998.38198141495.x; Dumont LJ, 2011, TRANSFUSION, V51, P1079, DOI 10.1111/j.1537-2995.2010.02941.x; Mathai J, 2009, TRANSFUS APHER SCI, V41, P139, DOI 10.1016/j.transci.2009.07.012; Jacobs JFM, 2011, NEW ENGL J MED, V364, P1981, DOI 10.1056/NEJMc1101692; Blumberg N, 2006, TRANSFUSION, V46, P1813, DOI 10.1111/j.1537-2995.2006.00979.x; Paglino JC, 2004, TRANSFUSION, V44, P16, DOI 10.1046/j.0041-1132.2004.00608.x; Veeraputhiran M, 2011, TRANSFUSION, V51, P1030, DOI 10.1111/j.1537-2995.2010.02897.x; CHAMBERS LA, 1990, TRANSFUSION, V30, P219, DOI 10.1046/j.1537-2995.1990.30390194340.x; Kelley WE, 2009, TRANSFUSION, V49, P1917, DOI 10.1111/j.1537-2995.2009.02209.x; Azuma H, 2009, TRANSFUSION, V49, P214, DOI 10.1111/j.1537-2995.2008.01918.x; Schoenfeld H, 2004, ANESTH ANALG, V99, P17, DOI 10.1213/01.ANE.0000116930.28250.15; BUCK SA, 1987, TRANSFUSION, V27, P391, DOI 10.1046/j.1537-2995.1987.27587320530.x; Ringwald J, 2006, TRANSFUSION, V46, P236, DOI 10.1111/j.1537-2995.2006.00716.x; Shimada E, 2002, TRANSFUSION, V42, P766, DOI 10.1046/j.1537-2995.2002.00117.x; Imoto S, 2010, TRANSFUSION MED, V20, P95, DOI 10.1111/j.1365-3148.2009.00972.x; HEDDLE NM, 1994, NEW ENGL J MED, V331, P625, DOI 10.1056/NEJM199409083311001; SANDLER SG, 1995, TRANSFUS MED REV, V9, P1, DOI 10.1016/S0887-7963(05)80026-4	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	OCT	2015	109	3					239	247		10.1111/vox.12284		9	Hematology	Hematology	CV0GC	WOS:000363926900005		
J	Omoto, K; Tashiro, S; Shionoya, M				Omoto, Kenichiro; Tashiro, Shohei; Shionoya, Mitsuhiko			Host-Guest Interactions by Metal-to-Metal Dative Bonding: Recognition of Ruthenocene by a Metallo-Host	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Metallo-host; Metal-metal bonding; Dative bonding; Ruthenium; Metallocenes	LEWIS-ACIDS; REACTION-PRODUCTS; 1-1 COMPLEXES; MOLECULES; OXIDATION; CHEMISTRY; PALLADIUM(II); FERROCENE; LIGANDS; HGCL2	Host-guest complexation driven by metal-to-metal dative bonding was studied using a mono-nuclear Ag-I complex of 2,9-bis(9-anthracenyl)-1,10-phenanthroline as a simple metallo-host. This host molecule can capture a ruthenocene with a Ru-Ag dative bond in solution as revealed by NMR spectroscopy and ESI-TOF MS spectrometry. Single-crystal XRD analysis of the host-guest complex revealed a Ru-Ag type dative bond with a significant change in the coordination arrangement of the central Ru atom of ruthenocene. The binding constant for the host-guest complexation was estimated to be over 10(4) M-1 in CD2Cl2 at 300 K.	[Omoto, Kenichiro; Tashiro, Shohei; Shionoya, Mitsuhiko] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Shionoya, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	shionoya@chem.s.u-tokyo.ac.jp			JSPS KAKENHI [26248016]	This study was supported by JSPS KAKENHI Grant Number 26248016 for M.S. K.O. thanks Advanced Leading Graduate Course for Photon Science (ALPS).	AKABORI S, 1987, CHEM LETT, P1783, DOI 10.1246/cl.1987.1783; DROEGE MW, 1987, INORG CHEM, V26, P1309, DOI 10.1021/ic00255a023; Gramigna KM, 2013, ORGANOMETALLICS, V32, P5966, DOI 10.1021/om400494t; Amendola V, 2001, COORDIN CHEM REV, V219, P821, DOI 10.1016/S0010-8545(01)00368-X; Bianchini C, 2004, J MOL CATAL A-CHEM, V224, P35, DOI 10.1016/j.molcata.2004.06.029; Russell AD, 2012, CHEM-EUR J, V18, P8000, DOI 10.1002/chem.201201129; Xia W, 2013, CHEM COMMUN, V49, P5085, DOI 10.1039/c3cc41903g; Campbell MG, 2011, NAT CHEM, V3, P949, DOI [10.1038/nchem.1197, 10.1038/NCHEM.1197]; Amouri H, 2012, CHEM REV, V112, P2015, DOI 10.1021/cr200345v; Omoto K, 2014, J AM CHEM SOC, V136, P17946, DOI 10.1021/ja5106249; Green JC, 1998, CHEM SOC REV, V27, P263; Yamaguchi T, 2001, J AM CHEM SOC, V123, P743, DOI 10.1021/ja002906a; Mayoral MJ, 2013, J AM CHEM SOC, V135, P2148, DOI 10.1021/ja312628g; Metallinos C, 2006, J ORGANOMET CHEM, V691, P2044, DOI 10.1016/j.jorganchem.2006.01.012; Koshevoy IO, 2010, ANGEW CHEM INT EDIT, V49, P8864, DOI 10.1002/anie.201004386; Goshe AJ, 2003, J AM CHEM SOC, V125, P444, DOI 10.1021/ja028910z; Bauer J, 2012, CHEM REV, V112, P4329, DOI 10.1021/cr3000048; Yamaguchi T, 2004, CHEM LETT, V33, P190, DOI 10.1246/cl.2004.190; Sculfort S, 2011, CHEM SOC REV, V40, P2741, DOI 10.1039/c0cs00102c; Pyykko P, 1997, CHEM REV, V97, P597, DOI 10.1021/cr940396v; Siebler D, 2011, DALTON T, V40, P3558, DOI 10.1039/c0dt01528h; Lin SB, 2013, J AM CHEM SOC, V135, P15830, DOI 10.1021/ja406696k; WATANABE M, 1990, B CHEM SOC JPN, V63, P1455, DOI 10.1246/bcsj.63.1455; Swarts JC, 2009, INORG CHEM, V48, P2156, DOI 10.1021/ic802105b; HARDGROVE GL, 1959, ACTA CRYSTALLOGR, V12, P28, DOI 10.1107/S0365110X59000081; Mizuta T, 2008, ORGANOMETALLICS, V27, P2457, DOI 10.1021/om800057w; Kersting B, 2009, ADV INORG CHEM, V61, P407, DOI 10.1016/S0898-8838(09)00207-4; Wasio NA, 2014, NATURE, V507, P86, DOI 10.1038/nature12993; Schmidbaur H, 2015, ANGEW CHEM INT EDIT, V54, P746, DOI 10.1002/anie.201405936; Durola F, 2014, ACCOUNTS CHEM RES, V47, P633, DOI 10.1021/ar4002153; SATO SD, 1989, B CHEM SOC JPN, V62, P3963, DOI 10.1246/bcsj.62.3963; Fukino T, 2014, SCIENCE, V344, P499, DOI 10.1126/science.1252120; Green AG, 2013, INORG CHEM, V52, P5603, DOI 10.1021/ic400773s; Katz MJ, 2008, CHEM SOC REV, V37, P1884, DOI 10.1039/b709061g; Watanabe M, 1998, B CHEM SOC JPN, V71, P1071, DOI 10.1246/bcsj.71.1071; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; MANN KR, 1974, INORG CHEM, V13, P1180, DOI 10.1021/ic50135a033; McConnell AJ, 2015, CHEM REV, V115, P7729, DOI 10.1021/cr500632f; Gramage-Doria R, 2013, COORDIN CHEM REV, V257, P776, DOI 10.1016/j.ccr.2012.10.006; MORRISON WH, 1972, INORG CHEM, V11, P2912, DOI 10.1021/ic50118a011; SATO S, 1989, B CHEM SOC JPN, V62, P532, DOI 10.1246/bcsj.62.532; Enders M, 2002, ORGANOMETALLICS, V21, P1111, DOI 10.1021/om010937o; Diez A, 2011, COORDIN CHEM REV, V255, P2426, DOI 10.1016/j.foodhyd.2010.12.024; Krogman JP, 2014, CHEM COMMUN, V50, P5115, DOI 10.1039/c3cc47537a; WATANABE M, 1988, B CHEM SOC JPN, V61, P827, DOI 10.1246/bcsj.61.827; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Grocka I, 2013, ANGEW CHEM INT EDIT, V52, P1044, DOI 10.1002/anie.201208289; HENDRICK.DN, 1972, INORG CHEM, V11, P808, DOI 10.1021/ic50110a030; Ito T., 2003, METAL ASSEMBLED COMP, P3; Kaifer A. E., 1999, SUPRAMOLECULAR ELECT; KROGMANN K, 1969, ANGEW CHEM INT EDIT, V8, P35, DOI 10.1002/anie.196900351; Murahashi T, 2012, NAT CHEM, V4, P52, DOI 10.1038/nchem.1202; Osuga T, 2014, ANGEW CHEM INT EDIT, V53, P11186, DOI 10.1002/anie.201404892; ROSENBLUM M, 1963, J AM CHEM SOC, V85, P1450, DOI 10.1021/ja00893a015	54	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2056	2059		10.1002/zaac.201500630		4	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000004		
J	Toda, T; Kuwata, S; Ikariya, T				Toda, Tatsuro; Kuwata, Shigeki; Ikariya, Takao			Synthesis and Structures of Ruthenium and Iron Complexes Bearing an Unsymmetrical Pincer-type Ligand with Protic Pyrazole and Tertiary Aminoalkyl Arms	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Iron; Ruthenium; N ligands; Tridentate ligands; Hydrogen bonds	N-HETEROCYCLIC CARBENE; CATALYTIC APPLICATIONS; BOND ACTIVATION; DONOR LIGANDS; REACTIVITIES	A protic pyrazole-armed NNN-type pincer ligand 2-(5-tertbutylpyrazol-3-yl)-6-(diethylaminomethyl) pyridine (LH) with a tertiary aminomethyl tether was synthesized as a new template for metalligand bifunctional catalysts furnished with proton-responsive pyrazole and hemilabile amine as the cooperating units. Treatment of LH with trans-[ RuCl2(Me2SO) 4] and anhydrous FeCl2 led to the formation of the pincer-type ruthenium complex [ RuCl2(Me2SO-S)(LH)] (2) and iron complex [ FeCl2(LH)] (3), respectively. Detailed structures of 2 (CH2Cl2)-C-. and 3 were determined by X-ray crystallography. The Bronsted acidic pyrazole NH group proved to be engaged in intra-or intermolecular hydrogen bonding. Catalytic hydrogenation of acetophenone with the protic pincer-type complexes 2 and 3 was also investigated.	[Toda, Tatsuro; Kuwata, Shigeki; Ikariya, Takao] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, Tokyo 1528552, Japan; [Kuwata, Shigeki] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kuwata, S (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Appl Chem, 2-12-1 O Okayama, Tokyo 1528552, Japan.	skuwata@apc.titech.ac.jp; tikariya@apc.titech.ac.jp	Kuwata, Shigeki/C-4920-2011	Kuwata, Shigeki/0000-0002-3165-9882	Ministry of Education, Culture, Sports, Science and Technology, Japan [22225004]; PRESTO program on "Molecular Technology and Creation of New Functions" from JST	We thank Grant-in-Aid for Scientific Research (S; no. 22225004) from Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was partially supported by the PRESTO program on "Molecular Technology and Creation of New Functions" from JST (to SK). TT acknowledges a Japan Society for the Promotion of Science Research Fellowship for Young Scientists.	ADDISON AW, 1984, J CHEM SOC DALTON, P1349, DOI 10.1039/dt9840001349; Gunanathan C, 2011, ACCOUNTS CHEM RES, V44, P588, DOI 10.1021/ar2000265; Bauer I, 2015, CHEM REV, V115, P3170, DOI 10.1021/cr500425u; O'Reilly RK, 2004, POLYHEDRON, V23, P2921, DOI 10.1016/j.poly.2004.09.001; Umehara K, 2014, INORG CHIM ACTA, V413, P136, DOI 10.1016/j.ica.2013.12.041; Yoshinari A, 2012, CHEM-ASIAN J, V7, P1417, DOI 10.1002/asia.201200014; Bratsos I, 2010, INORG SYN, V35, P148; Zhang J, 2006, INORG CHIM ACTA, V359, P1955, DOI 10.1016/j.ica.2005.11.039; Toda T, 2014, CHEM-EUR J, V20, P9539, DOI 10.1002/chem.201403179; Li HF, 2015, COORDIN CHEM REV, V293, P116, DOI 10.1016/j.ccr.2014.11.010; Umehara K, 2013, J AM CHEM SOC, V135, P6754, DOI 10.1021/ja3122944; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Ikariya T, 2011, B CHEM SOC JPN, V84, P1, DOI 10.1246/bcsj.20100249; Younus HA, 2015, ADV SYNTH CATAL, V357, P283, DOI 10.1002/adsc.201400777; Kuwata S, 2011, CHEM-EUR J, V17, P3542, DOI 10.1002/chem.201003296; Zhang J, 2005, J AM CHEM SOC, V127, P10840, DOI 10.1021/ja052862b; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0, P2000; Bain GA, 2008, J CHEM EDUC, V85, P532; O'Reilly ME, 2014, CHEM SOC REV, V43, P6325, DOI 10.1039/c4cs00111g; Deng QH, 2014, ACCOUNTS CHEM RES, V47, P3162, DOI 10.1021/ar5002457; Gunanathan C, 2014, CHEM REV, V114, P12024, DOI 10.1021/cr5002782; Bhattacharya P, 2011, COMMENT INORG CHEM, V32, P88, DOI 10.1080/02603594.2011.618855; Britovsek GJP, 2005, DALTON T, P945, DOI 10.1039/b414813d; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Jozak T, 2010, EUR J INORG CHEM, P5135, DOI 10.1002/ejic.201000802; Kuwata S, 2014, CHEM COMMUN, V50, P14290, DOI 10.1039/c4cc04457f; Morris RH, 2015, ACCOUNTS CHEM RES, V48, P1494, DOI 10.1021/acs.accounts.5b00045; Olguin J, 2011, COORDIN CHEM REV, V255, P203, DOI 10.1016/j.ccr.2010.08.002; Quintard A., 2014, ANGEW CHEM, V126, P4124; Quintard A, 2014, ANGEW CHEM INT EDIT, V53, P4044, DOI 10.1002/anie.201310788; Storr T, 2005, EUR J INORG CHEM, P2685, DOI 10.1002/ejic.200500018; Szabo KJ, 2014, PINCER AND PINCER-TYPE COMPLEXES: APPLICATIONS IN ORGANIC SYNTHESIS AND CATALYSIS, P1, DOI 10.1002/9783527681303; van Koten G, 2013, TOP ORGANOMETAL CHEM, V40, P1, DOI 10.1007/978-3-642-31081-2_1	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2135	2139		10.1002/zaac.201500558		5	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000015		
J	Arduengo, AJ; Calabrese, JC; Marshall, WJ; Runyon, JW; Schiel, C; Schinnen, C; Tamm, M; Uchiyama, Y				Arduengo, Anthony J., III; Calabrese, Joseph C.; Marshall, William J.; Runyon, Jason W.; Schiel, Christian; Schinnen, Christoph; Tamm, Matthias; Uchiyama, Yosuke			Imidazol-2-ylidene Reactivity towards Cyanocarbons	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Carbenes; Cyanogens; Tetrazole; Tetracyanoethylene; Cyanocarbon	N-HETEROCYCLIC CARBENES; PHOTOELECTRON-SPECTROSCOPY; TETRACYANOETHYLENE; ADDUCT; ANION; CONDENSATION; CHEMISTRY	The interaction of electron rich imidazol-2-ylidenes with electron poor cyanocarbons is reported. Contrary to previous reports of electron transfer products from imidazol-2-ylidenes and tetracyanoethylene, a number of ring forming cyanocarbon ring structures are isolated and characterized. Cyanation of the imidazole ring was explored by the addition of cyanogen chloride to imidazol-2-ylidenes. Backbone cyanation often occurs when hydrogen atoms are in the C-4/5 positions. When tetrasubstituted imidazol-2-ylidenes are employed, 2-cyanoimidazolium halide salts can be isolated. These salts maintain an electrophilic cyano group and are precursors to thermally stable high nitrogen content imidazolium tetrazolides.	[Arduengo, Anthony J., III; Runyon, Jason W.; Schiel, Christian; Schinnen, Christoph] Univ Alabama, Dept Chem, Tuscaloosa, AL 35401 USA; [Calabrese, Joseph C.; Marshall, William J.; Tamm, Matthias] DuPont Cent Res & Dev, Wilmington, DE 19880 USA; [Uchiyama, Yosuke] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Arduengo, AJ (reprint author), Univ Alabama, Dept Chem, 250 Hackberry Lane, Tuscaloosa, AL 35401 USA.	aj@ajarduengo.net			Kitasato University Research Grant for Young Researchers; E. I. du Pont de Nemours and Co.; University of Alabama	We gratefully acknowledge support for this research from the Kitasato University Research Grant for Young Researchers, E. I. du Pont de Nemours and Co., and The University of Alabama. The generous donation of reagents from Innovative Valency LLC enabled some of the studies herein. A.J.A. acknowledges the Saxon Endowment of The University of Alabama and would like to thank David Dixon for helpful discussions. Y.U. and J.W.R. thank Kenneth Belmore for his assistance with NMR spectroscopy.	WEBSTER OW, 1966, J AM CHEM SOC, V88, P3046, DOI 10.1021/ja00965a028; Mallah E, 2011, Z NATURFORSCH B, V66, P545; Eberspacher M, 2009, HELV CHIM ACTA, V92, P977; Fu DW, 2009, Z ANORG ALLG CHEM, V635, P2631, DOI 10.1002/zaac.200900251; Uchiyama Y, 2014, AUST J CHEM, V67, P405, DOI 10.1071/CH13460; Klapotke TM, 2011, INORG CHEM, V50, P2732, DOI 10.1021/ic200071q; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P9704, DOI 10.1021/ja00025a063; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; Kronig S, 2011, INORG CHEM, V50, P7344, DOI 10.1021/ic201290g; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P3625, DOI 10.1021/ja00087a069; Khuseynov D, 2012, CHEM PHYS LETT, V550, P15, DOI 10.1016/j.cplett.2012.08.035; WEBSTER OW, 1962, J AM CHEM SOC, V84, P3678, DOI 10.1021/ja00878a017; Kuhn N, 2002, Z ANORG ALLG CHEM, V628, P1721, DOI 10.1002/1521-3749(200208)628:8<1721::AID-ZAAC1721>3.0.CO;2-9; Baier H, 2013, Z ANORG ALLG CHEM, V639, P1731, DOI 10.1002/zaac.201300250; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P6641, DOI 10.1021/ja00094a020; ARDUENGO AJ, 1992, J AM CHEM SOC, V114, P5530, DOI 10.1021/ja00040a007; BRADFORTH SE, 1993, J CHEM PHYS, V98, P800, DOI 10.1063/1.464244; Arduengo AJ, 1997, J AM CHEM SOC, V119, P12742, DOI 10.1021/ja973241o; Kuhn N, 2004, Z ANORG ALLG CHEM, V630, P495, DOI 10.1002/zaac.200300401; FARES V, 1995, J AM CHEM SOC, V117, P11580, DOI 10.1021/ja00151a024; Arduengo A. J., 2015, PHOSPHORUS IN PRESS; Fischer D, 2015, NEW J CHEM, V39, P1619, DOI 10.1039/c4nj01351d; ARDUENGO AJ, 1995, J AM CHEM SOC, V117, P572, DOI 10.1021/ja00106a082; Grasa GA, 2004, CHEM COMMUN, P2890, DOI 10.1039/b410986d; Ikhile MI, 2010, ACTA CRYSTALLOGR E, V66, pM1493, DOI 10.1107/S1600536810043989; Ito M., 1974, Jpn. Tokkyo Koho., Patent No. [JP 49020182 B 19740523, 49020182, JP49020182 B 19740523]; Joo YH, 2009, EUR J ORG CHEM, P3573, DOI 10.1002/ejoc.200900389; Ramnial T, 2004, CHEM COMMUN, P1054, DOI 10.1039/b314110a; Richter H, 2009, SYNLETT, P193, DOI 10.1055/s-0028-1087676	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2190	2198		10.1002/zaac.201500578		9	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000022		
J	Maeta, N; Yamamoto, J; Fuku-En, SI; Shang, R; Yamamoto, Y				Maeta, Naoto; Yamamoto, Junki; Fuku-en, Shin-ichi; Shang, Rong; Yamamoto, Yohsuke			Synthesis of New Dipyrido-Annulated N-Heterocyclic Carbenes with Aryl Substituents	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Singlet carbene; N-Heterocyclic carbene; Annulated carbene; Gold	OXO GOLD CARBENES; NHC-LIGANDS; CATALYSIS; COMPLEXES; CHEMISTRY; REACTIVITY; CARBON; ACIDS	4,8- Aryl- substituted 2,10- di- tert- butyldipyrido[ 1,2- c; 2 -,1 - e]- imidazolium salts were synthesized from a newly prepared dibromoprecursor by use of Suzuki- Miyaura coupling. The corresponding carbenes were generated from the imidazolium salts by deprotonation. The trifluoromethyl- substituted derivative ( 10a) was trapped by AuCl( SMe2) to give an N- heterocyclic carbene- coordinated gold( I) complex ( 12a), in which the central AuI atom is well protected by the arylsubstituents of the NHC ligand.	[Maeta, Naoto; Yamamoto, Junki; Fuku-en, Shin-ichi; Shang, Rong; Yamamoto, Yohsuke] Hiroshima Univ, Grad Sch Sci, Dept Chem, Higashihiroshima 7398526, Japan	Yamamoto, Y (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Chem, 1-3-1 Kagamiyama, Higashihiroshima 7398526, Japan.	yyama@sci.hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [24109002, 26288017]	This work was supported by a Grant-in-Aid for Science Research on Innovative Areas (No. 24109002, Stimuli-responsive Chemical Species) and for Science Research B (No. 26288017) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Fuku-en, S.-i. acknowledges a JSPS Fellowship for Young Scientists. We thank Dr. Kajiya, Ms. Amimoto, and Ms. Kawata of Natural Science Center for Basic Research and Development (N-BARD), Hiroshima University for high-resolution mass spectrometry measurements and single-crystal X-ray structural analysis.	Freakley SJ, 2015, CATAL LETT, V145, P71, DOI 10.1007/s10562-014-1432-0; Riener K, 2014, CHEM REV, V114, P5215, DOI 10.1021/cr4006439; Gatineau D, 2013, ISR J CHEM, V53, P892, DOI 10.1002/ijch.201300059; Kunz D, 2010, Z NATURFORSCH B, V65, P861; Sugawara S, 2012, CHEM COMMUN, V48, P9735, DOI 10.1039/c2cc33510g; Zhang Y, 2014, NAT PROD REP, V31, P489, DOI 10.1039/c3np70075e; Jahnke MC, 2015, COORDIN CHEM REV, V293, P95, DOI 10.1016/j.ccr.2015.01.014; Frenking G, 2014, CHEM SOC REV, V43, P5106, DOI 10.1039/c4cs00073k; Gorin DJ, 2008, CHEM REV, V108, P3351, DOI 10.1021/cr068430g; Noisier AFM, 2014, CHEM REV, V114, P8775, DOI [10.1021/cr500200x, 10.1021/cr500200X]; Furstner A, 2007, ANGEW CHEM INT EDIT, V46, P3410, DOI 10.1002/anie.200604335; Fliedel C, 2014, COORDIN CHEM REV, V275, P63, DOI 10.1016/j.ccr.2014.04.003; Murphy LJ, 2015, CHEM COMMUN, V51, P3942, DOI 10.1039/c4cc08510h; Brooner REM, 2013, ANGEW CHEM INT EDIT, V52, P11714, DOI 10.1002/anie.201303468; Obradors C, 2014, CHEM COMMUN, V50, P16, DOI 10.1039/c3cc45518a; Wang YZ, 2014, INORG CHEM, V53, P11815, DOI 10.1021/ic502231m; Goodwin JA, 2015, CHEM COMMUN, V51, P8730, DOI 10.1039/c5cc00120j; Fuku-en S, 2013, INORG CHEM, V52, P11700, DOI 10.1021/ic402301u; Levin E, 2015, CHEM REV, V115, P4607, DOI 10.1021/cr400640e; Nonnenmacher M, 2005, J ORGANOMET CHEM, V690, P5647, DOI 10.1016/j.jorganchem.2005.07.033; Fuku-en S, 2014, CHEM LETT, V43, P468, DOI 10.1246/cl.131074; Arcadi A, 2008, CHEM REV, V108, P3266, DOI 10.1021/cr068435d; Bellemin-Laponnaz S, 2014, CHEM REV, V114, P8747, DOI 10.1021/cr500227y; Braunschweig H, 2014, ORGANOMETALLICS, V33, P6271, DOI 10.1021/om500875g; CALDER IC, 1963, TETRAHEDRON LETT, P95; Fuerstner A., 2014, ACCOUNTS CHEM RES, V47, P925; Gierz V, 2012, EUR J INORG CHEM, P1423, DOI 10.1002/ejic.201100905; Hashmi ASK, 2014, ACCOUNTS CHEM RES, V47, P864, DOI 10.1021/ar500015k; Izquierdo F, 2014, CHEM COMMUN, V50, P14926, DOI 10.1039/c4cc05289g; Jahnke MC, 2015, CHEM LETT, V44, P226, DOI 10.1246/cl.141052; Kuwata S, 2014, CHEM COMMUN, V50, P14290, DOI 10.1039/c4cc04457f; Li ZG, 2008, CHEM REV, V108, P3239, DOI 10.1021/cr068434l; Nonnenmacher M, 2006, CHEM COMMUN, P1378, DOI 10.1039/b517816a; Nonnenmacher M., 2008, ORGANOMETALLICS, V27, P1561, DOI 10.1021/om701196c; Soleilhavoup M, 2015, ACCOUNTS CHEM RES, V48, P256, DOI 10.1021/ar5003494; Wang YM, 2014, ACCOUNTS CHEM RES, V47, P889, DOI 10.1021/ar400188g; Weiss R, 2000, EUR J INORG CHEM, P1935; Weiss R, 1998, ANGEW CHEM INT EDIT, V37, P344, DOI 10.1002/(SICI)1521-3773(19980216)37:3<344::AID-ANIE344>3.0.CO;2-H; Yeom HS, 2014, ACCOUNTS CHEM RES, V47, P966, DOI 10.1021/ar4001839; Zhang DH, 2014, ACCOUNTS CHEM RES, V47, P913, DOI 10.1021/ar400159r; Zhang LM, 2014, ACCOUNTS CHEM RES, V47, P877, DOI 10.1021/ar400181x	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	OCT	2015	641	12-13			SI		2199	2203		10.1002/zaac.201500565		5	Chemistry, Inorganic & Nuclear	Chemistry	CT3EC	WOS:000362689000023		
J	Didas, SA; Choi, S; Chaikittisilp, W; Jones, CW				Didas, Stephanie A.; Choi, Sunho; Chaikittisilp, Watcharop; Jones, Christopher W.			Amine-Oxide Hybrid Materials for CO2 Capture from Ambient Air	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							CARBON-DIOXIDE CAPTURE; ETHYLENE POLYMERIZATION CATALYSTS; METAL-ORGANIC FRAMEWORK; SIMULATED FLUE-GAS; MESOPOROUS SILICA; HYPERBRANCHED AMINOSILICAS; ADSORPTION PROPERTIES; STRUCTURAL-CHANGES; SITE ISOLATION; SINGLE-SITE	CONSPECTUS: Oxide supports functionalized with amine moieties have been used for decades as catalysts and chromatographic media. Owing to the recognized impact of atmospheric CO2 on global climate change, the study of the use of amine-oxide hybrid materials as CO2 sorbents has exploded in the past decade. While the majority of the work has concerned separation of CO2 from dilute mixtures such as flue gas from coal-fired power plants, it has been recognized by us and others that such supported amine materials are also perhaps uniquely suited to extract CO2 from ultradilute gas mixtures, such as ambient air. As unique, low temperature chemisorbents, they can operate under ambient conditions, spontaneously extracting CO2 from ambient air, while being regenerated under mild conditions using heat or the combination of heat and vacuum. This Account describes the evolution of our activities on the design of amine-functionalized silica materials for catalysis to the design, characterization, and utilization of these materials in CO2 separations. New materials developed in our laboratory, such as hyperbranched aminosilica materials, and previously known amine-oxide hybrid compositions, have been extensively studied for CO2 extraction from simulated ambient air (400 ppm of CO2). The role of amine type and structure (molecular, polymeric), support type and structure, the stability of the various compositions under simulated operating conditions, and the nature of the adsorbed CO2 have been investigated in detail. The requirements for an effective, practical air capture process have been outlined and the ability of amine oxide hybrid materials to meet these needs has been discussed. Ultimately, the practicality of such a "direct air capture" process is predicated not only on the physicochemical properties of the sorbent, but also how the sorbent operates in a practical process that offers a scalable gas solid contacting strategy. In this regard, the utility of low pressure drop monolith contactors is suggested to offer a practical mode of amine sorbent/air contacting for direct air capture.	[Didas, Stephanie A.; Jones, Christopher W.] Georgia Inst Technol, Sch Chem & Biomol Eng, Atlanta, GA 30332 USA; [Choi, Sunho] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Chaikittisilp, Watcharop] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Jones, CW (reprint author), Georgia Inst Technol, Sch Chem & Biomol Eng, 311 Ferst Dr, Atlanta, GA 30332 USA.	cjones@chbe.gatech.edu			US Department of Energy [DE-FE0002438]; Camille and Henry Dreyfus Foundation	Our work in CO<INF>2</INF> capture from ambient air was catalyzed by an initial and ongoing collaboration with Dr. Peter Eisenberger and Global Thermostat, LLC. Additional funds in support of materials and/or process research in the area of direct air capture were provided by the US Department of Energy (DE-FE0002438) and the Camille and Henry Dreyfus Foundation. Ongoing collaborations with Dr. Bill Addiego, of Corning Inc., have significantly enriched our work on monolith contactors.	Nomura A, 2014, CHEM-EUR J, V20, P6381, DOI 10.1002/chem.201304954; Lee WR, 2014, ENERG ENVIRON SCI, V7, P744, DOI 10.1039/c3ee42328j; Hicks JC, 2006, CHEM MATER, V18, P5022, DOI 10.1021/cm061382w; TSUDA T, 1992, CHEM LETT, P2161, DOI 10.1246/cl.1992.2161; McKittrick MW, 2004, J AM CHEM SOC, V126, P3052, DOI 10.1021/ja031725g; Gebald C, 2013, ENVIRON SCI TECHNOL, V47, P10063, DOI 10.1021/es401731p; Hu YL, 2014, CHEMSUSCHEM, V7, P734, DOI 10.1002/cssc.201301163; Sakwa-Novak MA, 2014, ACS APPL MATER INTER, V6, P9245, DOI 10.1021/am501500q; Li W, 2010, ACS APPL MATER INTER, V2, P3363, DOI 10.1021/am100786z; Rosenholm JM, 2006, CHEM COMMUN, P3909, DOI 10.1039/b607886a; Lu WG, 2012, ANGEW CHEM INT EDIT, V51, P7480, DOI 10.1002/anie.201202176; Choi S, 2012, J PHYS CHEM LETT, V3, P1136, DOI 10.1021/jz300328j; Calleja G, 2011, TOP CATAL, V54, P135, DOI 10.1007/s11244-011-9652-7; Lu WG, 2013, J PHYS CHEM C, V117, P4057, DOI 10.1021/jp311512q; Didas SA, 2012, CHEMSUSCHEM, V5, P2058, DOI 10.1002/cssc.201200196; Drese JH, 2009, ADV FUNCT MATER, V19, P3821, DOI 10.1002/adfm.200901461; McDonald TM, 2012, J AM CHEM SOC, V134, P7056, DOI 10.1021/ja300034j; Bollini P, 2011, J MATER CHEM, V21, P15100, DOI 10.1039/c1jm12522b; Sanz R, 2013, J MATER CHEM A, V1, P1956, DOI 10.1039/c2ta01343f; Brunelli NA, 2012, J AM CHEM SOC, V134, P13950, DOI 10.1021/ja305601g; Choi S, 2011, ENVIRON SCI TECHNOL, V45, P2420, DOI 10.1021/es102797w; Phan NTS, 2006, ANGEW CHEM INT EDIT, V45, P2209, DOI 10.1002/anie.200503445; Heydari-Gorji A, 2011, MICROPOR MESOPOR MAT, V145, P146, DOI 10.1016/j.micromeso.2011.05.010; Bollini P, 2011, ENERG FUEL, V25, P2416, DOI 10.1021/ef200140z; Wurzbacher JA, 2011, ENERG ENVIRON SCI, V4, P3584, DOI 10.1039/c1ee01681d; Jones CW, 2011, ANNU REV CHEM BIOMOL, V2, P31, DOI 10.1146/annurev-chembioeng-061010-114252; Belmabkhout Y, 2010, CHEM ENG SCI, V65, P3695, DOI 10.1016/j.ces.2010.02.044; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Kim HJ, 2000, J COLLOID INTERF SCI, V227, P247, DOI 10.1006/jcis.2000.6861; Drese JH, 2012, MICROPOR MESOPOR MAT, V151, P231, DOI 10.1016/j.micromeso.2011.10.031; Chaikittisilp W, 2011, IND ENG CHEM RES, V50, P14203, DOI 10.1021/ie201584t; Gebald C, 2011, ENVIRON SCI TECHNOL, V45, P9101, DOI 10.1021/es202223p; Li W, 2010, CHEMSUSCHEM, V3, P899, DOI 10.1002/cssc.201000131; Alkhabbaz MA, 2014, J AM CHEM SOC, V136, P13170, DOI 10.1021/ja507655x; Lunn JD, 2009, CHEM MATER, V21, P3638, DOI 10.1021/cm901025n; Nomura A, 2013, ACS APPL MATER INTER, V5, P5569, DOI 10.1021/am400810s; Xu XC, 2002, ENERG FUEL, V16, P1463, DOI 10.1021/ef020058u; Hicks JC, 2006, LANGMUIR, V22, P2676, DOI 10.1021/la053024y; Brunelli NA, 2012, CHEM MATER, V24, P2433, DOI 10.1021/cm300753z; Serna-Guerrero R, 2010, CHEM ENG SCI, V65, P4166, DOI 10.1016/j.ces.2010.04.029; Long W, 2013, ACS CATAL, V3, P1700, DOI 10.1021/cs3007395; Choi S, 2011, CHEMSUSCHEM, V4, P628, DOI 10.1002/cssc.201000355; Yu KQ, 2004, ORGANOMETALLICS, V23, P4089, DOI 10.1021/om049765w; McKittrick MW, 2005, J MOL CATAL A-CHEM, V237, P26, DOI 10.1016/j.molcata.2005.04.037; Chaikittisilp W, 2011, ENERG FUEL, V25, P5528, DOI 10.1021/ef201224v; Kulkarni AR, 2012, IND ENG CHEM RES, V51, P8631, DOI 10.1021/ie300691c; Goeppert A, 2011, J AM CHEM SOC, V133, P20164, DOI 10.1021/ja2100005; Chaikittisilp W, 2013, CHEM MATER, V25, P613, DOI 10.1021/cm303931q; Heydari-Gorji A, 2012, IND ENG CHEM RES, V51, P6887, DOI 10.1021/ie3003446; McKittrick MW, 2003, CHEM MATER, V15, P1132, DOI 10.1021/cm020952z; TSUDA T, 1992, J CHEM SOC CHEM COMM, P1659, DOI 10.1039/c39920001659; Stuckert NR, 2011, ENVIRON SCI TECHNOL, V45, P10257, DOI 10.1021/es202647a; Hammache S, 2013, ENERG FUEL, V27, P6899, DOI 10.1021/ef401562w; Bali S, 2014, CHEMSUSCHEM, V7, P3145, DOI 10.1002/cssc.201402373; Chaikittisilp W, 2011, CHEM-EUR J, V17, P10556, DOI 10.1002/chem.201101480; Hicks JC, 2008, J AM CHEM SOC, V130, P2902, DOI 10.1021/ja077795v; Jones C. W., 2012, 2012 US FRONT ENG S; Jones C. W., 2012, U.S. Patent, Patent No. [US8298986 B2, 8298986, 8,298,986]; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Lackner K. S., 1999, P 24 INT TECHN C COA, P885; Lu WG, 2015, CHEMSUSCHEM, V8, P433, DOI 10.1002/cssc.201402622; McDonald TM, 2015, NATURE, V519, P303, DOI 10.1038/nature14327; Sayari A., 2012, J AM CHEM SOC, V134, P13834; Zeman FS, 2004, WORLD RESOURCE REV, V16, P157	64	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	OCT	2015	48	10					2680	2687		10.1021/acs.accounts.5b00284		8	Chemistry, Multidisciplinary	Chemistry	CU2IT	WOS:000363347900005		
J	Kunieda, K; Tsutsuki, H; Ida, T; Kishimoto, Y; Kasamatsu, S; Sawa, T; Goshima, N; Itakura, M; Takahashi, M; Akaike, T; Ihara, H				Kunieda, Kohei; Tsutsuki, Hiroyasu; Ida, Tomoaki; Kishimoto, Yusuke; Kasamatsu, Shingo; Sawa, Tomohiro; Goshima, Naoki; Itakura, Makoto; Takahashi, Masami; Akaike, Takaaki; Ihara, Hideshi			8-Nitro-cGMP Enhances SNARE Complex Formation through S-Guanylation of Cys90 in SNAP25	ACS CHEMICAL NEUROSCIENCE			English	Article						8-Nitroguanosine 3 ',5 '-cyclic monophosphate; protein S-guanylation; redox signaling; SNAP25; SNARE complex; neuronal nitric oxide synthase	NITRATED CYCLIC-GMP; NITRIC-OXIDE; 8-NITROGUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TYROSINE NITRATION; VESICLE FUSION; SPINAL-CORD; PC12 CELLS; SNAP-25	Nitrated guanine nucleotide 8-nitroguanosine 3',5'-cyclic monophosphate (8-nitro-cGMP) generated by reactive oxygen/nitrogen species causes protein S-guanylation. However, the mechanism of 8-nitro-cGMP formation and its protein targets in the normal brain have not been identified. Here, we investigated 8-nitro-cGMP generation and protein S-guanylation in the rodent brain. Immunohistochemistry indicated that 8-nitro-cGMP was produced by neurons, such as pyramidal cells and interneurons. Using liquid chromatography-tandem mass spectrometry, we determined endogenous 8-nitro-cGMP levels in the brain as 2.92 +/- 0.10 pmol/mg protein. Based on S-guanylation proteomics, we identified several S-guanylated neuronal proteins, including SNAP25 which is a core member of the soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) complex. SNAP25 post-translational modification including palmitoylation, phosphorylation, and oxidation, are known to regulate neurotransmission. Our results demonstrate that S-guanylation of SNAP25 enhanced the stability of the SNARE complex, which was further promoted by Ca2+-dependent activation of neuronal nitric oxide synthase. Using site-directed mutagenesis, we identified SNAP25 cysteine 90 as the main target of S-guanylation which enhanced the stability of the SNARE complex. The present study revealed a novel target of redox signaling via protein S-guanylation in the nervous system and provided the first substantial evidence of 8-nitro-cGMP function in the nervous system.	[Kunieda, Kohei; Kishimoto, Yusuke; Ihara, Hideshi] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Sakai, Osaka 5998531, Japan; [Tsutsuki, Hiroyasu; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Ida, Tomoaki; Kasamatsu, Shingo; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi 9808575, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Quantitat Prote Team, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan; [Itakura, Makoto; Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 2520374, Japan	Ihara, H (reprint author), Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	ihara@b.s.osakafu-u.ac.jp			Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) [22500337, 25430069, 20117001, 20117005, 26111011]; Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program [09801194]; Nagase Science and Technology Foundation	This work was supported, in part by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) Grants-in-Aid for Scientific Research (Grant Numbers 22500337 and 25430069), Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area; Grant Number 20117001), and the Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program (Grant Number 09801194).; This work was supported, in part by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) Grants-inAid for Scientific Research (Grant Numbers 22500337 and 25430069), Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Area;Grant Number 20117005 and 26111011), and the Nagase Science and Technology Foundation.	BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Hsieh HL, 2013, BIOMED RES INT, DOI 10.1155/2013/484613; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Kakizawa S, 2012, NEUROBIOL AGING, V33, P535, DOI 10.1016/j.neurobiolaging.2010.04.016; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Ahmed KA, 2012, BIOCHEM J, V441, P719, DOI 10.1042/BJ20111130; McKee AG, 2010, J NEUROCHEM, V112, P991, DOI 10.1111/j.1471-4159.2009.06516.x; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; Izawa T, 2008, BRAIN RES, V1195, P120, DOI 10.1016/j.brainres.2007.12.022; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Antonucci F, 2013, EMBO REP, V14, P645, DOI 10.1038/embor.2013.75; Di Stasi AMM, 2002, J NEUROCHEM, V82, P420, DOI 10.1046/j.1471-4159.2002.00980.x; Taniguchi M, 2007, J BIOL CHEM, V282, P7869, DOI 10.1074/jbc.M609457200; Song T, 2007, BIOCHEM J, V401, P391, DOI 10.1042/BJ20060580; Rahaman MM, 2014, ANTIOXID REDOX SIGN, V20, P295, DOI 10.1089/ars.2012.4606; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Iida Y, 2013, NEUROSCI RES, V75, P184, DOI 10.1016/j.neures.2013.01.002; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Nishida M, 2012, NAT CHEM BIOL, V8, P714, DOI [10.1038/nchembio.1018, 10.1038/NCHEMBIO.1018]; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; Giniatullin AR, 2006, J NEUROCHEM, V98, P1789, DOI 10.1111/j.1471-4159.2006.03997.x; Hou QL, 2004, EUR J NEUROSCI, V20, P1593, DOI 10.1111/j.1460-9568.2004.03600.x; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Kataoka M, 2006, NEUROSCI LETT, V407, P258, DOI 10.1016/j.neulet.2006.08.055; Kasamatsu S, 2014, BIOCHEM J, V459, P251, DOI 10.1042/BJ20131262; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Hou QL, 2006, BIOCHEM BIOPH RES CO, V347, P955, DOI 10.1016/j.bbrc.2006.06.184; Meffert MK, 1996, NEURON, V16, P1229, DOI 10.1016/S0896-6273(00)80149-X; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; Baca M, 2013, BRAIN RES, V1532, P85, DOI 10.1016/j.brainres.2013.08.012; Halemani ND, 2010, TRAFFIC, V11, P394, DOI 10.1111/j.1600-0854.2009.01020.x; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Greber S, 1999, ELECTROPHORESIS, V20, P928; Akaike T, 2013, J BIOCHEM, V153, P131, DOI 10.1093/jb/mvs145; BARK IC, 1995, P NATL ACAD SCI USA, V92, P1510, DOI 10.1073/pnas.92.5.1510; Graham ME, 2002, ANN NY ACAD SCI, V971, P210; Ihara H, 2011, NITRIC OXIDE-BIOL CH, V25, P169, DOI 10.1016/j.niox.2011.04.015; Kataoka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025158; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Sawa T, 2013, NITRIC OXIDE-BIOL CH, V34, P10, DOI 10.1016/j.niox.2013.04.004; Yarnamori S., 2014, NEUROSCI LETT, V561, P182	50	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT	2015	6	10					1715	1725		10.1021/acschemneuro.5b00196		11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	CU3OS	WOS:000363435300006		
J	Kudo, K; Furutani, M; Arimitsu, K				Kudo, Kenji; Furutani, Masahiro; Arimitsu, Koji			Imidazole Derivatives with an Intramolecular Hydrogen Bond as Thermal Latent Curing Agents for Thermosetting Resins	ACS MACRO LETTERS			English	Article							GLYCIDYL ETHER REACTIONS; EPOXY-RESIN; MECHANISM; MICROENCAPSULATION; CATALYSIS	Epoxy resins are important thermosetting resins widely used in industrial applications. Though imidazoles as curing agents have attracted particular attention because of their high reactivity in chain polymerizations with epoxides, polymerization of a liquid epoxy resin containing imidazoles proceeds gradually even at room temperature. This makes it difficult to use such mixtures as one-component materials for industrial applications. To improve the shelf life of the mixutures, we have developed a very simple and powerful thermal latent curing agent, a 2-(2-hydroxyphenyl)imidazole derivative (1), having an intramolecular hydrogen bond between the phenolic hydroxyl group and the nitrogen atom of the imidazole ring, leading to suppression of reactivity of 1 toward epoxy resins at room temperature. It was confirmed that high reactivity of 1 toward epoxy resins at 150 degrees C was based on breakage of the intramolecular hydrogen, whereas the epoxy resin composition showed long-term storage stability at room temperature.	[Kudo, Kenji; Furutani, Masahiro; Arimitsu, Koji] Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, Noda, Chiba 2788510, Japan; [Kudo, Kenji] Nippon Synthet Chem Ind Co Ltd, Cent Res Lab, Ibaraki, Osaka 5670052, Japan	Arimitsu, K (reprint author), Tokyo Univ Sci, Fac Sci & Technol, Dept Pure & Appl Chem, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	arimitsu@rs.noda.tus.ac.jp					Ham YR, 2010, J IND ENG CHEM, V16, P728, DOI 10.1016/j.jiec.2010.07.011; Rocks J, 2004, POLYMER, V45, P6799, DOI 10.1016/j.polymer.2004.07.066; SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028; Hart KR, 2015, POLYMER, V67, P174, DOI 10.1016/j.polymer.2015.04.068; MATUSZAK CA, 1976, J CHEM EDUC, V53, P280; Hamerton I, 1996, J MATER CHEM, V6, P305, DOI 10.1039/jm9960600305; Shin MJ, 2013, J APPL POLYM SCI, V129, P1036, DOI 10.1002/app.38767; SHECHTER L, 1956, IND ENG CHEM, V48, P94, DOI 10.1021/ie50553a029; HEISE MS, 1989, MACROMOLECULES, V22, P99, DOI 10.1021/ma00191a020; Chiang TH, 2006, INT J ADHES ADHES, V26, P520, DOI 10.1016/j.ijadhadh.2005.07.004; Maka H, 2012, IND ENG CHEM RES, V51, P5197, DOI 10.1021/ie202321j; FARKAS A, 1968, J APPL POLYM SCI, V12, P159, DOI 10.1002/app.1968.070120115; BARTON JM, 1994, J MATER CHEM, V4, P379, DOI 10.1039/jm9940400379; Wong FF, 2007, J APPL POLYM SCI, V104, P3292, DOI 10.1002/app.26002; Foces-Foces C, 1998, J MOL STRUCT, V440, P193, DOI 10.1016/S0022-2860(97)00270-6; Nishikubo T, 1996, POLYM J, V28, P795, DOI 10.1295/polymj.28.795; Fantini M, 2010, J COMB CHEM, V12, P181, DOI 10.1021/cc900152y; RICCIARDI F, 1983, J POLYM SCI POL CHEM, V21, P1475, DOI 10.1002/pol.1983.170210520; Silverstein R.M., 2005, SPECTROMETRIC IDENTI	19	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1085	1088		10.1021/acsmacrolett.5b00601		4	Polymer Science	Polymer Science	CU2PI	WOS:000363365000006		
J	Artar, M; Souren, ERJ; Terashima, T; Meijer, EW; Palmans, ARA				Artar, Muge; Souren, Erik R. J.; Terashima, Takaya; Meijer, E. W.; Palmans, Anja R. A.			Single Chain Polymeric Nanoparticles as Selective Hydrophobic Reaction Spaces in Water	ACS MACRO LETTERS			English	Article							CATALYTIC-ACTIVITY; NOBEL LECTURE; OXIDATION; ALCOHOLS; SHAPE; ARCHITECTURE; SURFACTANT; ACYLATION; COMPLEX; ENZYMES	A Ru(II)-based catalyst trapped within an amphiphilic, folded polymer is employed for the oxidation of secondary alcohols to their corresponding ketones using tBuOOH as the oxidant. Under the applied catalytic conditions, the polymer catalyst forms a compartmentalized structure with a hydrophobic interior. We selected secondary alcohols that differ in hydrophobicity, reactivity, and steric hindrance as substrates, with the aim to elucidate how this affects the rate and the end conversion of the oxidation reaction. Our investigations show that the Ru(II)-based catalyst is very efficient for oxidation reactions in water. Moreover, high selectivity toward the more hydrophobic substrate is observed, which originates from the hydrophobic interior of the compartmentalized catalyst system. This hydrophobic selectivity is also observed in the reverse reaction, the transfer hydrogenation.	[Artar, Muge; Souren, Erik R. J.; Meijer, E. W.; Palmans, Anja R. A.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; [Artar, Muge; Souren, Erik R. J.; Meijer, E. W.; Palmans, Anja R. A.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands; [Terashima, Takaya] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158510, Japan	Meijer, EW (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	e.w.meijer@tue.nl; a.palmans@tue.nl			The Netherlands Organization for Scientific Research (ECHO Grant) [713.011.001]; Dutch Ministry of Education, Culture and Science (Gravity Program) [024.001.035]; European Research Council (ERC Grant) [246829]	This work was financially supported by The Netherlands Organization for Scientific Research (ECHO Grant 713.011.001), the Dutch Ministry of Education, Culture and Science (Gravity Program 024.001.035), and the European Research Council (FP7/2007-2013, ERC Grant Agreement 246829). A.P. would like to thank Prof. Dr.). Meuldijk (TU/e) for insightful discussions. The ICMS Animation Studio (TU/e) is acknowledged for providing the art work.	Altintas O, 2012, MACROMOL RAPID COMM, V33, P958, DOI 10.1002/marc.201200049; Biscoe MR, 2005, J AM CHEM SOC, V127, P10812, DOI 10.1021/ja053660i; Terashima T, 2014, MACROMOLECULES, V47, P589, DOI 10.1021/ma402355v; Hamasaka G, 2011, ANGEW CHEM INT EDIT, V50, P4876, DOI 10.1002/anie.201100827; Ge ZS, 2007, MACROMOLECULES, V40, P3538, DOI 10.1021/ma070550i; WEISZ PB, 1979, SCIENCE, V206, P57, DOI 10.1126/science.206.4414.57; TSUJI Y, 1984, J ORGANOMET CHEM, V270, P333, DOI 10.1016/0022-328X(84)80381-2; Dusselier M, 2015, SCIENCE, V349, P78, DOI 10.1126/science.aaa7169; ENGBERTS JBFN, 1992, PURE APPL CHEM, V64, P1653, DOI 10.1351/pac199264111653; Gonzalez-Burgos M, 2015, CHEM SOC REV, V44, P6122, DOI 10.1039/c5cs00209e; Artar M, 2014, J POLYM SCI POL CHEM, V52, P12, DOI 10.1002/pola.26970; Chen BT, 2015, ACS CATAL, V5, P1313, DOI 10.1021/cs5020018; Terashima T, 2011, J AM CHEM SOC, V133, P4742, DOI 10.1021/ja2004494; Sanchez-Sanchez A, 2014, ACS MACRO LETT, V3, P439, DOI 10.1021/mz5001477; van Oers MCM, 2014, CHEM COMMUN, V50, P4040, DOI 10.1039/c3cc48865a; Willenbacher J, 2015, POLYM CHEM-UK, V6, P4358, DOI 10.1039/c5py00389j; Helms B, 2006, ADV SYNTH CATAL, V348, P1125, DOI 10.1002/adsc.200606095; Helms B, 2005, MACROMOLECULES, V38, P5411, DOI 10.1021/ma050701m; Liu Y, 2011, J AM CHEM SOC, V133, P14260, DOI 10.1021/ja206644d; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Terashima T, 2011, J POLYM SCI POL CHEM, V49, P1061, DOI 10.1002/pola.24501; Moore BL, 2014, POLYM CHEM-UK, V5, P3487, DOI 10.1039/c3py01734f; Perez-Baena I, 2013, ACS MACRO LETT, V2, P775, DOI 10.1021/mz4003744; SANGSTER J, 1989, J PHYS CHEM REF DATA, V18, P1111; Stals PJM, 2014, MACROMOLECULES, V47, P2947, DOI 10.1021/ma500273g; Berdugo C, 2013, CHEM COMMUN, V49, P10608, DOI 10.1039/c3cc45623d; YALKOWSKY SH, 1980, J PHARM SCI, V69, P912, DOI 10.1002/jps.2600690814; Lyon CK, 2015, POLYM CHEM-UK, V6, P181, DOI 10.1039/c4py01217h; Huerta E, 2013, ANGEW CHEM INT EDIT, V52, P2906, DOI 10.1002/anie.201207123; Cotanda P, 2012, CHEM COMMUN, V48, P10280, DOI 10.1039/c2cc35655d; Gillissen MAJ, 2013, MACROMOLECULES, V46, P4120, DOI 10.1021/ma4006846; Aliende C, 2012, ORGANOMETALLICS, V31, P6106, DOI 10.1021/om3004702; Artar M, 2014, ACS SYM SER, V1170, P313; Haimov A., 2006, J AM CHEM SOC, V128, P15697; Mavila S, 2014, CHEM SCI, V5, P4196, DOI 10.1039/c4sc01231c; MURAHASHI SI, 1993, SYNTHESIS-STUTTGART, P433; Noyori R, 2002, ANGEW CHEM INT EDIT, V41, P2008, DOI 10.1002/1521-3773(20020617)41:12<2008::AID-ANIE2008>3.0.CO;2-4; ten Brink GJ, 2000, SCIENCE, V287, P1636; Warshel A, 2014, ANGEW CHEM INT EDIT, V53, P10020, DOI 10.1002/anie.201403689; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250	40	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1099	1103		10.1021/acsmacrolett.5b00652		5	Polymer Science	Polymer Science	CU2PI	WOS:000363365000009		
J	Seo, JH; Fushimi, M; Matsui, N; Takagaki, T; Tagami, J; Yui, N				Seo, Ji-Hun; Fushimi, Mayu; Matsui, Naoko; Takagaki, Tomohiro; Tagami, Junji; Yui, Nobuhiko			UV-Cleavable Polyrotaxane Cross-Linker for Modulating Mechanical Strength of Photocurable Resin Plastics	ACS MACRO LETTERS			English	Article							NITROBENZYL; CHEMISTRY; POLYMERS; RELEASE; MODEL	A UV-cleavable supramolecular cross-linker was designed to effectively control the mechanical strength of photocurable resin plastics. The resin monomer-soluble polyrotaxane (PRX) cross-linker was synthesized by introducing a hydrophobic n-butyl group and a cross-linkable methacrylate group in a-cyclodextrin threading to a polyethylene glycol containing UV-cleavable end groups. The UV-cleavable PRX cross-linker was completely dissolved in 2-hydroxyethytl methacrylate (HEMA) and camphorquinone, representative photocurable resin components. The dumbbell-like stiff resin plastic was prepared by irradiating the mixture with 450 nm blue light. The stiffened resin plastic maintained its ultimate tensile strength (UTS) under visible light irradiation. However, the UTS of the resin plastic was remarkably decreased to 40% of the original value once the plastic was exposed to 254 nm UV light. This indicates that the suggested UV-cleavable PRX cross-linker is effective in modulating the mechanical strength of photocurable resin plastics.	[Seo, Ji-Hun; Fushimi, Mayu; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Matsui, Naoko; Takagaki, Tomohiro; Tagami, Junji] Tokyo Med & Dent Univ, Cardiol & Operat Dent, Tokyo 1138510, Japan; [Seo, Ji-Hun] Korea Univ, Dept Mat Sci & Engn, Seoul 136701, South Korea	Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.	yui.org@tmd.ac.jp			Japan Society for the Promotion of Science (JSPS) [KAKEN 24700477, KAKEN 24650274]	The authors acknowledge Dr. Atsushi Tamura and Dr. Yoshinori Arisaka, Tokyo Medical and Dental University, for their help and advice in a course of experiments. This research was financially supported by Grant-in-Aid for Young Scientists B (KAKEN 24700477: J.-H. S.) and Grant-in-Aid for Challenging Exploratory Research (KAKEN 24650274: N.Y.) from the Japan Society for the Promotion of Science (JSPS).	Aksommuang J., 2007, DENT MATER, V23, P226; Chen Y, 2010, CHEM SOC REV, V39, P495, DOI 10.1039/b816354p; Rueggeberg FA, 2011, DENT MATER, V27, P39, DOI 10.1016/j.dental.2010.10.021; Fomina N, 2010, J AM CHEM SOC, V132, P9540, DOI 10.1021/ja102595j; Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006; Dunn WJ, 2002, AM J ORTHOD DENTOFAC, V122, P236, DOI 10.1067/mod.2002.123949; Kretschy N, 2015, ANGEW CHEM INT EDIT, V54, P8555, DOI 10.1002/anie.201502125; Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+; Ilie N, 2014, CLIN ORAL INVEST, V18, P1081, DOI 10.1007/s00784-013-1085-1; Ryf S, 2012, EUR J ORTHODONT, V34, P25, DOI 10.1093/ejo/cjq128; Pardo R, 2011, CHEM SOC REV, V40, P672, DOI 10.1039/c0cs00065e; Thomas SW, 2012, MACROMOL CHEM PHYS, V213, P2443, DOI 10.1002/macp.201200486; Klinger D, 2011, MACROMOLECULES, V44, P9758, DOI 10.1021/ma201706r; Yang J, 2014, CHEM COMMUN, V50, P3993, DOI 10.1039/c4cc00590b; Ye Q, 2007, J BIOMED MATER RES A, V80A, P342, DOI 10.1002/jbm.a.30890; Masson F, 2004, PROG ORG COAT, V49, P1, DOI 10.1016/S0300-9440(03)00122-X; Holmes CP, 1997, J ORG CHEM, V62, P2370, DOI 10.1021/jo961602x; Han DH, 2011, MACROMOLECULES, V44, P437, DOI 10.1021/ma102778d; Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w; HARADA A, 1994, J AM CHEM SOC, V116, P3192, DOI 10.1021/ja00087a004; Doh J, 2004, J AM CHEM SOC, V126, P9170, DOI 10.1021/ja048261m; CAMERON JF, 1991, J AM CHEM SOC, V113, P4303, DOI 10.1021/ja00011a038; Brown AA, 2009, LANGMUIR, V25, P1744, DOI 10.1021/la8032308; Zhao H, 2012, MACROMOLECULES, V45, P1723, DOI 10.1021/ma201924h; Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI [10.4155/fmc.10.253, 10.4155/FMC.10.253]; Formina N., 2012, ADV DRUG DELIVERY RE, V64, P1005; Leonard Daniel L, 2002, J Esthet Restor Dent, V14, P286, DOI 10.1111/j.1708-8240.2002.tb00524.x; Seo JH, 2014, BEILSTEIN J ORG CHEM, V10, P2623, DOI 10.3762/bjoc.10.274; Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438; Zhu CC, 2014, BIOMACROMOLECULES, V15, P3474, DOI 10.1021/bm500990z	30	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1154	1157		10.1021/acsmacrolett.5b00619		4	Polymer Science	Polymer Science	CU2PI	WOS:000363365000020		
J	Inutsuka, M; Horinouchi, A; Tanaka, K				Inutsuka, Manabu; Horinouchi, Ayanobu; Tanaka, Keiji			Aggregation States of Polymers at Hydrophobic and Hydrophilic Solid Interfaces	ACS MACRO LETTERS			English	Article							SUM-FREQUENCY GENERATION; GLASS-TRANSITION TEMPERATURE; MOLECULAR-DYNAMICS SIMULATIONS; POLYSTYRENE THIN-FILMS; POLY(METHYL METHACRYLATE); VIBRATIONAL SPECTROSCOPY; PMMA SURFACE; MOBILITY; CHAINS; RELAXATION	Aggregation states of polystyrene (PS) and poly(methyl methacrylate) (PMMA) at hydrophobic deuterate-doctadecyltrichlorosilane (OTS-d) and hydrophilic SiOx interfaces are discussed, focusing on the interaction strength between polymer and substrate. Sum-frequency generation spectroscopy revealed that PS exhibited oriented phenyl groups along the normal direction at the interface in a spin-coated film because of the centrifugal force generated during the film solidification process, whereas it did not in a solvent-cast film. This result was common for both hydrophobic and hydrophilic substrates. That is, the aggregation states of PS depended little on which kind of substrate was used. This is because the interaction between PS and the surfaces is weak. In the case of a PMMA film on the hydrophobic OTS-d substrate, the interfacial local conformation was also dependent on the method of film preparation. PMMA at the hydrophilic SiOx interface, however, exhibited oriented ester methyl groups along the direction normal to the interface, regardless of the film preparation method. This is due to a stronger interaction via hydrogen bonding between carbonyl groups of PMMA and the substrate surface.	[Inutsuka, Manabu; Horinouchi, Ayanobu; Tanaka, Keiji] Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan; [Tanaka, Keiji] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8190395, Japan	Tanaka, K (reprint author), Kyushu Univ, Dept Appl Chem, Fukuoka 8190395, Japan.	k-tanaka@cstf.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25102535, 15H02183]; JST SENTANKEISOKU [13A0004]	We deeply thank Dr. Tomoyasu Hirai in Kyushu University for helping the preparation of OTS-d-modified prisms and substrates. This research was partly supported by Grant-in-Aids for the Scientific Research on Innovative Areas "New Polymeric Materials Based on Element-Blocks" (No. 25102535) program and for Scientific Research (A; No. 15H02183) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We also thank the support from the JST SENTANKEISOKU (13A0004).	Ogata Y, 2013, ACS MACRO LETT, V2, P856, DOI 10.1021/mz400322q; de Gennes PG, 2000, EUR PHYS J E, V2, P201, DOI 10.1007/PL00013665; Tanaka K, 2009, J PHYS CHEM B, V113, P4571, DOI 10.1021/jp810370f; Calchera AR, 2012, ACS APPL MATER INTER, V4, P3493, DOI 10.1021/am300585a; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r; Horinouchi A, 2012, MACROMOLECULES, V45, P4638, DOI 10.1021/ma3002559; WALLACE WE, 1995, PHYS REV E, V52, pR3329; Stafford CM, 2006, MACROMOLECULES, V39, P5095, DOI 10.1021/ma060790i; Zuo B, 2013, SOFT MATTER, V9, P9376, DOI 10.1039/c3sm51658j; Padding JT, 2002, J CHEM PHYS, V117, P925, DOI 10.1063/1.1481859; Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854; Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Schonherr H, 2003, MACROMOLECULES, V36, P1188, DOI 10.1021/ma020685i; O'Connell PA, 2005, SCIENCE, V307, P1760, DOI 10.1126/science.1105658; Frank B, 1996, MACROMOLECULES, V29, P6531, DOI 10.1021/ma960749n; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Tsuruta H, 2012, MACROMOLECULES, V45, P4643, DOI 10.1021/ma3007202; REITER G, 1992, PHYS REV LETT, V68, P75, DOI 10.1103/PhysRevLett.68.75; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Paeng K, 2011, J AM CHEM SOC, V133, P8444, DOI 10.1021/ja2022834; DeMaggio GB, 1997, PHYS REV LETT, V78, P1524, DOI 10.1103/PhysRevLett.78.1524; Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495; Li BL, 2015, ACS MACRO LETT, V4, P548, DOI 10.1021/acsmacrolett.5b00185; Fryer DS, 2001, MACROMOLECULES, V34, P5627, DOI 10.1021/ma001932q; Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d; Kim H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068302; Tanaka K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335593; Horinouchi A, 2013, RSC ADV, V3, P9446, DOI 10.1039/c3ra40631h; Horinouchi A, 2014, LANGMUIR, V30, P6565, DOI 10.1021/la500829p; Rao A, 2004, LANGMUIR, V20, P7183, DOI 10.1021/la049413u; Zhu H, 2014, LANGMUIR, V30, P11609, DOI 10.1021/la502333u; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Kim GM, 2001, POLYMER, V42, P1095, DOI 10.1016/S0032-3861(00)00468-7; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fukao K, 2000, PHYS REV E, V61, P1743, DOI 10.1103/PhysRevE.61.1743; Miyazaki T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061803; Fujii Y, 2009, MACROMOLECULES, V42, P7418, DOI 10.1021/ma901851w; Jena KC, 2011, J PHYS CHEM C, V115, P15570, DOI 10.1021/jp205712c; BEAUCAGE G, 1993, J POLYM SCI POL PHYS, V31, P319, DOI 10.1002/polb.1993.090310310; Koga T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.225901; Efremov MY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085703; Zhang LH, 2015, POLYMER, V65, P105, DOI 10.1016/j.polymer.2015.03.056; Grohens Y, 2002, EUR PHYS J E, V8, P217, DOI 10.1140/epje/i2001-10088-4; Tanaka K, 2003, LANGMUIR, V19, P6573, DOI 10.1021/la034542g; Tateishi Y, 2010, POLYM CHEM-UK, V1, P303, DOI 10.1039/b9py00227h; Curtis AD, 2013, VIB SPECTROSC, V68, P71, DOI 10.1016/j.vibspec.2013.05.011; Yang ZH, 2010, SCIENCE, V328, P1676, DOI 10.1126/science.1184394; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; Kim JH, 2000, LANGMUIR, V16, P4064, DOI 10.1021/la991618t; Long D, 2001, EUR PHYS J E, V4, P371, DOI 10.1007/s101890170120; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; Zax DB, 2000, J CHEM PHYS, V112, P2945, DOI 10.1063/1.480867; HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120; Jean YC, 1997, PHYS REV B, V56, pR8459; Napolitano S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1259; Xu JQ, 2014, SOFT MATTER, V10, P8992, DOI 10.1039/c4sm01743a	58	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2161-1653			ACS MACRO LETT	ACS Macro Lett.	OCT	2015	4	10					1174	1178		10.1021/acsmacrolett.5b00592		5	Polymer Science	Polymer Science	CU2PI	WOS:000363365000024		
J	Nakanotani, H; Furukawa, T; Adachi, C				Nakanotani, Hajime; Furukawa, Taro; Adachi, Chihaya			Light Amplification in an Organic Solid-State Film with the Aid of Triplet-to-Singlet Upconversion	ADVANCED OPTICAL MATERIALS			English	Article							ACTIVATED DELAYED FLUORESCENCE; EMITTING-DIODES; DYE-LASERS; THIN-FILMS; EFFICIENCY; EMISSION; DEVICES; ELECTROLUMINESCENCE; POLYMERS	Organic laser dyes can be optically excited to achieve light amplification. The buildup of an excessive population of triplets is generally believed to limit the duration of the light amplification because of optical losses through excited-state absorption, so triplet excitons are usually eliminated by using a triplet quencher. However, destroying the triplets limits the electroluminescence efficiency of organic materials under electrical pumping and is counterproductive to realizing electrically pumped organic laser devices. Herein, light amplification is reported which constructively uses triplet states in an optically pumped organic film. In this system, the triplets are converted into singlets by reverse intersystem crossing in a "triplet harvester," and then the singlets are resonantly transferred to the singlet state of the laser dye. Since this approach permits the constructive use of triplets, not only gain-narrowed emission but also enhanced electroluminescence efficiency was observed, indicating that the threshold current density for lasing might be reduced.	[Nakanotani, Hajime; Furukawa, Taro; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, Fukuoka 8190395, Japan; [Nakanotani, Hajime; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Adachi Mol Exciton Engn Project, JST,ERATO,Nishi Ku, Fukuoka 8190395, Japan; [Nakanotani, Hajime; Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res CNER WPI I2, Nishi Ku, Fukuoka 8190395, Japan	Nakanotani, H (reprint author), Kyushu Univ, Ctr Organ Photon & Elect Res OPERA, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	nakanotani@cstf.kyushu-u.ac.jp; adachi@cstf.kyushu-u.ac.jp			Japan Science and Technology Agency (JST); ERATO; Adachi Molecular Exciton Engineering Project;  [26810110]	H.N. and T.F. contributed equally to this work. The authors would like to acknowledge Ms. Kei Morimoto for assistance with the sample preparation, Ms. Asuka Yoshizaki for discussions about the design of OLED architecture, Mr. Munetomo Inoue for the construction of the STA measurement system, and Mr. Kou Yoshida for helpful discussions about energy transfer processes. The authors also thank Dr. W.J. Potscavage, Jr., for his kind assistance with the preparation of this manuscript. This work was supported by the Japan Science and Technology Agency (JST), ERATO, Adachi Molecular Exciton Engineering Project, and Grant-in-Aid for Young Scientists B; Grant Numbers 26810110.	Adachi C., 2006, SPIE INT S OPT PHOT; Masui K, 2013, ORG ELECTRON, V14, P2721, DOI 10.1016/j.orgel.2013.07.010; Togashi K, 2012, J MATER CHEM, V22, P20689, DOI 10.1039/c2jm33669c; Hide F, 1996, SCIENCE, V273, P1833, DOI 10.1126/science.273.5283.1833; Baldo MA, 1999, PHYS REV B, V60, P14422, DOI 10.1103/PhysRevB.60.14422; Kasemann D, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115208; Kozlov VG, 1997, NATURE, V389, P362, DOI 10.1038/38693; Frolov SV, 1997, PHYS REV LETT, V78, P729, DOI 10.1103/PhysRevLett.78.729; Uoyama H, 2012, NATURE, V492, P234, DOI 10.1038/nature11687; KARL N, 1972, PHYS STATUS SOLIDI A, V13, P651, DOI 10.1002/pssa.2210130237; Chen HF, 2009, J MATER CHEM, V19, P8112, DOI 10.1039/b913423a; MARLING JB, 1970, IEEE J QUANTUM ELECT, VQE 6, P570, DOI 10.1109/JQE.1970.1076525; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Baldo MA, 2000, NATURE, V403, P750; Zhang YF, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.241301; Berggren M, 1997, NATURE, V389, P466; Tessler N, 1996, NATURE, V382, P695, DOI 10.1038/382695a0; Smith LH, 2004, APPL PHYS LETT, V84, P2986, DOI 10.1063/1.1712036; Lehnhardt M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165206; Zhang QS, 2014, NAT PHOTONICS, V8, P326, DOI 10.1038/NPHOTON.2014.12; SOROKIN PP, 1966, IBM J RES DEV, V10, P162; HERMES RE, 1993, APPL PHYS LETT, V63, P877, DOI 10.1063/1.109887; Schols S, 2009, CHEMPHYSCHEM, V10, P1071, DOI 10.1002/cphc.200900054; Marling JB, 1970, APPL PHYS LETT, V17, P527, DOI 10.1063/1.1653296; SOFFER BH, 1967, APPL PHYS LETT, V10, P266, DOI 10.1063/1.1754804; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; Nakanotani H, 2007, ADV FUNCT MATER, V17, P2328, DOI 10.1002/adfm.200700069; Lempicki A., 1970, APPL PHYS LETT, V16, P267; Matsushima T, 2007, JPN J APPL PHYS 2, V46, pL861, DOI 10.1143/JJAP.46.L861; Nakanotani H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5016; Schols S, 2011, DEVICE ARCHITECTURE AND MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES: TARGETING HIGH CURRENT DENSITIES AND CONTROL OF THE TRIPLET CONCENTRATION, P1, DOI 10.1007/978-94-007-1608-7	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2195-1071			ADV OPT MATER	Adv. Opt. Mater.	OCT	2015	3	10					1381	1388		10.1002/adom.201500236		8	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	CU1IG	WOS:000363273600011		
J	Miah, AG; Saima, U; Hamano, K; Schellander, K				Miah, A. G.; Saima, U.; Hamano, K.; Schellander, K.			Physiological roles of relaxin in prefertilizing activities of spermatozoa	ANIMAL REPRODUCTION SCIENCE			English	Review						Relaxin; Physiological roles; Prefertilizing activities; Spermatozoa	PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERM CAPACITATION; THAWED BOVINE SPERMATOZOA; RAT ATRIAL MYOCYTES; ACROSOME REACTION; IMMUNOREACTIVE RELAXIN; BOAR SPERMATOZOA; SEMINAL PLASMA; IN-VITRO; SIGNAL-TRANSDUCTION	Relaxin was first introduced in 1926 by Frederick Hisaw. Previously, it was considered only having a role in pregnancy of mammals due to its important roles in pregnancy and parturition. In the last decade, the physiological role of relaxin in male reproduction has received attention, and it has become clear that relaxin can no longer be considered strictly as only a hormone of female reproduction. The accessory glands (especially the prostate gland) of the male reproductive system are the source of seminal relaxin, which is secreted into the seminal plasma and saturates the spermatozoa at the time of ejaculation. Several studies have reported that relaxin has important roles in improving motility in human spermatozoa. Investigations into the role of relaxin in other physiological sperm phenomena such as capacitation, acrosome reaction, and their mediating factors associated with successful fertilization have intensified. This review aims to provide up-to-date information about the physiological roles of relaxin in sperm motility, capacitation, acrosome reaction, and their mediating factors. Some studies demonstrated that relaxin increased the total motility and progressive motility. Several studies showed that relaxin not only increased sperm motility but also increased the rate of sperm capacitation and acrosome reaction. Though few studies revealed that relaxin improved the sperm prefertilizing activities through increasing the utilization of glucose and mediating the cholesterol efflux, Ca2+-influx, intracellular CAMP and protein tyrosine phosphorylation. Thus, the review concludes that the supplementation of relaxin into capacitating medium may have a beneficial role in prefertilizing activities of fresh and cryopreserved spermatozoa. (C) 2015 Elsevier B.V. All rights reserved.	[Miah, A. G.; Saima, U.] Hajee Mohammad Danesh Sci & Technol Univ, Fac Vet & Anim Sci, Dinajpur 5200, Bangladesh; [Hamano, K.] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Schellander, K.] Univ Bonn, Inst Anim Sci, D-53115 Bonn, Germany	Miah, AG (reprint author), Hajee Mohammad Danesh Sci & Technol Univ, Fac Vet & Anim Sci, Dept Genet & Anim Breeding, Dinajpur 5200, Bangladesh.	agmiah2009@gmail.com					Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Bailey JL, 2000, J ANDROL, V21, P1; PARKS JE, 1992, THERIOGENOLOGY, V38, P209, DOI 10.1016/0093-691X(92)90231-F; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Breitbart H, 1999, REV REPROD, V4, P151; Barros C, 1996, CELL BIOL INT, V20, P33, DOI 10.1006/cbir.1996.0006; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Pommer AC, 2003, BIOL REPROD, V68, P1208, DOI 10.1095/biolreprod.102.011106; ROGERS BJ, 1979, BIOL REPROD, V21, P365, DOI 10.1095/biolreprod21.2.365; Ferlin A, 2012, J ANDROL, V33, P474, DOI 10.2164/jandrol.110.012625; KOHSAKA T, 1992, J REPROD FERTIL, V95, P397; Sidhu KS, 2004, REPRODUCTION, V127, P95, DOI 10.1530/rep.1.00073; Hisaw FL, 1926, P SOC EXP BIOL MED, V23, P661; VANDEVOORT CA, 1995, J ANDROL, V16, P327; PUSCH HH, 1987, ANDROLOGIA, V19, P514; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Garde J, 2000, J REPROD FERTIL, V118, P57, DOI 10.1530/reprod/118.1.57; Miah AG, 2006, J REPROD DEVELOP, V52, P773, DOI 10.1262/jrd.18037; Familiari G, 2006, INT REV CYTOL, V249, P53, DOI 10.1016/S0074-7696(06)49002-1; Tsujii Hirotada, 2006, Reproductive Medicine and Biology, V5, P255, DOI 10.1111/j.1447-0578.2006.00150.x; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; CARRELL DT, 1995, ENDOCR RES, V21, P697; Breitbart H, 2002, MOL CELL ENDOCRINOL, V187, P139, DOI 10.1016/S0303-7207(01)00704-3; Samuel CS, 2003, LAB INVEST, V83, P1055, DOI 10.1097/01.LAB.0000079784.81186.B9; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Miah Abdul Gaffar, 2008, Reproductive Medicine and Biology, V7, P29, DOI 10.1111/j.1447-0578.2007.00198.x; Cardoso LC, 2010, REPRODUCTION, V139, P185, DOI 10.1530/REP-09-0146; FRASER LR, 1992, J REPROD FERTIL, V96, P363; HUDSON P, 1984, EMBO J, V3, P2333; FRASER LR, 1987, J REPROD FERTIL, V81, P77; Ivell R, 2002, TRENDS ENDOCRIN MET, V13, P343, DOI 10.1016/S1043-2760(02)00664-1; VANDUREN DBPJ, 1987, FERTIL STERIL, V47, P456; DUBOIS MP, 1978, CELL TISSUE RES, V187, P201; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; Cormier N, 1997, J ANDROL, V18, P461; JUANG HH, 1990, ANIM REPROD SCI, V22, P47, DOI 10.1016/0378-4320(90)90037-G; Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3; Pukazhenthi BS, 1998, MOL REPROD DEV, V49, P48, DOI 10.1002/(SICI)1098-2795(199801)49:1<48::AID-MRD6>3.0.CO;2-O; Kadirvel G, 2009, ANIM REPROD SCI, V116, P244, DOI 10.1016/j.anireprosci.2009.02.003; SCHIEFERSTEIN G, 1989, INT J FERTIL, V34, P215; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Miah Abdul Gaffar, 2006, Reproductive Medicine and Biology, V5, P215, DOI 10.1111/j.1447-0578.2006.00144.x; Gianesello L, 2009, ANN NY ACAD SCI, V1160, P192, DOI 10.1111/j.1749-6632.2008.03789.x; ZHOU R, 1990, BIOCHEM BIOPH RES CO, V172, P47, DOI 10.1016/S0006-291X(05)80171-8; LESSING JB, 1985, FERTIL STERIL, V44, P406; DECOOMAN S, 1983, FERTIL STERIL, V39, P111; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Kohsaka T, 2003, INT J ANDROL, V26, P115, DOI 10.1046/j.1365-2605.2003.00409.x; CHASSIN D, 1995, GENOMICS, V29, P465; LEBOUC Y, 1986, FEBS LETT, V196, P108, DOI 10.1016/0014-5793(86)80223-X; LOUMAYE E, 1980, J CLIN ENDOCR METAB, V50, P1142; ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Sasaki Y, 2001, INT J ANDROL, V24, P24, DOI 10.1046/j.1365-2605.2001.00259.x; Green CE, 2001, REPRODUCTION, V122, P889, DOI 10.1530/rep.0.1220889; Thomas AD, 2006, THERIOGENOLOGY, V65, P1531, DOI 10.1016/j.theriogenology.2005.08.022; Perez LJ, 1996, THERIOGENOLOGY, V45, P1037, DOI 10.1016/0093-691X(96)00031-3; Marin-Briggiler CI, 2003, FERTIL STERIL, V79, P1396, DOI 10.1016/S0015-0282(03)00267-X; CHAN SYW, 1984, IRCS MED SCI-BIOCHEM, V12, P879; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; LESSING JB, 1986, J REPROD MED, V31, P304; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; NAZ RK, 1991, J CELL SCI, V99, P157; Harrison RAP, 1996, MOL REPROD DEV, V45, P378; Miah AG, 2007, ANIM SCI J, V78, P495, DOI 10.1111/j.1740-0929.2007.00468.x; JUANG HH, 1989, ANIM REPROD SCI, V20, P21, DOI 10.1016/0378-4320(89)90110-3; Miah AG, 2011, ANIM REPROD SCI, V125, P30, DOI 10.1016/j.anireprosci.2011.03.010; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Kulanand J, 2001, ANDROLOGIA, V33, P95, DOI 10.1046/j.1439-0272.2001.00410.x; Williams AC, 2001, J ANDROL, V22, P680; Gunnersen JM, 1996, MOL CELL ENDOCRINOL, V118, P85, DOI 10.1016/0303-7207(96)03770-7; Cerolini S, 2001, REPRODUCTION, V121, P395, DOI 10.1530/rep.0.1210395; BELL GI, 1984, NATURE, V310, P775, DOI 10.1038/310775a0; Kalab P, 1998, MOL REPROD DEV, V51, P304, DOI 10.1002/(SICI)1098-2795(199811)51:3<304::AID-MRD10>3.3.CO;2-#; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; PURSEL VG, 1978, BIOL REPROD, V19, P69, DOI 10.1095/biolreprod19.1.69; PARK JM, 1988, AM J OBSTET GYNECOL, V158, P974; Aitken RJ, 1998, J CELL SCI, V111, P645; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; CORONEL CE, 1987, BIOL REPROD, V37, P1097, DOI 10.1095/biolreprod37.5.1097; DARINBEN.A, 1973, AUST J BIOL SCI, V26, P1409; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/ror.0.0020048; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Fuchs U., 1988, ANDROLOGIA, V21, P297; Fuchs U, 1993, Zentralbl Gynakol, V115, P117; Gagnon C., 1990, CONTROLS SPERM MOTIL; Han Young-Joon, 2006, J Reprod Dev, V52, P657, DOI 10.1262/jrd.18038; Hsu Y.H., 2002, SCIENCE, V295, P671; Hudson P., 1983, NATURE, V301; Kohsaka Tetsuya, 2001, Journal of Reproduction and Development, V47, P197, DOI 10.1262/jrd.47.197; Kohsaka T., 1988, 11 INT C AN REPR ART; Martinez P, 1996, FRONT BIOSCI, V1, P103; MEERA P, 1995, AM J PHYSIOL-CELL PH, V269, pC312; Naz R. K, 1996, FRONT BIOSCI, V1, P206; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; Piedras-Renteria ES, 1997, AM J PHYSIOL-HEART C, V272, pH1798; Piedras-Renteria ES, 1997, AM J PHYSIOL-HEART C, V272, pH1791; Sherwood O. David, 1994, P861; Steinetz B.G., 1959, RECENT PROGR ENDOCRI, P389	104	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320	1873-2232		ANIM REPROD SCI	Anim. Reprod. Sci.	OCT	2015	161						1	15		10.1016/j.anireprosci.2015.07.013		15	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CU2JW	WOS:000363350800001		
J	Faruque, OM; Miwa, H; Yasuda, M; Fujii, Y; Kaneko, T; Sato, S; Okazaki, S				Faruque, Omar M.; Miwa, Hiroki; Yasuda, Michiko; Fujii, Yoshiharu; Kaneko, Takakazu; Sato, Shusei; Okazaki, Shin			Identification of Bradyrhizobium elkanii Genes Involved in Incompatibility with Soybean Plants Carrying the Rj4 Allele	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							III SECRETION SYSTEM; SINORHIZOBIUM-FREDII USDA257; CULTIVAR-SPECIFIC NODULATION; FUNCTIONAL-ANALYSIS; RHIZOBIUM-MELILOTI; HOST-SPECIFICITY; RECEPTOR KINASE; JAPONICUM; PROTEINS; BACTERIA	Symbioses between leguminous plants and soil bacteria known as rhizobia are of great importance to agricultural production and nitrogen cycling. While these mutualistic symbioses can involve a wide range of rhizobia, some legumes exhibit incompatibility with specific strains, resulting in ineffective nodulation. The formation of nodules in soybean plants (Glycine max) is controlled by several host genes, which are referred to as Rj genes. The soybean cultivar BARC2 carries the Rj4 gene, which restricts nodulation by specific strains, including Bradyrhizobium elkanii USDA61. Here we employed transposon mutagenesis to identify the genetic locus in USDA61 that determines incompatibility with soybean varieties carrying the Rj4 allele. Introduction of the Tn5 transposon into USDA61 resulted in the formation of nitrogen fixation nodules on the roots of soybean cultivar BARC2 (Rj4 Rj4). Sequencing analysis of the sequence flanking the Tn5 insertion revealed that six genes encoding a putative histidine kinase, transcriptional regulator, DNA-binding transcriptional activator, helix-turn-helix-type transcriptional regulator, phage shock protein, and cysteine protease were disrupted. The cysteine protease mutant had a high degree of similarity with the type 3 effector protein XopD of Xanthomonas campestris. Our findings shed light on the diverse and complicated mechanisms that underlie these highly host-specific interactions and indicate the involvement of a type 3 effector in Rj4 nodulation restriction, suggesting that Rj4 incompatibility is partly mediated by effector-triggered immunity.	[Faruque, Omar M.; Miwa, Hiroki; Yasuda, Michiko; Fujii, Yoshiharu; Okazaki, Shin] Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan; [Kaneko, Takakazu] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Sato, Shusei] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Okazaki, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Agr, Tokyo, Japan.	sokazaki@cc.tuat.ac.jp			 [25450082]	This work was supported in part by a grant-in-aid (number 25450082) to S.O.	Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; RUMJANEK NG, 1993, APPL ENVIRON MICROB, V59, P4371; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; STACEY G, 1995, FEMS MICROBIOL LETT, V127, P1; SADOWSKY MJ, 1992, APPL ENVIRON MICROB, V58, P720; MEINHARDT LW, 1993, MOL MICROBIOL, V9, P17, DOI 10.1111/j.1365-2958.1993.tb01665.x; Zhukov V, 2008, MOL PLANT MICROBE IN, V21, P1600, DOI 10.1094/MPMI-21-12-1600; Stauffer LT, 2005, FEMS MICROBIOL LETT, V242, P333, DOI 10.1016/j.femsle.2004.11.027; Indrasumunar A, 2010, PLANT CELL PHYSIOL, V51, P201, DOI 10.1093/pcp/pcp178; HERRERO M, 1990, J BACTERIOL, V172, P6557; SADOWSKY MJ, 1987, APPL ENVIRON MICROB, V53, P2624; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Tsurumaru H, 2008, SOIL SCI PLANT NUTR, V54, P197, DOI 10.1111/j.1747-0765.2007.00225.x; Kim JG, 2011, MOL PLANT PATHOL, V12, P715, DOI [10.1111/j.1364-3703.2011.00706.x, 10.1111/J.1364-3703.2011.00706.X]; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1993, PLANT SOIL, V149, P205, DOI 10.1007/BF00016610; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; ROSSBACH S, 1991, MOL MICROBIOL, V5, P39, DOI 10.1111/j.1365-2958.1991.tb01824.x; Okazaki S, 2010, MOL PLANT MICROBE IN, V23, P223, DOI 10.1094/MPMI-23-2-0223; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; DAVID M, 1988, CELL, V54, P671, DOI 10.1016/S0092-8674(88)80012-6; Okazaki S, 2009, FEMS MICROBIOL LETT, V295, P88, DOI 10.1111/j.1574-6968.2009.01593.x; Lorio JC, 2010, APPL ENVIRON MICROB, V76, P4185, DOI 10.1128/AEM.00437-10; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Krishnan HB, 2003, MOL PLANT MICROBE IN, V16, P617, DOI 10.1094/MPMI.2003.16.7.617; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; Loh J, 2003, APPL ENVIRON MICROB, V69, P10, DOI 10.1128/AEM.69.1.10-17.2003; GOTTFERT M, 1992, MOL PLANT MICROBE IN, V5, P257, DOI 10.1094/MPMI-5-257; Indrasumunar A, 2011, PLANT J, V65, P39, DOI 10.1111/j.1365-313X.2010.04398.x; Soto MJ, 2009, CELL MICROBIOL, V11, P381, DOI [10.1111/j.1462-5822.2008.01282.x, 10.1111/j.1462-5822.2009.01282.x]; Tsukui T, 2013, APPL ENVIRON MICROB, V79, P1048, DOI 10.1128/AEM.03297-12; GROB P, 1994, FEMS MICROBIOL LETT, V120, P349, DOI 10.1016/0378-1097(94)90495-2; Cullimore JV, 2001, TRENDS PLANT SCI, V6, P24, DOI 10.1016/S1360-1385(00)01810-0; Tan CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117067; Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; Kwon YM, 2000, J MICROBIOL METH, V41, P195, DOI 10.1016/S0167-7012(00)00159-7; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; GOTTFERT M, 1989, MOL GEN GENET, V215, P407, DOI 10.1007/BF00427037; de Lyra MDCP, 2006, INT MICROBIOL, V9, P125; TRESE AT, 1995, EUPHYTICA, V81, P279, DOI 10.1007/BF00025618; CALDWELL BE, 1966, CROP SCI, V6, P427; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Bellato C, 1997, MICROBIOL-UK, V143, P1381; BROUGHTO.WJ, 1971, BIOCHEM J, V125, P1075; Hayashi M, 2011, BREEDING SCI, V61, P544, DOI 10.1270/jsbbs.61.544; Krause A, 2002, MOL PLANT MICROBE IN, V15, P1228, DOI 10.1094/MPMI.2002.15.12.1228; Sambrook J., 2012, MOL CLONING LAB MANU; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Simon R, 1983, NAT BIOTECHNOL, V1, P784, DOI DOI 10.1038/NBT1183-784	53	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	OCT	2015	81	19					6710	6717		10.1128/AEM.01942-15		8	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CU3XO	WOS:000363459800019		
J	Ono, HK; Sato'o, Y; Narita, K; Naito, I; Hirose, S; Hisatsune, J; Asano, K; Hu, DL; Omoe, K; Sugai, M; Nakane, A				Ono, Hisaya K.; Sato'o, Yusuke; Narita, Kouji; Naito, Ikunori; Hirose, Shouhei; Hisatsune, Junzo; Asano, Krisana; Hu, Dong-Liang; Omoe, Katsuhiko; Sugai, Motoyuki; Nakane, Akio			Identification and Characterization of a Novel Staphylococcal Emetic Toxin	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ENTEROTOXIN GENE; SHOCK-SYNDROME; AUREUS; SUPERANTIGENS; RESISTANT; INFECTION; PROTEIN; CLUSTER; GENOME	Staphylococcal enterotoxins (SEs) produced by Staphylococcus aureus have superantigenic and emetic activities, which cause toxic shock syndrome and staphylococcal food poisoning, respectively. Our previous study demonstrated that the sequence of SET has a low level of similarity to the sequences of other SEs and exhibits atypical bioactivities. Hence, we further explored whether there is an additional SET-related gene in S. aureus strains. One SET-like gene was found in the genome of S. aureus isolates that originated from a case of food poisoning, a human nasal swab, and a case of bovine mastitis. The deduced amino acid sequence of the SET-like gene showed 32% identity with the amino acid sequence of SET. The SET-like gene product was designated SElY. In the food poisoning and nasal swab isolates, mRNA encoding SElY was highly expressed in the early log phase of cultivation, whereas a high level of expression of this mRNA was found in the bovine mastitis isolate at the early stationary phase. To estimate whether SElY has both superantigenic and emetic activities, recombinant SElY was prepared. Cell proliferation and cytokine production were examined to assess the superantigenic activity of SElY. SElY exhibited superantigenic activity in human peripheral blood mononuclear cells but not in mouse splenocytes. In addition, SElY exhibited emetic activity in house musk shrews after intraperitoneal and oral administration. However, the stability of SElY against heating and pepsin and trypsin digestion was different from that of SET and SEA. From these results, we identified SElY to be a novel staphylococcal emetic toxin.	[Ono, Hisaya K.; Narita, Kouji; Hirose, Shouhei; Asano, Krisana; Nakane, Akio] Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan; [Sato'o, Yusuke; Hisatsune, Junzo; Sugai, Motoyuki] Hiroshima Univ, Dept Bacteriol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Naito, Ikunori; Omoe, Katsuhiko] Gifu Univ, Doctoral Course, United Grad Sch Vet Sci, Gifu, Japan; [Naito, Ikunori; Omoe, Katsuhiko] Iwate Univ, Fac Agr, Dept Vet Med, Morioka, Iwate 020, Japan; [Hu, Dong-Liang] Kitasato Univ, Sch Vet Med, Lab Zoonoses, Towada, Aomori, Japan	Nakane, A (reprint author), Hirosaki Univ, Grad Sch Med, Dept Microbiol & Immunol, Hirosaki, Aomori, Japan.	a27k03n0@hirosaki-u.ac.jp			JSPS KAKENHI [20580338, 23390100]; Sasakawa scientific research grant from The Japan Science Society	This study was supported in part by JSPS KAKENHI grant numbers 20580338 (to K.O.) and 23390100 (to A.N.) and a Sasakawa scientific research grant from The Japan Science Society.	Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16; Li SJ, 2011, J APPL MICROBIOL, V110, P729, DOI 10.1111/j.1365-2672.2010.04927.x; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Sato'o Y, 2013, MICROBIOL IMMUNOL, V57, P91, DOI 10.1111/1348-0421.12007; Thomas DY, 2006, INFECT IMMUN, V74, P4724, DOI 10.1128/IAI.00132-06; Ono HK, 2012, FEMS IMMUNOL MED MIC, V64, P392, DOI 10.1111/j.1574-695X.2011.00924.x; BETLEY MJ, 1985, SCIENCE, V229, P185, DOI 10.1126/science.3160112; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Jarraud S, 2001, J IMMUNOL, V166, P669; Joost I, 2009, J INFECT DIS, V199, P1471, DOI 10.1086/598484; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Duquenne M, 2010, APPL ENVIRON MICROB, V76, P1367, DOI 10.1128/AEM.01736-09; Chi YI, 2002, J BIOL CHEM, V277, P22839, DOI 10.1074/jbc.M201932200; Ono HK, 2008, INFECT IMMUN, V76, P4999, DOI 10.1128/IAI.00045-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; NAKANE A, 1992, INFECT IMMUN, V60, P523; Omoe K, 2003, INFECT IMMUN, V71, P6088, DOI 10.1128/IAI.71.10.6088-6094.2003; Munson SH, 1998, INFECT IMMUN, V66, P3337; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; UCHIYAMA T, 1993, J IMMUNOL, V151, P4407; HOVDE CJ, 1994, MOL MICROBIOL, V13, P897, DOI 10.1111/j.1365-2958.1994.tb00481.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; SU YC, 1995, APPL ENVIRON MICROB, V61, P1438; Hu DL, 2003, INFECT IMMUN, V71, P567, DOI 10.1128/IAI.71.1.567-570.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson GJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002271	26	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	OCT	2015	81	20					7034	7040		10.1128/AEM.01873-15		7	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CU3YC	WOS:000363461300010		
J	Ogawa, T				Ogawa, Tomoko			Goldilocks mastectomy for obese Japanese females with breast ptosis	ASIAN JOURNAL OF SURGERY			English	Article						breast cancer; breast reconstruction; subcutaneous mastectomy	SHAPED INCISION	The Goldilocks mastectomy is a method that uses redundant mastectomy flap tissue breast cancer; sue alone to create a breast mound in female American patients with macromastia. Goldilocks breast mastectomy was performed for obese Japanese females with breast ptosis, and its indications reconstruction; were considered for Japanese female patients. This report presents the results of five patients subcutaneous who underwent Goldilocks mastectomy, including one with bilateral breast cancer. The mastectomy average age of the patients was 72 years (range: 67-76 years). The body mass index (BMI) was more than 25 in all the cases. Four patients had invasive ductal carcinoma, and one patient had noninvasive ductal carcinoma of bilateral breasts. The cosmetic results were found to be good in two cases [a patient with bilateral breast cancer and a severely obese patient (BMI = 39)]. The cosmetic results in the other three cases were poor. Although the reconstructed breast size was small, this procedure resulted in better cosmetic results than what would be achieved with the usual method of mastectomy for Japanese patients with bilateral breast cancer and severely obese Japanese patients. Copyright (C) 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.	Mie Univ, Dept Breast Surg, Grad Sch Med, Tsu, Mie 5148507, Japan	Ogawa, T (reprint author), Mie Univ, Dept Breast Surg, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mokomoko@clin.medic.mie-u.ac.jp					Richardson H, 2012, INT J SURG, V10, P522, DOI 10.1016/j.ijsu.2012.08.003; Mirza M, 2003, ANN ROY COLL SURG, V85, P131, DOI 10.1308/003588403321219984; Szynglarewicz B, 2009, INT J GYNECOL CANCER, V19, P1454, DOI 10.1111/IGC.0b013e3181b692e0; NOWACKI MP, 1988, SURG GYNECOL OBSTET, V167, P251; Macmillan RD, 2009, BREAST SURG COMPANIO, P67	5	1	1	ELSEVIER SINGAPORE PTE LTD	SINGAPORE	3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE	1015-9584	0219-3108		ASIAN J SURG	Asian J. Surg.	OCT	2015	38	4					232	235		10.1016/j.asjsur.2013.07.003		4	Surgery	Surgery	CU2NS	WOS:000363360800010		
J	Maki, T; Hara, K; Kobayashi, F; Kurosaki, Y; Kakikawa, M; Matsuki, A; Chen, B; Shi, GY; Hasegawa, H; Iwasaka, Y				Maki, Teruya; Hara, Kazutaka; Kobayashi, Fumihisa; Kurosaki, Yasunori; Kakikawa, Makiko; Matsuki, Atsushi; Chen, Bin; Shi, Guangyu; Hasegawa, Hiroshi; Iwasaka, Yasunobu			Vertical distribution of airborne bacterial communities in an Asian-dust downwind area, Noto Peninsula	ATMOSPHERIC ENVIRONMENT			English	Article						Airborne bacteria; Asian dust; Bioaerosol; Free troposphere; Phylogenetic analysis	HIGH-ELEVATION SITE; CLOUD-WATER; PHYLOGENETIC DIVERSITY; BIOLOGICAL PARTICLES; DOME FRANCE; EAST SEA; ICE; MICROORGANISMS; ATMOSPHERE; JAPAN	Bacterial populations transported from ground environments to the atmosphere get dispersed throughout downwind areas and can influence ecosystem dynamics, human health, and climate change. However, the vertical bacterial distribution in the free troposphere was rarely investigated in detail. We collected aerosols at altitudes of 3000 m, 1000 m, and 10 m over the Noto Peninsula, Japan, where the westerly winds carry aerosols from continental and marine areas. During the sampling period on March 10, 2012, the air mass at 3000 m was transported from the Chinese desert region by the westerly winds, and a boundary layer was formed below 2000 m. Pyrosequencing targeting 16S rRNA genes (16S rDNA) revealed that the bacterial community at 3000 m was predominantly composed of terrestrial bacteria, such as Bacillus and Actinobacterium species. In contrast, those at 1000 m and 10 m included marine bacteria belonging to the classes Cyanobacteria and Alphaproteobacteria. The entire 16S rDNA sequences in the clone libraries were identical to those of the terrestrial and marine bacterial species, which originated from the Chinese desert region and the Sea of Japan, respectively. The origins of air masses and meteorological conditions contribute to vertical variations in the bacterial communities in downwind atmosphere. (C) 2015 Elsevier Ltd. All rights reserved.	[Maki, Teruya; Kobayashi, Fumihisa; Hasegawa, Hiroshi] Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Hara, Kazutaka; Kurosaki, Yasunori] Tottori Univ, Arid Land Res Ctr, Tottori 6800001, Japan; [Kakikawa, Makiko; Matsuki, Atsushi] Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; [Chen, Bin; Shi, Guangyu] Chinese Acad Sci, Inst Atmospher Phys, Beijing 100029, Peoples R China; [Iwasaka, Yasunobu] Univ Shiga Prefecture, Community Res Serv Grp, Hikoneshi, Shiga 5228533, Japan	Maki, T (reprint author), Kanazawa Univ, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan.	makiteru@se.kanazawa-u.ac.jp			Encouragement of Young Scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [26304003, 26340049]; Mitsui & Co., Ltd. Environment Fund [R11-G4-1076]; Strategic International Collaborative Research Program (SICORP) [7201006051]; National Natural Science Foundation of China [41475136]; International Science & Technology Cooperation Program of China [2013DFG22820]	Trajectories were produced by the NOAA Air Resources Laboratory (ARL) and provided for the HYSPLIT transport and dispersion model and/or READY website (http://www.ready.noaa.gov). Members of Hokkaido System Science Co., Ltd. and Fasmac Co., Ltd. helped with the pyrosequencing analyses. This research was supported by a Grant-in-Aid for the Encouragement of Young Scientists (26304003, 26340049) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The Mitsui & Co., Ltd. Environment Fund (R11-G4-1076) also supported this work, as did the Strategic International Collaborative Research Program (SICORP: 7201006051), the National Natural Science Foundation of China (41475136) and International Science & Technology Cooperation Program of China (2013DFG22820).	Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; An S, 2013, MICROB ECOL, V66, P850, DOI 10.1007/s00248-013-0276-2; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Vaitilingom M, 2012, ATMOS ENVIRON, V56, P88, DOI 10.1016/j.atmosenv.2012.03.072; Hua NP, 2007, AEROBIOLOGIA, V23, P291, DOI 10.1007/s10453-007-9076-9; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P2911, DOI 10.1111/j.1462-2920.2007.01461.x; Hara K, 2012, ATMOS ENVIRON, V47, P20, DOI 10.1016/j.atmosenv.2011.11.050; Ulrich A, 2008, MICROB ECOL, V55, P512, DOI 10.1007/s00248-007-9296-0; Choi DH, 2009, FEMS MICROBIOL ECOL, V69, P439, DOI 10.1111/j.1574-6941.2009.00729.x; Brinkmeyer R, 2003, APPL ENVIRON MICROB, V69, P6610, DOI 10.1128/AEM.69.11.6610-6619.2003; RUSSELL WC, 1975, NATURE, V253, P461, DOI 10.1038/253461a0; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Temkiv TS, 2012, FEMS MICROBIOL ECOL, V81, P684, DOI 10.1111/j.1574-6941.2012.01402.x; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Ichinose T, 2005, ENVIRON TOXICOL PHAR, V20, P48, DOI 10.1016/j.etap.2004.10.009; Asker D, 2008, SYST APPL MICROBIOL, V31, P43, DOI 10.1016/j.syapm.2007.10.002; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Woo AC, 2013, ATMOS ENVIRON, V74, P291, DOI 10.1016/j.atmosenv.2013.03.047; Vaitilingom M, 2013, P NATL ACAD SCI USA, V110, P559, DOI 10.1073/pnas.1205743110; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Bowers RM, 2012, ATMOS ENVIRON, V50, P41, DOI 10.1016/j.atmosenv.2012.01.005; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; ZHAO DW, 1988, ATMOS ENVIRON, V22, P349, DOI 10.1016/0004-6981(88)90040-6; Maki T, 2008, AIR QUAL ATMOS HLTH, V1, P81, DOI 10.1007/s11869-008-0016-9; Kourtev PS, 2011, ATMOS ENVIRON, V45, P5399, DOI 10.1016/j.atmosenv.2011.06.041; Cao SJ, 2010, INT J SYST EVOL MICR, V60, P2023, DOI 10.1099/ijs.0.017681-0; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Bottos EM, 2014, MICROB ECOL, V67, P120, DOI 10.1007/s00248-013-0296-y; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Delort AM, 2010, ATMOS RES, V98, P249, DOI 10.1016/j.atmosres.2010.07.004; Amato P, 2007, ATMOS ENVIRON, V41, P8253, DOI 10.1016/j.atmosenv.2007.06.022; Maki T, 2013, ATMOS ENVIRON, V74, P73, DOI 10.1016/j.atmosenv.2013.03.029; Mostajir B, 1995, AQUAT MICROB ECOL, V9, P259, DOI 10.3354/ame009259; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Joly M, 2013, ATMOS ENVIRON, V70, P392, DOI 10.1016/j.atmosenv.2013.01.027; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Jaenicke R, 2005, SCIENCE, V308, P73, DOI 10.1126/science.1106335; Song J, 2009, FEMS MICROBIOL LETT, V295, P141, DOI 10.1111/j.1574-6968.2009.01623.x; Jeon EM, 2011, ATMOS ENVIRON, V45, P4313, DOI 10.1016/j.atmosenv.2010.11.054; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Yi H, 2005, INT J SYST EVOL MICR, V55, P409, DOI 10.1099/ijs.0.63273-0; Bauermeister A, 2011, MICROB ECOL, V61, P715, DOI 10.1007/s00248-010-9785-4; COLWELL RK, 1994, PHILOS T ROY SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Griffin Dale W., 2003, Aerobiologia, V19, P143, DOI 10.1023/B:AERO.0000006530.32845.8d; Iwasaka Y, 2009, AIR QUAL ATMOS HLTH, V2, P29, DOI 10.1007/s11869-009-0031-5; Iwasaka Y., 1988, TELLUS, V40B, P494, DOI DOI 10.1111/11600-0889.198811300119.X; Kellogg Christina A., 2004, Aerobiologia, V20, P99, DOI 10.1023/B:AERO.0000032947.88335.bb; Kobayashi F., 2015, AIR QUAL AT IN PRESS; Liu B, 2014, CLIN IMMUNOL, V10, P10; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Maki T, 2014, SCI TOTAL ENVIRON, V488, P75, DOI 10.1016/j.scitotenv.2014.04.044; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Roling W.F.M., 2005, ADV METHODS, P25; Tanaka D., 2011, Bulletin of Glaciological Research, V29, P31, DOI 10.5331/bgr.29.31; Wu XiaoDan, 2011, Acta Agriculturae Zhejiangensis, V23, P409; Yamaguchi N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00525	64	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	119						282	293		10.1016/j.atmosenv.2015.08.052		12	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CT8PJ	WOS:000363078200027		
J	Garzon, JP; Huertas, JI; Magana, M; Huertas, ME; Cardenas, B; Watanabe, T; Maeda, T; Wakamatsu, S; Blanco, S				Garzon, Jessica P.; Huertas, Jose I.; Magana, Miguel; Huertas, Maria E.; Cardenas, Beatriz; Watanabe, Takuro; Maeda, Tsuneaki; Wakamatsu, Shinji; Blanco, Salvador			Volatile organic compounds in the atmosphere of Mexico City	ATMOSPHERIC ENVIRONMENT			English	Article						Volatile organic compound; Toxic volatile organic compound; Ozone; Ozone formation potential	ON-ROAD MEASUREMENTS; SOURCE APPORTIONMENT; METROPOLITAN-AREA; AIR-QUALITY; EMISSION SOURCES; OZONE FORMATION; VEHICLE EMISSIONS; FLUX MEASUREMENTS; SOUTHERN TAIWAN; FIELD CAMPAIGN	The Mexico City Metropolitan Area (MCMA) is one of the most polluted megacities in North America. Therefore, it is an excellent benchmark city to understand atmospheric chemistry and to implement pilot countermeasures. Air quality in the MCMA is not within acceptable levels, mainly due to high ground levels of ozone (O-3). Tropospheric O-3 is a secondary pollutant formed from the oxidation of volatile organic compounds (VOCs) in the presence of nitrogen oxides and sunlight. To gain a better understanding of O-3 formation in megacities, evaluate the effectiveness of already-implemented countermeasures, and identify new cost-effective alternatives to reduce tropospheric O-3 concentrations, researchers and environmental authorities require updated concentrations for a broader range of VOCs. Moreover, in an effort to protect human health and the environment, it is important to understand which VOCs exceed reference safe values or most contribute to O-3 formation, as well as to identify the most probable emission sources of those VOCs. In this work, 64 VOCs, including 36 toxic VOCs, were measured at four sites in the MCMA during 2011-2012. VOCs related to liquefied petroleum gas leakages exhibited the highest concentrations. Toxic VOCs with the highest average concentrations were acetone and ethanol. The toxic VOC benzene represented the highest risk to Mexican citizens, and toluene contributed the most to O-3 formation. Correlation analysis indicated that the measured VOCs come from vehicular emissions and solvent-related industrial sources. (C) 2015 Elsevier Ltd. All rights reserved.	[Garzon, Jessica P.; Huertas, Jose I.] Tecnol Monterrey, Toluca, Mexico; [Magana, Miguel; Blanco, Salvador] Natl Inst Ecol & Climate Change, Mexico City, DF, Mexico; [Watanabe, Takuro; Maeda, Tsuneaki] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Wakamatsu, Shinji] Ehime Univ, Matsuyama, Ehime, Japan; [Huertas, Maria E.] Univ Tecnol Bolivar, Cartagena, Colombia	Huertas, JI (reprint author), Tecnol Monterrey, Toluca, Mexico.	jhuertas@itesm.mx	Huertas Cardozo, Jose/K-6256-2014	Huertas Cardozo, Jose/0000-0003-4508-6453	Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)	This work was conducted as part of the "Joint Research Project on Formation Mechanism of Ozone, VOCs, and PM<INF>2.5</INF> and Proposal of Countermeasure Scenarios" undertaken by the Science and Technology Research Partnership for Sustainable Development (SATREPS) funded by the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA). The authors acknowledge the contributions of the National Institute of Ecology (INECC), the Secretariat of the Environment of Mexico City (SMA-GDF), and SEMARNAT for supporting the field campaign and for providing data from the Air Quality Monitoring Network. We thank Eng. Susana Gonzalez from INECC for processing the data acquired during the field campaign.	Thornhill DA, 2010, ATMOS CHEM PHYS, V10, P3629; Sun Y, 2011, J COMPUT GRAPH STAT, V20, P316, DOI 10.1198/jcgs.2011.09224; Atkinson R, 2000, ATMOS ENVIRON, V34, P2063, DOI 10.1016/S1352-2310(99)00460-4; Riuttanen L, 2013, ATMOS CHEM PHYS, V13, P2153, DOI 10.5194/acp-13-2153-2013; Yang KL, 2005, ATMOS ENVIRON, V39, P3221, DOI 10.1016/j.atmosenv.2005.02.003; Zalel A, 2008, ENVIRON POLLUT, V156, P553, DOI 10.1016/j.envpol.2008.01.016; CHATFIELD RB, 1987, J GEOPHYS RES-ATMOS, V92, P4208, DOI 10.1029/JD092iD04p04208; Wohrnschimmel H, 2010, ATMOS CHEM PHYS, V10, P9027, DOI 10.5194/acp-10-9027-2010; Velasco E, 2009, ATMOS CHEM PHYS, V9, P7325; Yokelson RJ, 2013, ATMOS CHEM PHYS, V13, P89, DOI 10.5194/acp-13-89-2013; Sillman S, 1999, ATMOS ENVIRON, V33, P1821, DOI 10.1016/S1352-2310(98)00345-8; Velasco E, 2008, ATMOS CHEM PHYS, V8, P3061; Emmons LK, 2010, ATMOS CHEM PHYS, V10, P6195, DOI 10.5194/acp-10-6195-2010; Suthawaree J, 2012, ATMOS RES, V104, P245, DOI 10.1016/j.atmosres.2011.10.019; Zhang J, 2008, ATMOS CHEM PHYS, V8, P4983; Hu L, 2013, ATMOS CHEM PHYS, V13, P3379, DOI 10.5194/acp-13-3379-2013; Schmitz T, 2000, ATMOS ENVIRON, V34, P4639, DOI 10.1016/S1352-2310(00)00303-4; NICKERSON EC, 1992, ATMOS ENVIRON B-URB, V26, P445, DOI 10.1016/0957-1272(92)90051-S; Chen JJ, 2012, ATMOS ENVIRON, V55, P448, DOI 10.1016/j.atmosenv.2012.02.082; Lee SC, 2002, CHEMOSPHERE, V48, P375; Leuchner M, 2010, ATMOS ENVIRON, V44, P4056, DOI 10.1016/j.atmosenv.2009.02.029; Na K, 2005, ATMOS ENVIRON, V39, P5517, DOI 10.1016/j.atmosenv.2005.06.005; Song Y, 2008, ENVIRON POLLUT, V156, P174, DOI 10.1016/j.envpol.2007.12.014; Parrish DD, 2012, ATMOS CHEM PHYS, V12, P3273, DOI 10.5194/acp-12-3273-2012; Jorquera H, 2004, ATMOS ENVIRON, V38, P4243, DOI 10.1016/j.atmosenv.2004.04.030; Watson JG, 2001, ATMOS ENVIRON, V35, P1567, DOI 10.1016/S1352-2310(00)00461-1; Chang CC, 2005, ATMOS ENVIRON, V39, P867, DOI 10.1016/j.atmosenv.2004.10.037; Velasco E, 2007, ATMOS CHEM PHYS, V7, P329; Goldstein AH, 1996, J GEOPHYS RES-ATMOS, V101, P9149, DOI 10.1029/96JD00334; Arriaga-Colina JL, 2004, ATMOS ENVIRON, V38, P2523, DOI 10.1016/j.atmosenv.2004.01.033; Ogawa H, 2011, INT J ENGINE RES, V12, P30, DOI 10.1243/14680874JER595; Gelencser A, 1997, ENVIRON SCI TECHNOL, V31, P2869, DOI 10.1021/es970004c; Streit GE, 1996, ATMOS ENVIRON, V30, P723, DOI 10.1016/1352-2310(95)00275-8; Molina LT, 2010, ATMOS CHEM PHYS, V10, P8697, DOI 10.5194/acp-10-8697-2010; Zavala M, 2006, ATMOS CHEM PHYS, V6, P5129; Liu PWG, 2008, SCI TOTAL ENVIRON, V398, P154, DOI 10.1016/j.scitotenv.2008.02.053; Molina LT, 2007, ATMOS CHEM PHYS, V7, P2447; Baker AK, 2008, ATMOS ENVIRON, V42, P170, DOI 10.1016/j.atmosenv.2007.09.007; Apel EC, 2010, ATMOS CHEM PHYS, V10, P2353; Rogers TM, 2006, INT J MASS SPECTROM, V252, P26, DOI 10.1016/j.ijms.2006.01.027; Zheng J, 2013, ATMOS ENVIRON, V70, P521, DOI 10.1016/j.atmosenv.2012.11.030; de Foy B, 2008, ATMOS CHEM PHYS, V8, P1209; Kirstine WV, 2012, ATMOS CHEM PHYS, V12, P545, DOI 10.5194/acp-12-545-2012; Lei W, 2007, ATMOS CHEM PHYS, V7, P1347; Ruiz ME, 1996, ATMOSFERA, V9, P119; Bravo H, 2002, ATMOS ENVIRON, V36, P3843, DOI 10.1016/S1352-2310(02)00292-3; Zhang RY, 2003, P NATL ACAD SCI USA, V100, P1505, DOI 10.1073/pnas.252763799; Na K, 2004, CHEMOSPHERE, V55, P585, DOI 10.1016/j.chemosphere.2004.01.010; Karl T, 2009, ATMOS CHEM PHYS, V9, P271; Tsai DH, 2008, J ENVIRON MONITOR, V10, P109, DOI 10.1039/b714479b; Arnold S.R., 2007, J GEOPHYS RES ATMOS, V112; BLAKE DR, 1995, SCIENCE, V269, P953, DOI 10.1126/science.269.5226.953; Carter W.P.L., 2010, CALIF AIR RESOUR BOA, V1, P1; CARTER WPL, 1994, J AIR WASTE MANAGE, V44, P881; Environmental Agency of Japan, 1999, ADM AIR POLL CONTR; European Concerted Action, 1991, 10 EUR CONC ACT; Institute for Governance & Sustainable Development, 2013, PRIM SHORT LIV CLIM; Islas V.H.S., 2011, P INT TRANSPORT FORU, V14, P1; Lindfors Virpi, 2000, Boreal Environment Research, V5, P95; MARI: Mexico City Air Quality Initiative, 1994, LA12699 MEX PETR I L; Martins LD, 2008, QUIM NOVA, V31, P2009, DOI 10.1590/S0100-40422008000800018; Mehta D, 2009, J PHYS CHEM A, V113, P12942, DOI 10.1021/jp905074j; Ministry of the Environment of the Government of Japan, 1997, ENV QUAL STAND JAP A; Molina L.T., 2009, WMO B, V58, P48; Murray F., 2000, CLEAN PRODUCT PROCES, V2, P28, DOI 10.1007/s100980050048; National Institute for Occupational Safety and Health, 2007, NAT I OCC SAF HLTH P; Occupational Safety and Health Standards, 2012, TOX HAZ SUBST ID CLA; Secretaria de Energia del Gobierno Federal de Mexico, 2008, LIQ PETR GAS MARK OU; Secretaria de Medio Ambiente del Distrito Federal, 2012, INV EM ZON METR VALL; Secretaria de Medio Ambiente del Distrito Federal, 2013, BAS DAT SIST MON ATM; Secretaria de Medio Ambiente del Distrito Federal, 2012, CAL AIR CIUD MEX 25; Secretaria de Medio Ambiente del Distrito Federal, 2010, CAL AIR CIUD MEX INF; Secretaria de Medio Ambiente del Distrito Federal e instituto Nacional de Ecologla y Cambio Ciimatico, 2008, INF TECN MON EV CONC; Secretaria de Medio Ambiente y Recursos Naturales de Mexico, 2010, INV EM ZON METR VALL; Secretaria del Trabajo y Prevision Social de Mexico, 2002, NORM OF MEX NOM 010; United Nations, 2011, WORLD URB PROSP 2011; USEPA, 1999, EPA625R96010B; Vardar N., 2008, ATMOS ENVIRON, V42, P5685; Velasco E., 2005, GEOPHYS RES LETT, V32; von Schneidemesser E, 2010, ATMOS ENVIRON, V44, P5053, DOI 10.1016/j.atmosenv.2010.09.010; White M.L., 2008, J GEOPHYS RES ATMOS, V113; Yuan Z.B., 2009, J GEOPHYS RES ATMOS, V114	82	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	OCT	2015	119						415	429		10.1016/j.atmosenv.2015.08.014		15	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CT8PJ	WOS:000363078200040		
J	Ahadian, S; Sadeghian, RB; Salehi, S; Ostrovidov, S; Bae, H; Ramalingam, M; Khademhosseini, A				Ahadian, Samad; Sadeghian, Ramin Banan; Salehi, Sahar; Ostrovidov, Serge; Bae, Hojae; Ramalingam, Murugan; Khademhosseini, Ali			Bioconjugated Hydrogels for Tissue Engineering and Regenerative Medicine	BIOCONJUGATE CHEMISTRY			English	Review							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; CHITOSAN/POLY(VINYL ALCOHOL) HYDROGEL; POLY(ETHYLENE GLYCOL) HYDROGELS; BONE MORPHOGENETIC PROTEIN-2; ARTICULAR-CARTILAGE DEFECTS; AGAROSE-GELATIN CONJUGATE; HYALURONIC-ACID HYDROGEL; SKELETAL-MUSCLE TISSUE; ALGINATE HYDROGELS	Hydrogels are hydrophilic polymer networks with high water content, which have played an important role as scaffolds for cells, as carriers for various biomolecules (e.g., drugs, genes, and soluble factors), and as injectable biomaterials in tissue engineering (TE) and regenerative medicine. Bioconjugation is an approach for improving the performance of hydrogels using cell-responsive components, such as proteins and peptides, which have high affinity to regulate cellular behaviors and tissue morphogenesis. However, the current knowledge on the role of those bioconjugated moieties in controlling cellular functions and tissue morphogenesis and bioconjugation methods are limited in the context of TE and organogenesis. Moreover, micro- and nanofabrication techniques have been used to manipulate bioconjugated hydrogels for regulating cell behaviors and function. This Review therefore describes synthesis, characteristics, and manipulation of various bioconjugated hydrogels and their potential in TE applications with special emphasis on preclinical/clinical translation.	[Ahadian, Samad; Sadeghian, Ramin Banan; Salehi, Sahar; Ostrovidov, Serge; Ramalingam, Murugan; Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Bae, Hojae; Khademhosseini, Ali] Konkuk Univ, Coll Anim Biosci & Technol, Dept Bioind Technol, Seoul 143701, South Korea; [Ramalingam, Murugan] Christian Med Coll & Hosp, Inst Stem Cell Biol & Regenerat Med, Ctr Stem Cell Res, Vellore 632002, Tamil Nadu, India; [Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA; [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Khademhosseini, Ali] King Abdulaziz Univ, Fac Sci, Dept Phys, Jeddah 21569, Saudi Arabia	Khademhosseini, A (reprint author), Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.	alik@rics.bwh.harvard.edu			World Premier International Research Center Initiative (WPI), MEXT, Japan	This work was supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan.	Al-Abboodi A, 2014, ADV HEALTHC MATER, V3, P1655, DOI 10.1002/adhm.201400072; Cao LP, 2015, J MATER CHEM B, V3, P1268, DOI 10.1039/c4tb01705f; Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]; Mather BD, 2006, PROG POLYM SCI, V31, P487, DOI 10.1016/j.progpolymsci.2006.03.001; Lu SY, 2015, ACS APPL MATER INTER, V7, P13029, DOI 10.1021/acsami.5b03143; Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Szlachcic A, 2011, BIOTECHNOL ADV, V29, P436, DOI 10.1016/j.biotechadv.2011.03.005; Jun Y, 2013, BIOMATERIALS, V34, P8122, DOI 10.1016/j.biomaterials.2013.07.079; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; da Costa JP, 2014, BIOTECHNOL ADV, V32, P952, DOI 10.1016/j.biotechadv.2014.04.013; Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018; Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025; Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063; Tang YJ, 2012, CARBOHYD POLYM, V88, P46, DOI 10.1016/j.carbpol.2011.11.058; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k; Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024; Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102; Koehler KC, 2013, BIOMATERIALS, V34, P4150, DOI 10.1016/j.biomaterials.2013.02.020; Boere KWM, 2014, ACTA BIOMATER, V10, P2602, DOI 10.1016/j.actbio.2014.02.041; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076; Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Luo TZ, 2013, EUR POLYM J, V49, P2998, DOI 10.1016/j.eurpolymj.2013.05.013; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233; Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196; Lee J, 2012, ACTA BIOMATER, V8, P2549, DOI 10.1016/j.actbio.2012.03.030; Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846; Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Ahadian S, 2014, BIOSENS BIOELECTRON, V59, P166, DOI 10.1016/j.bios.2014.03.031; Duan B, 2015, TISSUE ENG PART C-ME, V21, P795, DOI [10.1089/ten.TEC.2014.0589, 10.1089/ten.tec.2014.0589]; Teng SH, 2009, MATER LETT, V63, P2510, DOI 10.1016/j.matlet.2009.08.051; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI 10.1089/ten.TEA.2010.0202; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Chong SF, 2013, SMALL, V9, P942, DOI 10.1002/smll.201201774; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Ferris CJ, 2015, J MATER CHEM B, V3, P1106, DOI 10.1039/c4tb01727g; Wong DY, 2010, MACROMOLECULES, V43, P2824, DOI 10.1021/ma9023679; Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010; Ichikawa H, 2003, J BIOMED MATER RES A, V67A, P609, DOI 10.1002/jbm.a.10128; Hu M, 2010, BIOMATERIALS, V31, P863, DOI 10.1016/j.biomaterials.2009.10.002; Han J, 2011, CARBOHYD POLYM, V83, P270, DOI 10.1016/j.carbpol.2010.07.057; Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574; Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006; Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808; Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196; Choi B, 2015, ACTA BIOMATER, V12, P30, DOI 10.1016/j.actbio.2014.10.013; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; Obregon R, 2014, J NANOSCI NANOTECHNO, V14, P487, DOI 10.1166/jnn.2014.9051; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X; Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234; Hiraoka M, 2009, BIOCONJUGATE CHEM, V20, P976, DOI 10.1021/bc9000068; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8; Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]; Selimovic S, 2012, POLYMERS-BASEL, V4, P1554, DOI 10.3390/polym4031554; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j; Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270; Cerqueira MT, 2014, ACS APPL MATER INTER, V6, P19668, DOI 10.1021/am504520j; Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d; Lau HK, 2015, BIOMACROMOLECULES, V16, P28, DOI 10.1021/bm501361c; Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682; Waris E, 2008, BIOMATERIALS, V29, P2509, DOI 10.1016/j.biomaterials.2008.02.013; Liong M, 2011, BIOCONJUGATE CHEM, V22, P2390, DOI 10.1021/bc200490r; Tang YF, 2009, J BIOMED MATER RES A, V91A, P953, DOI 10.1002/jbm.a.32240; Fichna J, 2003, BIOCONJUGATE CHEM, V14, P3, DOI 10.1021/bc025542f; Hosseini V, 2012, TISSUE ENG PT A, V18, P2453, DOI [10.1089/ten.TEA.2012.0181, 10.1089/ten.tea.2012.0181]; Zamora-Mora V, 2014, CARBOHYD POLYM, V111, P348, DOI 10.1016/j.carbpol.2014.04.087; Losel R, 2010, MACROMOL BIOSCI, V10, P1177, DOI 10.1002/mabi.201000101; Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9; Wang LS, 2014, ACTA BIOMATER, V10, P2539, DOI 10.1016/j.actbio.2014.02.022; Bellan LM, 2012, ADV MATER, V24, P5187, DOI 10.1002/adma.201200810; Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009; Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Buttafoco L, 2005, J CONTROL RELEASE, V101, P322; Gruber HE, 2006, BIOMATERIALS, V27, P371, DOI 10.1016/j.biomaterials.2005.06.032; Qi BW, 2013, EXP BIOL MED, V238, P23, DOI 10.1258/ebm.2012.012223; Bubenikova S, 2012, CARBOHYD POLYM, V88, P1239, DOI 10.1016/j.carbpol.2012.01.089; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105; Sakai S, 2007, BIOTECHNOL LETT, V29, P731, DOI 10.1007/s10529-007-9312-y; Saito H, 2007, J BIOACT COMPAT POL, V22, P589, DOI 10.1177/0883911507084653; Hu M, 2009, BIOMATERIALS, V30, P3523, DOI 10.1016/j.biomaterials.2009.03.004; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083; Mahou R, 2012, J MATER SCI-MATER M, V23, P171, DOI 10.1007/s10856-011-4512-3; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; Lim HL, 2014, BIOMATER SCI-UK, V2, P603, DOI 10.1039/c3bm60288e; SAWHNEY AS, 1992, BIOMATERIALS, V13, P863, DOI 10.1016/0142-9612(92)90180-V; Lin XX, 2015, TISSUE ENG PART B-RE, V21, P177, DOI [10.1089/ten.TEB.2015.0004, 10.1089/ten.teb.2015.0004]; Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026; Hu JM, 2012, CHEM SOC REV, V41, P5933, DOI 10.1039/c2cs35103j; Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890; Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u; Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c; Hosseini V, 2014, SMALL, V10, P4851, DOI 10.1002/smll.201400263; Zhang HW, 2011, BIOMACROMOLECULES, V12, P1428, DOI 10.1021/bm101192b; Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014; Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782; MacNeil S, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70087-7; Liu JH, 2005, EUR J PHARM SCI, V25, P237, DOI 10.1016/j.ejps.2005.02.013; Yu F, 2013, CARBOHYD POLYM, V97, P188, DOI 10.1016/j.carbpol.2013.04.046; Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340; Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035; Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x; Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Wang T, 2006, CURR MED CHEM, V13, P525, DOI 10.2174/092986706776055742; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.TEA.2012.0581, 10.1089/ten.tea.2012.0581]; Lahiri DK, 2002, DRUG DEVELOP RES, V56, P267, DOI 10.1002/ddr.10081; Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9; Li YL, 2014, CARBOHYD POLYM, V110, P87, DOI 10.1016/j.carbpol.2014.03.058; Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024; Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI 10.1089/ten.TEA.2010.0096; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; Wu ATH, 2015, BIOMACROMOLECULES, V16, P166, DOI 10.1021/bm501356c; Huo Q, 2007, COLLOID SURFACE B, V59, P1, DOI 10.1016/j.colsurfb.2007.04.019; Hahn SK, 2006, INT J PHARM, V322, P44, DOI 10.1016/j.ijpharm.2006.05.024; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Shin HH, 2014, J MATER CHEM B, V2, P2508, DOI 10.1039/c3tb20984a; Sadri-Ardekani H, 2015, ADV DRUG DELIVER REV, V82-83, P145, DOI 10.1016/j.addr.2014.10.019; Wojtecki RJ, 2011, NAT MATER, V10, P14, DOI [10.1038/nmat2891, 10.1038/NMAT2891]; Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016; Ossipov DA, 2006, MACROMOLECULES, V39, P1709, DOI 10.1021/ma052545p; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Cheng F, 2011, POLYM CHEM-UK, V2, P2122, DOI 10.1039/c1py00123j; Yavvari PS, 2015, J MATER CHEM B, V3, P899, DOI 10.1039/c4tb01307g; Lee KY, 2000, NATURE, V408, P998; Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977; Sakai S, 2007, J BIOSCI BIOENG, V103, P22, DOI 10.1263/jbb.103.22; Yamada Y, 2013, BIOMATERIALS, V34, P6539, DOI 10.1016/j.biomaterials.2013.05.044; Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603; Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004; Shah SS, 2011, SOFT MATTER, V7, P3133, DOI 10.1039/c0sm00771d; Tamariz E, 2011, J MATER SCI-MATER M, V22, P2097, DOI 10.1007/s10856-011-4385-5; Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277; van Dijk M, 2010, BIOMACROMOLECULES, V11, P1608, DOI 10.1021/bm1002637; Andrianov AK, 1998, BIOMATERIALS, V19, P109, DOI 10.1016/S0142-9612(97)00227-5; Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039; Khademhosseini A, 2009, SCI AM, V300, P64; Li JJ, 2013, BIOMATERIALS, V34, P9071, DOI 10.1016/j.biomaterials.2013.08.031; Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021; Jabbari E, 2011, CURR OPIN BIOTECH, V22, P655, DOI 10.1016/j.copbio.2011.01.003; Park KM, 2011, J MATER CHEM, V21, P13180, DOI 10.1039/c1jm12527c; Liu SQ, 2009, BIOMATERIALS, V30, P1453, DOI 10.1016/j.biomaterials.2008.11.023; Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271; Carballo-Molina OA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00013; Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008; Deng CC, 2015, ACS MACRO LETT, V4, P220, DOI 10.1021/acsmacrolett.5b00018; Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048; Foster E, 2015, EUR POLYM J, V72, P726, DOI 10.1016/j.eurpolymj.2014.12.033; Gao GF, 2015, BIOTECHNOL J, V10, P1568, DOI 10.1002/biot.201400635; Sameiro M, 2009, CHEM REV, V109, P190, DOI 10.1021/cr0783840; Grover GN, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/1/014011; Harris J. M., 1992, INTRO BIOTECHNICAL B; Hernandez-Montiel HL, 2008, J COMP NEUROL, V506, P387, DOI 10.1002/cne.21503; Hou JX, 2015, POLYM CHEM-UK, V6, P2204, DOI 10.1039/c4py01757a; Hulsart-Billstrom G, 2013, BIOMACROMOLECULES, V14, P3055, DOI 10.1021/bm400639e; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt.767; Jha AK, 2015, BIOMATERIALS, V47, P1, DOI 10.1016/j.biomaterials.2014.12.043; Kim J, 2015, J BIOL ENG, V9, DOI 10.1186/1754-1611-9-1; Kim B, 2005, BIOMATERIALS, V26, P3597, DOI 10.1016/j.biomaterials.2004.09.045; Levato R., 2014, BIOFABRICATION, V6, P1; Li Z, 2015, ACTA BIOMATER, V13, P88, DOI 10.1016/j.actbio.2014.11.002; Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885; Madeira C, 2015, TRENDS BIOTECHNOL, V33, P35, DOI 10.1016/j.tibtech.2014.11.003; Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956; Mosiewicz Katarzyna A, 2013, Nat Mater, V12, P1072, DOI [10.1038/nmat3766, 10.1038/NMAT3766]; Noh SS, 2015, TISSUE ENG PT A, V21, P1275, DOI [10.1089/ten.TEA.2014.0182, 10.1089/ten.tea.2014.0182]; Oh SH, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5365-3; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.TEB.2013.0534, 10.1089/ten.teb.2013.0534]; Pardue Erin L, 2008, Organogenesis, V4, P203; Qasaimeh MA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1471; Saldoetsakun D., 2009, BIOMATERIALS, V30, P6151; Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050; Siddiqui N, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41534; Tabeling P., 2010, INTRO MICROFLUIDICS; Raja STK, 2015, J MATER CHEM B, V3, P1230, DOI 10.1039/c4tb01196a; Wade RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7639; Wen Jessica, 2012, Am J Cardiovasc Dis, V2, P20; Wong W. H., 1997, SYNTHETIC BIODEGRADA, P51; Yang JA, 2014, PROG POLYM SCI, V39, P1973, DOI 10.1016/j.progpolymsci.2014.07.006; Zahedi P., 2009, POLYM ADVAN TECHNOL, V21, P77; ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002; Zouraq F. A., 2013, REGENERATIVE MED TIS	213	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					1984	2001		10.1021/acs.bioconjchem.5b00360		18	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100002		
J	Mano, H; Nishikawa, M; Yasuda, K; Ikushiro, S; Saito, N; Takano, M; Kittaka, A; Sakaki, T				Mano, Hiroki; Nishikawa, Miyu; Yasuda, Kaori; Ikushiro, Shinichi; Saito, Nozomi; Takano, Masashi; Kittaka, Atsushi; Sakaki, Toshiyuki			Development of Novel Bioluminescent Sensor to Detect and Discriminate between Vitamin D Receptor Agonists and Antagonists in Living Cells	BIOCONJUGATE CHEMISTRY			English	Article							D-RESISTANT RICKETS; LUCIFERASE COMPLEMENTARY ASSAY; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; FIREFLY LUCIFERASE; ACTIVE VITAMIN-D3; NUCLEAR RECEPTOR; LIGAND; BONE; GENE	Active forms of vitamin D regulate the expression of multiple genes that play essential roles in calcium and phosphate homeostasis, cell differentiation, and the immune system via the vitamin D receptor (VDR). Many vitamin D analogs have been synthesized for clinical use in the treatment of type I rickets, osteoporosis, renal osteodystrophy, psoriasis, leukemia, and breast cancer. We have constructed two fusion proteins containing split-luciferase and the ligand binding domain (LBD) of the VDR designated as LucN-LBD-LucC and LucC-LBD-LucN. Remarkably, the LucC-LBD-LucN, which has the C-terminal domain of luciferase at the N-terminus of the fusion protein, was a significantly better biosensor than LucN-LBD-LucC. Addition of the VDR agonists to COS-7 cells expressing LucC-LBD-LucN dramatically reduced luciferase activity. In contrast, the VDR antagonist significantly increased the chimeric luciferase activity in a dose- and time-dependent manner. Our results on chimeric luciferases containing the LBDs of mutant VDRs derived from patients with vitamin D-dependent type II rickets indicated that our system could detect a conformational change of the LBD of the VDR likely based on a positional change of the helix 12, which occurs upon ligand binding. This novel system to detect and discriminate between VDR agonists and antagonists could be useful for the screening and identification of chemical compounds that bind to normal or mutant VDRs with high affinity.	[Mano, Hiroki; Nishikawa, Miyu; Yasuda, Kaori; Ikushiro, Shinichi; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Nishikawa, Miyu; Sakaki, Toshiyuki] TOPU BIO Res Co Ltd, Imizu Inst, Imizu, Toyama 9390398, Japan; [Saito, Nozomi; Takano, Masashi; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Itabashi Ku, Tokyo 1738605, Japan	Sakaki, T (reprint author), Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama 9390398, Japan.	tsakaki@pu-toyama.ac.jp					Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Nakabayashi M, 2013, J MED CHEM, V56, P6745, DOI 10.1021/jm400537h; Sprague SM, 2010, CLIN J AM SOC NEPHRO, V5, P512, DOI 10.2215/CJN.03850609; Shaffer PL, 2005, BIOCHEMISTRY-US, V44, P2678, DOI 10.1021/bi0477182; Matsumoto T, 2007, J STEROID BIOCHEM, V103, P584, DOI 10.1016/j.jsbmb.2006.12.088; Swami S, 2001, BONE, V28, P319, DOI 10.1016/S8756-3282(00)00432-4; Matsumoto T, 2005, J CLIN ENDOCR METAB, V90, P5031, DOI 10.1210/jc.2004-2552; Saito N, 2004, TETRAHEDRON, V60, P7951, DOI 10.1016/j.tet.2004.05.113; Munetsuna E, 2014, MOL CELL ENDOCRINOL, V382, P960, DOI 10.1016/j.mce.2013.11.014; Heaney RP, 2005, J STEROID BIOCHEM, V97, P13, DOI 10.1016/j.jsbmb.2005.06.020; Yamamoto K, 2000, P NATL ACAD SCI USA, V97, P1467, DOI 10.1073/pnas.020522697; Roodman GD, 2005, J CLIN INVEST, V115, P200, DOI 10.1172/JCI200524281; Ataei F, 2013, BIOSENS BIOELECTRON, V41, P642, DOI 10.1016/j.bios.2012.09.037; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Ishimoto T, 2012, BIOCONJUGATE CHEM, V23, P923, DOI 10.1021/bc200491j; Tashiro K, 2007, BIOCHEM BIOPH RES CO, V358, P259, DOI 10.1016/j.bbrc.2007.04.103; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Carlberg C, 2004, J STEROID BIOCHEM, V89-90, P227, DOI 10.1016/j.jsbmb.2004.03.112; Ozawa T, 2006, ANAL CHIM ACTA, V556, P58, DOI 10.1016/j.aca.2005.06.026; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Azad T, 2014, ANAL BIOANAL CHEM, V406, P5541, DOI 10.1007/s00216-014-7980-8; Saito N, 2006, J MED CHEM, V49, P7063, DOI 10.1021/jm060797q; Rachez C, 2000, MOL CELL BIOL, V20, P2718, DOI 10.1128/MCB.20.8.2718-2726.2000; Kittaka A, 2003, CHEM PHARM BULL, V51, P357; Paulmurugan R, 2006, P NATL ACAD SCI USA, V103, P15883, DOI 10.1073/pnas.0607385103; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Leyssens C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00122; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Matsumoto T, 2012, CURR OSTEOPOROS REP, V10, P248, DOI 10.1007/s11914-012-0116-1	34	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2038	2045		10.1021/acs.bioconjchem.5b00433		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100007		
J	Futami, J; Nonomura, H; Kido, M; Niidoi, N; Fujieda, N; Hosoi, A; Fujita, K; Mandai, K; Atago, Y; Kinoshita, R; Honjo, T; Matsushita, H; Uenaka, A; Nakayama, E; Kakimi, K				Futami, Junichiro; Nonomura, Hidenori; Kido, Momoko; Niidoi, Naomi; Fujieda, Nao; Hosoi, Akihiro; Fujita, Kana; Mandai, Komako; Atago, Yuki; Kinoshita, Rie; Honjo, Tomoko; Matsushita, Hirokazu; Uenaka, Akiko; Nakayama, Eiichi; Kakimi, Kazuhiro			Sensitive Multiplexed Quantitative Analysis of Autoantibodies to Cancer Antigens with Chemically S-Cationized Full-Length and Water-Soluble Denatured Proteins	BIOCONJUGATE CHEMISTRY			English	Article							CELL LUNG-CANCER; CANCER/TESTIS ANTIGENS; COLORECTAL-CANCER; TESTIS ANTIGENS; HIGH-THROUGHPUT; ANTIBODY; IMMUNOTHERAPY; DETERMINANTS; SPECIFICITY; MICROARRAY	Humoral immune responses against tumor-associated antigens (TAAs) or cancer/testis antigens (CTAs) aberrantly expressed in tumor cells are frequently observed in cancer patients. Recent clinical studies have elucidated that anticancer immune responses with increased levels of anti-TAA/CTA antibodies improve cancer survival rates. Thus, these antibody levels are promising biomarkers for diagnosing the efficiency of cancer immunotherapy. Full-length antigens are favored for detecting anti-TAA/CTA antibodies because candidate antigen proteins contain multiple epitopes throughout their structures. In this study, we developed a methodology to prepare purified water-soluble and full-length antigens by using cysteine sulfhydryl group cationization (S-cationization) chemistry. S-Cationized antigens can be prepared from bacterial inclusion bodies, and they exhibit improved protein solubility but preserved antigenicity. Anti-TAA/CTA antibodies detected in cancer patients appeared to recognize linear epitopes, as well as conformational epitopes, and because the frequency of cysteine side-residues on the epitope-paratope interface was low, any adverse effects of S-cationization were virtually negligible for antibody binding. Furthermore, S-cationized antigen-immobilized Luminex beads could be successfully used in highly sensitive quantitative-multiplexed assays. Indeed, patients with a more broadly induced serum anti-TAA/CTA antibody level showed improved progression-free survival after immunotherapy. The comprehensive anti-TAA/CTA assay system, which uses S-cationized full-length and water-soluble recombinant antigens, may be a useful diagnostic tool for assessing the efficiency of cancer immunotherapy.	[Futami, Junichiro; Nonomura, Hidenori; Kido, Momoko; Niidoi, Naomi; Fujita, Kana; Mandai, Komako; Atago, Yuki; Kinoshita, Rie; Honjo, Tomoko] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med Bioengn, Okayama 7008530, Japan; [Fujieda, Nao; Hosoi, Akihiro] Medinet Co Ltd, Yokohama, Kanagawa 2220033, Japan; [Fujieda, Nao; Hosoi, Akihiro; Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 1138655, Japan; [Uenaka, Akiko; Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Okayama 7010193, Japan	Futami, J (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med Bioengn, Okayama 7008530, Japan.	futamij@okayama-u.ac.jp			JSPS KAKENHI [23360370]; Development of Innovative Research on Cancer Therapeutics	This work was supported in part by JSPS KAKENHI (Grant Number 23360370 awarded to J. Futami) and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct awarded to K. Kakimi). We thank Emeritus Professor Hidenori Yamada for many helpful discussions.	Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Futami J, 2007, EXPERT OPIN DRUG DIS, V2, P261, DOI 10.1517/17460441.2.2.261; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; OKAZAKI K, 1985, ANAL BIOCHEM, V145, P87, DOI 10.1016/0003-2697(85)90330-6; Yao YB, 2012, BIOCHEM BIOPH RES CO, V423, P613, DOI 10.1016/j.bbrc.2012.06.050; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Inoue M, 1998, BIOTECHNOL APPL BIOC, V28, P207; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Chatterjee M, 2006, CANCER RES, V66, P1181, DOI 10.1158/0008-5472.CAN-04-2962; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Kawabata R, 2007, INT J CANCER, V120, P2178, DOI 10.1002/ijc.22583; Ramaraj T, 2012, BBA-PROTEINS PROTEOM, V1824, P520, DOI 10.1016/j.bbapap.2011.12.007; Chen HD, 2014, CANCER LETT, V346, P178, DOI 10.1016/j.canlet.2014.01.007; Murata H, 2006, BIOCHEMISTRY-US, V45, P6124, DOI 10.1021/bi052642a; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Beeton-Kempen N, 2014, INT J CANCER, V135, P1842, DOI 10.1002/ijc.28832; Gnjatic S, 2009, J IMMUNOL METHODS, V341, P50, DOI 10.1016/j.jim.2008.10.016; Ohue Y, 2012, INT J CANCER, V131, pE649, DOI 10.1002/ijc.27359; Bjerre M, 2009, VET IMMUNOL IMMUNOP, V130, P53, DOI 10.1016/j.vetimm.2009.01.007; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Wada H, 2014, J IMMUNOTHER, V37, P84, DOI 10.1097/CJI.0000000000000017; Gnjatic Sacha, 2009, V520, P11, DOI 10.1007/978-1-60327-811-9_2; Gelbart Y, 2004, PROTEIN EXPRES PURIF, V34, P183, DOI 10.1016/j.pep.2003.12.006; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Miura K, 2002, BIOCHEM BIOPH RES CO, V294, P1040, DOI 10.1016/S0006-291X(02)00585-5; Suyama T, 2010, PROSTATE, V70, P1778, DOI 10.1002/pros.21214; Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Patil A, 2010, INT J MOL SCI, V11, P1930, DOI 10.3390/ijms11041930; Peng HP, 2014, P NATL ACAD SCI USA, V111, pE2656, DOI 10.1073/pnas.1401131111; Shan Q, 2013, CANCER LETT, V328, P160, DOI 10.1016/j.canlet.2012.08.019; Sakamoto M, 2011, J IMMUNOTHER, V34, P202, DOI 10.1097/CJI.0b013e318207ecfb; Vinion-Dubiel AD, 2001, INFECT IMMUN, V69, P4329, DOI 10.1128/IAI.69.7.4329-4336.2001; Newton Dianne L, 2003, Methods Mol Biol, V207, P283; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Huang J, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-7; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095444; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; Middleton CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103867; Ohue Y, 2014, CLIN CANCER RES, V20, P5052, DOI 10.1158/1078-0432.CCR-14-0742; Olsen Dana, 2014, Front Oncol, V4, P105, DOI 10.3389/fonc.2014.00105; US Food and Drug Administration, 2014, IN VITR COMP DIAGN D	49	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2076	2084		10.1021/acs.bioconjchem.5b00328		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100012		
J	Kamada, K; Ito, D; Soh, N				Kamada, Kai; Ito, Daiki; Soh, Nobuaki			Visible-Light-Induced Activity Control of Peroxidase Bound to Fe-Doped Titanate Nanosheets with Nanometric Lateral Dimensions	BIOCONJUGATE CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; CATALYTIC-ACTIVITY; ENZYME-ACTIVITY; CARBON DOTS; PHOSPHATE; LAYERS	Catalytic performance of horseradish peroxidase (HRP) electrostatically adsorbed on nanometric and semiconducting Fe-doped titanate (FT) nanosheets was successfully manipulated by visible light illumination. A colloidal solution of FT with a narrow band gap corresponding to a visible light region was fabricated through a hydrolysis reaction of metals sources. HRP could be easily bound to the FT at pH = 4 through an electrostatic interaction between them, and the formed HRP-FT was utilized for the visible-light-driven enzymatic reaction. Under exposure to visible light with enough energy for band gap excitation of the FT, catalytic activity of HRP-FT was dramatically enhanced as compared with free (unbound) HRP and was simply adjusted by light intensity. In addition, wavelength dependence of an enzymatic reaction rate was analogous to an optical absorption spectrum of the FT. These results substantiated an expected reaction mechanism in which the photoenzymatic reaction was initiated by band gap excitation of FT followed by transferring holes generated in the valence band of irradiated FT to HRP. The excited HRP oxidized substrates (amplex ultrared: AUR) accompanied by two-electron reduction to regenerate the resting state. In addition, the catalytic activity was dearly switched by turning on and off the light source.	[Kamada, Kai; Ito, Daiki] Nagasaki Univ, Grad Sch Engn, Dept Chem & Mat Engn, Nagasaki 8528521, Japan; [Soh, Nobuaki] Saga Univ, Fac Agr, Saga 8408502, Japan	Kamada, K (reprint author), Nagasaki Univ, Grad Sch Engn, Dept Chem & Mat Engn, Nagasaki 8528521, Japan.	kkamada@nagasaki-u.ac.jp			JSPS KAKENHI [26410244, 15K05542]	The present work was partly supported by JSPS KAKENHI Grant No. 26410244 and 15K05542.	Besselink R, 2010, J PHYS CHEM C, V114, P21281, DOI 10.1021/jp108687q; Kamada K, 2014, RSC ADV, V4, P43052, DOI 10.1039/c4ra05665e; Miljevic M, 2014, ADV FUNCT MATER, V24, P907, DOI 10.1002/adfm.201301484; Kamada K, 2012, J PHYS CHEM C, V116, P20694, DOI 10.1021/jp3046559; Wang QG, 2004, J AM CHEM SOC, V126, P14346, DOI 10.1021/ja047224s; Bretschneider JC, 2009, SMALL, V5, P2549, DOI 10.1002/smll.200900544; Kamada K, 2015, J PHYS CHEM B, V119, P5309, DOI 10.1021/jp512038x; Fruk L, 2007, CHEMBIOCHEM, V8, P2195, DOI 10.1002/cbic.200700594; Kamada K, 2011, J PHYS CHEM C, V115, P13232, DOI 10.1021/jp203332v; Ohya T, 2002, CHEM MATER, V14, P3082, DOI 10.1021/cm0200588; Harada M, 2002, J PHOTOCH PHOTOBIO A, V148, P273, DOI 10.1016/S1010-6030(02)00053-9; Li H, 2014, J MATER CHEM B, V2, P5652, DOI 10.1039/c4tb00705k; Kohse S, 2014, CHEMCATCHEM, V6, P3511, DOI 10.1002/cctc.201402442; Sovic D, 2011, ELECTROCHIM ACTA, V56, P9953, DOI 10.1016/j.electacta.2011.08.077; Kumar CV, 1997, CHEM MATER, V9, P863, DOI 10.1021/cm960634y; Shimoboji T, 2003, BIOCONJUGATE CHEM, V14, P517, DOI 10.1021/bc025615v; Kamada K, 2011, CHEM MATER, V23, P2968, DOI 10.1021/cm200672f; Kamada K, 2010, J MATER CHEM, V20, P5646, DOI 10.1039/c0jm00173b; Kohse S, 2013, J AM CHEM SOC, V135, P9407, DOI 10.1021/ja400700x; Li H, 2015, ACS APPL MATER INTER, V7, P10004, DOI 10.1021/acsami.5b02386; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	21	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	OCT	2015	26	10					2161	2166		10.1021/acs.bioconjchem.5b00464		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	CU3PU	WOS:000363438100021		
J	Kotani, Y; Ohgami, Y; Ishiwata, T; Arai, J; Kiryu, S; Inoue, Y				Kotani, Yasunori; Ohgami, Yoshimi; Ishiwata, Takayuki; Arai, Jun-ichirou; Kiryu, Shigeru; Inoue, Yusuke			Source analysis of stimulus-preceding negativity constrained by functional magnetic resonance imaging	BIOLOGICAL PSYCHOLOGY			English	Article						Stimulus preceding negativity; Insular cortex; Dipole modeling; Salience network	RIGHT-HEMISPHERE PREPONDERANCE; ANTERIOR INSULAR CORTEX; TIME-ESTIMATION TASK; FEEDBACK STIMULI; PHYSIOLOGICAL CONDITION; REWARD ANTICIPATION; ATTENTION; NETWORKS; BRAIN; CONNECTIVITY	The stimulus-preceding negativity (SPN) is an event-related potential (ERP) reflecting anticipation. The anterior insular cortex is assumed to be one of the physiological sources of the SPN. However, the precise neural substrates of the SPN have yet to be confirmed. We therefore performed separate functional magnetic resonance imaging (fMRI) and ERP studies using the same time estimation task, followed by fMRI-constrained ERP source analysis. Dipole locations were determined by the fMRI results, while the time courses of dipole activities were modeled by the ERP data. Analysis revealed that the right anterior insula was significantly activated before delivery of the feedback stimulus, whereas the left anterior insula was not, and that the SPN mainly arose from four groups of brain regions related to, respectively: (1) the salience network, (2) reward expectation, (3) perceptual anticipation, and (4) arousal. The results suggest that the SPN pertains to multiple brain functions with complex interactions. (C) 2015 Elsevier B.V. All rights reserved.	[Kotani, Yasunori; Ohgami, Yoshimi] Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, Tokyo 152, Japan; [Ishiwata, Takayuki] Rikkyo Univ, Dept Sport & Wellness, Niiza, Saitama, Japan; [Arai, Jun-ichirou] Daikin Ind Ltd, Technol & Innovat Ctr Preparat Off, Minato Ku, Tokyo, Japan; [Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan; [Inoue, Yusuke] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Minami Ku, Sagamihara, Kanagawa 228, Japan	Kotani, Y (reprint author), Tokyo Inst Technol, Dept Human Syst Sci, Meguro Ku, 2-12-1 Ohokayama, Tokyo 152, Japan.	kotani@hum.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [23500724]	We thank Yumiko Kuramoto, Taro Tomatsu, and Tatsuya Yoshihiro for their assistance with data collection and analysis. This research was supported by a Grant-in-Aid for Scientific Research (C) 23500724 from the Japan Society for the Promotion of Science (JSPS).	Ham T, 2013, J NEUROSCI, V33, P7091, DOI 10.1523/JNEUROSCI.4692-12.2013; BRUNIA CHM, 1988, BIOL PSYCHOL, V26, P165, DOI 10.1016/0301-0511(88)90018-X; Kotani Y, 2003, PSYCHOPHYSIOLOGY, V40, P818, DOI 10.1111/1469-8986.00082; Kotani Y, 2009, NEUROSCI LETT, V450, P75, DOI 10.1016/j.neulet.2008.11.032; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Brunia CHM, 2000, EXP BRAIN RES, V130, P328, DOI 10.1007/s002219900293; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Kosillo P, 2010, BRAIN STRUCT FUNCT, V214, P623, DOI 10.1007/s00429-010-0267-8; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Becker MPI, 2014, J NEUROSCI, V34, P3005, DOI 10.1523/JNEUROSCI.3684-13.2014; Tsukamoto T, 2006, NEUROSCI LETT, V399, P39, DOI 10.1016/j.neulet.2006.01.061; Pujol J, 2002, NEUROIMAGE, V15, P103, DOI 10.1006/nimg.2001.0928; Foti D, 2012, PSYCHOPHYSIOLOGY, V49, P617, DOI 10.1111/j.1469-8986.2011.01343.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Frishkoff Gwen A, 2004, Brain Res Cogn Brain Res, V20, P329; van Boxtel GJM, 2004, J PSYCHOPHYSIOL, V18, P61, DOI 10.1027/0269-8803.18.23.61; Spati J, 2014, HUM BRAIN MAPP, V35, P4428, DOI 10.1002/hbm.22484; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Kotani Y, 2001, PSYCHOPHYSIOLOGY, V38, P873, DOI 10.1111/1469-8986.3860873; Touroutoglou A, 2012, NEUROIMAGE, V60, P1947, DOI 10.1016/j.neuroimage.2012.02.012; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Kotani Y, 1999, BIOL PSYCHOL, V50, P1, DOI 10.1016/S0301-0511(98)00047-7; Masaki H, 2010, NEUROREPORT, V21, P277, DOI 10.1097/WNR.0b013e3283360bc3; Ohgami Y, 2004, PSYCHOPHYSIOLOGY, V41, P729, DOI 10.1111/j.1469-8986.2004.00203.x; Poli S, 2007, INT J PSYCHOPHYSIOL, V65, P32, DOI 10.1016/j.ijpsycho.2007.02.008; Ohgami Y, 2014, PSYCHOPHYSIOLOGY, V51, P843, DOI 10.1111/psyp.12234; DAMEN EJP, 1994, PSYCHOPHYSIOLOGY, V31, P129, DOI 10.1111/j.1469-8986.1994.tb01033.x; Ohgami Y, 2006, PSYCHOPHYSIOLOGY, V43, P227, DOI 10.1111/j.1469-8986.2006.00396.x; [Anonymous], 1985, CLIN NEUROPHYSIOL; Brunia CHM, 2004, EXP BRAIN RES, V156, P231, DOI 10.1007/s00221-003-1780-2; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; Moris J, 2013, PSYCHOPHYSIOLOGY, V50, P931, DOI 10.1111/psyp.12073; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Mattox ST, 2006, CLIN NEUROPHYSIOL, V117, P2144, DOI 10.1016/j.clinph.2006.05.026; Kucyi A, 2012, J NEUROPHYSIOL, V108, P3382, DOI 10.1152/jn.00674.2012; Bocker Koen B. E., 1994, Brain Topography, V7, P71, DOI 10.1007/BF01184839; Catena A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040252; Luck S., 2014, INTRO EVENT RELATED; Scherg M., 2010, BESA RES TUTORIAL 1; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Singh-Curry V., 2009, NEUROPSYCHOLOGIA, V47, P1434; Stavropoulos KKM, 2014, SOC COGN AFFECT NEUR, V9, P1569, DOI 10.1093/scan/nst149; Van der Molen Melle J W, 2013, Front Hum Neurosci, V7, P936, DOI 10.3389/fnhum.2013.00936	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	OCT	2015	111						53	64		10.1016/j.biopsycho.2015.08.005		12	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	CU4HM	WOS:000363488500006		
J	Miyamoto, H; Matsueda, S; Moritsuka, A; Shimokawa, K; Hirata, H; Nakashima, M; Sasaki, H; Fumoto, S; Nishida, K				Miyamoto, Hirotaka; Matsueda, Satoshi; Moritsuka, Akihiro; Shimokawa, Kenta; Hirata, Haruna; Nakashima, Mikiro; Sasaki, Hitoshi; Fumoto, Shintaro; Nishida, Koyo			Evaluation of hypothermia on the in vitro metabolism and binding and in vivo disposition of midazolam in rats	BIOPHARMACEUTICS & DRUG DISPOSITION			English	Article						therapeutic hypothermia; midazolam; CYP3A2; protein binding; distribution	MILD THERAPEUTIC HYPOTHERMIA; DRUG-METABOLISM; CARDIAC-ARREST; PHARMACOKINETICS; CLEARANCE; 1-AMINOBENZOTRIAZOLE; CYTOCHROME-P-450; INHIBITION; SYSTEM; ELIMINATION	The effect of hypothermia on the in vivo pharmacokinetics of midazolam was evaluated, with a focus on altered metabolism in the liver and binding to serum proteins. Rat primary hepatocytes were incubated with midazolam (which is metabolized mainly by CYP3A2) at 37, 32 or 28 degrees C. The Michaelis-Menten constant (K-m) and maximum velocity (V-max) of midazolam were estimated using the Michaelis-Menten equation. The K-m of CYP3A2 midazolam remained unchanged, but the V-max decreased at 28 degrees C. In rats, whose temperature was maintained at 37, 32 or 28 degrees C by a heat lamp or ice pack, the plasma concentrations of midazolam were higher, whereas those in the brain and liver were unchanged at 28 degrees C. The tissue/plasma concentration ratios were, however, increased significantly. The unbound fraction of midazolam in serum at 28 degrees C was half that at 37 degrees C. These pharmacokinetic changes associated with hypothermic conditions were due to reductions in CYP3A2 activity and protein binding. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Miyamoto, Hirotaka; Matsueda, Satoshi; Shimokawa, Kenta; Hirata, Haruna; Nakashima, Mikiro; Fumoto, Shintaro; Nishida, Koyo] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Moritsuka, Akihiro; Sasaki, Hitoshi] Nagasaki Univ Hosp, Dept Hosp Pharm, Nagasaki, Japan	Nishida, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	dds.yakuzai@gmail.com			JSPS [26860108]	We thank Keiko Abe and Yurika Hori for their skillful assistance. This work was supported by JSPS KAKENHI Grant Number 26860108.	YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109; Desjardins JP, 1995, J PHARMACOL EXP THER, V275, P1608; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; Fukuoka N, 2004, RESUSCITATION, V60, P225, DOI 10.1016/j.resuscitation.2003.09.017; Imaoka S, 1996, BIOCHEM PHARMACOL, V51, P1041, DOI 10.1016/0006-2952(96)00052-4; Jurica J, 2007, J CHROMATOGR B, V852, P571, DOI 10.1016/j.jchromb.2007.02.034; Tveita T, 1996, CAN J PHYSIOL PHARM, V74, P376, DOI 10.1139/cjpp-74-4-376; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Field JM, 2010, CIRCULATION, V122, pS640, DOI 10.1161/CIRCULATIONAHA.110.970889; ARENDT RM, 1987, PSYCHOPHARMACOLOGY, V93, P72, DOI 10.1007/BF02439589; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; MICO BA, 1988, BIOCHEM PHARMACOL, V37, P2515, DOI 10.1016/0006-2952(88)90240-7; MATHEWS JM, 1985, J PHARMACOL EXP THER, V235, P186; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Holzer M, 2002, NEW ENGL J MED, V346, P549; Imanaga J, 2011, PHARMACOGENET GENOM, V21, P84, DOI 10.1097/FPC.0b013e32834300cc; MOSCHITTO LJ, 1983, J PHARM PHARMACOL, V35, P179; IMAOKA S, 1988, J BIOCHEM-TOKYO, V104, P481; Scherrmann JM, 2009, CHEM BIODIVERS, V6, P1933, DOI 10.1002/cbdv.200900171; HUIJZER JC, 1989, DRUG METAB DISPOS, V17, P37; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Nishida K, 2007, BIOL PHARM BULL, V30, P1763, DOI 10.1248/bpb.30.1763; Ghibellini G, 2007, CLIN PHARMACOL THER, V81, P406, DOI 10.1038/sj.clpt.6100059; Miyamoto H, 2013, J PHARM PHARMACOL, V65, P1536, DOI 10.1111/jphp.12130; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; MUGFORD CA, 1992, FUND APPL TOXICOL, V19, P43, DOI 10.1016/0272-0590(92)90026-E; Franke RM, 2008, CLIN PHARMACOL THER, V84, P704, DOI 10.1038/clpt.2008.94; Nagilla Rakesh, 2006, Journal of Pharmacological and Toxicological Methods, V53, P106, DOI 10.1016/j.vasen.2005.08.005; Baranczewski P, 2006, PHARMACOL REP, V58, P453; ECC Committee SaTFotAHA, 2005, CIRCULATION, V112, DOI 10.1161/CIRCULATIONAHA.105.166566; Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1; Hallifax D, 2006, DRUG METAB DISPOS, V34, P1829, DOI 10.1124/dmd.106.010413; NIES A S, 1976, Clinical Pharmacokinetics, V1, P135, DOI 10.2165/00003088-197601020-00005; Ortiz de Montellano PR, 1981, BIOCHEM J, V195, P761; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; WONG KC, 1983, WESTERN J MED, V138, P227	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2782	1099-081X		BIOPHARM DRUG DISPOS	Biopharm. Drug Dispos.	OCT	2015	36	7					481	489		10.1002/bdd.1960		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3EC	WOS:000363405900006		
J	Iwatani, J; Ishida, T; Donishi, T; Ukai, S; Shinosaki, K; Terada, M; Kaneoke, Y				Iwatani, Jun; Ishida, Takuya; Donishi, Tomohiro; Ukai, Satoshi; Shinosaki, Kazuhiro; Terada, Masaki; Kaneoke, Yoshiki			Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain	BRAIN AND BEHAVIOR			English	Article						magnetic resonance imaging; myelin; nucleus accumbens; schizophrenia; T1-weighted/T2-weighted ratio; ventral putamen	WHITE-MATTER INTEGRITY; REDUCED CORTICAL THICKNESS; PREFRONTAL CORTEX; 1ST-EPISODE SCHIZOPHRENIA; REGISTRATION ALGORITHM; LIKELIHOOD ESTIMATION; INTERSTITIAL-CELLS; NUCLEUS-ACCUMBENS; PYRAMIDAL NEURONS; T2-WEIGHTED MRI	Introduction: One leading hypothesis suggests that schizophrenia (SZ) is a neurodevelopmental disorder caused by genetic defects in association with environmental risk factors that affect synapse and myelin formation. Recent magnetic resonance imaging (MRI) studies of SZ brain showed both gray matter (GM) reduction and white matter (WM) fractional anisotropy reduction. In this study, we used T1-weighted (T1w)/T2-weighted (T2w) MRI ratio images, which increase myelin-related signal contrast and reduce receiver-coil bias. Methods: We measured T1w/T2w ratio image signal intensity in 29 patients with SZ and 33 healthy controls (HCs), and then compared them against bias-corrected T1w images. Results: Mean T1w/T2w ratio signal intensity values across all SZ GM and WM voxels were significantly lower than those for the HC values (analysis of covariance with age, gender, handedness, and premorbid intelligence quotient as nuisance covariates). SZ mean WM T1w/T2w ratio values were related to Global Assessment of Functioning (GAF) scores and were inversely related to the positive psychotic symptoms of the Positive and Negative Syndrome Scale. Voxel-based analysis revealed significantly lower T1w/T2w ratio image signal intensity values in the right ventral putamen in SZ GM. T1w image intensities did not differ between the SZ and HC groups. Conclusions: T1-weighted/T2-weighted ratio imaging increased the detectability of SZ pathological changes. Reduced SZ brain signal intensity is likely due to diminished myelin content; therefore, mapping myelin-related SZ brain changes using T1w/T2w ratio images may be useful for studies of SZ brain abnormalities.	[Iwatani, Jun; Ishida, Takuya; Ukai, Satoshi; Shinosaki, Kazuhiro] Wakayama Med Univ, Dept Neuropsychiat, Grad Sch, Wakayama 6418509, Japan; [Ishida, Takuya; Donishi, Tomohiro; Kaneoke, Yoshiki] Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, Wakayama 6418509, Japan; [Terada, Masaki] Wakayama Minami Radiol Clin, Wakayama 6410012, Japan	Ishida, T (reprint author), Wakayama Med Univ, Dept Syst Neurophysiol, Grad Sch, 811-1 Kimiidera, Wakayama 6418509, Japan.	ishitaku@wakayama-med.ac.jp			Japan Society for the Promotion of Science [24591303, 25350994]	This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (24591303 and 25350994) to Y.K and T.D.	Roussos P, 2012, ARCH GEN PSYCHIAT, V69, P7, DOI 10.1001/archgenpsychiatry.2011.110; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Lutti A, 2014, NEUROIMAGE, V93, P176, DOI 10.1016/j.neuroimage.2013.06.005; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; MELTZER HY, 1976, SCHIZOPHRENIA BULL, V2, P19; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Kubicki M, 2007, J PSYCHIAT RES, V41, P15, DOI 10.1016/j.jspychires.2005.05.005; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Selemon LD, 2003, ARCH GEN PSYCHIAT, V60, P69; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Raij TT, 2009, BRAIN, V132, P2994, DOI 10.1093/brain/awp186; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Garey L, 2010, J ANAT, V217, P324, DOI 10.1111/j.1469-7580.2010.01231.x; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; CROW TJ, 1977, PSYCHOL MED, V7, P213; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Whitford TJ, 2012, SCHIZOPHRENIA BULL, V38, P486, DOI 10.1093/schbul/sbq105; Billeke P, 2015, BIOL PSYCHIAT, V78, P421, DOI 10.1016/j.biopsych.2015.02.012; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; Kirkpatrick B, 2003, J NERV MENT DIS, V191, P563, DOI 10.1097/01.nmd.0000087181.61164.e1; Dean B, 2009, CURR OPIN PSYCHIATR, V22, P154, DOI 10.1097/YCO.0b013e328323d52e; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Pfefferbaum A, 1999, PSYCHIAT RES-NEUROIM, V91, P93, DOI 10.1016/S0925-4927(99)00023-2; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Flynn SW, 2003, MOL PSYCHIATR, V8, P811, DOI 10.1038/sj.mp.4001337; Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Grydeland H, 2013, J NEUROSCI, V33, P18618, DOI 10.1523/JNEUROSCI.2811-13.2013; Tkachev D, 2007, INT J NEUROPSYCHOPH, V10, P557, DOI 10.1017/S1461145706007334; Kubota M, 2011, SCHIZOPHR RES, V125, P21, DOI 10.1016/j.schres.2010.10.004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Iritani S, 2007, NEUROPATHOLOGY, V27, P604, DOI 10.1111/j.1440-1789.2007.00798.x; Kubota M, 2013, JAMA PSYCHIAT, V70, P12, DOI 10.1001/archgenpsychiatry.2012.1023; Iosifescu DV, 1997, NEUROIMAGE, V6, P13, DOI 10.1006/nimg.1997.0274; Bennett MR, 2011, PROG NEUROBIOL, V95, P275, DOI 10.1016/j.pneurobio.2011.08.003; Ellison-Wright I, 2008, AM J PSYCHIAT, V165, P1015, DOI 10.1176/appi.ajp.2008.07101562; Kubicki M, 2002, AM J PSYCHIAT, V159, P813, DOI 10.1176/appi.ajp.159.5.813; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Sasamoto A, 2014, SCHIZOPHRENIA BULL, V40, P420, DOI 10.1093/schbul/sbt030; Selemon LD, 1998, J COMP NEUROL, V392, P402; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Bengtsson-Tops A, 1999, EUR PSYCHIAT, V14, P256, DOI 10.1016/S0924-9338(99)00173-X; Kirkpatrick B, 1999, SYNAPSE, V34, P95, DOI 10.1002/(SICI)1098-2396(199911)34:2<95::AID-SYN2>3.0.CO;2-I; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Koch K, 2013, CORTEX, V49, P722, DOI 10.1016/j.cortex.2012.02.001; Lauer M, 2001, J NEURAL TRANSM, V108, P645, DOI 10.1007/s007020170042; Lang EJ, 2003, J NEUROPHYSIOL, V89, P2259, DOI 10.1152/jn.00922.2002; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Hoffman RE, 2011, BIOL PSYCHIAT, V69, P407, DOI 10.1016/j.biopsych.2010.09.050; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; Lee SH, 2013, SCHIZOPHR RES, V143, P231, DOI 10.1016/j.schres.2012.11.029; Garey LJ, 1998, J NEUROL NEUROSUR PS, V65, P446, DOI 10.1136/jnnp.65.4.446; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Knochel C, 2012, SCHIZOPHR RES, V140, P129, DOI 10.1016/j.schres.2012.06.001; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Sugai T, 2004, ANN NY ACAD SCI, V1025, P84, DOI 10.1196/annals.1316.011; Dazzan P, 2005, NEUROPSYCHOPHARMACOL, V30, P765, DOI 10.1038/sj.npp.1300603; Skelly LR, 2008, SCHIZOPHR RES, V98, P157, DOI 10.1016/j.schres.2007.10.009; Brandt Gerrit N, 2008, Wien Med Wochenschr, V158, P84, DOI 10.1007/s10354-007-0478-7; Brett M., HUMAN BRAIN MAPPING; Ganzetti M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00671; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; Inada T, 2008, JPN J CLIN PSYCHOPHA, V11, P887; Inagaki A., 2006, JPN J CLIN PSYCHOPHA, V9, P1443; Nelson H. E., 1982, NATL ADULT READING T; Rolland B., 2014, SCHIZOPHR B, V41, P291; Roussos P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00005; Shafee R, 2015, NEUROIMAGE, V105, P473, DOI 10.1016/j.neuroimage.2014.10.054; Teraguchi M., 2013, J MAGN RESON IMAGING, V40, P1199	80	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	OCT	2015	5	10							e00399	10.1002/brb3.399		14	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CU3KJ	WOS:000363423500013		
J	Yamamoto, M; Kushima, I; Kimura, H; Hayashi, A; Kawano, N; Aleksic, B; Iidaka, T; Ozaki, N				Yamamoto, Maeri; Kushima, Itaru; Kimura, Hiroki; Hayashi, Akiko; Kawano, Naoko; Aleksic, Branko; Iidaka, Tetsuya; Ozaki, Norio			White matter microstructure between the pre-SMA and the cingulum bundle is related to response conflict in healthy subjects	BRAIN AND BEHAVIOR			English	Article						Attention; connectivity; diffusion tractography; fractional anisotropy; functional MRI	MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; IMAGING TRACTOGRAPHY; ANTERIOR CINGULATE; LEARNING SUCCESS; BRAIN IMAGES; OLDER-ADULTS; DIFFUSION	Introduction: Response conflict involves selectively attending to relevant information and suppressing distracting, irrelevant information. The medial frontal cortex (MFC) is considered to be involved in response conflict. However, it remains unclear which white matter connectivity is associated with response conflict. This study aimed to delineate the neural connectivity of response conflict in healthy subjects and investigate the association between white matter microstructure and performance of a response conflict task. Method: Twenty-eight healthy subjects underwent functional magnetic resonance imaging (fMRI) during the Flanker task and diffusion MRI. We identified the presupplementary motor area (pre-SMA) using fMRI. Furthermore, we delineated the white matter connectivity between the pre-SMA and the cingulum bundle (CB), which is located in the MFC, using probabilistic tractography. We calculated the mean diffusivity (MD), index of white matter microstructure, of this tract and evaluate the association between MD and performance of the Flanker task. Result: The mean MD of this tract was significantly and positively associated with performance of the Flanker task. Conclusion: The present study suggests the white matter connectivity between the pre-SMA and the CB is related to the response conflict in healthy subjects and finer white matter microstructure is associated with smaller response conflict.	[Yamamoto, Maeri; Kushima, Itaru; Kimura, Hiroki; Hayashi, Akiko; Kawano, Naoko; Aleksic, Branko; Iidaka, Tetsuya; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4668550, Japan; [Kushima, Itaru] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4668550, Japan; [Kawano, Naoko] Nagoya Univ, Inst Innovat Future Soc, Nagoya, Aichi 4668550, Japan	Iidaka, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	iidaka@med.nagoya-u.ac.jp	Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; KUSHIMA, Itaru/M-8872-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; 	Japan Agency for Medical Research and development, AMED	Funding for this study was provided by research grants from Grant-in-Aid for "Integrated research on neuropsy-chiatric disorders" carried out under the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and development, AMED, the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from AMED and "Glial assembly: a new regulatory machinery of brain function and disorders".	Morecraft RJ, 2012, BRAIN RES BULL, V87, P457, DOI 10.1016/j.brainresbull.2011.12.005; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; O'Sullivan M, 2001, NEUROLOGY, V57, P632; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Wong FCK, 2011, J NEUROSCI, V31, P8780, DOI 10.1523/JNEUROSCI.0999-11.2011; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Della-Maggiore V, 2009, HUM BRAIN MAPP, V30, P4048, DOI 10.1002/hbm.20828; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Fjell AM, 2012, NEUROIMAGE, V61, P195, DOI 10.1016/j.neuroimage.2012.03.007; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Rae CL, 2015, J NEUROSCI, V35, P786, DOI 10.1523/JNEUROSCI.3093-13.2015; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Rudebeck SR, 2009, J NEUROSCI, V29, P14987, DOI 10.1523/JNEUROSCI.4707-09.2009; Gold BT, 2007, NEUROPSYCHOLOGIA, V45, P2439, DOI 10.1016/j.neuropsychologia.2007.04.011; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Baird AA, 2005, J COGNITIVE NEUROSCI, V17, P687, DOI 10.1162/0898929053467569; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Behrens TEJ, 2003, MAGNET RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Stuphorn V, 2000, NATURE, V408, P857; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Fuentemilla L, 2009, J NEUROSCI, V29, P8698, DOI 10.1523/JNEUROSCI.5270-08.2009; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Tamnes CK, 2012, J NEUROSCI, V32, P972, DOI 10.1523/JNEUROSCI.4779-11.2012; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Wolbers T, 2006, NEUROIMAGE, V32, P1450, DOI 10.1016/j.neuroimage.2006.05.011; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Cauda F, 2012, NEUROIMAGE, V62, P343, DOI 10.1016/j.neuroimage.2012.04.012; Bennett IJ, 2013, NEUROSCI BIOBEHAV R, V37, P1201, DOI 10.1016/j.neubiorev.2013.04.008; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Usami K, 2013, NEUROPSYCHOLOGIA, V51, P1011, DOI 10.1016/j.neuropsychologia.2013.02.002; Ge HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078831; Jbabdi Saad, 2011, Brain Connect, V1, P169, DOI 10.1089/brain.2011.0033; LesBihan D, 2003, NAT REV NEUROSCI, V4, P469; Niogi S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.002.2010; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN; vansVeen, 2001, NEUROIMAGE, V14, P1302	62	0	0	JOHN WILEY & SONS INC	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	OCT	2015	5	10							e00375	10.1002/brb3.375		11	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CU3KJ	WOS:000363423500006		
J	Ikota, H; Nobusawa, S; Arai, H; Kato, Y; Ishizawa, K; Hirose, T; Yokoo, H				Ikota, Hayato; Nobusawa, Sumihito; Arai, Hideo; Kato, Yukinari; Ishizawa, Keisuke; Hirose, Takanori; Yokoo, Hideaki			Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; IDH1; Immunohistochemistry	ISOCITRATE DEHYDROGENASE 1; MUTATIONS; DIFFERENTIATION; IDH1-R132G; INHIBITOR; TUMORS; CELLS	Glioma cells with the isocitrate dehydrogenase (IDH) 1 G395A mutation are strongly immunopositive for mIDH1(R132H), an antibody against mutant IDH1(R132H) (clone H09). However, we encountered some gliomas which were ambiguously positive for mIDH1(R132H) despite having the IDH1 G395A mutation. The aim of this study was to establish an evaluation procedure of IDH1 status by immunohistochemistry. Forty-three diffusely infiltrating gliomas were studied, and four of eight anaplastic oligoastrocytomas with the IDH1 G395A mutation were modestly or weakly positive for both the mIDH1(R132H) and an antibody against wild type IDH1, RcMab-1. Based on our staining results, the IDH1 expression of both wild and mutated types seemed to be codominant and also to be evenly suppressed under a certain condition. We propose a procedure for determining IDH1 status. If a glioma is weakly positive for mIDH1(R132H), immunohistochemistry for RcMab-1 should be performed. If the tumor cells are strongly positive for RcMab-1, the IDH1 G395A mutation is judged to be absent on the grounds that IDH1 expression is not suppressed. If the tumor cells are weakly positive for both mIDH1(R132H) and RcMab-1, then a conclusion should be made after DNA sequencing. This procedure is useful for practical evaluation of IDH1 status.	[Ikota, Hayato; Nobusawa, Sumihito; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gumma 3718511, Japan; [Arai, Hideo] Gunma Univ Hosp, Dept Diagnost Pathol, Maebashi, Gumma, Japan; [Kato, Yukinari] Tohoku Univ, Grad Sch Med, Dept Reg Innovat, Sendai, Miyagi 980, Japan; [Ishizawa, Keisuke] Saitama Med Univ, Dept Pathol, Saitama, Japan; [Hirose, Takanori] Kobe Univ, Dept Pathol Reg Commun, Kobe, Hyogo 657, Japan	Ikota, H (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	ikota@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [24790346]	We thank Mr. Koji Isoda and Mr. Yu Otaki (Gunma University) for their excellent technical assistance. This work was supported in part by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Y.K.), and a Grant-in-Aid for Young Scientists (B) (No. 24790346) from the Japan Society for the Promotion of Science (to H.I.).	Reitman ZJ, 2010, J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Ishizawa K, 2012, CLIN NEUROPATHOL, V31, P67, DOI 10.5414/NP300402; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Ikota H, 2011, BRAIN TUMOR PATHOL, V28, P107, DOI 10.1007/s10014-010-0016-y; Kato Y, 2009, BIOCHEM BIOPH RES CO, V390, P547, DOI 10.1016/j.bbrc.2009.10.001; Hirose T, 2013, HUM PATHOL, V44, P2353, DOI 10.1016/j.humpath.2013.02.013; Takano S, 2012, J NEURO-ONCOL, V108, P361, DOI 10.1007/s11060-012-0837-0; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Capper D, 2010, BRAIN PATHOL, V20, P245, DOI 10.1111/j.1750-3639.2009.00352.x; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Takano S, 2011, BRAIN TUMOR PATHOL, V28, P115, DOI 10.1007/s10014-011-0023-7; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Kaneko Mika Kato, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P224, DOI 10.1089/mab.2013.0006; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Kato Y, 2013, BIOCHEM BIOPH RES CO, V432, P564, DOI 10.1016/j.bbrc.2013.02.049; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P79, DOI 10.1007/s10014-014-0197-x; Kato Y, 2014, BRAIN TUMOR PATHOL, V32, P3; Louis DN, 2007, WHO CLASSIFICATION T	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					237	244		10.1007/s10014-015-0222-8		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700002		
J	Ishida, J; Kurozumi, K; Ichikawa, T; Otani, Y; Onishi, M; Fujii, K; Shimazu, Y; Oka, T; Shimizu, T; Date, I				Ishida, Joji; Kurozumi, Kazuhiko; Ichikawa, Tomotsugu; Otani, Yoshihiro; Onishi, Manabu; Fujii, Kentaro; Shimazu, Yosuke; Oka, Tetsuo; Shimizu, Toshihiko; Date, Isao			Evaluation of extracellular matrix protein CCN1 as a prognostic factor for glioblastoma	BRAIN TUMOR PATHOLOGY			English	Article						Glioma; CCN1; MGMT; Prognostic marker	IMMEDIATE-EARLY GENE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; ENDOMETRIAL CANCER; TUMOR PROGRESSION; MGMT EXPRESSION; POOR-PROGNOSIS; CYR61; GROWTH; CELLS	Recently, research efforts in identifying prognostic molecular biomarkers for malignant glioma have intensified. Cysteine-rich protein 61 (CCN1) is one of the CCN family of matricellular proteins that promotes cell growth and angiogenesis in cancers through its interaction with several integrins. In this study, we investigated the relationships among CCN1, O-6-methylguanine-DNA methyltransferase expression, the tumor removal rate, and prognosis in 46 glioblastoma patients treated at the Okayama University Hospital. CCN1 expression was high in 31 (67 %) of these patients. The median progression-free survival (PFS) and overall survival (OS) times of patients with high CCN1 expression was significantly shorter than those of patients with low CCN1 expression (p < 0.005). In a multivariate Cox analysis, CCN1 proved to be an independent prognostic factor for patient survival [PFS, hazard ratio (HR) = 3.53 (1.55-8.01), p = 0.003 and OS, HR = 3.05 (1.35-6.87), p = 0.007]. Moreover, in the 31 patients who underwent gross total resection, the PFS and OS times of those with high CCN1 expression were significantly shorter than those with low CCN1 expression. It was concluded that CCN1 might emerge as a significant prognostic factor regarding the prognosis of glioblastoma patients.	[Ishida, Joji; Kurozumi, Kazuhiko; Ichikawa, Tomotsugu; Otani, Yoshihiro; Onishi, Manabu; Fujii, Kentaro; Shimazu, Yosuke; Oka, Tetsuo; Shimizu, Toshihiko; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, Okayama 7008558, Japan	Kurozumi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	kkuro@md.okayama-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [20890133, 21791364, 19591675, 22591611]	We thank Dr. Koichi Ichimura in the Division of Brain Tumor Translational Research, National Cancer Center Research Institute, for advice concerning the MGMT pyrosequencing assay, and M. Arao and N. Uemori for their technical assistance. This study was supported by Grants-in-aid of Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology to K.K. (Nos. 20890133 and 21791364), and T.I. (Nos. 19591675 and 22591611).	Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Esteller M, 2000, CANCER RES, V60, P2368; Parisi MS, 2006, BONE, V38, P671, DOI 10.1016/j.bone.2005.10.005; Massague J, 2008, MOL CELL, V29, P149, DOI 10.1016/j.molcel.2008.01.006; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; De Salvo M, 2011, INT J RADIAT BIOL, V87, P518, DOI 10.3109/09553002.2011.556173; Chien WW, 2004, J BIOL CHEM, V279, P53087, DOI 10.1074/jbc.M410254200; Haseley A, 2012, CANCER RES, V72, P1353, DOI 10.1158/0008-5472.CAN-11-2526; Pistollato F, 2010, STEM CELLS, V28, P851, DOI 10.1002/stem.415; Watari H, 2009, GYNECOL ONCOL, V112, P229, DOI 10.1016/j.ygyno.2008.09.039; Xie D, 2001, J BIOL CHEM, V276, P14187; Esteller M, 1999, CANCER RES, V59, P793; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Kurozumi K, 2008, MOL THER, V16, P1382, DOI 10.1038/mt.2008.112; Maeta N, 2007, ONCOLOGY-BASEL, V73, P118, DOI 10.1159/000121000; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Tang QL, 2011, ORAL SURG ORAL MED O, V112, P228, DOI 10.1016/j.tripleo.2011.02.030; Xie JJ, 2011, EJSO-EUR J SURG ONC, V37, P669, DOI 10.1016/j.ejso.2011.05.009; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Xie D, 2004, CANCER RES, V64, P1987, DOI 10.1158/0008-5472.CAN-03-0666; Lafuente JV, 2000, NEUROPATHOLOGY, V20, P176, DOI 10.1046/j.1440-1789.2000.00329.x; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Fujii K, 2013, CANCER GENE THER, V20, P437, DOI 10.1038/cgt.2013.38; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Miyazaki M, 2014, NEUROPATHOLOGY, V34, P268, DOI 10.1111/neup.12091; PEGG AE, 1990, CANCER RES, V50, P6119; Walsh CT, 2008, FASEB J, V22, P4011, DOI 10.1096/fj.08-113266; Lalezari S, 2013, NEURO-ONCOLOGY, V15, P370, DOI 10.1093/neuonc/nos308; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Burke E, 2013, ACTA NEUROPATHOL COM, V1, P1; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Ishida J, 2014, TRANSL ONCOL, V7, pe291; Shimazu Y, 2015, GENE THER, V22, P146, DOI 10.1038/gt.2014.100; Zhou ZQ, 2009, BMC CANCER, V22, P291	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					245	252		10.1007/s10014-015-0227-3		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700003		
J	Yano, H; Ohe, N; Nakayama, N; Nomura, Y; Miwa, K; Shinoda, J; Iwama, T				Yano, Hirohito; Ohe, Naoyuki; Nakayama, Noriyuki; Nomura, Yu-ichi; Miwa, Kazuhiro; Shinoda, Jun; Iwama, Toru			Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components	BRAIN TUMOR PATHOLOGY			English	Article						Glioblastoma with oligodendroglial component; PET; Methionine; Dynamic; Pathology	GENETIC ALTERATIONS; IDH1 MUTATION; BRAIN-TUMORS; PROGNOSIS; GLIOMAS; 1P; CLASSIFICATION; CHEMOTHERAPY; RADIOTHERAPY; EXPRESSION	Anaplastic oligoastrocytoma (AOA) with necrosis is classified as glioblastoma (GBM) with oligodendroglioma component (GBMO), according to the 2007 World Health Organization classification. The prognosis of GBMO remains controversial because definitive diagnostic criteria regarding the percentage of the oligodendroglial components (OC) in the GBM do not exist. We previously reported dynamic methionine (MET) positron emission tomography (PET) in patients with these tumors. A significant decrease in the MET signal was seen in oligodendrocytic tumors, in contrast to a significant MET increase in GBMs. In this study, we analyzed the dynamic MET PET signal in four patients with primary (n = 2) and secondary (n = 2) GBMOs. Static PET scanning was performed in three consecutive phases. Both cases of primary GBMOs and one case of secondary GBMO presented with a gradual decrease in MET PET signal over the consecutive phases. In contrast, the remaining case of secondary GBMO presented with a pattern of slight increase. It is likely that the dynamic change of MET in patients with GBMO resemble those in patients with oligodendroglial tumor, however, further studies are needed to confirm them. We discuss the mechanisms from a viewpoint of pathological findings.	[Yano, Hirohito; Ohe, Naoyuki; Nakayama, Noriyuki; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu 5011194, Japan; [Nomura, Yu-ichi; Shinoda, Jun] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Dept Neurosurg, Minokamo 5058503, Japan; [Miwa, Kazuhiro] Gifu Prefectural Gero Hot Spring Hosp, Dept Neurosurg, Gero 5092292, Japan	Yano, H (reprint author), Gifu Univ, Grad Sch Med, Dept Neurosurg, 1-1 Yanagido, Gifu 5011194, Japan.	hirohito@gifu-u.ac.jp			MSD	This work was supported by a grant from MSD. The funders had no role in the study design, data collection and analysis, publication decision, or manuscript preparation.	Aki T, 2012, J NEURO-ONCOL, V109, P115, DOI 10.1007/s11060-012-0873-9; Kraus JA, 2001, ACTA NEUROPATHOL, V101, P311; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Saito T, 2013, AM J NEURORADIOL, V34, P85, DOI 10.3174/ajnr.A3173; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Pinto LW, 2008, VIRCHOWS ARCH, V452, P481, DOI 10.1007/s00428-007-0562-9; Homma T, 2006, J NEUROPATH EXP NEUR, V65, P846, DOI 10.1097/01.jnen.0000235118.75182.94; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; McDonald JM, 2005, CANCER, V104, P1468, DOI 10.1002/cncr.21338; Ha SY, 2013, J NEURO-ONCOL, V112, P439, DOI 10.1007/s11060-013-1073-y; Jiang HH, 2014, J NEURO-ONCOL, V116, P395, DOI 10.1007/s11060-013-1311-3; Nakamura H, 2011, BRAIN TUMOR PATHOL, V28, P185, DOI 10.1007/s10014-011-0039-z; He J, 2001, J NEUROPATH EXP NEUR, V60, P863; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Appin CL, 2013, BRAIN PATHOL, V23, P454, DOI 10.1111/bpa.12018; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Hegi ME, 2012, ACTA NEUROPATHOL, V123, P841, DOI 10.1007/s00401-011-0938-4; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Miller CR, 2006, J CLIN ONCOL, V24, P5419, DOI 10.1200/JCO.2006.08.1497; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Klink B, 2011, CELL ONCOL, V34, P261, DOI 10.1007/s13402-011-0034-8; Miyazaki M, 2014, NEUROPATHOLOGY, V34, P268, DOI 10.1111/neup.12091; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Myung JK, 2014, TRANSL ONCOL, V7, P712, DOI 10.1016/j.tranon.2014.10.002; Singh VY, 2014, NEUROL INDIA, V62, P32, DOI 10.4103/0028-3886.128275; Decaestecker C, 1998, J NEUROPATH EXP NEUR, V57, P791, DOI 10.1097/00005072-199808000-00008; Figarella-Branger D, 2014, BRAIN PATHOL; Hilton DA, 2004, HISTOPATHOLOGY, V44, P555, DOI 10.1111/j.1365-2559.2004.01887.x; Kanno H, 2012, PLOS ONE, V7, P7; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-247	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					253	260		10.1007/s10014-015-0218-4		8	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700004		
J	Matsumura, N; Nobusawa, S; Ikota, H; Hirato, J; Hirose, T; Yokoo, H; Nakazato, Y				Matsumura, Nozomi; Nobusawa, Sumihito; Ikota, Hayato; Hirato, Junko; Hirose, Takanori; Yokoo, Hideaki; Nakazato, Yoichi			Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors	BRAIN TUMOR PATHOLOGY			English	Article						Cyclin D1; Alpha-internexin; Oligodendroglioma; Oligodendrocyte precursor cells; Immunohistochemistry	III BETA-TUBULIN; NEURONAL MARKERS; 1P/19Q STATUS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ASTROCYTOMAS; LOCALIZATION; CARCINOMA; CANCER	Oligodendroglial tumors with neuronal differentiation cases have been reported in recent studies. Oligodendrocyte precursor cells (OPCs) give rise to both oligodendrocytes and neurons; however, little is known about the association between OPCs and oligodendroglial tumors with neuronal differentiation. Previously, we observed the coexpression of cyclin D1, one of the OPC markers, and alpha-internexin (INA) in oligodendroglial tumor cells. INA is a neuronal marker, and has been indicated as an immunohistochemical surrogate of chromosome 1p/19q co-deletion in oligodendroglial tumors. In this study, we investigated the expression status in 83 gliomas immunohistochemically, and found that cyclin D1-positive cells were commonly detected in gliomas. There was no correlation between the cyclin D1 and Ki-67 labeling indices, suggesting an unrecognized role of cyclin D1 other than a cell cycle regulator in gliomas. Cyclin D1/INA double-positive cells were consistently observed in oligodendroglial tumors regardless of histological grade. In 2 cases of oligodendroglioma with neuronal differentiation, the tumor cells of neuronal morphology showed higher expression of INA, suggesting INA expression may be associated with a bona fide neuronal phenotype. The prevalence of cyclin D1/INA double-positive cells is a distinct feature of oligodendroglial tumors. This new characteristic finding may have practical utility in glioma classification.	[Matsumura, Nozomi; Nobusawa, Sumihito; Ikota, Hayato; Yokoo, Hideaki] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 3718511, Japan; [Hirato, Junko] Gunma Univ Hosp, Dept Pathol, Maebashi, Gunma, Japan; [Hirose, Takanori] Hyogo Canc Ctr, Dept Diagnost Pathol, Akashi, Hyogo, Japan; [Nakazato, Yoichi] Hidaka Hosp, Dept Pathol, Takasaki, Gunma, Japan	Matsumura, N (reprint author), Gunma Univ, Grad Sch Med, Dept Human Pathol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	nozomim@gunma-u.ac.jp					Giannini C, 2002, AM J SURG PATHOL, V26, P479, DOI 10.1097/00000478-200204000-00010; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Ducray F, 2009, NEUROLOGY, V72, P156, DOI 10.1212/01.wnl.0000339055.64476.cb; Sallinen SL, 1999, J PATHOL, V188, P289; Vyberg M, 2007, HISTOPATHOLOGY, V50, P887, DOI 10.1111/j.1365-2559.2007.02686.x; Hirose T, 2013, HUM PATHOL, V44, P2353, DOI 10.1016/j.humpath.2013.02.013; Liu W, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/651207; Zhao X, 2010, MED ONCOL, V27, P985, DOI 10.1007/s12032-009-9320-y; Tanaka Y, 2012, BRAIN TUMOR PATHOL, V29, P221, DOI 10.1007/s10014-011-0078-5; Katsetos CD, 2001, ARCH PATHOL LAB MED, V125, P613; Arici DS, 2009, NEOPLASMA, V56, P63; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Katsetos CD, 2002, J NEUROPATH EXP NEUR, V61, P307; Eigenbrod S, 2011, J NEUROPATH EXP NEUR, V70, P970, DOI 10.1097/NEN.0b013e3182333ef5; Perry A, 2010, ACTA NEUROPATHOL, V120, P237, DOI 10.1007/s00401-010-0695-9; Perry A, 2002, J NEUROPATH EXP NEUR, V61, P947; Shamma A, 2000, INT J ONCOL, V16, P261; Barnes DM, 1998, BREAST CANCER RES TR, V52, P1, DOI 10.1023/A:1006103831990; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; GERDES J, 1984, J IMMUNOL, V133, P1710; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Nobs L, 2013, GLIA, V61, P1443, DOI 10.1002/glia.22533; Chojnacki A, 2008, ANN NEUROL, V64, P127, DOI 10.1002/ana.21421; Wang JY, 2012, J NEURO-ONCOL, V106, P473, DOI 10.1007/s11060-011-0692-4; Wharton SB, 2002, J CLIN NEUROSCI, V9, P165, DOI 10.1054/jocn.2001.1055; Bailey P, 1929, J PATHOL BACTERIOL, V32, P735, DOI 10.1002/path.1700320403; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Buckley PG, 2011, J NEUROPATH EXP NEUR, V70, P177, DOI 10.1097/NEN.0b013e31820c765b; Barrows Brad D, 2012, Turk Patoloji Derg, V28, P95, DOI 10.5146/tjpath.2012.01107; Ducray F, 2008, MOL CANCER, V7, P1, DOI DOI 10.1186/1476-4598-7-41; Liang S, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-138; Louis DN, 2007, WHO CLASSIFICATION T; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027628; Matsumura N, 2014, BRAIN TUMOR PATHOL, V31, P17, DOI 10.1007/s10014-012-0133-x; Nagaishi M, 2014, BRAIN TUMOR PATHOL, V31, P257, DOI 10.1007/s10014-013-0168-7; Reifenberger G, 2007, WHO CLASSIFICATION T, P54; Seiler R, 2014, MODERN PATHOL, V27, P87, DOI 10.1038/modpathol.2013.125	39	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					261	267		10.1007/s10014-015-0228-2		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700005		
J	Nakada, S; Minato, H; Takegami, T; Kurose, N; Ikeda, H; Kobayashi, M; Sasagawa, Y; Akai, T; Kato, T; Yamamoto, N; Nojima, T				Nakada, Satoko; Minato, Hiroshi; Takegami, Tsutomu; Kurose, Nozomu; Ikeda, Hiroko; Kobayashi, Masako; Sasagawa, Yasuo; Akai, Takuya; Kato, Takashi; Yamamoto, Norio; Nojima, Takayuki			NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases	BRAIN TUMOR PATHOLOGY			English	Article						Hemangiopericytoma; Solitary fibrous tumor; Meningeal tumor; Immunohistochemistry; NAB2-STAT6 fusion gene	TUMOR; HEMANGIOPERICYTOMA; STAT6; MENINGIOMA; EXPRESSION; DIAGNOSIS; VARIANTS; EGR-1	We present two cases of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma (HPC) with immunohistochemistry of STAT6 and analysis of NAB2-STAT6 fusion genes. Case 1 was a 37-year-old male with a left middle fossa tumor; case 2 was a 68-year-old female with a cerebellar tumor. They showed late metastasis to the lung or bone 8 or 13 years, respectively, after the first surgery. Histology of both primary and metastatic tumors showed a cellular hemangiopericytomatous pattern with nuclear atypia. The primary tumors showed nuclear staining of STAT6, but both metastatic tumors showed nuclear and cytoplasmic STAT6. DNA sequencing revealed two kinds of NAB2-STAT6 fusion genes. One consisted of exon 6 of NAB2, intron 6 of NAB2, and the middle of exon 17 of STAT6 (observed in the primary and metastatic tumors of case 1); the other consisted of exon 6 of NAB2 and the beginning of exon 17 of STAT6 (observed in the metastatic tumor of case 2). The primary tumor of case 2 had both fusion genes. To the best of our knowledge, we are the first to report NAB2-STAT6 fusion gene analysis in primary and metastatic meningeal SFT/HPCs and a case showed different fusion gene status in the metastatic tumor.	[Nakada, Satoko; Minato, Hiroshi; Kurose, Nozomu; Nojima, Takayuki] Kanazawa Med Univ, Dept Pathol & Lab Med, Kanazawa, Ishikawa, Japan; [Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Kanazawa, Ishikawa, Japan; [Ikeda, Hiroko] Kanazawa Univ Hosp, Sect Diagnost Pathol, Kanazawa, Ishikawa, Japan; [Kobayashi, Masako] Kanazawa Municipal Hosp, Dept Pathol, Kanazawa, Ishikawa, Japan; [Sasagawa, Yasuo; Akai, Takuya] Kanazawa Med Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan; [Kato, Takashi; Yamamoto, Norio] Kanazawa Univ Hosp, Dept Orthoped, Kanazawa, Ishikawa, Japan	Minato, H (reprint author), Kanazawa Med Univ, Dept Pathol & Lab Med, Kanazawa, Ishikawa, Japan.	hminato@kanazawa-med.ac.jp			Ministry of Health, Labor and Welfare [H26-084]; JSPS KAKENHI [26460660]	The authors specially thank Mr. Manabu Yamashita for technical assistance of fusion gene analysis. This study was supported in part by the Health and Labor Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labor and Welfare H26-084 (T. N.) and by JSPS KAKENHI Grant Number 26460660 (H. M.).	Robinson DR, 2013, NAT GENET, V45, P180, DOI 10.1038/ng.2509; Rajaram V, 2004, HUM PATHOL, V35, P1413, DOI 10.1016/j.humpath.2004.07.017; Chmielecki J, 2013, NAT GENET, V45, P131, DOI 10.1038/ng.2522; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Mohajeri A, 2013, GENE CHROMOSOME CANC, V52, P873, DOI 10.1002/gcc.22083; Doyle LA, 2014, MODERN PATHOL, V27, P1231, DOI 10.1038/modpathol.2013.247; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Guillou L, 2000, HUM PATHOL, V31, P1108, DOI 10.1053/hupa.2000.9777; Shirakawa T, 2011, J BIOL CHEM, V286, P4003, DOI 10.1074/jbc.M110.168435; Barthelmess S, 2014, AM J PATHOL, V184, P1209, DOI 10.1016/j.ajpath.2013.12.016; Doyle LA, 2014, MODERN PATHOL, V27, P390, DOI 10.1038/modpathol.2013.164; Schweizer L, 2013, ACTA NEUROPATHOL, V125, P651, DOI 10.1007/s00401-013-1117-6; Perry A, 1997, AM J SURG PATHOL, V21, P1354, DOI 10.1097/00000478-199711000-00010; Fountas KN, 2006, NEUROSURG REV, V29, P145, DOI 10.1007/s10143-005-0001-9; Damodaran O, 2014, J CLIN NEUROSCI, V21, P1310, DOI 10.1016/j.jocn.2013.11.026; Fletcher CDM, 2013, WHO CLASSIFICATION T, P80; Koelsche C, 2014, HISTOPATHOLOGY, V65, P613, DOI 10.1111/his.12431; Paulus W, 2007, WHO CLASSIFICATION T, P173; Reich N. C., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.27080; Yoshida A, 2014, AM J SURG PATHOL, V38, P552, DOI 10.1097/PAS.0000000000000137	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					268	274		10.1007/s10014-015-0220-x		7	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700006		
J	Tashiro, R; Kanamori, M; Suzuki, H; Utsunomiya, A; Meguro, K; Uenohara, H; Tominaga, T				Tashiro, Ryosuke; Kanamori, Masayuki; Suzuki, Hiroyoshi; Utsunomiya, Akihiro; Meguro, Kuniaki; Uenohara, Hiroshi; Tominaga, Teiji			Diffuse large B cell lymphoma of the cranial vault: two case reports	BRAIN TUMOR PATHOLOGY			English	Article						Cranial vault; Diffuse large B cell lymphoma; Skull; Pathological findings	MALIGNANT-LYMPHOMA; DURA-MATER; SKULL; SCALP; BONE	Malignant lymphoma of the cranial vault is a rare entity and the tumor growth patterns are not well understood. Here we report two cases of malignant lymphoma involving the scalp and epidural space with slight changes in the intervening skull. A 63-year-old woman presented with a scalp mass in her right frontal area. Computed tomography (CT) and magnetic resonance (MR) imaging demonstrated mass lesions in the scalp and epidural space with slight osteolytic changes in the intervening skull. She underwent resection of the lesions. A 53-year-old man presented with a mass in his right frontal area. CT and MR imaging showed mass lesions in the scalp and epidural space without changes in the skull. He underwent resection of the lesions. The histopathological diagnosis was diffuse large B cell lymphoma in both cases. Microscopic examination of the intervening skull found that the bone marrow was diffusely replaced by lymphoma cells, and lymphoma cells extended to the extra- or intra-cranial space along the emissary veins without destruction of the cortical or trabecular bone. These histopathological findings explain the radiological findings and provide the clues to elucidate the mechanism of extension of cranial vault lymphoma.	[Tashiro, Ryosuke; Kanamori, Masayuki; Utsunomiya, Akihiro; Uenohara, Hiroshi] Sendai Med Ctr, Dept Neurosurg, Miyagino Ku, Sendai, Miyagi 9838520, Japan; [Suzuki, Hiroyoshi] Sendai Med Ctr, Dept Pathol & Lab Med, Sendai, Miyagi 9838520, Japan; [Meguro, Kuniaki] Sendai Med Ctr, Dept Hematol, Sendai, Miyagi 9838520, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan	Kanamori, M (reprint author), Sendai Med Ctr, Dept Neurosurg, Miyagino Ku, 2-8-8 Miyagino, Sendai, Miyagi 9838520, Japan.	mkanamori@med.tohoku.ac.jp					Abdelwahab IF, 2007, SKELETAL RADIOL, V36, P335, DOI 10.1007/s00256-006-0096-2; Salunke P, 2013, NEUROL INDIA, V61, P201, DOI 10.4103/0028-3886.111161; Fukushima Y, 2007, ACTA NEUROCHIR, V149, P601, DOI 10.1007/s00701-007-1156-7; El Asri AC, 2012, ACTA NEUROCHIR, V154, P257, DOI 10.1007/s00701-011-1124-0; Ochiai H, 2010, NEUROL MED-CHIR, V50, P595; HOLTAS S, 1985, J COMPUT ASSIST TOMO, V9, P725, DOI 10.1097/00004728-198507010-00011; Mulligan ME, 1999, AM J ROENTGENOL, V173, P1691; Yoon SH, 2008, J NEUROSURG, V108, P1018, DOI 10.3171/JNS/2008/108/5/1018; Khalid M, 2010, JBR-BTR, V93, P296; TOMASZEK DE, 1984, SURG NEUROL, V21, P182, DOI 10.1016/0090-3019(84)90339-2; MORIOKA T, 1994, SURG NEUROL, V42, P117, DOI 10.1016/0090-3019(94)90370-0; Gonzalez-Bonet LG, 2008, ACTA NEUROCHIR, V150, P507, DOI 10.1007/s00701-007-1416-6; Nishimoto T, 2003, NEUROL SURG TOKYO, V31, P43; da Rocha AJ, 2010, J NEURO-ONCOL, V100, P9, DOI 10.1007/s11060-010-0137-5; Christine PH, 2004, BLOOD, V103, P275; Horstman AL, 2004, HAEMATOLOGICA, V89, pe42; Ko Myeong-Jin, 2013, Brain Tumor Res Treat, V1, P32, DOI 10.14791/btrt.2013.1.1.32; Kosugi Shigeki, 2013, J Clin Exp Hematop, V53, P215; Martin J, 2012, CASE REP NEUROL MED, V2012; Muin I A, 1997, Med J Malaysia, V52, P86; Razaei-Kalantari K, 2012, IRAN J RADIOL, V9, P88; Viella LM, 2007, J NEUROONCOL, V83, P181; Yuki K, 1989, Neurol Med Chir (Tokyo), V29, P762, DOI 10.2176/nmc.29.762	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					275	280		10.1007/s10014-015-0225-5		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700007		
J	Momota, H; Kato, S; Fujii, M; Tsujiuchi, T; Takahashi, Y; Kojima, S; Wakabayashi, T				Momota, Hiroyuki; Kato, Seiichi; Fujii, Masazumi; Tsujiuchi, Takashi; Takahashi, Yoshiyuki; Kojima, Seiji; Wakabayashi, Toshihiko			Primary peripheral T-cell lymphoma, not otherwise specified, of the central nervous system in a child	BRAIN TUMOR PATHOLOGY			English	Article						Peripheral T-cell lymphoma; Central nervous system; Radiochemotherapy; Pediatric	EXPERIENCE; DIAGNOSIS; JAPAN	Primary peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare disease that infrequently involves the central nervous system (CNS), and it is even rarer in pediatric patients. Here, we report of a 13-year-old male with primary CNS PTCL-NOS who exhibited a malignant clinical course with recurrence after radiochemotherapy followed by bone marrow transplantation; he died 43 months after diagnosis. Pathology revealed the proliferation of cytotoxic T-cells and clonal T-cell receptor gene rearrangements. Although the optimal therapy for PTCL remains controversial, intensive radiochemotherapy may be required for some patients.	[Momota, Hiroyuki; Fujii, Masazumi; Tsujiuchi, Takashi; Wakabayashi, Toshihiko] Nagoya Univ Hosp, Dept Neurosurg, Showa Ku, Nagoya, Aichi 4668560, Japan; [Kato, Seiichi] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan; [Kato, Seiichi] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan; [Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ Hosp, Dept Pediat, Nagoya, Aichi, Japan	Momota, H (reprint author), Univ Tokyo, Inst Med Sci, Dept Surg Neurooncol, Div Innovat Canc Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	momota-nsu@umin.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590478]	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (24590478) to Hiroyuki Momota.	Windsor R, 2008, PEDIATR BLOOD CANCER, V50, P784, DOI 10.1002/pbc.21293; Shibamoto Y, 2008, NEURO-ONCOLOGY, V10, P560, DOI 10.1215/15228517-2008-028; Lee DK, 2002, CLIN NEUROPATHOL, V21, P149; Asano N, 2005, AM J SURG PATHOL, V29, P1284, DOI 10.1097/01.pas.0000173238.17331.6b; Weisenburger DD, 2011, BLOOD, V117, P3402, DOI 10.1182/blood-2010-09-310342; Lim T, 2011, ANN HEMATOL, V90, P1391, DOI 10.1007/s00277-011-1225-0; Lueth M, 2012, J PEDIAT HEMATOL ONC, V34, pE66, DOI 10.1097/MPH.0b013e318219f95e; Kato Y, 2014, INTERNAL MED, V53, P1197, DOI 10.2169/internalmedicine.53.1902; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Liu D, 2003, AM J SURG PATHOL, V27, P682, DOI 10.1097/00000478-200305000-00012; Choi JS, 2003, AM J SURG PATHOL, V27, P919, DOI 10.1097/00000478-200307000-00007; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Al Mahmoud R, 2012, J PEDIAT HEMATOL ONC, V34, P611, DOI 10.1097/MPH.0b013e3182707592; Ogura R, 2013, NEUROPATHOLOGY, V33, P436, DOI 10.1111/neup.12005; Bataille B, 2000, J NEUROSURG, V92, P261, DOI 10.3171/jns.2000.92.2.0261; Ferreri AJM, 2002, NEUROLOGY, V58, P1513; Demetriades AK, 2003, BRIT J NEUROSURG, V17, P473, DOI 10.1080/02688690310001613880; Kato S, 2012, HISTOPATHOLOGY, V61, P186, DOI 10.1111/j.1365-2559.2012.04199.x; Harder A, 2003, ACTA NEUROPATHOL, V105, P65, DOI 10.1007/s00401-002-0619-4; Takiyama A, 2008, NEUROPATHOLOGY, V28, P640, DOI 10.1111/j.1440-1789.2008.00903.x; El-Mallawany NK, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.8; Kato S, 2015, AM J SURG PATHOL, V39, P462, DOI 10.1097/PAS.0000000000000323; Fujita M, 2000, PATHOL INT, V50, P696	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					281	285		10.1007/s10014-015-0229-1		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700008		
J	Noshiro, S; Wanibuchi, M; Akiyama, Y; Okawa, S; Ohtaki, S; Sugino, T; Iihoshi, S; Mikami, T; Sugita, S; Hasegawa, T; Mikuni, N				Noshiro, Shouhei; Wanibuchi, Masahiko; Akiyama, Yukinori; Okawa, Satoshi; Ohtaki, Shunya; Sugino, Toshiya; Iihoshi, Satoshi; Mikami, Takeshi; Sugita, Shintaro; Hasegawa, Tadashi; Mikuni, Nobuhiro			IgG4-related disease initially presented as an orbital mass lesion mimicking optic nerve sheath meningioma	BRAIN TUMOR PATHOLOGY			English	Article						IgG4-related disease; Orbital tumor; Optic nerve sheath meningioma	SYSTEMIC-DISEASE; SERUM IGG4; TUMORS	We report a case of an optic nerve mass lesion associated with IgG4-related disease. A 39-year-old man presented with right blurred vision and proptosis 8 years before admission. Magnetic resonance imaging showed a mass lesion in the center of the right orbit, which was diagnosed as optic nerve sheath meningioma by neuroradiologists and neurosurgeons. Irradiation was selected for treatment of the lesion on the basis of the radiological diagnosis; subsequently, the lesion gradually reduced in size. However, regrowth of an optic nerve mass lesion observed during the previous 2 years caused remarkable exophthalmos, and removal of the orbital mass lesion was performed via a transcranial orbital approach. Pathological examinations resulted in a diagnosis of IgG4-related disease, and hematological tests revealed an elevated level of serum IgG4. Additional radiological examinations showed mass lesions in the left maxillary nerve, bilateral inferior alveolar nerves, paravertebral tissue, and left kidney. Treatment with oral steroids has produced a reduction in the size of these lesions.	[Noshiro, Shouhei; Wanibuchi, Masahiko; Akiyama, Yukinori; Okawa, Satoshi; Ohtaki, Shunya; Sugino, Toshiya; Iihoshi, Satoshi; Mikami, Takeshi; Mikuni, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Neurosurg, Chuo Ku, Sapporo, Hokkaido 0608543, Japan; [Sugita, Shintaro; Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido 0608543, Japan	Wanibuchi, M (reprint author), Sapporo Med Univ, Sch Med, Dept Neurosurg, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	wanibuti@sapmed.ac.jp					Plaza JA, 2011, ARCH OPHTHALMOL-CHIC, V129, P421, DOI 10.1001/archophthalmol.2011.16; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Mendenhall WM, 2010, AM J CLIN ONCOL-CANC, V33, P304, DOI 10.1097/COC.0b013e3181a07567; Oyama T, 2011, JPN J OPHTHALMOL, V55, P304, DOI 10.1007/s10384-011-0003-9; Ebbo M, 2012, MEDICINE, V91, P49, DOI 10.1097/MD.0b013e3182433d77; Yamamoto M, 2012, MOD RHEUMATOL, V22, P419, DOI 10.1007/s10165-011-0532-6; Shields JA, 2004, OPHTHALMOLOGY, V111, P997, DOI 10.1016/j.orphtha.2003.01.002; Ohtsuka K, 2005, JPN J OPHTHALMOL, V49, P49, DOI 10.1007/s10384-004-0147-y; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Espinoza Gabriela M, 2010, Curr Rheumatol Rep, V12, P443, DOI 10.1007/s11926-010-0128-8; Nagai Kazuki, 2011, J Med Case Rep, V5, P427, DOI 10.1186/1752-1947-5-427; Turbin Roger E, 2004, Cancer Control, V11, P334; Yamamoto Motohisa, 2008, Nihon Rinsho Meneki Gakkai Kaishi, V31, P1	14	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					286	290		10.1007/s10014-015-0223-7		5	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700009		
J	Yamamoto, T; Matsubara, T; Satomi, K; Sakamoto, N; Matsuda, M; Muroi, A; Ishikawa, E; Akutsu, H; Nakai, K; Matsumura, A				Yamamoto, Tetsuya; Matsubara, Teppei; Satomi, Kaishi; Sakamoto, Noriaki; Matsuda, Masahide; Muroi, Ai; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsumura, Akira			Rosette-forming glioneuronal tumor originating in the hypothalamus	BRAIN TUMOR PATHOLOGY			English	Article						Hypothalamus; Rosette-forming glioneuronal tumor; Precocious puberty	DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR; CENTRAL-NERVOUS-SYSTEM; OF-THE-LITERATURE; KIAA1549-BRAF FUSION; 4TH-VENTRICLE RGNT; PATIENT; VENTRICLE; DIAGNOSIS; COMPONENT; FEATURES	Rosette-forming glioneuronal tumors (RGNT) of the fourth ventricle are slow-growing tumors that primarily involve the fourth ventricular region. We here report the first patient, an 8-year-old girl, with an RGNT originating in the hypothalamus and manifesting with precocious puberty. After partial removal, the remaining tumor showed rapid enlargement, and the pathologic diagnosis at the second surgery revealed histopathologic features similar to those found in the initial samples, including biphasic patterns of neurocytic rosettes and GFAP-stained astrocytic components. These tumor cells had mildly atypical nuclei; however, mitotic figures and necrosis were absent. Eosinophilic granular bodies and a glomeruloid vasculature were found, but Rosenthal fibers were absent. The Ki-67 proliferative index was 3.5 % (vs 1.1 % at the initial surgery). No recurrence was recorded during the 3-year period after the proton radiotherapy.	[Yamamoto, Tetsuya; Matsubara, Teppei; Matsuda, Masahide; Muroi, Ai; Ishikawa, Eiichi; Akutsu, Hiroyoshi; Nakai, Kei; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan; [Satomi, Kaishi; Sakamoto, Noriaki] Univ Tsukuba, Fac Med, Dept Pathol, Tsukuba, Ibaraki 3058575, Japan	Yamamoto, T (reprint author), Univ Tsukuba, Fac Med, Dept Neurosurg, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	yamamoto_neurosurg@md.tsukuba.ac.jp					Marhold F, 2008, J NEURO-ONCOL, V90, P301, DOI 10.1007/s11060-008-9661-y; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Jacques TS, 2006, NEUROPATH APPL NEURO, V32, P217, DOI 10.1111/j.1365-2990.2005.00692.x; Solis OE, 2011, J NEURO-ONCOL, V102, P477, DOI 10.1007/s11060-010-0335-1; Chiba K, 2014, CHILD NERV SYST, V30, P351, DOI 10.1007/s00381-013-2216-3; Li YM, 2009, J INT MED RES, V37, P958; Alturkustani M, 2012, CAN J NEUROL SCI, V39, P95; Johnson M, 2006, J NEUROSURG, V105, P129, DOI 10.3171/jns.2006.105.1.129; Thurston B, 2013, CHILD NERV SYST, V29, P839, DOI 10.1007/s00381-012-1993-4; Chakraborti S, 2012, VIRCHOWS ARCH, V461, P581, DOI 10.1007/s00428-012-1313-0; Anan M, 2009, HUM PATHOL, V40, P898, DOI 10.1016/j.humpath.2008.11.010; Wendt S, 2014, PEDIATR BLOOD CANCER, V61, P664, DOI 10.1002/pbc.24825; Shah MN, 2010, J NEUROS-PEDIATR, V5, P98, DOI 10.3171/2009.7.PEDS09113; Karafin M, 2011, CLIN NEUROPATHOL, V30, P297, DOI 10.5414/NP300374; Xiong J, 2012, NEUROPATHOLOGY, V32, P301, DOI 10.1111/j.1440-1789.2011.01261.x; Gessi M, 2012, J NEURO-ONCOL, V110, P21, DOI 10.1007/s11060-012-0940-2; Preusser M, 2003, ACTA NEUROPATHOL, V106, P506, DOI 10.1007/s00401-003-0758-2; Scheithauer BW, 2009, NEUROSURGERY, V64, P771, DOI 10.1227/01.NEU.0000340979.81362.F3; Albanese A, 2005, J NEURO-ONCOL, V71, P195, DOI 10.1007/s11060-004-1375-1; Joseph V, 2009, NEUROPATHOLOGY, V29, P309, DOI 10.1111/j.1440-1789.2008.00953.x; Wang Y, 2009, ACTA NEUROPATHOL, V118, P813, DOI 10.1007/s00401-009-0569-1; Frydenberg E, 2010, J CLIN NEUROSCI, V17, P1326, DOI 10.1016/j.jocn.2010.03.003; Podlesek D, 2011, J NEURO-ONCOL, V103, P727, DOI 10.1007/s11060-010-0408-1; Luan SH, 2010, CLIN NEUROL NEUROSUR, V112, P362, DOI 10.1016/j.clineuro.2010.01.006; Zhang J, 2013, J CLIN NEUROSCI, V20, P335, DOI 10.1016/j.jocn.2012.09.003; Matyja E, 2011, NEUROPATHOLOGY, V31, P427, DOI 10.1111/j.1440-1789.2010.01168.x; Ghosal N, 2010, DIAGN CYTOPATHOL, V38, P590, DOI 10.1002/dc.21269; Komori T, 2002, AM J SURG PATHOL, V26, P582, DOI 10.1097/00000478-200205000-00004; Kinno M, 2010, CYTOPATHOLOGY, V21, P194, DOI 10.1111/j.1365-2303.2008.00619.x; Sharma P, 2011, NEUROL INDIA, V59, P276, DOI 10.4103/0028-3886.79148; Rainov NG, 2010, CENT EUR NEUROSURG, V71, P219, DOI 10.1055/s-0029-1242760; Vajtai I, 2007, PATHOL RES PRACT, V203, P613, DOI 10.1016/j.prp.2007.04.009; Gao C, 2009, NEUROSCIENCES, V14, P292; Xiong J, 2013, NEUROPATHOLOGY, V33, P431, DOI 10.1111/neup.12000; Yin B, 2012, J NEURORADIOLOGY, V39, P129, DOI 10.1016/j.neurad.2011.02.004; Thommen F, 2013, CLIN NEUROPATHOL, V32, P370, DOI 10.5414/NP300612; Nandeesh BN, 2012, J CANCER RES THER, V8, P644, DOI 10.4103/0973-1482.106587; Arai A, 2010, NEUROL MED-CHIR, V50, P224; Tan CC, 2008, NEUROSURGERY, V63, P175, DOI 10.1227/01.NEU.0000319638.62586.52; Gessi M, 2011, NEUROPATHOLOGY, V31, P654, DOI 10.1111/j.1440-1789.2011.01220.x; Hsu C, 2012, BRIT J NEUROSURG, V26, P668, DOI 10.3109/02688697.2012.655808; Fushimi Y, 2011, JPN J RADIOL, V29, P445, DOI 10.1007/s11604-011-0566-x; Adachi J, 2005, SURG NEUROL, V63, P375, DOI 10.1016/j.surneu.2004.05.039; Lu JQ, 2009, NEUROSURGERY, V64, P1193, DOI 10.1227/01.NEU.0000345640.40566.48; Kemp S, 2012, J CLIN NEUROSCI, V19, P1180, DOI 10.1016/j.jocn.2011.12.013; Ellezam B, 2012, ACTA NEUROPATHOL, V123, P285, DOI 10.1007/s00401-011-0886-z; Cabezas SG, 2015, BRAIN TUMOR PATHOL, V32, P124, DOI 10.1007/s10014-014-0195-z; Pimentel José, 2008, Neurosurgery, V62, pE1162, DOI 10.1227/01.neu.0000325879.75376.63; Xu Junqing, 2012, Quant Imaging Med Surg, V2, P227, DOI 10.3978/j.issn.2223-4292.2012.09.03	49	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1433-7398	1861-387X		BRAIN TUMOR PATHOL	Brain Tumor Pathol.	OCT	2015	32	4					291	296		10.1007/s10014-015-0226-4		6	Oncology; Clinical Neurology; Pathology	Oncology; Neurosciences & Neurology; Pathology	CU1DV	WOS:000363260700010		
J	Tajika, A; Ogawa, Y; Takeshima, N; Hayasaka, Y; Furukawa, TA				Tajika, Aran; Ogawa, Yusuke; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.			Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up	BRITISH JOURNAL OF PSYCHIATRY			English	Article							PLACEBO-CONTROLLED-TRIAL; A-DOUBLE-BLIND; ALZHEIMERS-DISEASE; EMPIRICAL-EVIDENCE; BIPOLAR MANIA; OLANZAPINE; BIAS; SCHIZOPHRENIA; INTERVENTIONS; METAANALYSES	Background Contradictions and initial overestimates are not unusual among highly cited studies. However, this issue has not been researched in psychiatry. Aims To assess how highly cited studies in psychiatry are replicated by subsequent studies. Method We selected highly cited studies claiming effective psychiatric treatments in the years 2000 through 2002. For each of these studies we searched for subsequent studies with a better-controlled design, or with a similar design but a larger sample. Results Among 83 articles recommending effective interventions, 40 had not been subject to any attempt at replication, 16 were contradicted; 11 were found to have substantially smaller effects and only 16 were replicated. The standardised mean differences of the initial studies were overestimated by 132%. Studies with a total sample size of 100 or more tended to produce replicable results. Conclusions Caution is needed when a study with a small sample size reports a large effect.	[Tajika, Aran; Ogawa, Yusuke; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav, Kyoto 6068501, Japan	Tajika, A (reprint author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	aran.tajika28@gmail.com					Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Nieminen P, 2007, J CLIN EPIDEMIOL, V60, P939, DOI 10.1016/j.jclinepi.2006.11.014; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; McIntyre RS, 2009, BIPOLAR DISORD, V11, P673, DOI 10.1111/j.1399-5618.2009.00748.x; Breitner JC, 2011, ALZHEIMERS DEMENT, V7, P402, DOI 10.1016/j.jalz.2010.12.014; Tohen M, 2000, ARCH GEN PSYCHIAT, V57, P841, DOI 10.1001/archpsyc.57.9.841; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Ho PM, 2008, CIRCULATION, V118, P1675, DOI 10.1161/CIRCULATIONAHA.107.721357; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; De Deyn PP, 2004, INT J GERIATR PSYCH, V19, P115, DOI 10.1002/gps.1032; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Wood L, 2008, BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; Cohen J., 1988, STAT POWER ANAL BEHA; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Hunt GE, 2010, HARVARD REV PSYCHIAT, V18, P207, DOI 10.3109/10673229.2010.493742; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; loannidis J. P. A., 2005, JAMA-J AM MED ASSOC, V294, P218; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; US National Library of Medicine, 2015, FACT SHEET MEDLINE P	26	0	0	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	OCT	2015	207	4					357	362		10.1192/bjp.bp.113.143701		6	Psychiatry	Psychiatry	CU0QF	WOS:000363222900017		
J	Sato, A; Ikeda, K				Sato, Akira; Ikeda, Koichi			Visualization of diffusion phenomena in porous media by means of X-ray computed tomography (CT) scanning	CANADIAN GEOTECHNICAL JOURNAL			English	Article						diffusion; X-ray computed tomography (CT); visualization; porous media; permeation; rock	CO2	The migration of water and contamination materials in rock structures is a significant issue in projects that utilize deep underground locations such as "carbon-dioxide capture and storage" (CCS) and disposal of high-level nuclear waste. These phenomena are also important in the area of preservation of stone structures of cultural heritage signficance, as such stone structures are usually located outside, exposed to wind and rain. The migration of contamination materials in the underground environment, especially in porous rock mass, is governed mainly by water permeation and diffusion. In this study, one-dimensional diffusion testing was conducted and the process in the porous materials was visualized by X-ray computed tomography (CT) scanning. Diffusion is the process caused by the concentrate or density gradient, and is a suitable phenomenon for X-ray CT analysis. In this paper, information related to diffusion is extracted from X-ray CT image data and the distribution of concentration is estimated. From the obtained density distribution, diffusion coefficients are evaluated. One-dimensional permeation tests were also conducted and intrinsic permeabilities of porous materials are evaluated, then the relation between diffusion coefficients and intrinsic permeability is discussed.	[Sato, Akira; Ikeda, Koichi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan	Sato, A (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan.	asato@kumamoto-u.ac.jp					Suekane T, 2006, J THERM SCI TECH-JPN, V1, P1, DOI 10.1299/jtst.1.1; Ghaderi A, 2009, GEOPHYSICS, V74, pO17, DOI 10.1190/1.3054659; Chadwick RA, 2009, PETROL GEOSCI, V15, P59, DOI 10.1144/1354-079309-793; Cnudde V., 2013, P 1 INT C TOM MAT ST; Fukahori D., 2010, ADV XRAY TOMOGRAPHY, P287, DOI [10.1002/9780470612187.ch28, DOI 10.1002/9780470612187.CH28]; Lin W., 2000, CHISHITSU NEWS, V459, P61; Ota K., 2007, 044 JAEA; Polak A, 2003, J CONTAM HYDROL, V67, P95, DOI 10.1016/S0169-7722(03)00069-X; Sato A., 2010, J MMIJ, V126, P640, DOI [10.2473/journalofmmij.126.640, DOI 10.2473/JOURNALOFMMIJ.126.640]; Sato A., 2006, GEOMATERIALS, P315, DOI [10.1002/9780470612187.ch32, DOI 10.1002/9780470612187.CH32]; Sato A., 2011, P ISRM INT C ROCK ME, P1357; Sato A., 2013, MAT SCI APPL, V4, P18, DOI [10.4236/msa.2013.48A003, DOI 10.4236/MSA.2013.48A003]; Sato A., 2013, J MMIJ, V129, P529, DOI [10.2473/journalofmmij.129.529, DOI 10.2473/JOURNALOFMMIJ.129.529]; Walker A., 2012, SCI REPORTS, V2, P880, DOI [10.1038/srep00880, DOI 10.1038/SREP00880]; Yoshida H., 2002, J JAPAN SOC ENG GEOL, V43, P24, DOI 10.5110/jjseg.43.24	15	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-3674	1208-6010		CAN GEOTECH J	Can. Geotech. J.	OCT	2015	52	10					1448	1456		10.1139/cgj-2014-0451		9	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CU4DB	WOS:000363475700005		
J	Maehara, O; Sato, F; Natsuizaka, M; Asano, A; Kubota, Y; Itoh, J; Tsunematsu, S; Terashita, K; Tsukuda, Y; Nakai, M; Sho, T; Suda, G; Morikawa, K; Ogawa, K; Chuma, M; Nakagawa, K; Ohnishi, S; Komatsu, Y; Whelan, KA; Nakagawa, H; Takeda, H; Sakamoto, N				Maehara, Osamu; Sato, Fumiyuki; Natsuizaka, Mitsuteru; Asano, Ayaka; Kubota, Yoshimasa; Itoh, Jun; Tsunematsu, Seiji; Terashita, Katsumi; Tsukuda, Yoko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Chuma, Makoto; Nakagawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Whelan, Kelly A.; Nakagawa, Hiroshi; Takeda, Hiroshi; Sakamoto, Naoya			A pivotal role of Kruppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma	CANCER BIOLOGY & THERAPY			English	Article						acetylation; cancer stem cell; CD44; CD133; hepatocellular carcinoma; KLF5	TUMOR-INITIATING CELLS; EPITHELIAL-CELLS; EXTRAHEPATIC METASTASIS; STEM/PROGENITOR CELLS; TRANSCRIPTION FACTORS; CLINICAL-FEATURES; SELF-RENEWAL; BETA-CATENIN; LIVER-CANCER; KLF5	In hepatocellular carcinoma (HCC), there exists a highly tumorigenic subset of cells defined by high expression of CD44 and CD133 that has been reported to contain cancer stem-like cells (CSCs). Kruppel-like factor 5 (KLF5) regulates many factors involved in cell cycle, migration, inflammation, angiogenesis and stemness and has cancer-promoting effects in some cancers. While some reports have indicated that KLF5 may have important roles in regulation of CSCs, what role, if any, KLF5 plays in regulation of CSCs in HCC remains to be elucidated. Flow cytometric analysis of CD44 and CD133 in HCC cell lines revealed subpopulations of CD44(High)/CD133(High) and CD44(Low)/CD133(Low) cells. We subsequently sorted these subpopulations and identified KLF5 as a gene that is significantly upregulated in CD44(High)/CD44(High) cells via RNA sequencing using next generation sequencing technology. Moreover, KLF5 overexpression enriched the CD44(High)/CD133(High) subpopulation and, consistent with the up-regulation of CD44(High)/CD133(High) cells, KLF5 overexpressing cells were more resistant to anti-cancer drugs and displayed enhanced colony-formation capacity. By contrast, knock-down of KLF5 by siRNA diminished the CD44(High)/CD133(High) subpopulation. When KLF5 was acetylated by TGF-1, the KLF5-mediated CD44(High)/CD133(High) subpopulation enrichment was abrogated. Oppositely, ectopic expression of an acetylation-deficient KLF5 mutant further increased CD44(High)/CD133(High) subpopulations as compared to cell expressing wild-type KLF5. These findings provide novel mechanistic insight into a pivotal role for KLF5 in the regulation of CSCs in HCC.	[Maehara, Osamu; Sato, Fumiyuki; Natsuizaka, Mitsuteru; Asano, Ayaka; Kubota, Yoshimasa; Itoh, Jun; Tsunematsu, Seiji; Terashita, Katsumi; Tsukuda, Yoko; Nakai, Masato; Sho, Takuya; Suda, Goki; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Maehara, Osamu; Asano, Ayaka; Nakagawa, Koji; Takeda, Hiroshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Pathophysiol & Therapeut, Sapporo, Hokkaido, Japan; [Chuma, Makoto] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa 232, Japan; [Whelan, Kelly A.; Nakagawa, Hiroshi] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA; [Whelan, Kelly A.; Nakagawa, Hiroshi] Abramson Canc Ctr, Philadelphia, PA USA	Natsuizaka, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.	mitsuteru1975@huhp.hokudai.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant [25860512, 26460933, 15K08943]; Japanese Health Labor Sciences Research Grant	This study was supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Numbers 25860512, 26460933, and 15K08943, and Japanese Health Labor Sciences Research Grant.	Akita H, 2014, CANCER RES, V74, P5903, DOI 10.1158/0008-5472.CAN-14-0527; Mori A, 2009, MOL CANCER RES, V7, P1390, DOI 10.1158/1541-7786.MCR-08-0525; Dong Z, 2013, CELL PROLIFERAT, V46, P425, DOI 10.1111/cpr.12043; Ma YC, 2013, EUR J GASTROEN HEPAT, V25, P1007, DOI 10.1097/MEG.0b013e32836019d8; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Zhang ZP, 2003, NUCLEIC ACIDS RES, V31, P2196, DOI 10.1093/nar/gkg310; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Schulze K, 2013, INT J CANCER, V133, P2165, DOI 10.1002/ijc.28230; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Smith SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106966; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natsuizaka M, 2005, J GASTROEN HEPATOL, V20, P1781, DOI 10.1111/j.1440-1746.2005.03919.x; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Fujii Y, 2012, P NATL ACAD SCI USA, V109, P20584, DOI 10.1073/pnas.1208651109; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M5061873200; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Yoo DJ, 2011, J GASTROEN HEPATOL, V26, P145, DOI 10.1111/j.1440-1746.2010.06341.x; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Li X, 2015, INT J CANCER, V136, P536, DOI 10.1002/ijc.29028; Luan Yi, 2014, World J Biol Chem, V5, P216, DOI 10.4331/wjbc.v5.i2.216; Noto JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054344; Oishi Naoki, 2014, Liver Cancer, V3, P71, DOI 10.1159/000343863; Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039	46	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-4047	1555-8576		CANCER BIOL THER	Cancer Biol. Ther.	OCT	2015	16	10					1453	1461		10.1080/15384047.2015.1070992		9	Oncology	Oncology	CT8KC	WOS:000363064000006		
J	Kar, SP; Tyrer, JP; Li, QY; Lawrenson, K; Aben, KKH; Anton-Culver, H; Antonenkova, N; Chenevix-Trench, G; Baker, H; Bandera, EV; Bean, YT; Beckmann, MW; Berchuck, A; Bisogna, M; Bjorge, L; Bogdanova, N; Brinton, L; Brooks-Wilson, A; Butzow, R; Campbell, I; Carty, K; Chang-Claude, J; Chen, YA; Chen, ZH; Cook, LS; Cramer, D; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Dennis, J; Dicks, E; Doherty, JA; Dork, T; du Bois, A; Durst, M; Eccles, D; Easton, DF; Edwards, RP; Ekici, AB; Fasching, PA; Fridley, BL; Gao, YT; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goode, EL; Goodman, MT; Grownwald, J; Harrington, P; Harter, P; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, E; Hogdall, CK; Hosono, S; Iversen, ES; Jakubowska, A; Paul, J; Jensen, A; Ji, BT; Karlan, BY; Kjaer, SK; Kelemen, LE; Kellar, M; Kelley, J; Kiemeney, LA; Krakstad, C; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lee, AW; Lele, S; Leminen, A; Lester, J; Levine, DA; Liang, D; Lissowska, J; Lu, K; Lubinski, J; Lundvall, L; Massuger, L; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, IA; Menon, U; Modugno, F; Moysich, KB; Narod, SA; Nedergaard, L; Ness, RB; Nevanlinna, H; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Weber, RP; Pearce, CL; Pejovic, T; Pelttari, LM; Permuth-Wey, J; Phelan, CM; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rosen, B; Rossing, MA; Rothstein, JH; Rudolph, A; Runnebaum, IB; Rzepecka, IK; Salvesen, HB; Schildkraut, JM; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Sucheston-Campbell, LE; Tangen, IL; Teo, SH; Terry, KL; Thompson, PJ; Timorek, A; Tsai, YY; Tworoger, SS; van Altena, AM; Van Nieuwenhuysen, E; Vergote, I; Vierkant, RA; Wang-Gohrke, S; Walsh, C; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Woo, YL; Wu, XF; Wu, AN; Yang, HN; Zheng, W; Ziogas, A; Sellers, TA; Monteiro, ANA; Freedman, ML; Gayther, SA; Pharoah, PDP				Kar, Siddhartha P.; Tyrer, Jonathan P.; Li, Qiyuan; Lawrenson, Kate; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Chenevix-Trench, Georgia; Baker, Helen; Bandera, Elisa V.; Bean, Yukie T.; Beckmann, Matthias W.; Berchuck, Andrew; Bisogna, Maria; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise; Brooks-Wilson, Angela; Butzow, Ralf; Campbell, Ian; Carty, Karen; Chang-Claude, Jenny; Chen, Yian Ann; Chen, Zhihua; Cook, Linda S.; Cramer, Daniel; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Dennis, Joe; Dicks, Ed; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Eccles, Diana; Easton, Douglas F.; Edwards, Robert P.; Ekici, Arif B.; Fasching, Peter A.; Fridley, Brooke L.; Gao, Yu-Tang; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goode, Ellen L.; Goodman, Marc T.; Grownwald, Jacek; Harrington, Patricia; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Estrid; Hogdall, Claus K.; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Paul, James; Jensen, Allan; Ji, Bu-Tian; Karlan, Beth Y.; Kjaer, Susanne K.; Kelemen, Linda E.; Kellar, Melissa; Kelley, Joseph; Kiemeney, Lambertus A.; Krakstad, Camilla; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lee, Alice W.; Lele, Shashi; Leminen, Arto; Lester, Jenny; Levine, Douglas A.; Liang, Dong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain A.; Menon, Usha; Modugno, Francesmary; Moysich, Kirsten B.; Narod, Steven A.; Nedergaard, Lotte; Ness, Roberta B.; Nevanlinna, Heli; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Weber, Rachel Palmieri; Pearce, Celeste Leigh; Pejovic, Tanja; Pelttari, Liisa M.; Permuth-Wey, Jennifer; Phelan, Catherine M.; Pike, Malcolm C.; Poole, Elizabeth M.; Ramus, Susan J.; Risch, Harvey A.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Rudolph, Anja; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Salvesen, Helga B.; Schildkraut, Joellen M.; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Sucheston-Campbell, Lara E.; Tangen, Ingvild L.; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Timorek, Agnieszka; Tsai, Ya-Yu; Tworoger, Shelley S.; van Altena, Anne M.; Van Nieuwenhuysen, Els; Vergote, Ignace; Vierkant, Robert A.; Wang-Gohrke, Shan; Walsh, Christine; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Woo, Yin-Ling; Wu, Xifeng; Wu, Anna; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Sellers, Thomas A.; Monteiro, Alvaro N. A.; Freedman, Matthew L.; Gayther, Simon A.; Pharoah, Paul D. P.		Australian Canc Study; Australian Ovarian Canc Study Grp	Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; SUSCEPTIBILITY LOCI; BREAST-CANCER; VARIANTS; MODELS; SET; POPULATION; CARCINOMA; PROFILES	Background: Genome-wide association studies (GWAS) have so far reported 12 loci associated with serous epithelial ovarian cancer (EOC) risk. We hypothesized that some of these loci function through nearby transcription factor (TF) genes and that putative target genes of these TFs as identified by coexpression may also be enriched for additional EOC risk associations. Methods: We selected TF genes within 1 Mb of the top signal at the 12 genome-wide significant risk loci. Mutual information, a form of correlation, was used to build networks of genes strongly coexpressed with each selected TF gene in the unified microarray dataset of 489 serous EOC tumors from The Cancer Genome Atlas. Genes represented in this dataset were subsequently ranked using a gene-level test based on results for germline SNPs from a serous EOC GWAS meta-analysis (2,196 cases/4,396 controls). Results: Gene set enrichment analysis identified six networks centered on TF genes (HOXB2, HOXB5, HOXB6, HOXB7 at 17q21.32 and HOXD1, HOXD3 at 2q31) that were significantly enriched for genes from the risk-associated end of the ranked list (P < 0.05 and FDR < 0.05). These results were replicated (P < 0.05) using an independent association study (7,035 cases/21,693 controls). Genes underlying enrichment in the six networks were pooled into a combined network. Conclusion: We identified a HOX-centric network associated with serous EOC risk containing several genes with known or emerging roles in serous EOC development. Impact: Network analysis integrating large, context-specific datasets has the potential to offer mechanistic insights into cancer susceptibility and prioritize genes for experimental characterization. (C) 2015 AACR.	[Kar, Siddhartha P.; Dennis, Joe; Easton, Douglas F.; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tyrer, Jonathan P.; Baker, Helen; Dicks, Ed; Easton, Douglas F.; Harrington, Patricia; Song, Honglin; Pharoah, Paul D. P.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England; [Li, Qiyuan; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Lawrenson, Kate; Lee, Alice W.; Pearce, Celeste Leigh; Pike, Malcolm C.; Ramus, Susan J.; Wu, Anna; Gayther, Simon A.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr Netherlands, Utrecht, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Sch Med, Dept Epidemiol, Genet Epidemiol Res Inst, Irvine, CA 92717 USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, Byelarus; [Chenevix-Trench, Georgia; Australian Canc Study] QIMR Berghofer Med Res Inst, Canc Div, Brisbane, Qld, Australia; [Australian Ovarian Canc Study Grp] Peter MacCallum Canc Inst, East Melbourne, Vic, Australia; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Bisogna, Maria; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Haukeland Hosp, Dept Gynecol & Obstet, N-5021 Bergen, Norway; [Bjorge, Line; Krakstad, Camilla; Salvesen, Helga B.; Tangen, Ingvild L.] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brinton, Louise; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf; Leminen, Arto; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, HUS, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Campbell, Ian] Peter MacCallum Canc Ctr, Canc Genet Lab, Div Res, Melbourne, Vic, Australia; [Campbell, Ian; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Campbell, Ian] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson West Scotland Canc Ctr, Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Rudolph, Anja] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chen, Yian Ann; Chen, Zhihua] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Biostat, Tampa, FL 33682 USA; [Cook, Linda S.] Univ New Mexico, Dept Internal Med, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel; Terry, Kathryn L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Obstet & Gynecol Ctr, Boston, MA 02115 USA; [Cramer, Daniel; Terry, Kathryn L.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol & Lab Diagnost, Warsaw, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Inst Oncol, Warsaw, Poland; [Doherty, Jennifer A.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Dept Community & Family Med, Lebanon, NH USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany; [Duerst, Matthias; Runnebaum, Ingo B.] Univ Jena, Dept Gynecol, Jena Univ Hosp, Jena, Germany; [Eccles, Diana; Edwards, Robert P.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Edwards, Robert P.; Modugno, Francesmary] Univ Pittsburgh, Ovarian Canc Ctr Excellence, Pittsburgh, PA USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] Univ Kansas, Med Ctr, Biostat & Informat Shared Resource, Kansas City, KS 66103 USA; [Gao, Yu-Tang] Shanghai Canc Inst, Shanghai, Peoples R China; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Elizabeth Garrett Anderson Inst Womens Hlth, Womens Canc, London, England; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic, Australia; [Goode, Ellen L.; Vierkant, Robert A.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Canc Prevent & Control, Los Angeles, CA 90048 USA; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Dept Biomed Sci, Commun & Populat Hlth Res Inst, Los Angeles, CA 90048 USA; [Cybulski, Cezary; Grownwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hillemanns, Peter] Hannover Med Sch, Dept Obstet, Hannover, Germany; [Hillemanns, Peter] Hannover Med Sch, Dept Gynaecol, Hannover, Germany; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hogdall, Claus K.; Kjaer, Susanne K.; Lundvall, Lene] Univ Copenhagen, Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark; [Hosono, Satoyo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine] Cedars Sinai Med Ctr, Womens Canc Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Kelley, Joseph] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Lambrechts, Sandrina; Van Nieuwenhuysen, Els; Vergote, Ignace] Univ Hosp Leuven, Dept Oncol, Div Gynecol Oncol, Leuven, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston-Campbell, Lara E.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Liang, Dong] Texas So Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon; van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Matsuo, Keitaro] Kyushu Univ, Dept Prevent Med, Fac Med Sci, Fukuoka 812, Japan; [McGuire, Valerie; Rothstein, Joseph H.; Sieh, Weiva; Whittemore, Alice S.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Sch Med, Stanford, CA 94305 USA; [McLaughlin, John R.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [McNeish, Iain A.] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Beatson Inst Canc Res, Glasgow, Lanark, Scotland; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Narod, Steven A.] Womens Coll Res Inst, Toronto, ON, Canada; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Weber, Rachel Palmieri] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Dansonka-Mieszkowska, Agnieszka; Permuth-Wey, Jennifer; Phelan, Catherine M.; Tsai, Ya-Yu; Sellers, Thomas A.; Monteiro, Alvaro N. A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Canc Epidemiol, Tampa, FL 33682 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Poole, Elizabeth M.; Tworoger, Shelley S.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Rosen, Barry] Univ Toronto, Dept Gynecol Oncol, Princess Margaret Hosp, Toronto, ON, Canada; [Rosen, Barry] Univ Toronto, Fac Med, Dept Obstet & Gynecol, Toronto, ON, Canada; [Rossing, Mary Anne; Wicklund, Kristine G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, Seattle, WA 98104 USA; [Rossing, Mary Anne] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Schildkraut, Joellen M.] Duke Canc Inst, Canc Control & Populat Sci, Durham, NC USA; [Schwaab, Ira] Inst Humangenet Wiesbaden, Wiesbaden, Germany; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Epidemiol Ctr, Div Epidemiol,Sch Med, Nashville, TN 37212 USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Shvetsov, Yurii B.; Wilkens, Lynne R.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Siddiqui, Nadeem] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow G4 0SF, Lanark, Scotland; [Teo, Soo-Hwang] Sime Darby Med Ctr, Canc Res Initiat Fdn, Subang Jaya, Malaysia; [Teo, Soo-Hwang; Woo, Yin-Ling] Univ Malaya, Fac Med, Univ Malaya Med Ctr, Univ Malaya Canc Res Inst, Kuala Lumpur, Malaysia; [Timorek, Agnieszka] Warsaw Med Univ, IInd Fac Med, Dept Obstet Gynecol & Oncol, Warsaw, Poland; [Timorek, Agnieszka] Brodnowski Hosp, Warsaw, Poland; [Wang-Gohrke, Shan] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany; [Woo, Yin-Ling] Univ Malaya, Dept Obstet & Gynaecol, Univ Malaya Med Ctr, Kuala Lumpur, Malaysia	Kar, SP (reprint author), Univ Cambridge, Ctr Canc Genet Epidemiol, Strangeways Res Lab, Cambridge CB1 8RN, England.	sk718@medschl.cam.ac.uk	Dork, Thilo/J-8620-2012; Hein, Alexander/F-6999-2010; Bandera, Elisa/M-4169-2014; 	Hein, Alexander/0000-0003-2601-3398; Bandera, Elisa/0000-0002-8789-2755; Kjaer, Susanne/0000-0002-8347-1398; McNeish, Iain/0000-0002-9387-7586	European Commission [223175-HEALTH-F2-2009-223175]; U.S. National Cancer Institute GAME-ON Post-GWAS Initiative [U19-CA148112]; Ovarian Cancer Research Fund [PPD/RPCI.07]; Cancer Research UK Principal Research Fellowship; National Health and Medical Research Council of Australia; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; Canadian Institutes of Health Research Investigator award [MSH-87734]; U.S. National Institute of Environmental Health Sciences [T32ES013678]; U.S. National Cancer Institute [1K99CA184415-01]; Gates Cambridge Scholarship; NIH [R01-CA168758, R13-CA165638, P50-CA159981, R03-CA115195, R01-CA114343, R01-CA149429, T32-CA009001, R01-CA172404, R01-CA074850, P30-CA124435, K07-CA143047, R01-CA076016]; Cancer Research UK [C315/A2621, C490/A6187, C490/A10119, C490/A10124, C536/A13086, C536/A6689]; American Cancer Society [CRTG-00-196-01-CCE]; California Cancer Research Program [00-01389V-20170, N01-CN25403, 2II0200]; Canadian Institutes for Health Research [MOP-86727]; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; Cancer Institute of New Jersey; Celma Mastry Ovarian Cancer Foundation; Danish Cancer Society [94-222-52]; ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre [C1312/A15589]; Norwegian Cancer Society; Norwegian Research Council; Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan; L&S Milken Foundation; Polish Ministry of Science and Higher Education [4 PO5C 028 14, 2 PO5A 068 27]; Malaysian Ministry of Higher Education [UM.C/HlR/MOHE/06]; Cancer Research Initiatives Foundation; Roswell Park Cancer Institute Alliance Foundation; U.S. National Institutes of Health [R03-CA115195, R01-CA114343, R01-CA149429, R01-CA074850, K07-CA143047, R01-CA076016, K07-CA095666, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, UM1-CA186107, P01-CA87969, R01-CA49449, UM1-CA176726, R01-CA67262, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01-CA071766, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01-CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA126841, R01-CA136924, R03-CA113148, R37-CA070867, R37-CA70867, U01-CA069417, U01-CA071966]; U.S. Army Medical Research and Material Command [DAMD17-98-1-8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, W81XWH-10-1-0280]; National Health and Medical Research Council of Australia [199600, 400281]; German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research [01 GB 9401]; state of Baden-Wurttemberg through Medical Faculty of the University of Ulm [P. 685]; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation [LVS-39420]; Oak Foundation; OHSU Foundation; Mermaid I project; Rudolf-Bartling Foundation; Royal Marsden Hospital; WorkSafeBC; U.K. National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme"	Funding for the COGS infrastructure came from a European Commission's Seventh Framework Programme grant (agreement number 223175-HEALTH-F2-2009-223175). The scientific development and funding for this project were, in part, supported by the U.S. National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). Funding for the Ovarian Cancer Association Consortium (OCAC) GWAS infrastructure came from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). D.F. Easton is supported by a Cancer Research UK Principal Research Fellowship. G. Chenevix-Trench is supported by the National Health and Medical Research Council of Australia. B.Y. Karlan is supported by an American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN). L.E. Keleman was supported by a Canadian Institutes of Health Research Investigator award (MSH-87734). A.W. Lee is supported by a T32 grant from the U.S. National Institute of Environmental Health Sciences (T32ES013678). K. Lawrenson is supported by a K99/R00 grant from the U.S. National Cancer Institute (1K99CA184415-01). S.P. Kar is supported by a Gates Cambridge Scholarship.; The following authors would like to acknowledge specific grant support from the NIH: J.A. Doherty (R01-CA168758), R.P. Edwards (R13-CA165638), K. Odunsi (P50-CA159981), C.L. Pearce (R03-CA115195), J. Permuth-Wey (R01-CA114343), C.M. Phelan (R01-CA149429), E.M. Poole (T32-CA009001), S.J. Ramus (R01-CA172404), H.A. Risch (R01-CA074850), J.H. Rothstein (P30-CA124435), W. Sieh (K07-CA143047), L.E. Sucheston-Campbell (P50-CA159981), Rachel Palmieri Weber (R01-CA076016); and from Cancer Research UK: A. Gentry-Maharaj (C315/A2621) and P.D.P. Pharoah (C490/A10119). Funding of the constituent studies of the OCAC GWAS and COGS are listed by funding agency with each grant number in parentheses: American Cancer Society (CRTG-00-196-01-CCE); the California Cancer Research Program (00-01389V-20170, N01-CN25403, 2II0200); the Canadian Institutes for Health Research (MOP-86727); Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124, C536/A13086, and C536/A6689); the Celma Mastry Ovarian Cancer Foundation; the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; Imperial Experimental Cancer Research Centre (C1312/A15589); the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L&S Milken Foundation; the Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27); Malaysian Ministry of Higher Education (UM.C/HlR/MOHE/06) and Cancer Research Initiatives Foundation; the Roswell Park Cancer Institute Alliance Foundation; the U.S. National Institutes of Health (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, UM1-CA186107, P01-CA87969, R01-CA49449, UM1-CA176726, R01-CA67262, R01-CA061107, R01-CA061132, R01-CA063682, R01-CA064277, R01-CA067262, R01-CA071766, R01-CA074850, R01-CA076016, R01-CA080742, R01-CA080978, R01-CA083918, R01-CA087538, R01-CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01-CA136924, R01-CA149429, R03-CA113148, R03-CA115195, R37-CA070867, R37-CA70867, U01-CA069417, U01-CA071966, and Intramural research funds); the U.S. Army Medical Research and Material Command (DAMD17-98-1-8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, and W81XWH-10-1-0280); the National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01 GB 9401); the state of Baden-Wurttemberg through Medical Faculty of the University of Ulm (P. 685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V. Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the U.K.; National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme" and the Royal Marsden Hospital; WorkSafeBC.	Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Naora H, 2001, P NATL ACAD SCI USA, V98, P4060, DOI 10.1073/pnas.071594398; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Bahcall OG, 2013, NAT GENET, V45, P343, DOI 10.1038/ng.2592; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; di Pietro M, 2012, P NATL ACAD SCI USA, V109, P9077, DOI 10.1073/pnas.1116933109; Wang C, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-201364; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Kobel M, 2013, CANCER EPIDEM BIOMAR, V22, P1677, DOI 10.1158/1055-9965.EPI-13-0391; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bojesen SE, 2013, NAT GENET, V45, P371, DOI 10.1038/ng.2566; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Sur I, 2013, CANCER RES, V73, P4180, DOI 10.1158/0008-5472.CAN-13-0789; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5475.CAN-06-4283; Antoniou Antonis C, 2006, Future Oncol, V2, P257, DOI 10.2217/14796694.2.2.257; Couch FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003212; Cowper-Sallari R., 2012, NAT GENET, V44, P1191; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Lawrenson K, 2012, JOVE-J VIS EXP, DOI 10.3791/4206; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Michailidou K, 2013, NAT GENET, V45, P353; Parker HJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-637; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shen H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2629; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; The Cancer Genome Atlas, DAT PORT INT GEN AN; The Cancer Genome Atlas, DAT PORT PROGN REL G; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45	52	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	OCT	2015	24	10					1574	1584		10.1158/1055-9965.EPI-14-1270		11	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	CU3CR	WOS:000363401800016		
J	Koga-Yamakawa, E; Murata, M; Dovedi, SJ; Wilkinson, RW; Ota, Y; Umehara, H; Sugaru, E; Hirose, Y; Harada, H; Jewsbury, PJ; Yamamoto, S; Robinson, DT; Li, CJ				Koga-Yamakawa, Erina; Murata, Masashi; Dovedi, Simon J.; Wilkinson, Robert W.; Ota, Yosuke; Umehara, Hiroki; Sugaru, Eiji; Hirose, Yuko; Harada, Hideyuki; Jewsbury, Philip J.; Yamamoto, Setsuko; Robinson, David T.; Li, Chiang J.			TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Article						Toll-like receptor 7; Tolerance; DSR-6434; TLR7 downregulation; Cancer; Immunotherapy	PLASMACYTOID DENDRITIC CELLS; INTERFERON-PRODUCING CELLS; INNATE IMMUNE-RESPONSE; RECEPTOR 7; ADAPTIVE IMMUNITY; AGONIST; EXPRESSION; INDUCTION; SUBSETS; CANCER	Systemic administration of small molecule toll-like receptor (TLR)-7 agonists leads to potent activation of innate immunity and to the generation of anti-tumor immune responses. However, activation of TLRs with small molecule agonists may lead to the induction of TLR tolerance, defined as a state of hyporesponsiveness to subsequent agonism, which may limit immune activation, the generation of anti-tumor responses and clinical response. Our data reveal that dose scheduling impacts on the efficacy of systemic therapy with the selective TLR7 agonist, 6-amino-2-(butylamino)-9-((6-(2-(dimethylamino)ethoxy) pyridin-3-yl) methyl)-7,9-dihydro-8H-purin-8-one (DSR-6434). In a preclinical model of renal cell cancer, systemic administration of DSR-6434 dosed once weekly resulted in a significant anti-tumor response. However, twice weekly dosing of DSR-6434 led to the induction of TLR tolerance, and no anti-tumor response was observed. We show that TLR7 tolerance was independent of type I interferon (IFN) negative feedback because induction of TLR7 tolerance was also observed in IFN-alpha/beta receptor knockout mice treated with DSR-6434. Moreover, our data demonstrate that treatment of bone marrow-derived plasmacytoid dendritic cells (BM-pDC) with DSR-6434 led to downregulation of TLR7 expression. From our data, dose scheduling of systemically administered TLR7 agonists can impact on anti-tumor activity through the induction of TLR tolerance. Furthermore, TLR7 expression on pDC may be a useful biomarker of TLR7 tolerance and aid in the optimization of dosing schedules involving systemically administered TLR7 agonists.	[Koga-Yamakawa, Erina; Murata, Masashi; Ota, Yosuke; Umehara, Hiroki; Sugaru, Eiji; Hirose, Yuko; Yamamoto, Setsuko] Sumitomo Dainippon Pharma, Sumitomo Dainippon Pharma DSP Canc Inst, Konohana Ku, Osaka 5540022, Japan; [Dovedi, Simon J.; Wilkinson, Robert W.; Jewsbury, Philip J.; Robinson, David T.] AstraZeneca, Oncol Innovat Med & Early Dev iMed, Macclesfield SK10 4TG, Cheshire, England; [Umehara, Hiroki; Li, Chiang J.] Boston Biomed Inc, Cambridge, MA USA; [Harada, Hideyuki] Sumitomo Dainippon Pharma, Drug Res Div, Suita, Osaka 5640053, Japan	Koga-Yamakawa, E (reprint author), Sumitomo Dainippon Pharma, Sumitomo Dainippon Pharma DSP Canc Inst, Konohana Ku, 3-1-98 Kasugade Naka, Osaka 5540022, Japan.	erina-koga@ds-pharma.co.jp; masashi-murata@ds-pharma.co.jp					Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Poovassery JS, 2012, J IMMUNOL, V189, P1757, DOI 10.4049/jimmunol.1200624; Mangsbo SM, 2008, J IMMUNOTHER, V31, P34; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Bauer S, 2010, P NATL ACAD SCI USA, V107, pE139, DOI 10.1073/pnas.1008626107; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Fidock MD, 2011, CLIN PHARMACOL THER, V89, P821, DOI 10.1038/clpt.2011.60; Dummer R, 2008, CLIN CANCER RES, V14, P856, DOI 10.1158/1078-0432.CCR-07-1938; Hornung V, 2002, J IMMUNOL, V168, P4531; Nakamura T, 2013, BIOORG MED CHEM LETT, V23, P669, DOI 10.1016/j.bmcl.2012.11.114; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; VOGEL SN, 1982, INFECT IMMUN, V38, P681; Cella M, 1999, NAT MED, V5, P919; Haeryfar SMM, 2005, TRENDS IMMUNOL, V26, P311, DOI 10.1016/j.it.2005.04.002; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Lou YY, 2007, J IMMUNOL, V178, P1534; Bourquin C, 2011, CANCER RES, V71, P5123, DOI 10.1158/0008-5472.CAN-10-3903; Nomura F, 2000, J IMMUNOL, V164, P3476; Angelov GS, 2005, J IMMUNOL, V175, P189; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Geisel J, 2007, J IMMUNOL, V179, P5811; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Koga-Yamakawa E, 2013, INT J CANCER, V132, P580, DOI 10.1002/ijc.27691; Geller MA, 2010, CANCER IMMUNOL IMMUN, V59, P1877, DOI 10.1007/s00262-010-0914-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Whiteside TL, 2001, CURR PROTOC IMMUNOL, V7, P18, DOI 10.1002/0471142735.im0718s35	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	OCT	2015	64	10					1229	1239		10.1007/s00262-015-1730-4		11	Oncology; Immunology	Oncology; Immunology	CU0YZ	WOS:000363246900002		
J	Mitobe, Y; Yasunaga, J; Furuta, R; Matsuoka, M				Mitobe, Yuichi; Yasunaga, Jun-ichirou; Furuta, Rie; Matsuoka, Masao			HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival	CANCER RESEARCH			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; MESSENGER-RNA; HBZ GENE; REGULATES SURVIVIN; CANCER PATIENTS; LEUKEMIA-CELLS; YM155; TAX; OVEREXPRESSION	Infection of T cells with human T-cell leukemia virus type-1 (HTLV-1) induces clonal proliferation and is closely associated with the onset of adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. Although Tax expression is frequently suppressed in HTLV-1-infected cells, the accessory gene, HTLV-1 bZIP factor (HBZ), is continuously expressed and has been implicated in HTLV-1 pathogenesis. Here, we report that transduction of mouse T cells with specific mutants of HBZ that distinguish between its RNA and protein activity results in differential effects on T-cell proliferation and survival. HBZ RNA increased cell number by attenuating apoptosis, whereas HBZ protein induced apoptosis. However, both HBZ RNA and protein promoted S-phase entry of T cells. We further identified that the first 50 bp of the HBZ coding sequence are required for RNA-mediated cell survival. Transcriptional profiling of T cells expressing wild-type HBZ, RNA, or protein revealed that HBZ RNA is associated with genes involved in cell cycle, proliferation, and survival, while HBZ protein is more closely related to immunological properties of T cells. Specifically, HBZ RNA enhances the promoter activity of survivin, an inhibitor of apoptosis, to upregulate its expression. Inhibition of survivin using YM155 resulted in impaired proliferation of several ATL cell lines as well as a T-cell line expressing HBZ RNA. The distinct functions of HBZ RNA and protein may have several implications for the development of strategies to control the proliferation and survival mechanisms associated with HTLV-1 infection and ATL. (C) 2015 AACR.	[Mitobe, Yuichi; Yasunaga, Jun-ichirou; Furuta, Rie; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Sakyo Ku, Kyoto 6068507, Japan; [Mitobe, Yuichi] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Sakyo Ku, Kyoto 6068507, Japan	Matsuoka, M (reprint author), Kyoto Univ, Inst Virus Res, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	jyasunag@virus.kyoto-u.ac.jp; mmatsuok@virus.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25293219]; Japan Leukemia Research Fund; JSPS Core-to-Core Program A, Advanced Research Networks	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (M. Matsuoka; 25293219) and a grant from the Japan Leukemia Research Fund (M. Matsuoka). This study was supported in part by JSPS Core-to-Core Program A, Advanced Research Networks.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Hernandez JM, 2011, CLIN COLORECTAL CANC, V10, P188, DOI 10.1016/j.clcc.2011.03.014; Yoshida M, 2008, J VIROL, V82, P9359, DOI 10.1128/JVI.00242-08; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Lu J, 2009, J VIROL, V83, P7129, DOI 10.1128/JVI.00397-09; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Cullen BR, 2013, NAT IMMUNOL, V14, P205, DOI 10.1038/ni.2537; Ryan BM, 2006, ANN ONCOL, V17, P597, DOI 10.1093/annonc/mdj121; Kapellos G, 2013, ANTICANCER RES, V33, P3475; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Matsuoka M, 2011, ONCOGENE, V30, P1379, DOI 10.1038/onc.2010.537; Nanbo A, 2002, REV MED VIROL, V12, P321, DOI 10.1002/rmv.363; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; Sugata K, 2012, BLOOD, V119, P434, DOI 10.1182/blood-2011-05-357459; Rende F, 2011, BLOOD, V117, P4855, DOI 10.1182/blood-2010-11-316463; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Zhao TJ, 2011, BLOOD, V118, P1865, DOI 10.1182/blood-2010-12-326199; Kami K, 2004, SURGERY, V136, P443, DOI 10.1016/j.surg.2004.05.023; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Kamihira S, 2001, BRIT J HAEMATOL, V114, P63, DOI 10.1046/j.1365-2141.2001.02902.x; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Che XF, 2006, BLOOD, V107, P4880, DOI 10.1182/blood-2005-08-3423; Cheng SM, 2015, BRIT J PHARMACOL, V172, P214, DOI 10.1111/bph.12935; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Lee N, 2015, CELL, V160, P607, DOI 10.1016/j.cell.2015.01.015; MacNamara A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001117; Masuda K, 2008, PLOS MED, V5, P805, DOI 10.1371/journal.pmed.0050094; Matsuoka M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-71; Rowan AG, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0116-6; Saito M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-19; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Vernin C, 2014, CANCER RES, V74, P6082, DOI 10.1158/0008-5472.CAN-13-3564; Yamamoto-Taguchi N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003630; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103	50	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4143	4152		10.1158/0008-5472.CAN-15-0942		10	Oncology	Oncology	CU2ES	WOS:000363336800017		
J	Yamada, T; Amann, JM; Fukuda, K; Takeuchi, S; Fujita, N; Uehara, H; Iwakiri, S; Itoi, K; Shilo, K; Yano, S; Carbone, DP				Yamada, Tadaaki; Amann, Joseph M.; Fukuda, Koji; Takeuchi, Shinji; Fujita, Naoya; Uehara, Hisanori; Iwakiri, Shotaro; Itoi, Kazumi; Shilo, Konstantin; Yano, Seiji; Carbone, David P.			Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma	CANCER RESEARCH			English	Article							CELL LUNG-CANCER; PLEURAL MESOTHELIOMA; GROWTH-FACTOR; PHASE-II; GEFITINIB; RECEPTOR; THERAPY; PATHWAY; TARGET; GENE	Diffuse malignant mesothelioma (DMM) is a tumor of serosal membranes with propensity for progressive local disease. Because current treatment options are largely ineffective, novel therapeutic strategies based on molecular mechanisms and the disease characteristics are needed to improve the outcomes of patients with this disease. Akt kinase interacting protein 1 (Aki1; Freud-1/CC2D1A) is a scaffold protein for the PI3K-PDK1-Akt signaling module that helps determine receptor signal selectivity for EGFR. Aki1 has been suggested as a therapeutic target, but its potential has yet to be evaluated in a tumor setting. Here, we report evidence supporting its definition as a therapeutic target in DMM. In cell-based assays, Aki1 silencing decreased cell viability and caused cell-cycle arrest of multiple DMM cell lines via effects on the PKA-CREB1 signaling pathway. Blocking CREB activity phenocopied Aki1 silencing. Clinically, Aki1 was expressed in most human DMM specimens where its expression correlated with phosphorylated CREB1. Notably, Aki1 siRNA potently blocked tumor growth in an orthotopic implantation model of DMM when administered directly into the pleural cavity of tumor-bearing mice. Our findings suggest an important role for the Aki1-CREB axis in DMM pathogenesis and provide a preclinical rationale to target Aki1 by intrathoracic therapy in locally advanced tumors. (C) 2015 AACR.	[Yamada, Tadaaki; Amann, Joseph M.; Carbone, David P.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Yamada, Tadaaki; Fukuda, Koji; Takeuchi, Shinji; Yano, Seiji] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 920, Japan; [Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan; [Uehara, Hisanori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol & Environm Pathol, Tokushima 770, Japan; [Iwakiri, Shotaro; Itoi, Kazumi] Hyogo Kenritsu Amagasaki Hosp, Dept Resp Surg, Amagasaki, Hyogo, Japan; [Shilo, Konstantin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA	Carbone, DP (reprint author), Ohio State Univ, Med Ctr, 460 West 12th Ave, Columbus, OH 43210 USA.	syano@staff.kanazawa-u.ac.jp; david.carbone@osumc.edu			Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860638, 22112010A01]; Dellapezze Family Foundation	This study was supported by Grants-in-Aid for Cancer Research (25860638 to T. Yamada), Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" (22112010A01 to S. Yano) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Dellapezze Family Foundation (D.P. Carbone).	Al-Tawashi A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-47; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Giovannetti E, 2011, BRIT J CANCER, V105, P1542, DOI 10.1038/bjc.2011.400; Enns LC, 2010, AGEING RES REV, V9, P269, DOI 10.1016/j.arr.2010.02.004; Li Q, 2011, AM J PATHOL, V179, P1483, DOI 10.1016/j.ajpath.2011.05.060; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Pasello G, 2009, CURR DRUG TARGETS, V10, P1235; Nakataki E, 2006, CANCER SCI, V97, P183, DOI 10.1111/j.1349-7006.2006.00163.x; Seo HS, 2008, CANCER RES, V68, P6065, DOI 10.1158/0008-5472.CAN-07-5376; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Mani S, 2003, ANN NY ACAD SCI, V1002, P252, DOI 10.1196/annals.1281.028; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Janne PA, 2002, CANCER RES, V62, P5242; Hirsch FR, 2006, J CLIN ONCOL, V24, P5034, DOI 10.1200/JCO.2006.06.3958; Al-Tawashi A, 2012, J BIOL CHEM, V287, P14644, DOI 10.1074/jbc.M111.261875; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Mezzapelle R, 2013, BRIT J CANCER, V108, P1743, DOI 10.1038/bjc.2013.130; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Tortora G, 2002, ANN NY ACAD SCI, V968, P139; Broaddus VC, 1997, AM J RESP CELL MOL, V17, P657; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Yamada T, 2013, ONCOGENE, V32, P4427, DOI 10.1038/onc.2012.446; Cho Er-Chieh, 2011, Critical Reviews in Oncogenesis, V16, P37; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Kaufman JM, 2014, J THORAC ONCOL, V9, P794, DOI 10.1097/JTO.0000000000000173; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Morinaga K, 2001, IND HEALTH, V39, P65, DOI 10.2486/indhealth.39.65; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/nmat3765, 10.1038/NMAT3765]; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Taniguchi T, 2007, CANCER SCI, V98, P438, DOI 10.1111/j.1349-7006.2006.00386.x; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Ohtsubo K, 2014, PANCREAS, V43, P1093, DOI 10.1097/MPA.0000000000000168; Nanjo S, 2015, CANCER SCI, V106, P244, DOI 10.1111/cas.12600; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Westbom CM, 2014, AM J PATHOL, V184, P2816, DOI 10.1016/j.ajpath.2014.06.008; Zhang Xin, 2013, Zhongguo Fei Ai Za Zhi, V16, P153, DOI 10.3779/j.issn.1009-3419.2013.03.07	37	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4188	4197		10.1158/0008-5472.CAN-15-0858		10	Oncology	Oncology	CU2ES	WOS:000363336800021		
J	Kaneko, S; Nakatani, Y; Takezaki, T; Hide, T; Yamashita, D; Ohtsu, N; Ohnishi, T; Terasaka, S; Houkin, K; Kondo, T				Kaneko, Sadahiro; Nakatani, Yuka; Takezaki, Tatsuya; Hide, Takuichiro; Yamashita, Daisuke; Ohtsu, Naoki; Ohnishi, Takanori; Terasaka, Shunsuke; Houkin, Kiyohiro; Kondo, Toru			Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells	CANCER RESEARCH			English	Article							SHP-2 TYROSINE PHOSPHATASE; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE ASTROCYTES; EMBRYONIC ANTIGEN SSEA-1; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; ADHESION MOLECULE-1; HUMAN GRANULOCYTES; CANCER; ADULT	Glioblastoma-initiating cells (GIC) are a tumorigenic cell subpopulation resistant to radiotherapy and chemotherapy, and are a likely source of recurrence. However, the basis through which GICs are maintained has yet to be elucidated in detail. We herein demonstrated that the carcinoembryonic antigen-related cell adhesion molecule Ceacam1L acts as a crucial factor in GIC maintenance and tumorigenesis by activating c-Src/STAT3 signaling. Furthermore, we showed that monomers of the cytoplasmic domain of Ceacam1L bound to c-Src and STAT3 and induced their phosphorylation, whereas oligomerization of this domain ablated this function. Our results suggest that Ceacam1L-dependent adhesion between GIC and surrounding cells play an essential role in GIC maintenance and proliferation, as mediated by signals transmitted by monomeric forms of the Ceacam1L cytoplasmic domain. (C) 2015 AACR.	[Kaneko, Sadahiro; Ohtsu, Naoki; Kondo, Toru] Hokkaido Univ, Inst Med Genet, Div Stem Cell Biol, Sapporo, Hokkaido 0600815, Japan; [Kaneko, Sadahiro; Terasaka, Shunsuke; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0600815, Japan; [Nakatani, Yuka; Takezaki, Tatsuya; Hide, Takuichiro; Kondo, Toru] RIKEN, Ctr Dev Biol, Lab Cell Lineage Modulat, Kobe, Hyogo, Japan; [Takezaki, Tatsuya; Hide, Takuichiro] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Kumamoto, Kumamoto, Japan; [Yamashita, Daisuke; Ohnishi, Takanori] Ehime Univ, Grad Sch Med, Dept Neurosurg, Toon, Ehime, Japan	Kondo, T (reprint author), Hokkaido Univ, Inst Med Genet, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0600815, Japan.	tkondo@igm.hokudai.ac.jp			Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported, in part, by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT), Ministry of Education, Culture, Sports, Science and Technology of Japan (T. Kondo).	Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Prosniak M, 2013, CLIN CANCER RES, V19, P3776, DOI 10.1158/1078-0432.CCR-12-1940; Ergun S, 2000, MOL CELL, V5, P311, DOI 10.1016/S1097-2765(00)80426-8; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Bogoevska V, 2006, GLYCOBIOLOGY, V16, P197, DOI 10.1093/glycob/cwj057; Singh SK, 2003, CANCER RES, V63, P5821; Nagaishi T, 2006, ANN NY ACAD SCI, V1072, P155, DOI 10.1196/annals.1326.004; Kondo T, 2006, EUR J CANCER, V42, P1237, DOI 10.1016/j.ejca.2006.01.038; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Park CC, 2001, J IMMUNOL, V167, P1644; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Liu Y, 2010, ANTI-CANCER AGENT ME, V10, P512; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251; Horst AK, 2006, J CLIN INVEST, V116, P1596, DOI 10.1172/JCI24340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; You M, 1999, MOL CELL BIOL, V19, P2416; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Poy MN, 2002, J BIOL CHEM, V277, P1076, DOI 10.1074/jbc.M108415200; Qu CK, 1999, P NATL ACAD SCI USA, V96, P8528, DOI 10.1073/pnas.96.15.8528; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; You M, 2001, J EXP MED, V193, P101, DOI 10.1084/jem.193.1.101; Abou-Rjaily GA, 2004, J CLIN INVEST, V114, P944, DOI 10.1172/JCI200421786; Lucka L, 2005, GLYCOBIOLOGY, V15, P87, DOI 10.1093/glycob/cwh139; Hide T, 2011, STEM CELLS, V29, P590, DOI 10.1002/stem.618; Arabzadeh A, 2013, ONCOGENE, V32, P849, DOI 10.1038/onc.2012.112; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Metheny-Barlow LJ, 2003, CELL RES, V13, P309, DOI 10.1038/sj.cr.7290176; Yamashita D, 2015, CANCER RES, V75, P1123, DOI 10.1158/0008-5472.CAN-14-0938; FULLER GN, 1992, MUTAT RES, V276, P299, DOI 10.1016/0165-1110(92)90016-3; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Nakajima A, 2002, J IMMUNOL, V168, P1028; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Frisen J, 1998, CELL MOL LIFE SCI, V54, P935, DOI 10.1007/s000180050224; ALVAREZBUYLLA A, 1995, STEM CELLS, V13, P263; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; Carpenter Richard L, 2014, Cancers (Basel), V6, P897, DOI 10.3390/cancers6020897; Fischer-Colbrie R, 2005, CURR PROTEIN PEPT SC, V6, P373; Garofalo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7623; Markel G, 2002, J IMMUNOL, V168, P2803; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	OCT 1	2015	75	19					4224	4234		10.1158/0008-5472.CAN-15-0412		11	Oncology	Oncology	CU2ES	WOS:000363336800024		
J	Roth, C; Shao-Horn, Y; Myers, D; Inukai, J				Roth, Christina; Shao-Horn, Yang; Myers, Deborah; Inukai, Junji			Batteries and Fuel Cells: Leading the Way to a Cleaner and Brighter Future	CHEMELECTROCHEM			English	Editorial Material									[Roth, Christina] Free Univ Berlin, Inst Chem & Biochem Phys & Theoret Chem, D-14195 Berlin, Germany; [Shao-Horn, Yang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Myers, Deborah] Argonne Natl Lab, Chem Sci & Engn Div, Argonne, IL 60439 USA; [Inukai, Junji] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan	Roth, C (reprint author), Free Univ Berlin, Inst Chem & Biochem Phys & Theoret Chem, Takustr 3, D-14195 Berlin, Germany.	christina.roth@fu-berlin.de	Inukai, Junji/O-6304-2015	Inukai, Junji/0000-0002-7819-842X				0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1408	1409		10.1002/celc.201500385		2	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500001		
J	Nishida, K				Nishida, Kosuke			Optical Visualization and Spectroscopic Techniques for Probing Water Transport in a Polymer Electrolyte Fuel Cell	CHEMELECTROCHEM			English	Review						diagnostics; fuel cells; laser spectroscopy; optical visualization; water transport	GAS-DIFFUSION LAYERS; CROSS-SECTIONAL VISUALIZATION; RAY TOMOGRAPHIC MICROSCOPY; NEUTRON IMAGING TECHNIQUE; VAPOR PARTIAL-PRESSURE; 2-PHASE FLOW PHENOMENA; IN-SITU OBSERVATION; LIQUID WATER; CATHODE CHANNEL; DROPLET EMERGENCE	To solve the critical issues of water management in polymer electrolyte fuel cells (PEFCs), the comprehensive understanding of water transport in the catalyst layer, gas diffusion layer (GDL), electrolyte membrane and gas channel during cell operation is required. In this Minireview, optical visualization and laser spectroscopic techniques for investigating liquid water behavior and water vapor distribution in operating PEFCs are presented. Direct optical observation of water droplet buildup in the GDL and gas channel is conveniently performed using transparent cells. In addition, a novel visualization method using humidity test paper makes it possible to quantitatively measure the water vapor profile along a gas channel. Tunable diode laser absorption spectroscopy is available for noninvasive monitoring of water concentrations in flow channels with a high time resolution. These diagnostic techniques provide information useful for proper water management in PEFCs.	Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan	Nishida, K (reprint author), Kyoto Inst Technol, Fac Mech Engn, Sakyo Ku, Kyoto 6068585, Japan.	knishida@kit.ac.jp			Japan Society for the Promotion of Science (JSPS) [22246024, 17760157, 20760134, 22760150]	This work was financially supported by a Grant-in-Aid for Young Scientists (B) (No. 17760157, 20760134, 22760150) and a Grant-in-Aid for Scientific Research (A) (No. 22246024) of the Japan Society for the Promotion of Science (JSPS). The author would like to thank Prof. Shuichiro Hirai (Tokyo Institute of Technology) and Prof. Shohji Tsushima (Osaka University) for their invaluable advice and support, and a number of current and former students in the Thermal Energy Engineering Laboratory at Kyoto Institute of Technology for useful discussions and technical assistance.	Zhang JB, 2006, ELECTROCHIM ACTA, V51, P2715, DOI 10.1016/j.electacta.2005.08.010; Basu S, 2006, J FUEL CELL SCI TECH, V3, P1, DOI 10.1115/1.2133799; Bazylak A, 2008, J POWER SOURCES, V176, P240, DOI 10.1016/j.jpowsour.2007.10.066; Yoshizawa K, 2008, J ELECTROCHEM SOC, V155, pB223, DOI 10.1149/1.2823003; Zhang FY, 2007, J ELECTROCHEM SOC, V154, pB1152, DOI 10.1149/1.2777987; Okuhata G, 2013, ECS TRANSACTIONS, V58, P1047, DOI 10.1149/05801.1047ecst; Basu S, 2006, J POWER SOURCES, V159, P987, DOI 10.1016/j.jpowsour.2005.11.091; Yang XG, 2004, ELECTROCHEM SOLID ST, V7, pA408, DOI 10.1149/1.1803051; Ludlow DJ, 2006, J POWER SOURCES, V162, P271, DOI 10.1016/j.jpowsour.2006.06.068; Sinha PK, 2007, J MATER CHEM, V17, P3089, DOI 10.1039/b703485g; Boillat P, 2008, ELECTROCHEM COMMUN, V10, P546, DOI 10.1016/j.elecom.2008.01.018; Trabold TA, 2006, INT J HEAT MASS TRAN, V49, P4712, DOI 10.1016/j.ijheatmasstransfer.2006.07.003; Kimball E, 2008, AICHE J, V54, P1313, DOI 10.1002/aic.11464; Oberholzer P, 2012, ELECTROCHEM COMMUN, V20, P67, DOI 10.1016/j.elecom.2012.03.038; Zhang FY, 2006, J ELECTROCHEM SOC, V153, pA225, DOI 10.1149/1.2138675; Lee SJ, 2010, INT J HYDROGEN ENERG, V35, P10457, DOI 10.1016/j.ijhydene.2010.07.173; Basu S, 2006, J POWER SOURCES, V162, P286, DOI 10.1016/j.jpowsour.2006.06.073; Becker J, 2009, J ELECTROCHEM SOC, V156, pB1175, DOI 10.1149/1.3176876; Tuber K, 2003, J POWER SOURCES, V124, P403, DOI 10.1016/S0378-7753(03)00797-3; Kandlikar SG, 2011, FUEL CELLS, V11, P814, DOI 10.1002/fuce.201000172; Chen YS, 2007, J POWER SOURCES, V170, P376, DOI 10.1016/j.jpowsour.2007.03.076; Sasabe T, 2010, INT J HYDROGEN ENERG, V35, P11119, DOI 10.1016/j.ijhydene.2010.06.050; Kramer D, 2005, ELECTROCHIM ACTA, V50, P2603, DOI 10.1016/j.electacta.2004.11.005; Dai W, 2009, INT J HYDROGEN ENERG, V34, P9461, DOI 10.1016/j.ijhydene.2009.09.017; Park J, 2008, INT J HYDROGEN ENERG, V33, P3373, DOI 10.1016/j.ijhydene.2008.03.019; Hickner MA, 2010, J ELECTROCHEM SOC, V157, pB32, DOI 10.1149/1.3250864; Kim SG, 2013, J POWER SOURCES, V230, P101, DOI 10.1016/j.jpowsour.2012.12.030; Ma HP, 2006, J POWER SOURCES, V162, P469, DOI 10.1016/j.jpowsour.2006.06.055; Owejan JP, 2006, INT J HEAT MASS TRAN, V49, P4721, DOI 10.1016/j.ijheatmasstransfer.2006.07.004; Gao B, 2009, J POWER SOURCES, V190, P493, DOI 10.1016/j.jpowsour.2008.12.135; Mench MM, 2003, J POWER SOURCES, V124, P90, DOI 10.1016/S0378-7753(03)00617-7; Lee Y, 2009, INT J HYDROGEN ENERG, V34, P7768, DOI 10.1016/j.ijhydene.2009.07.010; Turhan A, 2006, J POWER SOURCES, V160, P1195, DOI 10.1016/j.jpowsour.2006.03.027; Bazylak A, 2009, INT J HYDROGEN ENERG, V34, P3845, DOI 10.1016/j.ijhydene.2009.02.084; Sinha PK, 2006, ELECTROCHEM SOLID ST, V9, pA344, DOI 10.1149/1.2203307; Boillat P, 2010, ELECTROCHEM SOLID ST, V13, pB25, DOI 10.1149/1.3279636; Ishikawa Y, 2008, J POWER SOURCES, V179, P547, DOI 10.1016/j.jpowsour.2008.01.031; Liu X, 2007, ELECTROCHIM ACTA, V52, P3607, DOI 10.1016/j.electacta.2006.10.030; Eller J, 2011, J ELECTROCHEM SOC, V158, pB963, DOI 10.1149/1.3596556; Hiramitsu Y, 2010, J POWER SOURCES, V195, P5543, DOI 10.1016/j.jpowsour.2010.03.039; Bellows RJ, 1999, J ELECTROCHEM SOC, V146, P1099, DOI 10.1149/1.1391727; Nishida K, 2010, J POWER SOURCES, V195, P3365, DOI 10.1016/j.jpowsour.2009.12.073; Owejan JP, 2007, J POWER SOURCES, V171, P626, DOI 10.1016/j.jpowsour.2007.06.174; Litster S, 2006, J POWER SOURCES, V154, P95, DOI 10.1016/j.jpowsour.2005.03.199; Turhan A, 2010, ELECTROCHIM ACTA, V55, P2734, DOI 10.1016/j.electacta.2009.11.095; Weng FB, 2006, J POWER SOURCES, V157, P674, DOI 10.1016/j.jpowsour.2006.01.002; Liu X, 2008, INT J HYDROGEN ENERG, V33, P1040, DOI 10.1016/j.ijhydene.2007.11.018; Sugiura K, 2005, J POWER SOURCES, V145, P526, DOI [10.1016/j.jpowsour.2005.02.037, 10.1016/j.jpowersour.2005.02.037]; Qin CZ, 2012, J ELECTROCHEM SOC, V159, pB434, DOI 10.1149/2.004205jes; Mosdale R, 1996, J MEMBRANE SCI, V118, P269, DOI 10.1016/0376-7388(96)00110-X; Hickner MA, 2006, J ELECTROCHEM SOC, V153, pA902, DOI 10.1149/1.2184893; Yang XG, 2005, J ELECTROCHEM SOC, V152, pA759, DOI 10.1149/1.1864492; Dong Q, 2005, J POWER SOURCES, V139, P106, DOI 10.1016/j.jpowsour.2004.06.068; Sur R, 2010, J ELECTROCHEM SOC, V157, pB45, DOI 10.1149/1.3247355; Wu TC, 2012, J POWER SOURCES, V208, P248, DOI 10.1016/j.jpowsour.2012.02.026; Owejan JP, 2009, INT J HYDROGEN ENERG, V34, P3436, DOI 10.1016/j.ijhydene.2008.12.100; Anderson R, 2010, J POWER SOURCES, V195, P4531, DOI 10.1016/j.jpowsour.2009.12.123; Satija R, 2004, J POWER SOURCES, V129, P238, DOI 10.1016/j.jpowsour.2003.11.068; Liu X, 2006, J POWER SOURCES, V156, P267, DOI 10.1016/j.jpowsour.2005.06.027; Lee SK, 2010, ECS TRANSACTIONS, V33, P1457, DOI 10.1149/1.3484638; Hussaini IS, 2009, J POWER SOURCES, V187, P444, DOI 10.1016/j.jpowsour.2008.11.030; Fluckiger R, 2011, ELECTROCHIM ACTA, V56, P2254, DOI 10.1016/j.electacta.2010.12.016; Lu Z, 2009, INT J HYDROGEN ENERG, V34, P3445, DOI 10.1016/j.ijhydene.2008.12.025; Hussey DS, 2007, J POWER SOURCES, V172, P225, DOI 10.1016/j.jpowsour.2007.07.036; Frish MB, 2007, P SOC PHOTO-OPT INS, V6765, P76506, DOI 10.1117/12.738195; Nishida K, 2011, ECS TRANSACTIONS, V41, P419, DOI 10.1149/1.3635576; Nishida K, 2014, ECS TRANSACTIONS, V64, P853, DOI 10.1149/06403.0853ecst; Ge SH, 2007, ELECTROCHIM ACTA, V52, P4825, DOI 10.1016/j.electacta.2007.01.038; Hakenjos A, 2004, J POWER SOURCES, V131, P213, DOI 10.1016/j.jpowsour.2003.11.081; Deevanhxay P, 2011, INT J HYDROGEN ENERG, V36, P10901, DOI 10.1016/j.ijhydene.2011.05.160; Hartnig C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907485; Kowal JJ, 2006, J ELECTROCHEM SOC, V153, pA1971, DOI 10.1149/1.2258049; Ha T, 2008, J MECH SCI TECHNOL, V22, P1030, DOI 10.1007/s12206-008-0209-z; Nishida K, 2013, J POWER SOURCES, V234, P111, DOI 10.1016/j.jpowsour.2013.01.160; Lee SK, 2014, J ELECTROCHEM SOC, V161, pF58, DOI 10.1149/2.055401jes; Owejan JP, 2007, INT J HYDROGEN ENERG, V32, P4489, DOI 10.1016/j.ijhydene.2007.05.044; Liu FQ, 2007, J MEMBRANE SCI, V287, P126, DOI 10.1016/j.memsci.2006.10.030; Ge SH, 2006, ELECTROCHEM SOLID ST, V9, pA499, DOI 10.1149/1.2337860; Turhan A, 2008, J POWER SOURCES, V180, P773, DOI 10.1016/j.jpowsour.2008.02.028; Spernjak D, 2007, J POWER SOURCES, V170, P334, DOI 10.1016/j.jpowsour.2007.04.020; Kim S, 2009, J ELECTROCHEM SOC, V156, pB353, DOI 10.1149/1.3046136; Fukuyama Y, 2011, ECS TRANSACTIONS, V41, P583, DOI 10.1149/1.3635591; Kumbur EC, 2006, J POWER SOURCES, V161, P333, DOI 10.1016/j.jpowsour.2006.04.093; Nishida K, 2015, J POWER SOURCES, V275, P447, DOI 10.1016/j.jpowsour.2014.11.059; Ishikawa Y, 2007, J POWER SOURCES, V163, P708, DOI 10.1016/j.jpowsour.2006.08.026; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Gopalan P, 2011, ECS TRANSACTIONS, V41, P479, DOI 10.1149/1.3635582; Zhu W, 2008, ECS TRANSACTIONS, V16, P995, DOI 10.1149/1.2981939; Fujii Y, 2008, ECS TRANSACTIONS, V16, P1635, DOI 10.1149/1.2982003; Li H, 2008, J POWER SOURCES, V178, P103, DOI 10.1016/j.jpowsour.2007.12.068; Manke I, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731440; Dong Q, 2005, J ELECTROCHEM SOC, V152, pA2114, DOI 10.1149/1.2039628; Nam JH, 2009, INT J HEAT MASS TRAN, V52, P2779, DOI 10.1016/j.ijheatmasstransfer.2009.01.002; Spernjak D, 2009, J ELECTROCHEM SOC, V156, pB109, DOI 10.1149/1.3009585; Mukaide T, 2008, J SYNCHROTRON RADIAT, V15, P329, DOI 10.1107/S0909049508006638; Lu GQ, 2007, J POWER SOURCES, V164, P134, DOI 10.1016/j.jpowsour.2006.10.035; Oberholzer P, 2012, J ELECTROCHEM SOC, V159, pB235, DOI 10.1149/2.085202jes; Boillat P, 2012, J ELECTROCHEM SOC, V159, pF210, DOI 10.1149/2.017207jes; Fujii Y., 2007, ECS T, V11, P451, DOI 10.1149/1.2780959; Ge S, 2007, J ELECTROCHEM SOC, V154, pB998, DOI 10.1149/1.2761830; Geiger AB, 2002, FUEL CELLS, V2, P92, DOI 10.1002/fuce.200290007; Nishida K., 2006, T JAPAN SOC MECH ENG, V72, P1627; Nishida K., 2010, P ASME 8 INT C FUEL, V1, P99; Pekula N, 2005, NUCL INSTRUM METH A, V542, P134, DOI 10.1016/j.nima.2005.01.090; Siegel JB, 2008, J ELECTROCHEM SOC, V155, pB1168, DOI 10.1149/1.2976356; Tsushima S, 2004, ELECTROCHEM SOLID ST, V7, pA269, DOI 10.1149/1.1774971; Utturkar A., 2011, P ASME 9 FUEL CELL S, P613; Weber AZ, 2005, J ELECTROCHEM SOC, V152, pA677, DOI 10.1149/1.1861194	108	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1458	1470		10.1002/celc.201500135		13	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500004		
J	Nagase, K; Motegi, H; Yoneda, M; Nagumo, Y; Suga, T; Uchida, M; Inukai, J; Nishide, H; Watanabe, M				Nagase, Katsuya; Motegi, Haruki; Yoneda, Masakazu; Nagumo, Yuzo; Suga, Takeo; Uchida, Makoto; Inukai, Junji; Nishide, Hiroyuki; Watanabe, Masahiro			Visualization of Oxygen Partial Pressure and Numerical Simulation of a Running Polymer Electrolyte Fuel Cell with Straight Flow Channels to Elucidate Reaction Distributions	CHEMELECTROCHEM			English	Article						fuel cells; gas diffusion layer; numerical simulation; oxygen; straight gas-flow channel	LIQUID WATER DISTRIBUTION; NEUTRON-RADIOGRAPHY; OPERATING PEMFC; MEMBRANE; CATHODE; PEFC; GDLS; PERFORMANCE; BEHAVIOR; LAYER	Visualization of the oxygen partial pressure (p(O(2))) was performed at the surface of a gas diffusion layer (GDL) and the upper part of the gas-flow channel of the cathode of an operating polymer electrolyte fuel cell (PEFC) with straight flow channels by using an oxygen-sensitive luminescent dye film. The gradient of p(O(2)) inside a channel was clearly observed, even on the GDL surface across the channel. A numerical simulation was performed to understand the reaction distributions inside the PEFC. By visualization and numerical simulation, the distributions of p(O(2)), the current density, water concentration, and temperature in the operating PEFC were obtained, and the relationships between the parameters were studied. Supersaturated water inside the cell was found both experimentally and computationally. p(O(2)) and the water concentration were concluded to be the two most important factors in determining the distribution of power generation.	[Uchida, Makoto; Inukai, Junji; Watanabe, Masahiro] Univ Yamanashi, Fuel Cell Nanomat Ctr, Kofu, Yamanashi 4000021, Japan; [Nagase, Katsuya] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Nagase, Katsuya] Takahata Precis Japan Co Ltd, Fuefuki, Yamanashi 4060843, Japan; [Motegi, Haruki; Yoneda, Masakazu] Mizuho Informat & Res Inst Inc, Chiyoda Ku, Tokyo 1018443, Japan; [Nagumo, Yuzo] Shimadzu Co Ltd, Kyoto 6190237, Japan; [Suga, Takeo; Nishide, Hiroyuki] Waseda Univ, Dept Appl Chem, Shinjuku Ku, Tokyo 1698555, Japan	Nagase, K (reprint author), Univ Yamanashi, Fuel Cell Nanomat Ctr, 6-43 Miyamae Cho, Kofu, Yamanashi 4000021, Japan.	jinukai@yamanashi.ac.jp	Inukai, Junji/O-6304-2015	Inukai, Junji/0000-0002-7819-842X	New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Science and Technology Agency (JST)	This manuscript was prepared with the help of Prof. Donald A. Tryk of University of Yamanashi. The research was performed under funds for the "Research on Nanotechnology for High Performance Fuel Cells (HiPer-FC)" project supported by The New Energy and Industrial Technology Development Organization (NEDO) of Japan and the "Development of Systems and Technology for Advanced Measurement and Analysis" program by the Japan Science and Technology Agency (JST).	Weber AZ, 2008, ELECTROCHIM ACTA, V53, P7668, DOI 10.1016/j.electacta.2008.05.018; Hara M, 2012, ELECTROCHIM ACTA, V82, P277, DOI 10.1016/j.electacta.2012.04.099; Sinha PK, 2007, J MATER CHEM, V17, P3089, DOI 10.1039/b703485g; Hirakata S, 2013, ELECTROCHIM ACTA, V108, P304, DOI 10.1016/j.electacta.2013.06.150; Takada K, 2011, J POWER SOURCES, V196, P2635, DOI 10.1016/j.jpowsour.2010.10.097; Tuber K, 2003, J POWER SOURCES, V124, P403, DOI 10.1016/S0378-7753(03)00797-3; Chen YS, 2007, J POWER SOURCES, V170, P376, DOI 10.1016/j.jpowsour.2007.03.076; Markotter H, 2012, J POWER SOURCES, V219, P120, DOI 10.1016/j.jpowsour.2012.07.043; Feser JP, 2006, J POWER SOURCES, V161, P404, DOI 10.1016/j.jpowsour.2006.04.129; Feindel KW, 2007, PHYS CHEM CHEM PHYS, V9, P1850, DOI 10.1039/b617551a; Sugiura K, 2005, J POWER SOURCES, V145, P526, DOI [10.1016/j.jpowsour.2005.02.037, 10.1016/j.jpowersour.2005.02.037]; Hickner MA, 2006, J ELECTROCHEM SOC, V153, pA902, DOI 10.1149/1.2184893; Lee J, 2013, J POWER SOURCES, V227, P123, DOI 10.1016/j.jpowsour.2012.11.006; Liu X, 2006, J POWER SOURCES, V156, P267, DOI 10.1016/j.jpowsour.2005.06.027; Wang CY, 2004, CHEM REV, V104, P4727, DOI 10.1021/cr020718s; Hussaini IS, 2009, J POWER SOURCES, V187, P444, DOI 10.1016/j.jpowsour.2008.11.030; Inukai J, 2008, ANGEW CHEM INT EDIT, V47, P2792, DOI 10.1002/anie.200705516; Ishigami Y, 2014, J POWER SOURCES, V269, P556, DOI 10.1016/j.jpowsour.2014.07.017; Takada K, 2011, ELECTROCHEMISTRY, V79, P388; Turhan A, 2008, J POWER SOURCES, V180, P773, DOI 10.1016/j.jpowsour.2008.02.028; Nagase K, 2015, J POWER SOURCES, V273, P873, DOI 10.1016/j.jpowsour.2014.09.169; Lee SJ, 2008, J POWER SOURCES, V185, P867, DOI 10.1016/j.jpowsour.2008.08.101; Li H, 2008, J POWER SOURCES, V178, P103, DOI 10.1016/j.jpowsour.2007.12.068; Deevanhxay P, 2012, ELECTROCHEM COMMUN, V22, P33, DOI 10.1016/j.elecom.2012.05.028; Hyakutake T, 2011, MACROMOL CHEM PHYS, V212, P42, DOI 10.1002/macp.201000449; Ishigami Y, 2011, J POWER SOURCES, V196, P3003, DOI 10.1016/j.jpowsour.2010.11.092; Hickner MA, 2008, J ELECTROCHEM SOC, V155, pB294, DOI 10.1149/1.2825298; Inukai J., 2008, ANGEW CHEM, V120, P2834, DOI 10.1002/ange.200705516; Khajeh-Hosseini-Dalasm N, 2010, J ELECTROCHEM SOC, V157, pB1358, DOI 10.1149/1.3467794; Murakawa H, 2009, NUCL INSTRUM METH A, V605, P127, DOI 10.1016/j.nima.2009.01.142; Oberholzer P, 2013, J ELECTROCHEM SOC, V160, pF659, DOI 10.1149/2.119306jes; Tsushima S, 2004, ELECTROCHEM SOLID ST, V7, pA269, DOI 10.1149/1.1774971; Tsushima S., 2007, ECS T, V11, P435, DOI DOI 10.1149/1.2780957; Wang J., 2011, ENERGY SCI TECHNOL, V2, P1; Yoneda M., 2010, P ASME 8 INT C FUEL, V1, P497	35	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1495	1501		10.1002/celc.201402385		7	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500008		
J	Tsushima, S; Hung, WH; Deevanhxay, P; Kobayashi, G; Kanno, R; Hirai, S				Tsushima, Shohji; Hung, Weihao; Deevanhxay, Phengxay; Kobayashi, Genki; Kanno, Ryoji; Hirai, Shuichiro			In Situ X-ray Visualization of the Lithiation Process in a Porous Graphite Electrode in an Operating Li-Ion Cell	CHEMELECTROCHEM			English	Article						in situ visualization; ion transport; lithiation; lithium-ion batteries; X-ray radiography	SURFACE-CHEMISTRY; CAPACITY FADE; LITHIUM; BATTERY; SPECTROSCOPY	An insitu X-ray radiography technique to observe an operating Li-ion cell was developed. Transient behaviors of lithiation processes in a porous graphite electrode were visualized in a specifically designed Li-ion cell consisting of a lithium-metal electrode and a graphite electrode, using a transmission X-ray microscope with high spatial and temporal resolution. X-ray attenuation profiles in both 15 and 30m thick graphite electrodes under discharge (lithiation) at the 2C rate were compared. X-ray attenuation was pronounced near the separator in the thicker graphite electrode during the lithiation process, whereas less variation was observed near the current collector in the electrode. These X-ray observations indicate less utilization of the thicker graphite electrode, presumably because of the longer Li-ion transport path and formation of a solid electrolyte interface layer in the porous electrode, resulting in less discharge capacity of the Li-ion cell.	[Tsushima, Shohji] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Tsushima, Shohji; Hung, Weihao; Deevanhxay, Phengxay; Hirai, Shuichiro] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528552, Japan; [Deevanhxay, Phengxay] Natl Univ Laos, Dept Chem, Viangchan 7322, Laos; [Kobayashi, Genki] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Kobayashi, Genki; Kanno, Ryoji] Tokyo Inst Technol, Dept Elect Chem, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tsushima, S (reprint author), Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan.	tsushima@mech.eng.osaka-u.ac.jp					Harris SJ, 2010, CHEM PHYS LETT, V485, P265, DOI 10.1016/j.cplett.2009.12.033; Aurbach D, 1999, ELECTROCHIM ACTA, V45, P67, DOI 10.1016/S0013-4686(99)00194-2; YADA K, 1989, J ELECTRON MICROSC, V38, P321; Sasabe T, 2010, INT J HYDROGEN ENERG, V35, P11119, DOI 10.1016/j.ijhydene.2010.06.050; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Arora P, 2004, CHEM REV, V104, P4419, DOI 10.1021/cr020738u; Yin XM, 2010, J PHYS CHEM C, V114, P8084, DOI 10.1021/jp100224x; Liu J, 2010, J PHYS CHEM LETT, V1, P2120, DOI 10.1021/jz100634n; Owejan JP, 2012, ELECTROCHIM ACTA, V66, P94, DOI 10.1016/j.electacta.2012.01.047; Deevanhxay P, 2014, ELECTROCHIM ACTA, V135, P68, DOI 10.1016/j.electacta.2014.04.144; Yazami R, 1999, ELECTROCHIM ACTA, V45, P87, DOI 10.1016/S0013-4686(99)00195-4; Zhang Q, 2008, J POWER SOURCES, V179, P793, DOI 10.1016/j.jpowsour.2008.01.028; Goers D, 2004, J POWER SOURCES, V130, P221, DOI 10.1016/j.jpowsour.2003.11.065; Andersson AM, 2003, J POWER SOURCES, V119, P522, DOI 10.1016/S0378-7753(03)00277-5; BESENHARD JO, 1995, J POWER SOURCES, V54, P228, DOI 10.1016/0378-7753(94)02073-C; Christensen J, 2004, J ELECTROCHEM SOC, V151, pA1977, DOI 10.1149/1.1804812; FULLER TF, 1994, J ELECTROCHEM SOC, V141, P1, DOI 10.1149/1.2054684; Nelson Weker Johanna, 2015, Advanced Functional Materials, V25, DOI 10.1002/adfm.201403409; Sikha G, 2004, J ELECTROCHEM SOC, V151, pA1104, DOI 10.1149/1.1759972; Takamatsu D, 2012, ANGEW CHEM INT EDIT, V51, P11597, DOI 10.1002/anie.201203910; Takamatsu D., 2012, ANGEW CHEM, V124, P11765, DOI DOI 10.1002/ANGE.201203910; Yada K, 2009, SPECTROCHIM ACTA B, V64, P729, DOI 10.1016/j.sab.2009.06.016	22	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1535	1540		10.1002/celc.201500141		6	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500013		
J	Takahashi, S; Mashio, T; Horibe, N; Akizuki, K; Ohma, A				Takahashi, Shinichi; Mashio, Tetsuya; Horibe, Norifumi; Akizuki, Ken; Ohma, Atsushi			Analysis of the Microstructure Formation Process and Its Influence on the Performance of Polymer Electrolyte Fuel-Cell Catalyst Layers	CHEMELECTROCHEM			English	Article						catalyst layer; fuel cells; inks; microporous materials; polymers	QUARTZ-CRYSTAL MICROBALANCE; CRYO-SEM; IMPEDANCE SPECTROSCOPY; PLATINUM NANOTUBES; PROTON TRANSPORT; IONOMER; OXYGEN; REDUCTION; INK; SOLVENT	To understand the formation process of the microstructure of the catalyst layer of a polymer electrolyte fuel cell (PEFC), we tried to observe the real structure of the catalyst ink by cryogenic scanning electron microscopy (cryo-SEM). Catalyst inks with different water/alcohol compositions were successfully visualized, and they correlated well with the particle-size distribution obtained by laser diffraction of the ink and the structures of the catalyst layers obtained by typical SEM. On the basis of other electrochemical characterization results, including current-voltage performance, oxygen reduction reaction kinetics, and mass-transport properties, the microstructures of the catalyst inks and the catalyst layers were proposed. The proposed microstructures can explain the relationship between the catalyst materials and the performance of the cathode catalyst layer of the membrane electrode assembly through its formation and apparent properties. It was also found that the microstructure of the catalyst ink plays an important role in performance.	[Takahashi, Shinichi; Mashio, Tetsuya; Horibe, Norifumi; Akizuki, Ken; Ohma, Atsushi] Nissan Motor Co Ltd, Div Res, Yokosuka, Kanagawa 2378523, Japan	Ohma, A (reprint author), Nissan Motor Co Ltd, Div Res, 1 Natsushima, Yokosuka, Kanagawa 2378523, Japan.	a-ohma@mail.nissan.co.jp					Malek K, 2007, J PHYS CHEM C, V111, P13627, DOI 10.1021/jp072692k; Iden H, 2013, J ELECTROANAL CHEM, V708, P87, DOI 10.1016/j.jelechem.2013.09.011; Shin SJ, 2002, J POWER SOURCES, V106, P146; Makharia R, 2005, J ELECTROCHEM SOC, V152, pA970, DOI 10.1149/1.1888367; Ohma A, 2010, ELECTROCHIM ACTA, V55, P8829, DOI 10.1016/j.electacta.2010.08.005; UCHIDA M, 1995, J ELECTROCHEM SOC, V142, P463, DOI 10.1149/1.2044068; Iden H, 2011, J ELECTROCHEM SOC, V158, pB987, DOI 10.1149/1.3598141; Sakai K, 2009, ECS TRANSACTIONS, V25, P1193, DOI 10.1149/1.3210674; Ishihara A, 2013, J PHYS CHEM C, V117, P18837, DOI 10.1021/jp405247m; Uchida M, 1998, J ELECTROCHEM SOC, V145, P3708, DOI 10.1149/1.1838863; Iden H, 2009, J ELECTROCHEM SOC, V156, pB1078, DOI 10.1149/1.3169514; Xu F, 2010, LANGMUIR, V26, P19199, DOI 10.1021/la1028228; Ma S, 2007, SOLID STATE IONICS, V178, P1568, DOI 10.1016/j.ssi.2007.10.007; Arumugam B, 2014, RSC ADV, V4, P27510, DOI 10.1039/c4ra04744c; Xie Z, 2008, ENERG ENVIRON SCI, V1, P184, DOI 10.1039/b808613n; Ito T, 2011, ELECTROCHEMISTRY, V79, P374; Ngo TT, 2013, J POWER SOURCES, V225, P293, DOI 10.1016/j.jpowsour.2012.10.055; Owejan JP, 2013, J ELECTROCHEM SOC, V160, pF824, DOI 10.1149/2.072308jes; Alia SM, 2013, ACS CATAL, V3, P358, DOI 10.1021/cs300664g; Ohma A, 2011, ELECTROCHIM ACTA, V56, P10832, DOI 10.1016/j.electacta.2011.04.058; Iden H, 2013, J ELECTROANAL CHEM, V693, P34, DOI 10.1016/j.jelechem.2013.01.026; Yano H, 2013, J ELECTROANAL CHEM, V688, P137, DOI 10.1016/j.jelechem.2012.09.028; Johnston CM, 2009, ECS TRANSACTIONS, V25, P1617, DOI 10.1149/1.3210717; Prakash SS, 2006, J MEMBRANE SCI, V283, P328, DOI 10.1016/j.memsci.2006.07.001; Omura J, 2011, LANGMUIR, V27, P6464, DOI 10.1021/la200694a; Park YC, 2015, J POWER SOURCES, V275, P384, DOI 10.1016/j.jpowsour.2014.10.149; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Buss F, 2011, J COLLOID INTERF SCI, V359, P112, DOI 10.1016/j.jcis.2011.03.054; Prakash SS, 2008, J MEMBRANE SCI, V313, P135, DOI 10.1016/j.memsci.2008.01.006; Papandrew AB, 2013, J ELECTROCHEM SOC, V160, pF848, DOI 10.1149/2.090308jes; Subbaraman R, 2010, J PHYS CHEM C, V114, P8414, DOI 10.1021/jp100814x; Adzic R, 2012, ELECTROCATALYSIS-US, V3, P163, DOI 10.1007/s12678-012-0112-3; Kodama K, 2014, J ELECTROCHEM SOC, V161, pF649, DOI 10.1149/2.051405jes; Lefebvre MC, 1999, ELECTROCHEM SOLID ST, V2, P259, DOI 10.1149/1.1390804; Strong A, 2015, J ELECTROCHEM SOC, V162, pF513, DOI 10.1149/2.0251506jes; Masuda T, 2013, J PHYS CHEM C, V117, P15704, DOI 10.1021/jp404376t; Wang QP, 2004, J ELECTROANAL CHEM, V573, P61, DOI 10.1016/j.jelechem.2004.06.022; Fernandez R, 2005, J POWER SOURCES, V151, P18, DOI 10.1016/j.jpowsour.2005.02.048; Luo H, 2007, J COLLOID INTERF SCI, V316, P500, DOI 10.1016/j.jcis.2007.07.047; Cleveland C. A., 2010, EFFECT SOLVENT COMPO; Daimon H., 2013, ELECTROCHEMISTRY, V81; Eikerling M, 2006, J ELECTROCHEM SOC, V153, pE58, DOI 10.1149/1.2160435; Furuya Y., 2012, 221 ECS M, P1522; Huang DC, 2011, INT J ELECTROCHEM SC, V6, P2551; Iiyama A., 2011, OBJECTIVES R D CHALL; Liu YX, 2009, J ELECTROCHEM SOC, V156, pB970, DOI 10.1149/1.3143965; Mashio T., 2007, ECS T, V11, P529, DOI 10.1149/1.2780966; Mashio T., 2014, 65 ISE M LAUS SWITZ; More K. L., 2014, P 2014 DOE ANN MER R; Nishino Y., 2013, JSM BA SEM JUP US; Nonoyama N, 2011, J ELECTROCHEM SOC, V158, pB416, DOI 10.1149/1.3546038; Shibayama M., 2014, J APPL POLYM SCI, V131, P39841	52	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1560	1567		10.1002/celc.201500131		8	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500016		
J	Samjeske, G; Higashi, K; Takao, S; Nagamatsu, S; Nagasawa, K; Sekizawa, O; Kaneko, T; Uruga, T; Iwasawa, Y				Samjeske, Gabor; Higashi, Kotaro; Takao, Shinobu; Nagamatsu, Shin-ichi; Nagasawa, Kensaku; Sekizawa, Oki; Kaneko, Takuma; Uruga, Tomoya; Iwasawa, Yasuhiro			In Situ Techniques to Study the Effects of Anode or Cathode Gas-Exchange Cycles on the Deterioration of Pt/C Cathode Catalysts in PEFCs	CHEMELECTROCHEM			English	Article						electron microscopy; fuel cells; gas-exchange effects; ORR activity; Pt/C catalyst degradation	MEMBRANE FUEL-CELL; ABSORPTION FINE-STRUCTURE; CARBON CORROSION; START-UP; PERFORMANCE DEGRADATION; MITIGATION STRATEGIES; INTERNAL CURRENTS; OXYGEN REDUCTION; SURFACE EVENTS; SHUT-DOWN	Repeated, quick anode gas-exchange (AGEX) or cathode gas-exchange (CGEX) cycles were applied to polymer electrolyte fuel cell (PEFC) membrane electrode assemblies (MEAs) with Pt/C cathode catalysts to simulate start-up/shut-down conditions and to examine a possible countermeasure for their effects on MEA cathode catalyst degradation. The peak height of the white line during insitu time-resolved X-ray absorption near-edge structure (XANES) spectra at the Pt L-III-edge decreased with an increasing number of AGEX cycles and only in the top region of the MEA cathode layer (close to the gas inlet of the fuel cell), not in the whole MEA area. End-of-life analysis after AGEX by using SEM and TEM revealed isolated Pt nanoparticles in micro-cracks and voids produced in the top region of the MEA cathode layer. The nanoparticle sizes remained almost unchanged for top, middle, and bottom regions of the MEA cathode layer. In the case of CGEX, a small increase in the Pt nanoparticle sizes in the top and bottom positions of the MEA cathode layer was observed. These findings support the role of carbon corrosion, leaving isolated, electrochemically inactive Pt nanoparticles as a consequence of the harsh reaction conditions caused by the reverse current decay mechanism during the start-up/shut-down phase, as in the case of AGEX cycles, to be the main cause for the cathode catalyst deterioration close to the anode gas inlet. On the other hand, the hydrogen gas feed to both the anode and cathode during start-up and shut-down processes seems to effectively suppress carbon corrosion and prevents a decrease in the performance.	[Samjeske, Gabor; Higashi, Kotaro; Takao, Shinobu; Nagamatsu, Shin-ichi; Nagasawa, Kensaku; Sekizawa, Oki; Kaneko, Takuma; Uruga, Tomoya; Iwasawa, Yasuhiro] Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan; [Uruga, Tomoya] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Iwasawa, Y (reprint author), Univ Electrocommun, Innovat Res Ctr Fuel Cells, Chofu, Tokyo 1828585, Japan.	iwasawa@pc.uec.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). XAFS measurements were performed with the approval of SPring-8 (2013B7801, 2014A7801, 2014B7802).	Jo YY, 2011, J POWER SOURCES, V196, P9906, DOI 10.1016/j.jpowsour.2011.08.035; Yu XW, 2007, J POWER SOURCES, V172, P145, DOI 10.1016/j.jpowsour.2007.07.048; Inoue H, 2002, ELECTROCHIM ACTA, V47, P3777, DOI 10.1016/S0013-4686(02)00348-1; Lamibrac A, 2011, J POWER SOURCES, V196, P9451, DOI 10.1016/j.jpowsour.2011.07.013; Yousfi-Steiner N, 2009, J POWER SOURCES, V194, P130, DOI 10.1016/j.jpowsour.2009.03.060; Shao YY, 2007, J POWER SOURCES, V171, P558, DOI 10.1016/j.jpowsour.2007.07.004; Tang H, 2006, J POWER SOURCES, V158, P1306, DOI 10.1016/j.jpowsour.2005.10.059; Wang JJ, 2007, J POWER SOURCES, V171, P331, DOI 10.1016/j.jpowsour.2007.06.084; Borup R, 2007, CHEM REV, V107, P3904, DOI 10.1021/cr050182l; Baumgartner WR, 2008, J POWER SOURCES, V182, P413, DOI 10.1016/j.jpowsour.2008.01.001; Carrette L, 2001, FUEL CELLS, V1, P5, DOI 10.1002/1615-6854(200105)1:1<5::AID-FUCE5>3.0.CO;2-G; SRINIVASAN S, 1991, J POWER SOURCES, V36, P299, DOI 10.1016/0378-7753(91)87009-Z; Hitchcock AP, 2014, J POWER SOURCES, V266, P66, DOI 10.1016/j.jpowsour.2014.04.119; Wu JF, 2008, J POWER SOURCES, V184, P104, DOI 10.1016/j.jpowsour.2008.06.006; Hu JW, 2009, ELECTROCHIM ACTA, V54, P5583, DOI 10.1016/j.electacta.2009.04.073; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Maass S, 2008, J POWER SOURCES, V176, P444, DOI 10.1016/j.jpowsour.2007.08.053; Yu Y, 2011, J POWER SOURCES, V196, P5077, DOI 10.1016/j.jpowsour.2011.01.075; Ishiguro N, 2012, ACS CATAL, V2, P1319, DOI 10.1021/cs300228p; Brightman E, 2014, J POWER SOURCES, V267, P160, DOI 10.1016/j.jpowsour.2014.05.040; Ishiguro N, 2013, PHYS CHEM CHEM PHYS, V15, P18827, DOI 10.1039/c3cp52578c; Stambouli AB, 2002, RENEW SUST ENERG REV, V6, P295; Ettingshausen F, 2009, J POWER SOURCES, V194, P899, DOI 10.1016/j.jpowsour.2009.06.003; SRINIVASAN S, 1988, J POWER SOURCES, V22, P359, DOI 10.1016/0378-7753(88)80030-2; Ishiguro N, 2014, J PHYS CHEM C, V118, P15874, DOI 10.1021/jp504738p; Piela P, 2004, J ELECTROCHEM SOC, V151, pA2053, DOI 10.1149/1.1814472; Yu Y, 2012, J POWER SOURCES, V205, P10, DOI 10.1016/j.jpowsour.2012.01.059; Tada M, 2007, ANGEW CHEM INT EDIT, V46, P4310, DOI 10.1002/anie.200604732; Siroma Z, 2007, J POWER SOURCES, V172, P155, DOI 10.1016/j.jpowsour.2007.07.062; Samjeske G, 2013, PHYS CHEM CHEM PHYS, V15, P17208, DOI 10.1039/c3cp52323c; Kreitmeier S, 2012, J ELECTROCHEM SOC, V159, pF787, DOI 10.1149/2.019212jes; Linse N, 2012, J POWER SOURCES, V219, P240, DOI 10.1016/j.jpowsour.2012.07.037; Nagasawa K, 2014, PHYS CHEM CHEM PHYS, V16, P10075, DOI 10.1039/c3cp54457e; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; WILSON MS, 1992, J ELECTROCHEM SOC, V139, pL28, DOI 10.1149/1.2069277; Kim J, 2009, J POWER SOURCES, V192, P674, DOI 10.1016/j.jpowsour.2009.03.039; Zhang SS, 2009, J POWER SOURCES, V194, P588, DOI 10.1016/j.jpowsour.2009.06.073; Nagamatsu S, 2013, J PHYS CHEM C, V117, P13094, DOI 10.1021/jp402438e; Maranzana G, 2010, J POWER SOURCES, V195, P5990, DOI 10.1016/j.jpowsour.2009.10.093; Saida T, 2012, ANGEW CHEM INT EDIT, V51, P10311, DOI 10.1002/anie.201204478; Meyers JP, 2006, J ELECTROCHEM SOC, V153, pA1432, DOI 10.1149/1.2203811; Cai M, 2006, J POWER SOURCES, V160, P977, DOI 10.1016/j.jpowsour.2006.03.033; Ishigami Y, 2011, J POWER SOURCES, V196, P3003, DOI 10.1016/j.jpowsour.2010.11.092; Franco AA, 2008, J ELECTROCHEM SOC, V155, pB367, DOI 10.1149/1.2838165; Ishigami Y, 2012, ELECTROCHEM SOLID ST, V15, pB51, DOI 10.1149/2.018204esl; Kunimatsu M, 2005, J ELECTROCHEM SOC, V152, pE161, DOI 10.1149/1.1874732; Mathias M. F., 2005, Electrochemical Society Interface, V14; Reiser CA, 2005, ELECTROCHEM SOLID ST, V8, pA273, DOI 10.1149/1.1896466; Saida T., 2012, ANGEW CHEM, V124, P10457; Samjeske G., 2013, ECS T, V50, P1651; Srinivasan S., 2006, FUEL CELLS; Tada M., 2007, ANGEW CHEM, V119, P4388, DOI 10.1002/ange.200604732; Vielstich W., 2003, HDB FUEL CELLS	53	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	2196-0216			CHEMELECTROCHEM	ChemElectroChem	OCT	2015	2	10			SI		1595	1606		10.1002/celc.201500099		12	Electrochemistry	Electrochemistry	CU2EP	WOS:000363336500020		
J	Li, YH; Zeng, WJ; Lai, WY; Shimada, S; Wang, S; Wang, LH; Huang, W				Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Shimada, Shigeru; Wang, Shi; Wang, Lianhui; Huang, Wei			Synthesis, Structural Characterization and Reactivity of a Bis(phosphine)(silyl) Platinum(II) Complex	CHINESE JOURNAL OF CHEMISTRY			English	Article						silyl; chelating; platinum; multinuclear NMR	TRANSITION-METAL-COMPLEXES; SI-H; PALLADIUM COMPLEXES; CATALYZED REACTIONS; SILYL COMPLEXES; RECENT PROGRESS; SILICON; ACTIVATION; BONDS; DINUCLEAR	Treatment of 1,2-C6H4(SiH3)(SiH3) (1) with Pt(dmpe)(PEt3)(2) (dmpe=Me2PCH2CH2PMe2) in the ratio of 1:1 leads to the complex {1,2-C6H4(SiH2)(SiH2)}Pt-II (dmpe) (2), which can react with proton organic reagent bearing hydroxy group with low steric hindrance to form a tetra-alkoxy substituted silyl platinum(II) compound (3). Compounds 2 and 3 are the very rare examples of silyl transition-metal complexes derived from this chelating hydrosilane ligand. To the best of our knowledge, there are only 6 examples of silyl metal complexes prepared from this ligand with such structural features registered in the Cambridge Structural Database, among them, only one silyl platinum(II) compound is presented. The structures of complexes 2 and 3 were unambiguously determined by multinuclear NMR spectroscopic studies and single crystal X-ray analysis.	[Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Wang, Shi; Wang, Lianhui; Huang, Wei] Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 210023, Jiangsu, Peoples R China; [Li, Yonghua; Zeng, Wenjin; Lai, Wenyong; Wang, Shi; Wang, Lianhui; Huang, Wei] Nanjing Univ Posts & Telecommun, IAM, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing, Jiangsu, Peoples R China; [Shimada, Shigeru] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan	Li, YH (reprint author), Nanjing Univ Posts & Telecommun, Key Lab Organ Elect & Informat Displays, Jiangsu Natl Synerget Innovat Ctr Adv Mat SICAM, Nanjing 210023, Jiangsu, Peoples R China.	iamyhli@njupt.edu.cn			National Key Basic Research Program of China [2014CB648300]; National Natural Science Foundation of China [51173082, 51274159]; Natural Science Foundation of Jiangsu Province [BK20141425]; Natural Science Foundation of Colleges and Universities in Jiangsu Province [13KJB150028]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Ministry of Education of China [IRT1148]	This work was financially supported by the National Key Basic Research Program of China (No. 2014CB648300), the National Natural Science Foundation of China (Nos. 51173082 and 51274159), the Natural Science Foundation of Jiangsu Province (No. BK20141425), the Natural Science Foundation of Colleges and Universities in Jiangsu Province (No. 13KJB150028), the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and the Ministry of Education of China (No. IRT1148).	SHIMADA S, 1995, J AM CHEM SOC, V117, P8289, DOI 10.1021/ja00136a035; Yamada T, 2004, ORGANOMETALLICS, V23, P4771, DOI 10.1021/om049858d; SHARMA HK, 1995, CHEM REV, V95, P1351, DOI 10.1021/cr00037a010; HORN KA, 1995, CHEM REV, V95, P1317, DOI 10.1021/cr00037a009; Braddock-Wilking J, 2000, ORGANOMETALLICS, V19, P5500, DOI 10.1021/om000602r; Crabtree RH, 2002, SCIENCE, V295, P288, DOI 10.1126/science.1067921; SPEIER JL, 1957, J AM CHEM SOC, V79, P974, DOI 10.1021/ja01561a054; Braddock-Wilking J, 2004, ORGANOMETALLICS, V23, P4576, DOI 10.1021/om0400447; Okazaki M, 2002, COORDIN CHEM REV, V226, P167, DOI 10.1016/S0010-8545(01)00422-2; Tanabe M, 2003, ORGANOMETALLICS, V22, P2190, DOI 10.1021/om030081i; Yu XH, 2004, ORGANOMETALLICS, V23, P2210, DOI 10.1021/om049862p; CRABTREE RH, 1993, ANGEW CHEM INT EDIT, V32, P789, DOI 10.1002/anie.199307891; Fontaine FG, 2002, ORGANOMETALLICS, V21, P401, DOI 10.1021/om010757e; Zell T, 2011, DALTON T, V40, P1852, DOI 10.1039/c0dt01442g; Shimada S, 2005, ORGANOMETALLICS, V24, P6029, DOI 10.1021/om050498j; Boyle RC, 2003, J AM CHEM SOC, V125, P3228, DOI 10.1021/ja029853c; Turculet L, 2004, ORGANOMETALLICS, V23, P2488, DOI 10.1021/om030686e; Shimada S, 2007, P NATL ACAD SCI USA, V104, P7758, DOI 10.1073/pnas.0700450104; Chen WZ, 2002, SCIENCE, V295, P308, DOI 10.1126/science.1067027; Takaya J, 2013, J SYN ORG CHEM JPN, V71, P417; Suginome M, 2000, CHEM REV, V100, P3221, DOI 10.1021/cr9902805; Corey JY, 2011, CHEM REV, V111, P863, DOI 10.1021/cr900359c; Putzien S, 2010, PROG POLYM SCI, V35, P687, DOI 10.1016/j.progpolymsci.2010.01.007; Varchi G, 2006, CURR ORG CHEM, V10, P1341, DOI 10.2174/138527206778018230; HEYN RH, 1992, J AM CHEM SOC, V114, P1917, DOI 10.1021/ja00031a077; Shimada S, 1996, ANGEW CHEM INT EDIT, V35, P1856, DOI 10.1002/anie.199618561; Beck R, 2012, ORGANOMETALLICS, V31, P3599, DOI 10.1021/om300120x; Esteruelas MA, 2013, INORG CHEM, V52, P12108, DOI 10.1021/ic401931y; PIPER TS, 1956, NATURWISSENSCHAFTEN, V43, P129; Shimada S, 1999, ORGANOMETALLICS, V18, P291, DOI 10.1021/om980904h; Oestreich M, 2015, CHEM SOC REV, V44, P2202, DOI 10.1039/c4cs00451e; Li YH, 2010, J ORGANOMET CHEM, V695, P2057, DOI 10.1016/j.jorganchem.2010.05.023; Ogino H, 1998, ADV ORGANOMET CHEM, V42, P223, DOI 10.1016/S0065-3055(08)60544-4; Lee YJ, 2004, ORGANOMETALLICS, V23, P203, DOI 10.1021/om0341121; CLEARY BP, 1995, ORGANOMETALLICS, V14, P2297, DOI 10.1021/om00005a031; Yoo BR, 2011, CURR ORG CHEM, V15, P2743; SEITZ F, 1988, ANGEW CHEM INT EDIT, V27, P289, DOI 10.1002/anie.198802891; EABORN C, 1977, J ORGANOMET CHEM, V131, P377; Sanow LM, 2000, ORGANOMETALLICS, V19, P192, DOI 10.1021/om990871l; Shimada S, 2006, ORGANOMETALLICS, V25, P3796, DOI 10.1021/om0604019; YOSHIDA T, 1990, INORG SYN, V28, P122, DOI 10.1002/9780470132593.ch32; Li YH, 2010, ORGANOMETALLICS, V29, P4406, DOI 10.1021/om100626k; BONNY A, 1978, COORDIN CHEM REV, V25, P229, DOI 10.1016/S0010-8545(00)82061-5; Chan C. Y., 1995, CHEM J CHINESE U, V16, P1806; HOLMESSMITH RD, 1981, J CHEM SOC CHEM COMM, P937, DOI 10.1039/c39810000937; Kim BH, 2005, ADV ORGANOMET CHEM, V52, P143, DOI 10.1016/S0065-3055(04)52003-8; Marciniec B, 2005, COORDIN CHEM REV, V249, P2374, DOI 10.1016/j.ccr.2005.02.025; Reichl JA, 1999, ADV ORGANOMET CHEM, V43, P197; Schubert U., 1990, ADV ORGANOMET CHEM, V30, P151, DOI 10.1016/S0065-3055(08)60501-8; Sheldrick G. M., 1997, SHELXS 97 PROGRAM CR; Sheldrick G.M., 1997, SHELXL 97 PROGRAM CR	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1001-604X	1614-7065		CHINESE J CHEM	Chin. J. Chem.	OCT	2015	33	10					1206	1210		10.1002/cjoc.201500418		5	Chemistry, Multidisciplinary	Chemistry	CU0OY	WOS:000363218000016		
J	Xu, Z; Keiji, Y; Liu, XJ				Xu Zheng; Keiji, Yasuda; Liu Xiao-Jun			Quantitative calculation of reaction performance in sonochemical reactor by bubble dynamics	CHINESE PHYSICS B			English	Article						reaction field; cavitation; bubble dynamics; hydroxide radical	WATER-SOLUBLE SOLUTES; NUMERICAL-SIMULATION; FREQUENCY REACTOR; ULTRASOUND WAVES; PRESSURE FIELDS; CAVITATION; SONOLUMINESCENCE; TEMPERATURE; ENHANCEMENT; IRRADIATION	In order to design a sonochemical reactor with high reaction efficiency, it is important to clarify the size and intensity of the sonochemical reaction field. In this study, the reaction field in a sonochemical reactor is estimated from the distribution of pressure above the threshold for cavitation. The quantitation of hydroxide radical in a sonochemical reactor is obtained from the calculation of bubble dynamics and reaction equations. The distribution of the reaction field of the numerical simulation is consistent with that of the sonochemical luminescence. The sound absorption coefficient of liquid in the sonochemical reactor is much larger than that attributed to classical contributions which are heat conduction and shear viscosity. Under the dual irradiation, the reaction field becomes extensive and intensive because the acoustic pressure amplitude is intensified by the interference of two ultrasonic waves.	[Xu Zheng] Tongji Univ, Sch Phys Sci & Engn, Shanghai 200092, Peoples R China; [Xu Zheng; Keiji, Yasuda] Nagoya Univ, Dept Chem Engn, Nagoya, Aichi 4648603, Japan; [Liu Xiao-Jun] Nanjing Univ, Sch Phys, Nanjing 210093, Jiangsu, Peoples R China	Liu, XJ (reprint author), Nanjing Univ, Sch Phys, Nanjing 210093, Jiangsu, Peoples R China.	liuxiaojun@nju.edu.cn			National Natural Science Foundation of China [11404245, 11204129, 11211140039]	Project supported by the National Natural Science Foundation of China (Grant Nos. 11404245, 11204129, and 11211140039).	Chowdhury P, 2009, SCI TOTAL ENVIRON, V407, P2474, DOI 10.1016/j.scitotenv.2008.12.031; Klima J, 2007, ULTRASON SONOCHEM, V14, P19, DOI 10.1016/j.ultsonch.2006.01.001; Yasui K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2790420; FLINT EB, 1991, SCIENCE, V253, P1397, DOI 10.1126/science.253.5026.1397; Yasui K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919119; Suslick KS, 2008, ANNU REV PHYS CHEM, V59, P659, DOI 10.1146/annurev.physchem.59.032607.093739; Servant G, 2000, ULTRASON SONOCHEM, V7, P217, DOI 10.1016/S1350-4177(00)00059-6; Yasui K, 1997, PHYS REV E, V56, P6750, DOI 10.1103/PhysRevE.56.6750; Brotchie A, 2007, J PHYS CHEM C, V111, P3066, DOI 10.1021/jp067524r; Yasui K, 1996, J PHYS SOC JPN, V65, P2830, DOI 10.1143/JPSJ.65.2830; HENGLEIN A, 1987, ULTRASONICS, V25, P6, DOI 10.1016/0041-624X(87)90003-5; Xu Z, 2013, ULTRASON SONOCHEM, V20, P452, DOI 10.1016/j.ultsonch.2012.04.011; Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4; HALL L, 1948, PHYS REV, V73, P775, DOI 10.1103/PhysRev.73.775; Gedanken A, 2004, ULTRASON SONOCHEM, V11, P47, DOI 10.1016/j.ultsonch.2004.01.037; Moholkar VS, 2000, ULTRASONICS, V38, P666, DOI 10.1016/S0041-624X(99)00204-8; Sivakumar M, 2002, CHEM ENG J, V85, P327, DOI 10.1016/S1385-8947(01)00179-6; Dahnke S, 1999, ULTRASON SONOCHEM, V6, P31, DOI 10.1016/S1350-4177(98)00026-1; Yasuda K, 1999, J CHEM ENG JPN, V32, P347, DOI 10.1252/jcej.32.347; Kanthale PM, 2007, CHEM ENG J, V127, P71, DOI 10.1016/j.cej.2006.09.023; Brotchie A, 2008, J PHYS CHEM C, V112, P10247, DOI 10.1021/jp801763v; BURTON CJ, 1948, J ACOUST SOC AM, V20, P186, DOI 10.1121/1.1906362; Servant G, 2001, ULTRASON SONOCHEM, V8, P163, DOI 10.1016/S1350-4177(01)00074-8; Kojima Y, 2010, ULTRASON SONOCHEM, V17, P978, DOI 10.1016/j.ultsonch.2009.11.020; Jamshidi R, 2012, CHEM ENG J, V189, P364, DOI 10.1016/j.cej.2012.02.029; Moholkar VS, 2004, AICHE J, V50, P58, DOI 10.1002/aic.10005; Yanagida H, 2000, ULTRASONICS, V38, P671, DOI 10.1016/S0041-624X(99)00203-6; Yasui K, 2007, ULTRASON SONOCHEM, V14, P605, DOI 10.1016/j.ultsonch.2006.09.010; Koda S, 2003, ULTRASON SONOCHEM, V10, P149, DOI 10.1016/S1350-4177(03)00084-1; Servant G, 2003, ULTRASON SONOCHEM, V10, P347, DOI 10.1016/S1350-4177(03)00105-6; Liu XZ, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/2/024301; MITOME H, 1991, JPN J APPL PHYS 1, V30, P60; NEPPIRAS EA, 1980, PHYS REP, V61, P159, DOI 10.1016/0370-1573(80)90115-5	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1674-1056	1741-4199		CHINESE PHYS B	Chin. Phys. B	OCT	2015	24	10							104301	10.1088/1674-1056/24/10/104301		7	Physics, Multidisciplinary	Physics	CU2BU	WOS:000363327400045		
J	Hida, K; Sakai, T; Hayashi, M; Tamagawa, T; Abe, Y				Hida, Kumiko; Sakai, Tetsuya; Hayashi, Maya; Tamagawa, Takao; Abe, Yoichiro			Sympathotomy for palmar hyperhidrosis: the cutting versus clamping methods	CLINICAL AUTONOMIC RESEARCH			English	Article						Thoracic sympathotomy; Postoperative compensatory sweating; Postoperative satisfaction; Hyperhidrosis; Clamping method	ENDOSCOPIC THORACIC SYMPATHECTOMY; RANDOMIZED CONTROL TRIAL; THORACOSCOPIC SYMPATHECTOMY; COMPLICATIONS; ABLATION; T3	Endoscopic thoracic sympathectomy/sympathotomy for the treatment of palmar hyperhidrosis is generally performed by either cutting or clamping the sympathetic chain. However, it remains unclear as to which of these methods is more effective and has fewer side effects. This study was conducted to compare the effects of sympathotomy by cutting or clamping at T3 on two outcomes-postoperative palmar sweating and compensatory sweating; it also evaluated postoperative patient satisfaction. The participants were among 289 patients who underwent bilateral sympathotomy at T3 for palmar hyperhidrosis. These patients were sent questionnaires by mail to assess their self-reported degree of postoperative palmar sweating and compensatory sweating, as well as their level of satisfaction. Of the 92 patients who responded to the questionnaire, 54 had undergone sympathotomy by cutting (cutting group) and 38 by clamping (clamping group). The degree of postoperative palmar sweating was significantly lower in the cutting group than in the clamping group. However, compensatory sweating was significantly more severe in the cutting group than in the clamping group. No significant difference was observed in the degree of patient satisfaction between the groups. Sympathotomy by clamping at T3 was less effective in reducing the primary symptom of postoperative palmar sweating, but induced less compensatory sweating than did sympathotomy by cutting at T3. However, both methods were similar with regard to patient satisfaction. The degree of postoperative palmar sweating and the severity of compensatory sweating were inversely correlated with the degree of patient satisfaction.	[Hida, Kumiko; Hayashi, Maya; Tamagawa, Takao; Abe, Yoichiro] NTT Med Ctr Tokyo, Pain Clin, Shinagawa Ku, Tokyo 1418625, Japan; [Sakai, Tetsuya] Nagasaki Univ, Sch Med, Dept Anesthesiol, Nagasaki 8528501, Japan	Sakai, T (reprint author), Nagasaki Univ, Sch Med, Dept Anesthesiol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	tscat@fb3.so-net.ne.jp					Dumont P, 2004, ANN THORAC SURG, V78, P1801, DOI 10.1016/j.athpracsur.2004.03.012; Yanagihara TK, 2010, J THORAC CARDIOV SUR, V140, P984, DOI 10.1016/j.jtcvs.2010.08.014; Atkinson JLD, 2011, MAYO CLIN PROC, V86, P721, DOI 10.4065/mcp.2011.0199; Findikcioglu A, 2014, THORAC CARDIOV SURG, V62, P445, DOI 10.1055/s-0033-1348920; Sugimura H, 2009, J THORAC CARDIOV SUR, V137, P1370, DOI 10.1016/j.jtcvs.2009.01.008; Baumgartner FJ, 2011, ANN THORAC SURG, V92, P2015, DOI 10.1016/j.athoracsur.2011.07.083; de Campos JRM, 2003, ANN THORAC SURG, V76, P886; Licht PB, 2004, ANN THORAC SURG, V78, P427, DOI 10.1016/j.athorascur.2004.02.087; Deng B, 2011, SURG ENDOSC, V25, P1893, DOI 10.1007/s00464-010-1482-3; Chang YT, 2007, ANN SURG, V246, P330, DOI 10.1097/SLA.0b013e3180caa466; Katara AN, 2007, SURG ENDOSC, V21, P1768, DOI 10.1007/s00464-007-9241-9; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105; Rodriguez PM, 2008, EUR J CARDIO-THORAC, V34, P514, DOI 10.1016/j.ejcts.2008.05.036; Yano M, 2005, SURGERY, V138, P40, DOI 10.1016/j.surg.2005.03.026; Miller DL, 2009, J THORAC CARDIOV SUR, V138, P581, DOI 10.1016/j.jtcvs.2009.03.059; Li X, 2008, ANN THORAC SURG, V85, P1747, DOI 10.1016/j.athoracsur.2008.01.060; Aoki H, 2014, J ANESTH, V28, P210, DOI 10.1007/s00540-013-1692-7; Fibla Juan J, 2009, Interact Cardiovasc Thorac Surg, V9, P970, DOI 10.1510/icvts.2009.212365	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	OCT	2015	25	5					271	276		10.1007/s10286-015-0293-y		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT8CR	WOS:000363043100001		
J	Sakai, T; Hida, K				Sakai, Tetsuya; Hida, Kumiko			In response: looking for a standardized approach in the surgical treatment of hyperhidrosis	CLINICAL AUTONOMIC RESEARCH			English	Letter									[Sakai, Tetsuya; Hida, Kumiko] Nagasaki Univ, Sch Med, Nagasaki 852, Japan	Sakai, T (reprint author), Nagasaki Univ, Sch Med, Nagasaki 852, Japan.	tscat@fb3.so-net.ne.jp					de Campos JRM, 2003, ANN THORAC SURG, V76, P886; Cerfolio RJ, 2011, ANN THORAC SURG, V91, P1642, DOI 10.1016/j.athoracsur.2011.01.105; Hida K, 2015, CLIN AUTON RES	3	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	OCT	2015	25	5					345	345		10.1007/s10286-015-0308-8		1	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CT8CR	WOS:000363043100012		
J	Kurose, K; Ohue, Y; Wada, H; Iida, S; Ishida, T; Kojima, T; Doi, T; Suzuki, S; Isobe, M; Funakoshi, T; Kakimi, K; Nishikawa, H; Udono, H; Oka, M; Ueda, R; Nakayama, E				Kurose, Koji; Ohue, Yoshihiro; Wada, Hisashi; Iida, Shinsuke; Ishida, Takashi; Kojima, Takashi; Doi, Toshihiko; Suzuki, Susumu; Isobe, Midori; Funakoshi, Takeru; Kakimi, Kazuhiro; Nishikawa, Hiroyoshi; Udono, Heiichiro; Oka, Mikio; Ueda, Ryuzo; Nakayama, Eiichi			Phase Ia Study of FoxP3(+) CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients	CLINICAL CANCER RESEARCH			English	Article							T-CELL LEUKEMIA/LYMPHOMA; MONOCLONAL-ANTIBODY; LUNG-CANCER; LEUKEMIA-LYMPHOMA; TUMORS; EXPRESSION; CCR4; RESPONSES; MAB; MELANOMA	Purpose: FoxP3(+) Tregs inhibit immune responses against tumors. KW-0761 is a humanized anti-human CCR4 monoclonal antibody (mAb) that has antibody-dependent cellular cytotoxicity activity. Depletion of CCR4-expressing FoxP3(+) CD4 Tregs by KW-0761 infusion was investigated in solid cancer patients. Experimental Design: We conducted a phase Ia clinical trial of KW-0761 infusion in 7 lung and 3 esophageal cancer patients. Toxicity, clinical efficacy, changes in lymphocyte subpopulations, including Tregs, and induction of immune responses were analyzed. Results: The results showed that KW-0761 infusion in a dose range between0.1mg/kg and 1.0mg/kgwas safe andwell tolerated. Nodose-limiting toxicitywas observed. Four of 10 patients showed stable disease during treatment and were long survivors. The monitoring of FoxP3(+) Tregs in the peripheral blood mononuclear cells during treatment indicated efficient depletion of those cells, even at the lowest dose of 0.1 mg/kg used. The reduction in Th 1 CD4 T cells and CD8 T cells was limited, whereas a significant reduction was observed with Th 2 and Th 17 CD4 T cells. Immune responses to cancer/testis (CT) antigens and an autoantibody response to thyroid peroxidase were observed in some patients. Conclusions: The findings showed Tregs depletion and the possible occurrence of an immune response following KW-0761 infusion. Combined use of KW-0761 to deplete FoxP3(+) Tregs with other immunotherapies, such as cancer vaccines or checkpoint inhibitors, is a promising approach to augment immune responses. (C) 2015 AACR.	[Kurose, Koji; Ohue, Yoshihiro; Isobe, Midori; Oka, Mikio] Kawasaki Med Univ, Dept Resp Med, Kurashiki, Okayama, Japan; [Wada, Hisashi] Osaka Univ, Dept Clin Res Tumor Immunol, Grad Sch Med, Suita, Osaka, Japan; [Iida, Shinsuke; Ishida, Takashi] Nagoya City Univ, Dept Hematol & Oncol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kojima, Takashi; Doi, Toshihiko] Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan; [Suzuki, Susumu; Ueda, Ryuzo] Aichi Med Univ, Dept Tumor Immunol, Nagakute, Aichi 48011, Japan; [Funakoshi, Takeru] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo, Japan; [Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Tokyo 113, Japan; [Nishikawa, Hiroyoshi] Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol, Suita, Osaka, Japan; [Udono, Heiichiro] Okayama Univ, Dept Immunol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008530, Japan; [Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama 7010193, Japan	Nakayama, E (reprint author), Kawasaki Univ Med Welf, 288 Matsushima, Kurashiki, Okayama 7010193, Japan.	uedaryu@aichi-med-u.ac.jp; nakayama@mw.kawasaki-m.ac.jp			Ministry of Health, Labour and Welfare, Japan [H24-applying-general-006]; Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI	This study was supported by grants-in-aid for Research on Applying Health Technology (H24-applying-general-006) from the Ministry of Health, Labour and Welfare, Japan, by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan, and by JSPS KAKENHI.	Ishida T, 2003, CLIN CANCER RES, V9, P3625; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Onizuka S, 1999, CANCER RES, V59, P3128; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Vivier E, 2011, SCIENCE, V331, P44, DOI 10.1126/science.1198687; Nouri-Aria KT, 2002, EUR J IMMUNOL, V32, P1933, DOI 10.1002/1521-4141(200207)32:7<1933::AID-IMMU1933>3.0.CO;2-R; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Kitano S, 2014, CANCER IMMUNOL RES, V2, P812, DOI 10.1158/2326-6066.CIR-14-0013; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Kawabata R, 2007, INT J CANCER, V120, P2178, DOI 10.1002/ijc.22583; Nakagawa K, 2005, CLIN CANCER RES, V11, P5496, DOI 10.1158/1078-0432.CCR-05-0216; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Ohue Y, 2012, INT J CANCER, V131, pE649, DOI 10.1002/ijc.27359; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Ishida T, 2013, CANCER SCI, V104, P647, DOI 10.1111/cas.12116; Funt SA, 2014, ONCOLOGY WILLISTON P, P28; Isobe Midori, 2009, Cancer Immun, V9, P8; Kurose K, 2015, J THORAC ONCOL, V10, P74, DOI 10.1097/JTO.0000000000000364; Ohue Y, 2014, CLIN CANCER RES, V20, P5052, DOI 10.1158/1078-0432.CCR-14-0742; Sato Shuichiro, 2007, Cancer Immun, V7, P5; Uenaka Akiko, 2007, Cancer Immun, V7, P9	36	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4327	4336		10.1158/1078-0432.CCR-15-0357		10	Oncology	Oncology	CU2CQ	WOS:000363330500014		
J	Komatsu, M; Wheeler, HE; Chung, SY; Low, SK; Wing, C; Delaney, SM; Gorsic, LK; Takahashi, A; Kubo, M; Kroetz, DL; Zhang, W; Nakamura, Y; Dolan, ME				Komatsu, Masaaki; Wheeler, Heather E.; Chung, Suyoun; Low, Siew-Kee; Wing, Claudia; Delaney, Shannon M.; Gorsic, Lidija K.; Takahashi, Atsushi; Kubo, Michiaki; Kroetz, Deanna L.; Zhang, Wei; Nakamura, Yusuke; Dolan, M. Eileen			Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy	CLINICAL CANCER RESEARCH			English	Article							GENOME-WIDE ASSOCIATION; METASTATIC BREAST-CANCER; GENETIC-VARIANTS; CLINICAL-TRIAL; WHOLE-GENOME; CELL-LINE; CHEMOTHERAPY; PROTEIN; POPULATION; EXPRESSION	Purpose: Paclitaxel is used worldwide in the treatment of breast, lung, ovarian, and other cancers. Sensory peripheral neuropathy is an associated adverse effect that cannot be predicted, prevented, or mitigated. To better understand the contribution of germline genetic variation to paclitaxel-induced peripheral neuropathy, we undertook an integrative approach that combines genome-wide association study (GWAS) data generated from HapMap lymphoblastoid cell lines (LCL) and Asian patients. Methods: GWAS was performed with paclitaxel-induced cytotoxicity generated in 363 LCLs and with paclitaxel-induced neuropathy from 145 Asian patients. A gene-based approach was used to identify overlapping genes and compare with a European clinical cohort of paclitaxel-induced neuropathy. Neurons derived from human-induced pluripotent stem cells were used for functional validation of candidate genes. Results: SNPs near AIPL1 were significantly associated with paclitaxel-induced cytotoxicity in Asian LCLs (P < 10(-6)). Decreased expression of AIPL1 resulted in decreased sensitivity of neurons to paclitaxel by inducing neurite morphologic changes as measured by increased relative total outgrowth, number of processes and mean process length. Using a gene-based analysis, there were 32 genes that overlapped between Asian LCL cytotoxicity and Asian patient neuropathy (P < 0.05), including BCR. Upon BCR knockdown, there was an increase in neuronal sensitivity to paclitaxel as measured by neurite morphologic characteristics. Conclusions: We identified genetic variants associated with Asian paclitaxel-induced cytotoxicity and functionally validated the AIPL1 and BCR in a neuronal cell model. Furthermore, the integrative pharmacogenomics approach of LCL/patient GWAS may help prioritize target genes associated with chemotherapeutic-induced peripheral neuropathy. (C) 2015 AACR.	[Komatsu, Masaaki; Wheeler, Heather E.; Chung, Suyoun; Wing, Claudia; Delaney, Shannon M.; Gorsic, Lidija K.; Nakamura, Yusuke; Dolan, M. Eileen] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA; [Chung, Suyoun] Natl Canc Ctr, Res Inst, Div Canc Dev Syst, Tokyo 104, Japan; [Low, Siew-Kee] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Core Genom Med, Yokohama, Kanagawa, Japan; [Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Core Genom Med, Yokohama, Kanagawa, Japan; [Kroetz, Deanna L.] Univ Calif San Francisco, Sch Pharm & Med, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Zhang, Wei] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA	Dolan, ME (reprint author), Univ Chicago, 900 East 57th St,Room 7100, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu			NIH/NIGMS Pharmacogenomics of Anticancer Agents Research Grant [U01GM61393]; NIH/NCI National Research Service Award [F32CA165823]; University of Chicago Breast Cancer SPORE Grant [NCI P50 CA125183]; NIH/NCI [R01 CA136765]; NIH/NIGMS Pharmacogenomics of Membrane Transporters [U01GM61390]; Japanese Ministry of Education, Culture, Sports, Science and Technology	This work is supported by the NIH/NIGMS Pharmacogenomics of Anticancer Agents Research Grant U01GM61393 (to M.E. Dolan), NIH/NCI National Research Service Award F32CA165823 (to H.E. Wheeler), University of Chicago Breast Cancer SPORE Grant NCI P50 CA125183 (to M.E. Dolan), NIH/NCI R01 CA136765 (to M.E. Dolan), and NIH/NIGMS Pharmacogenomics of Membrane Transporters grant U01GM61390. The Biobank Japan Project is funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. This work is part of the NIH Pharmacogenomics Research Network-RIKEN Center for Genomic Medicine Global Alliance.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Low SK, 2014, CLIN CANCER RES, V20, P2541, DOI 10.1158/1078-0432.CCR-13-2755; Huang RS, 2007, MOL CANCER THER, V6, P31, DOI 10.1158/1535-7163.MCT-06-0591; Cox NJ, 2012, CLIN PHARMACOL THER, V92, P425, DOI 10.1038/clpt.2012.115; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Hershman DL, 2014, J CLIN ONCOL, V32, P1941, DOI 10.1200/JCO.2013.54.0914; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Loprinzi CL, 2011, J CLIN ONCOL, V29, P1472, DOI 10.1200/JCO.2010.33.0308; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Wheeler HE, 2014, PHARMACOGENET GENOM, V24, P231, DOI 10.1097/FPC.0000000000000037; Wheeler HE, 2013, NAT REV GENET, V14, P23, DOI 10.1038/nrg3352; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Njiaju UO, 2012, PHARMACOGENET GENOM, V22, P498, DOI 10.1097/FPC.0b013e328352f436; Duno M, 2013, GENE, V515, P372, DOI 10.1016/j.gene.2012.12.066; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Huang RS, 2011, RNA BIOL, V8, P692, DOI 10.4161/rna.8.4.16029; Pulido R, 2013, HUM MOL GENET, V22, pR66, DOI 10.1093/hmg/ddt347; Moen EL, 2013, GENETICS, V194, P987, DOI 10.1534/genetics.113.151381; Hause RJ, 2014, AM J HUM GENET, V95, P194, DOI 10.1016/j.ajhg.2014.07.005; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Low SK, 2013, CANCER SCI, V104, P1074, DOI 10.1111/cas.12186; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Zhan R, 2013, J NEUROSCI RES, V91, P335, DOI 10.1002/jnr.23162; Leandro-Garcia LJ, 2013, J MED GENET, V50, P599, DOI 10.1136/jmedgenet-2012-101466; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Hartford CM, 2009, BLOOD, V113, P2145, DOI 10.1182/blood-2008-05-154302; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Winer EP, 2004, J CLIN ONCOL, V22, P2061, DOI 10.1200/JCO.2004.08.048; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; O'Donnell PH, 2009, CLIN CANCER RES, V15, P4806, DOI 10.1158/1078-0432.CCR-09-0344; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Laurent CE, 2004, EXP CELL RES, V299, P188, DOI 10.1016/j.yexcr.2004.05.010; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Diouf B, 2015, JAMA-J AM MED ASSOC, V313, P815, DOI 10.1001/jama.2015.0894; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Huang PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116372; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Rivera E, 2015, CANCER CHEMOTH PHARM, V75, P659, DOI 10.1007/s00280-014-2607-5; Schneider BP, 2011, J CLIN ONCOL, V29; Stark AL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004192; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Wheeler HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118020	56	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4337	4346		10.1158/1078-0432.CCR-15-0133		10	Oncology	Oncology	CU2CQ	WOS:000363330500015		
J	Lee, J; Condello, S; Yakubov, B; Emerson, R; Caperell-Grant, A; Hitomi, K; Xie, JW; Matei, D				Lee, Jiyoon; Condello, Salvatore; Yakubov, Bakhtiyor; Emerson, Robert; Caperell-Grant, Andrea; Hitomi, Kiyotaka; Xie, Jingwu; Matei, Daniela			Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression	CLINICAL CANCER RESEARCH			English	Article							DUCTAL ADENOCARCINOMA; OVARIAN-CANCER; EXTRACELLULAR-MATRIX; SUBSTRATE PEPTIDE; BREAST-CANCER; TGF-BETA; CELL; ACTIVATION; RESISTANCE; INHIBITION	Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2+-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression. (C) 2015 AACR.	[Lee, Jiyoon; Xie, Jingwu; Matei, Daniela] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Condello, Salvatore; Yakubov, Bakhtiyor; Caperell-Grant, Andrea; Matei, Daniela] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Emerson, Robert] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Xie, Jingwu] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Xie, Jingwu; Matei, Daniela] Indiana Univ Melvin & Bren Simon Canc Ctr, Indianapolis, IN USA; [Matei, Daniela] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Matei, Daniela] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA	Matei, D (reprint author), Indiana Univ Sch Med, Joseph E Walther Hall,Room C218D,980 W Walnut St, Indianapolis, IN 46202 USA.	dmatei@iu.edu			National Cancer Institute [CA152502]; Project Development Team within the ICTSI NIH/NCRR [UL1TR001108]; IUPUI Signature Center Initiative	This work was made possible by funding from the National Cancer Institute (Award CA152502), a Project Development Team within the ICTSI NIH/NCRR (Grant Number UL1TR001108), and the IUPUI Signature Center Initiative.	Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Muerkoster SS, 2008, INT J CANCER, V123, P1751, DOI 10.1002/ijc.23703; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Olsen KC, 2014, AM J RESP CELL MOL, V50, P737, DOI 10.1165/rcmb.2013-0092OC; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Faye C, 2010, BIOCHEM J, V427, P467, DOI 10.1042/BJ20091594; Alvarez R, 2013, BRIT J CANCER, V109, P926, DOI 10.1038/bjc.2013.415; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Fukui M, 2013, FEBS J, V280, P1420, DOI 10.1111/febs.12133; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Johnson KB, 2012, AM J PHYSIOL-HEART C, V302, pH1355, DOI 10.1152/ajpheart.00918.2011; Cheung W, 2008, PANCREATOLOGY, V8, P608, DOI 10.1159/000161012; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Olsen KC, 2011, AM J RESP CRIT CARE, V184, P699, DOI 10.1164/rccm.201101-0013OC; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Yakubov B, 2013, NEOPLASIA, V15, P609, DOI 10.1593/neo.121878; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Willett CG, 2005, J CLIN ONCOL, V23, P4538, DOI 10.1200/JCO.2005.23.911; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Koay EJ, 2014, J CLIN INVEST, V124, P1525, DOI 10.1172/JCI73455; Erkan M, 2013, J PATHOL, V231, P4, DOI 10.1002/path.4213; Koay EJ, 2014, PHYS BIOL, V11, DOI 10.1088/1478-3975/11/6/065002; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Satpathy Minati, 2007, Cancer Res, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Shannon HE FM, 2015, PANCREAS, V44, P64; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	50	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432	1557-3265		CLIN CANCER RES	Clin. Cancer Res.	OCT 1	2015	21	19					4482	4493		10.1158/1078-0432.CCR-15-0226		12	Oncology	Oncology	CU2CQ	WOS:000363330500030		
J	Umakoshi, H; Tanase-Nakao, K; Wada, N; Ichijo, T; Sone, M; Inagaki, N; Katabami, T; Kamemura, K; Matsuda, Y; Fujii, Y; Kai, T; Fukuoka, T; Sakamoto, R; Ogo, A; Suzuki, T; Tsuiki, M; Shimatsu, A; Naruse, M				Umakoshi, Hironobu; Tanase-Nakao, Kanako; Wada, Norio; Ichijo, Takamasa; Sone, Masakatsu; Inagaki, Nobuya; Katabami, Takuyuki; Kamemura, Kohei; Matsuda, Yuichi; Fujii, Yuichi; Kai, Tatsuya; Fukuoka, Tomikazu; Sakamoto, Ryuichi; Ogo, Atsushi; Suzuki, Tomoko; Tsuiki, Mika; Shimatsu, Akira; Naruse, Mitsuhide			Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism	CLINICAL ENDOCRINOLOGY			English	Article							COMPUTED-TOMOGRAPHY; DIAGNOSIS; HYPERTENSION; EXPERIENCE	Objectives Adrenal vein sampling (AVS) is the standard criterion for the subtype diagnosis in primary aldosteronism (PA). Although lateralized index (LI) >= 4 after cosyntropin stimulation is the commonly recommended cut-off for unilateral aldosterone hypersecretion, many of the referral centres in the world use LI cut-off of <4 without sufficient evidence for its diagnostic accuracy. Aim The aim of the study was to establish the diagnostic significance of contralateral (CL) aldosterone suppression for the subtype diagnosis in patients with LI <4 in AVS. Design and patients A retrospective multicentre study was conducted in Japan. Of 124 PA patients subjected to unilateral adrenalectomy after successful AVS with cosyntropin administration, 29 patients with LI < 4 were included in the study. The patients were divided into Group A with CL suppression (n = 16) and Group B (n = 13) without CL suppression. Three outcome indices were assessed after 6 months postoperatively: normalization/significant improvement of hypertension, normalization of the aldosterone to renin ratio (ARR) and normalization of hypokalaemia. Results The normalization/significant improvement of hypertension was 81% in Group A and 54% in Group B (P = 0.2). The normalization of ARR was 100% in Group A and 46% in Group B (P = 0.004). Hypokalaemia was normalized in all patients of both groups. The overall cure rate of PA based on meeting all the three criteria was 81% in Group A and 31% in Group B (P = 0.01). Conclusions In patients with PA, where the LI is < 4 on AVS, CL suppression of aldosterone is an accurate predictor of a unilateral source of aldosterone excess. CL suppression data should be interpreted in conjunction with computed tomographic adrenal imaging findings to guide surgical management.	[Umakoshi, Hironobu; Tanase-Nakao, Kanako; Tsuiki, Mika; Shimatsu, Akira; Naruse, Mitsuhide] Natl Hosp Org Kyoto, Med Ctr, Dept Endocrinol Metab & Hypertens, Kyoto 6128555, Japan; [Wada, Norio] Sapporo City Hosp, Dept Endocrinol & Diabet, Sapporo, Hokkaido, Japan; [Ichijo, Takamasa] Saiseikai Yokohama City Toubu Hosp, Dept Endocrinol & Diabet, Yokohama, Kanagawa, Japan; [Sone, Masakatsu; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Katabami, Takuyuki] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Kamemura, Kohei] Akashi Med Ctr, Dept Cardiol, Akashi, Hyogo, Japan; [Matsuda, Yuichi] Sanda City Hosp, Dept Cardiol, Sanda, Hyogo, Japan; [Fujii, Yuichi] West Japan Railway Co, Hiroshima Gen Hosp, Dept Cardiol, Hiroshima, Japan; [Kai, Tatsuya] Saiseikai Tondabayashi Hosp, Dept Cardiol, Tondabayashi, Japan; [Fukuoka, Tomikazu] Matsuyama Red Cross Hosp, Dept Internal Med, Matsuyama, Ehime, Japan; [Sakamoto, Ryuichi; Ogo, Atsushi] Natl Hosp Org Kyushu, Med Ctr, Dept Endocrinol & Metab, Fukuoka, Japan; [Suzuki, Tomoko] Kitasato Univ, Sch Med, Dept Publ Hlth, Tokyo, Japan	Naruse, M (reprint author), Natl Hosp Org Kyoto, Med Ctr, Dept Endocrinol Metab & Hypertens, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	mnaruse@kyotolan.hosp.go.jp			National Hospital Organization; Ministry of Health, Labor and Welfare, Japan	This study was supported in part by grants-in-aid for the study of primary aldosteronism from the National Hospital Organization and for the study of adrenal hormone disorders from the Ministry of Health, Labor and Welfare, Japan.	Rossi GP, 2008, HYPERTENSION, V51, P1366, DOI 10.1161/HYPERTENSIONAHA.108.111369; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2012, J CLIN ENDOCR METAB, V97, P1606, DOI 10.1210/jc.2011-2830; Kempers MJE, 2009, ANN INTERN MED, V151, P329; Magill SB, 2001, J CLIN ENDOCR METAB, V86, P1066, DOI 10.1210/jc.86.3.1066; Rossi GP, 2014, HYPERTENSION, V63, P151, DOI 10.1161/HYPERTENSIONAHA.113.02097; Auchus RJ, 2010, HORM METAB RES, V42, P411, DOI 10.1055/s-0030-1252060; Zarnegar R, 2008, ANN SURG, V247, P511, DOI 10.1097/SLA.0b013e318165c075; Stowasser M, 2001, J RENIN-ANGIO-ALDO S, V2, P156, DOI 10.3317/jraas.2001.022; Espiner EA, 2003, J CLIN ENDOCR METAB, V88, P3637, DOI 10.1210/jc.2002-022051; Wolley M, 2013, J HYPERTENS, V31, P2005, DOI 10.1097/HJH.0b013e328362add3; Rossi GP, 2001, J CLIN ENDOCR METAB, V86, P1083, DOI 10.1210/jc.86.3.1083; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Waldmann J, 2011, WORLD J SURG, V35, P2422, DOI 10.1007/s00268-011-1221-5; Steichen O, 2012, HORM METAB RES, V44, P221, DOI 10.1055/s-0031-1299681; Monticone S, 2014, J CLIN ENDOCR METAB, V99, P4158, DOI 10.1210/jc.2014-2345; Lim V, 2014, J CLIN ENDOCR METAB, V99, P2712, DOI 10.1210/jc.2013-4146; Sukor N, 2009, J CLIN ENDOCR METAB, V94, P2437, DOI 10.1210/jc.2008-2803; Miotto D, 2009, HYPERTENSION, V54, P885, DOI 10.1161/HYPERTENSIONAHA.109.134759; Nishikawa T, 2011, ENDOCR J, V58, P711; DOPPMAN JL, 1992, RADIOLOGY, V184, P677; Haase M, 2014, J CLIN ENDOCR METAB, V99, P4397, DOI 10.1210/jc.2014-2788; Monticone S., 2014, LANCET DIABETEENDO, V3, P296; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	OCT	2015	83	4					462	467		10.1111/cen.12761		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CT8BJ	WOS:000363039700004		
J	Tanoshima, M; Kobayashi, T; Tanoshima, R; Beyene, J; Koren, G; Ito, S				Tanoshima, M.; Kobayashi, T.; Tanoshima, R.; Beyene, J.; Koren, G.; Ito, S.			Risks of Congenital Malformations in Offspring Exposed to Valproic Acid In Utero: A Systematic Review and Cumulative Meta-analysis	CLINICAL PHARMACOLOGY & THERAPEUTICS			English	Article							ANTIEPILEPTIC DRUGS; MAJOR MALFORMATIONS; PREGNANCY REGISTRY; UK-EPILEPSY; WOMEN; FETAL; LAMOTRIGINE; INFANTS	Despite extensive research efforts over decades, the teratogenic profile of valproic acid (VPA) remains obscure. We performed cumulative and conventional meta-analyses of cohort studies to determine the time profiles of signal emergence of VPA-associated congenital malformations (CMs) and to define risk estimates of each of the CMs. Fifty-nine studies were identified and analyzed. We found that the significant risk signals began to emerge over the last 10-20 years even before large-scale studies were performed: neural tube defect (the significant risk signal emerged in 1992); genitourinary and musculoskeletal anomalies (2004); cleft lip and/or palate (2005); and congenital heart defects (2006). At present, the risks of VPA-associated CMs are 2-7-fold higher than other common antiepileptic drugs. VPA should not be used as a first-line therapy in women of childbearing age unless it is the only option for the patient.	[Tanoshima, M.; Kobayashi, T.; Tanoshima, R.; Koren, G.; Ito, S.] Univ Toronto, Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [Tanoshima, M.] Yokohama City Univ Med, Dept Obstet & Gynecol, Yokohama, Kanagawa, Japan; [Kobayashi, T.] Natl Ctr Child Hlth & Dev, Ctr Clin Res & Dev, Dept Dev Strategy, Yokohama, Kanagawa, Japan; [Tanoshima, R.] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan; [Beyene, J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Ito, S (reprint author), Univ Toronto, Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada.	shinya.ito@sickkids.ca			Japan Society of Clinical Pharmacology and Therapeutics; Joseph M. West Family Memorial Fund from the Post Graduate Medical Education at University of Toronto, Toronto, Canada	T.K. was financially supported by the Japan Society of Clinical Pharmacology and Therapeutics. R.T. was financially supported by the Joseph M. West Family Memorial Fund from the Post Graduate Medical Education at University of Toronto, Toronto, Canada during the period of this study. The authors do not have any competing interest to disclose.	Wyszynski DF, 2005, NEUROLOGY, V64, P961; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; Hernandez-Diaz S, 2012, NEUROLOGY, V78, P1692, DOI 10.1212/WNL.0b013e3182574f39; Koren G, 2006, CAN FAM PHYSICIAN, V52, P441; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Vajda FJE, 2007, J CLIN NEUROSCI, V14, P611, DOI 10.1016/j.jocn.2006.04.025; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thomas SV, 2008, PEDIATR CARDIOL, V29, P604, DOI 10.1007/s00246-007-9161-4; Kaaja E, 2003, NEUROLOGY, V60, P575; Etwel F, 2014, ANNU REV PHARMACOL, V54, P295, DOI 10.1146/annurev-pharmtox-011613-135930; Vajda FJE, 2007, AUST NZ J OBSTET GYN, V47, P468, DOI 10.1111/j.1479-828X.2007.00781.x; Cunnington MC, 2011, NEUROLOGY, V76, P1817, DOI 10.1212/WNL.0b013e31821ccd18; Vajda FJE, 2012, AUST NZ J OBSTET GYN, V52, P49, DOI 10.1111/j.1479-828X.2011.01359.x; Vajda FJE, 2006, EUR J NEUROL, V13, P645, DOI 10.1111/j.1468-1331.2006.01359.x; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Vajda FJE, 2010, SEIZURE-EUR J EPILEP, V19, P558, DOI 10.1016/j.seizure.2010.07.019; Vajda FJE, 2012, J CLIN NEUROSCI, V19, P57, DOI 10.1016/j.jocn.2011.08.003; Morrow JI, 2009, J NEUROL NEUROSUR PS, V80, P506, DOI 10.1136/jnnp.2008.156109; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Campbell E, 2014, J NEUROL NEUROSUR PS, V85, P1029, DOI 10.1136/jnnp-2013-306318; Kochen S., 2012, OPEN NEUROL J, V5, P63; Koren G, 2006, CAN FAM PHYSICIAN, V52, P447; Koren G, 2006, CAN FAM PHYSICIAN, V52, P444; Martinez Ferri. M., 2009, NEUROLOGIA, V24, P360; Moher D, 2009, BMJ-BRIT MED J, V339, P332, DOI DOI 10.1136/BMJ.B2535; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Wells G, NEWCASTLE OTTAWA SCA	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0009-9236	1532-6535		CLIN PHARMACOL THER	Clin. Pharmacol. Ther.	OCT	2015	98	4					417	441		10.1002/cpt.158		25	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CU3DW	WOS:000363405200025		
J	Tokuyoshi, Y				Tokuyoshi, Yusuke			Virtual Spherical Gaussian Lights for Real-time Glossy Indirect Illumination	COMPUTER GRAPHICS FORUM			English	Article							IMPERFECT SHADOW MAPS; GLOBAL ILLUMINATION	Virtual point lights (VPLs) are well established for real-time global illumination. However, this method suffers from spiky artifacts and flickering caused by singularities of VPLs, highly glossy materials, high-frequency textures, and discontinuous geometries. To avoid these artifacts, this paper introduces a virtual spherical Gaussian light (VSGL) which roughly represents a set of VPLs. For a VSGL, the total radiant intensity and positional distribution of VPLs are approximated using spherical Gaussians and a Gaussian distribution, respectively. Since this approximation can be computed using summations of VPL parameters, VSGLs can be dynamically generated using mipmapped reflective shadow maps. Our VSGL generation is simple and independent from any scene geometries. In addition, reflected radiance for a VSGL is calculated using an analytic formula. Hence, we are able to render one-bounce glossy interreflections at real-time frame rates with smaller artifacts.	Sq Enix Co Ltd, Tokyo, Japan	Tokuyoshi, Y (reprint author), Sq Enix Co Ltd, Tokyo, Japan.	tokuyosh@square-enix.com					Banerjee A, 2005, J MACH LEARN RES, V6, P1345; Iwasaki K, 2014, COMPUT GRAPH FORUM, V33, P333, DOI 10.1111/cgf.12302; Simon F, 2015, COMPUT GRAPH FORUM, V34, P575, DOI 10.1111/cgf.12585; Yan LQ, 2012, COMPUT GRAPH FORUM, V31, P2267, DOI 10.1111/j.1467-8659.2012.03220.x; Laurijssen J, 2010, COMPUT GRAPH FORUM, V29, P1305, DOI 10.1111/j.1467-8659.2010.01726.x; Ritschel T, 2011, COMPUT GRAPH FORUM, V30, P2258, DOI 10.1111/j.1467-8659.2011.01998.x; Tsai YT, 2006, ACM T GRAPHIC, V25, P967, DOI 10.1145/1141911.1141981; Crassin C, 2011, COMPUT GRAPH FORUM, V30, P1921, DOI 10.1111/j.1467-8659.2011.02063.x; Walter B, 2005, ACM T GRAPHIC, V24, P1098, DOI 10.1145/1073204.1073318; Ritschel T, 2012, COMPUT GRAPH FORUM, V31, P160, DOI 10.1111/j.1467-8659.2012.02093.x; Clarberg P, 2005, ACM T GRAPHIC, V24, P1166, DOI 10.1145/1073204.1073328; Barak T, 2013, COMPUT GRAPH FORUM, V32, P87, DOI 10.1111/cgf.12154; Dachsbacher C., 2006, I3D 06, P93; Dachsbacher C., 2005, I3D 05, P203; Dachsbacher C, 2014, COMPUT GRAPH FORUM, V33, P88, DOI 10.1111/cgf.12256; Dong Z., 2009, VISION MODELING VISU, P187; Haan M., 2009, ACM T GRAPHIC, V28, P5; Iwasaki K., 2012, ACM T GRAPHIC, V31; Kajiya J. T., 1986, ACM SIGGRAPH COMPUTE, V20, P143, DOI 10.1145/15886.15902; Keller A., 1997, P SIGGRAPH, V31, P49; Kivanek J., 2008, COMPUT GRAPH FORUM, V27, P1147; Kivanek J., 2010, ACM T GRAPHIC, V29; Luksch C., 2013, I3D 13, P87; Prutkin R., 2012, EUR, P9; Ritschel T., 2008, ACM T GRAPHIC, V27; Toksvig M., 2005, Journal of Graphics Tools, V10; Wald I., 2002, EGRW 02 P 13 EUR WOR, P15; Walter B., 2007, EGSR 07, V07, P195; Wang J., 2009, ACM T GRAPHIC, V28; XU K., 2011, ACM T GRAPHIC, V30, P173; Xu K., 2013, ACM T GRAPHIC, V32; Xu K., 2014, ACM T GRAPHIC, V33	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					89	98		10.1111/cgf.12748		10	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500009		
J	Iwamoto, N; Shum, HPH; Yang, LZ; Morishima, S				Iwamoto, Naoya; Shum, Hubert P. H.; Yang, Longzhi; Morishima, Shigeo			Multi-layer Lattice Model for Real-Time Dynamic Character Deformation	COMPUTER GRAPHICS FORUM			English	Article							ANIMATION; DRIVEN	Due to the recent advancement of computer graphics hardware and software algorithms, deformable characters have become more and more popular in real-time applications such as computer games. While there are mature techniques to generate primary deformation from skeletal movement, simulating realistic and stable secondary deformation such as jiggling of fats remains challenging. On one hand, traditional volumetric approaches such as the finite element method require higher computational cost and are infeasible for limited hardware such as game consoles. On the other hand, while shape matching based simulations can produce plausible deformation in real-time, they suffer from a stiffness problem in which particles either show unrealistic deformation due to high gains, or cannot catch up with the body movement. In this paper, we propose a unified multi-layer lattice model to simulate the primary and secondary deformation of skeleton-driven characters. The core idea is to voxelize the input character mesh into multiple anatomical layers including the bone, muscle, fat and skin. Primary deformation is applied on the bone voxels with lattice-based skinning. The movement of these voxels is propagated to other voxel layers using lattice shape matching simulation, creating a natural secondary deformation. Our multi-layer lattice framework can produce simulation quality comparable to those from other volumetric approaches with a significantly smaller computational cost. It is best to be applied in real-time applications such as console games or interactive animation creation.	[Iwamoto, Naoya] Waseda Univ, Tokyo, Japan; [Iwamoto, Naoya; Morishima, Shigeo] JST CREST, Tokyo, Japan; [Shum, Hubert P. H.; Yang, Longzhi] Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Morishima, Shigeo] Waseda Res Inst Sci & Engn, Tokyo, Japan	Shum, HPH (reprint author), Northumbria Univ, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	iwamoto@toki.waseda.jp; hubert.shum@northumbria.ac.uk; longzhi.yang@northumbria.ac.uk; shigeo@waseda.jp			Engineering and Physical Sciences Research Council (EPSRC) [EP/M002632/1]; CREST, JST	This project was supported in part by the Engineering and Physical Sciences Research Council (EPSRC) Ref: EP/M002632/1, and in part by CREST, JST.	Ali-Hamadi D, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508415; Chen CH, 2013, VISUAL COMPUT, V29, P241, DOI 10.1007/s00371-012-0759-z; Muller M, 2005, ACM T GRAPHIC, V24, P471, DOI 10.1145/1073204.1073216; Rhee T, 2011, IEEE T VIS COMPUT GR, V17, P368, DOI 10.1109/TVCG.2010.39; Teran J, 2005, IEEE T VIS COMPUT GR, V11, P317, DOI 10.1109/TVCG.2005.42; Angelidis A, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P129; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jveir.2007.01.005; Deul C., 2013, VIRTUAL REALITY INTE, P4; Dionne O., 2013, P 12 ACM SIGGRAPH EU, P173; Diziol R., 2011, P ACM SIGGRAPH EUR S, P237; Fan Y., 2014, ACM T GRAPHIC, V33, P152; Faure F, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964968; Hahn F., 2013, P 12 ACM SIGGRAPH EU, P165; Hahn F., 2012, ACM T GRAPHIC, V31, P72; Jacobson A., 2012, ACM T GRAPHIC, V31, P77; Kavan L., 2012, ACM T GRAPHIC, V31, P196; Kim J., 2011, ACM T GRAPHIC, V30, P121; Liu L., 2013, ACM T GRAPHIC, V32, P215; MACKLIN M., 2014, ACM T GRAPHIC, V33, P153; McAdams A., 2011, ACM T GRAPHIC, V30, P37; Miller E., 2007, ACM SIGGRAPH 2007 SK, P4; Muller M., 2011, ACM T GRAPHIC, V30, P92; Muller M., 2011, VIRTUAL REALITY INTE, P83; Muller M., 2014, EUR ACM SIGGRAPH S C, P2; Nealen A., 2005, EUROGRAPHICS STATE A, P71; Pratscher M., 2005, S COMP AN, P3; Rivers A. R., 2007, ACM T GRAPH, V26; Rumman N. A., 2014, P 30 SPRING C COMP G, P83; Schwarz M., 2010, ACM SIGGRAPH ASIA 20, P179; Shi X., 2008, ACM T GRAPHIC, V27, P29, DOI DOI 10.1145/1360612.1360628; Steinemann D., 2008, P ACM SIGGRAPH EUR S, P87; Takamatsu Kenji, 2011, Journal of the Institute of Image Electronics Engineers of Japan, V40; Umetani N., 2014, ACM SIGGRAPH 2014 TA, P47	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					99	109		10.1111/cgf.12749		11	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500010		
J	Fujisawa, M; Miura, KT				Fujisawa, Makoto; Miura, Kenjiro T.			An Efficient Boundary Handling with a Modified Density Calculation for SPH	COMPUTER GRAPHICS FORUM			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; INCOMPRESSIBLE SPH; CONTACT	We propose a new boundary handling method for smoothed particle hydrodynamics (SPH). Previous approaches required the use of boundary particles to prevent particles from sticking to the boundary. We address this issue by correcting the fundamental equations of SPH with the integration of a kernel function. Our approach is able to directly handle triangle mesh boundaries without the need for boundary particles. We also show how our approach can be integrated into a position-based fluid framework.	[Fujisawa, Makoto] Univ Tsukuba, Tsukuba, Ibaraki 305, Japan; [Miura, Kenjiro T.] Shizuoka Univ, Shizuoka 4228529, Japan	Fujisawa, M (reprint author), Univ Tsukuba, Tsukuba, Ibaraki 305, Japan.				JSPS KAKENHI [25730069, 25289021]	This work was supported by JSPS KAKENHI Grant Number 25730069 and 25289021. We also thank to anonymous reviewers for their constructive comments. The images in this paper were rendered using Mitsuba renderer<SUP>dagger</SUP>.	Akinci N., 2012, ACM T GRAPH, V31, P62; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; Oh S, 2009, COMPUT ANIMAT VIRT W, V20, P215, DOI 10.1002/cav.290; Colagrossi A, 2003, J COMPUT PHYS, V191, P448, DOI 10.1016/S0021-9991(03)00324-3; Sloan PP, 2002, ACM T GRAPHIC, V21, P527; Becker M, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P209; Ferrand M, 2013, INT J NUMER METH FL, V71, P446, DOI 10.1002/fld.3666; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Kulasegaram S, 2004, COMPUT MECH, V33, P316, DOI 10.1007/s00466-003-0534-0; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375; Akinci N, 2013, COMPUT ANIMAT VIRT W, V24, P195, DOI 10.1002/cav.1499; Ihmsen M, 2011, COMPUT GRAPH FORUM, V30, P99, DOI 10.1111/j.1467-8659.2010.01834.x; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jveir.2007.01.005; Feldman J, 2007, INT J NUMER METH ENG, V72, P295, DOI 10.1002/nme.2010; Becker M, 2009, IEEE T VIS COMPUT GR, V15, P493, DOI 10.1109/TVCG.2008.107; Becker M., 2009, P EUR WORKSH NAT PHE, P2; Bell N., 2005, SCA 05, P77; Clavet S., 2005, ACM SIGGRAPH EUR S C, P219; Du P., 2012, P ACM SIGGRAPH INT C, P309; Harada T., 2007, P SPRING C COMP GRAP, P235; He X., 2014, ACM T GRAPHIC, V34, P7; Huber M, 2015, COMPUT GRAPH FORUM, V34, P14, DOI 10.1111/cgf.12455; Ihmsen M, 2014, IEEE T VIS COMPUT GR, V20, P426, DOI 10.1109/TVCG.2013.105; IHMSEN M., 2014, EUROGRAPHICS 2014 ST, P21, DOI DOI 10.2312/EGST.20141034.2; Li SF, 1996, COMPUT METHOD APPL M, V139, P159, DOI 10.1016/S0045-7825(96)01082-1; Liu WK, 1997, COMPUT METHOD APPL M, V143, P113, DOI 10.1016/S0045-7825(96)01132-2; MACKLIN M., 2014, ACM T GRAPHIC, V33, P153; MACKLIN M., 2013, ACM T GRAPHIC, V32, P104, DOI DOI 10.1145/2461912.2461984.4; Mayrhofer A, 2015, NUMER ALGORITHMS, V68, P15, DOI 10.1007/s11075-014-9835-y; Muller M., 2003, SCA 03, P154; Muller M., 2004, SCA2004, P2; Panizzo A., 2004, THESIS U STUDI AQUIL, P2; Schechter H., 2012, ACM T GRAPHIC, V31, P61, DOI DOI 10.1145/2185520.2185557; Solenthaler B, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531346	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0167-7055	1467-8659		COMPUT GRAPH FORUM	Comput. Graph. Forum	OCT	2015	34	7					155	162		10.1111/cgf.12754		8	Computer Science, Software Engineering	Computer Science	CU0OJ	WOS:000363216500015		
J	Kubo, T; Shimose, S; Fujimori, J; Furuta, T; Ochi, M				Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo			Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis	CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY			English	Review						Meta-analysis; Rhabdomyosarcoma; Fusion gene; PAX3/7-FOXO1; Survival	CHILDRENS ONCOLOGY GROUP; NONMETASTATIC RHABDOMYOSARCOMA; PEDIATRIC RHABDOMYOSARCOMA; RISK STRATIFICATION; MOLECULAR MARKER; GENE FUSIONS; EXPRESSION; PAX3-FKHR; TRANSLOCATION; FKHR	Purpose: The objective of this systematic review is to provide an unprecedented summary of the prognostic impact of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma. Methods: Studies evaluating PAX3/7-FOXO1 fusion gene or its variants as a prognostic marker were systematically searched and comparative meta-analysis of overall survival was carried out. Results: A total of 7 studies comprising 993 patients with rhabdomyosarcoma were included. Three eligible studies showed no significant difference of survival between fusion positive and negative alveolar rhabdomyosarcoma. Four eligible studies showed that PAX3-FOXO1 fusion variant may indicate a lower survival probability than PAX7-FOXO1, although the effect did not reach a level of statistical significance (pooled hazard ratios, 1.66; 95% CI, 0.95-2.89; p = 0.07). Conclusions: There was no significant difference in the overall survival between patients with the positive and negative fusion gene, but there were indications of PAX3-FOXO1 being an unfavorable prognostic factor. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kubo, Tadahiko; Shimose, Shoji; Fujimori, Jun; Furuta, Taisuke; Ochi, Mitsuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Hiroshima 7348551, Japan	Kubo, T (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	kubot@hiroshima-ti.ac.jp					Meza JL, 2006, J CLIN ONCOL, V24, P3844, DOI 10.1200/JCO.2005.05.3801; DAVIS RJ, 1994, CANCER RES, V54, P2869; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Raney RB, 2001, J PEDIAT HEMATOL ONC, V23, P215, DOI 10.1097/00043426-200105000-00008; Lae M, 2007, J PATHOL, V212, P143, DOI 10.1002/path.2170; Kelly KM, 1997, J CLIN ONCOL, V15, P1831; SCRABLE H, 1989, GENE CHROMOSOME CANC, V1, P23, DOI 10.1002/gcc.2870010106; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Dumont SN, 2012, J CANCER RES CLIN, V138, P213, DOI 10.1007/s00432-011-1089-7; Slater O, 2007, J CLIN PATHOL, V60, P1187, DOI 10.1136/jcp.2006.040113; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; Stegmaier S, 2012, J CLIN ONCOL, V30, P4039, DOI 10.1200/JCO.2012.43.5628; Kazanowska B, 2007, FETAL PEDIATR PATHOL, V26, P17, DOI 10.1080/15513810701394702; Stegmaier S, 2011, PEDIATR BLOOD CANCER, V57, P406, DOI 10.1002/pbc.22958; Egger M, 1997, BRIT MED J, V315, P629; Arndt CAS, 2009, J CLIN ONCOL, V27, P5182, DOI 10.1200/JCO.2009.22.3768; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Weihkopf T, 2008, EUR J CANCER, V44, P432, DOI 10.1016/j.ejca.2007.11.013; Liu Z, 2013, BRIT J CANCER, V108, P2299, DOI 10.1038/bjc.2013.185; Stevens MCG, 2005, J CLIN ONCOL, V23, P2618, DOI 10.1200/JCO.2005.08.130; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; FREDERICKS WJ, 1995, MOL CELL BIOL, V15, P1522; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Anderson J, 2001, BRIT J CANCER, V85, P831, DOI 10.1054/bjoc.2001.2008; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Heerema-McKenney A, 2008, AM J SURG PATHOL, V32, P1513, DOI 10.1097/PAS.0b013e31817a909a; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Skapek SX, 2013, PEDIATR BLOOD CANCER, V60, P1411, DOI 10.1002/pbc.24532; Egufa-Aguilar P, 2010, ARCH MED RES, V41, P119; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Weiss SW, 2008, ENZINGER WEISSS SOFT, P595	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1040-8428	1879-0461		CRIT REV ONCOL HEMAT	Crit. Rev. Oncol./Hematol.	OCT	2015	96	1					46	53		10.1016/j.critrevonc.2015.04.012		8	Oncology; Hematology	Oncology; Hematology	CT8LY	WOS:000363069300005		
J	Hatayama, Y; Nakamura, T; Suzuki, M; Azami, Y; Ono, T; Yamaguchi, H; Hayashi, Y; Tsukiyama, I; Hareyama, M; Kikuchi, Y; Takai, Y				Hatayama, Y.; Nakamura, T.; Suzuki, M.; Azami, Y.; Ono, T.; Yamaguchi, H.; Hayashi, Y.; Tsukiyama, I.; Hareyama, M.; Kikuchi, Y.; Takai, Y.			Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer	CURRENT ONCOLOGY			English	Article						Proton-beam therapy; chemotherapy; stage III non-small-cell lung cancer	COOPERATIVE-ONCOLOGY-GROUP; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; PHASE-II; RADIOTHERAPY; TRIAL; METAANALYSIS	Background We conducted a preliminary retrospective evaluation of the efficacy and toxicity of proton-beam therapy (PBT) for stage III non-small-cell lung cancer. Methods Between January 2009 and August 2013, 27 patients (26 men, 1 woman) with stage III non-small-cell lung cancer underwent PBT. The relative biologic effectiveness value of the proton beam was defined as 1.1. The beam energy and spread-out Bragg peak were fine-tuned such that the 90% isodose volume of the prescribed dose encompassed the planning target volume. Of the 27 patients, 11 underwent neoadjuvant chemotherapy. Cumulative survival curves were calculated using the Kaplan-Meier method. Treatment toxicities were evaluated using version 4 of the Common Terminology Criteria for Adverse Events. Results Median age of the patients was 72 years (range: 57-91 years), and median follow-up was 15.4 months (range: 7.8-36.9 months). Clinical stage was IIIA in 14 patients (52%) and IIIB in 13 (48%). The median dose of PBT was 77 GyE (range: 66-86.4 GyE). The overall survival rate in the cohort was 92.3% at 1 year and 51.1% at 2 years. Locoregional failure occurred in 7 patients, and distant metastasis, in 10. In 2 patients, initial failure was both locoregional and distant. The 1-year and 2-year rates of local control were 68.1% and 36.4% respectively. The 1-year and 2-year rates of progression-free survival were 39.9% and 21.4% respectively. Two patients experienced grade 3 pneumonitis. Conclusions For patients with stage III non-small-cell lung cancer, PBT can be an effective and safe treatment option.	[Hatayama, Y.; Nakamura, T.; Suzuki, M.; Azami, Y.; Ono, T.; Yamaguchi, H.; Hayashi, Y.; Tsukiyama, I.; Hareyama, M.; Kikuchi, Y.] Southern Tohoku Proton Therapy Ctr, Dept Radiat Oncol, Koriyama, Fukushima, Japan; [Takai, Y.] Hirosaki Univ, Grad Sch Med, Dept Radiol & Radiat Oncol, Hirosaki, Aomori, Japan	Hatayama, Y (reprint author), Southern Tohoku Proton Beam Therapy Ctr, Dept Radiat Oncol, 7-172 Yatsuyamada, Koriyama, Fukushima 9638052, Japan.	yonoki2005@gmail.com					Nakayama H, 2011, INT J RADIAT ONCOL, V81, P979, DOI 10.1016/j.ijrobp.2010.06.024; Sause W, 2000, CHEST, V117, P358, DOI 10.1378/chest.117.2.358; SAUSE WT, 1995, J NATL CANCER I, V87, P198, DOI 10.1093/jnci/87.3.198; Oshiro Y, 2014, J RADIAT RES, V55, P959, DOI 10.1093/jrr/rru034; Green MR, 2000, SEMIN RADIAT ONCOL, V10, P289, DOI 10.1053/srav.2000.9611; Nichols RC, 2011, CLIN LUNG CANCER, V12, P252, DOI 10.1016/j.cllc.2011.03.027; Pritchard RS, 1996, ANN INTERN MED, V125, P723; Oshiro Y, 2012, J THORAC ONCOL, V7, P370, DOI 10.1097/JTO.0b013e31823c485f; Okawara G, 2006, J THORAC ONCOL, V1, P377, DOI 10.1097/01243894-200605000-00019; Ando K, 2001, J RADIAT RES, V42, P79, DOI 10.1269/jrr.42.79; Dillman RO, 1996, J NATL CANCER I, V88, P1210, DOI 10.1093/jnci/88.17.1210; Seppenwoolde Y, 2001, SEMIN RADIAT ONCOL, V11, P247, DOI 10.1053/srao.2001.23482; Chang JY, 2011, CANCER-AM CANCER SOC, V117, P4707, DOI 10.1002/cncr.26080; FURUSE K, 1995, J CLIN ONCOL, V13, P869; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Hoppe BS, 2012, CLIN LUNG CANCER, V13, P352, DOI 10.1016/j.cllc.2011.11.008; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; MARINO P, 1995, CANCER, V76, P593, DOI 10.1002/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N; Singer JM, 1998, BRIT J CANCER, V78, P1629, DOI 10.1038/bjc.1998.734; DILLMAN RO, 1990, NEW ENGL J MED, V323, P940, DOI 10.1056/NEJM199010043231403; Japan National Research and Development Institute National Cancer Research Center Cancer Control and Information Center, LAT CANC STAT; Kiura K, 2008, J CLIN ONCOL, V26; Non-small Cell Lung Cancer Collaborative Group, 1995, BMJ-BRIT MED J, V311, P899, DOI DOI 10.1136/BMJ.311.7010.899; Satouchi M, 2009, J CLIN ONCOL, V27	27	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	1198-0052			CURR ONCOL	Curr. Oncol.	OCT	2015	22	5					E370	E375		10.3747/co.22.2523		6	Oncology	Oncology	CU1YI	WOS:000363317900009		
J	Watanabe, Y; Yaginuma, H				Watanabe, Yuji; Yaginuma, Hiroyuki			Tangential cell migration during layer formation of chickoptic tectum	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Review						cell migration; chick; embryonic development; layer formation; optic tectum	CLONALLY RELATED CELLS; CHICKEN OPTIC TECTUM; LAMINAR FORMATION; CEREBRAL-CORTEX; VISUAL-SYSTEM; DIFFERENTIATION; NEURONS; EMBRYO; HISTOGENESIS; LINEAGE	The laminated structure of the optic tectum is formed by radial and tangential cell migration during development. Studies of developing chick optic tectum have revealed two streams of tangential cell migration in the middle and superficial layers, which have distinctive origins, migratory paths, modes of migration, and destinations. We will review the process of the two types of tangential migrations, in order to elucidate their roles in the formation of the optic tectum layers.	[Watanabe, Yuji; Yaginuma, Hiroyuki] Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima 9601295, Japan	Watanabe, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Neuroanat & Embryol, Fukushima 9601295, Japan.	yuji-w@fmu.ac.jp			Fukushima Medical University Research Project; JSPS KAKENHI [15K06740]	Our study was supported by Fukushima Medical University Research Project and JSPS KAKENHI Grant Number 15K06740.	GRAY GE, 1992, DEVELOPMENT, V114, P271; Karten HJ, 1997, J COMP NEUROL, V387, P449; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; COWAN WM, 1961, J ANAT, V95, P545; MARTINEZ S, 1992, DEV BRAIN RES, V66, P153, DOI 10.1016/0165-3806(92)90076-9; Watanabe Y, 2014, DEVELOPMENT, V141, P3572, DOI 10.1242/dev.110205; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; GOLDBERG S, 1974, DEV BIOL, V36, P24, DOI 10.1016/0012-1606(74)90188-2; Sugiyama S, 2003, DEVELOPMENT, V130, P451, DOI 10.1242/dev.00232; LAVAIL JH, 1971, BRAIN RES, V28, P421; ITASAKI N, 1992, NEURON, V8, P787, DOI 10.1016/0896-6273(92)90099-Y; DOMESICK VB, 1977, NEUROSCIENCE, V2, P459, DOI 10.1016/0306-4522(77)90011-2; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; Wu CC, 2000, J COMP NEUROL, V417, P115; Tan SS, 2002, DEV BIOL, V241, P117, DOI 10.1006/dbio.2001.0505; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; LAVAIL JH, 1971, BRAIN RES, V28, P391, DOI 10.1016/0006-8993(71)90053-9; GRAY GE, 1988, P NATL ACAD SCI USA, V85, P7356, DOI 10.1073/pnas.85.19.7356; SENUT MC, 1987, DEV BRAIN RES, V32, P187, DOI 10.1016/0165-3806(87)90100-3; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; Omi M, 2014, DEVELOPMENT, V141, P2131, DOI 10.1242/dev.102905; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Huber GC, 1933, P NATL ACAD SCI USA, V19, P15, DOI 10.1073/pnas.19.1.15; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; PUELLES L, 1978, NEUROSCIENCE, V3, P307, DOI 10.1016/0306-4522(78)90079-9; Ramon, 1911, HISTOLOGIE SYSTEME N, V2	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					539	543		10.1111/dgd.12238		5	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900001		
J	Hirate, Y; Hirahara, S; Inoue, K; Kiyonari, H; Niwa, H; Sasaki, H				Hirate, Yoshikazu; Hirahara, Shino; Inoue, Ken-ichi; Kiyonari, Hiroshi; Niwa, Hiroshi; Sasaki, Hiroshi			Par-aPKC-dependent and -independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16-cell stage mouse embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						asymmetric cell division; cell polarity; Hippo signaling; Par-aPKC; preimplantation embryo	TROPHECTODERM FATE; 8-CELL STAGE; PATHWAY; BLASTOMERES; LINEAGE; INNER; CDX2; MASS; SPECIFICATION; BLASTOCYST	In preimplantation mouse embryos, the Hippo signaling pathway plays a central role in regulating the fates of the trophectoderm (TE) and the inner cell mass (ICM). In early blastocysts with more than 32 cells, the Par-aPKC system controls polarization of the outer cells along the apicobasal axis, and cell polarity suppresses Hippo signaling. Inactivation of Hippo signaling promotes nuclear accumulation of a coactivator protein, Yap, leading to induction of TE-specific genes. However, whether similar mechanisms operate at earlier stages is not known. Here, we show that slightly different mechanisms operate in 16-cell stage embryos. Similar to 32-cell stage embryos, disruption of the Par-aPKC system activated Hippo signaling and suppressed nuclear Yap and Cdx2 expression in the outer cells. However, unlike 32-cell stage embryos, 16-cell stage embryos with a disrupted Par-aPKC system maintained apical localization of phosphorylated Ezrin/Radixin/Moesin (p-ERM), and the effects on Yap and Cdx2 were weak. Furthermore, normal 16-cell stage embryos often contained apolar cells in the outer position. In these cells, the Hippo pathway was strongly activated and Yap was excluded from the nuclei, thus resembling inner cells. Dissociated blastomeres of 8-cell stage embryos form polar-apolar couplets, which exhibit different levels of nuclear Yap, and the polar cell engulfed the apolar cell. These results suggest that cell polarization at the 16-cell stage is regulated by both Par-aPKC-dependent and -independent mechanisms. Asymmetric cell division is involved in cell polarity control, and cell polarity regulates cell positioning and most likely controls Hippo signaling.	[Hirate, Yoshikazu; Sasaki, Hiroshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Control, Chuo Ku, Kumamoto 8600811, Japan; [Hirahara, Shino] RIKEN, Ctr Dev Biol, Lab Embryon Induct, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Inoue, Ken-ichi; Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Div Biofunct Dynam Imaging,Anim Resource Dev Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Div Biofunct Dynam Imaging,Genet Engn Team, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hiroshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Niwa, Hiroshi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Chuo Ku, Kumamoto 8600811, Japan; [Sasaki, Hiroshi] Osaka Univ, Grad Sch Frontier BioSci, Lab Embryogenesis, Suita, Osaka 5650871, Japan	Sasaki, H (reprint author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Fate Control, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan.	sasaki@fbs.osaka-u.ac.jp			RIKEN; MEXT KAKENHI [21116003]; JSPS KAKENHI [25440112]	We thank M. Shibata, T. Ideue, M. Harano, A. Katsuyama, and N. Fujita for their excellent technical assistance; K. Yamagata, V. Alarcon, and A. Shitamukai for plasmids; and A. Shimono for the Amot antibody. We are also grateful to the Laboratory for Animal Resources Development and Genetic Engineering, RIKEN CDB for collecting mouse embryos and housing mice, as well as the CARD, Kumamoto University for housing mice. This work was supported by grants from RIKEN (to H.S.), MEXT KAKENHI (Grant Number 21116003 to H.S.), and JSPS KAKENHI (Grant Number 25440112 to Y.H.).	Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; PEDERSEN RA, 1986, DEV BIOL, V117, P581, DOI 10.1016/0012-1606(86)90327-1; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Cockburn K, 2013, CURR BIOL, V23, P1195, DOI 10.1016/j.cub.2013.05.044; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; DUCIBELLA T, 1977, J CELL BIOL, V74, P153, DOI 10.1083/jcb.74.1.153; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Hirate Y, 2012, P NATL ACAD SCI USA, V109, pE3389, DOI 10.1073/pnas.1211810109; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cb.04.110188.002331; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; McDole K, 2011, DEV BIOL, V355, P239, DOI 10.1016/j.ydbio.2011.04.024; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Skamagki M, 2013, CELL REP, V3, P442, DOI 10.1016/j.celrep.2013.01.006; GRAHAM CF, 1978, J EMBRYOL EXP MORPH, V48, P53; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Sasaki H, 2010, DEV GROWTH DIFFER, V52, P263, DOI 10.1111/j.1440-169X.2009.01158.x; Rayon T, 2014, DEV CELL, V30, P410, DOI 10.1016/j.devcel.2014.06.019; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; REEVE WJD, 1981, J EMBRYOL EXP MORPH, V62, P339; CALARCO PG, 1973, DEV BIOL, V32, P208, DOI 10.1016/0012-1606(73)90233-9; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007117; Hirate Y, 2014, TISSUE BARRIERS, V2; Hogan B., 1994, MANIPULATING MOUSE E; Johnson MH, 1981, CELLULAR MOL ASPECTS, P55; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Sasaki H, 2015, SEMIN CELL DEV BIOL, V47-48, P80, DOI 10.1016/j.semcdb.2015.05.003; TARKOWSK.AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					544	556		10.1111/dgd.12235		13	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900002		
J	Otsuka, T; Tsukahara, T; Takeda, H				Otsuka, Takayoshi; Tsukahara, Tatsuya; Takeda, Hiroyuki			Development of the pancreas in medaka, Oryzias latipes, from embryo to adult	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						islet; medaka; pancreas; pdx1; ptf1a	BETA-CELL FORMATION; ENDOCRINE PANCREAS; TRANSGENIC ZEBRAFISH; TRANSCRIPTION FACTOR; EXPRESSING CELLS; PROGENITOR CELLS; ISLET-CELL; GENE; EXOCRINE; PTF1A	To address conserved and unique features of fish pancreas development, we performed extensive analyses of pancreatic development in medaka embryos and adults using pdx1- and ptf1a-transgenic medaka, insitu hybridization and immunohistochemistry. The markers used in these analyses included pdx1, nkx6.1, nkx6.2, nkx2.2, Islet1, insulin, Somatostatin, glucagon, ptf1a, ela3l, trypsin, and amylase. The double transgenic (Tg) fish produced in the present study visualizes the development of endocrine (pdx1+) and exocrine (ptf1a+) parts simultaneously in living fishes. Like other vertebrates, the medaka pancreas develops as two (dorsal and ventral) buds in the anterior gut tube, which soon fuse into a single anlagen. The double Tg fish demonstrates that the differential property between the two buds is already established at the initial phase of bud development as indicated by strong pdx1 expression in the dorsal one. This Tg fish also allowed us to examine the gross morphology and the structure of adult pancreas and revealed unique characters of medaka pancreas such as broad and multiple connections with the gut tube along the anterior-posterior axis.	[Otsuka, Takayoshi; Tsukahara, Tatsuya; Takeda, Hiroyuki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Takeda, Hiroyuki] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Takeda, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.	htakeda@bs.s.u-tokyo.ac.jp			CREST, JST;  [22127002];  [25291048]	We thank Dr. A. Shimada for critical reading of the manuscript. We are grateful to Ms. Y. Ozawa and Ms. Y. Yamagishi for fish care. This work was supported in part by Grant-in-Aid for Scientific Research Priority Area Genome Science and Scientific Research on Innovative Areas 'Logic of Biological Pattern Formation' [22127002], Grant-in-Aid for Scientific Research (B) [25291048] and CREST, JST.	Sussel L, 1998, DEVELOPMENT, V125, P2213; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Takashima S, 2007, DEV DYNAM, V236, P2298, DOI 10.1002/dvdy.21245; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Yesil P, 2008, HISTOL HISTOPATHOL, V23, P883; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Moriyama Y, 2012, CURR BIOL, V22, P601, DOI 10.1016/j.cub.2012.01.063; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; GUZ Y, 1995, DEVELOPMENT, V121, P11; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; UPCHURCH BH, 1994, DEVELOPMENT, V120, P245; Yee NS, 2005, DEV BIOL, V284, P84, DOI 10.1016/j.ydbio.2005.04.035; Offield MF, 1996, DEVELOPMENT, V122, P983; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Moss JB, 2009, DIABETES, V58, P1844, DOI 10.2337/db08-0628; Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Burlison JS, 2008, DEV BIOL, V316, P74, DOI 10.1016/j.ydbio.2008.01.011; Assouline B, 2002, MECH DEVELOP, V117, P299, DOI 10.1016/S0925-4773(02)00190-9; Kim HJ, 2006, MOL ENDOCRINOL, V20, P194, DOI 10.1210/me.2005-0189; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Kelsh RN, 2004, MECH DEVELOP, V121, P841, DOI 10.1016/j.mod.2004.01.004; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Wierup N, 2002, REGUL PEPTIDES, V107, P63, DOI 10.1016/S0167-0115(02)00067-8; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Li Z, 2009, DIFFERENTIATION, V77, P128, DOI 10.1016/j.diff.2008.09.014; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Binot AC, 2010, DEV BIOL, V340, P397, DOI 10.1016/j.ydbio.2010.01.025; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P647, DOI 10.1016/j.mod.2004.04.016; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Sander M, 2000, DEVELOPMENT, V127, P5533; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Nakamura S, 2008, DEV GROWTH DIFFER, V50, P415, DOI [10.1111/j.1440-169X.2008.01027.x, 10.1111/j.1440-169x.2008.01027.x]; Castro LFC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2669; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1592	1440-169X		DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2015	57	8					557	569		10.1111/dgd.12237		13	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	CU3DK	WOS:000363403900003		
J	Hirahara, N; Matsubara, T; Hayashi, H; Takai, K; Fujii, Y; Tajima, Y				Hirahara, N.; Matsubara, T.; Hayashi, H.; Takai, K.; Fujii, Y.; Tajima, Y.			Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer	EJSO			English	Article						Esophageal cancer; Glasgow Prognostic Score; Neutrophil lymphocyte ratio; Prognosis	CELL LUNG-CANCER; C-REACTIVE PROTEIN; NEUTROPHIL-LYMPHOCYTE RATIO; PERFORMANCE STATUS ECOG; SYSTEMIC INFLAMMATION; COLORECTAL-CANCER; ENDOSCOPIC ULTRASONOGRAPHY; POOR-PROGNOSIS; GASTRIC-CANCER; WEIGHT-LOSS	Background: Despite recent improvements in early detection, progress in surgical techniques, and development of chemoradiation therapies, prognosis of esophageal cancer remains poor. The aim of the present study was to assess whether Glasgow Prognostic Score (GPS), an inflammation-based prognostic score, has prognostic value independent of conventional clinicopathological criteria in patients undergoing curative resection for esophageal cancer, even in elderly patients. Methods: We retrospectively reviewed the database of 141 consecutive patients with histologically verified esophageal squamous cell carcinoma who underwent potentially curative surgery in our institute, between January 2006 and December 2014. GPS and neutrophil lymphocyte ratio (NLR) were calculated. Results: On multivariate analysis, TNM stage (p < 0.0001) and GPS (p = 0.041) were independently associated with worse prognosis in overall patients with esophageal cancer. Multivariate analysis evaluated the prognostic factors in two different patient groups: patients younger than 70 years (non-elderly) and those aged 70 years or more (elderly). Multivariate analysis demonstrated that TNM stage (p = 0.0003) was an only independent risk factor for a worse prognosis among non-elderly group. Meanwhile, multivariate analysis demonstrated that TNM stage (p = 0.001) and GPS (p = 0.043) were the independent risk factor for a worse prognosis among elderly group. Conclusion: The present study demonstrated that GPS is associated with prognosis and can be considered as an independent prognostic marker in patients who underwent esophagectomy. Moreover, the GPS has the advantage of being simple to measure, routinely available and well standardized. But the present study failed to confirm the NLR as a significant predictor of survival following resection for esophageal cancer. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Hirahara, N.; Matsubara, T.; Hayashi, H.; Takai, K.; Fujii, Y.; Tajima, Y.] Shimane Univ, Fac Med, Dept Digest & Gen Surg, Izumo, Shimane 6938501, Japan	Hirahara, N (reprint author), Shimane Univ, Fac Med, Dept Digest & Gen Surg, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	norinorihirahara@yahoo.co.jp					Brown DJF, 2007, J CLIN PATHOL, V60, P705, DOI 10.1136/jcp.2005.033217; Ramsey S, 2007, CANCER, V109, P205, DOI 10.1002/cncr.22400; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Forrest LM, 2005, BRIT J CANCER, V92, P1834, DOI 10.1038/sj.bjc.6602591; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Kao SCH, 2010, CLIN CANCER RES, V16, P5805, DOI 10.1158/1078-0432.CCR-10-2245; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Guillem P, 2005, DIS ESOPHAGUS, V18, P146, DOI 10.1111/j.1442-2050.2005.00474.x; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; MORGAN DB, 1980, AM J CLIN NUTR, V33, P2101; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; McMillan DC, 2001, NUTR CANCER, V41, P64, DOI 10.1207/S15327914NC41-1&2_8; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Glen P, 2006, PANCREATOLOGY, V6, P450, DOI 10.1159/000094562; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Schumacher K, 2001, CANCER RES, V61, P3932; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Ahn HS, 2009, J SURG ONCOL, V99, P20, DOI 10.1002/jso.21170; Crumley ABC, 2008, J GASTROEN HEPATOL, V23, pE325, DOI 10.1111/j.1440-1746.2007.05105.x; Ando M, 2001, BRIT J CANCER, V85, P1634, DOI 10.1054/bjoc.2001.2162; Gabay C, 1999, NEW ENGL J MED, V340, P448; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Krzystek-Korpacka M, 2008, CLIN CHEM LAB MED, V46, P359, DOI 10.1515/CCLM.2008.089; Lee HH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-190; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Sobin LH, 2010, TNM CLASSIFICATION M	33	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1308	1315		10.1016/j.ejso.2015.07.008		8	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600006		
J	Yamashita, K; Ushiku, H; Katada, N; Hosoda, K; Moriya, H; Mieno, H; Kikuchi, S; Hoshi, K; Watanabe, M				Yamashita, K.; Ushiku, H.; Katada, N.; Hosoda, K.; Moriya, H.; Mieno, H.; Kikuchi, S.; Hoshi, K.; Watanabe, M.			Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test	EJSO			English	Article						Gastric cancer; CY1; Prognosis; Albumin; Long-term postoperative therapy; Peritoneal dissemination; Propensity score	INTRAPERITONEAL PACLITAXEL; OVARIAN-CANCER; S-1; CELLS; CHEMOTHERAPY; CISPLATIN; VIABILITY; TRIAL	Background: Peritoneal lavage cytology cancer-positive (CY1) is a critical prognostic factor and is taken as representing stage IV in gastric cancer. There is no consensus treatment strategy for CY1-gastric cancer, and the detailed clinicopathological features remain obscure. Patients and methods: Among 790 gastric cancer patients between 2005 and 2009, 52 cases of CY1 were identified (6.6%). A multivariate prognostic model was applied to the univariate prognostic factors to identify independent prognostic factors and factors associated with long-term survival in CY1-gastric cancer. Results:(1) Five-year overall survival (OS) was 17.6% in CY1-gastric cancer as compared with 93.9% in CYX and 77.7% in CY0(77.7%), where tumors with pT2 or beyond were included in 11% of CYX, 73% of CY0, and 98% of CY1 cases. (2) On univariate analysis, factors associated with a negative prognosis were the presence of peritoneal dissemination (p = 0.029) and high preoperative serum albumin (p = 0.011) in CY1-gastric cancer. The multivariate Cox proportional hazards and logistic regression model using propensity score identified preoperative albumin as a critical independent prognostic indicator. (3) Long-term survivors were identified and, were often characterized by long-term postoperative adjuvant treatment. Conclusion: Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival in patients with advanced gastric cancer with positive cytology test. Long-term postoperative adjuvant therapy might improve survival of patients with CY1. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamashita, K.; Ushiku, H.; Katada, N.; Hosoda, K.; Moriya, H.; Mieno, H.; Kikuchi, S.; Watanabe, M.] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa 2520380, Japan; [Hoshi, K.] Kitasato Univ, Dept Hyg, Sch Med, Sagamihara, Kanagawa 2520380, Japan	Yamashita, K (reprint author), Kitasato Univ, Dept Surg, Sch Med, Minami Ku, Asamizodai 2-1-1, Sagamihara, Kanagawa 2520380, Japan.	keishi23@med.kitasato-u.ac.jp					Yamashita K, 2013, SURG TODAY, V43, P1013, DOI 10.1007/s00595-012-0388-1; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; DEMETRAKOPOULOS GE, 1982, CANCER BIOCHEM BIOPH, V6, P65; Fukagawa T, 2010, WORLD J SURG, V34, P563, DOI 10.1007/s00268-009-0355-1; FRANCIS P, 1995, J CLIN ONCOL, V13, P2961; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Reutter M, 2013, INT J GYNECOL CANCER, V23, P34, DOI 10.1097/IGC.0b013e318275b028; Mezhir JJ, 2010, ANN SURG ONCOL, V17, P3173, DOI 10.1245/s10434-010-1183-0; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Lee SD, 2012, BRIT J SURG, V99, P397, DOI 10.1002/bjs.7812; Yamashita K, 2008, GASTRIC CANCER, V11, P111, DOI 10.1007/s10120-008-0466-7; Kitayama J, 2014, ANN SURG ONCOL, V21, P539, DOI 10.1245/s10434-013-3208-y; Ishii T, 2004, CANCER LETT, V213, P99, DOI 10.1016/j.canlet.2004.03.022; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Yamashita K, 2007, ANTICANCER RES, V27, P4381; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Okuyama T, 2012, SURG TODAY, V42, P734, DOI 10.1007/s00595-012-0129-5; Association JGC, 2011, GASTRIC CANCER, V14, P113; Cancer IUA, 2009, TNM CLASSIFICATION M; International Agency for Research on Cancer WHO, 2012, GLOBOCAN 2012 EST CA; Japanese Gastric Cancer A, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009003	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1324	1332		10.1016/j.ejso.2015.05.021		9	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600008		
J	Mine, S; Kurokawa, Y; Takeuchi, H; Kishi, K; Ito, Y; Ohi, M; Matsuda, T; Hamakawa, T; Hasegawa, S; Yoshikawa, T; Hiki, N				Mine, S.; Kurokawa, Y.; Takeuchi, H.; Kishi, K.; Ito, Y.; Ohi, M.; Matsuda, T.; Hamakawa, T.; Hasegawa, S.; Yoshikawa, T.; Hiki, N.			Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors	EJSO			English	Article						Adenocarcinoma; Esophagogastric junction; Gastrectomy; Esophagectomy; Lymphadenectomy	GASTROESOPHAGEAL JUNCTION; GASTRIC-CANCER; CHANGING PATTERNS; ADENOCARCINOMA; ESOPHAGEAL; RESECTION; MARGIN; CLASSIFICATION; GASTRECTOMY; DISSECTION	Background: The optimal surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction (AEG) has not yet been agreed. Here we investigated whether the distance from the esophagogastric junction (EGJ) to the distal end of the tumor was related to the distribution of involved abdominal lymph nodes in Siewert type II tumors. Methods: A total of 288 patients with pT2-4 AEG Siewert II, treated by R0 surgical resection at 7 institutions in Japan, were retrospectively investigated. The distribution of involved abdominal nodes was correlated with the distance from the EGJ to the distal end of the tumor. Results: In patients where the distance from the EGJ to the distal end of the tumor was <= 30 mm, the frequency of nodal involvement along the greater curvature or antrum was low (2.2%). In contrast, in patients where the distance was >50 mm, the incidence of this nodal involvement was 20.0%. In patients where the distance was 30-50 mm incidence was intermediate (8.0%). Multivariate analyses showed that the distance from the EGJ to the distal end of the tumor was significantly related to lymph node involvement along the greater curvature or antrum (odds ratio 3.7, 95% confidence interval 1.3-11, p = 0.006). Conclusions: When the distance from the EGJ to the distal end of the tumor is <= 30 mm for Siewert II AEG, esophagectomy or proximal gastrectomy is sufficient from the point of view of abdominal lymphadenectomy. However, a total gastrectomy should be considered for abdominal lymphadenectomy when this distance is > 50 mm. (C) 2015 Elsevier Ltd. All rights reserved.	[Mine, S.; Hiki, N.] Canc Inst Hosp Ariake, Dept Surg Gastroenterol, Tokyo, Japan; [Kurokawa, Y.; Hamakawa, T.] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Takeuchi, H.; Matsuda, T.] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Kishi, K.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ito, Y.] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Nagoya, Aichi 464, Japan; [Ohi, M.] Mie Univ, Grad Sch Med, Dept Innovat Surg, Tsu, Mie, Japan; [Hasegawa, S.; Yoshikawa, T.] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan	Yoshikawa, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	yoshikawat@kcch.jp; naoki.hiki@jfcr.or.jp					YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Deans C, 2011, WORLD J SURG, V35, P617, DOI 10.1007/s00268-010-0935-0; Mariette C, 2003, EUR J SURG ONCOL, V29, P588, DOI 10.1016/S0748-7983(03)00109-4; Kakeji Y, 2012, SURG TODAY, V42, P351, DOI 10.1007/s00595-011-0114-4; Dolan K, 1999, BRIT J CANCER, V80, P834, DOI 10.1038/sj.bjc.6690429; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Mariette C, 2011, LANCET ONCOL, V12, P296, DOI 10.1016/S1470-2045(10)70125-X; Grotenhuis BA, 2013, WORLD J SURG, V37, P147, DOI 10.1007/s00268-012-1804-9; Butte JM, 2011, SURG TODAY, V41, P1319, DOI 10.1007/s00595-010-4412-z; Mine S, 2013, BRIT J SURG, V100, P261, DOI 10.1002/bjs.8967; Lerut T, 2010, RECENT RESULTS CANC, V182, P127, DOI 10.1007/978-3-540-70579-6_11; TERZ JJ, 1987, AM J SURG, V154, P42, DOI 10.1016/0002-9610(87)90287-X; Siewert JR, 1998, BRIT J SURG, V85, P1457; Schiesser M, 2010, RECENT RESULTS CANC, V182, P93, DOI 10.1007/978-3-540-70579-6_8; PAPACHRISTOU DN, 1980, AM J SURG, V139, P711, DOI 10.1016/0002-9610(80)90369-4; Mine S, 2013, BRIT J SURG, V100, P1050, DOI 10.1002/bjs.9170; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; DeMeester SR, 2006, ANN SURG ONCOL, V13, P12, DOI 10.1245/ASO.2005.12.025; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Ito H, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-2; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/S101209800016]; Sobin L, 2009, TNM CLASSIFICATION M	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1348	1353		10.1016/j.ejso.2015.05.004		6	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600011		
J	Kinoshita, J; Fushida, S; Tsukada, T; Oyama, K; Okamoto, K; Makino, I; Nakamura, K; Miyashita, T; Tajima, H; Takamura, H; Ninomiya, I; Ohta, T				Kinoshita, J.; Fushida, S.; Tsukada, T.; Oyama, K.; Okamoto, K.; Makino, I.; Nakamura, K.; Miyashita, T.; Tajima, H.; Takamura, H.; Ninomiya, I.; Ohta, T.			Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer	EJSO			English	Article						Gastric cancer; Stage IV; Chemotherapy; Conversion gastrectomy	PHASE-III TRIAL; HEPATIC RESECTION; LIVER METASTASIS; NEOADJUVANT CHEMOTHERAPY; PLUS CISPLATIN; SURGERY; SURVIVAL; STOMACH	Background: Recent advances in gastric cancer chemotherapy have made macroscopic complete resection possible in some patients with stage IV disease. Methods: We retrospectively investigated the efficacy of multimodal therapy with combined docetaxel, cisplatin, and S-1 (DCS) and conversion gastrectomy in 57 patients with stage IV gastric cancer. Results: Of the 57 patients, 15 patients were categorized into potentially resectable case, which is defined as patients with single incurable factor including the upper abdominal para-aortic lymph node metastasis (16a2b1 PAN metastasis) or fewer than three peripheral liver metastases. The other 42 were categorized as initially unresectable. All of patients underwent DCS therapy, and then 34 patients underwent conversion gastrectomy. The 3-year overall survival (OS) rate among the patients who underwent conversion gastrectomy was 50.1% with MST of 29.9 months. They had significantly longer OS than patients who underwent DCS therapy alone (p < 0.01). Univariate analysis among the patents with conversion gastrectomy identified 16a2b1PAN metastasis, peritoneal metastasis, potential resectable case, R0 resection as significant prognostic factors. A 3-year OS in potential resectable cases was 92.9%. Multivariate analysis identified potential resectability as the only independent prognostic factor contributing to OS (HR 0.133, 95%CI 0.024-0. 744, p = 0.021). In contrast, clinical response was selected as the only independent prognostic factor in the subgroup of initially unresectable cases (HR 0.354, 95%CI 0.151-0.783, p = 0.021). Conclusion: Patients with potentially resectable disease had a remarkably good prognosis among stage IV gastric cancer patients, and might be ideal candidates for conversion gastrectomy following DCS therapy. (C) 2015 The Authors. Published by Elsevier Ltd.	[Kinoshita, J.; Fushida, S.; Tsukada, T.; Oyama, K.; Okamoto, K.; Makino, I.; Nakamura, K.; Miyashita, T.; Tajima, H.; Takamura, H.; Ninomiya, I.; Ohta, T.] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan	Fushida, S (reprint author), Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	fushida@staff.kanazawa-u.ac.jp					Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Takemura N, 2012, LANGENBECK ARCH SURG, V397, P951, DOI 10.1007/s00423-012-0959-z; Okano K, 2002, ANN SURG, V235, P86, DOI 10.1097/00000658-200201000-00011; [Anonymous], 2011, JPN GASTRIC CANC ASS, V14, P101; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Shirabe K, 2003, HEPATO-GASTROENTEROL, V50, P1560; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Cheon SH, 2008, ANN ONCOL, V19, P1146, DOI 10.1093/annonc/mdn026; Chen L, 2013, WORLD J GASTROENTERO, V19, P2097, DOI 10.3748/wjg.v19.i13.2097; Tsuburaya A, 2014, BRIT J SURG, V101, P653, DOI 10.1002/bjs.9484; YONEMURA Y, 1994, SURG TODAY, V24, P488; Yano M, 2002, WORLD J SURG, V26, P1155, DOI 10.1007/s00268-002-6362-0; Fushida S, 2009, ANTI-CANCER DRUG, V20, P752, DOI 10.1097/CAD.0b013e32832ec02b; Sakamoto Y, 2007, J SURG ONCOL, V95, P534, DOI 10.1002/jso.20739; Kanda T, 2012, GASTRIC CANCER, V15, P235, DOI 10.1007/s10120-011-0100-y; Nakajima T, 1997, ANN SURG ONCOL, V4, P203, DOI 10.1007/BF02306611; Roh HR, 2005, AM SURGEON, V71, P95; Ambiru S, 2001, AM J SURG, V181, P279, DOI 10.1016/S0002-9610(01)00567-0; Ishigami S, 2008, J GASTROINTEST SURG, V12, P1370, DOI 10.1007/s11605-008-0539-2; Suzuki T, 2010, ONCOL LETT, V1, P743, DOI 10.3892/ol_00000130; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Fukuchi M, 2015, ANN SURG ONCOL; Nakayama N, 2008, ONCOLOGY-BASEL, V75, P1, DOI 10.1159/000151613; Schlansky B, 2001, AM J GASTROENTEROL, V106, P1978; Shin Aesun, 2011, J Gastric Cancer, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Yabusaki H, 2013, HEPATO-GASTROENTEROL, V60, P377, DOI 10.5754/hge12683	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	OCT	2015	41	10					1354	1360		10.1016/j.ejso.2015.04.021		7	Oncology; Surgery	Oncology; Surgery	CU2HW	WOS:000363345600012		
J	Wu, CF; Wang, QH; Xiang, J; Yu, M; Chang, Q; Gao, M; Sonomoto, K				Wu, Chuanfu; Wang, Qunhui; Xiang, Juan; Yu, Miao; Chang, Qiang; Gao, Ming; Sonomoto, Kenji			Enhanced Productions and Recoveries of Ethanol and Methane from Food Waste by a Three-Stage Process	ENERGY & FUELS			English	Article							2-STAGE FERMENTATION PROCESS; 2-PHASE ANAEROBIC-DIGESTION; KITCHEN WASTE; CO-DIGESTION; HYDROGEN; PERFORMANCE; SUBSTRATE; GARBAGE; REACTOR; INHIBITION	A three-stage process that consisted of saccharification, ethanol fermentation of the saccharified liquid, and anaerobic treatment of the saccharified residue to convert food waste (FW) to ethanol and CH4 was developed. Results revealed that high sugar recovery (i.e., 61.7%) from FIAT could be achieved after saccharification and 15.2% saccharified sugar was retained in saccharified residue after solid-liquid separation. A high ethanol yield was obtained during ethanol fermentation of the saccharified liquid. This high yield indicates the superiority of the system. The ethanol productivity in the ethanol fermentation stage was 0.9 g L-1 h(-1). A CH4 yield of 248.4 mL/g of volatile solid (VS) was achieved in the CH4 fermentation stage, whereas that in the single-stage fermentation system was 252.6 mL/g of VS. A comparison of the two fermentation systems based on material balance and energy outcome demonstrated that the three-stage process achieved a 27.5% increase in the FIAT decomposition rate, a 51.8% reduction in the energy requirement for system operation, and a 17.6% improvement in the total energy yield. Therefore, the three-stage process is more suitable for practical application in terms of a lower post-treatment cost for the digester residue, a higher organic carbon utilization rate, and a higher bioenergy recovery efficiency compared to the single-stage system.	[Wu, Chuanfu; Wang, Qunhui; Xiang, Juan; Yu, Miao; Chang, Qiang] Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, Beijing 10083, Peoples R China; [Wu, Chuanfu; Wang, Qunhui] Univ Sci & Technol Beijing, Beijing Key Lab Resource Oriented Treatment Ind P, Beijing 10083, Peoples R China; [Gao, Ming; Sonomoto, Kenji] Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol,Higashi Ku, Fukuoka 8128581, Japan	Wang, QH (reprint author), Univ Sci & Technol Beijing, Sch Civil & Environm Engn, Dept Environm Engn, 30 Xueyuan Rd, Beijing 10083, Peoples R China.	wangqh59@sina.com			National Key Technology RD Program [2014BAC24B01]; National Natural Science Foundation of China [51278050]	This study was supported by the National Key Technology R&D Program (2014BAC24B01) and the National Natural Science Foundation of China (Grant 51278050).	AGUILAR A, 1995, WATER RES, V29, P505, DOI 10.1016/0043-1354(94)00179-B; Lee DY, 2010, BIORESOURCE TECHNOL, V101, pS42, DOI 10.1016/j.biortech.2009.03.037; Nasr N, 2012, BIORESOURCE TECHNOL, V111, P122, DOI 10.1016/j.biortech.2012.02.019; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Lee YW, 2010, INT J HYDROGEN ENERG, V35, P11746, DOI 10.1016/j.ijhydene.2010.08.093; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; FOX P, 1994, WATER ENVIRON RES, V66, P716; VINAS M, 1993, ENVIRON TECHNOL, V14, P995; Wang QH, 2008, BIOCHEM ENG J, V39, P604, DOI 10.1016/j.bej.2007.12.018; Park JH, 2012, BIORESOURCE TECHNOL, V113, P78, DOI 10.1016/j.biortech.2011.12.123; Ma HZ, 2009, RENEW ENERG, V34, P1466, DOI 10.1016/j.renene.2008.10.020; Dearman B, 2007, WASTE MANAGE, V27, P1792, DOI 10.1016/j.wasman.2006.08.006; Kawai M, 2014, BIORESOURCE TECHNOL, V157, P174, DOI 10.1016/j.biortech.2014.01.018; Li YQ, 2013, ENERG FUEL, V27, P2085, DOI 10.1021/ef400117f; Ueno Y, 2007, ENVIRON SCI TECHNOL, V41, P1413, DOI 10.1021/es062127f; Demirel B, 2002, J CHEM TECHNOL BIOT, V77, P743, DOI 10.1002/jctb.630; Koike Y, 2009, J BIOSCI BIOENG, V108, P508, DOI 10.1016/j.jbiosc.2009.06.007; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Youn JH, 2005, WASTE MANAGE RES, V23, P32, DOI 10.1177/0734242X05049766; Luo G, 2010, INT J HYDROGEN ENERG, V35, P11733, DOI 10.1016/j.ijhydene.2010.08.033; Kim DH, 2009, ENZYME MICROB TECH, V45, P181, DOI 10.1016/j.enzmictec.2009.06.013; Shin HS, 2001, WATER RES, V35, P3441, DOI 10.1016/S0043-1354(01)00041-0; Ozmihci S, 2007, BIORESOURCE TECHNOL, V98, P2978, DOI 10.1016/j.biortech.2006.10.005; Li RP, 2009, ENERG FUEL, V23, P2225, DOI 10.1021/ef8008772; Kim DH, 2013, BIORESOURCE TECHNOL, V127, P267, DOI 10.1016/j.biortech.2012.09.088; BUCKEE GK, 1993, J I BREWING, V99, P381; Liu XY, 2013, BIORESOURCE TECHNOL, V146, P317, DOI 10.1016/j.biortech.2013.07.096; Neves L, 2004, PROCESS BIOCHEM, V39, P2019, DOI 10.1016/j.procbio.2003.10.002; Forster-Carneiro T, 2008, BIORESOURCE TECHNOL, V99, P6994, DOI 10.1016/j.biortech.2008.01.018; Tang YQ, 2008, BIOMASS BIOENERG, V32, P1037, DOI 10.1016/j.biombioe.2008.01.027; Lakaniemi AM, 2013, BIORESOURCE TECHNOL, V135, P222, DOI 10.1016/j.biortech.2012.08.096; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030	32	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6494	6500		10.1021/acs.energyfuels.5b01507		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100036		
J	Wu, SJ; Katayama, R; Uddin, MA; Sasaoka, E; Xie, ZM				Wu, Sheng-ji; Katayama, Risa; Uddin, Md. Azhar; Sasaoka, Eiji; Xie, Zheng-miao			Study on Reactivity of HgO over Activated Carbon with HCI and SO2 in the Presence of Moisture by Temperature-Programmed Decomposition Desorption Mass Spectrometry	ENERGY & FUELS			English	Article							COMBUSTION FLUE-GAS; ELEMENTAL MERCURY REMOVAL; COAL; ADSORPTION; SORBENTS; CHLORIDE; CAPTURE; ACID	Reactivities of mercury compounds over mercury sorbents with HCl and SO2 are very important to the design of a solid sorbent for mercury vapor removal from coal-derived flue gases. However, presently available data on the reactivity of mercury oxide over mercury sorbent is insufficient. This study investigated the reactivity of mercury oxide with HCl and SO2 using a temperature-programmed decomposition and desorption technique and a mass spectrometer (TPDD-mass) method. Mercury desorption from HgO over activated carbon (HgO/AC) was observed at the same temperature range as from HgO/SiO2, but the mercury desorption peak from the HgO/AC was observed at a higher temperature than from the HgO/SiO2, indicating that some of the HgO was stabilized by the AC surface. When the HgO/AC was pretreated with HCl-H2O, the formation of HgCl2 was suggested by the mass spectra of m/z = 272 and 270. The mercury desorption temperatures in the TPDD spectra were lower than those of nonpretreated samples. On the basis of the shape of the peak, it was conjectured that the mercury evolved from a single surface complex. The main mercury desorption peak was around 240 degrees C when HgO/AC was pretreated with SO2-H2O and occurred at the lowest temperature of the three pretreatments. However, multiple peaks, indicating the formation of multicomplexes, were observed during the pretreatment. A mercury desorption peak (HgO) was observed at the intermediate position between the other two samples pretreated with SO2 and HCl. The peak shape revealed that the mercury evolved from a single surface complex. It was also suggested that HCl suppressed the sulfuration of HgO by SO2 during the pretreatment.	[Wu, Sheng-ji; Xie, Zheng-miao] Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Katayama, Risa; Uddin, Md. Azhar; Sasaoka, Eiji] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Wu, SJ (reprint author), Hangzhou Dianzi Univ, Coll Mat & Environm Engn, Xiasha Univ Pk, Hangzhou 310018, Zhejiang, Peoples R China.	wushengji26@hdu.edu.cn			National Natural Science Foundation of China [21406044]; Zhejiang Province Natural Science Foundation of China [LY12E06001]; Science and Technology Planning Project of Zhejiang Province, China [2013C31016]	This work was financially supported by the National Natural Science Foundation of China (grant no. 21406044), the Zhejiang Province Natural Science Foundation of China (grant no. LY12E06001), and the Science and Technology Planning Project of Zhejiang Province, China (grant no. 2013C31016).	Hutson ND, 2007, ENVIRON SCI TECHNOL, V41, P1747, DOI 10.1021/es062121q; Li YH, 2003, FUEL, V82, P451, DOI 10.1016/S0016-2361(02)00307-1; Vidic RD, 2001, CARBON, V39, P3, DOI 10.1016/S0008-6223(00)00081-6; Rodriguez-Perez J, 2013, J HAZARD MATER, V260, P869, DOI 10.1016/j.jhazmat.2013.06.026; Liu W, 1998, ENVIRON SCI TECHNOL, V32, P531, DOI 10.1021/es970630+; Lee SF, 2004, ATMOS ENVIRON, V38, P4887, DOI 10.1016/j.atmosenv.2004.05.043; Morris EA, 2012, ENVIRON SCI TECHNOL, V46, P7905, DOI 10.1021/es301209t; Lopez-Anton MA, 2010, FUEL, V89, P629, DOI 10.1016/j.fuel.2009.08.034; Jurng J, 2002, CHEMOSPHERE, V47, P907, DOI 10.1016/S0045-6535(01)00329-0; Wang YJ, 2009, FUEL PROCESS TECHNOL, V90, P643, DOI 10.1016/j.fuproc.2008.10.013; Zhang B, 2015, CHEM ENG J, V263, P1, DOI 10.1016/j.cej.2014.10.090; Zeng HC, 2004, FUEL, V83, P143, DOI 10.1016/S0016-2361(03)00235-7; Li GL, 2015, FUEL, V145, P189, DOI 10.1016/j.fuel.2014.12.083; Uddin MA, 2008, ENERG FUEL, V22, P2284, DOI 10.1021/ef800134t; Luo GQ, 2011, P COMBUST INST, V33, P2763, DOI 10.1016/j.proci.2010.06.108; Shen BX, 2015, CHEM ENG J, V272, P28, DOI 10.1016/j.cej.2015.03.006; Wu SJ, 2011, ENERG FUEL, V25, P144, DOI 10.1021/ef1009499; Granite EJ, 2000, IND ENG CHEM RES, V39, P1020, DOI 10.1021/ie990758v; Zhou Q, 2015, FUEL PROCESS TECHNOL, V134, P325, DOI 10.1016/j.fuproc.2014.12.052; Miller SJ, 2000, FUEL PROCESS TECHNOL, V65, P343, DOI 10.1016/S0378-3820(99)00103-4; [Anonymous], 1996, J ENV SCI TECHNOL; Ochiai R, 2009, ENERG FUEL, V23, P4734, DOI 10.1021/ef900057e; Murakami A, 2010, ENERG FUEL, V24, P4241, DOI 10.1021/ef100288f; Rumayor M, 2015, FUEL PROCESS TECHNOL, V132, P9, DOI 10.1016/j.fuproc.2014.12.032; Ghorishi SB, 2002, ENVIRON SCI TECHNOL, V36, P4454, DOI 10.1021/es0255608; Uddin MA, 2009, ENERG FUEL, V23, P4710, DOI 10.1021/ef801068z; Ma JF, 2015, APPL SURF SCI, V329, P292, DOI 10.1016/j.apsusc.2014.11.090; Feng XB, 2004, ANAL BIOANAL CHEM, V380, P683, DOI 10.1007/s00216-004-2803-y; Galbreath KC, 2000, FUEL PROCESS TECHNOL, V65, P289, DOI 10.1016/S0378-3820(99)00102-2; Bidstrup P. L., 1964, TOXICITY MERCURY ITS, P1; Ferens M. C., 1974, EPA660373022; Schroeder WH, 1998, ATMOS ENVIRON, V32, P809, DOI 10.1016/S1352-2310(97)00293-8; Reis AT, 2015, GEODERMA, V237, P98, DOI 10.1016/j.geoderma.2014.08.019	33	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6598	6604		10.1021/acs.energyfuels.5b01283		7	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100048		
J	Kitano, T; Tsuji, T; Kurose, R; Komori, S				Kitano, Tomoaki; Tsuji, Takafumi; Kurose, Ryoichi; Komori, Satoru			Effect of Pressure Oscillations on Flashback Characteristics in a Turbulent Channel Flow	ENERGY & FUELS			English	Article							PREMIXED FLAME; FUEL DROPLETS; COMBUSTION; HYDROGEN; EVAPORATION; MECHANISMS; SIMULATION	A flashback phenomenon is reproduced by a direct numerical simulation (DNS) of a premixed hydrogen-air flame in a turbulent channel flow, and effects of the pressure oscillation, is caused by a virtual combustion instability on the flashback characteristics, are investigated. In addition, the interaction between the flashback flame structure and the turbulent flow structure is examined in detail. For the hydrogen air reaction, a chemical reaction model, which considers 9 chemical species and 20 reactions, is employed. The results show that the pressure oscillation strongly affects the flashback characteristics, such as the flashback speed and heat flux on the wall, and is at risk for increasing the flashback speed, because the acceleration of the flashback speed by the pressure oscillation is greater than the deceleration of it. Independent of the pressure oscillation, the turbulent eddies passing through the flame tend to be suppressed and vanish by the acceleration of the streamwise flow caused by thermal expansion. However, other turbulent eddies are generated again in a form of longitudinal eddies behind the flame only at the cusps and center of the channel where the upper and lower flames meet, because of the strong fluid shear owing to the thermal expansion.	[Kurose, Ryoichi] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan; Kyoto Univ, Adv Res Inst Fluid Sci & Engn, Nishikyo Ku, Kyoto 6158540, Japan	Kurose, R (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto 6158540, Japan.	kurose@mech.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [hp130018]	This research was supported by the "Strategic Programs for Innovative Research (SPIRE)-Field No. 4: Industrial Innovations" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) using the K computer at RIKEN Advanced Institute for Computational Science (Project hp130018).	Strohle J, 2007, INT J HYDROGEN ENERG, V32, P125, DOI 10.1016/j.ijhydene.2006.04.005; Gruber A, 2012, J FLUID MECH, V709, P516, DOI 10.1017/jfm.2012.345; Franzelli B, 2012, COMBUST FLAME, V159, P621, DOI 10.1016/j.combustflame.2011.08.004; Kitano T, 2013, J THERM SCI TECH-JPN, V8, P269, DOI 10.1299/jtst.8.269; Ni M, 2006, FUEL PROCESS TECHNOL, V87, P461, DOI 10.1016/j.fuproc.2005.11.003; Santoso WB, 2013, ENRGY PROCED, V32, P3, DOI 10.1016/j.egypro.2013.05.002; Eichler C, 2012, J ENG GAS TURB POWER, V134, DOI 10.1115/1.4004149; Gou XL, 2010, COMBUST FLAME, V157, P1111, DOI 10.1016/j.combustflame.2010.02.020; Rabenstein G, 2008, J POWER SOURCES, V185, P1293, DOI 10.1016/j.jpowsour.2008.08.010; Sato K, 2009, PROCEEDINGS OF THE ASME TURBO EXPO 2009, VOL 2, P87; Tanahashi M, 2000, P COMBUST INST, V28, P529; Moureau V, 2007, J COMPUT PHYS, V226, P1256, DOI 10.1016/j.jcp.2007.05.035; LEE ST, 1982, COMBUST FLAME, V48, P273, DOI 10.1016/0010-2180(82)90134-1; Mayer C, 2012, J ENG GAS TURB POWER, V134, DOI 10.1115/1.4004255; Kitano T, 2014, FUEL, V136, P219, DOI 10.1016/j.fuel.2014.07.045; Tachibana S, 2015, COMBUST FLAME, V162, P2621, DOI 10.1016/j.combustflame.2015.03.014; Gruber A, 2015, P COMBUST INST, V35, P1485, DOI 10.1016/j.proci.2014.06.073; Kitano T, 2014, COMBUST FLAME, V161, P551, DOI 10.1016/j.combustflame.2013.09.009; MILLER JA, 1989, PROG ENERG COMBUST, V15, P287, DOI 10.1016/0360-1285(89)90017-8; Pitsch H., FLAMEMASTER C COMPUT; Poinsot T., 2005, THEORETICAL NUMERICA; Swaminathan N., 2011, TURBULENT PREMIXED F; Yenerdag B, 2015, P COMBUST INST, V35, P1277, DOI 10.1016/j.proci.2014.05.153	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	OCT	2015	29	10					6815	6822		10.1021/acs.energyfuels.5b01687		8	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CT8LM	WOS:000363068100070		
J	Kanemaru, Y; Suzuki, T; Niimi, N; Gruz, P; Matsumoto, K; Adachi, N; Honma, M; Nohmi, T				Kanemaru, Yuki; Suzuki, Tetsuya; Niimi, Naoko; Gruz, Petr; Matsumoto, Kyomu; Adachi, Noritaka; Honma, Masamitsu; Nohmi, Takehiko			Catalytic and non-catalytic roles of DNA polymerase kappa in the protection of human cells against genotoxic stresses	ENVIRONMENTAL AND MOLECULAR MUTAGENESIS			English	Article						translesion DNA synthesis; Nalm-6-MSH+; catalytically dead mutants	VERTEBRATE POL-KAPPA; ERROR-FREE BYPASS; IN-VIVO EVIDENCE; TRANSLESION SYNTHESIS; Y-FAMILY; LESION-BYPASS; MAMMALIAN-CELLS; XERODERMA-PIGMENTOSUM; REPLICATION FORKS; PHENYLALANINE 171	DNA polymerase (Pol ) is a specialized DNA polymerase involved in translesion DNA synthesis. Although its bypass activities across lesions are well characterized in biochemistry, its cellular protective roles against genotoxic insults are still elusive. To better understand the in vivo protective roles, we have established a human cell line deficient in the expression of Pol (KO) and another expressing catalytically dead Pol (CD), to examine the cytotoxic sensitivity to 11 genotoxins including ultraviolet C light (UV). These cell lines were established in a genetic background of Nalm-6-MSH+, a human lymphoblastic cell line that has high efficiency for gene targeting, and functional p53 and mismatch repair activities. We classified the genotoxins into four groups. Group 1 includes benzo[a]pyrene diolepoxide, mitomycin C, and bleomycin, where the sensitivity was equally higher in KO and CD than in the cell line expressing wild-type Pol (WT). Group 2 includes hydrogen peroxide and menadione, where hypersensitivity was observed only in KO. Group 3 includes methyl methanesulfonate and ethyl methanesulfonate, where hypersensitivity was observed only in CD. Group 4 includes UV and three chemicals, where the chemicals exhibited similar cytotoxicity to all three cell lines. The results suggest that Pol not only protects cells from genotoxic DNA lesions via DNA polymerase activities, but also contributes to genome integrity by acting as a non-catalytic protein against oxidative damage caused by hydrogen peroxide and menadione. The non-catalytic roles of Pol in protection against oxidative damage by hydrogen peroxide are discussed. Environ. Mol. Mutagen. 56:650-662, 2015. (c) 2015 Wiley Periodicals, Inc.	[Kanemaru, Yuki; Suzuki, Tetsuya; Niimi, Naoko; Gruz, Petr; Honma, Masamitsu; Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan; [Kanemaru, Yuki] Showa Univ, Div Toxicol, Dept Pharmacol Toxicol & Therapeut, Sch Pharm,Shinagawa Ku, Tokyo 1420064, Japan; [Matsumoto, Kyomu] Inst Environm Toxicol, Toxicol Div, Ibaraki 3030043, Japan; [Adachi, Noritaka] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan	Nohmi, T (reprint author), Natl Inst Hlth Sci, Biol Safety Res Ctr, Tokyo 1588501, Japan.	nohmi@nihs.go.jp					Jaloszynski P, 2005, GENES CELLS, V10, P543, DOI 10.1111/j.1365-2443.2005.000858.x; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Adachi N, 2004, BIOCHEM BIOPH RES CO, V318, P856, DOI 10.1016/j.bbrc.2004.04.099; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Kanagaraj R, 2012, NUCLEIC ACIDS RES, V40, P8449, DOI 10.1093/nar/gks648; Sassa A, 2014, DNA REPAIR, V15, P21, DOI 10.1016/j.dnarep.2013.12.008; Adachi N, 2006, DNA CELL BIOL, V25, P19, DOI 10.1089/dna.2006.25.19; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Kamiya H, 2012, CHEM RES TOXICOL, V25, P1771, DOI 10.1021/tx300259x; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1365-2443.2004.00747.x; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Masutani C, 1999, NATURE, V399, P700; Kawanishi S, 2006, TOXICOLOGY, V221, P172, DOI 10.1016/j.tox.2006.01.002; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Jones MJK, 2012, EMBO J, V31, P908, DOI 10.1038/emboj.2011.457; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Zhang XL, 2013, DNA REPAIR, V12, P377, DOI 10.1016/j.dnarep.2013.02.008; Huang XW, 2003, BIOCHEMISTRY-US, V42, P2456, DOI 10.1021/bi026912q; Rajao MA, 2009, MOL MICROBIOL, V71, P185, DOI 10.1111/j.1365-2958.2008.06521.x; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Betous R, 2013, EMBO J, V32, P2172, DOI 10.1038/emboj.2013.148; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Yoon JH, 2014, GENES CELLS, V19, P594, DOI 10.1111/gtc.12156; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Bavoux C, 2005, CANCER RES, V65, P325; Lv LN, 2013, NUCLEIC ACIDS RES, V41, P10312, DOI 10.1093/nar/gkt793; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Vermeulen C, 2007, RADIAT RES, V168, P683, DOI 10.1667/RR1057R.1; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Baptiste BA, 2012, ENVIRON MOL MUTAGEN, V53, P787, DOI 10.1002/em.21721; Sekiguchi M, 2002, ONCOGENE, V21, P8895, DOI 10.1038/sj.onc.1206023; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Maddukuri L, NUCL ACIDS IN PRESS; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061189; Takeiri A, 2014, DNA REPAIR, V24, P113, DOI 10.1016/j.dnarep.2014.09.002; Yoshimura Daisuke, 2003, Journal of Biological Chemistry, V278, P37965, DOI 10.1074/jbc.M306201200	71	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0893-6692	1098-2280		ENVIRON MOL MUTAGEN	Environ. Mol. Mutagen.	OCT	2015	56	8					650	662		10.1002/em.21961		13	Environmental Sciences; Genetics & Heredity; Toxicology	Environmental Sciences & Ecology; Genetics & Heredity; Toxicology	CU0LV	WOS:000363209100002		
J	Massana, R; Gobet, A; Audic, S; Bass, D; Bittner, L; Boutte, C; Chambouvet, A; Christen, R; Claverie, JM; Decelle, J; Dolan, JR; Dunthorn, M; Edvardsen, B; Forn, I; Forster, D; Guillou, L; Jaillon, O; Kooistra, WHCF; Logares, R; Mahe, F; Not, F; Ogata, H; Pawlowski, J; Pernice, MC; Probert, I; Romac, S; Richards, T; Santini, S; Shalchian-Tabrizi, K; Siano, R; Simon, N; Stoeck, T; Vaulot, D; Zingone, A; de Vargas, C				Massana, Ramon; Gobet, Angelique; Audic, Stephane; Bass, David; Bittner, Lucie; Boutte, Christophe; Chambouvet, Aurelie; Christen, Richard; Claverie, Jean-Michel; Decelle, Johan; Dolan, John R.; Dunthorn, Micah; Edvardsen, Bente; Forn, Irene; Forster, Dominik; Guillou, Laure; Jaillon, Olivier; Kooistra, Wiebe H. C. F.; Logares, Ramiro; Mahe, Frederic; Not, Fabrice; Ogata, Hiroyuki; Pawlowski, Jan; Pernice, Massimo C.; Probert, Ian; Romac, Sarah; Richards, Thomas; Santini, Sebastien; Shalchian-Tabrizi, Kamran; Siano, Raffaele; Simon, Nathalie; Stoeck, Thorsten; Vaulot, Daniel; Zingone, Adriana; de Vargas, Colomban			Marine protist diversity in European coastal waters and sediments as revealed by high-throughput sequencing	ENVIRONMENTAL MICROBIOLOGY			English	Article							RIBOSOMAL-RNA GENE; DEEP-SEA; EUKARYOTIC PICOPLANKTON; MICROBIAL EUKARYOTES; COMMUNITIES; PICOEUKARYOTES; PATTERNS; OCEANS; DNA; PHYTOPLANKTON	Although protists are critical components of marine ecosystems, they are still poorly characterized. Here we analysed the taxonomic diversity of planktonic and benthic protist communities collected in six distant European coastal sites. Environmental deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) from three size fractions (pico-, nano- and micro/mesoplankton), as well as from dissolved DNA and surface sediments were used as templates for tag pyrosequencing of the V4 region of the 18S ribosomal DNA. Beta-diversity analyses split the protist community structure into three main clusters: picoplankton-nanoplankton-dissolved DNA, micro/mesoplankton and sediments. Within each cluster, protist communities from the same site and time clustered together, while communities from the same site but different seasons were unrelated. Both DNA and RNA-based surveys provided similar relative abundances for most class-level taxonomic groups. Yet, particular groups were overrepresented in one of the two templates, such as marine alveolates (MALV)-I and MALV-II that were much more abundant in DNA surveys. Overall, the groups displaying the highest relative contribution were Dinophyceae, Diatomea, Ciliophora and Acantharia. Also, well represented were Mamiellophyceae, Cryptomonadales, marine alveolates and marine stramenopiles in the picoplankton, and Monadofilosa and basal Fungi in sediments. Our extensive and systematic sequencing of geographically separated sites provides the most comprehensive molecular description of coastal marine protist diversity to date.	[Massana, Ramon; Forn, Irene; Logares, Ramiro; Pernice, Massimo C.] CSIC, Inst Ciencias Mar, ES-08003 Barcelona, Catalonia, Spain; [Gobet, Angelique; Audic, Stephane; Bittner, Lucie; Boutte, Christophe; Decelle, Johan; Guillou, Laure; Not, Fabrice; Probert, Ian; Romac, Sarah; Simon, Nathalie; Vaulot, Daniel; de Vargas, Colomban] CNRS, Ecol Systemat Evolut, FR-29682 Roscoff, France; [Gobet, Angelique; Audic, Stephane; Bittner, Lucie; Boutte, Christophe; Decelle, Johan; Guillou, Laure; Not, Fabrice; Probert, Ian; Romac, Sarah; Simon, Nathalie; Vaulot, Daniel; de Vargas, Colomban] Univ Paris 06, Equipe EPPO Evolut Plancton & PaleoOceans, UMR7144, Roscoff, France; [Bass, David] Nat Hist Museum, London SW7 5BD, England; [Bass, David] Cefas, Weymouth DT4 8UB, Dorset, England; [Bittner, Lucie; Dunthorn, Micah; Forster, Dominik; Mahe, Frederic; Stoeck, Thorsten] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Chambouvet, Aurelie; Richards, Thomas] Univ Exeter, Biosci, Exeter EX4 4QD, Devon, England; [Christen, Richard] Univ Nice Sophia Antipolis, CNRS, UMR 7138, FR-06108 Nice, France; [Claverie, Jean-Michel; Santini, Sebastien] Aix Marseille Univ, CNRS, UMR 7256, FR-13288 Marseille, France; [Dolan, John R.] Univ Paris 06, CNRS, Lab Oceanog Villefranche, UMR 7093, FR-06230 Villefranche Sur Mer, France; [Edvardsen, Bente; Shalchian-Tabrizi, Kamran] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway; [Jaillon, Olivier] CEA, Genoscope, FR-91000 Evry, France; [Kooistra, Wiebe H. C. F.; Zingone, Adriana] Stn Zool Anton Dohrn, I-80121 Naples, Italy; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Pawlowski, Jan] Univ Geneva, CH-1211 Geneva, Switzerland; [Siano, Raffaele] IFREMER, DYNECO Pelagos, Plouzane, France	Massana, R (reprint author), CSIC, Inst Ciencias Mar, ES-08003 Barcelona, Catalonia, Spain.	ramonm@icm.csic.es		Audic, Stephane/0000-0001-6193-4374; Kooistra, Wiebe/0000-0002-8641-9739	European project BioMarKs (ERA-net Biodiversa, EU) [2008-6530]; MICINN, Spain [CGL2010-16304]; OCEANOMICS (France) [ANR-11-BTBR-0008]; Swiss National Foundation [31003A-125372]; RCN (Norway) [190307]	Financial support has been provided by the European project BioMarKs (2008-6530, ERA-net Biodiversa, EU), and state-based projects FLAME (CGL2010-16304, MICINN, Spain) to RM, OCEANOMICS (ANR-11-BTBR-0008, France) to CdV, grant 31003A-125372 (Swiss National Foundation) to JP, and RCN grant 190307 (Norway) to BE.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Logares R, 2012, ISME J, V6, P1823, DOI 10.1038/ismej.2012.36; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Satta CT, 2010, DEEP-SEA RES PT II, V57, P256, DOI 10.1016/j.dsr2.2009.09.013; KARL DM, 1989, LIMNOL OCEANOGR, V34, P543; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Bates ST, 2013, ISME J, V7, P652, DOI 10.1038/ismej.2012.147; Sorensen N, 2013, MICROB ECOL, V65, P964, DOI 10.1007/s00248-012-0174-z; Dolan JR, 2013, ISME J, V7, P1237, DOI 10.1038/ismej.2013.23; Nanjappa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103810; Graham JM, 2004, MICROBIAL ECOL, V48, P528, DOI 10.1007/s00248-004-0223-3; Berney C, 2013, ISME J, V7, P2387, DOI 10.1038/ismej.2013.116; Egge ES, 2015, MOL ECOL, V24, P3026, DOI 10.1111/mec.13160; Kimoto K, 2011, ENV MICROBIOL REP, V3, P86, DOI 10.1111/j.1758-2229.2010.00191.x; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; POULSEN LK, 1993, APPL ENVIRON MICROB, V59, P1354; Lee WJ, 1998, PROTIST, V149, P229; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; Diez B, 2001, APPL ENVIRON MICROB, V67, P2932, DOI 10.1128/AEM.67.7.2932-2941.2001; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Olguin HF, 2006, J PLANKTON RES, V28, P1107, DOI 10.1093/plankt/fbl045; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Pizay MD, 2009, PROTIST, V160, P565, DOI 10.1016/j.protis.2009.04.003; Lejzerowicz F, 2013, DEEP-SEA RES PT II, V86-87, P214, DOI 10.1016/j.dsr2.2012.08.008; He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6; Sherr BF, 2007, OCEANOGRAPHY, V20, P130; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Weinbauer MG, 2002, APPL ENVIRON MICROB, V68, P1082, DOI 10.1128/AEM.68.3.1082-1087.2002; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Decelle J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104297; desVargas C, 2015, SCIENCE, V348; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Guillou L, 2008, ENVIRON MICROBIOL, V10, P397; Massana R, 2014, ISME J, V8, P854, DOI 10.1038/ismej.2013.204; Not F, 2007, SCIENCE, V315, P252; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Oksanen J, 2008, VEGAN COMMUNITY ECOL; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pernice MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057170; Schaechter M, 2012, EUKARYOTIC MICROBES; Seenivasan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059565; Siano R., 2010, BIOGEOSCI DISCUSS, V7, P7391; Weber AAT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056739; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	65	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-2912	1462-2920		ENVIRON MICROBIOL	Environ. Microbiol.	OCT	2015	17	10			SI		4035	4049		10.1111/1462-2920.12955		15	Microbiology	Microbiology	CU3TO	WOS:000363448500045		
J	Yanagisawa, K; Nakanishi, T; Kitagawa, Y; Seki, T; Akama, T; Kobayashi, M; Taketsugu, T; Ito, H; Fushimi, K; Hasegawa, Y				Yanagisawa, Kei; Nakanishi, Takayuki; Kitagawa, Yuichi; Seki, Tomohiro; Akama, Tomoko; Kobayashi, Masato; Taketsugu, Tetsuya; Ito, Hajime; Fushimi, Koji; Hasegawa, Yasuchika			Seven-Coordinate Luminophores: Brilliant Luminescence of Lanthanide Complexes with C-3v Geometrical Structures	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Lanthanides; Luminescence; O ligands; Structure elucidation; Density functional calculations	ENERGY-TRANSFER; EU(III) COMPLEX; EUROPIUM COMPLEXES; BETA-DIKETONATE; TO-METAL; EU-III; LIGAND; SENSITIZATION; EMISSION; EXCITATION	Enhanced luminescence properties of mononuclear lanthanide complexes with asymmetric seven-coordination structures are reported for the first time. The lanthanide complexes are composed of a lanthanide ion (Eu-III or Tb-III), three tetramethyl heptanedionato ligands, and one triphenylphosphine oxide ligand. The coordination geometries of the lanthanide complexes have been evaluated by using single-crystal X-ray analyses and shape-measurement calculations. The complexes are categorized to be seven-coordinate monocapped octahedral structures (point group C-3v). The seven-coordinate lanthanide complexes show high intrinsic emission quantum yields, extra-large radiative rate constants, and unexpected small nonradiative rate constants. The brilliant luminescence properties have been elucidated in terms of the asymmetric coordination geometry and small vibrational quanta related to thermal relaxation.	[Yanagisawa, Kei] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Nakanishi, Takayuki; Kitagawa, Yuichi; Seki, Tomohiro; Ito, Hajime; Fushimi, Koji; Hasegawa, Yasuchika] Hokkaido Univ, Fac Engn, Sapporo, Hokkaido 0608628, Japan; [Akama, Tomoko; Kobayashi, Masato; Taketsugu, Tetsuya] Hokkaido Univ, Fac Sci, Sapporo, Hokkaido 0600810, Japan	Hasegawa, Y (reprint author), Hokkaido Univ, Fac Engn, Kita 13 Jo,Nishi 8 Chome, Sapporo, Hokkaido 0608628, Japan.	hasegaway@eng.hokudai.ac.jp	Kobayashi, Masato/A-9230-2008	Kobayashi, Masato/0000-0002-4001-3581	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [2401]; Ministry of Education, Culture, Sports Science and Technology through a Program for Leading Graduate Schools (Hokkaido University "Ambitious Leader's Program")	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area of "New Polymeric Materials Based on Element-Blocks" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (grant number 2401). K. Y. was supported by the Ministry of Education, Culture, Sports Science and Technology through a Program for Leading Graduate Schools (Hokkaido University "Ambitious Leader's Program").	DOLG M, 1993, J PHYS CHEM-US, V97, P5852, DOI 10.1021/j100124a012; Hasegawa Y, 2003, J PHYS CHEM A, V107, P1697, DOI 10.1021/jp022397u; Gao F, 2013, INORG CHEM, V52, P11164, DOI 10.1021/ic401421h; Goossens K, 2012, DALTON T, V41, P13271, DOI 10.1039/c2dt31870a; HAAS Y, 1974, J CHEM PHYS, V60, P258, DOI 10.1063/1.1680777; Lima NBD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02395; Divya V, 2011, DALTON T, V40, P3257, DOI 10.1039/c0dt01652g; Ke XS, 2014, CHEM-EUR J, V20, P4324, DOI 10.1002/chem.201303972; Kotova O, 2013, CHEM-EUR J, V19, P16181, DOI 10.1002/chem.201303660; PRODI L, 1991, INORG CHEM, V30, P3798, DOI 10.1021/ic00020a006; Freire RO, 2005, CHEM PHYS LETT, V405, P123, DOI 10.1016/j.cplett.2005.02.022; Ananias D, 2015, J AM CHEM SOC, V137, P3051, DOI 10.1021/ja512745y; Miyata K, 2011, CHEM-EUR J, V17, P521, DOI 10.1002/chem.201001993; Ahmed Z, 2013, J PHYS CHEM A, V117, P11183, DOI 10.1021/jp403668j; Zheng XL, 2007, ANGEW CHEM INT EDIT, V46, P7399, DOI 10.1002/anie.200702401; Eliseeva SV, 2008, J PHYS CHEM A, V112, P3614, DOI 10.1021/jp711305u; Biju S, 2014, INORG CHEM, V53, P8407, DOI 10.1021/ic500966z; Li CY, 2011, J AM CHEM SOC, V133, P11231, DOI 10.1021/ja202344c; Pavithran R, 2006, INORG CHEM, V45, P2184, DOI 10.1021/ic051781d; CARNALL WT, 1968, J CHEM PHYS, V49, P4450, DOI 10.1063/1.1669896; Miyata K, 2013, ANGEW CHEM INT EDIT, V52, P6413, DOI 10.1002/anie.201301448; Wong KMC, 2014, ADV MATER, V26, P5558, DOI 10.1002/adma.201306327; GORLLERWALRAND C, 1991, J CHEM PHYS, V95, P3099; Dogariu A, 1999, SYNTHETIC MET, V100, P95, DOI 10.1016/S0379-6779(98)00168-4; Stoll T, 2014, ANGEW CHEM INT EDIT, V53, P1654, DOI 10.1002/anie.201308132; SATO S, 1970, B CHEM SOC JPN, V43, P1955, DOI 10.1246/bcsj.43.1955; Jankolovits J, 2011, ANGEW CHEM INT EDIT, V50, P9660, DOI 10.1002/anie.201103851; Kang TS, 2003, ADV FUNCT MATER, V13, P205, DOI 10.1002/adfm.200390031; Trivedi ER, 2014, J AM CHEM SOC, V136, P1526, DOI 10.1021/ja4113337; Xu JD, 2000, INORG CHEM, V39, P4156, DOI 10.1021/ic000063i; Hasegawa Y, 1996, CHEM PHYS LETT, V248, P8, DOI 10.1016/0009-2614(95)01279-6; Liao ZY, 2015, CHEM COMMUN, V51, P2372, DOI 10.1039/c4cc09618e; Hasegawa Y, 1996, J PHYS CHEM-US, V100, P10201, DOI 10.1021/jp960290z; Kuriki K, 2002, CHEM REV, V102, P2347, DOI 10.1021/cr010309g; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Foucault-Collet A, 2014, ANGEW CHEM INT EDIT, V53, P2927, DOI 10.1002/anie.201311028; Dutra JDL, 2011, J PHOTOCH PHOTOBIO A, V217, P389, DOI 10.1016/j.jphotochem.2010.11.011; Gao F, 2013, INORG CHEM, V52, P6407, DOI 10.1021/ic400245n; Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h; Pacold JI, 2014, J AM CHEM SOC, V136, P4186, DOI 10.1021/ja407924m; Martins AF, 2014, CHEM-EUR J, V20, P14834, DOI 10.1002/chem.201403856; McGehee MD, 1999, ADV MATER, V11, P1349, DOI 10.1002/(SICI)1521-4095(199911)11:16<1349::AID-ADMA1349>3.0.CO;2-W; BAXTER I, 1995, INORG CHEM, V34, P1384, DOI 10.1021/ic00110a016; Martin-Ramos P, 2015, J ALLOY COMPD, V619, P553, DOI 10.1016/j.jallcom.2014.09.090; McMahon B, 2009, J AM CHEM SOC, V131, P17542, DOI 10.1021/ja908006r; Nakamura K, 2004, CHEM PHYS LETT, V398, P500, DOI 10.1016/j.cplett.2004.09.089; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bulter S. J., 2013, CHEM-EUR J, V19, P9511; de Battencourt-Dias A., 2012, J AM CHEM SOC, V134, P6987; Frisch M. J., 2009, GAUSSIAN 09; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Ito H., 2015, CHEM COMMUN, V21, P3882; Miranda YC, 2015, EUR J INORG CHEM, P3019, DOI 10.1002/ejic.201500263; Miyata K., 2009, EUR J INORG CHEM, V32, P4777; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Siesler H. W., 2008, NEAR INFRARED SPECTR, P16	56	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	OCT	2015		28					4769	4774		10.1002/ejic.201500820		6	Chemistry, Inorganic & Nuclear	Chemistry	CT5CD	WOS:000362824100019		
J	Abe, A; Abe, S; Oya, S; Matsui, T				Abe, A.; Abe, S.; Oya, S.; Matsui, T.			Usefulness of Preoperative Dual-Phase thallium-201 SPECT and Imaging Fusion with SPECT and MRI in Predicting Histopathology of Meningiomas and Hemangioblastomas	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Abe, A.; Oya, S.; Matsui, T.] Saitama Med Univ, Kawagoe, Saitama, Japan; [Abe, S.] Mitsui Mem Hosp, Tokyo 101, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P555	S605	S605				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203058		
J	Akamatsu, G; Ikari, Y; Ohnishi, A; Nishio, T; Nishida, H; Aita, K; Yamamoto, Y; Sasaki, M; Sasaki, M; Senda, M				Akamatsu, G.; Ikari, Y.; Ohnishi, A.; Nishio, T.; Nishida, H.; Aita, K.; Yamamoto, Y.; Sasaki, M.; Sasaki, M.; Senda, M.			Automated PET-only quantification of amyloid deposition with adaptive template and amyloid-specific region-of-interest	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Akamatsu, G.; Ikari, Y.; Ohnishi, A.; Nishio, T.; Nishida, H.; Aita, K.; Sasaki, M.; Senda, M.] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan; [Akamatsu, G.; Sasaki, M.] Kyushu Univ, Fukuoka 812, Japan; [Yamamoto, Y.] Kobe Univ, Kobe, Hyogo 657, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P486	S573	S573				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202654		
J	Alobthani, GS; Morita, T; Isohashi, K; Kato, H; Tatsumi, M; Shimosegawa, E; Hatazawa, J				Alobthani, G. S.; Morita, T.; Isohashi, K.; Kato, H.; Tatsumi, M.; Shimosegawa, E.; Hatazawa, J.			Prolonged effect of chemotherapy on FDG uptake of the noraml bone marrow in patients with malignant lymphoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Alobthani, G. S.; Morita, T.; Isohashi, K.; Kato, H.; Tatsumi, M.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Molcular Imaging Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P734	S692	S693				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203236		
J	Arakawa, Y; Shidahara, M; Nai, Y; Furumoto, S; Seki, C; Okamura, N; Tashiro, M; Tashiro, M; Kudo, Y; Yanai, K; Gonda, K; Watabe, H				Arakawa, Y.; Shidahara, M.; Nai, Y.; Furumoto, S.; Seki, C.; Okamura, N.; Tashiro, M.; Tashiro, M.; Kudo, Y.; Yanai, K.; Gonda, K.; Watabe, H.			Biomathematical modeling approach to predict clinical SUVR in amyloid PET imaging towards efficient radioligand discovery and development	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med			BRAIN		[Arakawa, Y.; Shidahara, M.; Okamura, N.; Kudo, Y.; Yanai, K.; Gonda, K.] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan; [Nai, Y.; Furumoto, S.; Tashiro, M.; Tashiro, M.; Watabe, H.] Tohoku Univ, CYRIC, Sendai, Miyagi 980, Japan; [Seki, C.] Natl Inst Radiol Sci, Chiba 260, Japan							[Anonymous], 2007, J MED CHEM, V50, P4606; [Anonymous], 2009, J NUCL MED, V50, P1715; [Anonymous], 2006, J PHARM EXP THER, V316, P1282	3	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP162	S70	S70				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201117		
J	Banno, Y; Onoguchi, M; Nakajima, K; Matsuo, S				Banno, Y.; Onoguchi, M.; Nakajima, K.; Matsuo, S.			Performance of image evaluation due to the difference in the acquisition time using multifocal collimator with 99mTc myocardial SPECT: Evidence from a phantom study	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Banno, Y.; Onoguchi, M.] Kanazawa Univ, Dept Quantum Med Technol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Nakajima, K.; Matsuo, S.] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP053	S835	S836				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203537		
J	Brendel, M; Jaworska, A; Probst, F; Overhoff, F; Carlsen, J; Lindner, S; Herms, J; Bartenstein, P; Okamura, N; Rominger, A				Brendel, M.; Jaworska, A.; Probst, F.; Overhoff, F.; Carlsen, J.; Lindner, S.; Herms, J.; Bartenstein, P.; Okamura, N.; Rominger, A.			PET Imaging of Tau Pathology in two Transgenic Mouse Models using [F-18]-THK-5117	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Brendel, M.; Probst, F.; Overhoff, F.; Carlsen, J.; Lindner, S.; Bartenstein, P.; Rominger, A.] Univ Munich, Munich, Germany; [Jaworska, A.; Herms, J.] DZNE, Munich, Germany; [Okamura, N.] Tohoku Univ, Sendai, Miyagi 980, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP051	S21	S21				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201025		
J	Endo, M; Asakura, K; Aramaki, T; Bekku, E; Sato, R; Yoza, K				Endo, M.; Asakura, K.; Aramaki, T.; Bekku, E.; Sato, R.; Yoza, K.			The evaluation of clinical usefulness of continuous bed motion scanning in positron emission tomography in diagnosis of patients with subsolid pulmonary nodule	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Endo, M.; Asakura, K.; Aramaki, T.; Bekku, E.; Sato, R.; Yoza, K.] Shizuoka Canc Ctr, Shizuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P636	S644	S645				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203139		
J	Fujiwara, K; Koyama, K; Suga, K; Takahashi, M; Kusano-Arai, O; Mitsui, K; Akiba, H; Iwanari, H; Tsumoto, K; Hamakubo, T; Momose, T				Fujiwara, K.; Koyama, K.; Suga, K.; Takahashi, M.; Kusano-Arai, O.; Mitsui, K.; Akiba, H.; Iwanari, H.; Tsumoto, K.; Hamakubo, T.; Momose, T.			Imaging of CDH17-positive gastric cancer xenografts with 64Cu-labeled anti-CDH17 IgG PET	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fujiwara, K.; Koyama, K.; Takahashi, M.; Momose, T.] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Suga, K.] SANKYO LABO SERV Co Ltd, Tokyo, Japan; [Kusano-Arai, O.; Mitsui, K.; Iwanari, H.; Hamakubo, T.] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Akiba, H.; Tsumoto, K.] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P166	S420	S420				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202341		
J	Fukuda, Y; Yamamoto, Y; Yamamoto, H; Ishikawa, R; Akamoto, S; Toyohara, J; Nishiyama, Y				Fukuda, Y.; Yamamoto, Y.; Yamamoto, H.; Ishikawa, R.; Akamoto, S.; Toyohara, J.; Nishiyama, Y.			Detection of gastrointestinal cancer using 4 '-[methyl-11C] thiothymidine PET/CT for proliferation imaging: comparison with 18F-FDG PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukuda, Y.; Yamamoto, Y.; Nishiyama, Y.] Kagawa Univ, Dept Radiol, Takamatsu, Kagawa 760, Japan; [Yamamoto, H.] Kagawa Univ, Dept Med Phys, Takamatsu, Kagawa 760, Japan; [Ishikawa, R.] Kagawa Univ, Dept Diag Pathol, Takamatsu, Kagawa 760, Japan; [Akamoto, S.] Kagawa Univ, Dept Gastroenterol Surg, Takamatsu, Kagawa 760, Japan; [Toyohara, J.] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P133	S404	S404				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202308		
J	Fukushima, K; Arias, P; Wakabayashi, H; Shinaji, T; Werner, R; Pelzer, H; Higuchi, T				Fukushima, K.; Arias, P.; Wakabayashi, H.; Shinaji, T.; Werner, R.; Pelzer, H.; Higuchi, T.			Myocardial Insulin Resistant under Hyperinsulinemic-Euglycemic Clamp in a Rat Model	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukushima, K.; Arias, P.; Wakabayashi, H.; Shinaji, T.; Werner, R.; Pelzer, H.; Higuchi, T.] Univ Wurzburg, D-97070 Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Shinaji, T.; Werner, R.; Higuchi, T.] Comprehens Heart Failure Cener, Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P334	S502	S502				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202507		
J	Fukushima, Y; Kumita, S; Hashimoto, H; Sugihara, Y				Fukushima, Y.; Kumita, S.; Hashimoto, H.; Sugihara, Y.			Prognostic impact of deep-inspiratory breath-hold pulmonary perfusion SPECT-CT in patients with pulmonary thromboembolism	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukushima, Y.; Kumita, S.; Hashimoto, H.; Sugihara, Y.] Nippon Med Coll Hosp, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P985	S808	S809				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203481		
J	Fukuzawa, S; Okino, S; Maekawa, J; Ichikawa, S; Kuroiwa, N; Yamanaka, K; Igarashi, T; Inagaki, M				Fukuzawa, S.; Okino, S.; Maekawa, J.; Ichikawa, S.; Kuroiwa, N.; Yamanaka, K.; Igarashi, T.; Inagaki, M.			Nuclear Cardiac Imaging Versus Fractional Flow Reserve in Diagonal Side Branch Ostial Stenosis After Left Anterior Descending Crossover Stenting	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Fukuzawa, S.; Okino, S.; Maekawa, J.; Ichikawa, S.; Kuroiwa, N.; Yamanaka, K.; Igarashi, T.; Inagaki, M.] Funabashi Municipal Med Ctr, Funabashi, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP170	S74	S74				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201125		
J	Hanaoka, K; Hosono, M; Otsuka, M; Asai, Y; Okumura, M; Ishii, K; Murakami, T				Hanaoka, K.; Hosono, M.; Otsuka, M.; Asai, Y.; Okumura, M.; Ishii, K.; Murakami, T.			Therapy planning and dose prescription in radioiodine-131 therapy for hyperthyroidism using radioiodine-123 SPECT/CT imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hanaoka, K.; Hosono, M.; Otsuka, M.; Asai, Y.; Okumura, M.; Ishii, K.; Murakami, T.] Kinki Univ, Sakai, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP074	S845	S846				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203558		
J	Hanaoka, K; Hosono, M; Inada, M; Sakaguchi, K; Shimomura, K; Tamura, M; Matsumoto, K; Monzen, H; Nishimura, Y				Hanaoka, K.; Hosono, M.; Inada, M.; Sakaguchi, K.; Shimomura, K.; Tamura, M.; Matsumoto, K.; Monzen, H.; Nishimura, Y.			Assessment of heart injury induced by radiation therapy for esophageal cancer using FDG-PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hanaoka, K.; Hosono, M.; Inada, M.; Sakaguchi, K.; Shimomura, K.; Tamura, M.; Matsumoto, K.; Monzen, H.; Nishimura, Y.] Kinki Univ, Sakai, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P142	S408	S408				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202317		
J	Hashimoto, H				Hashimoto, H.			Determining prognosis using lower limb perfusion SPECT-CT in patients with arteriosclerosis obliterans	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hashimoto, H.] Nippon Med Sch, Dept Radiol, Tokyo 113, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P979	S806	S806				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203476		
J	Hayakawa, N; Nakamoto, Y; Ishimori, T; Togashi, K				Hayakawa, N.; Nakamoto, Y.; Ishimori, T.; Togashi, K.			Is diffuse increased FDG uptake in renal parenchyma associated with impaired renal disfunction?	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hayakawa, N.; Nakamoto, Y.; Ishimori, T.; Togashi, K.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P980	S806	S807				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203477		
J	Hayasaka, K; Nihashi, T; Inoue, H; Saitoh, T; Shiraishi, Y; Yoshimori, K; Gotoh, H				Hayasaka, K.; Nihashi, T.; Inoue, H.; Saitoh, T.; Shiraishi, Y.; Yoshimori, K.; Gotoh, H.			Dual-phase F-18 FDG PET diagnosis of pulmonary adenocarcinoma smaller than 3 cm	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hayasaka, K.; Inoue, H.; Saitoh, T.; Shiraishi, Y.; Yoshimori, K.; Gotoh, H.] Fukujyuuji Hoaspital, Tokyo, Japan; [Nihashi, T.] Nagoya Grad Scholl Med, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P612	S633	S633				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203115		
J	Hosono, M; Takahara, N; Yakushiji, Y; Sakaguchi, K; Yamada, Y; Hosokawa, C; Ishii, K				Hosono, M.; Takahara, N.; Yakushiji, Y.; Sakaguchi, K.; Yamada, Y.; Hosokawa, C.; Ishii, K.			Occupational radiation exposure of nursing staff in PET facility in association with performance status of patients	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hosono, M.; Takahara, N.; Yakushiji, Y.; Sakaguchi, K.; Yamada, Y.; Hosokawa, C.; Ishii, K.] Kinki Univ, Fac Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP099	S856	S856				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203583		
J	Hosono, M; Tachibana, I; NIshimura, Y; Hanaoka, K; Kanamori, S; Nakamatsu, K; Ishikawa, K; Sakaguchi, K				Hosono, M.; Tachibana, I.; NIshimura, Y.; Hanaoka, K.; Kanamori, S.; Nakamatsu, K.; Ishikawa, K.; Sakaguchi, K.			Texture analysis for tumor hypoxia visualized by FMISO PET/CT during radiation therapy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Hosono, M.; Tachibana, I.; NIshimura, Y.; Hanaoka, K.; Kanamori, S.; Nakamatsu, K.; Ishikawa, K.; Sakaguchi, K.] Kinki Univ, Fac Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P775	S712	S712				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203277		
J	Imabayashi, E; Baba, H; Matsuda, H; Kuji, I				Imabayashi, E.; Baba, H.; Matsuda, H.; Kuji, I.			Pilot data on 11C-PiB PET in major depressive disorder	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Imabayashi, E.; Matsuda, H.] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Baba, H.] Juntendo Univ, Tokyo, Japan; [Kuji, I.] Saitama Med Univ, Saitama Int Ctr, Saitama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P445	S553	S554				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202614		
J	Inai, R; Takayoshi, S; Tanaka, T; Tsuboi, Y; Norikane, S; Kojima, K; Tada, A; Kunisada, T; Sato, S; Ozaki, T; Kanazawa, S				Inai, R.; Takayoshi, S.; Tanaka, T.; Tsuboi, Y.; Norikane, S.; Kojima, K.; Tada, A.; Kunisada, T.; Sato, S.; Ozaki, T.; Kanazawa, S.			Prominent thallium-201 uptake of giant cell tumor of bone : comparison with osteosarcoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Inai, R.; Tanaka, T.; Tsuboi, Y.; Norikane, S.; Kojima, K.; Tada, A.; Kunisada, T.; Sato, S.; Ozaki, T.; Kanazawa, S.] Okayama Univ Hosp, Okayama, Japan; [Takayoshi, S.] Tokushima Univ Hosp, Tokushima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P930	S783	S784				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203429		
J	Inaki, A; Nakajima, K; Watanabe, S; Kinuya, S				Inaki, A.; Nakajima, K.; Watanabe, S.; Kinuya, S.			Diagnostic accuracy of quantitative bone scintigraphy with artificial neural network in patients with breast cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Inaki, A.; Nakajima, K.; Watanabe, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P063	S371	S371				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202238		
J	Ishibashi, M; Tanabe, Y; Fujii, S; Ohta, Y; Ogawa, T				Ishibashi, M.; Tanabe, Y.; Fujii, S.; Ohta, Y.; Ogawa, T.			FDG-PET/CT in thymic epithelial tumors: correlation with the WHO classification and the tumor stage	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishibashi, M.; Tanabe, Y.; Fujii, S.; Ohta, Y.; Ogawa, T.] Tottori Univ, Fac Med, Dept Pathophysiol & Therapeut Sci, Div Radiol, Yonago, Tottori 683, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P634	S643	S644				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203137		
J	Ishiguchi, H; Ito, S; Sakurai, Y; Kawai, H; Kato, K; Naganawa, S; Hama, A; Muramatsu, H; Takahashi, Y; Kojima, S				Ishiguchi, H.; Ito, S.; Sakurai, Y.; Kawai, H.; Kato, K.; Naganawa, S.; Hama, A.; Muramatsu, H.; Takahashi, Y.; Kojima, S.			Comparison between FDG-PET and DWIBS in Diagnosing Neuroblastoma of Child	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishiguchi, H.; Ito, S.; Sakurai, Y.; Kawai, H.; Kato, K.; Naganawa, S.; Hama, A.; Muramatsu, H.; Takahashi, Y.; Kojima, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan			Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X				0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P139	S407	S407				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202314		
J	Ishii, K; Takahashi, R; Wakabyashi, Y; Hosokawa, C; Kaida, H; Murakami, T				Ishii, K.; Takahashi, R.; Wakabyashi, Y.; Hosokawa, C.; Kaida, H.; Murakami, T.			Introducing the Glucose Metabolism to Amyloid Deposition Ratio Image	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ishii, K.; Wakabyashi, Y.; Hosokawa, C.; Kaida, H.; Murakami, T.] Kinki Univ, Osakasayama, Japan; [Takahashi, R.] Hyogo Prefectural Rehabil Hosp Nishi Harima, Tatsuno, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P428	S546	S546				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202598		
J	Isohashi, K; Kato, H; Horitsugi, G; Naka, S; Mochida, I; Shimosegawa, E; Hatazawa, J				Isohashi, K.; Kato, H.; Horitsugi, G.; Naka, S.; Mochida, I.; Shimosegawa, E.; Hatazawa, J.			Dynamic whole body distribution of FBPA in humans studied with 3D PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Isohashi, K.; Kato, H.; Horitsugi, G.; Naka, S.; Mochida, I.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Shimosegawa, E.] Osaka Univ, Grad Sch Med, PET Mol Imaging Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P088	S382	S383				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202263		
J	Ito, S; Iwano, S; Kato, K; Naganawa, S				Ito, S.; Iwano, S.; Kato, K.; Naganawa, S.			Predictive factors for the outcome of I-131 1110MBq ablation therapy in the patients with differentiated thyroid cancer: urinary iodine, serum thyroglobulin, and uptake to thyroid bed	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ito, S.; Iwano, S.; Naganawa, S.] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4648601, Japan; [Kato, K.] Nagoya Univ, Grad Sch Med, Dept Radiol & Med Lab Sci, Nagoya, Aichi 4648601, Japan			Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X				0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P545	S600	S601				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203048		
J	Itoh, K; Kitsukawa, T; Takahashi, H; Myoujin, M; Oishi, T; Takenouchi, T; Watanabe, S; Kanegae, K; Hosokawa, M				Itoh, K.; Kitsukawa, T.; Takahashi, H.; Myoujin, M.; Oishi, T.; Takenouchi, T.; Watanabe, S.; Kanegae, K.; Hosokawa, M.			Tumor FDG-Metabolic Values to Predict Pathological Response After Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Itoh, K.; Watanabe, S.; Kanegae, K.] Keiyukai Sapporo Hosp, Radiol Imaging Ctr, Sapporo, Hokkaido, Japan; [Kitsukawa, T.; Hosokawa, M.] Keiyukai Sapporo Hosp, Dept Digest Surg, Sapporo, Hokkaido, Japan; [Takahashi, H.] Keiyukai Sapporo 2nd Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan; [Myoujin, M.] Keiyukai Sapporo Hosp, Deparrtment Radiotherapy, Sapporo, Hokkaido, Japan; [Oishi, T.; Takenouchi, T.] Keiyukai Sapporo Hosp, Dept Clin Pathol, Sapporo, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P773	S711	S712				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203275		
J	Jinguji, M; Nakajo, M; Nakajo, M; Nakabeppu, Y; Koriyama, C; Yoshiura, T				Jinguji, M.; Nakajo, M.; Nakajo, M.; Nakabeppu, Y.; Koriyama, C.; Yoshiura, T.			Thymic involution after radioiodine therapy for Graves' disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Jinguji, M.; Nakajo, M.; Nakajo, M.; Nakabeppu, Y.; Yoshiura, T.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 890, Japan; [Koriyama, C.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 890, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P807	S727	S728				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203309		
J	Kaida, H; Azuma, K; Kawahara, A; Hattori, S; Takamori, S; Sadashima, E; Fujimoto, K; Kage, M; Kurata, S; Hirose, Y; Ishii, K; Murakami, T; Ishibashi, M				Kaida, H.; Azuma, K.; Kawahara, A.; Hattori, S.; Takamori, S.; Sadashima, E.; Fujimoto, K.; Kage, M.; Kurata, S.; Hirose, Y.; Ishii, K.; Murakami, T.; Ishibashi, M.			The correlation between 18F-FDG uptake and Glut-1, Stat-1 and Stat-3 in non-small cell lung cancer patients.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kaida, H.; Ishii, K.; Murakami, T.] Kinki Univ, Fac Med, Osakasayama City, Japan; [Azuma, K.; Kawahara, A.; Hattori, S.; Takamori, S.; Sadashima, E.; Fujimoto, K.; Kage, M.; Kurata, S.; Hirose, Y.] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; [Ishibashi, M.] Fukuoka Tokushukai Hosp, Kasuga, Fukuoka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW040	S298	S298				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202098		
J	Kamiya, Y; Okumiya, S; Takaki, A; Yamashita, K; Ito, S				Kamiya, Y.; Okumiya, S.; Takaki, A.; Yamashita, K.; Ito, S.			Development of a new quantification method using the I-123 MIBG myocardial single photon emission tomography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kamiya, Y.; Okumiya, S.; Ito, S.] Kumamoto Univ, Kumamoto, Japan; [Kamiya, Y.] Chibana Clin, Okinawa, Japan; [Takaki, A.; Yamashita, K.] Fujifilm RI Pharma Co Ltd, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW041	S298	S299				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202099		
J	Kasai, T; Aiga, M; Iwasaki, Y; Oshima, K; Sasaki, Y; Fujita, Y; Tanaka, N; Yamashina, A				Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Sasaki, Y.; Fujita, Y.; Tanaka, N.; Yamashina, A.			Usefulness and safety of adenosine stress myocardial perfusion SPECT for patients with "inactive" bronchial asthma.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Sasaki, Y.; Fujita, Y.; Tanaka, N.] Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1608402, Japan; [Yamashina, A.] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P404	S534	S534				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202574		
J	Kasai, T; Aiga, M; Iwasaki, Y; Oshima, K; Fujita, Y; Sasaki, Y; Tanaka, N; Yamashina, A				Kasai, T.; Aiga, M.; Iwasaki, Y.; Oshima, K.; Fujita, Y.; Sasaki, Y.; Tanaka, N.; Yamashina, A.			Usefulness of simultaneous intermediate-level exercise for dobutamine stress myocardial perfusion imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kasai, T.; Aiga, M.; Oshima, K.; Fujita, Y.; Sasaki, Y.; Tanaka, N.] Tokyo Med Univ, Hachioji Med Ctr, Tokyo 1608402, Japan; [Iwasaki, Y.; Yamashina, A.] Tokyo Med Univ, Tokyo 1608402, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP187	S79	S79				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201134		
J	Kataoka, S; Momose, M; Fukushima, K; Serizawa, N; Suzuki, A; Kondo, C; Abe, K; Sakai, S; Hagiwara, N				Kataoka, S.; Momose, M.; Fukushima, K.; Serizawa, N.; Suzuki, A.; Kondo, C.; Abe, K.; Sakai, S.; Hagiwara, N.			Relationship between active inflammation and myocardial injury in patients with cardiac sarcoidosis as detected by non-invasive multi-modality imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kataoka, S.; Momose, M.; Fukushima, K.; Serizawa, N.; Suzuki, A.; Kondo, C.; Abe, K.; Sakai, S.; Hagiwara, N.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP437	S179	S179				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201315		
J	Kato, H; Shimosegawa, E; Fujino, K; Hatazawa, J				Kato, H.; Shimosegawa, E.; Fujino, K.; Hatazawa, J.			Attenuation correction by CTcan improve detectability of lesions by voxel based statistical analysis of brain SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Osaka, Japan; [Fujino, K.] Osaka Univ, Hosp Med, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P494	S576	S577				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202661		
J	Kato, K; Tsuchiya, S; Koshiba, Y; Odagawa, T; Abe, S; Kubota, T; Terasaki, H; Naganawa, S				Kato, K.; Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Abe, S.; Kubota, T.; Terasaki, H.; Naganawa, S.			Comparison of I-123-IMP SPECT, F-18-FDG PET, and F-18-FDOPA PET in Detection of Uveal Malignant Melanoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kato, K.; Tsuchiya, S.; Koshiba, Y.; Odagawa, T.; Terasaki, H.; Naganawa, S.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.] Nagoya Univ Hosp, Nagoya, Aichi, Japan; [Kubota, T.] Nagoya Med Ctr, Natl Hosp Org, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW088	S323	S323				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202146		
J	Kawabe, J; Higashiyama, S; Kotani, K; Yoshida, A; Shiomi, S				Kawabe, J.; Higashiyama, S.; Kotani, K.; Yoshida, A.; Shiomi, S.			Evaluation of ablation of thyroid remnants with 1850MBq iodine-131 in patients with thyroid cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawabe, J.; Higashiyama, S.; Kotani, K.; Yoshida, A.; Shiomi, S.] Osaka City Univ, Grad Sch Med, Osaka 558, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P813	S730	S731				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203315		
J	Kawamura, K; Shimoda, Y; Yui, J; Zhang, Y; Yamasaki, T; Wakizaka, H; Fujinaga, M; Kumata, K; Xie, L; Hatori, A; Ogawa, M; Kurihara, Y; Nengaki, N; Zhang, M				Kawamura, K.; Shimoda, Y.; Yui, J.; Zhang, Y.; Yamasaki, T.; Wakizaka, H.; Fujinaga, M.; Kumata, K.; Xie, L.; Hatori, A.; Ogawa, M.; Kurihara, Y.; Nengaki, N.; Zhang, M.			PET imaging of a feeding center using [11C]BU99008 with ultra-high specific activity	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawamura, K.; Shimoda, Y.; Yui, J.; Zhang, Y.; Yamasaki, T.; Wakizaka, H.; Fujinaga, M.; Kumata, K.; Xie, L.; Ogawa, M.; Kurihara, Y.; Nengaki, N.; Zhang, M.] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogawa, M.; Kurihara, Y.; Nengaki, N.] SHI Accelerator Serv, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW002	S278	S279				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202060		
J	Kawamura, K; Ogawa, M; Takei, M; Kumata, K; Furutsuka, K; Yamasaki, T; Yui, J; Xie, L; Hatori, A; Zhang, Y; Nengaki, N; Hirano, K; Zhang, MR				Kawamura, K.; Ogawa, M.; Takei, M.; Kumata, K.; Furutsuka, K.; Yamasaki, T.; Yui, J.; Xie, L.; Hatori, A.; Zhang, Y.; Nengaki, N.; Hirano, K.; Zhang, M. R.			Efficient synthesis of [18F]FEDAC, and evaluation of non-clinical safety and stability tests for clinical application.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kawamura, K.; Ogawa, M.; Takei, M.; Kumata, K.; Furutsuka, K.; Yamasaki, T.; Yui, J.; Xie, L.; Hatori, A.; Zhang, Y.; Nengaki, N.; Zhang, M. R.] Natl Inst Radiol Sci, Chiba 260, Japan; [Ogawa, M.; Furutsuka, K.; Nengaki, N.] SHI Accelerator Serv, Tokyo, Japan; [Hirano, K.] NMP Business Support Co, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW010	S282	S283				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202068		
J	Kinjo, T; Nakatani, K; Yoshino, K; Kitaguchi, K; Koyama, T				Kinjo, T.; Nakatani, K.; Yoshino, K.; Kitaguchi, K.; Koyama, T.			FDG-PET/CT in intravascular large B-cell lymphoma: evaluation of diffuse splenic and bone marrow uptake as predictive factors of hemophagocytic syndrome	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kinjo, T.; Nakatani, K.; Yoshino, K.; Kitaguchi, K.; Koyama, T.] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P723	S687	S687				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203225		
J	Kondo, C; Watanabe, E; Momose, M; Fukushima, K; Abe, K; Hagiwara, N; Sakai, S				Kondo, C.; Watanabe, E.; Momose, M.; Fukushima, K.; Abe, K.; Hagiwara, N.; Sakai, S.			In vivo validation of gated myocardial SPECT imaging for quantification of small hearts: comparison with cardiac MRI	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kondo, C.; Watanabe, E.; Momose, M.; Fukushima, K.; Abe, K.; Hagiwara, N.; Sakai, S.] Tokyo Womens Med Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP171	S74	S75				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201126		
J	Koshiba, Y; Abe, S; Tsuchiya, S; Fujita, N; Odagawa, T; Kato, K				Koshiba, Y.; Abe, S.; Tsuchiya, S.; Fujita, N.; Odagawa, T.; Kato, K.			Studies on measurement of thyroid uptake rate on I-131 scintigraphy images	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koshiba, Y.; Tsuchiya, S.; Odagawa, T.; Kato, K.] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Abe, S.; Fujita, N.] Nagoya Univ Hosp, Nagoya, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP008	S814	S814				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203492		
J	Koyama, K; Kubota, K; Mochiki, M; Ogura, T; Hoshizaki, H; Oshima, S; Higuchi, T; Tsushima, Y				Koyama, K.; Kubota, K.; Mochiki, M.; Ogura, T.; Hoshizaki, H.; Oshima, S.; Higuchi, T.; Tsushima, Y.			Quantification of left ventricular function using gated SPECT with two different automated software packages and cardiac MRI	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koyama, K.; Kubota, K.; Mochiki, M.; Ogura, T.; Hoshizaki, H.; Oshima, S.] Gunma Prefectural Cardiovasc Ctr, Maebashi, Gumma, Japan; [Higuchi, T.; Tsushima, Y.] Gunma Facul Med, Maebashi, Gumma, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P223	S447	S448				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202396		
J	Koyama, K; Mitsumoto, T; Inoue, K; Tsuda, K; Kotaka, K; Yoshikawa, K; Hatano, K; Fukushi, M				Koyama, K.; Mitsumoto, T.; Inoue, K.; Tsuda, K.; Kotaka, K.; Yoshikawa, K.; Hatano, K.; Fukushi, M.			development of metabolic tumor volume measurement based on suvpeak	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Koyama, K.; Mitsumoto, T.; Kotaka, K.; Yoshikawa, K.; Hatano, K.] Tokyo Bay Adv Imaging & Radiat Oncol Clinic MAKUH, Chiba, Japan; [Koyama, K.; Inoue, K.; Fukushi, M.] Tokyo Metropolitan Univ, Tokyo 158, Japan; [Tsuda, K.] Tsukuba Int Univ, Ibaraki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P074	S376	S376				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202249		
J	Kubota, K; Morooka, M; Okasaki, M; Kameyama, M; Miyata, Y; Minamimoto, R; Goda, Y; Yano, H				Kubota, K.; Morooka, M.; Okasaki, M.; Kameyama, M.; Miyata, Y.; Minamimoto, R.; Goda, Y.; Yano, H.			FDGPET/CT for Pseudomyxoma Peritonei (PMP) and other peritoneal malignancies: Diagnostic features and prognostic consideration	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kubota, K.; Morooka, M.; Okasaki, M.; Kameyama, M.; Miyata, Y.; Minamimoto, R.; Goda, Y.; Yano, H.] Natl Ctr Global Hlth & Med, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P791	S720	S721				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203293		
J	Kudo, T; Ideguchi, R; Uetani, M; Nanashima, A; Nagayasu, T				Kudo, T.; Ideguchi, R.; Uetani, M.; Nanashima, A.; Nagayasu, T.			Delayed FDG image obtained 90 min after injection gives incremental information which correlates histopathological data; Analysis with surgically resected pancreatic cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudo, T.; Ideguchi, R.; Uetani, M.; Nagayasu, T.] Nagasaki Univ, Nagasaki 852, Japan; [Nanashima, A.] Miyazaki Univ, Miyazaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P647	S650	S650				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203150		
J	Kudo, T; Ideguchi, R; Uetani, M; Koide, Y; Maemura, K				Kudo, T.; Ideguchi, R.; Uetani, M.; Koide, Y.; Maemura, K.			Interchangeability of cardiac volumetric and phase analysis parameters between two software (CardioRepo and Heart Function View)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudo, T.; Ideguchi, R.; Uetani, M.; Koide, Y.; Maemura, K.] Nagasaki Univ, Nagasaki 852, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P345	S506	S506				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202516		
J	Kudomi, N; NIshiyama, A; Maeda, Y; Hatakeyama, T; Yamamoto, Y; Nishiyama, Y				Kudomi, N.; NIshiyama, A.; Maeda, Y.; Hatakeyama, T.; Yamamoto, Y.; Nishiyama, Y.			Fully Parametric Imaging for Reversible Tracer of FLT within Reasonable Time	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Kudomi, N.; NIshiyama, A.; Maeda, Y.; Hatakeyama, T.; Yamamoto, Y.; Nishiyama, Y.] Kagawa Univ, Faclty Med, Takamatsu, Kagawa 760, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P487	S573	S574				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202655		
J	Makino, A; Miyazaki, A; Tomoike, A; Kimura, H; Hirata, M; Ohmomo, Y; Ono, M; Okazawa, H; Kiyono, Y; Saji, H				Makino, A.; Miyazaki, A.; Tomoike, A.; Kimura, H.; Hirata, M.; Ohmomo, Y.; Ono, M.; Okazawa, H.; Kiyono, Y.; Saji, H.			PET probe detecting acquired drug resistance against EGFR targeted molecular therapy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Makino, A.; Okazawa, H.; Kiyono, Y.] Univ Fukui, Eiheiji, Fukui, Japan; [Makino, A.; Miyazaki, A.; Tomoike, A.; Kimura, H.; Ono, M.; Saji, H.] Kyoto Univ, Kyoto, Japan; [Hirata, M.; Ohmomo, Y.] Osaka Univ Pharmaceut Sci, Takatsuki, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P147	S410	S411				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202322		
J	Mano, S; Tadokoro, M; Shirakawa, S; Ishiguro, M; Toyama, H				Mano, S.; Tadokoro, M.; Shirakawa, S.; Ishiguro, M.; Toyama, H.			Non-invasive quantification of the regional cerebral blood flow using I-123 IMP SPECT and phase contrast MRA; preliminary study of combination and revisit of the matured technologies.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mano, S.; Tadokoro, M.; Shirakawa, S.; Ishiguro, M.; Toyama, H.] Fujita Hlth Univ, Toyoake, Aichi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP022	S820	S821				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203506		
J	Matsuda, H; Imabayashi, E; Rokicki, J; Maikusa, N				Matsuda, H.; Imabayashi, E.; Rokicki, J.; Maikusa, N.			Graph-theoretical analysis for comparison of functional brain networks between very early Alzheimer's disease and healthy volunteers	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsuda, H.; Imabayashi, E.; Rokicki, J.; Maikusa, N.] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P443	S553	S553				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202613		
J	Matsumoto, K; Takahashi, Y; Takaki, A; Murase, K; Wada, Y; Watanabe, Y; Endo, K				Matsumoto, K.; Takahashi, Y.; Takaki, A.; Murase, K.; Wada, Y.; Watanabe, Y.; Endo, K.			Development of advanced data acquisition methods for quantitative single photon emission computed tomography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsumoto, K.; Endo, K.] Kyoto Coll Med Sci, Kyoto, Japan; [Matsumoto, K.; Takahashi, Y.; Murase, K.] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Matsumoto, K.; Wada, Y.; Watanabe, Y.] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo, Japan; [Takahashi, Y.] Gunma Prefectural Coll Hlth Sci, Maebashi, Gumma, Japan; [Takaki, A.] Fujifilm RI Pharma Co Ltd, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P038	S358	S359				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202213		
J	Matsunaga, K; Watabe, T; Nakae, A; Kang, H; Kanai, Y; Isohashi, K; Kato, H; Shimosegawa, E; Hatazawa, J				Matsunaga, K.; Watabe, T.; Nakae, A.; Kang, H.; Kanai, Y.; Isohashi, K.; Kato, H.; Shimosegawa, E.; Hatazawa, J.			Measurement of concentration-dependent effect of sevoflurane on myocardial oxygen consumption using 11C acetate PET in rats	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsunaga, K.; Watabe, T.; Isohashi, K.; Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Dept Nucl Med & Tracer Kinet, Suita, Osaka, Japan; [Nakae, A.; Kang, H.] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Suita, Osaka, Japan; [Kanai, Y.; Shimosegawa, E.] Osaka Univ, Grad Sch Med, Dept Mol Imaging Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P333	S502	S502				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202506		
J	Matsunari, I; Komatsu, J; Samuraki, M; Noguchi-Shinohara, M; Hamaguchi, T; Ono, K; Kuji, I; Yamada, M; Kinuya, S				Matsunari, I.; Komatsu, J.; Samuraki, M.; Noguchi-Shinohara, M.; Hamaguchi, T.; Ono, K.; Kuji, I.; Yamada, M.; Kinuya, S.			Agreement of brain amyloid PET interpretation between automated diagnosis using support vector machine and visual assessment by expert readers	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsunari, I.] Saitama Med Univ Hosp, Saitama, Japan; [Komatsu, J.; Samuraki, M.; Noguchi-Shinohara, M.; Hamaguchi, T.; Ono, K.; Yamada, M.; Kinuya, S.] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Kuji, I.] Saitama Med Univ, Int Med Ctr, Hidaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP562	S238	S238				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201423		
J	Matsuo, S; Nakajima, K; Kinuya, S; Takahara, K				Matsuo, S.; Nakajima, K.; Kinuya, S.; Takahara, K.			Cardiac involvement in systemic sclerosis patients can be detected by dual single-photon emission computed tomography of thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid scintigraphy	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Matsuo, S.; Nakajima, K.; Kinuya, S.; Takahara, K.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP435	S178	S178				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201313		
J	Maya, Y; Werner, RA; Jahns, V; Wakabayashi, H; Nakajo, M; Fukushima, K; Yanagisawa, T; Jahns, R; Higuchi, T				Maya, Y.; Werner, R. A.; Jahns, V.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Yanagisawa, T.; Jahns, R.; Higuchi, T.			Assessment of radiolabeled methionine for imaging myocardial inflammation in a rat model of autoimmune myocarditis: Comparison with18F-FDG and histological findings	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Maya, Y.; Werner, R. A.; Wakabayashi, H.; Nakajo, M.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Maya, Y.] Nihon Medi Phys Co Ltd, Res Ctr, Chiba, Japan; [Werner, R. A.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Jahns, V.] Univ Klinikum Wurzburg, Dept Pharmacol, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Yanagisawa, T.] Kitazato Univ, Sch Med, Dept Cardioangiol, Sagamihara, Kanagawa, Japan; [Jahns, R.] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP432	S176	S177				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201310		
J	Maya, Y; Werner, R; Wakabayashi, H; Nakajo, M; Fukushima, K; Lapa, C; Herrmann, K; Higuchi, T				Maya, Y.; Werner, R.; Wakabayashi, H.; Nakajo, M.; Fukushima, K.; Lapa, C.; Herrmann, K.; Higuchi, T.			Assessment of cardiac sympathetic nerve system in the rat heart using 11C-HED	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Maya, Y.; Werner, R.; Wakabayashi, H.; Nakajo, M.; Lapa, C.; Herrmann, K.; Higuchi, T.] Univ Klinikum Wurzburg, Dept Nucl Med, Wurzburg, Germany; [Maya, Y.] Nihon Med Phys Co Ltd, Res Ctr, Chiba, Japan; [Werner, R.; Higuchi, T.] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Fukushima, K.] Hyogo Coll Med, Nishinomiya, Hyogo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP542	S227	S228				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201403		
J	Miyauchi, H; Iimori, T; Sawada, K; Kuwabara, Y; Sakao, S; Tatsumi, K; Kobayashi, Y				Miyauchi, H.; Iimori, T.; Sawada, K.; Kuwabara, Y.; Sakao, S.; Tatsumi, K.; Kobayashi, Y.			Assessment of Right Ventricular Myocardial Perfusion and Fatty Acid Metabolism Using Planar Imaging in Patients with Chronic Thromboembolic Pulmonary Hypertension	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Miyauchi, H.; Kuwabara, Y.; Sakao, S.; Tatsumi, K.; Kobayashi, Y.] Chiba Univ, Grad Sch Med, Chiba, Japan; [Iimori, T.; Sawada, K.] Chiba Univ Hosp, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		PW016	S285	S286				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202074		
J	Mizutani, A; Matsunari, I; Kobayashi, M; Nishi, K; Fujita, W; Nekolla, SG; Kawai, K; Fukuchi, K				Mizutani, A.; Matsunari, I.; Kobayashi, M.; Nishi, K.; Fujita, W.; Nekolla, S. G.; Kawai, K.; Fukuchi, K.			Phase analysis using ECG-gated myocardial FDG PET in the rat in comparison with speckle tracking echocardiography	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mizutani, A.; Fukuchi, K.] Osaka Univ, Osaka, Japan; [Matsunari, I.] Saitama Med Univ Hosp, Saitama, Japan; [Kobayashi, M.] Kanazawa Univ, Kanazawa, Ishikawa, Japan; [Nishi, K.] Nagasaki Univ, Nagasaki 852, Japan; [Fujita, W.] Kanazawa Med Univ, Kanazawa, Ishikawa, Japan; [Nekolla, S. G.] Tech Univ Munich, Munich, Japan; [Kawai, K.] Kanazawa Univ, Osaka Univ, Kanazawa, Ishikawa, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP224	S91	S92				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201156		
J	Mochida, I; Matsunaga, K; Watanabe, S; Isohashi, K; Watabe, T; Tatsumi, M; Kato, H; Shimosegawa, E; Hatazawa, J				Mochida, I.; Matsunaga, K.; Watanabe, S.; Isohashi, K.; Watabe, T.; Tatsumi, M.; Kato, H.; Shimosegawa, E.; Hatazawa, J.			Initial experience of the dopamine transporter SPECT in three pediatric patients with rare neurodegenerative disorder	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Mochida, I.; Matsunaga, K.; Watanabe, S.; Isohashi, K.; Watabe, T.; Tatsumi, M.; Kato, H.; Shimosegawa, E.; Hatazawa, J.] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P460	S559	S560				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202628		
J	Momose, M				Momose, M.			The comparison of I-123-ioflupane dopamine transporter imaging with I-123-MIBG cardiac imaging in Parkinson's disease and Lewy body disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Momose, M.] Matsumoto Med Ctr, Matsumoto, Nagano, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P457	S558	S559				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202625		
J	Momose, M; Fukushima, K; Kondo, C; Serizawa, N; Suzuki, A; Abe, K; Hagiwara, N; Sakai, S				Momose, M.; Fukushima, K.; Kondo, C.; Serizawa, N.; Suzuki, A.; Abe, K.; Hagiwara, N.; Sakai, S.			Large myocardial injury attenuates a response to steroid therapy in patients with cardiac sarcoidosis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Momose, M.; Fukushima, K.; Kondo, C.; Abe, K.; Sakai, S.] Tokyo Womens Med Univ, Dept Diagnost Imaging & Nuclaer Med, Tokyo, Japan; [Serizawa, N.; Suzuki, A.; Hagiwara, N.] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P349	S508	S508				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202520		
J	Morita, N; Shimizu, A; Terakawa, Y; Kajimoto, K; Uehara, T; Maruyama, D; Nakagawara, J; Iida, H				Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.			Comparison with cerebral blood volume on 15Ogas-PET/CT in patients with chronic cerebrovascular disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P488	S574	S574				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202656		
J	Morita, N; Shimizu, A; Terakawa, Y; Kajimoto, K; Uehara, T; Maruyama, D; Nakagawara, J; Iida, H				Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.			Evaluation of increasing cerebral blood volume on 15Ogas-PET/CT in patients with severe ischemic cerebrovascular disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Morita, N.; Shimizu, A.; Terakawa, Y.; Kajimoto, K.; Uehara, T.; Maruyama, D.; Nakagawara, J.; Iida, H.] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P489	S574	S575				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202657		
J	Munechika, H; Saginoya, T; Miura, Y; Takekawa, S; Seto, K; Watanabe, K				Munechika, H.; Saginoya, T.; Miura, Y.; Takekawa, S.; Seto, K.; Watanabe, K.			FDG PET/CT and MRI in oral cavity carcinomas: anatomical considerations	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Munechika, H.; Saginoya, T.; Miura, Y.; Takekawa, S.; Seto, K.; Watanabe, K.] Southern Tohoku Gen Hosp, Koriyama, Fukushima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P556	S605	S606				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203059		
J	Murakami, K; Nakahara, T; Ogata, Y; Iwabuchi, Y; Katagiri, M; Matsusaka, Y				Murakami, K.; Nakahara, T.; Ogata, Y.; Iwabuchi, Y.; Katagiri, M.; Matsusaka, Y.			Evaluation of image quality on PET/CTwith Flow motion technology -Does it keep quantitative performance and uniformity ? -	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Murakami, K.; Nakahara, T.; Ogata, Y.; Iwabuchi, Y.; Katagiri, M.; Matsusaka, Y.] Keio Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P58	S368	S368				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202233		
J	Nagamachi, S; Onizuka, H; Nishii, R; Mizutani, Y; Hirai, T; Kitamura, K				Nagamachi, S.; Onizuka, H.; Nishii, R.; Mizutani, Y.; Hirai, T.; Kitamura, K.			Comparison of Phase analysis among three kinds of soft-ware (QGS, ETB and Heart function view) in diagnosing ischemic heart disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nagamachi, S.; Nishii, R.; Mizutani, Y.; Hirai, T.] Miyazaki Univ, Dept Radiol, Miyazaki, Japan; [Onizuka, H.] Miyazaki Univ, Dept Internal Med 1, Miyazaki, Japan; [Kitamura, K.] Miyazaki Univ, Dept Intenal Med 1, Miyazaki, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P396	S531	S531				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202566		
J	Nagamachi, S; Nishii, R; Mizutani, Y; Umemura, Y; Ohkubo, R; Takashima, H; Hirai, T				Nagamachi, S.; Nishii, R.; Mizutani, Y.; Umemura, Y.; Ohkubo, R.; Takashima, H.; Hirai, T.			The effectiveness of dopamine transporter volume estimated by C-11 PE-2I PET in diagnosing Parkinsonism-Novel parameter for quantifying the total amount of dopamine transporter	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nagamachi, S.; Nishii, R.; Mizutani, Y.; Hirai, T.] Miyazaki Univ, Miyazaki, Japan; [Umemura, Y.; Ohkubo, R.] Fujimoto Hayasuzu Hosp, Miyakonojou, Japan; [Takashima, H.] Kagoshima Univ, Kagoshima 890, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP089	S852	S852				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203573		
J	Nakagami, Y; Kano, D; Kusumoto, M				Nakagami, Y.; Kano, D.; Kusumoto, M.			Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakagami, Y.; Kano, D.; Kusumoto, M.] Natl Canc Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P747	S698	S699				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203249		
J	Nakagawa, K; Onodera, S; Uchida, T; Ozaki, Y; Henmi, H; Uchino, Y				Nakagawa, K.; Onodera, S.; Uchida, T.; Ozaki, Y.; Henmi, H.; Uchino, Y.			Value of ECG-gated study during dipyridamole stress in myocardial perfusion PET	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakagawa, K.] Tokyo Seaside Clin, Tokyo, Japan; [Onodera, S.; Uchida, T.; Ozaki, Y.; Henmi, H.; Uchino, Y.] Chiba Ryougo Ctr, Chiba, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P356	S511	S511				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202526		
J	Nakajima, K; Okuda, K; Matsuo, S; Nakata, T; Kinuya, S				Nakajima, K.; Okuda, K.; Matsuo, S.; Nakata, T.; Kinuya, S.			Effect of standardization of I-123 MIBG heart-to-mediastinum ratio on the prognostic threshold: application to multicenter database of chronic heart failure	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajima, K.; Matsuo, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Okuda, K.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan; [Nakata, T.] Hakodate Gryoukaku Hosp, Hakodate, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP065	S28	S28				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201039		
J	Nakajima, K; Matsuo, S; Okuda, K; Yokoyama, K; Bunko, H; Kinuya, S; Edenbrandt, L				Nakajima, K.; Matsuo, S.; Okuda, K.; Yokoyama, K.; Bunko, H.; Kinuya, S.; Edenbrandt, L.			Detection of myocardial ischemia using artificial neural network: different characteristics from conventional defect scoring methods	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajima, K.; Matsuo, S.; Kinuya, S.] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Okuda, K.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan; [Yokoyama, K.] Matto Ishikawa Cent Hosp, Haku San, Japan; [Bunko, H.] Kanazawa Cardiovasc Hosp, Kanazawa, Ishikawa, Japan; [Edenbrandt, L.] Univ Gothenburg, Gothenburg, Sweden								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP169	S73	S74				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201124		
J	Nakajo, M; Kajiya, Y; Tani, A; Jinguji, M; Nakabeppu, Y; Nakajo, M; Shimaoka, S; Nihara, T; Tanaka, S; Yoshiura, T				Nakajo, M.; Kajiya, Y.; Tani, A.; Jinguji, M.; Nakabeppu, Y.; Nakajo, M.; Shimaoka, S.; Nihara, T.; Tanaka, S.; Yoshiura, T.			Diagnostic performance of 18F-fluorothymidine PET/CT for primary gastric cancer and its lymph node metastasis: Comparison with 18F-fluorodeoxyglucose PET/CT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakajo, M.; Jinguji, M.; Nakabeppu, Y.; Yoshiura, T.] Kagoshima Univ, Dept Radiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Kajiya, Y.; Tani, A.; Nakajo, M.] Nanpuh Hosp, Dept Radiol, Kagoshima, Japan; [Shimaoka, S.; Nihara, T.] Nanpuh Hosp, Dept Gastroentenol, Kagoshima, Japan; [Tanaka, S.] Nanpuh Hosp, Dept Pathol, Kagoshima, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP057	S24	S24				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201031		
J	Nakamoto, Y; Sano, K; Ishimori, T; Togashi, K				Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.			Clinical efficacy of PET/CT using 68Ga-DOTATOC for restaging in renal cell carcinoma	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakamoto, Y.; Sano, K.; Ishimori, T.; Togashi, K.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P693	S672	S673				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203196		
J	Nakayama, M; Okizaki, A; Ishitoya, S; Uno, T; Suzuki, T; Mikami, Y; Sato, J; Takahashi, K				Nakayama, M.; Okizaki, A.; Ishitoya, S.; Uno, T.; Suzuki, T.; Mikami, Y.; Sato, J.; Takahashi, K.			Effectiveness of aromatherapy on Physiology and Psychology in patients undergoing I-131 ablation with differentiated thyroid cancer.-Using Physiological and Sensory evaluation-	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nakayama, M.; Okizaki, A.; Ishitoya, S.; Takahashi, K.] Asahikawa Med Univ, Asahikawa, Hokkaido, Japan; [Uno, T.; Suzuki, T.; Mikami, Y.; Sato, J.] Asahikawa Med Univ Hosp, Asahikawa, Hokkaido, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P530	S593	S594				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203033		
J	Nesterov, SV; Yoshinaga, K; Tomiyama, Y; Han, C; Sciagra, R; Berti, V; Knappen, P; Danad, I; Knuuti, JM				Nesterov, S. V.; Yoshinaga, K.; Tomiyama, Y.; Han, C.; Sciagra, R.; Berti, V.; Knappen, P.; Danad, I.; Knuuti, J. M.			AQUA-5: Four Software Tools for 15O-Water PET Myocardial Perfusion Quantification Exhibit Good Intraobserver Reproducibility	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nesterov, S. V.; Han, C.; Knuuti, J. M.] Turku PET Ctr, Turku, Finland; [Nesterov, S. V.] RAS, Inst Evolutionary Biochem & Physiol, St Petersburg, Russia; [Yoshinaga, K.; Tomiyama, Y.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Sciagra, R.; Berti, V.] Univ Florence, Nucl Med Unit, Florence, Italy; [Knappen, P.; Danad, I.] Vrije Univ Amsterdam, Dept Nucl Med, Amsterdam, Netherlands; [Knappen, P.; Danad, I.] Vrije Univ Amsterdam, Dept PET Res, Amsterdam, Netherlands								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP126	S55	S55				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013201088		
J	Niimi, T; Sugimoto, M; Nanasato, M; Maeda, H				Niimi, T.; Sugimoto, M.; Nanasato, M.; Maeda, H.			Evaluation of simultaneous Tc-99m and I-123 dual-isotope SPECT imaging using cardiac CZT camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Sugimoto, M.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P393	S529	S530				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202563		
J	Niimi, T; Nanasato, M; Maeda, H				Niimi, T.; Nanasato, M.; Maeda, H.			Contraction synchronicity and work measured in patients with coronary artery disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P405	S535	S535				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202575		
J	Niimi, T; Sugimoto, M; Nanasato, M; Maeda, H				Niimi, T.; Sugimoto, M.; Nanasato, M.; Maeda, H.			Evaluation of CZT-SPECT system for nuclear cardiology: comparison with conventional Anger SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Niimi, T.; Sugimoto, M.; Nanasato, M.] Nagoya Daini Red Cross Hosp, Nagoya, Aichi, Japan; [Maeda, H.] Nagoya Univ, Nagoya, Aichi 4648601, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP080	S848	S848				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203564		
J	Nogami, M; Iwasa, H; Miyatake, K; Kohsaki, S; Ohgi, K; Nishimori, M; Yamagami, T; Takenaka, D; Adachi, S				Nogami, M.; Iwasa, H.; Miyatake, K.; Kohsaki, S.; Ohgi, K.; Nishimori, M.; Yamagami, T.; Takenaka, D.; Adachi, S.			Diuretic FDG PET/CT and diffusion weighted MR imaging for urothelial carcinoma: capability for prediction of pathological characteristics and prognosis	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Nogami, M.; Takenaka, D.; Adachi, S.] Hyogo Canc Ctr, Akashi, Hyogo, Japan; [Iwasa, H.; Miyatake, K.; Kohsaki, S.; Ohgi, K.; Nishimori, M.; Yamagami, T.] Kochi Univ, Kochi Med Sch, Nankoku, Kochi, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P686	S668	S669				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203189		
J	Ogawa, K; Aitani, N; Hemuki, Y				Ogawa, K.; Aitani, N.; Hemuki, Y.			Quantitative Evaluation of Scattered Photons in a Myocardial Pinhole SPECT Imaging	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogawa, K.; Aitani, N.; Hemuki, Y.] Hosei Univ, Tokyo, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P066	S372	S372				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202241		
J	Ogushi, G; Kudo, S; Matsuda, R; Tomiguchi, S; Shiraishi, S; Yamashita, Y				Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.			Appropriate time interval of dynamic 201Tl SPECT-MPI data acquisition for quantitative myocardial blood flow analysis on cardiac dedicated ultrafast SPECT camera	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ogushi, G.; Kudo, S.; Matsuda, R.; Tomiguchi, S.; Shiraishi, S.; Yamashita, Y.] Kumamoto Univ, Kumamoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		TP096	S855	S855				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013203580		
J	Ohno, K; Higashi, T; Okuyama, C; Nakamoto, Y; Endo, K				Ohno, K.; Higashi, T.; Okuyama, C.; Nakamoto, Y.; Endo, K.			Promotion of measures to counter radiation health concerns using the comic (manga)	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Ohno, K.; Endo, K.] Kyoto Coll Med Sci, Nantan, Japan; [Higashi, T.] Shiga Med Ctr Res Inst, Moriyama, Japan; [Okuyama, C.] Image Communiat Corp, Kyoto, Japan; [Nakamoto, Y.] Kyoto Univ, Grad Sch Med, Kyoto, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		P027	S352	S353				2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202202		
J	Okazawa, H; Ikawa, M; Tsujikawa, T; Mori, T; Makino, A; Kiyono, Y; Yoneda, M				Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.; Yoneda, M.			Evaluation of nigrostriatal oxidative stress intensity in patients with Parkinson's disease using [Cu-62]ATSM PET and FP-CIT SPECT	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Meeting Abstract	28th Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)	OCT 10-14, 2015	Hamburg, GERMANY	European Assoc Nucl Med					[Okazawa, H.; Ikawa, M.; Tsujikawa, T.; Mori, T.; Makino, A.; Kiyono, Y.] Univ Fukui, Fukui 910, Japan; [Yoneda, M.] Fukui Prefectural Univ, Fukui, Japan								0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	OCT	2015	42			1		OP641	S273	S273				1	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CT7RW	WOS:000363013202051		
